Psyllid ID: psy14267
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 553 | 2.2.26 [Sep-21-2011] | |||||||
| Q8AYG3 | 982 | Dual specificity protein | yes | N/A | 0.549 | 0.309 | 0.394 | 1e-52 | |
| P54199 | 764 | Serine/threonine-protein | yes | N/A | 0.526 | 0.380 | 0.379 | 5e-52 | |
| O94235 | 678 | Serine/threonine-protein | yes | N/A | 0.613 | 0.5 | 0.357 | 1e-51 | |
| P35761 | 856 | Dual specificity protein | yes | N/A | 0.486 | 0.314 | 0.392 | 3e-48 | |
| Q4R945 | 856 | Dual specificity protein | N/A | N/A | 0.500 | 0.323 | 0.386 | 1e-47 | |
| P33981 | 857 | Dual specificity protein | yes | N/A | 0.500 | 0.323 | 0.386 | 8e-47 | |
| Q8SSH4 | 586 | Probable serine/threonine | yes | N/A | 0.488 | 0.460 | 0.381 | 1e-46 | |
| Q54UL8 | 983 | Probable serine/threonine | yes | N/A | 0.497 | 0.279 | 0.374 | 2e-46 | |
| O75116 | 1388 | Rho-associated protein ki | no | N/A | 0.412 | 0.164 | 0.296 | 2e-19 | |
| Q28021 | 1388 | Rho-associated protein ki | no | N/A | 0.412 | 0.164 | 0.296 | 2e-19 |
| >sp|Q8AYG3|TTK_DANRE Dual specificity protein kinase Ttk OS=Danio rerio GN=ttk PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 207 bits (528), Expect = 1e-52, Method: Compositional matrix adjust.
Identities = 137/347 (39%), Positives = 195/347 (56%), Gaps = 43/347 (12%)
Query: 204 TPVFK-RPLSVNSTKSSDPSVSKE---TIKPAKPQITTSNAKKSVET-----SQDVITLN 254
TPV K RP+ V S P+ +++ T P PQ S + +T S + IT+
Sbjct: 595 TPVVKQRPVIV-----SVPATAQKMCPTALPCTPQSGVSYIQPPTQTPSSAFSNESITIK 649
Query: 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAK 314
GKQ+ + ++G+GGSS VY V +H + A+K V+L + Q++ +SY NE+E L
Sbjct: 650 GKQFFIFKMIGRGGSSKVYQVFDHKKHVY---AVKYVNLEEADAQAV-ESYKNEIEHLNH 705
Query: 315 LQG-CPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYE 373
LQ +IK++DY + S ++Y+LME G DL+ ++RN + L +W
Sbjct: 706 LQQYSDQIIKLYDY--EITSSYIYMLMECGHLDLNTWLRNRKTVKPLDRKA-----YWRN 758
Query: 374 MLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHK 433
ML AV IH GI+HSDLKPANFL V LK+ID FGIA +Q D TS+ K
Sbjct: 759 MLEAVHTIHKHGIVHSDLKPANFLIVDGSLKLID----------FGIANQIQPDVTSIMK 808
Query: 434 DTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWA 493
D+ GTLNYM PEA TSS+G + +I+ K DVWSLGCILY M YG+TP+ +I N +
Sbjct: 809 DSQVGTLNYMPPEAIKDTSSNGKPGS-KISAKGDVWSLGCILYCMTYGKTPFQNITNQIS 867
Query: 494 KMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVG 540
K+ AI +I+F P + LL +K CL ++P+ R ++
Sbjct: 868 KIHAIIDPSHEIDF-PDIPEK-----DLLDVLKKCLVRNPRERISIA 908
|
Phosphorylates proteins on serine, threonine, and tyrosine (By similarity). Involved in mitotic cell cycle checkpoint control. Required for fin and heart regeneration. Required to prevent chromosome segregation errors during meiosis. Danio rerio (taxid: 7955) EC: 2EC: .EC: 7EC: .EC: 1EC: 2EC: .EC: 1 |
| >sp|P54199|MPS1_YEAST Serine/threonine-protein kinase MPS1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GN=MPS1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 206 bits (523), Expect = 5e-52, Method: Compositional matrix adjust.
Identities = 124/327 (37%), Positives = 183/327 (55%), Gaps = 36/327 (11%)
Query: 221 PSVSK--ETIKPAKPQITTSNAKKSVETSQDVITLNGKQYQVLSLLGKGGSSSVYLVGGT 278
P V+K E ++PAK S+ ++++IT+N QY+ + LLG+GGSS VY V G+
Sbjct: 409 PPVTKKVEIVEPAK--------SASLSNNRNIITVNDSQYEKIELLGRGGSSRVYKVKGS 460
Query: 279 SEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYV 338
+ ALK V D SI D + E+ELL KL+ VI++ DY + LY+
Sbjct: 461 GNRVY---ALKRVSFDAFDDSSI-DGFKGEIELLEKLKDQKRVIQLLDY--EMGDGLLYL 514
Query: 339 LMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLF 398
+ME GD DLS+ LN+ + +P + + EMLL +K +H AGI+HSDLKPANF+
Sbjct: 515 IMECGDHDLSQI---LNQRSGMPLDFNFVRFYTKEMLLCIKVVHDAGIVHSDLKPANFVL 571
Query: 399 VGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEA------AGQTS 452
V +LKIIDFGIA ++ + +++++T GT NYM+PEA +
Sbjct: 572 V----------KGILKIIDFGIANAVPEHTVNIYRETQIGTPNYMAPEALVAMNYTQNSE 621
Query: 453 SSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLA 512
+ GN +++ SD+WS GCI+Y MIYG+ PY ++LAI +I F +
Sbjct: 622 NQHEGNKWKVGRPSDMWSCGCIIYQMIYGKPPYGSFQGQ-NRLLAIMNPDVKIPFPEHTS 680
Query: 513 NNVTIPPTLLQSMKLCLQKDPKARPTV 539
NN IP + ++ MK CL ++P R TV
Sbjct: 681 NNEKIPKSAIELMKACLYRNPDKRWTV 707
|
Involved in the regulation of the onset of mitosis. Involved in a pathway that coordinates cell proliferation and differentiation. Implicated in spindle pole body (SPD) duplication. Dual specificity kinase that can phosphorylate serine, threonine and tyrosine residues. Phosphorylates the SPC29 and SPC110 spindle pole body components. Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (taxid: 559292) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 2 |
| >sp|O94235|MPH1_SCHPO Serine/threonine-protein kinase mph1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=mph1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 204 bits (519), Expect = 1e-51, Method: Compositional matrix adjust.
Identities = 136/380 (35%), Positives = 202/380 (53%), Gaps = 41/380 (10%)
Query: 179 PTQTKSVFSVRSASDQSLSQKKNESTPVFKRPLSV---NSTKSSDPSVSKETIKPAKPQI 235
P+Q +S FS R D + ++ +E + RP++V +S P S P
Sbjct: 237 PSQFESSFSPRVQFDHDVERRASE---LHSRPVTVFQEPQRSASQPYESHALSPKVAPLF 293
Query: 236 TTSNAKKSVETSQDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSD 295
S A + QDV+T+ Q+ L ++GKGGSS VY + ALK V+ +
Sbjct: 294 DNSQATPIPKRQQDVVTVANLQFIKLGVVGKGGSSMVYRIFSPDNSRL--YALKEVNFIN 351
Query: 296 ITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKY-MRNL 354
DQ+ Y NE+ LL KL G +IK++ + L ++ME G+TDL+ M+N+
Sbjct: 352 -ADQTTIQGYKNEIALLRKLSGNDRIIKLYAAEVNDTLGQLNMVMECGETDLANLLMKNM 410
Query: 355 NKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414
K P + I M+W +ML AV+ +H I+HSDLKPANFL V GN LK
Sbjct: 411 KK----PINLNFIRMYWEQMLEAVQVVHDQNIVHSDLKPANFLLVE---------GN-LK 456
Query: 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSS--SGGGNTYRITYKSDVWSLG 472
+IDFGIA ++ +D T++H+D+ GT+NYM+PEA ++ + G ++ SDVWSLG
Sbjct: 457 LIDFGIAKAIGNDTTNIHRDSHIGTINYMAPEALTDMNAHTNSGVKLVKLGRPSDVWSLG 516
Query: 473 CILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLA-------------NNVTIPP 519
CILY M+YGR P++H+ A + AI + I F P++A VT+ P
Sbjct: 517 CILYQMVYGRAPFAHLKMIQA-IAAIPNEQYHIHF-PEVALPANAVQEKEGSLPGVTVGP 574
Query: 520 TLLQSMKLCLQKDPKARPTV 539
L+ MK CL++D + R T+
Sbjct: 575 DLMDVMKRCLERDQRKRLTI 594
|
Involved in the regulation of the onset of mitosis. Involved in a pathway that coordinates cell proliferation and differentiation. Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 2 |
| >sp|P35761|TTK_MOUSE Dual specificity protein kinase TTK OS=Mus musculus GN=Ttk PE=1 SV=1 | Back alignment and function description |
|---|
Score = 193 bits (490), Expect = 3e-48, Method: Compositional matrix adjust.
Identities = 118/301 (39%), Positives = 175/301 (58%), Gaps = 32/301 (10%)
Query: 249 DVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPL-ALKVVDLSDITDQSIADSYLN 307
+ I++NG+ Y +L +G GGSS V+ V +E K + A+K V+L D Q+I +SY N
Sbjct: 515 ECISVNGRIYSILKQIGSGGSSKVFQVL----NEKKQINAIKYVNLEDADSQTI-ESYRN 569
Query: 308 EVELLAKLQG-CPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMII 366
E+ L KLQ +I+++DY + +++Y++ME G+ DL+ +++ +
Sbjct: 570 EIAFLNKLQQHSDKIIRLYDY--EITEQYIYMVMECGNIDLNSWLKKKKSINPWERKS-- 625
Query: 367 IIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQD 426
+W ML AV IH GI+HSDLKPANF+ V +LK+ID FGIA +Q
Sbjct: 626 ---YWKNMLEAVHIIHQHGIVHSDLKPANFVIVDGMLKLID----------FGIANQMQP 672
Query: 427 DKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYR--ITYKSDVWSLGCILYNMIYGRTP 484
D TS+ KD+ GT+NYM+PEA SSS + R ++ +SDVWSLGCILY M YGRTP
Sbjct: 673 DTTSIVKDSQVGTVNYMAPEAIRDMSSSRENSKIRTKVSPRSDVWSLGCILYYMTYGRTP 732
Query: 485 YSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVT 544
+ HI N +K+ AI +IEF P+++ L +K CL ++PK R ++ +T
Sbjct: 733 FQHIINQVSKLHAIINPAHEIEF-PEISEK-----DLRDVLKCCLVRNPKERISIPELLT 786
Query: 545 Q 545
Sbjct: 787 H 787
|
Essential for chromosome alignment by enhancing AURKB activity (via direct CDCA8 phosphorylation) at the centromere, and for the mitotic checkpoint (By similarity). Phosphorylates proteins on serine, threonine, and tyrosine. Probably associated with cell proliferation. May play some role in the control of cell proliferation or differentiation and could be involved in modulating different levels of signal transduction pathways. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q4R945|TTK_MACFA Dual specificity protein kinase TTK OS=Macaca fascicularis GN=TTK PE=2 SV=1 | Back alignment and function description |
|---|
Score = 191 bits (486), Expect = 1e-47, Method: Compositional matrix adjust.
Identities = 121/313 (38%), Positives = 178/313 (56%), Gaps = 36/313 (11%)
Query: 246 TSQDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSY 305
++ + I++ G+ Y +L +G GGSS V+ V + + A+K V+L + +Q++ DSY
Sbjct: 512 SANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIY---AIKFVNLEEADNQTL-DSY 567
Query: 306 LNEVELLAKLQG-CPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTM 364
NE+ L KLQ +I+++DY + +++Y++ME G+ DL+ +++ +
Sbjct: 568 RNEIAYLNKLQQHSDKIIRLYDY--EITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKS 625
Query: 365 IIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSL 424
+W ML AV IH GI+HSDLKPANFL V +LK+ID FGIA +
Sbjct: 626 -----YWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLID----------FGIANQM 670
Query: 425 QDDKTSVHKDTASGTLNYMSPEAAGQTSSS--GGGNTYRITYKSDVWSLGCILYNMIYGR 482
Q D TS+ KD+ GT+NYM PEA SSS G + +I+ KSDVWSLGCILY M YG+
Sbjct: 671 QPDTTSIVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 730
Query: 483 TPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQS-MKLCLQKDPKARPTV-- 539
TP+ HI N +K+ AI +IEF IP LQ +K CL++DPK R ++
Sbjct: 731 TPFQHIINQISKLHAIIDPNHEIEFP-------DIPEKDLQDVLKCCLKRDPKQRISIPE 783
Query: 540 --GNSVTQINNNP 550
+ QI +P
Sbjct: 784 LLAHPYVQIQTHP 796
|
Phosphorylates proteins on serine, threonine, and tyrosine. Probably associated with cell proliferation. Essential for chromosome alignment by enhancing AURKB activity (via direct CDCA8 phosphorylation) at the centromere, and for the mitotic checkpoint. Macaca fascicularis (taxid: 9541) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|P33981|TTK_HUMAN Dual specificity protein kinase TTK OS=Homo sapiens GN=TTK PE=1 SV=2 | Back alignment and function description |
|---|
Score = 188 bits (478), Expect = 8e-47, Method: Compositional matrix adjust.
Identities = 121/313 (38%), Positives = 177/313 (56%), Gaps = 36/313 (11%)
Query: 246 TSQDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSY 305
++ + I++ G+ Y +L +G GGSS V+ V + + A+K V+L + +Q++ DSY
Sbjct: 513 SANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIY---AIKYVNLEEADNQTL-DSY 568
Query: 306 LNEVELLAKLQG-CPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTM 364
NE+ L KLQ +I+++DY + +++Y++ME G+ DL+ +++ +
Sbjct: 569 RNEIAYLNKLQQHSDKIIRLYDY--EITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKS 626
Query: 365 IIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSL 424
+W ML AV IH GI+HSDLKPANFL V +LK+ID FGIA +
Sbjct: 627 -----YWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLID----------FGIANQM 671
Query: 425 QDDKTSVHKDTASGTLNYMSPEAAGQTSSS--GGGNTYRITYKSDVWSLGCILYNMIYGR 482
Q D TSV KD+ GT+NYM PEA SSS G + +I+ KSDVWSLGCILY M YG+
Sbjct: 672 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 731
Query: 483 TPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQS-MKLCLQKDPKARPTV-- 539
TP+ I N +K+ AI +IEF IP LQ +K CL++DPK R ++
Sbjct: 732 TPFQQIINQISKLHAIIDPNHEIEFP-------DIPEKDLQDVLKCCLKRDPKQRISIPE 784
Query: 540 --GNSVTQINNNP 550
+ QI +P
Sbjct: 785 LLAHPYVQIQTHP 797
|
Phosphorylates proteins on serine, threonine, and tyrosine. Probably associated with cell proliferation. Essential for chromosome alignment by enhancing AURKB activity (via direct CDCA8 phosphorylation) at the centromere, and for the mitotic checkpoint. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q8SSH4|MPS1_ENCCU Probable serine/threonine-protein kinase MPS1 homolog OS=Encephalitozoon cuniculi (strain GB-M1) GN=MPS1 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 187 bits (476), Expect = 1e-46, Method: Compositional matrix adjust.
Identities = 118/309 (38%), Positives = 169/309 (54%), Gaps = 39/309 (12%)
Query: 233 PQITTSNAKKSVETSQDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVD 292
P+ + S+ + S++ I + G++ ++L +GKGGSS VY V S ALK V+
Sbjct: 264 PEGSNSSPRSGAVRSRERIIIKGREIEILKQIGKGGSSKVYKVLFGS----NVYALKRVE 319
Query: 293 LSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMR 352
L I D+ + SY+NE+ LL K +G ++++ D+ + +L++L+E G+TDLSK +R
Sbjct: 320 L--IGDEKMLSSYINEINLLYKFKGTSEIVEIIDH--EVGEDYLHILLEYGETDLSKIIR 375
Query: 353 NLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNV 412
+M I W +MLL VK +H IIH DLKPANFLFV G V
Sbjct: 376 KGGL------SMNFIKDVWEQMLLIVKRVHIERIIHCDLKPANFLFVK---------GRV 420
Query: 413 LKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLG 472
K+IDFGI+ +++D TS+ + GT+NYMSPEA Q S ++ SD+WSLG
Sbjct: 421 -KLIDFGISKVIRNDTTSILSEEQCGTVNYMSPEAVTQNKS-------KVARSSDIWSLG 472
Query: 473 CILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKD 532
CILY M++ P PN K I R ++ EFK N + MK CL +D
Sbjct: 473 CILYEMVHSNPPLHEYPNLIQK---IQRLQEYSEFKYTSKNKAAV-----MVMKECLARD 524
Query: 533 PKARPTVGN 541
PK RPT+ N
Sbjct: 525 PKKRPTIDN 533
|
Involved in the regulation of the onset of mitosis. Involved in a pathway that coordinates cell proliferation and differentiation. Implicated in spindle pole body (SPD) duplication. Dual specificity kinase that can phosphorylate serine, threonine and tyrosine residues. Encephalitozoon cuniculi (strain GB-M1) (taxid: 284813) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 2 |
| >sp|Q54UL8|MPS1_DICDI Probable serine/threonine-protein kinase mps1 OS=Dictyostelium discoideum GN=mps1 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 187 bits (475), Expect = 2e-46, Method: Compositional matrix adjust.
Identities = 115/307 (37%), Positives = 171/307 (55%), Gaps = 32/307 (10%)
Query: 239 NAKKSVETSQ---DVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSD 295
+ +KS E ++ +V +NGK Y + +GKGGS VY V + K ALK V LSD
Sbjct: 692 DKEKSFEVAKSWSEVAMVNGKPYLRIEFIGKGGSGKVYKVLSG---DLKIYALKYVCLSD 748
Query: 296 ITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLN 355
+ ++ LNE+E+L +L+ +I++ DY + A ++ +++E G+ DLSK ++ L
Sbjct: 749 PNE---IEAQLNEIEMLKRLRKQVNIIQLIDYEVNMAKNYILLVLEFGEIDLSKLLQRLQ 805
Query: 356 KMTTLPN--TMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413
PN + I ++W +ML AV IH IIH DLKPANF+ + L
Sbjct: 806 T----PNGTNVNFIRIYWQQMLQAVHTIHEEKIIHGDLKPANFV----------SVQGSL 851
Query: 414 KIIDFGIACSLQ-DDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLG 472
K+IDFGIA ++Q DD T++ +++ GT+NY+SPEA TS G ++ SD+WSLG
Sbjct: 852 KLIDFGIAKAIQSDDTTNIVRESQIGTINYISPEALIDTSQGGPKQCMKLGRASDIWSLG 911
Query: 473 CILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKD 532
CILY M +G P+ N +K AI +IEF N LL+ +KLCL ++
Sbjct: 912 CILYEMAFGYPPFKSFSNIISKYQAIINPHHKIEFPVHPNEN------LLKVLKLCLIRN 965
Query: 533 PKARPTV 539
P RPT+
Sbjct: 966 PHERPTI 972
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O75116|ROCK2_HUMAN Rho-associated protein kinase 2 OS=Homo sapiens GN=ROCK2 PE=1 SV=4 | Back alignment and function description |
|---|
Score = 98.2 bits (243), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 77/260 (29%), Positives = 131/260 (50%), Gaps = 32/260 (12%)
Query: 251 ITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVE 310
+ + + Y V+ ++G+G V LV + K A+K++ ++ +S + + E +
Sbjct: 85 LQMKAEDYDVVKVIGRGAFGEVQLVRHKASQ--KVYAMKLLSKFEMIKRSDSAFFWEERD 142
Query: 311 LLAKLQGCPYVIKMHDYVYDTASKHLYVLME-KGDTDLSKYMRNLNKMTTLPNTMIIIIM 369
++A P+V+++ Y + ++LY++ME DL M N + +P
Sbjct: 143 IMA-FANSPWVVQLF-YAFQD-DRYLYMVMEYMPGGDLVNLMSNYD----VPEKWAKF-- 193
Query: 370 HWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKT 429
+ E++LA+ IH+ G+IH D+KP N L +D G+ LK+ DFG C D+
Sbjct: 194 YTAEVVLALDAIHSMGLIHRDVKPDNML--------LDKHGH-LKLADFG-TCMKMDETG 243
Query: 430 SVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY--SH 487
VH DTA GT +Y+SPE S GG Y + D WS+G LY M+ G TP+
Sbjct: 244 MVHCDTAVGTPDYISPEV---LKSQGGDGFY--GRECDWWSVGVFLYEMLVGDTPFYADS 298
Query: 488 IPNTWAKMLAIARHKDQIEF 507
+ T++K++ HK+ + F
Sbjct: 299 LVGTYSKIMD---HKNSLCF 315
|
Protein kinase which is a key regulator of actin cytoskeleton and cell polarity. Involved in regulation of smooth muscle contraction, actin cytoskeleton organization, stress fiber and focal adhesion formation, neurite retraction, cell adhesion and motility via phosphorylation of ADD1, BRCA2, CNN1, EZR, DPYSL2, EP300, MSN, MYL9/MLC2, NPM1, RDX, PPP1R12A and VIM. Phosphorylates SORL1 and IRF4. Acts as a negative regulator of VEGF-induced angiogenic endothelial cell activation. Positively regulates the activation of p42/MAPK1-p44/MAPK3 and of p90RSK/RPS6KA1 during myogenic differentiation. Plays an important role in the timely initiation of centrosome duplication. Inhibits keratinocyte terminal differentiation. May regulate closure of the eyelids and ventral body wall through organization of actomyosin bundles. Plays a critical role in the regulation of spine and synaptic properties in the hippocampus. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q28021|ROCK2_BOVIN Rho-associated protein kinase 2 OS=Bos taurus GN=ROCK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 97.8 bits (242), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 77/260 (29%), Positives = 131/260 (50%), Gaps = 32/260 (12%)
Query: 251 ITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVE 310
+ + + Y V+ ++G+G V LV + K A+K++ ++ +S + + E +
Sbjct: 85 LQMKAEDYDVVKVIGRGAFGEVQLVRHKASQ--KVYAMKLLSKFEMIKRSDSAFFWEERD 142
Query: 311 LLAKLQGCPYVIKMHDYVYDTASKHLYVLME-KGDTDLSKYMRNLNKMTTLPNTMIIIIM 369
++A P+V+++ D K+LY++ME DL M N + +P
Sbjct: 143 IMA-FANSPWVVQLFCAFQD--DKYLYMVMEYMPGGDLVNLMSNYD----VPEKWAKF-- 193
Query: 370 HWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKT 429
+ E++LA+ IH+ G+IH D+KP N L +D G+ LK+ DFG C D+
Sbjct: 194 YTAEVVLALDAIHSMGLIHRDVKPDNML--------LDKHGH-LKLADFG-TCMKMDETG 243
Query: 430 SVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY--SH 487
VH DTA GT +Y+SPE S GG+ Y + D WS+G L+ M+ G TP+
Sbjct: 244 MVHCDTAVGTPDYISPEVL----KSQGGDGY-YGRECDWWSVGVFLFEMLVGDTPFYADS 298
Query: 488 IPNTWAKMLAIARHKDQIEF 507
+ T++K++ HK+ + F
Sbjct: 299 LVGTYSKIMD---HKNSLCF 315
|
Protein kinase which is a key regulator of actin cytoskeleton and cell polarity. Involved in regulation of smooth muscle contraction, actin cytoskeleton organization, stress fiber and focal adhesion formation, neurite retraction, cell adhesion and motility via phosphorylation of ADD1, BRCA2, CNN1, EZR, DPYSL2, EP300, MSN, MYL9/MLC2, NPM1, RDX, PPP1R12A and VIM. Phosphorylates SORL1 and IRF4. Acts as a negative regulator of VEGF-induced angiogenic endothelial cell activation. Positively regulates the activation of p42/MAPK1-p44/MAPK3 and of p90RSK/RPS6KA1 during myogenic differentiation. Plays an important role in the timely initiation of centrosome duplication. Inhibits keratinocyte terminal differentiation. May regulate closure of the eyelids and ventral body wall through organization of actomyosin bundles. Plays a critical role in the regulation of spine and synaptic properties in the hippocampus. Bos taurus (taxid: 9913) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 553 | ||||||
| 328708853 | 587 | PREDICTED: serine/threonine-protein kina | 0.499 | 0.470 | 0.501 | 6e-70 | |
| 328700069 | 603 | PREDICTED: dual specificity protein kina | 0.488 | 0.447 | 0.488 | 6e-66 | |
| 350416261 | 840 | PREDICTED: hypothetical protein LOC10074 | 0.528 | 0.347 | 0.447 | 4e-60 | |
| 332030519 | 964 | Dual specificity protein kinase Ttk [Acr | 0.490 | 0.281 | 0.463 | 2e-59 | |
| 340711473 | 841 | PREDICTED: hypothetical protein LOC10064 | 0.528 | 0.347 | 0.434 | 3e-59 | |
| 156545671 | 870 | PREDICTED: hypothetical protein LOC10012 | 0.491 | 0.312 | 0.444 | 3e-58 | |
| 380030040 | 818 | PREDICTED: uncharacterized protein LOC10 | 0.663 | 0.448 | 0.381 | 4e-58 | |
| 324508060 | 483 | Dual specificity protein kinase Ttk [Asc | 0.623 | 0.714 | 0.371 | 6e-58 | |
| 443686490 | 787 | hypothetical protein CAPTEDRAFT_220365 [ | 0.481 | 0.337 | 0.439 | 1e-57 | |
| 383848511 | 830 | PREDICTED: uncharacterized protein LOC10 | 0.491 | 0.327 | 0.454 | 1e-57 |
| >gi|328708853|ref|XP_001943135.2| PREDICTED: serine/threonine-protein kinase mph1-like [Acyrthosiphon pisum] | Back alignment and taxonomy information |
|---|
Score = 271 bits (693), Expect = 6e-70, Method: Compositional matrix adjust.
Identities = 154/307 (50%), Positives = 195/307 (63%), Gaps = 31/307 (10%)
Query: 248 QDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLN 307
++ I++ G Y +L+ LG GGSS VY V ++ +A+K VDLS++ D IA YLN
Sbjct: 299 ENYISVKGINYNILNTLGHGGSSIVYEVLHPDTNQV--VAIKKVDLSEVED-IIAKGYLN 355
Query: 308 EVELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIII 367
EV LL LQ C VI++ D Y T K LY++MEKGDTDLSK +RN M+ + +I
Sbjct: 356 EVNLLQNLQSCESVIRLFDSQYTTKDKILYMVMEKGDTDLSKLIRNTKHMS-----VHMI 410
Query: 368 IMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDD 427
+ +W EML+ V EIHA G+IHSDLKPANFL V LK+ID FGIA +Q D
Sbjct: 411 MYYWSEMLITVNEIHAKGVIHSDLKPANFLLVSGRLKLID----------FGIASKIQGD 460
Query: 428 KTSVHKDTASGTLNYMSPEAAGQTSSSGGGN--TYRITYKSDVWSLGCILYNMIYGRTPY 485
TSV KD +GT NYMSPE SGG N ++I KSDVWSLGCILY++IYG+TPY
Sbjct: 461 MTSVLKDVTTGTWNYMSPECI----RSGGSNFQGHKINQKSDVWSLGCILYSLIYGKTPY 516
Query: 486 SHIPNTWAKMLAIARHKDQIEFKPQLANNVT----IPPTLLQSMKLCLQKDPKARPTVGN 541
SH+ NTW K+ AIA I F L+++ T IPP L+Q+MKLCL KD KARP V +
Sbjct: 517 SHLTNTWQKLQAIAESTQNISF---LSHSKTFTQGIPPVLMQTMKLCLIKDVKARPNVVD 573
Query: 542 SVTQINN 548
+ I N
Sbjct: 574 LLKLIEN 580
|
Source: Acyrthosiphon pisum Species: Acyrthosiphon pisum Genus: Acyrthosiphon Family: Aphididae Order: Hemiptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|328700069|ref|XP_003241140.1| PREDICTED: dual specificity protein kinase TTK-like [Acyrthosiphon pisum] | Back alignment and taxonomy information |
|---|
Score = 258 bits (659), Expect = 6e-66, Method: Compositional matrix adjust.
Identities = 145/297 (48%), Positives = 187/297 (62%), Gaps = 27/297 (9%)
Query: 247 SQDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYL 306
+ + I++ G +Y +L+ LG GGSS VY V ++ +A+K VDLS++ + IA YL
Sbjct: 311 TDNFISVKGIKYSILNTLGHGGSSIVYEVLHPETNQV--MAIKKVDLSEV-ENIIAKGYL 367
Query: 307 NEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMII 366
NEV LL LQ C VI++ D Y K LY++MEKGDTDLSK +R+ M+ + +
Sbjct: 368 NEVSLLQNLQDCESVIRLFDSQYTVKEKILYMVMEKGDTDLSKLIRSTKNMS-----VHM 422
Query: 367 IIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQD 426
I+ +W EML V EIHA G+IHSDLKPANFL V LK+ID FGIA +Q
Sbjct: 423 IMYYWTEMLTTVSEIHAKGVIHSDLKPANFLLVSGRLKLID----------FGIASKIQG 472
Query: 427 DKTSVHKDTASGTLNYMSPEAAGQTSSSGGGN--TYRITYKSDVWSLGCILYNMIYGRTP 484
D TSV KD +GT NYMSPE SGG N ++I KSDVWSLGCILY+++YG+TP
Sbjct: 473 DMTSVLKDVTTGTWNYMSPECI----RSGGSNFEGHKINQKSDVWSLGCILYSLVYGKTP 528
Query: 485 YSHIPNTWAKMLAIARHKDQIEFKPQLANNVT--IPPTLLQSMKLCLQKDPKARPTV 539
YSH+ NTW K+ +IA K I F P + T +P L Q+M+LCL KD KARP V
Sbjct: 529 YSHLTNTWQKLQSIAESKQNINF-PSHSKVFTEGVPSVLQQTMQLCLIKDVKARPYV 584
|
Source: Acyrthosiphon pisum Species: Acyrthosiphon pisum Genus: Acyrthosiphon Family: Aphididae Order: Hemiptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|350416261|ref|XP_003490891.1| PREDICTED: hypothetical protein LOC100749889 [Bombus impatiens] | Back alignment and taxonomy information |
|---|
Score = 239 bits (609), Expect = 4e-60, Method: Compositional matrix adjust.
Identities = 144/322 (44%), Positives = 192/322 (59%), Gaps = 30/322 (9%)
Query: 229 KPAKPQITT-SNAKKSVETSQDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLA 287
KP+ Q + SN KS +T + + GK+Y +L +LG+G S V V S + A
Sbjct: 488 KPSNVQFSIPSNVPKSRQTR--TLFVKGKEYLILGVLGQGMSGEVLRVQDLSSLQL--CA 543
Query: 288 LKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDL 347
+K V+L+ + D+ A L E+ +L KLQ P ++KM DY + +YV+ME GDTDL
Sbjct: 544 IKCVNLNRM-DKDSAQGCLEEISMLHKLQA-PCIVKMFDY--EIKYPMVYVVMEMGDTDL 599
Query: 348 SKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIID 407
S+ ++ +++ +P TMI+ +W EML AVK IH G+IHSDLKPANFL V LK+ID
Sbjct: 600 SRLLKTMSQEKQIPLTMIL--YYWTEMLTAVKHIHENGVIHSDLKPANFLLVRGRLKLID 657
Query: 408 CIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEA----AGQTSSSGGGNTYRIT 463
FGIA S+ D TSV K+ GTLNY+SPEA G + S Y+I+
Sbjct: 658 ----------FGIASSMNADMTSVVKNCPIGTLNYISPEALMDIGGNSDSPSQNVKYKIS 707
Query: 464 YKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQL----ANNVT-IP 518
+KSDVWSLGCILY+++YG TP+ HI + WAK+ AI K I F L AN V P
Sbjct: 708 FKSDVWSLGCILYSLVYGHTPFHHIRSQWAKVNAITNPKLNIPFPTTLQSEDANKVMPSP 767
Query: 519 PTLLQSMKLCLQKDPKARPTVG 540
P L+ M+ CLQ DPKARPTV
Sbjct: 768 PILIDVMRKCLQHDPKARPTVA 789
|
Source: Bombus impatiens Species: Bombus impatiens Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|332030519|gb|EGI70207.1| Dual specificity protein kinase Ttk [Acromyrmex echinatior] | Back alignment and taxonomy information |
|---|
Score = 236 bits (603), Expect = 2e-59, Method: Compositional matrix adjust.
Identities = 139/300 (46%), Positives = 181/300 (60%), Gaps = 29/300 (9%)
Query: 251 ITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVE 310
+ + K+Y +L LG+G S V V S E + A+K VDLS + D+ A L+E+
Sbjct: 616 LIIKDKEYLILGSLGRGMSGEVLRVQDVSCGELR--AIKCVDLSKM-DKDSAQGCLDEIS 672
Query: 311 LLAKLQGCPYVIKMHDY-VYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIM 369
+L KLQ P V+KM DY + D+ +YVLME GDTDLS+ ++++++ + TMI+
Sbjct: 673 MLRKLQA-PCVVKMFDYQIKDSM---VYVLMEMGDTDLSRLLKSMSQEKQISLTMIL--Y 726
Query: 370 HWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKT 429
+W EML AVK IH G+IHSDLKP NFL V LK+ID FGIA +L D T
Sbjct: 727 YWTEMLTAVKHIHDNGVIHSDLKPGNFLLVRGRLKLID----------FGIASNLNSDMT 776
Query: 430 SVHKDTASGTLNYMSPEAAGQTSSSGGGNT----YRITYKSDVWSLGCILYNMIYGRTPY 485
SV K+T GTLNY+SPEA S +G T Y+I++KSDVWSLGCILY+++YG TP+
Sbjct: 777 SVVKNTTIGTLNYISPEALMDISGNGDSPTHNVKYKISFKSDVWSLGCILYSLVYGYTPF 836
Query: 486 SHIPNTWAKMLAIARHKDQIEFKPQL--ANNVTI---PPTLLQSMKLCLQKDPKARPTVG 540
HI WAK+ AI K I F N T PP L+ M+ CLQ DPKARPTV
Sbjct: 837 QHIRTQWAKVNAITNPKPNISFSTTTNSENRQTCERTPPVLIDVMRKCLQHDPKARPTVS 896
|
Source: Acromyrmex echinatior Species: Acromyrmex echinatior Genus: Acromyrmex Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|340711473|ref|XP_003394300.1| PREDICTED: hypothetical protein LOC100643681 [Bombus terrestris] | Back alignment and taxonomy information |
|---|
Score = 236 bits (602), Expect = 3e-59, Method: Compositional matrix adjust.
Identities = 140/322 (43%), Positives = 190/322 (59%), Gaps = 30/322 (9%)
Query: 229 KPAKPQITT-SNAKKSVETSQDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLA 287
KP+ Q + SN KS + + + GK+Y +L +LG+G S V V S E A
Sbjct: 488 KPSNVQFSIPSNVPKSRQNR--TLFVKGKEYLILGILGQGMSGEVLRVQDLSSLEL--CA 543
Query: 288 LKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDL 347
+K V+L+ + D+ A L E+ +L KLQ P ++KM DY + +YV+ME GDTDL
Sbjct: 544 IKCVNLNRM-DKDSAQGCLEEISMLHKLQA-PCIVKMFDY--EIKYPMVYVVMEMGDTDL 599
Query: 348 SKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIID 407
S+ ++ +++ +P TMI+ +W EML AVK IH G+IHSDLKPANFL V LK+ID
Sbjct: 600 SRLLKTMSQEKQIPLTMIL--YYWTEMLTAVKHIHDNGVIHSDLKPANFLLVRGRLKLID 657
Query: 408 CIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEA----AGQTSSSGGGNTYRIT 463
FGIA S+ D TSV K+ GTLNY+SPEA G + S Y+I+
Sbjct: 658 ----------FGIASSMNADMTSVVKNCPIGTLNYISPEALMDIGGNSDSPSQNVKYKIS 707
Query: 464 YKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANN-----VTIP 518
+KSDVWSLGCILY+++YG TP+ H+ + WAK+ AI K I F L + + P
Sbjct: 708 FKSDVWSLGCILYSLVYGHTPFHHVRSQWAKVNAITNPKLNIPFPTTLQSEDGNKVMPSP 767
Query: 519 PTLLQSMKLCLQKDPKARPTVG 540
P L+ M+ CLQ DPKARPTV
Sbjct: 768 PILIDVMRKCLQHDPKARPTVA 789
|
Source: Bombus terrestris Species: Bombus terrestris Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|156545671|ref|XP_001604243.1| PREDICTED: hypothetical protein LOC100120622 [Nasonia vitripennis] | Back alignment and taxonomy information |
|---|
Score = 233 bits (593), Expect = 3e-58, Method: Compositional matrix adjust.
Identities = 132/297 (44%), Positives = 182/297 (61%), Gaps = 25/297 (8%)
Query: 250 VITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEV 309
+IT+ +QY VL +LG+G S V S E + A+K V+LS + D+ A L E+
Sbjct: 543 IITVKDRQYLVLGVLGQGMSCEVVRAQDLSSSELR--AIKCVNLSKM-DKDSAQGCLQEI 599
Query: 310 ELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRN-LNKMTTLPNTMIIII 368
+L +L+ P ++ M Y ++ ++V+ME GDTDLS+ +++ L + +P TMI+
Sbjct: 600 CMLDRLKA-PCIVHM--YNFEIKQPWVHVVMEIGDTDLSRLLKSMLQEKKQIPLTMIL-- 654
Query: 369 MHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDK 428
+W EML AVK IH G+IHSDLKPANFL V LK+ID FGIA ++ D
Sbjct: 655 YYWTEMLTAVKHIHENGVIHSDLKPANFLLVRGRLKLID----------FGIASNINSDM 704
Query: 429 TSVHKDTASGTLNYMSPEA-----AGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRT 483
TSV K+ GTLNY+SPEA AG T S N ++I+YKSDVWSLGCILY ++YG T
Sbjct: 705 TSVVKNCPIGTLNYISPEALMDVNAGSTDSPNHSNKFKISYKSDVWSLGCILYGLVYGVT 764
Query: 484 PYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVG 540
P++HI WAK+ AI K +I F P + +P L+ +M+ CLQ+D KARPTV
Sbjct: 765 PFNHIRQQWAKISAITDPKHKINF-PLKTGSEPVPLILVDAMRKCLQRDAKARPTVA 820
|
Source: Nasonia vitripennis Species: Nasonia vitripennis Genus: Nasonia Family: Pteromalidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|380030040|ref|XP_003698667.1| PREDICTED: uncharacterized protein LOC100870598 [Apis florea] | Back alignment and taxonomy information |
|---|
Score = 232 bits (591), Expect = 4e-58, Method: Compositional matrix adjust.
Identities = 157/411 (38%), Positives = 217/411 (52%), Gaps = 44/411 (10%)
Query: 139 DASQLSEDILATRKKYPFLVSSTSSLDKENVVPDNEKFKGPTQTKSVFSVRSASDQSLSQ 198
D S+ E + KKY + K++++PD E ++ + +
Sbjct: 393 DTSETVEHLELKEKKY--------NQSKKDILPDKETINKIANSRHI-------PHCIKN 437
Query: 199 KKNESTPVFKRPLSVNSTKSSDPSVSKETIKPAKPQITT-SNAKKSVETSQDVITLNGKQ 257
K VF+ S S ++ K P Q + SN KS ++ + + GK+
Sbjct: 438 NKETVKSVFQNQHSEVSNQNQHQEFKKVIDNPLNLQFSMPSNIPKSRQSR--TLFVKGKE 495
Query: 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG 317
Y +L LG+G S V S E A+K V+L+ + D+ A L E+ +L KLQ
Sbjct: 496 YLILGTLGQGMSGEVLRAQDLSSLEL--CAIKCVNLNRM-DKDSAQGCLEEISMLHKLQA 552
Query: 318 CPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLA 377
P V+KM DY + +YV+ME GDTDLS+ ++ ++ +P TMI+ +W EML A
Sbjct: 553 -PCVVKMFDY--EIKYPMVYVVMEMGDTDLSRLLKTTSQEKQIPLTMIL--YYWTEMLTA 607
Query: 378 VKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTAS 437
VK IH G+IHSDLKPANFL V LK+ID FGIA S+ D TSV K+
Sbjct: 608 VKHIHDNGVIHSDLKPANFLLVRGRLKLID----------FGIASSMNADMTSVVKNCPI 657
Query: 438 GTLNYMSPEA----AGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWA 493
GTLNY+SPEA G + S Y+I++KSDVWSLGCILY+++YG TP+ HI + WA
Sbjct: 658 GTLNYISPEALMDIGGNSDSPTQNVKYKISFKSDVWSLGCILYSLVYGHTPFHHIRSQWA 717
Query: 494 KMLAIARHKDQIEFKPQLANN---VTI-PPTLLQSMKLCLQKDPKARPTVG 540
K+ AI I F L+ N VT PP L+ M+ CLQ +PKARPTV
Sbjct: 718 KVNAITNPNLNIPFPKTLSENGNKVTFSPPILIDVMRKCLQHNPKARPTVA 768
|
Source: Apis florea Species: Apis florea Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|324508060|gb|ADY43408.1| Dual specificity protein kinase Ttk [Ascaris suum] | Back alignment and taxonomy information |
|---|
Score = 231 bits (590), Expect = 6e-58, Method: Compositional matrix adjust.
Identities = 159/428 (37%), Positives = 218/428 (50%), Gaps = 83/428 (19%)
Query: 160 STSSLDKENVV---PDNEKF--------KGPTQTKSVFSV------RSASDQSLSQKKNE 202
+T +DKEN V P +F S+F V R A+ +L+ + +
Sbjct: 26 TTGDVDKENSVATLPTGTRFVTAPLPRTGAADGNGSMFVVPTPSMSRPATTGALASSRIQ 85
Query: 203 STPVFKRPLSV-------------NSTKSSDPSVSKETIKPAKPQ--------------- 234
P RPLSV +S + + + E P +PQ
Sbjct: 86 GRPPTHRPLSVVEYQKDSMQGGKLSSQRQQERIANTEHAPPQRPQSHLPTPRSSSACDRR 145
Query: 235 ---ITTSNAKKSVETSQDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVV 291
+++SN K + +NG Y ++ LLGKGGSS VY V E + K A+K V
Sbjct: 146 NLHLSSSNGKH--------VLVNGCPYLLIDLLGKGGSSKVYQV--LDETKKKCRAVKFV 195
Query: 292 DLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYM 351
DLS+ D + ++YLNE++LL +L+ V+++ DY + HLY++MEKGDTDLS ++
Sbjct: 196 DLSE-ADNATKEAYLNEIKLLLELKDSGCVVQLFDY--ELRGSHLYMVMEKGDTDLSTFL 252
Query: 352 RNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGN 411
+ I I +W EML V IH+ G++HSDLKPANFL +G GN
Sbjct: 253 KTRRSKID----HIFIRFYWSEMLKCVNAIHSKGVVHSDLKPANFLLIG---------GN 299
Query: 412 VLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSL 471
LK+IDFGIA S+ ++TS+ KD+ GTL+YM PEA G Y++ KSDVWSL
Sbjct: 300 -LKLIDFGIASSIPSNRTSIMKDSQMGTLSYMPPEALAGAEPQHGKEVYKVQKKSDVWSL 358
Query: 472 GCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQK 531
GCILYNM+YGRTPY HI + K+ AI +EF P LL MK CL K
Sbjct: 359 GCILYNMVYGRTPYQHILSCAQKINAII--SKPVEFDP------IDDKELLDVMKKCLTK 410
Query: 532 DPKARPTV 539
DP+ R TV
Sbjct: 411 DPEKRATV 418
|
Source: Ascaris suum Species: Ascaris suum Genus: Ascaris Family: Ascarididae Order: Ascaridida Class: Chromadorea Phylum: Nematoda Superkingdom: Eukaryota |
| >gi|443686490|gb|ELT89748.1| hypothetical protein CAPTEDRAFT_220365 [Capitella teleta] | Back alignment and taxonomy information |
|---|
Score = 230 bits (587), Expect = 1e-57, Method: Compositional matrix adjust.
Identities = 131/298 (43%), Positives = 187/298 (62%), Gaps = 32/298 (10%)
Query: 250 VITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEV 309
++ +NGK+Y L +G+GGSS VYLV +HE+ A+K VDL++ D+ A SY+NE+
Sbjct: 501 MLRVNGKEYLALKQIGRGGSSKVYLVMSADQHEY---AVKCVDLNN-ADELTAQSYINEI 556
Query: 310 ELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIM 369
LL +LQ ++IKMHD+ Y+ + LYV+MEKG DL +R K + +M + +
Sbjct: 557 NLLQRLQYSNHIIKMHDFEYNESEGILYVVMEKGVRDLMTELRLCRKQGQMNWSM--VKL 614
Query: 370 HWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKT 429
+W++MLLAV+ +H GI+HSDLKPANF + +G L +IDFGIA ++Q D+T
Sbjct: 615 NWHQMLLAVQVLHKEGIVHSDLKPANF---------VRSVG--LTLIDFGIAHAIQQDRT 663
Query: 430 SVHKDTASGTLNYMSPEAAGQTSSSGGGNT--------YRITYKSDVWSLGCILYNMIYG 481
SV ++ G+LNYMSPEA S G G+ ++I KSDVWSLGCILYNM Y
Sbjct: 664 SVTREQQIGSLNYMSPEAIIDVSGGGLGDLGEEAKKPKFKIGVKSDVWSLGCILYNMAYN 723
Query: 482 RTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTV 539
RTP+ + N+ K+ AI +I+F P L + P LL +M+ CLQ+DPK RP++
Sbjct: 724 RTPFQDVANSL-KLHAIISPSCKIKFPP-LED-----PHLLDTMQRCLQRDPKLRPSI 774
|
Source: Capitella teleta Species: Capitella teleta Genus: Capitella Family: Capitellidae Order: Capitellida Class: Polychaeta Phylum: Annelida Superkingdom: Eukaryota |
| >gi|383848511|ref|XP_003699893.1| PREDICTED: uncharacterized protein LOC100880852 [Megachile rotundata] | Back alignment and taxonomy information |
|---|
Score = 230 bits (587), Expect = 1e-57, Method: Compositional matrix adjust.
Identities = 136/299 (45%), Positives = 179/299 (59%), Gaps = 27/299 (9%)
Query: 251 ITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVE 310
+ + GK+Y +L LG G S V S E A+K V+L+ + D+ A L E+
Sbjct: 501 LFVKGKEYLILGTLGHGMSGDVLRAQDLSSLEL--CAIKCVNLTRM-DKDSAQGCLEEIS 557
Query: 311 LLAKLQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMH 370
+L KLQ P ++KM DY + +YV+ME GDTDLS+ +++ + +P TMI+ +
Sbjct: 558 MLHKLQA-PCIVKMFDY--EIKYPMVYVVMEMGDTDLSRLTKSMLQEKEIPLTMIL--YY 612
Query: 371 WYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTS 430
W EML AVK IH G+IHSDLKPANFL V LK+ID FGIA S+ D TS
Sbjct: 613 WTEMLTAVKHIHDNGVIHSDLKPANFLLVRGRLKLID----------FGIASSMNADMTS 662
Query: 431 VHKDTASGTLNYMSPEA----AGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYS 486
V K+ GTLNY+SPEA G + SS Y+I++KSDVWSLGCILY+++YG TP+
Sbjct: 663 VVKNCPIGTLNYISPEALMDIGGNSDSSNQNVKYKISFKSDVWSLGCILYSLVYGHTPFH 722
Query: 487 HIPNTWAKMLAIARHKDQIEFKPQLA----NNVTIPP-TLLQSMKLCLQKDPKARPTVG 540
HI + WAK+ AI K I F L+ N VT P L++ M+ CLQ DPKARPTV
Sbjct: 723 HIRSQWAKVNAITNPKLNIPFPATLSSRDGNKVTSSPQILIEVMRKCLQHDPKARPTVA 781
|
Source: Megachile rotundata Species: Megachile rotundata Genus: Megachile Family: Megachilidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 553 | ||||||
| POMBASE|SPBC106.01 | 678 | mph1 "dual specificity protein | 0.730 | 0.595 | 0.320 | 8.1e-45 | |
| FB|FBgn0000063 | 630 | ald "altered disjunction" [Dro | 0.421 | 0.369 | 0.449 | 1.2e-44 | |
| UNIPROTKB|E1BQR2 | 871 | TTK "Uncharacterized protein" | 0.424 | 0.269 | 0.435 | 2.7e-44 | |
| UNIPROTKB|E2QYE4 | 820 | TTK "Uncharacterized protein" | 0.432 | 0.291 | 0.411 | 1.2e-43 | |
| UNIPROTKB|J9NVE1 | 855 | TTK "Uncharacterized protein" | 0.432 | 0.279 | 0.411 | 4.1e-43 | |
| UNIPROTKB|P33981 | 857 | TTK "Dual specificity protein | 0.432 | 0.278 | 0.411 | 1.1e-42 | |
| ASPGD|ASPL0000035269 | 828 | AN2927 [Emericella nidulans (t | 0.734 | 0.490 | 0.298 | 1.3e-42 | |
| UNIPROTKB|D4A4S7 | 835 | Ttk "Protein Ttk" [Rattus norv | 0.414 | 0.274 | 0.414 | 8.1e-42 | |
| MGI|MGI:1194921 | 856 | Ttk "Ttk protein kinase" [Mus | 0.645 | 0.417 | 0.330 | 1.8e-41 | |
| CGD|CAL0004016 | 690 | MPS1 [Candida albicans (taxid: | 0.627 | 0.502 | 0.310 | 1.8e-40 |
| POMBASE|SPBC106.01 mph1 "dual specificity protein kinase Mph1" [Schizosaccharomyces pombe (taxid:4896)] | Back alignment and assigned GO terms |
|---|
Score = 472 (171.2 bits), Expect = 8.1e-45, P = 8.1e-45
Identities = 145/453 (32%), Positives = 222/453 (49%)
Query: 119 RVDQCKKNLNYDPSIKTPCKDASQLSEDILATRKKYPFLVSSTS-SLDKENVVPDNEKFK 177
+ K + D I+ ++ S S + AT K P + +T +E+ P F
Sbjct: 181 KTSDTKNSTEADEDIEMKSREVSPASNSVAATTLK-PLQLHNTPLQTSQEHPKPS---FH 236
Query: 178 GPTQTKSVFSVRSASDQSLSQKKNESTPVFKRPLSV--NSTKSSDPSVSKETIKP-AKPQ 234
P+Q +S FS R D + ++ +E + RP++V +S+ + P P
Sbjct: 237 -PSQFESSFSPRVQFDHDVERRASE---LHSRPVTVFQEPQRSASQPYESHALSPKVAPL 292
Query: 235 ITTSNAKKSVETSQDVITLNGKQYQXXXXXXXXXXXXXXXXXXXXEHEFKPLALKVVDLS 294
S A + QDV+T+ Q+ + ALK V+
Sbjct: 293 FDNSQATPIPKRQQDVVTVANLQF--IKLGVVGKGGSSMVYRIFSPDNSRLYALKEVNFI 350
Query: 295 DITDQSIADSYLNEVELLAKLQGCPYVIKMHDY-VYDTASKHLYVLMEKGDTDLSKY-MR 352
+ DQ+ Y NE+ LL KL G +IK++ V DT + L ++ME G+TDL+ M+
Sbjct: 351 N-ADQTTIQGYKNEIALLRKLSGNDRIIKLYAAEVNDTLGQ-LNMVMECGETDLANLLMK 408
Query: 353 NLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNV 412
N+ K P + I M+W +ML AV+ +H I+HSDLKPANFL V GN
Sbjct: 409 NMKK----PINLNFIRMYWEQMLEAVQVVHDQNIVHSDLKPANFLLVE---------GN- 454
Query: 413 LKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSS--SGGGNTYRITYKSDVWS 470
LK+IDFGIA ++ +D T++H+D+ GT+NYM+PEA ++ + G ++ SDVWS
Sbjct: 455 LKLIDFGIAKAIGNDTTNIHRDSHIGTINYMAPEALTDMNAHTNSGVKLVKLGRPSDVWS 514
Query: 471 LGCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLA---N----------NVTI 517
LGCILY M+YGR P++H+ A + AI + I F P++A N VT+
Sbjct: 515 LGCILYQMVYGRAPFAHLKMIQA-IAAIPNEQYHIHF-PEVALPANAVQEKEGSLPGVTV 572
Query: 518 PPTLLQSMKLCLQKDPKARPTVGNSVTQINNNP 550
P L+ MK CL++D + R T+ + NP
Sbjct: 573 GPDLMDVMKRCLERDQRKRLTIPELLVHPFLNP 605
|
|
| FB|FBgn0000063 ald "altered disjunction" [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 470 (170.5 bits), Expect = 1.2e-44, P = 1.2e-44
Identities = 116/258 (44%), Positives = 152/258 (58%)
Query: 287 ALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEKGDTD 346
ALKVVDL D + YLNE +LLAKLQG V+ ++DY LY++MEKGD D
Sbjct: 364 ALKVVDLQ--ADPQVVQGYLNETKLLAKLQGNVCVVALYDYQLVREESKLYMVMEKGDCD 421
Query: 347 LSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKII 406
L+K +++ T LP ++ I+ Y+ML AV IH G+IHSDLKPANFL V
Sbjct: 422 LNKILQSYT--TNLPLYSLMNIL--YQMLQAVNYIHQHGVIHSDLKPANFLMVS------ 471
Query: 407 DCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNT------Y 460
G LK+IDFGIA ++ D TS+ K + +GT NY+SPEA TS+
Sbjct: 472 ---GR-LKLIDFGIASNIAVDSTSIIKFSQAGTFNYISPEALTDTSTGNSPMRRADQPKI 527
Query: 461 RITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPT 520
+I+ KSDVWSLGCILY ++Y +TP+ HI N +AKM AI IE+ P + P
Sbjct: 528 KISTKSDVWSLGCILYLLLYQKTPFGHIRNVYAKMSAITTPGTSIEY-PAIPPYY--PIM 584
Query: 521 LLQSMKLCLQKDPKARPT 538
L+ K CLQ +PK RP+
Sbjct: 585 LVHMAKNCLQLNPKKRPS 602
|
|
| UNIPROTKB|E1BQR2 TTK "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 452 (164.2 bits), Expect = 2.7e-44, Sum P(2) = 2.7e-44
Identities = 115/264 (43%), Positives = 155/264 (58%)
Query: 281 HEFKPL-ALKVVDLSDITDQSIADSYLNEVELLAKLQG-CPYVIKMHDYVYDTASKHLYV 338
+E K L A+K V+L + DQ +SY NE+ L+KLQ +I++ Y Y+ +H+Y+
Sbjct: 553 NEKKQLYAVKYVNLEE-ADQQTVESYKNEIAHLSKLQEHSDKIIRL--YSYEITDQHIYM 609
Query: 339 LMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLF 398
+ME G+ DL+ +++ + L +W ML AV IH GI+HSDLKPANFL
Sbjct: 610 VMECGNIDLNSWLKKKRNIDPLERKS-----YWKNMLEAVHTIHEHGIVHSDLKPANFL- 663
Query: 399 VGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGN 458
I+D +LK+IDFGIA +Q D TS+ KD+ GT+NYM PEA SSS G N
Sbjct: 664 ------IVD---GMLKLIDFGIANQMQPDVTSIVKDSQVGTMNYMPPEAIQDMSSSYGEN 714
Query: 459 ---TYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNV 515
+I+ KSDVWSLGCILY M YGRTP+ HI NT K+ AI +IEF P +A
Sbjct: 715 GKSQSKISPKSDVWSLGCILYCMTYGRTPFQHITNTRKKLYAIVDPHYEIEF-PDIAEK- 772
Query: 516 TIPPTLLQSMKLCLQKDPKARPTV 539
L +K CL ++PK R +V
Sbjct: 773 ----DLQDVLKRCLVRNPKQRISV 792
|
|
| UNIPROTKB|E2QYE4 TTK "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 435 (158.2 bits), Expect = 1.2e-43, Sum P(2) = 1.2e-43
Identities = 112/272 (41%), Positives = 158/272 (58%)
Query: 287 ALKVVDLSDITDQSIADSYLNEVELLAKLQG-CPYVIKMHDYVYDTASKHLYVLMEKGDT 345
A+K V+L + +Q+I +SY NE+ L KLQ +I+++DY + +++Y++ME G+
Sbjct: 529 AIKYVNLEEADNQTI-ESYRNEIAYLNKLQQHSDKIIRLYDY--EITDQYIYMVMECGNI 585
Query: 346 DLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKI 405
DL+ +++ + +W ML AV IH GI+HSDLKPANFL I
Sbjct: 586 DLNSWLKKKKSINPWERKS-----YWKNMLEAVYTIHQHGIVHSDLKPANFL-------I 633
Query: 406 IDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSS--GGGNTYRIT 463
+D +LK+IDFGIA +Q D TS+ KD+ GT+NYM PEA SSS G + +I+
Sbjct: 634 VD---GMLKLIDFGIANQMQPDTTSIVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKIS 690
Query: 464 YKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQ 523
KSDVWSLGCILY M YG+TP+ HI N +K+ AI +IEF P IP LQ
Sbjct: 691 PKSDVWSLGCILYYMTYGKTPFQHIINQISKLHAIIDPNHEIEF-PD------IPEKDLQ 743
Query: 524 S-MKLCLQKDPKARPTV----GNSVTQINNNP 550
+K CL +DPK R ++ + QI +P
Sbjct: 744 DVLKCCLIRDPKQRISIPDLLAHPYVQIQTHP 775
|
|
| UNIPROTKB|J9NVE1 TTK "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 435 (158.2 bits), Expect = 4.1e-43, Sum P(2) = 4.1e-43
Identities = 112/272 (41%), Positives = 158/272 (58%)
Query: 287 ALKVVDLSDITDQSIADSYLNEVELLAKLQG-CPYVIKMHDYVYDTASKHLYVLMEKGDT 345
A+K V+L + +Q+I +SY NE+ L KLQ +I+++DY + +++Y++ME G+
Sbjct: 548 AIKYVNLEEADNQTI-ESYRNEIAYLNKLQQHSDKIIRLYDY--EITDQYIYMVMECGNI 604
Query: 346 DLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKI 405
DL+ +++ + +W ML AV IH GI+HSDLKPANFL I
Sbjct: 605 DLNSWLKKKKSINPWERKS-----YWKNMLEAVYTIHQHGIVHSDLKPANFL-------I 652
Query: 406 IDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSS--GGGNTYRIT 463
+D +LK+IDFGIA +Q D TS+ KD+ GT+NYM PEA SSS G + +I+
Sbjct: 653 VD---GMLKLIDFGIANQMQPDTTSIVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKIS 709
Query: 464 YKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQ 523
KSDVWSLGCILY M YG+TP+ HI N +K+ AI +IEF P IP LQ
Sbjct: 710 PKSDVWSLGCILYYMTYGKTPFQHIINQISKLHAIIDPNHEIEF-PD------IPEKDLQ 762
Query: 524 S-MKLCLQKDPKARPTV----GNSVTQINNNP 550
+K CL +DPK R ++ + QI +P
Sbjct: 763 DVLKCCLIRDPKQRISIPDLLAHPYVQIQTHP 794
|
|
| UNIPROTKB|P33981 TTK "Dual specificity protein kinase TTK" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 434 (157.8 bits), Expect = 1.1e-42, Sum P(2) = 1.1e-42
Identities = 112/272 (41%), Positives = 158/272 (58%)
Query: 287 ALKVVDLSDITDQSIADSYLNEVELLAKLQG-CPYVIKMHDYVYDTASKHLYVLMEKGDT 345
A+K V+L + +Q++ DSY NE+ L KLQ +I+++DY + +++Y++ME G+
Sbjct: 551 AIKYVNLEEADNQTL-DSYRNEIAYLNKLQQHSDKIIRLYDY--EITDQYIYMVMECGNI 607
Query: 346 DLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKI 405
DL+ +++ + +W ML AV IH GI+HSDLKPANFL I
Sbjct: 608 DLNSWLKKKKSIDPWERKS-----YWKNMLEAVHTIHQHGIVHSDLKPANFL-------I 655
Query: 406 IDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSS--GGGNTYRIT 463
+D +LK+IDFGIA +Q D TSV KD+ GT+NYM PEA SSS G + +I+
Sbjct: 656 VD---GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKIS 712
Query: 464 YKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQ 523
KSDVWSLGCILY M YG+TP+ I N +K+ AI +IEF P IP LQ
Sbjct: 713 PKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF-PD------IPEKDLQ 765
Query: 524 S-MKLCLQKDPKARPTV----GNSVTQINNNP 550
+K CL++DPK R ++ + QI +P
Sbjct: 766 DVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 797
|
|
| ASPGD|ASPL0000035269 AN2927 [Emericella nidulans (taxid:162425)] | Back alignment and assigned GO terms |
|---|
Score = 458 (166.3 bits), Expect = 1.3e-42, P = 1.3e-42
Identities = 130/435 (29%), Positives = 207/435 (47%)
Query: 124 KKNLNYDPSIKTPCKDASQLSEDILATRKKYPFLVSSTSSLDKENVVPDNEKFKGPTQTK 183
K +++ S DAS K P + S+ D+EN P K P
Sbjct: 347 KSYVSHSKSTPGSSSDASSKPSSSKEPIFKVPPPPTLPSTRDQENEPPPTFKRTKPQGFD 406
Query: 184 SVFSVRSASDQSLSQKKNESTPVFKRPLSVNSTKSSDPSVSKETIKPAKPQITTSNAKKS 243
+ S KK++ P P + S +S++ P + T+ A
Sbjct: 407 FLDKPEKLSVVYGDDKKDQELPAGTSPRKILSNRSNNTPHRPAPPPPKMSVLETATATGG 466
Query: 244 VETS------QDVITLNGKQYQXXXXXXXXXXXXXXXXXXXXEHEFKPLALKVVDLSDIT 297
T+ + +++N K + +K ALK V+L D+
Sbjct: 467 AATASQSRKKRSQVSINHKPFTRLDCIGRGGSSRVYRVMA---ENYKIFALKRVNLEDVD 523
Query: 298 DQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKM 357
++A Y E++LL KL+ V+++ D+ ++ + L VLME G++DL K + K+
Sbjct: 524 PTTLA-GYKGEIDLLKKLENVDRVVRLFDWELNSDKRTLSVLMEIGESDLEKVLTY--KL 580
Query: 358 TTLPNTMIIII--MHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415
T I +W EML V+ +H ++HSDLKPANFL V G LK+
Sbjct: 581 NAEDATFDINFTRFYWKEMLECVQAVHEYNVVHSDLKPANFLLVQ---------GR-LKL 630
Query: 416 IDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGG-----GNTYRITYKSDVWS 470
IDFGIA ++QD+ +VH++ GT NYMSPEA +++S G G ++ SDVWS
Sbjct: 631 IDFGIANAIQDNTVNVHREQQVGTPNYMSPEALVDSNASLGLPASVGKMMKLGKPSDVWS 690
Query: 471 LGCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQ 530
LGCILY M+YG+ P++ I + +++AI K +I+F + +PP L++++K CLQ
Sbjct: 691 LGCILYKMVYGQPPFAKIAKYYERIMAIPNPKVKIDFPAFGVGGIQVPPGLIRTLKGCLQ 750
Query: 531 KDPKARPTVGNSVTQ 545
+D RPT+ + + Q
Sbjct: 751 RDQTLRPTISDLLGQ 765
|
|
| UNIPROTKB|D4A4S7 Ttk "Protein Ttk" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 435 (158.2 bits), Expect = 8.1e-42, Sum P(2) = 8.1e-42
Identities = 106/256 (41%), Positives = 152/256 (59%)
Query: 287 ALKVVDLSDITDQSIADSYLNEVELLAKLQG-CPYVIKMHDYVYDTASKHLYVLMEKGDT 345
A+K V+L D Q+I DSY NE+ L KLQ +I+++DY + +++Y++ME G+
Sbjct: 529 AIKYVNLEDADSQTI-DSYRNEIAYLNKLQQHSDKIIRLYDY--EITDRYIYMVMECGNI 585
Query: 346 DLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKI 405
DL+ +++ + +W ML AV IH GI+HSDLKPANFL I
Sbjct: 586 DLNSWLKKKKSINPWERKS-----YWKNMLEAVHTIHQHGIVHSDLKPANFL-------I 633
Query: 406 IDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSS--GGGNTYRIT 463
+D +LK+IDFGIA +Q D TS+ KD+ GT+NYM+PEA SSS G +I+
Sbjct: 634 VD---GMLKLIDFGIANQMQPDTTSIVKDSQVGTVNYMAPEAIRDMSSSRENGKIKTKIS 690
Query: 464 YKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQ 523
+SDVWSLGCILY M YG+TP+ HI N +K+ AI +IEF P+++ L
Sbjct: 691 PRSDVWSLGCILYYMTYGKTPFQHIINQVSKLHAIIDPSHEIEF-PEISEK-----DLRD 744
Query: 524 SMKLCLQKDPKARPTV 539
+K CL ++PK R ++
Sbjct: 745 VLKCCLVRNPKERISI 760
|
|
| MGI|MGI:1194921 Ttk "Ttk protein kinase" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 448 (162.8 bits), Expect = 1.8e-41, P = 1.8e-41
Identities = 133/402 (33%), Positives = 203/402 (50%)
Query: 168 NVVPDNEKFKGPTQTKSVFSVRSASDQSLSQKKNESTPVFKRPLSVN----STKSSDPSV 223
+V P +K P +SA + S ++ FK P+ N + SS P
Sbjct: 426 DVTPKADKESPPISVPKWLDPKSACETPSSSSLDDYMKCFKTPVVKNDFPPACPSSTPYS 485
Query: 224 SKETIKPAKPQ-ITTSNAKKSVETSQDV---ITLNGKQYQXXXXXXXXXXXXXXXXXXXX 279
++ + Q ++T + S + I++NG+ Y
Sbjct: 486 QLARLQQQQQQGLSTPLQSLQISGSSSINECISVNGRIYSILKQIGSGGSSKVFQVL--- 542
Query: 280 EHEFKPL-ALKVVDLSDITDQSIADSYLNEVELLAKLQG-CPYVIKMHDYVYDTASKHLY 337
+E K + A+K V+L D Q+I +SY NE+ L KLQ +I+++DY + +++Y
Sbjct: 543 -NEKKQINAIKYVNLEDADSQTI-ESYRNEIAFLNKLQQHSDKIIRLYDY--EITEQYIY 598
Query: 338 VLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFL 397
++ME G+ DL+ +++ + +W ML AV IH GI+HSDLKPANF+
Sbjct: 599 MVMECGNIDLNSWLKKKKSINPWERKS-----YWKNMLEAVHIIHQHGIVHSDLKPANFV 653
Query: 398 FVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGG 457
I+D +LK+IDFGIA +Q D TS+ KD+ GT+NYM+PEA SSS
Sbjct: 654 -------IVD---GMLKLIDFGIANQMQPDTTSIVKDSQVGTVNYMAPEAIRDMSSSREN 703
Query: 458 NTYR--ITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNV 515
+ R ++ +SDVWSLGCILY M YGRTP+ HI N +K+ AI +IEF P+++
Sbjct: 704 SKIRTKVSPRSDVWSLGCILYYMTYGRTPFQHIINQVSKLHAIINPAHEIEF-PEISEK- 761
Query: 516 TIPPTLLQSMKLCLQKDPKARPTVGNSVT----QINNNPEGS 553
L +K CL ++PK R ++ +T QI +P GS
Sbjct: 762 ----DLRDVLKCCLVRNPKERISIPELLTHPYVQIQPHP-GS 798
|
|
| CGD|CAL0004016 MPS1 [Candida albicans (taxid:5476)] | Back alignment and assigned GO terms |
|---|
Score = 435 (158.2 bits), Expect = 1.8e-40, P = 1.8e-40
Identities = 116/373 (31%), Positives = 183/373 (49%)
Query: 176 FKGPTQTKSVFSVRSASDQSLSQKKNESTPVFKRPLSVNSTKSSDPSVSKET---IKPAK 232
F+ P KS S S + QS S + PVF+ L P S + + P+
Sbjct: 283 FRKPKAPKSAISP-SPNVQSNSMIP-PAQPVFRNTLQDFPKPPQQPQASSQNQQQVLPSA 340
Query: 233 PQITTSNAKKSVET-SQDVITLNGKQYQXXXXXXXXXXXXXXXXXXXXEHEFKPLALKVV 291
P ++ + + ++ + +N K Y+ + ALK V
Sbjct: 341 PIPPKAHYDRPQHSGNKRALIINDKSYEKLELIGKGGSSKVYRVRSLNNNCV--YALKKV 398
Query: 292 DLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYM 351
+L D S + E++LL KL+ C V+ + DY T LY++MEKGD DL++ +
Sbjct: 399 ELGQFEDVS---GFKGEIDLLTKLKSCERVVTLVDYA--TTESSLYLIMEKGDLDLAEVL 453
Query: 352 RNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGN 411
+ K+ P + + H EM +K++H AGI+HSDLKPANFLFV +LKIID
Sbjct: 454 QYRLKLDA-PLDLNFVKYHTIEMFKCIKDVHDAGIVHSDLKPANFLFVRGMLKIID---- 508
Query: 412 VLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSL 471
FGIA ++ D +V+++ GT NYM+PEA +++ + +++ SD+WS+
Sbjct: 509 ------FGIANAVPDHTINVYRENQIGTPNYMAPEAICESNYTSA-RIWKVGKPSDIWSI 561
Query: 472 GCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQK 531
GCILY IYG+ P++ K++AI +I F N +P + ++ MK CL +
Sbjct: 562 GCILYQFIYGKAPFAGYSGN-QKLMAITNPHIKISFPSSGIGNTPVPVSAIELMKNCLHR 620
Query: 532 DPKARPTVGNSVT 544
DP R T+ +T
Sbjct: 621 DPNDRWTIEQCLT 633
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 553 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-57 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 8e-55 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-46 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-45 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-44 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-36 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 7e-36 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 7e-35 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-34 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-32 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-32 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-31 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-31 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 6e-31 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 8e-30 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-29 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-27 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-26 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 7e-25 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 9e-25 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-24 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-24 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-23 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-23 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-22 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-22 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-22 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-21 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-21 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-21 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-21 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-21 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-21 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 6e-21 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-20 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-20 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-20 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-20 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-20 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 6e-20 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 9e-20 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-19 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-19 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 7e-19 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-18 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-18 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-18 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-18 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 9e-18 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-17 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-17 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-17 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-17 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-17 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 7e-17 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 7e-17 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 9e-17 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-16 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-16 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-16 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-16 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-16 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-16 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-16 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-16 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-16 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 8e-16 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-15 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-15 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-15 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-15 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-15 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-15 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-15 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-15 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-15 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-15 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 6e-15 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 7e-15 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 7e-15 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 9e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-14 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-14 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-14 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-14 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-14 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 7e-14 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 7e-14 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-13 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-13 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-13 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-13 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-13 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-13 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-13 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-13 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 8e-13 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 9e-13 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-12 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-12 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-12 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-12 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-12 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-12 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-12 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-12 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-12 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-12 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 5e-12 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-12 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 7e-12 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 8e-12 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 8e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 9e-12 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 9e-12 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-11 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-11 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-11 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-11 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-11 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-11 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 6e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 6e-11 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 7e-11 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-11 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 8e-11 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-10 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-10 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-10 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-10 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-10 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-10 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-10 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-10 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-10 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-10 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-10 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-10 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-10 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-10 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-10 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 6e-10 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-10 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 8e-10 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 8e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 9e-10 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-09 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-09 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-09 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-09 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-09 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-09 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-09 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-09 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-09 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-09 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 6e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 6e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 6e-09 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 7e-09 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-08 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-08 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-08 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-08 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-08 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-08 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-08 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-08 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 4e-08 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-08 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 5e-08 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 5e-08 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 6e-08 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 7e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 7e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 8e-08 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 8e-08 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 9e-08 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-07 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-07 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-07 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 1e-07 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-07 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-07 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-07 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-07 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-07 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-07 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-07 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-07 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-07 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-07 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-07 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-07 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 7e-07 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 7e-07 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 7e-07 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-06 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-06 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-06 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-06 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-06 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 1e-06 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-06 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-06 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-06 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-06 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-06 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-06 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-06 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-06 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-06 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-06 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-06 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 7e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 7e-06 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 9e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-05 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-05 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-05 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 4e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-05 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-05 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 5e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 5e-05 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 6e-05 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 6e-05 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 8e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 9e-05 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 9e-05 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-04 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-04 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-04 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-04 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-04 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-04 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-04 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-04 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-04 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-04 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 8e-04 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 9e-04 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 0.001 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 0.001 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 0.001 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 0.002 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 0.002 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 0.003 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 0.004 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 0.004 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 190 bits (486), Expect = 6e-57
Identities = 73/285 (25%), Positives = 121/285 (42%), Gaps = 43/285 (15%)
Query: 258 YQVLSLLGKGGSSSVYLV--GGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKL 315
Y++L LG+G VYL T + +A+KV+ I + L E+++L KL
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKL----VAIKVIKKKKIKKD--RERILREIKILKKL 54
Query: 316 QGCPYVIKMHDYVYDTASKHLYVLMEKGDT-DLSKYMRNLNKMTTLPNTMIIIIMHWYEM 374
+ P +++++D D LY++ME + DL ++ + L + ++
Sbjct: 55 K-HPNIVRLYDVFED--EDKLYLVMEYCEGGDLFDLLKKRGR---LSEDEARFYL--RQI 106
Query: 375 LLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKD 434
L A++ +H+ GI+H DLKP N L + +K+ DFG+A L +
Sbjct: 107 LSALEYLHSKGIVHRDLKPENILLDED---------GHVKLADFGLARQLDPGEKL---T 154
Query: 435 TASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494
T GT YM+PE Y D+WSLG ILY ++ G+ P+ + +
Sbjct: 155 TFVGTPEYMAPEVLLGKG-------Y--GKAVDIWSLGVILYELLTGKPPFPGD-DQLLE 204
Query: 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTV 539
+ P I P ++ L KDP+ R T
Sbjct: 205 LFKKIGKPK----PPFPPPEWDISPEAKDLIRKLLVKDPEKRLTA 245
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 185 bits (472), Expect = 8e-55
Identities = 82/282 (29%), Positives = 122/282 (43%), Gaps = 33/282 (11%)
Query: 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG 317
Y++L LG G +VY + K +A+K++ + E+ +L +L
Sbjct: 1 YELLRKLGSGSFGTVYK--AKHKGTGKIVAVKILKKRSEKS-KKDQTARREIRILRRLS- 56
Query: 318 CPYVIKMHDYVYDTASKHLYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLL 376
P ++++ D D HLY++ME + DL Y+ ++ ++L
Sbjct: 57 HPNIVRLIDAFED--KDHLYLVMEYCEGGDLFDYLSRGGPLS-----EDEAKKIALQILR 109
Query: 377 AVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTA 436
++ +H+ GIIH DLKP N L N V+KI DFG+A L K+S T
Sbjct: 110 GLEYLHSNGIIHRDLKPENILLDEN---------GVVKIADFGLAKKL--LKSSSSLTTF 158
Query: 437 SGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKML 496
GT YM+PE GGN Y K DVWSLG ILY ++ G+ P+S L
Sbjct: 159 VGTPWYMAPEV------LLGGNGY--GPKVDVWSLGVILYELLTGKPPFSGENI--LDQL 208
Query: 497 AIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
+ R + + +K CL KDP RPT
Sbjct: 209 QLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPT 250
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 163 bits (415), Expect = 1e-46
Identities = 76/285 (26%), Positives = 129/285 (45%), Gaps = 36/285 (12%)
Query: 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQ 316
++ LLG+G SVYL + + +A+K V+LS + ++ E+ +L+ LQ
Sbjct: 1 EWTRGELLGRGSFGSVYL--ALDKDTGELMAVKSVELSGD-SEEELEALEREIRILSSLQ 57
Query: 317 GCPYVIKMHDYVYDTASKHLYVLME--KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEM 374
P +++ + D L + +E G + LS ++ K LP +I ++
Sbjct: 58 -HPNIVRYYGSERDEEKNTLNIFLEYVSGGS-LSSLLKKFGK---LPEPVIRKYTR--QI 110
Query: 375 LLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKD 434
L + +H+ GI+H D+K AN L +D G V K+ DFG A L D +T
Sbjct: 111 LEGLAYLHSNGIVHRDIKGANIL--------VDSDGVV-KLADFGCAKRLGDIETGEGTG 161
Query: 435 TASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494
+ GT +M+PE +D+WSLGC + M G+ P+S + N A
Sbjct: 162 SVRGTPYWMAPEVIRGEEY---------GRAADIWSLGCTVIEMATGKPPWSELGNPMAA 212
Query: 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTV 539
+ I + P++ + + ++ CL++DPK RPT
Sbjct: 213 LYKIGSSGE----PPEIPEH--LSEEAKDFLRKCLRRDPKKRPTA 251
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 4e-45
Identities = 76/277 (27%), Positives = 119/277 (42%), Gaps = 70/277 (25%)
Query: 264 LGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIK 323
LG+GG +VYL + K +A+K++ D S+ + L E+E+L KL P ++K
Sbjct: 1 LGEGGFGTVYL--ARDKKTGKKVAIKIIKKED--SSSLLEELLREIEILKKLN-HPNIVK 55
Query: 324 MHDYVYDTASKHLYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIH 382
++ D HLY++ME + L ++ L I+ I+ ++L ++ +H
Sbjct: 56 LYGVFEDE--NHLYLVMEYCEGGSLKDLLKENEG--KLSEDEILRIL--LQILEGLEYLH 109
Query: 383 AAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNY 442
+ GIIH DLKP N L +D +K+ DFG++ L DK+ + T GT Y
Sbjct: 110 SNGIIHRDLKPENIL--------LDSDNGKVKLADFGLSKLLTSDKSLLK--TIVGTPAY 159
Query: 443 MSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARHK 502
M+PE + KSD+WSLG ILY +
Sbjct: 160 MAPEVL--------LGKGYYSEKSDIWSLGVILYEL------------------------ 187
Query: 503 DQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTV 539
P L ++ LQKDP+ RP+
Sbjct: 188 ----------------PELKDLIRKMLQKDPEKRPSA 208
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 6e-44
Identities = 91/306 (29%), Positives = 146/306 (47%), Gaps = 62/306 (20%)
Query: 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQ 316
+Y+++ +GKG VYLV + + K LK +DLS+++++ D+ LNEV++L KL
Sbjct: 1 KYEIIKQIGKGSFGKVYLV--RRKSDGKLYVLKEIDLSNMSEKEREDA-LNEVKILKKLN 57
Query: 317 GCPYVIKMHD-YVYDTASKHLYVLMEKGD-TDLSKYMRNLNKM-TTLPNTMIIIIMHWYE 373
P +IK ++ + L ++ME D DLS+ ++ K P I+ +
Sbjct: 58 -HPNIIKYYESFEEKG---KLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWF--VQ 111
Query: 374 MLLAVKEIHAAGIIHSDLKPAN-FLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVH 432
+ LA+K +H+ I+H D+KP N FL ++K+ DFGI+ L T
Sbjct: 112 LCLALKYLHSRKILHRDIKPQNIFL----------TSNGLVKLGDFGISKVLSS--TVDL 159
Query: 433 KDTASGTLNYMSPEA-AGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNT 491
T GT Y+SPE + YKSD+WSLGC+LY + + P+
Sbjct: 160 AKTVVGTPYYLSPELCQNK----------PYNYKSDIWSLGCVLYELCTLKHPFEG---- 205
Query: 492 WAKMLAIARHKDQI---EFKPQLANNVTIPPTL---LQSM-KLCLQKDPKARPTVGNSVT 544
+L +A +I ++ P IP L+++ LQKDP+ RP S+
Sbjct: 206 -ENLLELAL---KILKGQYPP-------IPSQYSSELRNLVSSLLQKDPEERP----SIA 250
Query: 545 QINNNP 550
QI +P
Sbjct: 251 QILQSP 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 6e-36
Identities = 78/316 (24%), Positives = 130/316 (41%), Gaps = 59/316 (18%)
Query: 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKL 315
++ ++G+G S+V L + K A+K++D + + E E+L +L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLA--KEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRL 58
Query: 316 QGCPYVIKMHDYVYDTASKHLYVLME---KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWY 372
G P +IK++ D + LY ++E G+ L +Y+R K +L
Sbjct: 59 NGHPGIIKLYYTFQDEEN--LYFVLEYAPNGE--LLQYIR---KYGSLDEKCTRFYAA-- 109
Query: 373 EMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVH 432
E+LLA++ +H+ GIIH DLKP N L + +KI DFG A L + +
Sbjct: 110 EILLALEYLHSKGIIHRDLKPENILLDKD---------MHIKITDFGTAKVLDPNSSPES 160
Query: 433 KDTAS------------------GTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCI 474
+ GT Y+SPE + + SD+W+LGCI
Sbjct: 161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAG---------KSSDLWALGCI 211
Query: 475 LYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPK 534
+Y M+ G+ P+ N + I K + F P L++ + L DP+
Sbjct: 212 IYQMLTGKPPF-RGSNEYLTFQKIL--KLEYSF-PPNFPPDAKD--LIEKL---LVLDPQ 262
Query: 535 ARPTVGNSVTQINNNP 550
R V ++ +P
Sbjct: 263 DRLGVNEGYDELKAHP 278
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 7e-36
Identities = 84/287 (29%), Positives = 131/287 (45%), Gaps = 48/287 (16%)
Query: 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG 317
+++L +GKGG VY K +A+KV+ L + +NE+++L K +
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTG--KEVAIKVIKLESKEKKE---KIINEIQILKKCKH 56
Query: 318 CPYVIKMHD-YVYDTASKHLYVLME---KG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWY 372
P ++K + Y+ L+++ME G DL K + TL + I +
Sbjct: 57 -PNIVKYYGSYLKKD---ELWIVMEFCSGGSLKDLLK-----STNQTLTESQIAYVCK-- 105
Query: 373 EMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVH 432
E+L ++ +H+ GIIH D+K A N+L D +K+IDFG++ L D K
Sbjct: 106 ELLKGLEYLHSNGIIHRDIKAA------NILLTSDG---EVKLIDFGLSAQLSDTKAR-- 154
Query: 433 KDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTW 492
+T GT +M+PE Y YK+D+WSLG + G+ PYS +P
Sbjct: 155 -NTMVGTPYWMAPEVINGK-------PY--DYKADIWSLGITAIELAEGKPPYSELPPMK 204
Query: 493 AKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTV 539
A + IA + P L N +K CLQK+P+ RPT
Sbjct: 205 A-LFKIATN----GP-PGLRNPEKWSDEFKDFLKKCLQKNPEKRPTA 245
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 7e-35
Identities = 86/287 (29%), Positives = 127/287 (44%), Gaps = 44/287 (15%)
Query: 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQ 316
++VL LGKG SVY V S+++F ALK VDL ++ + D+ +NE+ +LA +
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQF--YALKEVDLGSMSQKEREDA-VNEIRILASVN 57
Query: 317 GCPYVIKMHDYVYDTASKHLYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHW---Y 372
P +I + D L ++ME DLSK + K L I W
Sbjct: 58 H-PNIISYKEAFLD--GNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEI----WRIFI 110
Query: 373 EMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVH 432
++L ++ +H I+H DLK AN I+ +++KI D GI+ L
Sbjct: 111 QLLRGLQALHEQKILHRDLKSAN---------ILLVANDLVKIGDLGISKVL----KKNM 157
Query: 433 KDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTW 492
T GT +YM+PE S YKSD+WSLGC+LY M P+
Sbjct: 158 AKTQIGTPHYMAPEVWKGRPYS---------YKSDIWSLGCLLYEMATFAPPFE------ 202
Query: 493 AKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTV 539
A+ + R+K Q P + + L ++ LQ PK RP
Sbjct: 203 ARSMQDLRYKVQRGKYPPIPPIYS--QDLQNFIRSMLQVKPKLRPNC 247
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 133 bits (334), Expect = 3e-34
Identities = 83/290 (28%), Positives = 136/290 (46%), Gaps = 32/290 (11%)
Query: 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG 317
Y++L LG+G VYL + K +ALKV+ + + +L E+++LA L
Sbjct: 2 YRILRKLGEGSFGEVYLA-----RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNH 56
Query: 318 CPYVIKMHDYVYDTASKHLYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLL 376
P ++K++D+ D LY++ME D L ++ + + L + + I+ ++L
Sbjct: 57 PPNIVKLYDFFQD--EGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFIL--AQILS 112
Query: 377 AVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVH---- 432
A++ +H+ GIIH D+KP N L +D G V+K+IDFG+A L D ++
Sbjct: 113 ALEYLHSKGIIHRDIKPENIL--------LDRDGRVVKLIDFGLAKLLPDPGSTSSIPAL 164
Query: 433 KDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY--SHIPN 490
T+ GT YM+PE G + + SD+WSLG LY ++ G P+ +
Sbjct: 165 PSTSVGTPGYMAPE------VLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSS 218
Query: 491 TWAKMLAIARHKDQIEFKPQL--ANNVTIPPTLLQSMKLCLQKDPKARPT 538
++ L I L +N I +K L KDPK R +
Sbjct: 219 ATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLS 268
|
Length = 384 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 1e-32
Identities = 75/293 (25%), Positives = 134/293 (45%), Gaps = 50/293 (17%)
Query: 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQ 316
++Q + +G G VY E +A+K + + D D +E+++L L+
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGEL--MAVKEIRIQD-NDPKTIKEIADEMKVLELLK 57
Query: 317 -----GCPYVIKMHDYVYDTASKHLYVLME--KGDT--DLSKYMRNLNKMTTLPNTMIII 367
Y +++H + +Y+ ME G T +L ++ R L+ +I
Sbjct: 58 HPNLVKY-YGVEVHR-------EKVYIFMEYCSGGTLEELLEHGRILD--------EHVI 101
Query: 368 IMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDD 427
++ ++L + +H+ GI+H D+KPAN N V+K+ DFG A L+++
Sbjct: 102 RVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHN---------GVIKLGDFGCAVKLKNN 152
Query: 428 KTSVHKDTAS--GTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY 485
T++ ++ S GT YM+PE G G +D+WSLGC++ M G+ P+
Sbjct: 153 TTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRA------ADIWSLGCVVLEMATGKRPW 206
Query: 486 SHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
S + N + M + KP + +++ + P + CL+ DPK RPT
Sbjct: 207 SELDNEFQIMFHVGAGH-----KPPIPDSLQLSPEGKDFLDRCLESDPKKRPT 254
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 3e-32
Identities = 78/296 (26%), Positives = 133/296 (44%), Gaps = 57/296 (19%)
Query: 264 LGKGGSSSVYLVGGT-SEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVI 322
LGKG V LV + + A+KV+ I + + L E +L+++ P+++
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLY---AMKVLKKKKIIKRKEVEHTLTERNILSRIN-HPFIV 56
Query: 323 KMHDYVYDTASKHLYVLME--KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWY--EMLLAV 378
K+H Y + T + LY+++E G +L ++ + +Y E++LA+
Sbjct: 57 KLH-YAFQT-EEKLYLVLEYAPGG-ELFSHLSKEGR---FSEERA----RFYAAEIVLAL 106
Query: 379 KEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASG 438
+ +H+ GII+ DLKP N L +D G+ +K+ DFG+A L + + + T G
Sbjct: 107 EYLHSLGIIYRDLKPENIL--------LDADGH-IKLTDFGLAKELSSEGSRTN--TFCG 155
Query: 439 TLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN---TWAKM 495
T Y++PE G G D WSLG +LY M+ G+ P+ + + + K+
Sbjct: 156 TPEYLAPEVL-----LGKG----YGKAVDWWSLGVLLYEMLTGKPPF-YAEDRKEIYEKI 205
Query: 496 LAIARHKDQIEFKPQLANNVTIPPTLLQS-MKLCLQKDPKARPTVGNSVTQINNNP 550
L KD + F L+ + + LQKDP R +I +P
Sbjct: 206 L-----KDPLRFPEFLSPE-------ARDLISGLLQKDPTKRLG-SGGAEEIKAHP 248
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 1e-31
Identities = 78/288 (27%), Positives = 129/288 (44%), Gaps = 50/288 (17%)
Query: 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQ 316
YQ+ L+G+G VY G + +A+K + L I ++++ S + E++LL L+
Sbjct: 1 NYQLGDLIGRGAFGVVY--KGLNLETGDFVAIKQISLEKIKEEALK-SIMQEIDLLKNLK 57
Query: 317 GCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRN------LNKMTTLPNTMIIIIMH 370
P ++K + S LY+++E Y N + K P +++ + +
Sbjct: 58 H-PNIVKYIGSIET--SDSLYIILE--------YAENGSLRQIIKKFGPFPESLVAVYV- 105
Query: 371 WYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTS 430
Y++L + +H G+IH D+K AN L + V+K+ DFG+A L D
Sbjct: 106 -YQVLQGLAYLHEQGVIHRDIKAANILTTKD---------GVVKLADFGVATKLNDVSKD 155
Query: 431 VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN 490
+ GT +M+PE SG + SD+WSLGC + ++ G PY + N
Sbjct: 156 DA--SVVGTPYWMAPEVIEM---SG------ASTASDIWSLGCTVIELLTGNPPYYDL-N 203
Query: 491 TWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
A + I + P L ++ P L + C QKDP RPT
Sbjct: 204 PMAALFRIVQDDH-----PPLPEGIS--PELKDFLMQCFQKDPNLRPT 244
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 3e-31
Identities = 80/294 (27%), Positives = 124/294 (42%), Gaps = 60/294 (20%)
Query: 259 QVLSLLGKGGSSSVYLV--GGTSEHEFKPLALKVVDLSDITD--QSIADSYLNEVELLAK 314
+ + +LG+G S VY V T K ALK + + + + + E++ L
Sbjct: 4 ERVKVLGQGSSGVVYKVRHKPTG----KIYALKKIHVDGDEEFRKQLL----RELKTLRS 55
Query: 315 LQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYM------RNLNKMTTLPNTMIIII 368
PYV+K + Y + +++E YM L K+ +P ++ I
Sbjct: 56 -CESPYVVKCYGAFYKEGE--ISIVLE--------YMDGGSLADLLKKVGKIPEPVLAYI 104
Query: 369 MHWYEMLLAVKEIHA-AGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDD 427
++L + +H IIH D+KP+N L I+ G V KI DFGI+ L +
Sbjct: 105 A--RQILKGLDYLHTKRHIIHRDIKPSNLL--------INSKGEV-KIADFGISKVL--E 151
Query: 428 KTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSH 487
T +T GT+ YMSPE G +Y +Y +D+WSLG L G+ P+
Sbjct: 152 NTLDQCNTFVGTVTYMSPERIQ-------GESY--SYAADIWSLGLTLLECALGKFPFLP 202
Query: 488 --IPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTV 539
P+ + M AI + + P + CLQKDPK RP+
Sbjct: 203 PGQPSFFELMQAICD-GPPPSLPAEEFS-----PEFRDFISACLQKDPKKRPSA 250
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 6e-31
Identities = 83/318 (26%), Positives = 133/318 (41%), Gaps = 80/318 (25%)
Query: 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKL 315
++V+ ++G+G V+LV + + A+KV+ SD+ ++ E ++LA
Sbjct: 1 DDFEVIKVIGRGAFGEVWLV--RDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADA 58
Query: 316 QGCPYVIKMHDYVYDTASKHLYVLME---KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWY 372
P+++K++ D +HLY++ME GD M L + P +Y
Sbjct: 59 D-SPWIVKLYYSFQDE--EHLYLVMEYMPGGD-----LMNLLIRKDVFPEETA----RFY 106
Query: 373 --EMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTS 430
E++LA+ +H G IH D+KP N L ID G++ K+ DFG+ + K
Sbjct: 107 IAELVLALDSVHKLGFIHRDIKPDNIL--------IDADGHI-KLADFGLCKKMNKAKDR 157
Query: 431 ---------------------------VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRIT 463
V ++ GT +Y++PE T Y
Sbjct: 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTP-------Y--G 208
Query: 464 YKSDVWSLGCILYNMIYGRTP-YSHIPN-TWAKMLAIARHKDQIEFKPQLANNVTIPP-- 519
+ D WSLG ILY M+YG P YS T+ K I K+ + F P + P
Sbjct: 209 LECDWWSLGVILYEMLYGFPPFYSDTLQETYNK---IINWKESLRFPPD----PPVSPEA 261
Query: 520 -TLLQSMKLCLQKDPKAR 536
L+ + LC DP+ R
Sbjct: 262 IDLICRL-LC---DPEDR 275
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 8e-30
Identities = 86/297 (28%), Positives = 139/297 (46%), Gaps = 55/297 (18%)
Query: 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQ 316
Y+VL +GKG +V V S+ + L K +D ++T++ ++EV +L +L+
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKI--LVWKEIDYGNMTEKE-KQQLVSEVNILRELK 57
Query: 317 GCPYVIKMHDYVYDTASKHLYVLME---KGDTDLSKYMRNLNKMTT-LPNTMIIIIMHWY 372
P +++ +D + D +++ LY++ME GD L++ ++ K + I I+
Sbjct: 58 H-PNIVRYYDRIIDRSNQTLYIVMEYCEGGD--LAQLIQKCKKERKYIEEEFIWRIL--T 112
Query: 373 EMLLAVKEIHAAG-----IIHSDLKPAN-FLFVGNVLKIIDCIGNVLKIIDFGIACSLQD 426
++LLA+ E H ++H DLKPAN FL D NV K+ DFG+A L
Sbjct: 113 QLLLALYECHNRSDPGNTVLHRDLKPANIFL---------DANNNV-KLGDFGLAKILGH 162
Query: 427 DKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYS 486
D + T GT YMSPE +Y KSD+WSLGC++Y + P++
Sbjct: 163 DSSFAK--TYVGTPYYMSPEQLN-------HMSY--DEKSDIWSLGCLIYELCALSPPFT 211
Query: 487 HIPNTWAKMLAIARHKDQIEFKPQLANNVTIP----PTLLQSMKLCLQKDPKARPTV 539
AR++ Q+ K + IP L + +K L DP RP+
Sbjct: 212 ------------ARNQLQLASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPST 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 80/299 (26%), Positives = 130/299 (43%), Gaps = 71/299 (23%)
Query: 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKL 315
+ + +L +GKG VY + + +A+KV+DL + D+ I D E++ L++
Sbjct: 1 ELFTLLECIGKGSFGEVYK--AIDKRTNQVVAIKVIDLEEAEDE-IED-IQQEIQFLSQC 56
Query: 316 QGCPYVIKMH-DYVYDTASKHLYVLMEKGDTDLSKYM-----RNLNKMTTLPNTMIIIIM 369
+ PY+ K + ++ + L+++ME Y +L K L T I I+
Sbjct: 57 R-SPYITKYYGSFLKGS---KLWIIME--------YCGGGSCLDLLKPGKLDETYIAFIL 104
Query: 370 HWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKT 429
E+LL ++ +H G IH D+K AN L G+V K+ DFG++ L T
Sbjct: 105 R--EVLLGLEYLHEEGKIHRDIKAANILLSEE--------GDV-KLADFGVSGQLTS--T 151
Query: 430 SVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIP 489
++T GT +M+PE Q+ K+D+WSLG + G P S +
Sbjct: 152 MSKRNTFVGTPFWMAPEVIKQSGYD---------EKADIWSLGITAIELAKGEPPLSDL- 201
Query: 490 NTWAKMLAIARHKDQIEFK-PQLANNVTIPPTLLQSM---------KLCLQKDPKARPT 538
H ++ F P+ PP+L + LCL KDPK RP+
Sbjct: 202 -----------HPMRVLFLIPKNN-----PPSLEGNKFSKPFKDFVSLCLNKDPKERPS 244
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 91/285 (31%), Positives = 139/285 (48%), Gaps = 45/285 (15%)
Query: 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQ 316
YQ L L+G+G +VY G + +ALK+++L D D ++D EV LL++L+
Sbjct: 2 LYQRLELIGRGAYGAVY--RGKHVPTGRVVALKIINL-DTPDDDVSDIQ-REVALLSQLR 57
Query: 317 GC--PYVIKMHD-YVYDTASKHLYVLME--KGDTDLSKYMRNLNKMTTLPNTMIIIIMHW 371
P + K + Y+ L+++ME +G + +R L K + I +I+
Sbjct: 58 QSQPPNITKYYGSYLKGP---RLWIIMEYAEGGS-----VRTLMKAGPIAEKYISVIIR- 108
Query: 372 YEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSV 431
E+L+A+K IH G+IH D+K AN L + GNV K+ DFG+A L + S
Sbjct: 109 -EVLVALKYIHKVGVIHRDIKAANIL--------VTNTGNV-KLCDFGVAALLN--QNSS 156
Query: 432 HKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNT 491
+ T GT +M+PE G Y K+D+WSLG +Y M G PYS +
Sbjct: 157 KRSTFVGTPYWMAPEVIT------EGKYY--DTKADIWSLGITIYEMATGNPPYSDVDAF 208
Query: 492 WAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKAR 536
A ML I + K P+L +N L + + CL ++PK R
Sbjct: 209 RAMML-IPKSK-----PPRLEDN-GYSKLLREFVAACLDEEPKER 246
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 6e-26
Identities = 78/303 (25%), Positives = 134/303 (44%), Gaps = 56/303 (18%)
Query: 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQ 316
+++L ++GKG V +V K A+K ++ ++ + LNE +L +L
Sbjct: 1 HFELLRVIGKGAFGKVCIV--QKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELN 58
Query: 317 GCPYVIKMHDYVYDTASKHLYV---LMEKGDTDLSKYMR-NLNKMTTLPNTMIIIIMHWY 372
P+++ + D +++Y+ L+ GD +R +L++ + +
Sbjct: 59 H-PFLVNLWYSFQD--EENMYLVVDLLLGGD------LRYHLSQKVKFSEEQVKFWI--C 107
Query: 373 EMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVH 432
E++LA++ +H+ GIIH D+KP N L D G+V I DF IA + D +
Sbjct: 108 EIVLALEYLHSKGIIHRDIKPDNILL--------DEQGHV-HITDFNIATKVTPDTLT-- 156
Query: 433 KDTASGTLNYMSPEA-AGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNT 491
+ SGT YM+PE Q S D WSLG Y + G+ PY T
Sbjct: 157 -TSTSGTPGYMAPEVLCRQGYS----------VAVDWWSLGVTAYECLRGKRPYRGHSRT 205
Query: 492 WAKMLAIARHKDQIEFKPQLANNVTIPPT----LLQSMKLCLQKDPKARPTVGNSVTQIN 547
DQI K Q +V P T + ++ L++DP+ R +G+++ +
Sbjct: 206 IR---------DQIRAK-QETADVLYPATWSTEAIDAINKLLERDPQKR--LGDNLKDLK 253
Query: 548 NNP 550
N+P
Sbjct: 254 NHP 256
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 83/309 (26%), Positives = 132/309 (42%), Gaps = 65/309 (21%)
Query: 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG 317
Y+ L LG+G VY + + +ALK + L D ++ I + L E+ LL +L+
Sbjct: 1 YEKLEKLGEGTYGVVYK--ARDKKTGEIVALKKIRL-DNEEEGIPSTALREISLLKELK- 56
Query: 318 CPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLA 377
P ++K+ D ++ + LY++ E D DL KY+ L +I IM Y++L
Sbjct: 57 HPNIVKLLDVIHT--ERKLYLVFEYCDMDLKKYLDKRPG--PLSPNLIKSIM--YQLLRG 110
Query: 378 VKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQ-DDKTSVHKDTA 436
+ H+ I+H DLKP N + + VLK+ DFG+A + +T H+
Sbjct: 111 LAYCHSHRILHRDLKPQN-ILINR--------DGVLKLADFGLARAFGIPLRTYTHEVV- 160
Query: 437 SGTLNYMSPEAAGQTSSSG---GGNTYRITYKSDVWSLGCILYNMIYGRTPY---SHI-- 488
TL Y +PE G Y + D+WS+GCI MI G+ + S I
Sbjct: 161 --TLWYRAPE---------ILLGSKHY--STAVDIWSVGCIFAEMITGKPLFPGDSEIDQ 207
Query: 489 ------------PNTWAKMLAIARHKDQI-EFKPQLANNVTIPPT------LLQSMKLCL 529
+W + + +K +F P+ V +P LL M L
Sbjct: 208 LFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKV-LPRLDPEGIDLLSKM---L 263
Query: 530 QKDPKARPT 538
Q +P R +
Sbjct: 264 QYNPAKRIS 272
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 9e-25
Identities = 84/300 (28%), Positives = 135/300 (45%), Gaps = 55/300 (18%)
Query: 264 LGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIK 323
+ KG V+L S A+KV+ +D+ ++ D L E ++L++ Q PYV+K
Sbjct: 1 ISKGAYGRVFLAKKKSTG--DIYAIKVIKKADMIRKNQVDQVLTERDILSQAQ-SPYVVK 57
Query: 324 MHDYVYDTASKHLYVLME---KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKE 380
+ Y K+LY++ME GD L+ + N+ +L + I + E++LA++
Sbjct: 58 L--YYSFQGKKNLYLVMEYLPGGD--LASLLENVG---SLDEDVARIYI--AEIVLALEY 108
Query: 381 IHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFG------IACSLQDDKTSVHKD 434
+H+ GIIH DLKP N L ID G+ LK+ DFG + + +
Sbjct: 109 LHSNGIIHRDLKPDNIL--------IDSNGH-LKLTDFGLSKVGLVRRQINLNDDEKEDK 159
Query: 435 TASGTLNYMSPEA-AGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN--- 490
GT +Y++PE GQ S D WSLGCILY + G P+ H
Sbjct: 160 RIVGTPDYIAPEVILGQGHS----------KTVDWWSLGCILYEFLVGIPPF-HGETPEE 208
Query: 491 TWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNP 550
+ +L +IE+ P+ + + + L DP+ R S+ +I N+P
Sbjct: 209 IFQNIL-----NGKIEW-PEDVE---VSDEAIDLISKLLVPDPEKRL-GAKSIEEIKNHP 258
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 76/295 (25%), Positives = 136/295 (46%), Gaps = 43/295 (14%)
Query: 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG 317
+++ +GKG S VY + + +ALK V + ++ D L E++LL +L
Sbjct: 4 FKIEKKIGKGQFSVVY--KAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDH 61
Query: 318 CPYVIKMHD-YVYDTASKHLYVLMEKGDT-DLSKYMRNLNKM-TTLPNTMIIIIMHW--- 371
P VIK ++ + L +++E D DLS+ +++ K +P I W
Sbjct: 62 -PNVIKYLASFIENN---ELNIVLELADAGDLSRMIKHFKKQKRLIPERTI-----WKYF 112
Query: 372 YEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSV 431
++ A++ +H+ I+H D+KPAN V+K+ D G+ T+
Sbjct: 113 VQLCSALEHMHSKRIMHRDIKPANVFITAT---------GVVKLGDLGLGRFFSSKTTAA 163
Query: 432 HKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNT 491
H + GT YMSPE N Y +KSD+WSLGC+LY M ++P+
Sbjct: 164 H--SLVGTPYYMSPERIH-------ENGY--NFKSDIWSLGCLLYEMAALQSPFY---GD 209
Query: 492 WAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQI 546
+ ++ + ++ ++ P A++ + L + C+ DP+ RP + + V Q+
Sbjct: 210 KMNLYSLCKKIEKCDYPPLPADHYSEE--LRDLVSRCINPDPEKRPDI-SYVLQV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 3e-24
Identities = 77/293 (26%), Positives = 125/293 (42%), Gaps = 46/293 (15%)
Query: 264 LGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIK 323
LG GG V LV + + + ALK V I + + +E E+L + P+++K
Sbjct: 1 LGVGGFGRVELV--KVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECN-HPFIVK 57
Query: 324 MHDYVYDTASKHLYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIH 382
++ D K++Y+LME +L +R+ I ++LA + +H
Sbjct: 58 LYRTFKD--KKYIYMLMEYCLGGELWTILRDRGLFDE-YTARFYIAC----VVLAFEYLH 110
Query: 383 AAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQD-DKTSVHKDTASGTLN 441
GII+ DLKP N L +D G V K++DFG A L+ KT T GT
Sbjct: 111 NRGIIYRDLKPENLL--------LDSNGYV-KLVDFGFAKKLKSGQKTW----TFCGTPE 157
Query: 442 YMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHI-PNTWAKMLAIAR 500
Y++PE + G + D WSLG +LY ++ GR P+ + I +
Sbjct: 158 YVAPE---IILNKGYD------FSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILK 208
Query: 501 HKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVG---NSVTQINNNP 550
++EF P I +K L+++P+ R +G + I +
Sbjct: 209 GNGKLEF-PNY-----IDKAAKDLIKQLLRRNPEER--LGNLKGGIKDIKKHK 253
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 98.3 bits (246), Expect = 4e-23
Identities = 66/282 (23%), Positives = 115/282 (40%), Gaps = 45/282 (15%)
Query: 264 LGKGGSSSVY---LVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPY 320
LG+G VY L G E +A+K L + + + +L E ++ KL P
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTE-TKVAVKT--LKEGASEEEREEFLEEASIMKKLS-HPN 62
Query: 321 VIKMHDYVYDTASKHLYVLME---KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLA 377
++++ T + LY++ E GD L ++R + TL + + + ++
Sbjct: 63 IVRLLGVC--TQGEPLYIVTEYMPGGD--LLDFLRKHGEKLTLKDLLQMA----LQIAKG 114
Query: 378 VKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTAS 437
++ + + +H DL N L V V+KI DFG++ + +D +
Sbjct: 115 MEYLESKNFVHRDLAARNCL-VTE--------NLVVKISDFGLSRDIYEDDYYRKRGGGK 165
Query: 438 GTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI-YGRTPYSHIPNTWAKML 496
+ +M+PE+ + T KSDVWS G +L+ + G PY + N
Sbjct: 166 LPIKWMAPESL---------KDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSN------ 210
Query: 497 AIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
+ +E +L P L + M C DP+ RPT
Sbjct: 211 --EEVLELLEDGYRLPRPENCPDELYELMLQCWAYDPEDRPT 250
|
Length = 258 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 4e-23
Identities = 76/305 (24%), Positives = 114/305 (37%), Gaps = 54/305 (17%)
Query: 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLS--DITDQSIADSYLNEVELLAKL 315
YQ L +G+G VY E +A+K + L A L E++LL +L
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEI--VAIKKIKLRFESEGIPKTA---LREIKLLKEL 55
Query: 316 QGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEML 375
P +IK+ D LY++ E DTDL K +++ + LP ++I + Y++L
Sbjct: 56 NH-PNIIKLLDVF--RHKGDLYLVFEFMDTDLYKLIKDRQRG--LPESLIKSYL--YQLL 108
Query: 376 LAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDT 435
+ H+ GI+H DLKP N L VLK+ DFG+A S
Sbjct: 109 QGLAFCHSHGILHRDLKPENLLINTE---------GVLKLADFGLARSFGSPVRPYTHYV 159
Query: 436 ASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRT--PYSHIPNTWA 493
T Y +PE G Y + D+WS+GCI ++ R P +
Sbjct: 160 V--TRWYRAPELL------LGDKGY--STPVDIWSVGCIFAELLSRRPLFPGKSEIDQLF 209
Query: 494 KMLAI---ARHKDQIEFKP-QLANNVTIP---------------PTLLQSMKLCLQKDPK 534
K+ + +F + P P L + L DP
Sbjct: 210 KIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPH 269
Query: 535 ARPTV 539
R T
Sbjct: 270 KRITA 274
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 1e-22
Identities = 86/300 (28%), Positives = 131/300 (43%), Gaps = 71/300 (23%)
Query: 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVV----DLSDITDQSIADSYLNEVEL 311
+ + +L LG+G SVY + + +A+KVV DL +I + E+ +
Sbjct: 3 EVFDILEKLGEGSYGSVY--KAIHKETGQVVAIKVVPVEEDLQEI---------IKEISI 51
Query: 312 LAKLQGCPYVIKMH-DYVYDTASKHLYVLMEK-GDTDLSKYMRNLNKMTTLPNTMIIIIM 369
L + PY++K + Y +T L+++ME G +S M+ NK TL I I+
Sbjct: 52 LKQCD-SPYIVKYYGSYFKNT---DLWIVMEYCGAGSVSDIMKITNK--TLTEEEIAAIL 105
Query: 370 HWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKT 429
Y+ L ++ +H+ IH D+K N L ++ G K+ DFG++ L D T
Sbjct: 106 --YQTLKGLEYLHSNKKIHRDIKAGNIL--------LNEEGQA-KLADFGVSGQLTD--T 152
Query: 430 SVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIP 489
++T GT +M+PE + K+D+WSLG M G+ PYS I
Sbjct: 153 MAKRNTVIGTPFWMAPEVIQEI---------GYNNKADIWSLGITAIEMAEGKPPYSDIH 203
Query: 490 NTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQS----------MKLCLQKDPKARPTV 539
M AI I KP PPTL +K CL KDP+ RP+
Sbjct: 204 ----PMRAIF----MIPNKP--------PPTLSDPEKWSPEFNDFVKKCLVKDPEERPSA 247
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 6e-22
Identities = 79/283 (27%), Positives = 128/283 (45%), Gaps = 42/283 (14%)
Query: 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG 317
+++L+ +GKG V+ V ++ A+K +DLS + ++ + ++E +LAKL
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRV--YAMKQIDLSKM-NRREREEAIDEARVLAKLDS 58
Query: 318 CPYVIKMHDYVYDTASKHLYVLME-KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLL 376
Y+I+ ++ D L ++ME + DL K ++ LP + + ++LL
Sbjct: 59 -SYIIRYYESFLDKGK--LNIVMEYAENGDLHKLLKMQRG-RPLPEDQVWRF--FIQILL 112
Query: 377 AVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTA 436
+ +H+ I+H D+K N D NV KI D G+A L D+ + +T
Sbjct: 113 GLAHLHSKKILHRDIKSLNLFL--------DAYDNV-KIGDLGVAKLLSDN--TNFANTI 161
Query: 437 SGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKML 496
GT Y+SPE + KSDVW+LG +LY G+ P+ N A +L
Sbjct: 162 VGTPYYLSPELCEDKPYNE---------KSDVWALGVVLYECCTGKHPFD-ANNQGALIL 211
Query: 497 AIARHKDQIEFKPQLANNVTIP--PTLLQSMKLCLQKDPKARP 537
I R F P V+ L Q + CL KD + RP
Sbjct: 212 KIIRGV----FPP-----VSQMYSQQLAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 6e-22
Identities = 81/312 (25%), Positives = 131/312 (41%), Gaps = 66/312 (21%)
Query: 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQ- 316
Y+ L+ +G+G +VY + + +ALK V + ++++ I S L E+ LL +L+
Sbjct: 1 YEELAEIGEGAYGTVYK--ARDLNTGRFVALKKVRVP-LSEEGIPLSTLREIALLKQLES 57
Query: 317 -GCPYVIKMHD--YVYDTASK-HLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWY 372
P ++++ D + T + L ++ E D DL+ Y+ K LP I +M
Sbjct: 58 FEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPK-PGLPPETIKDLMR-- 114
Query: 373 EMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDK--TS 430
++L V +H+ I+H DLKP N L + G V KI DFG+A + TS
Sbjct: 115 QLLRGVDFLHSHRIVHRDLKPQNIL--------VTSDGQV-KIADFGLARIYSFEMALTS 165
Query: 431 VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKS--DVWSLGCILYNMIYGRTP---- 484
V TL Y +PE Q+S Y + D+WS+GCI + + R P
Sbjct: 166 V-----VVTLWYRAPEVLLQSS-----------YATPVDMWSVGCIFAEL-FRRRPLFRG 208
Query: 485 YSHI------------P--NTWAKMLAIAR----HKDQIEFKPQLANNVTIPPTLLQSMK 526
S P W + +++ R FK + LL+ M
Sbjct: 209 TSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKM- 267
Query: 527 LCLQKDPKARPT 538
L +P R +
Sbjct: 268 --LTFNPHKRIS 277
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 1e-21
Identities = 63/235 (26%), Positives = 107/235 (45%), Gaps = 39/235 (16%)
Query: 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDL--SDITDQSIADSYLNEVELLAKL 315
Y++L +G G V + + +A+K + D+ D A L E++LL L
Sbjct: 2 YELLKPIGSGAYGVVCS--AVDKRTGRKVAIKKISNVFDDLID---AKRILREIKLLRHL 56
Query: 316 QGCPYVIKMHDYVYDTAS---KHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWY 372
+ +I + D + + +Y++ E +TDL K +++ +T + I + Y
Sbjct: 57 R-HENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLT---DDHIQYFL--Y 110
Query: 373 EMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVH 432
++L +K +H+A +IH DLKP+N + V N +C LKI DFG+A + D
Sbjct: 111 QILRGLKYLHSANVIHRDLKPSN-ILV-N----SNC---DLKICDFGLARGVDPD--EDE 159
Query: 433 KDTASG---TLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTP 484
K + T Y +PE + Y T D+WS+GCI ++ R P
Sbjct: 160 KGFLTEYVVTRWYRAPELL------LSSSRY--TKAIDIWSVGCIFAELL-TRKP 205
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 2e-21
Identities = 70/283 (24%), Positives = 121/283 (42%), Gaps = 40/283 (14%)
Query: 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG 317
Y + +LGKG L T + + K V+L+ + + LNE+ +L+ LQ
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSL--VVWKEVNLTRL-SEKERRDALNEIVILSLLQH 58
Query: 318 CPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLA 377
P +I +++ D L + ME + K M++ + ++++ A
Sbjct: 59 -PNIIAYYNHFMD--DNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYL--FQIVSA 113
Query: 378 VKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTAS 437
V IH AGI+H D+K N ++K+ DFGI+ L + + +T
Sbjct: 114 VSYIHKAGILHRDIKTLNIFLTKA---------GLIKLGDFGISKILGSEYS--MAETVV 162
Query: 438 GTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY--SHIPNTWAKM 495
GT YMSPE G Y +KSD+W+LGC+LY ++ + + ++ N K+
Sbjct: 163 GTPYYMSPELCQ-------GVKY--NFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKI 213
Query: 496 LAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
+ + + L+ + LQ+DP+ RPT
Sbjct: 214 VQGNYTPVVSVYSSE----------LISLVHSLLQQDPEKRPT 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 2e-21
Identities = 68/229 (29%), Positives = 102/229 (44%), Gaps = 34/229 (14%)
Query: 257 QYQVLSLLGKGGSSSVYLVG--GTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAK 314
+Y++L +G+G V+ T E +ALK V L + I + L E++ L
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGE----TVALKKVALRRLEG-GIPNQALREIKALQA 55
Query: 315 LQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEM 374
Q PYV+K+ D V+ S ++ME +DLS+ +R+ + + M +
Sbjct: 56 CQ-HPYVVKLLD-VFPHGS-GFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRM----L 108
Query: 375 LLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKD 434
L V +HA GI+H DLKPAN L I G VLKI DFG+A L ++
Sbjct: 109 LKGVAYMHANGIMHRDLKPANLL--------ISADG-VLKIADFGLA-RLFSEEEPRLYS 158
Query: 435 TASGTLNYMSPEAA-GQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGR 482
T Y +PE G G D+W++GCI ++ G
Sbjct: 159 HQVATRWYRAPELLYGARKYDPG---------VDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 2e-21
Identities = 74/279 (26%), Positives = 134/279 (48%), Gaps = 36/279 (12%)
Query: 264 LGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIK 323
+G+G S VY + P+ALK V + D+ D + E++LL +L P VIK
Sbjct: 10 IGRGQFSEVYRATCLLDG--VPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH-PNVIK 66
Query: 324 MH-DYVYDTASKHLYVLMEKGDT-DLSKYMRNLNKMTTL-PNTMIIIIMHWYEMLLAVKE 380
+ ++ D L +++E D DLS+ +++ K L P + ++ ++ A++
Sbjct: 67 YYASFIEDN---ELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVW--KYFVQLCSALEH 121
Query: 381 IHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTL 440
+H+ ++H D+KPAN V+K+ D G+ T+ H + GT
Sbjct: 122 MHSRRVMHRDIKPANVFITAT---------GVVKLGDLGLGRFFSSKTTAAH--SLVGTP 170
Query: 441 NYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIAR 500
YMSPE + N Y +KSD+WSLGC+LY M ++P+ + ++ +
Sbjct: 171 YYMSPERIHE-------NGY--NFKSDIWSLGCLLYEMAALQSPFY---GDKMNLYSLCK 218
Query: 501 HKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTV 539
+Q ++ P +++ + L Q + +C+ DP+ RP +
Sbjct: 219 KIEQCDYPPLPSDHYS--EELRQLVNMCINPDPEKRPDI 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 93.4 bits (233), Expect = 2e-21
Identities = 76/284 (26%), Positives = 120/284 (42%), Gaps = 44/284 (15%)
Query: 261 LSLLGKGGSSSVYL--VGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGC 318
LG+G VY + G + +A+K + D ++Q I + +L E ++ KL
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTL-KEDASEQQIEE-FLREARIMRKLD-H 60
Query: 319 PYVIKMHDYVYDTASKHLYVLME---KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEML 375
P V+K+ T + LY++ME GD L Y+R N+ + ++ ++
Sbjct: 61 PNVVKLLGVC--TEEEPLYIVMEYMEGGD--LLSYLRK-NRPKLSLSDLLSFA---LQIA 112
Query: 376 LAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDT 435
++ + + IH DL N L VG V+KI DFG++ L DD K
Sbjct: 113 RGMEYLESKNFIHRDLAARNCL-VGE--------NLVVKISDFGLSRDLYDDDY-YRKRG 162
Query: 436 ASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI-YGRTPYSHIPNTWAK 494
+ +M+PE+ + T KSDVWS G +L+ + G PY + N
Sbjct: 163 GKLPIRWMAPESL---------KEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNE--- 210
Query: 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
+ + PQ N PP L M C +DP+ RPT
Sbjct: 211 --EVLEYLKNGYRLPQPPN---CPPELYDLMLQCWAEDPEDRPT 249
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 93.0 bits (232), Expect = 3e-21
Identities = 73/284 (25%), Positives = 122/284 (42%), Gaps = 43/284 (15%)
Query: 261 LSLLGKGGSSSVYL--VGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGC 318
LG+G VY + G + + +A+K + D ++Q I + +L E ++ KL
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTL-KEDASEQQIEE-FLREARIMRKLD-H 60
Query: 319 PYVIKMHDYVYDTASKHLYVLME---KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEML 375
P ++K+ T + L ++ME GD L Y+R N+ L + ++ ++
Sbjct: 61 PNIVKLLGVC--TEEEPLMIVMEYMPGGD--LLDYLRK-NRPKELSLSDLLSFA--LQIA 113
Query: 376 LAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDT 435
++ + + IH DL N L VG V+KI DFG++ L DD
Sbjct: 114 RGMEYLESKNFIHRDLAARNCL-VGE--------NLVVKISDFGLSRDLYDDDY-YKVKG 163
Query: 436 ASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI-YGRTPYSHIPNTWAK 494
+ +M+PE+ + T KSDVWS G +L+ + G PY + N
Sbjct: 164 GKLPIRWMAPESL---------KEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNA--- 211
Query: 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
+ + + P+ N PP L + M C +DP+ RPT
Sbjct: 212 --EVLEYLKKGYRLPKPPN---CPPELYKLMLQCWAEDPEDRPT 250
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 6e-21
Identities = 77/288 (26%), Positives = 120/288 (41%), Gaps = 51/288 (17%)
Query: 260 VLSLLGKGGSSSVYLVGGTSEHEFKP----LALKVVDLSDITDQSIADSYLNEVELLAKL 315
L LG G S V V +P +A+K + L +++I L E+++L K
Sbjct: 5 YLGELGAGNSGVVSKV------LHRPTGKIMAVKTIRLE--INEAIQKQILRELDILHKC 56
Query: 316 QGCPYVIKMHDYVYDTASKHLYVLMEKGD-TDLSKYMRNLNKMTTLP--NTMIIIIMHWY 372
PY++ + Y+ + + ME D L K ++ + + + ++
Sbjct: 57 N-SPYIVGFYGAFYNNGD--ISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGL 113
Query: 373 EMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVH 432
L E H IIH D+KP+N L ++ G + K+ DFG++ L +
Sbjct: 114 TYL---HEKH--KIIHRDVKPSNIL--------VNSRGQI-KLCDFGVSGQLVNSLA--- 156
Query: 433 KDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTW 492
T GT +YM+PE GN Y + KSD+WSLG L + GR PY +
Sbjct: 157 -KTFVGTSSYMAPERIQ-------GNDYSV--KSDIWSLGLSLIELATGRFPYPPENDPP 206
Query: 493 AKMLAIARHKDQI--EFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
I I E P+L + P + LCL KDP+ RP+
Sbjct: 207 ---DGIFELLQYIVNEPPPRLPSGK-FSPDFQDFVNLCLIKDPRERPS 250
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (230), Expect = 1e-20
Identities = 60/237 (25%), Positives = 104/237 (43%), Gaps = 44/237 (18%)
Query: 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSD------ITDQSIADSYLNEVEL 311
Y+ ++ +G+G VY E +ALK + + + IT + E++L
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGEL--VALKKIRMENEKEGFPIT-------AIREIKL 51
Query: 312 LAKLQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHW 371
L KL+ P ++++ + V +Y++ E D DL+ + + T I M
Sbjct: 52 LQKLRH-PNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQ--IKCYMK- 107
Query: 372 YEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSV 431
++L ++ +H+ GI+H D+K +N L I+ G LK+ DFG+A +
Sbjct: 108 -QLLEGLQYLHSNGILHRDIKGSNIL--------INNDGV-LKLADFGLARPYTKRNS-- 155
Query: 432 HKDTASG--TLNYMSPEA-AGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY 485
D + TL Y PE G T Y + D+WS+GCIL + G+ +
Sbjct: 156 -ADYTNRVITLWYRPPELLLGATR-------Y--GPEVDMWSVGCILAELFLGKPIF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 1e-20
Identities = 77/290 (26%), Positives = 125/290 (43%), Gaps = 40/290 (13%)
Query: 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKL 315
Y+++ ++G G ++ VY +E +A+K +DL Q+ D EV+ +++
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNE--KVAIKRIDLE--KCQTSVDELRKEVQAMSQC 56
Query: 316 QGCPYVIKMH-DYVYDTASKHLYVLME-KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYE 373
P V+K + +V L+++M L M++ L +I ++ E
Sbjct: 57 NH-PNVVKYYTSFVVGDE---LWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLK--E 110
Query: 374 MLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHK 433
+L ++ +H+ G IH D+K N L + G+V KI DFG++ SL D K
Sbjct: 111 VLKGLEYLHSNGQIHRDIKAGNIL--------LGEDGSV-KIADFGVSASLADGGDRTRK 161
Query: 434 --DTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNT 491
T GT +M+PE Q + Y +K+D+WS G + G PYS P
Sbjct: 162 VRKTFVGTPCWMAPEVMEQ------VHGY--DFKADIWSFGITAIELATGAAPYSKYPPM 213
Query: 492 WAKMLAIARHKDQIEFKPQLANNVTIPP---TLLQSMKLCLQKDPKARPT 538
ML + P L + + + LCLQKDP RPT
Sbjct: 214 KVLMLTLQND------PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPT 257
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 2e-20
Identities = 78/260 (30%), Positives = 128/260 (49%), Gaps = 32/260 (12%)
Query: 251 ITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVE 310
+ + + Y V+ ++G+G V LV S K A+K++ ++ +S + + E +
Sbjct: 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQ--KVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 311 LLAKLQGCPYVIKMHDYVYDTASKHLYVLME-KGDTDLSKYMRNLNKMTTLPNTMIIIIM 369
++A P+V+++ D K+LY++ME DL M N + +P
Sbjct: 96 IMA-FANSPWVVQLFCAFQD--DKYLYMVMEYMPGGDLVNLMSNYD----VPEKWAK--F 146
Query: 370 HWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKT 429
+ E++LA+ IH+ G+IH D+KP N L +D G+ LK+ DFG C D+
Sbjct: 147 YTAEVVLALDAIHSMGLIHRDVKPDNML--------LDKHGH-LKLADFG-TCMKMDETG 196
Query: 430 SVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY--SH 487
V DTA GT +Y+SPE S GG Y + D WS+G L+ M+ G TP+
Sbjct: 197 MVRCDTAVGTPDYISPEV---LKSQGGDGYY--GRECDWWSVGVFLFEMLVGDTPFYADS 251
Query: 488 IPNTWAKMLAIARHKDQIEF 507
+ T++K I HK+ + F
Sbjct: 252 LVGTYSK---IMDHKNSLNF 268
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 4e-20
Identities = 81/286 (28%), Positives = 133/286 (46%), Gaps = 36/286 (12%)
Query: 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG 317
+Q+ +G+G S VY T + KP+ALK V + ++ D + E++LL +L
Sbjct: 4 FQIEKKIGRGQFSEVY--RATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNH 61
Query: 318 CPYVIKMHDYVYDTASKHLYVLMEKGDT-DLSKYMRNLNKMTTL-PNTMIIIIMHWYEML 375
P VIK D L +++E D DLS+ ++ K L P + ++ ++
Sbjct: 62 -PNVIKYLDSF--IEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVW--KYFVQLC 116
Query: 376 LAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDT 435
AV+ +H+ ++H D+KPAN V+K+ D G+ T+ H +
Sbjct: 117 SAVEHMHSRRVMHRDIKPANVFITAT---------GVVKLGDLGLGRFFSSKTTAAH--S 165
Query: 436 ASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTP-YSHIPNTWAK 494
GT YMSPE + N Y +KSD+WSLGC+LY M ++P Y N
Sbjct: 166 LVGTPYYMSPERIHE-------NGY--NFKSDIWSLGCLLYEMAALQSPFYGDKMN---- 212
Query: 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVG 540
+ ++ + +Q ++ P + + L SM C+ DP RP +G
Sbjct: 213 LFSLCQKIEQCDYPPLPTEHYSEKLRELVSM--CIYPDPDQRPDIG 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 4e-20
Identities = 81/289 (28%), Positives = 123/289 (42%), Gaps = 58/289 (20%)
Query: 263 LLGKGGSSSVYLVGGTSEHEFKPLALKVV--DLSDITDQSIADSYLNEVELLAKLQGCPY 320
LLG G SVY G + + A+K V T Q E+ LL+KLQ P
Sbjct: 7 LLGSGSFGSVYE--GLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQH-PN 63
Query: 321 VIKMHDYVYDTASKHLYVLME---KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLA 377
+++ + +LY+ +E G L+K ++ K + P +I ++ ++LL
Sbjct: 64 IVQY--LGTEREEDNLYIFLELVPGGS--LAKLLK---KYGSFPEP--VIRLYTRQILLG 114
Query: 378 VKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTAS 437
++ +H +H D+K AN L +D G V+K+ DFG+A K V A
Sbjct: 115 LEYLHDRNTVHRDIKGANIL--------VDTNG-VVKLADFGMA------KQVVEFSFAK 159
Query: 438 ---GTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494
G+ +M+PE Q G +D+WSLGC + M G+ P+S + A
Sbjct: 160 SFKGSPYWMAPEVIAQQGGYG--------LAADIWSLGCTVLEMATGKPPWSQL-EGVAA 210
Query: 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMK----LCLQKDPKARPTV 539
+ I R K+ IP L K CLQ+DP RPT
Sbjct: 211 VFKIGRSKELPP----------IPDHLSDEAKDFILKCLQRDPSLRPTA 249
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 6e-20
Identities = 83/304 (27%), Positives = 137/304 (45%), Gaps = 58/304 (19%)
Query: 251 ITLNGKQY-------QVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIAD 303
+T++G++Y + L +G G VY + + +A+K + + +++
Sbjct: 3 LTIDGQKYPADLNDLENLGEIGSGTCGQVYKM--RFKKTGHVMAVKQMRRTGNKEEN--K 58
Query: 304 SYLNEVELLAKLQGCPYVIKMHDY-VYDTASKHLYVLMEKGDTDLSKYMRN--------- 353
L +++++ K CPY++K + Y + D+ +++ ME T L K ++
Sbjct: 59 RILMDLDVVLKSHDCPYIVKCYGYFITDS---DVFICMELMSTCLDKLLKRIQGPIPEDI 115
Query: 354 LNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413
L KMT I+ +H+ +KE H G+IH D+KP+N L D GNV
Sbjct: 116 LGKMTV----AIVKALHY------LKEKH--GVIHRDVKPSNILL--------DASGNV- 154
Query: 414 KIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGC 473
K+ DFGI+ L D K K ++G YM+PE + Y I ++DVWSLG
Sbjct: 155 KLCDFGISGRLVDSKA---KTRSAGCAAYMAPE---RIDPPDPNPKYDI--RADVWSLGI 206
Query: 474 ILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDP 533
L + G+ PY T ++L ++ P L N P + LCL KD
Sbjct: 207 SLVELATGQFPY-KNCKTEFEVLTKILQEE----PPSLPPNEGFSPDFCSFVDLCLTKDH 261
Query: 534 KARP 537
+ RP
Sbjct: 262 RKRP 265
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 9e-20
Identities = 75/262 (28%), Positives = 125/262 (47%), Gaps = 36/262 (13%)
Query: 253 LNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELL 312
+ + + V+ ++G+G V LV S + A+K++ ++ +S + + E +++
Sbjct: 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSK--QVYAMKLLSKFEMIKRSDSAFFWEERDIM 97
Query: 313 AKLQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMI---IIIM 369
A +++++H D K+LY++ME YM + + + N I
Sbjct: 98 AHANS-EWIVQLHYAFQD--DKYLYMVME--------YMPGGDLVNLMSNYDIPEKWARF 146
Query: 370 HWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKT 429
+ E++LA+ IH+ G IH D+KP N L +D G+ LK+ DFG C D
Sbjct: 147 YTAEVVLALDAIHSMGFIHRDVKPDNML--------LDKSGH-LKLADFG-TCMKMDANG 196
Query: 430 SVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY--SH 487
V DTA GT +Y+SPE S GG Y + D WS+G LY M+ G TP+
Sbjct: 197 MVRCDTAVGTPDYISPEV---LKSQGGDGYY--GRECDWWSVGVFLYEMLVGDTPFYADS 251
Query: 488 IPNTWAKMLAIARHKDQIEFKP 509
+ T++K I HK+ + F
Sbjct: 252 LVGTYSK---IMDHKNSLTFPD 270
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 5e-19
Identities = 75/292 (25%), Positives = 117/292 (40%), Gaps = 60/292 (20%)
Query: 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG 317
Y+ L +G+G S VY T K +A+K + L + I +NE+ ++ +
Sbjct: 21 YKNLEKIGEGASGEVYK--ATDRATGKEVAIKKMRLRKQNKELI----INEILIMKDCKH 74
Query: 318 CPYVIKMHD-YVYDTASKHLYVLMEKGDTDLSKYM--RNL-----NKMTTLPNTMIIIIM 369
P ++ +D Y+ L+V+ME YM +L + I +
Sbjct: 75 -PNIVDYYDSYLVG---DELWVVME--------YMDGGSLTDIITQNFVRMNEPQIAYVC 122
Query: 370 HWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSL---QD 426
E+L ++ +H+ +IH D+K N L + G+V K+ DFG A L +
Sbjct: 123 R--EVLQGLEYLHSQNVIHRDIKSDNILLSKD--------GSV-KLADFGFAAQLTKEKS 171
Query: 427 DKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYS 486
+ SV GT +M+PE Y K D+WSLG + M G PY
Sbjct: 172 KRNSV-----VGTPYWMAPEVIK-------RKDY--GPKVDIWSLGIMCIEMAEGEPPYL 217
Query: 487 HIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
P A + I + P L N P + CL KDP+ RP+
Sbjct: 218 REPPLRA-LFLIT-----TKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPS 263
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 6e-19
Identities = 82/285 (28%), Positives = 139/285 (48%), Gaps = 40/285 (14%)
Query: 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKL 315
K + V SL+G+G V +V + + A+KV+ S + Q + E ++L+ +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDI--YAMKVMKKSVLLAQETVSFFEEERDILS-I 57
Query: 316 QGCPYVIKMHDYVYDTASKHLYVLME---KGD--TDLSKYMRNLNKMTTLPNTMIIIIMH 370
P++ ++ D +LY++ME GD + L++Y ++ + +
Sbjct: 58 SNSPWIPQLQYAFQD--KDNLYLVMEYQPGGDLLSLLNRYEDQFDED--------MAQFY 107
Query: 371 WYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTS 430
E++LA+ +H G +H D+KP N L ID G++ K+ DFG A L +K
Sbjct: 108 LAELVLAIHSVHQMGYVHRDIKPENVL--------IDRTGHI-KLADFGSAARLTANKMV 158
Query: 431 VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN 490
K GT +Y++PE T + G TY + + D WSLG I Y MIYGR+P+
Sbjct: 159 NSK-LPVGTPDYIAPEVL-TTMNGDGKGTYGV--ECDWWSLGVIAYEMIYGRSPFHE--G 212
Query: 491 TWAKMLA-IARHKDQIEF--KPQLANNVTIPPTLLQSMKLCLQKD 532
T AK I + ++F P+++++ L+QS+ LC QK+
Sbjct: 213 TSAKTYNNIMNFQRFLKFPEDPKVSSDFL---DLIQSL-LCGQKE 253
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 7e-19
Identities = 77/296 (26%), Positives = 131/296 (44%), Gaps = 58/296 (19%)
Query: 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG 317
++++ LG G VY F A K++ + ++ + D ++ E+++L++ +
Sbjct: 7 WEIIGELGDGAFGKVYKAQHKETGLFA--AAKIIQIES--EEELED-FMVEIDILSECKH 61
Query: 318 CPYVIKMHD-YVYDTASKHLYVLMEK-GDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEML 375
P ++ +++ Y Y+ L++L+E L M L + T P I + +ML
Sbjct: 62 -PNIVGLYEAYFYEN---KLWILIEFCDGGALDSIMLELERGLTEPQ--IRYVCR--QML 113
Query: 376 LAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDT 435
A+ +H+ +IH DLK N L + G+V K+ DFG+ S ++ T +DT
Sbjct: 114 EALNFLHSHKVIHRDLKAGNILLTLD--------GDV-KLADFGV--SAKNKSTLQKRDT 162
Query: 436 ASGTLNYMSPEA-AGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494
GT +M+PE A +T N Y YK+D+WSLG L + P+ +
Sbjct: 163 FIGTPYWMAPEVVACETFKD---NPY--DYKADIWSLGITLIELAQMEPPHHEL------ 211
Query: 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQS----------MKLCLQKDPKARPTVG 540
+ ++ K + PPTL Q +K CL KDP RPT
Sbjct: 212 ------NPMRVLLKILKSE----PPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAA 257
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (214), Expect = 1e-18
Identities = 83/314 (26%), Positives = 127/314 (40%), Gaps = 74/314 (23%)
Query: 258 YQVLSLLGKGGSSSVYLVGGTSEHEF---KPLALKVVDLSDITDQSIADSYLNEVELLAK 314
Y+V+ LG G SVYL E K + K + + L EV+ L K
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN-------LREVKSLRK 53
Query: 315 LQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEM 374
L P ++K+ + + LY + E + +L + M++ K ++I I+ Y++
Sbjct: 54 LNEHPNIVKLKEVFREN--DELYFVFEYMEGNLYQLMKD-RKGKPFSESVIRSII--YQI 108
Query: 375 LLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKD 434
L + IH G H DLKP N L G V+KI DFG+A ++ + D
Sbjct: 109 LQGLAHIHKHGFFHRDLKPENLLVSGPE---------VVKIADFGLAREIRSRPP--YTD 157
Query: 435 TASGTLNYMSPEAAGQTSSSGGGNTYRITYKS--DVWSLGCI---LYNM----------- 478
S T Y +PE +++S Y S D+W+LGCI LY +
Sbjct: 158 YVS-TRWYRAPEILLRSTS----------YSSPVDIWALGCIMAELYTLRPLFPGSSEID 206
Query: 479 -------IYGRTPYSHIPNTWAKMLAIARHKDQIEFK-PQLANNV------TIPPTLLQS 524
+ G TP W + +A ++ F+ PQ A P +
Sbjct: 207 QLYKICSVLG-TP---TKQDWPEGYKLAS---KLGFRFPQFAPTSLHQLIPNASPEAIDL 259
Query: 525 MKLCLQKDPKARPT 538
+K L+ DPK RPT
Sbjct: 260 IKDMLRWDPKKRPT 273
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 2e-18
Identities = 79/275 (28%), Positives = 135/275 (49%), Gaps = 37/275 (13%)
Query: 238 SNAKKSVETSQDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEF--KPLALKVVDLSD 295
+ K ++ +D + + + Y+V+ ++G+G V LV H+ K A+K++ +
Sbjct: 26 NRYKDTINKIRD-LRMKAEDYEVVKVIGRGAFGEVQLV----RHKSTRKVYAMKLLSKFE 80
Query: 296 ITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLME-KGDTDLSKYMRNL 354
+ +S + + E +++A P+V+++ D ++LY++ME DL M N
Sbjct: 81 MIKRSDSAFFWEERDIMA-FANSPWVVQLFYAFQD--DRYLYMVMEYMPGGDLVNLMSNY 137
Query: 355 NKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414
+ +P + E++LA+ IH+ G IH D+KP N L +D G+ LK
Sbjct: 138 D----VPEKWAR--FYTAEVVLALDAIHSMGFIHRDVKPDNML--------LDKSGH-LK 182
Query: 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCI 474
+ DFG C + + V DTA GT +Y+SPE S GG Y + D WS+G
Sbjct: 183 LADFG-TCMKMNKEGMVRCDTAVGTPDYISPEV---LKSQGGDGYY--GRECDWWSVGVF 236
Query: 475 LYNMIYGRTPY--SHIPNTWAKMLAIARHKDQIEF 507
LY M+ G TP+ + T++K I HK+ + F
Sbjct: 237 LYEMLVGDTPFYADSLVGTYSK---IMNHKNSLTF 268
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 3e-18
Identities = 77/250 (30%), Positives = 114/250 (45%), Gaps = 48/250 (19%)
Query: 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKL 315
K +Q+L+ +G+GG V+L E +ALK + S + + L E ++L
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEI--VALKRMKKSLLFKLNEVRHVLTERDILTTT 58
Query: 316 QGCPYVIKMHDYVYDTASKHLYVLME---KGDTDLSKYMRNLNKMTTLPNTMIIIIMH-- 370
+ +++K+ D ++LY+ ME GD R L L N ++ H
Sbjct: 59 KS-EWLVKLLYAFQDD--EYLYLAMEYVPGGD------FRTL-----LNNLGVLSEDHAR 104
Query: 371 WY--EMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDK 428
+Y EM AV +H G IH DLKP NFL ID G++ K+ DFG++ +
Sbjct: 105 FYMAEMFEAVDALHELGYIHRDLKPENFL--------IDASGHI-KLTDFGLSKGIVTYA 155
Query: 429 TSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYS-H 487
SV G+ +YM+PE G Y T D WSLGC+LY + G P+S
Sbjct: 156 NSV-----VGSPDYMAPEVL-------RGKGYDFTV--DYWSLGCMLYEFLCGFPPFSGS 201
Query: 488 IPN-TWAKML 496
PN TW +
Sbjct: 202 TPNETWENLK 211
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 5e-18
Identities = 71/304 (23%), Positives = 119/304 (39%), Gaps = 63/304 (20%)
Query: 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG 317
++++ ++G+G VY + + +A+K++D+ + ++ I + E +L K
Sbjct: 8 FELVEVIGEGTYGKVYK--ARHKKTGQLVAIKIMDIIEDEEEEIKE----EYNILRKYSN 61
Query: 318 CPYVIKMH----DYVYDTASKHLYVLMEKGD----TDLSKYMRNLNKMTTLPNTMIIIIM 369
P + + L+++ME TDL K +R K L I I+
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGK--RLKEEWIAYIL 119
Query: 370 HWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKT 429
E L + +H +IH D+K N L N V K++DFG+ S Q D T
Sbjct: 120 R--ETLRGLAYLHENKVIHRDIKGQNILLTKN--------AEV-KLVDFGV--SAQLDST 166
Query: 430 SVHKDTASGTLNYMSPE--AAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSH 487
++T GT +M+PE A + +SDVWSLG + G+ P
Sbjct: 167 LGRRNTFIGTPYWMAPEVIACDEQP------DASYDARSDVWSLGITAIELADGKPPLCD 220
Query: 488 IPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQS----------MKLCLQKDPKARP 537
+ A + I R+ PPTL + CL K+ + RP
Sbjct: 221 MHPMRA-LFKIPRNP---------------PPTLKSPENWSKKFNDFISECLIKNYEQRP 264
Query: 538 TVGN 541
+
Sbjct: 265 FMEE 268
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 9e-18
Identities = 76/283 (26%), Positives = 119/283 (42%), Gaps = 53/283 (18%)
Query: 264 LGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIK 323
LGKGG V + K A K +D + + LNE ++L K+ +++
Sbjct: 1 LGKGGFGEVC--ACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS-SRFIVS 57
Query: 324 MHDYVYDTASKHLYV--LMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEI 381
+ Y ++T V LM GD KY ++ + I + +++ ++ +
Sbjct: 58 L-AYAFETKDDLCLVMTLMNGGDL---KY--HIYNVGEPGFPEARAIFYAAQIICGLEHL 111
Query: 382 HAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLN 441
H I++ DLKP N L +D GNV +I D G+A L+ K + +GT
Sbjct: 112 HQRRIVYRDLKPENVL--------LDDHGNV-RISDLGLAVELKGGKKIKGR---AGTPG 159
Query: 442 YMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARH 501
YM+PE G Y + D ++LGC LY MI GR+P+ +
Sbjct: 160 YMAPEVLQ-------GEVY--DFSVDWFALGCTLYEMIAGRSPFR-------------QR 197
Query: 502 KDQIEFKP----QLANNVTIPPTLLQSMK-LC---LQKDPKAR 536
K+++E + L V P K LC LQKDP+ R
Sbjct: 198 KEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKR 240
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.2 bits (204), Expect = 2e-17
Identities = 71/264 (26%), Positives = 113/264 (42%), Gaps = 49/264 (18%)
Query: 287 ALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLME---KG 343
A+K + +++ D +L E ++ KL G P V+++ T + LY+++E G
Sbjct: 27 AVKTLKEDA-SEEERKD-FLKEARVMKKL-GHPNVVRL--LGVCTEEEPLYLVLEYMEGG 81
Query: 344 DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAG--------IIHSDLKPAN 395
D L Y+R + P + + ++L +I A G +H DL N
Sbjct: 82 D--LLDYLRKSRPVFPSPEKSTLSLK---DLLSFAIQI-AKGMEYLASKKFVHRDLAARN 135
Query: 396 FLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSG 455
L VG V+KI DFG++ + DD K + +M+PE+
Sbjct: 136 CL-VGE--------DLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESL------- 179
Query: 456 GGNTYRITYKSDVWSLGCILYNMI-YGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANN 514
T KSDVWS G +L+ + G TPY + N ++L R ++ KP+
Sbjct: 180 --KDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE--EVLEYLRKGYRLP-KPEYC-- 232
Query: 515 VTIPPTLLQSMKLCLQKDPKARPT 538
P L + M C Q DP+ RPT
Sbjct: 233 ---PDELYELMLSCWQLDPEDRPT 253
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-17
Identities = 74/262 (28%), Positives = 124/262 (47%), Gaps = 41/262 (15%)
Query: 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG 317
+++L ++G+G V +V + + A+K+++ ++ ++ + E ++L
Sbjct: 3 FEILKVIGRGAFGEVAVVKMKNTGQV--YAMKILNKWEMLKRAETACFREERDVLVN-GD 59
Query: 318 CPYVIKMHDYVYDTASKHLYVLME---KGD--TDLSKYMRNLNKMTTLPNTMIIIIMHWY 372
++ +H D +LY++M+ GD T LSK+ L P M +Y
Sbjct: 60 RRWITNLHYAFQD--ENNLYLVMDYYVGGDLLTLLSKFEDRL------PEDM----ARFY 107
Query: 373 --EMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTS 430
EM+LA+ +H G +H D+KP N L +D G++ ++ DFG L D T
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVL--------LDKNGHI-RLADFGSCLRLLADGT- 157
Query: 431 VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY--SHI 488
V + A GT +Y+SPE Q G G R + D WSLG +Y M+YG TP+ +
Sbjct: 158 VQSNVAVGTPDYISPEIL-QAMEDGKG---RYGPECDWWSLGVCMYEMLYGETPFYAESL 213
Query: 489 PNTWAKMLAIARHKDQIEFKPQ 510
T+ K I HK+ +F P
Sbjct: 214 VETYGK---IMNHKEHFQFPPD 232
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 2e-17
Identities = 86/311 (27%), Positives = 128/311 (41%), Gaps = 84/311 (27%)
Query: 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPL-ALKVVDLSDITDQSIADSYLNEVELLAKL 315
+Y + LGKG +VYLV + L LK + + ++ + E +LL+KL
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQ-EAQLLSKL 59
Query: 316 QGCPYVIKMHDYVYDTASKHLYVLMEK-GDTDLSKYMRNLNKM-TTLPNTMIIIIMHWY- 372
P ++K H + + ++ E DL + L TL + W+
Sbjct: 60 DH-PAIVKFHASFLERDA--FCIITEYCEGRDLDCKLEELKHTGKTLSENQVC---EWFI 113
Query: 373 EMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQ---DDKT 429
++LL V +H I+H DLK N +F+ N N+LKI DFG++ L D T
Sbjct: 114 QLLLGVHYMHQRRILHRDLKAKN-IFLKN---------NLLKIGDFGVSRLLMGSCDLAT 163
Query: 430 SVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNM----------- 478
T +GT YMSPEA G ++ KSD+WSLGCILY M
Sbjct: 164 -----TFTGTPYYMSPEAL----KHQGYDS-----KSDIWSLGCILYEMCCLAHAFEGQN 209
Query: 479 --------IYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQ 530
+ G TP +P T+++ L +++QSM L
Sbjct: 210 FLSVVLRIVEGPTP--SLPETYSRQLN----------------------SIMQSM---LN 242
Query: 531 KDPKARPTVGN 541
KDP RP+
Sbjct: 243 KDPSLRPSAAE 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 82.6 bits (205), Expect = 2e-17
Identities = 76/311 (24%), Positives = 130/311 (41%), Gaps = 65/311 (20%)
Query: 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDI--TDQSIADSYLNEVELLAK 314
+Y+ LG+G + VY + + +A+K + L + I + L E++LL +
Sbjct: 1 RYEKGKKLGEGTYAVVYK--ARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQE 58
Query: 315 LQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEM 374
L+ P +I + D V+ ++ ++ E +TDL K +++ + + T + ++M
Sbjct: 59 LKH-PNIIGLLD-VF-GHKSNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLM----T 111
Query: 375 LLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSV-HK 433
L ++ +H+ I+H DLKP N L + VLK+ DFG+A S + H+
Sbjct: 112 LRGLEYLHSNWILHRDLKPNNLLIASD---------GVLKLADFGLARSFGSPNRKMTHQ 162
Query: 434 DTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY-------- 485
T Y +PE G G D+WS+GCI ++ R P+
Sbjct: 163 VV---TRWYRAPELLFGARHYGVG--------VDMWSVGCIFAELLL-RVPFLPGDSDID 210
Query: 486 --SHI--------PNTWAKMLAIARHKDQIEFKPQLANNV-TIPPT-------LLQSMKL 527
I W + ++ D +EFKP + I P LLQ + L
Sbjct: 211 QLGKIFEALGTPTEENWPGVTSL---PDYVEFKPFPPTPLKQIFPAASDDALDLLQRL-L 266
Query: 528 CLQKDPKARPT 538
L +P R T
Sbjct: 267 TL--NPNKRIT 275
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 2e-17
Identities = 69/251 (27%), Positives = 120/251 (47%), Gaps = 46/251 (18%)
Query: 266 KGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMH 325
KG SVYL S ++ A+KV+ SD+ ++ + E ++ PYV K++
Sbjct: 6 KGAFGSVYLAKKRSTGDY--FAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 326 DYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWY-----EMLLAVKE 380
Y + + +LY++ME Y+ N +L T+ + W E++L V++
Sbjct: 64 -YSFQSKD-YLYLVME--------YL-NGGDCASLIKTLGGLPEDWAKQYIAEVVLGVED 112
Query: 381 IHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTL 440
+H GIIH D+KP N L ID G+ LK+ DFG++ + + GT
Sbjct: 113 LHQRGIIHRDIKPENLL--------IDQTGH-LKLTDFGLS------RNGLENKKFVGTP 157
Query: 441 NYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY-SHIPN-TWAKMLA- 497
+Y++PE + G G+ SD WSLGC+++ ++G P+ + P+ + +L+
Sbjct: 158 DYLAPE-----TILGVGD----DKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSR 208
Query: 498 -IARHKDQIEF 507
I ++ EF
Sbjct: 209 RINWPEEVKEF 219
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 7e-17
Identities = 90/293 (30%), Positives = 126/293 (43%), Gaps = 54/293 (18%)
Query: 259 QVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGC 318
+VL LGKG SVY V +A+K + L D+S + + E+++L K
Sbjct: 4 EVLDELGKGNYGSVYKV--LHRPTGVTMAMKEIRLE--LDESKFNQIIMELDILHKAVS- 58
Query: 319 PYVIKMHDYVYDTASKHLYVLMEKGDT-DLSKYMRNLNKMTTLPNTMIIIIMHWYEM-LL 376
PY++ + + + +Y+ ME D L K +P ++ I + L
Sbjct: 59 PYIVDFYGAFFIEGA--VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLK 116
Query: 377 AVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTA 436
+KE H IIH D+KP N L GN G V K+ DFG++ +L S+ K T
Sbjct: 117 FLKEEH--NIIHRDVKPTNVLVNGN--------GQV-KLCDFGVSGNLV---ASLAK-TN 161
Query: 437 SGTLNYMSPEAAGQTSSSGGGNTYRITY--KSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494
G +YM+PE GG TY +SDVWSLG + M GR PY P T+A
Sbjct: 162 IGCQSYMAPERI-----KSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYP--PETYAN 214
Query: 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQS---------MKLCLQKDPKARPT 538
+ A QL+ V P L S + CL K P RPT
Sbjct: 215 IFA------------QLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPT 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 7e-17
Identities = 62/230 (26%), Positives = 109/230 (47%), Gaps = 34/230 (14%)
Query: 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQ 316
+ + +G G V+LV + ALKV+ + ++ NE +L ++
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHY--YALKVMAIPEVIRLKQEQHVHNEKRVLKEVS 59
Query: 317 GCPYVIKMHDYVYDTASKHLYVLME-KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEML 375
P++I++ +D + LY+LME +L Y+RN + + N+ + + E++
Sbjct: 60 H-PFIIRLFWTEHD--QRFLYMLMEYVPGGELFSYLRNSGRFS---NSTGL--FYASEIV 111
Query: 376 LAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDT 435
A++ +H+ I++ DLKP N L +D G+ +K+ DFG A L+ D+T T
Sbjct: 112 CALEYLHSKEIVYRDLKPENIL--------LDKEGH-IKLTDFGFAKKLR-DRTW----T 157
Query: 436 ASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY 485
GT Y++PE S G N D W+LG ++Y M+ G P+
Sbjct: 158 LCGTPEYLAPEVIQ----SKGHNK-----AVDWWALGILIYEMLVGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 9e-17
Identities = 64/241 (26%), Positives = 109/241 (45%), Gaps = 45/241 (18%)
Query: 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKL 315
++ + LG G V LV + K ALK++ + I + LNE +L +
Sbjct: 1 DDFEFIKTLGTGSFGRVMLV--RHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI 58
Query: 316 QGCPYVIKMHDYVYDTASKHLYVLME---KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWY 372
+ P+++ ++ D +LY++ME G+ L ++R + P + Y
Sbjct: 59 R-HPFLVNLYGSFQDD--SNLYLVMEYVPGGE--LFSHLRKSGR---FPEPVARF----Y 106
Query: 373 --EMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTS 430
+++LA++ +H+ I++ DLKP N L +D G +KI DFG A + +T
Sbjct: 107 AAQVVLALEYLHSLDIVYRDLKPENLL--------LDSDGY-IKITDFGFAKRV-KGRTY 156
Query: 431 VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKS-DVWSLGCILYNMIYGRTP-YSHI 488
T GT Y++PE S G G K+ D W+LG ++Y M+ G P +
Sbjct: 157 ----TLCGTPEYLAPEI---ILSKGYG-------KAVDWWALGILIYEMLAGYPPFFDDN 202
Query: 489 P 489
P
Sbjct: 203 P 203
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 66/230 (28%), Positives = 100/230 (43%), Gaps = 30/230 (13%)
Query: 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG 317
Y+ L +G+G VY ++ K +ALK L + ++ I + L E+ LL L
Sbjct: 3 YEKLEKIGEGTYGKVY--KARDKNTGKLVALKKTRLE-MDEEGIPPTALREISLLQMLSE 59
Query: 318 CPYVIKMHDYVY---DTASKHLYVLMEKGDTDLSKYM-RNLNKMTT-LPNTMIIIIMHWY 372
Y++++ D + LY++ E D+DL K+M N LP I M Y
Sbjct: 60 SIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFM--Y 117
Query: 373 EMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDD-KTSV 431
++L V H G++H DLKP N L +D +LKI D G+ + K+
Sbjct: 118 QLLKGVAHCHKHGVMHRDLKPQNLL--------VDKQKGLLKIADLGLGRAFSIPVKSYT 169
Query: 432 HKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYG 481
H+ TL Y +PE G Y + D+WS+GCI M
Sbjct: 170 HEIV---TLWYRAPEVL------LGSTHY--STPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 2e-16
Identities = 81/298 (27%), Positives = 138/298 (46%), Gaps = 48/298 (16%)
Query: 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQ 316
+Y+ + ++G+G V+L ++ K + +K + + +T + NE ++L L
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQ--KLVIIKQIPVEQMTKDE-RLAAQNECQVLKLLS 57
Query: 317 GCPYVIKMHD-YVYDTASKHLYVLME--KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWY- 372
P +I+ ++ ++ D K L ++ME G T L++Y++ +T I+H++
Sbjct: 58 H-PNIIEYYENFLED---KALMIVMEYAPGGT-LAEYIQKRCNSLLDEDT----ILHFFV 108
Query: 373 EMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVH 432
++LLA+ +H I+H DLK N L +D V+KI DFGI+ L +
Sbjct: 109 QILLALHHVHTKLILHRDLKTQNIL--------LDKHKMVVKIGDFGISKILS---SKSK 157
Query: 433 KDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTW 492
T GT Y+SPE G Y KSD+W+LGC+LY + + + N
Sbjct: 158 AYTVVGTPCYISPELC-------EGKPY--NQKSDIWALGCVLYELASLKRAFEA-ANLP 207
Query: 493 AKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNP 550
A +L I F P +++ + P L Q + L DP RP ++QI P
Sbjct: 208 ALVLKIMSGT----FAP-ISDRYS--PDLRQLILSMLNLDPSKRPQ----LSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-16
Identities = 83/307 (27%), Positives = 137/307 (44%), Gaps = 57/307 (18%)
Query: 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQ 316
QY+ + +G+G VY + +ALK + L + D+ + + + E+ LL ++Q
Sbjct: 3 QYEKVEKIGEGTYGVVY--KARDRVTNETIALKKIRL-EQEDEGVPSTAIREISLLKEMQ 59
Query: 317 GCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLL 376
++++ D V+ + K LY++ E D DL K+M + P +I + Y++L
Sbjct: 60 H-GNIVRLQDVVH--SEKRLYLVFEYLDLDLKKHMDSSPDFAKNPR---LIKTYLYQILR 113
Query: 377 AVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDD-KTSVHKDT 435
+ H+ ++H DLKP N L ID N LK+ DFG+A + +T H+
Sbjct: 114 GIAYCHSHRVLHRDLKPQNLL--------IDRRTNALKLADFGLARAFGIPVRTFTHEVV 165
Query: 436 ASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY---SHI---- 488
TL Y +PE G Y + D+WS+GCI M+ + + S I
Sbjct: 166 ---TLWYRAPEIL------LGSRHY--STPVDIWSVGCIFAEMVNQKPLFPGDSEIDELF 214
Query: 489 --------PN--TWAKMLAIARHKDQI-EFKPQLANNVTIPPTL------LQSMKLCLQK 531
PN TW + ++ +K ++ P+ + T+ PTL L S L L
Sbjct: 215 KIFRILGTPNEETWPGVTSLPDYKSAFPKWPPK--DLATVVPTLEPAGVDLLSKMLRL-- 270
Query: 532 DPKARPT 538
DP R T
Sbjct: 271 DPSKRIT 277
|
Length = 294 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 76/320 (23%), Positives = 134/320 (41%), Gaps = 83/320 (25%)
Query: 256 KQYQVLSLLGKGGSSSVYLV--GGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLA 313
K ++ + LLGKG V+LV GT K ALKV+D ++ ++ L E E+LA
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTG----KLFALKVLDKKEMIKRNKVKRVLTEQEILA 56
Query: 314 KLQGCPYVIKMHDYVYDTASKHLYVLME---KGDTDLSKYMRNLNKMTTLPNTMIIIIMH 370
L P++ ++ + T +L ++M+ G+ + ++ +
Sbjct: 57 TLDH-PFLPTLY-ASFQT-ETYLCLVMDYCPGGELFRLLQRQPGKCLS-------EEVAR 106
Query: 371 WY--EMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDK 428
+Y E+LLA++ +H GI++ DLKP N L + G+++ + DF ++ +
Sbjct: 107 FYAAEVLLALEYLHLLGIVYRDLKPENILLHES--------GHIM-LSDFDLSKQSDVEP 157
Query: 429 T-------------SVHK---DTAS-----------GTLNYMSPE---AAGQTSSSGGGN 458
SV+ +T S GT Y++PE G S+
Sbjct: 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV---- 213
Query: 459 TYRITYKSDVWSLGCILYNMIYGRTPY--SHIPNTWAKMLAIARHKDQIEFKPQLANNVT 516
D W+LG +LY M+YG TP+ S+ T++ +L K+ +
Sbjct: 214 --------DWWTLGILLYEMLYGTTPFKGSNRDETFSNIL----KKE-----VTFPGSPP 256
Query: 517 IPPTLLQSMKLCLQKDPKAR 536
+ + ++ L KDP R
Sbjct: 257 VSSSARDLIRKLLVKDPSKR 276
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-16
Identities = 72/275 (26%), Positives = 128/275 (46%), Gaps = 37/275 (13%)
Query: 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG 317
++++ ++G+G V +V +H + A+K+++ ++ ++ + E +L
Sbjct: 3 FEIIKVIGRGAFGEVAVV--KMKHTERIYAMKILNKWEMLKRAETACFREERNVLVN-GD 59
Query: 318 CPYVIKMHDYVYDTASKHLYVLME---KGD--TDLSKYMRNLNKMTTLPNTMIIIIMHWY 372
C ++ +H D +LY++M+ GD T LSK+ L P M +
Sbjct: 60 CQWITTLHYAFQD--ENYLYLVMDYYVGGDLLTLLSKFEDRL------PEDMARFYIA-- 109
Query: 373 EMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVH 432
EM+LA+ IH +H D+KP N L +D G++ ++ DFG + D T V
Sbjct: 110 EMVLAIHSIHQLHYVHRDIKPDNVL--------LDMNGHI-RLADFGSCLKMNQDGT-VQ 159
Query: 433 KDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY--SHIPN 490
A GT +Y+SPE Q G G + + D WSLG +Y M+YG TP+ +
Sbjct: 160 SSVAVGTPDYISPEIL-QAMEDGMG---KYGPECDWWSLGVCMYEMLYGETPFYAESLVE 215
Query: 491 TWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSM 525
T+ K I H+++ +F + + L+Q +
Sbjct: 216 TYGK---IMNHEERFQFPSHITDVSEEAKDLIQRL 247
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 3e-16
Identities = 52/153 (33%), Positives = 72/153 (47%), Gaps = 28/153 (18%)
Query: 387 IHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPE 446
IH DL N L VG V KI DFG+A ++DD+ + + A + + +PE
Sbjct: 125 IHRDLAARNIL-VGE--------NLVCKIADFGLARLIEDDEYTARE-GAKFPIKWTAPE 174
Query: 447 AAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI-YGRTPYSHIPNTWAKMLAIARHKDQI 505
AA N R T KSDVWS G +L ++ YGR PY + N ++L +Q+
Sbjct: 175 AA---------NYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN--REVL------EQV 217
Query: 506 EFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
E ++ P L M C KDP+ RPT
Sbjct: 218 ERGYRMPRPPNCPEELYDLMLQCWDKDPEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 3e-16
Identities = 67/244 (27%), Positives = 106/244 (43%), Gaps = 45/244 (18%)
Query: 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAK 314
G +Y L LG G + V+ K +A+K + L+D QS+ L E++++ +
Sbjct: 4 GSRYMDLRPLGCGSNGLVF--SAVDSDCDKRVAVKKIVLTD--PQSV-KHALREIKIIRR 58
Query: 315 LQGCPYVIKMHDYVYDTASKH------------LYVLMEKGDTDLSKYMRNLNKMTTLPN 362
L ++K+++ + + S +Y++ E +TDL N+ + L
Sbjct: 59 LDH-DNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDL----ANVLEQGPLSE 113
Query: 363 TMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIAC 422
+ M Y++L +K IH+A ++H DLKPAN L VLKI DFG+A
Sbjct: 114 EHARLFM--YQLLRGLKYIHSANVLHRDLKPANVFINTEDL--------VLKIGDFGLAR 163
Query: 423 SLQDDKTSVHKDTASGTLN---YMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI 479
+ D HK S L Y SP N Y T D+W+ GCI M+
Sbjct: 164 IV--DPHYSHKGYLSEGLVTKWYRSPRLLLSP------NNY--TKAIDMWAAGCIFAEML 213
Query: 480 YGRT 483
G+
Sbjct: 214 TGKP 217
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 4e-16
Identities = 70/242 (28%), Positives = 111/242 (45%), Gaps = 42/242 (17%)
Query: 306 LNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSK-YMR-NLNKMTTLPNT 363
L +++++ + CPY++K + ++ ++ ME D L K Y + +P
Sbjct: 50 LMDLDVVMRSSDCPYIVKFYGALFREGD--CWICMELMDISLDKFYKYVYEVLKSVIPEE 107
Query: 364 MI-IIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIAC 422
++ I + + L +KE IIH D+KP+N L +D GN+ K+ DFGI+
Sbjct: 108 ILGKIAVATVKALNYLKEELK--IIHRDVKPSNIL--------LDRNGNI-KLCDFGISG 156
Query: 423 SLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGR 482
L D S+ K +G YM+PE S+ G Y + +SDVWSLG LY + G+
Sbjct: 157 QLVD---SIAKTRDAGCRPYMAPERI-DPSARDG---YDV--RSDVWSLGITLYEVATGK 207
Query: 483 TPYSHIPNTWAKMLAIARHKDQIEF-----KPQLANN--VTIPPTLLQSMKLCLQKDPKA 535
PY W + DQ+ P L+N+ P+ + + LCL KD
Sbjct: 208 FPYP----KWNSVF------DQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESK 257
Query: 536 RP 537
RP
Sbjct: 258 RP 259
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 6e-16
Identities = 49/225 (21%), Positives = 98/225 (43%), Gaps = 35/225 (15%)
Query: 258 YQVLSLLGKGGSSSVYLVGGTSEHEF---KPLALKVVDLSDITDQSIADSYLNEVELLAK 314
Y++L +G+G S V ++ K + L + + L E++ L +
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN-------LREIQALRR 53
Query: 315 LQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEM 374
L P ++++ + ++D + L ++ E D +L + ++ + LP + M Y++
Sbjct: 54 LSPHPNILRLIEVLFDRKTGRLALVFELMDMNLYELIKG--RKRPLPEKRVKSYM--YQL 109
Query: 375 LLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKD 434
L ++ +H GI H D+KP N L I ++LK+ DFG + + +
Sbjct: 110 LKSLDHMHRNGIFHRDIKPENIL--------IK--DDILKLADFGSCRGI--YSKPPYTE 157
Query: 435 TASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI 479
S T Y +PE + G K D+W++GC+ + ++
Sbjct: 158 YIS-TRWYRAPEC---LLTDG-----YYGPKMDIWAVGCVFFEIL 193
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 8e-16
Identities = 66/224 (29%), Positives = 104/224 (46%), Gaps = 31/224 (13%)
Query: 318 CPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRN-LNKMTTLPNTMIIIIMHWYEMLL 376
CPY + + ++ +++ ME DT L K+ + +K T+P ++ I ++
Sbjct: 59 CPYTVTFYGALFREGD--VWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIA--VSIVK 114
Query: 377 AVKEIHAA-GIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDT 435
A++ +H+ +IH D+KP+N L I+ G V K+ DFGI+ L D SV K
Sbjct: 115 ALEYLHSKLSVIHRDVKPSNVL--------INRNGQV-KLCDFGISGYLVD---SVAKTI 162
Query: 436 ASGTLNYMSPEAA-GQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494
+G YM+PE + + G Y + KSDVWSLG + + GR PY +W
Sbjct: 163 DAGCKPYMAPERINPELNQKG----YDV--KSDVWSLGITMIELATGRFPYD----SWKT 212
Query: 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
+ + E PQL P + CL+K+ K RP
Sbjct: 213 PFQQLKQVVE-EPSPQLPAE-KFSPEFQDFVNKCLKKNYKERPN 254
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 77/280 (27%), Positives = 129/280 (46%), Gaps = 44/280 (15%)
Query: 261 LSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPY 320
L +GKG VY G + +A+K++DL + D+ + E+ +L++ PY
Sbjct: 9 LERIGKGSFGEVY--KGIDNRTKEVVAIKIIDLEEAEDE--IEDIQQEITVLSQCDS-PY 63
Query: 321 VIKMHDYVYDTASKHLYVLME--KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAV 378
+ + + Y +K L+++ME G + L +L K L T I I+ E+L +
Sbjct: 64 ITRYYG-SYLKGTK-LWIIMEYLGGGSAL-----DLLKPGPLEETYIATILR--EILKGL 114
Query: 379 KEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASG 438
+H+ IH D+K AN L G+V K+ DFG+A L D T + ++T G
Sbjct: 115 DYLHSERKIHRDIKAANVLLSEQ--------GDV-KLADFGVAGQLTD--TQIKRNTFVG 163
Query: 439 TLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAI 498
T +M+PE Q++ +K+D+WSLG + G P S + + + I
Sbjct: 164 TPFWMAPEVIKQSAYD---------FKADIWSLGITAIELAKGEPPNSDL-HPMRVLFLI 213
Query: 499 ARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
++ P L + P + ++ CL KDP+ RPT
Sbjct: 214 PKNS-----PPTLEGQYSKP--FKEFVEACLNKDPRFRPT 246
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 82/292 (28%), Positives = 131/292 (44%), Gaps = 66/292 (22%)
Query: 261 LSLLGKGGSSSVYLVGGTSEHEF-KPLALKVVDLSDI-TDQSIADSYLNEVELLAKLQGC 318
L +LGKGG V+ V + + K A+KV+ + I +Q E +L ++
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKH- 59
Query: 319 PYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIII----IMHWYEM 374
P+++ + Y + T K LY+++E Y+ L I + + E+
Sbjct: 60 PFIVDLI-YAFQTGGK-LYLILE--------YLSGGELFMHLEREGIFMEDTACFYLSEI 109
Query: 375 LLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKD 434
LA++ +H GII+ DLKP N L +D G+V K+ DFG+ C K S+H+
Sbjct: 110 SLALEHLHQQGIIYRDLKPENIL--------LDAQGHV-KLTDFGL-C-----KESIHEG 154
Query: 435 ----TASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN 490
T GT+ YM+PE SG G D WSLG ++Y+M+ G P++
Sbjct: 155 TVTHTFCGTIEYMAPEI---LMRSGHGKAV------DWWSLGALMYDMLTGAPPFT---- 201
Query: 491 TWAKMLAIARHK--DQIEFKPQLANNVTIPPTLLQS----MKLCLQKDPKAR 536
A R K D+I L + +PP L +K L+++P +R
Sbjct: 202 ------AENRKKTIDKI-----LKGKLNLPPYLTPEARDLLKKLLKRNPSSR 242
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 65/232 (28%), Positives = 103/232 (44%), Gaps = 30/232 (12%)
Query: 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSI-ADSYLNEVELLAKLQ 316
Y+++ LG+G V E + +A+K + +++ + I A L E++LL +
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKI--TNVFSKKILAKRALRELKLLRHFR 59
Query: 317 GCPYVIKMHDY--VYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEM 374
G + ++D V+ LY+ E + DL + +R+ +T I Y++
Sbjct: 60 GHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFI-----YQI 114
Query: 375 LLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSV--H 432
L +K IH+A ++H DLKP GN+L DC LKI DFG+A ++
Sbjct: 115 LCGLKYIHSANVLHRDLKP------GNLLVNADC---ELKICDFGLARGFSENPGENAGF 165
Query: 433 KDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTP 484
T Y +PE S T DVWS+GCIL + GR P
Sbjct: 166 MTEYVATRWYRAPEIMLSFQS--------YTKAIDVWSVGCILAEL-LGRKP 208
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 44/147 (29%), Positives = 71/147 (48%), Gaps = 28/147 (19%)
Query: 337 YVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANF 396
Y++ DL+ ++ K++ + + ++ Y++L +K IH+AGIIH DLKP+N
Sbjct: 96 YLVTHLMGADLNNIVK-CQKLSD--DHIQFLV---YQILRGLKYIHSAGIIHRDLKPSN- 148
Query: 397 LFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGG 456
+ V DC LKI+DFG+A D+ T T Y +PE
Sbjct: 149 IAVNE-----DC---ELKILDFGLARHTDDEMT-----GYVATRWYRAPEIM-------- 187
Query: 457 GNTYRITYKSDVWSLGCILYNMIYGRT 483
N D+WS+GCI+ ++ G+T
Sbjct: 188 LNWMHYNQTVDIWSVGCIMAELLTGKT 214
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-15
Identities = 70/265 (26%), Positives = 128/265 (48%), Gaps = 37/265 (13%)
Query: 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKL 315
+ +++L ++G+G V +V ++ K A+K+++ ++ ++ + E ++L
Sbjct: 1 EDFEILKVIGRGAFGEVAVV--KLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG 58
Query: 316 QGCPYVIKMHDYVYDTASKHLYVLME---KGD--TDLSKYMRNLNKMTTLPNTMIIIIMH 370
++ +H D +LY++M+ GD T LSK+ L P M +
Sbjct: 59 DN-QWITTLHYAFQD--ENNLYLVMDYYVGGDLLTLLSKFEDRL------PEDMARFYLA 109
Query: 371 WYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTS 430
EM++A+ +H +H D+KP N L +D G++ ++ DFG L +D T
Sbjct: 110 --EMVIAIDSVHQLHYVHRDIKPDNIL--------MDMNGHI-RLADFGSCLKLMEDGT- 157
Query: 431 VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY--SHI 488
V A GT +Y+SPE Q G G + + D WSLG +Y M+YG TP+ +
Sbjct: 158 VQSSVAVGTPDYISPEIL-QAMEDGKG---KYGPECDWWSLGVCMYEMLYGETPFYAESL 213
Query: 489 PNTWAKMLAIARHKDQIEFKPQLAN 513
T+ K++ HK++ +F Q+ +
Sbjct: 214 VETYGKIM---NHKERFQFPAQVTD 235
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 76/308 (24%), Positives = 137/308 (44%), Gaps = 57/308 (18%)
Query: 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPL-ALKVVDLSDI-TDQSIADSYLNEVELLAKL 315
+++L +LG G V+LV H+ L A+KV+ + I A+ E ++L +
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 316 QGCPYVIKMHDYVYDTASKHLYVLME---KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWY 372
+ CP+++ +H Y + T +K L+++++ G+ Y R + T + I
Sbjct: 62 RRCPFLVTLH-YAFQTDTK-LHLILDYVNGGELFTHLYQR---EHFTESEVRVYIA---- 112
Query: 373 EMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVH 432
E++LA+ +H GII+ D+K N L +D G+V + DFG L + +
Sbjct: 113 EIVLALDHLHQLGIIYRDIKLENIL--------LDSEGHV-VLTDFG----LSKEFLAEE 159
Query: 433 KDTA---SGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIP 489
++ A GT+ YM+PE + S G D WSLG + + ++ G +P++
Sbjct: 160 EERAYSFCGTIEYMAPEVI-RGGSGGHDKAV------DWWSLGVLTFELLTGASPFT--- 209
Query: 490 NTWAKMLAIARHKDQIEFKPQLANNVTIPPT-------LLQSMKLCLQKDPKARPTVGNS 542
+ ++ + L + P T +Q + L+KDPK R N
Sbjct: 210 ------VDGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQKL---LEKDPKKR-LGANG 259
Query: 543 VTQINNNP 550
+I N+P
Sbjct: 260 ADEIKNHP 267
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 1e-15
Identities = 72/274 (26%), Positives = 125/274 (45%), Gaps = 34/274 (12%)
Query: 264 LGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIK 323
LGKGG V V ++ K A K +D + +S L E E+L K+ P+++
Sbjct: 1 LGKGGFGEVCAV--QVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNS-PFIVN 57
Query: 324 MHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHA 383
+ Y +++ + V+ DL ++ N+ + M +I + ++ + +H+
Sbjct: 58 LA-YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGL---EMERVIHYSAQITCGILHLHS 113
Query: 384 AGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYM 443
I++ D+KP N L +D GN ++ D G+A L+D KT + +GT YM
Sbjct: 114 MDIVYRDMKPENVL--------LDDQGNC-RLSDLGLAVELKDGKTITQR---AGTNGYM 161
Query: 444 SPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARH-K 502
+PE + S Y D +++GC +Y M+ GRTP+ AK R +
Sbjct: 162 APEILKEEPYS---------YPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLE 212
Query: 503 DQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKAR 536
D+++F+ Q N T + +L L K P+ R
Sbjct: 213 DEVKFEHQ---NFTEESKDI--CRLFLAKKPEDR 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 81/312 (25%), Positives = 137/312 (43%), Gaps = 59/312 (18%)
Query: 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQ-SIADSYLNEVELLAKL 315
+Y++ ++GKG V H + +A+K ++ D+ + S A L E++LL L
Sbjct: 1 RYKIQEVIGKGSYGVV--CSAIDTHTGEKVAIKKIN--DVFEHVSDATRILREIKLLRLL 56
Query: 316 QGCPYVIKMHDYVYDTAS---KHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWY 372
+ P ++++ + + K +YV+ E ++DL + ++ + +T + + Y
Sbjct: 57 RH-PDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFL-----Y 110
Query: 373 EMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIA-CSLQDDKTSV 431
++L A+K IH A + H DLKP N+L DC LKI DFG+A + D T++
Sbjct: 111 QLLRALKYIHTANVFHRDLKPK------NILANADC---KLKICDFGLARVAFNDTPTAI 161
Query: 432 HKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGR--------- 482
T Y +PE G S + T D+WS+GCI ++ G+
Sbjct: 162 FWTDYVATRWYRAPELCGSFFS-------KYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV 214
Query: 483 -----------TPYSH----IPNTWA-KMLAIARHKDQIEFKPQLANNVTIPPTLLQSMK 526
TP + N A + L+ R K + F + N + LL+ +
Sbjct: 215 HQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERL- 273
Query: 527 LCLQKDPKARPT 538
L DPK RPT
Sbjct: 274 --LAFDPKDRPT 283
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 3e-15
Identities = 70/292 (23%), Positives = 118/292 (40%), Gaps = 53/292 (18%)
Query: 263 LLGKGGSSSVYLVGGTSEHEFKPLALKVVDL-------SDITDQSIADSYLNEVELLAKL 315
L+GKG VYL + E +A+K V+L D + + + +E+E L L
Sbjct: 8 LIGKGTYGRVYLALNVTTGEM--MAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 316 QGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYM---------RNLNKMTTLPNTMII 366
+++ Y+ E + LS ++ L ++
Sbjct: 66 DH-LNIVQ-------------YLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVR 111
Query: 367 IIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQD 426
++L + +H+ GI+H DLK N L +D G + KI DFGI+ D
Sbjct: 112 FFTE--QVLEGLAYLHSKGILHRDLKADNLL--------VDADG-ICKISDFGISKKSDD 160
Query: 427 DKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYS 486
+ + G++ +M+PE + S G + K D+WSLGC++ M GR P+S
Sbjct: 161 IYDNDQNMSMQGSVFWMAPEVI-HSYSQG------YSAKVDIWSLGCVVLEMFAGRRPWS 213
Query: 487 HIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
A M + + P ++ N++ P L + C +P RPT
Sbjct: 214 DE-EAIAAMFKLGNKRSAPPIPPDVSMNLS--PVALDFLNACFTINPDNRPT 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 4e-15
Identities = 67/234 (28%), Positives = 109/234 (46%), Gaps = 37/234 (15%)
Query: 262 SLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQ------SIADSYLNEVELLAKL 315
+L+G G SVYL S E +A+K V+L ++ S+ D+ E+ LL +L
Sbjct: 6 ALIGSGSFGSVYLGMNASSGEL--MAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL 63
Query: 316 QGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEML 375
Q +++ D + HL + +E + LN T++ + ++L
Sbjct: 64 QH-ENIVQYLGSSLD--ADHLNIFLEYVPGGSVAAL--LNNYGAFEETLVRNFVR--QIL 116
Query: 376 LAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSV---- 431
+ +H GIIH D+K AN L V N I KI DFGI+ L+ + S
Sbjct: 117 KGLNYLHNRGIIHRDIKGANIL-VDNKGGI--------KISDFGISKKLEANSLSTKTNG 167
Query: 432 HKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY 485
+ + G++ +M+PE QTS T K+D+WSLGC++ M+ G+ P+
Sbjct: 168 ARPSLQGSVFWMAPEVVKQTSY---------TRKADIWSLGCLVVEMLTGKHPF 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 6e-15
Identities = 47/153 (30%), Positives = 70/153 (45%), Gaps = 28/153 (18%)
Query: 387 IHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPE 446
IH DL N L VG N+ K+ DFG+A +++D + A + + +PE
Sbjct: 125 IHRDLAARNVL-VGE--------NNICKVADFGLARVIKEDIYEAREG-AKFPIKWTAPE 174
Query: 447 AAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI-YGRTPYSHIPNTWAKMLAIARHKDQI 505
AA R + KSDVWS G +L ++ YGR PY + N A++L Q+
Sbjct: 175 AA---------LYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN--AEVL------QQV 217
Query: 506 EFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
+ ++ P L M C ++DP RPT
Sbjct: 218 DQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPT 250
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 7e-15
Identities = 63/230 (27%), Positives = 109/230 (47%), Gaps = 29/230 (12%)
Query: 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQ 316
+Y+++ +G+G +YL S+ E +K +DL+ + + ++ EV LLAK++
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEH--CVIKEIDLTKMPVKE-KEASKKEVILLAKMK 57
Query: 317 GCPYVIKMHDYVYDTASKHLYVLMEKGDT-DLSKYMRNLNKMTTLPNTMIIIIMHWYEML 375
P ++ + + L+++ME D DL M+ +N+ + + I+ + ++
Sbjct: 58 H-PNIVTFFASFQE--NGRLFIVMEYCDGGDL---MKRINRQRGVLFSEDQILSWFVQIS 111
Query: 376 LAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDT 435
L +K IH I+H D+K N N G V K+ DFGIA L D + T
Sbjct: 112 LGLKHIHDRKILHRDIKSQNIFLSKN--------GMVAKLGDFGIARQLND--SMELAYT 161
Query: 436 ASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY 485
GT Y+SPE + K+D+WSLGC+LY + + P+
Sbjct: 162 CVGTPYYLSPEICQNRPYNN---------KTDIWSLGCVLYELCTLKHPF 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 7e-15
Identities = 60/201 (29%), Positives = 94/201 (46%), Gaps = 36/201 (17%)
Query: 287 ALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEKGDTD 346
ALK + L + D+ + + + E+ LL +L P ++++ D V+ LY++ E D D
Sbjct: 28 ALKKIRL-ETEDEGVPSTAIREISLLKELNH-PNIVRLLDVVHS--ENKLYLVFEFLDLD 83
Query: 347 LSKYMRNLNKMTTLPNTMI---IIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVL 403
L KYM + P T + +I + Y++L + H+ ++H DLKP N L
Sbjct: 84 LKKYM------DSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLL------ 131
Query: 404 KIIDCIGNVLKIIDFGIACSLQDD-KTSVHKDTASGTLNYMSPEA-AGQTSSSGGGNTYR 461
ID G LK+ DFG+A + +T H+ TL Y +PE G S
Sbjct: 132 --IDREGA-LKLADFGLARAFGVPVRTYTHEVV---TLWYRAPEILLGSRQYSTP----- 180
Query: 462 ITYKSDVWSLGCILYNMIYGR 482
D+WS+GCI M+ R
Sbjct: 181 ----VDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 9e-15
Identities = 60/230 (26%), Positives = 101/230 (43%), Gaps = 31/230 (13%)
Query: 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKL 315
+ Y+VL GKGG V K A K ++ I + LNE ++L K+
Sbjct: 3 RHYRVL---GKGGFGEV--CACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV 57
Query: 316 QGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEML 375
+V+ + Y Y+T VL DL ++ N+ + + E+
Sbjct: 58 NS-RFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYNMGN-PGFDEERAV--FYAAEIT 112
Query: 376 LAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDT 435
++++H I++ DLKP N L +D G++ +I D G+A + + +T +
Sbjct: 113 CGLEDLHRERIVYRDLKPENIL--------LDDYGHI-RISDLGLAVEIPEGETIRGR-- 161
Query: 436 ASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY 485
GT+ YM+PE R T+ D W LGC++Y MI G++P+
Sbjct: 162 -VGTVGYMAPEVV---------KNERYTFSPDWWGLGCLIYEMIEGKSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 74.0 bits (181), Expect = 1e-14
Identities = 80/284 (28%), Positives = 132/284 (46%), Gaps = 46/284 (16%)
Query: 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG 317
+ L +GKG V+ G K +A+K++DL + D+ + E+ +L++
Sbjct: 6 FTKLEKIGKGSFGEVF--KGIDNRTQKVVAIKIIDLEEAEDE--IEDIQQEITVLSQCDS 61
Query: 318 CPYVIKMH-DYVYDTASKHLYVLME--KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEM 374
PYV K + Y+ DT L+++ME G + L +L + L T I I+ E+
Sbjct: 62 -PYVTKYYGSYLKDT---KLWIIMEYLGGGSAL-----DLLEPGPLDETQIATILR--EI 110
Query: 375 LLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKD 434
L + +H+ IH D+K AN L + G V K+ DFG+A L D T + ++
Sbjct: 111 LKGLDYLHSEKKIHRDIKAANVLLSEH--------GEV-KLADFGVAGQLTD--TQIKRN 159
Query: 435 TASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494
T GT +M+PE Q++ K+D+WSLG + G P+S + +
Sbjct: 160 TFVGTPFWMAPEVIKQSAYDS---------KADIWSLGITAIELAKGEPPHSEL-HPMKV 209
Query: 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
+ I ++ P L N + P L + ++ CL K+P RPT
Sbjct: 210 LFLIPKNN-----PPTLEGNYSKP--LKEFVEACLNKEPSFRPT 246
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 66/249 (26%), Positives = 109/249 (43%), Gaps = 38/249 (15%)
Query: 254 NGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLA 313
Y L LG+G ++VY G S + +ALKV+ + T++ + + + E LL
Sbjct: 3 AATSYLNLEKLGEGSYATVY--KGISRINGQLVALKVISMK--TEEGVPFTAIREASLLK 58
Query: 314 KLQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYE 373
L+ V+ +HD ++ + L + E TDL++YM N + + ++
Sbjct: 59 GLKHANIVL-LHDIIHTKET--LTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFM----FQ 111
Query: 374 MLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHK 433
+L + IH I+H DLKP N L I +G LK+ DFG+A + S+
Sbjct: 112 LLRGLAYIHGQHILHRDLKPQNLL--------ISYLGE-LKLADFGLARA-----KSIPS 157
Query: 434 DTASG---TLNYMSPEA-AGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIP 489
T S TL Y P+ G T S D+W GCI M+ G+ + +
Sbjct: 158 QTYSSEVVTLWYRPPDVLLGATDYSS---------ALDIWGAGCIFIEMLQGQPAFPGVS 208
Query: 490 NTWAKMLAI 498
+ + ++ I
Sbjct: 209 DVFEQLEKI 217
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 82/288 (28%), Positives = 133/288 (46%), Gaps = 40/288 (13%)
Query: 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLAL-KVVDLSDITDQSIADSYLNEVELLA 313
+ ++++ LG G VY E LA KV++ +++ + D Y+ E+E+LA
Sbjct: 11 NEVWEIIGELGDGAFGKVY---KAKNKETGALAAAKVIETK--SEEELED-YMVEIEILA 64
Query: 314 KLQGCPYVIKMHDYVYDTASKHLYVLME---KGDTDLSKYMRNLNKMTTLPNTMIIIIMH 370
PY++K+ Y L++++E G D M L++ T P +I
Sbjct: 65 TCNH-PYIVKLLGAFY--WDGKLWIMIEFCPGGAVD--AIMLELDRGLTEPQIQVIC--- 116
Query: 371 WYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTS 430
+ML A++ +H+ IIH DLK GNVL +D G++ K+ DFG+ S ++ KT
Sbjct: 117 -RQMLEALQYLHSMKIIHRDLK------AGNVLLTLD--GDI-KLADFGV--SAKNVKTL 164
Query: 431 VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN 490
+D+ GT +M+PE + Y YK+D+WSLG L M P+ H N
Sbjct: 165 QRRDSFIGTPYWMAPEVV--MCETMKDTPY--DYKADIWSLGITLIEMAQIEPPH-HELN 219
Query: 491 TWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
+L IA+ + P L+ +K L K P+ RP+
Sbjct: 220 PMRVLLKIAKSE-----PPTLSQPSKWSMEFRDFLKTALDKHPETRPS 262
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 3e-14
Identities = 77/306 (25%), Positives = 128/306 (41%), Gaps = 60/306 (19%)
Query: 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQ 316
++ L LG+G ++VY G + + +ALK + L ++ + + E+ L+ +L+
Sbjct: 1 NFKQLEKLGEGTYATVY--KGRNRTTGEIVALKEIHLD--AEEGTPSTAIREISLMKELK 56
Query: 317 GCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLL 376
++++HD V T +K L ++ E D DL KYM L + Y++L
Sbjct: 57 H-ENIVRLHD-VIHTENK-LMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFT--YQLLK 111
Query: 377 AVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTA 436
+ H ++H DLKP N L I+ G LK+ DFG+A + + +T
Sbjct: 112 GIAFCHENRVLHRDLKPQNLL--------INKRGE-LKLADFGLARAF-----GIPVNTF 157
Query: 437 SG---TLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGR----------- 482
S TL Y +P+ G TY + D+WS+GCI+ MI GR
Sbjct: 158 SNEVVTLWYRAPDVLL------GSRTY--STSIDIWSVGCIMAEMITGRPLFPGTNNEDQ 209
Query: 483 ---------TPYSHIPNTWAKMLAIARHKDQIE-FKPQLANNV--TIPPTLLQSMKLCLQ 530
TP TW + + +K + PQ + P + + LQ
Sbjct: 210 LLKIFRIMGTPTES---TWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQ 266
Query: 531 KDPKAR 536
+P+ R
Sbjct: 267 LNPELR 272
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 3e-14
Identities = 48/190 (25%), Positives = 75/190 (39%), Gaps = 41/190 (21%)
Query: 372 YEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSV 431
+++L A+ H+ IIH D+KP N L + VLK+ DFG A +L+ S
Sbjct: 107 WQLLQAIAYCHSHNIIHRDIKPENILVSES---------GVLKLCDFGFARALRARPASP 157
Query: 432 HKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY---SHI 488
D + T Y +PE ++ G DVW++GCI+ ++ G + S I
Sbjct: 158 LTDYVA-TRWYRAPELLVGDTNYGKP--------VDVWAIGCIMAELLDGEPLFPGDSDI 208
Query: 489 PNTWAKMLAIA----RHKDQIEFKPQLANNVTIPP----------------TLLQSMKLC 528
+ + H++ P+ A P L +K C
Sbjct: 209 DQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKAC 268
Query: 529 LQKDPKARPT 538
L+ DPK R T
Sbjct: 269 LRMDPKERLT 278
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 5e-14
Identities = 58/180 (32%), Positives = 90/180 (50%), Gaps = 30/180 (16%)
Query: 308 EVELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMR-NLNKMTTLPNTMII 366
E+ L +L P ++K+ + + K +Y++ E +TDL +R N+ L +
Sbjct: 56 EIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANI-----LEDVHKR 110
Query: 367 IIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSL-- 424
IM Y++L A+K IH+ +IH DLKP+N L N DC +K+ DFG+A SL
Sbjct: 111 YIM--YQLLKALKYIHSGNVIHRDLKPSNILL--NS----DCR---VKLADFGLARSLSE 159
Query: 425 --QDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGR 482
++ + V D + T Y +PE G Y T D+WS+GCIL M+ G+
Sbjct: 160 LEENPENPVLTDYVA-TRWYRAPEIL------LGSTRY--TKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 6e-14
Identities = 85/303 (28%), Positives = 135/303 (44%), Gaps = 45/303 (14%)
Query: 253 LNGKQY-QVLSLLGKGGSSSVYLVGGTSEHEFKPLAL-KVVDLSDITDQSIADSYLNEVE 310
LN +++ +++ LG G VY E LA KV+D +++ + D Y+ E++
Sbjct: 1 LNPEEFWEIIGELGDGAFGKVY---KAQNKETGVLAAAKVIDTK--SEEELED-YMVEID 54
Query: 311 LLAKLQGCPYVIKMHDYVYDTASKHLYVLME---KGDTDLSKYMRNLNKMTTLPNTMIII 367
+LA P ++K+ D Y +L++L+E G D M L + T P ++
Sbjct: 55 ILASCDH-PNIVKLLDAFY--YENNLWILIEFCAGGAVD--AVMLELERPLTEPQIRVVC 109
Query: 368 IMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDD 427
+ L A+ +H IIH DLK N LF + +K+ DFG+ S ++
Sbjct: 110 ----KQTLEALNYLHENKIIHRDLKAGNILFT---------LDGDIKLADFGV--SAKNT 154
Query: 428 KTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSH 487
+T +D+ GT +M+PE +S YK+DVWSLG L M P+ H
Sbjct: 155 RTIQRRDSFIGTPYWMAPEVVMCETS----KDRPYDYKADVWSLGITLIEMAQIEPPH-H 209
Query: 488 IPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQIN 547
N +L IA+ + P LA +K CL+K+ AR T TQ+
Sbjct: 210 ELNPMRVLLKIAKSE-----PPTLAQPSRWSSEFKDFLKKCLEKNVDARWT----TTQLL 260
Query: 548 NNP 550
+P
Sbjct: 261 QHP 263
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 7e-14
Identities = 74/296 (25%), Positives = 118/296 (39%), Gaps = 51/296 (17%)
Query: 257 QYQVLSLLGKGGSSSVYL---VGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLA 313
++ LG G SS Y V + K + S+ + + ++ E+ L+A
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEE--VVEALRKEIRLMA 58
Query: 314 KLQGCPYVIKMHDYVYDTASKHLYV-LMEKGD--TDLSKYMRNLNKMTTLPNTMIIIIMH 370
+L P++I+M + + +L+V M G LSKY +II +
Sbjct: 59 RLNH-PHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG---------AFKEAVIINY 108
Query: 371 WYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTS 430
++L + +H IIH D+K AN L ID G L+I DFG A L T
Sbjct: 109 TEQLLRGLSYLHENQIIHRDVKGANLL--------IDSTGQRLRIADFGAAARLAAKGTG 160
Query: 431 V--HKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHI 488
+ GT+ +M+PE G Y DVWS+GC++ M + P++
Sbjct: 161 AGEFQGQLLGTIAFMAPEVLR-------GEQY--GRSCDVWSVGCVIIEMATAKPPWNAE 211
Query: 489 PNTWAKMLAIARHKDQIEFKPQLANNV-TIPPTLLQSMK----LCLQKDPKARPTV 539
+ H + FK A +IP L ++ CL+ P+ RP
Sbjct: 212 --------KHSNHL-ALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPS 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 7e-14
Identities = 73/290 (25%), Positives = 117/290 (40%), Gaps = 51/290 (17%)
Query: 264 LGKGGSSSVY---LVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPY 320
LG+G VY G +A+K V+ + + I +LNE ++ K C +
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIE--FLNEASVM-KEFNCHH 70
Query: 321 VIKMHDYVYDTASKHLYVLME---KGDTDLSKYMRNLN-KMTTLPNTMIIIIMHWYEMLL 376
V+++ V + V+ME KGD L Y+R+ + P + + +M
Sbjct: 71 VVRLLGVVST--GQPTLVVMELMAKGD--LKSYLRSRRPEAENNPGLGPPTLQKFIQMAA 126
Query: 377 AVKE----IHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVH 432
+ + + A +H DL N + ++ +KI DFG+ + + T +
Sbjct: 127 EIADGMAYLAAKKFVHRDLAARNCMVAEDL---------TVKIGDFGMTRDIYE--TDYY 175
Query: 433 KDTASGTL--NYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI-YGRTPYSHIP 489
+ G L +M+PE+ G T KSDVWS G +L+ M PY +
Sbjct: 176 RKGGKGLLPVRWMAPESL----KDG-----VFTTKSDVWSFGVVLWEMATLAEQPYQGLS 226
Query: 490 NTWAKMLAIAR-HKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
N I H D E P LL+ M++C Q +PK RPT
Sbjct: 227 NEEVLKFVIDGGHLDLPE---------NCPDKLLELMRMCWQYNPKMRPT 267
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 1e-13
Identities = 69/243 (28%), Positives = 111/243 (45%), Gaps = 54/243 (22%)
Query: 255 GKQYQVLSLLGKGG----SSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVE 310
G +YQ LS +G+G S+ + G +A+K + S Q+ L E++
Sbjct: 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVK------VAIKKI--SPFEHQTFCQRTLREIK 55
Query: 311 LLAKLQGCPYVIKMHDYV----YDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMII 366
+L + + +I + D + +++ +Y++ E +TDL K ++ + L N I
Sbjct: 56 ILRRFK-HENIIGILDIIRPPSFESF-NDVYIVQELMETDLYKLIKTQH----LSNDHIQ 109
Query: 367 IIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQD 426
+ Y++L +K IH+A ++H DLKP+N L N C LKI DFG+A
Sbjct: 110 YFL--YQILRGLKYIHSANVLHRDLKPSNLLLNTN------CD---LKICDFGLARI--A 156
Query: 427 DKTSVHKDTASGTLN-------YMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI 479
D H +G L Y +PE +S G Y T D+WS+GCIL M+
Sbjct: 157 DPEHDH----TGFLTEYVATRWYRAPEI--MLNSKG----Y--TKAIDIWSVGCILAEML 204
Query: 480 YGR 482
R
Sbjct: 205 SNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 2e-13
Identities = 74/298 (24%), Positives = 129/298 (43%), Gaps = 71/298 (23%)
Query: 263 LLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLN----EVELLAKLQGC 318
+LGKG +VY G T++ + +A+K V+L D ++ A+ EV+LL L
Sbjct: 7 VLGKGAYGTVYC-GLTNQGQL--IAVKQVEL-DTSNVLAAEKEYEKLQEEVDLLKSL--- 59
Query: 319 PYVIKMHDYVYDTASKHLYVLMEKG----DTDLSKYM---------RNLNKMTTLPNTMI 365
KH+ ++ G D +S +M LN+ LP
Sbjct: 60 ---------------KHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPE--P 102
Query: 366 IIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIA---- 421
+ + ++L V +H ++H D+K N + + N ++K+IDFG A
Sbjct: 103 VFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPN---------GIIKLIDFGCARRLA 153
Query: 422 -CSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY 480
L +++ K + GT +M+PE + SG G KSD+WS+GC ++ M
Sbjct: 154 WVGLHGTHSNMLK-SMHGTPYWMAPEVINE---SGYGR------KSDIWSIGCTVFEMAT 203
Query: 481 GRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
G+ P + + A M I H+ + P+L ++ + + + CL +D RP+
Sbjct: 204 GKPPLASMDRL-AAMFYIGAHRGLM---PRLPDSFS--AAAIDFVTSCLTRDQHERPS 255
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 74/283 (26%), Positives = 124/283 (43%), Gaps = 51/283 (18%)
Query: 263 LLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQ--GCPY 320
++G+GG VY G K A+K +D I + LNE +L+ + CP+
Sbjct: 1 IIGRGGFGEVY--GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 58
Query: 321 VIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWY--EMLLAV 378
++ M Y + T K ++L DL ++ + M +Y E++L +
Sbjct: 59 IVCM-TYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKE-------MRFYATEIILGL 110
Query: 379 KEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASG 438
+ +H +++ DLKPAN L +D G+V +I D G+AC K + G
Sbjct: 111 EHMHNRFVVYRDLKPANIL--------LDEHGHV-RISDLGLACDFSKKKPH----ASVG 157
Query: 439 TLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAI 498
T YM+PE + G Y + +D +SLGC+L+ ++ G +P+
Sbjct: 158 THGYMAPEVLQK------GTAYDSS--ADWFSLGCMLFKLLRGHSPFRQ----------- 198
Query: 499 ARHKDQIEF-KPQLANNVTIP----PTLLQSMKLCLQKDPKAR 536
+ KD+ E + L NV +P P L ++ LQ+D R
Sbjct: 199 HKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDVSKR 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 69/234 (29%), Positives = 105/234 (44%), Gaps = 40/234 (17%)
Query: 255 GKQ--YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELL 312
GK Y+ L LG+G ++VY G S+ + +ALK + L ++ + + E LL
Sbjct: 2 GKLETYKKLDKLGEGSYATVY--KGRSKLTGQLVALKEIRLEH--EEGAPFTAIREASLL 57
Query: 313 AKLQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWY 372
L+ V +HD ++ K L ++ E DTDL +YM + ++ N + + +
Sbjct: 58 KDLKHANIVT-LHDIIH--TKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFL----F 110
Query: 373 EMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVH 432
++L + H ++H DLKP N L I G LK+ DFG+A + SV
Sbjct: 111 QLLRGLAYCHQRRVLHRDLKPQNLL--------ISERGE-LKLADFGLARA-----KSVP 156
Query: 433 KDTASG---TLNYMSPEA-AGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGR 482
T S TL Y P+ G T S D+W +GCI Y M GR
Sbjct: 157 SKTYSNEVVTLWYRPPDVLLGSTEYST---------SLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 60/235 (25%), Positives = 115/235 (48%), Gaps = 33/235 (14%)
Query: 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPL-ALKVVDLSDITDQS-IADSYLNEVELLAKL 315
+++L +LG G V+LV S H+ L A+KV+ + I ++ + E ++L +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 316 QGCPYVIKMHDYVYDTASK-HLYVLMEKGD---TDLSKYMRNLNKMTTLPNTMIIIIMHW 371
+ P+++ +H Y + T +K HL + G T LS+ R + + +
Sbjct: 62 RQSPFLVTLH-YAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQI---------YS 111
Query: 372 YEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSV 431
E++LA++ +H GII+ D+K N L +D G+V+ + DFG++ +D+
Sbjct: 112 GEIVLALEHLHKLGIIYRDIKLENIL--------LDSNGHVV-LTDFGLSKEFHEDEVER 162
Query: 432 HKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYS 486
GT+ YM+P+ GG+ + D WS+G ++Y ++ G +P++
Sbjct: 163 AYSFC-GTIEYMAPDI---VRGGDGGHDKAV----DWWSMGVLMYELLTGASPFT 209
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 52/148 (35%), Positives = 68/148 (45%), Gaps = 28/148 (18%)
Query: 336 LYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPAN 395
Y++M TDL K M K L I ++ Y+ML +K IHAAGIIH DLKP
Sbjct: 95 FYLVMPFMGTDLGKLM----KHEKLSEDRIQFLV--YQMLKGLKYIHAAGIIHRDLKP-- 146
Query: 396 FLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSG 455
GN+ DC LKI+DFG+A + T T Y +PE
Sbjct: 147 ----GNLAVNEDC---ELKILDFGLARQTDSEMTGY-----VVTRWYRAPEVI------- 187
Query: 456 GGNTYRITYKSDVWSLGCILYNMIYGRT 483
N T D+WS+GCI+ M+ G+
Sbjct: 188 -LNWMHYTQTVDIWSVGCIMAEMLTGKP 214
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 5e-13
Identities = 63/232 (27%), Positives = 104/232 (44%), Gaps = 35/232 (15%)
Query: 256 KQYQVLSLLGKGGSSSVYL--VGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLA 313
+QY+VL GKGG V V T K A K ++ I + LNE ++L
Sbjct: 3 RQYRVL---GKGGFGEVCACQVRATG----KMYACKRLEKKRIKKRKGESMALNEKQILE 55
Query: 314 KLQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYE 373
K+ +V+ + Y Y+T VL DL ++ N+ + + E
Sbjct: 56 KVNS-QFVVNLA-YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEER---ALFYAAE 110
Query: 374 MLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHK 433
+L ++++H ++ DLKP N L +D G++ +I D G+A + + ++ +
Sbjct: 111 ILCGLEDLHRENTVYRDLKPENIL--------LDDYGHI-RISDLGLAVKIPEGESIRGR 161
Query: 434 DTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY 485
GT+ YM+PE N R T D W LGC++Y MI G++P+
Sbjct: 162 ---VGTVGYMAPEVL---------NNQRYTLSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 6e-13
Identities = 51/173 (29%), Positives = 77/173 (44%), Gaps = 36/173 (20%)
Query: 372 YEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIA------CSLQ 425
++L V+ +H+ I+H D+K AN L D GNV K+ DFG + CS
Sbjct: 111 RQILEGVEYLHSNMIVHRDIKGANILR--------DSAGNV-KLGDFGASKRLQTICSSG 161
Query: 426 DDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY 485
SV GT +MSPE S G G K+DVWS+GC + M+ + P+
Sbjct: 162 TGMKSVT-----GTPYWMSPEV---ISGEGYGR------KADVWSVGCTVVEMLTEKPPW 207
Query: 486 SHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
+ A + IA PQL ++V+ P ++ ++ K RP+
Sbjct: 208 AEF-EAMAAIFKIATQ----PTNPQLPSHVS--PDARNFLRRTFVENAKKRPS 253
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 8e-13
Identities = 63/234 (26%), Positives = 106/234 (45%), Gaps = 35/234 (14%)
Query: 256 KQYQVLSLLGKGGSSSVYL--VGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLA 313
+QY+VL GKGG V V T K A K ++ I + LNE ++L
Sbjct: 3 RQYRVL---GKGGFGEVCACQVRATG----KMYACKKLEKKRIKKRKGESMALNEKQILE 55
Query: 314 KLQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYE 373
K+ +V+ + Y Y+T VL DL ++ ++ + + + E
Sbjct: 56 KVNS-RFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGE-AGFEEGRAV--FYAAE 110
Query: 374 MLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHK 433
+ ++++H I++ DLKP N L +D G++ +I D G+A + + +T +
Sbjct: 111 ICCGLEDLHQERIVYRDLKPENIL--------LDDHGHI-RISDLGLAVHVPEGQTIKGR 161
Query: 434 DTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSH 487
GT+ YM+PE R T+ D W+LGC+LY MI G++P+
Sbjct: 162 ---VGTVGYMAPEVV---------KNERYTFSPDWWALGCLLYEMIAGQSPFQQ 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 9e-13
Identities = 64/228 (28%), Positives = 105/228 (46%), Gaps = 37/228 (16%)
Query: 263 LLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLA--KLQGCPY 320
++G+GG VY G K A+K +D I + LNE +L+ CP+
Sbjct: 1 IIGRGGFGEVY--GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 58
Query: 321 VIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWY--EMLLAV 378
++ M Y + T K ++L DL ++ + M +Y E++L +
Sbjct: 59 IVCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAE-------MRFYAAEIILGL 110
Query: 379 KEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTAS- 437
+ +H +++ DLKPAN L +D G+V +I D G+AC S K AS
Sbjct: 111 EHMHNRFVVYRDLKPANIL--------LDEHGHV-RISDLGLACDF-----SKKKPHASV 156
Query: 438 GTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY 485
GT YM+PE + G Y + +D +SLGC+L+ ++ G +P+
Sbjct: 157 GTHGYMAPEVLQK------GVAYDSS--ADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 79/285 (27%), Positives = 130/285 (45%), Gaps = 43/285 (15%)
Query: 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQ 316
QY VL ++G+G LV + + A+K + L + ++ DS E LLAK++
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQ--KYAMKEIRLP-KSSSAVEDSR-KEAVLLAKMK 56
Query: 317 GCPYVIKMHDYVYDTASKHLYVLMEKGDT-DLSKYMRNLNKMTTLPNTMIIIIMHWY-EM 374
P ++ + A HLY++ME D DL + ++ L + P I + W+ +M
Sbjct: 57 H-PNIVAFKESF--EADGHLYIVMEYCDGGDLMQKIK-LQRGKLFPEDTI---LQWFVQM 109
Query: 375 LLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKD 434
L V+ IH ++H D+K N N G V K+ DFG A L +
Sbjct: 110 CLGVQHIHEKRVLHRDIKSKNIFLTQN--------GKV-KLGDFGSARLLTSPGA--YAC 158
Query: 435 TASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494
T GT Y+ PE + KSD+WSLGCILY + + P+ N+W
Sbjct: 159 TYVGTPYYVPPEIWENMPYNN---------KSDIWSLGCILYELCTLKHPFQ--ANSWKN 207
Query: 495 M-LAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
+ L + Q +KP ++ +L++ M +++P++RP+
Sbjct: 208 LILKVC----QGSYKPLPSHYSYELRSLIKQM---FKRNPRSRPS 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 68/243 (27%), Positives = 112/243 (46%), Gaps = 63/243 (25%)
Query: 261 LSLLGKGGSSSVYLV----GGTSEHEF-----KPLALKVVDLSDITDQSIADSYLNEVEL 311
L +LG+G V+LV G + + K LKV D E ++
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTK---------MERDI 51
Query: 312 LAKLQGCPYVIKMHDYVYDTASKHLYVLME---KGD--TDLSKYMRNLNKMTTLPNTMII 366
LA++ P+++K+H Y + T K LY++++ GD T LSK + M T +
Sbjct: 52 LAEVNH-PFIVKLH-YAFQTEGK-LYLILDFLRGGDLFTRLSKEV-----MFTEED---- 99
Query: 367 IIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQD 426
+ + E+ LA+ +H+ GII+ DLKP N L +D G++ K+ DFG++
Sbjct: 100 VKFYLAELALALDHLHSLGIIYRDLKPENIL--------LDEEGHI-KLTDFGLS----- 145
Query: 427 DKTSVHKDTAS----GTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGR 482
K S+ + + GT+ YM+PE N T +D WS G +++ M+ G
Sbjct: 146 -KESIDHEKKAYSFCGTVEYMAPEVV---------NRRGHTQSADWWSFGVLMFEMLTGS 195
Query: 483 TPY 485
P+
Sbjct: 196 LPF 198
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 80/331 (24%), Positives = 133/331 (40%), Gaps = 59/331 (17%)
Query: 220 DPSVSKETIKPAKPQITTSNAKKSVETSQDVITLNGKQYQVLSLLGKGGSSSVYLV--GG 277
DPS++ P ++S++ S S + + + ++ +G G +VY V
Sbjct: 38 DPSLAVPLPLPPPSSSSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRP 97
Query: 278 TSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLY 337
T + ALKV + + ++ E+E+L + P V+K HD ++D + +
Sbjct: 98 TG----RLYALKV--IYGNHEDTVRRQICREIEILRDVNH-PNVVKCHD-MFDHNGE-IQ 148
Query: 338 VLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLA---------VKEIHAAGIIH 388
VL+E +M +L T I E LA + +H I+H
Sbjct: 149 VLLE--------FMDG----GSLEGTHI-----ADEQFLADVARQILSGIAYLHRRHIVH 191
Query: 389 SDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAA 448
D+KP+N L I+ NV KI DFG++ L +T +++ GT+ YMSPE
Sbjct: 192 RDIKPSNLL--------INSAKNV-KIADFGVSRIL--AQTMDPCNSSVGTIAYMSPERI 240
Query: 449 GQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYS-HIPNTWAKMLAIARHKDQIEF 507
+ G + Y D+WSLG + GR P+ WA ++ E
Sbjct: 241 NTDLNHGAYD----GYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEA 296
Query: 508 KPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
T + CLQ++P R +
Sbjct: 297 PA------TASREFRHFISCCLQREPAKRWS 321
|
Length = 353 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 2e-12
Identities = 69/296 (23%), Positives = 121/296 (40%), Gaps = 63/296 (21%)
Query: 253 LNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELL 312
LN K+ ++L +GKG V L ++ +A+K I + + A ++L E ++
Sbjct: 3 LNMKELKLLQTIGKGEFGDVML----GDYRGNKVAVKC-----IKNDATAQAFLAEASVM 53
Query: 313 AKLQGCPYVIKMHDYVYDTASKHLYVL---MEKGDTDLSKYMRNLNKMTTLPNTMIIIIM 369
+L+ V + V + LY++ M KG L Y+R+ + + ++ +
Sbjct: 54 TQLRHSNLVQLLGVIVEEKGG--LYIVTEYMAKGS--LVDYLRSRGRSVLGGDCLLKFSL 109
Query: 370 HWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKT 429
E A++ + A +H DL N L + NV K+ DFG+ +
Sbjct: 110 DVCE---AMEYLEANNFVHRDLAARNVLVSED---------NVAKVSDFGLT-----KEA 152
Query: 430 SVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI-YGRTPYSHI 488
S +DT + + +PEA + + + KSDVWS G +L+ + +GR PY I
Sbjct: 153 SSTQDTGKLPVKWTAPEALREK---------KFSTKSDVWSFGILLWEIYSFGRVPYPRI 203
Query: 489 PNTWAKMLAIARHKDQIEFKPQLANNVTI------PPTLLQSMKLCLQKDPKARPT 538
P + P++ + PP + MK C D RP+
Sbjct: 204 PLK--------------DVVPRVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPS 245
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 75/289 (25%), Positives = 122/289 (42%), Gaps = 46/289 (15%)
Query: 259 QVLSLLGKGGSSSVYLVGGTSEHEFKP--LALKVVDLSDITDQSIADSYLNEVELLAKLQ 316
+ +S LG G SV V +H +A KVV + S+ L E++++ + +
Sbjct: 8 ETISDLGAGNGGSVSKV----KHIPTGTVMAKKVVHIG--AKSSVRKQILRELQIMHECR 61
Query: 317 GCPYVIKMHD-YVYDTASKHLYVLMEKGDTD-LSKYMRNLNKMTTLPNTMIIIIMHWYEM 374
PY++ + ++ + ++ + ME D L + + + I + + E
Sbjct: 62 -SPYIVSFYGAFLNEN---NICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAV--VEG 115
Query: 375 LLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKD 434
L + +H I+H D+KP+N L G + K+ DFG++ L + S+ D
Sbjct: 116 LTYLYNVHR--IMHRDIKPSNILVNSR--------GQI-KLCDFGVSGELIN---SI-AD 160
Query: 435 TASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494
T GT YMSPE G Y T KSDVWSLG + + G+ P++
Sbjct: 161 TFVGTSTYMSPERIQ-------GGKY--TVKSDVWSLGISIIELALGKFPFAFSNIDDDG 211
Query: 495 MLAIARHKDQI-----EFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
D + E P+L ++ P L + CL KDP RPT
Sbjct: 212 QDDPMGILDLLQQIVQEPPPRLPSS-DFPEDLRDFVDACLLKDPTERPT 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 2e-12
Identities = 52/154 (33%), Positives = 78/154 (50%), Gaps = 30/154 (19%)
Query: 387 IHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPE 446
IH DL+ AN L VG+ G V KI DFG+A ++D++ + + A + + +PE
Sbjct: 124 IHRDLRSANIL-VGD--------GLVCKIADFGLARLIEDNEYTA-RQGAKFPIKWTAPE 173
Query: 447 AAGQTSSSGGGNTY-RITYKSDVWSLGCILYNMIY-GRTPYSHIPNTWAKMLAIARHKDQ 504
AA Y R T KSDVWS G +L ++ GR PY + N ++L +Q
Sbjct: 174 AA----------LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR--EVL------EQ 215
Query: 505 IEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
+E ++ P +L + M C +KDP+ RPT
Sbjct: 216 VERGYRMPCPQDCPISLHELMLQCWKKDPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 50/136 (36%), Positives = 66/136 (48%), Gaps = 43/136 (31%)
Query: 372 YEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSV 431
Y+ML +K +H+AGIIH DLKP+N V+K DC LKI+DFG+A
Sbjct: 125 YQMLCGIKHLHSAGIIHRDLKPSNI-----VVK-SDC---TLKILDFGLA---------- 165
Query: 432 HKDTASGTLNYMSPEAAGQTSSSGGGNTYR-------ITYKS--DVWSLGCILYNMIYGR 482
TA GT M+P + YR + YK D+WS+GCI+ MI G
Sbjct: 166 --RTA-GTSFMMTPYVVTR--------YYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
Query: 483 T--P-YSHIPNTWAKM 495
P HI + W K+
Sbjct: 215 VLFPGTDHI-DQWNKI 229
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 3e-12
Identities = 78/305 (25%), Positives = 130/305 (42%), Gaps = 62/305 (20%)
Query: 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAK 314
K+Y + +LG G + +V S+ E P A+KVVD+ +++ + EV L
Sbjct: 31 AKKYWISRVLGSGATGTVLCAKRVSDGE--PFAVKVVDMEGMSEADKNRAQ-AEVCCLLN 87
Query: 315 LQGCPY--VIKMH-DYVYDTASKHLYVLM------EKGDTDLSKYMRNLNKMTTLPNTMI 365
C + ++K H D+ VLM DL + +++ K T
Sbjct: 88 ---CDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAK-TNRTFREH 143
Query: 366 IIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGI----A 421
+ + ++LLAV +H+ +IH D+K AN L N L +K+ DFG A
Sbjct: 144 EAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGL---------VKLGDFGFSKMYA 194
Query: 422 CSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYG 481
++ DD V + T GT Y++PE + S K+D++SLG +LY ++
Sbjct: 195 ATVSDD---VGR-TFCGTPYYVAPEIWRRKPYSK---------KADMFSLGVLLYELLTL 241
Query: 482 RTPY--SHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMK----LCLQKDPKA 535
+ P+ ++ K LA + P +PP++ M+ L DPK
Sbjct: 242 KRPFDGENMEEVMHKTLA-------GRYDP-------LPPSISPEMQEIVTALLSSDPKR 287
Query: 536 RPTVG 540
RP+
Sbjct: 288 RPSSS 292
|
Length = 496 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 69/270 (25%), Positives = 116/270 (42%), Gaps = 49/270 (18%)
Query: 287 ALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEKGDTD 346
ALK + + I +S L E +LA++ CP+++ + + + + K VL +
Sbjct: 22 ALKTIRKAHIVSRSEVTHTLAERTVLAQVN-CPFIVPL-KFSFQSPEKLYLVLAFINGGE 79
Query: 347 LSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKII 406
L +++ + E+L A++ +H +I+ DLKP N L +
Sbjct: 80 LFHHLQREGRFDLSRARFYTA-----ELLCALENLHKFNVIYRDLKPENIL--------L 126
Query: 407 DCIGNVLKIIDFGIACSL---QDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRIT 463
D G++ + DFG+ C L DDKT +T GT Y++PE G G T +
Sbjct: 127 DYQGHI-ALCDFGL-CKLNMKDDDKT----NTFCGTPEYLAPELL-----LGHGYTKAV- 174
Query: 464 YKSDVWSLGCILYNMIYGRTPY--SHIPNTWAKMLAIA-RHKDQIEFKPQLANNVTIPPT 520
D W+LG +LY M+ G P+ ++ + K+L R D + +
Sbjct: 175 ---DWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAK---------D 222
Query: 521 LLQSMKLCLQKDPKARPTVGNSVTQINNNP 550
LL + L +DP R N +I N+P
Sbjct: 223 LLIGL---LSRDPTRRLGY-NGAQEIKNHP 248
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 4e-12
Identities = 69/265 (26%), Positives = 111/265 (41%), Gaps = 57/265 (21%)
Query: 285 PLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYV---LME 341
+A+K++ D+ Q + EV+ L +L+ ++I + + + +Y+ LME
Sbjct: 32 RVAIKILKSDDLLKQ---QDFQKEVQALKRLRH-KHLISLFAVC--SVGEPVYIITELME 85
Query: 342 KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKE----IHAAGIIHSDLKPANFL 397
KG L ++R+ P ++ + +M V E + IH DL N L
Sbjct: 86 KGS--LLAFLRS-------PEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNIL 136
Query: 398 FVGNVLKIIDCIGNVLKIIDFGIACSLQDD--KTSVHKDTASGTLNYMSPEAAG-QTSSS 454
VG V K+ DFG+A +++D +S K T +PEAA T S+
Sbjct: 137 -VGE--------DLVCKVADFGLARLIKEDVYLSSDKKIPYKWT----APEAASHGTFST 183
Query: 455 GGGNTYRITYKSDVWSLGCILYNMI-YGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLAN 513
KSDVWS G +LY M YG+ PY + N DQI ++
Sbjct: 184 ----------KSDVWSFGILLYEMFTYGQVPYPGMNNHEV--------YDQITAGYRMPC 225
Query: 514 NVTIPPTLLQSMKLCLQKDPKARPT 538
P + + M C +P+ RP+
Sbjct: 226 PAKCPQEIYKIMLECWAAEPEDRPS 250
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 4e-12
Identities = 68/302 (22%), Positives = 124/302 (41%), Gaps = 55/302 (18%)
Query: 253 LNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELL 312
+N K+ ++ + +GKG V L ++ + +A+K + D + A ++L E ++
Sbjct: 3 INSKELKLGATIGKGEFGDVML----GDYRGQKVAVKCLK----DDSTAAQAFLAEASVM 54
Query: 313 AKLQGCPYVIKMHDYVYDTASKHLYVLME---KGDTDLSKYMRNLNKMTTLPNTMIIIIM 369
L+ P ++++ V LY++ E KG L Y+R+ + + +
Sbjct: 55 TTLRH-PNLVQLLGVVLQ--GNPLYIVTEYMAKGS--LVDYLRSRGRAVITLAQQLGFAL 109
Query: 370 HWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKT 429
E ++ + +H DL N L + V K+ DFG+A +
Sbjct: 110 DVCE---GMEYLEEKNFVHRDLAARNVLVSED---------LVAKVSDFGLA-----KEA 152
Query: 430 SVHKDTASGTLNYMSPEA--AGQTSSSGGGNTYRITYKSDVWSLGCILYNMI-YGRTPYS 486
S +D+ + + +PEA + S+ KSDVWS G +L+ + +GR PY
Sbjct: 153 SQGQDSGKLPVKWTAPEALREKKFST-----------KSDVWSFGILLWEIYSFGRVPYP 201
Query: 487 HIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQI 546
IP + +E ++ PP + + MK C + DP RPT Q+
Sbjct: 202 RIP--------LKDVVPHVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQL 253
Query: 547 NN 548
Sbjct: 254 AL 255
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 5e-12
Identities = 52/154 (33%), Positives = 77/154 (50%), Gaps = 30/154 (19%)
Query: 387 IHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPE 446
IH DL+ AN L N+ V KI DFG+A ++D++ + + A + + +PE
Sbjct: 124 IHRDLRAANILVGDNL---------VCKIADFGLARLIEDNEYTA-RQGAKFPIKWTAPE 173
Query: 447 AAGQTSSSGGGNTY-RITYKSDVWSLGCILYNMIY-GRTPYSHIPNTWAKMLAIARHKDQ 504
AA Y R T KSDVWS G +L ++ GR PY + N ++L +Q
Sbjct: 174 AA----------LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR--EVL------EQ 215
Query: 505 IEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
+E ++ P +L + MKLC +KDP RPT
Sbjct: 216 VERGYRMPCPQGCPESLHELMKLCWKKDPDERPT 249
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 5e-12
Identities = 65/258 (25%), Positives = 112/258 (43%), Gaps = 41/258 (15%)
Query: 284 KPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEKG 343
K +A+K++ +D D ++ D L E ++ +L PY+++M + ++ ++ME
Sbjct: 23 KTVAVKILK-NDNNDPALKDELLREANVMQQLDN-PYIVRM---IGICEAESWMLVMELA 77
Query: 344 DTD-LSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNV 402
+ L+K+++ NK T N I ++H M +K + +H DL N L V
Sbjct: 78 ELGPLNKFLQK-NKHVTEKN--ITELVHQVSM--GMKYLEETNFVHRDLAARNVLLVTQ- 131
Query: 403 LKIIDCIGNVLKIIDFGIACSLQDDKTSVH-KDTASGTLNYMSPEAAGQTSSSGGGNTYR 461
+ KI DFG++ +L D+ K + + +PE N Y+
Sbjct: 132 --------HYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECM---------NYYK 174
Query: 462 ITYKSDVWSLGCILYNMI-YGRTPYSHIP-NTWAKMLAIARHKDQIEFKPQLANNVTIPP 519
+ KSDVWS G +++ YG+ PY + N +M IE ++ PP
Sbjct: 175 FSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQM---------IESGERMECPQRCPP 225
Query: 520 TLLQSMKLCLQKDPKARP 537
+ MKLC RP
Sbjct: 226 EMYDLMKLCWTYGVDERP 243
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 6e-12
Identities = 45/172 (26%), Positives = 72/172 (41%), Gaps = 23/172 (13%)
Query: 367 IIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQD 426
II + ++L +K +H I+H D+K N L ++ V+KI DFG + L
Sbjct: 110 IIFYTKQILEGLKYLHDNQIVHRDIKGDNVL--------VNTYSGVVKISDFGTSKRLA- 160
Query: 427 DKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYS 486
+ +T +GTL YM+PE + G +D+WSLGC + M G+ P+
Sbjct: 161 -GINPCTETFTGTLQYMAPEVIDKGPRGYGA-------PADIWSLGCTIVEMATGKPPFI 212
Query: 487 HIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
+ A M + K E L+ + C + DP R +
Sbjct: 213 ELGEPQAAMFKVGMFKIHPEIPESLSAEAK------NFILRCFEPDPDKRAS 258
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 7e-12
Identities = 62/228 (27%), Positives = 99/228 (43%), Gaps = 38/228 (16%)
Query: 263 LLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVI 322
+LGKG V L E A+KV+ I + + E +LA P++
Sbjct: 2 VLGKGSFGKVLLAELKGTDEL--YAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLT 59
Query: 323 KMHDYVYDTASKHLYVLME--KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKE 380
++H + T L+ +ME G DL +++ + P + E++L ++
Sbjct: 60 QLHS-CFQTKD-RLFFVMEYVNGG-DLMFHIQRSGRFD-EPRA----RFYAAEIVLGLQF 111
Query: 381 IHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACS---LQDDKTSVHKDTAS 437
+H GII+ DLK N L +D G++ KI DFG+ C L TS T
Sbjct: 112 LHERGIIYRDLKLDNVL--------LDSEGHI-KIADFGM-CKEGILGGVTTS----TFC 157
Query: 438 GTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY 485
GT +Y++PE Y D W+LG +LY M+ G++P+
Sbjct: 158 GTPDYIAPEILSYQP-------Y--GPAVDWWALGVLLYEMLAGQSPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 7e-12
Identities = 74/294 (25%), Positives = 118/294 (40%), Gaps = 54/294 (18%)
Query: 256 KQYQVLSLLGKGGSSSVY----LVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVEL 311
+ Y+++ +G G VY + G +A+KV+ L D I E+ +
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGEL------VAIKVIKLEPGDDFEIIQ---QEISM 53
Query: 312 LAKLQGC--PYVIK-MHDYVYDTASKHLYVLME---KGD-TDLSKYMRNLNKMTTLPNTM 364
L + C P ++ Y+ L+++ME G D+ + R L
Sbjct: 54 L---KECRHPNIVAYFGSYLRRD---KLWIVMEYCGGGSLQDIYQVTR-----GPLSELQ 102
Query: 365 IIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSL 424
I + E L + +H G IH D+K AN L + G+V K+ DFG++ L
Sbjct: 103 IAYVCR--ETLKGLAYLHETGKIHRDIKGANILLTED--------GDV-KLADFGVSAQL 151
Query: 425 QDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTP 484
T + + GT +M+PE A GG + K D+W+LG + + P
Sbjct: 152 --TATIAKRKSFIGTPYWMAPEVA-AVERKGGYDG-----KCDIWALGITAIELAELQPP 203
Query: 485 YSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
+ A L I++ P+L + P +K CL KDPK RPT
Sbjct: 204 MFDLHPMRALFL-ISKSNFP---PPKLKDKEKWSPVFHDFIKKCLTKDPKKRPT 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 8e-12
Identities = 67/229 (29%), Positives = 106/229 (46%), Gaps = 38/229 (16%)
Query: 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG 317
Y L LG+G ++V+ G S+ +ALK + L ++ + + EV LL L+
Sbjct: 7 YVKLDKLGEGTYATVF--KGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLKNLKH 62
Query: 318 CPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLA 377
++ +HD ++ + L ++ E D+DL +Y+ N + ++ N I + +++L
Sbjct: 63 AN-IVTLHDIIH--TERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFM----FQLLRG 115
Query: 378 VKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTAS 437
+ H I+H DLKP N L I+ G LK+ DFG+A + SV T S
Sbjct: 116 LSYCHKRKILHRDLKPQNLL--------INEKGE-LKLADFGLARA-----KSVPTKTYS 161
Query: 438 G---TLNYMSPEAA-GQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGR 482
TL Y P+ G T S D+W +GCILY M GR
Sbjct: 162 NEVVTLWYRPPDVLLGSTEYST---------PIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 8e-12
Identities = 46/149 (30%), Positives = 72/149 (48%), Gaps = 23/149 (15%)
Query: 334 KHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKP 393
+ +YV+ E +DL K + ++ P + + + Y++L +K +H+AGI+H D+KP
Sbjct: 77 EEIYVVTELMQSDLHKII-----VSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKP 131
Query: 394 ANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSS 453
N L N C VLKI DFG+A +++ S H T Y +PE
Sbjct: 132 GNLLVNSN------C---VLKICDFGLA-RVEEPDESKHMTQEVVTQYYRAPEIL----- 176
Query: 454 SGGGNTYRITYKSDVWSLGCILYNMIYGR 482
G Y T D+WS+GCI ++ R
Sbjct: 177 -MGSRHY--TSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 9e-12
Identities = 44/154 (28%), Positives = 69/154 (44%), Gaps = 27/154 (17%)
Query: 334 KHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKP 393
K +YV+M+ ++DL + + +T I + Y++L +K IH+A +IH DLKP
Sbjct: 81 KDVYVVMDLMESDLHHIIHSDQPLTE---EHIRYFL--YQLLRGLKYIHSANVIHRDLKP 135
Query: 394 ANFLFVGNVLKIIDCIGNVLKIIDFGIA---CSLQDDKTSVHKDTASGTLNYMSPEAAGQ 450
+N L + L+I DFG+A S + + + T Y +PE
Sbjct: 136 SNLLVNEDCE---------LRIGDFGMARGLSSSPTEHKYFMTEYVA-TRWYRAPEL--- 182
Query: 451 TSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTP 484
S T D+WS+GCI M+ GR
Sbjct: 183 LLSLP-----EYTTAIDMWSVGCIFAEML-GRRQ 210
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 9e-12
Identities = 75/296 (25%), Positives = 125/296 (42%), Gaps = 51/296 (17%)
Query: 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDIT--------DQSIADSYLNEV 309
Y VL LG G VY V + + LALK +++ + D+SI ++EV
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQ-NLLALKEINVHNPAFGKDKRERDKSI-GDIVSEV 59
Query: 310 ELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEKGD-TDLSKYMRNLN-KMTTLPNTMIII 367
++ + P +++ + + LY++M+ + L ++ +L K I
Sbjct: 60 TIIKEQLRHPNIVRYYKTF--LENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWN 117
Query: 368 IMHWYEMLLAVKEIHAAG-IIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQD 426
I + +M+LA++ +H I+H DL P N + + + + I DFG+A Q
Sbjct: 118 I--FVQMVLALRYLHKEKRIVHRDLTPNNIMLGED---------DKVTITDFGLAKQKQP 166
Query: 427 DK--TSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTP 484
+ TSV GT+ Y PE Y K+DVW+ GCILY M + P
Sbjct: 167 ESKLTSV-----VGTILYSCPEIVK-------NEPY--GEKADVWAFGCILYQMCTLQPP 212
Query: 485 -YSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTV 539
YS ML++A + ++P + + CL D +ARP +
Sbjct: 213 FYS------TNMLSLATKIVEAVYEP--LPEGMYSEDVTDVITSCLTPDAEARPDI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 1e-11
Identities = 65/243 (26%), Positives = 112/243 (46%), Gaps = 46/243 (18%)
Query: 303 DSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRN--LNKMTTL 360
+++L E L+ +LQ P +++++ V + +Y++ E YM N L
Sbjct: 46 EAFLAEANLMKQLQH-PRLVRLYAVV---TQEPIYIITE--------YMENGSLVDFLKT 93
Query: 361 PNTMIIIIMHWYEMLLAVKE----IHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKII 416
P + + I +M + E I IH DL+ AN L V + + C KI
Sbjct: 94 PEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANIL----VSETLCC-----KIA 144
Query: 417 DFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILY 476
DFG+A ++D++ + ++ A + + +PEA N T KSDVWS G +L
Sbjct: 145 DFGLARLIEDNEYTA-REGAKFPIKWTAPEAI---------NYGTFTIKSDVWSFGILLT 194
Query: 477 NMI-YGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKA 535
++ YGR PY + N + ++ ++ P+ N P L + M+LC ++ P+
Sbjct: 195 EIVTYGRIPYPGMTNP-----EVIQNLERGYRMPRPDN---CPEELYELMRLCWKEKPEE 246
Query: 536 RPT 538
RPT
Sbjct: 247 RPT 249
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 66/304 (21%), Positives = 117/304 (38%), Gaps = 50/304 (16%)
Query: 261 LSLLGKGGSSSVYLV------GGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAK 314
+ LG+G V L T E +A+K ++ +Q +D + E+E+L
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQ----VAVKSLN-HSGEEQHRSD-FEREIEILRT 62
Query: 315 LQGCPYVIKMHDYVYDTASKHLYVLME---KGDTDLSKYMRNLNKMTTLPNTMIIIIMHW 371
L ++K + L ++ME G L Y++ L +++
Sbjct: 63 LDH-ENIVKYKGVCEKPGGRSLRLIMEYLPSGS--LRDYLQRHRDQINLKR----LLLFS 115
Query: 372 YEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSL-QDDKTS 430
++ + + + IH DL N L D + KI DFG+A L +D
Sbjct: 116 SQICKGMDYLGSQRYIHRDLAARNILVESE-----DLV----KISDFGLAKVLPEDKDYY 166
Query: 431 VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI-YGRTPYSHIP 489
K+ + + +PE T + + SDVWS G LY + YG P P
Sbjct: 167 YVKEPGESPIFWYAPECL---------RTSKFSSASDVWSFGVTLYELFTYGD-PSQSPP 216
Query: 490 NTWAKMLAIARHKDQIE-FKPQLANNVTIPP------TLLQSMKLCLQKDPKARPTVGNS 542
+ +M+ IA+ + + L +P + MKLC + +P+ RP+ +
Sbjct: 217 AEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADL 276
Query: 543 VTQI 546
+ +
Sbjct: 277 ILIV 280
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 82/302 (27%), Positives = 127/302 (42%), Gaps = 64/302 (21%)
Query: 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG 317
++++ +GKG VY V T++ + A+K++D D+ I Y +L L
Sbjct: 24 WEIIETIGKGTYGKVYKV--TNKKDGSLAAVKILDPISDVDEEIEAEY----NILQSLPN 77
Query: 318 CPYVIKMHDYVYDT---ASKHLYVLMEKGD----TDLSKYMRNLNKMTTLPNTMIIIIMH 370
P V+K + Y L++++E + T+L K + L L MI I+
Sbjct: 78 HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGL--LICGQRLDEAMISYIL- 134
Query: 371 WYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTS 430
Y LL ++ +H IIH D+K N L G V K++DFG++ L T
Sbjct: 135 -YGALLGLQHLHNNRIIHRDVKGNNILLTTE--------GGV-KLVDFGVSAQLT--STR 182
Query: 431 VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITY--KSDVWSLGCILYNMIYGRTPYSHI 488
+ ++T+ GT +M+PE Y +Y + DVWSLG + G P +
Sbjct: 183 LRRNTSVGTPFWMAPEVIACEQQ------YDYSYDARCDVWSLGITAIELGDGDPPLFDM 236
Query: 489 PNTWAKMLAIARHKDQIEFK-PQLANNVTIPPTLLQSMKL----------CLQKDPKARP 537
H + FK P+ PPTLL K CL KD +ARP
Sbjct: 237 ------------HPVKTLFKIPR-----NPPPTLLHPEKWCRSFNHFISQCLIKDFEARP 279
Query: 538 TV 539
+V
Sbjct: 280 SV 281
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 76/290 (26%), Positives = 132/290 (45%), Gaps = 51/290 (17%)
Query: 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG 317
Y + ++GKG V LV ++ K +K ++L + + + + E +LL++L+
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDG--KQYVIKKLNLRNASRRE-RKAAEQEAQLLSQLKH 58
Query: 318 CPYVIKMHDYVYDTASKHLYVLM---EKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWY-E 373
P ++ + ++ LY++M E GD L ++ K LP + + W+ +
Sbjct: 59 -PNIV-AYRESWEGEDGLLYIVMGFCEGGD--LYHKLKE-QKGKLLPENQV---VEWFVQ 110
Query: 374 MLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHK 433
+ +A++ +H I+H DLK N N++K+ D GIA L++
Sbjct: 111 IAMALQYLHEKHILHRDLKTQNVFLTRT---------NIIKVGDLGIARVLEN-----QC 156
Query: 434 DTAS---GTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN 490
D AS GT YMSPE + YKSDVW+LGC +Y M + ++
Sbjct: 157 DMASTLIGTPYYMSPELFSNKPYN---------YKSDVWALGCCVYEMATLKHAFN---- 203
Query: 491 TWAKMLAIARHKDQIEFK-PQLANNVTIPPTLLQSMKLCLQKDPKARPTV 539
AK + ++ IE K P + + + P L + + L K P+ RP+V
Sbjct: 204 --AKDMNSLVYR-IIEGKLPPMPKDYS--PELGELIATMLSKRPEKRPSV 248
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 1e-11
Identities = 50/159 (31%), Positives = 76/159 (47%), Gaps = 28/159 (17%)
Query: 381 IHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTL 440
I IH DL+ AN L V + + C KI DFG+A ++D++ + ++ A +
Sbjct: 119 IERKNYIHRDLRAANVL----VSESLMC-----KIADFGLARVIEDNEYTA-REGAKFPI 168
Query: 441 NYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI-YGRTPYSHIPNTWAKMLAIA 499
+ +PEA N T KSDVWS G +LY ++ YG+ PY + N+ M A+
Sbjct: 169 KWTAPEAI---------NFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS-DVMSALQ 218
Query: 500 RHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
R P++ N P L MK C ++ + RPT
Sbjct: 219 RGYRM----PRMEN---CPDELYDIMKTCWKEKAEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 28/200 (14%)
Query: 284 KPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEKG 343
+ +ALK + L D + + + + E+ LL +L P ++K+ D ++ LY++ E
Sbjct: 26 EVVALKKIRL-DTETEGVPSTAIREISLLKELNH-PNIVKLLDVIH--TENKLYLVFEFL 81
Query: 344 DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVL 403
DL K+M + +P + +I + +++L + H+ ++H DLKP N L
Sbjct: 82 HQDLKKFMDASPL-SGIP--LPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLL------ 132
Query: 404 KIIDCIGNVLKIIDFGIACSLQDD-KTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRI 462
I+ G + K+ DFG+A + +T H+ TL Y +PE G Y
Sbjct: 133 --INTEGAI-KLADFGLARAFGVPVRTYTHEVV---TLWYRAPEIL-------LGCKYYS 179
Query: 463 TYKSDVWSLGCILYNMIYGR 482
T D+WSLGCI M+ R
Sbjct: 180 T-AVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 72/298 (24%), Positives = 120/298 (40%), Gaps = 67/298 (22%)
Query: 264 LGKGGSSSVYLVGGTSEH-----EFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGC 318
LG+G V+L G H + + +A+K L + + E ELL Q
Sbjct: 13 LGEGAFGKVFL--GECYHLEPENDKELVAVKT--LKETASNDARKDFEREAELLTNFQH- 67
Query: 319 PYVIKMHDYVYDTASKHLYVL---MEKGDTDLSKYMR----NLNKMTTLPNTM---IIII 368
++K + T ++ ME GD L+K++R + + + + M +
Sbjct: 68 ENIVKFYGVC--TEGDPPIMVFEYMEHGD--LNKFLRSHGPDAAFLKSPDSPMGELTLSQ 123
Query: 369 MHWYEMLLAVKEIHAAG--IIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQD 426
+ + +A ++ A +H DL N L VG L V+KI DFG++ +D
Sbjct: 124 LLQIAVQIASGMVYLASQHFVHRDLATRNCL-VGYDL--------VVKIGDFGMS---RD 171
Query: 427 DKTSVHKDTASGTL---NYMSPEAAGQTSSSGGGNTYR-ITYKSDVWSLGCILYNMI-YG 481
T+ + T+ +M PE+ YR T +SDVWS G +L+ + YG
Sbjct: 172 VYTTDYYRVGGHTMLPIRWMPPESI----------MYRKFTTESDVWSFGVVLWEIFTYG 221
Query: 482 RTPYSHIPNTWAKMLAIARHKDQIEFKPQ---LANNVTIPPTLLQSMKLCLQKDPKAR 536
+ P+ + N + IE Q L T P + M C ++DP+ R
Sbjct: 222 KQPWYGLSNE-----------EVIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQR 268
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 2e-11
Identities = 80/329 (24%), Positives = 139/329 (42%), Gaps = 71/329 (21%)
Query: 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVV--DLSDITDQSIADSYLNEVELLAKL 315
Y ++ L+GKGG VYL + +ALK + DLS+ + + +L E ++ A L
Sbjct: 4 YDIIRLIGKGGMGEVYL--AYDPVCSRRVALKKIREDLSE--NPLLKKRFLREAKIAADL 59
Query: 316 QGCPYVIKMH------DYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTM----- 364
P ++ ++ D VY T Y+ +G T L ++++ + +L +
Sbjct: 60 IH-PGIVPVYSICSDGDPVYYTMP---YI---EGYT-LKSLLKSVWQKESLSKELAEKTS 111
Query: 365 ---IIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIA 421
+ I H ++ ++ +H+ G++H DLKP N L + G V+ I+D+G A
Sbjct: 112 VGAFLSIFH--KICATIEYVHSKGVLHRDLKPDNIL--------LGLFGEVV-ILDWGAA 160
Query: 422 CSL---QDDKTSVHKDTAS-------------GTLNYMSPEAAGQTSSSGGGNTYRITYK 465
++D + D + GT +YM+PE +S
Sbjct: 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPAS---------ES 211
Query: 466 SDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSM 525
+D+++LG ILY M+ PY K+ ++D I ++A IPP L Q
Sbjct: 212 TDIYALGVILYQMLTLSFPYRR--KKGRKIS----YRDVILSPIEVAPYREIPPFLSQIA 265
Query: 526 KLCLQKDPKAR-PTVGNSVTQINNNPEGS 553
L DP R +V + + +GS
Sbjct: 266 MKALAVDPAERYSSVQELKQDLEPHLQGS 294
|
Length = 932 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 71/301 (23%), Positives = 140/301 (46%), Gaps = 42/301 (13%)
Query: 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPL-ALKVVDLSDITDQS-IADSYLNEVELLAKL 315
+++L +LG G V+LV + H+ L A+KV+ + + ++ + E +L +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 316 QGCPYVIKMHDYVYDTASK-HLYV-LMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYE 373
+ P+++ +H Y + T +K HL + + G+ Y R+ + + E
Sbjct: 62 RQSPFLVTLH-YAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDE-------VRFYSGE 113
Query: 374 MLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACS-LQDDKTSVH 432
++LA++ +H GI++ D+K N L +D G+V+ + DFG++ L ++K +
Sbjct: 114 IILALEHLHKLGIVYRDIKLENIL--------LDSEGHVV-LTDFGLSKEFLSEEKERTY 164
Query: 433 KDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYS--HIPN 490
+ GT+ YM+PE G G D WSLG +++ ++ G +P++ N
Sbjct: 165 --SFCGTIEYMAPEII--RGKGGHGKAV------DWWSLGILIFELLTGASPFTLEGERN 214
Query: 491 TWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVG-NSVTQINNN 549
T +++ + ++ P + I P + L+KDPK R G ++I +
Sbjct: 215 TQSEV-----SRRILKCDPPFPS--FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267
Query: 550 P 550
P
Sbjct: 268 P 268
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 3e-11
Identities = 76/290 (26%), Positives = 117/290 (40%), Gaps = 64/290 (22%)
Query: 261 LSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPY 320
L +GKG V+ G + +A+K++DL + D+ + E+ +L++ PY
Sbjct: 9 LERIGKGSFGEVF--KGIDNRTQQVVAIKIIDLEEAEDE--IEDIQQEITVLSQCDS-PY 63
Query: 321 VIKMHDYVYDTASKHLYVLMEKGDTDLSKYM---RNLNKMTTLPNTMIIIIMHWYEMLLA 377
V K + Y +K L+++ME Y+ L+ + P I E+L
Sbjct: 64 VTKYYG-SYLKGTK-LWIIME--------YLGGGSALDLLRAGPFDEFQIATMLKEILKG 113
Query: 378 VKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTAS 437
+ +H+ IH D+K AN L G+V K+ DFG+A L D T + ++T
Sbjct: 114 LDYLHSEKKIHRDIKAANVLLSEQ--------GDV-KLADFGVAGQLTD--TQIKRNTFV 162
Query: 438 GTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYS---------HI 488
GT +M+PE Q++ K+D+WSLG + G P S I
Sbjct: 163 GTPFWMAPEVIQQSAYDS---------KADIWSLGITAIELAKGEPPNSDMHPMRVLFLI 213
Query: 489 PNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
P L K EF + CL KDP RPT
Sbjct: 214 PKNNPPTLTGEFSKPFKEF-----------------IDACLNKDPSFRPT 246
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 4e-11
Identities = 65/228 (28%), Positives = 105/228 (46%), Gaps = 36/228 (15%)
Query: 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG 317
Y L LG+G ++V+ G S+ +ALK + L ++ + + EV LL L+
Sbjct: 8 YIKLEKLGEGTYATVF--KGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLKDLKH 63
Query: 318 CPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLA 377
++ +HD V+ K L ++ E D DL +YM + + ++ N I + Y++L
Sbjct: 64 AN-IVTLHDIVH--TDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFL----YQILRG 116
Query: 378 VKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTAS 437
+ H ++H DLKP N L I+ G LK+ DFG+A + SV T S
Sbjct: 117 LAYCHRRKVLHRDLKPQNLL--------INERGE-LKLADFGLARA-----KSVPTKTYS 162
Query: 438 G---TLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGR 482
TL Y P+ +S + + D+W +GCI + M GR
Sbjct: 163 NEVVTLWYRPPDVLLGSS--------EYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-11
Identities = 75/300 (25%), Positives = 126/300 (42%), Gaps = 45/300 (15%)
Query: 256 KQYQVLSLLGKGGSSSVYL--VGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLA 313
+ Y+VL GKGG V V T K A K ++ I + LNE +L
Sbjct: 3 RHYRVL---GKGGFGEVCACQVRATG----KMYACKKLEKKRIKKRKGEAMALNEKRILE 55
Query: 314 KLQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYE 373
K+ +V+ + Y Y+T VL DL ++ N+ I + E
Sbjct: 56 KVNS-RFVVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAI---FYAAE 110
Query: 374 MLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHK 433
+ ++++ I++ DLKP N L +D G++ +I D G+A + + +T +
Sbjct: 111 LCCGLEDLQRERIVYRDLKPENIL--------LDDRGHI-RISDLGLAVQIPEGETVRGR 161
Query: 434 DTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWA 493
GT+ YM+PE N + T+ D W LGC++Y MI G++P+
Sbjct: 162 ---VGTVGYMAPEVI---------NNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER-V 208
Query: 494 KMLAIARH--KDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKAR-PTVGNSVTQINNNP 550
K + R +DQ E+ + + + ++ L K+PK R GN + +P
Sbjct: 209 KREEVDRRVKEDQEEYSEKFSEDAK------SICRMLLTKNPKERLGCRGNGAAGVKQHP 262
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 6e-11
Identities = 76/291 (26%), Positives = 128/291 (43%), Gaps = 42/291 (14%)
Query: 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG 317
++++ +GKG V+ V ++ A+K++D D+ I Y +L L
Sbjct: 20 WEIIETIGKGTYGKVFKV--LNKKNGSKAAVKILDPIHDIDEEIEAEY----NILKALSD 73
Query: 318 CPYVIKMHDYVYDTASK---HLYVLMEKGD----TDLSKYMRNLNKMTTLPNTMIIIIMH 370
P V+K + Y K L++++E + TDL K L + + +I I+H
Sbjct: 74 HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGF--LKRGERMEEPIIAYILH 131
Query: 371 WYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTS 430
E L+ ++ +H IH D+K N L +K++DFG++ L T
Sbjct: 132 --EALMGLQHLHVNKTIHRDVKGNNILLT---------TEGGVKLVDFGVSAQLTS--TR 178
Query: 431 VHKDTASGTLNYMSPE--AAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHI 488
+ ++T+ GT +M+PE A Q S TY + DVWSLG + G P + +
Sbjct: 179 LRRNTSVGTPFWMAPEVIACEQQLDS----TY--DARCDVWSLGITAIELGDGDPPLADL 232
Query: 489 PNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTV 539
A + I R+ +P+L +N ++ CL KD + RPTV
Sbjct: 233 HPMRA-LFKIPRNPPPTLHQPELWSN-----EFNDFIRKCLTKDYEKRPTV 277
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 6e-11
Identities = 58/229 (25%), Positives = 99/229 (43%), Gaps = 38/229 (16%)
Query: 263 LLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVI 322
+LGKG V L +EF A+K + + + + + E +LA P++
Sbjct: 2 VLGKGSFGKVMLAELKGTNEF--FAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLT 59
Query: 323 KMHDYVYDTASKHLYVLMEK-GDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEI 381
H + +HL+ +ME DL ++++ + + E++ ++ +
Sbjct: 60 --HLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARF-----YAAEIICGLQFL 112
Query: 382 HAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQ---DDKTSVHKDTASG 438
H GII+ DLK N L +D G++ KI DFG+ C + K S T G
Sbjct: 113 HKKGIIYRDLKLDNVL--------LDKDGHI-KIADFGM-CKENMNGEGKAS----TFCG 158
Query: 439 TLNYMSPEA-AGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYS 486
T +Y++PE GQ + D WS G +LY M+ G++P+
Sbjct: 159 TPDYIAPEILKGQ----------KYNESVDWWSFGVLLYEMLIGQSPFH 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 7e-11
Identities = 56/180 (31%), Positives = 80/180 (44%), Gaps = 28/180 (15%)
Query: 361 PNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGI 420
P TM +I + +++ ++ + + IH DL N L N NV+KI DFG+
Sbjct: 170 PLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSEN---------NVVKICDFGL 220
Query: 421 ACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI- 479
A + D V K +A L +M+PE S Y T +SDVWS G +L+ +
Sbjct: 221 ARDIYKDPDYVRKGSARLPLKWMAPE-------SIFDKVY--TTQSDVWSFGVLLWEIFS 271
Query: 480 YGRTPYSHIPNTWAKMLAIARHKDQIEFK-PQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
G +PY P R KD + P+ A P + + M C Q DPK RPT
Sbjct: 272 LGASPY---PGVQINEEFCQRLKDGTRMRAPENAT-----PEIYRIMLACWQGDPKERPT 323
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 7e-11
Identities = 51/193 (26%), Positives = 76/193 (39%), Gaps = 39/193 (20%)
Query: 306 LNEVELLAKLQGCPYVIKMHDYVYDTASKHL------YVLMEKGDTDLSKYMRNLNKMTT 359
L E+++L KL+ P V+ + D + K Y++ D DLS + N + T
Sbjct: 55 LREIKILKKLKH-PNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLT 113
Query: 360 LPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFG 419
I M ++L + +H I+H D+K AN L ID G +LKI DFG
Sbjct: 114 ESQ--IKCYM--LQLLEGINYLHENHILHRDIKAANIL--------IDNQG-ILKIADFG 160
Query: 420 IACSLQDDKTSVHKDTASGTLNYMS---------PE-AAGQTSSSGGGNTYRITYKSDVW 469
+A + GT Y + PE G+ R T D+W
Sbjct: 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGER---------RYTTAVDIW 211
Query: 470 SLGCILYNMIYGR 482
+GC+ M R
Sbjct: 212 GIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 8e-11
Identities = 49/148 (33%), Positives = 66/148 (44%), Gaps = 29/148 (19%)
Query: 336 LYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPAN 395
Y++M TDL K M P + + Y+ML +K IH+AGIIH DLKP
Sbjct: 95 FYLVMPYMQTDLQKIM-------GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKP-- 145
Query: 396 FLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSG 455
GN+ DC LKI+DFG+A + T T Y +PE
Sbjct: 146 ----GNLAVNEDC---ELKILDFGLARHADAEMTGY-----VVTRWYRAPEVI------- 186
Query: 456 GGNTYRITYKSDVWSLGCILYNMIYGRT 483
N D+WS+GCI+ M+ G+T
Sbjct: 187 -LNWMHYNQTVDIWSVGCIMAEMLTGKT 213
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 64/229 (27%), Positives = 103/229 (44%), Gaps = 38/229 (16%)
Query: 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG 317
Y L LG+G ++VY G S+ +ALK + L ++ + + EV LL L+
Sbjct: 8 YIKLDKLGEGTYATVY--KGRSKLTDNLVALKEIRLEH--EEGAPCTAIREVSLLKDLKH 63
Query: 318 CPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLA 377
++ +HD ++ K L ++ E D DL +Y+ + + N + + +++L
Sbjct: 64 AN-IVTLHDIIH--TEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFL----FQLLRG 116
Query: 378 VKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTAS 437
+ H ++H DLKP N L I+ G LK+ DFG+A + S+ T S
Sbjct: 117 LNYCHRRKVLHRDLKPQNLL--------INERGE-LKLADFGLARA-----KSIPTKTYS 162
Query: 438 G---TLNYMSPEAA-GQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGR 482
TL Y P+ G T S + D+W +GCI Y M GR
Sbjct: 163 NEVVTLWYRPPDILLGSTDYST---------QIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 47/163 (28%), Positives = 67/163 (41%), Gaps = 30/163 (18%)
Query: 387 IHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPE 446
IH DL N L G + KI DFG+A +++D V K A + +M+PE
Sbjct: 236 IHRDLAARNILLTH---------GRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPE 286
Query: 447 AAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI-YGRTPYSHIP--NTWAKMLAIARHKD 503
+ Y T++SDVWS G +L+ + G +PY +P + + KM+
Sbjct: 287 SIFNC-------VY--TFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRML 337
Query: 504 QIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQI 546
E P + MK C DP RPT V I
Sbjct: 338 SPECA---------PSEMYDIMKSCWDADPLKRPTFKQIVQLI 371
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 73/293 (24%), Positives = 127/293 (43%), Gaps = 57/293 (19%)
Query: 256 KQYQVLSLLGKGGSSSVY----LVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVEL 311
+ Q +LG G +VY L+ + LA+KV+ L DIT + + ++E+E+
Sbjct: 1 QDIQYQEILGHGNGGTVYKAYHLLTR------RILAVKVIPL-DITVE-LQKQIMSELEI 52
Query: 312 LAKLQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMR--NLNKMTTLPNTMI---- 365
L K PY+I + + +E + +++M +L+ +P ++
Sbjct: 53 LYKCDS-PYIIGFYGAFF----------VENRISICTEFMDGGSLDVYRKIPEHVLGRIA 101
Query: 366 IIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQ 425
+ ++ L ++K I+H D+KP+N L ++ G V K+ DFG++ L
Sbjct: 102 VAVVKGLTYLWSLK------ILHRDVKPSNML--------VNTRGQV-KLCDFGVSTQLV 146
Query: 426 DDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY 485
+ S+ K T GT YM+PE G Y I SDVWSLG + GR PY
Sbjct: 147 N---SIAK-TYVGTNAYMAPERIS-------GEQYGI--HSDVWSLGISFMELALGRFPY 193
Query: 486 SHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
I ++ + + ++ P + + + C++K PK RP
Sbjct: 194 PQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPA 246
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 1e-10
Identities = 58/224 (25%), Positives = 105/224 (46%), Gaps = 32/224 (14%)
Query: 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQ 316
+Y + +G+G LV S+ + K +K +++S ++ + +S EV +L+ ++
Sbjct: 1 KYVKVKKIGEGSFGKAILV--KSKEDGKQYVIKEINISKMSPKEREESR-KEVAVLSNMK 57
Query: 317 GCPYVIKMHDYVYDTASKHLYVLMEKGDT-DLSKYMRNLNKMTTLPNTMIIIIMHWY-EM 374
P +++ + + + +LY++M+ + DL K + N + P I + W+ ++
Sbjct: 58 H-PNIVQYQESFEE--NGNLYIVMDYCEGGDLYKKI-NAQRGVLFPEDQI---LDWFVQI 110
Query: 375 LLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKD 434
LA+K +H I+H D+K N +K+ DFGIA L + T
Sbjct: 111 CLALKHVHDRKILHRDIKSQNIFLTK---------DGTIKLGDFGIARVL--NSTVELAR 159
Query: 435 TASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNM 478
T GT Y+SPE + KSD+W+LGC+LY M
Sbjct: 160 TCIGTPYYLSPEICENRPYNN---------KSDIWALGCVLYEM 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 78/290 (26%), Positives = 117/290 (40%), Gaps = 48/290 (16%)
Query: 261 LSLLGKGGSSSVYLV----GGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQ 316
LS LG+G SV G ALK + D + L E+E+ +
Sbjct: 6 LSRLGEGAGGSVTKCRLKNTGMI------FALKTITTDPNPD--LQKQILRELEINKSCK 57
Query: 317 GCPYVIKMHDYVYDTASKHLYVLMEK-GDTDLSKYMRNLNKMTTLPNTMII---IIMHWY 372
PY++K + D +S + + ME L + + K I ++
Sbjct: 58 S-PYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKK-----RGGRIGEKVLGKIA 111
Query: 373 EMLL-AVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSV 431
E +L + +H+ IIH D+KP+N L + G V K+ DFG++ L +
Sbjct: 112 ESVLKGLSYLHSRKIIHRDIKPSNIL--------LTRKGQV-KLCDFGVSGELVNSLAG- 161
Query: 432 HKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY--SHIP 489
T +GT YM+PE G Y IT SDVWSLG L + R P+ P
Sbjct: 162 ---TFTGTSFYMAPERIQ-------GKPYSIT--SDVWSLGLTLLEVAQNRFPFPPEGEP 209
Query: 490 NTWA-KMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
++L+ + E K + N + +K CL+KDP RPT
Sbjct: 210 PLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPT 259
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 61/240 (25%), Positives = 106/240 (44%), Gaps = 49/240 (20%)
Query: 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNE--VELLAKL 315
++ L++LG+G V L E A+K + DI + +S + E + A
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGEL--YAIKALKKGDIIARDEVESLMCEKRIFETANS 58
Query: 316 QGCPYVIKMHDYVYDTASKHLYVLME---KGDTDLSKYMRNLNK-MTTLPNTMIIIIMHW 371
+ P+++ + + T H+ +ME GD M +++ + + P + +
Sbjct: 59 ERHPFLVNLFA-CFQTED-HVCFVMEYAAGGDL-----MMHIHTDVFSEPRAV------F 105
Query: 372 Y--EMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQ---D 426
Y ++L ++ +H I++ DLK N L +D G V KI DFG+ C
Sbjct: 106 YAACVVLGLQYLHENKIVYRDLKLDNLL--------LDTEGFV-KIADFGL-CKEGMGFG 155
Query: 427 DKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYS 486
D+TS T GT +++PE +TS Y T D W LG ++Y M+ G +P+
Sbjct: 156 DRTS----TFCGTPEFLAPEVLTETS-------Y--TRAVDWWGLGVLIYEMLVGESPFP 202
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 60/235 (25%), Positives = 101/235 (42%), Gaps = 43/235 (18%)
Query: 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQ 316
+Y+ L +G+G +V+ HE +ALK V L D D+ + S L E+ LL +L+
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEI--VALKRVRLDD-DDEGVPSSALREICLLKELK 57
Query: 317 GCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLN---KMTTLPNTMIIIIMHWYE 373
+++++D ++ + K L ++ E D DL KY + N + + M ++
Sbjct: 58 H-KNIVRLYDVLH--SDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFM-------FQ 107
Query: 374 MLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHK 433
+L + H+ ++H DLKP N L N LK+ DFG+A +
Sbjct: 108 LLKGLAFCHSHNVLHRDLKPQNLLINKN---------GELKLADFGLARAFGIPVRCYSA 158
Query: 434 DTASGTLNYMSPE----AAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTP 484
+ TL Y P+ A ++S D+WS GCI + P
Sbjct: 159 EVV--TLWYRPPDVLFGAKLYSTS------------IDMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 74/312 (23%), Positives = 125/312 (40%), Gaps = 56/312 (17%)
Query: 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKL 315
+++ L+ +G+G VY T+ E +ALK V + + D I S L E+ LL L
Sbjct: 7 TEFEKLNRIGEGTYGIVYRARDTTSGEI--VALKKVRMDNERD-GIPISSLREITLLLNL 63
Query: 316 QGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEML 375
+ P ++++ + V ++++ME + DL+ + N+ T + + +M ++L
Sbjct: 64 RH-PNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNM--PTPFSESQVKCLM--LQLL 118
Query: 376 LAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDT 435
++ +H IIH DLK +N L LKI DFG+A + +
Sbjct: 119 RGLQYLHENFIIHRDLKVSNLLLTDK---------GCLKIADFGLARTYGLPAKPMTPKV 169
Query: 436 ASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCIL------------------YN 477
TL Y +PE G TY T D+W++GCIL +
Sbjct: 170 V--TLWYRAPELL------LGCTTY--TTAIDMWAVGCILAELLAHKPLLPGKSEIEQLD 219
Query: 478 MIYGR--TPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQS-----MKLCLQ 530
+I TP I ++ + + + Q NN+ L + L
Sbjct: 220 LIIQLLGTPNESIWPGFSDLPLVG----KFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLM 275
Query: 531 KDPKARPTVGNS 542
DPK R T +
Sbjct: 276 YDPKKRATAEEA 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 81/294 (27%), Positives = 128/294 (43%), Gaps = 51/294 (17%)
Query: 264 LGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIK 323
+GKG V L ++ +F A+KV+ I + + E +L K P+++
Sbjct: 3 IGKGSFGKVLLAKHKADGKF--YAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 324 MHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWY--EMLLAVKEI 381
+H Y + TA K +VL +L +L + + P +Y E+ A+ +
Sbjct: 61 LH-YSFQTADKLYFVLDYVNGGEL---FFHLQRERSFPEPR----ARFYAAEIASALGYL 112
Query: 382 HAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIAC--SLQDDKTSVHKDTASGT 439
H+ II+ DLKP N L +D G+V+ + DFG+ C ++ KT+ T GT
Sbjct: 113 HSLNIIYRDLKPENIL--------LDSQGHVV-LTDFGL-CKEGIEHSKTT---STFCGT 159
Query: 440 LNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTP-YSHIPNTWAKMLAI 498
Y++PE + Y T D W LG +LY M+YG P YS
Sbjct: 160 PEYLAPEVLRK-------QPYDRTV--DWWCLGAVLYEMLYGLPPFYSR---------DT 201
Query: 499 ARHKDQIEFKP-QLANNVTIPPT-LLQSMKLCLQKDPKARPTVGNSVTQINNNP 550
A D I KP +L N+++ LL+ + LQKD R + +I N+
Sbjct: 202 AEMYDNILNKPLRLKPNISVSARHLLEGL---LQKDRTKRLGAKDDFLEIKNHV 252
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 66/241 (27%), Positives = 101/241 (41%), Gaps = 44/241 (18%)
Query: 264 LGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIK 323
LG G V + E+ A+K + +I E +L +L P+++
Sbjct: 26 LGTGSFGRVRIAKHKGTGEY--YAIKCLKKREILKMKQVQHVAQEKSILMELSH-PFIVN 82
Query: 324 MHDYVYDTASKHLYVLME---KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWY--EMLLAV 378
M D +Y L+E G+ +L K PN + +Y E++LA
Sbjct: 83 MMCSFQD--ENRVYFLLEFVVGGEL-----FTHLRKAGRFPND----VAKFYHAELVLAF 131
Query: 379 KEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASG 438
+ +H+ II+ DLKP N L +D G+V K+ DFG A + D+T T G
Sbjct: 132 EYLHSKDIIYRDLKPENLL--------LDNKGHV-KVTDFGFAKKVP-DRTF----TLCG 177
Query: 439 TLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTP-YSHIP-NTWAKML 496
T Y++PE S G G D W++G +LY I G P + P + K+L
Sbjct: 178 TPEYLAPEV---IQSKGHGKAV------DWWTMGVLLYEFIAGYPPFFDDTPFRIYEKIL 228
Query: 497 A 497
A
Sbjct: 229 A 229
|
Length = 329 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 73/311 (23%), Positives = 131/311 (42%), Gaps = 55/311 (17%)
Query: 244 VETSQDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIAD 303
E ++ ITL +G+G VY G E + +A+ V + T S+ +
Sbjct: 1 YEIQREDITLG-------RCIGEGQFGDVY-QGVYMSPENEKIAVAVKTCKNCTSPSVRE 52
Query: 304 SYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLME---KGDTDLSKYMRNLNKMTTL 360
+L E ++ + P+++K+ + + +++ME G+ L Y++ NK +
Sbjct: 53 KFLQEAYIMRQFDH-PHIVKLIGVITENPV---WIVMELAPLGE--LRSYLQV-NKYSL- 104
Query: 361 PNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGI 420
+ +I++ Y++ A+ + + +H D+ N L DC+ K+ DFG+
Sbjct: 105 --DLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSP-----DCV----KLGDFGL 153
Query: 421 ACSLQDDKTSVHKDTASGT---LNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLG-CILY 476
+ L+D+ S +K AS + +M+PE+ N R T SDVW G C+
Sbjct: 154 SRYLEDE--SYYK--ASKGKLPIKWMAPESI---------NFRRFTSASDVWMFGVCMWE 200
Query: 477 NMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKAR 536
++ G P+ + N +IE +L PPTL M C DP R
Sbjct: 201 ILMLGVKPFQGVKNNDVIG--------RIENGERLPMPPNCPPTLYSLMTKCWAYDPSKR 252
Query: 537 PTVGNSVTQIN 547
P Q++
Sbjct: 253 PRFTELKAQLS 263
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 51/170 (30%), Positives = 80/170 (47%), Gaps = 40/170 (23%)
Query: 334 KHLYVLMEKGDTDLSKYMR---NLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSD 390
+ +Y++ME D +L + ++ + +M+ L Y+ML +K +H+AGIIH D
Sbjct: 102 QDVYIVMELMDANLCQVIQMELDHERMSYL----------LYQMLCGIKHLHSAGIIHRD 151
Query: 391 LKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQ 450
LKP+N + DC LKI+DFG+A + TS T Y +PE
Sbjct: 152 LKPSNIVVKS------DC---TLKILDFGLA---RTAGTSFMMTPYVVTRYYRAPEV--- 196
Query: 451 TSSSGGGNTYRITYKS--DVWSLGCILYNMIYGRT--PYSHIPNTWAKML 496
+ YK D+WS+GCI+ MI G P + + W K++
Sbjct: 197 --------ILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI 238
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 46/155 (29%), Positives = 65/155 (41%), Gaps = 30/155 (19%)
Query: 387 IHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPE 446
IH DL N L G ++KI DFG+A + +D V K A + +M+PE
Sbjct: 163 IHRDLAARNVLL---------THGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPE 213
Query: 447 AAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI-YGRTPYSHIP--NTWAKMLAIARHKD 503
S Y T++SDVWS G +L+ + G PY +P + + K++
Sbjct: 214 -------SIFNCVY--TFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMA 264
Query: 504 QIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
Q E P + MK C DP RPT
Sbjct: 265 QPEHAPA---------EIYDIMKTCWDADPLKRPT 290
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 50/154 (32%), Positives = 70/154 (45%), Gaps = 35/154 (22%)
Query: 372 YEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSV 431
Y++L +K IH+A IIH DLKP+N L V DC LKI+DFG+A D+ T
Sbjct: 127 YQILRGLKYIHSADIIHRDLKPSN-LAVNE-----DC---ELKILDFGLARHTDDEMTGY 177
Query: 432 HKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNT 491
T Y +PE N D+WS+GCI+ ++ GRT + P T
Sbjct: 178 -----VATRWYRAPEIM--------LNWMHYNQTVDIWSVGCIMAELLTGRTLF---PGT 221
Query: 492 WAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSM 525
H DQ++ +L T LL+ +
Sbjct: 222 --------DHIDQLKLILRLVG--TPGAELLKKI 245
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 50/154 (32%), Positives = 75/154 (48%), Gaps = 30/154 (19%)
Query: 387 IHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPE 446
+H DL+ AN L VG L V K+ DFG+A ++D++ + + A + + +PE
Sbjct: 124 VHRDLRAANIL-VGENL--------VCKVADFGLARLIEDNEYTA-RQGAKFPIKWTAPE 173
Query: 447 AAGQTSSSGGGNTY-RITYKSDVWSLGCILYNM-IYGRTPYSHIPNTWAKMLAIARHKDQ 504
AA Y R T KSDVWS G +L + GR PY + N ++L DQ
Sbjct: 174 AA----------LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EVL------DQ 215
Query: 505 IEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
+E ++ P +L M C +K+P+ RPT
Sbjct: 216 VERGYRMPCPPECPESLHDLMCQCWRKEPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.1 bits (149), Expect = 3e-10
Identities = 58/227 (25%), Positives = 103/227 (45%), Gaps = 21/227 (9%)
Query: 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQ 316
+Y++ +G+G VY + + K A+K I+ S E+ LL +L+
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 317 GCPYVIKMHDYVYDTASKHLYVLMEKGDTDLS---KYMRNLNKMTTLPNTMIIIIMHWYE 373
V+ + + + A K +Y+L + + DL K+ R K ++P +M+ ++ ++
Sbjct: 61 H-ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQ-AKRVSIPPSMVKSLL--WQ 116
Query: 374 MLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDD-KTSVH 432
+L V +H+ ++H DLKPAN L +G + V+KI D G+A K
Sbjct: 117 ILNGVHYLHSNWVLHRDLKPANILVMGEGPE-----RGVVKIGDLGLARLFNAPLKPLAD 171
Query: 433 KDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI 479
D T+ Y +PE G Y T D+W++GCI ++
Sbjct: 172 LDPVVVTIWYRAPELL------LGARHY--TKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 4e-10
Identities = 69/258 (26%), Positives = 124/258 (48%), Gaps = 34/258 (13%)
Query: 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQ 316
+Y+V+ +G G V+LV EF K + + ++ + + EV ++ +L+
Sbjct: 14 EYEVIKKIGNGRFGEVFLVKHKRTQEF--FCWKAISYRGLKEREKSQLVI-EVNVMRELK 70
Query: 317 GCPYVIKMHDYVYDTASKHLYVLMEKGDT-DLSKYMRNLNKM-TTLPNTMIIIIMHWYEM 374
+++ D + A++ LY+LME D DLS+ ++ KM + I+ I ++
Sbjct: 71 H-KNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITR--QL 127
Query: 375 LLAVKEIH-------AAGIIHSDLKPAN-FLFVG--NVLKIIDCIGN-----VLKIIDFG 419
L A+ H ++H DLKP N FL G ++ KI N + KI DFG
Sbjct: 128 LHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFG 187
Query: 420 IACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI 479
++ ++ + + + GT Y SPE + S KSD+W+LGCI+Y +
Sbjct: 188 LSKNIGIESMA---HSCVGTPYYWSPELLLHETKS-------YDDKSDMWALGCIIYELC 237
Query: 480 YGRTPYSHIPNTWAKMLA 497
G+TP+ H N ++++++
Sbjct: 238 SGKTPF-HKANNFSQLIS 254
|
Length = 1021 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 6e-10
Identities = 62/245 (25%), Positives = 111/245 (45%), Gaps = 46/245 (18%)
Query: 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQ 316
++ + L+ G +VYLV + A+K ++ ++ ++ E ++L +
Sbjct: 2 DFETIKLISNGAYGAVYLVRHKETRQ--RFAMKKINKQNLILRNQIQQVFVERDILTFAE 59
Query: 317 GCPYVIKMHDYVYDTASKHLYVLMEKGDT-DLSKYMRNLNKMTTLPNTMIIIIMHWYEML 375
P+V+ M + +HL ++ME + D + ++N + LP M M++ E +
Sbjct: 60 N-PFVVSM--FCSFETKRHLCMVMEYVEGGDCATLLKN---IGALPVDMAR--MYFAETV 111
Query: 376 LAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIA-CSLQDDKTSVH-- 432
LA++ +H GI+H DLKP N L I +G++ K+ DFG++ L T+++
Sbjct: 112 LALEYLHNYGIVHRDLKPDNLL--------ITSMGHI-KLTDFGLSKIGLMSLTTNLYEG 162
Query: 433 ---KDTAS-------GTLNYMSPEAAGQTSSSGGGNTYRITYKS--DVWSLGCILYNMIY 480
KDT GT Y++PE R Y D W++G ILY +
Sbjct: 163 HIEKDTREFLDKQVCGTPEYIAPEV-----------ILRQGYGKPVDWWAMGIILYEFLV 211
Query: 481 GRTPY 485
G P+
Sbjct: 212 GCVPF 216
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 6e-10
Identities = 52/195 (26%), Positives = 91/195 (46%), Gaps = 29/195 (14%)
Query: 287 ALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEKGDTD 346
A+K + L + ++ + + + E+ LL +LQ P ++ + D + + LY++ E D
Sbjct: 29 AMKKIRL-ESEEEGVPSTAIREISLLKELQH-PNIVCLQDVLMQES--RLYLIFEFLSMD 84
Query: 347 LSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKII 406
L KY+ +L K + ++ + Y++L + H+ ++H DLKP N L I
Sbjct: 85 LKKYLDSLPKGQYMDAELVK--SYLYQILQGILFCHSRRVLHRDLKPQNLL--------I 134
Query: 407 DCIGNVLKIIDFGIACSLQDD-KTSVHKDTASGTLNYMSPEA-AGQTSSSGGGNTYRITY 464
D G V+K+ DFG+A + + H+ TL Y +PE G R +
Sbjct: 135 DNKG-VIKLADFGLARAFGIPVRVYTHEVV---TLWYRAPEVLLGSP---------RYST 181
Query: 465 KSDVWSLGCILYNMI 479
D+WS+G I M
Sbjct: 182 PVDIWSIGTIFAEMA 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 8e-10
Identities = 51/193 (26%), Positives = 80/193 (41%), Gaps = 34/193 (17%)
Query: 361 PNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGI 420
T+ +I + +++ ++ + + IH DL N L N NV+KI DFG+
Sbjct: 175 VLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEN---------NVVKICDFGL 225
Query: 421 ACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRI-TYKSDVWSLGCILYNMI 479
A + D V K A L +M+PE R+ T +SDVWS G +L+ +
Sbjct: 226 ARDIYKDPDYVRKGDARLPLKWMAPETIFD----------RVYTIQSDVWSFGVLLWEIF 275
Query: 480 -YGRTPYS--HIPNTWAKMLAIARHKDQIEFK-PQLANNVTIPPTLLQSMKLCLQKDPKA 535
G +PY I + + R K+ + P P + Q+M C +P
Sbjct: 276 SLGASPYPGVKIDEEFCR-----RLKEGTRMRAPDYTT-----PEMYQTMLDCWHGEPSQ 325
Query: 536 RPTVGNSVTQINN 548
RPT V + N
Sbjct: 326 RPTFSELVEHLGN 338
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 8e-10
Identities = 46/153 (30%), Positives = 68/153 (44%), Gaps = 28/153 (18%)
Query: 387 IHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPE 446
IH DL+ AN L V + C KI DFG+A ++D++ ++ A + + +PE
Sbjct: 124 IHRDLRAANIL----VSASLVC-----KIADFGLARVIEDNEY-TAREGAKFPIKWTAPE 173
Query: 447 AAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI-YGRTPYSHIPNTWAKMLAIARHKDQI 505
A S T KSDVWS G +L ++ YGR PY + N + R +
Sbjct: 174 AINFGS---------FTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-----EVIR---AL 216
Query: 506 EFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
E ++ P L M C + P+ RPT
Sbjct: 217 ERGYRMPRPENCPEELYNIMMRCWKNRPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 9e-10
Identities = 77/291 (26%), Positives = 127/291 (43%), Gaps = 53/291 (18%)
Query: 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG 317
Y + +L+G+ +++ ++ S+ + K +A K V L+D + A S E+ LA
Sbjct: 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVA-KFVMLNDERQAAYARS---ELHCLAACDH 124
Query: 318 CPYVIKMHDYVYDTASKHLYVLMEKGDT-DLSKYMRNLNKMTTLPNTMIIIIMHWYEMLL 376
V D+ D L ++ME G DL+K ++ K LP + + +Y+++L
Sbjct: 125 FGIVKHFDDFKSD---DKLLLIMEYGSGGDLNKQIKQRLK-EHLPFQEYEVGLLFYQIVL 180
Query: 377 AVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTA 436
A+ E+H+ ++H DLK AN + ++K+ DFG + D SV D A
Sbjct: 181 ALDEVHSRKMMHRDLKSANIFLMPT---------GIIKLGDFGFSKQYSD---SVSLDVA 228
Query: 437 S---GTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWA 493
S GT Y++PE + R + K+D+WSLG ILY ++ P+
Sbjct: 229 SSFCGTPYYLAPELWERK---------RYSKKADMWSLGVILYELLTLHRPF-------- 271
Query: 494 KMLAIARHKDQIEFKPQL--ANNVTIPPTLLQSMKLCLQ----KDPKARPT 538
+ Q E Q+ P + MK L K+P RPT
Sbjct: 272 ------KGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRPT 316
|
Length = 478 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 43/155 (27%), Positives = 64/155 (41%), Gaps = 27/155 (17%)
Query: 387 IHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPE 446
IH DL N L N NVLKI DFG++ + +V + + +PE
Sbjct: 115 IHRDLAARNCLVGEN---------NVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPE 165
Query: 447 AAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI-YGRTPYSHIPNTWAKMLAIARHKDQI 505
A N R T +SDVWS G +L+ G TPY + N + +++I
Sbjct: 166 AL---------NYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN--------QQTRERI 208
Query: 506 EFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVG 540
E ++ P + + M C DP+ RP+
Sbjct: 209 ESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFS 243
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 60/249 (24%), Positives = 107/249 (42%), Gaps = 58/249 (23%)
Query: 303 DSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH--LYVLMEKGDTDLSKYMRN------L 354
D ++ E +++ KL P ++++ Y +K ++++ E YM N L
Sbjct: 44 DDFIEEAKVMMKLSH-PNLVQL----YGVCTKQRPIFIVTE--------YMANGCLLNYL 90
Query: 355 NKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414
+ T ++ M ++ A++ + + G IH DL N L VG NV+K
Sbjct: 91 RERKGKLGTEWLLDM-CSDVCEAMEYLESNGFIHRDLAARNCL-VGE--------DNVVK 140
Query: 415 IIDFGIACSLQDDKTSVHKDTAS-GT---LNYMSPEAAGQTSSSGGGNTYRITYKSDVWS 470
+ DFG+A + DD+ T+S GT + + PE + R + KSDVWS
Sbjct: 141 VSDFGLARYVLDDQY-----TSSQGTKFPVKWAPPEVFDYS---------RFSSKSDVWS 186
Query: 471 LGCILYNMIY-GRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCL 529
G +++ + G+ PY N+ + + ++P+LA P + M C
Sbjct: 187 FGVLMWEVFSEGKMPYERFSNS---EVVESVSAGYRLYRPKLA-----PTEVYTIMYSCW 238
Query: 530 QKDPKARPT 538
+ P+ RP
Sbjct: 239 HEKPEDRPA 247
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 1e-09
Identities = 62/256 (24%), Positives = 114/256 (44%), Gaps = 41/256 (16%)
Query: 286 LALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLME-KGD 344
+A+KV L + ++S+ D + E E++ +L PY+++M + ++ L ++ME
Sbjct: 25 VAIKV--LKNENEKSVRDEMMREAEIMHQLDN-PYIVRM---IGVCEAEALMLVMEMASG 78
Query: 345 TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLK 404
L+K++ K + + ++ +MH M +K + +H DL N L V
Sbjct: 79 GPLNKFL--SGKKDEITVSNVVELMHQVSM--GMKYLEGKNFVHRDLAARNVLLVNQ--- 131
Query: 405 IIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGT--LNYMSPEAAGQTSSSGGGNTYRI 462
+ KI DFG++ +L D S +K ++G L + +PE N +
Sbjct: 132 ------HYAKISDFGLSKALGADD-SYYKARSAGKWPLKWYAPECI---------NFRKF 175
Query: 463 TYKSDVWSLGCILYNMI-YGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTL 521
+ +SDVWS G ++ YG+ PY + ++++ IE +L PP +
Sbjct: 176 SSRSDVWSYGITMWEAFSYGQKPYKKMKGP--EVMSF------IEQGKRLDCPAECPPEM 227
Query: 522 LQSMKLCLQKDPKARP 537
MK C + RP
Sbjct: 228 YALMKDCWIYKWEDRP 243
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 57/271 (21%), Positives = 106/271 (39%), Gaps = 47/271 (17%)
Query: 278 TSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLY 337
TS + P+A+K L I D +L E ++ L +I+++ V +
Sbjct: 18 TSGGKVIPVAVKC--LKSDKLSDIMDDFLKEAAIMHSLDH-ENLIRLYGVVLTHPLMMVT 74
Query: 338 VLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLA--VKEIHAAGIIHSDLKPAN 395
L G L +R + + I + Y + +A ++ + + IH DL N
Sbjct: 75 ELAPLGS--LLDRLR-KDALGHFL----ISTLCDYAVQIANGMRYLESKRFIHRDLAARN 127
Query: 396 FLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDK----TSVHKDTASGTLNYMSPEAAGQT 451
L + + +KI DFG+ +L ++ H + +PE+
Sbjct: 128 ILLASD---------DKVKIGDFGLMRALPQNEDHYVMEEHLKVP---FAWCAPESL--- 172
Query: 452 SSSGGGNTYRITYKSDVWSLGCILYNMI-YGRTPYSHIPNTWAKML-AIARHKDQIEFKP 509
T ++ SDVW G L+ M YG P++ + + +++L I + +++E +P
Sbjct: 173 ------RTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL--SGSQILKKIDKEGERLE-RP 223
Query: 510 QLANNVTIPPTLLQSMKLCLQKDPKARPTVG 540
+ P + M C +P RPT
Sbjct: 224 E-----ACPQDIYNVMLQCWAHNPADRPTFA 249
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 82/332 (24%), Positives = 140/332 (42%), Gaps = 79/332 (23%)
Query: 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG 317
++ L ++G+G V LV A+K++ +D+ ++ E ++L + G
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHI--YAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 318 CPYVIKMHDYVYDTASKHLYVLME---KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEM 374
+V+KM D ++LY++ME GD M L K TL + E
Sbjct: 61 A-WVVKMFYSFQD--KRNLYLIMEFLPGGDM-----MTLLMKKDTLSEEATQFYIA--ET 110
Query: 375 LLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQD-DKTSVHK 433
+LA+ IH G IH D+KP N L +D G+V K+ DFG+ L+ +T ++
Sbjct: 111 VLAIDAIHQLGFIHRDIKPDNLL--------LDAKGHV-KLSDFGLCTGLKKAHRTEFYR 161
Query: 434 D--------------------------------TASGTLNYMSPEAAGQTSSSGGGNTYR 461
+ + GT +Y++PE QT G N
Sbjct: 162 NLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT----GYNKL- 216
Query: 462 ITYKSDVWSLGCILYNMIYGRTPY-SHIPN-TWAKMLAIARHKDQIEFKPQLANNVTIPP 519
D WSLG I+Y M+ G P+ S P T+ K++ K+ + F P++ P
Sbjct: 217 ----CDWWSLGVIMYEMLIGYPPFCSETPQETYRKVM---NWKETLVFPPEV-------P 262
Query: 520 TLLQSMKLCLQKDPKARPTVGNS-VTQINNNP 550
++ L L+ + +G++ V +I ++P
Sbjct: 263 ISEKAKDLILRFCTDSENRIGSNGVEEIKSHP 294
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 71/282 (25%), Positives = 124/282 (43%), Gaps = 44/282 (15%)
Query: 263 LLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVI 322
++G+G + V LV + + A+KVV + D D E + + P+++
Sbjct: 2 VIGRGSYAKVLLV--RLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 59
Query: 323 KMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIH 382
+H + T S+ +V+ DL M ++ + LP + E+ LA+ +H
Sbjct: 60 GLHS-CFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHAR--FYSAEISLALNYLH 113
Query: 383 AAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHK-DTAS---G 438
GII+ DLK N L +D G++ K+ D+G+ K + DT S G
Sbjct: 114 ERGIIYRDLKLDNVL--------LDSEGHI-KLTDYGMC------KEGLRPGDTTSTFCG 158
Query: 439 TLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAI 498
T NY++PE G Y + D W+LG +++ M+ GR+P+ + ++
Sbjct: 159 TPNYIAPEILR-------GEDY--GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP---- 205
Query: 499 ARHKDQIEFKPQLANNVTIPPTL----LQSMKLCLQKDPKAR 536
++ + F+ L + IP +L +K L KDPK R
Sbjct: 206 DQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 73/286 (25%), Positives = 124/286 (43%), Gaps = 61/286 (21%)
Query: 264 LGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIK 323
+G+G + V + T + + +A+K +DL Q + NEV ++ Q P +++
Sbjct: 27 IGEGSTGIVCI--ATDKSTGRQVAVKKMDL---RKQQRRELLFNEVVIMRDYQH-PNIVE 80
Query: 324 MHD-YVYDTASKHLYVLME--KGD--TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAV 378
M+ Y+ L+V+ME +G TD+ + R + I + +L A+
Sbjct: 81 MYSSYLVG---DELWVVMEFLEGGALTDIVTHTR-------MNEEQIATVCL--AVLKAL 128
Query: 379 KEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDD----KTSVHKD 434
+HA G+IH D+K + L + G V K+ DFG + + K+ V
Sbjct: 129 SFLHAQGVIHRDIKSDSILLTSD--------GRV-KLSDFGFCAQVSKEVPRRKSLV--- 176
Query: 435 TASGTLNYMSPEAAGQTSSSGGGNTYRITYKS--DVWSLGCILYNMIYGRTPYSHIPNTW 492
GT +M+PE R+ Y + D+WSLG ++ M+ G PY + P
Sbjct: 177 ---GTPYWMAPEVIS-----------RLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP--- 219
Query: 493 AKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
+ A+ R +D P+L N + P L + L +DP R T
Sbjct: 220 -PLQAMKRIRD--NLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRAT 262
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 76/287 (26%), Positives = 128/287 (44%), Gaps = 54/287 (18%)
Query: 263 LLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVI 322
++G+G + V LV + A+KV+ + D D E + P+++
Sbjct: 2 VIGRGSYAKVLLVELKKTR--RIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLV 59
Query: 323 KMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWY--EMLLAVKE 380
+H + T S+ +V+ DL +M+ K LP +Y E+ LA+
Sbjct: 60 GLHS-CFQTESRLFFVIEFVSGGDLMFHMQRQRK---LPEEH----ARFYSAEISLALNF 111
Query: 381 IHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIAC--SLQD-DKTSVHKDTAS 437
+H GII+ DLK + NVL +D G++ K+ D+G+ C ++ D TS T
Sbjct: 112 LHERGIIYRDLK------LDNVL--LDAEGHI-KLTDYGM-CKEGIRPGDTTS----TFC 157
Query: 438 GTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLA 497
GT NY++PE G Y + D W+LG +++ M+ GR+P+ ++
Sbjct: 158 GTPNYIAPEILR-------GEDY--GFSVDWWALGVLMFEMMAGRSPFD--------IVG 200
Query: 498 IARHKDQIE----FKPQLANNVTIPPTL----LQSMKLCLQKDPKAR 536
++ + DQ F+ L + IP +L +K L KDPK R
Sbjct: 201 MSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKGFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 46/156 (29%), Positives = 68/156 (43%), Gaps = 31/156 (19%)
Query: 386 IIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTL--NYM 443
IH DL N L V +V+KI DFG+A + ++ T +G L +M
Sbjct: 153 CIHRDLAARNVL-VTE--------DHVMKIADFGLARDIHH--IDYYRKTTNGRLPVKWM 201
Query: 444 SPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYN-MIYGRTPYSHIPNTWAKMLAIARHK 502
+PEA Y T++SDVWS G +L+ G +PY IP ++ + +
Sbjct: 202 APEALFD-------RVY--THQSDVWSFGVLLWEIFTLGGSPYPGIP-VE-ELFKLLKEG 250
Query: 503 DQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
++E KPQ L M+ C + P RPT
Sbjct: 251 YRME-KPQNCTQ-----ELYHLMRDCWHEVPSQRPT 280
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 77/289 (26%), Positives = 126/289 (43%), Gaps = 41/289 (14%)
Query: 263 LLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVI 322
++GKG V L +E +F A+KV+ I + ++E +L K P+++
Sbjct: 2 VIGKGSFGKVLLARHKAEEKF--YAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 59
Query: 323 KMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIH 382
+H + + TA K +VL +L +++ + P + E+ A+ +H
Sbjct: 60 GLH-FSFQTADKLYFVLDYINGGELFYHLQR-ERCFLEPRAR----FYAAEIASALGYLH 113
Query: 383 AAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNY 442
+ I++ DLKP N L +D G+++ + DFG+ C + T GT Y
Sbjct: 114 SLNIVYRDLKPENIL--------LDSQGHIV-LTDFGL-CKENIEHNGT-TSTFCGTPEY 162
Query: 443 MSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARHK 502
++PE + Y T D W LG +LY M+YG P+ + NT A
Sbjct: 163 LAPEVLHK-------QPYDRTV--DWWCLGAVLYEMLYGLPPF-YSRNT-------AEMY 205
Query: 503 DQIEFKP-QLANNVTIPP-TLLQSMKLCLQKDPKARPTVGNSVTQINNN 549
D I KP QL N+T LL+ + LQKD R + +I N+
Sbjct: 206 DNILNKPLQLKPNITNSARHLLEGL---LQKDRTKRLGAKDDFMEIKNH 251
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 3e-09
Identities = 67/227 (29%), Positives = 104/227 (45%), Gaps = 36/227 (15%)
Query: 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG 317
Y+ L LG+G ++VY G S+ K +ALKV+ L + ++ + + E LL L+
Sbjct: 7 YEKLEKLGEGSYATVY--KGKSKVNGKLVALKVIRLQE--EEGTPFTAIREASLLKGLKH 62
Query: 318 CPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLA 377
V+ +HD ++ + L ++ E TDL +YM + + P + + + +++L
Sbjct: 63 ANIVL-LHDIIH--TKETLTLVFEYVHTDLCQYM-DKHPGGLHPENVKLFL---FQLLRG 115
Query: 378 VKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTAS 437
+ IH I+H DLKP N L I G LK+ DFG+A + SV T S
Sbjct: 116 LSYIHQRYILHRDLKPQNLL--------ISDTGE-LKLADFGLARA-----KSVPSHTYS 161
Query: 438 G---TLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYG 481
TL Y P+ G Y D+W +GCI MI G
Sbjct: 162 NEVVTLWYRPPDVL------LGSTEYSTCL--DMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 3e-09
Identities = 66/268 (24%), Positives = 107/268 (39%), Gaps = 71/268 (26%)
Query: 258 YQVLSLLGKGGSSSVYLV-GGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQ 316
++ + ++G+G V LV + H + A+K + S++ ++ E ++LA+
Sbjct: 3 FESIKVIGRGAFGEVRLVQKKDTGHIY---AMKKLRKSEMLEKEQVAHVRAERDILAEAD 59
Query: 317 GCPYVIKMHDYVYDTASKHLYVLME---KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYE 373
P+V+K++ D +LY++ME GD M L K T + E
Sbjct: 60 -NPWVVKLYYSFQD--ENYLYLIMEYLPGGDM-----MTLLMKKDTFTEEETRFYIA--E 109
Query: 374 MLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVH- 432
+LA+ IH G IH D+KP N L +D G++ K+ DFG+ L+ +
Sbjct: 110 TILAIDSIHKLGYIHRDIKPDNLL--------LDAKGHI-KLSDFGLCTGLKKSHRTEFY 160
Query: 433 -----------KDTAS------------------------GTLNYMSPEAAGQTSSSGGG 457
D S GT +Y++PE QT G
Sbjct: 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT---GYN 217
Query: 458 NTYRITYKSDVWSLGCILYNMIYGRTPY 485
D WSLG I+Y M+ G P+
Sbjct: 218 KE------CDWWSLGVIMYEMLVGYPPF 239
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 68/278 (24%), Positives = 119/278 (42%), Gaps = 45/278 (16%)
Query: 264 LGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIK 323
+G+G + V + +H + +A+K++DL Q + NEV ++ Q V
Sbjct: 29 IGEGSTGIVCI--AREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQHQNVVEM 83
Query: 324 MHDYVYDTASKHLYVLME--KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEI 381
Y+ + L+VLME +G + ++ T L I + +L A+ +
Sbjct: 84 YKSYL---VGEELWVLMEFLQGGA-----LTDIVSQTRLNEEQIATVCE--SVLQALCYL 133
Query: 382 HAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLN 441
H+ G+IH D+K + L + +K+ DFG + D + + GT
Sbjct: 134 HSQGVIHRDIKSDSILLT---------LDGRVKLSDFGFCAQISKDVPK--RKSLVGTPY 182
Query: 442 YMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY-SHIPNTWAKMLAIAR 500
+M+PE +T + D+WSLG ++ M+ G PY S P + A+ R
Sbjct: 183 WMAPEVISRTP---------YGTEVDIWSLGIMVIEMVDGEPPYFSDSP-----VQAMKR 228
Query: 501 HKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
+D P+L N I P L ++ L ++P+ R T
Sbjct: 229 LRD--SPPPKLKNAHKISPVLRDFLERMLTREPQERAT 264
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 49/169 (28%), Positives = 79/169 (46%), Gaps = 42/169 (24%)
Query: 336 LYVLMEKGDTDLSKYMR---NLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLK 392
+Y++ME D +L + + + +M+ L Y+ML +K +H+AGIIH DLK
Sbjct: 101 VYLVMELMDANLCQVIHMELDHERMSYL----------LYQMLCGIKHLHSAGIIHRDLK 150
Query: 393 PANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTS 452
P+N + DC LKI+DFG+A + T+ T Y +PE
Sbjct: 151 PSNIVVKS------DC---TLKILDFGLA---RTACTNFMMTPYVVTRYYRAPEV----- 193
Query: 453 SSGGGNTYRITYKS--DVWSLGCILYNMIYGRTPYS---HIPNTWAKML 496
+ YK D+WS+GCI+ ++ G + HI + W K++
Sbjct: 194 ------ILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHI-DQWNKVI 235
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 73/281 (25%), Positives = 119/281 (42%), Gaps = 44/281 (15%)
Query: 263 LLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVI 322
++G+G + V LV + A+KVV + D D E + + P+++
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQI--YAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLV 59
Query: 323 KMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIH 382
+H + T S+ V+ DL +M+ K LP + E+ +A+ +H
Sbjct: 60 GLHS-CFQTTSRLFLVIEYVNGGDLMFHMQRQRK---LPEEHAR--FYAAEICIALNFLH 113
Query: 383 AAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACS---LQDDKTSVHKDTASGT 439
GII+ DLK N L +D G++ K+ D+G+ C D TS T GT
Sbjct: 114 ERGIIYRDLKLDNVL--------LDADGHI-KLTDYGM-CKEGLGPGDTTS----TFCGT 159
Query: 440 LNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIA 499
NY++PE G Y + D W+LG +++ M+ GR+P+ I +
Sbjct: 160 PNYIAPEILR-------GEEY--GFSVDWWALGVLMFEMMAGRSPFDIITDN------PD 204
Query: 500 RHKDQIEFKPQLANNVTIPPTL----LQSMKLCLQKDPKAR 536
+ + F+ L + IP L +K L KDPK R
Sbjct: 205 MNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLNKDPKER 245
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 63/231 (27%), Positives = 106/231 (45%), Gaps = 44/231 (19%)
Query: 263 LLGKGGSSSVYLVGGTSEHEF---KPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCP 319
+LGKG V+L ++F K L VV + D + ++ E +L+ P
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMV-----EKRVLSLAWEHP 56
Query: 320 YVIKMHDYVYDTASKHLYVLMEK-GDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAV 378
++ H Y ++L+ +ME DL ++++ +K LP + E++ +
Sbjct: 57 FL--THLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFD-LPRAT----FYAAEIICGL 109
Query: 379 KEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACS---LQDDKTSVHKDT 435
+ +H+ GI++ DLK N L +D G++ KI DFG+ C L D KT T
Sbjct: 110 QFLHSKGIVYRDLKLDNIL--------LDTDGHI-KIADFGM-CKENMLGDAKTC----T 155
Query: 436 ASGTLNYMSPEAA-GQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY 485
GT +Y++PE GQ + D WS G +LY M+ G++P+
Sbjct: 156 FCGTPDYIAPEILLGQ----------KYNTSVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 81/325 (24%), Positives = 139/325 (42%), Gaps = 63/325 (19%)
Query: 245 ETSQDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKP-----LALKVVDLSDITDQ 299
E S+D +TL GK LG+G V + + KP +A+K++ D T++
Sbjct: 11 EFSRDKLTL-GKP------LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLK-DDATEK 62
Query: 300 SIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEKGDT-DLSKYMR------ 352
++D ++E+E++ + +I + T LYV++E +L +Y+R
Sbjct: 63 DLSD-LVSEMEMMKMIGKHKNIINLLGAC--TQDGPLYVIVEYASKGNLREYLRARRPPG 119
Query: 353 -----NLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIID 407
++ ++ T ++ Y++ ++ + + IH DL N L N
Sbjct: 120 MEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTEN------ 173
Query: 408 CIGNVLKIIDFGIACSLQDDKTSVHKDTASGTL--NYMSPEAAGQTSSSGGGNTYRI-TY 464
NV+KI DFG+A + + +K T +G L +M+PEA R+ T+
Sbjct: 174 ---NVMKIADFGLARDVNN--IDYYKKTTNGRLPVKWMAPEALFD----------RVYTH 218
Query: 465 KSDVWSLGCILYNMI-YGRTPYSHIP-NTWAKMLAIARHKDQIEFKPQLANNVTIPPTLL 522
+SDVWS G +++ + G +PY IP K+L D KP N L
Sbjct: 219 QSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMD----KPANCTN-----ELY 269
Query: 523 QSMKLCLQKDPKARPTVGNSVTQIN 547
M+ C P RPT V ++
Sbjct: 270 MMMRDCWHAIPSHRPTFKQLVEDLD 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 5e-09
Identities = 71/291 (24%), Positives = 122/291 (41%), Gaps = 48/291 (16%)
Query: 263 LLGKGGSSSVY-------LVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKL 315
LG G VY L G+ +A+K + TDQ + +L E L++
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGP---IRVAVKTLR-KGATDQEKKE-FLKEAHLMSNF 56
Query: 316 QGCPYVIKMHDYVYDTASKHLYV-LMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEM 374
P ++K+ +++ + LME GD L Y+R+ ++ ++ + ++
Sbjct: 57 NH-PNIVKLLGVCLLNEPQYIIMELMEGGD--LLSYLRDA-RVERFG-PPLLTLKELLDI 111
Query: 375 LLAVKE----IHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTS 430
L V + + IH DL N L K D V+KI DFG+A + K+
Sbjct: 112 CLDVAKGCVYLEQMHFIHRDLAARNCLVS---EKGYDA-DRVVKIGDFGLARDIY--KSD 165
Query: 431 VHKDTASGTLN--YMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYN-MIYGRTPYSH 487
++ G L +M+PE+ + T +SDVWS G +++ + G+ PY
Sbjct: 166 YYRKEGEGLLPVRWMAPESLLDG---------KFTTQSDVWSFGVLMWEILTLGQQPYPA 216
Query: 488 IPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
+ N ++L +++ KP+ P + Q M C +DP RPT
Sbjct: 217 LNNQ--EVLQHVTAGGRLQ-KPENC-----PDKIYQLMTNCWAQDPSERPT 259
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 6e-09
Identities = 44/153 (28%), Positives = 68/153 (44%), Gaps = 26/153 (16%)
Query: 387 IHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPE 446
IH D+ N L G V KI DFG+A + +D V K A + +M+PE
Sbjct: 234 IHRDVAARNVLLTD---------GRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPE 284
Query: 447 AAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI-YGRTPYSHIPNTWAKMLAIARHKDQI 505
+ Y T +SDVWS G +L+ + G++PY P +L ++ +
Sbjct: 285 SIFDC-------VY--TVQSDVWSYGILLWEIFSLGKSPY---PG----ILVNSKFYKMV 328
Query: 506 EFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
+ Q++ PP + MK+C +P RPT
Sbjct: 329 KRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPT 361
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 6e-09
Identities = 78/292 (26%), Positives = 127/292 (43%), Gaps = 47/292 (16%)
Query: 263 LLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVI 322
++GKG V L S+ F A+KV+ I + + + E +L K P+++
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSF--YAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59
Query: 323 KMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIH 382
+H Y + TA K +VL +L +++ + P + E+ A+ +H
Sbjct: 60 GLH-YSFQTAEKLYFVLDYVNGGELFFHLQR-ERCFLEPRAR----FYAAEVASAIGYLH 113
Query: 383 AAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACS--LQDDKTSVHKDTASGTL 440
+ II+ DLKP N L +D G+V+ + DFG+ C ++ ++T+ T GT
Sbjct: 114 SLNIIYRDLKPENIL--------LDSQGHVV-LTDFGL-CKEGVEPEETT---STFCGTP 160
Query: 441 NYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTP-YSHIPNTWAKMLAIA 499
Y++PE + Y T D W LG +LY M+YG P YS ++
Sbjct: 161 EYLAPEVLRK-------EPYDRTV--DWWCLGAVLYEMLYGLPPFYSR---------DVS 202
Query: 500 RHKDQIEFKP-QLANNVTIPP-TLLQSMKLCLQKDPKARPTVGNSVTQINNN 549
+ D I KP QL T+ LL + L KD + R +I N+
Sbjct: 203 QMYDNILHKPLQLPGGKTVAACDLLVGL---LHKDQRRRLGAKADFLEIKNH 251
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 6e-09
Identities = 66/240 (27%), Positives = 103/240 (42%), Gaps = 47/240 (19%)
Query: 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQ 316
QY+ ++ +G G +VY F +ALK V + + + S + EV LL +L+
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHF--VALKSVRVQT-NEDGLPLSTVREVALLKRLE 57
Query: 317 GC--PYVIKMHDYV----YDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMH 370
P ++++ D D +K + ++ E D DL Y+ + LP I +M
Sbjct: 58 AFDHPNIVRLMDVCATSRTDRETK-VTLVFEHVDQDLRTYLDKV-PPPGLPAETIKDLMR 115
Query: 371 WYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIA----CSLQD 426
+ L + +HA I+H DLKP N L G +K+ DFG+A C +
Sbjct: 116 --QFLRGLDFLHANCIVHRDLKPENILVTS---------GGQVKLADFGLARIYSCQMAL 164
Query: 427 DKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKS--DVWSLGCILYNMIYGRTP 484
V TL Y +PE Q+ TY + D+WS+GCI M + R P
Sbjct: 165 TPVVV-------TLWYRAPEVLLQS-----------TYATPVDMWSVGCIFAEM-FRRKP 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 6e-09
Identities = 72/305 (23%), Positives = 123/305 (40%), Gaps = 45/305 (14%)
Query: 185 VFSVRSASDQSLSQKKNESTPVF----KRPLSVNSTKSSDPSVSKETIKPAKPQITTSNA 240
+FS+ +D S S K+ + F + S + T ++D +E++ P Q
Sbjct: 22 IFSLTGGTDTSDS--KDTTGDKFDDCDELGDSDDVTHATDYDADEESLSP---QTDVCQE 76
Query: 241 KKSVETSQDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQS 300
+S D ++ QY +LS L G V++ + + K + +K V +
Sbjct: 77 PCETTSSSDPASVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAV--------T 128
Query: 301 IADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTL 360
+ E+++L + + +H Y + + + ++M K DL Y +++ L
Sbjct: 129 GGKTPGREIDILKTISHRAIINLIHAYRWKST---VCMVMPKYKCDLFTY---VDRSGPL 182
Query: 361 PNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGI 420
P I I +L A+ +H GIIH D+K N +D N + + DFG
Sbjct: 183 PLEQAITIQR--RLLEALAYLHGRGIIHRDVKTENIF--------LDEPENAV-LGDFGA 231
Query: 421 ACSLQDDKTSVHKDTA-SGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI 479
AC L D + SGTL SPE + Y K+D+WS G +L+ M
Sbjct: 232 ACKL-DAHPDTPQCYGWSGTLETNSPELLAL-------DPY--CAKTDIWSAGLVLFEMS 281
Query: 480 YGRTP 484
Sbjct: 282 VKNVT 286
|
Length = 392 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 7e-09
Identities = 55/198 (27%), Positives = 77/198 (38%), Gaps = 59/198 (29%)
Query: 375 LLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKD 434
L ++E H I+H D+KP+N L ++ G + K+ DFG++ L D +
Sbjct: 112 LTYLREKHK--IMHRDVKPSNIL--------VNSRGEI-KLCDFGVSGQLIDSMA----N 156
Query: 435 TASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494
+ GT +YMSPE G Y T +SD+WSLG L M GR P IP AK
Sbjct: 157 SFVGTRSYMSPERLQ-------GTHY--TVQSDIWSLGLSLVEMAIGRYP---IPPPDAK 204
Query: 495 MLAI--ARHKDQIEFKPQLANNVTIPPTLLQSMKL------------------------- 527
L R + E K PP + M +
Sbjct: 205 ELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQ 264
Query: 528 -----CLQKDPKARPTVG 540
CL+K+PK R +
Sbjct: 265 DFVDKCLKKNPKERADLK 282
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 70/287 (24%), Positives = 123/287 (42%), Gaps = 63/287 (21%)
Query: 264 LGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIK 323
+G+G + V + T +H K +A+K +DL Q + NEV ++
Sbjct: 30 IGEGSTGIVCI--ATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYH------- 77
Query: 324 MHDYVYDTASKHL-----YVLME----KGDTDLSKYMR-NLNKMTTLPNTMIIIIMHWYE 373
H+ V D + +L +V+ME TD+ + R N ++ T+
Sbjct: 78 -HENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATV----------CLS 126
Query: 374 MLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHK 433
+L A+ +H G+IH D+K + L + +K+ DFG C+ Q K +
Sbjct: 127 VLRALSYLHNQGVIHRDIKSDSILLTSD---------GRIKLSDFGF-CA-QVSKEVPKR 175
Query: 434 DTASGTLNYMSPEAAGQTSSSGGGNTYRITYKS--DVWSLGCILYNMIYGRTPYSHIPNT 491
+ GT +M+PE R+ Y + D+WSLG ++ MI G PY + P
Sbjct: 176 KSLVGTPYWMAPEVIS-----------RLPYGTEVDIWSLGIMVIEMIDGEPPYFNEP-- 222
Query: 492 WAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
+ A+ R +D + P++ ++ + L + L L ++P R T
Sbjct: 223 --PLQAMRRIRDNL--PPRVKDSHKVSSVLRGFLDLMLVREPSQRAT 265
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 49/164 (29%), Positives = 66/164 (40%), Gaps = 28/164 (17%)
Query: 387 IHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPE 446
IH DL N L N NV+KI DFG+A + D V K A L +M+PE
Sbjct: 195 IHRDLAARNILLSEN---------NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 245
Query: 447 AAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI-YGRTPYSHIPNTWAKMLAIARHKDQI 505
S Y T +SDVWS G +L+ + G +PY P R K+
Sbjct: 246 -------SIFDKVY--TTQSDVWSFGVLLWEIFSLGASPY---PGVQIDEEFCRRLKEGT 293
Query: 506 EF-KPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINN 548
P+ A P + M C +P+ RPT V + +
Sbjct: 294 RMRAPEYAT-----PEIYSIMLDCWHNNPEDRPTFSELVEILGD 332
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 63/242 (26%), Positives = 109/242 (45%), Gaps = 48/242 (19%)
Query: 256 KQYQVLSLLGKGGSSSVYLV-----GGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVE 310
+QY+ ++ +G+G V+ GG + +ALK V + ++ + S + EV
Sbjct: 1 QQYECVAEIGEGAYGKVFKARDLKNGG------RFVALKRVRVQ-TGEEGMPLSTIREVA 53
Query: 311 LLAKLQGC--PYVIKMHDYVY----DTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTM 364
+L L+ P V+++ D D +K L ++ E D DL+ Y+ + + T+
Sbjct: 54 VLRHLETFEHPNVVRLFDVCTVSRTDRETK-LTLVFEHVDQDLTTYLDKVPEPGVPTETI 112
Query: 365 IIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIA--C 422
++ +++L + +H+ ++H DLKP N L +K+ DFG+A
Sbjct: 113 KDMM---FQLLRGLDFLHSHRVVHRDLKPQNILVTS---------SGQIKLADFGLARIY 160
Query: 423 SLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGR 482
S Q TSV TL Y +PE Q+S + D+WS+GCI M + R
Sbjct: 161 SFQMALTSV-----VVTLWYRAPEVLLQSSYAT---------PVDLWSVGCIFAEM-FRR 205
Query: 483 TP 484
P
Sbjct: 206 KP 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 53/192 (27%), Positives = 82/192 (42%), Gaps = 49/192 (25%)
Query: 306 LNEVELLAKLQGCPYVIKMHDYV---YDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPN 362
L E++LL L VI + D + + A +Y++ E DTDL + +R+ ++
Sbjct: 52 LREIKLLRHLDH-ENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHC 110
Query: 363 TMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIAC 422
+ Y++L +K IH+A ++H DLKP+N L N LKI DFG+A
Sbjct: 111 QYFL-----YQLLRGLKYIHSANVLHRDLKPSNLLLNANCD---------LKICDFGLA- 155
Query: 423 SLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYR----------ITYKSDVWSLG 472
T S ++M+ + YR T DVWS+G
Sbjct: 156 -----------RTTSEKGDFMTEYVVTR--------WYRAPELLLNCSEYTTAIDVWSVG 196
Query: 473 CILYNMIYGRTP 484
CI ++ GR P
Sbjct: 197 CIFAELL-GRKP 207
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 50/171 (29%), Positives = 71/171 (41%), Gaps = 40/171 (23%)
Query: 385 GIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASG---TLN 441
G +H DL N L N+ V K+ DFG++ L+DD + + T G +
Sbjct: 126 GYVHRDLAARNILVNSNL---------VCKVSDFGLSRVLEDDPEAAY--TTRGGKIPIR 174
Query: 442 YMSPEAAGQTSSSGGGNTYR-ITYKSDVWSLGCILYN-MIYGRTPYSHIPNTWAKMLAIA 499
+ +PEA YR T SDVWS G +++ M YG PY + N
Sbjct: 175 WTAPEAIA----------YRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN--------- 215
Query: 500 RHKD---QIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQIN 547
+D IE +L + P L Q M C QKD RP V+ ++
Sbjct: 216 --QDVIKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILD 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 2e-08
Identities = 49/170 (28%), Positives = 79/170 (46%), Gaps = 40/170 (23%)
Query: 334 KHLYVLMEKGDTDLSKYMR---NLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSD 390
+ +Y++ME D +L + ++ + +M+ L Y+ML +K +H+AGIIH D
Sbjct: 95 QDVYLVMELMDANLCQVIQMELDHERMSYL----------LYQMLCGIKHLHSAGIIHRD 144
Query: 391 LKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQ 450
LKP+N + DC LKI+DFG+A + TS T Y +PE
Sbjct: 145 LKPSNIVVKS------DC---TLKILDFGLA---RTAGTSFMMTPYVVTRYYRAPEV--- 189
Query: 451 TSSSGGGNTYRITYKS--DVWSLGCILYNMIYGRT--PYSHIPNTWAKML 496
+ YK D+WS+GCI+ M+ + P + W K++
Sbjct: 190 --------ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 231
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 2e-08
Identities = 77/261 (29%), Positives = 115/261 (44%), Gaps = 41/261 (15%)
Query: 263 LLGKGGSSSVYLVGGTSEHEFKPLALKVVDLS-DITDQSIADSYLN-EVELLAKLQGCPY 320
LLG+G VYL + LA K V + + S S L E++LL LQ
Sbjct: 9 LLGQGAFGRVYLCYDVDTG--RELAAKQVQFDPESPETSKEVSALECEIQLLKNLQH-ER 65
Query: 321 VIKMHDYVYDTASKHLYVLME--KGDT--DLSKYMRNLNKMTTLPNTMIIIIMHWYEMLL 376
+++ + + D A K L + ME G + D K L + T T ++L
Sbjct: 66 IVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTR--------QILE 117
Query: 377 AVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTS-VHKDT 435
+ +H+ I+H D+K AN L D GNV K+ DFG + LQ S +
Sbjct: 118 GMSYLHSNMIVHRDIKGANILR--------DSAGNV-KLGDFGASKRLQTICMSGTGIRS 168
Query: 436 ASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKM 495
+GT +MSPE S G G K+DVWSLGC + M+ + P++ + M
Sbjct: 169 VTGTPYWMSPEV---ISGEGYGR------KADVWSLGCTVVEMLTEKPPWAE----YEAM 215
Query: 496 LAIARHKDQIEFKPQLANNVT 516
AI + Q PQL ++++
Sbjct: 216 AAIFKIATQ-PTNPQLPSHIS 235
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 66/267 (24%), Positives = 118/267 (44%), Gaps = 62/267 (23%)
Query: 295 DITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYD-----TASKHLYVLME---KGDTD 346
+ TD+ +AD ++E+EL+ +I H + + T LYV++E KG+
Sbjct: 55 NATDKDLAD-LISEMELMK-------LIGKHKNIINLLGVCTQEGPLYVIVEYAAKGN-- 104
Query: 347 LSKYMR-----------NLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPAN 395
L +++R ++ K+ + ++ Y++ ++ + + IH DL N
Sbjct: 105 LREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARN 164
Query: 396 FLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTL--NYMSPEAAGQTSS 453
L + NV+KI DFG+A + D +K T++G L +M+PEA
Sbjct: 165 VLVTED---------NVMKIADFGLARGVHD--IDYYKKTSNGRLPVKWMAPEALFD--- 210
Query: 454 SGGGNTYRI-TYKSDVWSLGCILYNMI-YGRTPYSHIPNTWAKMLAIARHKDQIEFKPQL 511
R+ T++SDVWS G +++ + G +PY IP ++ + R +++ KP
Sbjct: 211 -------RVYTHQSDVWSFGILMWEIFTLGGSPYPGIP--VEELFKLLREGHRMD-KPS- 259
Query: 512 ANNVTIPPTLLQSMKLCLQKDPKARPT 538
L M+ C P RPT
Sbjct: 260 ----NCTHELYMLMRECWHAVPTQRPT 282
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 38/111 (34%), Positives = 53/111 (47%), Gaps = 22/111 (19%)
Query: 372 YEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSV 431
Y++L +K IH+AGIIH DLKP NV DC L+I+DFG+A D+ T
Sbjct: 125 YQLLRGLKYIHSAGIIHRDLKP------SNVAVNEDC---ELRILDFGLARQADDEMTGY 175
Query: 432 HKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGR 482
T Y +PE N D+WS+GCI+ ++ G+
Sbjct: 176 -----VATRWYRAPEIM--------LNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 4e-08
Identities = 52/183 (28%), Positives = 87/183 (47%), Gaps = 32/183 (17%)
Query: 301 IADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTL 360
+A E++LL L+ +I + D ++ + + +Y + E TDL + + T+
Sbjct: 52 LAKRTYRELKLLKHLRH-ENIISLSD-IFISPLEDIYFVTELLGTDLHRLL------TSR 103
Query: 361 PNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGI 420
P I Y++L +K +H+AG++H DLKP+N L N C LKI DFG+
Sbjct: 104 PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINEN------CD---LKICDFGL 154
Query: 421 ACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTY-RITYKSDVWSLGCILYNMI 479
A +QD + + + T Y +PE T+ + + D+WS GCI M+
Sbjct: 155 A-RIQDPQMTGYVSTRY----YRAPEIM---------LTWQKYDVEVDIWSAGCIFAEML 200
Query: 480 YGR 482
G+
Sbjct: 201 EGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 76/310 (24%), Positives = 130/310 (41%), Gaps = 60/310 (19%)
Query: 245 ETSQDVITLNGKQYQVLSLLGKGGSSSVY------LVGGTSEHEFKPLALKVVDLSDITD 298
E S++ ITL L LG+G VY ++ G +E +A+K V+ S
Sbjct: 2 EVSREKITL-------LRELGQGSFGMVYEGNARDIIKGEAETR---VAVKTVNESASLR 51
Query: 299 QSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLME-KGDTDLSKYMRNL--- 354
+ I +LNE ++ K C +V+++ V + + V+ME DL Y+R+L
Sbjct: 52 ERI--EFLNEASVM-KGFTCHHVVRLLGVV--SKGQPTLVVMELMAHGDLKSYLRSLRPE 106
Query: 355 --NKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNV 412
N P T+ +I E+ + ++A +H DL N + +
Sbjct: 107 AENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHD---------FT 157
Query: 413 LKIIDFGIACSLQDDKTSVHKDTASGTL--NYMSPEAAGQTSSSGGGNTYRITYKSDVWS 470
+KI DFG+ + + T ++ G L +M+PE+ T SD+WS
Sbjct: 158 VKIGDFGMTRDIYE--TDYYRKGGKGLLPVRWMAPESLKDGV---------FTTSSDMWS 206
Query: 471 LGCILYNMI-YGRTPYSHIPNTWA-KMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLC 528
G +L+ + PY + N K + + DQ + P+ ++ M++C
Sbjct: 207 FGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDL---------MRMC 257
Query: 529 LQKDPKARPT 538
Q +PK RPT
Sbjct: 258 WQFNPKMRPT 267
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 4e-08
Identities = 72/297 (24%), Positives = 127/297 (42%), Gaps = 45/297 (15%)
Query: 264 LGKGGSSSVY--LVGGTSEHEFKP-LALKVVDLSDITDQSIADSYLNEVELLAKLQGCPY 320
LG+G VY + G + E + +A+K V+ + + I +LNE ++ + C +
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVMKEFN-CHH 70
Query: 321 VIKMHDYVYDTASKHLYV-LMEKGDTDLSKYMRNL-----NKMTTLPNTMIIIIMHWYEM 374
V+++ V + + LM +GD L Y+R+L N P ++ +I E+
Sbjct: 71 VVRLLGVVSQGQPTLVIMELMTRGD--LKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEI 128
Query: 375 LLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKD 434
+ ++A +H DL N + + +KI DFG+ + + T ++
Sbjct: 129 ADGMAYLNANKFVHRDLAARNCMVAEDF---------TVKIGDFGMTRDIYE--TDYYRK 177
Query: 435 TASGTL--NYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNM-IYGRTPYSHIPNT 491
G L +MSPE+ G TY SDVWS G +L+ + PY + N
Sbjct: 178 GGKGLLPVRWMSPESL----KDGVFTTY-----SDVWSFGVVLWEIATLAEQPYQGMSNE 228
Query: 492 WAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINN 548
++L ++ KP P L + M++C Q +PK RP+ ++ I
Sbjct: 229 --QVLRFVMEGGLLD-KPD-----NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 54/173 (31%), Positives = 80/173 (46%), Gaps = 28/173 (16%)
Query: 321 VIKMHDYVYDTASKH------LYVLMEKGDTDLSKYMRNLNKMT-TLPNTMIIIIMHWYE 373
+I + DY Y K L V+ME + KYM++ + LP + ++ ++ Y+
Sbjct: 121 IIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALP--LFLVKLYSYQ 178
Query: 374 MLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHK 433
+ A+ IH+ I H DLKP N L ID + LK+ DFG A +L + SV
Sbjct: 179 LCRALAYIHSKFICHRDLKPQNLL--------IDPNTHTLKLCDFGSAKNLLAGQRSV-- 228
Query: 434 DTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYS 486
+ + Y +PE G Y T D+WSLGCI+ MI G +S
Sbjct: 229 -SYICSRFYRAPELM------LGATNY--TTHIDLWSLGCIIAEMILGYPIFS 272
|
Length = 440 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 4e-08
Identities = 60/232 (25%), Positives = 104/232 (44%), Gaps = 29/232 (12%)
Query: 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG 317
++++ ++G G VY G + A+KV+D+++ ++ I E+ +L K
Sbjct: 18 FELVEVVGNGTYGQVY--KGRHVKTGQLAAIKVMDVTEDEEEEIK----LEINMLKKYSH 71
Query: 318 CPYVIKMHD-YVYDTASKH---LYVLMEK-GDTDLSKYMRNLNKMTTLPNTMIIIIMHWY 372
+ + ++ + H L+++ME G ++ ++N K L I I
Sbjct: 72 HRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKN-TKGNALKEDWIAYICR-- 128
Query: 373 EMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVH 432
E+L + +HA +IH D+K N L N +K++DFG+ S Q D+T
Sbjct: 129 EILRGLAHLHAHKVIHRDIKGQNVLLTENA---------EVKLVDFGV--SAQLDRTVGR 177
Query: 433 KDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTP 484
++T GT +M+PE TY Y+SD+WSLG M G P
Sbjct: 178 RNTFIGTPYWMAPEVIA--CDENPDATY--DYRSDIWSLGITAIEMAEGAPP 225
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 5e-08
Identities = 54/225 (24%), Positives = 98/225 (43%), Gaps = 31/225 (13%)
Query: 264 LGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAK--LQGCPYV 321
+GKG VY V A+KV+ +I + + E +L + L P++
Sbjct: 1 IGKGTFGQVYQVRKKDTRRI--YAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFI 58
Query: 322 IKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEI 381
+ + + + T S V +L +++ + + I E++LA++ +
Sbjct: 59 VGL-KFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIA-----ELVLALEHL 112
Query: 382 HAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIA-CSLQDDKTSVHKDTASGTL 440
H I++ DLKP N L +D G++ + DFG++ +L D+KT+ +T GT
Sbjct: 113 HKYDIVYRDLKPENIL--------LDATGHI-ALCDFGLSKANLTDNKTT---NTFCGTT 160
Query: 441 NYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY 485
Y++PE T D WSLG +++ M G +P+
Sbjct: 161 EYLAPEVLLDEKG--------YTKHVDFWSLGVLVFEMCCGWSPF 197
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 5e-08
Identities = 45/145 (31%), Positives = 68/145 (46%), Gaps = 24/145 (16%)
Query: 373 EMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTS-V 431
++L V +H+ I+H D+K AN L D GNV K+ DFG + +Q S
Sbjct: 114 QILQGVSYLHSNMIVHRDIKGANILR--------DSAGNV-KLGDFGASKRIQTICMSGT 164
Query: 432 HKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNT 491
+ +GT +MSPE S G G K+DVWS+ C + M+ + P++
Sbjct: 165 GIKSVTGTPYWMSPEV---ISGEGYGR------KADVWSVACTVVEMLTEKPPWAE---- 211
Query: 492 WAKMLAIARHKDQIEFKPQLANNVT 516
+ M AI + Q KP L + V+
Sbjct: 212 YEAMAAIFKIATQ-PTKPMLPDGVS 235
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 5e-08
Identities = 45/196 (22%), Positives = 85/196 (43%), Gaps = 35/196 (17%)
Query: 346 DLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKI 405
+L Y+R N+ + ++++ ++ A++ + IH DL N L N
Sbjct: 88 NLLDYLRECNR-QEVN--AVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN---- 140
Query: 406 IDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYK 465
+++K+ DFG++ + D + H A + + +PE+ N + I K
Sbjct: 141 -----HLVKVADFGLSRLMTGDTYTAHAG-AKFPIKWTAPESLAY-------NKFSI--K 185
Query: 466 SDVWSLGCILYNM-IYGRTPYSHI--PNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLL 522
SDVW+ G +L+ + YG +PY I + + K +P+ PP +
Sbjct: 186 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-----EKGYRMERPE-----GCPPKVY 235
Query: 523 QSMKLCLQKDPKARPT 538
+ M+ C Q +P RP+
Sbjct: 236 ELMRACWQWNPSDRPS 251
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 6e-08
Identities = 63/299 (21%), Positives = 107/299 (35%), Gaps = 79/299 (26%)
Query: 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG 317
+ + +G G V LV + A+K + +D+ ++ A E ++LA+
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTN--ALYAMKTLRKADVLMRNQAAHVKAERDILAEADN 60
Query: 318 CPYVIKMHDYVYDTASKHLYVLME---KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWY-- 372
+V+K++ D + LY +M+ GD M L ++ + +Y
Sbjct: 61 -EWVVKLYYSFQDKDN--LYFVMDYIPGGDM-----MSLLIRLGIFEEDL----ARFYIA 108
Query: 373 EMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSL-------- 424
E+ A++ +H G IH D+KP N L ID G++ K+ DFG+
Sbjct: 109 ELTCAIESVHKMGFIHRDIKPDNIL--------IDRDGHI-KLTDFGLCTGFRWTHDSKY 159
Query: 425 --------QD-------------------------DKTSVHKDTASGTLNYMSPEAAGQT 451
QD + GT NY++PE +T
Sbjct: 160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT 219
Query: 452 SSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQ 510
T D WS+G ILY M+ G+ P+ L + + + Q
Sbjct: 220 GY---------TQLCDWWSVGVILYEMLVGQPPF-LADTPAETQLKVINWETTLHIPSQ 268
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 7e-08
Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 36/210 (17%)
Query: 285 PLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYV--LMEK 342
P+A+KV L + T L+E ++A + P+V+++ +S+ + LM
Sbjct: 38 PVAIKV--LREETSPKANKEILDEAYVMASV-DHPHVVRL--LGICLSSQVQLITQLMPL 92
Query: 343 GDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLL-AVKEIHAAGIIHSDLKPANFLFVGN 401
G L Y+RN +K + ++W + + + ++H DL N L
Sbjct: 93 GC--LLDYVRN-HKDNIGSQYL----LNWCVQIAKGMSYLEEKRLVHRDLAARNVL---- 141
Query: 402 VLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYR 461
+K +KI DFG+A L D+ H + + +M+ E+ +R
Sbjct: 142 -VKT----PQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI----------LHR 186
Query: 462 I-TYKSDVWSLGCILYN-MIYGRTPYSHIP 489
I T+KSDVWS G ++ M +G PY IP
Sbjct: 187 IYTHKSDVWSYGVTVWELMTFGAKPYEGIP 216
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 7e-08
Identities = 70/286 (24%), Positives = 123/286 (43%), Gaps = 49/286 (17%)
Query: 261 LSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPY 320
L +LGKG V L E A+K++ + + + E +LA P+
Sbjct: 5 LMVLGKGSFGKVMLAERKGTDEL--YAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPF 62
Query: 321 VIKMHDYVYDTASKHLYVLMEK-GDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVK 379
+ ++H + T + LY +ME DL +++ + K P + + E+ + +
Sbjct: 63 LTQLHS-CFQTVDR-LYFVMEYVNGGDLMYHIQQVGKFKE-PQA----VFYAAEISVGLF 115
Query: 380 EIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGT 439
+H GII+ DLK N + +D G++ KI DFG+ D V T GT
Sbjct: 116 FLHRRGIIYRDLKLDNVM--------LDSEGHI-KIADFGMCKEHMVD--GVTTRTFCGT 164
Query: 440 LNYMSPEAAGQTSSSGGGNTYRITYKS-DVWSLGCILYNMIYGRTPYSHIPNTWAKMLAI 498
+Y++PE Y+ KS D W+ G +LY M+ G+ P+
Sbjct: 165 PDYIAPEIIA----------YQPYGKSVDWWAYGVLLYEMLAGQPPFD------------ 202
Query: 499 ARHKDQIEFKPQLANNVTIPPTL-LQSMKLC---LQKDPKARPTVG 540
+D++ F+ + +NV+ P +L +++ +C + K P R G
Sbjct: 203 GEDEDEL-FQSIMEHNVSYPKSLSKEAVSICKGLMTKHPSKRLGCG 247
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 8e-08
Identities = 73/296 (24%), Positives = 128/296 (43%), Gaps = 75/296 (25%)
Query: 256 KQYQVLSLLGKGGSSSVYLVGGT-SEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAK 314
+ ++ L ++G+G V LV + H + A+K++ +D+ ++ E ++L +
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVY---AMKILRKADMLEKEQVGHIRAERDILVE 57
Query: 315 LQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTL--PNTMIIIIMHWY 372
+V+KM D + LY++ME ++ + MT L +T+ +Y
Sbjct: 58 ADSL-WVVKMFYSFQDKLN--LYLIME--------FLPGGDMMTLLMKKDTLTEEETQFY 106
Query: 373 --EMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQD-DKT 429
E +LA+ IH G IH D+KP N L +D G+V K+ DFG+ L+ +T
Sbjct: 107 IAETVLAIDSIHQLGFIHRDIKPDNLL--------LDSKGHV-KLSDFGLCTGLKKAHRT 157
Query: 430 SVHKD--------------------------------TASGTLNYMSPEAAGQTSSSGGG 457
+++ + GT +Y++PE QT G
Sbjct: 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT----GY 213
Query: 458 NTYRITYKSDVWSLGCILYNMIYGRTPY-SHIPN-TWAKMLAIARHKDQIEFKPQL 511
N D WSLG I+Y M+ G P+ S P T+ K++ K+ + F P++
Sbjct: 214 NKL-----CDWWSLGVIMYEMLIGYPPFCSETPQETYKKVM---NWKETLIFPPEV 261
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (128), Expect = 8e-08
Identities = 59/232 (25%), Positives = 100/232 (43%), Gaps = 29/232 (12%)
Query: 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG 317
++++ L+G G VY G + A+KV+D++ ++ I E+ +L K
Sbjct: 8 FELVELVGNGTYGQVY--KGRHVKTGQLAAIKVMDVTGDEEEEIK----QEINMLKKYSH 61
Query: 318 CPYVIKMHDYVYDT----ASKHLYVLME-KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWY 372
+ + L+++ME G ++ ++N K TL I I
Sbjct: 62 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN-TKGNTLKEEWIAYICR-- 118
Query: 373 EMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVH 432
E+L + +H +IH D+K N L N +K++DFG++ L D+T
Sbjct: 119 EILRGLSHLHQHKVIHRDIKGQNVLLTENA---------EVKLVDFGVSAQL--DRTVGR 167
Query: 433 KDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTP 484
++T GT +M+PE + TY +KSD+WSLG M G P
Sbjct: 168 RNTFIGTPYWMAPEVIACDENPDA--TY--DFKSDLWSLGITAIEMAEGAPP 215
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 9e-08
Identities = 59/226 (26%), Positives = 99/226 (43%), Gaps = 34/226 (15%)
Query: 263 LLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVI 322
++GKG V L + + A+KV+ + ++ + E +L K P+++
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKC--YAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLV 59
Query: 323 KMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIH 382
+H Y + T K +VL +L +L + + P + E+ A+ +H
Sbjct: 60 GLH-YSFQTTEKLYFVLDFVNGGEL---FFHLQRERSFPEPRAR--FYAAEIASALGYLH 113
Query: 383 AAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACS---LQDDKTSVHKDTASGT 439
+ I++ DLKP N L +D G+V+ + DFG+ C Q D T+ T GT
Sbjct: 114 SINIVYRDLKPENIL--------LDSQGHVV-LTDFGL-CKEGIAQSDTTT----TFCGT 159
Query: 440 LNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY 485
Y++PE + Y T D W LG +LY M+YG P+
Sbjct: 160 PEYLAPEVIRK-------QPYDNTV--DWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 48/172 (27%), Positives = 75/172 (43%), Gaps = 41/172 (23%)
Query: 373 EMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVH 432
+++ ++ +H II+ DLKP N L +D GNV +I D G+A L+D ++
Sbjct: 105 QIISGLEHLHQRRIIYRDLKPENVL--------LDNDGNV-RISDLGLAVELKDGQSKTK 155
Query: 433 KDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTW 492
+GT +M+PE G Y + D ++LG LY MI R P+
Sbjct: 156 G--YAGTPGFMAPELL-------QGEEY--DFSVDYFALGVTLYEMIAARGPFR------ 198
Query: 493 AKMLAIARHKDQIEFKP----QLANNVTIPPTLLQSMK-LC---LQKDPKAR 536
+++E K L ++VT P + K C L KDP+ R
Sbjct: 199 -------ARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKDPEKR 243
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 53.6 bits (128), Expect = 1e-07
Identities = 63/283 (22%), Positives = 119/283 (42%), Gaps = 43/283 (15%)
Query: 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKL 315
K+Y +G+G S +V+ + +A+K ++L Q + +NE+ ++ +L
Sbjct: 19 KKYTRYEKIGQGASGTVFT--AIDVATGQEVAIKQINLQK---QPKKELIINEILVMKEL 73
Query: 316 QGCPYVIKMHDYVYDTASKHLYVLME--KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYE 373
+ V + ++ L+V+ME G + + ++ T + I + E
Sbjct: 74 KNPNIVNFLDSFL---VGDELFVVMEYLAGGS-----LTDVVTETCMDEAQIAAVCR--E 123
Query: 374 MLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHK 433
L A++ +HA +IH D+K N L + +K+ DFG + +++ +
Sbjct: 124 CLQALEFLHANQVIHRDIKSDNVLL---------GMDGSVKLTDFGFCAQITPEQSK--R 172
Query: 434 DTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWA 493
T GT +M+PE + + K D+WSLG + M+ G PY + N
Sbjct: 173 STMVGTPYWMAPEVVTRKAYGP---------KVDIWSLGIMAIEMVEGEPPYLN-ENPLR 222
Query: 494 KMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKAR 536
+ IA + P+L N + P + CL+ D + R
Sbjct: 223 ALYLIATNG-----TPELQNPEKLSPIFRDFLNRCLEMDVEKR 260
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 67/287 (23%), Positives = 119/287 (41%), Gaps = 51/287 (17%)
Query: 256 KQYQVLSLLGKGGSSSVYL-VGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAK 314
K+Y +G+G S +VY + + E +A+K ++L Q + +NE+ ++ +
Sbjct: 19 KKYTRFEKIGQGASGTVYTAIDVATGQE---VAIKQMNLQQ---QPKKELIINEILVMRE 72
Query: 315 LQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMI---IIIMHW 371
+ V + Y+ L+V+ME Y+ + + T + I
Sbjct: 73 NKHPNIVNYLDSYL---VGDELWVVME--------YLAGGSLTDVVTETCMDEGQIAAVC 121
Query: 372 YEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSV 431
E L A++ +H+ +IH D+K N L + G+V K+ DFG + +++
Sbjct: 122 RECLQALEFLHSNQVIHRDIKSDNIL--------LGMDGSV-KLTDFGFCAQITPEQSK- 171
Query: 432 HKDTASGTLNYMSPEAAGQTSSSGGGNTYRITY--KSDVWSLGCILYNMIYGRTPYSHIP 489
+ T GT +M+PE R Y K D+WSLG + M+ G PY +
Sbjct: 172 -RSTMVGTPYWMAPEV-----------VTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN-E 218
Query: 490 NTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKAR 536
N + IA + P+L N + + CL+ D + R
Sbjct: 219 NPLRALYLIATNG-----TPELQNPEKLSAIFRDFLNRCLEMDVEKR 260
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 1e-07
Identities = 40/170 (23%), Positives = 61/170 (35%), Gaps = 45/170 (26%)
Query: 261 LSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG--- 317
+ LL G ++ VYL+G E LK + EV +L L
Sbjct: 3 IKLLKGGLTNRVYLLGTKDED----YVLK-----INPSREKGADREREVAILQLLARKGL 53
Query: 318 -CPYVIKMHDYVYDTASKHLYVLME--KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEM 374
P V+ ++ Y+LME +G+T L++++ I
Sbjct: 54 PVPKVL----ASGESDGWS-YLLMEWIEGET--------LDEVSEEEKEDIAEQ---LAE 97
Query: 375 LLAVKEIHAA---GIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIA 421
LLA ++H + H DL P N L G +L IID+ A
Sbjct: 98 LLA--KLHQLPLLVLCHGDLHPGNILVDD---------GKILGIIDWEYA 136
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 70/283 (24%), Positives = 117/283 (41%), Gaps = 44/283 (15%)
Query: 261 LSLLGKGGSSSVY--LVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGC 318
+ +LG G +VY + E+ P+A+KV L + T L+E ++A + G
Sbjct: 12 VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKV--LRENTSPKANKEILDEAYVMAGV-GS 68
Query: 319 PYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMR-NLNKMTTLPNTMIIIIMHW-YEMLL 376
PYV ++ + + + LM G L Y+R N +++ + +++W ++
Sbjct: 69 PYVCRLLGICLTSTVQLVTQLMPYGC--LLDYVRENKDRIGSQD------LLNWCVQIAK 120
Query: 377 AVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTA 436
+ + ++H DL N L N +KI DFG+A L D+T H D
Sbjct: 121 GMSYLEEVRLVHRDLAARNVLVKSP---------NHVKITDFGLARLLDIDETEYHADGG 171
Query: 437 SGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYN-MIYGRTPYSHIPNTWAKM 495
+ +M+ E+ R T++SDVWS G ++ M +G PY IP
Sbjct: 172 KVPIKWMALESILHR---------RFTHQSDVWSYGVTVWELMTFGAKPYDGIP------ 216
Query: 496 LAIARH-KDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARP 537
AR D +E +L + M C D + RP
Sbjct: 217 ---AREIPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRP 256
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 68/244 (27%), Positives = 104/244 (42%), Gaps = 43/244 (17%)
Query: 263 LLGKGGSSSVYLVGGTSEHEFKPLALKVVDLS-DITDQSIADSYLN-EVELLAKLQGCPY 320
LLG+G VYL + LA+K V + + S + L E++LL L
Sbjct: 9 LLGQGAFGRVYLCYDADTG--RELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH-ER 65
Query: 321 VIKMHDYVYDTASKHLYVLMEKGD----TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLL 376
+++ + + D + L + ME D K L + T T ++L
Sbjct: 66 IVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTR--------QILE 117
Query: 377 AVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTS-VHKDT 435
V +H+ I+H D+K AN L D +GNV K+ DFG + LQ S +
Sbjct: 118 GVSYLHSNMIVHRDIKGANILR--------DSVGNV-KLGDFGASKRLQTICLSGTGMKS 168
Query: 436 ASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKM 495
+GT +MSPE S G G K+D+WS+GC + M+ + P WA+
Sbjct: 169 VTGTPYWMSPEV---ISGEGYGR------KADIWSVGCTVVEMLTEKPP-------WAEF 212
Query: 496 LAIA 499
A+A
Sbjct: 213 EAMA 216
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 1e-07
Identities = 60/249 (24%), Positives = 111/249 (44%), Gaps = 58/249 (23%)
Query: 303 DSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHL-YVLMEKGDTDLSKYMRN----LNKM 357
+ ++ E +++ KL P +++++ + + L + ME G LS Y+R ++
Sbjct: 44 EDFIEEAQVMMKLSH-PKLVQLYGVCTERSPICLVFEFMEHGC--LSDYLRAQRGKFSQE 100
Query: 358 TTLPNTMIIIIMHWYEMLLAVKE----IHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413
T L M L V E + ++ +IH DL N L N V+
Sbjct: 101 TLL------------GMCLDVCEGMAYLESSNVIHRDLAARNCLVGEN---------QVV 139
Query: 414 KIIDFGIACSLQDDKTSVHKDTASGT---LNYMSPEAAGQTSSSGGGNTYRITYKSDVWS 470
K+ DFG+ + DD+ + +++GT + + SPE + S KSDVWS
Sbjct: 140 KVSDFGMTRFVLDDQYT----SSTGTKFPVKWSSPEVFSFSKYSS---------KSDVWS 186
Query: 471 LGCILYNMIY-GRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCL 529
G +++ + G+TPY + N+ A + +KP+LA ++ + M+ C
Sbjct: 187 FGVLMWEVFSEGKTPYENRSNSEVVETINAGFR---LYKPRLA-----SQSVYELMQHCW 238
Query: 530 QKDPKARPT 538
++ P+ RP+
Sbjct: 239 KERPEDRPS 247
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 71/292 (24%), Positives = 122/292 (41%), Gaps = 36/292 (12%)
Query: 249 DVITLNGKQ-YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLN 307
D++ N + Y+++ +G G VY E A+K++ L D S+
Sbjct: 1 DILRRNPQHDYELIQRVGSGTYGDVYKARNLHTGELA--AVKIIKLEPGDDFSLIQ---Q 55
Query: 308 EVELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEK-GDTDLSKYMRNLNKMTTLPNTMII 366
E+ ++ + + C V Y+ + + L++ ME G L T P + +
Sbjct: 56 EIFMVKECKHCNIVAYFGSYL---SREKLWICMEYCGGGSLQDIYH-----VTGPLSELQ 107
Query: 367 IIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQD 426
I E L + +H+ G +H D+K AN L N G+V K+ DFG+A +
Sbjct: 108 IAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDN--------GDV-KLADFGVAAKIT- 157
Query: 427 DKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYS 486
T + + GT +M+PE A +GG N D+W++G + + P
Sbjct: 158 -ATIAKRKSFIGTPYWMAPEVAA-VEKNGGYNQL-----CDIWAVGITAIELAELQPPMF 210
Query: 487 HIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
+ A L +++ Q P+L + T +K+ L K+PK RPT
Sbjct: 211 DLHPMRALFL-MSKSNFQ---PPKLKDKTKWSSTFHNFVKISLTKNPKKRPT 258
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 75/294 (25%), Positives = 119/294 (40%), Gaps = 49/294 (16%)
Query: 263 LLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVI 322
++GKG VY G + + + + V L+ ITD + +L E ++ K P V+
Sbjct: 2 VIGKGHFGCVYH-GTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKE-GIIMKDFSHPNVL 59
Query: 323 KMHDYVYDTASKHLYVL--MEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEM-LLAVK 379
+ + L VL M+ GD L ++R+ T+ + + + M LA K
Sbjct: 60 SLLGICLPSEGSPLVVLPYMKHGD--LRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK 117
Query: 380 EIHAAGIIHSDLKPANFLFVGNVLKIIDCIGN---VLKIIDFGIACSLQDDK-TSVHKDT 435
+ +H DL N C+ + +K+ DFG+A + D + SVH T
Sbjct: 118 KF-----VHRDLAARN------------CMLDESFTVKVADFGLARDIYDKEYYSVHNHT 160
Query: 436 -ASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYN-MIYGRTPYSHI-PNTW 492
A + +M+ E+ T + T KSDVWS G +L+ M G PY +
Sbjct: 161 GAKLPVKWMALESL---------QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDI 211
Query: 493 AKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQI 546
L R Q E+ P L + M C P+ RPT V++I
Sbjct: 212 TVYLLQGRRLLQPEY---------CPDPLYEVMLSCWHPKPEMRPTFSELVSRI 256
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 76/296 (25%), Positives = 125/296 (42%), Gaps = 54/296 (18%)
Query: 264 LGKGGSSSVYL---VGGTSEHEFKPLALKVVDLSD-ITDQSIADSYLNEVELLAKLQGCP 319
LG+G V + +G + KP+ + V L D TD+ ++D ++E+E++ +
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSD-LVSEMEMMKMIGKHK 78
Query: 320 YVIKMHDYVYDTASKHLYVLMEKGDT-DLSKYMRNLN--------KMTTLPNTMII---I 367
+I + T LYVL+E +L +Y+R LP + +
Sbjct: 79 NIINLLGAC--TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDL 136
Query: 368 IMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDD 427
+ Y++ ++ + + IH DL N L + NV+KI DFG+A + +
Sbjct: 137 VSCAYQVARGMEYLASQKCIHRDLAARNVLVTED---------NVMKIADFGLARDVHN- 186
Query: 428 KTSVHKDTASGTL--NYMSPEAAGQTSSSGGGNTYRI-TYKSDVWSLGCILYNMI-YGRT 483
+K T +G L +M+PEA R+ T++SDVWS G +L+ + G +
Sbjct: 187 -IDYYKKTTNGRLPVKWMAPEALFD----------RVYTHQSDVWSFGVLLWEIFTLGGS 235
Query: 484 PYSHIP-NTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
PY IP K+L D KP + L M+ C P RPT
Sbjct: 236 PYPGIPVEELFKLLKEGHRMD----KPANCTH-----ELYMIMRECWHAVPSQRPT 282
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 64/255 (25%), Positives = 114/255 (44%), Gaps = 44/255 (17%)
Query: 239 NAKKSVETSQDVITLNGKQYQ---VLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSD 295
+ KK +++++ N +Y+ + LG G V L +E +F P+A+K + S
Sbjct: 10 HKKKDSDSTKEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNE-DFPPVAIKRFEKSK 68
Query: 296 ITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLME---KGD--TDLSKY 350
I Q D +E ++L + P+ + ++ D + +LY+++E G+ T L +
Sbjct: 69 IIKQKQVDHVFSERKILNYINH-PFCVNLYGSFKDES--YLYLVLEFVIGGEFFTFLRRN 125
Query: 351 MRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIG 410
R N + I++I + + L I++ DLKP N L +D G
Sbjct: 126 KRFPNDVGCFYAAQIVLIFEYLQSL---------NIVYRDLKPENLL--------LDKDG 168
Query: 411 NVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWS 470
+K+ DFG A + D +T T GT Y++PE + G G +D W+
Sbjct: 169 -FIKMTDFGFA-KVVDTRTY----TLCGTPEYIAPEI---LLNVGHGKA------ADWWT 213
Query: 471 LGCILYNMIYGRTPY 485
LG +Y ++ G P+
Sbjct: 214 LGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 52.2 bits (126), Expect = 2e-07
Identities = 45/178 (25%), Positives = 76/178 (42%), Gaps = 28/178 (15%)
Query: 304 SYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNT 363
+ L E+ +L KLQ P ++ + + V + +Y++ME + DL M + +
Sbjct: 50 TSLREINILLKLQH-PNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEV 108
Query: 364 MIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGN--VLKIIDFGIA 421
+++ ++L V +H I+H DLK +N L N +LKI DFG+A
Sbjct: 109 KCLML----QLLSGVAHLHDNWILHRDLKTSNLLL-----------NNRGILKICDFGLA 153
Query: 422 CSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI 479
+ TL Y +PE G Y + D+WS+GCI ++
Sbjct: 154 REYGSPLKPYTQLVV--TLWYRAPELL------LGAKEY--STAIDMWSVGCIFAELL 201
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 48/168 (28%), Positives = 71/168 (42%), Gaps = 33/168 (19%)
Query: 385 GIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASG--TLNY 442
+H DL N L V + L V K+ DFG++ L+D + + T G + +
Sbjct: 126 NYVHRDLAARNIL-VNSNL--------VCKVSDFGLSRRLEDSEATY--TTKGGKIPIRW 174
Query: 443 MSPEAAGQTSSSGGGNTYRI-TYKSDVWSLGCILYN-MIYGRTPYSHIPNTWAKMLAIAR 500
+PEA YR T SDVWS G +++ M YG PY + N ++
Sbjct: 175 TAPEAI----------AYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ--DVI---- 218
Query: 501 HKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINN 548
+E +L + P L Q M C QKD RPT V+ ++
Sbjct: 219 --KAVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 3e-07
Identities = 59/223 (26%), Positives = 93/223 (41%), Gaps = 28/223 (12%)
Query: 264 LGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIK 323
+G+G VY + + ALK I I+ S E+ LL +L+ P VI
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALK-----QIEGTGISMSACREIALLRELKH-PNVIS 62
Query: 324 MHDYVYDTASKHLYVLMEKGDTDL------SKYMRNLNKMTTLPNTMIIIIMHWYEMLLA 377
+ A + +++L + + DL + + K LP M+ ++ Y++L
Sbjct: 63 LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLL--YQILDG 120
Query: 378 VKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDD-KTSVHKDTA 436
+ +HA ++H DLKPAN L +G + G V KI D G A K D
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEGPE----RGRV-KIADMGFARLFNSPLKPLADLDPV 175
Query: 437 SGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI 479
T Y +PE G Y T D+W++GCI ++
Sbjct: 176 VVTFWYRAPELL------LGARHY--TKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 48/167 (28%), Positives = 77/167 (46%), Gaps = 30/167 (17%)
Query: 374 MLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHK 433
+L A+ +HA G+IH D+K + L + G V K+ DFG C+ Q K +
Sbjct: 125 VLKALSVLHAQGVIHRDIKSDSILLTHD--------GRV-KLSDFGF-CA-QVSKEVPRR 173
Query: 434 DTASGTLNYMSPEAAGQTSSSGGGNTYRITY--KSDVWSLGCILYNMIYGRTPYSHIPNT 491
+ GT +M+PE R+ Y + D+WSLG ++ M+ G PY + P
Sbjct: 174 KSLVGTPYWMAPELIS-----------RLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP-- 220
Query: 492 WAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
+ A+ +D + P+L N + P+L + L +DP R T
Sbjct: 221 --PLKAMKMIRDNL--PPKLKNLHKVSPSLKGFLDRLLVRDPAQRAT 263
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 3e-07
Identities = 48/197 (24%), Positives = 83/197 (42%), Gaps = 20/197 (10%)
Query: 346 DLSKYMR-NLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLK 404
DL Y+R N + + ++ M E+ + +H A IHSDL N ++
Sbjct: 81 DLKNYLRSNRGMVAQMAQKDVLQRMA-CEVASGLLWLHQADFIHSDLALRNCQLTADL-- 137
Query: 405 IIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITY 464
+KI D+G+A + + KD + L +++PE T
Sbjct: 138 -------SVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELV--EIRGQDLLPKDQTK 188
Query: 465 KSDVWSLGCILYNMI-YGRTPYSHIPNTWAKMLA-IARHKDQIEFKPQLANNVTIPPTLL 522
KS++WSLG ++ + PY + + ++L + R +D KPQL ++
Sbjct: 189 KSNIWSLGVTMWELFTAADQPYPDLSDE--QVLKQVVREQDIKLPKPQL--DLKYSDRWY 244
Query: 523 QSMKLCLQKDPKARPTV 539
+ M+ C DP+ RPT
Sbjct: 245 EVMQFCWL-DPETRPTA 260
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 4e-07
Identities = 59/223 (26%), Positives = 94/223 (42%), Gaps = 28/223 (12%)
Query: 264 LGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIK 323
+G+G VY + K ALK I I+ S E+ LL +L+ P VI
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALK-----QIEGTGISMSACREIALLRELKH-PNVIA 62
Query: 324 MHDYVYDTASKHLYVLMEKGDTDL------SKYMRNLNKMTTLPNTMIIIIMHWYEMLLA 377
+ + + +++L + + DL + + K LP +M+ ++ Y++L
Sbjct: 63 LQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLL--YQILDG 120
Query: 378 VKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDD-KTSVHKDTA 436
+ +HA ++H DLKPAN L +G + G V KI D G A K D
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEGPE----RGRV-KIADMGFARLFNSPLKPLADLDPV 175
Query: 437 SGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI 479
T Y +PE G Y T D+W++GCI ++
Sbjct: 176 VVTFWYRAPELL------LGARHY--TKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 4e-07
Identities = 49/166 (29%), Positives = 71/166 (42%), Gaps = 32/166 (19%)
Query: 387 IHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASG---TLNYM 443
+H DL N L N+ V K+ DFG++ L+DD + ++ G + +
Sbjct: 128 VHRDLAARNILVNSNL---------VCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWT 178
Query: 444 SPEAAGQTSSSGGGNTYR-ITYKSDVWSLGCILYN-MIYGRTPYSHIPNTWAKMLAIARH 501
+PEA YR T SDVWS G +++ M YG PY + N
Sbjct: 179 APEAI----------AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI------- 221
Query: 502 KDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQIN 547
+ IE +L + P L Q M C QKD ARP G V+ ++
Sbjct: 222 -NAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLD 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 4e-07
Identities = 64/294 (21%), Positives = 123/294 (41%), Gaps = 61/294 (20%)
Query: 253 LNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELL 312
LN ++ + ++G+G +V E+ + +A+K + D+T Q+ +L E ++
Sbjct: 3 LNLQKLTLGEIIGEGEFGAVL----QGEYTGQKVAVKNIK-CDVTAQA----FLEETAVM 53
Query: 313 AKLQGCPYV----IKMHDYVYDTASKHLYVLME---KGDTDLSKYMRNLNKMTTLPNTMI 365
KL V + +H+ LY++ME KG+ L ++R + ++
Sbjct: 54 TKLHHKNLVRLLGVILHN--------GLYIVMELMSKGN--LVNFLRTRGRALVSVIQLL 103
Query: 366 IIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQ 425
+ E ++ + + ++H DL N L + V K+ DFG+A
Sbjct: 104 QFSLDVAE---GMEYLESKKLVHRDLAARNILVSED---------GVAKVSDFGLA---- 147
Query: 426 DDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI-YGRTP 484
S+ D + + + +PEA + + KSDVWS G +L+ + YGR P
Sbjct: 148 -RVGSMGVDNSKLPVKWTAPEALKHK---------KFSSKSDVWSYGVLLWEVFSYGRAP 197
Query: 485 YSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
Y +++ K+ +E ++ P + M C + +PK RP+
Sbjct: 198 YPK--------MSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPS 243
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 7e-07
Identities = 78/308 (25%), Positives = 130/308 (42%), Gaps = 60/308 (19%)
Query: 264 LGKGGSSSVYLVGGTSEHEFKP-----LALKVVDLSDITDQSIADSYLNEVELLAKLQGC 318
LG+G V + + KP +A+K++ SD T++ ++D ++E+E++ +
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLK-SDATEKDLSD-LISEMEMMKMIGKH 83
Query: 319 PYVIKMHDYVYDTASKHLYVLME---KGDTDLSKYMRNLN--------KMTTLPNTMIII 367
+I + T LYV++E KG+ L +Y+R T +P +
Sbjct: 84 KNIINLLGAC--TQDGPLYVIVEYASKGN--LREYLRARRPPGMEYCYNPTQVPEEQLSF 139
Query: 368 ---IMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSL 424
+ Y++ ++ + + IH DL N L + NV+KI DFG+A +
Sbjct: 140 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED---------NVMKIADFGLARDI 190
Query: 425 QDDKTSVHKDTASGTL--NYMSPEAAGQTSSSGGGNTYRI-TYKSDVWSLGCILYNMI-Y 480
+K T +G L +M+PEA RI T++SDVWS G +L+ +
Sbjct: 191 H--HIDYYKKTTNGRLPVKWMAPEALFD----------RIYTHQSDVWSFGVLLWEIFTL 238
Query: 481 GRTPYSHIP-NTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTV 539
G +PY +P K+L D KP N L M+ C P RPT
Sbjct: 239 GGSPYPGVPVEELFKLLKEGHRMD----KPSNCTN-----ELYMMMRDCWHAVPSQRPTF 289
Query: 540 GNSVTQIN 547
V ++
Sbjct: 290 KQLVEDLD 297
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 7e-07
Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 26/200 (13%)
Query: 346 DLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKI 405
DL Y+R+ K + + E+ L + +H IHSDL N L ++
Sbjct: 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADL--- 137
Query: 406 IDCIGNVLKIIDFGIA-CSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRI-- 462
+KI D+G++ ++D V D L +++PE + GN +
Sbjct: 138 ------TVKIGDYGLSHNKYKED-YYVTPDQLWVPLRWIAPELVDEVH----GNLLVVDQ 186
Query: 463 TYKSDVWSLGCILYNMI-YGRTPYSHIPNTWAKMLAIARHKDQIEF-KPQLANNVTIPPT 520
T +S+VWSLG ++ + G PY H+ + ++L + Q++ KP+L + +
Sbjct: 187 TKESNVWSLGVTIWELFELGSQPYRHLSDE--QVLTYTVREQQLKLPKPRL--KLPLSDR 242
Query: 521 LLQSMKLC-LQKDPKARPTV 539
+ M+ C LQ P+ RP+
Sbjct: 243 WYEVMQFCWLQ--PEQRPSA 260
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 7e-07
Identities = 63/230 (27%), Positives = 105/230 (45%), Gaps = 42/230 (18%)
Query: 263 LLGKGGSSSVYL--VGGTSEH-EFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCP 319
+LGKG V L + G E+ K L VV + D + ++ E +LA P
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMV-----EKRVLALAWENP 56
Query: 320 YVIKMHDYVYDTASKHLYVLME-KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAV 378
++ H Y +HL+ +ME DL ++++ + T + E++ +
Sbjct: 57 FL--THLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATF-----YAAEIVCGL 109
Query: 379 KEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACS---LQDDKTSVHKDT 435
+ +H+ GII+ DLK N + +D G++ KI DFG+ C D++ S T
Sbjct: 110 QFLHSKGIIYRDLKLDNVM--------LDRDGHI-KIADFGM-CKENVFGDNRAS----T 155
Query: 436 ASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY 485
GT +Y++PE G Y T+ D WS G +LY M+ G++P+
Sbjct: 156 FCGTPDYIAPEILQ-------GLKY--TFSVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 46/175 (26%), Positives = 72/175 (41%), Gaps = 35/175 (20%)
Query: 375 LLAVKEIHAAGI--------IHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQD 426
L+ + E AAG+ IH DL N L NVLKI DFG++ +D
Sbjct: 96 LIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEK---------NVLKISDFGMSREEED 146
Query: 427 DKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI-YGRTPY 485
+ + + +PEA N R + +SDVWS G +L+ G PY
Sbjct: 147 GVYASTGGMKQIPVKWTAPEAL---------NYGRYSSESDVWSFGILLWEAFSLGAVPY 197
Query: 486 SHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVG 540
+++ N + ++ IE +L P + + M+ C + DP RP+
Sbjct: 198 ANLSNQ--------QTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFS 244
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 38/157 (24%), Positives = 64/157 (40%), Gaps = 34/157 (21%)
Query: 338 VLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFL 397
++M+ +DL K +++ L + + I+ ++L + +H +H DL PAN
Sbjct: 97 LVMDIMASDLKKV---VDRKIRLTESQVKCIL--LQILNGLNVLHKWYFMHRDLSPANIF 151
Query: 398 FVGNVLKIIDCIGNVLKIIDFGIA----CSLQDDKTSVHKDTASG--------TLNYMSP 445
I+ G + KI DFG+A D S + TL Y +P
Sbjct: 152 --------INSKG-ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAP 202
Query: 446 EAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGR 482
E G Y + D+WS+GCI ++ G+
Sbjct: 203 ELL------MGAEKY--HFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 54/232 (23%), Positives = 88/232 (37%), Gaps = 55/232 (23%)
Query: 334 KHLYVLMEKGD----TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHS 389
K LY++ E D DL KY L++ + +++L ++ H+ IIH
Sbjct: 73 KRLYLVFEFVDHTVLDDLEKYPNGLDESRVRK--------YLFQILRGIEFCHSHNIIHR 124
Query: 390 DLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAG 449
D+KP N L + V+K+ DFG A +L V+ D + T Y +PE
Sbjct: 125 DIKPENILVSQS---------GVVKLCDFGFARTLA-APGEVYTDYVA-TRWYRAPELLV 173
Query: 450 QTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY---------------------SHI 488
+ G D+W++GC++ M+ G P
Sbjct: 174 GDTKYGRA--------VDIWAVGCLVTEMLTGE-PLFPGDSDIDQLYHIIKCLGNLIPRH 224
Query: 489 PNTWAK--MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
+ K + A R + E +P + +L K CL+ DP RP+
Sbjct: 225 QEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPS 276
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 51/198 (25%), Positives = 70/198 (35%), Gaps = 59/198 (29%)
Query: 372 YEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSL---QDDK 428
++ L AV H IH D+KP N L +K+ DFG A L DD
Sbjct: 107 WQTLQAVNFCHKHNCIHRDVKPENILITKQ---------GQIKLCDFGFARILTGPGDDY 157
Query: 429 TSVHKDTASGTLNYMSPE-AAGQTSSSGGGNTYRITYKS--DVWSLGCILYNMIYGRTPY 485
T T Y +PE G T Y DVW++GC+ ++ G+ +
Sbjct: 158 TDY-----VATRWYRAPELLVGDTQ-----------YGPPVDVWAIGCVFAELLTGQPLW 201
Query: 486 S---------HIPNTWAKMLAIARHKDQIEFKPQLANNVTIP----------------PT 520
I T + I RH+ QI Q ++IP
Sbjct: 202 PGKSDVDQLYLIRKTLGDL--IPRHQ-QIFSTNQFFKGLSIPEPETREPLESKFPNISSP 258
Query: 521 LLQSMKLCLQKDPKARPT 538
L +K CLQ DP R +
Sbjct: 259 ALSFLKGCLQMDPTERLS 276
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 46/170 (27%), Positives = 80/170 (47%), Gaps = 33/170 (19%)
Query: 375 LLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCI---GNVLKIIDFGIACSLQDDKTSV 431
+LA+ A+G+++ A+ FV L +C+ G V+KI DFG++ +D ++
Sbjct: 124 MLAIASQIASGMVYL----ASLHFVHRDLATRNCLVGQGLVVKIGDFGMS---RDIYSTD 176
Query: 432 HKDTASGTL---NYMSPEAAGQTSSSGGGNTYR-ITYKSDVWSLGCILYNMI-YGRTPYS 486
+ T+ +M PE+ YR T +SD+WS G +L+ + YG+ P+
Sbjct: 177 YYRVGGRTMLPIRWMPPESI----------LYRKFTTESDIWSFGVVLWEIFTYGKQPWY 226
Query: 487 HIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKAR 536
+ NT A + I +L T PP + M+ C Q++P+ R
Sbjct: 227 QLSNTEA--------IECITQGRELERPRTCPPEVYAIMQGCWQREPQQR 268
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 61/249 (24%), Positives = 97/249 (38%), Gaps = 53/249 (21%)
Query: 250 VITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEF-KPLALKVVDLSDITDQSIADSYLNE 308
+I + GK++++ L+G GG VY S+H K+ +L + T Y N
Sbjct: 6 LIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNI 65
Query: 309 VEL----------------LAKLQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMR 352
++ + K GC + Y + ++L+EK + +
Sbjct: 66 YDIDKIALWKNIHNIDHLGIPKYYGCGSFKRCRMY-------YRFILLEKLVENTKEI-- 116
Query: 353 NLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNV 412
++ +I IM +ML ++ IH GI H D+KP N + GN N
Sbjct: 117 -FKRIKCKNKKLIKNIM--KDMLTTLEYIHEHGISHGDIKPENIMVDGN---------NR 164
Query: 413 LKIIDFGIACSLQDDKTSV-----HKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSD 467
IID+GIA + KD GTL Y +A N +T + D
Sbjct: 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAH---------NGACVTRRGD 215
Query: 468 VWSLG-CIL 475
+ SLG C+L
Sbjct: 216 LESLGYCML 224
|
Length = 294 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 46/166 (27%), Positives = 72/166 (43%), Gaps = 21/166 (12%)
Query: 373 EMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVH 432
E L + +H+ G +H D+K AN L N G+V K+ DFG+ S Q T
Sbjct: 114 ETLQGLYYLHSKGKMHRDIKGANILLTDN--------GHV-KLADFGV--SAQITATIAK 162
Query: 433 KDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTW 492
+ + GT +M+PE A GG N D+W++G + + P +
Sbjct: 163 RKSFIGTPYWMAPEVAA-VERKGGYNQL-----CDIWAVGITAIELAELQPPMFDLHPMR 216
Query: 493 AKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
A L K + P+L + + + +K+ L K+PK RPT
Sbjct: 217 ALFLMT---KSNFQ-PPKLKDKMKWSNSFHHFVKMALTKNPKKRPT 258
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 71/301 (23%), Positives = 129/301 (42%), Gaps = 58/301 (19%)
Query: 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG 317
+ L +LGKG V L E A+K++ + + + E +LA
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDEL--YAIKILKKDVVIQDDDVECTMVEKRVLALSGK 59
Query: 318 CPYVIKMHDYVYDTASKHLYVLMEK-GDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLL 376
P++ ++H + T + LY +ME DL ++ + + P+ + + E+ +
Sbjct: 60 PPFLTQLHS-CFQTMDR-LYFVMEYVNGGDLMYQIQQVGRFKE-PHA----VFYAAEIAI 112
Query: 377 AVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTA 436
+ +H+ GII+ DLK N + +D G++ KI DFG+ C ++ V T
Sbjct: 113 GLFFLHSKGIIYRDLKLDNVM--------LDSEGHI-KIADFGM-CK-ENMWDGVTTKTF 161
Query: 437 SGTLNYMSPEAAGQTSSSGGGNTYRITYKS-DVWSLGCILYNMIYGRTPYSHIPNTWAKM 495
GT +Y++PE Y+ KS D W+ G +LY M+ G+ P+
Sbjct: 162 CGTPDYIAPEII----------AYQPYGKSVDWWAFGVLLYEMLAGQAPFE--------- 202
Query: 496 LAIARHKDQIEFKPQLANNVTIPPTL-LQSMKLC---LQKDPKARPTVGNSVTQINNNPE 551
+D++ F+ + +NV P ++ +++ +C + K P R G PE
Sbjct: 203 ---GEDEDEL-FQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCG---------PE 249
Query: 552 G 552
G
Sbjct: 250 G 250
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 2e-06
Identities = 40/170 (23%), Positives = 66/170 (38%), Gaps = 28/170 (16%)
Query: 381 IHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKT--SVHKDTASG 438
+H+ IH DL N L + ++KI DFG+A ++ + V +D S
Sbjct: 123 LHSQHYIHRDLAARNVLLDND---------RLVKIGDFGLAKAVPEGHEYYRVREDGDSP 173
Query: 439 TLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAI 498
Y + E + + +Y SDVWS G LY ++ P + +M+
Sbjct: 174 VFWY-AVECLKE---------NKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGP 223
Query: 499 A-------RHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGN 541
R + +E +L P + MK C + + K RPT +
Sbjct: 224 KQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRS 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 74/288 (25%), Positives = 130/288 (45%), Gaps = 55/288 (19%)
Query: 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG 317
+ L +LGKG V L E A+K++ I + + E +LA
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDEL--YAIKILKKDVIIQDDDVECTMVEKRVLALPGK 59
Query: 318 CPYVIKMHDYVYDTASKHLYVLMEK-GDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLL 376
P++ ++H + T + LY +ME DL +++ + K P+ + + E+ +
Sbjct: 60 PPFLTQLHS-CFQTMDR-LYFVMEYVNGGDLMYHIQQVGKFKE-PHA----VFYAAEIAI 112
Query: 377 AVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIAC--SLQDDKTSVHKD 434
+ +H+ GII+ DLK + NV+ +D G++ KI DFG+ C ++ KT+
Sbjct: 113 GLFFLHSKGIIYRDLK------LDNVM--LDAEGHI-KIADFGM-CKENIFGGKTT---R 159
Query: 435 TASGTLNYMSPEAAGQTSSSGGGNTYRITYKS-DVWSLGCILYNMIYGRTPYSHIPNTWA 493
T GT +Y++PE Y+ KS D W+ G +LY M+ G+ P+
Sbjct: 160 TFCGTPDYIAPEII----------AYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE----- 204
Query: 494 KMLAIARHKDQIE-FKPQLANNVTIPPTLL-QSMKLC---LQKDPKAR 536
D+ E F+ + +NV+ P +L +++ +C L K P R
Sbjct: 205 ---------DEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKHPAKR 243
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 35/104 (33%), Positives = 48/104 (46%), Gaps = 19/104 (18%)
Query: 387 IHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPE 446
+H DL N L C G ++KI DFG+A + D + K + L +M+PE
Sbjct: 261 VHRDLAARNVLI---------CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPE 311
Query: 447 AAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI-YGRTPYSHIP 489
S N Y T SDVWS G +L+ + G TPY +P
Sbjct: 312 -------SIFNNLY--TTLSDVWSFGILLWEIFTLGGTPYPELP 346
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 3e-06
Identities = 66/251 (26%), Positives = 110/251 (43%), Gaps = 49/251 (19%)
Query: 253 LNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKP----LALKVVDLSDITDQSIADSYLNE 308
L ++ +S LG G V+ V KP +A K++ L +I + + E
Sbjct: 2 LKDDDFEKISELGAGNGGVVFKV------SHKPSGLIMARKLIHLE--IKPAIRNQIIRE 53
Query: 309 VELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEKGDT-DLSKYMRNLNKM--TTLPNTMI 365
+++L + PY++ + Y + + + ME D L + ++ ++ L I
Sbjct: 54 LQVLHECNS-PYIVGFYGAFY--SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSI 110
Query: 366 IIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQ 425
+I + L ++E H I+H D+KP+N L ++ G + K+ DFG++ L
Sbjct: 111 AVI----KGLTYLREKHK--IMHRDVKPSNIL--------VNSRGEI-KLCDFGVSGQLI 155
Query: 426 DDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY 485
D ++ GT +YMSPE T S +SD+WS+G L M GR P
Sbjct: 156 DSMA----NSFVGTRSYMSPERLQGTHYS---------VQSDIWSMGLSLVEMAIGRYP- 201
Query: 486 SHIPNTWAKML 496
IP AK L
Sbjct: 202 --IPPPDAKEL 210
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 3e-06
Identities = 68/293 (23%), Positives = 117/293 (39%), Gaps = 48/293 (16%)
Query: 253 LNGKQYQVLSLLGKGGSSSVY--LVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVE 310
L +++ + +LG G +VY L E P+A+K L + T L+E
Sbjct: 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE--LREATSPKANKEILDEAY 61
Query: 311 LLAKLQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMH 370
++A + P+V ++ + + + LM G L Y+R +K N +++
Sbjct: 62 VMASVDN-PHVCRLLGICLTSTVQLITQLMPFGC--LLDYVRE-HK----DNIGSQYLLN 113
Query: 371 W-YEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKT 429
W ++ + + ++H DL N L +KI DFG+A L D+
Sbjct: 114 WCVQIAKGMNYLEERRLVHRDLAARNVLVKTP---------QHVKITDFGLAKLLGADEK 164
Query: 430 SVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYN-MIYGRTPYSHI 488
H + + +M+ E+ Y T++SDVWS G ++ M +G PY I
Sbjct: 165 EYHAEGGKVPIKWMALESILH-------RIY--THQSDVWSYGVTVWELMTFGSKPYDGI 215
Query: 489 PNTWAKMLAIARHKDQIEFKPQLANNVTIPPT----LLQSMKLCLQKDPKARP 537
P + I+ ++ E PQ PP + M C D +RP
Sbjct: 216 PAS-----EISSILEKGERLPQ-------PPICTIDVYMIMVKCWMIDADSRP 256
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 4e-06
Identities = 71/280 (25%), Positives = 118/280 (42%), Gaps = 47/280 (16%)
Query: 263 LLGKGGSSSVYLVGGTSEHEFKPLALKVV--DLSDITDQSIADSYLNEVELLAKLQGCPY 320
LLGKG V+ GT + + P+A+K DL Q + +L+E +L K P
Sbjct: 2 LLGKGNFGEVF--KGTLKDK-TPVAVKTCKEDLP----QELKIKFLSEARIL-KQYDHPN 53
Query: 321 VIKMHDYVYDTASKHLYVLME--KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAV 378
++K+ T + +Y++ME G LS + +++ T ++ + +
Sbjct: 54 IVKLIGVC--TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQ-----LVKFALDAAAGM 106
Query: 379 KEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASG 438
+ + IH DL N L VG NVLKI DFG++ +DD
Sbjct: 107 AYLESKNCIHRDLAARNCL-VGE--------NNVLKISDFGMS-RQEDDGIYSSSGLKQI 156
Query: 439 TLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI-YGRTPYSHIPNTWAKMLA 497
+ + +PEA N R + +SDVWS G +L+ G PY + N A
Sbjct: 157 PIKWTAPEAL---------NYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA---- 203
Query: 498 IARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARP 537
++Q+E +++ P + + M+ C P+ RP
Sbjct: 204 ----REQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRP 239
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 4e-06
Identities = 47/163 (28%), Positives = 67/163 (41%), Gaps = 34/163 (20%)
Query: 387 IHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASG---TLNYM 443
+H DL N L N+ K+ DFG++ L+DD + T SG + +
Sbjct: 129 VHRDLAARNILVNSNL---------ECKVSDFGLSRVLEDDPEGTY--TTSGGKIPIRWT 177
Query: 444 SPEAAGQTSSSGGGNTYR-ITYKSDVWSLGCILYN-MIYGRTPYSHIPNTWAKMLAIARH 501
+PEA YR T SDVWS G +++ M +G PY + N M AI
Sbjct: 178 APEAI----------AYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEV-MKAIND- 225
Query: 502 KDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVT 544
F+ L + P + Q M C Q+D RP + V
Sbjct: 226 ----GFR--LPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 4e-06
Identities = 44/168 (26%), Positives = 72/168 (42%), Gaps = 37/168 (22%)
Query: 373 EMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVH 432
E++ A+ +H+ +++ DLK N + +D G++ KI DFG+ C +
Sbjct: 103 EIVSALGYLHSCDVVYRDLKLENLM--------LDKDGHI-KITDFGL-CK-EGISDGAT 151
Query: 433 KDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTW 492
T GT Y++PE N Y D W LG ++Y M+ GR P+ +
Sbjct: 152 MKTFCGTPEYLAPEVLED-------NDY--GRAVDWWGLGVVMYEMMCGRLPFYN----- 197
Query: 493 AKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKL----CLQKDPKAR 536
+ +++ F+ L + P TL K L+KDPK R
Sbjct: 198 -------QDHEKL-FELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 5e-06
Identities = 70/283 (24%), Positives = 119/283 (42%), Gaps = 49/283 (17%)
Query: 264 LGKG--GS--SSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCP 319
LG G GS VYL+ E +A+K L + +L E ++A+L P
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKE---VEVAVKT--LKQEHIAAGKKEFLREASVMAQLDH-P 56
Query: 320 YVIKMHDYVYDTASKHLYVLME-KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAV 378
++++ + + L ++ME L KY L K +P + + + H M +A
Sbjct: 57 CIVRL---IGVCKGEPLMLVMELAPLGPLLKY---LKKRREIPVSDLKELAHQVAMGMAY 110
Query: 379 KEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASG 438
E + +H DL N L V + KI DFG++ +L + ++ T +G
Sbjct: 111 LE--SKHFVHRDLAARNVLLVNR---------HQAKISDFGMSRALGAG-SDYYRATTAG 158
Query: 439 T--LNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI-YGRTPYSHIPNTWAKM 495
L + +PE N + + KSDVWS G L+ YG PY + A++
Sbjct: 159 RWPLKWYAPECI---------NYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEV 207
Query: 496 LAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
+A+ +++ +P+ P + M C + P+ RPT
Sbjct: 208 IAMLESGERLP-RPEEC-----PQEIYSIMLSCWKYRPEDRPT 244
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 5e-06
Identities = 72/327 (22%), Positives = 116/327 (35%), Gaps = 76/327 (23%)
Query: 245 ETSQDVITLNGKQYQVLSLLGKGGSSSVY--LVGGTSEHEFKPLALKVVDLSDITDQSIA 302
E +D ITL L LG G VY L G + + L + V L + +
Sbjct: 2 EVPRDSITL-------LRALGHGAFGEVYEGLYRGR-DGDAVELQVAVKTLPESCSEQDE 53
Query: 303 DSYLNEVELLAK-------------LQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSK 349
+L E +++K + P I L LM GD L
Sbjct: 54 SDFLMEALIMSKFNHQNIVRLIGVSFERLPRFI-------------LLELMAGGD--LKS 98
Query: 350 YMR----NLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKI 405
++R + ++L TM ++ ++ K + IH D+ N L
Sbjct: 99 FLRENRPRPERPSSL--TMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCL-------- 148
Query: 406 IDCIG--NVLKIIDFGIACSLQDDKTSVHK--DTASGTLNYMSPEAAGQTSSSGGGNTYR 461
+ C G V KI DFG+A + + S ++ A + +M PEA
Sbjct: 149 LTCKGPGRVAKIADFGMARDIY--RASYYRKGGRAMLPIKWMPPEAFLDGI--------- 197
Query: 462 ITYKSDVWSLGCILYN-MIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPT 520
T K+DVWS G +L+ G PY N +++ +++ P
Sbjct: 198 FTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ--EVMEFVTGGGRLDPPKG------CPGP 249
Query: 521 LLQSMKLCLQKDPKARPTVGNSVTQIN 547
+ + M C Q P+ RP + +I
Sbjct: 250 VYRIMTDCWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 7e-06
Identities = 55/251 (21%), Positives = 105/251 (41%), Gaps = 46/251 (18%)
Query: 303 DSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVL---MEKGDTDLSKYMRNLNKMTT 359
+ ++ E +++ KL P ++++ Y T K LY++ ME G L Y+R +
Sbjct: 44 EDFIEEAKVMMKLSH-PKLVQL--YGVCTQQKPLYIVTEFMENGC--LLNYLRQ--RQGK 96
Query: 360 LPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGN---VLKII 416
L M++ + ++ ++ + IH DL N C+ + V+K+
Sbjct: 97 LSKDMLLSMCQ--DVCEGMEYLERNSFIHRDLAARN------------CLVSSTGVVKVS 142
Query: 417 DFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILY 476
DFG+ + DD+ A + + PE N + + KSDVWS G +++
Sbjct: 143 DFGMTRYVLDDEY-TSSSGAKFPVKWSPPEVF---------NFSKYSSKSDVWSFGVLMW 192
Query: 477 NMIY-GRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKA 535
+ G+ P+ N + + ++P+LA+ T+ + M C + P+
Sbjct: 193 EVFTEGKMPFEKKSNYEVVEMISRGFR---LYRPKLASM-----TVYEVMYSCWHEKPEG 244
Query: 536 RPTVGNSVTQI 546
RPT + I
Sbjct: 245 RPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 47.5 bits (114), Expect = 7e-06
Identities = 49/236 (20%), Positives = 92/236 (38%), Gaps = 59/236 (25%)
Query: 254 NGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLA 313
+GK + +S+L + +++ F + V L
Sbjct: 26 DGK-FGKVSVLKHKPTQKLFVQKIIKAKNFNAIEPMVHQL-------------------- 64
Query: 314 KLQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYE 373
++ P IK++ Y T H+ ++ D DL ++ K++ II +
Sbjct: 65 -MKDNPNFIKLY-YSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKII-----RQ 117
Query: 374 MLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHK 433
++ A+ ++H IIH+D+K N L+ +I C D+G+
Sbjct: 118 LVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLC--------DYGL---------CKII 160
Query: 434 DTAS---GTLNYMSPEA-AGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY 485
T S GTL+Y SPE G Y +++ D W++G + Y ++ G+ P+
Sbjct: 161 GTPSCYDGTLDYFSPEKIKGH--------NYDVSF--DWWAVGVLTYELLTGKHPF 206
|
Length = 267 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 9e-06
Identities = 67/284 (23%), Positives = 116/284 (40%), Gaps = 57/284 (20%)
Query: 263 LLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVI 322
+LGKG V L A+KV+ I + + E +L+ + P++
Sbjct: 2 VLGKGSFGKVMLARLKESGRL--YAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLT 59
Query: 323 KMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWY--EMLLAVKE 380
+++ + T + +V+ DL M ++ K +Y E+ A+
Sbjct: 60 QLY-CCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEAR----ARFYAAEITSALMF 111
Query: 381 IHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACS--LQDDKTSVHKDTASG 438
+H GII+ DLK N L +D G+ K+ DFG+ C + + KT+ T G
Sbjct: 112 LHDKGIIYRDLKLDNVL--------LDHEGHC-KLADFGM-CKEGIFNGKTT---STFCG 158
Query: 439 TLNYMSPEAAGQTSSSGGGNTYRITYKSDV--WSLGCILYNMIYGRTPYSHIPNTWAKML 496
T +Y++PE + + Y V W++G +LY M+ G P+
Sbjct: 159 TPDYIAPEILQE-----------MLYGPSVDWWAMGVLLYEMLCGHAPFE---------- 197
Query: 497 AIARHKDQIEFKPQLANNVTIPPTLLQS----MKLCLQKDPKAR 536
A ++D + F+ L + V P L Q +K + K+P R
Sbjct: 198 --AENEDDL-FEAILNDEVVYPTWLSQDAVDILKAFMTKNPTMR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 66/276 (23%), Positives = 107/276 (38%), Gaps = 78/276 (28%)
Query: 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG 317
+ + ++GKG V LV K A+K + S++ + E ++LA+
Sbjct: 3 FHTVKVIGKGAFGEVRLVQKKDTG--KIYAMKTLLKSEMFKKDQLAHVKAERDVLAE-SD 59
Query: 318 CPYVIKMHDYVYDTASKHLYVLME---KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEM 374
P+V+ ++ D +LY++ME GD M L K T + M E
Sbjct: 60 SPWVVSLYYSFQDAQ--YLYLIMEFLPGGD-----LMTMLIKYDTFSEDVTRFYMA--EC 110
Query: 375 LLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFG--------------- 419
+LA++ +H G IH D+KP N L ID G++ K+ DFG
Sbjct: 111 VLAIEAVHKLGFIHRDIKPDNIL--------IDRGGHI-KLSDFGLSTGFHKQHDSAYYQ 161
Query: 420 ------IACSLQDDKTSVHKDTAS------------------------GTLNYMSPEAAG 449
+ D++ SV D+ + GT +Y++PE
Sbjct: 162 KLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFL 221
Query: 450 QTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY 485
Q G G + D WSLG I++ + G P+
Sbjct: 222 Q---QGYGQ------ECDWWSLGAIMFECLIGWPPF 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 40/122 (32%), Positives = 58/122 (47%), Gaps = 27/122 (22%)
Query: 375 LLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKD 434
L ++E H I+H D+KP+N L ++ G + K+ DFG++ L D +
Sbjct: 116 LAYLREKHQ--IMHRDVKPSNIL--------VNSRGEI-KLCDFGVSGQLIDSMA----N 160
Query: 435 TASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494
+ GT +YMSPE T S +SD+WS+G L + GR P IP AK
Sbjct: 161 SFVGTRSYMSPERLQGTHYS---------VQSDIWSMGLSLVELAIGRYP---IPPPDAK 208
Query: 495 ML 496
L
Sbjct: 209 EL 210
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 73/310 (23%), Positives = 127/310 (40%), Gaps = 59/310 (19%)
Query: 264 LGKGGSSSVYLVGGTSE-HEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVI 322
LG+G V+L + E + + V L D +D + D + E ELL LQ +++
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKD-FHREAELLTNLQH-EHIV 70
Query: 323 KMHDY-VYDTASKHLYVLMEKGDTDLSKYMR----------NLNKMTTLPNTMIIIIMHW 371
K + V ++ M+ GD L+K++R N+ L + ++ I
Sbjct: 71 KFYGVCVEGDPLIMVFEYMKHGD--LNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ- 127
Query: 372 YEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSV 431
++ + + + +H DL N L N+L +KI DFG++ +D ++
Sbjct: 128 -QIAAGMVYLASQHFVHRDLATRNCLVGENLL---------VKIGDFGMS---RDVYSTD 174
Query: 432 HKDTASGTL---NYMSPEAAGQTSSSGGGNTYR-ITYKSDVWSLGCILYNMI-YGRTPYS 486
+ T+ +M PE+ YR T +SDVWSLG +L+ + YG+ P+
Sbjct: 175 YYRVGGHTMLPIRWMPPESI----------MYRKFTTESDVWSLGVVLWEIFTYGKQPWY 224
Query: 487 HIPNTWAKMLAIARHKDQIEFKPQ---LANNVTIPPTLLQSMKLCLQKDPKARPTVGNSV 543
+ N + IE Q L T P + M C Q++P R +
Sbjct: 225 QLSNN-----------EVIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIH 273
Query: 544 TQINNNPEGS 553
+ + N + S
Sbjct: 274 SLLQNLAKAS 283
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 4e-05
Identities = 45/176 (25%), Positives = 76/176 (43%), Gaps = 41/176 (23%)
Query: 373 EMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQD----DK 428
++L A+ H GI+H DLKP N ++ + K++DFGI L D
Sbjct: 87 QVLDALACAHNQGIVHRDLKPQNI-----MVSQTG-VRPHAKVLDFGIGTLLPGVRDADV 140
Query: 429 TSVHKDTAS-GTLNYMSPEA-AGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYS 486
++ + T GT Y +PE G+ +T SD+++ G I + G+
Sbjct: 141 ATLTRTTEVLGTPTYCAPEQLRGEP----------VTPNSDLYAWGLIFLECLTGQ---- 186
Query: 487 HIPNTWAKMLAIARHKDQIEFKPQLA-NNVTIPPT-----LLQSMKLCLQKDPKAR 536
+A +I ++ QL+ +V++PP L Q ++ L KDP+ R
Sbjct: 187 --RVVQGASVA------EILYQ-QLSPVDVSLPPWIAGHPLGQVLRKALNKDPRQR 233
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 4e-05
Identities = 47/190 (24%), Positives = 78/190 (41%), Gaps = 50/190 (26%)
Query: 264 LGKGGSSSVYLVGGTSEHEFK--PLALKVVDLSDITDQSIADSYLNEVELLAKLQ-GCPY 320
LG+G VY ++ K LK T+ + ++NE +++ CP
Sbjct: 140 LGEGAFGVVYKASLVNKQSKKEGKYVLK-----KATEYGAVEIWMNE-----RVRRACPN 189
Query: 321 VIKMHDYVY------DTASKHLYVLMEK--GDTDLSKYMRN-----------LNKMTTLP 361
D+VY + + Y L+ + G++ L+ M++ L K+ LP
Sbjct: 190 SCA--DFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLP 247
Query: 362 ------NTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415
N +I IM ++L A+ +H+ GI+H D+KP N +F KI
Sbjct: 248 KGLERENKIIQTIMR--QILFALDGLHSTGIVHRDVKPQNIIF--------SEGSGSFKI 297
Query: 416 IDFGIACSLQ 425
ID G A L+
Sbjct: 298 IDLGAAADLR 307
|
Length = 566 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 4e-05
Identities = 60/237 (25%), Positives = 93/237 (39%), Gaps = 29/237 (12%)
Query: 291 VDLSDI-TDQSIADSYLNEVELLAKL--------QGCPYVIKMHDYVYDT------ASKH 335
V LS+I TD +A + E++ A QG PY I H + A +
Sbjct: 11 VLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPY 70
Query: 336 LYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPAN 395
L V DL Y+ +++ M E+ V +H +HSDL N
Sbjct: 71 LLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMAC-EIAAGVTHMHKHNFLHSDLALRN 129
Query: 396 FLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSG 455
++ V K+ D+GI S + +D L +++PE G G
Sbjct: 130 CFLTSDL--------TV-KVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVG--EFHG 178
Query: 456 GGNTYRITYKSDVWSLGCILYNMI-YGRTPYSHIPNTWAKMLAIARHKDQIEFKPQL 511
G T T S+VW+LG L+ + PYSH+ + + + + + FKPQL
Sbjct: 179 GLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREV-LNHVIKDQQVKLFKPQL 234
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 45.5 bits (107), Expect = 4e-05
Identities = 62/283 (21%), Positives = 116/283 (40%), Gaps = 43/283 (15%)
Query: 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKL 315
K+Y +G+G S +VY + + +A+K ++L Q + +NE+ ++ +
Sbjct: 19 KKYTRFEKIGQGASGTVYTAIDIATGQ--EVAIKQMNLQQ---QPKKELIINEILVMREN 73
Query: 316 QGCPYVIKMHDYVYDTASKHLYVLME--KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYE 373
+ V + Y+ L+V+ME G + + ++ T + I + E
Sbjct: 74 KNPNIVNYLDSYL---VGDELWVVMEYLAGGS-----LTDVVTETCMDEGQIAAVCR--E 123
Query: 374 MLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHK 433
L A+ +H+ +IH D+K N L + +K+ DFG + +++ +
Sbjct: 124 CLQALDFLHSNQVIHRDIKSDNILL---------GMDGSVKLTDFGFCAQITPEQSK--R 172
Query: 434 DTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWA 493
T GT +M+PE + + K D+WSLG + M+ G PY + N
Sbjct: 173 STMVGTPYWMAPEVVTRKAYGP---------KVDIWSLGIMAIEMVEGEPPYLN-ENPLR 222
Query: 494 KMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKAR 536
+ IA + P+L N + + CL+ D R
Sbjct: 223 ALYLIATNG-----TPELQNPERLSAVFRDFLNRCLEMDVDRR 260
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 5e-05
Identities = 60/229 (26%), Positives = 96/229 (41%), Gaps = 40/229 (17%)
Query: 263 LLGKGGSSSVYLV--GGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPY 320
+LGKG V L GT E A+KV+ I D + E +LA P+
Sbjct: 2 VLGKGSFGKVMLAELKGTDE----VYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPF 57
Query: 321 VIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWY--EMLLAV 378
+ +H + T + +V+ DL M + + +Y E+ LA+
Sbjct: 58 LTALHC-CFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPR----SRFYAAEVTLAL 109
Query: 379 KEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIAC--SLQDDKTSVHKDTA 436
+H G+I+ DLK N L +D G+ K+ DFG+ C + + T+ T
Sbjct: 110 MFLHRHGVIYRDLKLDNIL--------LDAEGHC-KLADFGM-CKEGILNGVTTT---TF 156
Query: 437 SGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY 485
GT +Y++PE Q G D W+LG ++Y M+ G+ P+
Sbjct: 157 CGTPDYIAPEIL-QELEYG--------PSVDWWALGVLMYEMMAGQPPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 5e-05
Identities = 41/168 (24%), Positives = 71/168 (42%), Gaps = 26/168 (15%)
Query: 372 YEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSV 431
Y++ ++ + + +H DL N L G ++KI DFG+A + D V
Sbjct: 244 YQVARGMEFLASKNCVHRDLAARNVLLAQ---------GKIVKICDFGLARDIMHDSNYV 294
Query: 432 HKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI-YGRTPYSHIPN 490
K + + +M+PE+ N Y T SDVWS G +L+ + G TPY
Sbjct: 295 SKGSTFLPVKWMAPESIFD-------NLY--TTLSDVWSYGILLWEIFSLGGTPYP---- 341
Query: 491 TWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
M+ + ++I+ ++A + M C +P+ RP+
Sbjct: 342 ---GMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPS 386
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 5e-05
Identities = 31/104 (29%), Positives = 49/104 (47%), Gaps = 18/104 (17%)
Query: 373 EMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVH 432
++L A+ IH GIIH D+K N + V I C+G DFG AC + ++
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTEN-VLVNGPEDI--CLG------DFGAACFARGSWSTPF 318
Query: 433 KDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILY 476
+GT++ +PE G+ Y T D+WS G +++
Sbjct: 319 HYGIAGTVDTNAPEVL-------AGDPY--TPSVDIWSAGLVIF 353
|
Length = 461 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 6e-05
Identities = 40/150 (26%), Positives = 63/150 (42%), Gaps = 24/150 (16%)
Query: 337 YVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANF 396
Y++ E + DL+ + N N TL ++ M +L + IH I+H D+K AN
Sbjct: 95 YLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKM----LLNGLYYIHRNKILHRDMKAANI 150
Query: 397 LFVGNVLKIIDCIGNVLKIIDFGIACSL-QDDKTSVHKDTAS-GTLNYMSPEAAGQTSSS 454
L + +LK+ DFG+A + + ++ T TL Y PE
Sbjct: 151 LITKD---------GILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDY 201
Query: 455 GGGNTYRITYKSDVWSLGCILYNMIYGRTP 484
G D+W GCI+ M + R+P
Sbjct: 202 GP--------PIDMWGAGCIMAEM-WTRSP 222
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 6e-05
Identities = 50/239 (20%), Positives = 99/239 (41%), Gaps = 28/239 (11%)
Query: 253 LNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELL 312
L + + + +LG G +VY E E + + + L++ T +++E ++
Sbjct: 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIM 63
Query: 313 AKLQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHW- 371
A + P+++++ + + LM G L Y+ N ++++W
Sbjct: 64 ASMDH-PHLVRLLGVCLSPTIQLVTQLMPHGC--LLDYVHEHKD-----NIGSQLLLNWC 115
Query: 372 YEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSV 431
++ + + ++H DL N L N +KI DFG+A L+ D+
Sbjct: 116 VQIAKGMMYLEERRLVHRDLAARNVLVKSP---------NHVKITDFGLARLLEGDEKEY 166
Query: 432 HKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYN-MIYGRTPYSHIP 489
+ D + +M+ E + + T++SDVWS G ++ M +G PY IP
Sbjct: 167 NADGGKMPIKWMALECI---------HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP 216
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 8e-05
Identities = 37/156 (23%), Positives = 65/156 (41%), Gaps = 31/156 (19%)
Query: 386 IIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSP 445
++H DL N L G +KI DFG++ + ++ + V + + +M+
Sbjct: 148 LVHRDLAARNVLVAE---------GRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAI 198
Query: 446 EAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI-YGRTPYSHIP--NTWAKMLAIARHK 502
E S + Y T +SDVWS G +L+ ++ G PY I + +L
Sbjct: 199 E-------SLFDHIY--TTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLF-NLLKTGYRM 248
Query: 503 DQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
++ E + N+ M C +++P RPT
Sbjct: 249 ERPENCSEEMYNL---------MLTCWKQEPDKRPT 275
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 9e-05
Identities = 40/169 (23%), Positives = 68/169 (40%), Gaps = 31/169 (18%)
Query: 316 QGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWY-EM 374
P ++ +H Y+ S L + +G S + LN +P + W EM
Sbjct: 42 HCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLN----IPEECV---KRWAAEM 94
Query: 375 LLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKD 434
++A+ +H GI+ DL P N L +D G++ ++ F + + S +
Sbjct: 95 VVALDALHREGIVCRDLNPNNIL--------LDDRGHI-QLTYF---SRWSEVEDSCDGE 142
Query: 435 TASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRT 483
Y +PE G + T D WSLG IL+ ++ G+T
Sbjct: 143 AVENM--YCAPEVGGISEE---------TEACDWWSLGAILFELLTGKT 180
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 9e-05
Identities = 53/221 (23%), Positives = 103/221 (46%), Gaps = 33/221 (14%)
Query: 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQ 316
+++VL ++G+G V E +A+K S+ ++ + ++ L E+++L L+
Sbjct: 2 KFEVLGVVGEGAYGVVLKCRHKETKEI--VAIKKFKDSE-ENEEVKETTLRELKMLRTLK 58
Query: 317 GCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMI--IIIMHWYEM 374
++++ + + K LY++ E + ++ L + +PN + + + Y++
Sbjct: 59 Q-ENIVELKE-AFRRRGK-LYLVFEYVEKNM------LELLEEMPNGVPPEKVRSYIYQL 109
Query: 375 LLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKD 434
+ A+ H I+H D+KP N L N +VLK+ DFG A +L + + + +
Sbjct: 110 IKAIHWCHKNDIVHRDIKPENLLISHN---------DVLKLCDFGFARNLSEGSNANYTE 160
Query: 435 TASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCIL 475
+ T Y SPE G Y D+WS+GCIL
Sbjct: 161 YVA-TRWYRSPELL-------LGAPY--GKAVDMWSVGCIL 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 41/164 (25%), Positives = 68/164 (41%), Gaps = 26/164 (15%)
Query: 373 EMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVH 432
E L A++ +H+ +IH D+K N L + +K+ DFG + +++
Sbjct: 124 ECLQALEFLHSNQVIHRDIKSDNILL---------GMDGSVKLTDFGFCAQITPEQSK-- 172
Query: 433 KDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTW 492
+ T GT +M+PE + + K D+WSLG + MI G PY + N
Sbjct: 173 RSTMVGTPYWMAPEVVTRKAYGP---------KVDIWSLGIMAIEMIEGEPPYLN-ENPL 222
Query: 493 AKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKAR 536
+ IA + P+L N + + CL D + R
Sbjct: 223 RALYLIATNG-----TPELQNPEKLSAIFRDFLNRCLDMDVEKR 261
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 73/299 (24%), Positives = 129/299 (43%), Gaps = 68/299 (22%)
Query: 264 LGKGGSSSVYLVGGTSEHEFKPLALK-VVDLSDITDQSIA--DSYLNEVELLAKLQGCPY 320
LG+G V+L + P K +V + + D ++A + E ELL LQ +
Sbjct: 13 LGEGAFGKVFL---AECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQH-EH 68
Query: 321 VIKMHDYVYDTASK-HLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIII---------MH 370
++K + D ++ M+ GD L+K++R P+ MI++ +
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGD--LNKFLRAHG-----PDAMILVDGQPRQAKGELG 121
Query: 371 WYEMLLAVKEIHAAGII--------HSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIAC 422
+ML +I A+G++ H DL N L VG L ++KI DFG++
Sbjct: 122 LSQMLHIASQI-ASGMVYLASQHFVHRDLATRNCL-VGANL--------LVKIGDFGMS- 170
Query: 423 SLQDDKTSVHKDTASGTL---NYMSPEAAGQTSSSGGGNTYR-ITYKSDVWSLGCILYNM 478
+D ++ + T+ +M PE+ YR T +SDVWS G IL+ +
Sbjct: 171 --RDVYSTDYYRVGGHTMLPIRWMPPESI----------MYRKFTTESDVWSFGVILWEI 218
Query: 479 I-YGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKAR 536
YG+ P+ + NT + + ++ +P++ P + M C Q++P+ R
Sbjct: 219 FTYGKQPWFQLSNT---EVIECITQGRVLERPRVC-----PKEVYDIMLGCWQREPQQR 269
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 47/182 (25%), Positives = 68/182 (37%), Gaps = 69/182 (37%)
Query: 351 MRNLNKMTTLPNTMIIIIMHWY--EMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDC 408
M L +M P + +Y E+ AV+ +H G IH D+KP N L ID
Sbjct: 89 MSLLIRMGIFPEDL----ARFYIAELTCAVESVHKMGFIHRDIKPDNIL--------IDR 136
Query: 409 IGNVLKIIDFGIACSL----------------QD--DKTSVHKDTAS------------- 437
G++ K+ DFG+ QD D ++ D A+
Sbjct: 137 DGHI-KLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERR 195
Query: 438 --------------GTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRT 483
GT NY++PE +T T D WS+G ILY M+ G+
Sbjct: 196 AARQHQRCLAHSLVGTPNYIAPEVLLRTG---------YTQLCDWWSVGVILYEMLVGQP 246
Query: 484 PY 485
P+
Sbjct: 247 PF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 69/308 (22%), Positives = 118/308 (38%), Gaps = 55/308 (17%)
Query: 261 LSLLGKGGSSSVYLVGGTSEHEFKPLA------LKVVDLSDITDQSIADSYLNEVELLAK 314
+ LGKG SV L + PL + V L T + + D + E+E+L
Sbjct: 9 IQQLGKGNFGSVELC------RYDPLQDNTGEVVAVKKLQHSTAEHLRD-FEREIEILKS 61
Query: 315 LQGCPYVIKMHDYVYDTASKHLYVLMEK-GDTDLSKYMRNLNKMTTLPNTMIII---IMH 370
LQ ++K Y ++L ++ME L Y++ ++ +++ I
Sbjct: 62 LQ-HDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQK-HRERLDHRKLLLYASQICK 119
Query: 371 WYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSL-QDDKT 429
E L + + +H DL N L N +KI DFG+ L QD +
Sbjct: 120 GMEYLGSKR------YVHRDLATRNILVESE---------NRVKIGDFGLTKVLPQDKEY 164
Query: 430 SVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIP 489
++ + + +PE+ ++ + + SDVWS G +LY + P
Sbjct: 165 YKVREPGESPIFWYAPESLTES---------KFSVASDVWSFGVVLYELFTYSDKSCSPP 215
Query: 490 NTWAKMLAIARHKDQIEFK--PQLANNVTIP-----PTLLQS-MKLCLQKDPKARPT--- 538
+ +M+ + I + L NN +P P + + MK C DP RP+
Sbjct: 216 AEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSE 275
Query: 539 VGNSVTQI 546
+ V I
Sbjct: 276 LALQVEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 43/167 (25%), Positives = 62/167 (37%), Gaps = 38/167 (22%)
Query: 377 AVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTA 436
+K + G +H L L ++ V KI F LQ+DK+ T
Sbjct: 119 GMKYLSEMGYVHKGLAAHKVLVNSDL---------VCKISGFR---RLQEDKSEAIYTTM 166
Query: 437 SG--TLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYN-MIYGRTPYSHIPNTWA 493
SG + + +PEA + + SDVWS G +++ M YG PY W
Sbjct: 167 SGKSPVLWAAPEAI---------QYHHFSSASDVWSFGIVMWEVMSYGERPY------WD 211
Query: 494 KMLAIARHKD---QIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARP 537
+D +E +L P L Q M C QK+ RP
Sbjct: 212 -----MSGQDVIKAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERP 253
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 62/270 (22%), Positives = 102/270 (37%), Gaps = 78/270 (28%)
Query: 264 LGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIK 323
LG G V L H A+K + D+ +++ E ++LA+ +V+K
Sbjct: 9 LGIGAFGEVCLACKVDTHAL--YAMKTLRKKDVLNRNQVAHVKAERDILAEADN-EWVVK 65
Query: 324 MHDYVYDTASKHLYVLME---KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKE 380
++ D + LY +M+ GD M L +M P + + E+ LA++
Sbjct: 66 LYYSFQDKDN--LYFVMDYIPGGDM-----MSLLIRMEVFPEVLARFYIA--ELTLAIES 116
Query: 381 IHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIAC------------------ 422
+H G IH D+KP N L ID G++ K+ DFG+
Sbjct: 117 VHKMGFIHRDIKPDNIL--------IDLDGHI-KLTDFGLCTGFRWTHNSKYYQKGSHIR 167
Query: 423 -----------------------SLQDDKTSVHKDTAS----GTLNYMSPEAAGQTSSSG 455
+L+ T H+ + GT NY++PE +
Sbjct: 168 QDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKG--- 224
Query: 456 GGNTYRITYKSDVWSLGCILYNMIYGRTPY 485
T D WS+G IL+ M+ G+ P+
Sbjct: 225 ------YTQLCDWWSVGVILFEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 59/293 (20%), Positives = 114/293 (38%), Gaps = 48/293 (16%)
Query: 259 QVLSLLGKGGSSSVYLV---GGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKL 315
Q ++ LG+G V+L G E + +K L D+++ + E+++ KL
Sbjct: 8 QEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKA--LQKTKDENLQSEFRRELDMFRKL 65
Query: 316 QGCPYVIKMHDYVYDTASKHLYVLMEKGD-TDLSKYMR----NLNKMTTLPNTMIIIIMH 370
V+++ + A H Y+++E D DL +++R K+ P + +
Sbjct: 66 SH-KNVVRLLGLCRE-AEPH-YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVAL 122
Query: 371 WYEMLLAVKEIHAAGIIHSDLKPAN-FLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKT 429
++ L + + A +H DL N + +K+ SL D
Sbjct: 123 CTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVS--------------LLSLSKDVY 168
Query: 430 S---VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI-YGRTPY 485
+ A L +++PEA + + + KSDVWS G +++ + G P+
Sbjct: 169 NSEYYKLRNALIPLRWLAPEAVQE-------DDFST--KSDVWSFGVLMWEVFTQGELPF 219
Query: 486 SHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
+ + ++L + +E P L + M C +PK RP+
Sbjct: 220 YGLSDE--EVLNRLQAGK-LELPVPEG----CPSRLYKLMTRCWAVNPKDRPS 265
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 45/164 (27%), Positives = 74/164 (45%), Gaps = 29/164 (17%)
Query: 373 EMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVH 432
E++ A+ +H+ I++ DLK N + +D G++ KI DFG+ D ++
Sbjct: 103 EIVSALDYLHSGKIVYRDLKLENLM--------LDKDGHI-KITDFGLCKEGITDAATM- 152
Query: 433 KDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTW 492
T GT Y++PE N Y D W LG ++Y M+ GR P+ +
Sbjct: 153 -KTFCGTPEYLAPEVLED-------NDY--GRAVDWWGLGVVMYEMMCGRLPFYN--QDH 200
Query: 493 AKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKAR 536
K+ + +D I+F L+ + +LL + L KDP R
Sbjct: 201 EKLFELILMED-IKFPRTLSADAK---SLLSGL---LIKDPNKR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 43/165 (26%), Positives = 76/165 (46%), Gaps = 31/165 (18%)
Query: 373 EMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVH 432
E++ A++ +H+ +++ D+K N + +D G++ KI DFG+ D ++
Sbjct: 103 EIVSALEYLHSRDVVYRDIKLENLM--------LDKDGHI-KITDFGLCKEGISDGATMK 153
Query: 433 KDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTP-YSHIPNT 491
T GT Y++PE N Y D W LG ++Y M+ GR P Y+
Sbjct: 154 --TFCGTPEYLAPEVLED-------NDY--GRAVDWWGLGVVMYEMMCGRLPFYNQDHER 202
Query: 492 WAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKAR 536
+++ + ++I F L+ +LL + L+KDPK R
Sbjct: 203 LFELILM----EEIRFPRTLSPEAK---SLLAGL---LKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 3e-04
Identities = 48/188 (25%), Positives = 64/188 (34%), Gaps = 76/188 (40%)
Query: 375 LLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKD 434
L + +H+ IH D+K N L +K+ DFG A SL S
Sbjct: 125 LQGLAYLHSHERIHRDIKAGNILLTEP---------GTVKLADFGSA-SLVSPANSF--- 171
Query: 435 TASGTLNYMSPEA-----AGQTSSSGGGNTYRITYKSDVWSLG--CI--------LYNMI 479
GT +M+PE GQ K DVWSLG CI L+NM
Sbjct: 172 --VGTPYWMAPEVILAMDEGQYDG-----------KVDVWSLGITCIELAERKPPLFNM- 217
Query: 480 YGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTL---------LQSMKLCLQ 530
N + + IA++ PTL + CLQ
Sbjct: 218 ----------NAMSALYHIAQND---------------SPTLSSNDWSDYFRNFVDSCLQ 252
Query: 531 KDPKARPT 538
K P+ RP+
Sbjct: 253 KIPQDRPS 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 5e-04
Identities = 44/162 (27%), Positives = 61/162 (37%), Gaps = 45/162 (27%)
Query: 387 IHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGT----LNY 442
+H DL N L N+ V+KI DFG L + S AS + +
Sbjct: 152 VHRDLATRNCLVGENM---------VVKIADFG----LSRNIYSADYYKASENDAIPIRW 198
Query: 443 MSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI-YGRTPYSHIPNTWAKMLAIARH 501
M PE+ R T +SDVW+ G +L+ + YG PY + + I
Sbjct: 199 MPPESIFYN---------RYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE----VIYYV 245
Query: 502 KDQIEFKPQLANNV-----TIPPTLLQSMKLCLQKDPKARPT 538
+D NV P L M+LC K P RP+
Sbjct: 246 RD---------GNVLSCPDNCPLELYNLMRLCWSKLPSDRPS 278
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 5e-04
Identities = 46/165 (27%), Positives = 66/165 (40%), Gaps = 31/165 (18%)
Query: 377 AVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTA 436
+ +H G+IH D+ N +ID V KI D ++ L D
Sbjct: 129 GMSYLHKRGVIHKDIAARNC--------VIDEELQV-KITDNALSRDLFPMDYHCLGDNE 179
Query: 437 SGTLNYMSPEA-AGQTSSSGGGNTYRITYKSDVWSLGCILYN-MIYGRTPYSHI-PNTWA 493
+ + +M+ E+ + SS SDVWS G +L+ M G+TPY I P A
Sbjct: 180 NRPVKWMALESLVNKEYSSA----------SDVWSFGVLLWELMTLGQTPYVEIDPFEMA 229
Query: 494 KMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
L KD +LA + P L M C DP+ RP+
Sbjct: 230 AYL-----KDGY----RLAQPINCPDELFAVMACCWALDPEERPS 265
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 8e-04
Identities = 55/252 (21%), Positives = 101/252 (40%), Gaps = 37/252 (14%)
Query: 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG 317
+ ++ +G+G VY + + +ALK V L D + + + E+++L +L
Sbjct: 9 FDIIGQIGEGTYGQVY--KARDKDTGELVALKKVRL-DNEKEGFPITAIREIKILRQLNH 65
Query: 318 CPYVIKMHDYVYDTA--------SKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIM 369
++ + + V D Y++ E D DL + + + I M
Sbjct: 66 -RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLES--GLVHFSEDHIKSFM 122
Query: 370 HWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKT 429
++L + H +H D+K +N L + N +I K+ DFG+A +++
Sbjct: 123 K--QLLEGLNYCHKKNFLHRDIKCSNIL-LNNKGQI--------KLADFGLARLYNSEES 171
Query: 430 SVHKDTASGTLNYMSPEAA-GQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHI 488
+ + TL Y PE G+ R DVWS GCIL + + + P
Sbjct: 172 RPYTNKVI-TLWYRPPELLLGEE---------RYGPAIDVWSCGCILGEL-FTKKPIFQA 220
Query: 489 PNTWAKMLAIAR 500
A++ I+R
Sbjct: 221 NQELAQLELISR 232
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 9e-04
Identities = 15/50 (30%), Positives = 25/50 (50%), Gaps = 10/50 (20%)
Query: 372 YEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIA 421
E+ V ++H AGI+H DL +N + + K+ +IDFG+
Sbjct: 97 REIGRLVGKLHKAGIVHGDLTTSNIIVRDD--KLY--------LIDFGLG 136
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.001
Identities = 25/107 (23%), Positives = 39/107 (36%), Gaps = 24/107 (22%)
Query: 306 LNEVELLAKLQG----CPYVIKMHDYVYDTASKHLYVLMEK-GDTDLSKYMRNLNKMTTL 360
E +LAK + P V Y D + + ME L +
Sbjct: 47 RREARILAKAREAGVPVPIV-----YDVDPDNGLIV--MEYIEGELLKDAL-----EEAR 94
Query: 361 PNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIID 407
P+ + E+ V ++H AGI+H DL +N + G + ID
Sbjct: 95 PDLL-------REVGRLVGKLHKAGIVHGDLTTSNIILSGGRIYFID 134
|
Length = 204 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (94), Expect = 0.001
Identities = 17/40 (42%), Positives = 22/40 (55%), Gaps = 10/40 (25%)
Query: 382 HAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIA 421
H+AGIIH DL +N + G KI +IDFG+A
Sbjct: 112 HSAGIIHGDLTTSNMILSGG--KIY--------LIDFGLA 141
|
Length = 211 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.001
Identities = 61/267 (22%), Positives = 109/267 (40%), Gaps = 60/267 (22%)
Query: 295 DITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEKGDT-DLSKYMR- 352
D +D + D +L EV++L++L P + ++ T L ++ME + DL+++++
Sbjct: 57 DASDNARED-FLKEVKILSRLSD-PNIARLLGVC--TVDPPLCMIMEYMENGDLNQFLQK 112
Query: 353 --------NLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGI--------IHSDLKPANF 396
N + +T++ + +I A+G+ +H DL N
Sbjct: 113 HVAETSGLACNSKSLSFSTLLYMAT----------QI-ASGMRYLESLNFVHRDLATRNC 161
Query: 397 LFVGNVLKIIDCIGNVLKIIDFGIACSL-QDDKTSVHKDTASGTLNYMSPEAAGQTSSSG 455
L VG I KI DFG++ +L D V + A + +M+ E+
Sbjct: 162 L-VGKNYTI--------KIADFGMSRNLYSSDYYRV-QGRAPLPIRWMAWESVLLG---- 207
Query: 456 GGNTYRITYKSDVWSLGCILYN--MIYGRTPYSHIPNTWAKMLAIARHKDQIEFK--PQL 511
+ T KSDVW+ G L+ + PY H+ + A +D P+
Sbjct: 208 -----KFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRP 262
Query: 512 ANNVTIPPTLLQSMKLCLQKDPKARPT 538
N P + + M C ++D + RPT
Sbjct: 263 PN---CPKDIYELMLECWRRDEEDRPT 286
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.002
Identities = 67/328 (20%), Positives = 132/328 (40%), Gaps = 38/328 (11%)
Query: 171 PDNEKFKGPTQTKSVFSVRSASDQSLSQKKNESTPVFKR--PLSVNSTKSSDPSVSKETI 228
+ ++ S +A+ + K+ + + + P K+ +
Sbjct: 43 TTSRSTNSARRSGSKRDRETATSTDSGRTKSHEGAATTKQATTTPTTNVEVAPPPKKKKV 102
Query: 229 KPAKPQITTSNAKKSVETSQDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLAL 288
A P + V +D I ++ +++++LSLLG+G V E+ A+
Sbjct: 103 TYALPNQSREEGHFYVVLGED-IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEY--CAV 159
Query: 289 KVV-DLSDIT-DQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEKGDTD 346
K+V ++ T D I ++ +V P ++K+ Y + + H+ ++M K
Sbjct: 160 KIVRNVPKYTRDAKIEIQFMEKVRQADPADRFP-LMKIQRY-FQNETGHMCIVMPKYGPC 217
Query: 347 LSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAA-GIIHSDLKPANFLFVGNVLKI 405
L ++ + II ++ +A+ H ++H+DLKP N L + +
Sbjct: 218 LLDWIMKHGPFSHRHLAQII-----FQTGVALDYFHTELHLMHTDLKPENILMETSD-TV 271
Query: 406 IDCIGNV--------LKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGG 457
+D + N ++I D G C + +T++ T +Y SPE G G
Sbjct: 272 VDPVTNRALPPDPCRVRICDLGGCCDERHSRTAI-----VSTRHYRSPEVV-----LGLG 321
Query: 458 NTYRITYKSDVWSLGCILYNMIYGRTPY 485
Y +D+WS+GCI+Y + G+ Y
Sbjct: 322 ----WMYSTDMWSMGCIIYELYTGKLLY 345
|
Length = 467 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 45/165 (27%), Positives = 74/165 (44%), Gaps = 30/165 (18%)
Query: 373 EMLLAVKEIHAA-GIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSV 431
E++ A+ +H+ +++ DLK N + +D G++ KI DFG+ C + K
Sbjct: 103 EIVSALDYLHSEKNVVYRDLKLENLM--------LDKDGHI-KITDFGL-CK-EGIKDGA 151
Query: 432 HKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNT 491
T GT Y++PE N Y D W LG ++Y M+ GR P+ +
Sbjct: 152 TMKTFCGTPEYLAPEVLED-------NDY--GRAVDWWGLGVVMYEMMCGRLPFYN--QD 200
Query: 492 WAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKAR 536
K+ + ++ I F P+ T+ P + L+KDPK R
Sbjct: 201 HEKLFELILMEE-IRF-PR-----TLSPEAKSLLSGLLKKDPKQR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.003
Identities = 60/242 (24%), Positives = 96/242 (39%), Gaps = 68/242 (28%)
Query: 336 LYV---LMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDL 391
LYV LM G DL ++ + LP I I+ ++L A+ IH+ G IH +
Sbjct: 74 LYVVSPLMAYGSCEDL---LKT-HFPEGLPELAIAFILK--DVLNALDYIHSKGFIHRSV 127
Query: 392 KPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGT--LNYMSPEAAG 449
K ++ L G+ ++ + + +I G + VH S L ++SPE
Sbjct: 128 KASHILLSGDGKVVLSGLRYSVSMIKHG------KRQRVVHDFPKSSVKNLPWLSPEVLQ 181
Query: 450 QTSSSGGGNTYRITYKSDVWSLG---CILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIE 506
Q N KSD++S+G C L N G P+ +P T +ML + + + +
Sbjct: 182 Q-------NLQGYNEKSDIYSVGITACELAN---GHVPFKDMPAT--QML-LEKVRGTV- 227
Query: 507 FKPQLANNVTIPPTLL-------------------------------QSMKLCLQKDPKA 535
P L + T P Q ++LCLQ+DP++
Sbjct: 228 --PCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPES 285
Query: 536 RP 537
RP
Sbjct: 286 RP 287
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.004
Identities = 44/167 (26%), Positives = 71/167 (42%), Gaps = 30/167 (17%)
Query: 387 IHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPE 446
IH DL N L VG L KI DFG++ + ++ V K + +M+ E
Sbjct: 141 IHRDLAARNVL-VGENL--------ASKIADFGLS---RGEEVYVKKTMGRLPVRWMAIE 188
Query: 447 AAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI-YGRTPYSHIPNTWAKMLAIARHKDQI 505
+ N T KSDVWS G +L+ ++ G TPY + T A++ ++
Sbjct: 189 SL---------NYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGM--TCAELYEKLPQGYRM 237
Query: 506 EFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNPEG 552
E KP+ ++ + + M+ C + P RP Q++ E
Sbjct: 238 E-KPRNCDD-----EVYELMRQCWRDRPYERPPFAQISVQLSRMLEA 278
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.004
Identities = 58/242 (23%), Positives = 99/242 (40%), Gaps = 54/242 (22%)
Query: 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG 317
Y V+ L G V++ T + P+ LK+ + L E LL +
Sbjct: 68 YTVIKTLTPGSEGRVFV--ATKPGQPDPVVLKI---------GQKGTTLIEAMLLQNVNH 116
Query: 318 CPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLA 377
P VI+M D + A + ++ +DL Y+ + LP +II ++L
Sbjct: 117 -PSVIRMKDTLVSGAITCM--VLPHYSSDLYTYLTK--RSRPLPIDQALIIEK--QILEG 169
Query: 378 VKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIG-------NVLKIIDFGIACSLQDDKTS 430
++ +HA IIH D+K N +F+ +V ++ CIG V+ G+A
Sbjct: 170 LRYLHAQRIIHRDVKTEN-IFINDVDQV--CIGDLGAAQFPVVAPAFLGLA--------- 217
Query: 431 VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI-YGRTPYSHIP 489
GT+ +PE + + K+D+WS G +L+ M+ Y T + P
Sbjct: 218 -------GTVETNAPEVLARD---------KYNSKADIWSAGIVLFEMLAYPSTIFEDPP 261
Query: 490 NT 491
+T
Sbjct: 262 ST 263
|
Length = 357 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.004
Identities = 24/77 (31%), Positives = 38/77 (49%), Gaps = 9/77 (11%)
Query: 463 TYKSDVWSLGCILYN-MIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTL 521
T KSDVW+ G ++ G+TPY + N ++ RH ++++ +P+ L
Sbjct: 193 TSKSDVWAFGVTMWEIATRGQTPYPGVEN--HEIYDYLRHGNRLK-QPE-----DCLDEL 244
Query: 522 LQSMKLCLQKDPKARPT 538
M C + DPK RPT
Sbjct: 245 YDLMYSCWRADPKDRPT 261
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 553 | |||
| KOG0193|consensus | 678 | 100.0 | ||
| KOG0694|consensus | 694 | 100.0 | ||
| KOG0615|consensus | 475 | 100.0 | ||
| KOG0598|consensus | 357 | 100.0 | ||
| KOG0575|consensus | 592 | 100.0 | ||
| KOG0696|consensus | 683 | 100.0 | ||
| KOG0581|consensus | 364 | 100.0 | ||
| KOG0592|consensus | 604 | 100.0 | ||
| KOG0596|consensus | 677 | 100.0 | ||
| KOG0595|consensus | 429 | 100.0 | ||
| KOG0616|consensus | 355 | 100.0 | ||
| KOG0593|consensus | 396 | 100.0 | ||
| KOG0591|consensus | 375 | 100.0 | ||
| KOG0192|consensus | 362 | 100.0 | ||
| KOG0661|consensus | 538 | 100.0 | ||
| KOG0610|consensus | 459 | 100.0 | ||
| KOG0582|consensus | 516 | 100.0 | ||
| KOG0605|consensus | 550 | 100.0 | ||
| KOG0198|consensus | 313 | 100.0 | ||
| KOG0600|consensus | 560 | 100.0 | ||
| KOG0197|consensus | 468 | 100.0 | ||
| KOG0583|consensus | 370 | 100.0 | ||
| KOG0695|consensus | 593 | 100.0 | ||
| KOG0659|consensus | 318 | 100.0 | ||
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4236|consensus | 888 | 100.0 | ||
| KOG0585|consensus | 576 | 100.0 | ||
| KOG0578|consensus | 550 | 100.0 | ||
| KOG0588|consensus | 786 | 100.0 | ||
| KOG0663|consensus | 419 | 100.0 | ||
| KOG0597|consensus | 808 | 100.0 | ||
| KOG0611|consensus | 668 | 100.0 | ||
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0660|consensus | 359 | 100.0 | ||
| KOG0658|consensus | 364 | 100.0 | ||
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1026|consensus | 774 | 100.0 | ||
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0580|consensus | 281 | 100.0 | ||
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0983|consensus | 391 | 100.0 | ||
| KOG0201|consensus | 467 | 100.0 | ||
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0032|consensus | 382 | 100.0 | ||
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0033|consensus | 355 | 100.0 | ||
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG4721|consensus | 904 | 100.0 | ||
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0599|consensus | 411 | 100.0 | ||
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0594|consensus | 323 | 100.0 | ||
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG4717|consensus | 864 | 100.0 | ||
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0667|consensus | 586 | 100.0 | ||
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1989|consensus | 738 | 100.0 | ||
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0589|consensus | 426 | 100.0 | ||
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG2345|consensus | 302 | 100.0 | ||
| KOG0690|consensus | 516 | 100.0 | ||
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0577|consensus | 948 | 100.0 | ||
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| KOG1095|consensus | 1025 | 100.0 | ||
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279|consensus | 1226 | 100.0 | ||
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0194|consensus | 474 | 100.0 | ||
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0579|consensus | 1187 | 100.0 | ||
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0574|consensus | 502 | 100.0 | ||
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1187|consensus | 361 | 100.0 | ||
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0614|consensus | 732 | 100.0 | ||
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| KOG0612|consensus | 1317 | 100.0 | ||
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG0584|consensus | 632 | 100.0 | ||
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1006|consensus | 361 | 100.0 | ||
| KOG4645|consensus | 1509 | 100.0 | ||
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0604|consensus | 400 | 100.0 | ||
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0986|consensus | 591 | 100.0 | ||
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1094|consensus | 807 | 100.0 | ||
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0586|consensus | 596 | 100.0 | ||
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG4278|consensus | 1157 | 100.0 | ||
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0666|consensus | 438 | 100.0 | ||
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG0196|consensus | 996 | 100.0 | ||
| KOG1035|consensus | 1351 | 100.0 | ||
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG4257|consensus | 974 | 100.0 | ||
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG0587|consensus | 953 | 100.0 | ||
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0607|consensus | 463 | 100.0 | ||
| KOG0199|consensus | 1039 | 100.0 | ||
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0671|consensus | 415 | 100.0 | ||
| KOG0603|consensus | 612 | 100.0 | ||
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0200|consensus | 609 | 100.0 | ||
| KOG0662|consensus | 292 | 100.0 | ||
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG4250|consensus | 732 | 100.0 | ||
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0669|consensus | 376 | 100.0 | ||
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0608|consensus | 1034 | 100.0 | ||
| KOG1024|consensus | 563 | 100.0 | ||
| KOG0984|consensus | 282 | 100.0 | ||
| KOG0668|consensus | 338 | 100.0 | ||
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.98 | |
| KOG1290|consensus | 590 | 99.98 | ||
| KOG1151|consensus | 775 | 99.98 | ||
| KOG1025|consensus | 1177 | 99.97 | ||
| KOG1027|consensus | 903 | 99.97 | ||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG3653|consensus | 534 | 99.97 | ||
| KOG0670|consensus | 752 | 99.97 | ||
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG2052|consensus | 513 | 99.97 | ||
| KOG1152|consensus | 772 | 99.97 | ||
| KOG0664|consensus | 449 | 99.97 | ||
| KOG1165|consensus | 449 | 99.96 | ||
| KOG0665|consensus | 369 | 99.96 | ||
| KOG0576|consensus | 829 | 99.96 | ||
| KOG1167|consensus | 418 | 99.95 | ||
| KOG1164|consensus | 322 | 99.95 | ||
| KOG1163|consensus | 341 | 99.95 | ||
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG1345|consensus | 378 | 99.95 | ||
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.89 | |
| KOG0590|consensus | 601 | 99.89 | ||
| KOG0603|consensus | 612 | 99.87 | ||
| KOG0606|consensus | 1205 | 99.84 | ||
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.83 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.83 | |
| KOG1240|consensus | 1431 | 99.83 | ||
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.81 | |
| KOG4158|consensus | 598 | 99.8 | ||
| KOG1166|consensus | 974 | 99.79 | ||
| KOG0195|consensus | 448 | 99.79 | ||
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.78 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.77 | |
| KOG1023|consensus | 484 | 99.74 | ||
| KOG1033|consensus | 516 | 99.71 | ||
| smart00090 | 237 | RIO RIO-like kinase. | 99.7 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.63 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.62 | |
| KOG0590|consensus | 601 | 99.62 | ||
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.61 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.59 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.58 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.54 | |
| KOG0601|consensus | 524 | 99.51 | ||
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.5 | |
| KOG0601|consensus | 524 | 99.17 | ||
| KOG0606|consensus | 1205 | 99.15 | ||
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.14 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.13 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.08 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.01 | |
| KOG1243|consensus | 690 | 99.0 | ||
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.98 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.94 | |
| KOG1266|consensus | 458 | 98.92 | ||
| KOG3087|consensus | 229 | 98.84 | ||
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.63 | |
| KOG3741|consensus | 655 | 98.62 | ||
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.57 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.53 | |
| KOG2137|consensus | 700 | 98.5 | ||
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.42 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.23 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.14 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.1 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.89 | |
| KOG0576|consensus | 829 | 97.81 | ||
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.79 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.75 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.69 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.62 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.56 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.56 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.54 | |
| KOG1035|consensus | 1351 | 97.53 | ||
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.4 | |
| PF00130 | 53 | C1_1: Phorbol esters/diacylglycerol binding domain | 97.39 | |
| cd00029 | 50 | C1 Protein kinase C conserved region 1 (C1) . Cyst | 97.08 | |
| KOG1235|consensus | 538 | 96.89 | ||
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 96.76 | |
| KOG4236|consensus | 888 | 96.61 | ||
| smart00109 | 49 | C1 Protein kinase C conserved region 1 (C1) domain | 96.58 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 96.53 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.49 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.48 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 96.42 | |
| KOG1826|consensus | 2724 | 96.38 | ||
| KOG1093|consensus | 725 | 96.33 | ||
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.3 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.15 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 95.91 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 95.73 | |
| KOG2268|consensus | 465 | 95.69 | ||
| KOG2270|consensus | 520 | 95.61 | ||
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 95.14 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 94.44 | |
| KOG0696|consensus | 683 | 94.36 | ||
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 94.25 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.17 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 94.14 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 93.98 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 93.64 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 93.57 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 93.36 | |
| PLN02236 | 344 | choline kinase | 92.98 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 92.92 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 92.73 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 92.24 | |
| PF07649 | 30 | C1_3: C1-like domain; InterPro: IPR011424 This sho | 92.08 | |
| PF13240 | 23 | zinc_ribbon_2: zinc-ribbon domain | 92.0 |
| >KOG0193|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-59 Score=486.93 Aligned_cols=273 Identities=20% Similarity=0.282 Sum_probs=224.9
Q ss_pred ccccceEEecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEe
Q psy14267 245 ETSQDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKM 324 (553)
Q Consensus 245 ~~~~~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l 324 (553)
..+...|++..+++.++..||+|.||+||++++. .+||||+++.+...++ ..+.|++|+.+|++.+| -||+.+
T Consensus 381 s~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh-----GdVAVK~Lnv~~pt~~-qlqaFKnEVa~lkkTRH-~NIlLF 453 (678)
T KOG0193|consen 381 SDSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH-----GDVAVKLLNVDDPTPE-QLQAFKNEVAVLKKTRH-ENILLF 453 (678)
T ss_pred CccccccccCHHHhhccceeccccccceeecccc-----cceEEEEEecCCCCHH-HHHHHHHHHHHHhhcch-hhheee
Confidence 3445778888899999999999999999987554 4599999999988775 67999999999999976 999999
Q ss_pred eeEEEeCCCceEEEEEe-cCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCcc
Q psy14267 325 HDYVYDTASKHLYVLME-KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVL 403 (553)
Q Consensus 325 ~~~~~~~~~~~~~iv~e-~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~ 403 (553)
+||+.. ..+ .|+.- +.|.+|+.++.... ..+.+...+.|++||++||.|||.++|||||||..||||.++
T Consensus 454 MG~~~~--p~~-AIiTqwCeGsSLY~hlHv~e----tkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~-- 524 (678)
T KOG0193|consen 454 MGACMN--PPL-AIITQWCEGSSLYTHLHVQE----TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHED-- 524 (678)
T ss_pred ehhhcC--Cce-eeeehhccCchhhhhccchh----hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccC--
Confidence 998854 334 55555 45567888887543 356778888999999999999999999999999999999776
Q ss_pred ceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCC
Q psy14267 404 KIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRT 483 (553)
Q Consensus 404 ~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~ 483 (553)
+.|||+||||+.....+..........|...|||||++++... ..|++.+||||||||+|||++|.+
T Consensus 525 -------~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~------nPfS~qSDVYaFGiV~YELltg~l 591 (678)
T KOG0193|consen 525 -------LKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDD------NPFSFQSDVYAFGIVWYELLTGEL 591 (678)
T ss_pred -------CcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhccc------CCCCcccchhhhhHHHHHHHhCcC
Confidence 6799999999988877766666667889999999999997643 359999999999999999999999
Q ss_pred CCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q psy14267 484 PYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNP 550 (553)
Q Consensus 484 Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~ 550 (553)
||. +.+..+.+.++-++...+. .......+++++++|+..||.+++++||.+.+|+..|++.+
T Consensus 592 Pys-i~~~dqIifmVGrG~l~pd---~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~ 654 (678)
T KOG0193|consen 592 PYS-IQNRDQIIFMVGRGYLMPD---LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELL 654 (678)
T ss_pred CcC-CCChhheEEEecccccCcc---chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhh
Confidence 999 6666566555544422211 12233478899999999999999999999999999888754
|
|
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-49 Score=420.08 Aligned_cols=248 Identities=24% Similarity=0.388 Sum_probs=208.2
Q ss_pred ecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC
Q psy14267 253 LNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA 332 (553)
Q Consensus 253 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~ 332 (553)
+..++|+++++||+|+||+|++|+.+.+++. ||||+++|+.+.....++..+.|.+|+.....||+++.+++.| +.
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~--yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f--QT 440 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEY--YAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF--QT 440 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcE--EEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc--cc
Confidence 4457899999999999999999999998876 9999999999988888999999999999998899999997765 67
Q ss_pred CceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCC
Q psy14267 333 SKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGN 411 (553)
Q Consensus 333 ~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~ 411 (553)
..++|.||||. ||++. ++++.. .+.+..+..|+++|+.||.|||++||||||||.+|||||.+ |
T Consensus 441 ~~~l~fvmey~~Ggdm~-~~~~~~-----~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~e---------G 505 (694)
T KOG0694|consen 441 KEHLFFVMEYVAGGDLM-HHIHTD-----VFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTE---------G 505 (694)
T ss_pred CCeEEEEEEecCCCcEE-EEEecc-----cccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEccc---------C
Confidence 88999999985 45532 222222 45677788899999999999999999999999999999888 7
Q ss_pred eEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCch
Q psy14267 412 VLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNT 491 (553)
Q Consensus 412 ~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~ 491 (553)
.+||+|||||+.....+. .+.++||||.|||||++.+. .|+.++|+|||||+|||||.|..||.+.+.
T Consensus 506 h~kiADFGlcKe~m~~g~--~TsTfCGTpey~aPEil~e~---------~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE- 573 (694)
T KOG0694|consen 506 HVKIADFGLCKEGMGQGD--RTSTFCGTPEFLAPEVLTEQ---------SYTRAVDWWGLGVLLYEMLVGESPFPGDDE- 573 (694)
T ss_pred cEEecccccccccCCCCC--ccccccCChhhcChhhhccC---------cccchhhHHHHHHHHHHHHcCCCCCCCCCH-
Confidence 899999999988764333 45699999999999999887 489999999999999999999999997543
Q ss_pred HHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCH
Q psy14267 492 WAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTV 539 (553)
Q Consensus 492 ~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~ 539 (553)
.+....|.. +.. ..+..++.+...+|+++|.++|++|..+
T Consensus 574 ee~FdsI~~--d~~------~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 574 EEVFDSIVN--DEV------RYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHHHHHhc--CCC------CCCCcccHHHHHHHHHHhccCcccccCC
Confidence 244444432 111 2223678999999999999999999865
|
|
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-49 Score=398.71 Aligned_cols=263 Identities=26% Similarity=0.413 Sum_probs=209.6
Q ss_pred cCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchh----HHHHHHHHHHHHHhhcCCCceeEeeeEEE
Q psy14267 254 NGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQS----IADSYLNEVELLAKLQGCPYVIKMHDYVY 329 (553)
Q Consensus 254 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~----~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~ 329 (553)
..+.|.+.+.||+|+||.|-+|..+.++.. ||||++.+....... ......+|++||++| +||+||++++++.
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~--vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL-~HP~IV~~~d~f~ 246 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQ--VAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKL-SHPNIVRIKDFFE 246 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcE--EEeeeeehhhcccccccccchhhhHHHHHHHHhc-CCCCEEEEeeeee
Confidence 346799999999999999999988888755 999999987655422 234467999999999 5699999999884
Q ss_pred eCCCceEEEEEec-CCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecC
Q psy14267 330 DTASKHLYVLMEK-GDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDC 408 (553)
Q Consensus 330 ~~~~~~~~iv~e~-~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~ 408 (553)
...+.|||||+ .||+|.+.+-...... +..-..+++|++.||.|||++||+||||||+|||+..+ .
T Consensus 247 --~~ds~YmVlE~v~GGeLfd~vv~nk~l~-----ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~------~ 313 (475)
T KOG0615|consen 247 --VPDSSYMVLEYVEGGELFDKVVANKYLR-----EDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSND------A 313 (475)
T ss_pred --cCCceEEEEEEecCccHHHHHHhccccc-----cchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccC------C
Confidence 45677999996 6789999888765433 23346667899999999999999999999999999776 2
Q ss_pred CCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy14267 409 IGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHI 488 (553)
Q Consensus 409 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~ 488 (553)
+...+||+|||+|+...... ...++||||.|.|||++..++.. .+..++|||||||+||-+|+|.+||.+.
T Consensus 314 e~~llKItDFGlAK~~g~~s---fm~TlCGTpsYvAPEVl~~kg~~------~~~~kVDiWSlGcvLfvcLsG~pPFS~~ 384 (475)
T KOG0615|consen 314 EDCLLKITDFGLAKVSGEGS---FMKTLCGTPSYVAPEVLASKGVE------YYPSKVDIWSLGCVLFVCLSGYPPFSEE 384 (475)
T ss_pred cceEEEecccchhhccccce---ehhhhcCCccccChhheecCCee------cccchheeeeccceEEEEeccCCCcccc
Confidence 34679999999999987443 34589999999999999877532 2446999999999999999999999874
Q ss_pred CchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 489 PNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 489 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
........++..++. .+.+ ..|..++++..+||.+||..||++|||+.|+|+|
T Consensus 385 ~~~~sl~eQI~~G~y--~f~p--~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 385 YTDPSLKEQILKGRY--AFGP--LQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred cCCccHHHHHhcCcc--cccC--hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 433223334443332 2222 3455789999999999999999999999999976
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=382.27 Aligned_cols=246 Identities=24% Similarity=0.378 Sum_probs=204.0
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
.++|+++++||+|+||+||+++.++++.. ||+|+++|..+......+..+.|..||.++ +||+||.++. ..++..
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~ki--YAmKvl~K~~iv~~~e~~~~~~Er~IL~~v-~hPFiv~l~y--sFQt~~ 98 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKI--YAMKVLKKKKIVEKKEVRHTKAERNILSKI-KHPFIVKLIY--SFQTEE 98 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCce--eehhhhhhhHhhhhhhHHHHHHHHHHHHhC-CCCcEeeeEE--ecccCC
Confidence 46899999999999999999999877755 999999999888777778899999999998 5699999954 446678
Q ss_pred eEEEEEec-CCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 335 HLYVLMEK-GDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 335 ~~~iv~e~-~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
.+|+|+++ .||+|..+|++... +.+..+..++++|+.||.|||++|||||||||+|||||.+ |+|
T Consensus 99 kLylVld~~~GGeLf~hL~~eg~-----F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~---------GHi 164 (357)
T KOG0598|consen 99 KLYLVLDYLNGGELFYHLQREGR-----FSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQ---------GHI 164 (357)
T ss_pred eEEEEEeccCCccHHHHHHhcCC-----cchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCC---------CcE
Confidence 89999986 66799999987664 4456677788899999999999999999999999999887 789
Q ss_pred EEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHH
Q psy14267 414 KIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWA 493 (553)
Q Consensus 414 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~ 493 (553)
+|+|||||+.....+. ...++|||+.|||||++.+.+ |+.++|+||||++||||++|.+||...+.. .
T Consensus 165 ~LtDFgL~k~~~~~~~--~t~tfcGT~eYmAPEil~~~g---------y~~~vDWWsLGillYeML~G~pPF~~~~~~-~ 232 (357)
T KOG0598|consen 165 KLTDFGLCKEDLKDGD--ATRTFCGTPEYMAPEILLGKG---------YDKAVDWWSLGILLYEMLTGKPPFYAEDVK-K 232 (357)
T ss_pred EEeccccchhcccCCC--ccccccCCccccChHHHhcCC---------CCcccchHhHHHHHHHHhhCCCCCcCccHH-H
Confidence 9999999997665543 234799999999999999885 788999999999999999999999874332 3
Q ss_pred HHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCC
Q psy14267 494 KMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538 (553)
Q Consensus 494 ~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt 538 (553)
....+...+ . ......++.+.+++|+++|++||++|..
T Consensus 233 ~~~~I~~~k--~-----~~~p~~ls~~ardll~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 233 MYDKILKGK--L-----PLPPGYLSEEARDLLKKLLKRDPRQRLG 270 (357)
T ss_pred HHHHHhcCc--C-----CCCCccCCHHHHHHHHHHhccCHHHhcC
Confidence 333333222 1 1112247899999999999999999974
|
|
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-47 Score=398.71 Aligned_cols=252 Identities=27% Similarity=0.486 Sum_probs=209.3
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
..+|...+.||+|||+.||.+++..+++. ||+|++.+..+......+.+.+|++|.+.|. |||||+++++| ++..
T Consensus 17 ~~~Y~~g~~LGkGgFA~cYe~~~~~tge~--~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~-HpnIV~f~~~F--EDs~ 91 (592)
T KOG0575|consen 17 SKRYKRGRFLGKGGFARCYEARDLDTGEV--VAVKVVPKKLLKKPKQREKVLNEIEIHRSLK-HPNIVQFYHFF--EDSN 91 (592)
T ss_pred cceeeeeeeeccCcceEEEEEEEcCCCcE--EEEEEeehHHhcCcchHHHHHHHHHHHHhcC-CCcEEeeeeEe--ecCC
Confidence 36799999999999999999999888765 9999999988888888899999999999995 59999999988 5578
Q ss_pred eEEEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 335 HLYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 335 ~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
++||+.|+|. ++|.+++++.. ++++-.+..+..||+.||.|||+++|||||||..|+||+++. +|
T Consensus 92 nVYivLELC~~~sL~el~Krrk-----~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~---------~V 157 (592)
T KOG0575|consen 92 NVYIVLELCHRGSLMELLKRRK-----PLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENM---------NV 157 (592)
T ss_pred ceEEEEEecCCccHHHHHHhcC-----CCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcC---------cE
Confidence 9999999776 67877777544 333445556667999999999999999999999999999884 69
Q ss_pred EEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHH
Q psy14267 414 KIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWA 493 (553)
Q Consensus 414 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~ 493 (553)
||+|||||..+...+. ...+.||||.|+|||++...+ .++.+||||+||+||-||.|++||....-. .
T Consensus 158 KIgDFGLAt~le~~~E--rk~TlCGTPNYIAPEVl~k~g---------HsfEvDiWSlGcvmYtLL~G~PPFetk~vk-e 225 (592)
T KOG0575|consen 158 KIGDFGLATQLEYDGE--RKKTLCGTPNYIAPEVLNKSG---------HSFEVDIWSLGCVMYTLLVGRPPFETKTVK-E 225 (592)
T ss_pred EecccceeeeecCccc--ccceecCCCcccChhHhccCC---------CCCchhhhhhhhHHHhhhhCCCCcccchHH-H
Confidence 9999999999986543 344899999999999998765 478999999999999999999999863221 2
Q ss_pred HHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 494 KMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 494 ~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
....+.. .+. ..+..++.++++||.++|+.||.+|||+++|+.+
T Consensus 226 ty~~Ik~-~~Y-------~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 226 TYNKIKL-NEY-------SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred HHHHHHh-cCc-------ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 2222222 111 1222688999999999999999999999999875
|
|
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-48 Score=384.76 Aligned_cols=395 Identities=22% Similarity=0.310 Sum_probs=278.0
Q ss_pred hhHhhhhh---hccccccccccccccCCCCCCCC---CCCccchhhhhhhcccCCCccccccccCCCCCCCCCCCCCCCC
Q psy14267 106 QSVEKIVL---NNINYRVDQCKKNLNYDPSIKTP---CKDASQLSEDILATRKKYPFLVSSTSSLDKENVVPDNEKFKGP 179 (553)
Q Consensus 106 ~~~~~~~~---~~~g~rC~~Cg~kfh~~C~~~vp---c~d~~~~~~~~~~~~~~~~~~~s~~ss~~~~~~~~~~~~~~~~ 179 (553)
||-|-.+| .-||++|++|.|++|.+|..+|| +.|+++.+++++......-..........++-+++++..++.|
T Consensus 124 CDhCGsLLyGl~HQGmKC~~C~mNVH~rCv~nVPslCG~DhtE~RGrl~l~~~~~~~~l~v~i~ea~NLiPMDpNGlSDP 203 (683)
T KOG0696|consen 124 CDHCGSLLYGLIHQGMKCDTCDMNVHHRCVENVPSLCGTDHTERRGRLYLEAHIKRDVLTVTIKEAKNLIPMDPNGLSDP 203 (683)
T ss_pred hhhHHHHHHHHHhcccccccccchHHHHHhhcCCcccCCcchhhcceEEEEEEecCceEEEEehhhccccccCCCCCCCc
Confidence 67777664 57999999999999999999999 7899999999876655444444455555566677777777777
Q ss_pred CCcccccccCCCCCcc-ccccCCCCCCC------cC------------------CCCCCC---CC--------CCC----
Q psy14267 180 TQTKSVFSVRSASDQS-LSQKKNESTPV------FK------------------RPLSVN---ST--------KSS---- 219 (553)
Q Consensus 180 ~~~~~~~s~~s~~~~s-~s~~~~~stp~------~~------------------~p~~~~---s~--------~ss---- 219 (553)
...-...+.+...+.. ....+.+=.|. ++ +..... +. +..
T Consensus 204 Yvk~kliPD~~~~sKqKTkTik~~LNP~wNEtftf~Lkp~DkdrRlsiEvWDWDrTsRNDFMGslSFgisEl~K~p~~GW 283 (683)
T KOG0696|consen 204 YVKLKLIPDPKNESKQKTKTIKATLNPVWNETFTFKLKPSDKDRRLSIEVWDWDRTSRNDFMGSLSFGISELQKAPVDGW 283 (683)
T ss_pred ceeEEeccCCcchhhhhhhhhhhhcCccccceeEEecccccccceeEEEEecccccccccccceecccHHHHhhcchhhH
Confidence 6655555433322111 00000000000 00 000000 00 000
Q ss_pred -------------CCCCCC--------------CCCCC--CCCCccCcccccccccccceEEecCcceEEEeeeeeeCce
Q psy14267 220 -------------DPSVSK--------------ETIKP--AKPQITTSNAKKSVETSQDVITLNGKQYQVLSLLGKGGSS 270 (553)
Q Consensus 220 -------------~~~~s~--------------~~~~p--~~~~~~~~~~~~~~~~~~~~~~~~~~~y~i~~~LG~G~fG 270 (553)
-+.... ....+ ..+.................-.+...+|.++.+||+|+||
T Consensus 284 yKlLsqeEGEyyNvp~~~~~~e~~~~lr~k~~~~~~~~~~s~p~~~~~~~~~~~~~~~~~d~i~~tDFnFl~VlGKGSFG 363 (683)
T KOG0696|consen 284 YKLLSQEEGEYYNVPVPDEDSEDNEELRQKFERARIGPGSSKPEKKTMPTDSKFHNSSKRDRIKATDFNFLMVLGKGSFG 363 (683)
T ss_pred HHHhhhhcCceeccCCCCchhhHHHHHHHHHhhcccCCCcCCCCCCCCCCcccCCCCCcccceeecccceEEEeccCccc
Confidence 000000 00000 0000000011111111122223445689999999999999
Q ss_pred EEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEEEEEec-CCCCHHH
Q psy14267 271 SVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEK-GDTDLSK 349 (553)
Q Consensus 271 ~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~iv~e~-~~~~L~~ 349 (553)
+|.+|+.+.+.+. ||||+++++.+.+...++.-+.|.++|......|.+++++.+| +....+|.|||| .||+|..
T Consensus 364 KVlLaerkgtdEL--yAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScF--QTmDRLyFVMEyvnGGDLMy 439 (683)
T KOG0696|consen 364 KVLLAERKGTDEL--YAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCF--QTMDRLYFVMEYVNGGDLMY 439 (683)
T ss_pred eeeeecccCcchh--hhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHh--hhhhheeeEEEEecCchhhh
Confidence 9999999988877 9999999999888888899999999999988889999998866 556788888886 6789999
Q ss_pred HHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEeccCccccCCCCC
Q psy14267 350 YMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKT 429 (553)
Q Consensus 350 ~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGla~~~~~~~~ 429 (553)
+++..++..+. .++.++++|+.||-+||++|||+||||.+||||+.+ |.|||+|||+++.-.-++.
T Consensus 440 hiQQ~GkFKEp-----~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~e---------GHiKi~DFGmcKEni~~~~ 505 (683)
T KOG0696|consen 440 HIQQVGKFKEP-----VAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSE---------GHIKIADFGMCKENIFDGV 505 (683)
T ss_pred HHHHhcccCCc-----hhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccC---------CceEeeecccccccccCCc
Confidence 99998876543 456677899999999999999999999999999888 7899999999987655444
Q ss_pred cccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHhhcccccccc
Q psy14267 430 SVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKP 509 (553)
Q Consensus 430 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~ 509 (553)
.+.++||||.|+|||++...+ |+..+|+||+||+|||||.|++||.+...+ .....+....
T Consensus 506 --TTkTFCGTPdYiAPEIi~YqP---------YgksvDWWa~GVLLyEmlaGQpPFdGeDE~-elF~aI~ehn------- 566 (683)
T KOG0696|consen 506 --TTKTFCGTPDYIAPEIIAYQP---------YGKSVDWWAFGVLLYEMLAGQPPFDGEDED-ELFQAIMEHN------- 566 (683)
T ss_pred --ceeeecCCCcccccceEEecc---------cccchhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHHcc-------
Confidence 345899999999999998774 789999999999999999999999985443 3344443322
Q ss_pred cccCCCCCCHHHHHHHHHhcccCCCCCCC
Q psy14267 510 QLANNVTIPPTLLQSMKLCLQKDPKARPT 538 (553)
Q Consensus 510 ~~~~~~~~s~~l~~li~~cL~~dP~~RPt 538 (553)
...+..+|.+...+.+..|.+.|.+|..
T Consensus 567 -vsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 567 -VSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred -CcCcccccHHHHHHHHHHhhcCCccccC
Confidence 1223367899999999999999999964
|
|
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=373.91 Aligned_cols=254 Identities=28% Similarity=0.472 Sum_probs=209.2
Q ss_pred ecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC
Q psy14267 253 LNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA 332 (553)
Q Consensus 253 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~ 332 (553)
+...+.+.++.||+|..|+||+|.++.++.. +|+|++... .+....+++.+|++++++. .+|+||.+++.|+...
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i--~AlK~I~~~--~~~~~~~Qi~rEl~il~~~-~spyIV~~ygaF~~~~ 150 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKI--YALKVILLN--IDPALQKQILRELEILRSC-QSPYIVGFYGAFYSNG 150 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcCCCeE--EEEEeeccc--CCHHHHHHHHHHHHHHhhC-CCCCeeeEeEEEEeCC
Confidence 3445788899999999999999999988866 999999433 4456778999999999999 5699999999998766
Q ss_pred CceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhh-CCcEecCCCCCCEEEecCccceecCCC
Q psy14267 333 SKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHA-AGIIHSDLKPANFLFVGNVLKIIDCIG 410 (553)
Q Consensus 333 ~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~-~gIiHrDLKp~NILl~~~~~~~~~~~~ 410 (553)
. .+.|+|||+ +|+|..++...++ ..+..+..++.++++||.|||+ ++||||||||+||||+..
T Consensus 151 ~-~isI~mEYMDgGSLd~~~k~~g~-----i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNsk--------- 215 (364)
T KOG0581|consen 151 E-EISICMEYMDGGSLDDILKRVGR-----IPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSK--------- 215 (364)
T ss_pred c-eEEeehhhcCCCCHHHHHhhcCC-----CCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccC---------
Confidence 5 799999975 5788888887643 4456666777899999999995 999999999999999776
Q ss_pred CeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCC--
Q psy14267 411 NVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHI-- 488 (553)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~-- 488 (553)
|.|||||||.++.+... ...+++||..|||||.+.+. .|+.++||||||++++|+++|+.||...
T Consensus 216 GeVKicDFGVS~~lvnS----~a~tfvGT~~YMsPERi~g~---------~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~ 282 (364)
T KOG0581|consen 216 GEVKICDFGVSGILVNS----IANTFVGTSAYMSPERISGE---------SYSVKSDIWSLGLSLLELAIGRFPYPPPNP 282 (364)
T ss_pred CCEEeccccccHHhhhh----hcccccccccccChhhhcCC---------cCCcccceecccHHHHHHhhCCCCCCCcCC
Confidence 78999999999988765 33588999999999999987 4788999999999999999999999764
Q ss_pred --CchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 489 --PNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 489 --~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
.+-...+..+... .+|.++.. .++++++.||..||++||.+||++.||++|
T Consensus 283 ~~~~~~~Ll~~Iv~~-----ppP~lP~~-~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 283 PYLDIFELLCAIVDE-----PPPRLPEG-EFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CCCCHHHHHHHHhcC-----CCCCCCcc-cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 2223333333321 12333322 589999999999999999999999999876
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-46 Score=381.91 Aligned_cols=255 Identities=29% Similarity=0.439 Sum_probs=215.4
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
..+|.+++.||+|+|++||+|+.+.++.. ||||++.|.-+..+..++.+.+|..+|.+|.+||.|++|+.-| +++.
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~ke--YAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF--QD~~ 147 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKE--YAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTF--QDEE 147 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCce--eeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEe--eccc
Confidence 35799999999999999999999887654 9999999998888888889999999999999999999996444 5566
Q ss_pred eEEEEEec-CCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 335 HLYVLMEK-GDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 335 ~~~iv~e~-~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
.+|+|+++ .+|+|.++|.+.+ .+.+.....+++||+.||+|||++|||||||||+|||||.| +.+
T Consensus 148 sLYFvLe~A~nGdll~~i~K~G-----sfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~d---------mhi 213 (604)
T KOG0592|consen 148 SLYFVLEYAPNGDLLDLIKKYG-----SFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKD---------GHI 213 (604)
T ss_pred ceEEEEEecCCCcHHHHHHHhC-----cchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCC---------CcE
Confidence 78888876 5799999999986 45567788889999999999999999999999999999998 679
Q ss_pred EEEeccCccccCCCCCc-----------ccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCC
Q psy14267 414 KIIDFGIACSLQDDKTS-----------VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGR 482 (553)
Q Consensus 414 kL~DFGla~~~~~~~~~-----------~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~ 482 (553)
||+|||.|+.+.+.... ....+++||..|.+||++.... .+..+|||+|||+||.|+.|.
T Consensus 214 kITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~---------~~~~sDiWAlGCilyQmlaG~ 284 (604)
T KOG0592|consen 214 KITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSP---------AGPSSDLWALGCILYQMLAGQ 284 (604)
T ss_pred EEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCC---------CCcccchHHHHHHHHHHhcCC
Confidence 99999999987654322 1125689999999999998763 678999999999999999999
Q ss_pred CCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 483 TPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 483 ~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
+||.+. +++..+..|... ...|++ ++++.+++||+++|..||.+|+|+++|.+|
T Consensus 285 PPFra~-NeyliFqkI~~l--~y~fp~------~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 285 PPFRAA-NEYLIFQKIQAL--DYEFPE------GFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred CCCccc-cHHHHHHHHHHh--cccCCC------CCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 999874 444555555432 233444 678999999999999999999999888765
|
|
| >KOG0596|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=381.00 Aligned_cols=273 Identities=45% Similarity=0.744 Sum_probs=234.8
Q ss_pred cceEEecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeE
Q psy14267 248 QDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDY 327 (553)
Q Consensus 248 ~~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~ 327 (553)
...+.+++..|+++++||+||.+.||++...+... ||+|.+.... .+...++.|.+|+..|.+|++|.+|+++++|
T Consensus 353 ~~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~i---yalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DY 428 (677)
T KOG0596|consen 353 NEIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQI---YALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDY 428 (677)
T ss_pred CeeEEECcchhhHHHhhcCCCcceeeeeecCCCcc---hhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeee
Confidence 46788999999999999999999999996654443 6777665544 3456679999999999999999999999997
Q ss_pred EEeCCCceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceec
Q psy14267 328 VYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIID 407 (553)
Q Consensus 328 ~~~~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~ 407 (553)
-.. +.++||||||++.||..+|+........ .++..+|.||++|+.++|..||||-||||.|+|+..
T Consensus 429 Ev~--d~~lYmvmE~Gd~DL~kiL~k~~~~~~~----~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk------- 495 (677)
T KOG0596|consen 429 EVT--DGYLYMVMECGDIDLNKILKKKKSIDPD----WFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK------- 495 (677)
T ss_pred ecc--CceEEEEeecccccHHHHHHhccCCCch----HHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-------
Confidence 644 7899999999999999999886544321 267888999999999999999999999999999866
Q ss_pred CCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCC--CCCccCCCccchHHHHHHHHHHHHhCCCCC
Q psy14267 408 CIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSG--GGNTYRITYKSDVWSLGCILYNMIYGRTPY 485 (553)
Q Consensus 408 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~--~~~~~~~s~~sDIwSlGvvl~elltG~~Pf 485 (553)
|.+||+|||+|..+..........+.+||+.||+||.+....++. +....++++++|||||||+||+|++|++||
T Consensus 496 ---G~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf 572 (677)
T KOG0596|consen 496 ---GRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPF 572 (677)
T ss_pred ---eeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCch
Confidence 469999999999998888877778889999999999998776552 334667899999999999999999999999
Q ss_pred CCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 486 SHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 486 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
+...+.++++..+......++|+..... .++.++|+.||+.||++||++.|||++
T Consensus 573 ~~~~n~~aKl~aI~~P~~~Iefp~~~~~-----~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 573 GQIINQIAKLHAITDPNHEIEFPDIPEN-----DELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred HHHHHHHHHHHhhcCCCccccccCCCCc-----hHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 9999999999999888777777664433 349999999999999999999999975
|
|
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=367.99 Aligned_cols=257 Identities=26% Similarity=0.449 Sum_probs=203.4
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
.+|.+.+.||+|+||+||+++++.++.. ||||.+.+..+.. +..+.+..|+++|+.++ |||||.++++.. .+++
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~--VAIK~i~~~~l~~-k~~e~L~~Ei~iLkel~-H~nIV~l~d~~~--~~~~ 83 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTE--VAIKCIAKKKLNK-KLVELLLSEIKILKELK-HPNIVRLLDCIE--DDDF 83 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCce--EEeeeehhhccCH-HHHHHHHHHHHHHHhcC-CcceeeEEEEEe--cCCe
Confidence 4799999999999999999999988854 9999999887643 55688999999999997 599999999774 4669
Q ss_pred EEEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
+|+|||||. |||..|+++.+.. .+..+..++.||+.||++||+++||||||||+||||+..... .....+|
T Consensus 84 i~lVMEyC~gGDLs~yi~~~~~l-----~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~---~~~~~LK 155 (429)
T KOG0595|consen 84 IYLVMEYCNGGDLSDYIRRRGRL-----PEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARN---DTSPVLK 155 (429)
T ss_pred EEEEEEeCCCCCHHHHHHHcCCC-----CHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCC---CCCceEE
Confidence 999999876 8999999998743 345556666799999999999999999999999999875210 1115799
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||+|+.+.++.. ..+.||++.|||||+++.. +|+.|+|+||+|++||+|++|+.||...... +.
T Consensus 156 IADFGfAR~L~~~~~---a~tlcGSplYMAPEV~~~~---------~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~-eL 222 (429)
T KOG0595|consen 156 IADFGFARFLQPGSM---AETLCGSPLYMAPEVIMSQ---------QYDAKADLWSIGTILYQCLTGKPPFDAETPK-EL 222 (429)
T ss_pred ecccchhhhCCchhH---HHHhhCCccccCHHHHHhc---------cccchhhHHHHHHHHHHHHhCCCCccccCHH-HH
Confidence 999999999986654 3489999999999999765 5889999999999999999999999864432 22
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVT 544 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~ 544 (553)
+..+......+...+. .++..+.+|+...|+.++..|-+..+-..
T Consensus 223 ~~~~~k~~~~~~~~~~-----~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~ 267 (429)
T KOG0595|consen 223 LLYIKKGNEIVPVLPA-----ELSNPLRELLISLLQRNPKDRISFEDFFD 267 (429)
T ss_pred HHHHhccccccCchhh-----hccCchhhhhhHHHhcCccccCchHHhhh
Confidence 2233333332222221 34456668888888888888877665443
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=353.75 Aligned_cols=240 Identities=27% Similarity=0.409 Sum_probs=208.1
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
.++|++++.||.|+||.|.+++.+.++.+ +|+|++++..+.....++...+|..+|+.+. ||+++++.+-+ .+..
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~y--YAmKvL~k~~vVklKQveH~~nEk~vL~~v~-~PFlv~l~~t~--~d~~ 117 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNY--YAMKVLDKQKVVKLKQVEHTHNEKRVLKAVS-HPFLVKLYGTF--KDNS 117 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCce--eehhhcCHHHHHHHHHHHHHhhHHHHHhhcc-CceeEEEEEee--ccCC
Confidence 45799999999999999999999999877 9999999999888888899999999999996 69999996554 5678
Q ss_pred eEEEEEec-CCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 335 HLYVLMEK-GDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 335 ~~~iv~e~-~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
++||+|++ .||.|..++++.++.. ...+..+++||+.||+|||+++||+|||||+|||||.+ |.+
T Consensus 118 ~lymvmeyv~GGElFS~Lrk~~rF~-----e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~---------G~i 183 (355)
T KOG0616|consen 118 NLYMVMEYVPGGELFSYLRKSGRFS-----EPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQN---------GHI 183 (355)
T ss_pred eEEEEEeccCCccHHHHHHhcCCCC-----chhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccC---------CcE
Confidence 99999997 6789999999987554 45567778899999999999999999999999999888 789
Q ss_pred EEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHH
Q psy14267 414 KIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWA 493 (553)
Q Consensus 414 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~ 493 (553)
||+|||+|+.+... +.+.||||.|+|||++..++ |+.++|+|||||++|||+.|.+||..... ..
T Consensus 184 KitDFGFAK~v~~r-----T~TlCGTPeYLAPEii~sk~---------ynkavDWWalGVLIYEMlaG~pPF~~~~~-~~ 248 (355)
T KOG0616|consen 184 KITDFGFAKRVSGR-----TWTLCGTPEYLAPEIIQSKG---------YNKAVDWWALGVLIYEMLAGYPPFYDDNP-IQ 248 (355)
T ss_pred EEEeccceEEecCc-----EEEecCCccccChHHhhcCC---------CCcchhHHHHHHHHHHHHcCCCCCcCCCh-HH
Confidence 99999999988664 23889999999999999885 68899999999999999999999987544 45
Q ss_pred HHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCC
Q psy14267 494 KMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKAR 536 (553)
Q Consensus 494 ~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~R 536 (553)
....|.... ..++. .++.++++||+.+|+.|-.+|
T Consensus 249 iY~KI~~~~--v~fP~------~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 249 IYEKILEGK--VKFPS------YFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred HHHHHHhCc--ccCCc------ccCHHHHHHHHHHHhhhhHhh
Confidence 555555443 23333 678999999999999999999
|
|
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=354.81 Aligned_cols=260 Identities=22% Similarity=0.368 Sum_probs=208.7
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
+.|+.+.++|+|+||+||++++++++.. ||||.+.-.+ .+....+-.++|+++|++|+ |+|+|.++++| .....
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqI--VAIKkF~Ese-dd~~VkKIAlREIrmLKqLk-H~NLVnLiEVF--rrkrk 75 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQI--VAIKKFVESE-DDPVVKKIALREIRMLKQLK-HENLVNLIEVF--RRKRK 75 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccE--EEEEeeccCC-ccHHHHHHHHHHHHHHHhcc-cchHHHHHHHH--Hhcce
Confidence 3688999999999999999999988865 9999986443 44555677899999999995 49999999977 45778
Q ss_pred EEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 336 LYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 336 ~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
+++|+||++.++.+.+++...... ...+..+++|++.|+.|+|++++|||||||+||||+.+ +++||
T Consensus 76 lhLVFE~~dhTvL~eLe~~p~G~~----~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~---------gvvKL 142 (396)
T KOG0593|consen 76 LHLVFEYCDHTVLHELERYPNGVP----SELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQN---------GVVKL 142 (396)
T ss_pred eEEEeeecchHHHHHHHhccCCCC----HHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecC---------CcEEe
Confidence 999999999999988888765433 34556667799999999999999999999999999877 78999
Q ss_pred EeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHH
Q psy14267 416 IDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKM 495 (553)
Q Consensus 416 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~ 495 (553)
||||+|+.+..++. .++.++.|.+|.|||++.+.. +|+..+||||+||++.||++|.+.|.+.++..+ +
T Consensus 143 CDFGFAR~L~~pgd--~YTDYVATRWYRaPELLvGDt--------qYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQ-L 211 (396)
T KOG0593|consen 143 CDFGFARTLSAPGD--NYTDYVATRWYRAPELLVGDT--------QYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQ-L 211 (396)
T ss_pred ccchhhHhhcCCcc--hhhhhhhhhhccChhhhcccC--------cCCCcccchhhhHHHHHHhcCCcCCCCcchHHH-H
Confidence 99999999985443 345778999999999999864 589999999999999999999999988655433 2
Q ss_pred HHHHhhcccc------------cc-----------cccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 496 LAIARHKDQI------------EF-----------KPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 496 ~~i~~~~~~~------------~~-----------~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
..+......+ .| .+.......++..+.+||+.||+.||.+|++-++++.|
T Consensus 212 y~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 212 YLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred HHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 2222211110 00 11111223566789999999999999999999999865
|
|
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=360.32 Aligned_cols=261 Identities=27% Similarity=0.485 Sum_probs=212.9
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
.+|+++++||+|+||+||+|.+..++.. ||.|.+..+.+.. ...+....|+.+|++|+| ||||+++++-+..+...
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l--~a~K~i~f~~md~-k~rq~~v~Ei~lLkQL~H-pNIVqYy~~~f~~~~ev 94 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKL--VALKKIQFGMMDA-KARQDCVKEISLLKQLNH-PNIVQYYAHSFIEDNEV 94 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcch--hhhhhcchhhccH-HHHHHHHHHHHHHHhcCC-chHHHHHHHhhhccchh
Confidence 4799999999999999999999988876 9999998665544 556889999999999965 99999998766666777
Q ss_pred EEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhh--CC--cEecCCCCCCEEEecCccceecCCC
Q psy14267 336 LYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHA--AG--IIHSDLKPANFLFVGNVLKIIDCIG 410 (553)
Q Consensus 336 ~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~--~g--IiHrDLKp~NILl~~~~~~~~~~~~ 410 (553)
++|+||+| .|||...++...+. .....+..++.++.|++.||.++|. .. |+||||||.||||+.+
T Consensus 95 lnivmE~c~~GDLsqmIk~~K~q-kr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~--------- 164 (375)
T KOG0591|consen 95 LNIVMELCDAGDLSQMIKHFKKQ-KRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTAN--------- 164 (375)
T ss_pred hHHHHHhhcccCHHHHHHHHHhc-cccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCC---------
Confidence 99999975 48999988865433 2345667788888999999999998 45 9999999999999877
Q ss_pred CeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCc
Q psy14267 411 NVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN 490 (553)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~ 490 (553)
|.|||+||||++.+..... ...+.+|||.||+||.+.+.+ |+++|||||+||++|||+.-+.||.+. +
T Consensus 165 gvvKLGDfGL~r~l~s~~t--fA~S~VGTPyYMSPE~i~~~~---------Y~~kSDiWslGCllyEMcaL~~PF~g~-n 232 (375)
T KOG0591|consen 165 GVVKLGDFGLGRFLSSKTT--FAHSLVGTPYYMSPERIHESG---------YNFKSDIWSLGCLLYEMCALQSPFYGD-N 232 (375)
T ss_pred CceeeccchhHhHhcchhH--HHHhhcCCCcccCHHHHhcCC---------CCcchhHHHHHHHHHHHHhcCCCcccc-c
Confidence 7899999999999876544 334789999999999998774 889999999999999999999999985 2
Q ss_pred hHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q psy14267 491 TWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINN 548 (553)
Q Consensus 491 ~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~ 548 (553)
+..+.....+-++++.+. ..+|.++..||..|+..||+.||+.-.++..+..
T Consensus 233 ----~~~L~~KI~qgd~~~~p~--~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 233 ----LLSLCKKIEQGDYPPLPD--EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred ----HHHHHHHHHcCCCCCCcH--HHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 222222233333333221 2678999999999999999999996666666654
|
|
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=370.90 Aligned_cols=267 Identities=24% Similarity=0.363 Sum_probs=212.8
Q ss_pred eEEecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEE
Q psy14267 250 VITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVY 329 (553)
Q Consensus 250 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~ 329 (553)
.+.+......+.+.||+|+||+||++.+.... .||||++......... .+.|.+|+.+|.+|+ |||||.++|++.
T Consensus 35 ~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~---~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~-HpNIV~f~G~~~ 109 (362)
T KOG0192|consen 35 EEEIDPDELPIEEVLGSGSFGTVYKGKWRGTD---VVAVKIISDPDFDDES-RKAFRREASLLSRLR-HPNIVQFYGACT 109 (362)
T ss_pred ceecChHHhhhhhhcccCCceeEEEEEeCCce---eEEEEEecchhcChHH-HHHHHHHHHHHHhCC-CCCeeeEEEEEc
Confidence 44555566777888999999999988766543 2899999887766655 689999999999995 599999999885
Q ss_pred eCCCceEEEEEec-CCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCC-cEecCCCCCCEEEecCccceec
Q psy14267 330 DTASKHLYVLMEK-GDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAG-IIHSDLKPANFLFVGNVLKIID 407 (553)
Q Consensus 330 ~~~~~~~~iv~e~-~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~g-IiHrDLKp~NILl~~~~~~~~~ 407 (553)
.... .+.||||| .+|+|.+++... ....+....++.++.||+.||+|||+++ ||||||||+||||+.+.
T Consensus 110 ~~~~-~~~iVtEy~~~GsL~~~l~~~---~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~----- 180 (362)
T KOG0192|consen 110 SPPG-SLCIVTEYMPGGSLSVLLHKK---RKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKG----- 180 (362)
T ss_pred CCCC-ceEEEEEeCCCCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCC-----
Confidence 4432 67888886 568899998874 1224456667777889999999999999 99999999999998872
Q ss_pred CCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCC
Q psy14267 408 CIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSH 487 (553)
Q Consensus 408 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~ 487 (553)
-++||+|||+++....... ......||+.|||||++.+. . ..|+.++||||||++||||+||+.||.+
T Consensus 181 ---~~~KI~DFGlsr~~~~~~~--~~~~~~GT~~wMAPEv~~~~-~------~~~~~K~DvySFgIvlWEl~t~~~Pf~~ 248 (362)
T KOG0192|consen 181 ---KTLKIADFGLSREKVISKT--SMTSVAGTYRWMAPEVLRGE-K------SPYTEKSDVYSFGIVLWELLTGEIPFED 248 (362)
T ss_pred ---CEEEECCCccceeeccccc--cccCCCCCccccChhhhcCC-C------CcCCccchhhhHHHHHHHHHHCCCCCCC
Confidence 2799999999987765321 11236799999999999854 1 1489999999999999999999999999
Q ss_pred CCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 488 IPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 488 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
... .+....+........++. .+++.+..||.+||..||+.||++.+|+..|+.+
T Consensus 249 ~~~-~~~~~~v~~~~~Rp~~p~------~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~ 303 (362)
T KOG0192|consen 249 LAP-VQVASAVVVGGLRPPIPK------ECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESI 303 (362)
T ss_pred CCH-HHHHHHHHhcCCCCCCCc------cCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence 877 455555544443333222 4889999999999999999999999999999853
|
|
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=372.47 Aligned_cols=261 Identities=27% Similarity=0.406 Sum_probs=211.4
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
-++|.++++||.|+||.||+|+.+.+++. ||||.++++...-++. --++|++.|++|..||||+++.+++.+...
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~--VAIK~MK~Kf~s~ee~--~nLREvksL~kln~hpniikL~Evi~d~~~- 83 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGEL--VAIKKMKKKFYSWEEC--MNLREVKSLRKLNPHPNIIKLKEVIRDNDR- 83 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCce--eeHHHHHhhhccHHHH--HHHHHHHHHHhcCCCCcchhhHHHhhccCc-
Confidence 46899999999999999999999988877 9999998765442222 237999999999878999999998876544
Q ss_pred eEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 335 HLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 335 ~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
.+|+|||+++.+|+++++.+++ .+++..+..+++||++||+|+|.+|+.||||||||||+..+ ..||
T Consensus 84 ~L~fVfE~Md~NLYqLmK~R~r----~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~---------~~iK 150 (538)
T KOG0661|consen 84 ILYFVFEFMDCNLYQLMKDRNR----LFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGN---------DVIK 150 (538)
T ss_pred eEeeeHHhhhhhHHHHHhhcCC----cCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEeccc---------ceeE
Confidence 9999999999999999998754 56677788888999999999999999999999999999855 4799
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||||+.+.... .++.++.|.+|+|||++...+ .|+.++|||++||||+|+++-++.|.+.+.. +.
T Consensus 151 iaDFGLARev~Skp---PYTeYVSTRWYRAPEvLLrs~--------~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~-Dq 218 (538)
T KOG0661|consen 151 IADFGLAREVRSKP---PYTEYVSTRWYRAPEVLLRSG--------YYSSPVDMWAVGCIMAELYSLRPLFPGASEI-DQ 218 (538)
T ss_pred ecccccccccccCC---CcchhhhcccccchHHhhhcc--------ccCCchHHHHHHHHHHHHHHhcccCCCCcHH-HH
Confidence 99999999886644 345788999999999998664 4899999999999999999999999875443 33
Q ss_pred HHHHHhhccccc-----------------cccc----ccC-CCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 495 MLAIARHKDQIE-----------------FKPQ----LAN-NVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 495 ~~~i~~~~~~~~-----------------~~~~----~~~-~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
+..++.-..... ++.. +.. ...++.++.++|.+||+.||++||||.+++++
T Consensus 219 i~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 219 IYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 333322111111 1110 000 12477899999999999999999999999875
|
|
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=354.13 Aligned_cols=286 Identities=24% Similarity=0.356 Sum_probs=220.1
Q ss_pred CCCCCccCcccccccccccceEEecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHH
Q psy14267 230 PAKPQITTSNAKKSVETSQDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEV 309 (553)
Q Consensus 230 p~~~~~~~~~~~~~~~~~~~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~ 309 (553)
|.......+.+...... .....+..+.|++++.||.|.-|+||+|+...++.. +|+|++.+..+...+...++..|.
T Consensus 52 ph~~~d~~w~a~~~~~~-~~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~--fAmKVmdK~~l~~rkKl~Ra~tE~ 128 (459)
T KOG0610|consen 52 PHKGNDVRWEAISSIRN-SKDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCL--FAMKVMDKESLASRKKLKRAQTER 128 (459)
T ss_pred CCCCCchhhhhhccccc-cCCCccCHHHHHHHHHcCCCCceeEEEEEecCCCce--EEEEEecHHHHhhhhHHHHHHHHH
Confidence 33333333444333332 233345567899999999999999999999888755 999999999988888889999999
Q ss_pred HHHHhhcCCCceeEeeeEEEeCCCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEe
Q psy14267 310 ELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIH 388 (553)
Q Consensus 310 ~iL~~l~~hp~Iv~l~~~~~~~~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiH 388 (553)
+||..+. ||.++.|++.+ +.+++.+++|||| ||+|..++++... ..+++..+.+++++++.||+|||-.|||+
T Consensus 129 eIL~~lD-HPFlPTLYa~f--et~~~~cl~meyCpGGdL~~LrqkQp~---~~fse~~aRFYaAEvl~ALEYLHmlGivY 202 (459)
T KOG0610|consen 129 EILSLLD-HPFLPTLYASF--ETDKYSCLVMEYCPGGDLHSLRQKQPG---KRFSESAARFYAAEVLLALEYLHMLGIVY 202 (459)
T ss_pred HHHHhcC-CCccchhhhee--eccceeEEEEecCCCccHHHHHhhCCC---CccchhhHHHHHHHHHHHHHHHHhhceee
Confidence 9999995 59999998876 6688999999975 5788877766543 35667788889999999999999999999
Q ss_pred cCCCCCCEEEecCccceecCCCCeEEEEeccCccccCC---------------------------------C-C------
Q psy14267 389 SDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQD---------------------------------D-K------ 428 (553)
Q Consensus 389 rDLKp~NILl~~~~~~~~~~~~~~vkL~DFGla~~~~~---------------------------------~-~------ 428 (553)
|||||+||||.++ |+|.|+||.|+..... . .
T Consensus 203 RDLKPENILvred---------GHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~ 273 (459)
T KOG0610|consen 203 RDLKPENILVRED---------GHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKD 273 (459)
T ss_pred ccCCcceeEEecC---------CcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhcccccccccc
Confidence 9999999999777 7899999999743211 0 0
Q ss_pred --------------CcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 429 --------------TSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 429 --------------~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
......+++||-+|+|||++.|.++ +.++|||+|||+|||||+|..||.+..+. +.
T Consensus 274 ~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH---------gsAVDWWtfGIflYEmLyG~TPFKG~~~~-~T 343 (459)
T KOG0610|consen 274 ESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH---------GSAVDWWTFGIFLYEMLYGTTPFKGSNNK-ET 343 (459)
T ss_pred ccccccchhhhcCCCCccccccccccccccceeeecCCC---------CchhhHHHHHHHHHHHHhCCCCcCCCCch-hh
Confidence 0011235679999999999999875 57899999999999999999999987665 44
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
+..+.... ..+ .....++.++++||+++|.+||.+|....-=...++++
T Consensus 344 l~NIv~~~--l~F----p~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 344 LRNIVGQP--LKF----PEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred HHHHhcCC--CcC----CCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcC
Confidence 44443222 222 22236788999999999999999999844444444443
|
|
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=355.64 Aligned_cols=272 Identities=25% Similarity=0.436 Sum_probs=218.4
Q ss_pred cceEEecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeE
Q psy14267 248 QDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDY 327 (553)
Q Consensus 248 ~~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~ 327 (553)
...|..+.+.|++..+||.|.-++||+|+.+..++. ||||+++.+..... ++.+.+|++.|..+ +||||+.++..
T Consensus 18 ~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~--VAIK~inLEkc~~~--ld~l~kE~~~msl~-~HPNIv~~~~s 92 (516)
T KOG0582|consen 18 EKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEV--VAIKIINLEKCNND--LDALRKEVQTMSLI-DHPNIVTYHCS 92 (516)
T ss_pred cccCCCCccceeEEEEEeccceeEeeeeeecccCCE--EEEEEeehhhhhhh--HHHHHHHHHHhhhc-CCCCcceEEEE
Confidence 344556778999999999999999999999988866 99999999887654 68899999999888 56999999776
Q ss_pred EEeCCCceEEEEEec-CCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCcccee
Q psy14267 328 VYDTASKHLYVLMEK-GDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKII 406 (553)
Q Consensus 328 ~~~~~~~~~~iv~e~-~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~ 406 (553)
|. .+..+++||++ .+|++.+.+...-.. .+.+..|..+.++++.||.|||.+|.||||||+.||||+.+
T Consensus 93 Fv--v~~~LWvVmpfMa~GS~ldIik~~~~~---Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~d----- 162 (516)
T KOG0582|consen 93 FV--VDSELWVVMPFMAGGSLLDIIKTYYPD---GLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSD----- 162 (516)
T ss_pred EE--ecceeEEeehhhcCCcHHHHHHHHccc---cccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCC-----
Confidence 64 46789999996 678899888876433 24556677777899999999999999999999999999888
Q ss_pred cCCCCeEEEEeccCccccCCCCCc-ccc-cCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCC
Q psy14267 407 DCIGNVLKIIDFGIACSLQDDKTS-VHK-DTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTP 484 (553)
Q Consensus 407 ~~~~~~vkL~DFGla~~~~~~~~~-~~~-~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~P 484 (553)
|.|||+|||.+..+...+.. ... .++.||+.|||||+++...+ -|++|+||||||++..||.+|..|
T Consensus 163 ----G~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~-------GYdfKaDIwSfGITA~ELA~G~aP 231 (516)
T KOG0582|consen 163 ----GTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLH-------GYDFKADIWSFGITACELAHGHAP 231 (516)
T ss_pred ----CcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhccc-------CccchhhhhhhhHHHHHHhcCCCC
Confidence 78999999998776554432 222 57789999999999765533 289999999999999999999999
Q ss_pred CCCCCchHHHHHHHHhhcccccc-cccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 485 YSHIPNTWAKMLAIARHKDQIEF-KPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 485 f~~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
|...+.....+..+.+.-..... ...-.....++..++.+|..||.+||++|||+++++++
T Consensus 232 f~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 232 FSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred cccCChHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 99988765555544433221110 01112233577899999999999999999999999875
|
|
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=366.25 Aligned_cols=252 Identities=25% Similarity=0.434 Sum_probs=205.3
Q ss_pred ecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC
Q psy14267 253 LNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA 332 (553)
Q Consensus 253 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~ 332 (553)
+..++|++++.||+|+||.||+|+.++++.. ||+|+++|..+...+.++.++.|-.||... ..|+||+|+. ..++
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~i--yAmK~LkKS~M~~~~Qv~hV~aERdiL~~~-ds~~vVKLyY--sFQD 212 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEI--YAMKILKKSEMLKKNQVEHVRAERDILAEV-DSPWVVKLYY--SFQD 212 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcE--EeeecccHHHHHhhhhHHHHHHHHHHhhhc-CCCcEEEEEE--EecC
Confidence 3456899999999999999999999999877 999999999988888889999999999996 5599999954 4477
Q ss_pred CceEEEEEec-CCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCC
Q psy14267 333 SKHLYVLMEK-GDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGN 411 (553)
Q Consensus 333 ~~~~~iv~e~-~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~ 411 (553)
..++|++||| .|||+..+|.+.. .+.+.++..++.+++.|++.||+.|||||||||+|+|||.. |
T Consensus 213 ~~~LYLiMEylPGGD~mTLL~~~~-----~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~---------G 278 (550)
T KOG0605|consen 213 KEYLYLIMEYLPGGDMMTLLMRKD-----TLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAK---------G 278 (550)
T ss_pred CCeeEEEEEecCCccHHHHHHhcC-----cCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCC---------C
Confidence 8899999997 6789999988766 44566777888899999999999999999999999999887 7
Q ss_pred eEEEEeccCccccCCC----------------------CCc----cc-------------------ccCCccCCCccCcc
Q psy14267 412 VLKIIDFGIACSLQDD----------------------KTS----VH-------------------KDTASGTLNYMSPE 446 (553)
Q Consensus 412 ~vkL~DFGla~~~~~~----------------------~~~----~~-------------------~~~~~Gt~~y~APE 446 (553)
++||+|||||..+... ... .. ..+.+|||.|||||
T Consensus 279 HiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPE 358 (550)
T KOG0605|consen 279 HIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPE 358 (550)
T ss_pred CEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchH
Confidence 8999999998532210 000 00 11456999999999
Q ss_pred cccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHH
Q psy14267 447 AAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMK 526 (553)
Q Consensus 447 ~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~ 526 (553)
++.+.+ |+..+|+|||||||||||.|.+||...... +....+...+..+.++. ...+++++++||.
T Consensus 359 Vll~kg---------Y~~~cDwWSLG~ImyEmLvGyPPF~s~tp~-~T~rkI~nwr~~l~fP~----~~~~s~eA~DLI~ 424 (550)
T KOG0605|consen 359 VLLGKG---------YGKECDWWSLGCIMYEMLVGYPPFCSETPQ-ETYRKIVNWRETLKFPE----EVDLSDEAKDLIT 424 (550)
T ss_pred HHhcCC---------CCccccHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhhhccCCC----cCcccHHHHHHHH
Confidence 999885 788999999999999999999999875443 33333433333333333 2356799999999
Q ss_pred HhcccCCCCCCC
Q psy14267 527 LCLQKDPKARPT 538 (553)
Q Consensus 527 ~cL~~dP~~RPt 538 (553)
+||. ||+.|..
T Consensus 425 rll~-d~~~RLG 435 (550)
T KOG0605|consen 425 RLLC-DPENRLG 435 (550)
T ss_pred HHhc-CHHHhcC
Confidence 9999 9999986
|
|
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=358.49 Aligned_cols=259 Identities=27% Similarity=0.471 Sum_probs=200.9
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
.+|..++.||+|+||.||++.+..++.. +|||.+...... ..+.+.+|+.+|.+|+ |||||++++.........
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~--~AvK~v~~~~~~---~~~~l~~Ei~iL~~l~-~p~IV~~~G~~~~~~~~~ 90 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGEL--MAVKSVELEDSP---TSESLEREIRILSRLN-HPNIVQYYGSSSSRENDE 90 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcc--eeeeeeecccch---hHHHHHHHHHHHHhCC-CCCEEeeCCccccccCee
Confidence 4689999999999999999988877655 999999776321 1578999999999998 799999988633322247
Q ss_pred EEEEEec-CCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEK-GDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~-~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
++++||| .+|+|.+++.+.+. .+.+..+..+.+||++||+|||++|||||||||+||||+.. ++.+|
T Consensus 91 ~~i~mEy~~~GsL~~~~~~~g~----~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~--------~~~~K 158 (313)
T KOG0198|consen 91 YNIFMEYAPGGSLSDLIKRYGG----KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPS--------NGDVK 158 (313)
T ss_pred eEeeeeccCCCcHHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCC--------CCeEE
Confidence 8899997 56899999998764 24456677778899999999999999999999999999873 15799
Q ss_pred EEeccCccccCCCC-CcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHH
Q psy14267 415 IIDFGIACSLQDDK-TSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWA 493 (553)
Q Consensus 415 L~DFGla~~~~~~~-~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~ 493 (553)
|+|||+++...... .........||+.|||||++.... ...+++|||||||+++||+||+.||........
T Consensus 159 laDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~--------~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~ 230 (313)
T KOG0198|consen 159 LADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGE--------VARRESDIWSLGCTVVEMLTGKPPWSEFFEEAE 230 (313)
T ss_pred eccCccccccccccccccccccccCCccccCchhhcCCC--------cCCccchhhhcCCEEEeccCCCCcchhhcchHH
Confidence 99999998877411 111223577999999999998521 123589999999999999999999987412222
Q ss_pred HHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q psy14267 494 KMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQI 546 (553)
Q Consensus 494 ~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L 546 (553)
.+..+..... .|.++ ..++.+++++|.+|+.+||++||||.++|+|.
T Consensus 231 ~~~~ig~~~~----~P~ip--~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 231 ALLLIGREDS----LPEIP--DSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred HHHHHhccCC----CCCCC--cccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 2333322221 12222 25889999999999999999999999999875
|
|
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=362.51 Aligned_cols=269 Identities=25% Similarity=0.379 Sum_probs=218.9
Q ss_pred eEEecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEE
Q psy14267 250 VITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVY 329 (553)
Q Consensus 250 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~ 329 (553)
......+.|+.+++||+|+||.||+|++..++.. ||+|.+..+.... ....-..+||.||++|. ||||++|.+++.
T Consensus 111 w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgki--vALKKvr~d~~~~-~~~~t~~REI~ILr~l~-HpNIikL~eivt 186 (560)
T KOG0600|consen 111 WGPRRADSFEKIEKIGEGTYGQVYKARDLETGKI--VALKKVRFDNEKE-GFPITAIREIKILRRLD-HPNIIKLEEIVT 186 (560)
T ss_pred ccccchHHHHHHHHhcCcchhheeEeeecccCcE--EEEEEeecccCCC-cchHHHHHHHHHHHhcC-CCcccceeeEEE
Confidence 3344556899999999999999999999888866 9999999887554 55577889999999995 599999999998
Q ss_pred eCCCceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCC
Q psy14267 330 DTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCI 409 (553)
Q Consensus 330 ~~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~ 409 (553)
......+|||+||++.||..++.... ..++.-+|.++++||+.||+|||.+||+|||||..|||||.+
T Consensus 187 ~~~~~siYlVFeYMdhDL~GLl~~p~----vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~-------- 254 (560)
T KOG0600|consen 187 SKLSGSIYLVFEYMDHDLSGLLSSPG----VKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNN-------- 254 (560)
T ss_pred ecCCceEEEEEecccchhhhhhcCCC----cccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCC--------
Confidence 87778999999999999999887643 356678899999999999999999999999999999999887
Q ss_pred CCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy14267 410 GNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIP 489 (553)
Q Consensus 410 ~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~ 489 (553)
|++||+|||||+.+...... .++..+-|.+|.|||++.|.. .|+.++|+||.||||.||++|++.|.+..
T Consensus 255 -G~LKiaDFGLAr~y~~~~~~-~~T~rVvTLWYRpPELLLG~t--------~Yg~aVDlWS~GCIl~El~~gkPI~~G~t 324 (560)
T KOG0600|consen 255 -GVLKIADFGLARFYTPSGSA-PYTSRVVTLWYRPPELLLGAT--------SYGTAVDLWSVGCILAELFLGKPILQGRT 324 (560)
T ss_pred -CCEEeccccceeeccCCCCc-ccccceEEeeccChHHhcCCc--------ccccceeehhhhHHHHHHHcCCCCcCCcc
Confidence 78999999999988766543 245677899999999999886 58999999999999999999999998854
Q ss_pred chHHHHHHHHhhccc-----cc---------cccc------cc-CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 490 NTWAKMLAIARHKDQ-----IE---------FKPQ------LA-NNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 490 ~~~~~~~~i~~~~~~-----~~---------~~~~------~~-~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
.. +.+..|...-.. |. +.+. +. .-..++....+|+..+|..||.+|.|+.++|..
T Consensus 325 Ev-eQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 325 EV-EQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred HH-HHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 43 333332221110 00 1110 00 112467889999999999999999999998753
|
|
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=365.77 Aligned_cols=264 Identities=23% Similarity=0.395 Sum_probs=215.4
Q ss_pred cceEEecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeE
Q psy14267 248 QDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDY 327 (553)
Q Consensus 248 ~~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~ 327 (553)
.+.|.+..+.+++++.||+|.||+||++.+.... +||+|.++...+.. +.|.+|+++|++|+| ++||+++++
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~---~vavk~ik~~~m~~----~~f~~Ea~iMk~L~H-~~lV~l~gV 269 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGST---KVAVKTIKEGSMSP----EAFLREAQIMKKLRH-EKLVKLYGV 269 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcCCC---cccceEEeccccCh----hHHHHHHHHHHhCcc-cCeEEEEEE
Confidence 6778888999999999999999999999876553 38999998765544 667899999999965 999999998
Q ss_pred EEeCCCceEEEEEec-CCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCcccee
Q psy14267 328 VYDTASKHLYVLMEK-GDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKII 406 (553)
Q Consensus 328 ~~~~~~~~~~iv~e~-~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~ 406 (553)
+.. +..++||||+ ..|+|.+|++...+. .......+.++.||++||+||+++++|||||-+.||||+++
T Consensus 270 ~~~--~~piyIVtE~m~~GsLl~yLr~~~~~---~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~----- 339 (468)
T KOG0197|consen 270 CTK--QEPIYIVTEYMPKGSLLDYLRTREGG---LLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDED----- 339 (468)
T ss_pred Eec--CCceEEEEEecccCcHHHHhhhcCCC---ccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccC-----
Confidence 854 3479999997 568999999983322 34456677778899999999999999999999999999887
Q ss_pred cCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCC
Q psy14267 407 DCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPY 485 (553)
Q Consensus 407 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf 485 (553)
..+||+|||||+...+.... ......-...|.|||.+... +++.+||||||||+||||+| |+.||
T Consensus 340 ----~~vKIsDFGLAr~~~d~~Y~-~~~~~kfPIkWtAPEa~~~~---------~FS~kSDVWSFGVlL~E~fT~G~~py 405 (468)
T KOG0197|consen 340 ----LVVKISDFGLARLIGDDEYT-ASEGGKFPIKWTAPEALNYG---------KFSSKSDVWSFGVLLWELFTYGRVPY 405 (468)
T ss_pred ----ceEEEcccccccccCCCcee-ecCCCCCCceecCHHHHhhC---------CcccccceeehhhhHHHHhccCCCCC
Confidence 68999999999955443332 22233346799999999765 58999999999999999997 99999
Q ss_pred CCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q psy14267 486 SHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNPE 551 (553)
Q Consensus 486 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~~ 551 (553)
.+..+. +.+..+.+ ..++..+..||+++.++|..||+.+|++|||++.+...|+.+..
T Consensus 406 ~~msn~-ev~~~le~-------GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 406 PGMSNE-EVLELLER-------GYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred CCCCHH-HHHHHHhc-------cCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 997764 23333322 23345556899999999999999999999999999999988764
|
|
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=362.34 Aligned_cols=255 Identities=27% Similarity=0.424 Sum_probs=202.1
Q ss_pred cCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCc--hhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeC
Q psy14267 254 NGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITD--QSIADSYLNEVELLAKLQGCPYVIKMHDYVYDT 331 (553)
Q Consensus 254 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~--~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~ 331 (553)
....|.+++.||+|+||+|++|.+..++.. ||+|++++..... ....+.+.+|+.+++++++||||+++++++..
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~--vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t- 91 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEK--VAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT- 91 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCe--EEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec-
Confidence 346899999999999999999999888755 9999887753221 13446677899999999988999999998744
Q ss_pred CCceEEEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCC
Q psy14267 332 ASKHLYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIG 410 (553)
Q Consensus 332 ~~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~ 410 (553)
...+|++|||+. |+|++++.+.++.. +..+..++.|++.|++|||++||+||||||+|||++.+.
T Consensus 92 -~~~~~ivmEy~~gGdL~~~i~~~g~l~-----E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~-------- 157 (370)
T KOG0583|consen 92 -PTKIYIVMEYCSGGDLFDYIVNKGRLK-----EDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNE-------- 157 (370)
T ss_pred -CCeEEEEEEecCCccHHHHHHHcCCCC-----hHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCC--------
Confidence 445999999865 59999999855433 355666778999999999999999999999999998762
Q ss_pred CeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccC-CCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy14267 411 NVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTS-SSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIP 489 (553)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~-~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~ 489 (553)
+.+||+|||++....... ....+.|||+.|+|||++.+.. ++ ..++||||+||+||.|++|..||....
T Consensus 158 ~~~Kl~DFG~s~~~~~~~--~~l~t~cGsp~Y~aPEvl~~~~~Y~--------g~~aDvWS~GViLy~ml~G~~PF~d~~ 227 (370)
T KOG0583|consen 158 GNLKLSDFGLSAISPGED--GLLKTFCGSPAYAAPEVLSGKGTYS--------GKAADVWSLGVILYVLLCGRLPFDDSN 227 (370)
T ss_pred CCEEEeccccccccCCCC--CcccCCCCCcccCCHHHhCCCCCcC--------CchhhhhhhHHHHHHHHhCCCCCCCcc
Confidence 479999999998874111 1334899999999999999876 44 478999999999999999999998833
Q ss_pred chHHHHHHHHhhcccccccccccCCCCC-CHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy14267 490 NTWAKMLAIARHKDQIEFKPQLANNVTI-PPTLLQSMKLCLQKDPKARPTVGNSVT 544 (553)
Q Consensus 490 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~-s~~l~~li~~cL~~dP~~RPt~~ell~ 544 (553)
.. .....+. .....++. .+ +.+++.|+.+||..||.+|+++.+|+.
T Consensus 228 ~~-~l~~ki~--~~~~~~p~------~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 228 VP-NLYRKIR--KGEFKIPS------YLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred HH-HHHHHHh--cCCccCCC------CcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 21 2222222 22222222 34 899999999999999999999999984
|
|
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=343.69 Aligned_cols=252 Identities=25% Similarity=0.391 Sum_probs=203.6
Q ss_pred EEecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEe
Q psy14267 251 ITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYD 330 (553)
Q Consensus 251 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~ 330 (553)
+.+...+|.++++||+|+|++|.+++.+.+... ||+|+++++-+++.+.++-...|..+..+..++|++|-++.+|
T Consensus 245 ~~l~l~df~ll~vigrgsyakvl~~~~~~t~qi--yamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscf-- 320 (593)
T KOG0695|consen 245 QGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQI--YAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCF-- 320 (593)
T ss_pred cccccccceeeeeecCcchhhhhheehccccee--eehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhh--
Confidence 445567899999999999999999999888755 9999999999998888899999999999999999999998865
Q ss_pred CCCceEEEEEe-cCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCC
Q psy14267 331 TASKHLYVLME-KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCI 409 (553)
Q Consensus 331 ~~~~~~~iv~e-~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~ 409 (553)
.....+|.|.| ..||+|.-++++..+.. +..+..+..+|+.||.|||+.|||+||||.+|||||.+
T Consensus 321 qtesrlffvieyv~ggdlmfhmqrqrklp-----eeharfys~ei~lal~flh~rgiiyrdlkldnvlldae-------- 387 (593)
T KOG0695|consen 321 QTESRLFFVIEYVNGGDLMFHMQRQRKLP-----EEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAE-------- 387 (593)
T ss_pred cccceEEEEEEEecCcceeeehhhhhcCc-----HHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccC--------
Confidence 33445555555 58899998888876554 44555666799999999999999999999999999887
Q ss_pred CCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCC--
Q psy14267 410 GNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSH-- 487 (553)
Q Consensus 410 ~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~-- 487 (553)
+.+||+|||+++.--..+. .+.++||||.|+|||++++.. |.+.+|+|+|||+|+||+.|+.||.-
T Consensus 388 -ghikltdygmcke~l~~gd--~tstfcgtpnyiapeilrgee---------ygfsvdwwalgvlmfemmagrspfdivg 455 (593)
T KOG0695|consen 388 -GHIKLTDYGMCKEGLGPGD--TTSTFCGTPNYIAPEILRGEE---------YGFSVDWWALGVLMFEMMAGRSPFDIVG 455 (593)
T ss_pred -CceeecccchhhcCCCCCc--ccccccCCCcccchhhhcccc---------cCceehHHHHHHHHHHHHcCCCCcceec
Confidence 7899999999987554443 345899999999999999884 78999999999999999999999962
Q ss_pred ----CCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCC
Q psy14267 488 ----IPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538 (553)
Q Consensus 488 ----~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt 538 (553)
..++...+.++.-.+ ++.++. .++-....+++..|++||++|..
T Consensus 456 m~n~d~ntedylfqvilek-qiripr------slsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 456 MDNPDMNTEDYLFQVILEK-QIRIPR------SLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred CCCcccchhHHHHHHHhhh-cccccc------eeehhhHHHHHHhhcCCcHHhcC
Confidence 223444444444322 222222 45566778999999999999963
|
|
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=331.54 Aligned_cols=260 Identities=24% Similarity=0.328 Sum_probs=209.7
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
.+|...++||+|.||.||+|++..+++. ||||.++..+..+ ......++|++.|+.++ |+||+.++++| .+...
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~--VAIKKIkl~~~kd-Gi~~talREIK~Lqel~-h~nIi~LiD~F--~~~~~ 75 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKR--VAIKKIKLGNAKD-GINRTALREIKLLQELK-HPNIIELIDVF--PHKSN 75 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcE--EEEEEeecccccc-CccHHHHHHHHHHHHcc-Ccchhhhhhhc--cCCCc
Confidence 4688999999999999999998887755 9999999887554 33357899999999995 69999999987 56778
Q ss_pred EEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 336 LYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 336 ~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
+.+|+|+...+|...++.... .++...+..++.+++.||+|||++.|+||||||.|+||+++ +.+||
T Consensus 76 l~lVfEfm~tdLe~vIkd~~i----~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~---------g~lKi 142 (318)
T KOG0659|consen 76 LSLVFEFMPTDLEVVIKDKNI----ILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSD---------GQLKI 142 (318)
T ss_pred eEEEEEeccccHHHHhccccc----ccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCC---------CcEEe
Confidence 999999999999999987654 45567788888899999999999999999999999999887 78999
Q ss_pred EeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHH
Q psy14267 416 IDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKM 495 (553)
Q Consensus 416 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~ 495 (553)
+|||+|+.+........ ..+-|.+|.|||++.|.. .|+..+||||.||++.||+.|.+-|.+.++- +++
T Consensus 143 ADFGLAr~f~~p~~~~~--~~V~TRWYRAPELLfGsr--------~Yg~~VDmWavGCI~AELllr~P~fpG~sDi-dQL 211 (318)
T KOG0659|consen 143 ADFGLARFFGSPNRIQT--HQVVTRWYRAPELLFGSR--------QYGTGVDMWAVGCIFAELLLRVPFFPGDSDI-DQL 211 (318)
T ss_pred ecccchhccCCCCcccc--cceeeeeccChHHhccch--------hcCCcchhhhHHHHHHHHHccCCCCCCCchH-HHH
Confidence 99999999987665433 226799999999999875 5889999999999999999999888875543 333
Q ss_pred HHHHhhccccc---c--------------ccccc---CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 496 LAIARHKDQIE---F--------------KPQLA---NNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 496 ~~i~~~~~~~~---~--------------~~~~~---~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
..+.+...... + .|... .-..++.++.+||..||..||.+|+++.|++++
T Consensus 212 ~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 212 SKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 33322111100 0 01000 112456788999999999999999999999875
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=356.60 Aligned_cols=274 Identities=24% Similarity=0.361 Sum_probs=207.0
Q ss_pred EEecCcceEEEeeeeeeCceEEEEEeeeC---CCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeE
Q psy14267 251 ITLNGKQYQVLSLLGKGGSSSVYLVGGTS---EHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDY 327 (553)
Q Consensus 251 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~---~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~ 327 (553)
|++..++|+++++||+|+||.||+|.+.. ....+.||||++.... .....+.+.+|+.+|.++.+||||++++++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~ 79 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGA 79 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeE
Confidence 56677899999999999999999997532 1223459999987542 223346789999999999888999999987
Q ss_pred EEeCCCceEEEEEec-CCCCHHHHHHHcccCC------------------------------------------------
Q psy14267 328 VYDTASKHLYVLMEK-GDTDLSKYMRNLNKMT------------------------------------------------ 358 (553)
Q Consensus 328 ~~~~~~~~~~iv~e~-~~~~L~~~l~~~~~~~------------------------------------------------ 358 (553)
+.. ....++++||+ .+++|.+++.......
T Consensus 80 ~~~-~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (338)
T cd05102 80 CTK-PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTN 158 (338)
T ss_pred ecC-CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccc
Confidence 653 34467888886 4689999987642110
Q ss_pred ---------CCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEeccCccccCCCCC
Q psy14267 359 ---------TLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKT 429 (553)
Q Consensus 359 ---------~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGla~~~~~~~~ 429 (553)
...+....+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.......
T Consensus 159 ~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~---------~~~kl~DfG~a~~~~~~~~ 229 (338)
T cd05102 159 PPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSEN---------NVVKICDFGLARDIYKDPD 229 (338)
T ss_pred cchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCC---------CcEEEeecccccccccCcc
Confidence 1234455667778899999999999999999999999999776 5799999999987654332
Q ss_pred cccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHhhccccccc
Q psy14267 430 SVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHIPNTWAKMLAIARHKDQIEFK 508 (553)
Q Consensus 430 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~i~~~~~~~~~~ 508 (553)
........+++.|+|||++.+. .++.++|||||||+||||++ |..||............+.. ....
T Consensus 230 ~~~~~~~~~~~~y~aPE~~~~~---------~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~~~--- 296 (338)
T cd05102 230 YVRKGSARLPLKWMAPESIFDK---------VYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD-GTRM--- 296 (338)
T ss_pred hhcccCCCCCccccCcHHhhcC---------CCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhc-CCCC---
Confidence 2222344567899999999765 37889999999999999997 99999875443222222221 1111
Q ss_pred ccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCCC
Q psy14267 509 PQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNPEG 552 (553)
Q Consensus 509 ~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~~~ 552 (553)
.....+++++.++|.+||..||++|||+.+|++.|+++..+
T Consensus 297 ---~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 297 ---RAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred ---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 11235788999999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG4236|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=358.20 Aligned_cols=250 Identities=24% Similarity=0.355 Sum_probs=202.7
Q ss_pred eeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEEEEEe
Q psy14267 262 SLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLME 341 (553)
Q Consensus 262 ~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~iv~e 341 (553)
++||+|.||+||-+.++.++.. ||||++.|-.+.... ...+.+|+.||+++ +||.||.+..++ +....+|+|||
T Consensus 570 evLGSGQFG~VYgg~hRktGrd--VAvKvIdKlrFp~kq-esqlR~EVaILq~l-~HPGiV~le~M~--ET~ervFVVME 643 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRD--VAVKVIDKLRFPTKQ-ESQLRNEVAILQNL-HHPGIVNLECMF--ETPERVFVVME 643 (888)
T ss_pred hhccCCcceeeecceecccCce--eeeeeeecccCCCch-HHHHHHHHHHHHhc-CCCCeeEEEEee--cCCceEEEEeh
Confidence 6899999999999888777754 999999998877644 37889999999999 569999997665 66788999999
Q ss_pred cCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEeccCc
Q psy14267 342 KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIA 421 (553)
Q Consensus 342 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGla 421 (553)
...|++.+.+....+... .+....++..||+.||.|||.++|||.||||+||||.+.. .-.++||||||+|
T Consensus 644 Kl~GDMLEMILSsEkgRL---~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~------~FPQvKlCDFGfA 714 (888)
T KOG4236|consen 644 KLHGDMLEMILSSEKGRL---PERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASAS------PFPQVKLCDFGFA 714 (888)
T ss_pred hhcchHHHHHHHhhcccc---hHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCC------CCCceeeccccce
Confidence 999999998887655433 3334444556999999999999999999999999997652 2257999999999
Q ss_pred cccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHhh
Q psy14267 422 CSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARH 501 (553)
Q Consensus 422 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~~i~~~ 501 (553)
+.+.+... +.+.+|||.|+|||+++.++ |++.-|+||.||++|--|.|..||....+. -.++++.
T Consensus 715 RiIgEksF---RrsVVGTPAYLaPEVLrnkG---------yNrSLDMWSVGVIiYVsLSGTFPFNEdEdI---ndQIQNA 779 (888)
T KOG4236|consen 715 RIIGEKSF---RRSVVGTPAYLAPEVLRNKG---------YNRSLDMWSVGVIIYVSLSGTFPFNEDEDI---NDQIQNA 779 (888)
T ss_pred eecchhhh---hhhhcCCccccCHHHHhhcc---------ccccccceeeeEEEEEEecccccCCCccch---hHHhhcc
Confidence 99876543 44788999999999999885 678899999999999999999999764332 2333322
Q ss_pred cccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 502 KDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 502 ~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
. ..++ ...|.+++....+||..+|+..=.+|.++...+.+
T Consensus 780 a--FMyP--p~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 780 A--FMYP--PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred c--cccC--CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 2 2222 34467899999999999999999999998877654
|
|
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=351.17 Aligned_cols=264 Identities=24% Similarity=0.398 Sum_probs=203.7
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCch-----------hHHHHHHHHHHHHHhhcCCCceeE
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQ-----------SIADSYLNEVELLAKLQGCPYVIK 323 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~-----------~~~~~~~~E~~iL~~l~~hp~Iv~ 323 (553)
..+|++++.||+|.||+|-+|++...+.. ||||++.+.....+ ..+++..+|+.||++|. |||||+
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l--~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~-H~nVV~ 172 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKL--YAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH-HPNVVK 172 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcE--EEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC-CcCeeE
Confidence 35899999999999999999999888877 99999988653321 12357899999999995 599999
Q ss_pred eeeEEEeCCCceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCcc
Q psy14267 324 MHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVL 403 (553)
Q Consensus 324 l~~~~~~~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~ 403 (553)
|+++.-+.....+|||+||+...-..+... ....+.+.+.+.++++++.||+|||.+|||||||||+|+||+++
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~----d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~-- 246 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPP----DKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSD-- 246 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCCC----CcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCC--
Confidence 999888888889999999876432222211 11126677888889999999999999999999999999999877
Q ss_pred ceecCCCCeEEEEeccCccccCCCCC---cccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh
Q psy14267 404 KIIDCIGNVLKIIDFGIACSLQDDKT---SVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY 480 (553)
Q Consensus 404 ~~~~~~~~~vkL~DFGla~~~~~~~~---~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt 480 (553)
++|||+|||.+.....+.. ........|||.|||||.+.++.. ....+++.||||+||+||-|++
T Consensus 247 -------g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~-----~~~~g~a~DiWalGVTLYCllf 314 (576)
T KOG0585|consen 247 -------GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNS-----FSYSGFALDIWALGVTLYCLLF 314 (576)
T ss_pred -------CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCC-----ccccchhhhhhhhhhhHHHhhh
Confidence 7899999999987643311 111223579999999999987421 1235789999999999999999
Q ss_pred CCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q psy14267 481 GRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQI 546 (553)
Q Consensus 481 G~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L 546 (553)
|+.||-+. ...+....|... .+.++. ...+.+++++||+++|.+||+.|.++.+|..|.
T Consensus 315 G~~PF~~~-~~~~l~~KIvn~--pL~fP~----~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 315 GQLPFFDD-FELELFDKIVND--PLEFPE----NPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred ccCCcccc-hHHHHHHHHhcC--cccCCC----cccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 99999763 223333444322 222222 225678999999999999999999999987765
|
|
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=363.56 Aligned_cols=250 Identities=27% Similarity=0.456 Sum_probs=209.4
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
..|....+||+|+.|.||.|....++.. ||||.+.+.....+ +-+++|+.+|+.+ +|+|||.+++-+.- ...
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~--VaiK~m~l~~Q~~k---eLilnEi~Vm~~~-~H~NiVnfl~Sylv--~de 344 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQE--VAIKRMDLRKQPKK---ELLLNEILVMRDL-HHPNIVNFLDSYLV--GDE 344 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCce--EEEEEEEeccCCch---hhhHHHHHHHHhc-cchHHHHHHHHhcc--cce
Confidence 4688899999999999999988877765 99999988765443 5578999999999 55999999886643 367
Q ss_pred EEEEEec-CCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEK-GDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~-~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
+++|||| .+|+|.+.+... .+.+.+|+.+++++++||+|||.+||||||||.+|||++.+ +.||
T Consensus 345 LWVVMEym~ggsLTDvVt~~------~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~---------g~vK 409 (550)
T KOG0578|consen 345 LWVVMEYMEGGSLTDVVTKT------RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMD---------GSVK 409 (550)
T ss_pred eEEEEeecCCCchhhhhhcc------cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccC---------CcEE
Confidence 8999997 567788877664 35678889999999999999999999999999999999777 6799
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||+|..+..... .+.+.+|||+|||||++.... |++++||||||++++||+-|++||-+... ...
T Consensus 410 ltDFGFcaqi~~~~~--KR~TmVGTPYWMAPEVvtrk~---------YG~KVDIWSLGIMaIEMveGEPPYlnE~P-lrA 477 (550)
T KOG0578|consen 410 LTDFGFCAQISEEQS--KRSTMVGTPYWMAPEVVTRKP---------YGPKVDIWSLGIMAIEMVEGEPPYLNENP-LRA 477 (550)
T ss_pred EeeeeeeeccccccC--ccccccCCCCccchhhhhhcc---------cCccccchhhhhHHHHHhcCCCCccCCCh-HHH
Confidence 999999988876654 455889999999999998774 78999999999999999999999986333 233
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
+..++... .+.+.....++..+++||.+||..|+++|+++.|||+|
T Consensus 478 lyLIa~ng-----~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 478 LYLIATNG-----TPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred HHHHhhcC-----CCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 44443332 34556666899999999999999999999999999986
|
|
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=363.98 Aligned_cols=251 Identities=25% Similarity=0.403 Sum_probs=208.7
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
.-|++++.||.|+-|.|-+|++..++.. +|||++.+.....+.....+.+|+-||+.+. ||||+++++++ +...+
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGql--aaiKii~k~~~~s~s~~~~IerEIviMkLi~-HpnVl~LydVw--e~~~~ 86 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQL--AAIKIIPKRSELSSSQPAGIEREIVIMKLIE-HPNVLRLYDVW--ENKQH 86 (786)
T ss_pred cceeccccccCCCCceehhhhcccccce--eEEEeeccccccccccccchhhhhHHHHHhc-CCCeeeeeeee--ccCce
Confidence 3599999999999999999999888866 9999998875444455677889999998885 59999999977 44566
Q ss_pred EEEEEec-CCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEK-GDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~-~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
+|++.|| .+|.|++++...+... +...+.++.||+.|+.|+|..+|+||||||+|+|||.. +.||
T Consensus 87 lylvlEyv~gGELFdylv~kG~l~-----e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~---------~nIK 152 (786)
T KOG0588|consen 87 LYLVLEYVPGGELFDYLVRKGPLP-----EREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVK---------NNIK 152 (786)
T ss_pred EEEEEEecCCchhHHHHHhhCCCC-----CHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcc---------cCEe
Confidence 7766665 7789999999887543 34456667899999999999999999999999999877 4599
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||+|..-.++.. ..+.||+|.|.|||+++|.+|+| .++||||.|||||.||+|++||++ +|....
T Consensus 153 IADFGMAsLe~~gkl---LeTSCGSPHYA~PEIV~G~pYdG--------~~sDVWSCGVILfALLtG~LPFdD-dNir~L 220 (786)
T KOG0588|consen 153 IADFGMASLEVPGKL---LETSCGSPHYAAPEIVSGRPYDG--------RPSDVWSCGVILFALLTGKLPFDD-DNIRVL 220 (786)
T ss_pred eeccceeecccCCcc---ccccCCCcccCCchhhcCCCCCC--------CccccchhHHHHHHHHhCCCCCCC-ccHHHH
Confidence 999999977665543 34889999999999999998875 689999999999999999999985 344455
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
+..++.+...+ +..++.++++||++||..||+.|.|++||++|
T Consensus 221 LlKV~~G~f~M--------Ps~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 221 LLKVQRGVFEM--------PSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred HHHHHcCcccC--------CCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 55555443322 23788999999999999999999999999987
|
|
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=336.89 Aligned_cols=262 Identities=21% Similarity=0.361 Sum_probs=212.8
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|+.+.+|++|+||+||+|+++.+++. ||+|.++.+... ..+--..++|+.+|.+++ |||||.+..++.+...+.
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eI--VALKr~kmekek-~GFPItsLREIniLl~~~-H~NIV~vkEVVvG~~~d~ 151 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEI--VALKRLKMEKEK-EGFPITSLREINILLKAR-HPNIVEVKEVVVGSNMDK 151 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCccee--EEeeeccccccc-CCCcchhHHHHHHHHhcC-CCCeeeeEEEEeccccce
Confidence 4799999999999999999999888866 999999887632 234446789999999996 699999999999988889
Q ss_pred EEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 336 LYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 336 ~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
+||||+|+..||..+++.... ++....+.++..|++.||+|||.+.|+|||||++|+|+... |.+||
T Consensus 152 iy~VMe~~EhDLksl~d~m~q----~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~---------G~lKi 218 (419)
T KOG0663|consen 152 IYIVMEYVEHDLKSLMETMKQ----PFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHK---------GILKI 218 (419)
T ss_pred eeeeHHHHHhhHHHHHHhccC----CCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccC---------CcEEe
Confidence 999999999999999998763 45566677777899999999999999999999999999766 78999
Q ss_pred EeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHH
Q psy14267 416 IDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKM 495 (553)
Q Consensus 416 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~ 495 (553)
+|||||+.+...... .+..+-|.+|.|||++.+.. .|+.++|+||+|||+.||+++++.|.+.... +.+
T Consensus 219 aDFGLAR~ygsp~k~--~T~lVVTLWYRaPELLLG~~--------tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~-dQl 287 (419)
T KOG0663|consen 219 ADFGLAREYGSPLKP--YTPLVVTLWYRAPELLLGAK--------TYSTAVDMWSVGCIFAELLTQKPLFPGKSEI-DQL 287 (419)
T ss_pred cccchhhhhcCCccc--CcceEEEeeecCHHHhcCCc--------ccCcchhhhhHHHHHHHHHhcCCCCCCCchH-HHH
Confidence 999999999876442 34566899999999999875 5899999999999999999999999875432 333
Q ss_pred HHHHhhcccc---cc--------------ccc----cc---CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 496 LAIARHKDQI---EF--------------KPQ----LA---NNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 496 ~~i~~~~~~~---~~--------------~~~----~~---~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
..+....... ++ ... +. ....+++.-.+|+..+|..||++|.|+++.|.+
T Consensus 288 ~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 288 DKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred HHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 3333322110 00 000 00 011256888999999999999999999999875
|
|
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=357.90 Aligned_cols=250 Identities=26% Similarity=0.436 Sum_probs=206.8
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|.+.+.||+|+||.||+++.+.+.+. ||+|.+.|..-.+ ..++.+.+|++|+++|+| |||+.++++| +...+
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~--vAik~i~K~gr~~-k~l~~l~~ev~i~r~lkH-pniv~m~esf--Et~~~ 75 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQV--VAIKFIDKSGRNE-KELKNLRQEVRILRSLKH-PNIVEMLESF--ETSAH 75 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeE--EEEEEehhcCCch-HHHHHHHHHHHHHHhcCC-cchhhHHHhh--cccce
Confidence 3688999999999999999988888766 9999998877555 445889999999999965 9999999987 56789
Q ss_pred EEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 336 LYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 336 ~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
+++|.||+.|+|..++....+.. +..+..++++++.||.|||+.+|+|||+||.||||+.+ +.+|+
T Consensus 76 ~~vVte~a~g~L~~il~~d~~lp-----Ee~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~---------~~~Kl 141 (808)
T KOG0597|consen 76 LWVVTEYAVGDLFTILEQDGKLP-----EEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKG---------GTLKL 141 (808)
T ss_pred EEEEehhhhhhHHHHHHhccCCC-----HHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCC---------Cceee
Confidence 99999999999999999876543 45666777899999999999999999999999999766 78999
Q ss_pred EeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHH
Q psy14267 416 IDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKM 495 (553)
Q Consensus 416 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~ 495 (553)
||||+|+....... ......|||.|||||+..+.+ |+..+|+|||||++|||+.|++||... .+
T Consensus 142 cdFg~Ar~m~~~t~--vltsikGtPlYmAPElv~e~p---------yd~~sDlWslGcilYE~~~G~PPF~a~-----si 205 (808)
T KOG0597|consen 142 CDFGLARAMSTNTS--VLTSIKGTPLYMAPELVEEQP---------YDHTSDLWSLGCILYELYVGQPPFYAR-----SI 205 (808)
T ss_pred chhhhhhhcccCce--eeeeccCcccccCHHHHcCCC---------ccchhhHHHHHHHHHHHhcCCCCchHH-----HH
Confidence 99999998876433 334677999999999999774 788999999999999999999999652 12
Q ss_pred HHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 496 LAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 496 ~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
..+.+...... .......+..+..|++.+|.+||.+|.+..+++.|
T Consensus 206 ~~Lv~~I~~d~----v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 206 TQLVKSILKDP----VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred HHHHHHHhcCC----CCCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 22222111111 11122788999999999999999999999998765
|
|
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=337.98 Aligned_cols=250 Identities=26% Similarity=0.415 Sum_probs=209.2
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
.+|++.+.||+|+||+|-+|+....+.. ||||.++++.+.++...-.+.+|++||..|. ||||+.++.+| +....
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~--VAiKsIrKdkIkdeqDlvhIRREIeIMSsLN-HPhII~IyEVF--ENkdK 127 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGRE--VAIKSIRKDKIKDEQDLVHIRREIEIMSSLN-HPHIIQIYEVF--ENKDK 127 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcE--eehhhhhhhhcccHHHHHHHHHHHHHHhhcC-CCceeehhhhh--cCCce
Confidence 4799999999999999999987666644 9999999999999888889999999999995 59999999877 55667
Q ss_pred EEEEEec-CCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEK-GDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~-~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
++||||| .+|+|++|+.++... ++.....+++||+.|+.|+|.++++|||||.+|||||.+ +++|
T Consensus 128 IvivMEYaS~GeLYDYiSer~~L-----sErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N---------~NiK 193 (668)
T KOG0611|consen 128 IVIVMEYASGGELYDYISERGSL-----SEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQN---------NNIK 193 (668)
T ss_pred EEEEEEecCCccHHHHHHHhccc-----cHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCC---------CCee
Confidence 8899997 568999999988744 345566777899999999999999999999999999988 6799
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+||||+-.+..... ..++||+|.|.+||++.|.+|. +..+|.|||||+||.|++|.+||++.+-. ..
T Consensus 194 IADFGLSNly~~~kf---LqTFCGSPLYASPEIvNG~PY~--------GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk-~l 261 (668)
T KOG0611|consen 194 IADFGLSNLYADKKF---LQTFCGSPLYASPEIVNGTPYK--------GPEVDSWSLGVLLYTLVYGTMPFDGRDHK-RL 261 (668)
T ss_pred eeccchhhhhccccH---HHHhcCCcccCCccccCCCCCC--------CCccchhhHHHHHHHHhhcccccCCchHH-HH
Confidence 999999988766543 3589999999999999998865 47899999999999999999999984321 22
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
..++.++... + | .-|.+...||++||..+|++|-|+.+|..|
T Consensus 262 vrQIs~GaYr-E--P------~~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 262 VRQISRGAYR-E--P------ETPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred HHHhhccccc-C--C------CCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 2233322221 1 1 234678999999999999999999999876
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=336.83 Aligned_cols=260 Identities=25% Similarity=0.359 Sum_probs=196.4
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|++.+.||+|+||.||+|++..++.. ||||++....... ....+.+|+.+++.+. ||||+++++++.+ ...
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~--~aiK~~~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~~~~~~~~--~~~ 77 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKL--VALKVIRLQEEEG--TPFTAIREASLLKGLK-HANIVLLHDIIHT--KET 77 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCE--EEEEEeccccccc--cchhHHHHHHHHhhCC-CCCcCeEEEEEec--CCe
Confidence 5799999999999999999988766644 9999997654322 2246788999999995 5999999987743 568
Q ss_pred EEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 336 LYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 336 ~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
++++||+++++|.+++..... ......+..++.|++.||+|||++||+||||||+|||++.+ +.+||
T Consensus 78 ~~lv~e~~~~~l~~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~---------~~~kl 144 (303)
T cd07869 78 LTLVFEYVHTDLCQYMDKHPG----GLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDT---------GELKL 144 (303)
T ss_pred EEEEEECCCcCHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC---------CCEEE
Confidence 899999999999998876432 22344556667899999999999999999999999999766 57999
Q ss_pred EeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHH
Q psy14267 416 IDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKM 495 (553)
Q Consensus 416 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~ 495 (553)
+|||++........ ......||+.|+|||++.+.. .++.++|||||||++|||++|..||.+..+....+
T Consensus 145 ~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~--------~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~ 214 (303)
T cd07869 145 ADFGLARAKSVPSH--TYSNEVVTLWYRPPDVLLGST--------EYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQL 214 (303)
T ss_pred CCCCcceeccCCCc--cCCCCcccCCCCChHHHcCCC--------CCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHH
Confidence 99999876543222 122456899999999986542 36789999999999999999999998765543333
Q ss_pred HHHHhhcccc------------ccccc------------ccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 496 LAIARHKDQI------------EFKPQ------------LANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 496 ~~i~~~~~~~------------~~~~~------------~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
..+....... .+.+. ......++..+.+||.+||+.||++|||+.++++|
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 215 ERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred HHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 3222111000 00000 00111345789999999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=351.45 Aligned_cols=266 Identities=21% Similarity=0.354 Sum_probs=191.2
Q ss_pred ecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcC-----CCceeEeeeE
Q psy14267 253 LNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG-----CPYVIKMHDY 327 (553)
Q Consensus 253 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~-----hp~Iv~l~~~ 327 (553)
....+|+++++||+|+||+||+|.+...+.. ||||+++... .....+..|+++++.+.+ +.+|+.++++
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~--vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~ 199 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEY--CAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRY 199 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcCCCeE--EEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEE
Confidence 4457899999999999999999988776644 9999996432 223456678888877754 3568888887
Q ss_pred EEeCCCceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhh-CCcEecCCCCCCEEEecCccce-
Q psy14267 328 VYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHA-AGIIHSDLKPANFLFVGNVLKI- 405 (553)
Q Consensus 328 ~~~~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~-~gIiHrDLKp~NILl~~~~~~~- 405 (553)
+.. ...+++++|++++++|.+++.... .+....+..++.||+.||+|||+ .|||||||||+||||+.+...+
T Consensus 200 ~~~-~~~~~~iv~~~~g~~l~~~l~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~ 273 (467)
T PTZ00284 200 FQN-ETGHMCIVMPKYGPCLLDWIMKHG-----PFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVD 273 (467)
T ss_pred EEc-CCceEEEEEeccCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccc
Confidence 653 356789999999999999887653 23445566777899999999997 5999999999999997652100
Q ss_pred ------ecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHH
Q psy14267 406 ------IDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI 479 (553)
Q Consensus 406 ------~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ell 479 (553)
.......+||+|||++...... ....+||+.|||||++.+. .|+.++|||||||+||||+
T Consensus 274 ~~~~~~~~~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~---------~~~~~~DiwSlGvil~ell 339 (467)
T PTZ00284 274 PVTNRALPPDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGL---------GWMYSTDMWSMGCIIYELY 339 (467)
T ss_pred cccccccCCCCceEEECCCCccccCccc-----cccccCCccccCcHHhhcC---------CCCcHHHHHHHHHHHHHHH
Confidence 0011235999999988643222 2256799999999999866 3788999999999999999
Q ss_pred hCCCCCCCCCchHHHHHHHHhhccccc---------------------cccc-----c--------cCCCCCCHHHHHHH
Q psy14267 480 YGRTPYSHIPNTWAKMLAIARHKDQIE---------------------FKPQ-----L--------ANNVTIPPTLLQSM 525 (553)
Q Consensus 480 tG~~Pf~~~~~~~~~~~~i~~~~~~~~---------------------~~~~-----~--------~~~~~~s~~l~~li 525 (553)
+|++||....+. ..+..+......+. ..+. + ......++.+.+||
T Consensus 340 tG~~pf~~~~~~-~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli 418 (467)
T PTZ00284 340 TGKLLYDTHDNL-EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLI 418 (467)
T ss_pred hCCCCCCCCChH-HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHH
Confidence 999999875432 22211111100000 0000 0 00001245688999
Q ss_pred HHhcccCCCCCCCHHHHHHH
Q psy14267 526 KLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 526 ~~cL~~dP~~RPt~~ell~~ 545 (553)
.+||+.||++|||++|+++|
T Consensus 419 ~~mL~~dP~~R~ta~e~L~H 438 (467)
T PTZ00284 419 YGLLHYDRQKRLNARQMTTH 438 (467)
T ss_pred HHhCCcChhhCCCHHHHhcC
Confidence 99999999999999999974
|
|
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=333.81 Aligned_cols=265 Identities=26% Similarity=0.344 Sum_probs=205.8
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEe---C
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYD---T 331 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~---~ 331 (553)
...|..++.||+|+||.|..|.++.++.. ||||.+.. .+......++.++|+++|+.++ |+||+.+.+++.. .
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~--VAIKKi~~-~F~~~~~akRtlRElklLr~~~-HeNIi~l~di~~p~~~~ 96 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEK--VAIKKILN-PFENQIDAKRTLRELKLLRHLR-HENIIGLLDIFRPPSRD 96 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCE--eehhhhhh-hhhchHHHHHHHHHHHHHHHhc-CCCcceEEeeccccccc
Confidence 35677789999999999999999888855 99998853 2445566799999999999997 6999999998765 2
Q ss_pred CCceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCC
Q psy14267 332 ASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGN 411 (553)
Q Consensus 332 ~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~ 411 (553)
.-+.+|+|+|+.+.+|...++.... +....+..+.+|++.||.|+|+.+|+||||||.|+|++.+ .
T Consensus 97 ~f~DvYiV~elMetDL~~iik~~~~-----L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~---------c 162 (359)
T KOG0660|consen 97 KFNDVYLVFELMETDLHQIIKSQQD-----LTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNAD---------C 162 (359)
T ss_pred ccceeEEehhHHhhHHHHHHHcCcc-----ccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccC---------C
Confidence 3457899999999999999987652 3455566667899999999999999999999999999887 6
Q ss_pred eEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCch
Q psy14267 412 VLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNT 491 (553)
Q Consensus 412 ~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~ 491 (553)
.+||+|||+|+..........-+..+.|.+|.|||++.... .|+.+.||||+||++.|||+|++.|.+....
T Consensus 163 ~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~--------~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v 234 (359)
T KOG0660|consen 163 DLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSS--------EYTKAIDIWSVGCILAEMLTGKPLFPGKDYV 234 (359)
T ss_pred CEEeccccceeeccccCcccchhcceeeeeecCHHHHhccc--------cccchhhhhhhhHHHHHHHcCCCCCCCCchH
Confidence 78999999999886542222234667899999999996543 5899999999999999999999999763221
Q ss_pred --------------HHHHHHHH--------hhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 492 --------------WAKMLAIA--------RHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 492 --------------~~~~~~i~--------~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
...+..+. .......-.+....-.+.++.+.+|+.+||..||.+|+|++|+|+|
T Consensus 235 ~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 235 HQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 11111111 0011111111111223678999999999999999999999999976
|
|
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=335.33 Aligned_cols=258 Identities=22% Similarity=0.373 Sum_probs=202.9
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc--
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK-- 334 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~-- 334 (553)
.|.-.+++|.|+||.||.+....+.+ .||||.+..+.- ---+|+++|+++. |||||++..+|....+.
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~--~vAIKKv~~d~r-------~knrEl~im~~l~-HpNIV~L~~~f~~~~~~d~ 94 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEE--EVAIKKVLQDKR-------YKNRELQIMRKLD-HPNIVRLLYFFSSSTESDE 94 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCc--eeEEEEecCCCC-------cCcHHHHHHHhcC-CcCeeeEEEEEEecCCCch
Confidence 58899999999999999998887754 499998865532 1247999999885 59999999888766655
Q ss_pred -eEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 335 -HLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 335 -~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
++.+||||...+|.++++..... ........+..+.+||++||.|||+.||+||||||+|||+|.+. +.+
T Consensus 95 ~~lnlVleymP~tL~~~~r~~~~~-~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~t--------g~L 165 (364)
T KOG0658|consen 95 VYLNLVLEYMPETLYRVIRHYTRA-NQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDT--------GVL 165 (364)
T ss_pred hHHHHHHHhchHHHHHHHHHHhhc-CCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCC--------CeE
Confidence 56789999999999999964221 12344556677778999999999999999999999999998875 789
Q ss_pred EEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHH
Q psy14267 414 KIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWA 493 (553)
Q Consensus 414 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~ 493 (553)
||||||.|+.+..+.... +...|..|+|||.+.|.. .|+.+.||||.||+|.||+.|++-|.+.+.. .
T Consensus 166 KicDFGSAK~L~~~epni---SYicSRyYRaPELifga~--------~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~-d 233 (364)
T KOG0658|consen 166 KICDFGSAKVLVKGEPNI---SYICSRYYRAPELIFGAT--------EYTTSIDIWSAGCVMAELLKGQPLFPGDSSV-D 233 (364)
T ss_pred EeccCCcceeeccCCCce---eEEEeccccCHHHHcCcc--------ccCceeEEhhhhHHHHHHhcCCcccCCCCHH-H
Confidence 999999999998776653 566899999999999875 5899999999999999999999999885443 3
Q ss_pred HHHHHHhhcc------------c------ccccccc--c-CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 494 KMLAIARHKD------------Q------IEFKPQL--A-NNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 494 ~~~~i~~~~~------------~------~~~~~~~--~-~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
.+..+.+... . ..+.... . .....++++.+|+.++|..+|.+|.++.|++.+
T Consensus 234 QL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 234 QLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred HHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 3332222111 0 0111100 0 123578999999999999999999999999865
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=332.45 Aligned_cols=259 Identities=24% Similarity=0.385 Sum_probs=196.0
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|++.++||.|+||.||+|++..++.. ||+|+++..... .....+.+|+.+++++. ||||+++++++. ....
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~--vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~~~~~~~--~~~~ 77 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENL--VALKEIRLEHEE--GAPCTAIREVSLLKNLK-HANIVTLHDIIH--TERC 77 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCE--EEEEEecccccC--CcchhHHHHHHHHHhCC-CCCEeeEEEEEc--CCCe
Confidence 5799999999999999999988766644 999999765422 12356789999999995 599999998774 4567
Q ss_pred EEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 336 LYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 336 ~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
.+++||++.++|.+++..... ......+..++.||+.||+|||++||+||||||+|||++.+ +.+||
T Consensus 78 ~~lv~e~~~~~l~~~l~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~---------~~~kl 144 (288)
T cd07871 78 LTLVFEYLDSDLKQYLDNCGN----LMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEK---------GELKL 144 (288)
T ss_pred EEEEEeCCCcCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC---------CCEEE
Confidence 899999999999998876542 23345566667899999999999999999999999999776 57999
Q ss_pred EeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHH
Q psy14267 416 IDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKM 495 (553)
Q Consensus 416 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~ 495 (553)
+|||+++........ .....|++.|+|||++.+.. .++.++|||||||++|||++|+.||.+..... .+
T Consensus 145 ~DfG~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~--------~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~-~~ 213 (288)
T cd07871 145 ADFGLARAKSVPTKT--YSNEVVTLWYRPPDVLLGST--------EYSTPIDMWGVGCILYEMATGRPMFPGSTVKE-EL 213 (288)
T ss_pred CcCcceeeccCCCcc--ccCceecccccChHHhcCCc--------ccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HH
Confidence 999999765433221 22456899999999986532 36889999999999999999999998754322 22
Q ss_pred HHHHhhccc-----------------ccc-----cccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 496 LAIARHKDQ-----------------IEF-----KPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 496 ~~i~~~~~~-----------------~~~-----~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
..+...... ..+ .+.......++.++++||.+||..||.+|||++|+++|
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 214 HLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred HHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 111111000 000 00011123567899999999999999999999999865
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=342.85 Aligned_cols=256 Identities=23% Similarity=0.387 Sum_probs=200.5
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|++++.||+|+||.||+|++..++.. ||||++.+...........+.+|+.+|.++. ||||+++++++. ...+
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~--vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~~--~~~~ 75 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEI--VALKRMKKSLLFKLNEVRHVLTERDILTTTK-SEWLVKLLYAFQ--DDEY 75 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCE--EEEEEEEHHHHhhhhHHHHHHHHHHHHHhCC-CCCCccEEEEEE--cCCE
Confidence 3699999999999999999988776654 9999998765444445577899999999996 699999988764 4668
Q ss_pred EEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
+|++||++ +++|.+++..... .....+..++.||+.||+|||++||+||||||+|||++.+ +.+|
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~-----l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~---------~~~k 141 (333)
T cd05600 76 LYLAMEYVPGGDFRTLLNNLGV-----LSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDAS---------GHIK 141 (333)
T ss_pred EEEEEeCCCCCCHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCC---------CCEE
Confidence 89999975 6789999876442 3345566677899999999999999999999999999776 6799
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||++...... .....||+.|+|||++.+. .++.++|||||||+||||++|..||...... ..
T Consensus 142 L~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~---------~~~~~~DvwslG~il~ell~g~~pf~~~~~~-~~ 206 (333)
T cd05600 142 LTDFGLSKGIVTY-----ANSVVGSPDYMAPEVLRGK---------GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN-ET 206 (333)
T ss_pred EEeCcCCcccccc-----cCCcccCccccChhHhcCC---------CCCCccceecchHHHhhhhhCCCCCCCCCHH-HH
Confidence 9999999766441 2256799999999999765 3788999999999999999999999875432 22
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
...+..................++.++.++|.+||..+|++||++.+++++
T Consensus 207 ~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 207 WENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred HHHHHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 222222221111111111123568999999999999999999999999976
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=332.66 Aligned_cols=271 Identities=19% Similarity=0.290 Sum_probs=199.8
Q ss_pred cCcceEEEeeeeeeCceEEEEEeeeCC--------------CccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCC
Q psy14267 254 NGKQYQVLSLLGKGGSSSVYLVGGTSE--------------HEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCP 319 (553)
Q Consensus 254 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~--------------~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp 319 (553)
...+|++.++||+|+||.||+|.+... +....||+|++.... .......+.+|+.+|.++. ||
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~ 79 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLK-DP 79 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcC-CC
Confidence 346899999999999999999975432 223469999987543 2344567999999999995 59
Q ss_pred ceeEeeeEEEeCCCceEEEEEecC-CCCHHHHHHHcccCC--------------CCchHHHHHHHHHHHHHHHHHHHhhC
Q psy14267 320 YVIKMHDYVYDTASKHLYVLMEKG-DTDLSKYMRNLNKMT--------------TLPNTMIIIIMHWYEMLLAVKEIHAA 384 (553)
Q Consensus 320 ~Iv~l~~~~~~~~~~~~~iv~e~~-~~~L~~~l~~~~~~~--------------~~~~~~~~i~~~~~qil~aL~yLH~~ 384 (553)
||+++++++.+ ...++++||++ +++|.+++....... .....+..++.++.||+.||.|||+.
T Consensus 80 niv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~ 157 (304)
T cd05096 80 NIIRLLGVCVD--EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL 157 (304)
T ss_pred CeeEEEEEEec--CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC
Confidence 99999998754 45688999975 678999886543211 11234456667788999999999999
Q ss_pred CcEecCCCCCCEEEecCccceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCc
Q psy14267 385 GIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITY 464 (553)
Q Consensus 385 gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~ 464 (553)
||+||||||+||||+.+ +.+||+|||+++.+.............++..|||||++.+. .++.
T Consensus 158 ~ivH~dlkp~Nill~~~---------~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~ 219 (304)
T cd05096 158 NFVHRDLATRNCLVGEN---------LTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG---------KFTT 219 (304)
T ss_pred CccccCcchhheEEcCC---------ccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcC---------CCCc
Confidence 99999999999999876 57999999999876544332222344568899999998755 3788
Q ss_pred cchHHHHHHHHHHHHh--CCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q psy14267 465 KSDVWSLGCILYNMIY--GRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNS 542 (553)
Q Consensus 465 ~sDIwSlGvvl~ellt--G~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~el 542 (553)
++|||||||++|||++ |..||...... ..+..+..................++..+.++|.+||..||++|||+.+|
T Consensus 220 ~~Dv~slG~~l~el~~~~~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i 298 (304)
T cd05096 220 ASDVWAFGVTLWEILMLCKEQPYGELTDE-QVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDI 298 (304)
T ss_pred hhhhHHHHHHHHHHHHccCCCCCCcCCHH-HHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHH
Confidence 9999999999999986 67888775432 22222111111111111112233678999999999999999999999999
Q ss_pred HHHHhc
Q psy14267 543 VTQINN 548 (553)
Q Consensus 543 l~~L~~ 548 (553)
.+.|++
T Consensus 299 ~~~l~~ 304 (304)
T cd05096 299 HAFLTE 304 (304)
T ss_pred HHHHhC
Confidence 998864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=339.10 Aligned_cols=263 Identities=27% Similarity=0.378 Sum_probs=196.1
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCC---
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTAS--- 333 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~--- 333 (553)
+|++.++||+|+||.||++.+..++.. ||||++...... .....++.+|+.+|++++ ||||+++++++.....
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~ 76 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEK--VAIKKINDVFEH-VSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREF 76 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCE--EEEEEechhhcc-chhHHHHHHHHHHHHhCC-CCCEeeecceEeccCCCCC
Confidence 589999999999999999988776644 999998754322 233467889999999995 5999999988764432
Q ss_pred ceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 334 KHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 334 ~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
..+|++||+++++|.+++..... .....+..++.||+.||+|||++||+||||||+|||++.+ +.+
T Consensus 77 ~~~~lv~e~~~~~L~~~l~~~~~-----~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~---------~~~ 142 (338)
T cd07859 77 KDIYVVFELMESDLHQVIKANDD-----LTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANAD---------CKL 142 (338)
T ss_pred ceEEEEEecCCCCHHHHHHhccc-----CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC---------CcE
Confidence 35899999999999998876432 3455666677899999999999999999999999999776 679
Q ss_pred EEEeccCccccCCCCC-cccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchH
Q psy14267 414 KIIDFGIACSLQDDKT-SVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTW 492 (553)
Q Consensus 414 kL~DFGla~~~~~~~~-~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~ 492 (553)
||+|||+++....... ........||+.|+|||++.+.. ..++.++|||||||++|||++|+.||.......
T Consensus 143 kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-------~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~ 215 (338)
T cd07859 143 KICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFF-------SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH 215 (338)
T ss_pred EEccCccccccccccCccccccCCCCCCCcCCHHHHhccc-------cccCchhHHHHHHHHHHHHHcCCCCCCCCChHH
Confidence 9999999986543221 11223457999999999986421 137889999999999999999999997643211
Q ss_pred HHHHHHHhh-----------------------cccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 493 AKMLAIARH-----------------------KDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 493 ~~~~~i~~~-----------------------~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
.+..+... .......+.......+++.+.++|.+||..||++|||++|++++
T Consensus 216 -~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 216 -QLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred -HHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 11000000 00000001011122567889999999999999999999999975
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=336.00 Aligned_cols=248 Identities=25% Similarity=0.371 Sum_probs=196.6
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|++++.||+|+||.||+|.+..++.. ||||++...........+.+.+|+.+|+++. ||||+++++++. +...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~--~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~--~~~~ 75 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHY--YALKVMAIPEVIRLKQEQHVHNEKRVLKEVS-HPFIIRLFWTEH--DQRF 75 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCE--EEEEEEEHHHHhhhHHHHHHHHHHHHHHhCC-CCcHhhhHhhhc--cCCe
Confidence 3699999999999999999988776654 9999998765444445577889999999995 599999987664 4568
Q ss_pred EEEEEec-CCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEK-GDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~-~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
++++||+ .+++|.+++..... .....+..++.|++.||+|||++||+||||||+|||++.+ +.+|
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~---------~~~k 141 (291)
T cd05612 76 LYMLMEYVPGGELFSYLRNSGR-----FSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKE---------GHIK 141 (291)
T ss_pred EEEEEeCCCCCCHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCC---------CCEE
Confidence 8999996 46789999876542 3344555667899999999999999999999999999766 5799
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||+++...... ...+||+.|+|||++.+.. ++.++|||||||++|||++|..||...... ..
T Consensus 142 l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~---------~~~~~DiwSlG~il~~l~~g~~pf~~~~~~-~~ 206 (291)
T cd05612 142 LTDFGFAKKLRDRT-----WTLCGTPEYLAPEVIQSKG---------HNKAVDWWALGILIYEMLVGYPPFFDDNPF-GI 206 (291)
T ss_pred EEecCcchhccCCc-----ccccCChhhcCHHHHcCCC---------CCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HH
Confidence 99999998764422 2457999999999997653 678999999999999999999999875432 22
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT-----VGNSVTQ 545 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt-----~~ell~~ 545 (553)
...+.... ..+ ...++..+++||++||+.||.+||+ ++++++|
T Consensus 207 ~~~i~~~~--~~~------~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 207 YEKILAGK--LEF------PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred HHHHHhCC--cCC------CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 33332221 111 1245789999999999999999995 8888866
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=331.39 Aligned_cols=263 Identities=22% Similarity=0.335 Sum_probs=197.4
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhc--CCCceeEeeeEEEe---
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQ--GCPYVIKMHDYVYD--- 330 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~--~hp~Iv~l~~~~~~--- 330 (553)
++|++++.||+|+||+||+|++...+ .+.||||+++...... .....+.+|+.+++++. .||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~-~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~ 78 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNG-GRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 78 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCC-CeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccC
Confidence 36999999999999999999875432 2449999987654332 22345678888888775 47999999987753
Q ss_pred CCCceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCC
Q psy14267 331 TASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIG 410 (553)
Q Consensus 331 ~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~ 410 (553)
.....++++||+.+++|..++...... ......+..++.|++.||+|||++||+||||||+|||++.+
T Consensus 79 ~~~~~~~lv~e~~~~~l~~~~~~~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~--------- 146 (290)
T cd07862 79 DRETKLTLVFEHVDQDLTTYLDKVPEP---GVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS--------- 146 (290)
T ss_pred CCCCcEEEEEccCCCCHHHHHHhCCCC---CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCC---------
Confidence 234578999999999999998764332 23455666777899999999999999999999999999776
Q ss_pred CeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCc
Q psy14267 411 NVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN 490 (553)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~ 490 (553)
+.+||+|||+++...... ......||+.|+|||++.+. .++.++|||||||++|||++|.+||.+...
T Consensus 147 ~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~---------~~~~~~DiwslG~il~el~~g~~~f~~~~~ 214 (290)
T cd07862 147 GQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQS---------SYATPVDLWSVGCIFAEMFRRKPLFRGSSD 214 (290)
T ss_pred CCEEEccccceEeccCCc---ccccccccccccChHHHhCC---------CCCCccchHHHHHHHHHHHcCCCCcCCCCH
Confidence 579999999998765432 22355689999999999755 367899999999999999999999987544
Q ss_pred hHHHHHHHHhhcccc---cccc-----------c----c-cCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 491 TWAKMLAIARHKDQI---EFKP-----------Q----L-ANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 491 ~~~~~~~i~~~~~~~---~~~~-----------~----~-~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
. ..+..+....... .+.. . + .....++..++++|.+||+.||++|||+.+++++
T Consensus 215 ~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 215 V-DQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred H-HHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 3 2333322211100 0000 0 0 0112467889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG1026|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=359.73 Aligned_cols=275 Identities=21% Similarity=0.358 Sum_probs=222.7
Q ss_pred ccceEEecCcceEEEeeeeeeCceEEEEEeeeCC---CccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeE
Q psy14267 247 SQDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSE---HEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIK 323 (553)
Q Consensus 247 ~~~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~---~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~ 323 (553)
...+..+...+.++.+.||+|+||+||+|+...- .....||||.++.+. +....++|.+|+++|..|. |||||+
T Consensus 477 ~~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~-H~nIVr 553 (774)
T KOG1026|consen 477 DLKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQ-HPNIVR 553 (774)
T ss_pred ccceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhcc-CCCeEE
Confidence 3456677778899999999999999999876432 333569999997654 3335688999999999995 599999
Q ss_pred eeeEEEeCCCceEEEEEec-CCCCHHHHHHHcccCC---------CCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCC
Q psy14267 324 MHDYVYDTASKHLYVLMEK-GDTDLSKYMRNLNKMT---------TLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKP 393 (553)
Q Consensus 324 l~~~~~~~~~~~~~iv~e~-~~~~L~~~l~~~~~~~---------~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp 393 (553)
|+|.|. .++-++||+|| ..|||.+||+...... ..++...+...+|.||+.||+||-++.+|||||-.
T Consensus 554 LlGVC~--~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLAT 631 (774)
T KOG1026|consen 554 LLGVCR--EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLAT 631 (774)
T ss_pred EEEEEc--cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhh
Confidence 999884 46678888887 5699999999664332 22377788889999999999999999999999999
Q ss_pred CCEEEecCccceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHH
Q psy14267 394 ANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGC 473 (553)
Q Consensus 394 ~NILl~~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGv 473 (553)
.|+||.++ -.|||+||||++.+-..++........-.++|||||.|+.. +||.+||||||||
T Consensus 632 RNCLVge~---------l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~---------kFTteSDVWs~GV 693 (774)
T KOG1026|consen 632 RNCLVGEN---------LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYG---------KFTTESDVWSFGV 693 (774)
T ss_pred hhceeccc---------eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcC---------cccchhhhhhhhh
Confidence 99999877 57999999999987665544333233457899999999876 5899999999999
Q ss_pred HHHHHHh-CCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCCC
Q psy14267 474 ILYNMIY-GRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNPEG 552 (553)
Q Consensus 474 vl~ellt-G~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~~~ 552 (553)
+|||+++ |+.||.+..++ +.+..+.... .++.+.+||.++..||..||+.+|++||+++||-..|+.+-.+
T Consensus 694 vLWEIFsyG~QPy~glSn~-EVIe~i~~g~-------lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 694 VLWEIFSYGKQPYYGLSNQ-EVIECIRAGQ-------LLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred hhhhhhccccCcccccchH-HHHHHHHcCC-------cccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 9999995 99999998886 3344444332 2455568999999999999999999999999999999876544
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=330.70 Aligned_cols=254 Identities=22% Similarity=0.369 Sum_probs=194.0
Q ss_pred eEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEE
Q psy14267 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLY 337 (553)
Q Consensus 258 y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~ 337 (553)
|++.+.||+|+||.||++.+..++.. ||||++.+...........+.+|+.+|+++. |++|+.+++++. ....++
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~--~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~iv~~~~~~~--~~~~~~ 76 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKM--YACKKLEKKRIKKRKGEAMALNEKRILEKVN-SRFVVSLAYAYE--TKDALC 76 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCce--EEEEEeeHhhhhhhhhHHHHHHHHHHHHhcC-CCcEEEEEEEEc--cCCeEE
Confidence 88999999999999999988777654 9999998765544344456789999999995 599999987664 355788
Q ss_pred EEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEE
Q psy14267 338 VLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKII 416 (553)
Q Consensus 338 iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~ 416 (553)
++||++ +++|..++...... ......+..++.|++.||+|||++||+||||||+|||++.+ +.+||+
T Consensus 77 lv~e~~~~g~L~~~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~---------~~~kl~ 144 (285)
T cd05631 77 LVLTIMNGGDLKFHIYNMGNP---GFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDR---------GHIRIS 144 (285)
T ss_pred EEEEecCCCcHHHHHHhhCCC---CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCC---------CCEEEe
Confidence 888865 57887777653321 24455666777899999999999999999999999999766 579999
Q ss_pred eccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHH
Q psy14267 417 DFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKML 496 (553)
Q Consensus 417 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~ 496 (553)
|||++........ .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......... .
T Consensus 145 Dfg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~---------~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~-~ 211 (285)
T cd05631 145 DLGLAVQIPEGET---VRGRVGTVGYMAPEVINNE---------KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR-E 211 (285)
T ss_pred eCCCcEEcCCCCe---ecCCCCCCCccCHhhhcCC---------CCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH-H
Confidence 9999987644322 1245799999999999765 3788999999999999999999999874432111 1
Q ss_pred HHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q psy14267 497 AIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT-----VGNSVTQ 545 (553)
Q Consensus 497 ~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt-----~~ell~~ 545 (553)
.+..... .........++.++.+||++||+.||++||+ +++++++
T Consensus 212 ~~~~~~~----~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 212 EVDRRVK----EDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred HHHHHhh----cccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 1111000 1111122357899999999999999999997 7888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=351.86 Aligned_cols=261 Identities=26% Similarity=0.349 Sum_probs=195.1
Q ss_pred cCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC-
Q psy14267 254 NGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA- 332 (553)
Q Consensus 254 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~- 332 (553)
...+|+++++||+|+||.||+|.+..++.. ||||++.... ....+|+.+|+++. ||||+++++++....
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~--vAiK~i~~~~-------~~~~~Ei~il~~l~-h~niv~l~~~~~~~~~ 133 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEK--VAIKKVLQDP-------QYKNRELLIMKNLN-HINIIFLKDYYYTECF 133 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCE--EEEEEEecCc-------chHHHHHHHHHhcC-CCCCcceeeeEeeccc
Confidence 346799999999999999999988766644 9999886432 23357999999995 599999988765431
Q ss_pred -----CceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceec
Q psy14267 333 -----SKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIID 407 (553)
Q Consensus 333 -----~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~ 407 (553)
..+++++||+++++|.+++...... ........+..++.||+.||+|||++|||||||||+||||+.+.
T Consensus 134 ~~~~~~~~l~lvmE~~~~~l~~~~~~~~~~-~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~----- 207 (440)
T PTZ00036 134 KKNEKNIFLNVVMEFIPQTVHKYMKHYARN-NHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNT----- 207 (440)
T ss_pred ccCCCceEEEEEEecCCccHHHHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCC-----
Confidence 2357899999999998887653221 12345566677778999999999999999999999999997552
Q ss_pred CCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCC
Q psy14267 408 CIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSH 487 (553)
Q Consensus 408 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~ 487 (553)
+.+||+|||+|+.+...... ....||+.|+|||++.+.. .++.++|||||||+||||++|.+||.+
T Consensus 208 ---~~vkL~DFGla~~~~~~~~~---~~~~~t~~y~aPE~~~~~~--------~~~~~~DiwSlGvil~elltG~~pf~~ 273 (440)
T PTZ00036 208 ---HTLKLCDFGSAKNLLAGQRS---VSYICSRFYRAPELMLGAT--------NYTTHIDLWSLGCIIAEMILGYPIFSG 273 (440)
T ss_pred ---CceeeeccccchhccCCCCc---ccCCCCcCccCHHHhcCCC--------CCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 46999999999877543322 2457899999999987542 378899999999999999999999987
Q ss_pred CCchHHHHHHHHhhccc---------------cccccc----c--cCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 488 IPNTWAKMLAIARHKDQ---------------IEFKPQ----L--ANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 488 ~~~~~~~~~~i~~~~~~---------------~~~~~~----~--~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
..... .+..+...... +.++.. + .-....+.++++||.+||.+||++|||+.|+++|
T Consensus 274 ~~~~~-~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 274 QSSVD-QLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred CChHH-HHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 54432 22222111100 000000 0 0012467899999999999999999999999865
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=341.37 Aligned_cols=245 Identities=24% Similarity=0.345 Sum_probs=191.5
Q ss_pred eeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEEEEEe
Q psy14267 262 SLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLME 341 (553)
Q Consensus 262 ~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~iv~e 341 (553)
+.||+|+||.||+|++..++.. ||||++++...........+.+|+.+|+++. ||||+.+++++. ....++++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~--~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~--~~~~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKY--YAMKILKKEVIIAKDEVAHTLTESRVLQNTR-HPFLTALKYSFQ--THDRLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCE--EEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCCCEEEEEE--cCCEEEEEEe
Confidence 4699999999999988776654 9999998765444455577889999999995 599999987664 4568899999
Q ss_pred cC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEeccC
Q psy14267 342 KG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGI 420 (553)
Q Consensus 342 ~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGl 420 (553)
++ +++|..++.... ...+..+..++.||+.||+|||++|||||||||+||||+.+ +.+||+|||+
T Consensus 76 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~---------~~~kl~DfG~ 141 (323)
T cd05571 76 YANGGELFFHLSRER-----VFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKD---------GHIKITDFGL 141 (323)
T ss_pred CCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCC---------CCEEEeeCCC
Confidence 75 578888887643 23455666677899999999999999999999999999776 5799999999
Q ss_pred ccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHh
Q psy14267 421 ACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIAR 500 (553)
Q Consensus 421 a~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~~i~~ 500 (553)
++....... .....+||+.|+|||++.+. .++.++|||||||++|||++|..||...... .....+..
T Consensus 142 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-~~~~~~~~ 209 (323)
T cd05571 142 CKEGISDGA--TMKTFCGTPEYLAPEVLEDN---------DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-KLFELILM 209 (323)
T ss_pred CcccccCCC--cccceecCccccChhhhcCC---------CCCccccCcccchhhhhhhcCCCCCCCCCHH-HHHHHHHc
Confidence 976433222 12356799999999999765 3788999999999999999999999764332 22222221
Q ss_pred hcccccccccccCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q psy14267 501 HKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARP-----TVGNSVTQ 545 (553)
Q Consensus 501 ~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RP-----t~~ell~~ 545 (553)
. ...+ ...++.++.++|++||..||++|| ++.+|++|
T Consensus 210 ~--~~~~------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 210 E--EIRF------PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred C--CCCC------CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 1 1111 235789999999999999999999 79998865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=315.91 Aligned_cols=252 Identities=25% Similarity=0.371 Sum_probs=207.5
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
.++|++++.||+|-||.||+|+.+.+... ||+|++.+..+......+++.+|++|-..|+| |||+++++||.+ ..
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~I--valKVlfKsqi~~~~v~~qlrREiEIqs~L~h-pnilrlY~~fhd--~~ 95 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFI--VALKVLFKSQILKTQVEHQLRREIEIQSHLRH-PNILRLYGYFHD--SK 95 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcE--EEEeeeeHHHHHHhcchhhhhheeEeecccCC-ccHHhhhhheec--cc
Confidence 35799999999999999999998888766 99999998887766777889999999999965 999999998854 67
Q ss_pred eEEEEEec-CCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 335 HLYVLMEK-GDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 335 ~~~iv~e~-~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
.+|+++|+ ..|+++..++..... .+.....+.+.+|++.||.|+|.++||||||||+|+|++.. +.+
T Consensus 96 riyLilEya~~gel~k~L~~~~~~---~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~---------~~l 163 (281)
T KOG0580|consen 96 RIYLILEYAPRGELYKDLQEGRMK---RFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSA---------GEL 163 (281)
T ss_pred eeEEEEEecCCchHHHHHHhcccc---cccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCC---------CCe
Confidence 78888887 568899888843322 23344555667799999999999999999999999999776 679
Q ss_pred EEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHH
Q psy14267 414 KIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWA 493 (553)
Q Consensus 414 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~ 493 (553)
||+|||.+...... .+.+.|||..|.+||+..+.. .+..+|+|++|++.||++.|.+||.... ...
T Consensus 164 kiAdfGwsV~~p~~----kR~tlcgt~dyl~pEmv~~~~---------hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~e 229 (281)
T KOG0580|consen 164 KIADFGWSVHAPSN----KRKTLCGTLDYLPPEMVEGRG---------HDKFVDLWSLGVLCYEFLVGLPPFESQS-HSE 229 (281)
T ss_pred eccCCCceeecCCC----CceeeecccccCCHhhcCCCC---------ccchhhHHHHHHHHHHHHhcCCchhhhh-hHH
Confidence 99999998766532 345899999999999998875 5678999999999999999999998744 334
Q ss_pred HHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 494 KMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 494 ~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
....+..... .+ ...++.+++++|.+||.++|.+|.+..|++.+
T Consensus 230 tYkrI~k~~~--~~------p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 230 TYKRIRKVDL--KF------PSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred HHHHHHHccc--cC------CcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 4444433221 12 24788999999999999999999999999876
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=341.15 Aligned_cols=249 Identities=24% Similarity=0.347 Sum_probs=197.2
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
..+|++.+.||+|+||.||+|++..++.. ||||++.+.........+.+.+|+.+|+++. ||||+++++++.+ ..
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~--~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~--~~ 91 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEY--YAIKCLKKREILKMKQVQHVAQEKSILMELS-HPFIVNMMCSFQD--EN 91 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCE--EEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCCCcEEEEEEc--CC
Confidence 35799999999999999999988776644 9999998765444445678899999999995 5999999987743 56
Q ss_pred eEEEEEec-CCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 335 HLYVLMEK-GDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 335 ~~~iv~e~-~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
.++++||+ .+++|.+++..... .....+..++.||+.||+|||++||+||||||+||||+.+ +.+
T Consensus 92 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~---------~~~ 157 (329)
T PTZ00263 92 RVYFLLEFVVGGELFTHLRKAGR-----FPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNK---------GHV 157 (329)
T ss_pred EEEEEEcCCCCChHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCC---------CCE
Confidence 78999997 46789988876542 2344555667799999999999999999999999999876 579
Q ss_pred EEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHH
Q psy14267 414 KIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWA 493 (553)
Q Consensus 414 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~ 493 (553)
||+|||+++....... ..+||+.|+|||++.+.. ++.++|||||||++|||++|..||.+.... .
T Consensus 158 kl~Dfg~~~~~~~~~~-----~~~gt~~y~aPE~~~~~~---------~~~~~DiwslG~il~elltg~~pf~~~~~~-~ 222 (329)
T PTZ00263 158 KVTDFGFAKKVPDRTF-----TLCGTPEYLAPEVIQSKG---------HGKAVDWWTMGVLLYEFIAGYPPFFDDTPF-R 222 (329)
T ss_pred EEeeccCceEcCCCcc-----eecCChhhcCHHHHcCCC---------CCCcceeechHHHHHHHHcCCCCCCCCCHH-H
Confidence 9999999987644322 457999999999997653 678999999999999999999999774432 2
Q ss_pred HHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q psy14267 494 KMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT-----VGNSVTQ 545 (553)
Q Consensus 494 ~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt-----~~ell~~ 545 (553)
....+.... ..+ ...++..+++||++||+.||++||+ +.+|+.|
T Consensus 223 ~~~~i~~~~--~~~------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 223 IYEKILAGR--LKF------PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred HHHHHhcCC--cCC------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 223332221 111 1246789999999999999999997 6777755
|
|
| >KOG0983|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=315.67 Aligned_cols=257 Identities=24% Similarity=0.437 Sum_probs=210.1
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
.+.+++..||.|+.|.|++++.+.++.. .|||.+.+.... +..++++..+.++.+...+|+||+.+|||... ..
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~i--iAVK~M~rt~Nk--ee~kRILmDldvv~~s~dcpyIV~c~GyFi~n--~d 165 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHI--IAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVQCFGYFITN--TD 165 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceE--EEEEeecccCCH--HHHHHHHHhhhHHhhccCCCeeeeeeeEEeeC--ch
Confidence 4566788999999999999999888765 999999887643 33488999999998887799999999999764 44
Q ss_pred EEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhh-CCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHA-AGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~-~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
++|.||.....+..++++... +..+..+-.+..-++.||.||.+ ++|||||+||+|||||+. |+||
T Consensus 166 V~IcMelMs~C~ekLlkrik~----piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~---------GniK 232 (391)
T KOG0983|consen 166 VFICMELMSTCAEKLLKRIKG----PIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDER---------GNIK 232 (391)
T ss_pred HHHHHHHHHHHHHHHHHHhcC----CchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccC---------CCEE
Confidence 677888777667777766543 34455555555689999999985 589999999999999887 7899
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|||||++.++.+...+. ...|.+.|||||.+.-.... .|+.++||||||++|+||.||+.||.+-..++..
T Consensus 233 lCDFGIsGrlvdSkAht---rsAGC~~YMaPERidp~~~~------kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ 303 (391)
T KOG0983|consen 233 LCDFGISGRLVDSKAHT---RSAGCAAYMAPERIDPPDKP------KYDIRADVWSLGITLVELATGQYPYKGCKTDFEV 303 (391)
T ss_pred eecccccceeecccccc---cccCCccccCccccCCCCCC------ccchhhhhhhhccchhhhhcccCCCCCCCccHHH
Confidence 99999998887765432 45699999999999755322 5899999999999999999999999998777777
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
+..+.+. .+|.+.....+++.+++|+..||++|+.+||.+.+|++|
T Consensus 304 ltkvln~-----ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 304 LTKVLNE-----EPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred HHHHHhc-----CCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 7777652 235555556799999999999999999999999999875
|
|
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=342.16 Aligned_cols=250 Identities=25% Similarity=0.441 Sum_probs=200.8
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
..|+...+||+|+||.||+|.+..+++. ||+|++..+...+ .++...+|+.+|.++++ +||..+++.++. +..
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~--vAiKii~Le~~~d--eIediqqei~~Ls~~~~-~~it~yygsyl~--g~~ 85 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKV--VAIKIIDLEEAED--EIEDIQQEISVLSQCDS-PNITEYYGSYLK--GTK 85 (467)
T ss_pred cccccchhccccccceeeeeeeccccce--EEEEEechhhcch--hhHHHHHHHHHHHhcCc-chHHhhhhheee--ccc
Confidence 4588889999999999999988877755 9999999886544 35778899999999966 999999887754 556
Q ss_pred EEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
+.++||++ +|++.+.++..+-+. +..+..+.++++.||.|||.++.||||||+.||||..+ +.||
T Consensus 86 LwiiMey~~gGsv~~lL~~~~~~~-----E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~---------g~vk 151 (467)
T KOG0201|consen 86 LWIIMEYCGGGSVLDLLKSGNILD-----EFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSES---------GDVK 151 (467)
T ss_pred HHHHHHHhcCcchhhhhccCCCCc-----cceeeeehHHHHHHhhhhhhcceecccccccceeEecc---------CcEE
Confidence 78899974 567777777654332 23344445699999999999999999999999999766 6799
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||++..+..... .+.+++|||.|||||++.+.+ |+.++||||||++++||++|.+||...... ..
T Consensus 152 l~DfgVa~ql~~~~~--rr~tfvGTPfwMAPEVI~~~~---------Y~~KADIWSLGITaiEla~GePP~s~~hPm-rv 219 (467)
T KOG0201|consen 152 LADFGVAGQLTNTVK--RRKTFVGTPFWMAPEVIKQSG---------YDTKADIWSLGITAIELAKGEPPHSKLHPM-RV 219 (467)
T ss_pred EEecceeeeeechhh--ccccccccccccchhhhcccc---------ccchhhhhhhhHHHHHHhcCCCCCcccCcc-eE
Confidence 999999988766543 336899999999999999654 789999999999999999999999876542 00
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
+..+ ....+|.+.. .+++.+++||..||.+||+.||+|.+|++|
T Consensus 220 lflI-----pk~~PP~L~~--~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 220 LFLI-----PKSAPPRLDG--DFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred EEec-----cCCCCCcccc--ccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 0000 1112444444 789999999999999999999999999976
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=341.77 Aligned_cols=258 Identities=23% Similarity=0.306 Sum_probs=196.4
Q ss_pred cCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCC
Q psy14267 254 NGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTAS 333 (553)
Q Consensus 254 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~ 333 (553)
...+|++++.||+|+||.||++........+.||+|.+... ..+.+|+++|+++. ||||+++++++. ..
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~-h~~iv~~~~~~~--~~ 158 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTIS-HRAIINLIHAYR--WK 158 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcC-CCCccceeeeEe--eC
Confidence 34579999999999999999997765555567999988643 23468999999995 599999988764 35
Q ss_pred ceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 334 KHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 334 ~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
..++++|++.+++|.+++.... .+.+..++.++.||+.||+|||++|||||||||+||||+.+ +.+
T Consensus 159 ~~~~lv~e~~~~~l~~~l~~~~-----~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~---------~~~ 224 (392)
T PHA03207 159 STVCMVMPKYKCDLFTYVDRSG-----PLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEP---------ENA 224 (392)
T ss_pred CEEEEEehhcCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCC---------CCE
Confidence 6789999998999999885433 34456677778899999999999999999999999999776 579
Q ss_pred EEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCc--h
Q psy14267 414 KIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN--T 491 (553)
Q Consensus 414 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~--~ 491 (553)
||+|||+++.+.............||+.|+|||++.+. .++.++|||||||+||||++|..||.+... .
T Consensus 225 ~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~ 295 (392)
T PHA03207 225 VLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALD---------PYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSS 295 (392)
T ss_pred EEccCccccccCcccccccccccccccCccCHhHhcCC---------CCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCc
Confidence 99999999876654433333356799999999999765 378899999999999999999999976322 1
Q ss_pred HHHHHHHHhhcc--cccc------------------------cccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 492 WAKMLAIARHKD--QIEF------------------------KPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 492 ~~~~~~i~~~~~--~~~~------------------------~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
...+..+..... ...+ .+.......++.++.++|.+||..||++|||+.|++.+
T Consensus 296 ~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 296 SSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 122222211100 0000 00011122457789999999999999999999999976
|
|
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=340.40 Aligned_cols=259 Identities=27% Similarity=0.397 Sum_probs=214.3
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
...|++.+.||+|.||.||++..+.++.. +|+|++.+...........+.+|+.||+++.+||||+.+++.+.+ ..
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~--~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~--~~ 109 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKE--VACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFED--PD 109 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCce--eEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEc--CC
Confidence 45799999999999999999998887644 999999988876655567889999999999878999999998844 55
Q ss_pred eEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 335 HLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 335 ~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
.++++||++ ||+|.+.+... ..++..+..++.|++.|+.|||+.||+||||||+|+|+.... ...+.+
T Consensus 110 ~~~lvmEL~~GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~-----~~~~~i 178 (382)
T KOG0032|consen 110 SVYLVMELCEGGELFDRIVKK------HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKD-----EGSGRI 178 (382)
T ss_pred eEEEEEEecCCchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeecccc-----CCCCcE
Confidence 899999965 58899988876 155666777778999999999999999999999999997653 112579
Q ss_pred EEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHH
Q psy14267 414 KIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWA 493 (553)
Q Consensus 414 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~ 493 (553)
|++|||+|.....+. .....+||+.|+|||++... .|+..+||||+|+++|.|++|.+||...... .
T Consensus 179 k~~DFGla~~~~~~~---~~~~~~Gtp~y~APEvl~~~---------~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~-~ 245 (382)
T KOG0032|consen 179 KLIDFGLAKFIKPGE---RLHTIVGTPEYVAPEVLGGR---------PYGDEVDVWSIGVILYILLSGVPPFWGETEF-E 245 (382)
T ss_pred EEeeCCCceEccCCc---eEeeecCCccccCchhhcCC---------CCCcccchhHHHHHHHHHhhCCCCCcCCChh-H
Confidence 999999999887722 23478999999999999865 3789999999999999999999999886543 3
Q ss_pred HHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 494 KMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 494 ~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
....+..... .+ ..+.|..++..++++|+.||..||.+|+|+.++++|
T Consensus 246 ~~~~i~~~~~--~f--~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 246 IFLAILRGDF--DF--TSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred HHHHHHcCCC--CC--CCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 3334443332 22 234456789999999999999999999999999987
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=343.13 Aligned_cols=272 Identities=22% Similarity=0.343 Sum_probs=204.8
Q ss_pred ceEEecCcceEEEeeeeeeCceEEEEEeeeCCC---ccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEee
Q psy14267 249 DVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEH---EFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMH 325 (553)
Q Consensus 249 ~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~---~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~ 325 (553)
..|.+..++|++++.||+|+||.||+|.+...+ ....||||+++..... .....+.+|+.+|+++..|+||++++
T Consensus 31 ~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~il~~l~~h~nIv~~~ 108 (374)
T cd05106 31 EKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT--DEREALMSELKILSHLGQHKNIVNLL 108 (374)
T ss_pred ccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH--HHHHHHHHHHHHHHhhccCCceeeEe
Confidence 345566678999999999999999999864332 2245999999765422 33467899999999997789999999
Q ss_pred eEEEeCCCceEEEEEecC-CCCHHHHHHHcccC-----------------------------------------------
Q psy14267 326 DYVYDTASKHLYVLMEKG-DTDLSKYMRNLNKM----------------------------------------------- 357 (553)
Q Consensus 326 ~~~~~~~~~~~~iv~e~~-~~~L~~~l~~~~~~----------------------------------------------- 357 (553)
+++. ....++++||++ +++|.++++.....
T Consensus 109 ~~~~--~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (374)
T cd05106 109 GACT--HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRP 186 (374)
T ss_pred eEec--CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCC
Confidence 8774 356788999964 67899988653210
Q ss_pred ------------------CCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEecc
Q psy14267 358 ------------------TTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFG 419 (553)
Q Consensus 358 ------------------~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFG 419 (553)
......+..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~---------~~~kL~DfG 257 (374)
T cd05106 187 VSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDG---------RVAKICDFG 257 (374)
T ss_pred ccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCC---------CeEEEeece
Confidence 01124556677788899999999999999999999999999766 579999999
Q ss_pred CccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHH
Q psy14267 420 IACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHIPNTWAKMLAI 498 (553)
Q Consensus 420 la~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~i 498 (553)
+++...............++..|||||++... .++.++|||||||++|||++ |..||........ +...
T Consensus 258 la~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~-~~~~ 327 (374)
T cd05106 258 LARDIMNDSNYVVKGNARLPVKWMAPESIFDC---------VYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK-FYKM 327 (374)
T ss_pred eeeeccCCcceeeccCCCCccceeCHHHhcCC---------CCCccccHHHHHHHHHHHHhCCCCCCccccccHH-HHHH
Confidence 99876544322222233456789999999755 37889999999999999997 9999987544322 2222
Q ss_pred HhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 499 ARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 499 ~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
........ ....+++++.++|.+||+.||++||++.++++.|++.
T Consensus 328 ~~~~~~~~------~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 328 VKRGYQMS------RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred HHcccCcc------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 22111111 1124579999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=336.98 Aligned_cols=245 Identities=24% Similarity=0.351 Sum_probs=192.6
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceE
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHL 336 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~ 336 (553)
+|++++.||+|+||.||+|++..++. .||||++.+.........+.+..|++++..+.||++|+.+++++. ....+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~--~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~--~~~~~ 76 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDE--LYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ--TMDRL 76 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCC--EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEE--cCCEE
Confidence 48999999999999999998877664 499999987654444556788999999999988888999987664 35678
Q ss_pred EEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 337 YVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 337 ~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
|++||++ +++|..++..... .....+..++.||+.||+|||++||+||||||+|||++.+ +.+||
T Consensus 77 ~lv~E~~~~g~L~~~~~~~~~-----~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~---------~~~kL 142 (324)
T cd05587 77 YFVMEYVNGGDLMYHIQQVGK-----FKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAE---------GHIKI 142 (324)
T ss_pred EEEEcCCCCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCC---------CCEEE
Confidence 9999975 6789888876542 3345566677899999999999999999999999999776 57999
Q ss_pred EeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHH
Q psy14267 416 IDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKM 495 (553)
Q Consensus 416 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~ 495 (553)
+|||++........ .....+||+.|+|||++.+.. ++.++|||||||+||||++|+.||...... ...
T Consensus 143 ~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~---------~~~~~DiwslGvil~elltG~~pf~~~~~~-~~~ 210 (324)
T cd05587 143 ADFGMCKENIFGGK--TTRTFCGTPDYIAPEIIAYQP---------YGKSVDWWAFGVLLYEMLAGQPPFDGEDED-ELF 210 (324)
T ss_pred eecCcceecCCCCC--ceeeecCCccccChhhhcCCC---------CCcccchhhhHHHHHHHHhCCCCCCCCCHH-HHH
Confidence 99999875432222 122567999999999997653 678999999999999999999999875432 223
Q ss_pred HHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCH
Q psy14267 496 LAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTV 539 (553)
Q Consensus 496 ~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~ 539 (553)
..+.... .. ....++.++.++|++||..||.+|++.
T Consensus 211 ~~i~~~~--~~------~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 211 QSIMEHN--VS------YPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred HHHHcCC--CC------CCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 3332211 11 122578999999999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=342.30 Aligned_cols=271 Identities=22% Similarity=0.323 Sum_probs=203.4
Q ss_pred eEEecCcceEEEeeeeeeCceEEEEEeee---CCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeee
Q psy14267 250 VITLNGKQYQVLSLLGKGGSSSVYLVGGT---SEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHD 326 (553)
Q Consensus 250 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~---~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~ 326 (553)
.+.+..++|++.+.||+|+||.||+|.+. .......||||+++..... ...+.+.+|+.+|..+.+||||+++++
T Consensus 29 ~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~Ei~il~~l~~HpnIv~l~~ 106 (375)
T cd05104 29 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHL--TEREALMSELKVLSYLGNHINIVNLLG 106 (375)
T ss_pred ccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCc--HHHHHHHHHHHHHHHhcCCcceeeeee
Confidence 34555678999999999999999999753 2223346999999754322 234678999999999977899999998
Q ss_pred EEEeCCCceEEEEEec-CCCCHHHHHHHcccCC-----------------------------------------------
Q psy14267 327 YVYDTASKHLYVLMEK-GDTDLSKYMRNLNKMT----------------------------------------------- 358 (553)
Q Consensus 327 ~~~~~~~~~~~iv~e~-~~~~L~~~l~~~~~~~----------------------------------------------- 358 (553)
++.. ....+++||+ .+|+|.++++......
T Consensus 107 ~~~~--~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 184 (375)
T cd05104 107 ACTV--GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKAD 184 (375)
T ss_pred eecc--CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccc
Confidence 7743 5567888886 5689999987643210
Q ss_pred -----------------------CCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 359 -----------------------TLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 359 -----------------------~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
.....+..+..++.||+.||+|||++||+||||||+|||++.+ +.+||
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~---------~~~kl 255 (375)
T cd05104 185 KRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHG---------RITKI 255 (375)
T ss_pred cccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECC---------CcEEE
Confidence 0123445667778899999999999999999999999999765 57999
Q ss_pred EeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCCCchHHH
Q psy14267 416 IDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHIPNTWAK 494 (553)
Q Consensus 416 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~~~~~~~ 494 (553)
+|||+++...............++..|+|||++.+. .++.++|||||||++|||++ |..||.........
T Consensus 256 ~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~ 326 (375)
T cd05104 256 CDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNC---------VYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKF 326 (375)
T ss_pred ecCccceeccCcccccccCCCCCCcceeChhHhcCC---------CCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHH
Confidence 999999876543322222233456789999999765 37889999999999999997 99999876544333
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
...+.... ... .....+.++.+||.+||+.||++||++.+|++.|++.
T Consensus 327 ~~~~~~~~-~~~------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 327 YKMIKEGY-RML------SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HHHHHhCc-cCC------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 33222211 111 1124578999999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=343.76 Aligned_cols=256 Identities=21% Similarity=0.370 Sum_probs=196.0
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceE
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHL 336 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~ 336 (553)
.|++++.||+|+||+||+|++..++.. ||||++.+.........+.+.+|+.+|+++. ||||+++++++. ...++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~--~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~--~~~~~ 76 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHAL--YAMKTLRKKDVLNRNQVAHVKAERDILAEAD-NEWVVKLYYSFQ--DKDNL 76 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCE--EEEEEEEHHHhhhhHHHHHHHHHHHHHHhcC-CCCeeeeEEEEe--cCCEE
Confidence 589999999999999999988776644 9999998776555566678999999999995 599999988774 35688
Q ss_pred EEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 337 YVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 337 ~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
+++||++ +++|.+++..... .....+..++.||+.||+|||++|||||||||+||||+.+ +.+||
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~~-----~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~---------~~~kL 142 (381)
T cd05626 77 YFVMDYIPGGDMMSLLIRMEV-----FPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLD---------GHIKL 142 (381)
T ss_pred EEEEecCCCCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCC---------CCEEE
Confidence 9999976 6789998876542 3345566677899999999999999999999999999765 67999
Q ss_pred EeccCccccCCCCC---------------------------------------------cccccCCccCCCccCcccccc
Q psy14267 416 IDFGIACSLQDDKT---------------------------------------------SVHKDTASGTLNYMSPEAAGQ 450 (553)
Q Consensus 416 ~DFGla~~~~~~~~---------------------------------------------~~~~~~~~Gt~~y~APE~l~~ 450 (553)
+|||+++.+..... .......+||+.|+|||++.+
T Consensus 143 ~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~ 222 (381)
T cd05626 143 TDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR 222 (381)
T ss_pred eeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC
Confidence 99999864321000 000124579999999999976
Q ss_pred cCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHh--
Q psy14267 451 TSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLC-- 528 (553)
Q Consensus 451 ~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~c-- 528 (553)
. .++.++|||||||++|||++|..||........ ...+....... .......+++++.+||.+|
T Consensus 223 ~---------~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~-~~~i~~~~~~~----~~~~~~~~s~~~~dli~~ll~ 288 (381)
T cd05626 223 K---------GYTQLCDWWSVGVILFEMLVGQPPFLAPTPTET-QLKVINWENTL----HIPPQVKLSPEAVDLITKLCC 288 (381)
T ss_pred C---------CCCCccceeehhhHHHHHHhCCCCCcCCCHHHH-HHHHHcccccc----CCCCCCCCCHHHHHHHHHHcc
Confidence 5 368899999999999999999999987544322 22222111111 1223346789999999994
Q ss_pred cccCCCCCCCHHHHHHH
Q psy14267 529 LQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 529 L~~dP~~RPt~~ell~~ 545 (553)
+..++..||++.+++.|
T Consensus 289 ~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 289 SAEERLGRNGADDIKAH 305 (381)
T ss_pred CcccccCCCCHHHHhcC
Confidence 45566669999999876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=335.12 Aligned_cols=254 Identities=24% Similarity=0.391 Sum_probs=189.6
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
..+|+++++||+|+||.||++.+..++. .||||++.... .......+.+|+++|+++. |+||+++++++ ....
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~--~~~~ 145 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGR--LYALKVIYGNH--EDTVRRQICREIEILRDVN-HPNVVKCHDMF--DHNG 145 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCC--EEEEEEEecCC--cHHHHHHHHHHHHHHHhCC-CCCcceeeeEe--ccCC
Confidence 3578899999999999999998876654 49999996543 2344577899999999995 59999999876 4466
Q ss_pred eEEEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 335 HLYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 335 ~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
.++++||++. ++|.... ......+..++.||+.||+|||++|||||||||+||||+.+ +.+
T Consensus 146 ~~~lv~e~~~~~~L~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~---------~~~ 207 (353)
T PLN00034 146 EIQVLLEFMDGGSLEGTH---------IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSA---------KNV 207 (353)
T ss_pred eEEEEEecCCCCcccccc---------cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCC---------CCE
Confidence 7889999765 4553211 11234455677899999999999999999999999999776 579
Q ss_pred EEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCC-chH
Q psy14267 414 KIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIP-NTW 492 (553)
Q Consensus 414 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~-~~~ 492 (553)
||+|||+++.+..... ......||..|+|||++......+ ...+.++|||||||+||||++|+.||.... ..+
T Consensus 208 kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~----~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~ 281 (353)
T PLN00034 208 KIADFGVSRILAQTMD--PCNSSVGTIAYMSPERINTDLNHG----AYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDW 281 (353)
T ss_pred EEcccccceecccccc--cccccccCccccCccccccccccC----cCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccH
Confidence 9999999987654322 122457999999999985432111 124568999999999999999999997422 222
Q ss_pred HHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 493 AKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 493 ~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
............ ......++.++++||.+||+.||++||++.|++++
T Consensus 282 ~~~~~~~~~~~~------~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 282 ASLMCAICMSQP------PEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred HHHHHHHhccCC------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 222221111111 11223678999999999999999999999999986
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=327.60 Aligned_cols=259 Identities=22% Similarity=0.368 Sum_probs=196.1
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceE
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHL 336 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~ 336 (553)
+|++.+.||+|+||.||++++..++.. ||||++....... ...+.+.+|+.+++++. ||||+++++++. .+..+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~--~avK~~~~~~~~~-~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--~~~~~ 75 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEI--VAIKKFKDSEENE-EVKETTLRELKMLRTLK-QENIVELKEAFR--RRGKL 75 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcE--EEEEEEecccccc-cchhhHHHHHHHHHhCC-CccccchhhhEe--cCCEE
Confidence 699999999999999999988776644 9999998664333 33467889999999995 599999998774 46689
Q ss_pred EEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEE
Q psy14267 337 YVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKII 416 (553)
Q Consensus 337 ~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~ 416 (553)
+++||++.+++...+..... ......+..++.|++.||+|||+.+|+||||||+|||++.+ +.+||+
T Consensus 76 ~lv~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~---------~~~kl~ 142 (287)
T cd07848 76 YLVFEYVEKNMLELLEEMPN----GVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHN---------DVLKLC 142 (287)
T ss_pred EEEEecCCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC---------CcEEEe
Confidence 99999988877776654322 23445566677899999999999999999999999999766 579999
Q ss_pred eccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHH
Q psy14267 417 DFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKML 496 (553)
Q Consensus 417 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~ 496 (553)
|||++......... ......|++.|+|||++.+. .++.++|||||||++|||++|++||....... ...
T Consensus 143 Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~---------~~~~~~DiwslGvil~el~~g~~pf~~~~~~~-~~~ 211 (287)
T cd07848 143 DFGFARNLSEGSNA-NYTEYVATRWYRSPELLLGA---------PYGKAVDMWSVGCILGELSDGQPLFPGESEID-QLF 211 (287)
T ss_pred eccCcccccccccc-cccccccccccCCcHHHcCC---------CCCCchhHHhHHHHHHHHHhCCCCCCCCCHHH-HHH
Confidence 99999876543221 12345689999999999765 36889999999999999999999998754321 111
Q ss_pred HHHhhccc------------ccc----ccccc--------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 497 AIARHKDQ------------IEF----KPQLA--------NNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 497 ~i~~~~~~------------~~~----~~~~~--------~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
.+...... ..+ .+... ....++.++.+||++||+.||++|||++++++|
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 212 TIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred HHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 11111000 000 00000 011367899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=318.63 Aligned_cols=258 Identities=23% Similarity=0.343 Sum_probs=208.2
Q ss_pred cCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCC
Q psy14267 254 NGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTAS 333 (553)
Q Consensus 254 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~ 333 (553)
..++|.+-++||+|.|+.||.+-+..++.. +|+|+++...+... ..+.+.+|++|-+.|+| |||+++++-. ...
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~--fa~kiin~~k~~~~-~~e~l~rEarIC~~LqH-P~IvrL~~ti--~~~ 82 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLE--FAAKIINTKKLSAR-DFQKLEREARICRKLQH-PNIVRLHDSI--QEE 82 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHH--HHHHHhhhhhhccc-cHHHHHHHHHHHHhcCC-CcEeehhhhh--ccc
Confidence 346799999999999999998877776655 99999998887765 45889999999999965 9999998755 456
Q ss_pred ceEEEEEec-CCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCe
Q psy14267 334 KHLYVLMEK-GDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNV 412 (553)
Q Consensus 334 ~~~~iv~e~-~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~ 412 (553)
.+.||+++. .|++|..-+-.+ ...++..+-.+.+||++||.|+|.+||||||+||+|+||.+. ..+--
T Consensus 83 ~~~ylvFe~m~G~dl~~eIV~R-----~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK------~~~A~ 151 (355)
T KOG0033|consen 83 SFHYLVFDLVTGGELFEDIVAR-----EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASK------AKGAA 151 (355)
T ss_pred ceeEEEEecccchHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeec------cCCCc
Confidence 788999985 566776665544 245566666777899999999999999999999999999765 33467
Q ss_pred EEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchH
Q psy14267 413 LKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTW 492 (553)
Q Consensus 413 vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~ 492 (553)
+||+|||+|..+..+... ..+.|||.|||||+++..+ |+..+|||+.||+||-||.|.+||.+... .
T Consensus 152 vKL~~FGvAi~l~~g~~~---~G~~GtP~fmaPEvvrkdp---------y~kpvDiW~cGViLfiLL~G~~PF~~~~~-~ 218 (355)
T KOG0033|consen 152 VKLADFGLAIEVNDGEAW---HGFAGTPGYLSPEVLKKDP---------YSKPVDIWACGVILYILLVGYPPFWDEDQ-H 218 (355)
T ss_pred eeecccceEEEeCCcccc---ccccCCCcccCHHHhhcCC---------CCCcchhhhhhHHHHHHHhCCCCCCCccH-H
Confidence 999999999998844332 3677999999999998774 78999999999999999999999987433 2
Q ss_pred HHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 493 AKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 493 ~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
.....+.....+. ....|.+++++.++|+++||..||.+|.|+.|+|+|
T Consensus 219 rlye~I~~g~yd~----~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 219 RLYEQIKAGAYDY----PSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred HHHHHHhccccCC----CCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 3344444333222 233566899999999999999999999999999875
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=340.27 Aligned_cols=257 Identities=25% Similarity=0.386 Sum_probs=196.0
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|++++.||+|+||+||+|++..++.. ||||++.+...........+.+|+.++.++. |++|+++++.+. ....
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~--~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~-~~~iv~~~~~~~--~~~~ 75 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHV--YAMKILRKADMLEKEQVGHIRAERDILVEAD-SLWVVKMFYSFQ--DKLN 75 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCE--EEEEEEEHHHHHHhhHHHHHHHHHHHHHhCC-CCCcceEEEEEe--cCCe
Confidence 3699999999999999999988776644 9999998765444455677889999999995 599999988764 4568
Q ss_pred EEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
+|++||++ +++|.+++.... ......+..++.|++.||+|||++|||||||||+||||+.+ +.+|
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~---------~~vk 141 (363)
T cd05628 76 LYLIMEFLPGGDMMTLLMKKD-----TLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSK---------GHVK 141 (363)
T ss_pred EEEEEcCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCC---------CCEE
Confidence 89999976 578999887643 23455666777899999999999999999999999999776 5799
Q ss_pred EEeccCccccCCCCCc---------------------------------ccccCCccCCCccCcccccccCCCCCCCccC
Q psy14267 415 IIDFGIACSLQDDKTS---------------------------------VHKDTASGTLNYMSPEAAGQTSSSGGGNTYR 461 (553)
Q Consensus 415 L~DFGla~~~~~~~~~---------------------------------~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~ 461 (553)
|+|||+++.+...... ......+||+.|+|||++.+..
T Consensus 142 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~--------- 212 (363)
T cd05628 142 LSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTG--------- 212 (363)
T ss_pred EeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCC---------
Confidence 9999999765321100 0012457999999999997653
Q ss_pred CCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcc--cCCCCCCCH
Q psy14267 462 ITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQ--KDPKARPTV 539 (553)
Q Consensus 462 ~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~--~dP~~RPt~ 539 (553)
++.++|||||||+||||++|..||...... .....+........+++ ...++++++++|.+++. .++..||++
T Consensus 213 ~~~~~DvwSlGvil~ell~G~~Pf~~~~~~-~~~~~i~~~~~~~~~p~----~~~~s~~~~~li~~l~~~~~~r~~r~~~ 287 (363)
T cd05628 213 YNKLCDWWSLGVIMYEMLIGYPPFCSETPQ-ETYKKVMNWKETLIFPP----EVPISEKAKDLILRFCCEWEHRIGAPGV 287 (363)
T ss_pred CCCchhhhhhHHHHHHHHhCCCCCCCCCHH-HHHHHHHcCcCcccCCC----cCCCCHHHHHHHHHHcCChhhcCCCCCH
Confidence 678999999999999999999999875432 33333333222222222 23578899999998664 233356899
Q ss_pred HHHHHH
Q psy14267 540 GNSVTQ 545 (553)
Q Consensus 540 ~ell~~ 545 (553)
+||++|
T Consensus 288 ~ei~~h 293 (363)
T cd05628 288 EEIKTN 293 (363)
T ss_pred HHHhCC
Confidence 999876
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=342.33 Aligned_cols=256 Identities=24% Similarity=0.397 Sum_probs=198.3
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|++++.||+|+||+||+|++..++.. ||||++.+...........+.+|+.+|+.+. ||||+.+++++. ...+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~--vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~~~--~~~~ 75 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHI--YAMKKLRKSEMLEKEQVAHVRAERDILAEAD-NPWVVKLYYSFQ--DENY 75 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCE--EEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceEEEEE--cCCe
Confidence 3699999999999999999998877654 9999998765444455577889999999995 699999988764 4668
Q ss_pred EEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
++++||++ +++|.+++.... .+....+..++.||+.||+|||++||+||||||+||||+.+ +.+|
T Consensus 76 ~~lv~E~~~~g~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~---------~~~k 141 (364)
T cd05599 76 LYLIMEYLPGGDMMTLLMKKD-----TFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAK---------GHIK 141 (364)
T ss_pred EEEEECCCCCcHHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC---------CCEE
Confidence 89999975 678988887643 23455666777899999999999999999999999999776 6799
Q ss_pred EEeccCccccCCCCCcc------------------------------------cccCCccCCCccCcccccccCCCCCCC
Q psy14267 415 IIDFGIACSLQDDKTSV------------------------------------HKDTASGTLNYMSPEAAGQTSSSGGGN 458 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~------------------------------------~~~~~~Gt~~y~APE~l~~~~~~~~~~ 458 (553)
|+|||++..+....... .....+||+.|+|||++...
T Consensus 142 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------- 214 (364)
T cd05599 142 LSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT------- 214 (364)
T ss_pred EeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCC-------
Confidence 99999987653221100 01134699999999999765
Q ss_pred ccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCC
Q psy14267 459 TYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538 (553)
Q Consensus 459 ~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt 538 (553)
.++.++|||||||++|||++|..||...... .....+........ ......++++++++|++||. +|.+|++
T Consensus 215 --~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~-~~~~~i~~~~~~~~----~~~~~~~s~~~~~li~~ll~-~p~~R~~ 286 (364)
T cd05599 215 --GYNKECDWWSLGVIMYEMLVGYPPFCSDNPQ-ETYRKIINWKETLQ----FPDEVPLSPEAKDLIKRLCC-EAERRLG 286 (364)
T ss_pred --CCCCeeeeecchhHHHHhhcCCCCCCCCCHH-HHHHHHHcCCCccC----CCCCCCCCHHHHHHHHHHcc-CHhhcCC
Confidence 3788999999999999999999999875432 22333332222222 12223578999999999997 9999998
Q ss_pred ---HHHHHHH
Q psy14267 539 ---VGNSVTQ 545 (553)
Q Consensus 539 ---~~ell~~ 545 (553)
+.+++.+
T Consensus 287 ~~~~~~ll~h 296 (364)
T cd05599 287 NNGVNEIKSH 296 (364)
T ss_pred CCCHHHHhcC
Confidence 8888774
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=334.73 Aligned_cols=245 Identities=23% Similarity=0.367 Sum_probs=193.7
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceE
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHL 336 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~ 336 (553)
+|++.+.||+|+||.||+|++..++.. ||||++.+.........+.+..|..++..+.+|++|+.+++++. ....+
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~--~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~--~~~~~ 76 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDEL--YAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQ--TMDRL 76 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCE--EEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEe--cCCEE
Confidence 488999999999999999988766644 99999987654444455678889999999988999999988764 35678
Q ss_pred EEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 337 YVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 337 ~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
+++||++ +++|..++..... .....+..++.||+.||+|||++||+||||||+||||+.+ +.+||
T Consensus 77 ~lv~E~~~~g~L~~~~~~~~~-----~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~---------~~~kL 142 (323)
T cd05616 77 YFVMEYVNGGDLMYQIQQVGR-----FKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSE---------GHIKI 142 (323)
T ss_pred EEEEcCCCCCCHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCC---------CcEEE
Confidence 9999975 5789888876542 3345566777899999999999999999999999999876 57999
Q ss_pred EeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHH
Q psy14267 416 IDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKM 495 (553)
Q Consensus 416 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~ 495 (553)
+|||+++....... .....+||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ...
T Consensus 143 ~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwSlGvil~elltg~~Pf~~~~~~-~~~ 210 (323)
T cd05616 143 ADFGMCKENMWDGV--TTKTFCGTPDYIAPEIIAYQ---------PYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-ELF 210 (323)
T ss_pred ccCCCceecCCCCC--ccccCCCChhhcCHHHhcCC---------CCCCccchhchhHHHHHHHhCCCCCCCCCHH-HHH
Confidence 99999976543222 12356799999999999765 3788999999999999999999999875432 223
Q ss_pred HHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCH
Q psy14267 496 LAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTV 539 (553)
Q Consensus 496 ~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~ 539 (553)
..+.... ..+ ...++.++.+++.+||+.||++|+++
T Consensus 211 ~~i~~~~--~~~------p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 211 QSIMEHN--VAY------PKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred HHHHhCC--CCC------CCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 3333221 111 22578999999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG4721|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=346.62 Aligned_cols=250 Identities=25% Similarity=0.429 Sum_probs=198.7
Q ss_pred cceEEecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeE
Q psy14267 248 QDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDY 327 (553)
Q Consensus 248 ~~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~ 327 (553)
.+.|++.-+...-++.||.|+.|.||+++... +.||||.++ +.-..+|+-|++|+| |||+.+.++
T Consensus 116 ~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~n----etVAVKKV~----------elkETdIKHLRkLkH-~NII~FkGV 180 (904)
T KOG4721|consen 116 EELWEIPFEEISELEWLGSGAQGAVFLGRLHN----ETVAVKKVR----------ELKETDIKHLRKLKH-PNIITFKGV 180 (904)
T ss_pred hhhccCCHHHhhhhhhhccCcccceeeeeccC----ceehhHHHh----------hhhhhhHHHHHhccC-cceeeEeee
Confidence 44566665566667899999999999986543 349999773 112357788999965 999999998
Q ss_pred EEeCCCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCcccee
Q psy14267 328 VYDTASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKII 406 (553)
Q Consensus 328 ~~~~~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~ 406 (553)
| .....++|+|||| .|-|+.+|+..... ....++.+..+|+.||.|||.+.|||||||.-||||..+
T Consensus 181 C--tqsPcyCIiMEfCa~GqL~~VLka~~~i-----tp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~----- 248 (904)
T KOG4721|consen 181 C--TQSPCYCIIMEFCAQGQLYEVLKAGRPI-----TPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYD----- 248 (904)
T ss_pred e--cCCceeEEeeeccccccHHHHHhccCcc-----CHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeecc-----
Confidence 8 5566788999976 47899999876533 334556666799999999999999999999999999877
Q ss_pred cCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCC
Q psy14267 407 DCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYS 486 (553)
Q Consensus 407 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~ 486 (553)
..|||+|||.++....... ...++||..|||||+|+..+ .+.++|||||||||||||||..||.
T Consensus 249 ----d~VKIsDFGTS~e~~~~ST---kMSFaGTVaWMAPEvIrneP---------csEKVDIwSfGVVLWEmLT~EiPYk 312 (904)
T KOG4721|consen 249 ----DVVKISDFGTSKELSDKST---KMSFAGTVAWMAPEVIRNEP---------CSEKVDIWSFGVVLWEMLTGEIPYK 312 (904)
T ss_pred ----ceEEeccccchHhhhhhhh---hhhhhhhHhhhCHHHhhcCC---------cccccceehhHHHHHHHHhcCCCcc
Confidence 5799999999988776533 34889999999999999885 7899999999999999999999998
Q ss_pred CCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q psy14267 487 HIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQIN 547 (553)
Q Consensus 487 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~ 547 (553)
+.... +++.-+-.. .-.+..+..||+.++-||+.||+..|..||++.+|+.||+
T Consensus 313 dVdss-AIIwGVGsN------sL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 313 DVDSS-AIIWGVGSN------SLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLD 366 (904)
T ss_pred ccchh-eeEEeccCC------cccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence 85442 111111111 1123345589999999999999999999999999999986
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=336.35 Aligned_cols=257 Identities=24% Similarity=0.325 Sum_probs=193.5
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCC--
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTAS-- 333 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~-- 333 (553)
++|++.+.||+|+||.||++.+..++. .||||++..... .......+.+|+.+++.+. ||||+++++++.....
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 96 (359)
T cd07876 21 KRYQQLKPIGSGAQGIVCAAFDTVLGI--NVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVN-HKNIISLLNVFTPQKSLE 96 (359)
T ss_pred hceEEEEEeecCCCEEEEEEEEcCCCc--eeEEEEeccccc-chhHHHHHHHHHHHHHhCC-CCCEeeeeeeeccCCCcc
Confidence 579999999999999999998876664 499999976532 2344577889999999995 5999999988754332
Q ss_pred --ceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCC
Q psy14267 334 --KHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGN 411 (553)
Q Consensus 334 --~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~ 411 (553)
..+|++||+++++|...+... .....+..++.|++.||+|||++||+||||||+|||++.+ +
T Consensus 97 ~~~~~~lv~e~~~~~l~~~~~~~-------~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~---------~ 160 (359)
T cd07876 97 EFQDVYLVMELMDANLCQVIHME-------LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD---------C 160 (359)
T ss_pred ccceeEEEEeCCCcCHHHHHhcc-------CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC---------C
Confidence 357999999999888776431 2334455667799999999999999999999999999776 6
Q ss_pred eEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCch
Q psy14267 412 VLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNT 491 (553)
Q Consensus 412 ~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~ 491 (553)
.+||+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|..||.+....
T Consensus 161 ~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~---------~~~~~~DiwSlG~il~el~tg~~pf~~~~~~ 228 (359)
T cd07876 161 TLKILDFGLARTACTNFM---MTPYVVTRYYRAPEVILGM---------GYKENVDIWSVGCIMGELVKGSVIFQGTDHI 228 (359)
T ss_pred CEEEecCCCccccccCcc---CCCCcccCCCCCchhccCC---------CCCcchhhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 799999999976543221 2245789999999999765 3678999999999999999999999865332
Q ss_pred HHHHHHHHh----------------------hccc------------ccccccccCCCCCCHHHHHHHHHhcccCCCCCC
Q psy14267 492 WAKMLAIAR----------------------HKDQ------------IEFKPQLANNVTIPPTLLQSMKLCLQKDPKARP 537 (553)
Q Consensus 492 ~~~~~~i~~----------------------~~~~------------~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RP 537 (553)
.. ...+.. .... +.+..........+..+++||.+||..||++||
T Consensus 229 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~ 307 (359)
T cd07876 229 DQ-WNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRI 307 (359)
T ss_pred HH-HHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCC
Confidence 11 110000 0000 000000011113467899999999999999999
Q ss_pred CHHHHHHH
Q psy14267 538 TVGNSVTQ 545 (553)
Q Consensus 538 t~~ell~~ 545 (553)
|+.|+++|
T Consensus 308 t~~e~l~h 315 (359)
T cd07876 308 SVDEALRH 315 (359)
T ss_pred CHHHHhcC
Confidence 99999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=331.26 Aligned_cols=266 Identities=21% Similarity=0.317 Sum_probs=193.8
Q ss_pred EeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEEEEE
Q psy14267 261 LSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLM 340 (553)
Q Consensus 261 ~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~iv~ 340 (553)
.++||+|+||+||+|++......+.||+|.+..... ...+.+|+++|+++. ||||+++++++....+..++++|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELK-HPNVISLQKVFLSHADRKVWLLF 79 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcC-CCCCcceeeeEecCCCcEEEEEE
Confidence 468999999999999877655556799999865432 245678999999995 59999999988777778899999
Q ss_pred ecCCCCHHHHHHHcccC----CCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEE
Q psy14267 341 EKGDTDLSKYMRNLNKM----TTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKII 416 (553)
Q Consensus 341 e~~~~~L~~~l~~~~~~----~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~ 416 (553)
++++++|..++...... .........+..++.||+.||+|||++||+||||||+|||+..+. ...+.+||+
T Consensus 80 e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~-----~~~~~~kl~ 154 (317)
T cd07868 80 DYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEG-----PERGRVKIA 154 (317)
T ss_pred eccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCC-----CCcCcEEEe
Confidence 99999999888643211 112345566777788999999999999999999999999995431 223579999
Q ss_pred eccCccccCCCCCc-ccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCch----
Q psy14267 417 DFGIACSLQDDKTS-VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNT---- 491 (553)
Q Consensus 417 DFGla~~~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~---- 491 (553)
|||+|+........ .......||+.|+|||++.+.. .++.++|||||||++|||++|++||......
T Consensus 155 DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--------~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~ 226 (317)
T cd07868 155 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGAR--------HYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTS 226 (317)
T ss_pred ecCceeccCCCCccccccCCccccccccCCHHHcCCC--------CcCchhhHHHHHHHHHHHHhCCCCccCCccccccc
Confidence 99999876543221 1123457899999999997643 3688999999999999999999999643211
Q ss_pred ----HHHHHHHHhhccc-----------c----c----c----------cccc-cCCCCCCHHHHHHHHHhcccCCCCCC
Q psy14267 492 ----WAKMLAIARHKDQ-----------I----E----F----------KPQL-ANNVTIPPTLLQSMKLCLQKDPKARP 537 (553)
Q Consensus 492 ----~~~~~~i~~~~~~-----------~----~----~----------~~~~-~~~~~~s~~l~~li~~cL~~dP~~RP 537 (553)
...+..+...... . . + .... ......+..+.+||++||+.||++||
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ 306 (317)
T cd07868 227 NPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRI 306 (317)
T ss_pred ccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCC
Confidence 0111111110000 0 0 0 0000 00113356789999999999999999
Q ss_pred CHHHHHHH
Q psy14267 538 TVGNSVTQ 545 (553)
Q Consensus 538 t~~ell~~ 545 (553)
|++|+++|
T Consensus 307 t~~e~l~h 314 (317)
T cd07868 307 TSEQAMQD 314 (317)
T ss_pred CHHHHhcC
Confidence 99999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=335.95 Aligned_cols=273 Identities=23% Similarity=0.343 Sum_probs=206.0
Q ss_pred EEecCcceEEEeeeeeeCceEEEEEeeeCCC---ccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeE
Q psy14267 251 ITLNGKQYQVLSLLGKGGSSSVYLVGGTSEH---EFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDY 327 (553)
Q Consensus 251 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~---~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~ 327 (553)
|.+.+++|+++++||+|+||.||+|.....+ ..+.||+|++.... . ....+.+.+|+.++.++.+|+||++++++
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~-~~~~~~~~~E~~~~~~l~~h~niv~~~~~ 79 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-T-ASEYKALMTELKILIHIGHHLNVVNLLGA 79 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-C-HHHHHHHHHHHHHHHhhccCcchhheeee
Confidence 5567789999999999999999999754332 23569999986443 2 23346788999999999778999999987
Q ss_pred EEeCCCceEEEEEec-CCCCHHHHHHHcccCC------------------------------------------------
Q psy14267 328 VYDTASKHLYVLMEK-GDTDLSKYMRNLNKMT------------------------------------------------ 358 (553)
Q Consensus 328 ~~~~~~~~~~iv~e~-~~~~L~~~l~~~~~~~------------------------------------------------ 358 (553)
+... +..++++|++ .+++|.+++.......
T Consensus 80 ~~~~-~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (337)
T cd05054 80 CTKP-GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEE 158 (337)
T ss_pred EecC-CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhccc
Confidence 7543 4567777776 5678988886532110
Q ss_pred --------CCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEeccCccccCCCCCc
Q psy14267 359 --------TLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTS 430 (553)
Q Consensus 359 --------~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~ 430 (553)
.....+..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++..+......
T Consensus 159 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~---------~~vkL~DfG~a~~~~~~~~~ 229 (337)
T cd05054 159 DEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSEN---------NVVKICDFGLARDIYKDPDY 229 (337)
T ss_pred chhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCC---------CcEEEeccccchhcccCcch
Confidence 1134566677788899999999999999999999999999876 57999999999877544333
Q ss_pred ccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHhhcccccccc
Q psy14267 431 VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHIPNTWAKMLAIARHKDQIEFKP 509 (553)
Q Consensus 431 ~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~i~~~~~~~~~~~ 509 (553)
.......++..|+|||++.+. .++.++|||||||+||||++ |..||............+. ......
T Consensus 230 ~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~~--- 296 (337)
T cd05054 230 VRKGDARLPLKWMAPESIFDK---------VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLK-EGTRMR--- 296 (337)
T ss_pred hhccCCCCCccccCcHHhcCC---------CCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHh-ccCCCC---
Confidence 333345567889999998765 37889999999999999997 9999976433222212211 111111
Q ss_pred cccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q psy14267 510 QLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNPE 551 (553)
Q Consensus 510 ~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~~ 551 (553)
....+++++.+++.+||+.+|++||++.+++++|++...
T Consensus 297 ---~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 297 ---APEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred ---CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 122567899999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=339.21 Aligned_cols=251 Identities=23% Similarity=0.340 Sum_probs=198.5
Q ss_pred cCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCC
Q psy14267 254 NGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTAS 333 (553)
Q Consensus 254 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~ 333 (553)
..++|++.+.||+|+||.||+|.+.... ...||+|++.+.........+.+.+|+.+++.+. ||||+++++++.+ .
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~--~ 103 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNED-FPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN-HPFCVNLYGSFKD--E 103 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCC-CeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCCcceEEEEEe--C
Confidence 3467999999999999999999865543 2459999998765444455678899999999995 6999999988744 5
Q ss_pred ceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCe
Q psy14267 334 KHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNV 412 (553)
Q Consensus 334 ~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~ 412 (553)
..++++||++ +++|.+++..... .....+..++.|++.||+|||++||+||||||+|||++.+ +.
T Consensus 104 ~~~~lv~Ey~~~g~L~~~i~~~~~-----~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~---------~~ 169 (340)
T PTZ00426 104 SYLYLVLEFVIGGEFFTFLRRNKR-----FPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKD---------GF 169 (340)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCC---------CC
Confidence 6889999975 6789999876542 3455566677899999999999999999999999999766 67
Q ss_pred EEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchH
Q psy14267 413 LKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTW 492 (553)
Q Consensus 413 vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~ 492 (553)
+||+|||+++...... ...+||+.|||||++.+. .++.++|||||||++|||++|..||......
T Consensus 170 ikL~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~---------~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~- 234 (340)
T PTZ00426 170 IKMTDFGFAKVVDTRT-----YTLCGTPEYIAPEILLNV---------GHGKAADWWTLGIFIYEILVGCPPFYANEPL- 234 (340)
T ss_pred EEEecCCCCeecCCCc-----ceecCChhhcCHHHHhCC---------CCCccccccchhhHHHHHhcCCCCCCCCCHH-
Confidence 9999999998764322 256799999999999765 3678999999999999999999999875432
Q ss_pred HHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q psy14267 493 AKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARP-----TVGNSVTQ 545 (553)
Q Consensus 493 ~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RP-----t~~ell~~ 545 (553)
.....+.... ..+ ...++..+.++|++||+.||++|+ ++++++++
T Consensus 235 ~~~~~i~~~~--~~~------p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 235 LIYQKILEGI--IYF------PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred HHHHHHhcCC--CCC------CCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 2222222211 111 225678999999999999999995 88888876
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=341.45 Aligned_cols=262 Identities=26% Similarity=0.419 Sum_probs=202.6
Q ss_pred ecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC
Q psy14267 253 LNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA 332 (553)
Q Consensus 253 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~ 332 (553)
+..++|++.++||+|+||.||+|++..++.. ||+|++.+.........+.+.+|+.+++.+ +||||+.+++++. .
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~--~aiK~~~~~~~~~~~~~~~~~~e~~il~~~-~h~~iv~~~~~~~--~ 114 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQV--YAMKLLSKFEMIKRSDSAFFWEERDIMAHA-NSEWIVQLHYAFQ--D 114 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCE--EEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCcceEEEEEe--c
Confidence 4456899999999999999999988777654 999999865444444446678999999999 4699999987663 4
Q ss_pred CceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCC
Q psy14267 333 SKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGN 411 (553)
Q Consensus 333 ~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~ 411 (553)
..+++++||++ +++|..++.... ....++..++.||+.||+|||++||+||||||+||||+.+ +
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~l~~~~------l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~---------~ 179 (370)
T cd05596 115 DKYLYMVMEYMPGGDLVNLMSNYD------IPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS---------G 179 (370)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhcC------CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCC---------C
Confidence 66899999975 678988886532 2345566667799999999999999999999999999776 6
Q ss_pred eEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCch
Q psy14267 412 VLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNT 491 (553)
Q Consensus 412 ~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~ 491 (553)
.+||+|||++........ ......+||+.|||||++.+.... ..++.++|||||||+||||++|..||......
T Consensus 180 ~~kL~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~-----~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~ 253 (370)
T cd05596 180 HLKLADFGTCMKMDANGM-VRCDTAVGTPDYISPEVLKSQGGD-----GYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 253 (370)
T ss_pred CEEEEeccceeeccCCCc-ccCCCCCCCcCeECHHHhccCCCC-----CCCCCceeeeehhHHHHHHHhCCCCcCCCCHH
Confidence 799999999987654322 122356799999999999764321 13789999999999999999999999874432
Q ss_pred HHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q psy14267 492 WAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKA--RPTVGNSVTQ 545 (553)
Q Consensus 492 ~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~--RPt~~ell~~ 545 (553)
.....+......+. ......++.++++||.+||..+|++ |+++.++++|
T Consensus 254 -~~~~~i~~~~~~~~----~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 254 -GTYSKIMDHKNSLT----FPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred -HHHHHHHcCCCcCC----CCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 23333332222222 2223357899999999999999988 9999999876
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=340.35 Aligned_cols=256 Identities=26% Similarity=0.460 Sum_probs=201.1
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|++++.||+|+||.||+|++..++.. ||||++.+...........+.+|+.+|..+. ||||+++++++. ...+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~--~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~--~~~~ 75 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQV--YAMKVLRKSDMIKRNQIAHVRAERDILADAD-SPWIVKLYYSFQ--DEEH 75 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCE--EEEEEEEHHHHhhccHHHHHHHHHHHHHhcC-CCCccchhhhee--cCCe
Confidence 3699999999999999999988776644 9999998765544455677899999999995 699999988764 4668
Q ss_pred EEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
++++||++ +++|.+++.... ......+..++.||+.||+|||++||+||||||+||||+.+ +.+|
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~---------~~~k 141 (350)
T cd05573 76 LYLVMEYMPGGDLMNLLIRKD-----VFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDAD---------GHIK 141 (350)
T ss_pred EEEEEcCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC---------CCEE
Confidence 89999975 678999987753 23445566677899999999999999999999999999776 5799
Q ss_pred EEeccCccccCCCC---------------------------CcccccCCccCCCccCcccccccCCCCCCCccCCCccch
Q psy14267 415 IIDFGIACSLQDDK---------------------------TSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSD 467 (553)
Q Consensus 415 L~DFGla~~~~~~~---------------------------~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sD 467 (553)
|+|||++....... .........||+.|+|||++.+. .++.++|
T Consensus 142 L~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~D 212 (350)
T cd05573 142 LADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT---------PYGLECD 212 (350)
T ss_pred eecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC---------CCCCcee
Confidence 99999998765433 00112345699999999999866 3788999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q psy14267 468 VWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT-VGNSVTQ 545 (553)
Q Consensus 468 IwSlGvvl~elltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt-~~ell~~ 545 (553)
||||||+||||++|+.||...... .....+........+ .....+++++.++|..||. ||++||+ +++++++
T Consensus 213 iwSlG~il~ell~g~~Pf~~~~~~-~~~~~i~~~~~~~~~----p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 213 WWSLGVILYEMLYGFPPFYSDTLQ-ETYNKIINWKESLRF----PPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred eEecchhhhhhccCCCCCCCCCHH-HHHHHHhccCCcccC----CCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 999999999999999999875432 223333321122221 1222478999999999997 9999999 9999976
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=343.34 Aligned_cols=255 Identities=19% Similarity=0.259 Sum_probs=190.8
Q ss_pred ecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC
Q psy14267 253 LNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA 332 (553)
Q Consensus 253 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~ 332 (553)
+...+|++++.||+|+||.||+|.+..++.. ||||... .+.+.+|+++|++|. ||||+++++++..
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~--vaiK~~~---------~~~~~~E~~il~~l~-HpnIv~~~~~~~~-- 154 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEH--VVIKAGQ---------RGGTATEAHILRAIN-HPSIIQLKGTFTY-- 154 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCE--EEEechh---------hhhhHHHHHHHHhCC-CCCCCCEeEEEEE--
Confidence 3445799999999999999999998877755 9999643 135678999999995 5999999987743
Q ss_pred CceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCe
Q psy14267 333 SKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNV 412 (553)
Q Consensus 333 ~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~ 412 (553)
....+++|++..++|..++..... .....++.++.||+.||+|||++|||||||||+||||+.+ +.
T Consensus 155 ~~~~~lv~e~~~~~L~~~l~~~~~-----l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~---------~~ 220 (391)
T PHA03212 155 NKFTCLILPRYKTDLYCYLAAKRN-----IAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHP---------GD 220 (391)
T ss_pred CCeeEEEEecCCCCHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCC---------CC
Confidence 567889999888999988876432 3345566777899999999999999999999999999766 57
Q ss_pred EEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCc--
Q psy14267 413 LKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN-- 490 (553)
Q Consensus 413 vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~-- 490 (553)
+||+|||+|+........ ......||+.|+|||++.+. .++.++|||||||+||||++|..||.....
T Consensus 221 vkL~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwSlGvil~elltg~~p~~~~~~~~ 290 (391)
T PHA03212 221 VCLGDFGAACFPVDINAN-KYYGWAGTIATNAPELLARD---------PYGPAVDIWSAGIVLFEMATCHDSLFEKDGLD 290 (391)
T ss_pred EEEEeCCccccccccccc-ccccccCccCCCChhhhcCC---------CCCcHHHHHHHHHHHHHHHHCCCCcCCccccc
Confidence 999999999754332211 22346799999999999765 378899999999999999999988643210
Q ss_pred ----hHHHHHHHHhhcc---------------------------cccccccccCCCCCCHHHHHHHHHhcccCCCCCCCH
Q psy14267 491 ----TWAKMLAIARHKD---------------------------QIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTV 539 (553)
Q Consensus 491 ----~~~~~~~i~~~~~---------------------------~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~ 539 (553)
....+..+..... .....+.+.....++.++.+||.+||+.||++|||+
T Consensus 291 ~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta 370 (391)
T PHA03212 291 GDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSA 370 (391)
T ss_pred ccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCH
Confidence 0111111111000 000001111112456789999999999999999999
Q ss_pred HHHHHH
Q psy14267 540 GNSVTQ 545 (553)
Q Consensus 540 ~ell~~ 545 (553)
+|++++
T Consensus 371 ~elL~h 376 (391)
T PHA03212 371 EALLDF 376 (391)
T ss_pred HHHhcC
Confidence 999864
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=335.55 Aligned_cols=257 Identities=21% Similarity=0.356 Sum_probs=193.8
Q ss_pred ceEEEeeeeeeCceEEEEEeeeC-CCccceEEEEEEecCCcC-chhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTS-EHEFKPLALKVVDLSDIT-DQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~-~~~~~~vAvK~l~~~~~~-~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
+|++++.||+|+||.||+++... ....+.||+|++.+.... .....+.+.+|+.+|+++.+||+|+.+++++ ....
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~--~~~~ 78 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF--QTEA 78 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE--ecCC
Confidence 48999999999999999997643 223456999999764322 2233467889999999998899999998766 3456
Q ss_pred eEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 335 HLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 335 ~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
.++++||++ +++|.+++..... .....+..++.||+.||+|||++||+||||||+||||+.+ +.+
T Consensus 79 ~~~lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~---------~~~ 144 (332)
T cd05614 79 KLHLILDYVSGGEMFTHLYQRDN-----FSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSE---------GHV 144 (332)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCC---------CCE
Confidence 788999975 5689888876432 3345566677899999999999999999999999999776 579
Q ss_pred EEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCc--h
Q psy14267 414 KIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN--T 491 (553)
Q Consensus 414 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~--~ 491 (553)
||+|||+++.+...... .....+||+.|||||++.+.. .++.++|||||||+||||++|..||..... .
T Consensus 145 kl~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--------~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 215 (332)
T cd05614 145 VLTDFGLSKEFLSEEKE-RTYSFCGTIEYMAPEIIRGKG--------GHGKAVDWWSLGILIFELLTGASPFTLEGERNT 215 (332)
T ss_pred EEeeCcCCccccccCCC-ccccccCCccccCHHHhcCCC--------CCCCccccccchhhhhhhhcCCCCCCCCCCCCC
Confidence 99999999875443322 122467999999999997542 257899999999999999999999964321 1
Q ss_pred HHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q psy14267 492 WAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARP-----TVGNSVTQ 545 (553)
Q Consensus 492 ~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RP-----t~~ell~~ 545 (553)
...+..... ... + .....++..+.++|.+||+.||++|| ++++++++
T Consensus 216 ~~~~~~~~~-~~~----~--~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 216 QSEVSRRIL-KCD----P--PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred HHHHHHHHh-cCC----C--CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 111111110 111 1 11235789999999999999999999 77788765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=315.48 Aligned_cols=260 Identities=24% Similarity=0.399 Sum_probs=206.7
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCc-----CchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeC
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDI-----TDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDT 331 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~-----~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~ 331 (553)
.|.-.+.||+|..++|-.+..+.++.. +|+|++..... ...+..+...+|+.||+++.+||+|+.+.+++ +
T Consensus 18 ~y~pkeilgrgvss~vrRci~k~t~~e--~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y--e 93 (411)
T KOG0599|consen 18 KYEPKEILGRGVSSVVRRCIHKETGKE--FAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY--E 93 (411)
T ss_pred hcChHHHhcccchhhhhhhhhcccccc--eeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec--c
Confidence 577778999999999988777666644 89999875432 23445567789999999999999999999977 5
Q ss_pred CCceEEEEEec-CCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCC
Q psy14267 332 ASKHLYVLMEK-GDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIG 410 (553)
Q Consensus 332 ~~~~~~iv~e~-~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~ 410 (553)
.+..+|+|++. ..|.|.+++...- ..++.....+++|+++|++|||.++||||||||+|||++++
T Consensus 94 s~sF~FlVFdl~prGELFDyLts~V-----tlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn--------- 159 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTSKV-----TLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDN--------- 159 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhhhe-----eecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccc---------
Confidence 57788999996 4588999998754 33445555667899999999999999999999999999988
Q ss_pred CeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCc
Q psy14267 411 NVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN 490 (553)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~ 490 (553)
.+|||+|||+|+.+.++..- ...||||+|+|||.+....+.+. + -|+..+|+|++||+||.||.|.+||.+...
T Consensus 160 ~~i~isDFGFa~~l~~GekL---relCGTPgYLAPEtikC~m~e~~--p-GYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ 233 (411)
T KOG0599|consen 160 MNIKISDFGFACQLEPGEKL---RELCGTPGYLAPETIKCSMYENH--P-GYSKEVDEWACGVIMYTLLAGCPPFWHRKQ 233 (411)
T ss_pred cceEEeccceeeccCCchhH---HHhcCCCcccChhheeeecccCC--C-CccchhhHHHHHHHHHHHHcCCCchhHHHH
Confidence 47999999999999887643 47899999999999986654321 1 289999999999999999999999987322
Q ss_pred hHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 491 TWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 491 ~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
..|...+..... . -..+.|.+++.+.++||.+||+.||++|.|++|+|.|
T Consensus 234 --mlMLR~ImeGky-q--F~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 234 --MLMLRMIMEGKY-Q--FRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred --HHHHHHHHhccc-c--cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 222222222222 2 2234566789999999999999999999999999876
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=342.74 Aligned_cols=256 Identities=21% Similarity=0.369 Sum_probs=195.2
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|++++.||+|+||+||++.+..++.. ||||++.+.........+.+.+|+++|+++. ||||+++++++. ...+
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~--~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~~~~~~~--~~~~ 75 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKI--YAMKTLLKSEMFKKDQLAHVKAERDVLAESD-SPWVVSLYYSFQ--DAQY 75 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCE--EEEEEEEHHHHHHhHHHHHHHHHHHHHHhCC-CCCcceEEEEEE--cCCe
Confidence 3699999999999999999988777654 9999997755444455678899999999985 599999988774 4668
Q ss_pred EEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
+|++||++ +++|.+++..... .....+..++.|++.||+|||++||+||||||+||||+.+ +.+|
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~-----~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~---------~~~k 141 (377)
T cd05629 76 LYLIMEFLPGGDLMTMLIKYDT-----FSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRG---------GHIK 141 (377)
T ss_pred eEEEEeCCCCCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCC---------CCEE
Confidence 99999976 6889998876432 3344555667899999999999999999999999999766 6799
Q ss_pred EEeccCccccCCCCCc---------------------------------------------ccccCCccCCCccCccccc
Q psy14267 415 IIDFGIACSLQDDKTS---------------------------------------------VHKDTASGTLNYMSPEAAG 449 (553)
Q Consensus 415 L~DFGla~~~~~~~~~---------------------------------------------~~~~~~~Gt~~y~APE~l~ 449 (553)
|+|||+++.+...... ......+||+.|+|||++.
T Consensus 142 l~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 221 (377)
T cd05629 142 LSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFL 221 (377)
T ss_pred EeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHc
Confidence 9999999643211000 0001246999999999997
Q ss_pred ccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhc
Q psy14267 450 QTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCL 529 (553)
Q Consensus 450 ~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL 529 (553)
+. .++.++|||||||+||||++|..||...... .....+......+. ++....++.++++||.+||
T Consensus 222 ~~---------~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~~~~~~----~p~~~~~s~~~~dli~~lL 287 (377)
T cd05629 222 QQ---------GYGQECDWWSLGAIMFECLIGWPPFCSENSH-ETYRKIINWRETLY----FPDDIHLSVEAEDLIRRLI 287 (377)
T ss_pred cC---------CCCCceeeEecchhhhhhhcCCCCCCCCCHH-HHHHHHHccCCccC----CCCCCCCCHHHHHHHHHHh
Confidence 65 3788999999999999999999999875432 22333332222222 2233357899999999999
Q ss_pred ccCCCCC---CCHHHHHHH
Q psy14267 530 QKDPKAR---PTVGNSVTQ 545 (553)
Q Consensus 530 ~~dP~~R---Pt~~ell~~ 545 (553)
. +|.+| +++.+++.+
T Consensus 288 ~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 288 T-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred c-CHhhcCCCCCHHHHhcC
Confidence 8 67765 599998876
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=324.89 Aligned_cols=250 Identities=16% Similarity=0.239 Sum_probs=196.1
Q ss_pred eeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEe--CCCceEEEE
Q psy14267 262 SLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYD--TASKHLYVL 339 (553)
Q Consensus 262 ~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~--~~~~~~~iv 339 (553)
..||+|++|.||++... + +.||||++++.........+.+.+|+.+|+++.| |||+++++++.+ .....++++
T Consensus 26 ~~i~~g~~~~v~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~~~g~~~~~~~~~~~~~lv 100 (283)
T PHA02988 26 VLIKENDQNSIYKGIFN--N--KEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDS-NNILKIYGFIIDIVDDLPRLSLI 100 (283)
T ss_pred eEEeeCCceEEEEEEEC--C--EEEEEEeccccccccHHHHHHHHHHHHHHHhcCC-CCEEEEeeeEEecccCCCceEEE
Confidence 57999999999998762 3 4599999987665555556788999999999965 899999998876 445678899
Q ss_pred EecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhh-CCcEecCCCCCCEEEecCccceecCCCCeEEEEe
Q psy14267 340 MEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHA-AGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIID 417 (553)
Q Consensus 340 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~-~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~D 417 (553)
||++. ++|.+++.... ...+...+.++.|++.||.|||+ .+++||||||+|||++.+ +.+||+|
T Consensus 101 ~Ey~~~g~L~~~l~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~---------~~~kl~d 166 (283)
T PHA02988 101 LEYCTRGYLREVLDKEK-----DLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTEN---------YKLKIIC 166 (283)
T ss_pred EEeCCCCcHHHHHhhCC-----CCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCC---------CcEEEcc
Confidence 99754 68999987643 23344556667799999999998 599999999999999876 5799999
Q ss_pred ccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHHH
Q psy14267 418 FGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLA 497 (553)
Q Consensus 418 FGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~~ 497 (553)
||+++....... ...|+..|+|||++.+.. ..++.++|||||||++|||++|..||.+.... .....
T Consensus 167 fg~~~~~~~~~~-----~~~~~~~y~aPE~~~~~~-------~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~-~~~~~ 233 (283)
T PHA02988 167 HGLEKILSSPPF-----KNVNFMVYFSYKMLNDIF-------SEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK-EIYDL 233 (283)
T ss_pred cchHhhhccccc-----cccCcccccCHHHhhhcc-------ccccchhhhhHHHHHHHHHHHCCCCCCCCCHH-HHHHH
Confidence 999987644321 446899999999997521 14789999999999999999999999876443 22222
Q ss_pred HHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 498 IARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 498 i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
+........ ....+++.+.++|.+||+.||++|||+.++++.|++.
T Consensus 234 i~~~~~~~~------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 234 IINKNNSLK------LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred HHhcCCCCC------CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 322222211 1225789999999999999999999999999999875
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=337.22 Aligned_cols=248 Identities=23% Similarity=0.344 Sum_probs=190.9
Q ss_pred eeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEEEEEe
Q psy14267 262 SLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLME 341 (553)
Q Consensus 262 ~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~iv~e 341 (553)
++||+|+||.||+|++..++.. ||||++++.........+.+..|+.++.++.+||||+.+++++. ....+|++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~--~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~--~~~~~~lv~e 76 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRI--YAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQ--TESRLFFVIE 76 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCE--EEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEE--cCCEEEEEEe
Confidence 4699999999999988777644 99999987665555556778899999999988899999998764 4567899999
Q ss_pred cC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEeccC
Q psy14267 342 KG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGI 420 (553)
Q Consensus 342 ~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGl 420 (553)
++ +++|..++.... ......+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+
T Consensus 77 ~~~~g~L~~~~~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~---------~~~kL~Dfg~ 142 (329)
T cd05588 77 FVSGGDLMFHMQRQR-----KLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAE---------GHIKLTDYGM 142 (329)
T ss_pred CCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC---------CCEEECcCcc
Confidence 75 578888876543 24456666777899999999999999999999999999776 5799999999
Q ss_pred ccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCc-------hHH
Q psy14267 421 ACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN-------TWA 493 (553)
Q Consensus 421 a~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~-------~~~ 493 (553)
++....... .....+||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ...
T Consensus 143 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~ 211 (329)
T cd05588 143 CKEGIRPGD--TTSTFCGTPNYIAPEILRGE---------DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTED 211 (329)
T ss_pred ccccccCCC--ccccccCCccccCHHHHcCC---------CCCCccceechHHHHHHHHHCCCCcccccccccccccchH
Confidence 875332222 12356799999999999765 367899999999999999999999963211 111
Q ss_pred HHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCC------HHHHHHH
Q psy14267 494 KMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT------VGNSVTQ 545 (553)
Q Consensus 494 ~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt------~~ell~~ 545 (553)
........ ... .....++..+.++|++||+.||.+|++ +.++++|
T Consensus 212 ~~~~~~~~-~~~------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 212 YLFQVILE-KQI------RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred HHHHHHHc-CCC------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 11111111 111 112257889999999999999999997 5677654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=332.22 Aligned_cols=245 Identities=23% Similarity=0.334 Sum_probs=189.8
Q ss_pred eeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEEEEEe
Q psy14267 262 SLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLME 341 (553)
Q Consensus 262 ~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~iv~e 341 (553)
++||+|+||.||+|++..++.. ||||++++.........+.+..|..++..+.+||||+++++++. ....++++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~--vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~--~~~~~~lv~e 76 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEF--FAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQ--TKEHLFFVME 76 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCE--EEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEE--cCCEEEEEEc
Confidence 4699999999999988776654 99999987644334445667788888888778899999988764 4568899999
Q ss_pred cC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEeccC
Q psy14267 342 KG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGI 420 (553)
Q Consensus 342 ~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGl 420 (553)
++ +++|..++..... .....+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+
T Consensus 77 ~~~gg~L~~~~~~~~~-----~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~---------~~~kL~Dfg~ 142 (316)
T cd05592 77 YLNGGDLMFHIQSSGR-----FDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKD---------GHIKIADFGM 142 (316)
T ss_pred CCCCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCC---------CCEEEccCcC
Confidence 75 6788888876442 3445566677899999999999999999999999999776 5799999999
Q ss_pred ccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHh
Q psy14267 421 ACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIAR 500 (553)
Q Consensus 421 a~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~~i~~ 500 (553)
++....... .....+||+.|+|||++.+. .++.++|||||||++|||++|..||.+.... .....+..
T Consensus 143 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~---------~~~~~~DvwslG~il~ell~G~~Pf~~~~~~-~~~~~i~~ 210 (316)
T cd05592 143 CKENMNGEG--KASTFCGTPDYIAPEILKGQ---------KYNESVDWWSFGVLLYEMLIGQSPFHGEDED-ELFDSILN 210 (316)
T ss_pred CeECCCCCC--ccccccCCccccCHHHHcCC---------CCCCcccchhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHc
Confidence 976543322 22356799999999999765 3688999999999999999999999875442 22222221
Q ss_pred hcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHH-HHHH
Q psy14267 501 HKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVG-NSVT 544 (553)
Q Consensus 501 ~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~-ell~ 544 (553)
. ... ....++.++.++|.+||..||++||++. ++++
T Consensus 211 ~--~~~------~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 211 D--RPH------FPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred C--CCC------CCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 1 111 1225788999999999999999999875 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=321.72 Aligned_cols=269 Identities=26% Similarity=0.417 Sum_probs=208.0
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCc-eeEeeeEEEeCC--
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPY-VIKMHDYVYDTA-- 332 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~-Iv~l~~~~~~~~-- 332 (553)
..|..+++||+|+||+||+|+.+.++.. ||+|.+..+... +..-....+|+.+|+.|+| +| |+.+++++....
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~--VALKkirl~~~~-EG~P~taiREisllk~L~~-~~~iv~L~dv~~~~~~~ 86 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKF--VALKKIRLEFEE-EGVPSTAIREISLLKRLSH-ANHIVRLHDVIHTSNNH 86 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCE--EEEEEEeccccc-cCCCchhhHHHHHHHHhCC-CcceEEEEeeeeecccc
Confidence 3578888999999999999999988855 999999876532 2233567899999999977 65 999999876543
Q ss_pred --CceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCC
Q psy14267 333 --SKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIG 410 (553)
Q Consensus 333 --~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~ 410 (553)
...+++++|+...+|..+++...+.. .......+..+++||+.||+|||+++|+||||||+||||+.+
T Consensus 87 ~~~~~l~lvfe~~d~DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~--------- 156 (323)
T KOG0594|consen 87 RGIGKLYLVFEFLDRDLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSS--------- 156 (323)
T ss_pred cccceEEEEEEeecccHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCC---------
Confidence 23789999999999999999887531 122235677778899999999999999999999999999876
Q ss_pred CeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCc
Q psy14267 411 NVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN 490 (553)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~ 490 (553)
+.+||+|||+|+.+.-+... +....+|.+|.|||++.+.. .|+..+||||+||+++||++++.-|.+...
T Consensus 157 G~lKlaDFGlAra~~ip~~~--yt~evvTlWYRaPEvLlGs~--------~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se 226 (323)
T KOG0594|consen 157 GVLKLADFGLARAFSIPMRT--YTPEVVTLWYRAPEVLLGST--------SYSTSVDIWSLGCIFAEMFTRRPLFPGDSE 226 (323)
T ss_pred CcEeeeccchHHHhcCCccc--ccccEEEeeccCHHHhcCCC--------cCCCCcchHhHHHHHHHHHhCCCCCCCCcH
Confidence 78999999999977643332 33567899999999999774 388999999999999999999999988655
Q ss_pred hHHHHHHHHhhccccc---c---------cccccC----------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH--H
Q psy14267 491 TWAKMLAIARHKDQIE---F---------KPQLAN----------NVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ--I 546 (553)
Q Consensus 491 ~~~~~~~i~~~~~~~~---~---------~~~~~~----------~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~--L 546 (553)
. ..+..+.+...... + ...... ....+.+..+++.+||+.+|..|.|++.++.| +
T Consensus 227 ~-~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf 305 (323)
T KOG0594|consen 227 I-DQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYF 305 (323)
T ss_pred H-HHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhh
Confidence 3 33333332222110 0 000011 11233588999999999999999999999987 5
Q ss_pred hcC
Q psy14267 547 NNN 549 (553)
Q Consensus 547 ~~~ 549 (553)
...
T Consensus 306 ~~~ 308 (323)
T KOG0594|consen 306 SEL 308 (323)
T ss_pred ccc
Confidence 544
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=333.14 Aligned_cols=245 Identities=23% Similarity=0.343 Sum_probs=190.3
Q ss_pred eeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEEEEEe
Q psy14267 262 SLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLME 341 (553)
Q Consensus 262 ~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~iv~e 341 (553)
+.||+|+||.||++++..++.. ||+|++.+...........+.+|+++++++. ||||+.+++++. ....++++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~--vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~i~~~~~~~~--~~~~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRY--YAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQ--THDRLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCE--EEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCcceeeEEe--cCCEEEEEEe
Confidence 4699999999999988776644 9999998765444445567889999999995 599999988764 3568899999
Q ss_pred cC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEeccC
Q psy14267 342 KG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGI 420 (553)
Q Consensus 342 ~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGl 420 (553)
++ +++|..++.... ......+..++.||+.||+|||++||+||||||+||||+.+ +.+||+|||+
T Consensus 76 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~---------~~~kL~Dfg~ 141 (323)
T cd05595 76 YANGGELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD---------GHIKITDFGL 141 (323)
T ss_pred CCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCC---------CCEEecccHH
Confidence 75 578887776543 23455666777899999999999999999999999999776 5799999999
Q ss_pred ccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHh
Q psy14267 421 ACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIAR 500 (553)
Q Consensus 421 a~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~~i~~ 500 (553)
+........ ......||+.|+|||++.+. .++.++|||||||++|||++|..||...... .....+..
T Consensus 142 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-~~~~~~~~ 209 (323)
T cd05595 142 CKEGISDGA--TMKTFCGTPEYLAPEVLEDN---------DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-RLFELILM 209 (323)
T ss_pred hccccCCCC--ccccccCCcCcCCcccccCC---------CCCchhchhhhHHHHHHHHhCCCCCCCCCHH-HHHHHHhc
Confidence 876433222 12256799999999999765 3688999999999999999999999764332 22222221
Q ss_pred hcccccccccccCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q psy14267 501 HKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARP-----TVGNSVTQ 545 (553)
Q Consensus 501 ~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RP-----t~~ell~~ 545 (553)
. ...+ ...+++++.++|.+||+.||++|| ++.+++++
T Consensus 210 ~--~~~~------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 210 E--EIRF------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred C--CCCC------CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 1 1111 225789999999999999999998 88888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=322.18 Aligned_cols=261 Identities=24% Similarity=0.336 Sum_probs=195.9
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhc--CCCceeEeeeEEEeC---
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQ--GCPYVIKMHDYVYDT--- 331 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~--~hp~Iv~l~~~~~~~--- 331 (553)
+|++++.||+|+||+||+|++..++.. ||+|.++...... .....+.+|+.+++.+. .||||+++++++...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~--~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~ 77 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHF--VALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTD 77 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcE--EEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCC
Confidence 489999999999999999998877644 9999997654222 22245678888888775 479999999887543
Q ss_pred CCceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCC
Q psy14267 332 ASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGN 411 (553)
Q Consensus 332 ~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~ 411 (553)
....++++||+..++|..++...... ......+..++.|++.||+|||++||+||||||+|||++.+ +
T Consensus 78 ~~~~~~lv~e~~~~~l~~~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~---------~ 145 (288)
T cd07863 78 RETKVTLVFEHVDQDLRTYLDKVPPP---GLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSG---------G 145 (288)
T ss_pred CCceEEEEEcccccCHHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC---------C
Confidence 23568999999989999988764322 24456667778899999999999999999999999999776 5
Q ss_pred eEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCch
Q psy14267 412 VLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNT 491 (553)
Q Consensus 412 ~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~ 491 (553)
.+||+|||++........ .....||..|+|||++.+. .++.++|||||||++|||++|.+||......
T Consensus 146 ~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~---------~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~ 213 (288)
T cd07863 146 QVKLADFGLARIYSCQMA---LTPVVVTLWYRAPEVLLQS---------TYATPVDMWSVGCIFAEMFRRKPLFCGNSEA 213 (288)
T ss_pred CEEECccCccccccCccc---CCCccccccccCchHhhCC---------CCCCcchhhhHHHHHHHHHhCCcCcCCCCHH
Confidence 799999999987653322 1245689999999999765 3688999999999999999999999765433
Q ss_pred HHHHHHHHhhc---cccccc-----------cc-----ccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 492 WAKMLAIARHK---DQIEFK-----------PQ-----LANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 492 ~~~~~~i~~~~---~~~~~~-----------~~-----~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
. .+..+.... ....+. +. ......++..+.++|.+||+.||++|||+.+++.+
T Consensus 214 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 214 D-QLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred H-HHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 2 222221110 000000 00 01112567889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=346.89 Aligned_cols=262 Identities=23% Similarity=0.335 Sum_probs=202.6
Q ss_pred ecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC
Q psy14267 253 LNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA 332 (553)
Q Consensus 253 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~ 332 (553)
...++|++.+.||+|+||+||+|++..++.. ||||++....... .....+.+|+.+|..+. |++|+++++.+....
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~--vAvK~i~~~~~~~-~~~~~~~~Ei~~l~~~~-h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEP--FAVKVVDMEGMSE-ADKNRAQAEVCCLLNCD-FFSIVKCHEDFAKKD 104 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCE--EEEEEEecccCCH-HHHHHHHHHHHHHhcCC-CCcEEEeecceeccc
Confidence 3456899999999999999999988777654 9999998776543 44577889999999985 599999877654332
Q ss_pred C------ceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccce
Q psy14267 333 S------KHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKI 405 (553)
Q Consensus 333 ~------~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~ 405 (553)
. ..++++||++ +++|.+++...... ...+....+..++.|++.||+|||+++||||||||+||||+.+
T Consensus 105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~-~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~---- 179 (496)
T PTZ00283 105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKT-NRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSN---- 179 (496)
T ss_pred ccCcccceEEEEEEeCCCCCcHHHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCC----
Confidence 1 2467888875 57999988764322 2245556667777899999999999999999999999999876
Q ss_pred ecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCC
Q psy14267 406 IDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY 485 (553)
Q Consensus 406 ~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf 485 (553)
+.+||+|||+++.+............+||+.|+|||++.+. .++.++|||||||+||||++|+.||
T Consensus 180 -----~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~---------~~s~k~DVwSlGvilyeLltG~~Pf 245 (496)
T PTZ00283 180 -----GLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRK---------PYSKKADMFSLGVLLYELLTLKRPF 245 (496)
T ss_pred -----CCEEEEecccCeeccccccccccccccCCcceeCHHHhCCC---------CCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 57999999999876543322233467799999999999765 3789999999999999999999999
Q ss_pred CCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 486 SHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 486 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
...... ..+..+..... .. ....+++++.++|.+||+.||++||++.+++++
T Consensus 246 ~~~~~~-~~~~~~~~~~~-~~------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 246 DGENME-EVMHKTLAGRY-DP------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCCHH-HHHHHHhcCCC-CC------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 875432 22222221111 11 123678999999999999999999999999875
|
|
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=332.95 Aligned_cols=251 Identities=25% Similarity=0.438 Sum_probs=207.6
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceE
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHL 336 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~ 336 (553)
-|.+.+.||+|.|++|-+|++..+++. ||||++.+..+..... ..+++|++-|+.++ |||||+++++. +..-.+
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGek--VAVKviDKTKlD~~st-~hlfqEVRCMKLVQ-HpNiVRLYEVi--DTQTKl 92 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEK--VAVKVIDKTKLDTLST-GHLFQEVRCMKLVQ-HPNIVRLYEVI--DTQTKL 92 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccce--eEEEEecccccchhhh-hHHHHHHHHHHHhc-CcCeeeeeehh--cccceE
Confidence 589999999999999999999999877 9999999988766443 67889999998885 59999998754 345578
Q ss_pred EEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 337 YVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 337 ~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
|+++|.++ |+|++|+.+.... ..+.....+++||+.|+.|+|...+|||||||+||.+-+.. |.|||
T Consensus 93 yLiLELGD~GDl~DyImKHe~G----l~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKl--------GlVKL 160 (864)
T KOG4717|consen 93 YLILELGDGGDLFDYIMKHEEG----LNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKL--------GLVKL 160 (864)
T ss_pred EEEEEecCCchHHHHHHhhhcc----ccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeec--------CceEe
Confidence 88888765 5999999987653 44566777889999999999999999999999999886553 78999
Q ss_pred EeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHH
Q psy14267 416 IDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKM 495 (553)
Q Consensus 416 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~ 495 (553)
.|||++-.+.++.. ..+.||+..|-|||++.|..|+ .+++||||||||||.|++|++||...++. +.+
T Consensus 161 TDFGFSNkf~PG~k---L~TsCGSLAYSAPEILLGDsYD--------APAVDiWSLGVILyMLVCGq~PFqeANDS-ETL 228 (864)
T KOG4717|consen 161 TDFGFSNKFQPGKK---LTTSCGSLAYSAPEILLGDSYD--------APAVDIWSLGVILYMLVCGQPPFQEANDS-ETL 228 (864)
T ss_pred eeccccccCCCcch---hhcccchhhccCchhhhcCccC--------CcchhhhHHHHHHHHHHhCCCccccccch-hhh
Confidence 99999988877654 3489999999999999999865 47899999999999999999999875443 333
Q ss_pred HHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 496 LAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 496 ~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
..|...+. ..+..++.+.++||..||..||++|.+.+||+..
T Consensus 229 TmImDCKY--------tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 229 TMIMDCKY--------TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred hhhhcccc--------cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 33322221 2233678999999999999999999999999764
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=334.01 Aligned_cols=258 Identities=23% Similarity=0.314 Sum_probs=193.8
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC---
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA--- 332 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~--- 332 (553)
++|++.+.||+|+||.||+|.+...+.. ||||++..... ......++.+|+.+++.+. ||||+.+++++....
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 92 (355)
T cd07874 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQ-NQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKSLE 92 (355)
T ss_pred hceeEEEEeeecCCEEEEEEEecCCCce--EEEEEeCCccc-ChHHHHHHHHHHHHHHHhC-CCchhceeeeeecccccc
Confidence 5899999999999999999987766544 99999876543 2344577889999999995 599999998775432
Q ss_pred -CceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCC
Q psy14267 333 -SKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGN 411 (553)
Q Consensus 333 -~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~ 411 (553)
...++++||+++++|..++... .....+..++.|++.||+|||++||+||||||+||||+.+ +
T Consensus 93 ~~~~~~lv~e~~~~~l~~~~~~~-------l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~---------~ 156 (355)
T cd07874 93 EFQDVYLVMELMDANLCQVIQME-------LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD---------C 156 (355)
T ss_pred ccceeEEEhhhhcccHHHHHhhc-------CCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCC---------C
Confidence 2467999999999988877542 2344556677899999999999999999999999999776 5
Q ss_pred eEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCch
Q psy14267 412 VLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNT 491 (553)
Q Consensus 412 ~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~ 491 (553)
.+||+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+....
T Consensus 157 ~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~---------~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 224 (355)
T cd07874 157 TLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGM---------GYKENVDIWSVGCIMGEMVRHKILFPGRDYI 224 (355)
T ss_pred CEEEeeCcccccCCCccc---cCCccccCCccCHHHHcCC---------CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 799999999986543321 2245789999999999765 3688999999999999999999999764322
Q ss_pred HHHHHHHHhh---------------------ccc---cc---------ccccccCCCCCCHHHHHHHHHhcccCCCCCCC
Q psy14267 492 WAKMLAIARH---------------------KDQ---IE---------FKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538 (553)
Q Consensus 492 ~~~~~~i~~~---------------------~~~---~~---------~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt 538 (553)
......+... ... .. +..........+..+++||.+||..||++|||
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps 304 (355)
T cd07874 225 DQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 304 (355)
T ss_pred HHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCC
Confidence 1111100000 000 00 00000111124568899999999999999999
Q ss_pred HHHHHHH
Q psy14267 539 VGNSVTQ 545 (553)
Q Consensus 539 ~~ell~~ 545 (553)
+.|++++
T Consensus 305 ~~ell~h 311 (355)
T cd07874 305 VDEALQH 311 (355)
T ss_pred HHHHhcC
Confidence 9999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=331.19 Aligned_cols=245 Identities=23% Similarity=0.356 Sum_probs=193.1
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceE
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHL 336 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~ 336 (553)
+|++.+.||+|+||.||+|++..++.. ||||++.+.........+.+..|+.+++.+.||++|+.+++++. ....+
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~--vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~--~~~~~ 76 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDEL--YAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQ--TVDRL 76 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCE--EEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEe--cCCEE
Confidence 378899999999999999988777654 99999987654444455778899999999988899999987663 35678
Q ss_pred EEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 337 YVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 337 ~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
|++||++ +++|..++.... ...+..+..++.||+.||+|||++||+||||||+|||++.+ +.+||
T Consensus 77 ~lv~Ey~~~g~L~~~i~~~~-----~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~---------~~ikL 142 (323)
T cd05615 77 YFVMEYVNGGDLMYHIQQVG-----KFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSE---------GHIKI 142 (323)
T ss_pred EEEEcCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC---------CCEEE
Confidence 9999976 578988887644 23455667778899999999999999999999999999876 57999
Q ss_pred EeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHH
Q psy14267 416 IDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKM 495 (553)
Q Consensus 416 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~ 495 (553)
+|||+++....... .....+||+.|+|||++.+. .++.++|||||||++|||++|..||...... ...
T Consensus 143 ~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslGvil~elltG~~pf~~~~~~-~~~ 210 (323)
T cd05615 143 ADFGMCKEHMVDGV--TTRTFCGTPDYIAPEIIAYQ---------PYGKSVDWWAYGVLLYEMLAGQPPFDGEDED-ELF 210 (323)
T ss_pred eccccccccCCCCc--cccCccCCccccCHHHHcCC---------CCCCccchhhhHHHHHHHHhCCCCCCCCCHH-HHH
Confidence 99999876543222 12356799999999999765 3688999999999999999999999875432 222
Q ss_pred HHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCH
Q psy14267 496 LAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTV 539 (553)
Q Consensus 496 ~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~ 539 (553)
..+.... .. ....++.++.+++.+||+++|.+|++.
T Consensus 211 ~~i~~~~--~~------~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 211 QSIMEHN--VS------YPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred HHHHhCC--CC------CCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 3332211 11 122578899999999999999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=333.64 Aligned_cols=245 Identities=23% Similarity=0.329 Sum_probs=190.7
Q ss_pred eeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEEEEEe
Q psy14267 262 SLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLME 341 (553)
Q Consensus 262 ~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~iv~e 341 (553)
++||+|+||.||++++..++.. ||||++.+...........+.+|+++|+.+. ||||+.+++++. ....++++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~--~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~--~~~~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKY--YAMKILKKEVIIAKDEVAHTLTESRVLKNTR-HPFLTSLKYSFQ--TKDRLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCE--EEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceEEEEE--cCCEEEEEEe
Confidence 4699999999999988777654 9999998765444455678899999999995 599999987663 4668899999
Q ss_pred cC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEeccC
Q psy14267 342 KG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGI 420 (553)
Q Consensus 342 ~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGl 420 (553)
++ +++|..++.... ......+..++.||+.||+|||++||+||||||+||||+.+ +.+||+|||+
T Consensus 76 y~~~g~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~---------~~~kL~DfG~ 141 (328)
T cd05593 76 YVNGGELFFHLSRER-----VFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKD---------GHIKITDFGL 141 (328)
T ss_pred CCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCC---------CcEEEecCcC
Confidence 75 567877776543 23455566677899999999999999999999999999776 5799999999
Q ss_pred ccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHh
Q psy14267 421 ACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIAR 500 (553)
Q Consensus 421 a~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~~i~~ 500 (553)
++....... .....+||+.|+|||++.+. .++.++|||||||++|||++|..||...... .....+..
T Consensus 142 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslGvil~elltG~~Pf~~~~~~-~~~~~~~~ 209 (328)
T cd05593 142 CKEGITDAA--TMKTFCGTPEYLAPEVLEDN---------DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-KLFELILM 209 (328)
T ss_pred CccCCCccc--ccccccCCcCccChhhhcCC---------CCCccCCccccchHHHHHhhCCCCCCCCCHH-HHHHHhcc
Confidence 876433222 12356799999999999765 3688999999999999999999999764332 11222111
Q ss_pred hcccccccccccCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q psy14267 501 HKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARP-----TVGNSVTQ 545 (553)
Q Consensus 501 ~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RP-----t~~ell~~ 545 (553)
....+ ...++.++.++|++||..||++|+ ++.+++++
T Consensus 210 --~~~~~------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 210 --EDIKF------PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred --CCccC------CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 11111 235789999999999999999997 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=343.09 Aligned_cols=255 Identities=21% Similarity=0.334 Sum_probs=194.4
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceE
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHL 336 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~ 336 (553)
+|++++.||+|+||.||+|++..++.. ||||++.+.........+.+.+|+.+|+++. |+||+++++.+. ....+
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~--~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~~~--~~~~~ 76 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNAL--YAMKTLRKADVLMRNQAAHVKAERDILAEAD-NEWVVKLYYSFQ--DKDNL 76 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCE--EEEEEEcHHHHHhhhhHHHHHHHHHHHHhCC-CCCcceEEEEEE--cCCEE
Confidence 699999999999999999988777644 9999997655444444577889999999995 599999988764 46689
Q ss_pred EEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 337 YVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 337 ~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
+++||++ +++|.+++..... .....+..++.||+.||+|||++||+||||||+||||+.+ +.+||
T Consensus 77 ~lv~E~~~~g~L~~~i~~~~~-----~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~---------~~ikL 142 (376)
T cd05598 77 YFVMDYIPGGDMMSLLIRLGI-----FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRD---------GHIKL 142 (376)
T ss_pred EEEEeCCCCCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCC---------CCEEE
Confidence 9999976 6789999876432 2344555667799999999999999999999999999766 67999
Q ss_pred EeccCccccCCCCC-----------------------------------------cccccCCccCCCccCcccccccCCC
Q psy14267 416 IDFGIACSLQDDKT-----------------------------------------SVHKDTASGTLNYMSPEAAGQTSSS 454 (553)
Q Consensus 416 ~DFGla~~~~~~~~-----------------------------------------~~~~~~~~Gt~~y~APE~l~~~~~~ 454 (553)
+|||+|..+..... .......+||+.|||||++.+..
T Consensus 143 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-- 220 (376)
T cd05598 143 TDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG-- 220 (376)
T ss_pred EeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCC--
Confidence 99999853321000 00012357999999999997653
Q ss_pred CCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCC
Q psy14267 455 GGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPK 534 (553)
Q Consensus 455 ~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~ 534 (553)
++.++|||||||++|||++|+.||...... .....+....... .......+++++.++|.+|+ .+|+
T Consensus 221 -------~~~~~DiwSlGvilyell~G~~Pf~~~~~~-~~~~~i~~~~~~~----~~~~~~~~s~~~~~li~~l~-~~p~ 287 (376)
T cd05598 221 -------YTQLCDWWSVGVILYEMLVGQPPFLADTPA-ETQLKVINWETTL----HIPSQAKLSREASDLILRLC-CGAE 287 (376)
T ss_pred -------CCcceeeeeccceeeehhhCCCCCCCCCHH-HHHHHHhccCccc----cCCCCCCCCHHHHHHHHHHh-cCHh
Confidence 678999999999999999999999875432 2222222211111 12223467899999999977 5999
Q ss_pred CCC---CHHHHHHH
Q psy14267 535 ARP---TVGNSVTQ 545 (553)
Q Consensus 535 ~RP---t~~ell~~ 545 (553)
+|+ ++.+++++
T Consensus 288 ~R~~~~t~~ell~h 301 (376)
T cd05598 288 DRLGKNGADEIKAH 301 (376)
T ss_pred hcCCCCCHHHHhCC
Confidence 999 89999876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=340.02 Aligned_cols=255 Identities=21% Similarity=0.351 Sum_probs=194.8
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceE
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHL 336 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~ 336 (553)
.|+++++||+|+||.||+|++..++.. ||||++.+.........+.+.+|+.+|+++. |+||+++++.+.+ ...+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~--~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~-h~~iv~~~~~~~~--~~~~ 76 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKAL--YAMKTLRKKDVLLRNQVAHVKAERDILAEAD-NEWVVRLYYSFQD--KDNL 76 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCE--EEEEEEeHHHhhhHHHHHHHHHHHHHHHhCC-CCcCCeEEEEEEe--CCEE
Confidence 589999999999999999988777654 9999998765544555678899999999995 5999999887743 5689
Q ss_pred EEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 337 YVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 337 ~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
+++||++ +++|.+++.+.. ......+..++.||+.||+|||++|||||||||+||||+.+ +.+||
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~---------g~~kL 142 (382)
T cd05625 77 YFVMDYIPGGDMMSLLIRMG-----IFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRD---------GHIKL 142 (382)
T ss_pred EEEEeCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC---------CCEEE
Confidence 9999975 578988887643 23345556667899999999999999999999999999776 67999
Q ss_pred EeccCccccCCCCC---------------------------------------------cccccCCccCCCccCcccccc
Q psy14267 416 IDFGIACSLQDDKT---------------------------------------------SVHKDTASGTLNYMSPEAAGQ 450 (553)
Q Consensus 416 ~DFGla~~~~~~~~---------------------------------------------~~~~~~~~Gt~~y~APE~l~~ 450 (553)
+|||+|..+..... .......+||+.|+|||++.+
T Consensus 143 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~ 222 (382)
T cd05625 143 TDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR 222 (382)
T ss_pred eECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC
Confidence 99999854321000 000123579999999999976
Q ss_pred cCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcc
Q psy14267 451 TSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQ 530 (553)
Q Consensus 451 ~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~ 530 (553)
. .++.++|||||||+||||++|..||...... .....+........ .+....+++++.++|.+|+
T Consensus 223 ~---------~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~~~~~~----~p~~~~~s~~~~~li~~l~- 287 (382)
T cd05625 223 T---------GYTQLCDWWSVGVILYEMLVGQPPFLAQTPL-ETQMKVINWQTSLH----IPPQAKLSPEASDLIIKLC- 287 (382)
T ss_pred C---------CCCCeeeEEechHHHHHHHhCCCCCCCCCHH-HHHHHHHccCCCcC----CCCcccCCHHHHHHHHHHc-
Confidence 5 3678999999999999999999999875443 22222222211111 2223467899999999976
Q ss_pred cCCCCCCC---HHHHHHH
Q psy14267 531 KDPKARPT---VGNSVTQ 545 (553)
Q Consensus 531 ~dP~~RPt---~~ell~~ 545 (553)
.+|++|++ +.++++|
T Consensus 288 ~~p~~R~~~~~~~ei~~h 305 (382)
T cd05625 288 RGPEDRLGKNGADEIKAH 305 (382)
T ss_pred cCHhHcCCCCCHHHHhcC
Confidence 59999997 8887764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=338.29 Aligned_cols=263 Identities=26% Similarity=0.415 Sum_probs=201.5
Q ss_pred EecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeC
Q psy14267 252 TLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDT 331 (553)
Q Consensus 252 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~ 331 (553)
.+..++|++.+.||+|+||.||++++..++.. ||+|++.+.........+.+.+|+.+++.+ +||||+++++++.
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~--~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~-- 113 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKV--YAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFCAFQ-- 113 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCE--EEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEE--
Confidence 34457899999999999999999998777654 999999765444444456678899999888 4699999988764
Q ss_pred CCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCC
Q psy14267 332 ASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIG 410 (553)
Q Consensus 332 ~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~ 410 (553)
...+++++||++ +++|.+++.... .....+..++.||+.||+|||++||+||||||+||||+.+
T Consensus 114 ~~~~~~lv~Ey~~gg~L~~~l~~~~------~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~--------- 178 (370)
T cd05621 114 DDKYLYMVMEYMPGGDLVNLMSNYD------VPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKH--------- 178 (370)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHhcC------CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCC---------
Confidence 467899999975 678999886532 2345566677899999999999999999999999999776
Q ss_pred CeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCc
Q psy14267 411 NVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN 490 (553)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~ 490 (553)
+.+||+|||+|........ ......+||+.|||||++.+...+ ..++.++|||||||+||||++|..||.....
T Consensus 179 ~~~kL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~-----~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~ 252 (370)
T cd05621 179 GHLKLADFGTCMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGD-----GYYGRECDWWSVGVFLFEMLVGDTPFYADSL 252 (370)
T ss_pred CCEEEEecccceecccCCc-eecccCCCCcccCCHHHHhccCCC-----CCCCcccCEEeehHHHHHHHhCCCCCCCCCH
Confidence 6799999999987654322 122366799999999999765321 1368899999999999999999999987543
Q ss_pred hHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q psy14267 491 TWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKA--RPTVGNSVTQ 545 (553)
Q Consensus 491 ~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~--RPt~~ell~~ 545 (553)
. .....+........ ......++..++++|..||..++.+ |+++.++++|
T Consensus 253 ~-~~~~~i~~~~~~~~----~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 253 V-GTYSKIMDHKNSLN----FPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred H-HHHHHHHhCCcccC----CCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 2 33333333222222 2223357899999999999865544 8899999887
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=330.75 Aligned_cols=249 Identities=21% Similarity=0.351 Sum_probs=191.1
Q ss_pred eEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhc--CCCceeEeeeEEEeCCCce
Q psy14267 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQ--GCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 258 y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~--~hp~Iv~l~~~~~~~~~~~ 335 (553)
|++++.||+|+||.||+|.+..++.. ||||++++.........+.+.+|++++..+. .||||+++++++. ....
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~--~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~--~~~~ 76 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGEL--YAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQ--TEDH 76 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCE--EEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEE--cCCE
Confidence 78899999999999999988766644 9999998765444444567888887765443 4799999998774 4568
Q ss_pred EEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
+|++||++ +++|..++... ......+..++.||+.||+|||++||+||||||+||||+.+ +.+|
T Consensus 77 ~~lv~E~~~~~~L~~~~~~~------~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~---------~~~k 141 (324)
T cd05589 77 VCFVMEYAAGGDLMMHIHTD------VFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTE---------GFVK 141 (324)
T ss_pred EEEEEcCCCCCcHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCC---------CcEE
Confidence 89999975 56777666432 24455666778899999999999999999999999999876 5799
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||+++....... .....+|++.|||||++.+. .++.++|||||||++|||++|..||...... ..
T Consensus 142 L~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~---------~~~~~~DiwslG~il~el~~G~~pf~~~~~~-~~ 209 (324)
T cd05589 142 IADFGLCKEGMGFGD--RTSTFCGTPEFLAPEVLTET---------SYTRAVDWWGLGVLIYEMLVGESPFPGDDEE-EV 209 (324)
T ss_pred eCcccCCccCCCCCC--cccccccCccccCHhHhcCC---------CCCcccchhhHHHHHHHHHhCCCCCCCCCHH-HH
Confidence 999999875433222 22356799999999999765 3688999999999999999999999875432 22
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARP-----TVGNSVTQ 545 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RP-----t~~ell~~ 545 (553)
...+.... .. ....++..+.++|.+||+.||++|| ++.+++++
T Consensus 210 ~~~i~~~~--~~------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 210 FDSIVNDE--VR------YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred HHHHHhCC--CC------CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 22222211 11 1225789999999999999999999 57777654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=332.18 Aligned_cols=240 Identities=22% Similarity=0.304 Sum_probs=187.7
Q ss_pred eeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEEEEEe
Q psy14267 262 SLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLME 341 (553)
Q Consensus 262 ~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~iv~e 341 (553)
++||+|+||.||+|++..++.. ||||++.+.........+.+..|+.++..+.+||||+++++++. ....+|++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~--~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~--~~~~~~iv~E 76 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRL--YAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQ--TPDRLFFVME 76 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCE--EEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEE--cCCEEEEEEc
Confidence 4699999999999988776644 99999987644444455778899999998888899999988764 4567899999
Q ss_pred cC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEeccC
Q psy14267 342 KG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGI 420 (553)
Q Consensus 342 ~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGl 420 (553)
++ +++|..++..... .....+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+
T Consensus 77 y~~~g~L~~~i~~~~~-----l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~---------~~~kL~DfG~ 142 (320)
T cd05590 77 FVNGGDLMFHIQKSRR-----FDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHE---------GHCKLADFGM 142 (320)
T ss_pred CCCCchHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCC---------CcEEEeeCCC
Confidence 75 5788888876542 3345566677899999999999999999999999999776 5799999999
Q ss_pred ccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHh
Q psy14267 421 ACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIAR 500 (553)
Q Consensus 421 a~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~~i~~ 500 (553)
++....... .....+||+.|+|||++.+. .++.++|||||||++|||++|..||...... .....+..
T Consensus 143 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-~~~~~i~~ 210 (320)
T cd05590 143 CKEGIFNGK--TTSTFCGTPDYIAPEILQEM---------LYGPSVDWWAMGVLLYEMLCGHAPFEAENED-DLFEAILN 210 (320)
T ss_pred CeecCcCCC--cccccccCccccCHHHHcCC---------CCCCccchhhhHHHHHHHhhCCCCCCCCCHH-HHHHHHhc
Confidence 876433222 12356799999999999765 3678999999999999999999999875432 22222221
Q ss_pred hcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCH
Q psy14267 501 HKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTV 539 (553)
Q Consensus 501 ~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~ 539 (553)
. ... ....++.++.++|++||+.||++||++
T Consensus 211 ~--~~~------~~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 211 D--EVV------YPTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred C--CCC------CCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 1 111 122478899999999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=340.41 Aligned_cols=202 Identities=27% Similarity=0.397 Sum_probs=173.5
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcC-----CCceeEeeeEEEe
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG-----CPYVIKMHDYVYD 330 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~-----hp~Iv~l~~~~~~ 330 (553)
-+|.+.+.||+|+||.|.+|.+..+++. ||||+++.. ..+..+...|+.+|..|+. .-|||++++||
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~--VAIKIiKN~----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F-- 257 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEI--VAIKIIKNK----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF-- 257 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcE--EEEEeeccC----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc--
Confidence 3899999999999999999999888876 999999754 4667888999999999973 35899999988
Q ss_pred CCCceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCC
Q psy14267 331 TASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIG 410 (553)
Q Consensus 331 ~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~ 410 (553)
...+|+|||+|..+.+|+++++..... .++...+..++.||+.||.+||+.+|||+|||||||||..-. .
T Consensus 258 ~fr~HlciVfELL~~NLYellK~n~f~---Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~-------r 327 (586)
T KOG0667|consen 258 YFRNHLCIVFELLSTNLYELLKNNKFR---GLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPK-------R 327 (586)
T ss_pred ccccceeeeehhhhhhHHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCC-------c
Confidence 457899999999999999999986543 355666777788999999999999999999999999996542 3
Q ss_pred CeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy14267 411 NVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIP 489 (553)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~ 489 (553)
..|||+|||.|+.....-. +.+-+..|+|||+|.|.+ |+.+.||||||||++||++|.+.|.+.+
T Consensus 328 ~~vKVIDFGSSc~~~q~vy-----tYiQSRfYRAPEVILGlp---------Y~~~IDmWSLGCIlAEL~tG~PLfpG~n 392 (586)
T KOG0667|consen 328 SRIKVIDFGSSCFESQRVY-----TYIQSRFYRAPEVILGLP---------YDTAIDMWSLGCILAELFTGEPLFPGDN 392 (586)
T ss_pred CceeEEecccccccCCcce-----eeeeccccccchhhccCC---------CCCccceeehhhhHHhHhcCccccCCCC
Confidence 5799999999987655432 667899999999999884 7899999999999999999999997643
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=335.63 Aligned_cols=248 Identities=24% Similarity=0.358 Sum_probs=189.5
Q ss_pred eeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEEEEEe
Q psy14267 262 SLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLME 341 (553)
Q Consensus 262 ~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~iv~e 341 (553)
+.||+|+||.||+|++..++.. ||+|++++.........+.+.+|+.++.++.+||||+.+++++.. ...++++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~--~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~E 76 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERI--YAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESRLFFVIE 76 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCE--EEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe--CCEEEEEEe
Confidence 4799999999999988777654 999999877555555567788999999998888999999987744 567889999
Q ss_pred cC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEeccC
Q psy14267 342 KG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGI 420 (553)
Q Consensus 342 ~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGl 420 (553)
++ +++|..++.... ......+..++.||+.||+|||++||+||||||+||||+.+ +.+||+|||+
T Consensus 77 ~~~~~~L~~~~~~~~-----~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~---------~~~kL~DfG~ 142 (329)
T cd05618 77 YVNGGDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE---------GHIKLTDYGM 142 (329)
T ss_pred CCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCC---------CCEEEeeCCc
Confidence 75 578887776543 23455666677899999999999999999999999999776 5799999999
Q ss_pred ccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCc-------hHH
Q psy14267 421 ACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN-------TWA 493 (553)
Q Consensus 421 a~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~-------~~~ 493 (553)
++....... .....+||+.|+|||++.+. .++.++|||||||++|||++|..||..... ...
T Consensus 143 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~ 211 (329)
T cd05618 143 CKEGLRPGD--TTSTFCGTPNYIAPEILRGE---------DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTED 211 (329)
T ss_pred cccccCCCC--ccccccCCccccCHHHHcCC---------CCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHH
Confidence 976433222 12356799999999999765 367899999999999999999999953211 111
Q ss_pred HHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q psy14267 494 KMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTV------GNSVTQ 545 (553)
Q Consensus 494 ~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~------~ell~~ 545 (553)
.+..... ..... .+..++..+.++|++||+.||++||++ .++++|
T Consensus 212 ~~~~~i~-~~~~~------~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 212 YLFQVIL-EKQIR------IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred HHHHHHh-cCCCC------CCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 1111111 11111 123578899999999999999999984 566544
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=331.96 Aligned_cols=246 Identities=24% Similarity=0.310 Sum_probs=192.3
Q ss_pred eeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEEEEEe
Q psy14267 262 SLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLME 341 (553)
Q Consensus 262 ~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~iv~e 341 (553)
++||+|+||.||+|++..++. .||||++.+.........+.+..|++++..+.+||+|+.+++++. ....++++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~--~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~--~~~~~~lv~E 76 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDE--VYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQ--TKDRLFFVME 76 (321)
T ss_pred CccccCCCeEEEEEEECCCCC--EEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE--cCCeEEEEEe
Confidence 469999999999998876664 499999987654444556778899999998888999999988774 4567899999
Q ss_pred cC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEeccC
Q psy14267 342 KG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGI 420 (553)
Q Consensus 342 ~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGl 420 (553)
++ +++|..++..... ..+..+..++.||+.||+|||++||+||||||+||||+.+ +.+||+|||+
T Consensus 77 ~~~~~~L~~~l~~~~~-----~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~---------~~~kL~Dfg~ 142 (321)
T cd05591 77 YVNGGDLMFQIQRSRK-----FDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAE---------GHCKLADFGM 142 (321)
T ss_pred CCCCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC---------CCEEEeeccc
Confidence 75 5688888876442 3345556677899999999999999999999999999776 5799999999
Q ss_pred ccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHh
Q psy14267 421 ACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIAR 500 (553)
Q Consensus 421 a~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~~i~~ 500 (553)
+........ .....+||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .....+..
T Consensus 143 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~---------~~~~~~DvwslG~il~el~tg~~Pf~~~~~~-~~~~~i~~ 210 (321)
T cd05591 143 CKEGILNGV--TTTTFCGTPDYIAPEILQEL---------EYGPSVDWWALGVLMYEMMAGQPPFEADNED-DLFESILH 210 (321)
T ss_pred ceecccCCc--cccccccCccccCHHHHcCC---------CCCCccceechhHHHHHHhcCCCCCCCCCHH-HHHHHHHc
Confidence 976543322 12356799999999999765 3688999999999999999999999875432 22232222
Q ss_pred hcccccccccccCCCCCCHHHHHHHHHhcccCCCCCC-------CHHHHHHH
Q psy14267 501 HKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARP-------TVGNSVTQ 545 (553)
Q Consensus 501 ~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RP-------t~~ell~~ 545 (553)
. ... ....++.++.++|.+||+.||++|| ++.+++++
T Consensus 211 ~--~~~------~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 211 D--DVL------YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred C--CCC------CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 1 111 1124679999999999999999999 78888765
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=332.56 Aligned_cols=258 Identities=23% Similarity=0.309 Sum_probs=194.4
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC--
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA-- 332 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~-- 332 (553)
.++|++.+.||+|+||.||++.+...+.. ||||++..... .....+.+.+|+.+++.+. ||||+.+++++....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~ii~~~~~~~~~~~~ 98 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQ-NQTHAKRAYRELVLMKCVN-HKNIIGLLNVFTPQKSL 98 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcE--EEEEEeCcccc-CchhHHHHHHHHHHHHhcC-CCCccccceeecccccc
Confidence 35899999999999999999988766644 99999976442 2344577889999999995 699999988764332
Q ss_pred --CceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCC
Q psy14267 333 --SKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIG 410 (553)
Q Consensus 333 --~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~ 410 (553)
...+|++||+++++|..++... .....+..++.|++.||+|||++||+||||||+|||++.+
T Consensus 99 ~~~~~~~lv~e~~~~~l~~~~~~~-------~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~--------- 162 (364)
T cd07875 99 EEFQDVYIVMELMDANLCQVIQME-------LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD--------- 162 (364)
T ss_pred cccCeEEEEEeCCCCCHHHHHHhc-------CCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCC---------
Confidence 2468999999999998887542 2344556677899999999999999999999999999776
Q ss_pred CeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCc
Q psy14267 411 NVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN 490 (553)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~ 490 (553)
+.+||+|||+++....... .....||+.|+|||++.+. .++.++|||||||+||||++|+.||.....
T Consensus 163 ~~~kL~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~---------~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 230 (364)
T cd07875 163 CTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGM---------GYKENVDIWSVGCIMGEMIKGGVLFPGTDH 230 (364)
T ss_pred CcEEEEeCCCccccCCCCc---ccCCcccCCcCCHHHHhCC---------CCCchhhHHhHHHHHHHHHhCCCCCCCCCH
Confidence 5799999999976543321 2245789999999999765 378899999999999999999999976443
Q ss_pred hHHHHHHHHhhcc--------------------cc--------------cccccccCCCCCCHHHHHHHHHhcccCCCCC
Q psy14267 491 TWAKMLAIARHKD--------------------QI--------------EFKPQLANNVTIPPTLLQSMKLCLQKDPKAR 536 (553)
Q Consensus 491 ~~~~~~~i~~~~~--------------------~~--------------~~~~~~~~~~~~s~~l~~li~~cL~~dP~~R 536 (553)
. ..+..+..... .. .+..........+..+++||.+||+.||++|
T Consensus 231 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R 309 (364)
T cd07875 231 I-DQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 309 (364)
T ss_pred H-HHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccC
Confidence 2 11111111000 00 0000001111235688999999999999999
Q ss_pred CCHHHHHHH
Q psy14267 537 PTVGNSVTQ 545 (553)
Q Consensus 537 Pt~~ell~~ 545 (553)
||+.++++|
T Consensus 310 ~t~~e~L~h 318 (364)
T cd07875 310 ISVDEALQH 318 (364)
T ss_pred CCHHHHhcC
Confidence 999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG1989|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=351.55 Aligned_cols=268 Identities=27% Similarity=0.391 Sum_probs=210.1
Q ss_pred cceEEecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeee-
Q psy14267 248 QDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHD- 326 (553)
Q Consensus 248 ~~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~- 326 (553)
...+++.+-+++|.++|-+|||+.||+|++...+ ..||+|++-.. ++...+...+|+++|++|.+|+|||.+++
T Consensus 29 G~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~--~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yids 103 (738)
T KOG1989|consen 29 GQTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGG--KKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDS 103 (738)
T ss_pred ceEEEECCEEEEEEEEEccCCcEEEEEEEecCCC--ceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEecc
Confidence 3577888899999999999999999999887775 44999998654 45667889999999999999999999998
Q ss_pred EEEeC---C-CceEEEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCC--cEecCCCCCCEEEe
Q psy14267 327 YVYDT---A-SKHLYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAG--IIHSDLKPANFLFV 399 (553)
Q Consensus 327 ~~~~~---~-~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~g--IiHrDLKp~NILl~ 399 (553)
..... . ...++|+||||. +.|.++|..+.... +.+..++.|++|+++|+.+||.+. |||||||-|||||+
T Consensus 104 s~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~---lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls 180 (738)
T KOG1989|consen 104 SAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTR---LTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLS 180 (738)
T ss_pred ccccccCCCceeEEEeehhhccCCcHHHHHHHHHhcc---CChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEc
Confidence 33222 1 246789999988 79999998654432 556677778889999999999887 99999999999998
Q ss_pred cCccceecCCCCeEEEEeccCccccCCCCCcccc-------cCCccCCCccCcccccccCCCCCCCccCCCccchHHHHH
Q psy14267 400 GNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHK-------DTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLG 472 (553)
Q Consensus 400 ~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~-------~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlG 472 (553)
.+ +..||||||.|............ -...-|+.|+|||++.--.. ..++.|+|||+||
T Consensus 181 ~~---------g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg------~pI~eKsDIWALG 245 (738)
T KOG1989|consen 181 AD---------GNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSG------LPIGEKSDIWALG 245 (738)
T ss_pred CC---------CCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcC------CCCcchhHHHHHH
Confidence 87 67999999998754433211100 01236999999999964322 2489999999999
Q ss_pred HHHHHHHhCCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 473 CILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 473 vvl~elltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
|+||.|++...||+.... .+|...... +++ ...++..|++||+.||+.||++||++-+++.++-.+
T Consensus 246 clLYkLCy~t~PFe~sg~-----laIlng~Y~--~P~----~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l 311 (738)
T KOG1989|consen 246 CLLYKLCYFTTPFEESGK-----LAILNGNYS--FPP----FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFEL 311 (738)
T ss_pred HHHHHHHHhCCCcCcCcc-----eeEEecccc--CCC----CccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHH
Confidence 999999999999987321 122222222 222 236789999999999999999999999999988664
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=319.05 Aligned_cols=264 Identities=20% Similarity=0.296 Sum_probs=202.0
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCC---ccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeC
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEH---EFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDT 331 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~---~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~ 331 (553)
..+|++.+.||+|+||.||++...... ....||+|.+.... .......+.+|+.+|.++. ||||+.+++++.
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~-- 78 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQ-HPNIVCLLGVCT-- 78 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcC-CcccceEEEEEc--
Confidence 357999999999999999999875543 22459999986543 2334567899999999995 599999998774
Q ss_pred CCceEEEEEecC-CCCHHHHHHHcccCCC-----------CchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEe
Q psy14267 332 ASKHLYVLMEKG-DTDLSKYMRNLNKMTT-----------LPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFV 399 (553)
Q Consensus 332 ~~~~~~iv~e~~-~~~L~~~l~~~~~~~~-----------~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~ 399 (553)
.....+++||+. +++|.+++........ .......++.++.|++.||+|||++||+||||||+|||++
T Consensus 79 ~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~ 158 (283)
T cd05048 79 KEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVG 158 (283)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEc
Confidence 345678888865 5799999986533222 2344556677788999999999999999999999999997
Q ss_pred cCccceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHH
Q psy14267 400 GNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI 479 (553)
Q Consensus 400 ~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ell 479 (553)
.+ +.+||+|||+++...............+++.|+|||.+.+. .++.++|||||||++|||+
T Consensus 159 ~~---------~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~sDv~slG~il~el~ 220 (283)
T cd05048 159 EG---------LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG---------KFTTESDIWSFGVVLWEIF 220 (283)
T ss_pred CC---------CcEEECCCcceeeccccccccccCCCcccccccCHHHhccC---------cCchhhhHHHHHHHHHHHH
Confidence 76 57999999999866443322223344578899999998755 3688999999999999999
Q ss_pred h-CCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 480 Y-GRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 480 t-G~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
+ |..||.+.... .....+... ... .....++.++.+|+.+||+.||.+||++.+|+++|+.+
T Consensus 221 ~~g~~p~~~~~~~-~~~~~i~~~-~~~------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 221 SYGLQPYYGFSNQ-EVIEMIRSR-QLL------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred cCCCCCCCCCCHH-HHHHHHHcC-CcC------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 7 99999875442 222222211 111 11236889999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=326.72 Aligned_cols=257 Identities=24% Similarity=0.380 Sum_probs=195.6
Q ss_pred cCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCC
Q psy14267 254 NGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTAS 333 (553)
Q Consensus 254 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~ 333 (553)
..++|++++.||+|+||.||++++..++.. ||+|++.... .....+++.+|+++|+++. ||||+++++++.. +
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~--~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~--~ 75 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLI--MARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYS--D 75 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcE--EEEEEeeccc--CHHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEE--C
Confidence 457899999999999999999988777654 9999997643 2344578999999999995 5999999998754 4
Q ss_pred ceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhC-CcEecCCCCCCEEEecCccceecCCCC
Q psy14267 334 KHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAA-GIIHSDLKPANFLFVGNVLKIIDCIGN 411 (553)
Q Consensus 334 ~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~-gIiHrDLKp~NILl~~~~~~~~~~~~~ 411 (553)
..++++||++ +++|.+++..... .....+..++.|++.||.|||+. +|+||||||+|||++.+ +
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~---------~ 141 (331)
T cd06649 76 GEISICMEHMDGGSLDQVLKEAKR-----IPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSR---------G 141 (331)
T ss_pred CEEEEEeecCCCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCC---------C
Confidence 5788999975 5689998876432 33455666778999999999986 69999999999999776 5
Q ss_pred eEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCch
Q psy14267 412 VLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNT 491 (553)
Q Consensus 412 ~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~ 491 (553)
.+||+|||++........ ....||+.|+|||++.+. .++.++|||||||+||||++|+.||......
T Consensus 142 ~~kl~Dfg~~~~~~~~~~----~~~~g~~~y~aPE~~~~~---------~~~~~~DiwslG~il~el~tg~~p~~~~~~~ 208 (331)
T cd06649 142 EIKLCDFGVSGQLIDSMA----NSFVGTRSYMSPERLQGT---------HYSVQSDIWSMGLSLVELAIGRYPIPPPDAK 208 (331)
T ss_pred cEEEccCccccccccccc----ccCCCCcCcCCHhHhcCC---------CCCchHhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 799999999976644322 245699999999999765 3788999999999999999999999753321
Q ss_pred HHHHHHHHhhcc----------------------------------------ccc-ccccccCCCCCCHHHHHHHHHhcc
Q psy14267 492 WAKMLAIARHKD----------------------------------------QIE-FKPQLANNVTIPPTLLQSMKLCLQ 530 (553)
Q Consensus 492 ~~~~~~i~~~~~----------------------------------------~~~-~~~~~~~~~~~s~~l~~li~~cL~ 530 (553)
.+..+..... .+. ..........+++++++||.+||+
T Consensus 209 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 286 (331)
T cd06649 209 --ELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLI 286 (331)
T ss_pred --HHHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHcc
Confidence 1111110000 000 000000112467899999999999
Q ss_pred cCCCCCCCHHHHHHHH
Q psy14267 531 KDPKARPTVGNSVTQI 546 (553)
Q Consensus 531 ~dP~~RPt~~ell~~L 546 (553)
.||++|||+++|+++.
T Consensus 287 ~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 287 KNPAERADLKMLMNHT 302 (331)
T ss_pred CCcccCCCHHHHhcCh
Confidence 9999999999999863
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=334.85 Aligned_cols=274 Identities=19% Similarity=0.278 Sum_probs=207.3
Q ss_pred ceEEecCcceEEEeeeeeeCceEEEEEeeeCCCc---cceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEee
Q psy14267 249 DVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHE---FKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMH 325 (553)
Q Consensus 249 ~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~---~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~ 325 (553)
..+.+..++|+++++||+|+||.||++.+..... ...||||++..... ....+.+++|+++|+++..||||++++
T Consensus 30 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~~l~~l~~HpnIv~l~ 107 (400)
T cd05105 30 SRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR--SSEKQALMSELKIMTHLGPHLNIVNLL 107 (400)
T ss_pred CceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhcCCCCCeeeEE
Confidence 3466777899999999999999999997643321 23599999965432 233467999999999997689999999
Q ss_pred eEEEeCCCceEEEEEecC-CCCHHHHHHHcccCC----------------------------------------------
Q psy14267 326 DYVYDTASKHLYVLMEKG-DTDLSKYMRNLNKMT---------------------------------------------- 358 (553)
Q Consensus 326 ~~~~~~~~~~~~iv~e~~-~~~L~~~l~~~~~~~---------------------------------------------- 358 (553)
+++. ....+|++||++ +++|.+++.......
T Consensus 108 ~~~~--~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 185 (400)
T cd05105 108 GACT--KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADT 185 (400)
T ss_pred EEEc--cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccc
Confidence 9874 456789999975 678998887532100
Q ss_pred ---------------------------------------------CCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCC
Q psy14267 359 ---------------------------------------------TLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKP 393 (553)
Q Consensus 359 ---------------------------------------------~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp 393 (553)
...+.+..++.++.||+.||+|||+.+|+||||||
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp 265 (400)
T cd05105 186 TQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAA 265 (400)
T ss_pred cccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCh
Confidence 01244555677888999999999999999999999
Q ss_pred CCEEEecCccceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHH
Q psy14267 394 ANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGC 473 (553)
Q Consensus 394 ~NILl~~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGv 473 (553)
+|||++.+ +.+||+|||+++...............++..|+|||.+.+. .++.++|||||||
T Consensus 266 ~Nill~~~---------~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~DiwSlGv 327 (400)
T cd05105 266 RNVLLAQG---------KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDN---------LYTTLSDVWSYGI 327 (400)
T ss_pred HhEEEeCC---------CEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCC---------CCCchhhHHHHHH
Confidence 99999876 57999999999876543332222344577899999998765 3688999999999
Q ss_pred HHHHHHh-CCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q psy14267 474 ILYNMIY-GRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNPE 551 (553)
Q Consensus 474 vl~ellt-G~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~~ 551 (553)
++|||++ |..||............+... .. ......++.++.++|.+||+.||++||++.+|.+.|++...
T Consensus 328 il~ellt~g~~P~~~~~~~~~~~~~~~~~-~~------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 328 LLWEIFSLGGTPYPGMIVDSTFYNKIKSG-YR------MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HHHHHHHCCCCCCcccchhHHHHHHHhcC-CC------CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 9999996 999997743322222222211 11 11223678999999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=324.15 Aligned_cols=259 Identities=25% Similarity=0.397 Sum_probs=195.5
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|.+.+.||+|+||.||++++..++.. ||+|+++...... ....+.+|+.++++++ ||||+++++++.. +..
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~--vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~--~~~ 78 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENL--VALKEIRLEHEEG--APCTAIREVSLLKDLK-HANIVTLHDIVHT--DKS 78 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCe--EEEEEeeccccCC--cchhHHHHHHHHHhCC-CCCcceEEEEEee--CCe
Confidence 5799999999999999999988766654 9999997654322 2345778999999995 5999999998754 567
Q ss_pred EEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 336 LYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 336 ~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
++++||+..++|.+++..... ......+..++.||+.||+|||++||+||||||+||||+.+ +.+||
T Consensus 79 ~~lv~e~~~~~l~~~~~~~~~----~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~---------~~~kl 145 (309)
T cd07872 79 LTLVFEYLDKDLKQYMDDCGN----IMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINER---------GELKL 145 (309)
T ss_pred EEEEEeCCCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC---------CCEEE
Confidence 899999999999998876532 23344556667799999999999999999999999999776 57999
Q ss_pred EeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHH
Q psy14267 416 IDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKM 495 (553)
Q Consensus 416 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~ 495 (553)
+|||++......... .....+++.|+|||++.+.. .++.++|||||||++|||++|+.||...... ..+
T Consensus 146 ~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~--------~~~~~~DiwslG~il~el~tg~~pf~~~~~~-~~~ 214 (309)
T cd07872 146 ADFGLARAKSVPTKT--YSNEVVTLWYRPPDVLLGSS--------EYSTQIDMWGVGCIFFEMASGRPLFPGSTVE-DEL 214 (309)
T ss_pred CccccceecCCCccc--cccccccccccCCHHHhCCC--------CCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHH
Confidence 999999765433221 12446899999999986542 3688999999999999999999999764432 111
Q ss_pred HHHHhhcc-----------------ccccc-----ccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 496 LAIARHKD-----------------QIEFK-----PQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 496 ~~i~~~~~-----------------~~~~~-----~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
..+..... ...+. +.......++.++++||.+||+.||++|||+.|++.+
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 215 HLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred HHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 11111000 00000 0011123578899999999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=329.10 Aligned_cols=243 Identities=23% Similarity=0.339 Sum_probs=188.4
Q ss_pred eeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEEEEEecC
Q psy14267 264 LGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEKG 343 (553)
Q Consensus 264 LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~iv~e~~ 343 (553)
||+|+||.||+|++..++.. ||+|++.+...........+.+|+.+|+++ +||||+.+++++. ....++++||++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~--~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~--~~~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRI--YALKTIRKAHIVSRSEVTHTLAERTVLAQV-NCPFIVPLKFSFQ--SPEKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECCCCCE--EEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCcEeceeeEEe--cCCeEEEEEcCC
Confidence 79999999999988776644 999999865544445567888999999999 5699999988764 456788999974
Q ss_pred -CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEeccCcc
Q psy14267 344 -DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIAC 422 (553)
Q Consensus 344 -~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGla~ 422 (553)
+++|.+++..... .....+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++
T Consensus 76 ~~g~L~~~l~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~---------~~~kl~Dfg~~~ 141 (312)
T cd05585 76 NGGELFHHLQREGR-----FDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQ---------GHIALCDFGLCK 141 (312)
T ss_pred CCCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCC---------CcEEEEECcccc
Confidence 6789888876432 3445566677899999999999999999999999999776 579999999997
Q ss_pred ccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHhhc
Q psy14267 423 SLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARHK 502 (553)
Q Consensus 423 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~~i~~~~ 502 (553)
....... .....+||+.|+|||++.+. .++.++|||||||++|||++|..||...... .....+..
T Consensus 142 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~---------~~~~~~DvwslGvil~el~tg~~pf~~~~~~-~~~~~~~~-- 207 (312)
T cd05585 142 LNMKDDD--KTNTFCGTPEYLAPELLLGH---------GYTKAVDWWTLGVLLYEMLTGLPPFYDENVN-EMYRKILQ-- 207 (312)
T ss_pred cCccCCC--ccccccCCcccCCHHHHcCC---------CCCCccceechhHHHHHHHhCCCCcCCCCHH-HHHHHHHc--
Confidence 6433222 22356799999999999765 3788999999999999999999999874332 22222221
Q ss_pred ccccccccccCCCCCCHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q psy14267 503 DQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT---VGNSVTQ 545 (553)
Q Consensus 503 ~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt---~~ell~~ 545 (553)
.... ....+++.++++|.+||..||++||+ +.+++.|
T Consensus 208 ~~~~------~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 208 EPLR------FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred CCCC------CCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 1111 12357899999999999999999985 5666654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=333.26 Aligned_cols=262 Identities=24% Similarity=0.411 Sum_probs=200.9
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|.+.+.||+|+||+||+|++..++.. ||||++++.........+.+.+|+.+++.+ +|+||+.+++++. ....
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~--~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~~~~i~~~~~~~~--~~~~ 75 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDI--YAMKVMKKSVLLAQETVSFFEEERDILSIS-NSPWIPQLQYAFQ--DKDN 75 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCE--EEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceeeEEe--cCCe
Confidence 3699999999999999999988776654 999999876554445567788999999887 5699999987764 3567
Q ss_pred EEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
++++||++ +++|.+++..... ......+..++.||+.||+|||++||+||||||+||||+.+ +.+|
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~---------~~~k 142 (330)
T cd05601 76 LYLVMEYQPGGDLLSLLNRYED----QFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRT---------GHIK 142 (330)
T ss_pred EEEEECCCCCCCHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCC---------CCEE
Confidence 89999975 6899999877532 23445556667799999999999999999999999999776 6799
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||++..+...... ......||+.|+|||++.....++ ...++.++|||||||++|||++|..||...... ..
T Consensus 143 L~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~---~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-~~ 217 (330)
T cd05601 143 LADFGSAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDG---KGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA-KT 217 (330)
T ss_pred eccCCCCeECCCCCce-eeecccCCccccCHHHhccccccc---cCCCCCcceeecccceeeeeccCCCCCCCCCHH-HH
Confidence 9999999876544322 222457999999999987432210 114788999999999999999999999875432 22
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
+..+........ ......++.++.+||..||. +|++||++.+++.+
T Consensus 218 ~~~i~~~~~~~~----~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 218 YNNIMNFQRFLK----FPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred HHHHHcCCCccC----CCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 233322221111 12233578999999999998 99999999999865
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=329.35 Aligned_cols=244 Identities=23% Similarity=0.336 Sum_probs=188.3
Q ss_pred eeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEEEEEe
Q psy14267 262 SLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLME 341 (553)
Q Consensus 262 ~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~iv~e 341 (553)
++||+|+||.||+|++..++.. ||||++++.........+.+..|..++..+.+||+|+++++++. ...++|++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~--~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~--~~~~~~lv~E 76 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEY--FAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQ--TKEHLFFVME 76 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCE--EEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEE--eCCEEEEEEC
Confidence 4799999999999998877654 99999987543323345677889999988778899999988774 3568999999
Q ss_pred cC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEeccC
Q psy14267 342 KG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGI 420 (553)
Q Consensus 342 ~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGl 420 (553)
++ +++|..++.... ......+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+
T Consensus 77 ~~~~g~L~~~i~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~---------~~~kl~Dfg~ 142 (316)
T cd05620 77 FLNGGDLMFHIQDKG-----RFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRD---------GHIKIADFGM 142 (316)
T ss_pred CCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC---------CCEEeCccCC
Confidence 75 568888887643 23455666677899999999999999999999999999776 5799999999
Q ss_pred ccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHh
Q psy14267 421 ACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIAR 500 (553)
Q Consensus 421 a~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~~i~~ 500 (553)
++....... .....+||+.|+|||++.+. .++.++|||||||++|||++|..||...... .....+..
T Consensus 143 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslGvil~el~~g~~Pf~~~~~~-~~~~~~~~ 210 (316)
T cd05620 143 CKENVFGDN--RASTFCGTPDYIAPEILQGL---------KYTFSVDWWSFGVLLYEMLIGQSPFHGDDED-ELFESIRV 210 (316)
T ss_pred CeecccCCC--ceeccCCCcCccCHHHHcCC---------CCCcccchhhhHHHHHHHHhCCCCCCCCCHH-HHHHHHHh
Confidence 875432222 12356799999999999765 3788999999999999999999999765432 22222221
Q ss_pred hcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHH-HHH
Q psy14267 501 HKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVG-NSV 543 (553)
Q Consensus 501 ~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~-ell 543 (553)
. . +... ..++.+++++|.+||+.||++||++. +++
T Consensus 211 ~--~----~~~~--~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 211 D--T----PHYP--RWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred C--C----CCCC--CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 1 1 1111 14678999999999999999999984 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=336.35 Aligned_cols=254 Identities=29% Similarity=0.470 Sum_probs=209.5
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|.++++||+|+||.+++++++..... |++|.+.......... +...+|+.++++++ |||||.+.+.|+.. +.+
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~--~vlK~I~l~~~t~~~r-~~A~~E~~lis~~~-hP~iv~y~ds~~~~-~~~ 78 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKL--YVLKKINLEKLTEPER-RSAIQEMDLLSKLL-HPNIVEYKDSFEED-GQL 78 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCce--EEEEEEeccccCchhh-HHHHHHHHHHHhcc-CCCeeeeccchhcC-Cce
Confidence 5799999999999999999998877765 9999999988776443 57899999999985 59999999987653 556
Q ss_pred EEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
++|+|+|+ ||++.+.+.+.. ...+.+..+..++.|++.|+.|||+++|+|||||+.|||+..+ +.||
T Consensus 79 l~Ivm~Y~eGg~l~~~i~~~k---~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~---------~~Vk 146 (426)
T KOG0589|consen 79 LCIVMEYCEGGDLAQLIKEQK---GVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKD---------KKVK 146 (426)
T ss_pred EEEEEeecCCCCHHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhcccc---------Ccee
Confidence 89999975 568888887765 2355667778888899999999999999999999999999877 4689
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||+|+.+.+... ...+..||+.||.||++.+.+ |+.++|||||||++|||++-+.+|...+.. ..
T Consensus 147 LgDfGlaK~l~~~~~--~a~tvvGTp~YmcPEil~d~p---------Yn~KSDiWsLGC~~yEm~~lk~aF~a~~m~-~L 214 (426)
T KOG0589|consen 147 LGDFGLAKILNPEDS--LASTVVGTPYYMCPEILSDIP---------YNEKSDIWSLGCCLYEMCTLKPAFKASNMS-EL 214 (426)
T ss_pred ecchhhhhhcCCchh--hhheecCCCcccCHHHhCCCC---------CCccCcchhhcchHHHHHhcccccCccchH-HH
Confidence 999999999987652 234788999999999999884 789999999999999999999999874332 22
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
...+.... ..| ....++.+++.+|+.||.++|+.||++.+||.+
T Consensus 215 i~ki~~~~----~~P---lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 215 ILKINRGL----YSP---LPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HHHHhhcc----CCC---CCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 33333222 222 223678999999999999999999999999875
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=329.46 Aligned_cols=246 Identities=24% Similarity=0.332 Sum_probs=192.5
Q ss_pred eeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEEEEEe
Q psy14267 262 SLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLME 341 (553)
Q Consensus 262 ~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~iv~e 341 (553)
+.||+|+||+||+|++..++.. ||||++++...........+.+|+.+++.+.+||||+++++++. ....++++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~--~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~--~~~~~~lv~e 76 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDEL--YAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQ--TKDRLFFVME 76 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCE--EEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE--cCCEEEEEEc
Confidence 4699999999999988766644 99999987654444556778899999999988899999998764 3567899999
Q ss_pred cC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEeccC
Q psy14267 342 KG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGI 420 (553)
Q Consensus 342 ~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGl 420 (553)
++ +++|..++.... ......+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+
T Consensus 77 ~~~~~~L~~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~---------~~~kl~Dfg~ 142 (318)
T cd05570 77 YVNGGDLMFHIQRSG-----RFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSE---------GHIKIADFGM 142 (318)
T ss_pred CCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCC---------CcEEecccCC
Confidence 75 578888877653 23455666677899999999999999999999999999776 5799999999
Q ss_pred ccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHh
Q psy14267 421 ACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIAR 500 (553)
Q Consensus 421 a~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~~i~~ 500 (553)
++....... .....+||+.|+|||++.+. .++.++|||||||++|||++|..||...... .....+..
T Consensus 143 ~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~---------~~~~~~DiwslGvil~~l~~G~~pf~~~~~~-~~~~~i~~ 210 (318)
T cd05570 143 CKEGILGGV--TTSTFCGTPDYIAPEILSYQ---------PYGPAVDWWALGVLLYEMLAGQSPFEGDDED-ELFQSILE 210 (318)
T ss_pred CeecCcCCC--cccceecCccccCHHHhcCC---------CCCcchhhhhHHHHHHHHhhCCCCCCCCCHH-HHHHHHHc
Confidence 875433222 12245799999999999765 3788999999999999999999999865432 22222221
Q ss_pred hcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q psy14267 501 HKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTV-----GNSVTQ 545 (553)
Q Consensus 501 ~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~-----~ell~~ 545 (553)
. ...+ ...++..+.+||++||..||++||++ .+++++
T Consensus 211 ~--~~~~------~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 211 D--EVRY------PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred C--CCCC------CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 1 1111 22578999999999999999999999 887764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=334.88 Aligned_cols=264 Identities=26% Similarity=0.419 Sum_probs=200.5
Q ss_pred EecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeC
Q psy14267 252 TLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDT 331 (553)
Q Consensus 252 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~ 331 (553)
.+..++|++.+.||+|+||.||+|++..++.. ||+|++.+.........+.+.+|+.+++.+ +||||+++++.+.
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~--~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~-- 113 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKV--YAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQ-- 113 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcE--EEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEE--
Confidence 44557899999999999999999988877654 999999765444444456678899999888 5699999987764
Q ss_pred CCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCC
Q psy14267 332 ASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIG 410 (553)
Q Consensus 332 ~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~ 410 (553)
...+++++||++ +++|..++.... .....+..++.||+.||+|||++||+||||||+||||+.+
T Consensus 114 ~~~~~~lv~Ey~~gg~L~~~~~~~~------~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~--------- 178 (371)
T cd05622 114 DDRYLYMVMEYMPGGDLVNLMSNYD------VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS--------- 178 (371)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHhcC------CCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCC---------
Confidence 467899999986 678988886532 2344556667899999999999999999999999999776
Q ss_pred CeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCc
Q psy14267 411 NVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN 490 (553)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~ 490 (553)
+.+||+|||+++........ .....+||+.|||||++.+...++ .++.++|||||||+||||++|..||.....
T Consensus 179 ~~ikL~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~-----~~~~~~DiwSlGvilyell~G~~Pf~~~~~ 252 (371)
T cd05622 179 GHLKLADFGTCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDG-----YYGRECDWWSVGVFLYEMLVGDTPFYADSL 252 (371)
T ss_pred CCEEEEeCCceeEcCcCCcc-cccCcccCccccCHHHHhccCCCc-----cCCCccceeehhHHHHHHHhCCCCCCCCCH
Confidence 67999999999876543221 223567999999999997653211 378899999999999999999999987443
Q ss_pred hHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCC--CCCHHHHHHHH
Q psy14267 491 TWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKA--RPTVGNSVTQI 546 (553)
Q Consensus 491 ~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~--RPt~~ell~~L 546 (553)
. .....+........ ......++..++++|..||..++.+ |+++.+++++.
T Consensus 253 ~-~~~~~i~~~~~~~~----~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 253 V-GTYSKIMNHKNSLT----FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred H-HHHHHHHcCCCccc----CCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 2 23333332222222 2223468899999999999844433 78999998864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=316.80 Aligned_cols=267 Identities=22% Similarity=0.365 Sum_probs=200.2
Q ss_pred EEecCcceEEEeeeeeeCceEEEEEeeeCC---CccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeE
Q psy14267 251 ITLNGKQYQVLSLLGKGGSSSVYLVGGTSE---HEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDY 327 (553)
Q Consensus 251 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~---~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~ 327 (553)
|++..++|++.+.||+|+||.||++.+... .....||||++..... ......+.+|+.+++.+. ||||++++++
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~-~~~iv~~~~~ 77 (277)
T cd05062 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS--MRERIEFLNEASVMKEFN-CHHVVRLLGV 77 (277)
T ss_pred CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC--HHHHHHHHHHHHHHHhCC-CCCeeeEEEE
Confidence 345677899999999999999999876421 2235599998865432 223467889999999985 6999999887
Q ss_pred EEeCCCceEEEEEec-CCCCHHHHHHHcccCC-----CCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecC
Q psy14267 328 VYDTASKHLYVLMEK-GDTDLSKYMRNLNKMT-----TLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGN 401 (553)
Q Consensus 328 ~~~~~~~~~~iv~e~-~~~~L~~~l~~~~~~~-----~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~ 401 (553)
+ ......+++||+ .+++|.+++....... ........++.++.|++.||+|||+.|++||||||+|||++.+
T Consensus 78 ~--~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~ 155 (277)
T cd05062 78 V--SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED 155 (277)
T ss_pred E--cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCC
Confidence 6 345678889986 5578999987643211 1223455667778899999999999999999999999999876
Q ss_pred ccceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-
Q psy14267 402 VLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY- 480 (553)
Q Consensus 402 ~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt- 480 (553)
+.++|+|||+++...............+++.|||||++.+. .++.++|||||||++|||++
T Consensus 156 ---------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~~l~el~~~ 217 (277)
T cd05062 156 ---------FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG---------VFTTYSDVWSFGVVLWEIATL 217 (277)
T ss_pred ---------CCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcC---------CcCchhHHHHHHHHHHHHHcC
Confidence 57999999999766443322222234567889999998755 36889999999999999998
Q ss_pred CCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q psy14267 481 GRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINN 548 (553)
Q Consensus 481 G~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~ 548 (553)
|..||.+.... .....+.. ..... ....++..+.+++.+||+.+|++|||+.|+++.|+.
T Consensus 218 ~~~p~~~~~~~-~~~~~~~~-~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 218 AEQPYQGMSNE-QVLRFVME-GGLLD------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred CCCCCCCCCHH-HHHHHHHc-CCcCC------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 79999875443 22222211 11111 123578899999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=324.18 Aligned_cols=266 Identities=21% Similarity=0.307 Sum_probs=192.9
Q ss_pred EeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEEEEE
Q psy14267 261 LSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLM 340 (553)
Q Consensus 261 ~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~iv~ 340 (553)
..+||+|+||.||+|+.........||+|.+..... ...+.+|+.+|+++. ||||+++++++....+..++++|
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELK-HPNVIALQKVFLSHSDRKVWLLF 79 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCC-CCCeeeEEEEEeccCCCeEEEEE
Confidence 368999999999999877655556799999865432 245778999999995 59999999988777778899999
Q ss_pred ecCCCCHHHHHHHcccC----CCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEE
Q psy14267 341 EKGDTDLSKYMRNLNKM----TTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKII 416 (553)
Q Consensus 341 e~~~~~L~~~l~~~~~~----~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~ 416 (553)
++++++|.+++...... .........+..++.||+.||+|||++||+||||||+|||+..+. ...+.+||+
T Consensus 80 e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~-----~~~~~~kl~ 154 (317)
T cd07867 80 DYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEG-----PERGRVKIA 154 (317)
T ss_pred eeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCC-----CCCCcEEEe
Confidence 99999999888643211 122345566777788999999999999999999999999995431 123579999
Q ss_pred eccCccccCCCCCc-ccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCch----
Q psy14267 417 DFGIACSLQDDKTS-VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNT---- 491 (553)
Q Consensus 417 DFGla~~~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~---- 491 (553)
|||+++........ .......||+.|+|||++.+.. .++.++|||||||+||||++|.+||......
T Consensus 155 DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--------~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~ 226 (317)
T cd07867 155 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGAR--------HYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTS 226 (317)
T ss_pred eccceeccCCCcccccccCcceecccccCcHHhcCCC--------ccCcHHHHHhHHHHHHHHHhCCCCccccccccccc
Confidence 99999876543221 1123456899999999987542 3688999999999999999999999743211
Q ss_pred ----HHHHHHHHhhcc-------------------------cccccc-----cccCCCCCCHHHHHHHHHhcccCCCCCC
Q psy14267 492 ----WAKMLAIARHKD-------------------------QIEFKP-----QLANNVTIPPTLLQSMKLCLQKDPKARP 537 (553)
Q Consensus 492 ----~~~~~~i~~~~~-------------------------~~~~~~-----~~~~~~~~s~~l~~li~~cL~~dP~~RP 537 (553)
...+..+..... ...... ........+..+.+||.+||..||++||
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~ 306 (317)
T cd07867 227 NPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRI 306 (317)
T ss_pred ccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCccccc
Confidence 000100000000 000000 0001113456789999999999999999
Q ss_pred CHHHHHHH
Q psy14267 538 TVGNSVTQ 545 (553)
Q Consensus 538 t~~ell~~ 545 (553)
|+.|++++
T Consensus 307 t~~e~l~h 314 (317)
T cd07867 307 TSEQALQD 314 (317)
T ss_pred CHHHHhcC
Confidence 99999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG2345|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=302.74 Aligned_cols=275 Identities=27% Similarity=0.432 Sum_probs=210.6
Q ss_pred cceEEecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeE
Q psy14267 248 QDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDY 327 (553)
Q Consensus 248 ~~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~ 327 (553)
...+.+++++|++.++||+|||+.||+++...++.. ||+|.+.-.. .+..+..++|++..+++.+ |||++++++
T Consensus 13 ~~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~--YAlKkI~c~~---~~~~e~~~rEid~~rkf~s-~~vl~l~dh 86 (302)
T KOG2345|consen 13 RGTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHL--YALKKILCHS---QEDIEEALREIDNHRKFNS-PNVLRLVDH 86 (302)
T ss_pred CCcEEEcCceEEEeeeecCCCceeeeeecccCcccc--hhhheeeccc---hHHHHHHHHHHHHHHhhCC-cchHHHHHH
Confidence 445678999999999999999999999998888766 9999997654 3456889999999999966 999999887
Q ss_pred EEeCC---CceEEEEEe-cCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCC--cEecCCCCCCEEEecC
Q psy14267 328 VYDTA---SKHLYVLME-KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAG--IIHSDLKPANFLFVGN 401 (553)
Q Consensus 328 ~~~~~---~~~~~iv~e-~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~g--IiHrDLKp~NILl~~~ 401 (553)
..... ....|++++ |..|+|.+.++...... ...++..+..++.++++||++||+.. ++||||||.|||+.++
T Consensus 87 ~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg-~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~ 165 (302)
T KOG2345|consen 87 QLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKG-NFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDS 165 (302)
T ss_pred HHHhhccCceeEEEEeehhccccHHHHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCC
Confidence 54432 345788888 46788999998875433 24566777788889999999999998 9999999999999775
Q ss_pred ccceecCCCCeEEEEeccCccccCCCCC----ccc---ccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHH
Q psy14267 402 VLKIIDCIGNVLKIIDFGIACSLQDDKT----SVH---KDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCI 474 (553)
Q Consensus 402 ~~~~~~~~~~~vkL~DFGla~~~~~~~~----~~~---~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvv 474 (553)
+.++|.|||.++...-.-. ... -.....|..|.|||++..+.+. .++.++|||||||+
T Consensus 166 ---------~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~------ti~ertDIWSLGCt 230 (302)
T KOG2345|consen 166 ---------GLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHC------TITERTDIWSLGCT 230 (302)
T ss_pred ---------CceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCc------ccccccchhhhhHH
Confidence 6799999999875432111 000 1122368999999999876543 48999999999999
Q ss_pred HHHHHhCCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 475 LYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 475 l~elltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
||+|++|.-||...-..-.. .+.+....++ .+++...++..+.++|+.||+.||.+||++.+++..++..
T Consensus 231 LYa~mf~~sPfe~~~~~GgS-laLAv~n~q~----s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 231 LYAMMFGESPFERIYQQGGS-LALAVQNAQI----SIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred HHHHHHcCCcchHHhhcCCe-EEEeeecccc----ccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 99999999999642110000 0000001111 1233345899999999999999999999999999999864
|
|
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=318.95 Aligned_cols=244 Identities=23% Similarity=0.355 Sum_probs=199.6
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
-++|..+++||+|+||+|.+++.+.++.. ||||+++++.+.....+..-+.|-++|+..+| |++..+...| +...
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~--YAiKIlkKeviiakdEVAHTlTE~RVL~~~~H-PFLt~LKYsF--Qt~d 241 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKL--YAIKILKKEVIIAKDEVAHTLTENRVLQNCRH-PFLTSLKYSF--QTQD 241 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCce--eehhhhhhhheeehHHhhhhhhHHHHHHhccC-cHHHHhhhhh--ccCc
Confidence 45799999999999999999999888876 99999999988887778888999999999965 9998875333 4567
Q ss_pred eEEEEEec-CCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 335 HLYVLMEK-GDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 335 ~~~iv~e~-~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
+++.|||| .||.|.-++.+.. .+++.....+..+|+.||.|||+++||+||||.+|+|||.+ |.|
T Consensus 242 rlCFVMeyanGGeLf~HLsrer-----~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkD---------GHI 307 (516)
T KOG0690|consen 242 RLCFVMEYANGGELFFHLSRER-----VFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKD---------GHI 307 (516)
T ss_pred eEEEEEEEccCceEeeehhhhh-----cccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccC---------Cce
Confidence 88888886 6778888777644 34455566777899999999999999999999999999888 789
Q ss_pred EEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHH
Q psy14267 414 KIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWA 493 (553)
Q Consensus 414 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~ 493 (553)
||+||||++.-...+. ...++||||.|+|||++... .|++++|+|.+||+||||++|++||.+-.. .
T Consensus 308 KitDFGLCKE~I~~g~--t~kTFCGTPEYLAPEVleDn---------DYgraVDWWG~GVVMYEMmCGRLPFyn~dh--~ 374 (516)
T KOG0690|consen 308 KITDFGLCKEEIKYGD--TTKTFCGTPEYLAPEVLEDN---------DYGRAVDWWGVGVVMYEMMCGRLPFYNKDH--E 374 (516)
T ss_pred Eeeecccchhcccccc--eeccccCChhhcCchhhccc---------cccceeehhhhhHHHHHHHhccCcccccch--h
Confidence 9999999987554433 24589999999999999766 488999999999999999999999987433 2
Q ss_pred HHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCC
Q psy14267 494 KMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARP 537 (553)
Q Consensus 494 ~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RP 537 (553)
.+..++- ...+.|+ ..++++.+.|+..+|.+||.+|.
T Consensus 375 kLFeLIl-~ed~kFP------r~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 375 KLFELIL-MEDLKFP------RTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred HHHHHHH-hhhccCC------ccCCHHHHHHHHHHhhcChHhhc
Confidence 2222221 1222333 37889999999999999999996
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=319.07 Aligned_cols=255 Identities=23% Similarity=0.363 Sum_probs=194.4
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceE
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHL 336 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~ 336 (553)
.|++.++||+|+||+||++.+..++.. ||||++.............+.+|+.+++++. ||||+.+++++. ....+
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~--vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--~~~~~ 75 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKM--YACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSLAYAYE--TKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCce--EEEEEEehhhhhhhhhHHHHHHHHHHHHhcC-CCCEeeeeeeec--CCCeE
Confidence 388999999999999999987766544 9999998765544444466789999999995 599999988763 35678
Q ss_pred EEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 337 YVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 337 ~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
+++||++ +++|..++..... .......+..++.|++.||.|||+.||+||||||+||+++.+ +.++|
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~---------~~~~l 143 (285)
T cd05605 76 CLVLTLMNGGDLKFHIYNMGN---PGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDY---------GHIRI 143 (285)
T ss_pred EEEEeccCCCcHHHHHHhcCc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCC---------CCEEE
Confidence 9999975 5788877765432 134455666677899999999999999999999999999766 57999
Q ss_pred EeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHH
Q psy14267 416 IDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKM 495 (553)
Q Consensus 416 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~ 495 (553)
+|||++........ .....|++.|+|||++.+. .++.++|||||||++|||++|..||.+..... ..
T Consensus 144 ~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~---------~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~-~~ 210 (285)
T cd05605 144 SDLGLAVEIPEGET---IRGRVGTVGYMAPEVVKNE---------RYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV-KR 210 (285)
T ss_pred eeCCCceecCCCCc---cccccCCCCccCcHHhcCC---------CCCccccchhHHHHHHHHHHCCCCCCCCchhh-HH
Confidence 99999987643322 1245789999999999755 36889999999999999999999998743321 11
Q ss_pred HHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q psy14267 496 LAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARP-----TVGNSVTQ 545 (553)
Q Consensus 496 ~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RP-----t~~ell~~ 545 (553)
..+...... ........++..+.+||.+||..||++|| ++++++++
T Consensus 211 ~~~~~~~~~----~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 211 EEVERRVKE----DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred HHHHHHhhh----cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 111111000 00111225788999999999999999999 88898765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=322.60 Aligned_cols=262 Identities=20% Similarity=0.315 Sum_probs=197.5
Q ss_pred cCcceEEEeeeeeeCceEEEEEeeeCCCc--cceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeC
Q psy14267 254 NGKQYQVLSLLGKGGSSSVYLVGGTSEHE--FKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDT 331 (553)
Q Consensus 254 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~--~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~ 331 (553)
...+|++.+.||+|+||.||+|.+...+. ...||||+++... .....+++.+|+.+++.+ +||||+++++++..
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~g~~~~- 80 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASV-DNPHVCRLLGICLT- 80 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEcC-
Confidence 45679999999999999999998754433 2348999986432 234457789999999999 55999999998754
Q ss_pred CCceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCC
Q psy14267 332 ASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGN 411 (553)
Q Consensus 332 ~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~ 411 (553)
....++++++.+++|.+++..... ......++.++.||+.||+|||++||+||||||+|||++.+ +
T Consensus 81 -~~~~~v~e~~~~g~l~~~l~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~---------~ 146 (316)
T cd05108 81 -STVQLITQLMPFGCLLDYVREHKD----NIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTP---------Q 146 (316)
T ss_pred -CCceeeeecCCCCCHHHHHHhccc----cCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCC---------C
Confidence 333344444577899999886532 22344555667799999999999999999999999999776 5
Q ss_pred eEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCCCc
Q psy14267 412 VLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHIPN 490 (553)
Q Consensus 412 ~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~~~ 490 (553)
.+||+|||+++.+.............++..|+|||.+.+. .++.++|||||||++|||++ |..||.+...
T Consensus 147 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~---------~~~~~~Di~slGv~l~el~t~g~~p~~~~~~ 217 (316)
T cd05108 147 HVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHR---------IYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 217 (316)
T ss_pred cEEEccccccccccCCCcceeccCCccceeecChHHhccC---------CCCchhhhHHHHHHHHHHHcCCCCCCCCCCH
Confidence 6999999999877654332222233457789999999765 37889999999999999997 9999987543
Q ss_pred hHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q psy14267 491 TWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNP 550 (553)
Q Consensus 491 ~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~ 550 (553)
. .+..+....... .....++.++.++|.+||..+|++||++.+++..|....
T Consensus 218 ~--~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 218 S--EISSILEKGERL------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred H--HHHHHHhCCCCC------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 2 222222222211 122356789999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=327.92 Aligned_cols=274 Identities=23% Similarity=0.334 Sum_probs=204.5
Q ss_pred EEecCcceEEEeeeeeeCceEEEEEeeeC---CCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeE
Q psy14267 251 ITLNGKQYQVLSLLGKGGSSSVYLVGGTS---EHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDY 327 (553)
Q Consensus 251 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~---~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~ 327 (553)
|.+..++|++++.||+|+||.||+|.+.. ....+.||||+++.... ......+.+|+.+|.++.+||||++++++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~ 79 (343)
T cd05103 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGA 79 (343)
T ss_pred cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC--hHHHHHHHHHHHHHHhccCCccHhhhcce
Confidence 45667789999999999999999997542 22335699999975432 23346789999999999889999999987
Q ss_pred EEeCCCceEEEEEecC-CCCHHHHHHHcccCC------------------------------------------------
Q psy14267 328 VYDTASKHLYVLMEKG-DTDLSKYMRNLNKMT------------------------------------------------ 358 (553)
Q Consensus 328 ~~~~~~~~~~iv~e~~-~~~L~~~l~~~~~~~------------------------------------------------ 358 (553)
+... ...++++||++ +++|.+++.......
T Consensus 80 ~~~~-~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (343)
T cd05103 80 CTKP-GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSL 158 (343)
T ss_pred eecC-CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcc
Confidence 6543 45677888864 578998887532100
Q ss_pred --------------CCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEeccCcccc
Q psy14267 359 --------------TLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSL 424 (553)
Q Consensus 359 --------------~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGla~~~ 424 (553)
........+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~---------~~~kl~dfg~~~~~ 229 (343)
T cd05103 159 SDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEN---------NVVKICDFGLARDI 229 (343)
T ss_pred ccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCC---------CcEEEEeccccccc
Confidence 0123455566778899999999999999999999999999766 57999999999876
Q ss_pred CCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHhhcc
Q psy14267 425 QDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHIPNTWAKMLAIARHKD 503 (553)
Q Consensus 425 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~i~~~~~ 503 (553)
.............++..|+|||.+.+. .++.++|||||||++|||++ |..||............+.. ..
T Consensus 230 ~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~ 299 (343)
T cd05103 230 YKDPDYVRKGDARLPLKWMAPETIFDR---------VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE-GT 299 (343)
T ss_pred ccCcchhhcCCCCCCcceECcHHhcCC---------CCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhc-cC
Confidence 433222222234467789999998755 37889999999999999996 99999875433222222221 11
Q ss_pred cccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCCC
Q psy14267 504 QIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNPEG 552 (553)
Q Consensus 504 ~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~~~ 552 (553)
... ....+++++.+++.+||+.||++||++.+|+++|++....
T Consensus 300 ~~~------~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 300 RMR------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred CCC------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 111 1123578999999999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=313.17 Aligned_cols=264 Identities=18% Similarity=0.278 Sum_probs=198.7
Q ss_pred eEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC----C
Q psy14267 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA----S 333 (553)
Q Consensus 258 y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~----~ 333 (553)
|.+.++||+|+||.||++.....+....||+|.++.... .....+.+.+|+++|+.++ |+||+++++++.... .
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~ 78 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC-TRSEMEDFLSEAVCMKEFD-HPNVMRLIGVCLQTVESEGY 78 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC-CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEccCCcccCC
Confidence 356789999999999999887666545699999876543 3344678899999999995 699999998765432 1
Q ss_pred ceEEEEEec-CCCCHHHHHHHccc-CCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCC
Q psy14267 334 KHLYVLMEK-GDTDLSKYMRNLNK-MTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGN 411 (553)
Q Consensus 334 ~~~~iv~e~-~~~~L~~~l~~~~~-~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~ 411 (553)
...+++|++ .+++|..++..... ..........++.++.|++.||+|||+++|+||||||+|||++.+ +
T Consensus 79 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~---------~ 149 (272)
T cd05075 79 PSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNEN---------M 149 (272)
T ss_pred CCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCC---------C
Confidence 245667775 45788888754321 112234566677778899999999999999999999999999766 5
Q ss_pred eEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCCCc
Q psy14267 412 VLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHIPN 490 (553)
Q Consensus 412 ~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~~~ 490 (553)
.+||+|||+++...............+++.|+|||.+.+. .++.++|||||||++|||++ |..||.....
T Consensus 150 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~---------~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 220 (272)
T cd05075 150 NVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADR---------VYTTKSDVWSFGVTMWEIATRGQTPYPGVEN 220 (272)
T ss_pred CEEECCCCcccccCcccceecCCcccCCcccCCHHHccCC---------CcChHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 7999999999876544322222234567899999998755 37889999999999999999 8999977543
Q ss_pred hHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 491 TWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 491 ~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
. .....+.. .... .....++..+.++|.+||+.||++|||+.+|++.|++.
T Consensus 221 ~-~~~~~~~~-~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 221 S-EIYDYLRQ-GNRL------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred H-HHHHHHHc-CCCC------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 2 22222222 1111 12236788999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=340.58 Aligned_cols=255 Identities=25% Similarity=0.397 Sum_probs=196.6
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceE
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHL 336 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~ 336 (553)
.|.+.+.||+|+||.||+|....+.. ..||+|.+.... ......+.+|+.+|+.+. ||||+++++++.. ...+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~-~~vv~K~~~~~~---~~~~~~~~~E~~~l~~l~-Hpniv~~~~~~~~--~~~~ 140 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPK-EKVVAKFVMLND---ERQAAYARSELHCLAACD-HFGIVKHFDDFKS--DDKL 140 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCC-eEEEEEEcccCC---HHHHHHHHHHHHHHHhCC-CCCEeEEEEEEEE--CCEE
Confidence 59999999999999999998765522 348888765443 334466788999999995 5999999998754 5688
Q ss_pred EEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 337 YVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 337 ~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
|++||++ +++|.+++..... ...++....+..++.||+.||+|||+++||||||||+||||+.+ +.+||
T Consensus 141 ~lv~E~~~gg~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~---------~~~kL 210 (478)
T PTZ00267 141 LLIMEYGSGGDLNKQIKQRLK-EHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPT---------GIIKL 210 (478)
T ss_pred EEEEECCCCCCHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCC---------CcEEE
Confidence 9999986 6799888865322 12234556666777899999999999999999999999999876 57999
Q ss_pred EeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHH
Q psy14267 416 IDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKM 495 (553)
Q Consensus 416 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~ 495 (553)
+|||+++.+............+||+.|+|||++.+. .++.++|||||||++|||++|..||...... ..+
T Consensus 211 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~-~~~ 280 (478)
T PTZ00267 211 GDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERK---------RYSKKADMWSLGVILYELLTLHRPFKGPSQR-EIM 280 (478)
T ss_pred EeCcCceecCCccccccccccCCCccccCHhHhCCC---------CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-HHH
Confidence 999999877554322223456799999999999765 3788999999999999999999999764432 222
Q ss_pred HHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 496 LAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 496 ~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
..+..... . .....++.+++++|.+||..||++||++.+++.+
T Consensus 281 ~~~~~~~~-~------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 281 QQVLYGKY-D------PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred HHHHhCCC-C------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 22222111 1 1123578899999999999999999999998754
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=326.62 Aligned_cols=245 Identities=21% Similarity=0.310 Sum_probs=188.3
Q ss_pred eeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEEEEEe
Q psy14267 262 SLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLME 341 (553)
Q Consensus 262 ~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~iv~e 341 (553)
+.||+|+||+||+|++..++.. ||||++++...........+..|..++..+.+||||+++++++.. ...++++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~--vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~e 76 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQF--FAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT--KENLFFVME 76 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCE--EEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEe--CCEEEEEEe
Confidence 4699999999999988776654 999999875433233346678899999887788999999887743 567899999
Q ss_pred cC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEeccC
Q psy14267 342 KG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGI 420 (553)
Q Consensus 342 ~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGl 420 (553)
++ +++|..++..... .....+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+
T Consensus 77 y~~~g~L~~~l~~~~~-----~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~---------~~~kl~Dfg~ 142 (316)
T cd05619 77 YLNGGDLMFHIQSCHK-----FDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTD---------GHIKIADFGM 142 (316)
T ss_pred CCCCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCC---------CCEEEccCCc
Confidence 75 6799988876432 3344556677899999999999999999999999999776 5799999999
Q ss_pred ccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHh
Q psy14267 421 ACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIAR 500 (553)
Q Consensus 421 a~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~~i~~ 500 (553)
++....... ......||+.|+|||++.+. .++.++|||||||++|||++|..||...... .....+..
T Consensus 143 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~---------~~~~~~DvwslG~il~el~~G~~pf~~~~~~-~~~~~i~~ 210 (316)
T cd05619 143 CKENMLGDA--KTCTFCGTPDYIAPEILLGQ---------KYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE-ELFQSIRM 210 (316)
T ss_pred ceECCCCCC--ceeeecCCccccCHHHHcCC---------CCCchhhhhhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHh
Confidence 876433222 12255799999999999765 3788999999999999999999999875432 22222221
Q ss_pred hcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHH-HHHH
Q psy14267 501 HKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVG-NSVT 544 (553)
Q Consensus 501 ~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~-ell~ 544 (553)
.. ..+ ...++.+++++|.+||+.||++||++. +++.
T Consensus 211 ~~--~~~------~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 211 DN--PCY------PRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred CC--CCC------CccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 11 111 124678999999999999999999997 5644
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=333.98 Aligned_cols=256 Identities=24% Similarity=0.403 Sum_probs=195.4
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|++++.||+|+||.||+|++..++.. ||||++.+...........+.+|+.++..+. ||+|+++++.+. ....
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~--~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~--~~~~ 75 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHI--YAMKILRKADMLEKEQVAHIRAERDILVEAD-GAWVVKMFYSFQ--DKRN 75 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCE--EEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCEeeEEEEEE--cCCE
Confidence 3699999999999999999988877654 9999998765444455678889999999995 599999987663 4668
Q ss_pred EEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
++++||++ +++|.+++.... ......+..++.|++.||+|||++|||||||||+||||+.+ +.+|
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~---------~~vk 141 (360)
T cd05627 76 LYLIMEFLPGGDMMTLLMKKD-----TLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAK---------GHVK 141 (360)
T ss_pred EEEEEeCCCCccHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCC---------CCEE
Confidence 89999976 578999887643 23455566677899999999999999999999999999776 6799
Q ss_pred EEeccCccccCCCCCc---------------------------------ccccCCccCCCccCcccccccCCCCCCCccC
Q psy14267 415 IIDFGIACSLQDDKTS---------------------------------VHKDTASGTLNYMSPEAAGQTSSSGGGNTYR 461 (553)
Q Consensus 415 L~DFGla~~~~~~~~~---------------------------------~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~ 461 (553)
|+|||++..+...... ......+||+.|+|||++.+..
T Consensus 142 L~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~--------- 212 (360)
T cd05627 142 LSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTG--------- 212 (360)
T ss_pred EeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCC---------
Confidence 9999998755321100 0012457999999999997653
Q ss_pred CCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCC---
Q psy14267 462 ITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT--- 538 (553)
Q Consensus 462 ~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt--- 538 (553)
++.++|||||||+||||++|..||...... .....+........+++ ...++.+++++|.+|+. ||++|++
T Consensus 213 ~~~~~DiwSlGvilyel~tG~~Pf~~~~~~-~~~~~i~~~~~~~~~p~----~~~~s~~~~~li~~l~~-~p~~R~~~~~ 286 (360)
T cd05627 213 YNKLCDWWSLGVIMYEMLIGYPPFCSETPQ-ETYRKVMNWKETLVFPP----EVPISEKAKDLILRFCT-DSENRIGSNG 286 (360)
T ss_pred CCCcceeccccceeeecccCCCCCCCCCHH-HHHHHHHcCCCceecCC----CCCCCHHHHHHHHHhcc-ChhhcCCCCC
Confidence 678999999999999999999999875443 22233332222222222 22478899999999774 9999985
Q ss_pred HHHHHHH
Q psy14267 539 VGNSVTQ 545 (553)
Q Consensus 539 ~~ell~~ 545 (553)
+.++++|
T Consensus 287 ~~ei~~h 293 (360)
T cd05627 287 VEEIKSH 293 (360)
T ss_pred HHHHhcC
Confidence 6666654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=329.92 Aligned_cols=242 Identities=24% Similarity=0.365 Sum_probs=188.2
Q ss_pred eeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEEEEEe
Q psy14267 262 SLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLME 341 (553)
Q Consensus 262 ~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~iv~e 341 (553)
++||+|+||.||+|+...++.. ||+|++.+.........+.+.+|+.++.++.+||+|+.+++++. ....++++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~--~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~--~~~~~~lv~e 76 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQI--YAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQ--TTSRLFLVIE 76 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCE--EEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEE--eCCEEEEEEe
Confidence 4799999999999988777654 99999987765555566788999999999988999999988764 3567899999
Q ss_pred cC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEeccC
Q psy14267 342 KG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGI 420 (553)
Q Consensus 342 ~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGl 420 (553)
++ +++|..++.... ......+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+
T Consensus 77 ~~~~~~L~~~~~~~~-----~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~---------~~~kl~Dfg~ 142 (327)
T cd05617 77 YVNGGDLMFHMQRQR-----KLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDAD---------GHIKLTDYGM 142 (327)
T ss_pred CCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCC---------CCEEEecccc
Confidence 76 678888876543 24456667778899999999999999999999999999876 5799999999
Q ss_pred ccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCc-----hHHHH
Q psy14267 421 ACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN-----TWAKM 495 (553)
Q Consensus 421 a~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~-----~~~~~ 495 (553)
++....... .....+||+.|+|||++.+. .++.++|||||||+||||++|..||..... .....
T Consensus 143 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~ 211 (327)
T cd05617 143 CKEGLGPGD--TTSTFCGTPNYIAPEILRGE---------EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYL 211 (327)
T ss_pred ceeccCCCC--ceecccCCcccCCHHHHCCC---------CCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHH
Confidence 975432222 12356799999999999765 368899999999999999999999964221 11112
Q ss_pred HHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCH
Q psy14267 496 LAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTV 539 (553)
Q Consensus 496 ~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~ 539 (553)
...... ... .....++..+.++|.+||+.||++|+++
T Consensus 212 ~~~~~~-~~~------~~p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 212 FQVILE-KPI------RIPRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred HHHHHh-CCC------CCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 221111 111 1122577899999999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=330.71 Aligned_cols=245 Identities=24% Similarity=0.349 Sum_probs=189.7
Q ss_pred eeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEEEEEe
Q psy14267 262 SLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLME 341 (553)
Q Consensus 262 ~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~iv~e 341 (553)
+.||+|+||.||++++..++.. ||+|++.+...........+.+|+++++.+. ||||+.+++++. ....++++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~--~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~-hp~i~~~~~~~~--~~~~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRY--YAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTALKYSFQ--THDRLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCE--EEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCCceEEEEE--cCCEEEEEEe
Confidence 4699999999999988776644 9999998765444455577889999999985 599999987663 4568899999
Q ss_pred cC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhh-CCcEecCCCCCCEEEecCccceecCCCCeEEEEecc
Q psy14267 342 KG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHA-AGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFG 419 (553)
Q Consensus 342 ~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~-~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFG 419 (553)
++ +++|..++.... ...+..+..++.||+.||+|||+ +||+||||||+||||+.+ +.+||+|||
T Consensus 76 ~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~---------~~~kL~Dfg 141 (325)
T cd05594 76 YANGGELFFHLSRER-----VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD---------GHIKITDFG 141 (325)
T ss_pred CCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCC---------CCEEEecCC
Confidence 75 567877776543 23455566677899999999997 899999999999999776 579999999
Q ss_pred CccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHH
Q psy14267 420 IACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIA 499 (553)
Q Consensus 420 la~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~~i~ 499 (553)
+++........ .....||+.|+|||++.+. .++.++|||||||++|||++|..||...... .....+.
T Consensus 142 ~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~el~tG~~Pf~~~~~~-~~~~~i~ 209 (325)
T cd05594 142 LCKEGIKDGAT--MKTFCGTPEYLAPEVLEDN---------DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-KLFELIL 209 (325)
T ss_pred CCeecCCCCcc--cccccCCcccCCHHHHccC---------CCCCccccccccceeeeeccCCCCCCCCCHH-HHHHHHh
Confidence 98764332221 2245799999999999765 3688999999999999999999999764332 2222221
Q ss_pred hhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q psy14267 500 RHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARP-----TVGNSVTQ 545 (553)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RP-----t~~ell~~ 545 (553)
. ....+ ...+++++.++|.+||+.||++|+ ++.+++++
T Consensus 210 ~--~~~~~------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 210 M--EEIRF------PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred c--CCCCC------CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 1 11111 225789999999999999999997 89999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=332.68 Aligned_cols=261 Identities=23% Similarity=0.328 Sum_probs=195.9
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCC---
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTAS--- 333 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~--- 333 (553)
+|++++.||+|+||.||++.+..++. .||||++.... ......+++.+|+.+|+.++ |+||+.+++++.....
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~ 76 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGK--RVALKKMPNVF-QNLVSCKRVFRELKMLCFFK-HDNVLSALDILQPPHIDPF 76 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCC--EEEEEeccccc-cchHHHHHHHHHHHHHHhCC-CCCcCCHhheecCCCcccc
Confidence 47889999999999999998766654 49999986542 22234567899999999995 5999999998754331
Q ss_pred ceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 334 KHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 334 ~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
..+|++||+.+++|..++.... ......+..++.||+.||+|||++||+||||||+|||++.+ +.+
T Consensus 77 ~~~~lv~e~~~~~l~~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~---------~~~ 142 (372)
T cd07853 77 EEIYVVTELMQSDLHKIIVSPQ-----PLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSN---------CVL 142 (372)
T ss_pred ceEEEEeeccccCHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCC---------CCE
Confidence 2689999999999988876533 34455667777899999999999999999999999999776 679
Q ss_pred EEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHH
Q psy14267 414 KIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWA 493 (553)
Q Consensus 414 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~ 493 (553)
||+|||+++........ ......+++.|+|||++.+.. .++.++|||||||++|||++|+.||...... .
T Consensus 143 kL~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~--------~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~ 212 (372)
T cd07853 143 KICDFGLARVEEPDESK-HMTQEVVTQYYRAPEILMGSR--------HYTSAVDIWSVGCIFAELLGRRILFQAQSPI-Q 212 (372)
T ss_pred EeccccceeecccCccc-cCCCCCcCCCcCCHHHHcCCC--------CCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH-H
Confidence 99999999876443221 122446899999999997643 3678999999999999999999999865432 2
Q ss_pred HHHHHHhhcc--------------------ccccccc----ccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 494 KMLAIARHKD--------------------QIEFKPQ----LANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 494 ~~~~i~~~~~--------------------~~~~~~~----~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
.+..+..... .....+. .......++++.+||.+||+.||++|||+.+++++
T Consensus 213 ~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 213 QLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 2211111000 0000000 01122457899999999999999999999999976
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=318.34 Aligned_cols=251 Identities=21% Similarity=0.310 Sum_probs=190.0
Q ss_pred eeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEEEEEecC
Q psy14267 264 LGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEKG 343 (553)
Q Consensus 264 LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~iv~e~~ 343 (553)
||+|+||+||++.+..++.. ||+|.+.+.........+.+..|+++|+++ +|+||+.+.+++. ....++++||++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~--~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~--~~~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKL--YACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLAYAFQ--TKTDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEccCCcE--EEEEeeeHHHHhhhHHHHHHHHHHHHHHhC-CCCcEeeeeEEEc--CCCeEEEEEeCC
Confidence 79999999999988776654 999999876554444456788999999999 6699999987663 456788999975
Q ss_pred -CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEeccCcc
Q psy14267 344 -DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIAC 422 (553)
Q Consensus 344 -~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGla~ 422 (553)
+++|..++..... ......+..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++.
T Consensus 76 ~~g~L~~~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~---------~~~~l~dfg~~~ 145 (280)
T cd05608 76 NGGDLRYHIYNVDE-ENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDND---------GNVRISDLGLAV 145 (280)
T ss_pred CCCCHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC---------CCEEEeeCccce
Confidence 6788777754322 12234556667778899999999999999999999999999766 579999999998
Q ss_pred ccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHhhc
Q psy14267 423 SLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARHK 502 (553)
Q Consensus 423 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~~i~~~~ 502 (553)
.+...... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......... ..+....
T Consensus 146 ~~~~~~~~--~~~~~g~~~y~aPE~~~~~---------~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~-~~~~~~~ 213 (280)
T cd05608 146 ELKDGQSK--TKGYAGTPGFMAPELLQGE---------EYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN-KELKQRI 213 (280)
T ss_pred ecCCCCcc--ccccCCCcCccCHHHhcCC---------CCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH-HHHHHhh
Confidence 76543321 2345789999999999765 3678999999999999999999999764322111 1111100
Q ss_pred ccccccccccCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q psy14267 503 DQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARP-----TVGNSVTQ 545 (553)
Q Consensus 503 ~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RP-----t~~ell~~ 545 (553)
..........++..+.+++.+||+.||++|| ++++++++
T Consensus 214 ----~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 214 ----LNDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred ----cccCCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 0111122235789999999999999999999 77788765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=319.21 Aligned_cols=271 Identities=21% Similarity=0.345 Sum_probs=204.3
Q ss_pred eEEecCcceEEEeeeeeeCceEEEEEeeeCCC-----ccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEe
Q psy14267 250 VITLNGKQYQVLSLLGKGGSSSVYLVGGTSEH-----EFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKM 324 (553)
Q Consensus 250 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l 324 (553)
.+++..++|.+.+.||+|+||.||+|++.... ....+|+|++.... . ......+.+|+.+++++..|+||+++
T Consensus 12 ~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~-~~~~~~~~~e~~~l~~l~~h~~i~~~ 89 (307)
T cd05098 12 RWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-T-EKDLSDLISEMEMMKMIGKHKNIINL 89 (307)
T ss_pred cceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-C-hHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence 45566678999999999999999999764322 12359999987643 2 23346788999999999778999999
Q ss_pred eeEEEeCCCceEEEEEecC-CCCHHHHHHHcccC-----------CCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCC
Q psy14267 325 HDYVYDTASKHLYVLMEKG-DTDLSKYMRNLNKM-----------TTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLK 392 (553)
Q Consensus 325 ~~~~~~~~~~~~~iv~e~~-~~~L~~~l~~~~~~-----------~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLK 392 (553)
++++.. ...++++||++ +++|.+++...... ......+..++.++.|++.||+|||++|++|||||
T Consensus 90 ~~~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlk 167 (307)
T cd05098 90 LGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLA 167 (307)
T ss_pred EEEEec--CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCccccccc
Confidence 987744 45678899875 57999999865321 11235556677778899999999999999999999
Q ss_pred CCCEEEecCccceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHH
Q psy14267 393 PANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLG 472 (553)
Q Consensus 393 p~NILl~~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlG 472 (553)
|+|||++.+ +.+||+|||+++...............+++.|+|||++.+. .++.++||||||
T Consensus 168 p~Nill~~~---------~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~DvwslG 229 (307)
T cd05098 168 ARNVLVTED---------NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR---------IYTHQSDVWSFG 229 (307)
T ss_pred HHheEEcCC---------CcEEECCCcccccccccchhhccccCCCccceeChHHhccC---------CCCcHHHHHHHH
Confidence 999999776 57999999999766432221111122345789999998765 368899999999
Q ss_pred HHHHHHHh-CCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q psy14267 473 CILYNMIY-GRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNP 550 (553)
Q Consensus 473 vvl~ellt-G~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~ 550 (553)
|++|||++ |..||...+. ..+.......... .....++.++.++|.+||..+|++||++.++++.|+++.
T Consensus 230 ~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~ 300 (307)
T cd05098 230 VLLWEIFTLGGSPYPGVPV--EELFKLLKEGHRM------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300 (307)
T ss_pred HHHHHHHcCCCCCCCcCCH--HHHHHHHHcCCCC------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 99999998 8999976443 2222222222111 122357899999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0577|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=337.82 Aligned_cols=252 Identities=24% Similarity=0.335 Sum_probs=208.2
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceE
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHL 336 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~ 336 (553)
.|.-++.||.|+||.||.|++..+.+. ||||.+....-...+..+.+++|+..|++|+| ||++.+.++|..+ ...
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~ev--VAIKKMsySGKQs~EKWqDIlKEVrFL~~l~H-PntieYkgCyLre--~Ta 101 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEV--VAIKKMSYSGKQSNEKWQDILKEVRFLRQLRH-PNTIEYKGCYLRE--HTA 101 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccce--eeeeeccccccccHHHHHHHHHHHHHHHhccC-CCcccccceeecc--chH
Confidence 577788999999999999999888766 99999987776666777899999999999965 9999999988654 456
Q ss_pred EEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEE
Q psy14267 337 YVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKII 416 (553)
Q Consensus 337 ~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~ 416 (553)
++|||||-|+-.+++.-..+ ++.+..|+.+..+.++||+|||+.+.||||||..||||.+. +.|||+
T Consensus 102 WLVMEYClGSAsDlleVhkK----plqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~---------g~VKLa 168 (948)
T KOG0577|consen 102 WLVMEYCLGSASDLLEVHKK----PLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEP---------GLVKLA 168 (948)
T ss_pred HHHHHHHhccHHHHHHHHhc----cchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCC---------Ceeeec
Confidence 89999999988888876654 45566677777899999999999999999999999999776 789999
Q ss_pred eccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHH
Q psy14267 417 DFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKML 496 (553)
Q Consensus 417 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~ 496 (553)
|||.|....+.. +++|||+|||||+|.... .+.|+-++||||||++..||.-.++|+-+.+...+...
T Consensus 169 DFGSAsi~~PAn------sFvGTPywMAPEVILAMD------EGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYH 236 (948)
T KOG0577|consen 169 DFGSASIMAPAN------SFVGTPYWMAPEVILAMD------EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH 236 (948)
T ss_pred cccchhhcCchh------cccCCccccchhHheecc------ccccCCccceeeccchhhhhhhcCCCccCchHHHHHHH
Confidence 999997766543 788999999999997542 22689999999999999999999999988655433322
Q ss_pred HHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 497 AIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 497 ~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
|.... +|.+. ...+++.++.|+..||++-|.+|||.++++.|
T Consensus 237 -IAQNe-----sPtLq-s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 237 -IAQNE-----SPTLQ-SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred -HHhcC-----CCCCC-CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 22211 12222 23678999999999999999999999999876
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=317.11 Aligned_cols=270 Identities=20% Similarity=0.315 Sum_probs=202.8
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCc--------------cceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCc
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHE--------------FKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPY 320 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~--------------~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~ 320 (553)
..+|++++.||+|+||.||+|.+...+. ...||+|.+..... ....+.+.+|+++|+++. |||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~-~~~ 80 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNAREDFLKEVKILSRLS-DPN 80 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhcC-CCC
Confidence 4579999999999999999997755332 23489999876542 244578899999999995 599
Q ss_pred eeEeeeEEEeCCCceEEEEEec-CCCCHHHHHHHcccCCC------CchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCC
Q psy14267 321 VIKMHDYVYDTASKHLYVLMEK-GDTDLSKYMRNLNKMTT------LPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKP 393 (553)
Q Consensus 321 Iv~l~~~~~~~~~~~~~iv~e~-~~~~L~~~l~~~~~~~~------~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp 393 (553)
|+++++++.. +...+++||+ .+++|..++........ .......++.++.|++.||+|||+.||+||||||
T Consensus 81 i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp 158 (296)
T cd05051 81 IARLLGVCTV--DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLAT 158 (296)
T ss_pred EeEEEEEEec--CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccch
Confidence 9999987744 4677888886 46789999877542221 1455667777788999999999999999999999
Q ss_pred CCEEEecCccceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHH
Q psy14267 394 ANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGC 473 (553)
Q Consensus 394 ~NILl~~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGv 473 (553)
+||+++.+ +.++|+|||++................+++.|+|||.+.+. .++.++|||||||
T Consensus 159 ~Nili~~~---------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Dv~slG~ 220 (296)
T cd05051 159 RNCLVGKN---------YTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG---------KFTTKSDVWAFGV 220 (296)
T ss_pred hceeecCC---------CceEEccccceeecccCcceeecCcCCCCceecCHHHhhcC---------CCCccchhhhhHH
Confidence 99999776 57999999999776544332222345578899999998754 3788999999999
Q ss_pred HHHHHHh--CCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q psy14267 474 ILYNMIY--GRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINN 548 (553)
Q Consensus 474 vl~ellt--G~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~ 548 (553)
++|||++ |..||....... .+.....................++.++.++|.+||+.||++|||+.+|++.|++
T Consensus 221 ~l~el~~~~~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 221 TLWEILTLCREQPYEHLTDQQ-VIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred HHHHHHhcCCCCCCCCcChHH-HHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 9999997 788987754432 2222221111111111122233577899999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=315.75 Aligned_cols=271 Identities=21% Similarity=0.332 Sum_probs=205.9
Q ss_pred eEEecCcceEEEeeeeeeCceEEEEEeeeCCC---ccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeee
Q psy14267 250 VITLNGKQYQVLSLLGKGGSSSVYLVGGTSEH---EFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHD 326 (553)
Q Consensus 250 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~---~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~ 326 (553)
.+.+...+|++.+.||+|+||.||++...... ....+|+|.+..... ......+.+|+.+++++..|+||+++++
T Consensus 6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 83 (293)
T cd05053 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLLG 83 (293)
T ss_pred ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC--HHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 35566778999999999999999999876432 234599999875432 2334678999999999977799999998
Q ss_pred EEEeCCCceEEEEEec-CCCCHHHHHHHccc-----------CCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCC
Q psy14267 327 YVYDTASKHLYVLMEK-GDTDLSKYMRNLNK-----------MTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPA 394 (553)
Q Consensus 327 ~~~~~~~~~~~iv~e~-~~~~L~~~l~~~~~-----------~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~ 394 (553)
++. ....++++||+ .+++|..++..... .......+..++.++.|++.||.|||+++|+||||||+
T Consensus 84 ~~~--~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~ 161 (293)
T cd05053 84 VCT--QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAAR 161 (293)
T ss_pred EEc--CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCcccccccee
Confidence 774 45568888886 56799999876421 12224556667778889999999999999999999999
Q ss_pred CEEEecCccceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHH
Q psy14267 395 NFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCI 474 (553)
Q Consensus 395 NILl~~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvv 474 (553)
|||++.+ +.+||+|||+++.+.............++..|+|||++.+. .++.++|||||||+
T Consensus 162 Nil~~~~---------~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~i 223 (293)
T cd05053 162 NVLVTED---------HVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDR---------VYTHQSDVWSFGVL 223 (293)
T ss_pred eEEEcCC---------CeEEeCccccccccccccceeccCCCCCCccccCHHHhccC---------CcCcccceeehhhH
Confidence 9999766 67999999999876554322222233456789999998655 36889999999999
Q ss_pred HHHHHh-CCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q psy14267 475 LYNMIY-GRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNP 550 (553)
Q Consensus 475 l~ellt-G~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~ 550 (553)
+|||++ |..||...... . +......... ......++..+.+|+.+||..||++|||+.++++.|+++.
T Consensus 224 l~el~~~g~~p~~~~~~~-~-~~~~~~~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 224 LWEIFTLGGSPYPGIPVE-E-LFKLLKEGYR------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHHhcCCCCCCCCCCHH-H-HHHHHHcCCc------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 999997 99999875432 1 2221111111 1223367889999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=311.38 Aligned_cols=264 Identities=26% Similarity=0.448 Sum_probs=203.0
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|++.+.||+|+||.||++++..++.. ||||.+.............+.+|+++++.+. ||||+++++++.+ ...
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~--~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~ 76 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKP--VALKKVQIFEMMDAKARQDCVKEIDLLKQLN-HPNVIKYLDSFIE--DNE 76 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCE--EEEEEeeccccCCHHHHHHHHHHHHHHHhCC-CcceeeeeeeEEE--CCe
Confidence 4799999999999999999988776644 9999987655555555678899999999995 5999999988754 457
Q ss_pred EEEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
.+++||+.. ++|..++....... .......+..++.|++.||+|||+++|+||||||+|||++.+ +.++
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~---------~~~~ 146 (267)
T cd08228 77 LNIVLELADAGDLSQMIKYFKKQK-RLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITAT---------GVVK 146 (267)
T ss_pred EEEEEEecCCCcHHHHHHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCC---------CCEE
Confidence 788888755 68888876543211 234455666777899999999999999999999999999776 5699
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||++......... .....|++.|+|||.+.+. .++.++|+||||+++|||++|..||.........
T Consensus 147 l~d~g~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~---------~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~ 215 (267)
T cd08228 147 LGDLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHEN---------GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFS 215 (267)
T ss_pred ECccccceeccchhHH--HhcCCCCccccChhhhccC---------CCCchhhHHHHHHHHHHHhcCCCCCccccccHHH
Confidence 9999999876543321 1245689999999998755 3678999999999999999999999764332222
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNP 550 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~ 550 (553)
....... ....+.. ...++..+.++|.+||..+|++||++.++++.|++..
T Consensus 216 ~~~~~~~---~~~~~~~--~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 216 LCQKIEQ---CDYPPLP--TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred HHHHHhc---CCCCCCC--hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 2222111 1111211 1246789999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=324.76 Aligned_cols=256 Identities=23% Similarity=0.389 Sum_probs=193.6
Q ss_pred ecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC
Q psy14267 253 LNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA 332 (553)
Q Consensus 253 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~ 332 (553)
+..++|++.++||+|+||.||++.+..++.. +|+|++.... .......+.+|+++|+++. ||||+++++++..
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~--~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~-- 74 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLI--MARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYS-- 74 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcE--EEEEEeeccc--CHHHHHHHHHHHHHHHHCC-CCcccceeEEEEE--
Confidence 3457899999999999999999988766644 9999887653 2234567899999999995 6999999998765
Q ss_pred CceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhC-CcEecCCCCCCEEEecCccceecCCC
Q psy14267 333 SKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAA-GIIHSDLKPANFLFVGNVLKIIDCIG 410 (553)
Q Consensus 333 ~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~-gIiHrDLKp~NILl~~~~~~~~~~~~ 410 (553)
...++++||++ +++|.+++..... .....+..++.|++.||.|||+. +|+||||||+|||++.+
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~--------- 140 (333)
T cd06650 75 DGEISICMEHMDGGSLDQVLKKAGR-----IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR--------- 140 (333)
T ss_pred CCEEEEEEecCCCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCC---------
Confidence 56889999976 6799999876432 33455566677999999999975 79999999999999776
Q ss_pred CeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCc
Q psy14267 411 NVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN 490 (553)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~ 490 (553)
+.+||+|||++..+..... ....|+..|+|||++.+. .++.++|||||||++|||++|+.||.....
T Consensus 141 ~~~kL~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~---------~~~~~~DvwslG~il~~l~~g~~p~~~~~~ 207 (333)
T cd06650 141 GEIKLCDFGVSGQLIDSMA----NSFVGTRSYMSPERLQGT---------HYSVQSDIWSMGLSLVEMAIGRYPIPPPDA 207 (333)
T ss_pred CCEEEeeCCcchhhhhhcc----ccCCCCccccCHHHhcCC---------CCCcHHHHHHHHHHHHHHHHCCCCCCCcch
Confidence 5699999999976643221 245689999999999765 367899999999999999999999975332
Q ss_pred hHHHHHHHHhhcc--------------------------------------ccc--ccccccCCCCCCHHHHHHHHHhcc
Q psy14267 491 TWAKMLAIARHKD--------------------------------------QIE--FKPQLANNVTIPPTLLQSMKLCLQ 530 (553)
Q Consensus 491 ~~~~~~~i~~~~~--------------------------------------~~~--~~~~~~~~~~~s~~l~~li~~cL~ 530 (553)
. .+........ .+. ..+.. ....++.++++||.+||+
T Consensus 208 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~ 284 (333)
T cd06650 208 K--ELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKL-PSGVFGAEFQDFVNKCLI 284 (333)
T ss_pred h--HHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccC-CCCCcCHHHHHHHHHhcc
Confidence 1 1111000000 000 00000 011357889999999999
Q ss_pred cCCCCCCCHHHHHHH
Q psy14267 531 KDPKARPTVGNSVTQ 545 (553)
Q Consensus 531 ~dP~~RPt~~ell~~ 545 (553)
+||++|||+.|++.+
T Consensus 285 ~~P~~Rpt~~ell~h 299 (333)
T cd06650 285 KNPAERADLKQLMVH 299 (333)
T ss_pred CCcccCcCHHHHhhC
Confidence 999999999999865
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=310.84 Aligned_cols=264 Identities=20% Similarity=0.304 Sum_probs=199.6
Q ss_pred eEEEeeeeeeCceEEEEEeeeCCC-ccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCC---
Q psy14267 258 YQVLSLLGKGGSSSVYLVGGTSEH-EFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTAS--- 333 (553)
Q Consensus 258 y~i~~~LG~G~fG~Vy~a~~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~--- 333 (553)
|++++.||+|+||.||.|...... ....||||+++..... ......+.+|+.+++.+. |+||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~ 78 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT-YSEIEEFLSEAACMKDFD-HPNVMKLIGVCFEASSLQK 78 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCC-HHHHHHHHHHHHHHHhCC-CCCeeeEEeeeccCCcccc
Confidence 578899999999999999876433 3356999999765433 344578999999999995 6999999987754332
Q ss_pred -ceEEEEEec-CCCCHHHHHHHccc-CCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCC
Q psy14267 334 -KHLYVLMEK-GDTDLSKYMRNLNK-MTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIG 410 (553)
Q Consensus 334 -~~~~iv~e~-~~~~L~~~l~~~~~-~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~ 410 (553)
...+++||+ .+++|..++..... .......+..++.++.|++.||+|||+.+|+||||||+||+++.+
T Consensus 79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~--------- 149 (273)
T cd05035 79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLRED--------- 149 (273)
T ss_pred CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCC---------
Confidence 346788886 56788888765422 122245556677778899999999999999999999999999776
Q ss_pred CeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCCC
Q psy14267 411 NVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHIP 489 (553)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~~ 489 (553)
+.+||+|||+++...............++..|+|||.+.+. .++.++|||||||++|||++ |..||.+..
T Consensus 150 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~---------~~~~~~Dv~SlG~il~el~~~g~~p~~~~~ 220 (273)
T cd05035 150 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR---------VYTSKSDVWAFGVTMWEIATRGQTPYPGVE 220 (273)
T ss_pred CeEEECCccceeeccccccccccccccCCccccCHhhcccC---------CCCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence 57999999999876544332222233457789999998655 36889999999999999999 999998755
Q ss_pred chHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 490 NTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 490 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
+. .....+.. .... .....++..+.++|.+||+.||++||++.++++.|+++
T Consensus 221 ~~-~~~~~~~~-~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 221 NH-EIYDYLRH-GNRL------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred HH-HHHHHHHc-CCCC------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 43 22222221 1111 12236789999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=315.82 Aligned_cols=253 Identities=26% Similarity=0.368 Sum_probs=189.2
Q ss_pred eeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEEEEEecC
Q psy14267 264 LGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEKG 343 (553)
Q Consensus 264 LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~iv~e~~ 343 (553)
||+|+||.||+++...++.. ||+|.+.............+..|+++++++ +||||+.+++++. ...+++++||+.
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~--~a~K~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~i~~~~~~~~--~~~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKM--YACKKLDKKRLKKKSGEKMALLEKEILEKV-NSPFIVNLAYAFE--SKTHLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEccCCcE--EEEEEEcHHHhhcchhhHHHHHHHHHHHhc-CCCcEEEEEEEEe--cCCeEEEEEecC
Confidence 79999999999988776644 999999765544333345567799999999 5699999987763 456889999975
Q ss_pred -CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEeccCcc
Q psy14267 344 -DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIAC 422 (553)
Q Consensus 344 -~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGla~ 422 (553)
+++|..++...... ......++.++.|++.||+|||+.||+||||||+|||++.+ +.++|+|||++.
T Consensus 76 ~g~~L~~~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~---------~~~~l~Dfg~~~ 143 (277)
T cd05607 76 NGGDLKYHIYNVGER---GLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQ---------GNCRLSDLGLAV 143 (277)
T ss_pred CCCCHHHHHHhcccc---CCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCC---------CCEEEeeceeee
Confidence 67888777654322 23455566677899999999999999999999999999776 579999999998
Q ss_pred ccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHhhc
Q psy14267 423 SLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARHK 502 (553)
Q Consensus 423 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~~i~~~~ 502 (553)
....... .....|+..|+|||++.+. .++.++|||||||++|||++|..||.................
T Consensus 144 ~~~~~~~---~~~~~~~~~y~aPE~~~~~---------~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~ 211 (277)
T cd05607 144 ELKDGKT---ITQRAGTNGYMAPEILKEE---------PYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTL 211 (277)
T ss_pred ecCCCce---eeccCCCCCccCHHHHccC---------CCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhh
Confidence 7654322 1245689999999999765 368899999999999999999999976433211111111111
Q ss_pred ccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 503 DQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 503 ~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
..... .....++.+++++|.+||+.||++||+++|+++.+...
T Consensus 212 -~~~~~---~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h 254 (277)
T cd05607 212 -EDEVK---FEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKH 254 (277)
T ss_pred -ccccc---cccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcC
Confidence 10110 01125789999999999999999999998777665543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=318.02 Aligned_cols=270 Identities=21% Similarity=0.353 Sum_probs=204.8
Q ss_pred EEecCcceEEEeeeeeeCceEEEEEeeeC-----CCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEee
Q psy14267 251 ITLNGKQYQVLSLLGKGGSSSVYLVGGTS-----EHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMH 325 (553)
Q Consensus 251 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~-----~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~ 325 (553)
+.+...+|.+.+.||+|+||.||+|+... ......||+|.+.... .....+.+.+|+.+++.+.+||||++++
T Consensus 10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 87 (304)
T cd05101 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLL 87 (304)
T ss_pred ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchhee
Confidence 45667899999999999999999997532 1223468999886542 2233577899999999997789999999
Q ss_pred eEEEeCCCceEEEEEecC-CCCHHHHHHHcccC-----------CCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCC
Q psy14267 326 DYVYDTASKHLYVLMEKG-DTDLSKYMRNLNKM-----------TTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKP 393 (553)
Q Consensus 326 ~~~~~~~~~~~~iv~e~~-~~~L~~~l~~~~~~-----------~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp 393 (553)
+++.. ...++++||+. +++|.+++...... ......+..++.++.||+.||.|||++||+||||||
T Consensus 88 ~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp 165 (304)
T cd05101 88 GACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAA 165 (304)
T ss_pred EEEec--CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeeccccc
Confidence 87743 55778899875 57999998864321 112345566777788999999999999999999999
Q ss_pred CCEEEecCccceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHH
Q psy14267 394 ANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGC 473 (553)
Q Consensus 394 ~NILl~~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGv 473 (553)
+|||++.+ +.+||+|||+++...............+++.|+|||++.+. .++.++||||||+
T Consensus 166 ~Nili~~~---------~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~ 227 (304)
T cd05101 166 RNVLVTEN---------NVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR---------VYTHQSDVWSFGV 227 (304)
T ss_pred ceEEEcCC---------CcEEECCCccceecccccccccccCCCCCceeeCchhhccC---------CCCchhhHHHHHH
Confidence 99999766 57999999999877543332222234467889999999765 3688999999999
Q ss_pred HHHHHHh-CCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q psy14267 474 ILYNMIY-GRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNP 550 (553)
Q Consensus 474 vl~ellt-G~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~ 550 (553)
++|||++ |..||...+.. .+.......... .....++..+.++|.+||+.+|++||++.++++.|+++.
T Consensus 228 ~l~el~~~g~~p~~~~~~~--~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~ 297 (304)
T cd05101 228 LMWEIFTLGGSPYPGIPVE--ELFKLLKEGHRM------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL 297 (304)
T ss_pred HHHHHHcCCCCCcccCCHH--HHHHHHHcCCcC------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence 9999998 88999765432 222222211111 122367899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=327.29 Aligned_cols=248 Identities=23% Similarity=0.346 Sum_probs=185.6
Q ss_pred eeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHH-HHhhcCCCceeEeeeEEEeCCCceEEEEE
Q psy14267 262 SLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVEL-LAKLQGCPYVIKMHDYVYDTASKHLYVLM 340 (553)
Q Consensus 262 ~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~i-L~~l~~hp~Iv~l~~~~~~~~~~~~~iv~ 340 (553)
+.||+|+||+||+|++..++.. ||+|++.+...........+..|..+ ++.+ .||||+++++++. ....++++|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~--~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~Iv~~~~~~~--~~~~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKF--YAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQ--TADKLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCE--EEEEEEEHHHHHhhhHHHHHHHHHHHHHHhC-CCCCCCceeEEEE--cCCeEEEEE
Confidence 4699999999999988776644 99999986543333333455666655 4555 6699999988764 456788999
Q ss_pred ecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEecc
Q psy14267 341 EKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFG 419 (553)
Q Consensus 341 e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFG 419 (553)
|++ +++|..++..... .....+..++.||+.||+|||++||+||||||+||||+.+ +.+||+|||
T Consensus 76 e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~---------~~~kl~DfG 141 (325)
T cd05602 76 DYINGGELFYHLQRERC-----FLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ---------GHIVLTDFG 141 (325)
T ss_pred eCCCCCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC---------CCEEEccCC
Confidence 975 5688888876432 2334455567899999999999999999999999999766 579999999
Q ss_pred CccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHH
Q psy14267 420 IACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIA 499 (553)
Q Consensus 420 la~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~~i~ 499 (553)
+++....... .....+||+.|+|||++.+. .++.++|||||||++|||++|..||...... .....+.
T Consensus 142 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~ 209 (325)
T cd05602 142 LCKENIEHNG--TTSTFCGTPEYLAPEVLHKQ---------PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-EMYDNIL 209 (325)
T ss_pred CCcccccCCC--CcccccCCccccCHHHHcCC---------CCCCccccccccHHHHHHhcCCCCCCCCCHH-HHHHHHH
Confidence 9976533222 12356799999999999765 3678999999999999999999999874432 2222222
Q ss_pred hhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q psy14267 500 RHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINN 548 (553)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~ 548 (553)
.. ... ....++..+.++|.+||+.||.+||++.+.+..+.+
T Consensus 210 ~~--~~~------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~ 250 (325)
T cd05602 210 NK--PLQ------LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKN 250 (325)
T ss_pred hC--CcC------CCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhc
Confidence 11 111 123678999999999999999999998865555544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=324.72 Aligned_cols=263 Identities=22% Similarity=0.401 Sum_probs=196.3
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|++++.||+|+||.||++++..++.. ||||++.+.........+.+.+|+.++..+ +|+||+.+++++. ...+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~--~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~--~~~~ 75 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQV--YAMKILNKWEMLKRAETACFREERDVLVNG-DRRWITNLHYAFQ--DENN 75 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCE--EEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCceEEEEe--cCCe
Confidence 3699999999999999999988776644 999999865444444456788999999888 5699999988764 4568
Q ss_pred EEEEEec-CCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEK-GDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~-~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
++++||+ .+++|.+++..... ......+..++.||+.||+|||++||+||||||+||||+.+ +.+|
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~---------~~~k 142 (331)
T cd05597 76 LYLVMDYYVGGDLLTLLSKFED----RLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKN---------GHIR 142 (331)
T ss_pred EEEEEecCCCCcHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCC---------CCEE
Confidence 8999997 47899999876432 23345556677899999999999999999999999999766 5799
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||++..+...... .....+||+.|||||++...... ...++.++|||||||++|||++|+.||...... ..
T Consensus 143 l~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~----~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~-~~ 216 (331)
T cd05597 143 LADFGSCLRLLADGTV-QSNVAVGTPDYISPEILQAMEDG----KGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-ET 216 (331)
T ss_pred EEECCceeecCCCCCc-cccceeccccccCHHHHhhcccc----ccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH-HH
Confidence 9999999776543321 11235699999999999743210 113678999999999999999999999764332 22
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKA--RPTVGNSVTQ 545 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~--RPt~~ell~~ 545 (553)
...+........+.+ ....++.+++++|++||..++++ |+++.+++++
T Consensus 217 ~~~i~~~~~~~~~~~---~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 217 YGKIMNHKEHFQFPP---DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred HHHHHcCCCcccCCC---ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 333332222222222 12247899999999988664443 7899999876
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=328.37 Aligned_cols=258 Identities=23% Similarity=0.325 Sum_probs=194.0
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC--
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA-- 332 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~-- 332 (553)
.++|++++.||+|+||.||+|.+..++. .||||++..... .....+.+.+|+.+|+++. ||||+++++++....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 89 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQ--KVAVKKLSRPFQ-SLIHARRTYRELRLLKHMK-HENVIGLLDVFTPATSI 89 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCC--EEEEEEeCchhh-hhHHHHHHHHHHHHHHhcC-CCchhhhhhhhcccccc
Confidence 3679999999999999999998876664 499999875432 2233466789999999995 599999998764332
Q ss_pred --CceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCC
Q psy14267 333 --SKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIG 410 (553)
Q Consensus 333 --~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~ 410 (553)
...++++|++.+++|..++... ......+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 90 ~~~~~~~~~~~~~~~~l~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~--------- 154 (343)
T cd07878 90 ENFNEVYLVTNLMGADLNNIVKCQ------KLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNED--------- 154 (343)
T ss_pred cccCcEEEEeecCCCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCC---------
Confidence 2457899999999998877542 24456667778899999999999999999999999999876
Q ss_pred CeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCc
Q psy14267 411 NVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN 490 (553)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~ 490 (553)
+.+||+|||+++...... ....||+.|+|||++.+.. .++.++|||||||++|||++|..||.....
T Consensus 155 ~~~kl~Dfg~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~--------~~~~~~DiwslG~il~el~~g~~pf~~~~~ 221 (343)
T cd07878 155 CELRILDFGLARQADDEM-----TGYVATRWYRAPEIMLNWM--------HYNQTVDIWSVGCIMAELLKGKALFPGNDY 221 (343)
T ss_pred CCEEEcCCccceecCCCc-----CCccccccccCchHhcCCc--------cCCchhhhHhHHHHHHHHHHCCCCCCCCCH
Confidence 579999999998764432 2457899999999987532 368899999999999999999999976432
Q ss_pred hHHHHHHHHhhcc--------------------cccccc--cc-cCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 491 TWAKMLAIARHKD--------------------QIEFKP--QL-ANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 491 ~~~~~~~i~~~~~--------------------~~~~~~--~~-~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
. ..+..+..... .+...+ .+ ......++.+.+||.+||..||++|||+.|+++|
T Consensus 222 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 222 I-DQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred H-HHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1 11111111000 000000 00 0012356788999999999999999999999976
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=313.66 Aligned_cols=263 Identities=20% Similarity=0.310 Sum_probs=200.8
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCC---CccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeC
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSE---HEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDT 331 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~---~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~ 331 (553)
.++|.+.+.||+|+||.||+|..... ...+.||||+++.... .+..+.+.+|+++|+++. |+||+.+++++..
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~- 79 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS--NDARKDFEREAELLTNFQ-HENIVKFYGVCTE- 79 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC--HHHHHHHHHHHHHHHhcC-CCCchheeeEEec-
Confidence 45799999999999999999977543 3345699999875432 234578999999999995 5999999988754
Q ss_pred CCceEEEEEec-CCCCHHHHHHHccc---------CCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecC
Q psy14267 332 ASKHLYVLMEK-GDTDLSKYMRNLNK---------MTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGN 401 (553)
Q Consensus 332 ~~~~~~iv~e~-~~~~L~~~l~~~~~---------~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~ 401 (553)
....+++||+ .+++|.++++.... .......+..+..++.|++.||.|||++||+||||||+|||++.+
T Consensus 80 -~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~ 158 (280)
T cd05049 80 -GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYD 158 (280)
T ss_pred -CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCC
Confidence 4678889886 56899999986532 112234556667778899999999999999999999999999776
Q ss_pred ccceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-
Q psy14267 402 VLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY- 480 (553)
Q Consensus 402 ~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt- 480 (553)
+.+||+|||++................+++.|+|||++.+. .++.++|||||||++|||++
T Consensus 159 ---------~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~e~~~~ 220 (280)
T cd05049 159 ---------LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYR---------KFTTESDVWSFGVVLWEIFTY 220 (280)
T ss_pred ---------CeEEECCcccceecccCcceecCCCCcccceecChhhhccC---------CcchhhhHHHHHHHHHHHHhc
Confidence 67999999999765433221112233467899999999765 37889999999999999998
Q ss_pred CCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q psy14267 481 GRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINN 548 (553)
Q Consensus 481 G~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~ 548 (553)
|..||...... .....+.... .. .....++..+.++|.+||..||++||++.|+++.|++
T Consensus 221 g~~p~~~~~~~-~~~~~~~~~~-~~------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 221 GKQPWYGLSNE-EVIECITQGR-LL------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred CCCCCCCCCHH-HHHHHHHcCC-cC------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 99999775443 2222222111 11 1122578999999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=311.78 Aligned_cols=267 Identities=22% Similarity=0.323 Sum_probs=199.8
Q ss_pred cCcceEEEeeeeeeCceEEEEEeeeCCC---ccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEe
Q psy14267 254 NGKQYQVLSLLGKGGSSSVYLVGGTSEH---EFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYD 330 (553)
Q Consensus 254 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~---~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~ 330 (553)
..++|.+.+.||+|+||.||+|.+.... ....||+|.+.... .......+.+|+.+++++. |+||+++++++.+
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~ 80 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFN-HQNIVRLIGVSFE 80 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEcc
Confidence 4567999999999999999999887521 33458999876433 2233456899999999995 5999999987754
Q ss_pred CCCceEEEEEecC-CCCHHHHHHHcccC--CCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceec
Q psy14267 331 TASKHLYVLMEKG-DTDLSKYMRNLNKM--TTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIID 407 (553)
Q Consensus 331 ~~~~~~~iv~e~~-~~~L~~~l~~~~~~--~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~ 407 (553)
....+++||+. +++|.+++...... ......+..++.++.||+.||+|||+++++||||||+|||++.+.
T Consensus 81 --~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~----- 153 (277)
T cd05036 81 --RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKG----- 153 (277)
T ss_pred --CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccC-----
Confidence 44567888865 78999998775422 122456667777888999999999999999999999999997652
Q ss_pred CCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCC
Q psy14267 408 CIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYS 486 (553)
Q Consensus 408 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~ 486 (553)
....+||+|||+++................+..|+|||++.+. .++.++|||||||++|||++ |..||.
T Consensus 154 -~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~DiwslG~il~el~~~g~~pf~ 223 (277)
T cd05036 154 -PGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDG---------IFTSKTDVWSFGVLLWEIFSLGYMPYP 223 (277)
T ss_pred -CCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcC---------CcCchhHHHHHHHHHHHHHcCCCCCCC
Confidence 1246899999999876433221111123345689999999755 37899999999999999996 999998
Q ss_pred CCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q psy14267 487 HIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINN 548 (553)
Q Consensus 487 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~ 548 (553)
..... .....+. ...... ....++..+.++|.+||+.+|++||++.+++++|++
T Consensus 224 ~~~~~-~~~~~~~-~~~~~~------~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 224 GRTNQ-EVMEFVT-GGGRLD------PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred CCCHH-HHHHHHH-cCCcCC------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 75443 2222222 111111 123678999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=321.99 Aligned_cols=271 Identities=22% Similarity=0.338 Sum_probs=204.8
Q ss_pred eEEecCcceEEEeeeeeeCceEEEEEeeeCCC-----ccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEe
Q psy14267 250 VITLNGKQYQVLSLLGKGGSSSVYLVGGTSEH-----EFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKM 324 (553)
Q Consensus 250 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l 324 (553)
.|++...+|++++.||+|+||.||+|++.... ....||+|+++... .....+.+.+|+++++++.+||||+++
T Consensus 6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~ 83 (334)
T cd05100 6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINL 83 (334)
T ss_pred ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeee
Confidence 45667778999999999999999999865322 12358999886432 223457889999999999778999999
Q ss_pred eeEEEeCCCceEEEEEecC-CCCHHHHHHHccc-----------CCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCC
Q psy14267 325 HDYVYDTASKHLYVLMEKG-DTDLSKYMRNLNK-----------MTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLK 392 (553)
Q Consensus 325 ~~~~~~~~~~~~~iv~e~~-~~~L~~~l~~~~~-----------~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLK 392 (553)
++++. ....++++||+. +++|.+++..... .......+..++.++.|++.||+|||++||+|||||
T Consensus 84 ~~~~~--~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlk 161 (334)
T cd05100 84 LGACT--QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLA 161 (334)
T ss_pred eEEEc--cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccc
Confidence 98774 355788888865 6799999876431 122234556677778899999999999999999999
Q ss_pred CCCEEEecCccceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHH
Q psy14267 393 PANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLG 472 (553)
Q Consensus 393 p~NILl~~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlG 472 (553)
|+|||++.+ +.+||+|||+++...............++..|+|||++.+. .++.++||||||
T Consensus 162 p~Nill~~~---------~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG 223 (334)
T cd05100 162 ARNVLVTED---------NVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDR---------VYTHQSDVWSFG 223 (334)
T ss_pred cceEEEcCC---------CcEEECCcccceecccccccccccCCCcCceEcCHHHhccC---------CcCchhhhHHHH
Confidence 999999776 57999999999876543322122233356789999999765 368899999999
Q ss_pred HHHHHHHh-CCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q psy14267 473 CILYNMIY-GRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNP 550 (553)
Q Consensus 473 vvl~ellt-G~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~ 550 (553)
|++|||++ |..||...... .....+. ..... .....++..+.++|.+||+.+|++||++.++++.|+++.
T Consensus 224 ~il~el~~~g~~p~~~~~~~-~~~~~~~-~~~~~------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 224 VLLWEIFTLGGSPYPGIPVE-ELFKLLK-EGHRM------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred HHHHHHHhcCCCCCCCCCHH-HHHHHHH-cCCCC------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 99999998 89999775432 2222221 11111 112356789999999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=311.24 Aligned_cols=260 Identities=17% Similarity=0.256 Sum_probs=197.5
Q ss_pred cCcceEEEeeeeeeCceEEEEEeeeC-CCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC
Q psy14267 254 NGKQYQVLSLLGKGGSSSVYLVGGTS-EHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA 332 (553)
Q Consensus 254 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~ 332 (553)
...+|++.+.||+|+||.||++.... ......||+|.++.... ......+.+|+.+|+++. ||||+++++++. .
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~--~ 77 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS--DKQRRGFLAEALTLGQFD-HSNIVRLEGVIT--R 77 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC--HHHHHHHHHHHHHHhcCC-CCCcCeEEEEEe--c
Confidence 45679999999999999999987643 23345699999876432 233467899999999995 599999998774 4
Q ss_pred CceEEEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCC
Q psy14267 333 SKHLYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGN 411 (553)
Q Consensus 333 ~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~ 411 (553)
...++++||+.+ ++|.+++..... ...+..++.++.|++.||+|||++|++||||||+|||++.+ +
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~~~----~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~---------~ 144 (266)
T cd05064 78 GNTMMIVTEYMSNGALDSFLRKHEG----QLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSD---------L 144 (266)
T ss_pred CCCcEEEEEeCCCCcHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCC---------C
Confidence 567899999764 678888875432 33456667778899999999999999999999999999776 5
Q ss_pred eEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCCCc
Q psy14267 412 VLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHIPN 490 (553)
Q Consensus 412 ~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~~~ 490 (553)
.+||+|||++........ .......++..|+|||.+.+. .++.++|||||||++||+++ |..||.+...
T Consensus 145 ~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~~l~ell~~g~~p~~~~~~ 214 (266)
T cd05064 145 VCKISGFRRLQEDKSEAI-YTTMSGKSPVLWAAPEAIQYH---------HFSSASDVWSFGIVMWEVMSYGERPYWDMSG 214 (266)
T ss_pred cEEECCCcccccccccch-hcccCCCCceeecCHHHHhhC---------CccchhHHHHHHHHHHHHhcCCCCCcCcCCH
Confidence 799999998765432221 111133456789999998765 37889999999999999875 9999987544
Q ss_pred hHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 491 TWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 491 ~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
. .....+.. ... ......++..+.+++.+||+.+|++||++.+|++.|.+.
T Consensus 215 ~-~~~~~~~~-~~~------~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 215 Q-DVIKAVED-GFR------LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred H-HHHHHHHC-CCC------CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 3 22222221 111 112336789999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=308.96 Aligned_cols=258 Identities=24% Similarity=0.392 Sum_probs=198.6
Q ss_pred EecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeC
Q psy14267 252 TLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDT 331 (553)
Q Consensus 252 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~ 331 (553)
++..++|++.+.||+|+||.||++..... +.||||.++..... .+.+.+|+.+++++. |+||+++++++.
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~---~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~-h~~i~~~~~~~~-- 71 (261)
T cd05068 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNT---TPVAVKTLKPGTMD----PKDFLAEAQIMKKLR-HPKLIQLYAVCT-- 71 (261)
T ss_pred ccchhheeeEEEecccCCccEEEEEecCC---eEEEEEeeCCCccc----HHHHHHHHHHHHHCC-CCCccceeEEEe--
Confidence 45567899999999999999999875433 45999998765432 356889999999996 599999988764
Q ss_pred CCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCC
Q psy14267 332 ASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIG 410 (553)
Q Consensus 332 ~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~ 410 (553)
....++++||+. +++|.+++..... ....+..+..++.|++.||.|||++||+||||||+||+++.+
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~--------- 139 (261)
T cd05068 72 LEEPIYIVTELMKYGSLLEYLQGGAG---RALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGEN--------- 139 (261)
T ss_pred cCCCeeeeeecccCCcHHHHHhccCC---CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCC---------
Confidence 355788999986 7899999876541 233455667777899999999999999999999999999876
Q ss_pred CeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCCC
Q psy14267 411 NVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHIP 489 (553)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~~ 489 (553)
+.+||+|||+++......... .....++..|+|||.+.+. .++.++||||||+++|||++ |+.||....
T Consensus 140 ~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 209 (261)
T cd05068 140 NICKVADFGLARVIKEDIYEA-REGAKFPIKWTAPEAALYN---------RFSIKSDVWSFGILLTEIVTYGRMPYPGMT 209 (261)
T ss_pred CCEEECCcceEEEccCCcccc-cCCCcCceeccCccccccC---------CCCchhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 579999999998775332211 1112234589999998755 37889999999999999999 999998754
Q ss_pred chHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 490 NTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 490 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
.. .....+.. .... .....++..+.+++.+||+.+|++||++.+|+..|++.
T Consensus 210 ~~-~~~~~~~~-~~~~------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 210 NA-EVLQQVDQ-GYRM------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred HH-HHHHHHHc-CCCC------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 32 22222221 1111 11235789999999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=325.19 Aligned_cols=247 Identities=24% Similarity=0.387 Sum_probs=188.3
Q ss_pred eeeeeeCceEEEEEeeeC-CCccceEEEEEEecCCcC-chhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEEEE
Q psy14267 262 SLLGKGGSSSVYLVGGTS-EHEFKPLALKVVDLSDIT-DQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVL 339 (553)
Q Consensus 262 ~~LG~G~fG~Vy~a~~~~-~~~~~~vAvK~l~~~~~~-~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~iv 339 (553)
+.||+|+||.||+|+... ....+.||||++++.... .......+.+|+.+|+++. ||||+++++++. .+..+|++
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~~~~~~~--~~~~~~lv 78 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK-HPFIVDLIYAFQ--TGGKLYLI 78 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCC-CCchhceeeEEe--cCCeEEEE
Confidence 679999999999997643 233466999999865432 2233456789999999995 599999988764 35678999
Q ss_pred EecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEec
Q psy14267 340 MEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDF 418 (553)
Q Consensus 340 ~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DF 418 (553)
||++ +++|.+++..... .....+..++.||+.||+|||++||+||||||+||||+.+ +.+||+||
T Consensus 79 ~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~---------~~~kl~Df 144 (323)
T cd05584 79 LEYLSGGELFMHLEREGI-----FMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQ---------GHVKLTDF 144 (323)
T ss_pred EeCCCCchHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC---------CCEEEeeC
Confidence 9975 5688888876442 2234455566799999999999999999999999999776 57999999
Q ss_pred cCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHHHH
Q psy14267 419 GIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAI 498 (553)
Q Consensus 419 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~~i 498 (553)
|+++....... ......||+.|+|||++.+.. ++.++|||||||+||||++|..||...... ..+..+
T Consensus 145 g~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~---------~~~~~DiwslG~il~ell~G~~pf~~~~~~-~~~~~~ 212 (323)
T cd05584 145 GLCKESIHEGT--VTHTFCGTIEYMAPEILMRSG---------HGKAVDWWSLGALMYDMLTGAPPFTAENRK-KTIDKI 212 (323)
T ss_pred cCCeecccCCC--cccccCCCccccChhhccCCC---------CCCcceecccHHHHHHHhcCCCCCCCCCHH-HHHHHH
Confidence 99876433322 123467999999999997653 678999999999999999999999875432 223333
Q ss_pred HhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q psy14267 499 ARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARP-----TVGNSVTQ 545 (553)
Q Consensus 499 ~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RP-----t~~ell~~ 545 (553)
... ... ....+++.+.++|++||+.||++|| ++.+++++
T Consensus 213 ~~~--~~~------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 213 LKG--KLN------LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred HcC--CCC------CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 221 111 1235688999999999999999999 78888764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=326.60 Aligned_cols=242 Identities=22% Similarity=0.341 Sum_probs=183.6
Q ss_pred eeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHH-HhhcCCCceeEeeeEEEeCCCceEEEEE
Q psy14267 262 SLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELL-AKLQGCPYVIKMHDYVYDTASKHLYVLM 340 (553)
Q Consensus 262 ~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL-~~l~~hp~Iv~l~~~~~~~~~~~~~iv~ 340 (553)
++||+|+||+||+|.+..++.. ||||++.+...........++.|..++ +.+ +||||+++++++. ....++++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l-~hp~iv~~~~~~~--~~~~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKF--YAVKVLQKKAILKKKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQ--TADKLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCE--EEEEEEEHHHHhhhhHHHHHHHHHHHHHhhC-CCCCCCCeeEEEE--eCCEEEEEE
Confidence 4799999999999988776654 999999876544334445667776654 555 5699999987764 356788999
Q ss_pred ecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEecc
Q psy14267 341 EKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFG 419 (553)
Q Consensus 341 e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFG 419 (553)
|++ +++|..++.... ......+..++.||+.||+|||++||+||||||+||||+.+ +.+||+|||
T Consensus 76 e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~---------~~~kl~Dfg 141 (323)
T cd05575 76 DYVNGGELFFHLQRER-----SFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQ---------GHVVLTDFG 141 (323)
T ss_pred cCCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCC---------CcEEEeccC
Confidence 975 578888887643 23345566677899999999999999999999999999776 579999999
Q ss_pred CccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHH
Q psy14267 420 IACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIA 499 (553)
Q Consensus 420 la~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~~i~ 499 (553)
+++....... .....+||+.|+|||++.+. .++.++|||||||++|||++|..||...... .....+.
T Consensus 142 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~---------~~~~~~DvwslG~il~ell~g~~pf~~~~~~-~~~~~i~ 209 (323)
T cd05575 142 LCKEGIEHSK--TTSTFCGTPEYLAPEVLRKQ---------PYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA-EMYDNIL 209 (323)
T ss_pred CCcccccCCC--ccccccCChhhcChhhhcCC---------CCCccccccccchhhhhhhcCCCCCCCCCHH-HHHHHHH
Confidence 9876433222 12356799999999999765 3688999999999999999999999874332 2222222
Q ss_pred hhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q psy14267 500 RHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNS 542 (553)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~el 542 (553)
.. ... ....++..+.++|++||+.||++||++.+.
T Consensus 210 ~~--~~~------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~ 244 (323)
T cd05575 210 NK--PLR------LKPNISVSARHLLEGLLQKDRTKRLGAKDD 244 (323)
T ss_pred cC--CCC------CCCCCCHHHHHHHHHHhhcCHHhCCCCCCC
Confidence 11 111 122568999999999999999999998533
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=314.55 Aligned_cols=266 Identities=21% Similarity=0.325 Sum_probs=202.7
Q ss_pred cCcceEEEeeeeeeCceEEEEEeeeC---CCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEe
Q psy14267 254 NGKQYQVLSLLGKGGSSSVYLVGGTS---EHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYD 330 (553)
Q Consensus 254 ~~~~y~i~~~LG~G~fG~Vy~a~~~~---~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~ 330 (553)
+..+|.+.+.||+|+||.||++.... ......+|+|.+.... ....+.+.+|+++|+++. ||+|+++++++.
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~- 77 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQ-HEHIVKFYGVCV- 77 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCC-CCCcceEEEEEe-
Confidence 45689999999999999999997533 2223458999886542 344577899999999995 599999998774
Q ss_pred CCCceEEEEEecC-CCCHHHHHHHccc--------CCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecC
Q psy14267 331 TASKHLYVLMEKG-DTDLSKYMRNLNK--------MTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGN 401 (553)
Q Consensus 331 ~~~~~~~iv~e~~-~~~L~~~l~~~~~--------~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~ 401 (553)
....++++||+. +++|.+++..... .......+..++.++.|++.||+|||++||+||||||+|||++.+
T Consensus 78 -~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~ 156 (288)
T cd05093 78 -EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN 156 (288)
T ss_pred -cCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence 356788899864 6899999876532 112235566777778899999999999999999999999999776
Q ss_pred ccceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-
Q psy14267 402 VLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY- 480 (553)
Q Consensus 402 ~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt- 480 (553)
+.+||+|||+++...............++..|+|||++.+. .++.++|||||||++|||++
T Consensus 157 ---------~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~sDiwslG~il~~l~t~ 218 (288)
T cd05093 157 ---------LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR---------KFTTESDVWSLGVVLWEIFTY 218 (288)
T ss_pred ---------CcEEeccCCccccccCCceeecCCCCCccccccCHHHhccC---------CCCchhhHHHHHHHHHHHHhC
Confidence 57999999999866443322222234467899999999765 37889999999999999998
Q ss_pred CCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q psy14267 481 GRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNPE 551 (553)
Q Consensus 481 G~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~~ 551 (553)
|..||...... .....+..... . .....++.++.+++.+||+.||.+|||+.++++.|+++..
T Consensus 219 g~~p~~~~~~~-~~~~~i~~~~~-~------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 219 GKQPWYQLSNN-EVIECITQGRV-L------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred CCCCCCCCCHH-HHHHHHHcCCc-C------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 99999875443 22222322111 1 1122578899999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=311.40 Aligned_cols=266 Identities=24% Similarity=0.367 Sum_probs=201.4
Q ss_pred EecCcceEEEeeeeeeCceEEEEEeeeCCC---ccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEE
Q psy14267 252 TLNGKQYQVLSLLGKGGSSSVYLVGGTSEH---EFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYV 328 (553)
Q Consensus 252 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~---~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~ 328 (553)
++..++|++.+.||+|+||.||++...... ....||+|.+..... ......+.+|+.+|+.+. |+||+++++++
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~ 78 (277)
T cd05032 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENAS--MRERIEFLNEASVMKEFN-CHHVVRLLGVV 78 (277)
T ss_pred ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccC--HHHHHHHHHHHHHHHhCC-CCceeEEEEEE
Confidence 456678999999999999999999876432 335699999865432 233467889999999995 59999999987
Q ss_pred EeCCCceEEEEEecC-CCCHHHHHHHcccCC-----CCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCc
Q psy14267 329 YDTASKHLYVLMEKG-DTDLSKYMRNLNKMT-----TLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNV 402 (553)
Q Consensus 329 ~~~~~~~~~iv~e~~-~~~L~~~l~~~~~~~-----~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~ 402 (553)
.. ....+++||+. +++|.+++....... .....+..++.++.|++.||.|||+.+|+||||||+|||++.+
T Consensus 79 ~~--~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~- 155 (277)
T cd05032 79 ST--GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAED- 155 (277)
T ss_pred cC--CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCC-
Confidence 44 46788899975 579999987643221 1123445566677899999999999999999999999999876
Q ss_pred cceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-C
Q psy14267 403 LKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-G 481 (553)
Q Consensus 403 ~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G 481 (553)
+.+||+|||+++...............++..|+|||.+... .++.++|||||||++|||++ |
T Consensus 156 --------~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~el~t~g 218 (277)
T cd05032 156 --------LTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG---------VFTTKSDVWSFGVVLWEMATLA 218 (277)
T ss_pred --------CCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcC---------CCCcccchHHHHHHHHHhhccC
Confidence 57999999999876543322222344578899999998654 36889999999999999998 9
Q ss_pred CCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q psy14267 482 RTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINN 548 (553)
Q Consensus 482 ~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~ 548 (553)
..||...... .....+. ...... ....++..+.++|.+||+.+|++|||+.++++.|+.
T Consensus 219 ~~p~~~~~~~-~~~~~~~-~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 219 EQPYQGLSNE-EVLKFVI-DGGHLD------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred CCCCccCCHH-HHHHHHh-cCCCCC------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 9999764432 2222222 111111 122468999999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG1095|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=352.56 Aligned_cols=267 Identities=25% Similarity=0.376 Sum_probs=212.1
Q ss_pred ecCcceEEEeeeeeeCceEEEEEeeeCCCc---cceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEE
Q psy14267 253 LNGKQYQVLSLLGKGGSSSVYLVGGTSEHE---FKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVY 329 (553)
Q Consensus 253 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~---~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~ 329 (553)
+.....++...||+|.||.||.+...+... ...||||.+++. .+......|++|..+|+++. |||||+++|+++
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~-HpNiv~liGv~l 765 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFD-HPNIVSLIGVCL 765 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCC-CcceeeEEEeec
Confidence 567788999999999999999987765433 234777777544 45566789999999999995 599999999998
Q ss_pred eCCCceEEEEEe-cCCCCHHHHHHHcc--cCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCcccee
Q psy14267 330 DTASKHLYVLME-KGDTDLSKYMRNLN--KMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKII 406 (553)
Q Consensus 330 ~~~~~~~~iv~e-~~~~~L~~~l~~~~--~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~ 406 (553)
+ ....+|++| +.+|||..||++.. .......++...+.++.||+.|++||+++++|||||...|+||+..
T Consensus 766 ~--~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~----- 838 (1025)
T KOG1095|consen 766 D--SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDER----- 838 (1025)
T ss_pred C--CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeeccc-----
Confidence 7 333445555 68899999999762 2234456777888888999999999999999999999999999876
Q ss_pred cCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCC
Q psy14267 407 DCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPY 485 (553)
Q Consensus 407 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf 485 (553)
..|||+|||+|+.+-............-...|||||.++.. .++.++|||||||+|||+++ |..||
T Consensus 839 ----r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~---------iFtskSDvWsFGVllWEifslG~~PY 905 (1025)
T KOG1095|consen 839 ----RVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDG---------IFTSKSDVWSFGVLLWEIFSLGATPY 905 (1025)
T ss_pred ----CcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhc---------ccccccchhhhHHHHHHHHhCCCCCC
Confidence 57999999999966554433222222345799999999865 58999999999999999997 99999
Q ss_pred CCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q psy14267 486 SHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNP 550 (553)
Q Consensus 486 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~ 550 (553)
.+..+. +.+..+.... ++..+..||+.+.++|..||+.+|++||++..|++.+.++.
T Consensus 906 ~~~~n~-~v~~~~~~gg-------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~ 962 (1025)
T KOG1095|consen 906 PSRSNF-EVLLDVLEGG-------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS 962 (1025)
T ss_pred CCcchH-HHHHHHHhCC-------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence 997765 3333333332 34455689999999999999999999999999999887753
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=309.54 Aligned_cols=254 Identities=24% Similarity=0.479 Sum_probs=193.0
Q ss_pred EEEeeeeeeCceEEEEEeee--CCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceE
Q psy14267 259 QVLSLLGKGGSSSVYLVGGT--SEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHL 336 (553)
Q Consensus 259 ~i~~~LG~G~fG~Vy~a~~~--~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~ 336 (553)
.+.+.||.|.||.||+|... .......|+||+++.. ...+..+.+.+|+++|+++ +||||+++++++. ....+
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l-~h~ni~~~~g~~~--~~~~~ 76 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKL-RHPNIVKLYGFCI--ENEPL 76 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTH-SBTTBE-EEEEEE--SSSSE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeecccccccc-ccccccccccccc--ccccc
Confidence 46789999999999999888 4455577999999543 2334468899999999999 6699999999887 34447
Q ss_pred EEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 337 YVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 337 ~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
++++|++ +++|.+++...... ......++.++.||+.||.|||+++|+|+||+++|||++.+ +.+||
T Consensus 77 ~lv~e~~~~g~L~~~L~~~~~~---~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~---------~~~Kl 144 (259)
T PF07714_consen 77 FLVMEYCPGGSLDDYLKSKNKE---PLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSN---------GQVKL 144 (259)
T ss_dssp EEEEE--TTEBHHHHHHHTCTT---TSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETT---------TEEEE
T ss_pred cccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccccc---------ccccc
Confidence 8888876 47999999987222 34456667777899999999999999999999999999887 68999
Q ss_pred EeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCCCchHHH
Q psy14267 416 IDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHIPNTWAK 494 (553)
Q Consensus 416 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~~~~~~~ 494 (553)
+|||++................+...|+|||.+... .++.++||||||++||||++ |+.||.+.... ..
T Consensus 145 ~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~---------~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~-~~ 214 (259)
T PF07714_consen 145 SDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDG---------EYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE-EI 214 (259)
T ss_dssp ESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHS---------EESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH-HH
T ss_pred cccccccccccccccccccccccccccccccccccc---------cccccccccccccccccccccccccccccccc-cc
Confidence 999999887433332223344578899999999766 37899999999999999999 78999887443 33
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQI 546 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L 546 (553)
...+... .... ....++..+.++|..||..||++||++.+|++.|
T Consensus 215 ~~~~~~~-~~~~------~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 215 IEKLKQG-QRLP------IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHHHTT-EETT------SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ccccccc-ccce------eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 3333222 1111 2236789999999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=308.99 Aligned_cols=260 Identities=20% Similarity=0.363 Sum_probs=199.6
Q ss_pred EecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeC
Q psy14267 252 TLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDT 331 (553)
Q Consensus 252 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~ 331 (553)
.+...+|.+.+.||+|+||.||++.+...+.. ||+|++..+. .....+.+|+++++++. |+||+++++++.
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~--~~~K~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~-- 72 (263)
T cd05052 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLT--VAVKTLKEDT----MEVEEFLKEAAVMKEIK-HPNLVQLLGVCT-- 72 (263)
T ss_pred CCchHHeEEeeecCCcccceEEEEEEecCCce--EEEEEecCCc----hHHHHHHHHHHHHHhCC-CCChhheEEEEc--
Confidence 34556799999999999999999988766544 9999987543 22467889999999995 599999998764
Q ss_pred CCceEEEEEec-CCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCC
Q psy14267 332 ASKHLYVLMEK-GDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIG 410 (553)
Q Consensus 332 ~~~~~~iv~e~-~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~ 410 (553)
.+..++++||+ .+++|.+++...... ......+..++.|++.||+|||++||+||||||+|||++.+
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~~~~~~~~---~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~--------- 140 (263)
T cd05052 73 REPPFYIITEFMTYGNLLDYLRECNRQ---EVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN--------- 140 (263)
T ss_pred CCCCcEEEEEeCCCCcHHHHHHhCCCC---CCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCC---------
Confidence 45677888986 468899988764322 23445566677899999999999999999999999999766
Q ss_pred CeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCCC
Q psy14267 411 NVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHIP 489 (553)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~~ 489 (553)
+.+||+|||++.......... .....++..|+|||.+.+. .++.++|||||||++|||++ |..||.+..
T Consensus 141 ~~~kl~df~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~---------~~~~~~Dv~slG~il~el~t~g~~p~~~~~ 210 (263)
T cd05052 141 HLVKVADFGLSRLMTGDTYTA-HAGAKFPIKWTAPESLAYN---------KFSIKSDVWAFGVLLWEIATYGMSPYPGID 210 (263)
T ss_pred CcEEeCCCccccccccceeec-cCCCCCccccCCHHHhccC---------CCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 579999999998765433211 1122346789999998765 36889999999999999998 999997643
Q ss_pred chHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q psy14267 490 NTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNP 550 (553)
Q Consensus 490 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~ 550 (553)
.. .....+.. .... .....++.++.++|.+||..+|++||++.++++.|+++.
T Consensus 211 ~~-~~~~~~~~-~~~~------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 263 (263)
T cd05052 211 LS-QVYELLEK-GYRM------ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETMF 263 (263)
T ss_pred HH-HHHHHHHC-CCCC------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhhC
Confidence 32 22222211 1111 122367899999999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=309.04 Aligned_cols=259 Identities=24% Similarity=0.397 Sum_probs=198.8
Q ss_pred EEecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEe
Q psy14267 251 ITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYD 330 (553)
Q Consensus 251 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~ 330 (553)
|.+..++|+++++||+|+||.||+|..... ..||+|.+..... ..+.+.+|+.+++++. |+||+++++++
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~---~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~-- 70 (261)
T cd05072 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNS---TKVAVKTLKPGTM----SVQAFLEEANLMKTLQ-HDKLVRLYAVV-- 70 (261)
T ss_pred CcCchHHeEEeeecCCcCCceEEEEEecCC---ceEEEEEccCCch----hHHHHHHHHHHHHhCC-CCCeeeEEEEE--
Confidence 345667899999999999999999976433 3489998865432 2467899999999995 59999998766
Q ss_pred CCCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCC
Q psy14267 331 TASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCI 409 (553)
Q Consensus 331 ~~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~ 409 (553)
......+++||+. +++|.+++...... ......+..++.|++.||+|||+.+++||||||+||+++.+
T Consensus 71 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~-------- 139 (261)
T cd05072 71 TKEEPIYIITEYMAKGSLLDFLKSDEGG---KVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSES-------- 139 (261)
T ss_pred cCCCCcEEEEecCCCCcHHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCC--------
Confidence 3456788999975 67999988764322 23344556667799999999999999999999999999776
Q ss_pred CCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCC
Q psy14267 410 GNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHI 488 (553)
Q Consensus 410 ~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~ 488 (553)
+.+||+|||++......... ......++..|+|||.+.+. .++.++|||||||++|||++ |..||...
T Consensus 140 -~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~~l~~l~t~g~~p~~~~ 208 (261)
T cd05072 140 -LMCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFG---------SFTIKSDVWSFGILLYEIVTYGKIPYPGM 208 (261)
T ss_pred -CcEEECCCccceecCCCcee-ccCCCccceecCCHHHhccC---------CCChhhhhhhhHHHHHHHHccCCCCCCCC
Confidence 57999999999876543321 11233467789999998755 36789999999999999998 99999875
Q ss_pred CchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 489 PNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 489 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
... .....+... .. ......++.++.+++.+||..+|++||+++++++.|+++
T Consensus 209 ~~~-~~~~~~~~~-~~------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 209 SNS-DVMSALQRG-YR------MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CHH-HHHHHHHcC-CC------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 443 222222211 11 112235789999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG4279|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=337.85 Aligned_cols=249 Identities=25% Similarity=0.394 Sum_probs=205.7
Q ss_pred eeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEEEEEe-
Q psy14267 263 LLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLME- 341 (553)
Q Consensus 263 ~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~iv~e- 341 (553)
+||+|+||+||.+++..+... +|||.+.... ....+-++.|+.+.++|+| .|||+++|.+ ..+.++-|.||
T Consensus 582 VLGKGTYG~VYA~RD~~tqvr--IaIKEIpekd---sr~~QPLhEEIaLH~~LrH-kNIVrYLGs~--senGf~kIFMEq 653 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVR--IAIKEIPEKD---SREVQPLHEEIALHSTLRH-KNIVRYLGSV--SENGFFKIFMEQ 653 (1226)
T ss_pred EeecCceeEEEeeccccceeE--EEeeeccccc---chhhccHHHHHHHHHHHhh-HhHHHHhhcc--CCCCeEEEEeec
Confidence 799999999999999887754 9999886543 3445788999999999976 9999999976 45668888888
Q ss_pred cCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEeccCc
Q psy14267 342 KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIA 421 (553)
Q Consensus 342 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGla 421 (553)
..||+|..+++..= ....-.+..+..+.+||++||.|||++.|||||||-+||||+. ..|.+||.|||-+
T Consensus 654 VPGGSLSsLLrskW--GPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNT--------ySGvlKISDFGTs 723 (1226)
T KOG4279|consen 654 VPGGSLSSLLRSKW--GPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNT--------YSGVLKISDFGTS 723 (1226)
T ss_pred CCCCcHHHHHHhcc--CCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEee--------ccceEEecccccc
Confidence 68899999998642 2223345667778889999999999999999999999999854 3489999999999
Q ss_pred cccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHhh
Q psy14267 422 CSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARH 501 (553)
Q Consensus 422 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~~i~~~ 501 (553)
+++..-.. -+.++.||..|||||++..++- -|+.++|||||||++.||.||++||..+.+..+.|..+...
T Consensus 724 KRLAginP--~TETFTGTLQYMAPEvIDqG~R-------GYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmy 794 (1226)
T KOG4279|consen 724 KRLAGINP--CTETFTGTLQYMAPEVIDQGPR-------GYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMY 794 (1226)
T ss_pred hhhccCCc--cccccccchhhhChHhhccCCc-------CCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcce
Confidence 98865443 3458899999999999976542 28999999999999999999999999988877777776655
Q ss_pred cccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy14267 502 KDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVT 544 (553)
Q Consensus 502 ~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~ 544 (553)
+....++. .++.+.+.+|.+|+..||..||+++++|.
T Consensus 795 KvHP~iPe------elsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 795 KVHPPIPE------ELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred ecCCCCcH------HHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 54433333 67789999999999999999999999985
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=317.01 Aligned_cols=270 Identities=21% Similarity=0.326 Sum_probs=203.5
Q ss_pred eEEecCcceEEEeeeeeeCceEEEEEeeeCC-----CccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEe
Q psy14267 250 VITLNGKQYQVLSLLGKGGSSSVYLVGGTSE-----HEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKM 324 (553)
Q Consensus 250 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~-----~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l 324 (553)
.|.+...+|.+.+.||+|+||.||++++... .....||+|+++.... ......+.+|+.+++++.+||||+++
T Consensus 6 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~ 83 (314)
T cd05099 6 KWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT--DKDLADLISEMELMKLIGKHKNIINL 83 (314)
T ss_pred cccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC--hHHHHHHHHHHHHHHhccCCCCeeeE
Confidence 3455667899999999999999999976422 2234589999875432 23356789999999999778999999
Q ss_pred eeEEEeCCCceEEEEEecC-CCCHHHHHHHccc-----------CCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCC
Q psy14267 325 HDYVYDTASKHLYVLMEKG-DTDLSKYMRNLNK-----------MTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLK 392 (553)
Q Consensus 325 ~~~~~~~~~~~~~iv~e~~-~~~L~~~l~~~~~-----------~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLK 392 (553)
++++.+ ...++++||+. +++|.+++..... .......+..+..++.|++.||.|||++||+|||||
T Consensus 84 ~~~~~~--~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlk 161 (314)
T cd05099 84 LGVCTQ--EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLA 161 (314)
T ss_pred EEEEcc--CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecccc
Confidence 987743 55688889874 6799999976432 112235556667778899999999999999999999
Q ss_pred CCCEEEecCccceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHH
Q psy14267 393 PANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLG 472 (553)
Q Consensus 393 p~NILl~~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlG 472 (553)
|+|||++.+ +.+||+|||+++...............++..|||||++.+. .++.++||||||
T Consensus 162 p~Nill~~~---------~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~DiwslG 223 (314)
T cd05099 162 ARNVLVTED---------NVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDR---------VYTHQSDVWSFG 223 (314)
T ss_pred ceeEEEcCC---------CcEEEccccccccccccccccccccCCCCccccCHHHHccC---------CcCccchhhHHH
Confidence 999999766 57999999999876543222111223345689999998755 378899999999
Q ss_pred HHHHHHHh-CCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 473 CILYNMIY-GRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 473 vvl~ellt-G~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
|++|||++ |..||...... .....+. ..... .....++.++++++.+||..+|++||++.++++.|+++
T Consensus 224 ~~l~el~~~g~~p~~~~~~~-~~~~~~~-~~~~~------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 293 (314)
T cd05099 224 ILMWEIFTLGGSPYPGIPVE-ELFKLLR-EGHRM------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV 293 (314)
T ss_pred HHHHHHHhCCCCCCCCCCHH-HHHHHHH-cCCCC------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 99999998 89999775432 2222222 11111 11236788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=333.18 Aligned_cols=256 Identities=21% Similarity=0.291 Sum_probs=191.2
Q ss_pred cCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCC
Q psy14267 254 NGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTAS 333 (553)
Q Consensus 254 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~ 333 (553)
.+..|.+.+.||+|+||.||+|.+...+. .||||.... ..+.+|+++|++|. |+||+++++++.. .
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~--~vavK~~~~---------~~~~~E~~iL~~L~-HpnIv~l~~~~~~--~ 232 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQ--RVVVKAGWY---------ASSVHEARLLRRLS-HPAVLALLDVRVV--G 232 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCC--EEEEecccc---------cCHHHHHHHHHHCC-CCCCCcEEEEEEE--C
Confidence 35679999999999999999998877664 499995421 34568999999995 5999999987654 5
Q ss_pred ceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 334 KHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 334 ~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
...+++|++..++|..++..... .+.+..++.++.||+.||+|||++|||||||||+||||+.+ +.+
T Consensus 233 ~~~~lv~e~~~~~L~~~l~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~---------~~v 299 (461)
T PHA03211 233 GLTCLVLPKYRSDLYTYLGARLR----PLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGP---------EDI 299 (461)
T ss_pred CEEEEEEEccCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCC---------CCE
Confidence 67788899888899998876432 34566777788899999999999999999999999999776 569
Q ss_pred EEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCc---
Q psy14267 414 KIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN--- 490 (553)
Q Consensus 414 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~--- 490 (553)
||+|||+++.+.............||+.|||||++.+. .++.++|||||||+||||++|..|+-....
T Consensus 300 kL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~---------~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~ 370 (461)
T PHA03211 300 CLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGD---------PYTPSVDIWSAGLVIFEAAVHTASLFSASRGDE 370 (461)
T ss_pred EEcccCCceecccccccccccccCCCcCCcCHHHHcCC---------CCCchHHHHHHHHHHHHHHHcCCCcccCCcccc
Confidence 99999999876543322222345799999999999765 378899999999999999998766532111
Q ss_pred ----hHHHHHHHHhhcccc-cc-------------------------cccccCCCCCCHHHHHHHHHhcccCCCCCCCHH
Q psy14267 491 ----TWAKMLAIARHKDQI-EF-------------------------KPQLANNVTIPPTLLQSMKLCLQKDPKARPTVG 540 (553)
Q Consensus 491 ----~~~~~~~i~~~~~~~-~~-------------------------~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ 540 (553)
..+....+....... .+ .+.+.....++.++.+||.+||+.||++|||+.
T Consensus 371 ~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~ 450 (461)
T PHA03211 371 RRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAA 450 (461)
T ss_pred cCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHH
Confidence 111111111111000 00 011112224567899999999999999999999
Q ss_pred HHHHH
Q psy14267 541 NSVTQ 545 (553)
Q Consensus 541 ell~~ 545 (553)
|||++
T Consensus 451 elL~h 455 (461)
T PHA03211 451 ELLRL 455 (461)
T ss_pred HHhhC
Confidence 99986
|
|
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=331.50 Aligned_cols=270 Identities=21% Similarity=0.384 Sum_probs=211.5
Q ss_pred cccceEEecCcceEEEeeeeeeCceEEEEEeeeCCCc--cceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeE
Q psy14267 246 TSQDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHE--FKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIK 323 (553)
Q Consensus 246 ~~~~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~--~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~ 323 (553)
.....|++..++..+.++||+|+||+||+++.+..+. ...||||..+.+.......+..+++|+++|+++. |||||+
T Consensus 147 I~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~-H~NVVr 225 (474)
T KOG0194|consen 147 IPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLN-HPNVVR 225 (474)
T ss_pred ccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCC-CCCEEE
Confidence 3455688888888999999999999999998876544 2238999998755555677899999999999985 599999
Q ss_pred eeeEEEeCCCceEEEEEec-CCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCc
Q psy14267 324 MHDYVYDTASKHLYVLMEK-GDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNV 402 (553)
Q Consensus 324 l~~~~~~~~~~~~~iv~e~-~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~ 402 (553)
++|+.. ....++++||+ .+|+|.++|+.... ..+....+.++.+.+.||+|||++++|||||-.+|+|++.+
T Consensus 226 ~yGVa~--~~~Pl~ivmEl~~gGsL~~~L~k~~~----~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~- 298 (474)
T KOG0194|consen 226 FYGVAV--LEEPLMLVMELCNGGSLDDYLKKNKK----SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKK- 298 (474)
T ss_pred EEEEEc--CCCccEEEEEecCCCcHHHHHHhCCC----CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCC-
Confidence 998774 46678999996 56799999998765 23345556666799999999999999999999999999776
Q ss_pred cceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-C
Q psy14267 403 LKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-G 481 (553)
Q Consensus 403 ~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G 481 (553)
..+||+||||++.-..... ......-...|+|||.+... .|+.++|||||||++||+++ |
T Consensus 299 --------~~vKISDFGLs~~~~~~~~--~~~~~klPirWLAPEtl~~~---------~~s~kTDV~sfGV~~~Eif~~g 359 (474)
T KOG0194|consen 299 --------GVVKISDFGLSRAGSQYVM--KKFLKKLPIRWLAPETLNTG---------IFSFKTDVWSFGVLLWEIFENG 359 (474)
T ss_pred --------CeEEeCccccccCCcceee--ccccccCcceecChhhhccC---------ccccccchhheeeeEEeeeccC
Confidence 4689999999876541111 11111246799999999755 48999999999999999998 8
Q ss_pred CCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 482 RTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 482 ~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
..||.+..+. +....+.........+. ..|.++..++.+||..+|+.||++.++.+.|+.+
T Consensus 360 ~~Py~g~~~~-~v~~kI~~~~~r~~~~~------~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~ 420 (474)
T KOG0194|consen 360 AEPYPGMKNY-EVKAKIVKNGYRMPIPS------KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEAL 420 (474)
T ss_pred CCCCCCCCHH-HHHHHHHhcCccCCCCC------CCHHHHHHHHHHhccCChhhccCHHHHHHHHHHH
Confidence 9999997665 23333322222222222 6678999999999999999999999999988764
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=314.89 Aligned_cols=264 Identities=17% Similarity=0.260 Sum_probs=198.1
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCC---CccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeC
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSE---HEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDT 331 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~---~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~ 331 (553)
...|++.+.||+|+||.||++....+ ...+.||||+++... .....+.+.+|+.++.++. ||||+++++++..
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~- 79 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQ-HPNIVCLLGVVTK- 79 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEcC-
Confidence 45688999999999999999977543 233569999997543 2334567889999999995 5999999987743
Q ss_pred CCceEEEEEec-CCCCHHHHHHHcccC-----------CCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEe
Q psy14267 332 ASKHLYVLMEK-GDTDLSKYMRNLNKM-----------TTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFV 399 (553)
Q Consensus 332 ~~~~~~iv~e~-~~~~L~~~l~~~~~~-----------~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~ 399 (553)
...+++++++ .+++|..++...... .........+..++.|++.||+|||++||+||||||+|||++
T Consensus 80 -~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~ 158 (283)
T cd05091 80 -EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVF 158 (283)
T ss_pred -CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEec
Confidence 4567788886 457888887532110 111244555667778999999999999999999999999997
Q ss_pred cCccceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHH
Q psy14267 400 GNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI 479 (553)
Q Consensus 400 ~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ell 479 (553)
.+ +.+||+|||+++...............+++.|+|||.+.+. .++.++|||||||++|||+
T Consensus 159 ~~---------~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Dv~slG~~l~el~ 220 (283)
T cd05091 159 DK---------LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYG---------KFSIDSDIWSYGVVLWEVF 220 (283)
T ss_pred CC---------CceEecccccccccccchheeeccCccCCccccCHHHHhcC---------CCCcchhHHHHHHHHHHHH
Confidence 66 56999999999876544332222344567899999998654 3678999999999999999
Q ss_pred h-CCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 480 Y-GRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 480 t-G~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
+ |..||.+.... .....+.... .. .....++..+.+++.+||+.+|++||++.+|+..|+++
T Consensus 221 ~~g~~p~~~~~~~-~~~~~i~~~~-~~------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 283 (283)
T cd05091 221 SYGLQPYCGYSNQ-DVIEMIRNRQ-VL------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRTW 283 (283)
T ss_pred cCCCCCCCCCCHH-HHHHHHHcCC-cC------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhCC
Confidence 8 88999775432 2233222211 11 11236889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=308.14 Aligned_cols=260 Identities=22% Similarity=0.364 Sum_probs=199.6
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCC-CccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCC
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSE-HEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTAS 333 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~-~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~ 333 (553)
.++|++.+.||+|+||+||+|..... .....||||+++... .......+.+|+.+++++. ||||+++++++. ..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~ 77 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFD-HPNIIRLEGVVT--KS 77 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCC-CCCcceEeEEEe--cC
Confidence 35799999999999999999987654 223469999886543 2334467899999999995 599999998764 35
Q ss_pred ceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCe
Q psy14267 334 KHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNV 412 (553)
Q Consensus 334 ~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~ 412 (553)
...+++||+. +++|.+++..... ......+..++.|++.||+|||+++|+||||||+|||++.+ +.
T Consensus 78 ~~~~iv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~---------~~ 144 (266)
T cd05033 78 RPVMIITEYMENGSLDKFLRENDG----KFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSN---------LV 144 (266)
T ss_pred CceEEEEEcCCCCCHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCC---------CC
Confidence 6688899965 5689998876432 33455666777899999999999999999999999999776 57
Q ss_pred EEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCCCch
Q psy14267 413 LKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHIPNT 491 (553)
Q Consensus 413 vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~~~~ 491 (553)
++|+|||+++...............++..|+|||.+.+. .++.++||||||+++|||++ |..||......
T Consensus 145 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~---------~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~ 215 (266)
T cd05033 145 CKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYR---------KFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ 215 (266)
T ss_pred EEECccchhhcccccccceeccCCCCCccccChhhhccC---------CCccccchHHHHHHHHHHHccCCCCCCCCCHH
Confidence 999999999887532222222233456789999998765 36889999999999999997 99999775443
Q ss_pred HHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 492 WAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 492 ~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
.....+... ... .....++..+.+++.+||+.+|++||++.+++++|++.
T Consensus 216 -~~~~~~~~~-~~~------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 216 -DVIKAVEDG-YRL------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -HHHHHHHcC-CCC------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 222222211 111 11235789999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=327.84 Aligned_cols=271 Identities=20% Similarity=0.327 Sum_probs=205.1
Q ss_pred eEEecCcceEEEeeeeeeCceEEEEEeeeC---CCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeee
Q psy14267 250 VITLNGKQYQVLSLLGKGGSSSVYLVGGTS---EHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHD 326 (553)
Q Consensus 250 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~---~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~ 326 (553)
.|.+..++|.++++||+|+||.||+|.+.. ....+.||||+++..... ...+.+++|+.+|.++..||||+++++
T Consensus 31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l~~H~niv~~~~ 108 (401)
T cd05107 31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS--SEKQALMSELKIMSHLGPHLNIVNLLG 108 (401)
T ss_pred cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCCh--hHHHHHHHHHHHHHhcCCCCCeEEEEE
Confidence 366777889999999999999999998643 222356999999764322 234678999999999976799999998
Q ss_pred EEEeCCCceEEEEEec-CCCCHHHHHHHcccC------------------------------------------------
Q psy14267 327 YVYDTASKHLYVLMEK-GDTDLSKYMRNLNKM------------------------------------------------ 357 (553)
Q Consensus 327 ~~~~~~~~~~~iv~e~-~~~~L~~~l~~~~~~------------------------------------------------ 357 (553)
++.. ...++++||+ .+++|.+++......
T Consensus 109 ~~~~--~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (401)
T cd05107 109 ACTK--GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDES 186 (401)
T ss_pred EEcc--CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccc
Confidence 7743 4578999986 457999998764320
Q ss_pred ---------------------------------------------CCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCC
Q psy14267 358 ---------------------------------------------TTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLK 392 (553)
Q Consensus 358 ---------------------------------------------~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLK 392 (553)
....+....++.++.||+.||+|||+.+|+|||||
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlk 266 (401)
T cd05107 187 ADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLA 266 (401)
T ss_pred cCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCC
Confidence 00123344566777899999999999999999999
Q ss_pred CCCEEEecCccceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHH
Q psy14267 393 PANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLG 472 (553)
Q Consensus 393 p~NILl~~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlG 472 (553)
|+|||++.+ +.+||+|||+++.+.............+++.|+|||.+.+. .++.++||||||
T Consensus 267 p~NiLl~~~---------~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~DvwslG 328 (401)
T cd05107 267 ARNVLICEG---------KLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNN---------LYTTLSDVWSFG 328 (401)
T ss_pred cceEEEeCC---------CEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCC---------CCCcHhHHHHHH
Confidence 999999765 57999999999876433221122234578899999999755 368899999999
Q ss_pred HHHHHHHh-CCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 473 CILYNMIY-GRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 473 vvl~ellt-G~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
|++|||++ |..||............+.. ... ......++.++.++|.+||..+|++||++.+|+..|++.
T Consensus 329 vil~e~l~~g~~P~~~~~~~~~~~~~~~~-~~~------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 329 ILLWEIFTLGGTPYPELPMNEQFYNAIKR-GYR------MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred HHHHHHHHcCCCCCCCCCchHHHHHHHHc-CCC------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 99999998 89999875543222222221 111 112235789999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=314.17 Aligned_cols=270 Identities=20% Similarity=0.327 Sum_probs=197.3
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeC--------------CCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCc
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTS--------------EHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPY 320 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~--------------~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~ 320 (553)
.++|++.+.||+|+||.||++++.. .+....||+|++.... .....+.+.+|+.+|+++. |+|
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~-~~~ 80 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLK-DPN 80 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCC
Confidence 4579999999999999999986432 1222458999987542 2344578899999999995 599
Q ss_pred eeEeeeEEEeCCCceEEEEEecC-CCCHHHHHHHcccCCC------CchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCC
Q psy14267 321 VIKMHDYVYDTASKHLYVLMEKG-DTDLSKYMRNLNKMTT------LPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKP 393 (553)
Q Consensus 321 Iv~l~~~~~~~~~~~~~iv~e~~-~~~L~~~l~~~~~~~~------~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp 393 (553)
|+++++++.. ...++++||+. +++|.+++........ .......+..++.|++.||+|||+.||+||||||
T Consensus 81 i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp 158 (296)
T cd05095 81 IIRLLAVCIT--SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLAT 158 (296)
T ss_pred cceEEEEEec--CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCCh
Confidence 9999987744 45678889865 5799999886532211 1234456777788999999999999999999999
Q ss_pred CCEEEecCccceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHH
Q psy14267 394 ANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGC 473 (553)
Q Consensus 394 ~NILl~~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGv 473 (553)
+|||++.+ +.++|+|||+++.+.............+++.|+|||.+.+. .++.++|||||||
T Consensus 159 ~Nili~~~---------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~---------~~~~~~DiwSlG~ 220 (296)
T cd05095 159 RNCLVGKN---------YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG---------KFTTASDVWAFGV 220 (296)
T ss_pred heEEEcCC---------CCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcC---------CccchhhhhHHHH
Confidence 99999765 57999999999876443322112233457789999987654 3788999999999
Q ss_pred HHHHHHh--CCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q psy14267 474 ILYNMIY--GRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINN 548 (553)
Q Consensus 474 vl~ellt--G~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~ 548 (553)
++|||++ |..||...... ..+.....................++..+.+||.+||+.||++||++.+|++.|++
T Consensus 221 ~l~el~~~~~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 221 TLWEILTLCKEQPYSQLSDE-QVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHHHHHhCCCCCccccChH-HHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 9999998 78999765432 11111111000000011112233577999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=309.67 Aligned_cols=253 Identities=29% Similarity=0.534 Sum_probs=194.4
Q ss_pred eEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEE
Q psy14267 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLY 337 (553)
Q Consensus 258 y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~ 337 (553)
|++++.||+|+||+||++.+...+.. ||+|++......... .....+|+.+++++ .||||+++++++.. ...++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~--~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l-~~~~i~~~~~~~~~--~~~~~ 74 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQK--VAVKIIDKSEIEEEE-REENIREIKILRRL-RHPNIVQILDVFQD--DNYLY 74 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEE--EEEEEEESTTHHHHH-HHHHHHHHHHHHHH-TBTTBCHEEEEEEE--SSEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeE--EEEEEeccccccccc-cchhhhhhhccccc-cccccccccccccc--ccccc
Confidence 88999999999999999988877654 999999887644332 23456699999999 56999999988765 67788
Q ss_pred EEEecCCC-CHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEE
Q psy14267 338 VLMEKGDT-DLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKII 416 (553)
Q Consensus 338 iv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~ 416 (553)
++|+++.+ +|.+++.... ......+..++.|++.||++||++||+||||||+|||++.+ +.++|+
T Consensus 75 ~v~~~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~---------~~~~l~ 140 (260)
T PF00069_consen 75 IVMEYCPGGSLQDYLQKNK-----PLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDEN---------GEVKLI 140 (260)
T ss_dssp EEEEEETTEBHHHHHHHHS-----SBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTT---------SEEEES
T ss_pred ccccccccccccccccccc-----ccccccccccccccccccccccccccccccccccccccccc---------cccccc
Confidence 99998766 9999998433 33566677778899999999999999999999999999866 678999
Q ss_pred eccCccccCCCCCcccccCCccCCCccCccccc-ccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCc--hHH
Q psy14267 417 DFGIACSLQDDKTSVHKDTASGTLNYMSPEAAG-QTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN--TWA 493 (553)
Q Consensus 417 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~-~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~--~~~ 493 (553)
|||++........ ......++..|+|||++. +. .++.++||||||+++|+|++|..||..... ...
T Consensus 141 Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~---------~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~ 209 (260)
T PF00069_consen 141 DFGSSVKLSENNE--NFNPFVGTPEYMAPEVLQQGK---------KYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLE 209 (260)
T ss_dssp SGTTTEESTSTTS--EBSSSSSSGGGSCHHHHTTTS---------SBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHH
T ss_pred ccccccccccccc--ccccccccccccccccccccc---------cccccccccccccccccccccccccccccchhhhh
Confidence 9999976522221 233567899999999987 33 478999999999999999999999987621 111
Q ss_pred HHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 494 KMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 494 ~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
.+...... .. ..........+..+.++|.+||+.||++||++.+++++
T Consensus 210 ~~~~~~~~--~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 210 IIEKILKR--PL--PSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp HHHHHHHT--HH--HHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred hhhhcccc--cc--cccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11111111 11 11111111223799999999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=315.14 Aligned_cols=262 Identities=20% Similarity=0.291 Sum_probs=197.2
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|++.++||+|+||.||+|.....+....+++|.++.. ......+.+.+|+.++.++.+||||+++++++.. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~~~ 77 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACEN--RGY 77 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc--CCc
Confidence 479999999999999999998876654444788887632 2334457789999999999878999999987643 456
Q ss_pred EEEEEecC-CCCHHHHHHHcccCC-----------CCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCcc
Q psy14267 336 LYVLMEKG-DTDLSKYMRNLNKMT-----------TLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVL 403 (553)
Q Consensus 336 ~~iv~e~~-~~~L~~~l~~~~~~~-----------~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~ 403 (553)
++++||+. +++|.+++....... ........++.++.|++.||+|||++||+||||||+|||++.+
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~-- 155 (297)
T cd05089 78 LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGEN-- 155 (297)
T ss_pred ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCC--
Confidence 78888874 579999987643211 1134556677778899999999999999999999999999776
Q ss_pred ceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CC
Q psy14267 404 KIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GR 482 (553)
Q Consensus 404 ~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~ 482 (553)
+.+||+|||++....... .......+..|+|||.+.+. .++.++|||||||++|||++ |.
T Consensus 156 -------~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~---------~~~~~~DvwSlG~il~el~t~g~ 216 (297)
T cd05089 156 -------LASKIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYS---------VYTTKSDVWSFGVLLWEIVSLGG 216 (297)
T ss_pred -------CeEEECCcCCCcccccee---ccCCCCcCccccCchhhccC---------CCCchhhHHHHHHHHHHHHcCCC
Confidence 579999999986432211 11122235679999998755 36889999999999999997 99
Q ss_pred CCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q psy14267 483 TPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNP 550 (553)
Q Consensus 483 ~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~ 550 (553)
.||...... .....+... .. ......++..+.++|.+||..+|.+||++.++++.|+++.
T Consensus 217 ~pf~~~~~~-~~~~~~~~~-~~------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 276 (297)
T cd05089 217 TPYCGMTCA-ELYEKLPQG-YR------MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRML 276 (297)
T ss_pred CCCCCCCHH-HHHHHHhcC-CC------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 999775432 112222111 11 1122357899999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=311.34 Aligned_cols=260 Identities=23% Similarity=0.407 Sum_probs=199.1
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|++++.||+|+||.||++.+..++.. ||||+++...... ...++..|+.++.+..+||||+++++++.. +..
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~--vaiK~~~~~~~~~--~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~--~~~ 74 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTI--MAVKRIRATVNSQ--EQKRLLMDLDISMRSVDCPYTVTFYGALFR--EGD 74 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcE--EEEEEEecCCCcH--HHHHHHHHHHHHHHHcCCCCeeeeeEEEec--CCc
Confidence 3699999999999999999988776644 9999997654332 235667788876677788999999998754 556
Q ss_pred EEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhC-CcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAA-GIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~-gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
++++||+..++|.++++...... ....+..++.++.|++.||+|||++ +++||||||+|||++.+ +.+|
T Consensus 75 ~~lv~e~~~~~l~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~---------~~~k 144 (283)
T cd06617 75 VWICMEVMDTSLDKFYKKVYDKG-LTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRN---------GQVK 144 (283)
T ss_pred EEEEhhhhcccHHHHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCC---------CCEE
Confidence 89999999999988887643222 3456677777788999999999997 99999999999999776 5799
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||++........ .....|+..|+|||.+.+... ...++.++|+|||||++|||++|..||.........
T Consensus 145 l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~-----~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~ 216 (283)
T cd06617 145 LCDFGISGYLVDSVA---KTIDAGCKPYMAPERINPELN-----QKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQ 216 (283)
T ss_pred Eeecccccccccccc---cccccCCccccChhhcCCccc-----ccccCccccchhhHHHHHHHHhCCCCCCccccCHHH
Confidence 999999987643221 123468899999999865321 123688999999999999999999999765444344
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
+..+..... ..+. ...++.++.++|.+||..+|++||++.+++++
T Consensus 217 ~~~~~~~~~-~~~~-----~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 217 LKQVVEEPS-PQLP-----AEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred HHHHHhcCC-CCCC-----ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 333322111 1111 12478999999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=325.37 Aligned_cols=249 Identities=21% Similarity=0.297 Sum_probs=186.2
Q ss_pred eeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEEEEEe
Q psy14267 262 SLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLME 341 (553)
Q Consensus 262 ~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~iv~e 341 (553)
++||+|+||.||+|.+..++.. ||||++.+...........+..|..++.+..+||||+++++++. ....++++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~--~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~--~~~~~~lv~e 76 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKC--YAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ--TTEKLYFVLD 76 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCE--EEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEe--cCCEEEEEEc
Confidence 4699999999999988776654 99999987644433444667777766544346799999987664 3567889999
Q ss_pred cC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEeccC
Q psy14267 342 KG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGI 420 (553)
Q Consensus 342 ~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGl 420 (553)
++ +++|..++.... ......+..++.||+.||+|||++||+||||||+||||+.+ +.+||+|||+
T Consensus 77 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~---------~~~kL~DfG~ 142 (325)
T cd05604 77 FVNGGELFFHLQRER-----SFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQ---------GHVVLTDFGL 142 (325)
T ss_pred CCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCC---------CCEEEeecCC
Confidence 75 567887776543 23455566677899999999999999999999999999776 5799999999
Q ss_pred ccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHh
Q psy14267 421 ACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIAR 500 (553)
Q Consensus 421 a~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~~i~~ 500 (553)
++....... .....+||+.|+|||++.+. .++.++|||||||++|||++|..||...... .....+..
T Consensus 143 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~---------~~~~~~DvwslG~il~el~~G~~pf~~~~~~-~~~~~~~~ 210 (325)
T cd05604 143 CKEGIAQSD--TTTTFCGTPEYLAPEVIRKQ---------PYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA-EMYDNILH 210 (325)
T ss_pred cccCCCCCC--CcccccCChhhCCHHHHcCC---------CCCCcCccccccceehhhhcCCCCCCCCCHH-HHHHHHHc
Confidence 875432222 12356799999999999765 3678999999999999999999999874432 22222221
Q ss_pred hcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q psy14267 501 HKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINN 548 (553)
Q Consensus 501 ~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~ 548 (553)
. ... ....++..+.++|++||+.+|++||++.+.++.+.+
T Consensus 211 ~--~~~------~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~ 250 (325)
T cd05604 211 K--PLV------LRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQE 250 (325)
T ss_pred C--Ccc------CCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhc
Confidence 1 111 122578899999999999999999998654444433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=322.78 Aligned_cols=263 Identities=21% Similarity=0.378 Sum_probs=196.0
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|++.++||+|+||.||+++....+. .||+|++.+...........+..|+.++..+ +|++|+.+++++. ....
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~--~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~--~~~~ 75 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADK--VFAMKILNKWEMLKRAETACFREERDVLVNG-DNQWITTLHYAFQ--DENN 75 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCC--EEEEEEEeHHHHHHhhHHHHHHHHHHHHhhC-CCCCEeeEEEEEe--cCCE
Confidence 369999999999999999998876664 4999999765433334445678899999888 5599999987664 4568
Q ss_pred EEEEEec-CCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEK-GDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~-~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
++++||+ .+++|.+++.+... ......+..++.||+.||+|||++||+||||||+|||++.+ +.+|
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~~----~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~---------~~~k 142 (332)
T cd05623 76 LYLVMDYYVGGDLLTLLSKFED----RLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMN---------GHIR 142 (332)
T ss_pred EEEEEeccCCCcHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCC---------CCEE
Confidence 8999997 46899999976432 23344556667899999999999999999999999999766 5799
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||++..+...... .....+||+.|+|||++.+.... ...++.++|||||||+||||++|+.||...... ..
T Consensus 143 L~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~----~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~-~~ 216 (332)
T cd05623 143 LADFGSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEDG----KGKYGPECDWWSLGVCMYEMLYGETPFYAESLV-ET 216 (332)
T ss_pred EeecchheecccCCcc-eecccccCccccCHHHHhccccC----CCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH-HH
Confidence 9999999765443221 22345799999999998643210 113788999999999999999999999875432 33
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKA--RPTVGNSVTQ 545 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~--RPt~~ell~~ 545 (553)
...+........++. ....+++++++||++||..++++ |+++.++++|
T Consensus 217 ~~~i~~~~~~~~~p~---~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 217 YGKIMNHKERFQFPA---QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred HHHHhCCCccccCCC---ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 333332222222222 22357899999999999765544 6899999877
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0579|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=336.12 Aligned_cols=257 Identities=26% Similarity=0.428 Sum_probs=204.9
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
+.|.|+..||.|+||+||+|..+.++-. .|-|++.... ++.++.++-|+.||..+. ||+||.+++.|+. ++.
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~l--AAaKvIetks---eEELEDylVEIeILa~Cd-HP~ivkLl~ayy~--enk 103 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLL--AAAKVIETKS---EEELEDYLVEIEILAECD-HPVIVKLLSAYYF--ENK 103 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhh--hhhhhhcccc---hhHHhhhhhhhhhhhcCC-ChHHHHHHHHHhc--cCc
Confidence 5799999999999999999988877655 6788886543 455688999999999996 6999999987654 455
Q ss_pred EEEEEecCCC-CHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKGDT-DLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
++|+.|+|+| .....+....+ .+...+|..+++|++.||.|||+++|||||||..|||+.-+ |.|+
T Consensus 104 LwiliEFC~GGAVDaimlEL~r----~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~Tld---------Gdir 170 (1187)
T KOG0579|consen 104 LWILIEFCGGGAVDAIMLELGR----VLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLD---------GDIR 170 (1187)
T ss_pred eEEEEeecCCchHhHHHHHhcc----ccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEec---------CcEe
Confidence 7777776654 45555555543 44556677777899999999999999999999999999877 6799
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||++...... ...+.++.|||+|||||+.++..+. ...|+.++||||||++|.||..+.+|...++.. ..
T Consensus 171 LADFGVSAKn~~t--~qkRDsFIGTPYWMAPEVvmCET~K----D~PYDykaDiWSlGITLIEMAqiEPPHhelnpM-RV 243 (1187)
T KOG0579|consen 171 LADFGVSAKNKST--RQKRDSFIGTPYWMAPEVVMCETFK----DQPYDYKADIWSLGITLIEMAQIEPPHHELNPM-RV 243 (1187)
T ss_pred eecccccccchhH--HhhhccccCCcccccchheeecccc----CCCchhhhhHHhhhhHHHHHhccCCCccccchH-HH
Confidence 9999998654332 2235588999999999999887653 335888999999999999999999999887654 23
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
+..+... -+|.+..+..++..+.+++++||.+||..||++.+|++|
T Consensus 244 llKiaKS-----ePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 244 LLKIAKS-----EPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred HHHHhhc-----CCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 3333322 245556666888999999999999999999999999876
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=311.76 Aligned_cols=262 Identities=22% Similarity=0.324 Sum_probs=196.4
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceE
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHL 336 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~ 336 (553)
+|++++.||+|+||.||+|++..++. .||||++....... ...+.+.+|+.+++++. ||||+++++++.. ...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~--~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~ 74 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQ--IVAMKKIRLESEEE-GVPSTAIREISLLKELQ-HPNIVCLQDVLMQ--ESRL 74 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCc--EEEEEEeccccccC-CchHHHHHHHHHHHhcC-CCCEeeeEEEEee--CCeE
Confidence 48999999999999999998876664 49999987654332 33467889999999996 6999999998754 5688
Q ss_pred EEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEE
Q psy14267 337 YVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKII 416 (553)
Q Consensus 337 ~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~ 416 (553)
+++|+++.++|.+++....... ......++.++.|++.||+|||++||+||||||+|||++.+ +.+||+
T Consensus 75 ~~v~e~~~~~l~~~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~---------~~~~l~ 143 (285)
T cd07861 75 YLIFEFLSMDLKKYLDSLPKGQ--YMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNK---------GVIKLA 143 (285)
T ss_pred EEEEecCCCCHHHHHhcCCCCC--cCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCC---------CcEEEC
Confidence 9999998889998887654322 34456666777899999999999999999999999999776 679999
Q ss_pred eccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHH
Q psy14267 417 DFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKML 496 (553)
Q Consensus 417 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~ 496 (553)
|||++........ ......+++.|+|||++.+.. .++.++|||||||++|||++|+.||...........
T Consensus 144 dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~--------~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~ 213 (285)
T cd07861 144 DFGLARAFGIPVR--VYTHEVVTLWYRAPEVLLGSP--------RYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFR 213 (285)
T ss_pred cccceeecCCCcc--cccCCcccccccChHHhcCCC--------CcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 9999976543321 112345789999999986542 367899999999999999999999986433211111
Q ss_pred HHHhhc-----------------c---cccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 497 AIARHK-----------------D---QIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 497 ~i~~~~-----------------~---~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
...... . .............+++++.++|.+||..||++|||+.+|+.+
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 214 IFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 110000 0 000000001123578999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=308.82 Aligned_cols=260 Identities=22% Similarity=0.351 Sum_probs=195.4
Q ss_pred cCcceEEEeeeeeeCceEEEEEeeeCCCcc--ceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeC
Q psy14267 254 NGKQYQVLSLLGKGGSSSVYLVGGTSEHEF--KPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDT 331 (553)
Q Consensus 254 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~--~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~ 331 (553)
...+|+++++||+|+||+||+|.+..++.. .+||+|++.... .......+.+|+.+++.+. ||||+.+++++..
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~- 80 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVG-SPYVCRLLGICLT- 80 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcC-CCCCceEEEEEcC-
Confidence 356899999999999999999987655432 248999986543 2334467889999999984 6999999987753
Q ss_pred CCceEEEEEe-cCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCC
Q psy14267 332 ASKHLYVLME-KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIG 410 (553)
Q Consensus 332 ~~~~~~iv~e-~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~ 410 (553)
. ..+++++ ..+++|.+++..... ......+..++.|++.||+|||+++|+||||||+|||++.+
T Consensus 81 -~-~~~l~~~~~~~g~l~~~l~~~~~----~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~--------- 145 (279)
T cd05109 81 -S-TVQLVTQLMPYGCLLDYVRENKD----RIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSP--------- 145 (279)
T ss_pred -C-CcEEEEEcCCCCCHHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCC---------
Confidence 2 3455565 466899988876432 23345566667799999999999999999999999999765
Q ss_pred CeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCCC
Q psy14267 411 NVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHIP 489 (553)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~~ 489 (553)
+.+||+|||+++...............+++.|+|||.+.+. .++.++|||||||++|||++ |..||....
T Consensus 146 ~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~---------~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 216 (279)
T cd05109 146 NHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHR---------RFTHQSDVWSYGVTVWELMTFGAKPYDGIP 216 (279)
T ss_pred CcEEECCCCceeecccccceeecCCCccchhhCCHHHhccC---------CCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 56999999999877543332222233457789999998755 37889999999999999998 999997654
Q ss_pred chHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 490 NTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 490 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
.. . ........... .....++.++.+++.+||..||++||++.++++.|++.
T Consensus 217 ~~-~-~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~ 268 (279)
T cd05109 217 AR-E-IPDLLEKGERL------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM 268 (279)
T ss_pred HH-H-HHHHHHCCCcC------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 32 1 12222211111 11235788999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=327.47 Aligned_cols=245 Identities=22% Similarity=0.347 Sum_probs=185.8
Q ss_pred eeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhc--CCCceeEeeeEEEeCCCceEEEEEe
Q psy14267 264 LGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQ--GCPYVIKMHDYVYDTASKHLYVLME 341 (553)
Q Consensus 264 LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~--~hp~Iv~l~~~~~~~~~~~~~iv~e 341 (553)
||+|+||+||+|++..++.. ||||++.+...........+..|..++.++. +||+|+.+++++. ....++++||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~--~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~--~~~~~~lv~e 76 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRI--YAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQ--TDSDLYLVTD 76 (330)
T ss_pred CCCCCceEEEEEEECCCCCE--EEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEe--cCCeEEEEEc
Confidence 79999999999988777654 9999997655444444556677888887765 7899999987663 4567899999
Q ss_pred cC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEeccC
Q psy14267 342 KG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGI 420 (553)
Q Consensus 342 ~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGl 420 (553)
++ +++|..++..... .....+..++.||+.||+|||++||+||||||+||||+.+ +.+||+|||+
T Consensus 77 ~~~~g~L~~~l~~~~~-----~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~---------~~~kl~Dfg~ 142 (330)
T cd05586 77 YMSGGELFWHLQKEGR-----FSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDAT---------GHIALCDFGL 142 (330)
T ss_pred CCCCChHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC---------CCEEEecCCc
Confidence 75 5788888876432 3455666677899999999999999999999999999776 5799999999
Q ss_pred ccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHh
Q psy14267 421 ACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIAR 500 (553)
Q Consensus 421 a~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~~i~~ 500 (553)
+........ .....+||+.|+|||++.+.. .++.++|||||||++|||++|..||...... .....+..
T Consensus 143 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~--------~~~~~~DvwslGvil~elltG~~Pf~~~~~~-~~~~~i~~ 211 (330)
T cd05586 143 SKANLTDNK--TTNTFCGTTEYLAPEVLLDEK--------GYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ-QMYRNIAF 211 (330)
T ss_pred CcCCCCCCC--CccCccCCccccCHHHHcCCC--------CCCCccceeccccEEEEeccCCCCCCCCCHH-HHHHHHHc
Confidence 876433222 123567999999999987542 2678999999999999999999999764332 22222221
Q ss_pred hcccccccccccCCCCCCHHHHHHHHHhcccCCCCCC----CHHHHHH
Q psy14267 501 HKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARP----TVGNSVT 544 (553)
Q Consensus 501 ~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RP----t~~ell~ 544 (553)
.. ..+. ...+++++.++|++||..||++|| ++.++++
T Consensus 212 ~~--~~~~-----~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 212 GK--VRFP-----KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CC--CCCC-----CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 11 1111 124688999999999999999998 5666655
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=312.41 Aligned_cols=264 Identities=20% Similarity=0.346 Sum_probs=198.8
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCC---ccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCC
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEH---EFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTAS 333 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~---~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~ 333 (553)
+|++.+.||+|+||.||+|...... ....+|+|.+..... ....+.+.+|+.+++.+. ||||+++++.+. ..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--~~ 75 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS--SSELRDLLSEFNLLKQVN-HPHVIKLYGACS--QD 75 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC--HHHHHHHHHHHHHHhhCC-CCCEeeEEEEEe--cC
Confidence 4788999999999999999765322 224589998865432 233477899999999995 599999998764 34
Q ss_pred ceEEEEEecC-CCCHHHHHHHcccC-------------------CCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCC
Q psy14267 334 KHLYVLMEKG-DTDLSKYMRNLNKM-------------------TTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKP 393 (553)
Q Consensus 334 ~~~~iv~e~~-~~~L~~~l~~~~~~-------------------~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp 393 (553)
...+++||++ +++|.+++...... ......+..++.++.|++.||+|||+++|+||||||
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp 155 (290)
T cd05045 76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAA 155 (290)
T ss_pred CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhh
Confidence 5567788864 58899988764221 112345667778888999999999999999999999
Q ss_pred CCEEEecCccceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHH
Q psy14267 394 ANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGC 473 (553)
Q Consensus 394 ~NILl~~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGv 473 (553)
+||||+.+ +.+||+|||+++...............++..|+|||.+.+. .++.++||||||+
T Consensus 156 ~nill~~~---------~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~---------~~~~~~Di~slG~ 217 (290)
T cd05045 156 RNVLVAEG---------RKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDH---------IYTTQSDVWSFGV 217 (290)
T ss_pred heEEEcCC---------CcEEeccccccccccCccchhcccCCCCCccccCHHHHccC---------CcchHhHHHHHHH
Confidence 99999766 57999999999876443322222234567789999998655 3688999999999
Q ss_pred HHHHHHh-CCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q psy14267 474 ILYNMIY-GRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNPE 551 (553)
Q Consensus 474 vl~ellt-G~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~~ 551 (553)
++|||++ |..||...... .+.......... .....++.++.++|..||+.+|++||++.++++.|++...
T Consensus 218 ~l~el~t~g~~p~~~~~~~--~~~~~~~~~~~~------~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 218 LLWEIVTLGGNPYPGIAPE--RLFNLLKTGYRM------ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHHHHHhcCCCCCCCCCHH--HHHHHHhCCCCC------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 9999998 99999765432 222222211111 1223678999999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=313.65 Aligned_cols=272 Identities=20% Similarity=0.246 Sum_probs=186.4
Q ss_pred eEEecCcceEEEeeeeeeCceEEEEEeeeCCCc-cceEEEEEEecCCcCc--hhHH------HHHHHHHHHHHhhcCCCc
Q psy14267 250 VITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHE-FKPLALKVVDLSDITD--QSIA------DSYLNEVELLAKLQGCPY 320 (553)
Q Consensus 250 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~-~~~vAvK~l~~~~~~~--~~~~------~~~~~E~~iL~~l~~hp~ 320 (553)
+.++.+++|++.++||+|+||.||+|....+.. ...+|+|+........ +... .....+...+..+ .|++
T Consensus 6 ~~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~-~h~~ 84 (294)
T PHA02882 6 LIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNI-DHLG 84 (294)
T ss_pred eeccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccC-CCCC
Confidence 345667899999999999999999998766521 2336777654332111 1000 0112222333444 4699
Q ss_pred eeEeeeEEEeCCC--ceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEE
Q psy14267 321 VIKMHDYVYDTAS--KHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLF 398 (553)
Q Consensus 321 Iv~l~~~~~~~~~--~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl 398 (553)
|+.+++++..... .+.+++++....++.+.+..... .....+..++.|++.||+|||+++|+||||||+|||+
T Consensus 85 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill 159 (294)
T PHA02882 85 IPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKC-----KNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMV 159 (294)
T ss_pred CCcEEEeeeEecCCceEEEEEEehhccCHHHHHHhhcc-----CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 9999876554433 24577888877777777665321 1234456677899999999999999999999999999
Q ss_pred ecCccceecCCCCeEEEEeccCccccCCCCCc-----ccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHH
Q psy14267 399 VGNVLKIIDCIGNVLKIIDFGIACSLQDDKTS-----VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGC 473 (553)
Q Consensus 399 ~~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~-----~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGv 473 (553)
+.+ +.++|+|||+|+.+...... .......||+.|+|||++.+. .++.++|||||||
T Consensus 160 ~~~---------~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~---------~~~~~~DiwSlG~ 221 (294)
T PHA02882 160 DGN---------NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGA---------CVTRRGDLESLGY 221 (294)
T ss_pred cCC---------CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCC---------CCCcHHHHHHHHH
Confidence 765 56899999999876432211 112234699999999998765 3789999999999
Q ss_pred HHHHHHhCCCCCCCCCchHHHHHHH-HhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q psy14267 474 ILYNMIYGRTPYSHIPNTWAKMLAI-ARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQIN 547 (553)
Q Consensus 474 vl~elltG~~Pf~~~~~~~~~~~~i-~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~ 547 (553)
+||||++|.+||.+........... ......+. .. ......+++.+.++|+.||..+|++||++.+|++.|+
T Consensus 222 ~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 222 CMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLH-EG-KIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHHHhCCCCCCccccchHHHHHhHHHHHHHhh-hh-hhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 9999999999998763321111111 00001110 00 0012256789999999999999999999999998763
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=310.25 Aligned_cols=266 Identities=20% Similarity=0.321 Sum_probs=196.5
Q ss_pred eEEEeeeeeeCceEEEEEeee--CCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 258 YQVLSLLGKGGSSSVYLVGGT--SEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 258 y~i~~~LG~G~fG~Vy~a~~~--~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
|++++.||+|+||+||++... .....+.||+|+++.... ......+.+|+++|+++. ||||+++++++.......
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG--QQNTSGWKKEINILKTLY-HENIVKYKGCCSEQGGKG 82 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC--hHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecCCCce
Confidence 499999999999999886532 122335699999876532 223467889999999995 699999999877666677
Q ss_pred EEEEEec-CCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEK-GDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~-~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
++++||+ .+++|.+++... ...+..++.++.|++.||+|||++||+||||||+|||++.+ +.+|
T Consensus 83 ~~lv~e~~~~~~l~~~~~~~------~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~---------~~~~ 147 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPKH------KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDND---------RLVK 147 (283)
T ss_pred EEEEecCCCCCCHHHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCC---------CcEE
Confidence 8899986 457888888653 24456677778899999999999999999999999999776 5799
Q ss_pred EEeccCccccCCCCCccc-ccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHH
Q psy14267 415 IIDFGIACSLQDDKTSVH-KDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWA 493 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~-~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~ 493 (553)
|+|||++........... .....++..|+|||.+.+. .++.++||||||+++|||++|..||........
T Consensus 148 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~---------~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~ 218 (283)
T cd05080 148 IGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKEN---------KFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE 218 (283)
T ss_pred EeecccccccCCcchhhccCCCCCCCceeeCHhHhccc---------CCCcccccHHHHHHHHHHHhCCCCCCCCcchhh
Confidence 999999987654332111 1123456789999998754 368899999999999999999999976433211
Q ss_pred HHHHHHhhcc-c------ccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q psy14267 494 KMLAIARHKD-Q------IEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNP 550 (553)
Q Consensus 494 ~~~~i~~~~~-~------~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~ 550 (553)
.+........ . ............++..+.+++.+||+.+|++|||++++++.|+++.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 219 EMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 1111100000 0 0001111223357899999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=315.90 Aligned_cols=262 Identities=20% Similarity=0.307 Sum_probs=198.5
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
.+|++.+.||+|+||.||+|.+..++....+|+|.++.. ........+.+|+.++.++.+|+||+++++++ .....
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~--~~~~~ 82 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGAC--EHRGY 82 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEE--CCCCC
Confidence 579999999999999999998876655445677776532 23344567889999999997789999999876 44567
Q ss_pred EEEEEecC-CCCHHHHHHHcccCC-----------CCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCcc
Q psy14267 336 LYVLMEKG-DTDLSKYMRNLNKMT-----------TLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVL 403 (553)
Q Consensus 336 ~~iv~e~~-~~~L~~~l~~~~~~~-----------~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~ 403 (553)
++++||+. +++|.+++....... ........+..++.|++.||+|||++||+||||||+|||++.+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~-- 160 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN-- 160 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCC--
Confidence 88999975 678999987653221 1234566677788899999999999999999999999999776
Q ss_pred ceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CC
Q psy14267 404 KIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GR 482 (553)
Q Consensus 404 ~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~ 482 (553)
+.+||+|||++....... ......++..|+|||.+.+. .++.++|||||||+||||++ |.
T Consensus 161 -------~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~ellt~g~ 221 (303)
T cd05088 161 -------YVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYS---------VYTTNSDVWSYGVLLWEIVSLGG 221 (303)
T ss_pred -------CcEEeCccccCcccchhh---hcccCCCcccccCHHHHhcc---------CCcccccchhhhhHHHHHHhcCC
Confidence 579999999986432111 11122346789999988654 36789999999999999998 99
Q ss_pred CCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q psy14267 483 TPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNP 550 (553)
Q Consensus 483 ~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~ 550 (553)
.||...... .....+. .. ........++.++.++|.+||+.+|++||++.+++..|+++.
T Consensus 222 ~p~~~~~~~-~~~~~~~-~~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~ 281 (303)
T cd05088 222 TPYCGMTCA-ELYEKLP-QG------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 281 (303)
T ss_pred CCcccCChH-HHHHHHh-cC------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 999764432 1111111 11 111223357889999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=312.64 Aligned_cols=252 Identities=23% Similarity=0.387 Sum_probs=194.0
Q ss_pred eEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEE
Q psy14267 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLY 337 (553)
Q Consensus 258 y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~ 337 (553)
|++.++||+|+||.||++.+..++.. ||||.+.+...........+.+|+.+++++. |++|+.+++.+. ....++
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~--~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~--~~~~~~ 76 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKM--YACKKLEKKRIKKRKGESMALNEKQILEKVN-SRFVVSLAYAYE--TKDALC 76 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCce--EEEEEEehhhccchHHHHHHHHHHHHHHhCC-CCCeeeeeEEEe--cCCEEE
Confidence 78889999999999999988877644 9999998765554444566789999999995 599999987664 356788
Q ss_pred EEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEE
Q psy14267 338 VLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKII 416 (553)
Q Consensus 338 iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~ 416 (553)
++||+. +++|.+++...... ......+..++.|++.||+|||+.+|+||||||+||+++.+ +.++|+
T Consensus 77 lv~e~~~g~~L~~~l~~~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~---------~~~~l~ 144 (285)
T cd05630 77 LVLTLMNGGDLKFHIYHMGEA---GFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDH---------GHIRIS 144 (285)
T ss_pred EEEEecCCCcHHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCC---------CCEEEe
Confidence 998864 67898888654321 24455666777899999999999999999999999999766 569999
Q ss_pred eccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchH--HH
Q psy14267 417 DFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTW--AK 494 (553)
Q Consensus 417 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~--~~ 494 (553)
|||++........ .....|+..|+|||++.+. .++.++|||||||++|||++|..||....... ..
T Consensus 145 Dfg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~---------~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~ 212 (285)
T cd05630 145 DLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNE---------RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE 212 (285)
T ss_pred eccceeecCCCcc---ccCCCCCccccChHHHcCC---------CCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHH
Confidence 9999976543322 1244689999999999765 37889999999999999999999998643321 11
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT-----VGNSVTQ 545 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt-----~~ell~~ 545 (553)
........ . ......+++++++||.+||+.||++||| +.|++++
T Consensus 213 ~~~~~~~~-----~--~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 213 VERLVKEV-----Q--EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred HHhhhhhh-----h--hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 11111100 0 0112357889999999999999999999 8888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=313.16 Aligned_cols=266 Identities=22% Similarity=0.360 Sum_probs=201.9
Q ss_pred EEecCcceEEEeeeeeeCceEEEEEeeeC---CCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeE
Q psy14267 251 ITLNGKQYQVLSLLGKGGSSSVYLVGGTS---EHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDY 327 (553)
Q Consensus 251 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~---~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~ 327 (553)
+.+..++|.+.+.||+|+||.||++.+.. ......||||+++.... ....+.+.+|+.+++++.+|+||++++++
T Consensus 30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 107 (302)
T cd05055 30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH--SSEREALMSELKIMSHLGNHENIVNLLGA 107 (302)
T ss_pred ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC--hHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence 44556789999999999999999997532 22234599998875432 23346789999999999777999999987
Q ss_pred EEeCCCceEEEEEec-CCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCcccee
Q psy14267 328 VYDTASKHLYVLMEK-GDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKII 406 (553)
Q Consensus 328 ~~~~~~~~~~iv~e~-~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~ 406 (553)
+.. ...++++||+ .+++|.+++...... ......+..++.|++.||+|||+++|+||||||+|||++.+
T Consensus 108 ~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~---~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~----- 177 (302)
T cd05055 108 CTI--GGPILVITEYCCYGDLLNFLRRKRES---FLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHG----- 177 (302)
T ss_pred Eec--CCceEEEEEcCCCCcHHHHHHhCCCC---CCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCC-----
Confidence 743 4568899997 458999998754321 14556677777899999999999999999999999999765
Q ss_pred cCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCC
Q psy14267 407 DCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPY 485 (553)
Q Consensus 407 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf 485 (553)
+.++|+|||+++...............++..|+|||.+.+. .++.++|||||||++|||++ |..||
T Consensus 178 ----~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~DiwslGvil~el~t~g~~p~ 244 (302)
T cd05055 178 ----KIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNC---------VYTFESDVWSYGILLWEIFSLGSNPY 244 (302)
T ss_pred ----CeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccC---------CCCcHhHHHHHHHHHHHHHhCCCCCc
Confidence 57999999999876543322222234567899999998765 36889999999999999998 99999
Q ss_pred CCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q psy14267 486 SHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINN 548 (553)
Q Consensus 486 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~ 548 (553)
........ ........... ......+..+.+++.+||..+|++||++.+++..|++
T Consensus 245 ~~~~~~~~-~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 245 PGMPVDSK-FYKLIKEGYRM------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred CCCCchHH-HHHHHHcCCcC------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 87544322 22221111111 1122467899999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=349.03 Aligned_cols=268 Identities=25% Similarity=0.375 Sum_probs=203.9
Q ss_pred cCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCC
Q psy14267 254 NGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTAS 333 (553)
Q Consensus 254 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~ 333 (553)
...+|++++.||+|+||+||+|.+...+.. ||+|++....... .....+..|+.+|++|. ||||+.+++++.+...
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~--vAlKvIk~~~l~e-~~~~~~~~EI~IL~~L~-HPNIVrl~d~f~de~~ 86 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEF--FCWKAISYRGLKE-REKSQLVIEVNVMRELK-HKNIVRYIDRFLNKAN 86 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeE--EEEEEEeccccCH-HHHHHHHHHHHHHHHcC-CCCcCeEEEEEEecCC
Confidence 345899999999999999999998876654 9999998765443 34578899999999995 5999999998887777
Q ss_pred ceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhC-------CcEecCCCCCCEEEecCccce
Q psy14267 334 KHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAA-------GIIHSDLKPANFLFVGNVLKI 405 (553)
Q Consensus 334 ~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~-------gIiHrDLKp~NILl~~~~~~~ 405 (553)
..+||+||++ +++|..+|...... ...+.+..++.++.||+.||+|||+. +||||||||+||||+.+...+
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~-~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l 165 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKM-FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI 165 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence 8899999986 47899988764221 12345666777888999999999984 499999999999997542111
Q ss_pred e--------cCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHH
Q psy14267 406 I--------DCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYN 477 (553)
Q Consensus 406 ~--------~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~e 477 (553)
. ......+||+|||++..+..... .....||+.|+|||++.+... .++.++|||||||||||
T Consensus 166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~-------~~s~KSDVWSLG~ILYE 235 (1021)
T PTZ00266 166 GKITAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETK-------SYDDKSDMWALGCIIYE 235 (1021)
T ss_pred ccccccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCC-------CCCchhHHHHHHHHHHH
Confidence 0 01224589999999987644322 224579999999999864321 36889999999999999
Q ss_pred HHhCCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy14267 478 MIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVT 544 (553)
Q Consensus 478 lltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~ 544 (553)
|++|..||.........+..+.. ... +. ....+.++.+||..||..+|++||++.+++.
T Consensus 236 LLTGk~PF~~~~~~~qli~~lk~-~p~------lp-i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 236 LCSGKTPFHKANNFSQLISELKR-GPD------LP-IKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred HHHCCCCCCcCCcHHHHHHHHhc-CCC------CC-cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 99999999865443232222221 111 11 1246789999999999999999999999985
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=312.55 Aligned_cols=270 Identities=19% Similarity=0.306 Sum_probs=197.6
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCC------------CccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCcee
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSE------------HEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVI 322 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~------------~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv 322 (553)
..+|++.+.||+|+||.||++++... +....||+|.+.... .......+.+|+++|+++. |+||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~-h~~i~ 80 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLK-NPNII 80 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCC-CCCcC
Confidence 45899999999999999999876532 222348999987542 2334567899999999996 59999
Q ss_pred EeeeEEEeCCCceEEEEEecC-CCCHHHHHHHcccC-------CCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCC
Q psy14267 323 KMHDYVYDTASKHLYVLMEKG-DTDLSKYMRNLNKM-------TTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPA 394 (553)
Q Consensus 323 ~l~~~~~~~~~~~~~iv~e~~-~~~L~~~l~~~~~~-------~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~ 394 (553)
++++++. .....+++||++ +++|.+++...... .........+..++.|++.||+|||++|++||||||+
T Consensus 81 ~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~ 158 (295)
T cd05097 81 RLLGVCV--SDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATR 158 (295)
T ss_pred eEEEEEc--CCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChh
Confidence 9998774 456788999965 57899988654211 1112345566677789999999999999999999999
Q ss_pred CEEEecCccceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHH
Q psy14267 395 NFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCI 474 (553)
Q Consensus 395 NILl~~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvv 474 (553)
|||++.+ +.+||+|||++................++..|+|||++.+. .++.++|||||||+
T Consensus 159 Nill~~~---------~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~DvwSlG~~ 220 (295)
T cd05097 159 NCLVGNH---------YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG---------KFTTASDVWAFGVT 220 (295)
T ss_pred hEEEcCC---------CcEEecccccccccccCcceeccCcCcCceeecChhhhccC---------CcCchhhHHHHHHH
Confidence 9999766 56999999999766443322222234467899999998755 37899999999999
Q ss_pred HHHHHh--CCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q psy14267 475 LYNMIY--GRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINN 548 (553)
Q Consensus 475 l~ellt--G~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~ 548 (553)
+|||++ |..||...... .....+..................++..+.+|+.+||..||++||++.+|++.|++
T Consensus 221 l~el~~~~~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 221 LWEMFTLCKEQPYSLLSDE-QVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHHHHcCCCCCCcccChH-HHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 999987 67888765442 22222211111111111111223568899999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=310.95 Aligned_cols=269 Identities=26% Similarity=0.374 Sum_probs=199.8
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCC--
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTAS-- 333 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~-- 333 (553)
++|++.+.||+|+||.||++.+..++. .||||++...... ......+.+|+.+++++.+||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~--~v~lK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 77 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGK--LVALKKTRLEMDE-EGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNG 77 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCc--EEEEEeehhhccc-cCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCC
Confidence 369999999999999999998876664 4999998765322 22346788999999999888999999987754332
Q ss_pred -ceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCe
Q psy14267 334 -KHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNV 412 (553)
Q Consensus 334 -~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~ 412 (553)
...|++||++.++|.+++...............+..++.||+.||+|||++||+||||||+|||++.+. +.
T Consensus 78 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~--------~~ 149 (295)
T cd07837 78 KPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQK--------GL 149 (295)
T ss_pred CceEEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCC--------Ce
Confidence 247999999999999998765443233456677777788999999999999999999999999998732 67
Q ss_pred EEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchH
Q psy14267 413 LKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTW 492 (553)
Q Consensus 413 vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~ 492 (553)
+||+|||++..+...... .....+++.|+|||++.+.. .++.++||||||+++|+|++|..||.......
T Consensus 150 ~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~--------~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~ 219 (295)
T cd07837 150 LKIADLGLGRAFSIPVKS--YTHEIVTLWYRAPEVLLGST--------HYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ 219 (295)
T ss_pred EEEeecccceecCCCccc--cCCcccccCCCChHHhhCCC--------CCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH
Confidence 999999999866433221 12335788999999986532 36889999999999999999999998654332
Q ss_pred HHHHHHHhhcc--cc---------------ccccc-c-cCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 493 AKMLAIARHKD--QI---------------EFKPQ-L-ANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 493 ~~~~~i~~~~~--~~---------------~~~~~-~-~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
........... .. .+.+. . .....++..+.++|.+||..||.+||++.+++.+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 220 QLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred HHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 22111110000 00 00000 0 0112478899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=309.51 Aligned_cols=268 Identities=23% Similarity=0.361 Sum_probs=200.3
Q ss_pred EEecCcceEEEeeeeeeCceEEEEEeeeCC---CccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeE
Q psy14267 251 ITLNGKQYQVLSLLGKGGSSSVYLVGGTSE---HEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDY 327 (553)
Q Consensus 251 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~---~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~ 327 (553)
|++..++|++.++||+|+||.||++..++. .....||+|.+..... ......+.+|+.+++++. |+||++++++
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~-~~~i~~~~~~ 77 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS--LRERIEFLNEASVMKGFT-CHHVVRLLGV 77 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC--HHHHHHHHHHHHHHHhCC-CCCeeeEEEE
Confidence 456678999999999999999999876532 2234699998865432 223356889999999995 6999999987
Q ss_pred EEeCCCceEEEEEecC-CCCHHHHHHHcccCC-----CCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecC
Q psy14267 328 VYDTASKHLYVLMEKG-DTDLSKYMRNLNKMT-----TLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGN 401 (553)
Q Consensus 328 ~~~~~~~~~~iv~e~~-~~~L~~~l~~~~~~~-----~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~ 401 (553)
+.. ....+++||++ +++|.++++...... ........+..++.|++.||.|||+++|+||||||+|||++.+
T Consensus 78 ~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~ 155 (288)
T cd05061 78 VSK--GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHD 155 (288)
T ss_pred EcC--CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCC
Confidence 643 45678999975 689999998643211 1223344566677899999999999999999999999999876
Q ss_pred ccceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-
Q psy14267 402 VLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY- 480 (553)
Q Consensus 402 ~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt- 480 (553)
+.++|+|||+++...............++..|+|||.+.+. .++.++|||||||++|||++
T Consensus 156 ---------~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~---------~~~~~~DvwslG~~l~el~~~ 217 (288)
T cd05061 156 ---------FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG---------VFTTSSDMWSFGVVLWEITSL 217 (288)
T ss_pred ---------CcEEECcCCccccccccccccccCCCcccccccCHHHhccC---------CCChHhHHHHHHHHHHHHHhC
Confidence 57999999999865443322222233467789999998755 36889999999999999998
Q ss_pred CCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 481 GRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 481 G~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
|..||...... .....+. ...... ....++..+.++|.+||+.||++||++.++++.|++.
T Consensus 218 ~~~p~~~~~~~-~~~~~~~-~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 218 AEQPYQGLSNE-QVLKFVM-DGGYLD------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred CCCCCCCCCHH-HHHHHHH-cCCCCC------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 89999775432 2222221 111111 1225678999999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=321.69 Aligned_cols=263 Identities=21% Similarity=0.381 Sum_probs=195.3
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|++.+.||+|+||.||++++..++.. ||+|++.+...........+.+|+.++..+ +|++|+.+++++. ...+
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~--~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~l~~~~~--~~~~ 75 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERI--YAMKILNKWEMLKRAETACFREERNVLVNG-DCQWITTLHYAFQ--DENY 75 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCE--EEEEEEeHHHHHhhHHHHHHHHHHHHHHhC-CCCCEeeEEEEEE--cCCE
Confidence 3699999999999999999988766644 999999764433334446678899998888 5699999988764 4678
Q ss_pred EEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
+|++||++ +++|..++..... ......+..++.|++.||+|||++||+||||||+||||+.+ +.+|
T Consensus 76 ~~lv~Ey~~gg~L~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~---------~~~k 142 (331)
T cd05624 76 LYLVMDYYVGGDLLTLLSKFED----RLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMN---------GHIR 142 (331)
T ss_pred EEEEEeCCCCCcHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCC---------CCEE
Confidence 89999975 6899999876432 23344556667899999999999999999999999999766 5799
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||++......... .....+||+.|+|||++.+.... ...++.++|||||||+||||++|+.||...... ..
T Consensus 143 l~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~----~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-~~ 216 (331)
T cd05624 143 LADFGSCLKMNQDGTV-QSSVAVGTPDYISPEILQAMEDG----MGKYGPECDWWSLGVCMYEMLYGETPFYAESLV-ET 216 (331)
T ss_pred EEeccceeeccCCCce-eeccccCCcccCCHHHHhccccC----CCCCCCcccEEeeehhhhhhhhCCCCccCCCHH-HH
Confidence 9999999876543321 12245799999999998753211 013678999999999999999999999764432 23
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKA--RPTVGNSVTQ 545 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~--RPt~~ell~~ 545 (553)
...+........++. ....++.+++++|.+||..++.+ |+++++++++
T Consensus 217 ~~~i~~~~~~~~~p~---~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 217 YGKIMNHEERFQFPS---HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred HHHHHcCCCcccCCC---ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 333332222222222 12357899999999999876544 4688888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=311.86 Aligned_cols=260 Identities=25% Similarity=0.344 Sum_probs=195.4
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceE
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHL 336 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~ 336 (553)
+|++.+.||+|+||.||+|.+..++.. ||+|++....... .....+.+|+.+++++. ||||+++++++. ....+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~--~~~k~~~~~~~~~-~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~--~~~~~ 74 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEI--VALKRVRLDDDDE-GVPSSALREICLLKELK-HKNIVRLYDVLH--SDKKL 74 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcE--EEEEEeecccccc-cCccchhHHHHHHHhcC-CCCeeeHHHHhc--cCCce
Confidence 489999999999999999988777654 9999997654322 33356788999999995 599999998874 45678
Q ss_pred EEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEE
Q psy14267 337 YVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKII 416 (553)
Q Consensus 337 ~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~ 416 (553)
++++|+++++|..++..... ......+..++.||+.||.|||++||+||||||+||+++.+ +.+||+
T Consensus 75 ~lv~e~~~~~l~~~~~~~~~----~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~---------~~~~l~ 141 (284)
T cd07839 75 TLVFEYCDQDLKKYFDSCNG----DIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKN---------GELKLA 141 (284)
T ss_pred EEEEecCCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCC---------CcEEEC
Confidence 99999999999988876432 24456667777899999999999999999999999999776 579999
Q ss_pred eccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHH
Q psy14267 417 DFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKML 496 (553)
Q Consensus 417 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~ 496 (553)
|||+++........ .....+++.|+|||++.+.. .++.++|||||||++|||++|..||....+....+.
T Consensus 142 dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~--------~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~ 211 (284)
T cd07839 142 DFGLARAFGIPVRC--YSAEVVTLWYRPPDVLFGAK--------LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK 211 (284)
T ss_pred ccchhhccCCCCCC--cCCCccccCCcChHHHhCCc--------ccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHH
Confidence 99999866443221 12345789999999987542 367899999999999999999988654333222222
Q ss_pred HHHhhc---------------ccccccccc------cCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 497 AIARHK---------------DQIEFKPQL------ANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 497 ~i~~~~---------------~~~~~~~~~------~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
.+.... ....+.... .....++.++.++|.+||+.||.+|||+++++.+
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 212 RIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred HHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 221110 000000000 0112467899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=315.64 Aligned_cols=275 Identities=20% Similarity=0.304 Sum_probs=203.4
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceE
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHL 336 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~ 336 (553)
+|++.+.||+|+||.||+|.+...+..+.||||++...........+.+.+|+.+++++. ||||+++++++.+.....+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~ 79 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK-HENVVSLVEVFLEHADKSV 79 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcC-CCCccceEEEEeCCCCceE
Confidence 488999999999999999988773234569999998754333344567789999999995 5999999999877666889
Q ss_pred EEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEE
Q psy14267 337 YVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKII 416 (553)
Q Consensus 337 ~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~ 416 (553)
+++||+++++|..++...............+..++.|++.||+|||+++|+||||||+|||++.+. ...+.+||+
T Consensus 80 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~-----~~~~~~kl~ 154 (316)
T cd07842 80 YLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEG-----PERGVVKIG 154 (316)
T ss_pred EEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCC-----CccceEEEC
Confidence 999999999998888765444333555666777788999999999999999999999999998731 223689999
Q ss_pred eccCccccCCCCC-cccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchH---
Q psy14267 417 DFGIACSLQDDKT-SVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTW--- 492 (553)
Q Consensus 417 DFGla~~~~~~~~-~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~--- 492 (553)
|||++........ ........++..|+|||++.+.. .++.++|||||||+||||++|..||.......
T Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--------~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~ 226 (316)
T cd07842 155 DLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGAR--------HYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKS 226 (316)
T ss_pred CCccccccCCCcccccccCCccccccccCHHHHhCCC--------CCCcHHHHHHHHHHHHHHHhcCCCCcCCccccccc
Confidence 9999987654332 11222446889999999886542 36789999999999999999999997543221
Q ss_pred -----HHHHHHHhhc------------------------cccccc-----ccccCCCCCCHHHHHHHHHhcccCCCCCCC
Q psy14267 493 -----AKMLAIARHK------------------------DQIEFK-----PQLANNVTIPPTLLQSMKLCLQKDPKARPT 538 (553)
Q Consensus 493 -----~~~~~i~~~~------------------------~~~~~~-----~~~~~~~~~s~~l~~li~~cL~~dP~~RPt 538 (553)
..+..+.... ....+. .........+..+.++|.+||+.||++|||
T Consensus 227 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps 306 (316)
T cd07842 227 NPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRIT 306 (316)
T ss_pred chhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcC
Confidence 0111110000 000000 000011145678999999999999999999
Q ss_pred HHHHHHH
Q psy14267 539 VGNSVTQ 545 (553)
Q Consensus 539 ~~ell~~ 545 (553)
+.|++.+
T Consensus 307 ~~eil~~ 313 (316)
T cd07842 307 AEEALEH 313 (316)
T ss_pred HHHHhcC
Confidence 9999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=305.86 Aligned_cols=266 Identities=22% Similarity=0.300 Sum_probs=191.5
Q ss_pred eeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEEEEEe
Q psy14267 262 SLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLME 341 (553)
Q Consensus 262 ~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~iv~e 341 (553)
+.||+|+||.||++..........+|+|.+.... .......+.+|+.+++.+. |+||+++++++. ....++++||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~-h~nii~~~~~~~--~~~~~~lv~e 75 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELN-HPNVLQCLGQCI--ESIPYLLVLE 75 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCC-CCCcceEEEEEC--CCCceEEEEE
Confidence 3699999999999976555444568888775432 2333467889999999984 699999998774 4567889999
Q ss_pred cC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEeccC
Q psy14267 342 KG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGI 420 (553)
Q Consensus 342 ~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGl 420 (553)
+. +++|.+++...............+..++.||+.||+|||+++|+||||||+|||++.+ +.+||+|||+
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~---------~~~kl~dfg~ 146 (269)
T cd05042 76 FCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTAD---------LSVKIGDYGL 146 (269)
T ss_pred eCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCC---------CcEEEecccc
Confidence 75 5799999887654332233345566677899999999999999999999999999876 5799999999
Q ss_pred ccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHH
Q psy14267 421 ACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHIPNTWAKMLAIA 499 (553)
Q Consensus 421 a~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~i~ 499 (553)
+................++..|+|||++....... ....++.++|||||||++|||++ |..||....+.. ......
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~--~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~~~~ 223 (269)
T cd05042 147 ALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDL--LPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-VLKQVV 223 (269)
T ss_pred ccccccchheeccCCCCCcccccCHHHHhhccccc--cccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH-HHHHHh
Confidence 87654432221122344677899999986432110 11246889999999999999998 889998754432 222222
Q ss_pred hhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q psy14267 500 RHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQIN 547 (553)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~ 547 (553)
.........+. ....++..+.+++..|| .||++|||+++|++.|.
T Consensus 224 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 224 REQDIKLPKPQ--LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred hccCccCCCCc--ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 22111111111 12367889999999999 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=304.64 Aligned_cols=258 Identities=23% Similarity=0.415 Sum_probs=197.4
Q ss_pred EEecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEe
Q psy14267 251 ITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYD 330 (553)
Q Consensus 251 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~ 330 (553)
|++..+.|+++++||+|+||.||+|..... +.||+|.+...... ...+.+|+.+++++. |+||+.+++++.
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~---~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~-h~~i~~~~~~~~- 71 (260)
T cd05067 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGH---TKVAIKSLKQGSMS----PEAFLAEANLMKQLQ-HPRLVRLYAVVT- 71 (260)
T ss_pred CccchHHceeeeeeccCccceEEeeecCCC---ceEEEEEecCCCCc----HHHHHHHHHHHHhcC-CcCeeeEEEEEc-
Confidence 345678899999999999999999975543 34999998765532 256889999999995 699999988652
Q ss_pred CCCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCC
Q psy14267 331 TASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCI 409 (553)
Q Consensus 331 ~~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~ 409 (553)
...++++|++. +++|.+++...... ......+..++.|++.||+|||+.|++||||||+||+++.+
T Consensus 72 --~~~~~~v~e~~~~~~L~~~~~~~~~~---~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~-------- 138 (260)
T cd05067 72 --QEPIYIITEYMENGSLVDFLKTPEGI---KLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSET-------- 138 (260)
T ss_pred --cCCcEEEEEcCCCCCHHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCC--------
Confidence 34578888865 67899988764322 33445566667899999999999999999999999999776
Q ss_pred CCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCC
Q psy14267 410 GNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHI 488 (553)
Q Consensus 410 ~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~ 488 (553)
+.++|+|||++......... ......++..|+|||++... .++.++||||||+++|||++ |++||...
T Consensus 139 -~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~---------~~~~~~Di~slG~~l~el~~~g~~p~~~~ 207 (260)
T cd05067 139 -LCCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYG---------TFTIKSDVWSFGILLTEIVTYGRIPYPGM 207 (260)
T ss_pred -CCEEEccCcceeecCCCCcc-cccCCcccccccCHHHhccC---------CcCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 57999999999776533221 11233467889999998755 36789999999999999998 99999865
Q ss_pred CchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 489 PNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 489 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
... .....+. .... ......++.++.++|.+||+.+|++||++++++..|+++
T Consensus 208 ~~~-~~~~~~~-~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 260 (260)
T cd05067 208 TNP-EVIQNLE-RGYR------MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF 260 (260)
T ss_pred ChH-HHHHHHH-cCCC------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence 432 1122211 1111 122235788999999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=307.19 Aligned_cols=263 Identities=18% Similarity=0.280 Sum_probs=198.7
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCC--CccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCC
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSE--HEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTAS 333 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~--~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~ 333 (553)
..|++.+.||+|+||.||+|..... .....||+|.+.... .......+.+|+.+++++. ||||+++++++.. .
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~--~ 79 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELH-HPNIVCLLGVVTQ--E 79 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEec--C
Confidence 5799999999999999999975422 233569999987543 2334467889999999995 6999999987643 4
Q ss_pred ceEEEEEecC-CCCHHHHHHHcccC------------CCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEec
Q psy14267 334 KHLYVLMEKG-DTDLSKYMRNLNKM------------TTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVG 400 (553)
Q Consensus 334 ~~~~iv~e~~-~~~L~~~l~~~~~~------------~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~ 400 (553)
...+++||+. +++|.+++...... .........+..++.|++.||+|||++||+||||||+|||++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~ 159 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGE 159 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcC
Confidence 5678999975 57899888643211 0122445566677789999999999999999999999999987
Q ss_pred CccceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh
Q psy14267 401 NVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY 480 (553)
Q Consensus 401 ~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt 480 (553)
+ +.+||+|||+++...............++..|+|||.+.+. .++.++|||||||++|||++
T Consensus 160 ~---------~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Dv~slG~il~el~~ 221 (283)
T cd05090 160 Q---------LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG---------KFSSDSDIWSFGVVLWEIFS 221 (283)
T ss_pred C---------CcEEeccccccccccCCcceecccCCCccceecChHHhccC---------CCCchhhhHHHHHHHHHHHc
Confidence 6 56999999999876543322222344567889999998754 36889999999999999998
Q ss_pred -CCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 481 -GRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 481 -G~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
|..||.+.... ..+..+. .... ......++..+.++|.+||+.||++||++.+|+++|+.|
T Consensus 222 ~g~~p~~~~~~~-~~~~~~~-~~~~------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05090 222 FGLQPYYGFSNQ-EVIEMVR-KRQL------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRSW 283 (283)
T ss_pred CCCCCCCCCCHH-HHHHHHH-cCCc------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhcC
Confidence 99999775432 2222222 1111 112336789999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=303.61 Aligned_cols=252 Identities=21% Similarity=0.378 Sum_probs=192.6
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
.++|++.+.||+|+||.||++..... ..+|+|.+...... ...+.+|+.+|+++. ||||+++++++. ...
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~---~~~a~K~~~~~~~~----~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~ 72 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWRAQ---IKVAIKAINEGAMS----EEDFIEEAKVMMKLS-HPKLVQLYGVCT--QQK 72 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEeccC---ceEEEEecccCCcc----HHHHHHHHHHHHHCC-CCCceeEEEEEc--cCC
Confidence 35799999999999999999976543 34899988655432 256889999999995 599999988764 456
Q ss_pred eEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 335 HLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 335 ~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
.++++||+. +++|.+++..... ......++.++.|++.||+|||++||+||||||+||+++.+ +.+
T Consensus 73 ~~~iv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~---------~~~ 139 (256)
T cd05114 73 PLYIVTEFMENGCLLNYLRQRQG----KLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSST---------GVV 139 (256)
T ss_pred CEEEEEEcCCCCcHHHHHHhCcc----CCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCC---------CeE
Confidence 788999976 5789888875432 23455666777899999999999999999999999999776 579
Q ss_pred EEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCCCchH
Q psy14267 414 KIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHIPNTW 492 (553)
Q Consensus 414 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~~~~~ 492 (553)
||+|||+++........ ......++..|+|||.+.+. .++.++||||||+++|||++ |+.||......
T Consensus 140 kl~d~g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~- 208 (256)
T cd05114 140 KVSDFGMTRYVLDDEYT-SSSGAKFPVKWSPPEVFNFS---------KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY- 208 (256)
T ss_pred EECCCCCccccCCCcee-ccCCCCCchhhCChhhcccC---------ccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH-
Confidence 99999999866433221 11122356789999998755 36789999999999999999 99999775432
Q ss_pred HHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q psy14267 493 AKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQIN 547 (553)
Q Consensus 493 ~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~ 547 (553)
.....+.... .. ......+..+.+++.+||..+|++||++.++++.|.
T Consensus 209 ~~~~~i~~~~-~~------~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 209 EVVEMISRGF-RL------YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred HHHHHHHCCC-CC------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 2233332211 11 112245789999999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=303.40 Aligned_cols=251 Identities=24% Similarity=0.388 Sum_probs=191.7
Q ss_pred eeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEEEEEec
Q psy14267 263 LLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEK 342 (553)
Q Consensus 263 ~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~iv~e~ 342 (553)
.||+|+||.||++........+.+|+|+++.... .....+.+.+|+.+++++. ||||+++++++. ....+++||+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~---~~~~~lv~e~ 76 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNN-DPALKDELLREANVMQQLD-NPYIVRMIGICE---AESWMLVMEL 76 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCC-cHHHHHHHHHHHHHHHhCC-CCCcceEEEEEc---CCCcEEEEec
Confidence 6899999999999765555556699999875543 3345678899999999995 599999988763 3356788886
Q ss_pred C-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEeccCc
Q psy14267 343 G-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIA 421 (553)
Q Consensus 343 ~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGla 421 (553)
. +++|.+++.... ......+..++.|++.||+|||++||+||||||.|||++.+ +.+||+|||++
T Consensus 77 ~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~---------~~~kl~Dfg~~ 142 (257)
T cd05116 77 AELGPLNKFLQKNK-----HVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQ---------HYAKISDFGLS 142 (257)
T ss_pred CCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCC---------CeEEECCCccc
Confidence 4 478988887543 23345566677899999999999999999999999999776 57999999999
Q ss_pred cccCCCCCccc-ccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHH
Q psy14267 422 CSLQDDKTSVH-KDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHIPNTWAKMLAIA 499 (553)
Q Consensus 422 ~~~~~~~~~~~-~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~i~ 499 (553)
........... .....++..|+|||.+... .++.++|||||||++|||++ |..||...... .....+.
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-~~~~~i~ 212 (257)
T cd05116 143 KALGADENYYKAKTHGKWPVKWYAPECMNYY---------KFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN-EVTQMIE 212 (257)
T ss_pred cccCCCCCeeeecCCCCCCccccCHhHhccC---------CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHH
Confidence 87654432111 1123356799999998654 36789999999999999997 99999875432 2223332
Q ss_pred hhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 500 RHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
. ..... ....++.++.++|.+||+.||++||++.+|...|++.
T Consensus 213 ~-~~~~~------~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 213 S-GERME------CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred C-CCCCC------CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 2 11111 1235789999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=309.56 Aligned_cols=254 Identities=23% Similarity=0.373 Sum_probs=193.0
Q ss_pred eEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEE
Q psy14267 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLY 337 (553)
Q Consensus 258 y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~ 337 (553)
|++.+.||+|+||+||++.+..++.. ||+|.+.+...........+.+|+++|+++. |++|+.+.+++. .+..++
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~--~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~--~~~~~~ 76 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKM--YACKRLEKKRIKKRKGESMALNEKQILEKVN-SQFVVNLAYAYE--TKDALC 76 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcE--EEEEEeehhhhhhhhHHHHHHHHHHHHHHcC-CcCceeEEEEEe--cCCEEE
Confidence 78889999999999999988776644 9999998766554444566789999999995 599999977664 355788
Q ss_pred EEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEE
Q psy14267 338 VLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKII 416 (553)
Q Consensus 338 iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~ 416 (553)
++||+. +++|..++...... ......+..++.|++.||+|||+.||+||||||+||+++.+ +.+||+
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~---------~~~kl~ 144 (285)
T cd05632 77 LVLTIMNGGDLKFHIYNMGNP---GFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDY---------GHIRIS 144 (285)
T ss_pred EEEEeccCccHHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCC---------CCEEEe
Confidence 888864 56788777653321 34556667777899999999999999999999999999776 569999
Q ss_pred eccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHH
Q psy14267 417 DFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKML 496 (553)
Q Consensus 417 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~ 496 (553)
|||++........ .....|+..|+|||++.+. .++.++|+|||||++|||++|..||........ ..
T Consensus 145 Dfg~~~~~~~~~~---~~~~~g~~~~~aPE~~~~~---------~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~-~~ 211 (285)
T cd05632 145 DLGLAVKIPEGES---IRGRVGTVGYMAPEVLNNQ---------RYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK-RE 211 (285)
T ss_pred cCCcceecCCCCc---ccCCCCCcCccChHHhcCC---------CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH-HH
Confidence 9999976543322 1245689999999999755 368899999999999999999999987543211 11
Q ss_pred HHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q psy14267 497 AIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT-----VGNSVTQ 545 (553)
Q Consensus 497 ~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt-----~~ell~~ 545 (553)
.+....... .......++.++.+|+..||+.||++||+ +.+++.+
T Consensus 212 ~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 212 EVDRRVLET----EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred HHHHhhhcc----ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 111111110 11112357889999999999999999999 6677664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=312.65 Aligned_cols=259 Identities=23% Similarity=0.364 Sum_probs=194.9
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|++.+.||.|+||.||++.+..++. .||+|.+....... ....+.+|+.+++++. ||||+++++++. ....
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~--~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~-h~nI~~~~~~~~--~~~~ 78 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDN--LVALKEIRLEHEEG--APCTAIREVSLLKDLK-HANIVTLHDIIH--TEKS 78 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCc--EEEEEEEecccccC--chhHHHHHHHHHHhcC-CCCcceEEEEEe--cCCe
Confidence 579999999999999999998876664 49999997654222 2346778999999995 599999999874 4567
Q ss_pred EEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 336 LYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 336 ~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
++++||++.++|..++..... ......+..++.|++.||+|||+.||+||||||+|||++.+ +.+||
T Consensus 79 ~~lv~e~~~~~l~~~l~~~~~----~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~---------~~~kl 145 (301)
T cd07873 79 LTLVFEYLDKDLKQYLDDCGN----SINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINER---------GELKL 145 (301)
T ss_pred EEEEEeccccCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCC---------CcEEE
Confidence 899999999999998876432 23345566677799999999999999999999999999776 57999
Q ss_pred EeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHH
Q psy14267 416 IDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKM 495 (553)
Q Consensus 416 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~ 495 (553)
+|||++......... .....+++.|+|||++.+.. .++.++|||||||++|||++|++||...... ..+
T Consensus 146 ~dfg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~--------~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~-~~~ 214 (301)
T cd07873 146 ADFGLARAKSIPTKT--YSNEVVTLWYRPPDILLGST--------DYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE-EQL 214 (301)
T ss_pred CcCcchhccCCCCCc--ccccceeecccCcHHHhCCC--------CCccHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHH
Confidence 999999765433221 12345789999999986542 3678999999999999999999999865432 111
Q ss_pred HHHHhhccc-----------------ccccc---c--ccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 496 LAIARHKDQ-----------------IEFKP---Q--LANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 496 ~~i~~~~~~-----------------~~~~~---~--~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
..+...... ..... . ......+++.+++||.+||+.||.+|||+.|++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 215 HFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred HHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 111110000 00000 0 00123578899999999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=307.20 Aligned_cols=268 Identities=19% Similarity=0.274 Sum_probs=203.4
Q ss_pred ecCcceEEEeeeeeeCceEEEEEeeeCCC--ccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEe
Q psy14267 253 LNGKQYQVLSLLGKGGSSSVYLVGGTSEH--EFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYD 330 (553)
Q Consensus 253 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~--~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~ 330 (553)
+.+++|++.++||+|+||.||++.+.... ....|++|++... ......+.+.+|+.+|+++ .|+||+++++++..
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~ 79 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGL-SHQNILPILHVCIE 79 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEec
Confidence 45678999999999999999999877532 2355999988643 2334457889999999999 56999999997765
Q ss_pred CCCceEEEEEec-CCCCHHHHHHHcccC---CCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCcccee
Q psy14267 331 TASKHLYVLMEK-GDTDLSKYMRNLNKM---TTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKII 406 (553)
Q Consensus 331 ~~~~~~~iv~e~-~~~~L~~~l~~~~~~---~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~ 406 (553)
. ....++++++ .+++|..++...... ....+....++.++.|++.||+|||+++|+||||||+|||++.+
T Consensus 80 ~-~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~----- 153 (280)
T cd05043 80 D-GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEE----- 153 (280)
T ss_pred C-CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCC-----
Confidence 4 3456677776 468999998765322 11234566667777899999999999999999999999999766
Q ss_pred cCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCC
Q psy14267 407 DCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPY 485 (553)
Q Consensus 407 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf 485 (553)
+.+||+|||+++.+.............++..|+|||++.+. .++.++|||||||++||+++ |..||
T Consensus 154 ----~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~---------~~~~~~Di~slG~~l~el~~~g~~p~ 220 (280)
T cd05043 154 ----LQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNK---------EYSSASDVWSFGVLLWELMTLGQTPY 220 (280)
T ss_pred ----CcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcC---------CCCchhhHHHhHHHHHHHhcCCCCCc
Confidence 57999999999876544332222234467789999999755 37889999999999999998 99999
Q ss_pred CCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q psy14267 486 SHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNP 550 (553)
Q Consensus 486 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~ 550 (553)
...... .....+. .... +.....+++++.+++.+||..||++|||+.++++.|+.+.
T Consensus 221 ~~~~~~-~~~~~~~-~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 221 VEIDPF-EMAAYLK-DGYR------LAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred CcCCHH-HHHHHHH-cCCC------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 875332 2222211 1111 1223357899999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=304.85 Aligned_cols=266 Identities=21% Similarity=0.316 Sum_probs=190.7
Q ss_pred eeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEEEEEe
Q psy14267 262 SLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLME 341 (553)
Q Consensus 262 ~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~iv~e 341 (553)
+.||+|+||.||++..........+|+|.++..... .....+.+|+.+++++. ||||+++++++. ....++++||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--~~~~~~lv~e 75 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASV--QEQMKFLEEAQPYRSLQ-HSNLLQCLGQCT--EVTPYLLVME 75 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCCh--HHHHHHHHHHHHHHhCC-CCCEeeEEEEEc--CCCCcEEEEE
Confidence 369999999999997765544556999988765422 23357889999999995 599999988764 3456788999
Q ss_pred cC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEeccC
Q psy14267 342 KG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGI 420 (553)
Q Consensus 342 ~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGl 420 (553)
+. +++|.+++...............+..++.|++.||+|||+.+++||||||+||+++.+ +.+||+|||+
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~---------~~~kL~dfg~ 146 (269)
T cd05087 76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTAD---------LTVKIGDYGL 146 (269)
T ss_pred CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCC---------CcEEECCccc
Confidence 75 5789999876443222233344455566799999999999999999999999999776 5799999999
Q ss_pred ccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHH
Q psy14267 421 ACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHIPNTWAKMLAIA 499 (553)
Q Consensus 421 a~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~i~ 499 (553)
++...............|+..|+|||++.+.... .....++.++||||||+++|||++ |..||............+.
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~--~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~ 224 (269)
T cd05087 147 SHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGN--LLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVR 224 (269)
T ss_pred cccccCcceeecCCCcCCcccccCHhHhcccccc--ccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhh
Confidence 9765443322222245578899999998643211 001136789999999999999996 9999987554322222121
Q ss_pred hhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q psy14267 500 RHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQIN 547 (553)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~ 547 (553)
...... ..+.. ....++.+.++|..|| .+|++|||+++|+..|+
T Consensus 225 ~~~~~~-~~~~~--~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 225 EQQLKL-PKPRL--KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred cccCCC-CCCcc--CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 111111 11111 1246788999999999 68999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=307.39 Aligned_cols=260 Identities=22% Similarity=0.336 Sum_probs=197.2
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC--
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA-- 332 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~-- 332 (553)
...|++.+.||+|+||.||++.....+. .||+|++..... ....+.+|+.++.++.+|+||+++++++....
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~--~~aik~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQ--LAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 78 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCc--EEEEEEEEcCCc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCC
Confidence 3568999999999999999998876654 499999976532 23567899999999977899999999886543
Q ss_pred --CceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCC
Q psy14267 333 --SKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCI 409 (553)
Q Consensus 333 --~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~ 409 (553)
...++++||++ +++|.+++...... ...+..+..++.|++.||+|||+++|+||||||+||+++.+
T Consensus 79 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~-------- 147 (272)
T cd06637 79 GMDDQLWLVMEFCGAGSVTDLIKNTKGN---TLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTEN-------- 147 (272)
T ss_pred CCCcEEEEEEEcCCCCcHHHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCC--------
Confidence 34688999975 46898888764321 23455566677899999999999999999999999999876
Q ss_pred CCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy14267 410 GNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIP 489 (553)
Q Consensus 410 ~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~ 489 (553)
+.+||+|||++........ ......|++.|+|||++.+.... ...++.++|||||||++|||++|..||....
T Consensus 148 -~~~~l~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~----~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~ 220 (272)
T cd06637 148 -AEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENP----DATYDFKSDLWSLGITAIEMAEGAPPLCDMH 220 (272)
T ss_pred -CCEEEccCCCceecccccc--cCCcccccccccCHhHhccccCc----CCCCCchhhHHHHHHHHHHHHhCCCCccccC
Confidence 5799999999986643222 22356789999999998743211 1147889999999999999999999997654
Q ss_pred chHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 490 NTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 490 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
.......... . .........++.++.+||.+||..+|++|||+.+++.+
T Consensus 221 ~~~~~~~~~~--~-----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 221 PMRALFLIPR--N-----PAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred HHHHHHHHhc--C-----CCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 3322221111 0 01111123578899999999999999999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=320.53 Aligned_cols=240 Identities=23% Similarity=0.323 Sum_probs=180.8
Q ss_pred eeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHH-HHhhcCCCceeEeeeEEEeCCCceEEEEE
Q psy14267 262 SLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVEL-LAKLQGCPYVIKMHDYVYDTASKHLYVLM 340 (553)
Q Consensus 262 ~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~i-L~~l~~hp~Iv~l~~~~~~~~~~~~~iv~ 340 (553)
++||+|+||.||+|++...+.. ||+|++.+...........+..|... ++.+ +||||+++++++. ....++++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~--~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~iv~~~~~~~--~~~~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSF--YAVKVLQKKTILKKKEQNHIMAERNVLLKNL-KHPFLVGLHYSFQ--TAEKLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCE--EEEEEEEHHHHHHhhHHHHHHHHHHHHHHhC-CCCCccceeeEEE--cCCEEEEEE
Confidence 4799999999999988776654 99999986554333344566677664 5556 6699999987663 456789999
Q ss_pred ecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEecc
Q psy14267 341 EKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFG 419 (553)
Q Consensus 341 e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFG 419 (553)
|++ +++|..++.... ......+..++.||+.||+|||++||+||||||+||||+.+ +.+||+|||
T Consensus 76 e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~---------~~~kl~Dfg 141 (321)
T cd05603 76 DYVNGGELFFHLQRER-----CFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQ---------GHVVLTDFG 141 (321)
T ss_pred cCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC---------CCEEEccCC
Confidence 975 568877776543 22344555667899999999999999999999999999776 579999999
Q ss_pred CccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHH
Q psy14267 420 IACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIA 499 (553)
Q Consensus 420 la~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~~i~ 499 (553)
+++....... .....+||+.|+|||++.+. .++.++|||||||++|||++|..||...... .....+.
T Consensus 142 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~ 209 (321)
T cd05603 142 LCKEGVEPEE--TTSTFCGTPEYLAPEVLRKE---------PYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS-QMYDNIL 209 (321)
T ss_pred CCccCCCCCC--ccccccCCcccCCHHHhcCC---------CCCCcCcccccchhhhhhhcCCCCCCCCCHH-HHHHHHh
Confidence 9876433222 12356799999999999765 3678999999999999999999999875332 2222222
Q ss_pred hhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHH
Q psy14267 500 RHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVG 540 (553)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ 540 (553)
.. ... .....+.++.++|.+||+.||.+||++.
T Consensus 210 ~~--~~~------~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 210 HK--PLQ------LPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred cC--CCC------CCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 11 111 1225678999999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=302.86 Aligned_cols=255 Identities=24% Similarity=0.344 Sum_probs=195.6
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCc--hhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCC
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITD--QSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTAS 333 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~--~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~ 333 (553)
+.|.+.+.||+|+||.||.+.+..++. .||+|.+....... ....+.+.+|+++++++. ||||+++++++.. .
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~--~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~ 76 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGR--ELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ-HERIVQYYGCLRD--D 76 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCc--EEEEEEEeecccchhhHHHHHHHHHHHHHHHhCC-CCCeeeeEEEEcc--C
Confidence 369999999999999999998766654 49999987654322 223467889999999995 5999999988754 4
Q ss_pred ceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCe
Q psy14267 334 KHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNV 412 (553)
Q Consensus 334 ~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~ 412 (553)
..+++++|+. +++|.+++.... ......+..++.|++.||.|||+.||+||||||+||+++.+ +.
T Consensus 77 ~~~~~v~e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~---------~~ 142 (263)
T cd06625 77 ETLSIFMEYMPGGSVKDQLKAYG-----ALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSA---------GN 142 (263)
T ss_pred CeEEEEEEECCCCcHHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC---------CC
Confidence 5889999875 578888887643 23345556677899999999999999999999999999776 57
Q ss_pred EEEEeccCccccCCCCCccc-ccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCch
Q psy14267 413 LKIIDFGIACSLQDDKTSVH-KDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNT 491 (553)
Q Consensus 413 vkL~DFGla~~~~~~~~~~~-~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~ 491 (553)
++|+|||+++.......... .....|+..|+|||++.+. .++.++||||||+++|||++|+.||......
T Consensus 143 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~el~~g~~p~~~~~~~ 213 (263)
T cd06625 143 VKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGE---------GYGRKADVWSVGCTVVEMLTEKPPWAEFEAM 213 (263)
T ss_pred EEEeecccceeccccccccccccCCCcCccccCcceeccC---------CCCchhhhHHHHHHHHHHHhCCCCccccchH
Confidence 99999999976643221111 1245688999999999865 3678999999999999999999999775332
Q ss_pred HHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 492 WAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 492 ~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
............ ......++..+.++|++||..+|++|||+.+++++
T Consensus 214 -~~~~~~~~~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 214 -AAIFKIATQPTN------PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -HHHHHHhccCCC------CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 222222211111 11223578899999999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=307.30 Aligned_cols=263 Identities=22% Similarity=0.379 Sum_probs=197.1
Q ss_pred CcceEEEeeeeeeCceEEEEEeee--CCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGT--SEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA 332 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~--~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~ 332 (553)
..+|++++.||+|+||.||++... .......||||.+.... ....+.+.+|+++|+++. ||||+++++++....
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~ 78 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSAG 78 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCC-CCCeeEEEEEEccCC
Confidence 357999999999999999998743 23334569999986543 334577899999999995 599999999877666
Q ss_pred CceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCC
Q psy14267 333 SKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGN 411 (553)
Q Consensus 333 ~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~ 411 (553)
...++++||+. +++|.+++..... ...+..+..++.|++.||+|||++||+||||||+|||++.+ +
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~----~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~---------~ 145 (284)
T cd05081 79 RRNLRLVMEYLPYGSLRDYLQKHRE----RLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESE---------N 145 (284)
T ss_pred CCceEEEEEecCCCCHHHHHHhcCc----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCC---------C
Confidence 66788999975 6899999875432 23445566677899999999999999999999999999776 5
Q ss_pred eEEEEeccCccccCCCCCccc-ccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCc
Q psy14267 412 VLKIIDFGIACSLQDDKTSVH-KDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN 490 (553)
Q Consensus 412 ~vkL~DFGla~~~~~~~~~~~-~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~ 490 (553)
.+||+|||++........... .....++..|+|||++.+. .++.++|||||||++|||++|..|+.....
T Consensus 146 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~~l~el~~~~~~~~~~~~ 216 (284)
T cd05081 146 RVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTES---------KFSVASDVWSFGVVLYELFTYSDKSCSPPA 216 (284)
T ss_pred eEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccC---------CcChHHHHHHHHHHHHHHhhcCCcCCCcch
Confidence 799999999987754332111 1122244569999998754 368899999999999999999877654322
Q ss_pred hHHH--------------HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 491 TWAK--------------MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 491 ~~~~--------------~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
.+.. +...... .........++.++.++|.+||..+|++|||+.+|++.|+.+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 217 EFMRMMGNDKQGQMIVYHLIELLKN------NGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred hhhhhcccccccccchHHHHHHHhc------CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 1110 0000100 111122346788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0574|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=316.31 Aligned_cols=250 Identities=26% Similarity=0.411 Sum_probs=204.8
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
+.|.++.+||+|+||.||+|-++.++.. +|||.+..+ ..++.+.+|+.||+++.. |+||++++.++.. ..
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v--~AIK~VPV~-----sDLQEIIKEISIMQQC~S-~yVVKYYGSYFK~--sD 102 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHV--LAIKKVPVD-----TDLQEIIKEISIMQQCKS-KYVVKYYGSYFKH--SD 102 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcE--EEEEecCcc-----chHHHHHHHHHHHHHcCC-chhhhhhhhhccC--Cc
Confidence 4688999999999999999988888755 999988654 446889999999999966 9999999877653 45
Q ss_pred EEEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
++||||||| |++.+.++.+++ ++.+..+..+++..+.||+|||...-||||||..||||+.+ |..|
T Consensus 103 LWIVMEYCGAGSiSDI~R~R~K----~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~---------G~AK 169 (502)
T KOG0574|consen 103 LWIVMEYCGAGSISDIMRARRK----PLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTD---------GIAK 169 (502)
T ss_pred eEeehhhcCCCcHHHHHHHhcC----CccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEccc---------chhh
Confidence 899999876 788888887655 45566677777899999999999999999999999999776 7899
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||+|..+.+.-. .+.+..|||.|||||++..-+ |+.++||||||++..||.-|++||.++....+.
T Consensus 170 LADFGVAGQLTDTMA--KRNTVIGTPFWMAPEVI~EIG---------Y~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI 238 (502)
T KOG0574|consen 170 LADFGVAGQLTDTMA--KRNTVIGTPFWMAPEVIEEIG---------YDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI 238 (502)
T ss_pred hhhccccchhhhhHH--hhCccccCcccccHHHHHHhc---------cchhhhHhhhcchhhhhhcCCCCccccccccee
Confidence 999999987765322 345788999999999998764 778999999999999999999999986553111
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
+. + .-..+|....+..++.++-++++.||.++|++|-|+-+|++|
T Consensus 239 FM-I-----PT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 239 FM-I-----PTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred Ee-c-----cCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 10 0 111234445555778999999999999999999999999876
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=301.32 Aligned_cols=255 Identities=25% Similarity=0.404 Sum_probs=199.1
Q ss_pred eeeeeeCceEEEEEeeeCC-CccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEEEEE
Q psy14267 262 SLLGKGGSSSVYLVGGTSE-HEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLM 340 (553)
Q Consensus 262 ~~LG~G~fG~Vy~a~~~~~-~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~iv~ 340 (553)
+.||+|+||.||+|..... .....||+|++....... ..+.+.+|++++..+. |+||+++++++.. ...++++|
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~--~~~~~lv~ 75 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLG-HPNVVRLLGVCTE--EEPLYLVL 75 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcC-CCChheeeeeecC--CCceEEEE
Confidence 4699999999999988764 223559999997665332 4578899999999997 7999999987754 67789999
Q ss_pred ecC-CCCHHHHHHHcccC----CCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 341 EKG-DTDLSKYMRNLNKM----TTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 341 e~~-~~~L~~~l~~~~~~----~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
|++ +++|.+++...... ......+..++.++.|++.||+|||++||+||||||+||+++.+ +.+||
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~---------~~~~l 146 (262)
T cd00192 76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGED---------LVVKI 146 (262)
T ss_pred EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCC---------CcEEE
Confidence 986 88999998875211 02245566777788899999999999999999999999999876 57999
Q ss_pred EeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCCCchHHH
Q psy14267 416 IDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHIPNTWAK 494 (553)
Q Consensus 416 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~~~~~~~ 494 (553)
+|||++................++..|+|||.+... .++.++|||||||++|||++ |..||...... ..
T Consensus 147 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-~~ 216 (262)
T cd00192 147 SDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDG---------IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE-EV 216 (262)
T ss_pred cccccccccccccccccccCCCcCccccCHHHhccC---------CcchhhccHHHHHHHHHHHhcCCCCCCCCCHH-HH
Confidence 999999887654322223345578999999998765 37889999999999999998 69999876432 22
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQIN 547 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~ 547 (553)
...+.. ... ......++.++.+++.+||..+|++||++.+++++|+
T Consensus 217 ~~~~~~-~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 217 LEYLRK-GYR------LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HHHHHc-CCC------CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 222221 111 1222356899999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=306.62 Aligned_cols=263 Identities=25% Similarity=0.450 Sum_probs=202.1
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
.+|++.+.||+|+||.||++.+..++. .||||.+...........+.+.+|+.+++.+ +|+||+++++++.. ...
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~--~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~--~~~ 76 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGV--PVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFIE--DNE 76 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCc--eEEEEeeeehhhhhHHHHHHHHHHHHHHHHc-cCCchhhhhheeEe--CCe
Confidence 368899999999999999998766654 4999998776555555567889999999999 46999999988754 457
Q ss_pred EEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
.+++|++. +++|.+++...... .....+..++.++.|++.||.|||++||+|+||||+||+++.+ +.++
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~---------~~~~ 146 (267)
T cd08229 77 LNIVLELADAGDLSRMIKHFKKQ-KRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITAT---------GVVK 146 (267)
T ss_pred EEEEEEecCCCCHHHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC---------CCEE
Confidence 78888865 56898888754321 2234556667777899999999999999999999999999776 5799
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||++......... .....|+..|+|||.+.+. .++.++|+||||+++|||++|..||.........
T Consensus 147 l~dfg~~~~~~~~~~~--~~~~~~~~~~~ape~~~~~---------~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~ 215 (267)
T cd08229 147 LGDLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHEN---------GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS 215 (267)
T ss_pred ECcchhhhccccCCcc--cccccCCcCccCHHHhcCC---------CccchhhHHHHHHHHHHHHhCCCCcccccchHHH
Confidence 9999998776543321 1245689999999999765 3678999999999999999999999764332222
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
...... .....+. ....++..+.++|.+||..||++|||+.+|++.+++.
T Consensus 216 ~~~~~~---~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 216 LCKKIE---QCDYPPL--PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred Hhhhhh---cCCCCCC--CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 211111 1111111 1225788999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=301.96 Aligned_cols=252 Identities=20% Similarity=0.337 Sum_probs=196.6
Q ss_pred eeeeeeCceEEEEEeeeC-CCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEEEEE
Q psy14267 262 SLLGKGGSSSVYLVGGTS-EHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLM 340 (553)
Q Consensus 262 ~~LG~G~fG~Vy~a~~~~-~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~iv~ 340 (553)
++||+|+||.||++.+.. .+....||||.+...... ...+.+.+|+.+++++. ||||+++++++.+ ...+++|
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~---~~~~~v~ 74 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLD-HENLIRLYGVVLT---HPLMMVT 74 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcC-CCCccceeEEEcC---CeEEEEE
Confidence 468999999999998865 333346999999876643 45678999999999995 5999999988755 6788889
Q ss_pred ecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEecc
Q psy14267 341 EKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFG 419 (553)
Q Consensus 341 e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFG 419 (553)
|+. +++|.+++..... ....+..++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|||
T Consensus 75 e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~---------~~~kl~dfg 142 (257)
T cd05040 75 ELAPLGSLLDRLRKDAL---GHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASD---------DKVKIGDFG 142 (257)
T ss_pred EecCCCcHHHHHHhccc---ccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecC---------CEEEecccc
Confidence 875 6899999887542 234566667777899999999999999999999999999877 679999999
Q ss_pred CccccCCCCCcc-cccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCCCchHHHHHH
Q psy14267 420 IACSLQDDKTSV-HKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHIPNTWAKMLA 497 (553)
Q Consensus 420 la~~~~~~~~~~-~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~ 497 (553)
++..+....... ......++..|+|||.+.+. .++.++|||||||++|||++ |..||...... .....
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~---------~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-~~~~~ 212 (257)
T cd05040 143 LMRALPQNEDHYVMEEHLKVPFAWCAPESLRTR---------TFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS-QILKK 212 (257)
T ss_pred ccccccccccceecccCCCCCceecCHHHhccc---------CcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH-HHHHH
Confidence 998775533221 11234578899999998755 37889999999999999998 99999765433 22222
Q ss_pred HHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q psy14267 498 IARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQIN 547 (553)
Q Consensus 498 i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~ 547 (553)
+..... .+.....++..+.+++.+||..+|++||++.++++.|.
T Consensus 213 ~~~~~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 213 IDKEGE------RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HHhcCC------cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 222111 11222357889999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=334.41 Aligned_cols=268 Identities=21% Similarity=0.251 Sum_probs=187.0
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEE--------------EEecCCcCchhHHHHHHHHHHHHHhhcCCCc
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALK--------------VVDLSDITDQSIADSYLNEVELLAKLQGCPY 320 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK--------------~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~ 320 (553)
..+|++++.||+|+||+||++..+..... .+++| ++.+...........+.+|+.+|+++. |||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~-Hpn 224 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEE-AEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLN-HEN 224 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchh-hhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCC-CCC
Confidence 35799999999999999999865432211 11111 111111122234567889999999995 599
Q ss_pred eeEeeeEEEeCCCceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEec
Q psy14267 321 VIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVG 400 (553)
Q Consensus 321 Iv~l~~~~~~~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~ 400 (553)
|+++++++.. ....|+++++.+++|..++...............+..++.||+.||+|||++|||||||||+||||+.
T Consensus 225 Iv~l~~~~~~--~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~ 302 (501)
T PHA03210 225 ILKIEEILRS--EANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNC 302 (501)
T ss_pred cCcEeEEEEE--CCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC
Confidence 9999998754 45678899988889988876543221112223445567789999999999999999999999999977
Q ss_pred CccceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh
Q psy14267 401 NVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY 480 (553)
Q Consensus 401 ~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt 480 (553)
+ +.+||+|||+++.+...... ......||+.|+|||++.+. .++.++|||||||+||||++
T Consensus 303 ~---------~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwSlGvil~ell~ 363 (501)
T PHA03210 303 D---------GKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGD---------GYCEITDIWSCGLILLDMLS 363 (501)
T ss_pred C---------CCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCC---------CCCcHHHHHHHHHHHHHHHH
Confidence 6 57999999999877544322 12246799999999999765 37889999999999999999
Q ss_pred CCCC-CCCCC-chHHHHHHHHhhcc--cccc----------------------cccccCCCCCCHHHHHHHHHhcccCCC
Q psy14267 481 GRTP-YSHIP-NTWAKMLAIARHKD--QIEF----------------------KPQLANNVTIPPTLLQSMKLCLQKDPK 534 (553)
Q Consensus 481 G~~P-f~~~~-~~~~~~~~i~~~~~--~~~~----------------------~~~~~~~~~~s~~l~~li~~cL~~dP~ 534 (553)
|..+ |.... .....+..+..... ...+ .+.+-....++.++.++|.+||+.||+
T Consensus 364 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~ 443 (501)
T PHA03210 364 HDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWH 443 (501)
T ss_pred CCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcc
Confidence 8754 43321 22122222211100 0000 001112234677889999999999999
Q ss_pred CCCCHHHHHHH
Q psy14267 535 ARPTVGNSVTQ 545 (553)
Q Consensus 535 ~RPt~~ell~~ 545 (553)
+|||+.|++.+
T Consensus 444 ~Rpsa~elL~h 454 (501)
T PHA03210 444 LRPGAAELLAL 454 (501)
T ss_pred cCcCHHHHhhC
Confidence 99999999875
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=303.89 Aligned_cols=257 Identities=23% Similarity=0.368 Sum_probs=196.5
Q ss_pred ecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC
Q psy14267 253 LNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA 332 (553)
Q Consensus 253 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~ 332 (553)
+...+|++.++||+|+||.||+|.+..+. .||+|++...... .+.+.+|+++++++. |+||+++++++.
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~---~valK~~~~~~~~----~~~~~~E~~~l~~l~-~~~i~~~~~~~~--- 71 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGTT---RVAIKTLKPGTMS----PEAFLQEAQVMKKLR-HEKLVQLYAVVS--- 71 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCCc---eEEEEecccCccC----HHHHHHHHHHHHhCC-CCCcceEEEEEC---
Confidence 45678999999999999999999765442 3999999764432 256889999999995 699999987652
Q ss_pred CceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCC
Q psy14267 333 SKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGN 411 (553)
Q Consensus 333 ~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~ 411 (553)
....+++|++. +++|.+++...... ...+..+..++.|++.||+|||+.+|+||||||+||+++.+ +
T Consensus 72 ~~~~~lv~e~~~~~~L~~~~~~~~~~---~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~---------~ 139 (262)
T cd05071 72 EEPIYIVTEYMSKGSLLDFLKGEMGK---YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN---------L 139 (262)
T ss_pred CCCcEEEEEcCCCCcHHHHHhhcccc---CCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCC---------C
Confidence 34568899875 56999998764221 23445566677899999999999999999999999999776 5
Q ss_pred eEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCCCc
Q psy14267 412 VLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHIPN 490 (553)
Q Consensus 412 ~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~~~ 490 (553)
.+||+|||+++.+...... ......++..|+|||++.+. .++.++|||||||++|||++ |..||.....
T Consensus 140 ~~~L~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~---------~~~~~~DvwslG~~l~ellt~g~~p~~~~~~ 209 (262)
T cd05071 140 VCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYG---------RFTIKSDVWSFGILLTELTTKGRVPYPGMVN 209 (262)
T ss_pred cEEeccCCceeeccccccc-cccCCcccceecCHhHhccC---------CCCchhhHHHHHHHHHHHHcCCCCCCCCCCh
Confidence 7999999999876543321 11233467789999988655 37889999999999999999 8999987544
Q ss_pred hHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q psy14267 491 TWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNP 550 (553)
Q Consensus 491 ~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~ 550 (553)
. .....+... .. ......++..+.++|.+||+.+|++||+++++++.|++..
T Consensus 210 ~-~~~~~~~~~-~~------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 210 R-EVLDQVERG-YR------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred H-HHHHHHhcC-CC------CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 3 222222111 11 1112357899999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=322.05 Aligned_cols=242 Identities=24% Similarity=0.400 Sum_probs=185.8
Q ss_pred eeeeeeCceEEEEEeeeC-CCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEEEEE
Q psy14267 262 SLLGKGGSSSVYLVGGTS-EHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLM 340 (553)
Q Consensus 262 ~~LG~G~fG~Vy~a~~~~-~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~iv~ 340 (553)
+.||+|+||.||++++.. ....+.||+|++.+..... ....++.+|+++|+++. ||||+++++++. ....+|++|
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~--~~~~~~lv~ 77 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKV-RDRVRTKMERDILAEVN-HPFIVKLHYAFQ--TEGKLYLIL 77 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHhCC-CCCcccEEEEEE--cCCEEEEEE
Confidence 579999999999997743 2234569999998654332 23356788999999995 599999988764 456889999
Q ss_pred ecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEecc
Q psy14267 341 EKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFG 419 (553)
Q Consensus 341 e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFG 419 (553)
|++ +++|.+++.... ......+..++.||+.||+|||++||+||||||+||||+.+ +.+||+|||
T Consensus 78 e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~---------~~~kL~Dfg 143 (318)
T cd05582 78 DFLRGGDLFTRLSKEV-----MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEE---------GHIKLTDFG 143 (318)
T ss_pred cCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCC---------CcEEEeecc
Confidence 975 678988886543 23456667777899999999999999999999999999776 579999999
Q ss_pred CccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHH
Q psy14267 420 IACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIA 499 (553)
Q Consensus 420 la~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~~i~ 499 (553)
+++....... .....+||+.|+|||++.+.. ++.++|||||||++|||++|+.||...... ..+..+.
T Consensus 144 ~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~---------~~~~~DiwslG~il~el~tg~~p~~~~~~~-~~~~~i~ 211 (318)
T cd05582 144 LSKESIDHEK--KAYSFCGTVEYMAPEVVNRRG---------HTQSADWWSFGVLMFEMLTGSLPFQGKDRK-ETMTMIL 211 (318)
T ss_pred CCcccCCCCC--ceecccCChhhcCHHHHcCCC---------CCCccceeccceEeeeeccCCCCCCCCCHH-HHHHHHH
Confidence 9976544322 122567999999999997653 678999999999999999999999864432 2233332
Q ss_pred hhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHH
Q psy14267 500 RHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGN 541 (553)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~e 541 (553)
... .. ....+++.+.++|++||+.||++||++.+
T Consensus 212 ~~~--~~------~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 212 KAK--LG------MPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred cCC--CC------CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 211 11 12257899999999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=306.63 Aligned_cols=258 Identities=21% Similarity=0.353 Sum_probs=194.8
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
.++|++.+.||+|+||.||++++..++. .||+|++..... .....+.+|+.+++++. ||||+.+++++.. ..
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~--~~aik~~~~~~~---~~~~~~~~e~~~l~~~~-h~~ii~~~~~~~~--~~ 79 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGE--LAAVKIIKLEPG---DDFSLIQQEIFMVKECK-HCNIVAYFGSYLS--RE 79 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCe--EEEEEEEecCcc---chHHHHHHHHHHHHhcC-CCCeeeeeEEEEe--CC
Confidence 4579999999999999999998876654 499999975432 22356788999999995 5999999987754 46
Q ss_pred eEEEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 335 HLYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 335 ~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
.++++||+.+ ++|.+++.... ......+..++.|++.||+|||+.||+||||||+||+++.+ +.+
T Consensus 80 ~~~iv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~---------~~~ 145 (267)
T cd06646 80 KLWICMEYCGGGSLQDIYHVTG-----PLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDN---------GDV 145 (267)
T ss_pred EEEEEEeCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCC---------CCE
Confidence 7889999854 68888886543 23455666777899999999999999999999999999766 569
Q ss_pred EEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHH
Q psy14267 414 KIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWA 493 (553)
Q Consensus 414 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~ 493 (553)
||+|||++........ ......|+..|+|||.+...... .++.++|||||||++|||++|..||........
T Consensus 146 ~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~------~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~ 217 (267)
T cd06646 146 KLADFGVAAKITATIA--KRKSFIGTPYWMAPEVAAVEKNG------GYNQLCDIWAVGITAIELAELQPPMFDLHPMRA 217 (267)
T ss_pred EECcCccceeeccccc--ccCccccCccccCHhHcccccCC------CCcchhhHHHHHHHHHHHHhCCCCccccchhhh
Confidence 9999999987643321 12245689999999998543211 367899999999999999999999965432211
Q ss_pred HHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q psy14267 494 KMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQI 546 (553)
Q Consensus 494 ~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L 546 (553)
...+.. ... ..+.+.....++..+.++|++||..+|++||++++|+++|
T Consensus 218 -~~~~~~--~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 218 -LFLMSK--SNF-QPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred -heeeec--CCC-CCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 111111 011 1122222335788999999999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=302.86 Aligned_cols=252 Identities=19% Similarity=0.331 Sum_probs=193.5
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
.++|++.+.||+|+||.||++..... ..+|||.+...... .+.+.+|+.+++++. ||||+++++++. ...
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~---~~~aik~~~~~~~~----~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~ 72 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRGQ---YDVAIKMIKEGSMS----EDEFIEEAKVMMKLS-HEKLVQLYGVCT--KQR 72 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecCC---CcEEEEEcCCCccc----HHHHHHHHHHHhcCC-CCCeeeEEEEEc--cCC
Confidence 45799999999999999999976543 24899998755432 256889999999995 699999998774 345
Q ss_pred eEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 335 HLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 335 ~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
.++++||+. +++|.+++..... ...+..++.++.||+.||+|||+.||+||||||+|||++.+ +.+
T Consensus 73 ~~~lv~e~~~~~~l~~~i~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~---------~~~ 139 (256)
T cd05113 73 PIYIVTEYMSNGCLLNYLREHGK----RFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQ---------GCV 139 (256)
T ss_pred CcEEEEEcCCCCcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCC---------CCE
Confidence 678999975 5689988876432 23456667778899999999999999999999999999776 579
Q ss_pred EEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCCCchH
Q psy14267 414 KIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHIPNTW 492 (553)
Q Consensus 414 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~~~~~ 492 (553)
||+|||+++........ ......++..|+|||.+.+. .++.++|||||||++|||++ |..||......
T Consensus 140 kl~d~g~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~---------~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~- 208 (256)
T cd05113 140 KVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLLYS---------KFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS- 208 (256)
T ss_pred EECCCccceecCCCcee-ecCCCccChhhCCHHHHhcC---------cccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-
Confidence 99999998876543321 11122356789999999754 36789999999999999998 99999875542
Q ss_pred HHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q psy14267 493 AKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQIN 547 (553)
Q Consensus 493 ~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~ 547 (553)
.....+..... . ......+..+++++.+||+.+|++||++.+|+..|+
T Consensus 209 ~~~~~~~~~~~--~-----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 209 ETVEKVSQGLR--L-----YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred HHHHHHhcCCC--C-----CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 22222222111 1 111245789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=300.90 Aligned_cols=250 Identities=22% Similarity=0.386 Sum_probs=188.2
Q ss_pred eeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEEEEEe
Q psy14267 262 SLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLME 341 (553)
Q Consensus 262 ~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~iv~e 341 (553)
+.||+|+||.||+|.+..++. .||+|.+.... .......+.+|+++++++. ||||+++++++.. ...++++||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~--~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e 73 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNT--PVAVKSCRETL--PPDLKAKFLQEARILKQYS-HPNIVRLIGVCTQ--KQPIYIVME 73 (252)
T ss_pred CccCcccCccEEEEEEecCCc--eEEEEecCccC--CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEcC--CCCeEEEEe
Confidence 469999999999998876664 49999876432 2344567899999999995 6999999987743 567889998
Q ss_pred c-CCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEeccC
Q psy14267 342 K-GDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGI 420 (553)
Q Consensus 342 ~-~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGl 420 (553)
+ .+++|.+++..... ...+..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+
T Consensus 74 ~~~~~~L~~~~~~~~~----~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~---------~~~kl~dfg~ 140 (252)
T cd05084 74 LVQGGDFLTFLRTEGP----RLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEK---------NVLKISDFGM 140 (252)
T ss_pred eccCCcHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCC---------CcEEECcccc
Confidence 6 46789988875431 23455566677899999999999999999999999999766 5799999999
Q ss_pred ccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHH
Q psy14267 421 ACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHIPNTWAKMLAIA 499 (553)
Q Consensus 421 a~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~i~ 499 (553)
+................++..|+|||.+.+. .++.++|||||||++|||++ |..||....... ....+.
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~-~~~~~~ 210 (252)
T cd05084 141 SREEEDGVYASTGGMKQIPVKWTAPEALNYG---------RYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ-TREAIE 210 (252)
T ss_pred CcccccccccccCCCCCCceeecCchhhcCC---------CCChHHHHHHHHHHHHHHHhCCCCCccccCHHH-HHHHHH
Confidence 8765432211111112235679999998655 36889999999999999997 999997654432 111111
Q ss_pred hhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q psy14267 500 RHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINN 548 (553)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~ 548 (553)
. .... .....++..+.+++.+||+.+|++||++.++++.|+.
T Consensus 211 ~-~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 211 Q-GVRL------PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred c-CCCC------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 1 1111 1123568899999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=301.41 Aligned_cols=257 Identities=25% Similarity=0.397 Sum_probs=195.3
Q ss_pred EecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeC
Q psy14267 252 TLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDT 331 (553)
Q Consensus 252 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~ 331 (553)
++..++|++.+.||+|+||.||++.+.... .+|+|.+...... .+.+.+|+++++++. |++|+.+++++.
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~---~~~lK~~~~~~~~----~~~~~~E~~~l~~l~-h~~i~~~~~~~~-- 71 (260)
T cd05069 2 EIPRESLRLDVKLGQGCFGEVWMGTWNGTT---KVAIKTLKPGTMM----PEAFLQEAQIMKKLR-HDKLVPLYAVVS-- 71 (260)
T ss_pred cCChHHeeeeeeecCcCCCeEEEEEEcCCc---eEEEEEcccCCcc----HHHHHHHHHHHHhCC-CCCeeeEEEEEc--
Confidence 345678999999999999999999765543 3899988654422 356889999999995 599999987652
Q ss_pred CCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCC
Q psy14267 332 ASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIG 410 (553)
Q Consensus 332 ~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~ 410 (553)
....+++|++. +++|.+++...... ...+..+..++.|++.||+|||+.||+||||||+||+++.+
T Consensus 72 -~~~~~~v~e~~~~~~L~~~~~~~~~~---~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~--------- 138 (260)
T cd05069 72 -EEPIYIVTEFMGKGSLLDFLKEGDGK---YLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDN--------- 138 (260)
T ss_pred -CCCcEEEEEcCCCCCHHHHHhhCCCC---CCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCC---------
Confidence 34567888875 46899998764321 23455566677899999999999999999999999999776
Q ss_pred CeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCCC
Q psy14267 411 NVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHIP 489 (553)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~~ 489 (553)
+.++|+|||++......... ......++..|+|||.+.+. .++.++||||||+++|||++ |..||.+..
T Consensus 139 ~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~---------~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 208 (260)
T cd05069 139 LVCKIADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYG---------RFTIKSDVWSFGILLTELVTKGRVPYPGMV 208 (260)
T ss_pred CeEEECCCccceEccCCccc-ccCCCccchhhCCHHHhccC---------CcChHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 57999999999776443221 11233467789999988654 37889999999999999999 999998754
Q ss_pred chHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 490 NTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 490 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
.. .....+.. .... .....++..+.+++.+||+.||++||+++++++.|++.
T Consensus 209 ~~-~~~~~~~~-~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 260 (260)
T cd05069 209 NR-EVLEQVER-GYRM------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLEDY 260 (260)
T ss_pred HH-HHHHHHHc-CCCC------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 43 22222211 1111 11235788999999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=306.76 Aligned_cols=264 Identities=20% Similarity=0.293 Sum_probs=200.2
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCC---CccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeC
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSE---HEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDT 331 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~---~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~ 331 (553)
..+|.+.+.||+|+||.||+++.... .....+++|.+.... ....+.+.+|+++++++. |+||+++++++.
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~-- 77 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQ-HEHIVKFYGVCG-- 77 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCC-CCCcceEEEEEc--
Confidence 45799999999999999999975432 223458888876443 233467889999999995 599999998774
Q ss_pred CCceEEEEEecC-CCCHHHHHHHcccC-----------CCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEe
Q psy14267 332 ASKHLYVLMEKG-DTDLSKYMRNLNKM-----------TTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFV 399 (553)
Q Consensus 332 ~~~~~~iv~e~~-~~~L~~~l~~~~~~-----------~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~ 399 (553)
.....+++||+. +++|.+++...... ......+..++.++.||+.||+|||++||+||||||+|||++
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~ 157 (291)
T cd05094 78 DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG 157 (291)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEc
Confidence 355788999874 68999999764321 112245566777788999999999999999999999999998
Q ss_pred cCccceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHH
Q psy14267 400 GNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI 479 (553)
Q Consensus 400 ~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ell 479 (553)
.+ +.++|+|||++................++..|+|||.+.+. .++.++|||||||++|||+
T Consensus 158 ~~---------~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~el~ 219 (291)
T cd05094 158 AN---------LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR---------KFTTESDVWSFGVILWEIF 219 (291)
T ss_pred cC---------CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccC---------CCCchhhHHHHHHHHHHHH
Confidence 76 57999999999766543322222344578899999998765 3788999999999999999
Q ss_pred h-CCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q psy14267 480 Y-GRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNP 550 (553)
Q Consensus 480 t-G~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~ 550 (553)
+ |..||....... ....+.. .... .....++..+.+++.+||+.+|++||++.++++.|+++.
T Consensus 220 t~g~~p~~~~~~~~-~~~~~~~-~~~~------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~ 283 (291)
T cd05094 220 TYGKQPWFQLSNTE-VIECITQ-GRVL------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALG 283 (291)
T ss_pred hCCCCCCCCCCHHH-HHHHHhC-CCCC------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 8 999997754432 2222211 1111 112246889999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=302.37 Aligned_cols=252 Identities=22% Similarity=0.402 Sum_probs=192.2
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
..+|++.+.||+|+||.||++.+... ..+|+|++...... ...+.+|+.+++++. |+||+++++++. ...
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~~~---~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~-~~~i~~~~~~~~--~~~ 72 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWRGK---IDVAIKMIREGAMS----EDDFIEEAKVMMKLS-HPNLVQLYGVCT--KQR 72 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEecCC---ccEEEEEeccCCCC----HHHHHHHHHHHHhCC-CCCEEEEEEEEc--CCC
Confidence 35799999999999999999976532 34899998755432 246788999999995 599999988763 456
Q ss_pred eEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 335 HLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 335 ~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
..+++||+. +++|.+++..... ...+..+..++.|++.||+|||+.||+||||||+|||++.+ +.+
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~---------~~~ 139 (256)
T cd05059 73 PIFIVTEYMANGCLLNYLRERKG----KLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGED---------NVV 139 (256)
T ss_pred ceEEEEecCCCCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCC---------CcE
Confidence 788999975 6789998876432 34455666777899999999999999999999999999776 579
Q ss_pred EEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCCCchH
Q psy14267 414 KIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHIPNTW 492 (553)
Q Consensus 414 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~~~~~ 492 (553)
||+|||+++......... .....++..|+|||.+.+. .++.++||||||++||||++ |..||......
T Consensus 140 kl~dfg~~~~~~~~~~~~-~~~~~~~~~y~~Pe~~~~~---------~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~- 208 (256)
T cd05059 140 KVSDFGLARYVLDDQYTS-SQGTKFPVKWAPPEVFDYS---------RFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS- 208 (256)
T ss_pred EECCcccceecccccccc-cCCCCCCccccCHHHhccC---------CCCchhhHHHHHHHHHHHhccCCCCCCCCCHH-
Confidence 999999997664332211 1112245689999999765 36789999999999999998 89999765432
Q ss_pred HHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q psy14267 493 AKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQIN 547 (553)
Q Consensus 493 ~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~ 547 (553)
.....+.. ... ......++.++.+++.+||..+|++|||+.++++.|.
T Consensus 209 ~~~~~~~~-~~~------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 209 EVVESVSA-GYR------LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred HHHHHHHc-CCc------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 22222221 111 1122357899999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=300.58 Aligned_cols=252 Identities=24% Similarity=0.419 Sum_probs=193.2
Q ss_pred ecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC
Q psy14267 253 LNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA 332 (553)
Q Consensus 253 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~ 332 (553)
+..++|++.+.||+|+||.||++.... ..||+|.++... ..+.+.+|+.+++++. |++|+++++++...
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~----~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~- 71 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDYRG----NKVAVKCIKNDA-----TAQAFLAEASVMTQLR-HSNLVQLLGVIVEE- 71 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEEcC----CcEEEEEeCCCc-----hHHHHHHHHHHHHhCC-CCCeeeEEEEEEcC-
Confidence 455689999999999999999986542 348999886432 2467889999999995 59999999876543
Q ss_pred CceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCC
Q psy14267 333 SKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGN 411 (553)
Q Consensus 333 ~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~ 411 (553)
...++++||+. +++|.+++...... ...+..++.++.|++.||+|||++||+||||||+||+++.+ +
T Consensus 72 ~~~~~lv~e~~~~~~L~~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~---------~ 139 (256)
T cd05082 72 KGGLYIVTEYMAKGSLVDYLRSRGRS---VLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSED---------N 139 (256)
T ss_pred CCceEEEEECCCCCcHHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCC---------C
Confidence 45678889875 57999998765432 23345556667799999999999999999999999999776 5
Q ss_pred eEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCCCc
Q psy14267 412 VLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHIPN 490 (553)
Q Consensus 412 ~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~~~ 490 (553)
.+||+|||++........ ...++..|+|||++.+. .++.++|||||||++|||++ |+.||.....
T Consensus 140 ~~kl~dfg~~~~~~~~~~-----~~~~~~~y~aPE~~~~~---------~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~ 205 (256)
T cd05082 140 VAKVSDFGLTKEASSTQD-----TGKLPVKWTAPEALREK---------KFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 205 (256)
T ss_pred cEEecCCccceeccccCC-----CCccceeecCHHHHccC---------CCCchhhhHHHHHHHHHHHhCCCCCCCCCCH
Confidence 799999999876543322 33456789999998755 36889999999999999997 9999976432
Q ss_pred hHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 491 TWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 491 ~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
. .....+. ...... ....+++.+.++|.+||+.+|++|||+.++++.|+++
T Consensus 206 ~-~~~~~~~-~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 206 K-DVVPRVE-KGYKMD------APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred H-HHHHHHh-cCCCCC------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 1 1111221 111111 1236789999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG1187|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=319.99 Aligned_cols=263 Identities=27% Similarity=0.411 Sum_probs=197.0
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
.++|.-..+||+|+||.||++...+. ..||||.+....... ..+|.+|+.+|.+++ |||||.++|||.+...
T Consensus 74 T~~Fs~~~~ig~Ggfg~VYkG~l~~~---~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~-H~Nlv~LlGyC~e~~~- 145 (361)
T KOG1187|consen 74 TNNFSESNLIGEGGFGTVYKGVLSDG---TVVAVKRLSSNSGQG---EREFLNEVEILSRLR-HPNLVKLLGYCLEGGE- 145 (361)
T ss_pred HhCCchhcceecCCCeEEEEEEECCC---CEEEEEEecCCCCcc---hhHHHHHHHHHhcCC-CcCcccEEEEEecCCc-
Confidence 35788889999999999999866554 459999876554321 355999999999996 7999999999976544
Q ss_pred eEEEEEec-CCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCC---cEecCCCCCCEEEecCccceecCCC
Q psy14267 335 HLYVLMEK-GDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAG---IIHSDLKPANFLFVGNVLKIIDCIG 410 (553)
Q Consensus 335 ~~~iv~e~-~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~g---IiHrDLKp~NILl~~~~~~~~~~~~ 410 (553)
..++|+|| ..|+|.+++...... +..|...+.|+.+++.||+|||... ||||||||.|||||.++
T Consensus 146 ~~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~-------- 214 (361)
T KOG1187|consen 146 HRLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDF-------- 214 (361)
T ss_pred eEEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCC--------
Confidence 56677775 558999998875543 5577888888899999999999743 99999999999999884
Q ss_pred CeEEEEeccCccccCCCCCcccccCC-ccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy14267 411 NVLKIIDFGIACSLQDDKTSVHKDTA-SGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIP 489 (553)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~~~~~~~~-~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~ 489 (553)
++||+|||+|+........ ..+. .||..|+|||.+..+ .++.++|||||||+|+||++|+.+.....
T Consensus 215 -~aKlsDFGLa~~~~~~~~~--~~~~~~gt~gY~~PEy~~~g---------~lt~KsDVySFGVvllElitgr~~~d~~~ 282 (361)
T KOG1187|consen 215 -NAKLSDFGLAKLGPEGDTS--VSTTVMGTFGYLAPEYASTG---------KLTEKSDVYSFGVVLLELITGRKAVDQSR 282 (361)
T ss_pred -CEEccCccCcccCCccccc--eeeecCCCCccCChhhhccC---------CcCcccccccchHHHHHHHhCCcccCCCC
Confidence 6999999999655441111 1122 799999999999754 48999999999999999999998887532
Q ss_pred -------chHHHHHHHHhhcccccccccccCCCCCC-----HHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q psy14267 490 -------NTWAKMLAIARHKDQIEFKPQLANNVTIP-----PTLLQSMKLCLQKDPKARPTVGNSVTQINNNP 550 (553)
Q Consensus 490 -------~~~~~~~~i~~~~~~~~~~~~~~~~~~~s-----~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~ 550 (553)
..|. ...+........+++.+.. ...+ ..+..+..+|++.+|++||++.++++.|+.+.
T Consensus 283 ~~~~~~l~~w~-~~~~~~~~~~eiiD~~l~~-~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 283 PRGELSLVEWA-KPLLEEGKLREIVDPRLKE-GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred CcccccHHHHH-HHHHHCcchhheeCCCccC-CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 1222 1112222222234454432 1222 23566777899999999999999999997654
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=304.87 Aligned_cols=259 Identities=18% Similarity=0.281 Sum_probs=194.3
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCcc--ceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEF--KPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA 332 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~--~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~ 332 (553)
.++|++++.||+|+||+||++.+...+.. ..+++|.+... .......++..|+.+++++. ||||+++++++. .
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~-h~~iv~~~~~~~--~ 80 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLD-HAYIVRLLGICP--G 80 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCC-CCCcceEEEEEC--C
Confidence 45799999999999999999987655432 24777777432 22233467788888999985 599999998763 2
Q ss_pred CceEEEEEe-cCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCC
Q psy14267 333 SKHLYVLME-KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGN 411 (553)
Q Consensus 333 ~~~~~iv~e-~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~ 411 (553)
. ..+++++ +.+++|.+++..... ...+..+..++.||+.||+|||+++++||||||+|||++.+ +
T Consensus 81 ~-~~~~i~e~~~~gsL~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~---------~ 146 (279)
T cd05111 81 A-SLQLVTQLSPLGSLLDHVRQHRD----SLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSD---------S 146 (279)
T ss_pred C-ccEEEEEeCCCCcHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCC---------C
Confidence 3 3445555 567899999876432 23455666677899999999999999999999999999776 5
Q ss_pred eEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCCCc
Q psy14267 412 VLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHIPN 490 (553)
Q Consensus 412 ~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~~~ 490 (553)
.+||+|||+++...............++..|+|||.+.+. .++.++|||||||++|||++ |..||.+...
T Consensus 147 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~---------~~~~~~Dv~slG~il~el~t~g~~p~~~~~~ 217 (279)
T cd05111 147 IVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFG---------RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP 217 (279)
T ss_pred cEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccC---------CcCchhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 7999999999876544333233345577899999999755 37889999999999999998 9999987533
Q ss_pred hHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 491 TWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 491 ~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
..+..+....... .....++.++..++.+||..||++||++.|+++.|...
T Consensus 218 --~~~~~~~~~~~~~------~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~ 268 (279)
T cd05111 218 --HEVPDLLEKGERL------AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRM 268 (279)
T ss_pred --HHHHHHHHCCCcC------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 2222222222211 11224678999999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=303.88 Aligned_cols=256 Identities=20% Similarity=0.310 Sum_probs=192.2
Q ss_pred eeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEEEEEe
Q psy14267 262 SLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLME 341 (553)
Q Consensus 262 ~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~iv~e 341 (553)
+.||+|+||.||++....++....+|+|.++... .....+.+.+|++++.++.+||||+++++++.. ...++++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~~~~lv~e 76 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYLYLAIE 76 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec--CCCceEEEE
Confidence 3699999999999988776654457888876432 234456789999999999888999999987743 456788998
Q ss_pred cC-CCCHHHHHHHcccCC-----------CCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCC
Q psy14267 342 KG-DTDLSKYMRNLNKMT-----------TLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCI 409 (553)
Q Consensus 342 ~~-~~~L~~~l~~~~~~~-----------~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~ 409 (553)
+. +++|.+++....... ........+..++.|++.||+|||++|++||||||+|||++.+
T Consensus 77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~-------- 148 (270)
T cd05047 77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN-------- 148 (270)
T ss_pred eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCC--------
Confidence 75 679999987643211 1124456667778899999999999999999999999999776
Q ss_pred CCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCC
Q psy14267 410 GNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHI 488 (553)
Q Consensus 410 ~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~ 488 (553)
+.+||+|||++....... .......+..|+|||++... .++.++|||||||++|||++ |..||...
T Consensus 149 -~~~kl~dfgl~~~~~~~~---~~~~~~~~~~y~apE~~~~~---------~~~~~~Di~slG~il~el~~~g~~pf~~~ 215 (270)
T cd05047 149 -YVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYS---------VYTTNSDVWSYGVLLWEIVSLGGTPYCGM 215 (270)
T ss_pred -CeEEECCCCCccccchhh---hccCCCCccccCChHHHccC---------CCCchhhHHHHHHHHHHHHcCCCCCcccc
Confidence 579999999986432111 11122346679999998654 36889999999999999996 99999764
Q ss_pred CchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q psy14267 489 PNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNP 550 (553)
Q Consensus 489 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~ 550 (553)
... .....+. .... ......++.++.+++.+||..+|.+||++.+++..|+++.
T Consensus 216 ~~~-~~~~~~~-~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 216 TCA-ELYEKLP-QGYR------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CHH-HHHHHHh-CCCC------CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 332 1111111 1111 1122357789999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=310.54 Aligned_cols=263 Identities=23% Similarity=0.399 Sum_probs=196.4
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|...+.||+|+||.||++.+..++. .||+|.+.+.... .....+.+|+.++.++..|+||+++++++.. ...
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~--~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~--~~~ 77 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGT--IMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFR--EGD 77 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCC--EEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEec--CCc
Confidence 357778899999999999998876664 4999998765433 3346789999999999768999999997754 456
Q ss_pred EEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhh-CCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHA-AGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~-~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
.+++|++.+.++..+................+..++.|++.||+|||+ .+|+||||||+|||++.+ +.+|
T Consensus 78 ~~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~---------~~~k 148 (288)
T cd06616 78 CWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRN---------GNIK 148 (288)
T ss_pred EEEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccC---------CcEE
Confidence 788999988877665543221122244556667777899999999997 599999999999999766 5799
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||++..+...... ....|+..|+|||++.+... ..++.++|||||||++|||++|+.||.........
T Consensus 149 l~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~------~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~ 219 (288)
T cd06616 149 LCDFGISGQLVDSIAK---TRDAGCRPYMAPERIDPSAR------DGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQ 219 (288)
T ss_pred EeecchhHHhccCCcc---ccccCccCccCHHHhccccc------cCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHH
Confidence 9999999776543221 23468999999999875420 13788999999999999999999999765432222
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
+..+... ....... .....++.++.+||.+||+.+|++|||+++|+.+
T Consensus 220 ~~~~~~~-~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 220 LTQVVKG-DPPILSN--SEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred HhhhcCC-CCCcCCC--cCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 2222111 1111111 1123578999999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=307.74 Aligned_cols=249 Identities=26% Similarity=0.413 Sum_probs=186.6
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceE
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHL 336 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~ 336 (553)
+|+++++||+|+||.||++.+..++.. ||+|++.+... ....+.+.+|+++++++. ||||+.+++++.. ....
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~--~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~--~~~~ 74 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRI--LAVKVIPLDIT--VELQKQIMSELEILYKCD-SPYIIGFYGAFFV--ENRI 74 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcE--EEEEEEecCCC--hHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEE--CCEE
Confidence 688999999999999999988766644 99999976532 233467899999999995 5999999998755 4567
Q ss_pred EEEEecCCC-CHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 337 YVLMEKGDT-DLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 337 ~iv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
+++||+..+ +|..+ . ......+..++.|++.||+|||+.||+|+||||+|||++.+ +.++|
T Consensus 75 ~lv~e~~~~~~l~~~-~--------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~---------~~~~l 136 (279)
T cd06619 75 SICTEFMDGGSLDVY-R--------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTR---------GQVKL 136 (279)
T ss_pred EEEEecCCCCChHHh-h--------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCC---------CCEEE
Confidence 889997654 44332 1 12234455677899999999999999999999999999776 57999
Q ss_pred EeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH-
Q psy14267 416 IDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK- 494 (553)
Q Consensus 416 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~- 494 (553)
+|||++....... .....|+..|+|||++.+. .++.++|+|||||++|+|++|..||.........
T Consensus 137 ~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~---------~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~ 203 (279)
T cd06619 137 CDFGVSTQLVNSI----AKTYVGTNAYMAPERISGE---------QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL 203 (279)
T ss_pred eeCCcceeccccc----ccCCCCChhhcCceeecCC---------CCCCcchHHHHHHHHHHHHhCCCCchhhccccccc
Confidence 9999997764432 2245789999999999765 3688999999999999999999999753221000
Q ss_pred -HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 495 -MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 495 -~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
............ .+.+ .....+.++.++|.+||+.+|++||++++++++
T Consensus 204 ~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 204 MPLQLLQCIVDED-PPVL-PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred chHHHHHHHhccC-CCCC-CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 001110000000 1111 122467899999999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=298.26 Aligned_cols=252 Identities=29% Similarity=0.487 Sum_probs=197.4
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceE
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHL 336 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~ 336 (553)
+|.+.+.||+|+||.||++....++.. |++|.+....... ...+.+.+|+++++++. ||||+++++++.. ....
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~--~~~k~~~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~ 74 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRV--YAMKQIDLSKMNR-REREEAIDEARVLAKLD-SSYIIRYYESFLD--KGKL 74 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcE--EEEEEeehhhCCH-HHHHHHHHHHHHHHhcC-CCCeehheeeecc--CCEE
Confidence 488999999999999999988766644 9999998765443 34578899999999995 5999999887743 5678
Q ss_pred EEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 337 YVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 337 ~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
+++||+. +++|.+++...... ......++.++.|++.||.|||+.||+||||||+||+++.+ +.++|
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~---------~~~~l 142 (256)
T cd08529 75 NIVMEYAENGDLHKLLKMQRGR---PLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAY---------DNVKI 142 (256)
T ss_pred EEEEEeCCCCcHHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCC---------CCEEE
Confidence 8999965 68999998865222 34455566677799999999999999999999999999876 57999
Q ss_pred EeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHH
Q psy14267 416 IDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKM 495 (553)
Q Consensus 416 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~ 495 (553)
+|||+++........ .....|++.|+|||++.+. .++.++|+|||||++|||++|+.||...... ...
T Consensus 143 ~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~ 210 (256)
T cd08529 143 GDLGVAKLLSDNTNF--ANTIVGTPYYLSPELCEDK---------PYNEKSDVWALGVVLYECCTGKHPFDANNQG-ALI 210 (256)
T ss_pred cccccceeccCccch--hhccccCccccCHHHhcCC---------CCCCccchHHHHHHHHHHHhCCCCCCCCCHH-HHH
Confidence 999999877554321 2345689999999999765 3678999999999999999999999875532 222
Q ss_pred HHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 496 LAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 496 ~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
..+... . ..+ . ...++..+.++|.+||+.+|++||++.+++.+
T Consensus 211 ~~~~~~-~---~~~-~--~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 211 LKIIRG-V---FPP-V--SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred HHHHcC-C---CCC-C--ccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 222111 1 111 1 11577899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=321.43 Aligned_cols=252 Identities=24% Similarity=0.345 Sum_probs=185.9
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
...|++++.||+|+||.||+|.+...+. .||+|+..+. ....|+.+|+++. |+||+++++++.. ..
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~--~valK~~~~~---------~~~~E~~~l~~l~-h~~iv~~~~~~~~--~~ 130 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPD--PVVLKIGQKG---------TTLIEAMLLQNVN-HPSVIRMKDTLVS--GA 130 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCc--eEEEEeCCcc---------ccHHHHHHHHhCC-CCCCcChhheEEe--CC
Confidence 3469999999999999999998876654 4999975432 2356999999995 5999999998754 55
Q ss_pred eEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 335 HLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 335 ~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
..+++|++..++|..++..... ...+..+..++.||+.||.|||++|||||||||+|||++.+ +.+|
T Consensus 131 ~~~lv~e~~~~~l~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~---------~~~k 197 (357)
T PHA03209 131 ITCMVLPHYSSDLYTYLTKRSR----PLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDV---------DQVC 197 (357)
T ss_pred eeEEEEEccCCcHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC---------CCEE
Confidence 7889999988999998876432 34456667777899999999999999999999999999776 5699
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCC-CCCCCCCch--
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGR-TPYSHIPNT-- 491 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~-~Pf~~~~~~-- 491 (553)
|+|||+++....... .....||+.|+|||++.+. .++.++|||||||+||||+++. .+|......
T Consensus 198 l~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~ 265 (357)
T PHA03209 198 IGDLGAAQFPVVAPA---FLGLAGTVETNAPEVLARD---------KYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPE 265 (357)
T ss_pred EecCccccccccCcc---cccccccccccCCeecCCC---------CCCchhhHHHHHHHHHHHHHcCCccccCCCCcHH
Confidence 999999975432221 1245699999999999765 3788999999999999999754 444432211
Q ss_pred ------HHHHHHHHhh-cc-ccccc--------------------c----cccCCCCCCHHHHHHHHHhcccCCCCCCCH
Q psy14267 492 ------WAKMLAIARH-KD-QIEFK--------------------P----QLANNVTIPPTLLQSMKLCLQKDPKARPTV 539 (553)
Q Consensus 492 ------~~~~~~i~~~-~~-~~~~~--------------------~----~~~~~~~~s~~l~~li~~cL~~dP~~RPt~ 539 (553)
...+..+... .. ...+. + .......++.++.+||.+||+.||++|||+
T Consensus 266 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta 345 (357)
T PHA03209 266 EYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSA 345 (357)
T ss_pred HHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCH
Confidence 0111111110 00 00000 0 001123567788899999999999999999
Q ss_pred HHHHHH
Q psy14267 540 GNSVTQ 545 (553)
Q Consensus 540 ~ell~~ 545 (553)
.|+++|
T Consensus 346 ~e~l~h 351 (357)
T PHA03209 346 EEILNY 351 (357)
T ss_pred HHHhcC
Confidence 999875
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=298.98 Aligned_cols=264 Identities=25% Similarity=0.425 Sum_probs=203.2
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|++.+.||+|+||.||+|....++. .||+|.++..........+++.+|+++++++. |++|+.+++++.. ...
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~--~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~-~~~i~~~~~~~~~--~~~ 76 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGR--VVALKKVQIFEMMDAKARQDCLKEIDLLKQLD-HPNVIKYLASFIE--NNE 76 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCC--EEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCeeeeeeeeec--CCe
Confidence 479999999999999999998876554 49999998655555555678999999999995 5999999988754 467
Q ss_pred EEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
.+++||+. +++|..++...... ........+..++.|++.||.|||+.||+||||||+||+++.+ +.++
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~---------~~~~ 146 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHFKKQ-KRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITAT---------GVVK 146 (267)
T ss_pred EEEEEecCCCCCHHHHHHHhccc-CCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCC---------CcEE
Confidence 88999975 57999888764321 1234556677778899999999999999999999999999776 5799
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||++......... .....|++.|+|||.+.+. .++.++|||||||++|+|++|..||.........
T Consensus 147 l~d~~~~~~~~~~~~~--~~~~~~~~~y~apE~~~~~---------~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 215 (267)
T cd08224 147 LGDLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHEN---------GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS 215 (267)
T ss_pred EeccceeeeccCCCcc--cceecCCccccCHHHhccC---------CCCchhcHHHHHHHHHHHHHCCCCcccCCccHHH
Confidence 9999998766443221 2245689999999998755 3688999999999999999999999654322222
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNP 550 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~ 550 (553)
........ ...+.. ...++..+.++|.+||..+|++||++.+|++.|+++.
T Consensus 216 ~~~~~~~~---~~~~~~--~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 216 LCKKIEKC---DYPPLP--ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred HHhhhhcC---CCCCCC--hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 21111111 111111 1256789999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=342.59 Aligned_cols=267 Identities=23% Similarity=0.332 Sum_probs=199.5
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|+++++||+|+||.||+|.+..++.. ||||++...........+++.+|+++++++. ||||+++++++.+ ...
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~--VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~-HPNIVkl~~v~~d--~~~ 76 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRR--VALKKIREDLSENPLLKKRFLREAKIAADLI-HPGIVPVYSICSD--GDP 76 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcE--EEEEEECcccccCHHHHHHHHHHHHHHHhCC-CcCcCeEEEEEee--CCE
Confidence 4799999999999999999988776644 9999997655444455678999999999995 5999999887743 567
Q ss_pred EEEEEecC-CCCHHHHHHHcccCC------CCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecC
Q psy14267 336 LYVLMEKG-DTDLSKYMRNLNKMT------TLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDC 408 (553)
Q Consensus 336 ~~iv~e~~-~~~L~~~l~~~~~~~------~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~ 408 (553)
.+++||++ +++|.+++....... ........++.++.||+.||+|||++|||||||||+|||++.+
T Consensus 77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~d------- 149 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLF------- 149 (932)
T ss_pred EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCC-------
Confidence 88999974 678998887532111 1122344556677899999999999999999999999999776
Q ss_pred CCCeEEEEeccCccccCCCCC----------------cccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHH
Q psy14267 409 IGNVLKIIDFGIACSLQDDKT----------------SVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLG 472 (553)
Q Consensus 409 ~~~~vkL~DFGla~~~~~~~~----------------~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlG 472 (553)
+.+||+|||+++....... .......+||+.|||||++.+. .++.++||||||
T Consensus 150 --g~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~---------~~S~kSDIWSLG 218 (932)
T PRK13184 150 --GEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV---------PASESTDIYALG 218 (932)
T ss_pred --CCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC---------CCCcHhHHHHHH
Confidence 5799999999987621110 0011235699999999999766 368899999999
Q ss_pred HHHHHHHhCCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCC-CHHHHHHHHhcCCC
Q psy14267 473 CILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARP-TVGNSVTQINNNPE 551 (553)
Q Consensus 473 vvl~elltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RP-t~~ell~~L~~~~~ 551 (553)
|++|||++|..||....... .... ..............+++.+.+++.+||..||++|| +++++++.|+++..
T Consensus 219 VILyELLTG~~PF~~~~~~k-i~~~-----~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 219 VILYQMLTLSFPYRRKKGRK-ISYR-----DVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred HHHHHHHHCCCCCCCcchhh-hhhh-----hhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 99999999999997633211 1110 11111111222336789999999999999999996 67777777776543
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=304.54 Aligned_cols=255 Identities=22% Similarity=0.348 Sum_probs=198.3
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
..+|+++++||.|+||.||+|.+.. + +.+|+|++..... .....+.+|+.+++.+. |+||+++++++. ...
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~--~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--~~~ 75 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-R--VRVAIKILKSDDL---LKQQDFQKEVQALKRLR-HKHLISLFAVCS--VGE 75 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-C--CcEEEEeccccch---hhHHHHHHHHHHHhcCC-CcchhheeeeEe--cCC
Confidence 4579999999999999999998776 3 3499999876543 22467889999999995 599999988764 355
Q ss_pred eEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 335 HLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 335 ~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
..+++||++ +++|.+++...... ......+..++.|++.||.|||++||+||||||+||||+.+ +.+
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~---~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~---------~~~ 143 (261)
T cd05148 76 PVYIITELMEKGSLLAFLRSPEGQ---VLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGED---------LVC 143 (261)
T ss_pred CeEEEEeecccCCHHHHHhcCCCC---CCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCC---------ceE
Confidence 788999975 56999998764322 23455566677899999999999999999999999999876 579
Q ss_pred EEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCCCchH
Q psy14267 414 KIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHIPNTW 492 (553)
Q Consensus 414 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~~~~~ 492 (553)
||+|||++......... .....++..|+|||.+.+. .++.++||||||+++|+|++ |..||......
T Consensus 144 kl~d~g~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~---------~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~- 211 (261)
T cd05148 144 KVADFGLARLIKEDVYL--SSDKKIPYKWTAPEAASHG---------TFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH- 211 (261)
T ss_pred EEccccchhhcCCcccc--ccCCCCceEecCHHHHccC---------CCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH-
Confidence 99999999876543221 1133467789999998755 36789999999999999998 89999775432
Q ss_pred HHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 493 AKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 493 ~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
.....+... .. ......++..+.++|.+||+.||++|||+++|++.|+++
T Consensus 212 ~~~~~~~~~-~~------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 212 EVYDQITAG-YR------MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred HHHHHHHhC-Cc------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 222222211 11 122236789999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=326.09 Aligned_cols=255 Identities=25% Similarity=0.397 Sum_probs=215.4
Q ss_pred ecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC
Q psy14267 253 LNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA 332 (553)
Q Consensus 253 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~ 332 (553)
+...+++++..||-|+||.|-++....... .+|+|++++..+.+....+....|..||..++. |+||+++--| .+
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~--~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s-~fIvrLYrTf--rd 491 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQKA--TFALKILKKKHIVDTKQQEHVFSERNIMMECRS-DFIVRLYRTF--RD 491 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecccch--HHHHHHHhHhhccchhHHHHHHhHHHHHHhcCc-hHHHHHHHHh--cc
Confidence 344578888999999999999987665554 489999999988887777889999999999975 9999997655 55
Q ss_pred CceEEEEEe-cCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCC
Q psy14267 333 SKHLYVLME-KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGN 411 (553)
Q Consensus 333 ~~~~~iv~e-~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~ 411 (553)
++++||+|| +.||+|+..++.++.+.. ....+++..+++|++|||++|||+|||||+|+||+.+ |
T Consensus 492 ~kyvYmLmEaClGGElWTiLrdRg~Fdd-----~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~---------G 557 (732)
T KOG0614|consen 492 SKYVYMLMEACLGGELWTILRDRGSFDD-----YTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNR---------G 557 (732)
T ss_pred chhhhhhHHhhcCchhhhhhhhcCCccc-----chhhhhHHHHHHHHHHHHhcCceeccCChhheeeccC---------C
Confidence 889999999 678999999998875443 3344455689999999999999999999999999887 6
Q ss_pred eEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCch
Q psy14267 412 VLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNT 491 (553)
Q Consensus 412 ~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~ 491 (553)
-+||.|||+|+.+..+.. +.++||||.|.|||++..+++ +.++|.||||+++||||+|.+||.+.+..
T Consensus 558 y~KLVDFGFAKki~~g~K---TwTFcGTpEYVAPEIILnKGH---------D~avDyWaLGIli~ELL~G~pPFs~~dpm 625 (732)
T KOG0614|consen 558 YLKLVDFGFAKKIGSGRK---TWTFCGTPEYVAPEIILNKGH---------DRAVDYWALGILIYELLTGSPPFSGVDPM 625 (732)
T ss_pred ceEEeehhhHHHhccCCc---eeeecCCcccccchhhhccCc---------chhhHHHHHHHHHHHHHcCCCCCCCCchH
Confidence 799999999999987765 459999999999999998875 47899999999999999999999986543
Q ss_pred HHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q psy14267 492 WAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT-----VGNSVTQ 545 (553)
Q Consensus 492 ~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt-----~~ell~~ 545 (553)
.....+..+.+.++++. .+++...+||+++-+.+|.+|.. +.+|.+|
T Consensus 626 -ktYn~ILkGid~i~~Pr------~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 626 -KTYNLILKGIDKIEFPR------RITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred -HHHHHHHhhhhhhhccc------ccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 66777788888888775 56789999999999999999986 4555444
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=305.36 Aligned_cols=265 Identities=23% Similarity=0.390 Sum_probs=197.5
Q ss_pred cCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeC--
Q psy14267 254 NGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDT-- 331 (553)
Q Consensus 254 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~-- 331 (553)
..++|++.+.||+|+||.||++.+...+. .+|+|++..... ....+.+|+.+++++..||||+++++++...
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~--~~~ik~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGS--KAAVKILDPIHD----IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCc--eeEEEeeccccc----hHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 34689999999999999999998876654 499998864321 2256778999999997789999999977542
Q ss_pred -CCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCC
Q psy14267 332 -ASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCI 409 (553)
Q Consensus 332 -~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~ 409 (553)
.+...+++||++ +++|.+++...... ........+..++.|++.||.|||+.+|+||||||+||+++.+
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~-------- 160 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFLKR-GERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTE-------- 160 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhhcc-CccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCC--------
Confidence 345789999975 67888887643211 1234455566677899999999999999999999999999776
Q ss_pred CCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy14267 410 GNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIP 489 (553)
Q Consensus 410 ~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~ 489 (553)
+.+||+|||+++....... ......|++.|+|||++...... ...++.++|||||||++|||++|..||....
T Consensus 161 -~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~----~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~ 233 (286)
T cd06638 161 -GGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQL----DSTYDARCDVWSLGITAIELGDGDPPLADLH 233 (286)
T ss_pred -CCEEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhc----cccccchhhhhhHHHHHHHHhcCCCCCCCCc
Confidence 5699999999987654322 12245689999999998643211 1137889999999999999999999997754
Q ss_pred chHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q psy14267 490 NTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQI 546 (553)
Q Consensus 490 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L 546 (553)
.. ..+..+... ..+.......++..+.++|.+||+.||++||++.||++++
T Consensus 234 ~~-~~~~~~~~~-----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 234 PM-RALFKIPRN-----PPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred hh-HHHhhcccc-----CCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 32 111111111 1111222234678999999999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=349.11 Aligned_cols=264 Identities=22% Similarity=0.413 Sum_probs=213.1
Q ss_pred EecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeC
Q psy14267 252 TLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDT 331 (553)
Q Consensus 252 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~ 331 (553)
.+..++|.++++||+|+||.|.+++++.++.. ||+|++.+-.+........|..|-.||..-. .+.|+.++-.| .
T Consensus 71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~V--YAMK~lnK~eMlKr~~tA~F~EERDimv~~n-s~Wiv~LhyAF--Q 145 (1317)
T KOG0612|consen 71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKV--YAMKILNKWEMLKRAETACFREERDIMVFGN-SEWIVQLHYAF--Q 145 (1317)
T ss_pred hCCHHhhHHHHHhcccccceeEEEEeeccccc--hhHHHhhHHHHhhchhHHHHHHHhHHHHcCC-cHHHHHHHHHh--c
Confidence 45567899999999999999999999988865 9999999866554455567888888887764 58999986444 6
Q ss_pred CCceEEEEEec-CCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCC
Q psy14267 332 ASKHLYVLMEK-GDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIG 410 (553)
Q Consensus 332 ~~~~~~iv~e~-~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~ 410 (553)
++.++|+||+| .||||..++.+.. ..++.++.+|+++|+.||+-||+.|+|||||||+|||||..
T Consensus 146 D~~~LYlVMdY~pGGDlltLlSk~~-----~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~--------- 211 (1317)
T KOG0612|consen 146 DERYLYLVMDYMPGGDLLTLLSKFD-----RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKS--------- 211 (1317)
T ss_pred CccceEEEEecccCchHHHHHhhcC-----CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEeccc---------
Confidence 78899999995 7899999988764 35567778888999999999999999999999999999887
Q ss_pred CeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCc
Q psy14267 411 NVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN 490 (553)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~ 490 (553)
|+|||+|||.|..+...+ .+...+.+|||.|++||++...+.+ .+.|+...|+||+||+||||++|..||....
T Consensus 212 GHikLADFGsClkm~~dG-~V~s~~aVGTPDYISPEvLqs~~~~----~g~yG~ecDwWSlGV~~YEMlyG~TPFYads- 285 (1317)
T KOG0612|consen 212 GHIKLADFGSCLKMDADG-TVRSSVAVGTPDYISPEVLQSQGDG----KGEYGRECDWWSLGVFMYEMLYGETPFYADS- 285 (1317)
T ss_pred CcEeeccchhHHhcCCCC-cEEeccccCCCCccCHHHHHhhcCC----ccccCCccchhhhHHHHHHHHcCCCcchHHH-
Confidence 789999999998876544 3455678899999999999866432 2369999999999999999999999997632
Q ss_pred hHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q psy14267 491 TWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT---VGNSVTQ 545 (553)
Q Consensus 491 ~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt---~~ell~~ 545 (553)
-......|..+...+.|+. ...+|.++++||.+.+. +|+.|.. ++++..|
T Consensus 286 lveTY~KIm~hk~~l~FP~----~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 286 LVETYGKIMNHKESLSFPD----ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH 338 (1317)
T ss_pred HHHHHHHHhchhhhcCCCc----ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence 2234445555555555553 23589999999999887 7889987 7777654
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=304.09 Aligned_cols=263 Identities=21% Similarity=0.359 Sum_probs=197.0
Q ss_pred cCcceEEEeeeeeeCceEEEEEeeeC---CCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEe
Q psy14267 254 NGKQYQVLSLLGKGGSSSVYLVGGTS---EHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYD 330 (553)
Q Consensus 254 ~~~~y~i~~~LG~G~fG~Vy~a~~~~---~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~ 330 (553)
+..+|++.++||+|+||.||++.... ......+|+|.+.... ....+.+.+|+++++.+. |+||+++++++.+
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~ 78 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQ-HQHIVRFYGVCTE 78 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC---HHHHHHHHHHHHHHhcCC-CCCCceEEEEEec
Confidence 34678999999999999999986532 2233458999876432 344578899999999994 5999999887644
Q ss_pred CCCceEEEEEec-CCCCHHHHHHHcccC----------CCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEe
Q psy14267 331 TASKHLYVLMEK-GDTDLSKYMRNLNKM----------TTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFV 399 (553)
Q Consensus 331 ~~~~~~~iv~e~-~~~~L~~~l~~~~~~----------~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~ 399 (553)
....+++||+ .+++|.+++...... ......+..+..++.|++.||+|||+.||+||||||+|||++
T Consensus 79 --~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~ 156 (280)
T cd05092 79 --GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVG 156 (280)
T ss_pred --CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEc
Confidence 4567888886 467899998765321 011245566777778999999999999999999999999997
Q ss_pred cCccceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHH
Q psy14267 400 GNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI 479 (553)
Q Consensus 400 ~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ell 479 (553)
.+ +.+||+|||++................+++.|+|||.+.+. .++.++|||||||++|||+
T Consensus 157 ~~---------~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~el~ 218 (280)
T cd05092 157 QG---------LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR---------KFTTESDIWSFGVVLWEIF 218 (280)
T ss_pred CC---------CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccC---------CcCchhhHHHHHHHHHHHH
Confidence 65 57999999999765433221112233457889999998765 3788999999999999999
Q ss_pred h-CCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q psy14267 480 Y-GRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINN 548 (553)
Q Consensus 480 t-G~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~ 548 (553)
+ |.+||...... .....+... .. ......+++.+.++|.+||+.||++||++.+|++.|+.
T Consensus 219 ~~g~~p~~~~~~~-~~~~~~~~~-~~------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 219 TYGKQPWYQLSNT-EAIECITQG-RE------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred cCCCCCCccCCHH-HHHHHHHcC-cc------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 8 99999765432 222222211 11 11223678999999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=298.11 Aligned_cols=253 Identities=22% Similarity=0.355 Sum_probs=193.9
Q ss_pred eeeeeeCceEEEEEeeeCCC-ccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEEEEE
Q psy14267 262 SLLGKGGSSSVYLVGGTSEH-EFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLM 340 (553)
Q Consensus 262 ~~LG~G~fG~Vy~a~~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~iv~ 340 (553)
++||+|+||.||+|...... ....||+|.+...... ...+.+.+|+++++++. |+||+++++++. ....+++|
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~---~~~~~~v~ 74 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLD-HPCIVRLIGVCK---GEPLMLVM 74 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcC-CCCeeeEEEEEc---CCceEEEE
Confidence 47999999999999775554 3356999999766543 34577899999999995 599999998763 33567888
Q ss_pred ec-CCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEecc
Q psy14267 341 EK-GDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFG 419 (553)
Q Consensus 341 e~-~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFG 419 (553)
++ .+++|.+++.... ...+..+..++.|++.||+|||+.+|+||||||+|||++.+ +.+||+|||
T Consensus 75 e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~---------~~~kl~df~ 140 (257)
T cd05060 75 ELAPLGPLLKYLKKRR-----EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNR---------HQAKISDFG 140 (257)
T ss_pred EeCCCCcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCC---------CcEEecccc
Confidence 86 4678999998654 23455667777899999999999999999999999999776 579999999
Q ss_pred CccccCCCCCccc-ccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCCCchHHHHHH
Q psy14267 420 IACSLQDDKTSVH-KDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHIPNTWAKMLA 497 (553)
Q Consensus 420 la~~~~~~~~~~~-~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~ 497 (553)
+++.......... .....++..|+|||.+.+. .++.++|||||||++|||++ |..||...... .....
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~-~~~~~ 210 (257)
T cd05060 141 MSRALGAGSDYYRATTAGRWPLKWYAPECINYG---------KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA-EVIAM 210 (257)
T ss_pred ccceeecCCcccccccCccccccccCHHHhcCC---------CCCccchHHHHHHHHHHHHcCCCCCcccCCHH-HHHHH
Confidence 9987654432211 1112245689999998655 37889999999999999997 99999875442 22222
Q ss_pred HHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q psy14267 498 IARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNPE 551 (553)
Q Consensus 498 i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~~ 551 (553)
+. .... ......++..++++|.+||..+|++||++.++++.|+++.+
T Consensus 211 ~~-~~~~------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~ 257 (257)
T cd05060 211 LE-SGER------LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDPE 257 (257)
T ss_pred HH-cCCc------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhccC
Confidence 22 1111 12233678999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=298.60 Aligned_cols=252 Identities=24% Similarity=0.418 Sum_probs=197.0
Q ss_pred ecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC
Q psy14267 253 LNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA 332 (553)
Q Consensus 253 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~ 332 (553)
+...+|++.+.||.|+||.||++... + +.||||.+..... ..+++.+|+.+++++. |+||+++++++.+
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~~--~--~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~-- 71 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDYR--G--QKVAVKCLKDDST----AAQAFLAEASVMTTLR-HPNLVQLLGVVLQ-- 71 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEec--C--cEEEEEEeccchh----HHHHHHHHHHHHHhcC-CcceeeeEEEEcC--
Confidence 45678999999999999999998654 2 4499999975532 3578899999999995 5999999988754
Q ss_pred CceEEEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCC
Q psy14267 333 SKHLYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGN 411 (553)
Q Consensus 333 ~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~ 411 (553)
....+++||+.. ++|.+++...... ...+..+..++.|++.||.|||+.||+||||||+|||++.+ +
T Consensus 72 ~~~~~~v~e~~~~~~L~~~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~---------~ 139 (256)
T cd05039 72 GNPLYIVTEYMAKGSLVDYLRSRGRA---VITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSED---------L 139 (256)
T ss_pred CCCeEEEEEecCCCcHHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCC---------C
Confidence 567888998755 7999998765422 23456666777899999999999999999999999999776 5
Q ss_pred eEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCCCc
Q psy14267 412 VLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHIPN 490 (553)
Q Consensus 412 ~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~~~ 490 (553)
.+||+|||+++....... ...++..|+|||.+... .++.++||||||+++|||++ |..||.....
T Consensus 140 ~~~l~d~g~~~~~~~~~~-----~~~~~~~~~ape~~~~~---------~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 205 (256)
T cd05039 140 VAKVSDFGLAKEASQGQD-----SGKLPVKWTAPEALREK---------KFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 205 (256)
T ss_pred CEEEcccccccccccccc-----cCCCcccccCchhhcCC---------cCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 799999999987743221 23356789999998654 36789999999999999997 9999987543
Q ss_pred hHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 491 TWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 491 ~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
. .+.......... .....+++.+.++|.+||..+|++||++.++++.|+++
T Consensus 206 ~--~~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 206 K--DVVPHVEKGYRM------EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred H--HHHHHHhcCCCC------CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 2 222211111111 11235789999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=299.81 Aligned_cols=257 Identities=25% Similarity=0.406 Sum_probs=196.1
Q ss_pred EecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeC
Q psy14267 252 TLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDT 331 (553)
Q Consensus 252 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~ 331 (553)
.+..++|++.++||+|+||.||+|..... ..||+|.+...... .+.+.+|+.+++++. |++|+++++++.
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~---~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~-~~~i~~~~~~~~-- 71 (260)
T cd05070 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGN---TKVAVKTLKPGTMS----PESFLEEAQIMKKLR-HDKLVQLYAVVS-- 71 (260)
T ss_pred CCchHHhhhhheeccccCceEEEEEecCC---ceeEEEEecCCCCC----HHHHHHHHHHHHhcC-CCceEEEEeEEC--
Confidence 45567899999999999999999966533 33899999765433 256889999999995 599999988662
Q ss_pred CCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCC
Q psy14267 332 ASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIG 410 (553)
Q Consensus 332 ~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~ 410 (553)
....+++|++. +++|.+++...... ...+..+..++.|++.||+|||+.+|+||||||+||+++.+
T Consensus 72 -~~~~~lv~e~~~~~~L~~~~~~~~~~---~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~--------- 138 (260)
T cd05070 72 -EEPIYIVTEYMSKGSLLDFLKDGEGR---ALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDG--------- 138 (260)
T ss_pred -CCCcEEEEEecCCCcHHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCC---------
Confidence 33467888865 57899988764321 23455667777899999999999999999999999999876
Q ss_pred CeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCCC
Q psy14267 411 NVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHIP 489 (553)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~~ 489 (553)
+.++|+|||++..+...... ......++..|+|||.+.+. .++.++||||||+++|||++ |.+||....
T Consensus 139 ~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~~l~~l~~~g~~p~~~~~ 208 (260)
T cd05070 139 LVCKIADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYG---------RFTIKSDVWSFGILLTELVTKGRVPYPGMN 208 (260)
T ss_pred ceEEeCCceeeeeccCcccc-cccCCCCCccccChHHHhcC---------CCcchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 57999999999876543321 11223456789999998654 47889999999999999999 999997754
Q ss_pred chHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 490 NTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 490 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
.. .....+.. ... .......+..+.+++.+||..+|++|||+.++++.|+++
T Consensus 209 ~~-~~~~~~~~-~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 260 (260)
T cd05070 209 NR-EVLEQVER-GYR------MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLEDY 260 (260)
T ss_pred HH-HHHHHHHc-CCC------CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 32 22222221 111 111235688999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=302.75 Aligned_cols=263 Identities=21% Similarity=0.362 Sum_probs=199.5
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC--
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA-- 332 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~-- 332 (553)
.++|++.+.||+|+||.||+|.+...+. .+++|++..... ..+.+.+|+.+++++..|+||+++++++....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~--~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQ--LVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPP 78 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCc--EEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCC
Confidence 3689999999999999999998876654 499999876542 23678899999999977899999999887643
Q ss_pred --CceEEEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCC
Q psy14267 333 --SKHLYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCI 409 (553)
Q Consensus 333 --~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~ 409 (553)
...++++|+++. ++|.+++...... ........+..++.|++.||.|||+.+++||||+|+||+++.+
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~-------- 149 (275)
T cd06608 79 GNDDQLWLVMELCGGGSVTDLVKGLRKK-GKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKN-------- 149 (275)
T ss_pred CcceEEEEEEEcCCCCcHHHHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccC--------
Confidence 456889999765 5788887654311 1233455566677899999999999999999999999999776
Q ss_pred CCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy14267 410 GNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIP 489 (553)
Q Consensus 410 ~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~ 489 (553)
+.++|+|||++........ ......|+..|+|||++...... ...++.++|||||||+||+|++|..||....
T Consensus 150 -~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~----~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 222 (275)
T cd06608 150 -AEVKLVDFGVSAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQP----DASYDARSDVWSLGITAIELADGKPPLCDMH 222 (275)
T ss_pred -CeEEECCCccceecccchh--hhcCccccccccCHhHhcccccc----cCCccccccHHHhHHHHHHHHhCCCCccccc
Confidence 5799999999876644322 12345689999999998654321 1247889999999999999999999997643
Q ss_pred chHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 490 NTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 490 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
.. .....+.... .+.......++.+++++|.+||..||++|||+.+++++
T Consensus 223 ~~-~~~~~~~~~~-----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 223 PM-RALFKIPRNP-----PPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred hH-HHHHHhhccC-----CCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 32 2222222111 11222223467899999999999999999999999864
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=305.26 Aligned_cols=259 Identities=22% Similarity=0.360 Sum_probs=195.7
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeC----
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDT---- 331 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~---- 331 (553)
..|++.+.||.|+||.||++.+...+. .||+|++.... .....+..|+.+++++.+|+||+++++++...
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~--~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 89 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQ--LAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG 89 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCc--EEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence 579999999999999999998876664 49999986543 22356889999999998889999999987643
Q ss_pred CCceEEEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCC
Q psy14267 332 ASKHLYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIG 410 (553)
Q Consensus 332 ~~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~ 410 (553)
....++++||+++ ++|.+++...... ......+..++.|++.||.|||+.||+||||||+||+++.+
T Consensus 90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~--------- 157 (282)
T cd06636 90 HDDQLWLVMEFCGAGSVTDLVKNTKGN---ALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTEN--------- 157 (282)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHccCC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC---------
Confidence 3467899999765 5888888764322 23345566667799999999999999999999999999766
Q ss_pred CeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCc
Q psy14267 411 NVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN 490 (553)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~ 490 (553)
+.++|+|||++........ ......|++.|+|||++..... ....++.++|||||||++|||++|..||.....
T Consensus 158 ~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~----~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~ 231 (282)
T cd06636 158 AEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDEN----PDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP 231 (282)
T ss_pred CCEEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccC----cCcCCCcccchhHHHHHHHHHHhCCCCccccCH
Confidence 5699999999876543221 1235668999999999864321 111478899999999999999999999976443
Q ss_pred hHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 491 TWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 491 ~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
.... ..+... .. + ......++..+.++|.+||..||++||++.||+++
T Consensus 232 ~~~~-~~~~~~-~~----~-~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 232 MRAL-FLIPRN-PP----P-KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred Hhhh-hhHhhC-CC----C-CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 2111 111111 00 1 01122578999999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0584|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=327.87 Aligned_cols=252 Identities=23% Similarity=0.349 Sum_probs=205.6
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcC-chhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDIT-DQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~-~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
-.+...+||+|+|-+||+|.+...+-. ||--.++..++. .....++|..|+.+|+.|.| |||++++++|.+...+.
T Consensus 41 y~k~~evLGrGafKtVYka~De~~giE--VAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H-~NIirfy~SW~d~~n~~ 117 (632)
T KOG0584|consen 41 YLKFDEVLGRGAFKTVYKAFDEEEGIE--VAWNQVKIRDVTQSPEELERLYSEVHLLKSLKH-PNIIRFYDSWVDTDNKT 117 (632)
T ss_pred eeehhhhcccccceeeeeccccccchh--hHHHHHhHHHhhcChHHHHHHHHHHHHHccCCC-CceeeeeeheecCCCce
Confidence 345667899999999999988665533 665555444333 34556899999999999965 99999999999988888
Q ss_pred EEEEEe-cCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhC--CcEecCCCCCCEEEecCccceecCCCCe
Q psy14267 336 LYVLME-KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAA--GIIHSDLKPANFLFVGNVLKIIDCIGNV 412 (553)
Q Consensus 336 ~~iv~e-~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~--gIiHrDLKp~NILl~~~~~~~~~~~~~~ 412 (553)
+.++.| +-.|+|..|+++..+.. ...+..|++||+.||.|||++ .|||||||.+||||+.+. |.
T Consensus 118 in~iTEL~TSGtLr~Y~kk~~~vn-----~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~--------G~ 184 (632)
T KOG0584|consen 118 INFITELFTSGTLREYRKKHRRVN-----IKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNL--------GE 184 (632)
T ss_pred eeeeeecccCCcHHHHHHHhccCC-----HHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCc--------Cc
Confidence 888888 46799999999887543 457788889999999999976 599999999999998875 78
Q ss_pred EEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchH
Q psy14267 413 LKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTW 492 (553)
Q Consensus 413 vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~ 492 (553)
|||+|.|||+....... ....|||.|||||+.... |+..+||||||++|+||+|+..||..-.+..
T Consensus 185 VKIGDLGLAtl~r~s~a----ksvIGTPEFMAPEmYEE~----------YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~A 250 (632)
T KOG0584|consen 185 VKIGDLGLATLLRKSHA----KSVIGTPEFMAPEMYEEN----------YNELVDVYAFGMCMLEMVTSEYPYSECTNPA 250 (632)
T ss_pred eeecchhHHHHhhcccc----ceeccCccccChHHHhhh----------cchhhhhhhhhHHHHHHHhccCChhhhCCHH
Confidence 99999999988765432 256799999999999744 8999999999999999999999999877776
Q ss_pred HHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 493 AKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 493 ~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
+....+..+.....+.- --.+++++||.+||.. .++|||+.|||.+
T Consensus 251 QIYKKV~SGiKP~sl~k------V~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 251 QIYKKVTSGIKPAALSK------VKDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred HHHHHHHcCCCHHHhhc------cCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 77777766554322221 1258999999999999 9999999999874
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=301.47 Aligned_cols=255 Identities=25% Similarity=0.357 Sum_probs=193.7
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcC--chhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDIT--DQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~--~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
+|++.+.||+|+||.||+|.+..++. .||+|++...... .......+.+|+.+++++. ||||+.+++++......
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~--~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 79 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGR--ELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ-HERIVQYYGCLRDRAEK 79 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCc--EEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcC-CCCeeeEEEEEEcCCCC
Confidence 68999999999999999998877664 4999998765422 2234567889999999995 69999999987766667
Q ss_pred eEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 335 HLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 335 ~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
.++++||+. +++|.+++..... .....+..++.|++.||+|||+.+|+||||||+||+++.+ +.+
T Consensus 80 ~~~l~~e~~~~~~L~~~l~~~~~-----l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~---------~~~ 145 (266)
T cd06651 80 TLTIFMEYMPGGSVKDQLKAYGA-----LTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSA---------GNV 145 (266)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCC---------CCE
Confidence 888999975 5689888876432 2344455667899999999999999999999999999776 569
Q ss_pred EEEeccCccccCCCCC-cccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchH
Q psy14267 414 KIIDFGIACSLQDDKT-SVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTW 492 (553)
Q Consensus 414 kL~DFGla~~~~~~~~-~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~ 492 (553)
||+|||++........ ........++..|+|||.+.+. .++.++|||||||++|||++|+.||......
T Consensus 146 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~- 215 (266)
T cd06651 146 KLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGE---------GYGRKADVWSLGCTVVEMLTEKPPWAEYEAM- 215 (266)
T ss_pred EEccCCCccccccccccCCccccCCccccccCHHHhCCC---------CCCchhhhHHHHHHHHHHHHCCCCccccchH-
Confidence 9999999976543211 1112235589999999999765 3688999999999999999999999875433
Q ss_pred HHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 493 AKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 493 ~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
............ +.. ...+++.++++| .||..+|++||+++||+++
T Consensus 216 ~~~~~~~~~~~~----~~~--~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 216 AAIFKIATQPTN----PQL--PSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred HHHHHHhcCCCC----CCC--chhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 222222211111 111 224678899999 6888899999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG1006|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=306.21 Aligned_cols=271 Identities=23% Similarity=0.361 Sum_probs=214.0
Q ss_pred ccceEEecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeee
Q psy14267 247 SQDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHD 326 (553)
Q Consensus 247 ~~~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~ 326 (553)
....+++..++.+-+..||.|+||+|++..++.++.. .|||.+..... +...++++.|..+.++-..+|+||+++|
T Consensus 55 ~~~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~--mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyG 130 (361)
T KOG1006|consen 55 DAHLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKL--MAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYG 130 (361)
T ss_pred cccccccccchHHHHHHhcCCcchhhhhhhcCccCcE--EEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhh
Confidence 3445666667788888999999999999988888755 99999987654 3345889999999999999999999999
Q ss_pred EEEeCCCceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHh-hCCcEecCCCCCCEEEecCccce
Q psy14267 327 YVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIH-AAGIIHSDLKPANFLFVGNVLKI 405 (553)
Q Consensus 327 ~~~~~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH-~~gIiHrDLKp~NILl~~~~~~~ 405 (553)
..+.+ ...+|.||..+.+|..+-............+..+-.+..-.+.||+||- +..||||||||+||||+..
T Consensus 131 a~F~E--GdcWiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~---- 204 (361)
T KOG1006|consen 131 ALFSE--GDCWICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRH---- 204 (361)
T ss_pred hhhcC--CceeeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecC----
Confidence 87664 4578899999988877655443333334444555555557889999998 5689999999999999877
Q ss_pred ecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCC
Q psy14267 406 IDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY 485 (553)
Q Consensus 406 ~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf 485 (553)
|.|||||||++..+.+.- ..+.-.|...|||||.+..... -|+.+||+||||++|||+.||..||
T Consensus 205 -----G~vKLCDFGIcGqLv~Si---AkT~daGCrpYmAPERi~p~~~-------gyDiRSDvWSLGITL~EvAtG~fPy 269 (361)
T KOG1006|consen 205 -----GDVKLCDFGICGQLVDSI---AKTVDAGCRPYMAPERIDPSDK-------GYDIRSDVWSLGITLYEVATGNFPY 269 (361)
T ss_pred -----CCEeeecccchHhHHHHH---HhhhccCCccccChhccCCccC-------CcchhhhhhhhcceEeeeecCCCCc
Confidence 679999999997765432 2335568999999999975431 2789999999999999999999999
Q ss_pred CCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy14267 486 SHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVT 544 (553)
Q Consensus 486 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~ 544 (553)
..+.+.++.+.++..+...+...+ ....+++..+..+|..||.+|-..||.+.+|++
T Consensus 270 r~w~svfeql~~Vv~gdpp~l~~~--~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 270 RKWDSVFEQLCQVVIGDPPILLFD--KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred chHHHHHHHHHHHHcCCCCeecCc--ccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 998888777777766554433222 233468899999999999999999999999875
|
|
| >KOG4645|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=355.63 Aligned_cols=256 Identities=26% Similarity=0.464 Sum_probs=209.7
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceE
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHL 336 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~ 336 (553)
+|.....||.|.||.||-|.+.++++. .|+|-++..... ........+|..+|..++| ||+|+++++- -+...+
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGel--lAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnH-pNlV~YyGVE--vHRekv 1309 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGEL--LAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNH-PNLVRYYGVE--VHREKV 1309 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccch--hhhhhhhcCccc-cccCcchHHHHHHHHhccC-ccccccCcee--ecHHHH
Confidence 688889999999999999999888877 999999877655 4556788999999999965 9999997654 567788
Q ss_pred EEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 337 YVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 337 ~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
+|.||||. |+|.++++..... .+.....+-.|++.|++|||+.|||||||||+||||+.+ |.+|+
T Consensus 1310 ~IFMEyC~~GsLa~ll~~gri~-----dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~---------g~iK~ 1375 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHGRIE-----DEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFN---------GLIKY 1375 (1509)
T ss_pred HHHHHHhccCcHHHHHHhcchh-----hhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecC---------CcEEe
Confidence 99999764 6788887765432 223333344699999999999999999999999999877 68999
Q ss_pred EeccCccccCCCCCcc--cccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHH
Q psy14267 416 IDFGIACSLQDDKTSV--HKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWA 493 (553)
Q Consensus 416 ~DFGla~~~~~~~~~~--~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~ 493 (553)
+|||.|..+....... .....+||+.|||||++.+...+| -..+.||||||||.+||+||+.||.+.++.|+
T Consensus 1376 ~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG------~~~A~DiWslGCVVlEM~tGkrPW~~~dne~a 1449 (1509)
T KOG4645|consen 1376 GDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKG------HGGAADIWSLGCVVLEMATGKRPWAELDNEWA 1449 (1509)
T ss_pred ecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCC------CCcchhhhcccceEEEeecCCCchhhccchhH
Confidence 9999998877653221 223667999999999998765443 24689999999999999999999999999999
Q ss_pred HHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 494 KMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 494 ~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
.|..+..+.. |+++. .++.+-+++|.+||..||++|.++.||+++
T Consensus 1450 IMy~V~~gh~-----Pq~P~--~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1450 IMYHVAAGHK-----PQIPE--RLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred HHhHHhccCC-----CCCch--hhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 9998875532 22222 378999999999999999999999988875
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=309.00 Aligned_cols=263 Identities=25% Similarity=0.375 Sum_probs=199.0
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
.++|++.+.||+|+||.||++.+..++.. ||+|+++...... .....+.+|+.++++++ |+||+++++++.+....
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~--vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~ 81 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEI--VALKKVRMDNERD-GIPISSLREITLLLNLR-HPNIVELKEVVVGKHLD 81 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcE--EEEEEEEeccCCC-CCcchhhHHHHHHHhCC-CCCCcceEEEEecCCCC
Confidence 35799999999999999999988766644 9999997654332 22245678999999996 59999999988776667
Q ss_pred eEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 335 HLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 335 ~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
.++++||+++++|.+++..... ......+..++.||+.||+|||+.||+||||||+||+++.+ +.+|
T Consensus 82 ~~~lv~e~~~~~l~~~l~~~~~----~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~---------~~~k 148 (309)
T cd07845 82 SIFLVMEYCEQDLASLLDNMPT----PFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDK---------GCLK 148 (309)
T ss_pred eEEEEEecCCCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC---------CCEE
Confidence 7899999999999988876432 34556667778899999999999999999999999999766 5799
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||++......... .....+++.|+|||.+.+.. .++.++|||||||++|||++|..||...... ..
T Consensus 149 L~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~--------~~~~~~DvwslG~il~el~~g~~~f~~~~~~-~~ 217 (309)
T cd07845 149 IADFGLARTYGLPAKP--MTPKVVTLWYRAPELLLGCT--------TYTTAIDMWAVGCILAELLAHKPLLPGKSEI-EQ 217 (309)
T ss_pred ECccceeeecCCccCC--CCcccccccccChhhhcCCC--------CcCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HH
Confidence 9999999877543221 11234688899999986532 3678999999999999999999999875433 22
Q ss_pred HHHHHhhccc-----------------cccccc----cc-CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 495 MLAIARHKDQ-----------------IEFKPQ----LA-NNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 495 ~~~i~~~~~~-----------------~~~~~~----~~-~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
...+...... ...... +. .....++.+.++|.+||..||++|||+.+++.+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 218 LDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred HHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 2222221100 000000 00 011257889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=306.19 Aligned_cols=264 Identities=19% Similarity=0.278 Sum_probs=197.0
Q ss_pred CcceEEEeeeeeeCceEEEEEeee--CCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGT--SEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA 332 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~--~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~ 332 (553)
.+-|++++.||+|+||.||+|... .....+.||+|.++... .......+.+|+++++++. ||||+++.+++....
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 79 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLY-HENIVKYKGICTEDG 79 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEecCC
Confidence 345899999999999999998743 12233569999986543 2334567899999999995 599999999887655
Q ss_pred CceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCC
Q psy14267 333 SKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGN 411 (553)
Q Consensus 333 ~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~ 411 (553)
....+++||+. +++|.+++..... ...+..+..++.|++.||+|||++||+||||||+|||++.+ +
T Consensus 80 ~~~~~lv~e~~~g~~L~~~l~~~~~----~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~---------~ 146 (284)
T cd05079 80 GNGIKLIMEFLPSGSLKEYLPRNKN----KINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESE---------H 146 (284)
T ss_pred CCceEEEEEccCCCCHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCC---------C
Confidence 66788999976 6889998865432 23445556677899999999999999999999999999766 5
Q ss_pred eEEEEeccCccccCCCCCc-ccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCc
Q psy14267 412 VLKIIDFGIACSLQDDKTS-VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN 490 (553)
Q Consensus 412 ~vkL~DFGla~~~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~ 490 (553)
.++|+|||+++.+...... .......++..|+|||.+.+. .++.++|||||||++|||+++..|+.....
T Consensus 147 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~---------~~~~~~Di~slG~il~ellt~~~~~~~~~~ 217 (284)
T cd05079 147 QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQS---------KFYIASDVWSFGVTLYELLTYCDSESSPMT 217 (284)
T ss_pred CEEECCCccccccccCccceeecCCCCCCccccCHHHhccC---------CCCccccchhhhhhhhhhhcCCCCCccccc
Confidence 7999999999876543321 112245577889999998654 368899999999999999998776532111
Q ss_pred h-------------HHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 491 T-------------WAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 491 ~-------------~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
. ........... ........++..+.+||.+||+.+|++||+++++++.|+++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 218 LFLKMIGPTHGQMTVTRLVRVLEEG------KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred hhhhhcccccccccHHHHHHHHHcC------ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0 00000111000 11122346789999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=298.40 Aligned_cols=251 Identities=27% Similarity=0.414 Sum_probs=193.8
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceE
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHL 336 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~ 336 (553)
+|++.+.||+|+||.||++.+..++. .||+|.++.... ....+.+.+|+.+++.+. |+||+.+++.+. ....+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~--~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~ 73 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQ--KYAMKEIRLPKS--SSAVEDSRKEAVLLAKMK-HPNIVAFKESFE--ADGHL 73 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCc--eEEEEEEEcCcc--hHHHHHHHHHHHHHHhCC-CCCcceEEEEEE--ECCEE
Confidence 48899999999999999998877664 499999875432 233577889999999995 599999998774 45688
Q ss_pred EEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 337 YVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 337 ~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
+++|++. +++|.+++...... ......+..++.|++.||.|||++||+|+||||+||+++.+ +.++|
T Consensus 74 ~lv~e~~~~~~l~~~~~~~~~~---~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~---------~~~~l 141 (255)
T cd08219 74 YIVMEYCDGGDLMQKIKLQRGK---LFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQN---------GKVKL 141 (255)
T ss_pred EEEEeeCCCCcHHHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCC---------CcEEE
Confidence 9999976 57888887653221 23455566677899999999999999999999999999766 57999
Q ss_pred EeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHH
Q psy14267 416 IDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKM 495 (553)
Q Consensus 416 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~ 495 (553)
+|||++........ ......|++.|+|||++.+. .++.++|+||||+++|+|++|..||...... ...
T Consensus 142 ~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~---------~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-~~~ 209 (255)
T cd08219 142 GDFGSARLLTSPGA--YACTYVGTPYYVPPEIWENM---------PYNNKSDIWSLGCILYELCTLKHPFQANSWK-NLI 209 (255)
T ss_pred cccCcceeeccccc--ccccccCCccccCHHHHccC---------CcCchhhhhhhchhheehhhccCCCCCCCHH-HHH
Confidence 99999977654332 12245689999999998765 3688999999999999999999999864322 112
Q ss_pred HHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 496 LAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 496 ~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
..+.. ..... ....++..+.++|.+||+.||++||++.+|+..
T Consensus 210 ~~~~~-~~~~~------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 210 LKVCQ-GSYKP------LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHhc-CCCCC------CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 22211 11111 112567899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=298.97 Aligned_cols=257 Identities=23% Similarity=0.402 Sum_probs=196.5
Q ss_pred EEecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEe
Q psy14267 251 ITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYD 330 (553)
Q Consensus 251 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~ 330 (553)
|++..++|++.+.||+|+||.||++..... ..+|+|.+.... ...+.+.+|+++++++. |+||+++++++..
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~---~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~ 72 (260)
T cd05073 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKH---TKVAVKTMKPGS----MSVEAFLAEANVMKTLQ-HDKLVKLHAVVTK 72 (260)
T ss_pred CcccccceeEEeEecCccceEEEEEEecCC---ccEEEEecCCCh----hHHHHHHHHHHHHHhcC-CCCcceEEEEEcC
Confidence 456678999999999999999999965433 238999886543 22467889999999995 6999999887643
Q ss_pred CCCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCC
Q psy14267 331 TASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCI 409 (553)
Q Consensus 331 ~~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~ 409 (553)
...+++||+. +++|.+++...... ...+..+..++.|++.||+|||+.|++||||||+||+++.+
T Consensus 73 ---~~~~~v~e~~~~~~L~~~~~~~~~~---~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~-------- 138 (260)
T cd05073 73 ---EPIYIITEFMAKGSLLDFLKSDEGS---KQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSAS-------- 138 (260)
T ss_pred ---CCeEEEEEeCCCCcHHHHHHhCCcc---ccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCC--------
Confidence 5678889876 57999998764322 23344556667799999999999999999999999999766
Q ss_pred CCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCC
Q psy14267 410 GNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHI 488 (553)
Q Consensus 410 ~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~ 488 (553)
+.+||+|||++......... ......++..|+|||++... .++.++|+|||||++|++++ |..||...
T Consensus 139 -~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~---------~~~~~~Di~slG~~l~~l~t~g~~p~~~~ 207 (260)
T cd05073 139 -LVCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFG---------SFTIKSDVWSFGILLMEIVTYGRIPYPGM 207 (260)
T ss_pred -CcEEECCCcceeeccCCCcc-cccCCcccccccCHhHhccC---------CcCccccchHHHHHHHHHHhcCCCCCCCC
Confidence 67999999999876543221 11223456789999999754 36889999999999999998 99999875
Q ss_pred CchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q psy14267 489 PNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINN 548 (553)
Q Consensus 489 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~ 548 (553)
... .....+. .... .......+.++.+++.+||+.+|++||++.++++.|++
T Consensus 208 ~~~-~~~~~~~-~~~~------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 208 SNP-EVIRALE-RGYR------MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CHH-HHHHHHh-CCCC------CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 432 1122221 1111 11223678899999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=296.94 Aligned_cols=256 Identities=29% Similarity=0.452 Sum_probs=200.8
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceE
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHL 336 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~ 336 (553)
+|++.+.||.|+||.||+|.+..++. .||+|++....... ...+++..|+++++++. |+||+++++++.......+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~--~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~ 76 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGK--ILVWKEIDYGNMTE-KEKQQLVSEVNILRELK-HPNIVRYYDRIIDRSNQTL 76 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCC--EEEEEEEecccCCH-HHHHHHHHHHHHHHhcC-CCccceeeeeeecCCCCEE
Confidence 48899999999999999998877664 49999998765443 44578899999999995 5999999998877667788
Q ss_pred EEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHh-----hCCcEecCCCCCCEEEecCccceecCCC
Q psy14267 337 YVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIH-----AAGIIHSDLKPANFLFVGNVLKIIDCIG 410 (553)
Q Consensus 337 ~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH-----~~gIiHrDLKp~NILl~~~~~~~~~~~~ 410 (553)
+++||++ +++|.+++...... .....+..++.++.||+.||+||| +.+|+||||||+||+++.+
T Consensus 77 ~~~~e~~~~~~L~~~l~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~--------- 146 (265)
T cd08217 77 YIVMEYCEGGDLAQLIQKCKKE-RKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDAN--------- 146 (265)
T ss_pred EEEehhccCCCHHHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecC---------
Confidence 9999975 57899888764221 123445666777789999999999 9999999999999999876
Q ss_pred CeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCc
Q psy14267 411 NVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN 490 (553)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~ 490 (553)
+.+||+|||++......... .....|++.|+|||++.+. .++.++|+||||+++|+|++|..||.....
T Consensus 147 ~~~kl~d~g~~~~~~~~~~~--~~~~~~~~~~~~pE~~~~~---------~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 215 (265)
T cd08217 147 NNVKLGDFGLAKILGHDSSF--AKTYVGTPYYMSPEQLNHM---------SYDEKSDIWSLGCLIYELCALSPPFTARNQ 215 (265)
T ss_pred CCEEEecccccccccCCccc--ccccccCCCccChhhhcCC---------CCCchhHHHHHHHHHHHHHHCCCcccCcCH
Confidence 67999999999877554321 2245689999999998765 367899999999999999999999987542
Q ss_pred hHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 491 TWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 491 ~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
..+........... ....++..+.+++.+||..+|++||++.+|+++
T Consensus 216 --~~~~~~~~~~~~~~------~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 216 --LQLASKIKEGKFRR------IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred --HHHHHHHhcCCCCC------CccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 22222221111111 122567899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=302.14 Aligned_cols=260 Identities=23% Similarity=0.349 Sum_probs=191.9
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
.+|++++.||+|+||.||++.+..++. .||+|++....... ....+.+|+.+|+.+. |+||+++++++. ....
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~--~~~iK~~~~~~~~~--~~~~~~~e~~~l~~l~-h~ni~~~~~~~~--~~~~ 77 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQ--LVALKVISMKTEEG--VPFTAIREASLLKGLK-HANIVLLHDIIH--TKET 77 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCc--EEEEEEecccCcCC--CcHHHHHHHHHHHhcC-CCCEeEEEEEEe--cCCe
Confidence 579999999999999999998876664 49999997654222 2245678999999995 599999999874 3567
Q ss_pred EEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 336 LYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 336 ~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
.+++||+.+++|..++...... .....+..++.|++.||+|||+.||+||||||+|||++.+ +.+||
T Consensus 78 ~~lv~e~~~~~l~~~~~~~~~~----~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~---------~~~~l 144 (291)
T cd07870 78 LTFVFEYMHTDLAQYMIQHPGG----LHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYL---------GELKL 144 (291)
T ss_pred EEEEEecccCCHHHHHHhCCCC----CCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCC---------CcEEE
Confidence 8999999889998887654321 2233445566799999999999999999999999999766 57999
Q ss_pred EeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHH
Q psy14267 416 IDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKM 495 (553)
Q Consensus 416 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~ 495 (553)
+|||+++........ .....+++.|+|||.+.+.. .++.++|||||||++|||++|..||.........+
T Consensus 145 ~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~--------~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~ 214 (291)
T cd07870 145 ADFGLARAKSIPSQT--YSSEVVTLWYRPPDVLLGAT--------DYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQL 214 (291)
T ss_pred eccccccccCCCCCC--CCCccccccccCCceeecCC--------CCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHH
Confidence 999998765432221 22445789999999987532 25788999999999999999999998755432332
Q ss_pred HHHHhhccc----------------ccc-----cc---cccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 496 LAIARHKDQ----------------IEF-----KP---QLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 496 ~~i~~~~~~----------------~~~-----~~---~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
..+...... ..+ .. ........+..+.++|.+||..||++|||+.+++.+
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 215 EKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred HHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 222110000 000 00 000111236789999999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=304.52 Aligned_cols=248 Identities=24% Similarity=0.374 Sum_probs=197.2
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|++.+.||+|+||.||++.+...+. .||+|++.+.........+.+.+|+++|+++. ||||+++++++. ....
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~--~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~ 75 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGK--YYALKILSKAKIVKLKQVEHVLNEKRILQSIR-HPFLVNLYGSFQ--DDSN 75 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCC--EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCccceeeEEE--cCCe
Confidence 369999999999999999998876654 49999998765555555678999999999996 699999998774 3567
Q ss_pred EEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
++++||++ +++|.+++.... ......+..++.|++.||+|||+.||+||||+|+||||+.+ +.+|
T Consensus 76 ~~~v~e~~~~~~L~~~~~~~~-----~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~---------~~~k 141 (290)
T cd05580 76 LYLVMEYVPGGELFSHLRKSG-----RFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSD---------GYIK 141 (290)
T ss_pred EEEEEecCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCC---------CCEE
Confidence 89999987 789999987753 23345566667799999999999999999999999999776 5799
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||++...... ....+|++.|+|||.+.+. .++.++||||||+++|+|++|..||...... ..
T Consensus 142 l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~ 206 (290)
T cd05580 142 ITDFGFAKRVKGR-----TYTLCGTPEYLAPEIILSK---------GYGKAVDWWALGILIYEMLAGYPPFFDDNPI-QI 206 (290)
T ss_pred EeeCCCccccCCC-----CCCCCCCccccChhhhcCC---------CCCccccHHHHHHHHHHHHhCCCCCCCCCHH-HH
Confidence 9999999876544 2245789999999998755 3678899999999999999999999775422 22
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARP-----TVGNSVTQ 545 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RP-----t~~ell~~ 545 (553)
...+.. ....+ ...++..++++|.+||..||.+|+ +++|++++
T Consensus 207 ~~~~~~--~~~~~------~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 207 YEKILE--GKVRF------PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred HHHHhc--CCccC------CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 222221 11111 124578999999999999999999 77777654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=306.13 Aligned_cols=250 Identities=24% Similarity=0.393 Sum_probs=194.2
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
.+|++.+.||+|+||.||++.+...+. .||+|.+....... .+.+.+|+.+++.+ .|+||+++++++.. ..+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~--~v~ik~~~~~~~~~---~~~~~~e~~~l~~~-~h~~v~~~~~~~~~--~~~ 91 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQ--EVAIRQMNLQQQPK---KELIINEILVMREN-KNPNIVNYLDSYLV--GDE 91 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCc--EEEEEEEecCCcch---HHHHHHHHHHHHhC-CCCCEeeEEEEEEe--CCE
Confidence 579999999999999999998766654 49999997655332 36788999999998 45999999988754 557
Q ss_pred EEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
.+++||+. +++|.+++... ......+..++.|++.||+|||+.||+||||||+|||++.+ +.++
T Consensus 92 ~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~---------~~~k 156 (296)
T cd06654 92 LWVVMEYLAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD---------GSVK 156 (296)
T ss_pred EEEeecccCCCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCC---------CCEE
Confidence 89999975 57898888643 13345566777899999999999999999999999999766 5799
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||++......... .....|++.|+|||.+.+. .++.++|||||||++|+|++|+.||.........
T Consensus 157 l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~---------~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~ 225 (296)
T cd06654 157 LTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRK---------AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL 225 (296)
T ss_pred ECccccchhccccccc--cCcccCCccccCHHHHcCC---------CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH
Confidence 9999998766443221 1245689999999998754 3678999999999999999999999765432221
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
.. +.... .+.+.....++..+.++|.+||..+|++||++.+++.+
T Consensus 226 ~~-~~~~~-----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 226 YL-IATNG-----TPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred HH-HhcCC-----CCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 11 11111 11122233577899999999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=303.43 Aligned_cols=264 Identities=21% Similarity=0.355 Sum_probs=196.9
Q ss_pred cCcceEEEeeeeeeCceEEEEEeeeC---CCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEe
Q psy14267 254 NGKQYQVLSLLGKGGSSSVYLVGGTS---EHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYD 330 (553)
Q Consensus 254 ~~~~y~i~~~LG~G~fG~Vy~a~~~~---~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~ 330 (553)
...+|++++.||+|+||.||+|.+.. ......||+|++..... ......+.+|+.+++++. ||||+++++++.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~ei~~l~~l~-h~~iv~~~~~~~- 78 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALMAEFD-HPNIVKLLGVCA- 78 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcC--HHHHHHHHHHHHHHHhcC-CCchheEEEEEc-
Confidence 34679999999999999999998643 22345699999875432 233467889999999995 599999988764
Q ss_pred CCCceEEEEEecC-CCCHHHHHHHcccCC-----------------CCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCC
Q psy14267 331 TASKHLYVLMEKG-DTDLSKYMRNLNKMT-----------------TLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLK 392 (553)
Q Consensus 331 ~~~~~~~iv~e~~-~~~L~~~l~~~~~~~-----------------~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLK 392 (553)
.....+++||+. +++|.+++....... ........++.++.|++.||+|||+++++|||||
T Consensus 79 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~ 157 (288)
T cd05050 79 -VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLA 157 (288)
T ss_pred -CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeeccccc
Confidence 355678899874 579999998643211 1123455667778899999999999999999999
Q ss_pred CCCEEEecCccceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHH
Q psy14267 393 PANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLG 472 (553)
Q Consensus 393 p~NILl~~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlG 472 (553)
|+|||++.+ +.++|+|||++..+.............++..|+|||.+.+. .++.++||||||
T Consensus 158 p~nil~~~~---------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Dv~slG 219 (288)
T cd05050 158 TRNCLVGEN---------MVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN---------RYTTESDVWAYG 219 (288)
T ss_pred HhheEecCC---------CceEECccccceecccCccccccCCCccChhhcCHHHHhcC---------CCCchhHHHHHH
Confidence 999999776 57999999998765433221111223356789999998755 378899999999
Q ss_pred HHHHHHHh-CCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q psy14267 473 CILYNMIY-GRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINN 548 (553)
Q Consensus 473 vvl~ellt-G~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~ 548 (553)
|++|||++ |..||.+.... .....+... .. ......++..+.++|.+||+.+|++|||+.|+++.|++
T Consensus 220 ~il~el~~~~~~p~~~~~~~-~~~~~~~~~-~~------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 220 VVLWEIFSYGMQPYYGMAHE-EVIYYVRDG-NV------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHHHHHhCCCCCCCCCCHH-HHHHHHhcC-CC------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 99999997 88899765432 222222211 11 11122578899999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=298.26 Aligned_cols=256 Identities=23% Similarity=0.334 Sum_probs=194.0
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCc--CchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCC
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDI--TDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTAS 333 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~ 333 (553)
.+|++.++||+|+||.||++.+..++. .||||.+..... ......+.+.+|+.+++++ +||||+++++++.+...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~--~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~ 78 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGR--ELAVKQVQFDPESPETSKEVNALECEIQLLKNL-LHERIVQYYGCLRDPME 78 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCc--EEEEEEeecCcCCcccHHHHHHHHHHHHHHHhc-CCCCeeeEEeEeccCCC
Confidence 469999999999999999998876664 499999865432 2233457889999999999 56999999998766556
Q ss_pred ceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCe
Q psy14267 334 KHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNV 412 (553)
Q Consensus 334 ~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~ 412 (553)
..++++||+. +++|.+++..... .....+..++.|++.||+|||+++|+|+||||+|||++.+ +.
T Consensus 79 ~~~~~v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~---------~~ 144 (265)
T cd06652 79 RTLSIFMEHMPGGSIKDQLKSYGA-----LTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSV---------GN 144 (265)
T ss_pred ceEEEEEEecCCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCC---------CC
Confidence 6788999976 5789988876432 2334455667899999999999999999999999999766 57
Q ss_pred EEEEeccCccccCCCCCc-ccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCch
Q psy14267 413 LKIIDFGIACSLQDDKTS-VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNT 491 (553)
Q Consensus 413 vkL~DFGla~~~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~ 491 (553)
++|+|||++......... .......|+..|+|||++.+. .++.++|||||||++|||++|+.||......
T Consensus 145 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Dv~slG~il~el~~g~~p~~~~~~~ 215 (265)
T cd06652 145 VKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGE---------GYGRKADIWSVGCTVVEMLTEKPPWAEFEAM 215 (265)
T ss_pred EEECcCccccccccccccccccccCCCCccccChhhhcCC---------CCCcchhHHHHHHHHHHHhhCCCCCCccchH
Confidence 999999999765432111 112245689999999998754 3678999999999999999999999875433
Q ss_pred HHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 492 WAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 492 ~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
.. ......... .+ .....++..+.++|.+||. +|++||++++++.+
T Consensus 216 ~~-~~~~~~~~~----~~--~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 216 AA-IFKIATQPT----NP--VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred HH-HHHHhcCCC----CC--CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 22 222211111 11 1122567889999999995 99999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=296.86 Aligned_cols=252 Identities=22% Similarity=0.394 Sum_probs=190.3
Q ss_pred eeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEEEEEec
Q psy14267 263 LLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEK 342 (553)
Q Consensus 263 ~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~iv~e~ 342 (553)
.||+|+||.||++.....+....||+|++.... .....+.+.+|+.+++++. |+||+++++++. ....+++||+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~ii~~~~~~~---~~~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLD-NPYIVRMIGVCE---AEALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcC-CCCeEEEEEEEc---CCCeEEEEEe
Confidence 489999999999877644444459999986543 2344577899999999994 599999998762 3457788886
Q ss_pred C-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEeccCc
Q psy14267 343 G-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIA 421 (553)
Q Consensus 343 ~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGla 421 (553)
. +++|.+++..... ......+..++.|++.||+|||++|++||||||+|||++.+ +.+||+|||++
T Consensus 76 ~~~~~L~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~---------~~~kl~dfg~~ 142 (257)
T cd05115 76 ASGGPLNKFLSGKKD----EITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQ---------HYAKISDFGLS 142 (257)
T ss_pred CCCCCHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCC---------CcEEeccCCcc
Confidence 5 6789888875332 33456666777899999999999999999999999999766 57999999999
Q ss_pred cccCCCCCccc-ccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHH
Q psy14267 422 CSLQDDKTSVH-KDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHIPNTWAKMLAIA 499 (553)
Q Consensus 422 ~~~~~~~~~~~-~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~i~ 499 (553)
........... .....++..|+|||.+... .++.++|||||||++|||++ |..||...... .....+.
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-~~~~~~~ 212 (257)
T cd05115 143 KALGADDSYYKARSAGKWPLKWYAPECINFR---------KFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP-EVMSFIE 212 (257)
T ss_pred ccccCCccceeccCCCCCCcccCCHHHHccC---------CCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH-HHHHHHH
Confidence 86544322111 1122346789999998755 36889999999999999996 99999876543 2222222
Q ss_pred hhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q psy14267 500 RHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNP 550 (553)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~ 550 (553)
. ..... ....+++++.++|.+||..+|++||++.++.+.|+...
T Consensus 213 ~-~~~~~------~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05115 213 Q-GKRLD------CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTYY 256 (257)
T ss_pred C-CCCCC------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhhc
Confidence 1 11111 12256899999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=297.13 Aligned_cols=259 Identities=23% Similarity=0.397 Sum_probs=198.3
Q ss_pred EEecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEe
Q psy14267 251 ITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYD 330 (553)
Q Consensus 251 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~ 330 (553)
|++..++|++.+.||+|+||.||+|..... +.||||.+...... .+.+.+|+.+++++. |+||+++++++.
T Consensus 1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~~~---~~~~vK~~~~~~~~----~~~~~~e~~~l~~l~-h~~i~~~~~~~~- 71 (261)
T cd05034 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGT---TKVAVKTLKPGTMS----PEAFLQEAQIMKKLR-HDKLVQLYAVCS- 71 (261)
T ss_pred CccchhheeeeeeeccCcceEEEEEEEcCC---ceEEEEEecCCccC----HHHHHHHHHHHhhCC-CCCEeeeeeeee-
Confidence 345678999999999999999999976533 44899998765432 356889999999996 599999988763
Q ss_pred CCCceEEEEEec-CCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCC
Q psy14267 331 TASKHLYVLMEK-GDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCI 409 (553)
Q Consensus 331 ~~~~~~~iv~e~-~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~ 409 (553)
.....+++||+ .+++|.+++...... ......+..++.|++.||.|||++||+||||||+||+|+.+
T Consensus 72 -~~~~~~~v~e~~~~~~L~~~i~~~~~~---~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~-------- 139 (261)
T cd05034 72 -EEEPIYIVTEYMSKGSLLDFLKSGEGK---KLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGEN-------- 139 (261)
T ss_pred -cCCceEEEEeccCCCCHHHHHhccccC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCC--------
Confidence 34568889987 467899988764321 23455566777899999999999999999999999999776
Q ss_pred CCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCC
Q psy14267 410 GNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHI 488 (553)
Q Consensus 410 ~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~ 488 (553)
+.+||+|||+++........ ......++..|+|||.+.+. .++.++||||||+++|||++ |+.||...
T Consensus 140 -~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~---------~~~~~~Di~slG~il~~l~t~g~~p~~~~ 208 (261)
T cd05034 140 -LVCKIADFGLARLIEDDEYT-AREGAKFPIKWTAPEAANYG---------RFTIKSDVWSFGILLTEIVTYGRVPYPGM 208 (261)
T ss_pred -CCEEECccccceeccchhhh-hhhccCCCccccCHHHhccC---------CcCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 57999999999876542211 11122346789999999765 36889999999999999998 99999775
Q ss_pred CchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 489 PNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 489 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
... ..+..+... .. ......++.++.+++.+||..+|++||+++++++.|++.
T Consensus 209 ~~~-~~~~~~~~~-~~------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~~ 261 (261)
T cd05034 209 TNR-EVLEQVERG-YR------MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLEDY 261 (261)
T ss_pred CHH-HHHHHHHcC-CC------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhcC
Confidence 432 222222211 11 112234578999999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=298.87 Aligned_cols=259 Identities=24% Similarity=0.378 Sum_probs=196.7
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCc-cceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHE-FKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~-~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
..|++.+.||+|+||.||+|.....+. ...||||+++... .....+.+..|+.+++++. ||||+++++++ ..+.
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~--~~~~ 78 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFD-HPNIIHLEGVV--TKSR 78 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCC-CcCcceEEEEE--CCCC
Confidence 469999999999999999998765543 2459999986542 2344578999999999995 69999998876 3456
Q ss_pred eEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 335 HLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 335 ~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
.++++||+. +++|.+++..... ......++.++.|++.||+|||++|++||||||+||+++.+ +.+
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~---------~~~ 145 (269)
T cd05065 79 PVMIITEFMENGALDSFLRQNDG----QFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSN---------LVC 145 (269)
T ss_pred ceEEEEecCCCCcHHHHHhhCCC----CCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCC---------CcE
Confidence 788899875 5688888876432 23455667777899999999999999999999999999766 579
Q ss_pred EEEeccCccccCCCCCcccccCCc---cCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCCC
Q psy14267 414 KIIDFGIACSLQDDKTSVHKDTAS---GTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHIP 489 (553)
Q Consensus 414 kL~DFGla~~~~~~~~~~~~~~~~---Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~~ 489 (553)
||+|||++................ .+..|+|||.+.+. .++.++|||||||++|||++ |..||....
T Consensus 146 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~---------~~~~~~DvwslG~~l~e~l~~g~~p~~~~~ 216 (269)
T cd05065 146 KVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR---------KFTSASDVWSYGIVMWEVMSYGERPYWDMS 216 (269)
T ss_pred EECCCccccccccCccccccccccCCCcceeecCHhHhccC---------cccchhhhhhhHHHHHHHhcCCCCCCCCCC
Confidence 999999987665433211111111 24579999998755 36889999999999999886 999998754
Q ss_pred chHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 490 NTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 490 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
.. .....+. .... ......++..+.+++.+||..+|.+||++.+|+..|+++
T Consensus 217 ~~-~~~~~i~-~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 217 NQ-DVINAIE-QDYR------LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred HH-HHHHHHH-cCCc------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 32 2222221 1111 112236788999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=299.04 Aligned_cols=260 Identities=24% Similarity=0.379 Sum_probs=198.6
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCC-ccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCC
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEH-EFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTAS 333 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~ 333 (553)
..+|++.+.||+|+||.||++.+...+ ....+|+|.++.... ....+.+.+|+.+++++. ||||+++++++. .+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~ 77 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT--EKQRRDFLSEASIMGQFD-HPNIIHLEGVVT--KS 77 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC--HHHHHHHHHHHHHHHhCC-CCCcceEEEEEe--cC
Confidence 457999999999999999999876443 334689998865432 234568899999999995 699999998774 45
Q ss_pred ceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCe
Q psy14267 334 KHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNV 412 (553)
Q Consensus 334 ~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~ 412 (553)
..++++||+. +++|.+++..... ......+..++.|++.||.|||++||+||||||+|||++.+ +.
T Consensus 78 ~~~~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~---------~~ 144 (267)
T cd05066 78 KPVMIVTEYMENGSLDAFLRKHDG----QFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSN---------LV 144 (267)
T ss_pred CccEEEEEcCCCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCC---------Ce
Confidence 6788999976 5789999876432 23445566677899999999999999999999999999776 57
Q ss_pred EEEEeccCccccCCCCCccc-ccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCCCc
Q psy14267 413 LKIIDFGIACSLQDDKTSVH-KDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHIPN 490 (553)
Q Consensus 413 vkL~DFGla~~~~~~~~~~~-~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~~~ 490 (553)
++|+|||++........... .....++..|+|||.+.+. .++.++|+|||||++||+++ |..||.....
T Consensus 145 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~---------~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~ 215 (267)
T cd05066 145 CKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR---------KFTSASDVWSYGIVMWEVMSYGERPYWEMSN 215 (267)
T ss_pred EEeCCCCcccccccccceeeecCCCccceeecCHhHhccC---------ccCchhhhHHHHHHHHHHhcCCCCCcccCCH
Confidence 99999999987654332211 1122345789999999765 36889999999999999886 9999987543
Q ss_pred hHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 491 TWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 491 ~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
. .....+... .. ......++..+.+++.+||+.+|++||++.++++.|++.
T Consensus 216 ~-~~~~~~~~~-~~------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 216 Q-DVIKAIEEG-YR------LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred H-HHHHHHhCC-Cc------CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 2 222222211 11 122235788999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=300.78 Aligned_cols=260 Identities=22% Similarity=0.330 Sum_probs=193.3
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|++.+.||+|+||.||++.+..++. .||+|++....... ...+.+.+|+.+++++. |+||+++++++.. ...
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~--~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~--~~~ 74 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQ--IVAIKKFVESEDDP-VIKKIALREIRMLKQLK-HPNLVNLIEVFRR--KRK 74 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCc--EEEEEEEeecccCc-cccHHHHHHHHHHHhCC-CCCEeeeeeEEee--CCE
Confidence 369999999999999999998876654 49999987554222 23356789999999996 5999999988754 567
Q ss_pred EEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 336 LYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 336 ~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
++++||+..+.+...+..... ...+..+..++.|++.||+|||++||+||||||+||+++.+ +.++|
T Consensus 75 ~~~v~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~---------~~~~l 141 (286)
T cd07847 75 LHLVFEYCDHTVLNELEKNPR----GVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQ---------GQIKL 141 (286)
T ss_pred EEEEEeccCccHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCC---------CcEEE
Confidence 889999877665555443221 23456666777899999999999999999999999999776 57999
Q ss_pred EeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHH
Q psy14267 416 IDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKM 495 (553)
Q Consensus 416 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~ 495 (553)
+|||++......... .....++..|+|||.+.+.. .++.++||||||+++|||++|..||.+...... .
T Consensus 142 ~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~--------~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~-~ 210 (286)
T cd07847 142 CDFGFARILTGPGDD--YTDYVATRWYRAPELLVGDT--------QYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ-L 210 (286)
T ss_pred CccccceecCCCccc--ccCcccccccCCHHHHhCCC--------CcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH-H
Confidence 999999877554321 22455789999999987532 367899999999999999999999987554322 2
Q ss_pred HHHHhhcccc-----------------cccc-c-----ccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 496 LAIARHKDQI-----------------EFKP-Q-----LANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 496 ~~i~~~~~~~-----------------~~~~-~-----~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
..+....... .... . ......++..+.+||.+||..+|++||++.|++.+
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 211 YLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred HHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 2211110000 0000 0 00112467889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=302.18 Aligned_cols=256 Identities=20% Similarity=0.323 Sum_probs=194.5
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|++.+.||+|+||.||+|.+..++. .||+|+++.... .....+.+|+.+++.+. ||||+++++++.. ...
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~--~~~ik~~~~~~~---~~~~~~~~e~~~~~~l~-h~~ii~~~~~~~~--~~~ 80 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGE--LAAIKVIKLEPG---EDFAVVQQEIIMMKDCK-HSNIVAYFGSYLR--RDK 80 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCc--EEEEEEEecCch---hHHHHHHHHHHHHHhCC-CCCeeeEEEEEEe--CCE
Confidence 579999999999999999998876664 499999876532 22356788999999995 5999999987744 567
Q ss_pred EEEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
++++||+++ ++|.+++.... ......+..++.|++.||+|||+.||+||||||+||+++.+ +.++
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~---------~~~~ 146 (267)
T cd06645 81 LWICMEFCGGGSLQDIYHVTG-----PLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDN---------GHVK 146 (267)
T ss_pred EEEEEeccCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC---------CCEE
Confidence 889999864 68988887644 23456677777899999999999999999999999999766 5799
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||++........ ......|+..|+|||++..... ..++.++|||||||++|||++|..||.........
T Consensus 147 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~------~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~ 218 (267)
T cd06645 147 LADFGVSAQITATIA--KRKSFIGTPYWMAPEVAAVERK------GGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL 218 (267)
T ss_pred ECcceeeeEccCccc--ccccccCcccccChhhhccccC------CCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH
Confidence 999999876643221 1234578999999999853211 13678999999999999999999999764432221
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
. ...... ...+.......++..+.++|.+||..+|++||++++|+++
T Consensus 219 ~-~~~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 219 F-LMTKSN---FQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred H-hhhccC---CCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 1 111111 1112222233578899999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=300.51 Aligned_cols=260 Identities=26% Similarity=0.358 Sum_probs=197.4
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceE
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHL 336 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~ 336 (553)
+|+..+.||.|++|.||++.+...+. .||+|.+...... ....++.+|+++++++. ||||+.+++++.+.....+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~--~~~~k~~~~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~ 76 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGM--IFALKTITTDPNP--DLQKQILRELEINKSCK-SPYIVKYYGAFLDESSSSI 76 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCe--EEEEEEEecCCch--HHHHHHHHHHHHHHhCC-CCCeeeeeeEEEccCCCeE
Confidence 68999999999999999998876654 4999999765332 34577899999999995 6999999998877777788
Q ss_pred EEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 337 YVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 337 ~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
+++||++ +++|.+++..... .........+..++.||+.||+|||+.|++|+||+|+||+++.+ +.++|
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~---------~~~~l 146 (287)
T cd06621 77 GIAMEYCEGGSLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRK---------GQVKL 146 (287)
T ss_pred EEEEEecCCCCHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecC---------CeEEE
Confidence 9999976 5688887764322 12234455666777899999999999999999999999999776 57999
Q ss_pred EeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCC----ch
Q psy14267 416 IDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIP----NT 491 (553)
Q Consensus 416 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~----~~ 491 (553)
+|||++........ ....++..|+|||.+.+. .++.++|||||||++|+|++|..||.... ..
T Consensus 147 ~dfg~~~~~~~~~~----~~~~~~~~y~~pE~~~~~---------~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~ 213 (287)
T cd06621 147 CDFGVSGELVNSLA----GTFTGTSFYMAPERIQGK---------PYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGP 213 (287)
T ss_pred eecccccccccccc----ccccCCccccCHHHhcCC---------CCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCCh
Confidence 99999876543322 134578899999998755 36789999999999999999999997642 11
Q ss_pred HHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 492 WAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 492 ~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
......+.. ...............+++.+.++|.+||..+|++|||+.|++.+
T Consensus 214 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 214 IELLSYIVN-MPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred HHHHHHHhc-CCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 111111111 11111122222222456889999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=299.47 Aligned_cols=260 Identities=21% Similarity=0.339 Sum_probs=198.8
Q ss_pred cCcceEEEeeeeeeCceEEEEEeeeCCCc--cceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeC
Q psy14267 254 NGKQYQVLSLLGKGGSSSVYLVGGTSEHE--FKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDT 331 (553)
Q Consensus 254 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~--~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~ 331 (553)
...+|++++.||+|+||.||+|.....+. ...||+|.+..... ......+.+|+.+++++. ||||+++++++..
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~- 80 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVD-HPHVVRLLGICLS- 80 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCC-CCCcceEEEEEec-
Confidence 45689999999999999999998765543 23589998876543 334567899999999995 5999999998764
Q ss_pred CCceEEEEEec-CCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCC
Q psy14267 332 ASKHLYVLMEK-GDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIG 410 (553)
Q Consensus 332 ~~~~~~iv~e~-~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~ 410 (553)
...+++||+ .+++|.+++..... ......+..++.|++.||+|||+.+|+||||||+|||++.+
T Consensus 81 --~~~~~v~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~--------- 145 (279)
T cd05057 81 --SQVQLITQLMPLGCLLDYVRNHKD----NIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTP--------- 145 (279)
T ss_pred --CceEEEEecCCCCcHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCC---------
Confidence 456777775 56899998876432 23455666777899999999999999999999999999766
Q ss_pred CeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCCC
Q psy14267 411 NVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHIP 489 (553)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~~ 489 (553)
+.+||+|||+++...............++..|+|||.+... .++.++|||||||++|||++ |..||....
T Consensus 146 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~---------~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 216 (279)
T cd05057 146 QHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHR---------IYTHKSDVWSYGVTVWELMTFGAKPYEGIP 216 (279)
T ss_pred CeEEECCCcccccccCcccceecCCCcccccccCHHHhhcC---------CcCchhhHHHHHHHHHHHhcCCCCCCCCCC
Confidence 57999999999877644332222223346789999998654 36889999999999999998 999998754
Q ss_pred chHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 490 NTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 490 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
.. .+......... ......++..+.+++.+||..+|.+||++.++++.|++.
T Consensus 217 ~~--~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 217 AV--EIPDLLEKGER------LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred HH--HHHHHHhCCCC------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 32 22222221111 112224678999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=304.93 Aligned_cols=262 Identities=23% Similarity=0.370 Sum_probs=199.1
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|++.+.||.|+||.||+|.+..++. .+|+|.++..... ......+.+|+.+++++. ||||+.+++++.+.....
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~--~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~ 80 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGE--IVALKKLKMEKEK-EGFPITSLREINILLKLQ-HPNIVTVKEVVVGSNLDK 80 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCc--EEEEEEEeecccc-ccchhhHHHHHHHHHhcC-CCCEEEEEEEEEecCCCc
Confidence 479999999999999999998876654 4999999866543 233456788999999996 699999999887766688
Q ss_pred EEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 336 LYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 336 ~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
.+++||+.+++|.+++..... ......+..++.|++.||+|||++||+||||||+|||++.+ +.+||
T Consensus 81 ~~lv~e~~~~~L~~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~---------~~~~l 147 (293)
T cd07843 81 IYMVMEYVEHDLKSLMETMKQ----PFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNR---------GILKI 147 (293)
T ss_pred EEEEehhcCcCHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCC---------CcEEE
Confidence 999999998999988876543 34456666777899999999999999999999999999776 57999
Q ss_pred EeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHH
Q psy14267 416 IDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKM 495 (553)
Q Consensus 416 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~ 495 (553)
+|||++......... .....+++.|+|||.+.+.. .++.++||||||+++|||++|..||...... ...
T Consensus 148 ~d~g~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~--------~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~-~~~ 216 (293)
T cd07843 148 CDFGLAREYGSPLKP--YTQLVVTLWYRAPELLLGAK--------EYSTAIDMWSVGCIFAELLTKKPLFPGKSEI-DQL 216 (293)
T ss_pred eecCceeeccCCccc--cccccccccccCchhhcCCc--------cccchhhHHHHHHHHHHHHhCCCCCCCCChH-HHH
Confidence 999999877554221 12345789999999987543 2578999999999999999999999764432 111
Q ss_pred HHHHhhcc-------------------ccc-c-cccccC-C--CCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 496 LAIARHKD-------------------QIE-F-KPQLAN-N--VTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 496 ~~i~~~~~-------------------~~~-~-~~~~~~-~--~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
..+..... ... . ...+.. . ..+++.+.++|++||+.+|++|||+.|++.+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 217 NKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred HHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 11111000 000 0 000000 0 1157889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=311.88 Aligned_cols=267 Identities=26% Similarity=0.386 Sum_probs=197.0
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC--
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA-- 332 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~-- 332 (553)
+++|++.++||+|+||.||++.+..++. .||||++.... ......++.+|+.++++++ |+||+.+++++....
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~--~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 78 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGV--KVAIKKISPFE--HQTFCQRTLREIKILRRFK-HENIIGILDIIRPPSFE 78 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCC--eEEEEEecccc--cchhHHHHHHHHHHHHhCC-CCCcCchhheeeccccc
Confidence 4689999999999999999998876664 49999986432 2234567889999999996 599999998765432
Q ss_pred -CceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCC
Q psy14267 333 -SKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGN 411 (553)
Q Consensus 333 -~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~ 411 (553)
..++++++++.+++|..++... .+....+..++.|++.||+|||+.||+||||||+|||++.+ +
T Consensus 79 ~~~~~~lv~e~~~~~l~~~~~~~------~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~---------~ 143 (336)
T cd07849 79 SFNDVYIVQELMETDLYKLIKTQ------HLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTN---------C 143 (336)
T ss_pred ccceEEEEehhcccCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCC---------C
Confidence 2468999999999998877643 24455566777899999999999999999999999999776 5
Q ss_pred eEEEEeccCccccCCCCCcc-cccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCc
Q psy14267 412 VLKIIDFGIACSLQDDKTSV-HKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN 490 (553)
Q Consensus 412 ~vkL~DFGla~~~~~~~~~~-~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~ 490 (553)
.+||+|||++.......... ......|++.|+|||.+.+.. .++.++|||||||++|+|++|+.||.....
T Consensus 144 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--------~~~~~~DvwslGvil~el~~G~~~f~~~~~ 215 (336)
T cd07849 144 DLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSK--------GYTKAIDIWSVGCILAEMLSNRPLFPGKDY 215 (336)
T ss_pred CEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCC--------CCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 79999999998765432211 112356899999999875432 368899999999999999999999975332
Q ss_pred hHHHHHHHHhhcc--------------------cccccccc---cCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH--
Q psy14267 491 TWAKMLAIARHKD--------------------QIEFKPQL---ANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ-- 545 (553)
Q Consensus 491 ~~~~~~~i~~~~~--------------------~~~~~~~~---~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~-- 545 (553)
. ..+..+..... .....+.. ......+.++.++|.+||+.+|++|||+.+++++
T Consensus 216 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~ 294 (336)
T cd07849 216 L-HQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPY 294 (336)
T ss_pred H-HHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence 1 11111100000 00000000 0112457889999999999999999999999987
Q ss_pred HhcCC
Q psy14267 546 INNNP 550 (553)
Q Consensus 546 L~~~~ 550 (553)
+++..
T Consensus 295 ~~~~~ 299 (336)
T cd07849 295 LEQYH 299 (336)
T ss_pred ccccC
Confidence 55543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=298.09 Aligned_cols=256 Identities=26% Similarity=0.338 Sum_probs=201.5
Q ss_pred cceEEE-eeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC--
Q psy14267 256 KQYQVL-SLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA-- 332 (553)
Q Consensus 256 ~~y~i~-~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~-- 332 (553)
++|.+. ++||-|--|+|..+.++.+++. +|+|++.- .....+|+++.-....|||||.+++++....
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~ek--fALKvL~D--------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~ 130 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQEK--FALKVLLD--------SPKARREVELHWMASGHPHIVSIIDVYENSYQG 130 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchhh--hHHHHHhc--------CHHHHhHhhhhhhhcCCCceEEeehhhhhhccC
Confidence 456664 5899999999999999888876 99999842 2567899999777788999999999875443
Q ss_pred CceEEEEEec-CCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCC
Q psy14267 333 SKHLYVLMEK-GDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGN 411 (553)
Q Consensus 333 ~~~~~iv~e~-~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~ 411 (553)
...++||||+ .||+|+..++..+.. .+++..+..+..||..|+.|||+.+|.||||||+|+|..... ...
T Consensus 131 rkcLLiVmE~meGGeLfsriq~~g~~---afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~------~na 201 (400)
T KOG0604|consen 131 RKCLLIVMECMEGGELFSRIQDRGDQ---AFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTS------PNA 201 (400)
T ss_pred ceeeEeeeecccchHHHHHHHHcccc---cchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCC------CCc
Confidence 3467889996 678899888877643 466667777778999999999999999999999999997663 336
Q ss_pred eEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCc-
Q psy14267 412 VLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN- 490 (553)
Q Consensus 412 ~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~- 490 (553)
.+||+|||+|+.-..... ..+.|-||+|.|||++... +|+...|+||+||+||-||+|.+||.....
T Consensus 202 ~lKLtDfGFAK~t~~~~~---L~TPc~TPyYvaPevlg~e---------KydkscdmwSlgVimYIlLCGyPPFYS~hg~ 269 (400)
T KOG0604|consen 202 PLKLTDFGFAKETQEPGD---LMTPCFTPYYVAPEVLGPE---------KYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 269 (400)
T ss_pred ceEecccccccccCCCcc---ccCCcccccccCHHHhCch---------hcCCCCCccchhHHHHHhhcCCCcccccCCc
Confidence 799999999987665332 3488999999999999755 478899999999999999999999975221
Q ss_pred -hHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 491 -TWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 491 -~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
...-|...+. ..+..|+. +.|..+|++.+++|+.+|+.+|++|.|+.+++++
T Consensus 270 aispgMk~rI~-~gqy~FP~--pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 270 AISPGMKRRIR-TGQYEFPE--PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred cCChhHHhHhh-ccCccCCC--hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 1112222222 22333332 3466789999999999999999999999998865
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=297.71 Aligned_cols=264 Identities=21% Similarity=0.387 Sum_probs=200.7
Q ss_pred EecCcceEEEeeeeeeCceEEEEEeeeCC-CccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEe
Q psy14267 252 TLNGKQYQVLSLLGKGGSSSVYLVGGTSE-HEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYD 330 (553)
Q Consensus 252 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~-~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~ 330 (553)
++...+|.+.+.||+|+||.||+|.+... .....||||....... ....+.+.+|+.+++++. ||||+++++++.+
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~ 78 (270)
T cd05056 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS--PSVREKFLQEAYIMRQFD-HPHIVKLIGVITE 78 (270)
T ss_pred eechhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC--HHHHHHHHHHHHHHHhCC-CCchhceeEEEcC
Confidence 34567899999999999999999987654 3334589998865432 334578899999999995 5999999987643
Q ss_pred CCCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCC
Q psy14267 331 TASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCI 409 (553)
Q Consensus 331 ~~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~ 409 (553)
...+++||++ +++|.+++..... ......+..++.|++.||+|||+.|++||||||+|||++.+
T Consensus 79 ---~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~-------- 143 (270)
T cd05056 79 ---NPVWIVMELAPLGELRSYLQVNKY----SLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSP-------- 143 (270)
T ss_pred ---CCcEEEEEcCCCCcHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecC--------
Confidence 3456788864 6799999876432 23455666677899999999999999999999999999776
Q ss_pred CCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCC
Q psy14267 410 GNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHI 488 (553)
Q Consensus 410 ~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~ 488 (553)
+.+||+|||+++........ ......++..|+|||.+... .++.++||||||+++|||++ |..||...
T Consensus 144 -~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~el~~~g~~pf~~~ 212 (270)
T cd05056 144 -DCVKLGDFGLSRYLEDESYY-KASKGKLPIKWMAPESINFR---------RFTSASDVWMFGVCMWEILMLGVKPFQGV 212 (270)
T ss_pred -CCeEEccCceeeecccccce-ecCCCCccccccChhhhccC---------CCCchhhhHHHHHHHHHHHHcCCCCCCCC
Confidence 57999999999876544221 11123345789999998655 36889999999999999986 99999875
Q ss_pred CchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCCC
Q psy14267 489 PNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNPEG 552 (553)
Q Consensus 489 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~~~ 552 (553)
... .....+.. ...+ .....++..+.++|.+||..+|++|||+.+++..|+++.++
T Consensus 213 ~~~-~~~~~~~~-~~~~------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 213 KNN-DVIGRIEN-GERL------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred CHH-HHHHHHHc-CCcC------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 543 22222221 1111 12236789999999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=306.66 Aligned_cols=257 Identities=24% Similarity=0.393 Sum_probs=197.3
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|++.+.||+|+||.||+|.+...+. .||||.+.+.........+.+..|+++++++. |++|+++++++. ....
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~--~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--~~~~ 75 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGK--LFALKVLDKKEMIKRNKVKRVLTEQEILATLD-HPFLPTLYASFQ--TETY 75 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCc--EEEEEEEeccccchHHHHHHHHHHHHHHHhCC-CCCchhheeeee--cCCE
Confidence 369999999999999999998877554 49999998876655455678999999999996 599999988763 4667
Q ss_pred EEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
.+++||++ +++|.+++..... ..+....+..++.|++.||+|||+.||+||||||+||||+.+ +.++
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~---------~~~~ 143 (316)
T cd05574 76 LCLVMDYCPGGELFRLLQRQPG---KCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHES---------GHIM 143 (316)
T ss_pred EEEEEEecCCCCHHHHHHhCCC---CccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCC---------CCEE
Confidence 88999964 6789988875432 234455566677899999999999999999999999999876 5799
Q ss_pred EEeccCccccCCCCCc---------------------------ccccCCccCCCccCcccccccCCCCCCCccCCCccch
Q psy14267 415 IIDFGIACSLQDDKTS---------------------------VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSD 467 (553)
Q Consensus 415 L~DFGla~~~~~~~~~---------------------------~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sD 467 (553)
|+|||++......... .......|+..|+|||++.+. .++.++|
T Consensus 144 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~---------~~~~~~D 214 (316)
T cd05574 144 LSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD---------GHGSAVD 214 (316)
T ss_pred EeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC---------CCCchHH
Confidence 9999998765332110 011234689999999999765 3688999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCC----HHHHH
Q psy14267 468 VWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT----VGNSV 543 (553)
Q Consensus 468 IwSlGvvl~elltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt----~~ell 543 (553)
|||||+++|+|++|..||...... ..+..+.... .. ......++..+.++|++||..||++||+ +++++
T Consensus 215 i~slG~ll~~l~~g~~pf~~~~~~-~~~~~~~~~~--~~----~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll 287 (316)
T cd05574 215 WWTLGILLYEMLYGTTPFKGSNRD-ETFSNILKKE--VT----FPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIK 287 (316)
T ss_pred HHHHHHHHHHHhhCCCCCCCCchH-HHHHHHhcCC--cc----CCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHH
Confidence 999999999999999999875443 2222222111 11 1122237899999999999999999999 77777
Q ss_pred HH
Q psy14267 544 TQ 545 (553)
Q Consensus 544 ~~ 545 (553)
.+
T Consensus 288 ~~ 289 (316)
T cd05574 288 QH 289 (316)
T ss_pred cC
Confidence 64
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=303.12 Aligned_cols=258 Identities=26% Similarity=0.415 Sum_probs=194.9
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
.+.|+++++||.|+||.||++++...+. .||+|++.... ....+.+.+|+.+++++. |+||+++++++.. +.
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~--~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~ 82 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGA--LAAAKVIETKS---EEELEDYMVEIEILATCN-HPYIVKLLGAFYW--DG 82 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCc--eEEEEEeccCC---HHHHHHHHHHHHHHHhCC-CCcEeeeEEEEEe--CC
Confidence 4679999999999999999998876664 49999987543 344577899999999996 5999999997754 45
Q ss_pred eEEEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 335 HLYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 335 ~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
.++++||+.. ++|..++.+... ......+..++.|++.||+|||+.+|+||||||+||+++.+ +.+
T Consensus 83 ~~~lv~e~~~~~~l~~~~~~~~~----~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~---------~~~ 149 (292)
T cd06644 83 KLWIMIEFCPGGAVDAIMLELDR----GLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLD---------GDI 149 (292)
T ss_pred eEEEEEecCCCCcHHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCC---------CCE
Confidence 7888999754 566666654322 23455666777899999999999999999999999999765 579
Q ss_pred EEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHH
Q psy14267 414 KIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWA 493 (553)
Q Consensus 414 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~ 493 (553)
||+|||++........ ......+++.|+|||++.+.... ...++.++|||||||++|||++|..||...... .
T Consensus 150 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~----~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-~ 222 (292)
T cd06644 150 KLADFGVSAKNVKTLQ--RRDSFIGTPYWMAPEVVMCETMK----DTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-R 222 (292)
T ss_pred EEccCccceecccccc--ccceecCCccccCceeecccccc----CCCCCchhhhHhHHHHHHHHhcCCCCCccccHH-H
Confidence 9999999876433221 12245688999999998654321 124688999999999999999999999765432 2
Q ss_pred HHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 494 KMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 494 ~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
....+.... .+.......++.++.++|.+||..+|++||++++++++
T Consensus 223 ~~~~~~~~~-----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 223 VLLKIAKSE-----PPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred HHHHHhcCC-----CccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 222222111 11122233677899999999999999999999999864
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=300.75 Aligned_cols=260 Identities=27% Similarity=0.425 Sum_probs=198.6
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceE
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHL 336 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~ 336 (553)
+|++.+.||+|+||.||+|.+..++. .||||++....... .....+.+|+.+++++. ||||+++++++.. ...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~--~~~vK~~~~~~~~~-~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~--~~~~ 74 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGE--TVALKKVALRRLEG-GIPNQALREIKALQACQ-HPYVVKLLDVFPH--GSGF 74 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCc--eEEEEEEEcccccc-hhhHHHHHHHHHHHhCC-CCCCcceeeEEec--CCee
Confidence 48999999999999999998876654 49999998765433 34577899999999996 6999999988754 6688
Q ss_pred EEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEE
Q psy14267 337 YVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKII 416 (553)
Q Consensus 337 ~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~ 416 (553)
+++||+.+++|.+++..... ......+..++.||+.||+|||+.||+|+||||+||+++.+ +.++|+
T Consensus 75 ~~v~e~~~~~L~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~---------~~~~l~ 141 (286)
T cd07832 75 VLVMEYMPSDLSEVLRDEER----PLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISAD---------GVLKIA 141 (286)
T ss_pred EEEecccCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCC---------CcEEEe
Confidence 99999889999999876542 34556677778899999999999999999999999999775 579999
Q ss_pred eccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHH
Q psy14267 417 DFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKML 496 (553)
Q Consensus 417 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~ 496 (553)
|||++........ .......|+..|+|||++.+.. .++.++|||||||++|||++|.+||....+.. ...
T Consensus 142 dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~--------~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~-~~~ 211 (286)
T cd07832 142 DFGLARLFSEEEP-RLYSHQVATRWYRAPELLYGAR--------KYDPGVDLWAVGCIFAELLNGSPLFPGENDIE-QLA 211 (286)
T ss_pred eeeecccccCCCC-CccccccCcccccCceeeeccc--------cCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH-HHH
Confidence 9999987755432 1122456899999999986542 35789999999999999999988887644321 111
Q ss_pred HHHhhccc-----------------cccccc----c-cCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 497 AIARHKDQ-----------------IEFKPQ----L-ANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 497 ~i~~~~~~-----------------~~~~~~----~-~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
.+...... +.+... + ......+.++.++|.+||..+|++||++++++.+
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 212 IVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred HHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 11111000 000000 0 0112457899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=299.40 Aligned_cols=258 Identities=21% Similarity=0.348 Sum_probs=193.7
Q ss_pred eEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEE
Q psy14267 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLY 337 (553)
Q Consensus 258 y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~ 337 (553)
|++++.||+|+||.||++.+..++.. ||+|++++..... .. ....+|+.++.++.+|+||+++++++.+.....++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~--~aik~~~~~~~~~-~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 76 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKY--YAIKCMKKHFKSL-EQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLA 76 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcE--EEEEEehhccCCc-hh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEE
Confidence 67899999999999999988766644 9999987653222 22 34468999999998789999999988776557889
Q ss_pred EEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEe
Q psy14267 338 VLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIID 417 (553)
Q Consensus 338 iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~D 417 (553)
++||+..++|.+++..... ...+..+..++.|++.||+|||+.||+||||||+||+++. +.+||+|
T Consensus 77 lv~e~~~~~l~~~l~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~----------~~~kl~d 142 (282)
T cd07831 77 LVFELMDMNLYELIKGRKR----PLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD----------DILKLAD 142 (282)
T ss_pred EEEecCCccHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC----------CCeEEEe
Confidence 9999998999988876432 3345566677789999999999999999999999999965 3699999
Q ss_pred ccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHHH
Q psy14267 418 FGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLA 497 (553)
Q Consensus 418 FGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~~ 497 (553)
||++......... ....++..|+|||.+.... .++.++|||||||++|||++|..||...... .....
T Consensus 143 fg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~--------~~~~~~Di~slGv~l~el~~~~~p~~~~~~~-~~~~~ 210 (282)
T cd07831 143 FGSCRGIYSKPPY---TEYISTRWYRAPECLLTDG--------YYGPKMDIWAVGCVFFEILSLFPLFPGTNEL-DQIAK 210 (282)
T ss_pred cccccccccCCCc---CCCCCCcccCChhHhhcCC--------CCCcchhHHHHHHHHHHHHcCCcCCCCCCHH-HHHHH
Confidence 9999876543321 2345889999999875432 3678999999999999999999999764321 11111
Q ss_pred HHhhcc----------------cccccccc-----cCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 498 IARHKD----------------QIEFKPQL-----ANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 498 i~~~~~----------------~~~~~~~~-----~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
+..... ...+.... .....++.++.++|.+||..+|++||++++++.+
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 211 IHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred HHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 111000 00000000 0012467899999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=301.96 Aligned_cols=260 Identities=25% Similarity=0.386 Sum_probs=192.4
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|++.+.||+|+||.||++.+..++. .||||.+....... ....+.+|+.+++++. |+||+++++++. ....
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~--~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l~-h~~i~~~~~~~~--~~~~ 77 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQ--LVALKEIRLEHEEG--APFTAIREASLLKDLK-HANIVTLHDIIH--TKKT 77 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCc--EEEEEEEecccccC--CchhHHHHHHHHhhCC-CcceeeEEEEEe--cCCe
Confidence 579999999999999999998776654 49999987653221 1245678999999995 599999998874 4568
Q ss_pred EEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 336 LYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 336 ~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
.+++||+..++|.+++..... ......+..++.|++.||.|||+.+|+||||||+|||++.+ +.+||
T Consensus 78 ~~lv~e~~~~~L~~~~~~~~~----~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~---------~~~kl 144 (291)
T cd07844 78 LTLVFEYLDTDLKQYMDDCGG----GLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISER---------GELKL 144 (291)
T ss_pred EEEEEecCCCCHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCC---------CCEEE
Confidence 899999988999998876543 23455566667799999999999999999999999999776 57999
Q ss_pred EeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHH
Q psy14267 416 IDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKM 495 (553)
Q Consensus 416 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~ 495 (553)
+|||+++........ .....++..|+|||++.+.. .++.++||||||+++|||++|..||.........+
T Consensus 145 ~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~--------~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~ 214 (291)
T cd07844 145 ADFGLARAKSVPSKT--YSNEVVTLWYRPPDVLLGST--------EYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQL 214 (291)
T ss_pred CccccccccCCCCcc--ccccccccccCCcHHhhcCc--------ccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHH
Confidence 999998765322211 11334688999999987532 36789999999999999999999997654322222
Q ss_pred HHHHhhcccc---c-------------------ccccccCCCCCC--HHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 496 LAIARHKDQI---E-------------------FKPQLANNVTIP--PTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 496 ~~i~~~~~~~---~-------------------~~~~~~~~~~~s--~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
..+....... . ..+.......++ .++.++|.+||+.+|++|||+.+++.+
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 215 HKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred HHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 2211110000 0 000000111233 788999999999999999999998864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=301.69 Aligned_cols=264 Identities=21% Similarity=0.385 Sum_probs=201.5
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCC--CccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSE--HEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA 332 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~--~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~ 332 (553)
.+.|++.+.||+|+||.||++..... +..+.||||++...... ...+.+.+|+++++++. |+||+++++++....
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~-~~~i~~~~~~~~~~~ 79 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLD-HENIVKYKGVCEKPG 79 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCC-CCChheEEeeeecCC
Confidence 35788999999999999999976432 33456999999766433 34578999999999994 699999999887666
Q ss_pred CceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCC
Q psy14267 333 SKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGN 411 (553)
Q Consensus 333 ~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~ 411 (553)
....+++||+. +++|.+++..... ...+..+..++.|++.||+|||++||+||||||+|||++.+ +
T Consensus 80 ~~~~~lv~e~~~~~~l~~~l~~~~~----~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~---------~ 146 (284)
T cd05038 80 GRSLRLIMEYLPSGSLRDYLQRHRD----QINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESE---------D 146 (284)
T ss_pred CCceEEEEecCCCCCHHHHHHhCcc----ccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCC---------C
Confidence 77889999976 6799999876542 24455666777899999999999999999999999999776 5
Q ss_pred eEEEEeccCccccCCCCCccc-ccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCc
Q psy14267 412 VLKIIDFGIACSLQDDKTSVH-KDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN 490 (553)
Q Consensus 412 ~vkL~DFGla~~~~~~~~~~~-~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~ 490 (553)
.++|+|||++........... .....++..|+|||.+.+. .++.++||||||+++|||++|..|+.....
T Consensus 147 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~---------~~~~~~Di~slG~~l~el~tg~~p~~~~~~ 217 (284)
T cd05038 147 LVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTS---------KFSSASDVWSFGVTLYELFTYGDPSQSPPA 217 (284)
T ss_pred CEEEcccccccccccCCcceeccCCCCCcccccCcHHHccC---------CCCcccchHHHhhhhheeeccCCCcccccc
Confidence 799999999987764322111 1123356679999998655 368899999999999999999999865332
Q ss_pred hH-------------HHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 491 TW-------------AKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 491 ~~-------------~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
.. ..+....... ........++.++.+++.+||+.+|++||++.+|++.|+++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 218 EFLRMIGIAQGQMIVTRLLELLKEG------ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred hhccccccccccccHHHHHHHHHcC------CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 21 1111111111 11122235678999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=302.11 Aligned_cols=261 Identities=23% Similarity=0.342 Sum_probs=195.4
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceE
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHL 336 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~ 336 (553)
+|++++.||.|+||.||+|.+..++. .||||.+....... .....+.+|+++++++. ||||+++++++. .....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~--~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~--~~~~~ 74 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGE--VVALKKIRLDTETE-GVPSTAIREISLLKELN-HPNIVKLLDVIH--TENKL 74 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCC--EEEEEEcccccccc-ccchHHHHHHHHHHhcC-CCCCcchhhhcc--cCCcE
Confidence 48899999999999999998876664 49999987654332 23367889999999995 599999999874 45678
Q ss_pred EEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEE
Q psy14267 337 YVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKII 416 (553)
Q Consensus 337 ~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~ 416 (553)
+++||+..++|..++...... ......+..++.|++.||+|||+.+++||||+|+||+++.+ +.+||+
T Consensus 75 ~~v~e~~~~~l~~~~~~~~~~---~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~---------~~~~l~ 142 (284)
T cd07860 75 YLVFEFLHQDLKKFMDASPLS---GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTE---------GAIKLA 142 (284)
T ss_pred EEEeeccccCHHHHHHhCCCC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC---------CCEEEe
Confidence 999999888898888764322 34456667777899999999999999999999999999876 579999
Q ss_pred eccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHH
Q psy14267 417 DFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKML 496 (553)
Q Consensus 417 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~ 496 (553)
|||++......... .....+++.|+|||++.+.. .++.++|||||||++|||++|+.||...........
T Consensus 143 dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~--------~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~ 212 (284)
T cd07860 143 DFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGCK--------YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 212 (284)
T ss_pred eccchhhcccCccc--cccccccccccCCeEEecCC--------CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 99998766433221 12345788999999986542 257889999999999999999999976543222211
Q ss_pred HHHhhcccc---------------cccc----cc-cCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 497 AIARHKDQI---------------EFKP----QL-ANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 497 ~i~~~~~~~---------------~~~~----~~-~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
.+....... .+.. .. .....++.+++++|.+||+.||++|||+++++.+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 213 IFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 111111000 0000 00 0012467899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=301.04 Aligned_cols=257 Identities=28% Similarity=0.424 Sum_probs=193.4
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
+.|++.+.||+|+||.||++.+...+. .+|+|.+.... ....+.+.+|+++++.+. |+||+.+++++.. ...
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~--~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~-h~~ii~~~~~~~~--~~~ 76 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGV--LAAAKVIDTKS---EEELEDYMVEIDILASCD-HPNIVKLLDAFYY--ENN 76 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCe--EEEEEEeCCCC---HHHHHHHHHHHHHHHHCC-CCCeeeEEEEEee--CCE
Confidence 347889999999999999998876654 48999886543 334577899999999995 6999999987754 457
Q ss_pred EEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
.+++||+. +++|..++..... ...+..+..++.|++.||+|||+.||+||||||+|||++.+ +.+|
T Consensus 77 ~~~v~e~~~~~~l~~~~~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~---------~~~k 143 (282)
T cd06643 77 LWILIEFCAGGAVDAVMLELER----PLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLD---------GDIK 143 (282)
T ss_pred EEEEEEecCCCcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccC---------CCEE
Confidence 88888875 4567666654321 34455666677899999999999999999999999999766 5799
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||++........ ......|+..|+|||++...... ...++.++|||||||++|||++|..||...... ..
T Consensus 144 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~----~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-~~ 216 (282)
T cd06643 144 LADFGVSAKNTRTIQ--RRDSFIGTPYWMAPEVVMCETSK----DRPYDYKADVWSLGITLIEMAQIEPPHHELNPM-RV 216 (282)
T ss_pred Ecccccccccccccc--ccccccccccccCHhhccccCCC----CCCCCccchhhhHHHHHHHHccCCCCccccCHH-HH
Confidence 999999876543222 12345689999999998643221 114788999999999999999999999875432 22
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
...+..... +.......++.++.++|.+||+.||++||++.+++++
T Consensus 217 ~~~~~~~~~-----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 217 LLKIAKSEP-----PTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred HHHHhhcCC-----CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 222222111 1112233578899999999999999999999998864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=297.16 Aligned_cols=253 Identities=27% Similarity=0.457 Sum_probs=193.4
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCc------hhHHHHHHHHHHHHHhhcCCCceeEeeeEEEe
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITD------QSIADSYLNEVELLAKLQGCPYVIKMHDYVYD 330 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~------~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~ 330 (553)
+|.+.+.||.|+||.||+|.+...+. .||+|.+....... ....+.+.+|+.+++++. ||||+++++++..
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~--~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~ 77 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGE--LMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ-HENIVQYLGSSLD 77 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCc--EEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEe
Confidence 47888999999999999998766554 49999987654332 233467889999999995 5999999987754
Q ss_pred CCCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCC
Q psy14267 331 TASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCI 409 (553)
Q Consensus 331 ~~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~ 409 (553)
..+.+++||+. +++|..++..... .....+..++.|++.||+|||++|++||||||+||+++.+
T Consensus 78 --~~~~~lv~e~~~~~~L~~~l~~~~~-----l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~-------- 142 (267)
T cd06628 78 --ADHLNIFLEYVPGGSVAALLNNYGA-----FEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNK-------- 142 (267)
T ss_pred --CCccEEEEEecCCCCHHHHHHhccC-----ccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCC--------
Confidence 45777888875 6689988876532 3344555667899999999999999999999999999776
Q ss_pred CCeEEEEeccCccccCCCCCc----ccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCC
Q psy14267 410 GNVLKIIDFGIACSLQDDKTS----VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY 485 (553)
Q Consensus 410 ~~~vkL~DFGla~~~~~~~~~----~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf 485 (553)
+.++|+|||+++........ .......|+..|+|||.+.+. .++.++|+|||||++|+|++|..||
T Consensus 143 -~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~---------~~~~~~Dv~slG~il~~l~~g~~p~ 212 (267)
T cd06628 143 -GGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQT---------SYTRKADIWSLGCLVVEMLTGKHPF 212 (267)
T ss_pred -CCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccC---------CCCchhhhHHHHHHHHHHhhCCCCC
Confidence 57999999999877532211 111234688999999998765 3678999999999999999999999
Q ss_pred CCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 486 SHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 486 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
...... ..+..+... ..+ .....++..+.++|++||+.||++||++.+++++
T Consensus 213 ~~~~~~-~~~~~~~~~-----~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 213 PDCTQL-QAIFKIGEN-----ASP--EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred CCccHH-HHHHHHhcc-----CCC--cCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 875432 222222211 011 1123578999999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=293.15 Aligned_cols=252 Identities=27% Similarity=0.408 Sum_probs=196.4
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceE
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHL 336 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~ 336 (553)
+|++.+.||+|+||.||+|.+..++. .+|||.+........ ..+.+.+|+++|+++. ||||+.+++.+. ....+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~--~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~~~-~~~i~~~~~~~~--~~~~~ 74 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQK--LVIIKQIPVEQMTKD-ERLAAQNECQVLKLLS-HPNIIEYYENFL--EDKAL 74 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCc--EEEEEEEeccccccH-HHHHHHHHHHHHhhCC-CCchhheeeeEe--cCCEE
Confidence 58999999999999999998876654 499999987665443 3578999999999995 599999988764 45678
Q ss_pred EEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 337 YVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 337 ~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
+++||+. +++|.+++...... ......+..++.+++.||+|||++||+||||||+||+++.+. ..+||
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~--------~~~~l 143 (256)
T cd08220 75 MIVMEYAPGGTLAEYIQKRCNS---LLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHK--------MVVKI 143 (256)
T ss_pred EEEEecCCCCCHHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--------CEEEE
Confidence 8999975 67899998764322 234555666778999999999999999999999999997542 56899
Q ss_pred EeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHH
Q psy14267 416 IDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKM 495 (553)
Q Consensus 416 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~ 495 (553)
+|||++......... ....|+..|+|||.+.+. .++.++||||||+++|+|++|..||...... ...
T Consensus 144 ~d~~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~---------~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-~~~ 210 (256)
T cd08220 144 GDFGISKILSSKSKA---YTVVGTPCYISPELCEGK---------PYNQKSDIWALGCVLYELASLKRAFEAANLP-ALV 210 (256)
T ss_pred ccCCCceecCCCccc---cccccCCcccCchhccCC---------CCCcccchHHHHHHHHHHHhCCCCcccCchH-HHH
Confidence 999999877543321 235689999999998754 3678999999999999999999999775432 222
Q ss_pred HHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 496 LAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 496 ~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
..+.... ... ....++..+.+++.+||..+|++|||+.+++.+
T Consensus 211 ~~~~~~~-~~~------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 211 LKIMSGT-FAP------ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred HHHHhcC-CCC------CCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 2222111 111 112578899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=295.69 Aligned_cols=261 Identities=26% Similarity=0.424 Sum_probs=197.9
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|++.+.||.|+||+||++....++. .+|+|++....... ..+.+.+|+++|+.+. |+||+.+++.+.. ...
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~--~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~ 73 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNE--KVAIKRIDLEKCQT--SVDELRKEVQAMSQCN-HPNVVKYYTSFVV--GDE 73 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCc--EEEEEEeccCCcch--HHHHHHHHHHHHHhcC-CCCEEEEEEEEee--CCE
Confidence 369999999999999999998766554 49999997655433 4578899999999995 5999999887644 567
Q ss_pred EEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
.+++|+++ +++|.++++...... ...+..+..++.|++.||+|||+.||+||||||+||+++++ +.++
T Consensus 74 ~~iv~e~~~~~~l~~~~~~~~~~~--~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~---------~~~~ 142 (267)
T cd06610 74 LWLVMPYLSGGSLLDIMKSSYPRG--GLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGED---------GSVK 142 (267)
T ss_pred EEEEEeccCCCcHHHHHHHhcccC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCC---------CCEE
Confidence 88899875 678888887643211 23445566667899999999999999999999999999876 5699
Q ss_pred EEeccCccccCCCCCcc--cccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchH
Q psy14267 415 IIDFGIACSLQDDKTSV--HKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTW 492 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~--~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~ 492 (553)
|+|||++..+....... ......|+..|+|||++.... .++.++|+|||||++|||++|+.||.......
T Consensus 143 l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~--------~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~ 214 (267)
T cd06610 143 IADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVH--------GYDFKADIWSFGITAIELATGAAPYSKYPPMK 214 (267)
T ss_pred EcccchHHHhccCccccccccccccCChhhcChHHHcccc--------CcCcccchHhHhHHHHHHHhCCCCccccChhh
Confidence 99999998776543321 223456899999999987542 36889999999999999999999998754432
Q ss_pred HHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 493 AKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 493 ~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
......... ...+. .......++..+.++|.+||..||++||++.+|+.+
T Consensus 215 -~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 215 -VLMLTLQND-PPSLE-TGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred -hHHHHhcCC-CCCcC-CccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 222222111 11111 111123678999999999999999999999999874
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=311.30 Aligned_cols=264 Identities=26% Similarity=0.341 Sum_probs=198.0
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
.++|++.+.||+|+||.||++.+..++. .||||.+.+..... .....+.+|+.+++++.+||||+++++++......
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~--~~~vK~~~~~~~~~-~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~ 82 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKE--VVALKKIFDAFRNA-TDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK 82 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCe--EEEEEeeccccCcc-hhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence 3579999999999999999998766554 49999886543222 23456788999999996679999999988666667
Q ss_pred eEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 335 HLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 335 ~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
.++++||++.++|..++... ......+..++.||+.||+|||+.||+||||||+|||++.+ +.+|
T Consensus 83 ~~~lv~e~~~~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~---------~~~k 147 (337)
T cd07852 83 DIYLVFEYMETDLHAVIRAN------ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSD---------CRVK 147 (337)
T ss_pred eEEEEecccccCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC---------CcEE
Confidence 88999999999999888653 22234555567899999999999999999999999999877 6799
Q ss_pred EEeccCccccCCCCCc---ccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCch
Q psy14267 415 IIDFGIACSLQDDKTS---VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNT 491 (553)
Q Consensus 415 L~DFGla~~~~~~~~~---~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~ 491 (553)
|+|||++......... .......|+..|+|||.+.+.. .++.++||||||+++|||++|+.||......
T Consensus 148 l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--------~~~~~sDi~slG~~l~el~tg~~pf~~~~~~ 219 (337)
T cd07852 148 LADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGST--------RYTKGVDMWSVGCILGEMLLGKPLFPGTSTL 219 (337)
T ss_pred EeeccchhccccccccccCcchhcccccccccCceeeeccc--------cccccchHHHHHHHHHHHHhCCCCCCCCChH
Confidence 9999999876543321 1222456899999999886432 3678999999999999999999999764332
Q ss_pred HHHHHHHHhhc-----------------------ccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 492 WAKMLAIARHK-----------------------DQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 492 ~~~~~~i~~~~-----------------------~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
.. ...+.... ......+.......++.++.++|.+||+.||++|||+.+++++
T Consensus 220 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 220 NQ-LEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HH-HHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 11 11111000 0000001011112368899999999999999999999999976
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=292.47 Aligned_cols=253 Identities=26% Similarity=0.415 Sum_probs=195.3
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceE
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHL 336 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~ 336 (553)
.|++.+.||+|+||.||++.+..++. .||+|.+....... ...+.+.+|+++++++. |+||+.+++.+. ..+..+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~--~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~-~~~~~~ 75 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGK--QYVIKKLNLRNASR-RERKAAEQEAQLLSQLK-HPNIVAYRESWE-GEDGLL 75 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCc--EEEEEEEehhhcCH-HHHHHHHHHHHHHHhCC-CCCeeeeeeeec-CCCCEE
Confidence 48999999999999999998876654 49999997655433 33467889999999995 599999987653 235568
Q ss_pred EEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 337 YVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 337 ~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
+++||++ +++|.+++...... ......++.++.|++.||+|||+.||+||||||+||+++.+ +.++|
T Consensus 76 ~lv~e~~~~~~l~~~l~~~~~~---~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~---------~~~~l 143 (257)
T cd08223 76 YIVMGFCEGGDLYHKLKEQKGK---LLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRT---------NIIKV 143 (257)
T ss_pred EEEecccCCCcHHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecC---------CcEEE
Confidence 8999875 57898888764221 23456667777899999999999999999999999999776 57999
Q ss_pred EeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHH
Q psy14267 416 IDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKM 495 (553)
Q Consensus 416 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~ 495 (553)
+|||++........ ......|++.|+|||++.+. .++.++|||||||++|||++|..||...... ...
T Consensus 144 ~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~---------~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~-~~~ 211 (257)
T cd08223 144 GDLGIARVLENQCD--MASTLIGTPYYMSPELFSNK---------PYNYKSDVWALGCCVYEMATLKHAFNAKDMN-SLV 211 (257)
T ss_pred ecccceEEecccCC--ccccccCCcCccChhHhcCC---------CCCchhhhHHHHHHHHHHHcCCCCCCCCCHH-HHH
Confidence 99999987644322 22355689999999998765 3678999999999999999999999764432 222
Q ss_pred HHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 496 LAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 496 ~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
..+.... . + .....+++.+.++|.+||+.+|++||++.+++++
T Consensus 212 ~~~~~~~--~---~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 212 YRIIEGK--L---P--PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred HHHHhcC--C---C--CCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 2222111 1 1 1123578999999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=301.78 Aligned_cols=257 Identities=24% Similarity=0.412 Sum_probs=197.8
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|++.+.||.|+||.||++.+..++ ..||+|++.... ....+.+.+|+++++++. |+||+++++++.. ...
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~--~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~ 76 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETG--LFAAAKIIQIES---EEELEDFMVEIDILSECK-HPNIVGLYEAYFY--ENK 76 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCC--cEEEEEEEeeCC---HHHHHHHHHHHHHHHhCC-CCceeEEEEEEec--CCe
Confidence 56999999999999999999876655 449999987543 344577899999999996 6999999998754 567
Q ss_pred EEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
++++||+. +++|..++..... ......++.++.|++.||.|||+.||+||||||+||+++.+ +.++
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~----~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~---------~~~~ 143 (280)
T cd06611 77 LWILIEFCDGGALDSIMLELER----GLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLD---------GDVK 143 (280)
T ss_pred EEEEeeccCCCcHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCC---------CCEE
Confidence 89999975 5688888776432 24455666778899999999999999999999999999776 5799
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||++........ ......|++.|+|||++...... ...++.++||||||+++|||++|..||...... ..
T Consensus 144 l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~----~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~-~~ 216 (280)
T cd06611 144 LADFGVSAKNKSTLQ--KRDTFIGTPYWMAPEVVACETFK----DNPYDYKADIWSLGITLIELAQMEPPHHELNPM-RV 216 (280)
T ss_pred EccCccchhhccccc--ccceeecchhhcCHHHHhhcccC----CCCCCccccHHHHHHHHHHHHhCCCCcccCCHH-HH
Confidence 999999876543322 12245689999999998644221 113678999999999999999999999875432 22
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
+..+.... .+.+.....++.++.++|.+||..+|.+||++.+++++
T Consensus 217 ~~~~~~~~-----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 217 LLKILKSE-----PPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred HHHHhcCC-----CCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 22222111 11222233578899999999999999999999999876
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=299.78 Aligned_cols=263 Identities=24% Similarity=0.418 Sum_probs=196.6
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC--
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA-- 332 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~-- 332 (553)
.++|.+.+.||+|+||.||++....++. .+|+|++.... .....+.+|+.+++++.+||||+++++++....
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~--~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~ 94 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGS--LAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKL 94 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCC--EEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecccc
Confidence 4579999999999999999998876654 49999986543 123567789999999977899999999876543
Q ss_pred -CceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCC
Q psy14267 333 -SKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIG 410 (553)
Q Consensus 333 -~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~ 410 (553)
...++++||+. +++|.+++...... .....+..+..++.|++.||+|||+.+|+||||||+||+++.+
T Consensus 95 ~~~~~~lv~ey~~~~sL~~~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~--------- 164 (291)
T cd06639 95 VGGQLWLVLELCNGGSVTELVKGLLIC-GQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTE--------- 164 (291)
T ss_pred CCCeeEEEEEECCCCcHHHHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCC---------
Confidence 24688999875 67888887643211 1133455666677899999999999999999999999999766
Q ss_pred CeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCc
Q psy14267 411 NVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN 490 (553)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~ 490 (553)
+.+||+|||++......... .....|+..|+|||++..... ....++.++|||||||++|||++|+.||.....
T Consensus 165 ~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~----~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~ 238 (291)
T cd06639 165 GGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQ----YDYSYDARCDVWSLGITAIELGDGDPPLFDMHP 238 (291)
T ss_pred CCEEEeecccchhccccccc--ccCccCCccccChhhhcCCCC----cccccCCccchHHHHHHHHHHhhCCCCCCCCcH
Confidence 56999999999876543321 124568999999999864321 011368899999999999999999999987543
Q ss_pred hHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 491 TWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 491 ~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
. .....+.... .+.......++..+.++|.+||+.+|++||++.+|+++
T Consensus 239 ~-~~~~~~~~~~-----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 239 V-KTLFKIPRNP-----PPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred H-HHHHHHhcCC-----CCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 2 2222221111 11112223466789999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=292.78 Aligned_cols=253 Identities=26% Similarity=0.441 Sum_probs=198.9
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceE
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHL 336 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~ 336 (553)
+|++.+.||.|+||.||++++..++.. +++|.+....... ...+++.+|+++++++ +|+||+++++++.+ ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~--~~~k~~~~~~~~~-~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~--~~~~ 74 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSL--VVWKEVNLTRLSE-KERRDALNEIVILSLL-QHPNIIAYYNHFMD--DNTL 74 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcE--EEEEEEeecccch-hHHHHHHHHHHHHHhC-CCCCeeEEEeEEec--CCeE
Confidence 589999999999999999988776644 9999988766444 3346789999999999 46999999998754 5678
Q ss_pred EEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 337 YVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 337 ~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
+++||++ +++|.+++..... .......+..++.|++.||+|||+.|++||||||+||+++.+ +.+||
T Consensus 75 ~~~~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~---------~~~kl 142 (256)
T cd08221 75 LIEMEYANGGTLYDKIVRQKG---QLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKA---------GLIKL 142 (256)
T ss_pred EEEEEecCCCcHHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCC---------CCEEE
Confidence 8899975 5799998876532 133455666677899999999999999999999999999876 57999
Q ss_pred EeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHH
Q psy14267 416 IDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKM 495 (553)
Q Consensus 416 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~ 495 (553)
+|||++........ ......|++.|+|||.+.+. .++.++||||||+++|||++|..||...... ...
T Consensus 143 ~d~~~~~~~~~~~~--~~~~~~~~~~y~ape~~~~~---------~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-~~~ 210 (256)
T cd08221 143 GDFGISKILGSEYS--MAETVVGTPYYMSPELCQGV---------KYNFKSDIWALGCVLYELLTLKRTFDATNPL-NLV 210 (256)
T ss_pred CcCcceEEcccccc--cccccCCCccccCHhhcCCC---------CCCCcchhHHHHHHHHHHHHCCCCCCCCCHH-HHH
Confidence 99999987654432 12355689999999998755 3678899999999999999999999764322 222
Q ss_pred HHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q psy14267 496 LAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQI 546 (553)
Q Consensus 496 ~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L 546 (553)
..+..... .+ ....++.++.++|.+||..+|++||++.++++++
T Consensus 211 ~~~~~~~~----~~---~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 211 VKIVQGNY----TP---VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred HHHHcCCC----CC---CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 23222111 11 1135788999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=295.17 Aligned_cols=257 Identities=24% Similarity=0.396 Sum_probs=195.9
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|++.+.||.|+||.||+|.+..++. .+|+|++...... ..+.+.+|+++++++. ||||+++++++.. ...
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~--~~~ik~~~~~~~~---~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~--~~~ 74 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGE--LVAIKVIKLEPGD---DFEIIQQEISMLKECR-HPNIVAYFGSYLR--RDK 74 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCC--EEEEEEEEcCchh---hHHHHHHHHHHHHhCC-CCChhceEEEEEe--CCE
Confidence 579999999999999999998876654 4999999765422 3578899999999995 5999999887744 567
Q ss_pred EEEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
++++||+.+ ++|.+++..... ......+..++.|++.||+|||+++|+||||||+||+++.+ +.+|
T Consensus 75 ~~l~~e~~~~~~l~~~~~~~~~----~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~---------~~~~ 141 (262)
T cd06613 75 LWIVMEYCGGGSLQDIYQVTRG----PLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTED---------GDVK 141 (262)
T ss_pred EEEEEeCCCCCcHHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCC---------CCEE
Confidence 899999755 678887766421 23355566777899999999999999999999999999876 5799
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||++........ ......++..|+|||.+..... ..++.++|||||||++|||++|..||........
T Consensus 142 l~d~g~~~~~~~~~~--~~~~~~~~~~y~~Pe~~~~~~~------~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~- 212 (262)
T cd06613 142 LADFGVSAQLTATIA--KRKSFIGTPYWMAPEVAAVERK------GGYDGKCDIWALGITAIELAELQPPMFDLHPMRA- 212 (262)
T ss_pred ECccccchhhhhhhh--ccccccCCccccCchhhccccc------CCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-
Confidence 999999977654321 1224568999999999865411 1367899999999999999999999987554322
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
...+...... .+.......++.++.++|++||..+|.+|||+++++.+
T Consensus 213 ~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 213 LFLISKSNFP---PPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred HHHHHhccCC---CccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 2222211111 11112223467889999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=303.82 Aligned_cols=261 Identities=19% Similarity=0.343 Sum_probs=195.3
Q ss_pred cCcceEEEeeeeeeCceEEEEEeeeCCCcc--ceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeC
Q psy14267 254 NGKQYQVLSLLGKGGSSSVYLVGGTSEHEF--KPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDT 331 (553)
Q Consensus 254 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~--~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~ 331 (553)
...+|++.+.||+|+||.||++.+...+.. ..||+|++..... ......+.+|+.+++++ +||||+++++++...
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~ 81 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG--PKANVEFMDEALIMASM-DHPHLVRLLGVCLSP 81 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC--HHHHHHHHHHHHHHHhC-CCCCcccEEEEEcCC
Confidence 346799999999999999999987655542 2478898865432 23335688999999999 569999999977532
Q ss_pred CCceEEEEEec-CCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCC
Q psy14267 332 ASKHLYVLMEK-GDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIG 410 (553)
Q Consensus 332 ~~~~~~iv~e~-~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~ 410 (553)
..++++++ .+++|.+++..... ......+..++.|++.||+|||+++|+||||||+|||++.+
T Consensus 82 ---~~~~v~e~~~~g~l~~~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~--------- 145 (303)
T cd05110 82 ---TIQLVTQLMPHGCLLDYVHEHKD----NIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSP--------- 145 (303)
T ss_pred ---CceeeehhcCCCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCC---------
Confidence 34556664 56889988876432 23344556667899999999999999999999999999765
Q ss_pred CeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCCC
Q psy14267 411 NVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHIP 489 (553)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~~ 489 (553)
+.+||+|||+++.+.............++..|+|||.+.+. .++.++|||||||++|||++ |..||.+..
T Consensus 146 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~---------~~~~~~DiwslG~~l~el~t~g~~p~~~~~ 216 (303)
T cd05110 146 NHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYR---------KFTHQSDVWSYGVTIWELMTFGGKPYDGIP 216 (303)
T ss_pred CceEEccccccccccCcccccccCCCccccccCCHHHhccC---------CCChHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 56999999999876543332222234467799999998755 37889999999999999997 999997754
Q ss_pred chHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q psy14267 490 NTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNP 550 (553)
Q Consensus 490 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~ 550 (553)
.. ....+....... .....++..+.++|..||..+|++||++.++++.|+...
T Consensus 217 ~~--~~~~~~~~~~~~------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~ 269 (303)
T cd05110 217 TR--EIPDLLEKGERL------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA 269 (303)
T ss_pred HH--HHHHHHHCCCCC------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 32 222222222111 112346789999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=303.66 Aligned_cols=253 Identities=24% Similarity=0.346 Sum_probs=196.7
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
+.|.+.+.||+|+||.||++.....+. .||+|++...........+.+.+|+.+++.+. ||||+++++++.+ ...
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~--~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~--~~~ 89 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNE--VVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR-HPNTIEYKGCYLR--EHT 89 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCc--EEEEEEEeccccCcHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEEe--CCe
Confidence 469999999999999999998776654 49999997665454555678899999999995 6999999998764 556
Q ss_pred EEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 336 LYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 336 ~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
.+++||+..+++.+++..... ......+..++.|++.||.|||+.||+||||+|+||+++.+ +.++|
T Consensus 90 ~~lv~e~~~g~l~~~~~~~~~----~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~---------~~~kL 156 (307)
T cd06607 90 AWLVMEYCLGSASDILEVHKK----PLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEP---------GTVKL 156 (307)
T ss_pred EEEEHHhhCCCHHHHHHHccc----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCC---------CCEEE
Confidence 889999988998888765432 23455566677899999999999999999999999999776 57999
Q ss_pred EeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHH
Q psy14267 416 IDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKM 495 (553)
Q Consensus 416 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~ 495 (553)
+|||++....... ...|++.|+|||++.+.. ...++.++||||||+++|||++|..||........ .
T Consensus 157 ~dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~------~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~-~ 223 (307)
T cd06607 157 ADFGSASLVSPAN------SFVGTPYWMAPEVILAMD------EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-L 223 (307)
T ss_pred eecCcceecCCCC------CccCCccccCceeeeccC------CCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH-H
Confidence 9999987654322 446888999999985321 11478899999999999999999999977543221 1
Q ss_pred HHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 496 LAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 496 ~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
..+.. ... +.. ....++..+.++|.+||..+|++||++.+++.+
T Consensus 224 ~~~~~-~~~----~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 224 YHIAQ-NDS----PTL-SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred HHHhc-CCC----CCC-CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 11111 111 111 112467899999999999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=294.79 Aligned_cols=265 Identities=20% Similarity=0.327 Sum_probs=189.1
Q ss_pred eeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEEEEEe
Q psy14267 262 SLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLME 341 (553)
Q Consensus 262 ~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~iv~e 341 (553)
+.||+|+||.||+++.........+++|.+..... ....+.+.+|+.+++.+. ||||+++++++.. ...++++||
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~--~~~~~lv~e 75 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS--SKEQNEFLQQGDPYRILQ-HPNILQCLGQCVE--AIPYLLVFE 75 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC--hHHHHHHHHHHHHHhccC-CcchhheEEEecC--CCccEEEEe
Confidence 36999999999999766555545567777655432 233578999999999995 5999999987753 557889999
Q ss_pred cCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEeccC
Q psy14267 342 KGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGI 420 (553)
Q Consensus 342 ~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGl 420 (553)
++. ++|.+++...... ........+..++.||+.||+|||+.+|+||||||+|||++.+ +.+||+|||+
T Consensus 76 ~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~---------~~~~l~Dfg~ 145 (268)
T cd05086 76 YCELGDLKSYLSQEQWH-RRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSD---------LTVKVGDYGI 145 (268)
T ss_pred cCCCCcHHHHHHhhhcc-cccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCC---------ccEEeccccc
Confidence 754 7999998764322 1233444556667899999999999999999999999999776 5799999999
Q ss_pred ccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHH
Q psy14267 421 ACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHIPNTWAKMLAIA 499 (553)
Q Consensus 421 a~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~i~ 499 (553)
+................|+..|+|||++...... .....++.++|||||||++|||++ |..||...... ..+..+.
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~--~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-~~~~~~~ 222 (268)
T cd05086 146 GPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGG--LITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR-EVLNHVI 222 (268)
T ss_pred ccccCcchhhhcccCCcCcccccCchhcccccCc--cccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHH
Confidence 8653322211112245688999999998643211 112246889999999999999996 67888765443 2222222
Q ss_pred hhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q psy14267 500 RHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQIN 547 (553)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~ 547 (553)
.........+.+. ..+++.+.++|..|| .+|++||++++|++.|.
T Consensus 223 ~~~~~~~~~~~~~--~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 223 KDQQVKLFKPQLE--LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred hhcccccCCCccC--CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 2211111222222 246789999999999 68999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=310.67 Aligned_cols=258 Identities=24% Similarity=0.336 Sum_probs=193.3
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC--
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA-- 332 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~-- 332 (553)
.++|++.+.||+|+||.||+|.+..++. .||||++.+... .......+.+|+.+++++. |+||+++++++....
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~--~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 90 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQ--NVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVN-HKNIIGLLNVFTPQKSL 90 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCC--EEEEEecCcccc-ChhHHHHHHHHHHHHHhcC-CCCCcceeeeeccCCCc
Confidence 4679999999999999999998877664 499999865432 2334467889999999995 599999998775432
Q ss_pred --CceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCC
Q psy14267 333 --SKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIG 410 (553)
Q Consensus 333 --~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~ 410 (553)
..+.|++||++.++|.+++... .....+..++.|++.||+|||++||+||||||+|||++.+
T Consensus 91 ~~~~~~~lv~e~~~~~l~~~~~~~-------l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~--------- 154 (353)
T cd07850 91 EEFQDVYLVMELMDANLCQVIQMD-------LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD--------- 154 (353)
T ss_pred cccCcEEEEEeccCCCHHHHHhhc-------CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCC---------
Confidence 2467999999999998887643 2344555667899999999999999999999999999776
Q ss_pred CeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCc
Q psy14267 411 NVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN 490 (553)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~ 490 (553)
+.+||+|||+++....... .....|+..|+|||++.+. .++.++|||||||++|+|++|+.||.....
T Consensus 155 ~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~---------~~~~~~DvwslG~~l~~l~~g~~pf~~~~~ 222 (353)
T cd07850 155 CTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGM---------GYKENVDIWSVGCIMGEMIRGTVLFPGTDH 222 (353)
T ss_pred CCEEEccCccceeCCCCCC---CCCCcccccccCHHHHhCC---------CCCCchhhHhHHHHHHHHHHCCCCCCCCCH
Confidence 5799999999987644322 2245689999999999765 368899999999999999999999976432
Q ss_pred hHHHHHHHHhhc----------------------ccc------------cccccccC-CCCCCHHHHHHHHHhcccCCCC
Q psy14267 491 TWAKMLAIARHK----------------------DQI------------EFKPQLAN-NVTIPPTLLQSMKLCLQKDPKA 535 (553)
Q Consensus 491 ~~~~~~~i~~~~----------------------~~~------------~~~~~~~~-~~~~s~~l~~li~~cL~~dP~~ 535 (553)
. .....+.... ... .+...... ....+..++++|.+||+.||++
T Consensus 223 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 301 (353)
T cd07850 223 I-DQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEK 301 (353)
T ss_pred H-HHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhh
Confidence 1 1111110000 000 00000000 1134667899999999999999
Q ss_pred CCCHHHHHHH
Q psy14267 536 RPTVGNSVTQ 545 (553)
Q Consensus 536 RPt~~ell~~ 545 (553)
|||+.|++.+
T Consensus 302 R~t~~eiL~~ 311 (353)
T cd07850 302 RISVDDALQH 311 (353)
T ss_pred CcCHHHHhcC
Confidence 9999999976
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=312.62 Aligned_cols=254 Identities=24% Similarity=0.387 Sum_probs=201.3
Q ss_pred EecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeC
Q psy14267 252 TLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDT 331 (553)
Q Consensus 252 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~ 331 (553)
.+....|+.-++||+|+||.||.++...++.. ||+|.+.++.+.........++|.+||.++.. ++||.+- |.+.+
T Consensus 181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKM--YAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s-~FiVsla-YAfeT 256 (591)
T KOG0986|consen 181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKM--YACKKLDKKRIKKRKGETMALNEKQILEKVSS-PFIVSLA-YAFET 256 (591)
T ss_pred hccccceeeeEEEecccccceeEEEEecchhh--HHHHHHHHHHHHHhhhhHHhhHHHHHHHHhcc-CcEEEEe-eeecC
Confidence 34456799999999999999999988888766 99999988877766666778999999999965 8999884 34444
Q ss_pred CCceEEEEEe-cCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCC
Q psy14267 332 ASKHLYVLME-KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIG 410 (553)
Q Consensus 332 ~~~~~~iv~e-~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~ 410 (553)
...+++||. +.||||.-+|-+.+. ..+.+..+++++++|+.||++||..+||+|||||+|||||+.
T Consensus 257 -kd~LClVLtlMNGGDLkfHiyn~g~---~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~--------- 323 (591)
T KOG0986|consen 257 -KDALCLVLTLMNGGDLKFHIYNHGN---PGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDH--------- 323 (591)
T ss_pred -CCceEEEEEeecCCceeEEeeccCC---CCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccC---------
Confidence 445555555 788999888877654 356677888999999999999999999999999999999887
Q ss_pred CeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCc
Q psy14267 411 NVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN 490 (553)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~ 490 (553)
|+|.|+|.|||..+..+... ...+||.+|||||++..+ .|+...|+|||||+||||+.|+.||.....
T Consensus 324 GhvRISDLGLAvei~~g~~~---~~rvGT~GYMAPEvl~ne---------~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke 391 (591)
T KOG0986|consen 324 GHVRISDLGLAVEIPEGKPI---RGRVGTVGYMAPEVLQNE---------VYDFSPDWFSLGCLLYEMIAGHSPFRQRKE 391 (591)
T ss_pred CCeEeeccceEEecCCCCcc---ccccCcccccCHHHHcCC---------cccCCccHHHHHhHHHHHHcccCchhhhhh
Confidence 78999999999998876643 245899999999999877 478899999999999999999999976322
Q ss_pred hHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCH
Q psy14267 491 TWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTV 539 (553)
Q Consensus 491 ~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~ 539 (553)
. .....+. +........-...++++++++.+.+|++||++|..-
T Consensus 392 K-vk~eEvd----rr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 392 K-VKREEVD----RRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred h-hhHHHHH----HHHhcchhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 1 1111111 111111122234788999999999999999999753
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=302.51 Aligned_cols=258 Identities=22% Similarity=0.401 Sum_probs=192.5
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceE
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHL 336 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~ 336 (553)
+|++.+.||+|+||.||++.+...+. .||+|.+.+.........+.+.+|+.+++.+. ||||+++++.+. ...++
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~--~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~--~~~~~ 76 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQ--RFAMKKINKQNLILRNQIQQVFVERDILTFAE-NPFVVSMFCSFE--TKRHL 76 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCc--EEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeeEEEEe--cCCEE
Confidence 68999999999999999998877664 49999998765444455577889999999985 599999988763 46688
Q ss_pred EEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 337 YVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 337 ~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
+++||+. +++|.+++.... ......+..++.|++.||+|||+.+|+||||||+|||++.+ +.+||
T Consensus 77 ~lv~e~~~g~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~---------~~~~l 142 (305)
T cd05609 77 CMVMEYVEGGDCATLLKNIG-----ALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSM---------GHIKL 142 (305)
T ss_pred EEEEecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCC---------CCEEE
Confidence 9999975 568999987643 23344555566799999999999999999999999999766 67999
Q ss_pred EeccCccccCCCC-------------CcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCC
Q psy14267 416 IDFGIACSLQDDK-------------TSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGR 482 (553)
Q Consensus 416 ~DFGla~~~~~~~-------------~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~ 482 (553)
+|||+++...... .........|+..|+|||.+... .++.++|+|||||++|||++|.
T Consensus 143 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~vl~el~~g~ 213 (305)
T cd05609 143 TDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQ---------GYGKPVDWWAMGIILYEFLVGC 213 (305)
T ss_pred eeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCC---------CCCchhhHHHHHHHHHHHHhCC
Confidence 9999986421100 00011134578899999998765 3688999999999999999999
Q ss_pred CCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q psy14267 483 TPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINN 548 (553)
Q Consensus 483 ~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~ 548 (553)
.||.+.... .....+.... ... + .....++.++.++|.+||+.+|++||+..++++.|+.
T Consensus 214 ~pf~~~~~~-~~~~~~~~~~--~~~-~--~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 214 VPFFGDTPE-ELFGQVISDD--IEW-P--EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred CCCCCCCHH-HHHHHHHhcc--cCC-C--CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 999864432 2222221111 111 1 1112578999999999999999999996555555443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=295.01 Aligned_cols=261 Identities=21% Similarity=0.332 Sum_probs=196.4
Q ss_pred cCcceEEEeeeeeeCceEEEEEeeeCCCc-cceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC
Q psy14267 254 NGKQYQVLSLLGKGGSSSVYLVGGTSEHE-FKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA 332 (553)
Q Consensus 254 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~-~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~ 332 (553)
...+|+..+.||+|+||.||+|.....+. ...+|+|.++.... ....+.+.+|+++++++. |+||+++.+++. .
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~ 77 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT--EKQRQDFLSEASIMGQFS-HHNIIRLEGVVT--K 77 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC--HHHHHHHHHHHHHHhcCC-CCCeeEEEEEEc--c
Confidence 34579999999999999999998765432 34689998865432 233567899999999995 599999998774 4
Q ss_pred CceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCC
Q psy14267 333 SKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGN 411 (553)
Q Consensus 333 ~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~ 411 (553)
....+++||+. +++|..++..... ......+..++.|++.||+|||+.||+||||||+||+++.+ +
T Consensus 78 ~~~~~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~---------~ 144 (268)
T cd05063 78 FKPAMIITEYMENGALDKYLRDHDG----EFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSN---------L 144 (268)
T ss_pred CCCcEEEEEcCCCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCC---------C
Confidence 55778899964 5688888865432 23445566677899999999999999999999999999766 5
Q ss_pred eEEEEeccCccccCCCCCcccc-cCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCCC
Q psy14267 412 VLKIIDFGIACSLQDDKTSVHK-DTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHIP 489 (553)
Q Consensus 412 ~vkL~DFGla~~~~~~~~~~~~-~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~~ 489 (553)
.+||+|||++............ .....+..|+|||++... .++.++|||||||++|||++ |..||....
T Consensus 145 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~---------~~~~~~Dv~slG~il~ell~~g~~p~~~~~ 215 (268)
T cd05063 145 ECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYR---------KFTSASDVWSFGIVMWEVMSFGERPYWDMS 215 (268)
T ss_pred cEEECCCccceecccccccceeccCCCcCceecCHHHhhcC---------CcChHhHHHHHHHHHHHHHhCCCCCCCcCC
Confidence 7999999999876543221111 112235679999998754 36889999999999999997 999997644
Q ss_pred chHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 490 NTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 490 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
.. .....+.. .. .......++.++.+++.+||..+|++||++.++++.|+++
T Consensus 216 ~~-~~~~~i~~-~~------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 216 NH-EVMKAIND-GF------RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HH-HHHHHHhc-CC------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 32 22222221 11 1112235789999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=295.77 Aligned_cols=254 Identities=24% Similarity=0.385 Sum_probs=191.7
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcC---chhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCC
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDIT---DQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTAS 333 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~---~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~ 333 (553)
+|++.+.||.|+||.||++... .+ +.+|||.+...... .......+.+|+++|+++. |+||+++++++.+ .
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~--~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~ 74 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QG--QLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK-HVNIVQYLGTCLD--D 74 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CC--CeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcC-CCCEeeEeeEeec--C
Confidence 4888999999999999999653 33 34999998754321 2234467889999999996 5999999998754 4
Q ss_pred ceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCe
Q psy14267 334 KHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNV 412 (553)
Q Consensus 334 ~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~ 412 (553)
..++++||+. +++|.+++.+... .....+..++.|++.||+|||+.+|+|+||||+||+++.+ +.
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~---------~~ 140 (265)
T cd06631 75 NTISIFMEFVPGGSISSILNRFGP-----LPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPN---------GI 140 (265)
T ss_pred CeEEEEEecCCCCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCC---------Ce
Confidence 6888999975 6789998876432 2345555667899999999999999999999999999766 67
Q ss_pred EEEEeccCccccCCCCC----cccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy14267 413 LKIIDFGIACSLQDDKT----SVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHI 488 (553)
Q Consensus 413 vkL~DFGla~~~~~~~~----~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~ 488 (553)
++|+|||++........ ........|+..|+|||.+.+. .++.++|||||||++|+|++|..||...
T Consensus 141 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~---------~~~~~~Dv~slG~~~~~l~~g~~p~~~~ 211 (265)
T cd06631 141 IKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES---------GYGRKSDIWSIGCTVFEMATGKPPLASM 211 (265)
T ss_pred EEeccchhhHhhhhccccccccccccccCCCccccChhhhcCC---------CCcchhhHHHHHHHHHHHHhCCCccccC
Confidence 99999999876532111 1112245689999999999765 3678999999999999999999999865
Q ss_pred CchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 489 PNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 489 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
..... ...+...... .+ .....++.++.++|++||..+|++||++.+++.+
T Consensus 212 ~~~~~-~~~~~~~~~~---~~--~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 212 DRLAA-MFYIGAHRGL---MP--RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred ChHHH-HHHhhhccCC---CC--CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 43322 2222111111 11 1123578999999999999999999999999863
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=294.47 Aligned_cols=256 Identities=21% Similarity=0.340 Sum_probs=187.1
Q ss_pred eeeeeeCceEEEEEeeeCC-CccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEEEEE
Q psy14267 262 SLLGKGGSSSVYLVGGTSE-HEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLM 340 (553)
Q Consensus 262 ~~LG~G~fG~Vy~a~~~~~-~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~iv~ 340 (553)
+.||+|+||.||+|..... .....||||.+... ......+.+.+|+.+++.+ +||||+.+++++... +...+++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-~~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDF-SHPNVLSLLGICLPS-EGSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccC-CCCCcceEEEEeecC-CCCcEEEE
Confidence 4689999999999987543 23356999987532 2233457888999999998 569999999866543 34566777
Q ss_pred ec-CCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEecc
Q psy14267 341 EK-GDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFG 419 (553)
Q Consensus 341 e~-~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFG 419 (553)
++ .+++|.+++...... .....+..++.|++.||+|||+.+|+||||||+|||++.+ +.+||+|||
T Consensus 77 e~~~~~~L~~~~~~~~~~----~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~---------~~~kl~dfg 143 (262)
T cd05058 77 PYMKHGDLRNFIRSETHN----PTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDES---------FTVKVADFG 143 (262)
T ss_pred ecCCCCCHHHHHHhcCCC----CCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCC---------CcEEECCcc
Confidence 75 568999998764322 2233445666799999999999999999999999999776 579999999
Q ss_pred CccccCCCCCc--ccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCCCchHHHHH
Q psy14267 420 IACSLQDDKTS--VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHIPNTWAKML 496 (553)
Q Consensus 420 la~~~~~~~~~--~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~~~~~~~~~ 496 (553)
+++........ .......++..|+|||.+... .++.++|||||||++|||++ |.+||...... ....
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~-~~~~ 213 (262)
T cd05058 144 LARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQ---------KFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF-DITV 213 (262)
T ss_pred ccccccCCcceeecccccCcCCccccChhHhccC---------ccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH-HHHH
Confidence 99765432211 111133467789999998654 36889999999999999999 56677654322 2222
Q ss_pred HHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q psy14267 497 AIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNPE 551 (553)
Q Consensus 497 ~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~~ 551 (553)
.+... .. ......+++.+.+++.+||..+|++||++.+++..|+++..
T Consensus 214 ~~~~~-~~------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 214 YLLQG-RR------LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred HHhcC-CC------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 22111 11 11122467899999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=300.43 Aligned_cols=246 Identities=22% Similarity=0.375 Sum_probs=181.9
Q ss_pred eeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhh--cCCCceeEeeeEEEeCCCceEEEEE
Q psy14267 263 LLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKL--QGCPYVIKMHDYVYDTASKHLYVLM 340 (553)
Q Consensus 263 ~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l--~~hp~Iv~l~~~~~~~~~~~~~iv~ 340 (553)
+||+|+||.||++.+..++. .||+|.+.+...........+.+|..+++.+ .+||+|+.+++++.. .+..+++|
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~--~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~ 76 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGK--MYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT--PDKLCFIL 76 (279)
T ss_pred CcccCCCeEEEEEEECCCCc--EEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec--CCeEEEEE
Confidence 48999999999998876654 4999999876544333334455665555444 357999999876643 45778888
Q ss_pred ec-CCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEecc
Q psy14267 341 EK-GDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFG 419 (553)
Q Consensus 341 e~-~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFG 419 (553)
|+ .+++|..++.... ...+..+..++.|++.||+|||+++|+||||||+|||++.+ +.++|+|||
T Consensus 77 e~~~~~~L~~~i~~~~-----~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~---------~~~~l~dfg 142 (279)
T cd05633 77 DLMNGGDLHYHLSQHG-----VFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEH---------GHVRISDLG 142 (279)
T ss_pred ecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCC---------CCEEEccCC
Confidence 86 5678888887543 34456667778899999999999999999999999999776 579999999
Q ss_pred CccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCch-HHHHHHH
Q psy14267 420 IACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNT-WAKMLAI 498 (553)
Q Consensus 420 la~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~-~~~~~~i 498 (553)
++........ ....|+..|+|||.+.... .++.++|||||||++|||++|..||...... .......
T Consensus 143 ~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~--------~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 210 (279)
T cd05633 143 LACDFSKKKP----HASVGTHGYMAPEVLQKGT--------AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM 210 (279)
T ss_pred cceeccccCc----cCcCCCcCccCHHHhcCCC--------CCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH
Confidence 9876543322 2446899999999986321 3678999999999999999999999764321 1111111
Q ss_pred HhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q psy14267 499 ARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARP-----TVGNSVTQ 545 (553)
Q Consensus 499 ~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RP-----t~~ell~~ 545 (553)
. .... ......++.++.++|.+||..||++|| +++++++|
T Consensus 211 ~-~~~~------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 211 T-LTVN------VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred h-hcCC------cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 1 1111 111235789999999999999999999 59988876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=296.27 Aligned_cols=263 Identities=20% Similarity=0.376 Sum_probs=198.5
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCC---ccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeC
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEH---EFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDT 331 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~---~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~ 331 (553)
.++|++++.||+|+||.||+|+.+... ..+.||+|.+.... .....+.+.+|+++|+++. |+||+++++++ .
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~--~ 78 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLS-HKNVVRLLGLC--R 78 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcC-CcceeeeEEEE--C
Confidence 467999999999999999999875432 33569999886543 2234578999999999994 69999998876 3
Q ss_pred CCceEEEEEecCC-CCHHHHHHHcccCC----CCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCcccee
Q psy14267 332 ASKHLYVLMEKGD-TDLSKYMRNLNKMT----TLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKII 406 (553)
Q Consensus 332 ~~~~~~iv~e~~~-~~L~~~l~~~~~~~----~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~ 406 (553)
.....+++||++. ++|.+++....... ........+..++.|++.||+|||+.+|+||||||+|||++.+
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~----- 153 (275)
T cd05046 79 EAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQ----- 153 (275)
T ss_pred CCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCC-----
Confidence 4567789999764 79999987654211 1134566677778899999999999999999999999999776
Q ss_pred cCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCC
Q psy14267 407 DCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPY 485 (553)
Q Consensus 407 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf 485 (553)
+.++|+|||++........ .......++..|+|||.+.+. .++.++||||||+++|+|++ |..||
T Consensus 154 ----~~~~l~~~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~---------~~~~~~Di~slG~~l~~l~~~~~~p~ 219 (275)
T cd05046 154 ----REVKVSLLSLSKDVYNSEY-YKLRNALIPLRWLAPEAVQED---------DFSTKSDVWSFGVLMWEVFTQGELPF 219 (275)
T ss_pred ----CcEEEcccccccccCcccc-cccCCceeEEeecChhhhccC---------CCCchhhHHHHHHHHHHHHhCCCCCc
Confidence 5799999999875543221 122234567889999998755 25789999999999999998 88999
Q ss_pred CCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q psy14267 486 SHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINN 548 (553)
Q Consensus 486 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~ 548 (553)
...... .....+...... +.....++..+.++|.+||..+|++||++.+++..|.+
T Consensus 220 ~~~~~~-~~~~~~~~~~~~------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 220 YGLSDE-EVLNRLQAGKLE------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred cccchH-HHHHHHHcCCcC------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 765432 222222211111 11223678999999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=301.75 Aligned_cols=263 Identities=25% Similarity=0.448 Sum_probs=200.5
Q ss_pred EEecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEe
Q psy14267 251 ITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYD 330 (553)
Q Consensus 251 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~ 330 (553)
+.+..++|++.+.||+|+||.||++.+..++. .||||++++..... ....+..|+.++.++..|+||+++++++..
T Consensus 10 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~--~~avK~~~~~~~~~--~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~ 85 (296)
T cd06618 10 YPADLNDLENLGEIGSGTCGQVYKMRFKKTGH--VMAVKQMRRTGNKE--ENKRILMDLDVVLKSHDCPYIVKCYGYFIT 85 (296)
T ss_pred ccCCcchheeeeEeeccCCeEEEEEEECCCCe--EEEEEEEeccCChH--HHHHHHHHHHHHHhccCCCchHhhheeeec
Confidence 34556789999999999999999998876554 49999997654322 235677888888888778999999998754
Q ss_pred CCCceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhh-CCcEecCCCCCCEEEecCccceecCC
Q psy14267 331 TASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHA-AGIIHSDLKPANFLFVGNVLKIIDCI 409 (553)
Q Consensus 331 ~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~-~gIiHrDLKp~NILl~~~~~~~~~~~ 409 (553)
...++++||+.++.+..++..... ......+..++.|++.||+|||+ .||+||||+|+||+++.+
T Consensus 86 --~~~~~~v~e~~~~~l~~l~~~~~~----~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~-------- 151 (296)
T cd06618 86 --DSDVFICMELMSTCLDKLLKRIQG----PIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDAS-------- 151 (296)
T ss_pred --CCeEEEEeeccCcCHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCC--------
Confidence 567899999998888887766432 34445566677899999999997 699999999999999766
Q ss_pred CCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy14267 410 GNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIP 489 (553)
Q Consensus 410 ~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~ 489 (553)
+.+||+|||++..+...... ....++..|+|||.+.+....+ .++.++||||||+++|||++|+.||....
T Consensus 152 -~~~kL~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~-----~~~~~~Di~slG~il~el~~g~~p~~~~~ 222 (296)
T cd06618 152 -GNVKLCDFGISGRLVDSKAK---TRSAGCAAYMAPERIDPPDPNP-----KYDIRADVWSLGISLVELATGQFPYKNCK 222 (296)
T ss_pred -CCEEECccccchhccCCCcc---cCCCCCccccCHhhcCCCCCcc-----ccccchhHHHHHHHHHHHHhCCCCCCcch
Confidence 57999999999776543321 2335788999999997553111 36889999999999999999999997644
Q ss_pred chHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 490 NTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 490 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
...+.+..+.... .+.......++.++.+||.+||..||++||++.+++.+
T Consensus 223 ~~~~~~~~~~~~~-----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 223 TEFEVLTKILQEE-----PPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred hHHHHHHHHhcCC-----CCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 4333333222211 11112222578899999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG1094|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=308.12 Aligned_cols=272 Identities=18% Similarity=0.300 Sum_probs=213.5
Q ss_pred cceEEecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeE
Q psy14267 248 QDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDY 327 (553)
Q Consensus 248 ~~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~ 327 (553)
..+.++..+...++++||+|.||+|.+++-.. ...||||.++..... .....|.+|+++|.+|+ ||||+.+++.
T Consensus 530 ~al~EfPRs~L~~~ekiGeGqFGEVhLCeveg---~lkVAVK~Lr~~a~~--~~r~~F~kEIkiLsqLk-hPNIveLvGV 603 (807)
T KOG1094|consen 530 PALVEFPRSRLRFKEKIGEGQFGEVHLCEVEG---PLKVAVKILRPDATK--NARNDFLKEIKILSRLK-HPNIVELLGV 603 (807)
T ss_pred cchhhcchhheehhhhhcCcccceeEEEEecC---ceEEEEeecCcccch--hHHHHHHHHHHHHhccC-CCCeeEEEee
Confidence 44556677889999999999999999996543 345999999876533 33578999999999995 5999999998
Q ss_pred EEeCCCceEEEEEec-CCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCcccee
Q psy14267 328 VYDTASKHLYVLMEK-GDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKII 406 (553)
Q Consensus 328 ~~~~~~~~~~iv~e~-~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~ 406 (553)
|.. ++.++|++|| ..|+|.+|+.+..... ......+.++.||+.||+||.+.++|||||.+.|+|++.+
T Consensus 604 C~~--DePicmI~EYmEnGDLnqFl~aheapt---~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e----- 673 (807)
T KOG1094|consen 604 CVQ--DDPLCMITEYMENGDLNQFLSAHELPT---AETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGE----- 673 (807)
T ss_pred eec--CCchHHHHHHHhcCcHHHHHHhccCcc---cccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCc-----
Confidence 854 5567777775 4499999999874433 1223344467799999999999999999999999999988
Q ss_pred cCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHH--hCCCC
Q psy14267 407 DCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI--YGRTP 484 (553)
Q Consensus 407 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ell--tG~~P 484 (553)
.++||+|||+++.+-.+.........+-.++|||+|.+... +++.++|+|+||++|||++ +..-|
T Consensus 674 ----~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillg---------kFttaSDvWafgvTlwE~~~~C~e~P 740 (807)
T KOG1094|consen 674 ----FTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLG---------KFTTASDVWAFGVTLWEVFMLCREQP 740 (807)
T ss_pred ----ccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhc---------cccchhhhhhhHHHHHHHHHHHhhCc
Confidence 47999999999977666554333345567899999999766 5899999999999999987 58899
Q ss_pred CCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 485 YSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 485 f~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
|..+.++ +.................+..+.-|+..+.++|-+||+.|-++||++++|...|.+.
T Consensus 741 y~~lt~e-~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 741 YSQLTDE-QVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred hhhhhHH-HHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 9987664 333333322233333344556668999999999999999999999999999998764
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=309.76 Aligned_cols=265 Identities=25% Similarity=0.336 Sum_probs=198.3
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCC--
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTAS-- 333 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~-- 333 (553)
.+|.+.+.||+|+||+||++.+..++. .||||.+....... .....+.+|+.+++.+. |+||+++++++.....
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~--~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~~~~~~ 80 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNE--KVAIKKIANAFDNR-IDAKRTLREIKLLRHLD-HENVIAIKDIMPPPHREA 80 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCC--eEEEEEeccccccc-chhHHHHHHHHHHHhcC-CCCccchHHheecccccc
Confidence 579999999999999999998876664 49999987643222 33467789999999995 5999999987754432
Q ss_pred -ceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCe
Q psy14267 334 -KHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNV 412 (553)
Q Consensus 334 -~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~ 412 (553)
..++++|++.+++|.+++.... ......+..++.|++.||+|||+++++||||||+|||++.+ +.
T Consensus 81 ~~~~~lv~e~~~~~L~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~---------~~ 146 (337)
T cd07858 81 FNDVYIVYELMDTDLHQIIRSSQ-----TLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN---------CD 146 (337)
T ss_pred cCcEEEEEeCCCCCHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC---------CC
Confidence 4689999999999998887543 24455667777899999999999999999999999999776 57
Q ss_pred EEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchH
Q psy14267 413 LKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTW 492 (553)
Q Consensus 413 vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~ 492 (553)
+||+|||++........ ......++..|+|||.+.... .++.++|||||||++|+|++|..||.+....
T Consensus 147 ~kL~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~--------~~~~~~DiwslG~il~~l~~g~~pf~~~~~~- 215 (337)
T cd07858 147 LKICDFGLARTTSEKGD--FMTEYVVTRWYRAPELLLNCS--------EYTTAIDVWSVGCIFAELLGRKPLFPGKDYV- 215 (337)
T ss_pred EEECcCccccccCCCcc--cccccccccCccChHHHhcCC--------CCCCcccHHHHHHHHHHHHcCCCCCCCCChH-
Confidence 99999999987654321 122456899999999986432 3678999999999999999999999764321
Q ss_pred HHHHHHHhhcc--------------------cccc---cccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH--Hh
Q psy14267 493 AKMLAIARHKD--------------------QIEF---KPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ--IN 547 (553)
Q Consensus 493 ~~~~~i~~~~~--------------------~~~~---~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~--L~ 547 (553)
.....+..... .... .........++.++.++|.+||+.+|++|||+++++++ ++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~ 295 (337)
T cd07858 216 HQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLA 295 (337)
T ss_pred HHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchh
Confidence 11111100000 0000 00011123578899999999999999999999999988 55
Q ss_pred cC
Q psy14267 548 NN 549 (553)
Q Consensus 548 ~~ 549 (553)
..
T Consensus 296 ~~ 297 (337)
T cd07858 296 SL 297 (337)
T ss_pred hh
Confidence 43
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=298.93 Aligned_cols=263 Identities=25% Similarity=0.385 Sum_probs=194.9
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|++.+.||+|+||.||++.+..++. .||+|.+....... .....+.+|+++++++. ||||+++++++. ...+
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~--~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~ 75 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNE--TIALKKIRLEQEDE-GVPSTAIREISLLKEMQ-HGNIVRLQDVVH--SEKR 75 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCc--EEEEEehhhccccc-cchHHHHHHHHHHHhcc-CCCEeeEEEEEe--cCCe
Confidence 469999999999999999998776654 49999987654332 33467889999999995 599999999875 4568
Q ss_pred EEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 336 LYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 336 ~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
.+++||+.+++|..++...... ......+..++.||+.||+|||+++|+||||||+||+++.+. +.+||
T Consensus 76 ~~lv~e~~~~~l~~~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~--------~~~kl 144 (294)
T PLN00009 76 LYLVFEYLDLDLKKHMDSSPDF---AKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRT--------NALKL 144 (294)
T ss_pred EEEEEecccccHHHHHHhCCCC---CcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCC--------CEEEE
Confidence 9999999988998888654332 233455556677999999999999999999999999997542 56899
Q ss_pred EeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHH
Q psy14267 416 IDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKM 495 (553)
Q Consensus 416 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~ 495 (553)
+|||++......... .....+++.|+|||.+.+.. .++.++|||||||++|+|++|..||..........
T Consensus 145 ~dfg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~--------~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~ 214 (294)
T PLN00009 145 ADFGLARAFGIPVRT--FTHEVVTLWYRAPEILLGSR--------HYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELF 214 (294)
T ss_pred cccccccccCCCccc--cccCceeecccCHHHHhCCC--------CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 999999765432211 12345789999999986532 36789999999999999999999998654322211
Q ss_pred HHHHhhccccc------------------ccc-c-ccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 496 LAIARHKDQIE------------------FKP-Q-LANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 496 ~~i~~~~~~~~------------------~~~-~-~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
........... +.. . ......++.++.++|.+||+.+|++||++.+++.+
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 215 KIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred HHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11110000000 000 0 00122567899999999999999999999999864
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=295.68 Aligned_cols=264 Identities=19% Similarity=0.324 Sum_probs=195.5
Q ss_pred eEEEeeeeeeCceEEEEEeeeCC-CccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc--
Q psy14267 258 YQVLSLLGKGGSSSVYLVGGTSE-HEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK-- 334 (553)
Q Consensus 258 y~i~~~LG~G~fG~Vy~a~~~~~-~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~-- 334 (553)
|++.+.||+|+||.||+|..... +..+.||||++..+... ....+++.+|+++|+++. ||||+++++++......
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~ 78 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFS-SSDIEEFLREAACMKEFD-HPNVIKLIGVSLRSRAKGR 78 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCC-hHHHHHHHHHHHHHhcCC-CCCcceEEEEEccCCCCCc
Confidence 67788999999999999976543 33456999999765433 334577899999999995 69999999977554321
Q ss_pred --eEEEEEec-CCCCHHHHHHHcc-cCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCC
Q psy14267 335 --HLYVLMEK-GDTDLSKYMRNLN-KMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIG 410 (553)
Q Consensus 335 --~~~iv~e~-~~~~L~~~l~~~~-~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~ 410 (553)
..++++++ .+++|..++.... ...........+..++.|++.||+|||+.||+||||||+||+++.+
T Consensus 79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~--------- 149 (273)
T cd05074 79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNEN--------- 149 (273)
T ss_pred ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCC---------
Confidence 23566665 5678887765332 1122234556667778899999999999999999999999999766
Q ss_pred CeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCCC
Q psy14267 411 NVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHIP 489 (553)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~~ 489 (553)
+.+||+|||+++...............+++.|++||.+.... ++.++|||||||++|||++ |..||....
T Consensus 150 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~---------~~~~sDi~slG~il~el~~~g~~p~~~~~ 220 (273)
T cd05074 150 MTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNV---------YTTHSDVWAFGVTMWEIMTRGQTPYAGVE 220 (273)
T ss_pred CCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCc---------cchhhhhHHHHHHHHHHhhCCCCCCCCCC
Confidence 569999999998765433222222334667899999987553 6789999999999999998 899997754
Q ss_pred chHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 490 NTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 490 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
.. .....+... .. ......++..+.+++.+||+.+|++||++.+++..|+++
T Consensus 221 ~~-~~~~~~~~~-~~------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 221 NS-EIYNYLIKG-NR------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred HH-HHHHHHHcC-Cc------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 32 222222211 11 112235678999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=299.76 Aligned_cols=250 Identities=25% Similarity=0.418 Sum_probs=194.6
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
.+|++++.||.|+||.||++.+..++. .||||.+...... ..+.+.+|+.+++.+. ||||+.+++++.. ...
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~--~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~--~~~ 90 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQ--EVAIKQINLQKQP---KKELIINEILVMKELK-NPNIVNFLDSFLV--GDE 90 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCc--EEEEEEEecccCc---hHHHHHHHHHHHHhcC-CCceeeeeeeEec--Cce
Confidence 579999999999999999998766664 4999998765422 2467889999999995 5999999998754 567
Q ss_pred EEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
+++++|+. +++|..++... ...+..+..++.|++.||+|||+.|++||||||+||+++.+ +.+|
T Consensus 91 ~~lv~e~~~~~~L~~~~~~~------~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~---------~~~k 155 (296)
T cd06655 91 LFVVMEYLAGGSLTDVVTET------CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMD---------GSVK 155 (296)
T ss_pred EEEEEEecCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC---------CCEE
Confidence 88889865 56788777643 23456666777899999999999999999999999999766 5799
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||++......... .....|+..|+|||.+.+. .++.++|||||||++|+|++|..||........
T Consensus 156 l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~---------~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~- 223 (296)
T cd06655 156 LTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRK---------AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA- 223 (296)
T ss_pred EccCccchhccccccc--CCCcCCCccccCcchhcCC---------CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-
Confidence 9999998876543321 2245689999999998755 367899999999999999999999987544322
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
+..+.... .+.+.....++..+.++|.+||..||++||++.+++.+
T Consensus 224 ~~~~~~~~-----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 224 LYLIATNG-----TPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred HHHHHhcC-----CcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 22221111 11222334678999999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=302.26 Aligned_cols=252 Identities=25% Similarity=0.379 Sum_probs=191.4
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceE
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHL 336 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~ 336 (553)
+|++.+.||+|+||.||++.+..++. .+|+|.+.... ......++.+|+++++++. ||||+++++++.. +..+
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~--~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~--~~~~ 74 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGL--IMARKLIHLEI--KPAIRNQIIRELKVLHECN-SPYIVGFYGAFYS--DGEI 74 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCe--EEEEEEecccc--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEee--CCEE
Confidence 69999999999999999998877664 49999887542 2334567899999999994 6999999988754 5688
Q ss_pred EEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhh-CCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 337 YVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHA-AGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 337 ~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~-~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
+++||+. +++|.+++.... ......+..++.|++.||+|||+ .+++||||||+|||++.+ +.+|
T Consensus 75 ~lv~ey~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~---------~~~~ 140 (308)
T cd06615 75 SICMEHMDGGSLDQVLKKAG-----RIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSR---------GEIK 140 (308)
T ss_pred EEEeeccCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecC---------CcEE
Confidence 9999975 578999987653 23345566777899999999997 699999999999999876 5699
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||++....... .....|+..|+|||.+.+. .++.++|||||||++|||++|..||...... .
T Consensus 141 l~dfg~~~~~~~~~----~~~~~~~~~~~aPE~~~~~---------~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~--~ 205 (308)
T cd06615 141 LCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGT---------HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK--E 205 (308)
T ss_pred EccCCCcccccccc----cccCCCCcCccChhHhcCC---------CCCccchHHHHHHHHHHHHhCCCCCCCcchh--h
Confidence 99999987654322 1255789999999998654 3678999999999999999999999653211 1
Q ss_pred HHHHHhhccc-c-------------------------------cccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q psy14267 495 MLAIARHKDQ-I-------------------------------EFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNS 542 (553)
Q Consensus 495 ~~~i~~~~~~-~-------------------------------~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~el 542 (553)
.......... . ...+... ...++.+++++|.+||..+|++||++.++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~l 284 (308)
T cd06615 206 LEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLP-SGAFSDEFQDFVDKCLKKNPKERADLKEL 284 (308)
T ss_pred HHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCc-CcccCHHHHHHHHHHccCChhhCcCHHHH
Confidence 1111100000 0 0001000 11367889999999999999999999999
Q ss_pred HHH
Q psy14267 543 VTQ 545 (553)
Q Consensus 543 l~~ 545 (553)
+.+
T Consensus 285 l~~ 287 (308)
T cd06615 285 TKH 287 (308)
T ss_pred hcC
Confidence 987
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=300.22 Aligned_cols=264 Identities=24% Similarity=0.332 Sum_probs=198.1
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcC--chhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDIT--DQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~--~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
+|++.+.||+|+||.||++.+..++. .||||.+...... .......+..|+++++++. |+||+++++++.+ ..
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~--~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~--~~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGR--IVAIKKIKLGERKEAKDGINFTALREIKLLQELK-HPNIIGLLDVFGH--KS 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCc--EEEEEEEeccccccccchhhHHHHHHHHHHhhcC-CCCChhhhheeec--CC
Confidence 48899999999999999998776654 4999999876544 1233456788999999996 6999999998755 66
Q ss_pred eEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 335 HLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 335 ~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
.++++||+.+++|..++.... .......++.++.||+.||.|||++||+||||||+|||++.+ +.++
T Consensus 76 ~~~lv~e~~~~~L~~~i~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~---------~~~~ 142 (298)
T cd07841 76 NINLVFEFMETDLEKVIKDKS----IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASD---------GVLK 142 (298)
T ss_pred EEEEEEcccCCCHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCC---------CCEE
Confidence 889999988999999987643 124455566677899999999999999999999999999876 5799
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||+++........ .....+++.|+|||.+.+.. .++.++|||||||++|||++|.+||...... ..
T Consensus 143 l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~--------~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~-~~ 211 (298)
T cd07841 143 LADFGLARSFGSPNRK--MTHQVVTRWYRAPELLFGAR--------HYGVGVDMWSVGCIFAELLLRVPFLPGDSDI-DQ 211 (298)
T ss_pred EccceeeeeccCCCcc--ccccccceeeeCHHHHhCCC--------CCCcHHHHHHHHHHHHHHHcCCccccCCccH-HH
Confidence 9999999877554321 12345688999999985432 3688999999999999999998888764432 22
Q ss_pred HHHHHhhcccc---------------cccc-----cccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH--HhcC
Q psy14267 495 MLAIARHKDQI---------------EFKP-----QLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ--INNN 549 (553)
Q Consensus 495 ~~~i~~~~~~~---------------~~~~-----~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~--L~~~ 549 (553)
+..+....... .... ........+..+.++|.+||+.||++|||+.+++.+ +++.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~ 288 (298)
T cd07841 212 LGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSND 288 (298)
T ss_pred HHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCC
Confidence 22221111000 0000 000112457889999999999999999999999986 5443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=290.75 Aligned_cols=248 Identities=24% Similarity=0.387 Sum_probs=188.2
Q ss_pred eeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEEEEEe
Q psy14267 262 SLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLME 341 (553)
Q Consensus 262 ~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~iv~e 341 (553)
++||.|+||.||++.+.. + +.||+|.+...... .....+.+|+++++++. |+||+.+++++.. ....+++|+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~--~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~~~~v~e 72 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-N--TEVAVKTCRSTLPP--DLKRKFLQEAEILKQYD-HPNIVKLIGVCVQ--KQPIYIVME 72 (251)
T ss_pred CccccCCCceEEEEEEeC-C--CcEEEEeccccCCH--HHHHHHHHHHHHHHhCC-CCCeEEEEEEEec--CCCeEEEEE
Confidence 479999999999998765 4 34999998765433 34567899999999995 5999999887643 457788888
Q ss_pred cC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEeccC
Q psy14267 342 KG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGI 420 (553)
Q Consensus 342 ~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGl 420 (553)
+. +++|.+++..... ......+..++.+++.||+|||+++++||||||+|||++.+ +.+||+|||+
T Consensus 73 ~~~~~~l~~~l~~~~~----~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~---------~~~~l~d~g~ 139 (251)
T cd05041 73 LVPGGSLLTFLRKKKN----RLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGEN---------NVLKISDFGM 139 (251)
T ss_pred cCCCCcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCC---------CcEEEeeccc
Confidence 75 6789888876432 23455566667799999999999999999999999999776 5799999999
Q ss_pred ccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHH
Q psy14267 421 ACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHIPNTWAKMLAIA 499 (553)
Q Consensus 421 a~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~i~ 499 (553)
+................++..|+|||.+.+. .++.++|||||||++|||++ |..||...... .....+.
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~---------~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~-~~~~~~~ 209 (251)
T cd05041 140 SREEEGGIYTVSDGLKQIPIKWTAPEALNYG---------RYTSESDVWSYGILLWETFSLGDTPYPGMSNQ-QTRERIE 209 (251)
T ss_pred cccccCCcceeccccCcceeccCChHhhccC---------CCCcchhHHHHHHHHHHHHhccCCCCccCCHH-HHHHHHh
Confidence 9766432221111123346679999998755 36889999999999999998 89999775432 1111111
Q ss_pred hhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q psy14267 500 RHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQIN 547 (553)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~ 547 (553)
.... ......++..+.++|.+||..+|++||++.|+++.|+
T Consensus 210 -~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 210 -SGYR------MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred -cCCC------CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 1111 1122356889999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=303.23 Aligned_cols=250 Identities=24% Similarity=0.381 Sum_probs=193.3
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
.+|++++.||+|+||.||++.+...+. .||+|.+...... ..+.+.+|+.+++.+ +|+||+.+++++.. ..+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~--~vaiK~~~~~~~~---~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~--~~~ 90 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQ--EVAIKQMNLQQQP---KKELIINEILVMREN-KNPNIVNYLDSYLV--GDE 90 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCC--EEEEEEEecCccc---hHHHHHHHHHHHHhC-CCCCEeeEEEEEec--CCE
Confidence 579999999999999999998766654 4999999765433 236678999999998 56999999988754 567
Q ss_pred EEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
++++||+. +++|.+++... ......+..++.|++.||.|||+.||+||||||+|||++.+ +.++
T Consensus 91 ~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~---------~~~~ 155 (297)
T cd06656 91 LWVVMEYLAGGSLTDVVTET------CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMD---------GSVK 155 (297)
T ss_pred EEEeecccCCCCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC---------CCEE
Confidence 88999975 67888887653 23345566777899999999999999999999999999766 5799
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||++......... .....|++.|+|||.+.+. .++.++|+|||||++|+|++|..||........
T Consensus 156 l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~- 223 (297)
T cd06656 156 LTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRK---------AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA- 223 (297)
T ss_pred ECcCccceEccCCccC--cCcccCCccccCHHHHcCC---------CCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh-
Confidence 9999999776543321 2245689999999999765 367899999999999999999999976433211
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
...+... ..+.......++..++++|.+||..+|++||++++++.+
T Consensus 224 ~~~~~~~-----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 224 LYLIATN-----GTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred eeeeccC-----CCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111100 111122233577899999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=306.90 Aligned_cols=261 Identities=18% Similarity=0.283 Sum_probs=188.0
Q ss_pred EEeeeeee--CceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEE
Q psy14267 260 VLSLLGKG--GSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLY 337 (553)
Q Consensus 260 i~~~LG~G--~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~ 337 (553)
++++||+| +||+||++.+..++.. ||||+++..... ....+.+.+|+.+++.+ +||||+++++++.. +..++
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~--vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~--~~~~~ 75 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEY--VTVRRINLEACT-NEMVTFLQGELHVSKLF-NHPNIVPYRATFIA--DNELW 75 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcE--EEEEEechhhcc-HHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEE--CCEEE
Confidence 56789999 7899999988877765 999999766433 34456778899999999 45999999988754 45788
Q ss_pred EEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEE
Q psy14267 338 VLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKII 416 (553)
Q Consensus 338 iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~ 416 (553)
++||++ +++|.+++...... ......+..++.|++.||+|||+++||||||||+|||++.+ +.++|+
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~---------~~~~l~ 143 (327)
T cd08227 76 VVTSFMAYGSAKDLICTHFMD---GMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVD---------GKVYLS 143 (327)
T ss_pred EEEeccCCCcHHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecC---------CcEEEc
Confidence 999975 57888888654321 23455566677899999999999999999999999999776 578999
Q ss_pred eccCccccCCCCCcc-----cccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCch
Q psy14267 417 DFGIACSLQDDKTSV-----HKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNT 491 (553)
Q Consensus 417 DFGla~~~~~~~~~~-----~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~ 491 (553)
|||.+.......... ......++..|+|||++.+... .++.++|||||||++|||++|..||......
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-------~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 216 (327)
T cd08227 144 GLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQ-------GYDAKSDIYSVGITACELANGHVPFKDMPAT 216 (327)
T ss_pred ccchhhccccccccccccccccccccceecccChHHhhcccC-------CCCchhhHHHHHHHHHHHHHCCCCCCCcchh
Confidence 998765443221110 0112346788999999975311 3788999999999999999999999875443
Q ss_pred HHHHHHHHhhccccc------------------cc-------------------ccccCCCCCCHHHHHHHHHhcccCCC
Q psy14267 492 WAKMLAIARHKDQIE------------------FK-------------------PQLANNVTIPPTLLQSMKLCLQKDPK 534 (553)
Q Consensus 492 ~~~~~~i~~~~~~~~------------------~~-------------------~~~~~~~~~s~~l~~li~~cL~~dP~ 534 (553)
............... .. ........+++.+.+||.+||+.||+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~ 296 (327)
T cd08227 217 QMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPD 296 (327)
T ss_pred HHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCch
Confidence 222211111000000 00 00001123567899999999999999
Q ss_pred CCCCHHHHHHH
Q psy14267 535 ARPTVGNSVTQ 545 (553)
Q Consensus 535 ~RPt~~ell~~ 545 (553)
+|||+.+++++
T Consensus 297 ~Rpt~~ell~~ 307 (327)
T cd08227 297 ARPSASTLLNH 307 (327)
T ss_pred hcCCHHHHhcC
Confidence 99999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=296.14 Aligned_cols=261 Identities=23% Similarity=0.361 Sum_probs=192.7
Q ss_pred eeeeeeCceEEEEEeeeCCC----ccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEE
Q psy14267 262 SLLGKGGSSSVYLVGGTSEH----EFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLY 337 (553)
Q Consensus 262 ~~LG~G~fG~Vy~a~~~~~~----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~ 337 (553)
+.||+|+||.||+++..... ..+.+|||.+.+... ......+.+|+.+++.+. ||||+++++++.+ ....+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~ 75 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT--DQEKKEFLKEAHLMSNFN-HPNIVKLLGVCLL--NEPQY 75 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccc--hhhHHHHHHHHHHHHhcC-CCCeeeEeeeecC--CCCeE
Confidence 36999999999999775432 224589998865432 223467889999999995 5999999987754 45678
Q ss_pred EEEec-CCCCHHHHHHHcccC--CCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 338 VLMEK-GDTDLSKYMRNLNKM--TTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 338 iv~e~-~~~~L~~~l~~~~~~--~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
++||+ .+++|.+++...... ......+..+..++.|++.||+|||+.+++|+||||+|||++.+.. .....++
T Consensus 76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~----~~~~~~~ 151 (269)
T cd05044 76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGY----DADRVVK 151 (269)
T ss_pred EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCC----CCCcceE
Confidence 88886 568999999764322 1223455666777789999999999999999999999999987620 1123699
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCCCchHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHIPNTWA 493 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~~~~~~ 493 (553)
|+|||++................++..|+|||.+.+. .++.++|||||||++|||++ |..||....+. .
T Consensus 152 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~-~ 221 (269)
T cd05044 152 IGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDG---------KFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ-E 221 (269)
T ss_pred ECCcccccccccccccccCcccCCCccccCHHHHccC---------CcccchhHHHHHHHHHHHHHcCCCCCcccCHH-H
Confidence 9999999776443322222234467899999999755 37889999999999999998 99999765432 2
Q ss_pred HHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q psy14267 494 KMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINN 548 (553)
Q Consensus 494 ~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~ 548 (553)
....+.. ... ......++..+.++|.+||..+|++||++.++++.|++
T Consensus 222 ~~~~~~~-~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 222 VLQHVTA-GGR------LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred HHHHHhc-CCc------cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 2222211 111 11223578899999999999999999999999999874
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=299.80 Aligned_cols=264 Identities=23% Similarity=0.309 Sum_probs=193.8
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC---
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA--- 332 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~--- 332 (553)
++|++.+.||+|+||.||+|.+..++. .||||.+....... .....+.+|+++++++. ||||+++++++....
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~--~~aik~~~~~~~~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~ 87 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQ--IVALKKVLMENEKE-GFPITALREIKILQLLK-HENVVNLIEICRTKATPY 87 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCc--EEEEEEEeccCCcC-CchhHHHHHHHHHHhCC-CCCccceEEEEecccccc
Confidence 479999999999999999998876664 49999987654322 22345678999999995 599999999876543
Q ss_pred ---CceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCC
Q psy14267 333 ---SKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCI 409 (553)
Q Consensus 333 ---~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~ 409 (553)
....+++||+++++|..++..... ...+..+..++.|++.||+|||++||+||||||+||+++.+
T Consensus 88 ~~~~~~~~lv~e~~~~~l~~~l~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~-------- 155 (310)
T cd07865 88 NRYKGSFYLVFEFCEHDLAGLLSNKNV----KFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKD-------- 155 (310)
T ss_pred cCCCceEEEEEcCCCcCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCC--------
Confidence 246799999999999888865431 24456666777899999999999999999999999999766
Q ss_pred CCeEEEEeccCccccCCCCCc--ccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCC
Q psy14267 410 GNVLKIIDFGIACSLQDDKTS--VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSH 487 (553)
Q Consensus 410 ~~~vkL~DFGla~~~~~~~~~--~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~ 487 (553)
+.+||+|||++..+...... .......++..|+|||.+.+.. .++.++||||||+++|||++|..||..
T Consensus 156 -~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--------~~~~~~Di~slG~~l~el~t~~~~~~~ 226 (310)
T cd07865 156 -GILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGER--------DYGPPIDMWGAGCIMAEMWTRSPIMQG 226 (310)
T ss_pred -CcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCc--------ccCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 57999999999876443221 1122345788999999986542 257899999999999999999999976
Q ss_pred CCchHHHHHHHHhhcccc-----------------cccccc-------cCCCCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q psy14267 488 IPNTWAKMLAIARHKDQI-----------------EFKPQL-------ANNVTIPPTLLQSMKLCLQKDPKARPTVGNSV 543 (553)
Q Consensus 488 ~~~~~~~~~~i~~~~~~~-----------------~~~~~~-------~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell 543 (553)
.... .....+....... .+.... -.....+..+.++|.+||..||++|||+++++
T Consensus 227 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l 305 (310)
T cd07865 227 NTEQ-HQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTAL 305 (310)
T ss_pred CCHH-HHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHh
Confidence 4432 1111111110000 000000 00112356788999999999999999999998
Q ss_pred HH
Q psy14267 544 TQ 545 (553)
Q Consensus 544 ~~ 545 (553)
++
T Consensus 306 ~h 307 (310)
T cd07865 306 NH 307 (310)
T ss_pred cC
Confidence 65
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=305.08 Aligned_cols=265 Identities=25% Similarity=0.340 Sum_probs=195.0
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeC--CCc
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDT--ASK 334 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~--~~~ 334 (553)
+|++.+.||+|+||.||++.+........||||++.... ......+.+.+|+.+++++.+||||++++++.... ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 488999999999999999988766223559999986533 22234567889999999998889999998865432 235
Q ss_pred eEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 335 HLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 335 ~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
.++++|++.+++|..++.... ......++.++.||+.||+|||++||+||||||+|||++.+ +.+|
T Consensus 80 ~~~~~~e~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~---------~~~k 145 (332)
T cd07857 80 ELYLYEELMEADLHQIIRSGQ-----PLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNAD---------CELK 145 (332)
T ss_pred cEEEEEecccCCHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCC---------CCEE
Confidence 678999998899999886543 23445566677899999999999999999999999999776 5799
Q ss_pred EEeccCccccCCCCCc--ccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchH
Q psy14267 415 IIDFGIACSLQDDKTS--VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTW 492 (553)
Q Consensus 415 L~DFGla~~~~~~~~~--~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~ 492 (553)
|+|||+++.+...... .......|+..|+|||.+.+.. .++.++|||||||++|+|++|..||......
T Consensus 146 l~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--------~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~- 216 (332)
T cd07857 146 ICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQ--------SYTKAIDVWSVGCILAELLGRKPVFKGKDYV- 216 (332)
T ss_pred eCcCCCceecccccccccccccCcccCccccCcHHHhCCC--------CCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH-
Confidence 9999999876543221 1122456899999999886432 3688999999999999999999999764321
Q ss_pred HHHHHHHhh-----------------------cccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 493 AKMLAIARH-----------------------KDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 493 ~~~~~i~~~-----------------------~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
..+..+... ...............++..+.++|.+||+.||++|||+.+++.+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 217 DQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 111110000 00000000001122457899999999999999999999999764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=316.29 Aligned_cols=250 Identities=22% Similarity=0.362 Sum_probs=203.8
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
..|.+.+.||+|.|++|.++++..++.. ||||++++........ +.+.+|+++|+.|. |||||+++.+. .....
T Consensus 56 g~y~i~~tig~g~f~~V~La~~~~t~~~--VaiK~idkt~ln~~~~-~k~~rev~imk~l~-HPnIvkl~~v~--~t~~~ 129 (596)
T KOG0586|consen 56 GLYVIIKTIGKGNFAKVKLARHILTGTE--VAIKIIDKTQLNPSKR-QKLGREVDIMKSLN-HPNIVKLFSVI--ETEAT 129 (596)
T ss_pred cceeeeeeeccceeEEEEeeEecCCCce--EEEEEehhcccChHHH-HHHHHHHHHHHhcC-Ccceeeeeeee--eecce
Confidence 4699999999999999999999888755 9999999988776554 55999999999995 59999998866 45678
Q ss_pred EEEEEec-CCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEK-GDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~-~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
+|+|||| .++++.+|+.+..+... .....++.|++.|++|||+++|||||||++||||+.+. ++|
T Consensus 130 lylV~eya~~ge~~~yl~~~gr~~e-----~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~m---------nik 195 (596)
T KOG0586|consen 130 LYLVMEYASGGELFDYLVKHGRMKE-----KEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENM---------NIK 195 (596)
T ss_pred eEEEEEeccCchhHHHHHhcccchh-----hhhhhhhHHHHHHHHHHhhcceeccccchhhccccccc---------cee
Confidence 9999997 56899999999887654 33444556999999999999999999999999999884 599
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||++..+..+.. ..++||++.|.|||++.+..++ ++++|+||+|++||-|+.|.+||++-.-. ..
T Consensus 196 IaDfgfS~~~~~~~~---lqt~cgsppyAaPEl~~g~~y~--------gpe~D~Wslgvvly~LV~GsLPFDG~~lk-~L 263 (596)
T KOG0586|consen 196 IADFGFSTFFDYGLM---LQTFCGSPPYAAPELFNGKKYD--------GPEVDIWSLGVVLYALVEGSLPFDGQNLK-EL 263 (596)
T ss_pred eeccccceeeccccc---ccccCCCCCccChHhhcCcccC--------CcceehhhhhhhheeeeecccccCCcccc-cc
Confidence 999999999875443 3489999999999999998764 58999999999999999999999862110 00
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
...+...+.. -+.-++-+..++|+++|..+|.+|++.+++..+
T Consensus 264 r~rvl~gk~r--------Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 264 RPRVLRGKYR--------IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred cchheeeeec--------ccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 0011111111 122456789999999999999999999998764
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=292.42 Aligned_cols=256 Identities=22% Similarity=0.307 Sum_probs=195.6
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCc--CchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCC
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDI--TDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTAS 333 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~ 333 (553)
.+|++.+.||+|+||.||++.+..++. .||+|++..... ........+.+|+++++++. |+||+++++++.+...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~--~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~~ 78 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGR--ELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR-HDRIVQYYGCLRDPEE 78 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCC--EEEEEEEecCcccchhhHHHHHHHHHHHHHHHcC-CCCcceEEEEEEcCCC
Confidence 469999999999999999998876654 499998865421 22344578899999999995 5999999998776666
Q ss_pred ceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCe
Q psy14267 334 KHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNV 412 (553)
Q Consensus 334 ~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~ 412 (553)
..++++||+. +++|.+++..... .....+..++.|++.||.|||++||+||||||+||+++.+ +.
T Consensus 79 ~~~~~v~e~~~~~~L~~~~~~~~~-----l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~---------~~ 144 (264)
T cd06653 79 KKLSIFVEYMPGGSIKDQLKAYGA-----LTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSA---------GN 144 (264)
T ss_pred CEEEEEEEeCCCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC---------CC
Confidence 6788888875 5789888876432 2344556677899999999999999999999999999766 56
Q ss_pred EEEEeccCccccCCCCC-cccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCch
Q psy14267 413 LKIIDFGIACSLQDDKT-SVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNT 491 (553)
Q Consensus 413 vkL~DFGla~~~~~~~~-~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~ 491 (553)
++|+|||+++....... ........|+..|+|||.+.+. .++.++|+|||||++|||++|+.||......
T Consensus 145 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 215 (264)
T cd06653 145 VKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGE---------GYGRKADVWSVACTVVEMLTEKPPWAEYEAM 215 (264)
T ss_pred EEECccccccccccccccCccccccCCcccccCHhhhcCC---------CCCccccHHHHHHHHHHHHhCCCCCCccCHH
Confidence 99999999987643211 1112245689999999999765 3678999999999999999999999875433
Q ss_pred HHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 492 WAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 492 ~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
.....+...... ...+..+++.+.++|.+||. +|..||++.+++.|
T Consensus 216 -~~~~~~~~~~~~------~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 216 -AAIFKIATQPTK------PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred -HHHHHHHcCCCC------CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 222222211111 11223678999999999999 57999999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG4278|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=313.01 Aligned_cols=268 Identities=20% Similarity=0.372 Sum_probs=215.0
Q ss_pred ccccceEEecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEe
Q psy14267 245 ETSQDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKM 324 (553)
Q Consensus 245 ~~~~~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l 324 (553)
....+.|++...+.....+||-|.||.||.+.++.-.-. ||||.++-+.+ .+++|++|+.+|+.++ |||+|++
T Consensus 256 SPn~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslT--vAVKtLKEDtM----eveEFLkEAAvMKeik-HpNLVqL 328 (1157)
T KOG4278|consen 256 SPNADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLT--VAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPNLVQL 328 (1157)
T ss_pred cCCcchhhccchheeeeeccCCCcccceeeeeeecccee--eehhhhhhcch----hHHHHHHHHHHHHhhc-CccHHHH
Confidence 344567888888888899999999999999988876654 99999976543 3588999999999994 5999999
Q ss_pred eeEEEeCCCceEEEEEec-CCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCcc
Q psy14267 325 HDYVYDTASKHLYVLMEK-GDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVL 403 (553)
Q Consensus 325 ~~~~~~~~~~~~~iv~e~-~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~ 403 (553)
+++| ..+.-+||+.|+ +.|+|++|+++.++.. ...+.++.++-||..||+||..+++|||||-..|+|+.++
T Consensus 329 LGVC--T~EpPFYIiTEfM~yGNLLdYLRecnr~e---v~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEn-- 401 (1157)
T KOG4278|consen 329 LGVC--THEPPFYIITEFMCYGNLLDYLRECNRSE---VPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN-- 401 (1157)
T ss_pred hhhh--ccCCCeEEEEecccCccHHHHHHHhchhh---cchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhcccccc--
Confidence 9988 556678888884 8899999999987653 3334555667799999999999999999999999999777
Q ss_pred ceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CC
Q psy14267 404 KIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GR 482 (553)
Q Consensus 404 ~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~ 482 (553)
..||++||||++.+.......+. ...-.+.|.|||.+... .++.++|||+|||+|||+.| |-
T Consensus 402 -------hiVKvADFGLsRlMtgDTYTAHA-GAKFPIKWTAPEsLAyN---------tFSiKSDVWAFGVLLWEIATYGM 464 (1157)
T KOG4278|consen 402 -------HIVKVADFGLSRLMTGDTYTAHA-GAKFPIKWTAPESLAYN---------TFSIKSDVWAFGVLLWEIATYGM 464 (1157)
T ss_pred -------ceEEeeccchhhhhcCCceeccc-CccCcccccCccccccc---------ccccchhhHHHHHHHHHHHhcCC
Confidence 68999999999988765543221 22246789999999755 47899999999999999986 99
Q ss_pred CCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q psy14267 483 TPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNPE 551 (553)
Q Consensus 483 ~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~~ 551 (553)
.||.++.-. ....+.... .+.....+|++.+.+||+.||+..|..||++.||-+.++..+.
T Consensus 465 sPYPGidlS--qVY~LLEkg------yRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 465 SPYPGIDLS--QVYGLLEKG------YRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred CCCCCccHH--HHHHHHhcc------ccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 999986432 112222222 2233445899999999999999999999999999999987543
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=292.29 Aligned_cols=256 Identities=24% Similarity=0.374 Sum_probs=190.5
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceE
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHL 336 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~ 336 (553)
.+.....||+|+||.||++.+..++ ..||+|.+.... ....+.+.+|+.++++++ |+||+++++++.. ....
T Consensus 9 ~~~~~~~lg~g~~g~v~~~~~~~~~--~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~--~~~~ 80 (268)
T cd06624 9 ENGERVVLGKGTYGIVYAARDLSTQ--VRIAIKEIPERD---SRYVQPLHEEIALHSYLK-HRNIVQYLGSDSE--NGFF 80 (268)
T ss_pred cCCceEEEecCCceEEEEeEecCCC--cEEEEEEecCCC---HHHHHHHHHHHHHHHhcC-CCCeeeeeeeecc--CCEE
Confidence 3445568999999999999876655 449999887553 233467899999999995 5999999987743 5678
Q ss_pred EEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 337 YVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 337 ~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
++++|+. +++|..++...... .......+..++.||+.||+|||++||+||||||+||+++.+. +.++|
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~--------~~~~l 150 (268)
T cd06624 81 KIFMEQVPGGSLSALLRSKWGP--LKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYS--------GVVKI 150 (268)
T ss_pred EEEEecCCCCCHHHHHHHhccc--CCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC--------CeEEE
Confidence 8888875 57899988764221 1113445566677999999999999999999999999997542 57999
Q ss_pred EeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHH
Q psy14267 416 IDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKM 495 (553)
Q Consensus 416 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~ 495 (553)
+|||++......... .....|++.|+|||.+..... .++.++||||||+++|+|++|..||..........
T Consensus 151 ~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~-------~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~ 221 (268)
T cd06624 151 SDFGTSKRLAGINPC--TETFTGTLQYMAPEVIDKGPR-------GYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM 221 (268)
T ss_pred ecchhheecccCCCc--cccCCCCccccChhhhccccc-------cCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH
Confidence 999999766433221 223458999999999864321 26789999999999999999999997654332222
Q ss_pred HHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 496 LAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 496 ~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
......... +. ....+++++.+++.+||..+|++|||+.+++.+
T Consensus 222 ~~~~~~~~~----~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 222 FKVGMFKIH----PE--IPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred hhhhhhccC----CC--CCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 221111111 11 122577899999999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=294.33 Aligned_cols=260 Identities=24% Similarity=0.433 Sum_probs=194.5
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcC-------chhHHHHHHHHHHHHHhhcCCCceeEeeeEEE
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDIT-------DQSIADSYLNEVELLAKLQGCPYVIKMHDYVY 329 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~-------~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~ 329 (553)
+|.+.+.||.|+||.||++....++. .||||.++..... .....+.+.+|+.+++++. |+||+++++++.
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~--~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~ 78 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGE--MMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD-HLNIVQYLGFET 78 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCc--eeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcC-CCCcceEEEEec
Confidence 58899999999999999998766654 4999988653211 1223456889999999995 599999988764
Q ss_pred eCCCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecC
Q psy14267 330 DTASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDC 408 (553)
Q Consensus 330 ~~~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~ 408 (553)
....++++||+. +++|.++++... ......+..++.|++.||.|||+++++||||||+||+++.+
T Consensus 79 --~~~~~~lv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~------- 144 (272)
T cd06629 79 --TEEYLSIFLEYVPGGSIGSCLRTYG-----RFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDAD------- 144 (272)
T ss_pred --cCCceEEEEecCCCCcHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCC-------
Confidence 356788888875 678999887653 23344556667899999999999999999999999999766
Q ss_pred CCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy14267 409 IGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHI 488 (553)
Q Consensus 409 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~ 488 (553)
+.++|+|||+++...............|+..|+|||.+..... .++.++|+||||+++|||++|..||...
T Consensus 145 --~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-------~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 215 (272)
T cd06629 145 --GICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQ-------GYSAKVDIWSLGCVVLEMFAGRRPWSDE 215 (272)
T ss_pred --CeEEEeeccccccccccccccccccccCCccccCHHHhccccC-------CCCccchhHHHHHHHHHHHhCCCCCcCc
Confidence 6799999999976543322222234568999999999875421 2688999999999999999999999754
Q ss_pred CchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 489 PNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 489 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
... ..+..+........+... ....++..+.++|.+||..+|++||++.+++++
T Consensus 216 ~~~-~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 216 EAI-AAMFKLGNKRSAPPIPPD--VSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred chH-HHHHHhhccccCCcCCcc--ccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 332 222222222212222221 123578999999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=297.46 Aligned_cols=260 Identities=24% Similarity=0.342 Sum_probs=195.1
Q ss_pred eEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEE
Q psy14267 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLY 337 (553)
Q Consensus 258 y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~ 337 (553)
|++.+.||.|++|.||++.+..++. .||+|++....... .....+.+|+++++++. ||||+++++++. .....+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~--~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~l~-~~~iv~~~~~~~--~~~~~~ 74 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGE--IVALKKIRLETEDE-GVPSTAIREISLLKELN-HPNIVRLLDVVH--SENKLY 74 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCC--EEEEEEeecccccc-cchhHHHHHHHHHHhcC-CCCccCHhheec--cCCeEE
Confidence 6788999999999999998876664 49999998664332 33356789999999996 599999998874 457889
Q ss_pred EEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEe
Q psy14267 338 VLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIID 417 (553)
Q Consensus 338 iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~D 417 (553)
++|++.+++|.+++..... ....+..+..++.|++.||+|||+++++||||+|+||+++.+ +.++|+|
T Consensus 75 iv~e~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~---------~~~~l~d 142 (283)
T cd07835 75 LVFEFLDLDLKKYMDSSPL---TGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDRE---------GALKLAD 142 (283)
T ss_pred EEEeccCcCHHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCC---------CcEEEee
Confidence 9999988899998876543 234456666777899999999999999999999999999775 6799999
Q ss_pred ccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHHH
Q psy14267 418 FGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLA 497 (553)
Q Consensus 418 FGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~~ 497 (553)
||++......... .....++..|+|||++.+.. .++.++||||||+++|||++|.+||............
T Consensus 143 f~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~--------~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 212 (283)
T cd07835 143 FGLARAFGVPVRT--YTHEVVTLWYRAPEILLGSR--------QYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRI 212 (283)
T ss_pred cccccccCCCccc--cCccccccCCCCCceeecCc--------ccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 9999765433221 12335688999999886532 3578999999999999999999999765432221111
Q ss_pred HHhhc--------------------ccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 498 IARHK--------------------DQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 498 i~~~~--------------------~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
..... ..............++..+.++|.+||+.+|++|||+++++.+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 213 FRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred HHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 11000 0000011111123577899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0666|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=296.45 Aligned_cols=275 Identities=21% Similarity=0.311 Sum_probs=206.0
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccc--eEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCC
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFK--PLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTAS 333 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~--~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~ 333 (553)
..|++++.||+|+||.||+|..+.++..+ .+|||.++...-. ........+|+.+++.|+ ||||+.+..++... +
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~-tGiS~SAcREiaL~REl~-h~nvi~Lv~Vfl~~-d 100 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDG-TGISMSACREIALLRELK-HPNVISLVKVFLSH-D 100 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCC-CCcCHHHHHHHHHHHHhc-CCcchhHHHHHhcc-C
Confidence 46999999999999999999776665543 7999999765321 123367789999999995 59999998877654 7
Q ss_pred ceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 334 KHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 334 ~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
..++++++|.+.+|...++-.............+..+..||+.|++|||++=|+||||||.||||..+. .+.|.|
T Consensus 101 ~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdg-----perG~V 175 (438)
T KOG0666|consen 101 KKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDG-----PERGRV 175 (438)
T ss_pred ceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccC-----CccCee
Confidence 889999999999999999876555445555666777778999999999999999999999999998774 445889
Q ss_pred EEEeccCccccCCCCCcc-cccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCc--
Q psy14267 414 KIIDFGIACSLQDDKTSV-HKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN-- 490 (553)
Q Consensus 414 kL~DFGla~~~~~~~~~~-~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~-- 490 (553)
||+|||+|+.+...-... .....+-|.+|.|||++.|.. .|+.+.|||+.||+..||++-.+.|.+...
T Consensus 176 KIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~--------hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~ 247 (438)
T KOG0666|consen 176 KIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGAR--------HYTKAIDVWAIGCIFAELLTLEPLFKGREEKI 247 (438)
T ss_pred EeecccHHHHhhccccccccCCceEEEEEecChHHhcccc--------cccchhhhHHHHHHHHHHHccCccccchhhhc
Confidence 999999999887653322 223445799999999999876 589999999999999999998887754110
Q ss_pred ------hHHHHHHHHhhcc---cccc----------------c-----c-ccc----CCCCCCHHHHHHHHHhcccCCCC
Q psy14267 491 ------TWAKMLAIARHKD---QIEF----------------K-----P-QLA----NNVTIPPTLLQSMKLCLQKDPKA 535 (553)
Q Consensus 491 ------~~~~~~~i~~~~~---~~~~----------------~-----~-~~~----~~~~~s~~l~~li~~cL~~dP~~ 535 (553)
....+..+..... ...+ . + .+. .+..-++...+|+.++|..||.+
T Consensus 248 ~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~k 327 (438)
T KOG0666|consen 248 KTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIK 327 (438)
T ss_pred ccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchh
Confidence 0111111111000 0000 0 0 000 11112455889999999999999
Q ss_pred CCCHHHHHHHH
Q psy14267 536 RPTVGNSVTQI 546 (553)
Q Consensus 536 RPt~~ell~~L 546 (553)
|.|+++++++.
T Consensus 328 RIta~qAleh~ 338 (438)
T KOG0666|consen 328 RITAEQALEHP 338 (438)
T ss_pred hccHHHHhccc
Confidence 99999998763
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=300.76 Aligned_cols=254 Identities=22% Similarity=0.322 Sum_probs=197.5
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceE
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHL 336 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~ 336 (553)
.|...+.||+|+||.||++.+..++. .||+|++.............+.+|+++++++. |+|++.+++++.+ ....
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~--~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~--~~~~ 100 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNE--VVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK-HPNSIEYKGCYLR--EHTA 100 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCc--EEEEEEEecCCCCchHHHHHHHHHHHHHHhCC-CCCEEEEEEEEee--CCeE
Confidence 48889999999999999998876654 49999998765555555678899999999995 6999999998754 5578
Q ss_pred EEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEE
Q psy14267 337 YVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKII 416 (553)
Q Consensus 337 ~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~ 416 (553)
+++||++.++|.+++..... ...+..+..++.|++.||.|||+.+|+||||+|+||+++.+ +.+||+
T Consensus 101 ~lv~e~~~g~l~~~~~~~~~----~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~---------~~~kl~ 167 (317)
T cd06635 101 WLVMEYCLGSASDLLEVHKK----PLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEP---------GQVKLA 167 (317)
T ss_pred EEEEeCCCCCHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCC---------CCEEEe
Confidence 89999988898887765432 24456666677899999999999999999999999999766 579999
Q ss_pred eccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHH
Q psy14267 417 DFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKML 496 (553)
Q Consensus 417 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~ 496 (553)
|||++...... ....|++.|+|||.+..... ..++.++|||||||++|||++|..||...... ....
T Consensus 168 dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~------~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-~~~~ 234 (317)
T cd06635 168 DFGSASIASPA------NSFVGTPYWMAPEVILAMDE------GQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALY 234 (317)
T ss_pred cCCCccccCCc------ccccCCccccChhhhhcCCC------CCCCccccHHHHHHHHHHHHhCCCCCCCccHH-HHHH
Confidence 99998755432 24568899999999853211 13688999999999999999999999775432 2222
Q ss_pred HHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q psy14267 497 AIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQIN 547 (553)
Q Consensus 497 ~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~ 547 (553)
.+...... ......++..+.++|.+||+.+|++||++.++++++-
T Consensus 235 ~~~~~~~~------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 235 HIAQNESP------TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred HHHhccCC------CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence 22221111 1112256789999999999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=290.46 Aligned_cols=258 Identities=26% Similarity=0.464 Sum_probs=199.2
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceE
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHL 336 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~ 336 (553)
+|.+.+.||+|+||.||++....++ +.||+|+++..... ....+.+.+|+.++++++ |+||+++++++ .....+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~--~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~--~~~~~~ 74 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTG--ELMAVKEIRIQDND-PKTIKEIADEMKVLELLK-HPNLVKYYGVE--VHREKV 74 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCC--cEEEEEEEECcccc-hHHHHHHHHHHHHHHhCC-CCChhheeeeE--ecCCEE
Confidence 5899999999999999999776555 44999999877644 355688999999999995 59999998865 345678
Q ss_pred EEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 337 YVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 337 ~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
++++|+. +++|.+++..... .....+..++.|++.||+|||+.||+||||||+||+++.+ +.+||
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~---------~~~kl 140 (264)
T cd06626 75 YIFMEYCSGGTLEELLEHGRI-----LDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHN---------GVIKL 140 (264)
T ss_pred EEEEecCCCCcHHHHHhhcCC-----CChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC---------CCEEE
Confidence 8899875 5789888876432 2334455566799999999999999999999999999775 57999
Q ss_pred EeccCccccCCCCCccc--ccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHH
Q psy14267 416 IDFGIACSLQDDKTSVH--KDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWA 493 (553)
Q Consensus 416 ~DFGla~~~~~~~~~~~--~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~ 493 (553)
+|||++........... .....+++.|+|||++.+... ..++.++||||||+++|||++|..||......+.
T Consensus 141 ~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~------~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~ 214 (264)
T cd06626 141 GDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKG------KGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ 214 (264)
T ss_pred cccccccccCCCCCcccccccCCcCCcCccChhhccCCCC------CCCCcccchHHHHHHHHHHHhCCCCccCCcchHH
Confidence 99999987755433211 123568899999999975531 1368899999999999999999999987655444
Q ss_pred HHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 494 KMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 494 ~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
....+.. . ..+.......++..+.++|++||+.+|++||++.+++.+
T Consensus 215 ~~~~~~~-~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 215 IMFHVGA-G----HKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred HHHHHhc-C----CCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 4333322 1 122233334568999999999999999999999998763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=297.90 Aligned_cols=260 Identities=21% Similarity=0.350 Sum_probs=191.8
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|++.++||+|+||.||+|.+...+ +.||+|++.+..... ...+.+.+|+++++++. ||||+++++++. ....
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~--~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~ 74 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETG--QIVAIKKFLESEDDK-MVKKIAMREIRMLKQLR-HENLVNLIEVFR--RKKR 74 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCC--CEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcC-CcchhhHHHhcc--cCCe
Confidence 36999999999999999999876655 449999987654333 34467889999999995 599999999874 4678
Q ss_pred EEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 336 LYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 336 ~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
.+++||+..+.+...+..... ......+..++.|++.||+|||+.+|+||||+|+||+++.+ +.++|
T Consensus 75 ~~lv~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~---------~~~~l 141 (286)
T cd07846 75 LYLVFEFVDHTVLDDLEKYPN----GLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQS---------GVVKL 141 (286)
T ss_pred EEEEEecCCccHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCC---------CcEEE
Confidence 899999877655444433221 23455666777899999999999999999999999999776 57999
Q ss_pred EeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHH
Q psy14267 416 IDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKM 495 (553)
Q Consensus 416 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~ 495 (553)
+|||++......... .....++..|+|||++.+.. .++.++||||||+++|||++|.+||...... ...
T Consensus 142 ~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~--------~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~-~~~ 210 (286)
T cd07846 142 CDFGFARTLAAPGEV--YTDYVATRWYRAPELLVGDT--------KYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI-DQL 210 (286)
T ss_pred EeeeeeeeccCCccc--cCcccceeeccCcHHhcccc--------ccCchHhHHHHHHHHHHHHcCCCCCCCCchH-HHH
Confidence 999999876544321 22456899999999986532 3678999999999999999999999754321 111
Q ss_pred HHHHhhccc--------------------cc---ccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 496 LAIARHKDQ--------------------IE---FKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 496 ~~i~~~~~~--------------------~~---~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
..+...... .. ..+.......++..+.++|.+||..+|++||++.+++.+
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 211 YHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred HHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 111100000 00 000001123568899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=294.97 Aligned_cols=249 Identities=24% Similarity=0.417 Sum_probs=195.1
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceE
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHL 336 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~ 336 (553)
+|++.+.||.|+||.||++.+..++.. ||+|++.+.........+.+.+|+++++++. ||||+.+++++ .....+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~--~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~--~~~~~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKM--FAMKYMNKQKCVEKGSVRNVLNERRILQELN-HPFLVNLWYSF--QDEENM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcE--EEEEEEehhhhcchhHHHHHHHHHHHHHhCC-CCChHHHHHhh--cCCCeE
Confidence 489999999999999999988766544 9999998776555455688999999999995 59999998876 346678
Q ss_pred EEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 337 YVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 337 ~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
++++++. +++|..++.... ......+..++.|++.||.|||+++|+|+||||+||+++.+ +.++|
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~---------~~~~l 141 (258)
T cd05578 76 YLVVDLLLGGDLRYHLSQKV-----KFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQ---------GHVHI 141 (258)
T ss_pred EEEEeCCCCCCHHHHHHhcC-----CcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCC---------CCEEE
Confidence 8999864 678988887652 33455566677899999999999999999999999999876 57999
Q ss_pred EeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCch-HHH
Q psy14267 416 IDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNT-WAK 494 (553)
Q Consensus 416 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~-~~~ 494 (553)
+|||++........ .....|+..|+|||.+... .++.++|+||||+++|+|++|..||...... ...
T Consensus 142 ~d~~~~~~~~~~~~---~~~~~~~~~y~~PE~~~~~---------~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~ 209 (258)
T cd05578 142 TDFNIATKVTPDTL---TTSTSGTPGYMAPEVLCRQ---------GYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQ 209 (258)
T ss_pred eecccccccCCCcc---ccccCCChhhcCHHHHccc---------CCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHH
Confidence 99999887654432 1245688999999999765 2678999999999999999999999875532 111
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCH--HHHH
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTV--GNSV 543 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~--~ell 543 (553)
+...... .. ......++..+.++|.+||..||.+||++ +|++
T Consensus 210 ~~~~~~~-~~------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 210 IRAKQET-AD------VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred HHHHhcc-cc------ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 1111110 11 11222567999999999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=292.44 Aligned_cols=250 Identities=28% Similarity=0.471 Sum_probs=194.6
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|++.+.||+|+||.||++.....+ +.||+|.+..... .+.+.+|+++++++ +|+||+.+++++.. ...
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~--~~~~~k~~~~~~~-----~~~~~~e~~~~~~l-~~~~i~~~~~~~~~--~~~ 72 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETG--QVVAIKVVPVEED-----LQEIIKEISILKQC-DSPYIVKYYGSYFK--NTD 72 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCC--cEEEEEEeecHHH-----HHHHHHHHHHHHhC-CCCcEeeeeeeeec--CCc
Confidence 57999999999999999999877655 4499999865421 57899999999999 66999999988754 467
Q ss_pred EEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
+++++|+. +++|.+++..... ...+..+..++.|++.||.|||+.+|+||||+|+||+++.+ +.++
T Consensus 73 ~~l~~e~~~~~~L~~~l~~~~~----~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~---------~~~~ 139 (256)
T cd06612 73 LWIVMEYCGAGSVSDIMKITNK----TLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEE---------GQAK 139 (256)
T ss_pred EEEEEecCCCCcHHHHHHhCcc----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCC---------CcEE
Confidence 88899875 4688888865432 33456666777899999999999999999999999999776 5799
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||++........ ......|+..|+|||++.+. .++.++||||||+++|+|++|+.||........
T Consensus 140 l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~---------~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~- 207 (256)
T cd06612 140 LADFGVSGQLTDTMA--KRNTVIGTPFWMAPEVIQEI---------GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA- 207 (256)
T ss_pred EcccccchhcccCcc--ccccccCCccccCHHHHhcC---------CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh-
Confidence 999999987654432 12245588999999998765 378899999999999999999999987543211
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
...+.. ...........++..+.++|.+||+.||++|||+.+++.+
T Consensus 208 ~~~~~~-----~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 208 IFMIPN-----KPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred hhhhcc-----CCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 111111 1111122233567899999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=292.85 Aligned_cols=256 Identities=25% Similarity=0.429 Sum_probs=192.7
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcC---chhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCC
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDIT---DQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTAS 333 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~---~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~ 333 (553)
+|+..+.||+|+||.||++.+..++.. ||+|++...... .....+.+.+|++++++++ |+||+++++++. ..
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~--~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~--~~ 75 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTL--MAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN-HPHIIRMLGATC--ED 75 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcE--EEEEEeecccCCchhHHHHHHHHHHHHHHHHHcC-CCceehhhceec--cC
Confidence 488889999999999999987666644 999999765422 2234578899999999995 599999999874 45
Q ss_pred ceEEEEEec-CCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCe
Q psy14267 334 KHLYVLMEK-GDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNV 412 (553)
Q Consensus 334 ~~~~iv~e~-~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~ 412 (553)
..++++|++ .+++|.+++.... ......+..++.|++.||.|||++||+||||||+||+++.+ +..
T Consensus 76 ~~~~~v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~--------~~~ 142 (268)
T cd06630 76 SHFNLFVEWMAGGSVSHLLSKYG-----AFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDST--------GQR 142 (268)
T ss_pred CeEEEEEeccCCCcHHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC--------CCE
Confidence 577788886 5578988887643 23345566677899999999999999999999999999655 246
Q ss_pred EEEEeccCccccCCCCCc--ccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCc
Q psy14267 413 LKIIDFGIACSLQDDKTS--VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN 490 (553)
Q Consensus 413 vkL~DFGla~~~~~~~~~--~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~ 490 (553)
+||+|||++......... .......|+..|+|||.+.+. .++.++||||||+++|+|++|..||.....
T Consensus 143 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~---------~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~ 213 (268)
T cd06630 143 LRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGE---------QYGRSCDVWSVGCVIIEMATAKPPWNAEKH 213 (268)
T ss_pred EEEcccccccccccccccCCccccccccccceeCHhHhccC---------CCCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999877543211 112234688999999998755 367899999999999999999999975332
Q ss_pred h--HHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 491 T--WAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 491 ~--~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
. ......+...... + .....++.++.+++.+||..+|++||++.+++++
T Consensus 214 ~~~~~~~~~~~~~~~~----~--~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 214 SNHLALIFKIASATTA----P--SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred cchHHHHHHHhccCCC----C--CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 1 1111111111111 1 1112567899999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=289.86 Aligned_cols=252 Identities=28% Similarity=0.448 Sum_probs=193.9
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCc--CchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDI--TDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
+|+..+.||+|+||+||+|....++. .|++|.+..... ..+...+.+.+|+.+++++. |+||+++++++. ...
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~--~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~--~~~ 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGD--FFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ-HPNIVQYLGTER--EED 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCc--EEEEEEEEEccccccchHHHHHHHHHHHHHHhcC-CCCchheeeeEe--cCC
Confidence 47788999999999999998765554 499999876542 22345578899999999995 599999998764 456
Q ss_pred eEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 335 HLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 335 ~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
.+++++|+. +++|.+++.... ......+..++.|++.||+|||+.||+|+||||+||+++.+ +.+
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~---------~~~ 141 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLKKYG-----SFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTN---------GVV 141 (258)
T ss_pred eEEEEEEecCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC---------CCE
Confidence 788889876 568999887643 23345556667899999999999999999999999999766 579
Q ss_pred EEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHH
Q psy14267 414 KIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWA 493 (553)
Q Consensus 414 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~ 493 (553)
||+|||++....... ......|+..|+|||.+.... .++.++|+|||||++|+|++|..||...... .
T Consensus 142 kl~d~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~--------~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~-~ 209 (258)
T cd06632 142 KLADFGMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQG--------GYGLAADIWSLGCTVLEMATGKPPWSQLEGV-A 209 (258)
T ss_pred EEccCccceeccccc---cccccCCCcceeCHHHhcCCC--------CCCchhhhHHHHHHHHHHHhCCCCcccCcHH-H
Confidence 999999988765433 122456899999999986542 2688999999999999999999999775432 2
Q ss_pred HHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 494 KMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 494 ~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
....+....... .....+++++.++|.+||..+|++||++.+++.+
T Consensus 210 ~~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 210 AVFKIGRSKELP------PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred HHHHHHhcccCC------CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 222222111111 1122568999999999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=298.58 Aligned_cols=258 Identities=28% Similarity=0.388 Sum_probs=193.7
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|++++.||+|+||.||++.+...+. .||+|.+.... .......+.+|+.+++++. |+||+++++++.. ...
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~--~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~--~~~ 73 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGV--TMAMKEIRLEL--DESKFNQIIMELDILHKAV-SPYIVDFYGAFFI--EGA 73 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCc--EEEEEEeeccc--CHHHHHHHHHHHHHHHhcC-CCcHHhhhhheec--CCe
Confidence 368999999999999999998876654 49999887542 2233478899999999995 5999999987643 568
Q ss_pred EEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhh-CCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 336 LYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHA-AGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 336 ~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~-~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
++++||++ +++|..++..... ........+..++.|++.||.|||+ .+|+||||||+||+++.+ +.+
T Consensus 74 ~~lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~---------~~~ 142 (286)
T cd06622 74 VYMCMEYMDAGSLDKLYAGGVA--TEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGN---------GQV 142 (286)
T ss_pred EEEEEeecCCCCHHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCC---------CCE
Confidence 88999976 4578877765321 1234556667777899999999996 599999999999999775 579
Q ss_pred EEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchH-
Q psy14267 414 KIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTW- 492 (553)
Q Consensus 414 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~- 492 (553)
||+|||++..+..... ....|++.|+|||.+.+...+ ....++.++|||||||++|||++|..||.......
T Consensus 143 ~l~dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~---~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 215 (286)
T cd06622 143 KLCDFGVSGNLVASLA----KTNIGCQSYMAPERIKSGGPN---QNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI 215 (286)
T ss_pred EEeecCCcccccCCcc----ccCCCccCccCcchhcCCCCC---ccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH
Confidence 9999999976643322 245688899999998654321 11246889999999999999999999997643211
Q ss_pred -HHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 493 -AKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 493 -~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
..+..+.. .... .....++.++.++|.+||..+|++||++.+++.+
T Consensus 216 ~~~~~~~~~-~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 216 FAQLSAIVD-GDPP------TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred HHHHHHHhh-cCCC------CCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 11111111 1111 1122478999999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=294.93 Aligned_cols=250 Identities=26% Similarity=0.460 Sum_probs=195.4
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|++.+.||.|+||.||++.+..++. .||+|++..... ......+.+|+++++++. |+||+.+++++.+ ...
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~--~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~ 73 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQ--VVAIKVIDLEEA--EDEIEDIQQEIQFLSQCR-SPYITKYYGSFLK--GSK 73 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCe--EEEEEEeecccc--chHHHHHHHHHHHHHHcC-CCCeeeeeEEEEE--CCe
Confidence 368899999999999999998876654 499999976542 233467889999999996 6999999987754 467
Q ss_pred EEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
+++++|+. +++|.+++... ......+..++.|++.||.|||+++++||||+|+||+++.+ +.++
T Consensus 74 ~~~v~e~~~~~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~---------~~~~ 138 (274)
T cd06609 74 LWIIMEYCGGGSCLDLLKPG------KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEE---------GDVK 138 (274)
T ss_pred EEEEEEeeCCCcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC---------CCEE
Confidence 88999864 67898888754 33456667777899999999999999999999999999876 5799
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||+++....... ......|++.|+|||.+.+. .++.++|||||||++|+|++|..||...... ..
T Consensus 139 l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~---------~~~~~sDv~slG~il~~l~tg~~p~~~~~~~-~~ 206 (274)
T cd06609 139 LADFGVSGQLTSTMS--KRNTFVGTPFWMAPEVIKQS---------GYDEKADIWSLGITAIELAKGEPPLSDLHPM-RV 206 (274)
T ss_pred Ecccccceeeccccc--ccccccCCccccChhhhccC---------CCCchhhHHHHHHHHHHHHhCCCCcccCchH-HH
Confidence 999999988765422 12245688999999999765 3789999999999999999999999764432 22
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
...+... ..+.+.. ..++.++.++|.+||..+|++|||+++++++
T Consensus 207 ~~~~~~~-----~~~~~~~-~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 207 LFLIPKN-----NPPSLEG-NKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred HHHhhhc-----CCCCCcc-cccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 2222111 1111111 1278899999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=289.40 Aligned_cols=252 Identities=23% Similarity=0.409 Sum_probs=195.0
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceE
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHL 336 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~ 336 (553)
+|++.+.||+|+||.||++.+...+. .||+|.+....... ...+.+.+|+.+++++. ||||+.+++++ ....+.
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~--~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~-~~~i~~~~~~~--~~~~~~ 74 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGK--QYVIKEINISKMSP-KEREESRKEVAVLSNMK-HPNIVQYQESF--EENGNL 74 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCC--EEEEEEEEhHhCCh-HHHHHHHHHHHHHHhCC-CCCeeeeEeee--cCCCeE
Confidence 58999999999999999998876654 49999997654433 33467899999999995 59999999876 345688
Q ss_pred EEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 337 YVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 337 ~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
+++||+. +++|.+++...... ......+..++.|++.||.|||+++++|+||+|+|||++.+ +.++|
T Consensus 75 ~lv~e~~~~~~l~~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~---------~~~~l 142 (256)
T cd08218 75 YIVMDYCEGGDLYKKINAQRGV---LFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKD---------GTIKL 142 (256)
T ss_pred EEEEecCCCCcHHHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC---------CCEEE
Confidence 9999975 67898888754322 23345556667799999999999999999999999999776 56999
Q ss_pred EeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHH
Q psy14267 416 IDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKM 495 (553)
Q Consensus 416 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~ 495 (553)
+|||++......... .....|++.|+|||++.+. .++.++|+|||||++|+|++|..||...... ...
T Consensus 143 ~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~---------~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-~~~ 210 (256)
T cd08218 143 GDFGIARVLNSTVEL--ARTCIGTPYYLSPEICENR---------PYNNKSDIWALGCVLYEMCTLKHAFEAGNMK-NLV 210 (256)
T ss_pred eeccceeecCcchhh--hhhccCCccccCHHHhCCC---------CCCCccchhHHHHHHHHHHcCCCCccCCCHH-HHH
Confidence 999999876543221 1244588999999998755 3678999999999999999999999764332 222
Q ss_pred HHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 496 LAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 496 ~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
..+.... .. .....++.++.++|.+||+.+|++||++.+++++
T Consensus 211 ~~~~~~~-~~------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 211 LKIIRGS-YP------PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred HHHhcCC-CC------CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 2222111 11 1122568899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=300.10 Aligned_cols=264 Identities=24% Similarity=0.351 Sum_probs=194.7
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC---
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA--- 332 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~--- 332 (553)
++|++.+.||+|+||.||+|.+..++.. ||||++......+. ....+.+|+++++++. ||||+++++++....
T Consensus 8 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~--~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 83 (311)
T cd07866 8 RDYEILGKLGEGTFGEVYKARQIKTGRV--VALKKILMHNEKDG-FPITALREIKILKKLK-HPNVVPLIDMAVERPDKS 83 (311)
T ss_pred ccEEEEEEeccCCCEEEEEEEECCCCcE--EEEEEEEeccCCCC-cchhHHHHHHHHHhcC-CCCccchhhheecccccc
Confidence 5899999999999999999988766644 99999876543332 2245678999999995 599999998776543
Q ss_pred ---CceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCC
Q psy14267 333 ---SKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCI 409 (553)
Q Consensus 333 ---~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~ 409 (553)
...++++|++.+.+|...+..... ......+..++.|+++||+|||++||+||||||+|||++.+
T Consensus 84 ~~~~~~~~lv~~~~~~~l~~~~~~~~~----~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~-------- 151 (311)
T cd07866 84 KRKRGSVYMVTPYMDHDLSGLLENPSV----KLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQ-------- 151 (311)
T ss_pred cccCceEEEEEecCCcCHHHHHhcccc----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC--------
Confidence 236799999998888887765321 34566677778899999999999999999999999999876
Q ss_pred CCeEEEEeccCccccCCCCCcc---------cccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh
Q psy14267 410 GNVLKIIDFGIACSLQDDKTSV---------HKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY 480 (553)
Q Consensus 410 ~~~vkL~DFGla~~~~~~~~~~---------~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt 480 (553)
+.++|+|||+++......... ......|++.|+|||.+.+.. .++.++|||||||++|||++
T Consensus 152 -~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--------~~~~~~Dv~slG~il~el~~ 222 (311)
T cd07866 152 -GILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGER--------RYTTAVDIWGIGCVFAEMFT 222 (311)
T ss_pred -CCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCC--------ccCchhHhHHHHHHHHHHHh
Confidence 579999999997664332211 112345788999999986532 36789999999999999999
Q ss_pred CCCCCCCCCchHHHHHHHHhhcccc---------------------ccccccc-CCCCCCHHHHHHHHHhcccCCCCCCC
Q psy14267 481 GRTPYSHIPNTWAKMLAIARHKDQI---------------------EFKPQLA-NNVTIPPTLLQSMKLCLQKDPKARPT 538 (553)
Q Consensus 481 G~~Pf~~~~~~~~~~~~i~~~~~~~---------------------~~~~~~~-~~~~~s~~l~~li~~cL~~dP~~RPt 538 (553)
|++||.+.... .....+....... ...+.+. ....++..+.++|.+||..||++|||
T Consensus 223 g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t 301 (311)
T cd07866 223 RRPILQGKSDI-DQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLT 301 (311)
T ss_pred CCCCCCCCCHH-HHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcC
Confidence 99999764332 2111111110000 0000000 11234578999999999999999999
Q ss_pred HHHHHHH
Q psy14267 539 VGNSVTQ 545 (553)
Q Consensus 539 ~~ell~~ 545 (553)
+.+++.+
T Consensus 302 ~~ell~~ 308 (311)
T cd07866 302 ASDALEH 308 (311)
T ss_pred HHHHhcC
Confidence 9998864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=296.45 Aligned_cols=250 Identities=28% Similarity=0.452 Sum_probs=193.7
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceE
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHL 336 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~ 336 (553)
+|++.+.||.|+||.||++.+..++.. ||+|.+...... ...+++.+|+++++++. ||||+.+++++.. ...+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~--~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~--~~~~ 74 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKI--MAVKTIRLEINE--AIQKQILRELDILHKCN-SPYIVGFYGAFYN--NGDI 74 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcE--EEEEEEecccCh--HHHHHHHHHHHHHHHCC-CCchhhhheeeec--CCEE
Confidence 588899999999999999988766644 999998765432 34577899999999996 6999999987754 4678
Q ss_pred EEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhh-CCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 337 YVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHA-AGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 337 ~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~-~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
++++++.. ++|.+++.... .......+..++.|++.||+|||+ .|++||||||+||+++.+ +.++
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~---------~~~~ 141 (265)
T cd06605 75 SICMEYMDGGSLDKILKEVQ----GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSR---------GQIK 141 (265)
T ss_pred EEEEEecCCCcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCC---------CCEE
Confidence 89999766 78999887653 233455566677899999999999 999999999999999776 5799
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCC----c
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIP----N 490 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~----~ 490 (553)
|+|||++......... ...++..|+|||.+.+. .++.++||||||+++|+|++|..||.... .
T Consensus 142 l~d~g~~~~~~~~~~~----~~~~~~~y~~PE~~~~~---------~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~ 208 (265)
T cd06605 142 LCDFGVSGQLVNSLAK----TFVGTSSYMAPERIQGN---------DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG 208 (265)
T ss_pred EeecccchhhHHHHhh----cccCChhccCHHHHcCC---------CCCchhhHHHHHHHHHHHHhCCCCCCcccccccc
Confidence 9999998766433221 26688999999998765 37889999999999999999999997642 1
Q ss_pred hHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 491 TWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 491 ~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
....+..+... . .+.+... .++.++.++|.+||..+|++|||+.+++.+
T Consensus 209 ~~~~~~~~~~~-~----~~~~~~~-~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 209 IFELLQYIVNE-P----PPRLPSG-KFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred HHHHHHHHhcC-C----CCCCChh-hcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 11111111111 1 1111111 278899999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=288.49 Aligned_cols=252 Identities=21% Similarity=0.385 Sum_probs=189.4
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
..+|++.+.||+|+||.||++.+... +.+|+|++....... ..+.+|+++++++. ||+|+++++++. ...
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~~---~~~~~k~~~~~~~~~----~~~~~e~~~l~~l~-~~~i~~~~~~~~--~~~ 72 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLEK---RKVAIKTIREGAMSE----EDFIEEAQVMMKLS-HPKLVQLYGVCT--ERS 72 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeCC---CeEEEEECCCCCCCH----HHHHHHHHHHHhCC-CCCeeeEEEEEc--cCC
Confidence 35799999999999999999977532 348999987654332 56788999999995 599999988763 355
Q ss_pred eEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 335 HLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 335 ~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
..+++|++. +++|.+++..... ......+..++.|++.||+|||+.+++||||||+||+++.+ +.+
T Consensus 73 ~~~~v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~---------~~~ 139 (256)
T cd05112 73 PICLVFEFMEHGCLSDYLRAQRG----KFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGEN---------QVV 139 (256)
T ss_pred ceEEEEEcCCCCcHHHHHHhCcc----CCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCC---------CeE
Confidence 678888864 5688888875432 23345566667799999999999999999999999999765 579
Q ss_pred EEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCCCchH
Q psy14267 414 KIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHIPNTW 492 (553)
Q Consensus 414 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~~~~~ 492 (553)
||+|||++.......... .....++..|+|||.+.+. .++.++||||||+++|||++ |..||......
T Consensus 140 ~l~d~g~~~~~~~~~~~~-~~~~~~~~~~~aPe~~~~~---------~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~- 208 (256)
T cd05112 140 KVSDFGMTRFVLDDQYTS-STGTKFPVKWSSPEVFSFS---------KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS- 208 (256)
T ss_pred EECCCcceeecccCcccc-cCCCccchhhcCHhHhccC---------CcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH-
Confidence 999999997664432211 1122356789999998755 37889999999999999998 99999764332
Q ss_pred HHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q psy14267 493 AKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQIN 547 (553)
Q Consensus 493 ~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~ 547 (553)
.....+.. .... .. ....+.++.+++.+||+.+|++||++.++++.|.
T Consensus 209 ~~~~~~~~-~~~~-~~-----~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 209 EVVETINA-GFRL-YK-----PRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred HHHHHHhC-CCCC-CC-----CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 11222111 1111 11 1235789999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=294.51 Aligned_cols=260 Identities=25% Similarity=0.392 Sum_probs=194.8
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceE
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHL 336 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~ 336 (553)
+|++++.||.|++|.||+|++..++.. ||||++...... .....+.+|+.+++++. |+||+++++++.+ ....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~--~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~--~~~~ 73 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEI--VALKEIHLDAEE--GTPSTAIREISLMKELK-HENIVRLHDVIHT--ENKL 73 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeE--EEEEEecccccc--cchHHHHHHHHHHHhhc-CCCEeeeeeeEee--CCcE
Confidence 489999999999999999988766644 999999765432 22356778999999995 6999999998754 4678
Q ss_pred EEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEE
Q psy14267 337 YVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKII 416 (553)
Q Consensus 337 ~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~ 416 (553)
+++||+..++|.+++...... ....+..+..++.|++.||+|||+.||+||||||+||+++++ +.++|+
T Consensus 74 ~lv~e~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~---------~~~~l~ 142 (284)
T cd07836 74 MLVFEYMDKDLKKYMDTHGVR--GALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKR---------GELKLA 142 (284)
T ss_pred EEEEecCCccHHHHHHhcCCC--CCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCC---------CcEEEe
Confidence 999999889999988765432 234556666777899999999999999999999999999776 579999
Q ss_pred eccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHH
Q psy14267 417 DFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKML 496 (553)
Q Consensus 417 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~ 496 (553)
|||++........ ......++..|+|||.+.+.. .++.++|||||||++|+|++|..||.+...... ..
T Consensus 143 d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~--------~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~-~~ 211 (284)
T cd07836 143 DFGLARAFGIPVN--TFSNEVVTLWYRAPDVLLGSR--------TYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ-LL 211 (284)
T ss_pred ecchhhhhcCCcc--ccccccccccccChHHhcCCC--------CCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH-HH
Confidence 9999976543221 112345789999999986542 367899999999999999999999986543211 11
Q ss_pred HHHhhc------------cccccccccc---------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 497 AIARHK------------DQIEFKPQLA---------NNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 497 ~i~~~~------------~~~~~~~~~~---------~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
.+.... ....+..... ....++..+.++|.+||+.||++||++.+++++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 212 KIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred HHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 111100 0000000000 011457889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=290.48 Aligned_cols=248 Identities=21% Similarity=0.394 Sum_probs=189.3
Q ss_pred cCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCC
Q psy14267 254 NGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTAS 333 (553)
Q Consensus 254 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~ 333 (553)
..++|++.+.||+|+||.||++.. .+ +.||+|.+.... ..+.+.+|+.+++++. ||||+++++++..
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~--~~--~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~--- 70 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEY--TG--QKVAVKNIKCDV-----TAQAFLEETAVMTKLH-HKNLVRLLGVILH--- 70 (254)
T ss_pred cHHHceeeeeeccCCCCceEeccc--CC--CceEEEeecCcc-----hHHHHHHHHHHHHhCC-CCCcCeEEEEEcC---
Confidence 346799999999999999998753 22 349999986432 2357889999999995 5999999987643
Q ss_pred ceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCe
Q psy14267 334 KHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNV 412 (553)
Q Consensus 334 ~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~ 412 (553)
...+++||+. +++|.+++...... ......++.++.|++.||.|||+.|++||||||+|||++.+ +.
T Consensus 71 ~~~~~v~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~---------~~ 138 (254)
T cd05083 71 NGLYIVMELMSKGNLVNFLRTRGRA---LVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSED---------GV 138 (254)
T ss_pred CCcEEEEECCCCCCHHHHHHhcCcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCC---------Cc
Confidence 2367888875 57999998765422 23445566677899999999999999999999999999776 57
Q ss_pred EEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCCCch
Q psy14267 413 LKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHIPNT 491 (553)
Q Consensus 413 vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~~~~ 491 (553)
+||+|||++........ ....+..|+|||.+.+. .++.++|+|||||++|||++ |..||......
T Consensus 139 ~kl~Dfg~~~~~~~~~~-----~~~~~~~y~~pe~~~~~---------~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~ 204 (254)
T cd05083 139 AKVSDFGLARVGSMGVD-----NSKLPVKWTAPEALKHK---------KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK 204 (254)
T ss_pred EEECCCccceeccccCC-----CCCCCceecCHHHhccC---------CcCchhhHHHHHHHHHHHHhCCCCCCccCCHH
Confidence 99999999876533211 22346789999998654 37889999999999999997 99999875432
Q ss_pred HHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q psy14267 492 WAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINN 548 (553)
Q Consensus 492 ~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~ 548 (553)
............. ....++..+.+++.+||+.+|++||++++++..|++
T Consensus 205 --~~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 205 --EVKECVEKGYRME------PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred --HHHHHHhCCCCCC------CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 1222211111111 123578999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=286.13 Aligned_cols=256 Identities=27% Similarity=0.439 Sum_probs=201.2
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceE
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHL 336 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~ 336 (553)
+|++.+.||+|++|.||++.+..++. .|++|++...... ....+.+.+|+.+++++. |+||+.+++++.......+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~--~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~ 76 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGE--LMAVKSVELSGDS-EEELEALEREIRILSSLQ-HPNIVRYYGSERDEEKNTL 76 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCc--EEEEEEeeccccc-hHHHHHHHHHHHHHHHcC-CCCEeeEEEEEecCCCCeE
Confidence 48889999999999999998876554 4999999776543 344578999999999996 6999999988765433678
Q ss_pred EEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 337 YVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 337 ~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
++++|+. +++|.+++.... ......++.++.|++.||+|||+.+++|+||+|+||+++.+ +.++|
T Consensus 77 ~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~---------~~~~l 142 (260)
T cd06606 77 NIFLEYVSGGSLSSLLKKFG-----KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSD---------GVVKL 142 (260)
T ss_pred EEEEEecCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCC---------CCEEE
Confidence 8999976 789999988754 34455566777899999999999999999999999999775 57999
Q ss_pred EeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHH
Q psy14267 416 IDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKM 495 (553)
Q Consensus 416 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~ 495 (553)
+|||.+................++..|+|||.+.+. .++.++||||||+++|+|++|..||....+.....
T Consensus 143 ~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~---------~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~ 213 (260)
T cd06606 143 ADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE---------EYGRAADIWSLGCTVIEMATGKPPWSELGNPMAAL 213 (260)
T ss_pred cccccEEecccccccccccCCCCCccccCHhhhcCC---------CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHH
Confidence 999999887665431112345689999999998765 26889999999999999999999998765333333
Q ss_pred HHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 496 LAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 496 ~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
..+....... .....++..+.++|.+||..+|++||++.+++.+
T Consensus 214 ~~~~~~~~~~------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 214 YKIGSSGEPP------EIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred HhccccCCCc------CCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 2222111111 1122458999999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=295.09 Aligned_cols=260 Identities=23% Similarity=0.378 Sum_probs=195.7
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceE
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHL 336 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~ 336 (553)
+|++.+.||+|+||.||+|.+..++. .||||+++..... ....+.+.+|+++|+++. |+||+.+++++.. ...+
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~--~v~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~~ 75 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGE--IVAIKKFKESEDD-EDVKKTALREVKVLRQLR-HENIVNLKEAFRR--KGRL 75 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCc--EEEEehhhhhccc-ccchhHHHHHHHHHHhcC-CCCeeehhheEEE--CCEE
Confidence 69999999999999999998876654 4999998765432 234578899999999996 6999999998855 5678
Q ss_pred EEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEE
Q psy14267 337 YVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKII 416 (553)
Q Consensus 337 ~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~ 416 (553)
+++||+.++++...+..... ......+..++.|++.||+|||+.+|+||||||+||+++.+ +.+||+
T Consensus 76 ~iv~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~---------~~~kl~ 142 (288)
T cd07833 76 YLVFEYVERTLLELLEASPG----GLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSES---------GVLKLC 142 (288)
T ss_pred EEEEecCCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC---------CCEEEE
Confidence 99999988777666554322 23456666777899999999999999999999999999876 679999
Q ss_pred eccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHH
Q psy14267 417 DFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKML 496 (553)
Q Consensus 417 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~ 496 (553)
|||++......... ......++..|+|||++.+.. .++.++||||||+++|+|++|..||...... ....
T Consensus 143 d~g~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~--------~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~-~~~~ 212 (288)
T cd07833 143 DFGFARALRARPAS-PLTDYVATRWYRAPELLVGDT--------NYGKPVDVWAIGCIMAELLDGEPLFPGDSDI-DQLY 212 (288)
T ss_pred eeecccccCCCccc-cccCcccccCCcCCchhcCCC--------CcCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHH
Confidence 99999877654331 223456889999999997652 2678999999999999999999999764332 1111
Q ss_pred HHHhhccc-----------------ccccccc-------cCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 497 AIARHKDQ-----------------IEFKPQL-------ANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 497 ~i~~~~~~-----------------~~~~~~~-------~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
........ ..+.... .....++.++.++|++||..+|++||++++++.+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 213 LIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred HHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 11110000 0000000 0011347899999999999999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=293.77 Aligned_cols=261 Identities=25% Similarity=0.415 Sum_probs=196.5
Q ss_pred eEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEE
Q psy14267 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLY 337 (553)
Q Consensus 258 y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~ 337 (553)
|++.+.||.|+||.||++.+...+.. ||+|++.... ......+.+.+|+++++++. |+||+.+++++.+......+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~--~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~ 76 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGEL--VALKKIRMEN-EKEGFPITAIREIKLLQKLR-HPNIVRLKEIVTSKGKGSIY 76 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeE--EEEEEEeccc-ccccchHHHHHHHHHHHhcc-CCCeeeheeeEecCCCCcEE
Confidence 67899999999999999988766544 9999998765 22334467889999999996 69999999988655447899
Q ss_pred EEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEe
Q psy14267 338 VLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIID 417 (553)
Q Consensus 338 iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~D 417 (553)
++|++.+++|..++.... .......+..++.||+.||+|||+.|++|+||||+|||++.+ +.+||+|
T Consensus 77 lv~e~~~~~l~~~~~~~~----~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~---------~~~~l~d 143 (287)
T cd07840 77 MVFEYMDHDLTGLLDSPE----VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINND---------GVLKLAD 143 (287)
T ss_pred EEeccccccHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCC---------CCEEEcc
Confidence 999998889988886543 134455666777899999999999999999999999999876 5799999
Q ss_pred ccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHHH
Q psy14267 418 FGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLA 497 (553)
Q Consensus 418 FGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~~ 497 (553)
||++......... ......++..|+|||.+.+.. .++.++||||||+++|||++|+.||...... ..+..
T Consensus 144 ~g~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~--------~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~-~~~~~ 213 (287)
T cd07840 144 FGLARPYTKRNSA-DYTNRVITLWYRPPELLLGAT--------RYGPEVDMWSVGCILAELFLGKPIFQGSTEL-EQLEK 213 (287)
T ss_pred ccceeeccCCCcc-cccccccccccCCceeeEccc--------cCChHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHH
Confidence 9999877554321 112345788999999886532 3678999999999999999999999764432 22222
Q ss_pred HHhhccccc---c------------------ccccc-CCCC-CCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 498 IARHKDQIE---F------------------KPQLA-NNVT-IPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 498 i~~~~~~~~---~------------------~~~~~-~~~~-~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
+........ + ...+. .... ++.++.++|++||..+|++||++++++.+
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 214 IFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred HHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 211110000 0 00000 0011 37899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=288.24 Aligned_cols=254 Identities=24% Similarity=0.404 Sum_probs=193.6
Q ss_pred eEEEeeeeeeCceEEEEEeeeCCC--ccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 258 YQVLSLLGKGGSSSVYLVGGTSEH--EFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 258 y~i~~~LG~G~fG~Vy~a~~~~~~--~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
+++.+.||.|+||.||++.+...+ ....||+|++...... ...+.+..|+.+++.+ +|+||+++++++.. ...
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~ 75 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADE--QQIEEFLREARIMRKL-DHPNIVKLLGVCTE--EEP 75 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCCh--HHHHHHHHHHHHHHhc-CCCchheEEEEEcC--CCe
Confidence 356789999999999999887644 2255999999655322 2457889999999999 67999999987754 467
Q ss_pred EEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
.+++|++. +++|.+++....... ..+..+..++.|++.||+|||+.+++||||||+||+++.+ +.++
T Consensus 76 ~~~i~e~~~~~~l~~~~~~~~~~~---~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~---------~~~~ 143 (258)
T smart00219 76 LMIVMEYMEGGDLLDYLRKNRPKE---LSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGEN---------LVVK 143 (258)
T ss_pred eEEEEeccCCCCHHHHHHhhhhcc---CCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccC---------CeEE
Confidence 88888865 678998887644211 4566677778899999999999999999999999999876 5799
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCCCchHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHIPNTWA 493 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~~~~~~ 493 (553)
|+|||+++.......... ....+++.|+|||.+.+. .++.++||||||+++|+|++ |..||...... .
T Consensus 144 l~dfg~~~~~~~~~~~~~-~~~~~~~~y~~Pe~~~~~---------~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~-~ 212 (258)
T smart00219 144 ISDFGLSRDLYDDDYYKK-KGGKLPIRWMAPESLKDG---------KFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE-E 212 (258)
T ss_pred EcccCCceeccccccccc-ccCCCcccccChHHhccC---------CCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH-H
Confidence 999999987765432211 122367899999998544 37889999999999999998 89999764332 2
Q ss_pred HHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q psy14267 494 KMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQI 546 (553)
Q Consensus 494 ~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L 546 (553)
....+.. .... .....++.++.+++.+||..+|++|||+.++++.|
T Consensus 213 ~~~~~~~-~~~~------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 213 VLEYLKK-GYRL------PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHHHHhc-CCCC------CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 2222221 1111 11224789999999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=298.72 Aligned_cols=257 Identities=26% Similarity=0.402 Sum_probs=193.2
Q ss_pred cCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCC
Q psy14267 254 NGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTAS 333 (553)
Q Consensus 254 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~ 333 (553)
...+|++++.||+|+||+||++.+...+. .||+|++.... .....+.+.+|+++++.+. ||||+++++++.. .
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~--~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~--~ 75 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGT--VMAKKVVHIGA--KSSVRKQILRELQIMHECR-SPYIVSFYGAFLN--E 75 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCc--EEEEEEEEecC--cchHHHHHHHHHHHHHHcC-CCCcceEeeeEec--C
Confidence 34679999999999999999998876664 49999987543 2334578899999999995 6999999988754 4
Q ss_pred ceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhh-CCcEecCCCCCCEEEecCccceecCCCC
Q psy14267 334 KHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHA-AGIIHSDLKPANFLFVGNVLKIIDCIGN 411 (553)
Q Consensus 334 ~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~-~gIiHrDLKp~NILl~~~~~~~~~~~~~ 411 (553)
..++++||+. +++|..++.... ......+..++.+++.||.|||+ .+++||||||+||+++.+ +
T Consensus 76 ~~~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~---------~ 141 (284)
T cd06620 76 NNICMCMEFMDCGSLDRIYKKGG-----PIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSR---------G 141 (284)
T ss_pred CEEEEEEecCCCCCHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCC---------C
Confidence 6788999975 567888776543 23455566677899999999997 699999999999999766 5
Q ss_pred eEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCch
Q psy14267 412 VLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNT 491 (553)
Q Consensus 412 ~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~ 491 (553)
.++|+|||++........ ....|+..|+|||++.+. .++.++|||||||++|+|++|..||......
T Consensus 142 ~~~l~d~gl~~~~~~~~~----~~~~~~~~~~aPE~~~~~---------~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~ 208 (284)
T cd06620 142 QIKLCDFGVSGELINSIA----DTFVGTSTYMSPERIQGG---------KYTVKSDVWSLGISIIELALGKFPFAFSNID 208 (284)
T ss_pred cEEEccCCcccchhhhcc----CccccCcccCCHHHHccC---------CCCccchHHHHHHHHHHHHhCCCCCcccchh
Confidence 799999999876533221 245789999999998655 3688999999999999999999999864331
Q ss_pred ------HHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q psy14267 492 ------WAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQI 546 (553)
Q Consensus 492 ------~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L 546 (553)
............. ...+.+ ....++..+.+||.+||..||++|||+.|++++.
T Consensus 209 ~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 209 DDGQDDPMGILDLLQQIVQ-EPPPRL-PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred hhhhhhhhHHHHHHHHHhh-ccCCCC-CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 0000111110000 001111 1113678999999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0196|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=321.93 Aligned_cols=260 Identities=25% Similarity=0.419 Sum_probs=212.0
Q ss_pred ecCcceEEEeeeeeeCceEEEEEeeeCC-CccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeC
Q psy14267 253 LNGKQYQVLSLLGKGGSSSVYLVGGTSE-HEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDT 331 (553)
Q Consensus 253 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~-~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~ 331 (553)
+......|.++||.|.||+||.++.+.. +....||||.++..- .+.....|+.|+.||.+.. ||||++|.|++ +
T Consensus 626 Id~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFd-HPNIIrLEGVV--T 700 (996)
T KOG0196|consen 626 IDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFD-HPNIIRLEGVV--T 700 (996)
T ss_pred cChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCC-CCcEEEEEEEE--e
Confidence 4445678899999999999999877644 334679999997553 3455678999999999995 59999999987 5
Q ss_pred CCceEEEEEec-CCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCC
Q psy14267 332 ASKHLYVLMEK-GDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIG 410 (553)
Q Consensus 332 ~~~~~~iv~e~-~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~ 410 (553)
..+.+.|+.|| ..|.|..||+.... .+.+.++..+.+.|+.||.||-+.++|||||...||||+.+
T Consensus 701 ks~PvMIiTEyMENGsLDsFLR~~DG----qftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsn--------- 767 (996)
T KOG0196|consen 701 KSKPVMIITEYMENGSLDSFLRQNDG----QFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSN--------- 767 (996)
T ss_pred cCceeEEEhhhhhCCcHHHHHhhcCC----ceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccc---------
Confidence 56778888886 56899999998764 35667777888899999999999999999999999999998
Q ss_pred CeEEEEeccCccccCCCCCcccccCCcc--CCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHH-hCCCCCCC
Q psy14267 411 NVLKIIDFGIACSLQDDKTSVHKDTASG--TLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI-YGRTPYSH 487 (553)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~~~~~~~~~G--t~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ell-tG~~Pf~~ 487 (553)
-+.|++||||++.+.+.... .+.+..| ..+|.|||.|.-. +++.+|||||||++|||.+ +|..||.+
T Consensus 768 LvCKVsDFGLSRvledd~~~-~ytt~GGKIPiRWTAPEAIa~R---------KFTsASDVWSyGIVmWEVmSyGERPYWd 837 (996)
T KOG0196|consen 768 LVCKVSDFGLSRVLEDDPEA-AYTTLGGKIPIRWTAPEAIAYR---------KFTSASDVWSYGIVMWEVMSYGERPYWD 837 (996)
T ss_pred eEEEeccccceeecccCCCc-cccccCCccceeecChhHhhhc---------ccCchhhccccceEEEEecccCCCcccc
Confidence 47999999999988765522 2223333 5699999999755 5899999999999999988 69999999
Q ss_pred CCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q psy14267 488 IPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINN 548 (553)
Q Consensus 488 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~ 548 (553)
..|. +.+..+.. ..+++.+.+||..|.+||..||++|..+||.+.+|+..|.+
T Consensus 838 mSNQ-dVIkaIe~-------gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDk 890 (996)
T KOG0196|consen 838 MSNQ-DVIKAIEQ-------GYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDK 890 (996)
T ss_pred cchH-HHHHHHHh-------ccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHH
Confidence 8875 33333322 33455566899999999999999999999999999999987
|
|
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=332.74 Aligned_cols=260 Identities=28% Similarity=0.422 Sum_probs=192.2
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeC---
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDT--- 331 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~--- 331 (553)
..+|+.+++||+||||.||+|+++-++.. ||||.+.... ........++|+.+|.+| +|||||+++..|...
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~--YAIKKIpl~~--s~~~~skI~rEVk~LArL-nHpNVVRYysAWVEs~~~ 552 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGRE--YAIKKIPLKA--SDKLYSKILREVKLLARL-NHPNVVRYYSAWVESTAE 552 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchh--hhhhhccCch--HHHHHHHHHHHHHHHhhc-CCcceeeeehhhhccCCc
Confidence 35788999999999999999999988866 9999998775 334457889999999999 569999997422100
Q ss_pred --------------------------------------------------------------------------------
Q psy14267 332 -------------------------------------------------------------------------------- 331 (553)
Q Consensus 332 -------------------------------------------------------------------------------- 331 (553)
T Consensus 553 ~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~ 632 (1351)
T KOG1035|consen 553 LTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSN 632 (1351)
T ss_pred cccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccc
Confidence
Q ss_pred --------------------------CC--------ceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHH
Q psy14267 332 --------------------------AS--------KHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLA 377 (553)
Q Consensus 332 --------------------------~~--------~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~a 377 (553)
.. ..+||-||||..++..++-+.+.... .....+.++++|+.|
T Consensus 633 tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---~~d~~wrLFreIlEG 709 (1351)
T KOG1035|consen 633 TSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---QRDEAWRLFREILEG 709 (1351)
T ss_pred ccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---hhHHHHHHHHHHHHH
Confidence 00 25789999999888777776655432 234566677899999
Q ss_pred HHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEeccCccccC----------------CCCCcccccCCccCCC
Q psy14267 378 VKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQ----------------DDKTSVHKDTASGTLN 441 (553)
Q Consensus 378 L~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGla~~~~----------------~~~~~~~~~~~~Gt~~ 441 (553)
|.|+|++|||||||||.||||+++ +.|||+|||+|+... .+......+..+||..
T Consensus 710 LaYIH~~giIHRDLKP~NIFLd~~---------~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTal 780 (1351)
T KOG1035|consen 710 LAYIHDQGIIHRDLKPRNIFLDSR---------NSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTAL 780 (1351)
T ss_pred HHHHHhCceeeccCCcceeEEcCC---------CCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceee
Confidence 999999999999999999999876 679999999998722 0111113346789999
Q ss_pred ccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHhhc-ccccccccccCCCCCCHH
Q psy14267 442 YMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARHK-DQIEFKPQLANNVTIPPT 520 (553)
Q Consensus 442 y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~~s~~ 520 (553)
|+|||++.+... ..|+.|+|+||||||++||+. ||...- +....+...+ ..+..++.+.. .--+.
T Consensus 781 YvAPEll~~~~~------~~Yn~KiDmYSLGIVlFEM~y---PF~TsM---ERa~iL~~LR~g~iP~~~~f~~--~~~~~ 846 (1351)
T KOG1035|consen 781 YVAPELLSDTSS------NKYNSKIDMYSLGIVLFEMLY---PFGTSM---ERASILTNLRKGSIPEPADFFD--PEHPE 846 (1351)
T ss_pred eecHHHhccccc------ccccchhhhHHHHHHHHHHhc---cCCchH---HHHHHHHhcccCCCCCCccccc--ccchH
Confidence 999999976642 258999999999999999985 464322 2222222222 22222211111 12246
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 521 LLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 521 l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
-..+|++||+.||.+||||.|||+.
T Consensus 847 e~slI~~Ll~hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 847 EASLIRWLLSHDPSKRPTATELLNS 871 (1351)
T ss_pred HHHHHHHHhcCCCccCCCHHHHhhc
Confidence 6889999999999999999999863
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=305.27 Aligned_cols=262 Identities=24% Similarity=0.338 Sum_probs=192.7
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCC-
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTAS- 333 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~- 333 (553)
+.+|.+.+.||.|+||.||+|.+..++. .||+|.+..... ...+.+.+|+++++++. ||||+++++++.....
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~--~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~-h~~i~~~~~~~~~~~~~ 77 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDK--RVAVKKIVLTDP---QSVKHALREIKIIRRLD-HDNIVKVYEVLGPSGSD 77 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCc--EEEEEEEecCCC---chHHHHHHHHHHHHhcC-CCcchhhHhhhcccccc
Confidence 4689999999999999999998876664 499999876653 23467889999999995 5999999876544321
Q ss_pred -----------ceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCc
Q psy14267 334 -----------KHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNV 402 (553)
Q Consensus 334 -----------~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~ 402 (553)
..++++||+.+++|..++... ......+..++.||+.||+|||+.||+||||||+|||++.+.
T Consensus 78 ~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~ 151 (342)
T cd07854 78 LTEDVGSLTELNSVYIVQEYMETDLANVLEQG------PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTED 151 (342)
T ss_pred cccccccccccceEEEEeecccccHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCC
Confidence 357899999988988877542 233556667778999999999999999999999999997542
Q ss_pred cceecCCCCeEEEEeccCccccCCCCCcc-cccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhC
Q psy14267 403 LKIIDCIGNVLKIIDFGIACSLQDDKTSV-HKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYG 481 (553)
Q Consensus 403 ~~~~~~~~~~vkL~DFGla~~~~~~~~~~-~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG 481 (553)
..+||+|||++.......... ......|+..|+|||.+.... .++.++|||||||++|||++|
T Consensus 152 --------~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--------~~~~~~DiwSlGvil~el~~g 215 (342)
T cd07854 152 --------LVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPN--------NYTKAIDMWAAGCIFAEMLTG 215 (342)
T ss_pred --------ceEEECCcccceecCCccccccccccccccccccCHHHHhCcc--------ccCchhhHHHHHHHHHHHHhC
Confidence 578999999997664322111 112335788999999875432 367899999999999999999
Q ss_pred CCCCCCCCchHHHHHHHHhhc----------------------ccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCH
Q psy14267 482 RTPYSHIPNTWAKMLAIARHK----------------------DQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTV 539 (553)
Q Consensus 482 ~~Pf~~~~~~~~~~~~i~~~~----------------------~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~ 539 (553)
..||........ ...+.... ......+.......++.++.++|.+||..||++|||+
T Consensus 216 ~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~ 294 (342)
T cd07854 216 KPLFAGAHELEQ-MQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTA 294 (342)
T ss_pred CCCCCCCCHHHH-HHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCH
Confidence 999976433211 11111000 0000000000112567899999999999999999999
Q ss_pred HHHHHH
Q psy14267 540 GNSVTQ 545 (553)
Q Consensus 540 ~ell~~ 545 (553)
.+++.+
T Consensus 295 ~ell~h 300 (342)
T cd07854 295 EEALMH 300 (342)
T ss_pred HHHhCC
Confidence 999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=304.86 Aligned_cols=264 Identities=26% Similarity=0.359 Sum_probs=197.4
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeC--C
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDT--A 332 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~--~ 332 (553)
+.+|++.+.||+|+||.||++.+..++. .||+|++...... ....+.+.+|+.+|+++. ||||+++++++... .
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~--~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~ 79 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGK--KVAIKKIPHAFDV-PTLAKRTLRELKILRHFK-HDNIIAIRDILRPPGAD 79 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCC--EEEEEEecccccc-ccchHHHHHHHHHHHhcC-CCCccCHHHhccccCCC
Confidence 3689999999999999999998877664 4999999765432 234577889999999996 69999998876533 3
Q ss_pred CceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCe
Q psy14267 333 SKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNV 412 (553)
Q Consensus 333 ~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~ 412 (553)
...++++|++.+++|..++.... ......+..++.||+.||+|||+++|+||||||+|||++.+ +.
T Consensus 80 ~~~~~lv~e~~~~~l~~~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~---------~~ 145 (334)
T cd07855 80 FKDVYVVMDLMESDLHHIIHSDQ-----PLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNED---------CE 145 (334)
T ss_pred CceEEEEEehhhhhHHHHhccCC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC---------Cc
Confidence 45789999999899988876543 24456667777899999999999999999999999999876 67
Q ss_pred EEEEeccCccccCCCCCc--ccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCc
Q psy14267 413 LKIIDFGIACSLQDDKTS--VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN 490 (553)
Q Consensus 413 vkL~DFGla~~~~~~~~~--~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~ 490 (553)
+||+|||++......... .......|+..|+|||.+.+.. .++.++|||||||++|||++|+.||.....
T Consensus 146 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--------~~~~~~Di~slG~~l~el~~g~~pf~~~~~ 217 (334)
T cd07855 146 LRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLP--------EYTTAIDMWSVGCIFAEMLGRRQLFPGKNY 217 (334)
T ss_pred EEecccccceeecccCcCCCcccccccccccccChHHhcCCc--------ccccccchHHHHHHHHHHHcCCCccCCCCh
Confidence 999999999776543221 1112456899999999986532 368899999999999999999999976432
Q ss_pred hHHHHHHHHhhcc--------------------ccccccc--c-cCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 491 TWAKMLAIARHKD--------------------QIEFKPQ--L-ANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 491 ~~~~~~~i~~~~~--------------------~~~~~~~--~-~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
. ..+..+..... ....... + ......+.++.++|++||+.+|++||++.+++.+
T Consensus 218 ~-~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 218 V-HQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred H-HHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 2 11111111000 0000000 0 0012468899999999999999999999999874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=285.57 Aligned_cols=247 Identities=23% Similarity=0.388 Sum_probs=185.7
Q ss_pred eeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEEEEEe
Q psy14267 262 SLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLME 341 (553)
Q Consensus 262 ~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~iv~e 341 (553)
++||+|+||.||++.... + +.||+|++.... .......+.+|+++++++ +||||+++++++.. ....+++||
T Consensus 1 ~~ig~g~~g~vy~~~~~~-~--~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv~e 72 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKD-K--TPVAVKTCKEDL--PQELKIKFLSEARILKQY-DHPNIVKLIGVCTQ--RQPIYIVME 72 (250)
T ss_pred CccCCCCCceEEEEEecC-C--cEEEEEecCCcC--CHHHHHHHHHHHHHHHhC-CCCCcCeEEEEEec--CCccEEEEE
Confidence 369999999999997543 2 459999886543 233345788999999999 56999999987743 456788998
Q ss_pred c-CCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEeccC
Q psy14267 342 K-GDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGI 420 (553)
Q Consensus 342 ~-~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGl 420 (553)
+ .+++|.+++..... ...+..+..++.|++.||.|||++|++||||||+||+++.+ +.+||+|||+
T Consensus 73 ~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~---------~~~~l~d~g~ 139 (250)
T cd05085 73 LVPGGDFLSFLRKKKD----ELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGEN---------NVLKISDFGM 139 (250)
T ss_pred CCCCCcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCC---------CeEEECCCcc
Confidence 7 46889888865432 23345556667799999999999999999999999999766 5799999999
Q ss_pred ccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHH
Q psy14267 421 ACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHIPNTWAKMLAIA 499 (553)
Q Consensus 421 a~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~i~ 499 (553)
+......... ......++..|+|||++.+. .++.++||||||+++|||++ |..||...... .....+.
T Consensus 140 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~-~~~~~~~ 208 (250)
T cd05085 140 SRQEDDGIYS-SSGLKQIPIKWTAPEALNYG---------RYSSESDVWSYGILLWETFSLGVCPYPGMTNQ-QAREQVE 208 (250)
T ss_pred ceeccccccc-cCCCCCCcccccCHHHhccC---------CCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH-HHHHHHH
Confidence 8764432211 11123356789999998654 37889999999999999998 99999875432 2222221
Q ss_pred hhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q psy14267 500 RHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQIN 547 (553)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~ 547 (553)
.... ......++..+.+++.+||..+|++||++.++++.|.
T Consensus 209 -~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 209 -KGYR------MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred -cCCC------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 1111 1122357899999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=293.11 Aligned_cols=250 Identities=17% Similarity=0.254 Sum_probs=179.4
Q ss_pred eeeeeeCceEEEEEeeeCC----------CccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeC
Q psy14267 262 SLLGKGGSSSVYLVGGTSE----------HEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDT 331 (553)
Q Consensus 262 ~~LG~G~fG~Vy~a~~~~~----------~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~ 331 (553)
+.||+|+||.||++..... .....||+|++.... ......+..|+.+++.+. ||||+++++++..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~-hp~iv~~~~~~~~- 75 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVS-HKHIVLLYGVCVR- 75 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCC-CCCEeeEEEEEec-
Confidence 3689999999999865322 122348888876532 234467888999999995 5999999998754
Q ss_pred CCceEEEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCC
Q psy14267 332 ASKHLYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIG 410 (553)
Q Consensus 332 ~~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~ 410 (553)
....+++||+++ +.|..++..... ......++.++.||+.||+|||+++|+||||||+||||+.+.. ....+
T Consensus 76 -~~~~~lv~e~~~~~~l~~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~--~~~~~ 148 (262)
T cd05077 76 -DVENIMVEEFVEFGPLDLFMHRKSD----VLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGI--DGECG 148 (262)
T ss_pred -CCCCEEEEecccCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCc--cCCCC
Confidence 445678888755 567666654322 2445566777889999999999999999999999999976521 01122
Q ss_pred CeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHH-hCCCCCCCCC
Q psy14267 411 NVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI-YGRTPYSHIP 489 (553)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ell-tG~~Pf~~~~ 489 (553)
..++|+|||++....... ...++..|+|||.+.... .++.++|||||||+||||+ .|..||....
T Consensus 149 ~~~~l~d~g~~~~~~~~~------~~~~~~~y~aPE~~~~~~--------~~~~~~DiwslG~~l~el~~~~~~p~~~~~ 214 (262)
T cd05077 149 PFIKLSDPGIPITVLSRQ------ECVERIPWIAPECVEDSK--------NLSIAADKWSFGTTLWEICYNGEIPLKDKT 214 (262)
T ss_pred ceeEeCCCCCCccccCcc------cccccccccChhhhcCCC--------CCCchhHHHHHHHHHHHHHhCCCCCCCCcc
Confidence 348999999986653321 345788999999886332 3688999999999999998 5899987633
Q ss_pred chHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q psy14267 490 NTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQIN 547 (553)
Q Consensus 490 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~ 547 (553)
.. ........ . .......++++.+||.+||+.||++||++.+|+++|.
T Consensus 215 ~~--~~~~~~~~--~------~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 215 LA--EKERFYEG--Q------CMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred hh--HHHHHHhc--C------ccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 21 11111111 0 1111234578999999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=293.16 Aligned_cols=251 Identities=29% Similarity=0.468 Sum_probs=193.0
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhc--CCCceeEeeeEEEeCCCc
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQ--GCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~--~hp~Iv~l~~~~~~~~~~ 334 (553)
.|++.+.||+|+||.||+|.+..++. .||+|++..... ......+.+|+.+++++. .||||+++++++.. ..
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~--~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~--~~ 75 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGR--VVALKIINLDTP--DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK--GP 75 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCc--EEEEEEecCCCC--chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee--CC
Confidence 48889999999999999998866654 499999876532 233467889999999997 47999999987754 56
Q ss_pred eEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 335 HLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 335 ~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
..+++||+. +++|.++++.. ......++.++.|++.||.|||+.||+||||+|+||+++.+ +.+
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~------~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~---------~~~ 140 (277)
T cd06917 76 RLWIIMEYAEGGSVRTLMKAG------PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNT---------GNV 140 (277)
T ss_pred EEEEEEecCCCCcHHHHHHcc------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCC---------CCE
Confidence 788999965 67888887653 23455666677899999999999999999999999999775 679
Q ss_pred EEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHH
Q psy14267 414 KIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWA 493 (553)
Q Consensus 414 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~ 493 (553)
+|+|||++..+...... .....|+..|+|||.+.+.. .++.++|+|||||++|+|++|..||........
T Consensus 141 ~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~--------~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~ 210 (277)
T cd06917 141 KLCDFGVAALLNQNSSK--RSTFVGTPYWMAPEVITEGK--------YYDTKADIWSLGITIYEMATGNPPYSDVDAFRA 210 (277)
T ss_pred EEccCCceeecCCCccc--cccccCCcceeCHHHhccCC--------ccccchhHHHHHHHHHHHHhCCCCCCCCChhhh
Confidence 99999999877654321 22456899999999986432 367899999999999999999999987533211
Q ss_pred HHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 494 KMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 494 ~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
. ..+. .. ..+.+. ...++.++.++|.+||..||++||++.+++.+
T Consensus 211 ~-~~~~----~~-~~~~~~-~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 211 M-MLIP----KS-KPPRLE-DNGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred h-hccc----cC-CCCCCC-cccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 1 1110 00 111111 11377899999999999999999999999864
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=293.01 Aligned_cols=246 Identities=22% Similarity=0.366 Sum_probs=181.3
Q ss_pred eeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhh--cCCCceeEeeeEEEeCCCceEEEEE
Q psy14267 263 LLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKL--QGCPYVIKMHDYVYDTASKHLYVLM 340 (553)
Q Consensus 263 ~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l--~~hp~Iv~l~~~~~~~~~~~~~iv~ 340 (553)
+||+|+||.||+|.+..++. .||+|.+.+...........+..|..+++.+ .+||+|+.+++++. ....++++|
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~--~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~--~~~~~~~v~ 76 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGK--MYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH--TPDKLSFIL 76 (278)
T ss_pred CcccCCCeEEEEEEEecCCC--EEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeee--cCCEEEEEE
Confidence 48999999999998876654 4999999876544322223345555544443 35799999987664 345788888
Q ss_pred ecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEecc
Q psy14267 341 EKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFG 419 (553)
Q Consensus 341 e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFG 419 (553)
|++ +++|..++.... ...+..+..++.|++.||+|||+.+|+||||||+||+++.+ +.+||+|||
T Consensus 77 e~~~g~~L~~~l~~~~-----~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~---------~~~kl~dfg 142 (278)
T cd05606 77 DLMNGGDLHYHLSQHG-----VFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH---------GHVRISDLG 142 (278)
T ss_pred ecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCC---------CCEEEccCc
Confidence 865 678888776532 34456677778899999999999999999999999999776 579999999
Q ss_pred CccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCch-HHHHHHH
Q psy14267 420 IACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNT-WAKMLAI 498 (553)
Q Consensus 420 la~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~-~~~~~~i 498 (553)
++..+..... ....|+..|+|||++.+.. .++.++|||||||++|||++|..||...... .......
T Consensus 143 ~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~--------~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~ 210 (278)
T cd05606 143 LACDFSKKKP----HASVGTHGYMAPEVLQKGV--------AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM 210 (278)
T ss_pred CccccCccCC----cCcCCCcCCcCcHHhcCCC--------CCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHH
Confidence 9876543221 2457999999999986432 3678999999999999999999999764321 1111111
Q ss_pred HhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q psy14267 499 ARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARP-----TVGNSVTQ 545 (553)
Q Consensus 499 ~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RP-----t~~ell~~ 545 (553)
. .... ......++..+.+++.+||..+|.+|| ++.+++++
T Consensus 211 ~-~~~~------~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 211 T-LTMA------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred h-hccC------CCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 1 1111 111224689999999999999999999 99999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG4257|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=307.79 Aligned_cols=262 Identities=22% Similarity=0.388 Sum_probs=209.6
Q ss_pred EecCcceEEEeeeeeeCceEEEEEeeeCC--CccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEE
Q psy14267 252 TLNGKQYQVLSLLGKGGSSSVYLVGGTSE--HEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVY 329 (553)
Q Consensus 252 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~--~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~ 329 (553)
++......+.++||.|.||.||.+....- ++.-.||||.-+.+.-.+ ..+.|+.|..+|+++. ||||++++|++.
T Consensus 385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d--~tekflqEa~iMrnfd-HphIikLIGv~~ 461 (974)
T KOG4257|consen 385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPD--DTEKFLQEASIMRNFD-HPHIIKLIGVCV 461 (974)
T ss_pred eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChh--hHHHHHHHHHHHHhCC-Ccchhheeeeee
Confidence 33444555667999999999999876543 334458999887654332 2588999999999995 599999999885
Q ss_pred eCCCceEEEEEec-CCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecC
Q psy14267 330 DTASKHLYVLMEK-GDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDC 408 (553)
Q Consensus 330 ~~~~~~~~iv~e~-~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~ 408 (553)
+ ...+|+||. .-|.|..|++.... .+.......+++||+.||.|||+..+|||||...|||+.+.
T Consensus 462 e---~P~WivmEL~~~GELr~yLq~nk~----sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp------- 527 (974)
T KOG4257|consen 462 E---QPMWIVMELAPLGELREYLQQNKD----SLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSP------- 527 (974)
T ss_pred c---cceeEEEecccchhHHHHHHhccc----cchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCc-------
Confidence 4 467899995 45889999987653 45566777888899999999999999999999999999776
Q ss_pred CCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHH-hCCCCCCC
Q psy14267 409 IGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI-YGRTPYSH 487 (553)
Q Consensus 409 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ell-tG~~Pf~~ 487 (553)
..|||+||||++.+.+...... ....-.+.|||||.+.-. +++.++|||.|||+|||++ .|.-||.+
T Consensus 528 --~CVKLaDFGLSR~~ed~~yYka-S~~kLPIKWmaPESINfR---------rFTtASDVWMFgVCmWEIl~lGvkPfqg 595 (974)
T KOG4257|consen 528 --QCVKLADFGLSRYLEDDAYYKA-SRGKLPIKWMAPESINFR---------RFTTASDVWMFGVCMWEILSLGVKPFQG 595 (974)
T ss_pred --ceeeecccchhhhccccchhhc-cccccceeecCccccchh---------cccchhhHHHHHHHHHHHHHhcCCcccc
Confidence 5799999999999887665322 233457799999999654 6899999999999999988 59999998
Q ss_pred CCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q psy14267 488 IPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNP 550 (553)
Q Consensus 488 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~ 550 (553)
..+... ...++-..+++.+..||+.|..||.+||+.||.+||.+.+|...|..+.
T Consensus 596 vkNsDV--------I~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~ 650 (974)
T KOG4257|consen 596 VKNSDV--------IGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVL 650 (974)
T ss_pred ccccce--------EEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHH
Confidence 665311 2334455667777799999999999999999999999999999887653
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=293.69 Aligned_cols=251 Identities=16% Similarity=0.277 Sum_probs=183.6
Q ss_pred eeeeeeCceEEEEEeeeCCCc-----cceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceE
Q psy14267 262 SLLGKGGSSSVYLVGGTSEHE-----FKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHL 336 (553)
Q Consensus 262 ~~LG~G~fG~Vy~a~~~~~~~-----~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~ 336 (553)
+.||+|+||.||++.....+. ...||+|.+.... ....+.+..|+.+++.+. ||||+++++++.. ....
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~~~--~~~~ 74 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLS-HKHLVLNYGVCVC--GDES 74 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCC-CCChhheeeEEEe--CCCc
Confidence 369999999999997754322 2348888875432 334567889999999985 6999999998765 3457
Q ss_pred EEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 337 YVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 337 ~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
+++||++ +++|..+++.... ...+..++.++.||+.||+|||++||+||||||+|||++.+.... ....+.++|
T Consensus 75 ~lv~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~-~~~~~~~~l 149 (258)
T cd05078 75 IMVQEYVKFGSLDTYLKKNKN----LINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRK-TGNPPFIKL 149 (258)
T ss_pred EEEEecCCCCcHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccc-cCCCceEEe
Confidence 7888875 5689888876432 234555666778999999999999999999999999998763110 011235899
Q ss_pred EeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhC-CCCCCCCCchHHH
Q psy14267 416 IDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYG-RTPYSHIPNTWAK 494 (553)
Q Consensus 416 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG-~~Pf~~~~~~~~~ 494 (553)
+|||++....... ...+++.|+|||++.+.. .++.++|||||||++|||++| ..||...... ..
T Consensus 150 ~d~g~~~~~~~~~------~~~~~~~y~aPE~~~~~~--------~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~-~~ 214 (258)
T cd05078 150 SDPGISITVLPKE------ILLERIPWVPPECIENPQ--------NLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ-KK 214 (258)
T ss_pred cccccccccCCch------hccccCCccCchhccCCC--------CCCchhhHHHHHHHHHHHHcCCCCChhhccHH-HH
Confidence 9999987654322 356888999999997532 368899999999999999998 5666554332 11
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQIN 547 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~ 547 (553)
..+.... ..+ ....+.++.++|.+||+.||++|||+++|++.|+
T Consensus 215 -~~~~~~~--~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 215 -LQFYEDR--HQL------PAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -HHHHHcc--ccC------CCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 1111111 111 1134578999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=289.92 Aligned_cols=260 Identities=25% Similarity=0.337 Sum_probs=193.5
Q ss_pred eEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhc--CCCceeEeeeEEEeCCC--
Q psy14267 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQ--GCPYVIKMHDYVYDTAS-- 333 (553)
Q Consensus 258 y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~--~hp~Iv~l~~~~~~~~~-- 333 (553)
|++.+.||+|+||.||++++..++ +.||+|+++...... .....+.+|+.+++++. .|+||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~--~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~ 77 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTG--RFVALKKVRVPLSEE-GIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDR 77 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCC--CEEEEEEeccccccc-hhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCC
Confidence 678999999999999999887655 449999997654322 33356678988888875 47999999998865432
Q ss_pred -ceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCe
Q psy14267 334 -KHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNV 412 (553)
Q Consensus 334 -~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~ 412 (553)
..++++||+..++|.+++...... ...+..+..++.|++.||.|||+.+++|+||||+||+++.+ +.
T Consensus 78 ~~~~~l~~e~~~~~l~~~l~~~~~~---~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~---------~~ 145 (287)
T cd07838 78 ELKLTLVFEHVDQDLATYLSKCPKP---GLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSD---------GQ 145 (287)
T ss_pred CceeEEEehhcccCHHHHHHHccCC---CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccC---------CC
Confidence 248899999888999888764332 24456667777899999999999999999999999999876 57
Q ss_pred EEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchH
Q psy14267 413 LKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTW 492 (553)
Q Consensus 413 vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~ 492 (553)
+||+|||++..+...... ....++..|+|||++.+. .++.++|||||||++|||++|.+||......
T Consensus 146 ~~l~dfg~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~---------~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~- 212 (287)
T cd07838 146 VKIADFGLARIYSFEMAL---TSVVVTLWYRAPEVLLQS---------SYATPVDMWSVGCIFAELFRRRPLFRGTSEA- 212 (287)
T ss_pred EEEeccCcceeccCCccc---ccccccccccChHHhccC---------CCCCcchhhhHHHHHHHHHhCCCcccCCChH-
Confidence 999999999876543221 133478899999999765 3678999999999999999999999864432
Q ss_pred HHHHHHHhhc---cccccc-----------cc-----ccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 493 AKMLAIARHK---DQIEFK-----------PQ-----LANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 493 ~~~~~i~~~~---~~~~~~-----------~~-----~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
.....+.... ....+. .. ......++..+.++|.+||+.||++||++.+++.+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 213 DQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred HHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 2222111100 000000 00 00011346788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=295.88 Aligned_cols=252 Identities=23% Similarity=0.346 Sum_probs=194.8
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceE
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHL 336 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~ 336 (553)
.|...+.||+|+||+||++.+..++. .||+|++...........+.+.+|++++++++ ||||+.+++++.+ ....
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~--~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~--~~~~ 96 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNE--VVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK-HPNTIEYKGCYLK--EHTA 96 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCc--EEEEEEEeccccCchHHHHHHHHHHHHHHhCC-CCCCccEEEEEEe--CCEE
Confidence 47777889999999999998766654 49999998765555555577899999999995 5999999998754 5678
Q ss_pred EEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEE
Q psy14267 337 YVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKII 416 (553)
Q Consensus 337 ~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~ 416 (553)
+++||++.+++.+++..... ......+..++.|++.||.|||++||+||||||+||+++.+ +.+||+
T Consensus 97 ~lv~e~~~~~l~~~l~~~~~----~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~---------~~~kL~ 163 (313)
T cd06633 97 WLVMEYCLGSASDLLEVHKK----PLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEP---------GQVKLA 163 (313)
T ss_pred EEEEecCCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCC---------CCEEEe
Confidence 99999988999888875432 23455666677899999999999999999999999999766 579999
Q ss_pred eccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHH
Q psy14267 417 DFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKML 496 (553)
Q Consensus 417 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~ 496 (553)
|||++...... ....|+..|+|||++..... ..++.++|||||||++|||++|..||........ ..
T Consensus 164 dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~------~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~-~~ 230 (313)
T cd06633 164 DFGSASKSSPA------NSFVGTPYWMAPEVILAMDE------GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LY 230 (313)
T ss_pred ecCCCcccCCC------CCccccccccChhhccccCC------CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH-HH
Confidence 99998643221 24568999999999853211 1367899999999999999999999977543222 22
Q ss_pred HHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 497 AIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 497 ~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
.+..... +.. ....++..++++|.+||+.+|++||++.+++.+
T Consensus 231 ~~~~~~~-----~~~-~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 231 HIAQNDS-----PTL-QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred HHHhcCC-----CCC-CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 2211111 111 122467889999999999999999999999865
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=294.95 Aligned_cols=264 Identities=22% Similarity=0.315 Sum_probs=196.8
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC--
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA-- 332 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~-- 332 (553)
.++|++.+.||+|+||.||++.+...+. .||||+++...... .....+.+|++++++++ ||||+++++++.+..
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~--~v~iK~~~~~~~~~-~~~~~~~~e~~~~~~l~-h~~i~~~~~~~~~~~~~ 81 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGE--LVALKKVRLDNEKE-GFPITAIREIKILRQLN-HRNIVNLKEIVTDKQDA 81 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCc--EEEEEEEeeccccc-CchHHHHHHHHHHHhCC-CCCeeeeeheecCcchh
Confidence 4679999999999999999998876654 49999997654322 23356778999999995 699999998876543
Q ss_pred ------CceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCcccee
Q psy14267 333 ------SKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKII 406 (553)
Q Consensus 333 ------~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~ 406 (553)
...+++++|+.++++..++.... .......+..++.|++.||+|||+.||+||||||+||+++.+
T Consensus 82 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~----- 152 (302)
T cd07864 82 LDFKKDKGAFYLVFEYMDHDLMGLLESGL----VHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNK----- 152 (302)
T ss_pred hhccccCCcEEEEEcccCccHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-----
Confidence 34789999999888888776542 134556677777899999999999999999999999999776
Q ss_pred cCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCC
Q psy14267 407 DCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYS 486 (553)
Q Consensus 407 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~ 486 (553)
+.+||+|||++......... ......++..|+|||.+.+.. .++.++|||||||++|||++|++||.
T Consensus 153 ----~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~--------~~~~~~Di~slG~~~~el~~g~~~~~ 219 (302)
T cd07864 153 ----GQIKLADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEE--------RYGPAIDVWSCGCILGELFTKKPIFQ 219 (302)
T ss_pred ----CcEEeCcccccccccCCccc-ccccceeccCccChHHhcCCC--------CCCchhHHHHHHHHHHHHHhCCCCCC
Confidence 57999999999876544321 112334688999999886432 35789999999999999999999997
Q ss_pred CCCchHHHHHHHHhhc-cc-c-ccc-------------------ccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy14267 487 HIPNTWAKMLAIARHK-DQ-I-EFK-------------------PQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVT 544 (553)
Q Consensus 487 ~~~~~~~~~~~i~~~~-~~-~-~~~-------------------~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~ 544 (553)
..... ..+..+.... .. . .+. ........++..+.++|..||+.||.+||++++++.
T Consensus 220 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 220 ANQEL-AQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CCChH-HHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 64332 2222221110 00 0 000 000112246899999999999999999999999986
Q ss_pred H
Q psy14267 545 Q 545 (553)
Q Consensus 545 ~ 545 (553)
+
T Consensus 299 ~ 299 (302)
T cd07864 299 S 299 (302)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=288.85 Aligned_cols=244 Identities=28% Similarity=0.426 Sum_probs=190.3
Q ss_pred eeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEEEEEec-
Q psy14267 264 LGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEK- 342 (553)
Q Consensus 264 LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~iv~e~- 342 (553)
||.|+||.||++.+...+. .||+|++.+.........+.+.+|+.+++++ +||||+++++++. ....++++||+
T Consensus 1 lg~g~~~~v~~~~~~~~~~--~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~--~~~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNR--TFALKCVKKRHIVETGQQEHIFSEKEILEEC-NHPFIVKLYRTFK--DKKYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECCCCc--EEEEEEEehhcchhhhHHHHHHHHHHHHHhC-CCCCEeeeeeeEE--cCCccEEEEecC
Confidence 7999999999998876554 4999999877655555567899999999999 4699999998764 35678889987
Q ss_pred CCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEeccCcc
Q psy14267 343 GDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIAC 422 (553)
Q Consensus 343 ~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGla~ 422 (553)
.+++|.+++..... .....+..++.|++.||+|||+++++|+||||+||+++.+ +.++|+|||++.
T Consensus 76 ~~~~L~~~l~~~~~-----l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~---------~~~~l~df~~~~ 141 (262)
T cd05572 76 LGGELWTILRDRGL-----FDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSN---------GYVKLVDFGFAK 141 (262)
T ss_pred CCCcHHHHHhhcCC-----CCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCC---------CCEEEeeCCccc
Confidence 56899999876432 3445566667799999999999999999999999999776 579999999998
Q ss_pred ccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCc-hHHHHHHHHhh
Q psy14267 423 SLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN-TWAKMLAIARH 501 (553)
Q Consensus 423 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~-~~~~~~~i~~~ 501 (553)
....... .....|+..|+|||.+.+. .++.++|+||||+++|+|++|..||..... .......+...
T Consensus 142 ~~~~~~~---~~~~~~~~~~~~PE~~~~~---------~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 209 (262)
T cd05572 142 KLKSGQK---TWTFCGTPEYVAPEIILNK---------GYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKG 209 (262)
T ss_pred ccCcccc---cccccCCcCccChhHhcCC---------CCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhcc
Confidence 7755431 1245689999999998654 367899999999999999999999987542 21222222211
Q ss_pred cccccccccccCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q psy14267 502 KDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT-----VGNSVT 544 (553)
Q Consensus 502 ~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt-----~~ell~ 544 (553)
.....++ ..++.++.++|.+||..+|++||+ ++|+++
T Consensus 210 ~~~~~~~------~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 210 NGKLEFP------NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CCCCCCC------cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 2222222 244789999999999999999999 788776
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=285.65 Aligned_cols=250 Identities=27% Similarity=0.460 Sum_probs=197.7
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceE
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHL 336 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~ 336 (553)
+|++.+.||+|++|.||+|.+..++.. ||||++...... ...+.+.+|+.++.++. |+||+++++++.. ...+
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~--~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~~ 74 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKI--YALKKIHVDGDE--EFRKQLLRELKTLRSCE-SPYVVKCYGAFYK--EGEI 74 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcE--EEEEEeccCcch--HHHHHHHHHHHHHHhcC-CCCeeeEEEEEcc--CCeE
Confidence 689999999999999999988876644 999999776532 34578899999999996 6999999987744 5778
Q ss_pred EEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhh-CCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 337 YVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHA-AGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 337 ~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~-~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
+++||+.. ++|.+++.... ......+..++.|++.||+|||+ .+++||||+|+||+++.+ +.++
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~---------~~~~ 140 (264)
T cd06623 75 SIVLEYMDGGSLADLLKKVG-----KIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSK---------GEVK 140 (264)
T ss_pred EEEEEecCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCC---------CCEE
Confidence 89998765 88999987652 33455666677899999999999 999999999999999776 5799
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCC--chH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIP--NTW 492 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~--~~~ 492 (553)
|+|||++......... .....++..|+|||.+... .++.++|+||||+++|+|++|..||.... ...
T Consensus 141 l~df~~~~~~~~~~~~--~~~~~~~~~y~~pE~~~~~---------~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~ 209 (264)
T cd06623 141 IADFGISKVLENTLDQ--CNTFVGTVTYMSPERIQGE---------SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFF 209 (264)
T ss_pred EccCccceecccCCCc--ccceeecccccCHhhhCCC---------CCCchhhHHHHHHHHHHHHhCCCCCccccccCHH
Confidence 9999999876543322 1245688999999998755 36889999999999999999999998764 322
Q ss_pred HHHHHHHhhcccccccccccCCCC-CCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 493 AKMLAIARHKDQIEFKPQLANNVT-IPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 493 ~~~~~i~~~~~~~~~~~~~~~~~~-~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
.....+. ...... .... ++..+.++|.+||..+|++||++.+++++
T Consensus 210 ~~~~~~~-~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 210 ELMQAIC-DGPPPS------LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred HHHHHHh-cCCCCC------CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 2222222 111111 1123 78999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=298.30 Aligned_cols=250 Identities=23% Similarity=0.393 Sum_probs=191.0
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
+.|.....||+|+||.||++.+..++. .||||.+.... ....+.+.+|+.+++++. |+||+.+++.+.. ..+
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~--~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~ii~~~~~~~~--~~~ 93 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGK--QVAVKKMDLRK---QQRRELLFNEVVIMRDYH-HENVVDMYNSYLV--GDE 93 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCC--EEEEEEEecch---HHHHHHHHHHHHHHHhCC-CCcHHHHHHheec--CCe
Confidence 346667789999999999998766654 49999986543 233467889999999995 6999999987743 567
Q ss_pred EEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
.+++||++ +++|.+++... ......+..++.||+.||+|||+++|+||||||+||+++.+ +.++
T Consensus 94 ~~lv~e~~~~~~L~~~~~~~------~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~---------~~~k 158 (292)
T cd06658 94 LWVVMEFLEGGALTDIVTHT------RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSD---------GRIK 158 (292)
T ss_pred EEEEEeCCCCCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCC---------CCEE
Confidence 89999976 45777776432 13345566777899999999999999999999999999776 5799
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||++........ ......|+..|+|||.+.+. .++.++||||||+++|||++|..||...... ..
T Consensus 159 L~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~---------~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-~~ 226 (292)
T cd06658 159 LSDFGFCAQVSKEVP--KRKSLVGTPYWMAPEVISRL---------PYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL-QA 226 (292)
T ss_pred EccCcchhhcccccc--cCceeecCccccCHHHHccC---------CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HH
Confidence 999999876543222 12245689999999998654 3678999999999999999999999764432 22
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
+..+... ..+.......++..+.++|.+||..||++|||+++++++
T Consensus 227 ~~~~~~~-----~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 227 MRRIRDN-----LPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHHHhc-----CCCccccccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 2222211 122222333568899999999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=297.48 Aligned_cols=255 Identities=24% Similarity=0.315 Sum_probs=196.6
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
..|...+.||+|+||.||++.+..++. .||+|.+...........+++.+|+++++.+. |+|++.+++++.. ...
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~--~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~ 89 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSE--VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLR--EHT 89 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCc--EEEEEEEecccccChHHHHHHHHHHHHHHhCC-CCCcccEEEEEEc--CCe
Confidence 458888999999999999998876654 49999987654444455577889999999995 6999999988755 467
Q ss_pred EEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 336 LYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 336 ~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
.+++||++.+++..++..... ......+..++.|++.||.|||+.+++||||||+|||++.+ +.++|
T Consensus 90 ~~lv~e~~~~~l~~~~~~~~~----~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~---------~~~kl 156 (308)
T cd06634 90 AWLVMEYCLGSASDLLEVHKK----PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP---------GLVKL 156 (308)
T ss_pred eEEEEEccCCCHHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCC---------CcEEE
Confidence 889999988888887765432 23455666777899999999999999999999999999765 57999
Q ss_pred EeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHH
Q psy14267 416 IDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKM 495 (553)
Q Consensus 416 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~ 495 (553)
+|||++....... ...|++.|+|||.+.+... ..++.++|||||||++|||++|..||....... ..
T Consensus 157 ~dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~------~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~ 223 (308)
T cd06634 157 GDFGSASIMAPAN------XFVGTPYWMAPEVILAMDE------GQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-AL 223 (308)
T ss_pred CCcccceeecCcc------cccCCccccCHHHHhhccc------CCCCcccchHHHHHHHHHHHcCCCCCccccHHH-HH
Confidence 9999987654322 4468899999999853211 136789999999999999999999997754322 22
Q ss_pred HHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q psy14267 496 LAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQIN 547 (553)
Q Consensus 496 ~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~ 547 (553)
..+..... +. .....++..+.++|++||..+|++||++.+++.+.-
T Consensus 224 ~~~~~~~~-----~~-~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 224 YHIAQNES-----PA-LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred HHHhhcCC-----CC-cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 22221111 10 112256789999999999999999999999998743
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=292.12 Aligned_cols=253 Identities=27% Similarity=0.456 Sum_probs=199.1
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceE
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHL 336 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~ 336 (553)
+|.+.+.||+|+||.||++....++. .||+|++.+.........+.+.+|+.+++++..|+||+++++++. ....+
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~--~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~--~~~~~ 77 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNK--EYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQ--DEENL 77 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCC--EEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhc--CCceE
Confidence 69999999999999999998876654 499999987655555555778999999999975799999988763 45678
Q ss_pred EEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 337 YVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 337 ~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
+++||+. +++|.+++.... ...+..+..++.|++.||+|||+.|++|+||||+||+++.+ +.++|
T Consensus 78 ~lv~e~~~~~~L~~~l~~~~-----~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~---------~~~~l 143 (280)
T cd05581 78 YFVLEYAPNGELLQYIRKYG-----SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKD---------MHIKI 143 (280)
T ss_pred EEEEcCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCC---------CCEEe
Confidence 9999987 889999988754 34455667777899999999999999999999999999766 57999
Q ss_pred EeccCccccCCCCCc------------------ccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHH
Q psy14267 416 IDFGIACSLQDDKTS------------------VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYN 477 (553)
Q Consensus 416 ~DFGla~~~~~~~~~------------------~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~e 477 (553)
+|||++......... .......|+..|+|||++... .++.++|+||||+++|+
T Consensus 144 ~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~---------~~~~~~Di~slG~~l~~ 214 (280)
T cd05581 144 TDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK---------PAGKSSDLWALGCIIYQ 214 (280)
T ss_pred cCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCC---------CCChhhhHHHHHHHHHH
Confidence 999999876543321 122344688999999998755 36889999999999999
Q ss_pred HHhCCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCH----HHHHHH
Q psy14267 478 MIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTV----GNSVTQ 545 (553)
Q Consensus 478 lltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~----~ell~~ 545 (553)
|++|..||..... ......+... .. .....+++.+.++|.+||+.+|++||++ ++++++
T Consensus 215 l~~g~~p~~~~~~-~~~~~~~~~~--~~------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 215 MLTGKPPFRGSNE-YLTFQKILKL--EY------SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred HHhCCCCCCCccH-HHHHHHHHhc--CC------CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 9999999987542 2222222211 11 1122568899999999999999999999 777654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=300.29 Aligned_cols=258 Identities=25% Similarity=0.332 Sum_probs=191.6
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC--
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA-- 332 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~-- 332 (553)
.++|.+.+.||+|+||.||++.+..++. .||+|++.+.... ....+.+.+|+.++++++ ||||+++++++....
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~--~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~-h~~iv~~~~~~~~~~~~ 91 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGL--RVAVKKLSRPFQS-IIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSL 91 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCe--EEEEEEecCcchh-hHHHHHHHHHHHHHHHcC-CCcccceeeeeeecccc
Confidence 3679999999999999999998766654 4999998764322 223467889999999995 599999998765432
Q ss_pred --CceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCC
Q psy14267 333 --SKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIG 410 (553)
Q Consensus 333 --~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~ 410 (553)
...+++++++.+++|.+++... ......+..++.|++.||+|||++||+||||||+||+++.+
T Consensus 92 ~~~~~~~lv~~~~~~~L~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~--------- 156 (345)
T cd07877 92 EEFNDVYLVTHLMGADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED--------- 156 (345)
T ss_pred cccccEEEEehhcccCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCC---------
Confidence 2457889999999998877542 23345566677899999999999999999999999999776
Q ss_pred CeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCc
Q psy14267 411 NVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN 490 (553)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~ 490 (553)
+.+||+|||++....... ....|+..|+|||.+.+.. .++.++|||||||++|||++|+.||.....
T Consensus 157 ~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~--------~~~~~~DvwslG~il~el~~g~~pf~~~~~ 223 (345)
T cd07877 157 CELKILDFGLARHTDDEM-----TGYVATRWYRAPEIMLNWM--------HYNQTVDIWSVGCIMAELLTGRTLFPGTDH 223 (345)
T ss_pred CCEEEecccccccccccc-----cccccCCCccCHHHHhCcc--------CCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 579999999987653322 2456889999999986532 367899999999999999999999975433
Q ss_pred hHHHHHHHHhhccc--------------------ccccc--cc-cCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 491 TWAKMLAIARHKDQ--------------------IEFKP--QL-ANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 491 ~~~~~~~i~~~~~~--------------------~~~~~--~~-~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
. .....+...... ....+ .. ......++++.++|.+||+.||++||++.+++.+
T Consensus 224 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 224 I-DQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred H-HHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 2 111111110000 00000 00 0011457889999999999999999999999875
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=300.41 Aligned_cols=258 Identities=26% Similarity=0.362 Sum_probs=193.1
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCC-
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTAS- 333 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~- 333 (553)
.++|++++.||+|+||.||++.+..++. .||||++.+.. ........+.+|+.+|+++. ||||+.+++++.....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGA--KVAIKKLYRPF-QSELFAKRAYRELRLLKHMK-HENVIGLLDVFTPDLSL 89 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCc--EEEEEEecccc-cchHHHHHHHHHHHHHHhcC-CCCccceeeeecCCccc
Confidence 4679999999999999999998776654 49999986543 22334467889999999995 5999999987754332
Q ss_pred ---ceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCC
Q psy14267 334 ---KHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIG 410 (553)
Q Consensus 334 ---~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~ 410 (553)
..++++|++.+++|..++... ......+..++.|++.||+|||+.||+||||||+|||++.+
T Consensus 90 ~~~~~~~lv~e~~~~~l~~~~~~~------~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~--------- 154 (343)
T cd07880 90 DRFHDFYLVMPFMGTDLGKLMKHE------KLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNED--------- 154 (343)
T ss_pred cccceEEEEEecCCCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC---------
Confidence 256899999998998887642 23455666777899999999999999999999999999766
Q ss_pred CeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCc
Q psy14267 411 NVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN 490 (553)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~ 490 (553)
+.++|+|||++....... ....+++.|+|||.+.+.. .++.++|+|||||++|+|++|..||.....
T Consensus 155 ~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~--------~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 221 (343)
T cd07880 155 CELKILDFGLARQTDSEM-----TGYVVTRWYRAPEVILNWM--------HYTQTVDIWSVGCIMAEMLTGKPLFKGHDH 221 (343)
T ss_pred CCEEEeecccccccccCc-----cccccCCcccCHHHHhCCC--------CCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 579999999997654322 1446789999999986432 367899999999999999999999986443
Q ss_pred hHHHHHHHHhhccc-----------------cc----cc-ccc-cCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 491 TWAKMLAIARHKDQ-----------------IE----FK-PQL-ANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 491 ~~~~~~~i~~~~~~-----------------~~----~~-~~~-~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
.. ....+...... .. +. ... .....++..+.++|.+||+.||++|||+.+++.+
T Consensus 222 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 222 LD-QLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred HH-HHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 21 11111110000 00 00 000 1123567889999999999999999999999853
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=293.01 Aligned_cols=249 Identities=16% Similarity=0.241 Sum_probs=179.4
Q ss_pred eeeeeCceEEEEEeeeC----------------------CCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCc
Q psy14267 263 LLGKGGSSSVYLVGGTS----------------------EHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPY 320 (553)
Q Consensus 263 ~LG~G~fG~Vy~a~~~~----------------------~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~ 320 (553)
.||+|+||.||++.... ......||+|++.... ......+.+|+.+++++. |||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~-h~n 77 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVS-HIH 77 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCC-CCC
Confidence 69999999999886422 1222358899886442 233467888999998885 599
Q ss_pred eeEeeeEEEeCCCceEEEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEe
Q psy14267 321 VIKMHDYVYDTASKHLYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFV 399 (553)
Q Consensus 321 Iv~l~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~ 399 (553)
|+++++++.. ....+++|||+. ++|..+++.... ......+..++.||+.||+|||+++|+||||||+|||++
T Consensus 78 iv~~~~~~~~--~~~~~lv~ey~~~g~L~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~ 151 (274)
T cd05076 78 LAFVHGVCVR--GSENIMVEEFVEHGPLDVCLRKEKG----RVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLA 151 (274)
T ss_pred eeeEEEEEEe--CCceEEEEecCCCCcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEe
Confidence 9999998754 456788899754 667777765322 223445566778999999999999999999999999997
Q ss_pred cCccceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHH
Q psy14267 400 GNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI 479 (553)
Q Consensus 400 ~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ell 479 (553)
.... .+.....+||+|||++....... ...++..|+|||.+.+.. .++.++|||||||++|||+
T Consensus 152 ~~~~--~~~~~~~~kl~d~g~~~~~~~~~------~~~~~~~~~aPe~~~~~~--------~~~~~~Dv~slG~~l~el~ 215 (274)
T cd05076 152 RLGL--AEGTSPFIKLSDPGVSFTALSRE------ERVERIPWIAPECVPGGN--------SLSTAADKWSFGTTLLEIC 215 (274)
T ss_pred ccCc--ccCccceeeecCCcccccccccc------ccccCCcccCchhhcCCC--------CCCcHHHHHHHHHHHHHHH
Confidence 6421 11222458999999986543221 234788899999986532 3788999999999999995
Q ss_pred -hCCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q psy14267 480 -YGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQIN 547 (553)
Q Consensus 480 -tG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~ 547 (553)
+|..||........ ....... .... ...+..+.++|.+||+.+|++||++.++++.|.
T Consensus 216 ~~g~~p~~~~~~~~~--~~~~~~~--~~~~------~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 216 FDGEVPLKERTPSEK--ERFYEKK--HRLP------EPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred hCCCCCccccChHHH--HHHHHhc--cCCC------CCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 79999987543211 1111111 1111 134568999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=281.58 Aligned_cols=250 Identities=31% Similarity=0.531 Sum_probs=195.3
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceE
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHL 336 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~ 336 (553)
+|.+.+.||+|++|.||++.+..++. .|++|++..... ...+.+.+|+.+++++. |++|+.+++++.. ....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~--~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~~ 72 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGK--EVAIKVIKLESK---EKKEKIINEIQILKKCK-HPNIVKYYGSYLK--KDEL 72 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCc--EEEEEEecccch---hHHHHHHHHHHHHHhCC-CCCEeEEEEEEec--CCeE
Confidence 48889999999999999998876554 499999976543 34578899999999996 6999999997754 4667
Q ss_pred EEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 337 YVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 337 ~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
++++++.+ ++|.+++.... .......+..++.|++.||+|||+.|++||||+|+||+++.+ +.++|
T Consensus 73 ~l~~e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~---------~~~~l 139 (253)
T cd05122 73 WIVMEFCSGGSLKDLLKSTN----QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSD---------GEVKL 139 (253)
T ss_pred EEEEecCCCCcHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccC---------CeEEE
Confidence 88888755 88988887653 133455566677899999999999999999999999999775 57999
Q ss_pred EeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHH
Q psy14267 416 IDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKM 495 (553)
Q Consensus 416 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~ 495 (553)
+|||++........ .....|+..|+|||.+.+. .++.++|+||||++||+|++|..||.........
T Consensus 140 ~d~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~---------~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~- 206 (253)
T cd05122 140 IDFGLSAQLSDTKA---RNTMVGTPYWMAPEVINGK---------PYDYKADIWSLGITAIELAEGKPPYSELPPMKAL- 206 (253)
T ss_pred eecccccccccccc---ccceecCCcccCHHHHcCC---------CCCccccHHHHHHHHHHHHhCCCCCCCCchHHHH-
Confidence 99999987765432 2355689999999998755 2678999999999999999999999875432222
Q ss_pred HHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 496 LAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 496 ~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
..... .. .+.......++..+.++|.+||..||++|||+.+++.+
T Consensus 207 ~~~~~-~~----~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 207 FKIAT-NG----PPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred HHHHh-cC----CCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 22111 11 11122222457899999999999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=286.51 Aligned_cols=253 Identities=27% Similarity=0.454 Sum_probs=194.5
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceE
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHL 336 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~ 336 (553)
+|.+.+.||+|+||.||++.....+.. ||+|.+....... ...+.+.+|++++++++ |+||+++++++. .....
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~--~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~~-h~~i~~~~~~~~--~~~~~ 74 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEH--CVIKEIDLTKMPV-KEKEASKKEVILLAKMK-HPNIVTFFASFQ--ENGRL 74 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCce--EEEEEeeHhhccc-hhhHHHHHHHHHHHhCC-CCChhhhhheec--cCCeE
Confidence 488999999999999999988776654 9999997754433 23467889999999995 599999998763 45678
Q ss_pred EEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 337 YVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 337 ~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
++++|+. +++|.+++...... ......+..++.|++.||.|||+.+|+|+||||+||+++.+. ..+||
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~--------~~~~l 143 (257)
T cd08225 75 FIVMEYCDGGDLMKRINRQRGV---LFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNG--------MVAKL 143 (257)
T ss_pred EEEEecCCCCcHHHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCC--------CeEEe
Confidence 8999876 67898888764322 234555666777999999999999999999999999997652 45799
Q ss_pred EeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHH
Q psy14267 416 IDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKM 495 (553)
Q Consensus 416 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~ 495 (553)
+|||.+......... .....|++.|+|||++... .++.++|+||||+++|||++|..||...... ...
T Consensus 144 ~d~~~~~~~~~~~~~--~~~~~~~~~~~ape~~~~~---------~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~ 211 (257)
T cd08225 144 GDFGIARQLNDSMEL--AYTCVGTPYYLSPEICQNR---------PYNNKTDIWSLGCVLYELCTLKHPFEGNNLH-QLV 211 (257)
T ss_pred cccccchhccCCccc--ccccCCCccccCHHHHcCC---------CCCchhhHHHHHHHHHHHHhCCCCCCCccHH-HHH
Confidence 999999876543321 1234689999999998654 3678999999999999999999999764332 122
Q ss_pred HHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 496 LAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 496 ~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
..+.... +.+ ....++.++.++|.+||..+|++|||+.+++.+
T Consensus 212 ~~~~~~~----~~~---~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 212 LKICQGY----FAP---ISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred HHHhccc----CCC---CCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 2221111 111 112567899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=291.80 Aligned_cols=249 Identities=26% Similarity=0.430 Sum_probs=193.0
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
..|+..+.||.|+||.||++.+...+. .||||++..... ....+.+.+|+.+++++. |+||+++++++.+ ...
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~--~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~ 76 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQ--VVAIKIIDLEEA--EDEIEDIQQEITVLSQCD-SPYVTKYYGSYLK--GTK 76 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCE--EEEEEEEecccc--HHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEE--CCE
Confidence 358888999999999999998776654 499999876542 233578899999999995 5999999998754 568
Q ss_pred EEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
++++||+. +++|.++++.. ......+..++.|++.||+|||+.+++|+||+|+||+++.+ +.++
T Consensus 77 ~~lv~e~~~~~~L~~~i~~~------~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~---------~~~~ 141 (277)
T cd06640 77 LWIIMEYLGGGSALDLLRAG------PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQ---------GDVK 141 (277)
T ss_pred EEEEEecCCCCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCC---------CCEE
Confidence 89999975 56888888643 23345566667899999999999999999999999999766 5799
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||++........ ......++..|+|||++.+. .++.++|+|||||++|||++|..||...... ..
T Consensus 142 l~dfg~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~---------~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-~~ 209 (277)
T cd06640 142 LADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIQQS---------AYDSKADIWSLGITAIELAKGEPPNSDMHPM-RV 209 (277)
T ss_pred EcccccceeccCCcc--ccccccCcccccCHhHhccC---------CCccHHHHHHHHHHHHHHHHCCCCCCCcChH-hH
Confidence 999999977654332 12245688999999998755 3688999999999999999999999764432 11
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
...+.. .. .+ .....++..+.++|.+||..+|++||++.+++.+
T Consensus 210 ~~~~~~-~~----~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 210 LFLIPK-NN----PP--TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred hhhhhc-CC----CC--CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 111111 11 11 1122567899999999999999999999999876
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=287.37 Aligned_cols=260 Identities=25% Similarity=0.410 Sum_probs=196.4
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCc-------CchhHHHHHHHHHHHHHhhcCCCceeEeeeEEE
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDI-------TDQSIADSYLNEVELLAKLQGCPYVIKMHDYVY 329 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~-------~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~ 329 (553)
.|++.+.||+|+||.||++.+.... .+.+|+|.+..... .......++.+|+.++.+...|+||+.+++++.
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~-~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 79 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNG-QNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFL 79 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCC-CceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEc
Confidence 3788999999999999999887622 24599998865432 223345677889999887667899999998774
Q ss_pred eCCCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhh-CCcEecCCCCCCEEEecCccceec
Q psy14267 330 DTASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHA-AGIIHSDLKPANFLFVGNVLKIID 407 (553)
Q Consensus 330 ~~~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~-~gIiHrDLKp~NILl~~~~~~~~~ 407 (553)
.+.+.+++||+. +++|.+++...... ........++.++.|++.||.|||+ .+|+||||||+|||++.+
T Consensus 80 --~~~~~~lv~e~~~~~~l~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~------ 150 (269)
T cd08528 80 --ENDRLYIVMDLIEGAPLGEHFNSLKEK-KQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGED------ 150 (269)
T ss_pred --cCCeEEEEEecCCCCcHHHHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCC------
Confidence 466889999975 56888887653221 1234556677777899999999996 789999999999999776
Q ss_pred CCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCC
Q psy14267 408 CIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSH 487 (553)
Q Consensus 408 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~ 487 (553)
+.+||+|||++....... ......|+..|+|||.+.+. .++.++|+||||+++|||++|..||..
T Consensus 151 ---~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~---------~~~~~~Dv~slG~ll~~l~~g~~p~~~ 215 (269)
T cd08528 151 ---DKVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNE---------PYGEKADVWAFGCILYQMCTLQPPFYS 215 (269)
T ss_pred ---CcEEEecccceeeccccc---ccccccCcccCcChhhhcCC---------CCchHHHHHHHHHHHHHHHhCCCcccc
Confidence 579999999998765543 12355689999999999754 368899999999999999999999976
Q ss_pred CCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q psy14267 488 IPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINN 548 (553)
Q Consensus 488 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~ 548 (553)
.... .....+.... ..+. ....++..+.++|.+||+.||++||++.|+.++|++
T Consensus 216 ~~~~-~~~~~~~~~~----~~~~--~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 216 TNML-SLATKIVEAV----YEPL--PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred cCHH-HHHHHHhhcc----CCcC--CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 4332 1122222111 1111 112567899999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=287.19 Aligned_cols=245 Identities=26% Similarity=0.388 Sum_probs=184.9
Q ss_pred eeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEEEEEe
Q psy14267 262 SLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLME 341 (553)
Q Consensus 262 ~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~iv~e 341 (553)
+.||.|+||.||+|.+...+. .||||++.+...........+..|..++....+|+||+++++++. ....++++||
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~--~~~~~~lv~e 77 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGD--YFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQ--SKDYLYLVME 77 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCC--eEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEE--cCCeEEEEEe
Confidence 569999999999998876654 499999977654433444556777777766667899999998774 4568899999
Q ss_pred cC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEeccC
Q psy14267 342 KG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGI 420 (553)
Q Consensus 342 ~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGl 420 (553)
++ +++|..++.... ......+..++.|++.||.|||+.+++||||+|+|||++.+ +.++|+|||+
T Consensus 78 ~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~---------~~~~l~dfg~ 143 (260)
T cd05611 78 YLNGGDCASLIKTLG-----GLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQT---------GHLKLTDFGL 143 (260)
T ss_pred ccCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC---------CcEEEeeccc
Confidence 75 678998887653 23455566677899999999999999999999999999766 5799999999
Q ss_pred ccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHh
Q psy14267 421 ACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIAR 500 (553)
Q Consensus 421 a~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~~i~~ 500 (553)
+...... ....|+..|+|||.+.+. .++.++||||||+++|||++|..||...... .....+..
T Consensus 144 ~~~~~~~------~~~~~~~~y~~pe~~~~~---------~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~ 207 (260)
T cd05611 144 SRNGLEN------KKFVGTPDYLAPETILGV---------GDDKMSDWWSLGCVIFEFLFGYPPFHAETPD-AVFDNILS 207 (260)
T ss_pred ceecccc------ccCCCCcCccChhhhcCC---------CCcchhhhHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHh
Confidence 8765431 245688999999998765 2678999999999999999999999765432 22222221
Q ss_pred hcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy14267 501 HKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVT 544 (553)
Q Consensus 501 ~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~ 544 (553)
.. ..+.. .....++..+.++|.+||+.+|++||++.++.+
T Consensus 208 ~~--~~~~~--~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~ 247 (260)
T cd05611 208 RR--INWPE--EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQE 247 (260)
T ss_pred cc--cCCCC--cccccCCHHHHHHHHHHccCCHHHccCCCcHHH
Confidence 11 11111 112257899999999999999999996654433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=291.05 Aligned_cols=248 Identities=24% Similarity=0.354 Sum_probs=186.5
Q ss_pred eeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEEEEEecC
Q psy14267 264 LGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEKG 343 (553)
Q Consensus 264 LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~iv~e~~ 343 (553)
||+|+||+||+|.+..++.. ||+|++.+...........+.+|+++|++++ ||||+.+++++. ....++++||+.
T Consensus 1 lg~g~~g~vy~~~~~~~~~~--~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--~~~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKM--YACKKLDKKRLKKRKGEQMALNEKKILEKVS-SRFIVSLAYAFE--TKDDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcCCCcE--EEEEEEehhhhhhhhhhHHHHHHHHHHHhCC-CCCEeeeeeEEe--cCCeEEEEEecC
Confidence 69999999999987766644 9999998765444444566789999999996 699999987763 356788999975
Q ss_pred -CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEeccCcc
Q psy14267 344 -DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIAC 422 (553)
Q Consensus 344 -~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGla~ 422 (553)
+++|.+++..... .......+..++.|++.||.|||+.||+||||||+||+++.+ +.++|+|||++.
T Consensus 76 ~~~~L~~~l~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~---------~~~~l~dfg~~~ 143 (277)
T cd05577 76 NGGDLKYHIYNVGE---PGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDH---------GNVRISDLGLAV 143 (277)
T ss_pred CCCcHHHHHHHcCc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC---------CCEEEccCcchh
Confidence 5789888876543 134455666667899999999999999999999999999776 579999999987
Q ss_pred ccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHhhc
Q psy14267 423 SLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARHK 502 (553)
Q Consensus 423 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~~i~~~~ 502 (553)
....... .....++..|+|||.+.+. .++.++|||||||++|+|++|+.||........ ...+....
T Consensus 144 ~~~~~~~---~~~~~~~~~y~~PE~~~~~---------~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~ 210 (277)
T cd05577 144 ELKGGKK---IKGRAGTPGYMAPEVLQGE---------VYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE-KEELKRRT 210 (277)
T ss_pred hhccCCc---cccccCCCCcCCHHHhcCC---------CCCchhhhHHHHHHHHHHhhCCCCCCCCccccc-HHHHHhcc
Confidence 6644221 1244578899999998755 367899999999999999999999976433101 11111111
Q ss_pred ccccccccccCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q psy14267 503 DQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARP-----TVGNSVTQ 545 (553)
Q Consensus 503 ~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RP-----t~~ell~~ 545 (553)
.. ........+++.+.++|.+||+.+|++|| ++.+++.+
T Consensus 211 ~~----~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 211 LE----MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred cc----ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence 10 11112225689999999999999999999 66667653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=300.58 Aligned_cols=260 Identities=26% Similarity=0.357 Sum_probs=191.4
Q ss_pred EEecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEe
Q psy14267 251 ITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYD 330 (553)
Q Consensus 251 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~ 330 (553)
|++ ..+|.+.+.||+|+||.||+|.+..++. .||||++.+.... ......+.+|+.+++++. ||||+++++++..
T Consensus 11 ~~~-~~~y~~~~~ig~g~~g~v~~~~~~~~~~--~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~ 85 (342)
T cd07879 11 WEL-PERYTSLKQVGSGAYGSVCSAIDKRTGE--KVAIKKLSRPFQS-EIFAKRAYRELTLLKHMQ-HENVIGLLDVFTS 85 (342)
T ss_pred hcc-ccceEEEEEeeecCCeEEEEEEeCCCCc--EEEEEEecCcccc-ccchhHHHHHHHHHHhcC-CCCccchhheecc
Confidence 444 3579999999999999999998776654 4999998764322 233467889999999994 6999999998754
Q ss_pred CC----CceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCcccee
Q psy14267 331 TA----SKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKII 406 (553)
Q Consensus 331 ~~----~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~ 406 (553)
.. ...++++|++...+|..++.. ......+..++.|++.||+|||+++|+||||||+|||++.+
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~----- 153 (342)
T cd07879 86 AVSGDEFQDFYLVMPYMQTDLQKIMGH-------PLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNED----- 153 (342)
T ss_pred cccCCCCceEEEEecccccCHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-----
Confidence 32 235689999888777665421 23345556667899999999999999999999999999776
Q ss_pred cCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCC
Q psy14267 407 DCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYS 486 (553)
Q Consensus 407 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~ 486 (553)
+.+||+|||+++...... ....++..|+|||++.+.. .++.++|||||||++|||++|+.||.
T Consensus 154 ----~~~kL~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~--------~~~~~~Dv~slGvil~el~~g~~pf~ 216 (342)
T cd07879 154 ----CELKILDFGLARHADAEM-----TGYVVTRWYRAPEVILNWM--------HYNQTVDIWSVGCIMAEMLTGKTLFK 216 (342)
T ss_pred ----CCEEEeeCCCCcCCCCCC-----CCceeeecccChhhhcCcc--------ccCchHHHHHHHHHHHHHHhCCCCCC
Confidence 579999999987653322 2446789999999986532 36789999999999999999999998
Q ss_pred CCCchHHHHHHHHhhcc--------------------cccc--ccccc-CCCCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q psy14267 487 HIPNTWAKMLAIARHKD--------------------QIEF--KPQLA-NNVTIPPTLLQSMKLCLQKDPKARPTVGNSV 543 (553)
Q Consensus 487 ~~~~~~~~~~~i~~~~~--------------------~~~~--~~~~~-~~~~~s~~l~~li~~cL~~dP~~RPt~~ell 543 (553)
..... ..+..+..... .... ...+. ....++..+.++|.+||+.||++||++.+++
T Consensus 217 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l 295 (342)
T cd07879 217 GKDYL-DQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEAL 295 (342)
T ss_pred CCCHH-HHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 64321 11111111000 0000 00000 1124678899999999999999999999999
Q ss_pred HH
Q psy14267 544 TQ 545 (553)
Q Consensus 544 ~~ 545 (553)
.+
T Consensus 296 ~h 297 (342)
T cd07879 296 EH 297 (342)
T ss_pred cC
Confidence 76
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=296.88 Aligned_cols=249 Identities=24% Similarity=0.381 Sum_probs=191.0
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceE
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHL 336 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~ 336 (553)
.|.....||+|+||.||++.+...+. .||+|++...... ..+.+.+|+.+++.+. ||||+++++++.. ....
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~--~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~--~~~~ 93 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGR--QVAVKMMDLRKQQ---RRELLFNEVVIMRDYQ-HQNVVEMYKSYLV--GEEL 93 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCC--EEEEEEEEecccc---hHHHHHHHHHHHHhCC-CCchhhhhhheee--CCeE
Confidence 45566789999999999998876654 4999999765432 2366889999999995 6999999987754 5678
Q ss_pred EEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 337 YVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 337 ~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
+++||+. +++|..++... ......+..++.|++.||+|||++||+||||||+|||++.+ +.+||
T Consensus 94 ~iv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~---------~~~kL 158 (297)
T cd06659 94 WVLMEFLQGGALTDIVSQT------RLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLD---------GRVKL 158 (297)
T ss_pred EEEEecCCCCCHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccC---------CcEEE
Confidence 8888865 46777766542 23455667777899999999999999999999999999776 57999
Q ss_pred EeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHH
Q psy14267 416 IDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKM 495 (553)
Q Consensus 416 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~ 495 (553)
+|||++........ ......|+..|+|||++.+. .++.++|||||||++|||++|..||...... ..+
T Consensus 159 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~---------~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-~~~ 226 (297)
T cd06659 159 SDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRT---------PYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV-QAM 226 (297)
T ss_pred eechhHhhcccccc--cccceecCccccCHHHHccC---------CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHH
Confidence 99999876543322 12245689999999999765 3678999999999999999999999764332 222
Q ss_pred HHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 496 LAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 496 ~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
..+.... .+.......++..+.++|.+||+.+|++||++++++++
T Consensus 227 ~~~~~~~-----~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 227 KRLRDSP-----PPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred HHHhccC-----CCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 2222111 11222234678899999999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=285.23 Aligned_cols=249 Identities=16% Similarity=0.265 Sum_probs=182.9
Q ss_pred eeeeeeCceEEEEEeeeCCCcc--------ceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCC
Q psy14267 262 SLLGKGGSSSVYLVGGTSEHEF--------KPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTAS 333 (553)
Q Consensus 262 ~~LG~G~fG~Vy~a~~~~~~~~--------~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~ 333 (553)
+.||+|+||.||++.+...... ..+++|++...... ...+.+|+.+|+++. ||||+.+++++..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~----~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--- 72 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD----SLAFFETASLMSQLS-HKHLVKLYGVCVR--- 72 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh----HHHHHHHHHHHHcCC-CcchhheeeEEec---
Confidence 4699999999999988765521 34777876544311 477889999999995 6999999998765
Q ss_pred ceEEEEEec-CCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCe
Q psy14267 334 KHLYVLMEK-GDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNV 412 (553)
Q Consensus 334 ~~~~iv~e~-~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~ 412 (553)
...+++||+ .+++|.+++..... ......+..++.||+.||+|||++||+||||||+|||++.+... +.....
T Consensus 73 ~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~--~~~~~~ 146 (259)
T cd05037 73 DENIMVEEYVKFGPLDVFLHREKN----NVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLN--EGYVPF 146 (259)
T ss_pred CCcEEEEEcCCCCcHHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccc--cCCcee
Confidence 345788886 45788888876543 23445566677899999999999999999999999999876311 112236
Q ss_pred EEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCCCch
Q psy14267 413 LKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHIPNT 491 (553)
Q Consensus 413 vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~~~~ 491 (553)
+||+|||++....... ...++..|+|||++.+.. ..++.++|||||||++|||++ |..||......
T Consensus 147 ~kl~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~-------~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~ 213 (259)
T cd05037 147 IKLSDPGIPITVLSRE------ERVERIPWIAPECIRNGQ-------ASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS 213 (259)
T ss_pred EEeCCCCccccccccc------ccccCCCccChhhhcCCC-------CCcchhhHHHHHHHHHHHHHhCCCCCcccCCch
Confidence 9999999998764421 344678899999987541 136889999999999999999 68888765322
Q ss_pred HHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q psy14267 492 WAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQIN 547 (553)
Q Consensus 492 ~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~ 547 (553)
....... .... .. ......+.++|.+||..+|++||++.++++.|+
T Consensus 214 -~~~~~~~-~~~~------~~--~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 214 -EKERFYQ-DQHR------LP--MPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred -hHHHHHh-cCCC------CC--CCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 1111111 1110 00 112378999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=292.15 Aligned_cols=249 Identities=26% Similarity=0.442 Sum_probs=191.7
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
+.|++.+.||+|+||.||++.+...+. .||+|++..... ....+.+.+|+.+++++. |+||+++++++.. ...
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~--~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~ 76 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKE--VVAIKIIDLEEA--EDEIEDIQQEITVLSQCD-SPYITRYYGSYLK--GTK 76 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCe--EEEEEEeccccc--hHHHHHHHHHHHHHHcCC-CCccHhhhccccc--CCc
Confidence 357788899999999999998766554 499999875532 234567899999999995 6999999987743 567
Q ss_pred EEEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
.+++||++. ++|.+++... ......+..++.|++.||.|||++|++|+||+|+||+++.+ +.++
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~---------~~~~ 141 (277)
T cd06642 77 LWIIMEYLGGGSALDLLKPG------PLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQ---------GDVK 141 (277)
T ss_pred eEEEEEccCCCcHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCC---------CCEE
Confidence 899999764 6788777542 23455666777899999999999999999999999999766 5799
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||++..+..... ......|+..|+|||.+.+. .++.++|+|||||++|||++|..||....... .
T Consensus 142 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~---------~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-~ 209 (277)
T cd06642 142 LADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQS---------AYDFKADIWSLGITAIELAKGEPPNSDLHPMR-V 209 (277)
T ss_pred EccccccccccCcch--hhhcccCcccccCHHHhCcC---------CCchhhhHHHHHHHHHHHHhCCCCCcccchhh-H
Confidence 999999977654322 12245689999999999765 36789999999999999999999997643321 1
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
...+... ..+.+ ...++.++.++|.+||..+|++||++.+++.+
T Consensus 210 ~~~~~~~-----~~~~~--~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 210 LFLIPKN-----SPPTL--EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred HhhhhcC-----CCCCC--CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 1111111 01111 12567899999999999999999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG0587|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=313.13 Aligned_cols=260 Identities=23% Similarity=0.365 Sum_probs=214.2
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC---
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA--- 332 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~--- 332 (553)
+-|++..+||.|.+|.||+++.+..+.. .|+|++....-.+ ++...|..+|+.+.+|||++.++++++...
T Consensus 19 d~~ei~evig~Gtygkv~k~k~~~~~~~--aa~kI~~~~~d~d----eEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~ 92 (953)
T KOG0587|consen 19 DIFEIIEVIGNGTYGKVYKGRHVKTGQL--AAIKIMDPTEDEE----EEIELEYNMLKKYSHHPNVATFYGAFIKKDPGN 92 (953)
T ss_pred CccEEEEEEeeccceeEEEEeeeecCce--eeeEeecCCcccc----HHHHHHHHHHHhccCCCCcceEEEEEEEecCCC
Confidence 4699999999999999999999888877 8999887765443 456689999999999999999999887543
Q ss_pred CceEEEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCC
Q psy14267 333 SKHLYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGN 411 (553)
Q Consensus 333 ~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~ 411 (553)
++.+++|||+|+ |+..++++... ...+.+.+++.+++.++.||.+||...+||||||-.|||++.+ +
T Consensus 93 ~DqLWLVMEfC~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e---------~ 160 (953)
T KOG0587|consen 93 GDQLWLVMEFCGGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTEN---------A 160 (953)
T ss_pred CCeEEEEeeccCCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEecc---------C
Confidence 457999999754 78888887765 4466778888888999999999999999999999999999887 5
Q ss_pred eEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCch
Q psy14267 412 VLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNT 491 (553)
Q Consensus 412 ~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~ 491 (553)
.|||+|||++..+..... .+.+..|||.|||||++..... ....|+.++|+||||++..||.-|.+|+.+....
T Consensus 161 ~VKLvDFGvSaQldsT~g--rRnT~iGtP~WMAPEViac~e~----~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm 234 (953)
T KOG0587|consen 161 EVKLVDFGVSAQLDSTVG--RRNTFIGTPYWMAPEVIACDES----PDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM 234 (953)
T ss_pred cEEEeeeeeeeeeecccc--cccCcCCCcccccceeeecccC----CCCCcccccchhhccceeehhcCCCCCccCcchh
Confidence 799999999988765443 3458889999999999987653 2335889999999999999999999999886543
Q ss_pred HHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 492 WAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 492 ~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
.+.+ .+ ...-+|.+..+..++..+.++|..||.+|.++||++.+++.|
T Consensus 235 raLF-~I-----pRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 235 RALF-LI-----PRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred hhhc-cC-----CCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 2111 11 112355666777889999999999999999999999998865
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=295.80 Aligned_cols=258 Identities=24% Similarity=0.354 Sum_probs=191.9
Q ss_pred cCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCC
Q psy14267 254 NGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTAS 333 (553)
Q Consensus 254 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~ 333 (553)
..++|++++.||.|+||.||+|.+..++.. ||||++.+..... ...+.+.+|+.+++++. ||||+++.+++... .
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~--vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~-~ 82 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQN--VAIKKIMKPFSTP-VLAKRTYRELKLLKHLR-HENIISLSDIFISP-L 82 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCE--EEEEEeccccccc-chhHHHHHHHHHHHhcC-CCCeeeEeeeEecC-C
Confidence 346799999999999999999988766644 9999887643322 33467889999999996 59999999877543 4
Q ss_pred ceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 334 KHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 334 ~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
...+++|++.+++|..++... ......+..++.|++.||+|||+++|+||||||+|||++.+ +.+
T Consensus 83 ~~~~lv~e~~~~~L~~~~~~~------~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~---------~~~ 147 (328)
T cd07856 83 EDIYFVTELLGTDLHRLLTSR------PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINEN---------CDL 147 (328)
T ss_pred CcEEEEeehhccCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCC---------CCE
Confidence 467899999988988877642 22334455567799999999999999999999999999765 579
Q ss_pred EEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHH
Q psy14267 414 KIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWA 493 (553)
Q Consensus 414 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~ 493 (553)
+|+|||++....... ....++..|+|||.+.+.. .++.++|||||||++|+|++|..||........
T Consensus 148 ~l~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~--------~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~ 214 (328)
T cd07856 148 KICDFGLARIQDPQM-----TGYVSTRYYRAPEIMLTWQ--------KYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQ 214 (328)
T ss_pred EeCccccccccCCCc-----CCCcccccccCceeeeccC--------CcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 999999987543321 2446788999999986432 368899999999999999999999976432111
Q ss_pred HHHHHHhhcc--------------cccc---------cccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 494 KMLAIARHKD--------------QIEF---------KPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 494 ~~~~i~~~~~--------------~~~~---------~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
...+..... ...+ .+.......++..+.++|.+||+.+|++||++.+++.+
T Consensus 215 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 215 -FSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred -HHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 110000000 0000 00001112467899999999999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=293.24 Aligned_cols=251 Identities=24% Similarity=0.382 Sum_probs=192.4
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
.++|.+.+.||+|+||.||++.+..++ +.||+|.+..... ...+.+.+|+.+++++. ||||+.+++++.. ..
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~--~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~--~~ 89 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATG--QEVAIKQMNLQQQ---PKKELIINEILVMRENK-HPNIVNYLDSYLV--GD 89 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCC--CEEEEEEeccccc---hHHHHHHHHHHHHhhcC-CCCeeehhheeee--CC
Confidence 358999999999999999999776554 3499999865432 22467889999999995 6999999988754 45
Q ss_pred eEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 335 HLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 335 ~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
..++++|+. +++|.+++.... .....+..++.|++.||.|||++|++||||||+||+++.+ +.+
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~~~------l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~---------~~~ 154 (293)
T cd06647 90 ELWVVMEYLAGGSLTDVVTETC------MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD---------GSV 154 (293)
T ss_pred cEEEEEecCCCCcHHHHHhhcC------CCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCC---------CCE
Confidence 678888875 678988886532 2344556667899999999999999999999999999766 579
Q ss_pred EEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHH
Q psy14267 414 KIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWA 493 (553)
Q Consensus 414 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~ 493 (553)
+|+|||++......... .....|++.|+|||.+... .++.++|+|||||++|+|++|..||.......
T Consensus 155 kL~dfg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~---------~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~- 222 (293)
T cd06647 155 KLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRK---------AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR- 222 (293)
T ss_pred EEccCcceecccccccc--cccccCChhhcCchhhccC---------CCCchhhHHHHHHHHHHHHhCCCCCCCCChhh-
Confidence 99999998766543321 2244689999999998754 36789999999999999999999997643321
Q ss_pred HHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 494 KMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 494 ~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
....+.. . ..+.......++..++++|.+||..+|++||++.+++.+
T Consensus 223 ~~~~~~~-~----~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 223 ALYLIAT-N----GTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred heeehhc-C----CCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111110 0 111122233567899999999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=297.69 Aligned_cols=262 Identities=19% Similarity=0.276 Sum_probs=192.2
Q ss_pred cceE-EEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchh-----------HHHHHHHHHHHHHhhcCCCceeE
Q psy14267 256 KQYQ-VLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQS-----------IADSYLNEVELLAKLQGCPYVIK 323 (553)
Q Consensus 256 ~~y~-i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~-----------~~~~~~~E~~iL~~l~~hp~Iv~ 323 (553)
++|. +.+.||.|+||+||+|.+...+. .||||++......... ....+.+|+++++++. |+||+.
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~--~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~ 84 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGK--IVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIK-HENIMG 84 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCC--eEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCC-Ccceee
Confidence 3565 45789999999999998776654 4999998765432211 1125789999999995 599999
Q ss_pred eeeEEEeCCCceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCcc
Q psy14267 324 MHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVL 403 (553)
Q Consensus 324 l~~~~~~~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~ 403 (553)
+++++. ...+++++||+..++|.+++.... ......+..++.|++.||+|||+.||+||||||+|||++.+
T Consensus 85 ~~~~~~--~~~~~~lv~e~~~~~l~~~l~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~-- 155 (335)
T PTZ00024 85 LVDVYV--EGDFINLVMDIMASDLKKVVDRKI-----RLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSK-- 155 (335)
T ss_pred eeEEEe--cCCcEEEEEeccccCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCC--
Confidence 999874 356889999999999999987643 23455666777899999999999999999999999999776
Q ss_pred ceecCCCCeEEEEeccCccccCCCCC------------cccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHH
Q psy14267 404 KIIDCIGNVLKIIDFGIACSLQDDKT------------SVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSL 471 (553)
Q Consensus 404 ~~~~~~~~~vkL~DFGla~~~~~~~~------------~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSl 471 (553)
+.++|+|||++........ ........+++.|+|||.+.+.. .++.++|||||
T Consensus 156 -------~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--------~~~~~~Dv~sl 220 (335)
T PTZ00024 156 -------GICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAE--------KYHFAVDMWSV 220 (335)
T ss_pred -------CCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCC--------CCCcHHHHHHH
Confidence 5799999999977652110 01112334688999999987542 36789999999
Q ss_pred HHHHHHHHhCCCCCCCCCchHHHHHHHHhhccccc---cc----------------ccc-cCCCCCCHHHHHHHHHhccc
Q psy14267 472 GCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIE---FK----------------PQL-ANNVTIPPTLLQSMKLCLQK 531 (553)
Q Consensus 472 Gvvl~elltG~~Pf~~~~~~~~~~~~i~~~~~~~~---~~----------------~~~-~~~~~~s~~l~~li~~cL~~ 531 (553)
||++|||++|..||...... ..+..+........ +. ... .....++..+.++|.+||..
T Consensus 221 G~~l~el~tg~~p~~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 299 (335)
T PTZ00024 221 GCIFAELLTGKPLFPGENEI-DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKL 299 (335)
T ss_pred HHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCC
Confidence 99999999999999875443 22222211111000 00 000 01124578899999999999
Q ss_pred CCCCCCCHHHHHHH
Q psy14267 532 DPKARPTVGNSVTQ 545 (553)
Q Consensus 532 dP~~RPt~~ell~~ 545 (553)
+|++||++.+++.+
T Consensus 300 ~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 300 NPLERISAKEALKH 313 (335)
T ss_pred CchhccCHHHHhcC
Confidence 99999999999874
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=300.68 Aligned_cols=258 Identities=25% Similarity=0.338 Sum_probs=194.3
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCC-
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTAS- 333 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~- 333 (553)
.++|++.+.||+|+||.||++++..++.. ||||++...... ....+.+.+|+.+++++ .||||+.+++++.....
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~--~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRK--VAIKKLSRPFQS-AIHAKRTYRELRLLKHM-DHENVIGLLDVFTPASSL 89 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcE--EEEEecccccch-hhHHHHHHHHHHHHHhc-cCCCHHHHHHHhhccccc
Confidence 45799999999999999999988776644 999998754322 23446788999999999 55999999886644322
Q ss_pred ---ceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCC
Q psy14267 334 ---KHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIG 410 (553)
Q Consensus 334 ---~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~ 410 (553)
..+++++++.+++|.+++... ......+..++.|++.||+|||+.||+||||||+||+++.+
T Consensus 90 ~~~~~~~lv~e~~~~~L~~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~--------- 154 (343)
T cd07851 90 EDFQDVYLVTHLMGADLNNIVKCQ------KLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED--------- 154 (343)
T ss_pred cccccEEEEEecCCCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC---------
Confidence 358999999999999988752 23455566677899999999999999999999999999776
Q ss_pred CeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCc
Q psy14267 411 NVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN 490 (553)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~ 490 (553)
+.+||+|||++....... ....++..|+|||.+.+.. .++.++|||||||++|||++|+.||.....
T Consensus 155 ~~~kL~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~--------~~~~~~DvwslGv~l~elltg~~pf~~~~~ 221 (343)
T cd07851 155 CELKILDFGLARHTDDEM-----TGYVATRWYRAPEIMLNWM--------HYNQTVDIWSVGCIMAELLTGKTLFPGSDH 221 (343)
T ss_pred CCEEEccccccccccccc-----cCCcccccccCHHHHhCCC--------CCCchHhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 579999999998764431 2446789999999986432 367899999999999999999999976443
Q ss_pred hHHHHHHHHhhccc--------------------ccc--cccc-cCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 491 TWAKMLAIARHKDQ--------------------IEF--KPQL-ANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 491 ~~~~~~~i~~~~~~--------------------~~~--~~~~-~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
. .....+...... ... .... .....++.++.++|.+||..+|++|||+.+|+.+
T Consensus 222 ~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 222 I-DQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred H-HHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 2 222221111100 000 0000 0012457899999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=288.26 Aligned_cols=258 Identities=28% Similarity=0.416 Sum_probs=195.1
Q ss_pred eEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEE
Q psy14267 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLY 337 (553)
Q Consensus 258 y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~ 337 (553)
|++.+.||.|++|.||++.+..++. .+|+|.+....... .....+.+|+++|+++. |++|+++++++.+ ...++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~--~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~~~ 74 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGE--IVAIKKIKLRFESE-GIPKTALREIKLLKELN-HPNIIKLLDVFRH--KGDLY 74 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCc--EEEEEEeccccccc-hhHHHHHHHHHHHHHhc-CCCcchHHHhhcc--CCCEE
Confidence 6678899999999999998766554 49999987665332 34467889999999996 6999999987743 57889
Q ss_pred EEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEe
Q psy14267 338 VLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIID 417 (553)
Q Consensus 338 iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~D 417 (553)
+++|+.+++|..++..... ......+..++.|++.||+|||+.+|+|+||||+||+++.+ +.++|+|
T Consensus 75 ~v~e~~~~~l~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~---------~~~~l~d 141 (283)
T cd05118 75 LVFEFMDTDLYKLIKDRQR----GLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTE---------GVLKLAD 141 (283)
T ss_pred EEEeccCCCHHHHHHhhcc----cCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCC---------CcEEEee
Confidence 9999988999988877431 34455666777899999999999999999999999999776 5799999
Q ss_pred ccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHHH
Q psy14267 418 FGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLA 497 (553)
Q Consensus 418 FGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~~ 497 (553)
||.+........ ......++..|+|||.+.+.. .++.++|+||||+++|+|++|+.||...... .....
T Consensus 142 f~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~--------~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-~~~~~ 210 (283)
T cd05118 142 FGLARSFGSPVR--PYTHYVVTRWYRAPELLLGDK--------GYSTPVDIWSVGCIFAELLSRRPLFPGKSEI-DQLFK 210 (283)
T ss_pred eeeeEecCCCcc--cccCccCcccccCcHHHhcCC--------CCCchhHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHH
Confidence 999987765431 122345788999999986542 3688999999999999999999999764432 11111
Q ss_pred HHhhccc-----------------cccc-----ccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 498 IARHKDQ-----------------IEFK-----PQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 498 i~~~~~~-----------------~~~~-----~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
+...... ..+. ........++.++.++|.+||+.||.+||++.+++.+
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 211 IFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred HHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 1111000 0000 0000112467899999999999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=286.58 Aligned_cols=261 Identities=22% Similarity=0.319 Sum_probs=197.3
Q ss_pred eEE-EeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceE
Q psy14267 258 YQV-LSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHL 336 (553)
Q Consensus 258 y~i-~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~ 336 (553)
|++ .+.||+|+||.|--+....++.. ||||++.+.. .....+..+|++++.+.++|+||+.+++||. ++..+
T Consensus 79 YkLt~e~LGeGAyasVqtcv~i~t~~E--YAVKiidKq~---gHsR~RvfREVe~f~~Cqgh~nilqLiefFE--dd~~F 151 (463)
T KOG0607|consen 79 YKLTSELLGEGAYASVQTCVSIQTGKE--YAVKIIDKQP---GHSRSRVFREVETFYQCQGHKNILQLIEFFE--DDTRF 151 (463)
T ss_pred HHhHHHHhcCccceeeeeeeeeccchh--hhhhhhhcCC---chHHHHHHHHHHHHHHhcCCccHHHHHHHhc--ccceE
Confidence 444 35899999999998877777654 9999998874 3445889999999999999999999999884 46678
Q ss_pred EEEEe-cCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 337 YVLME-KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 337 ~iv~e-~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
|+||| +.||.|..++.+..-+. +..+-.+.++|+.||.|||.+||.||||||+|||-.... .. .-|||
T Consensus 152 YLVfEKm~GGplLshI~~~~~F~-----E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn-----~v-sPvKi 220 (463)
T KOG0607|consen 152 YLVFEKMRGGPLLSHIQKRKHFN-----EREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPN-----KV-SPVKI 220 (463)
T ss_pred EEEEecccCchHHHHHHHhhhcc-----HHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCC-----Cc-Cceee
Confidence 89998 57888999998876443 333344456999999999999999999999999985542 11 34899
Q ss_pred EeccCccccCCC-----CCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCc
Q psy14267 416 IDFGIACSLQDD-----KTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN 490 (553)
Q Consensus 416 ~DFGla~~~~~~-----~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~ 490 (553)
|||.|..-.... .......+.+|+..|||||+..--. ++...|+.+.|+||||||||-||.|.+||.+.-.
T Consensus 221 CDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv----~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg 296 (463)
T KOG0607|consen 221 CDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFV----DQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCG 296 (463)
T ss_pred eccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhc----cccccccccccHHHHHHHHHHHHhCCCCccCccC
Confidence 999987543221 1122334788999999999874221 1222589999999999999999999999975211
Q ss_pred ---h-----------HHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy14267 491 ---T-----------WAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVT 544 (553)
Q Consensus 491 ---~-----------~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~ 544 (553)
. ......|+.+ +.+|+. ..|..++.+.+++|..+|..|+..|.++..+++
T Consensus 297 ~dCGWdrGe~Cr~CQ~~LFesIQEG--kYeFPd--kdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 297 ADCGWDRGEVCRVCQNKLFESIQEG--KYEFPD--KDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CcCCccCCCccHHHHHHHHHHHhcc--CCcCCh--hhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 1 1122233332 233333 557789999999999999999999999988876
|
|
| >KOG0199|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=310.43 Aligned_cols=258 Identities=22% Similarity=0.333 Sum_probs=205.5
Q ss_pred cCcceEEEeeeeeeCceEEEEEeeeC-CCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC
Q psy14267 254 NGKQYQVLSLLGKGGSSSVYLVGGTS-EHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA 332 (553)
Q Consensus 254 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~ 332 (553)
..+...+.++||+|.||+|+.+.+.. ++..-.||||.++.+.... ....|++|+.+|.+|.| +||++|+|++.+
T Consensus 108 pee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H-~hliRLyGvVl~-- 182 (1039)
T KOG0199|consen 108 PEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQH-PHLIRLYGVVLD-- 182 (1039)
T ss_pred cHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccC-cceeEEeeeecc--
Confidence 34567788999999999999998864 3444669999998776554 46889999999999965 999999998865
Q ss_pred CceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCC
Q psy14267 333 SKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGN 411 (553)
Q Consensus 333 ~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~ 411 (553)
.-+.||||.+ .|+|++.|++..+ ..+-+..+..++.||+.||.||..+++|||||-..||||... .
T Consensus 183 -qp~mMV~ELaplGSLldrLrka~~---~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasp---------r 249 (1039)
T KOG0199|consen 183 -QPAMMVFELAPLGSLLDRLRKAKK---AILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASP---------R 249 (1039)
T ss_pred -chhhHHhhhcccchHHHHHhhccc---cceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheeccc---------c
Confidence 4678889964 5788888887322 234455666778899999999999999999999999999765 5
Q ss_pred eEEEEeccCccccCCCCCcc-cccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCCC
Q psy14267 412 VLKIIDFGIACSLQDDKTSV-HKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHIP 489 (553)
Q Consensus 412 ~vkL~DFGla~~~~~~~~~~-~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~~ 489 (553)
.|||+||||.+.+......+ ......-...|.|||.++-. .++.++|||+|||+||||++ |+.||-+..
T Consensus 250 tVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~---------kFShaSDvWmyGVTiWEMFtyGEePW~G~~ 320 (1039)
T KOG0199|consen 250 TVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHR---------KFSHASDVWMYGVTIWEMFTYGEEPWVGCR 320 (1039)
T ss_pred eeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccc---------cccccchhhhhhhhHHhhhccCCCCCCCCC
Confidence 79999999999988765543 22223346799999999755 58999999999999999996 999998865
Q ss_pred chHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q psy14267 490 NTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQI 546 (553)
Q Consensus 490 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L 546 (553)
.. +.+..+ +....+.....|++++.++|+.||..+|++|||+..|++.+
T Consensus 321 g~-qIL~~i-------D~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 321 GI-QILKNI-------DAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred HH-HHHHhc-------cccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 42 222222 23445666678999999999999999999999999997443
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=289.36 Aligned_cols=258 Identities=21% Similarity=0.359 Sum_probs=190.8
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCC-CccceEEEEEEecCCcC-chhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSE-HEFKPLALKVVDLSDIT-DQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~-~~~~~vAvK~l~~~~~~-~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
+|++.+.||.|+||.||+|+.... ...+.||+|++...... .....+.+.+|+++|+++.+|++|+.+++++. .+.
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~--~~~ 78 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ--TDT 78 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEee--cCC
Confidence 488999999999999999987532 23456999999764322 22334677899999999988999999987663 456
Q ss_pred eEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 335 HLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 335 ~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
.++++||+. +++|.+++..... .....+..++.|++.||+|||+.|++||||||+|||++.+ +.+
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~-----l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~---------~~~ 144 (290)
T cd05613 79 KLHLILDYINGGELFTHLSQRER-----FKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSN---------GHV 144 (290)
T ss_pred eEEEEEecCCCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCC---------CCE
Confidence 788999975 4689988876432 3345556666799999999999999999999999999776 579
Q ss_pred EEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCc--h
Q psy14267 414 KIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN--T 491 (553)
Q Consensus 414 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~--~ 491 (553)
||+|||++......... ......|+..|+|||.+..... .++.++||||||+++|+|++|..||..... .
T Consensus 145 kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~-------~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~ 216 (290)
T cd05613 145 VLTDFGLSKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDG-------GHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS 216 (290)
T ss_pred EEeeCccceeccccccc-ccccccCCcccCChhhccCCCC-------CCCccccHHHHHHHHHHHhcCCCCCCcCCcccc
Confidence 99999999876443221 1224568999999999865321 257889999999999999999999964322 1
Q ss_pred HHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q psy14267 492 WAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARP-----TVGNSVTQ 545 (553)
Q Consensus 492 ~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RP-----t~~ell~~ 545 (553)
...+....... ... ....++..+.+++.+||..||++|| ++.+++.+
T Consensus 217 ~~~~~~~~~~~-~~~------~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 217 QAEISRRILKS-EPP------YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred HHHHHHHhhcc-CCC------CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 11111111000 111 1225778999999999999999997 77777664
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=298.31 Aligned_cols=262 Identities=27% Similarity=0.352 Sum_probs=197.9
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC---C
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA---S 333 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~---~ 333 (553)
+|++.+.||.|+||.||+|.+...+. .||||++..... .....+.+.+|+.+++.+. |+||+.+++++.... .
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~--~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~ 76 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGR--KVAIKKISNVFD-DLIDAKRILREIKLLRHLR-HENIIGLLDILRPPSPEDF 76 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCc--EEEEEeeccccc-cchhhhhHHHHHHHHHhcC-CcchhhhhhhhcccCcccc
Confidence 58999999999999999998766554 499999876432 2334577899999999995 699999999875543 2
Q ss_pred ceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 334 KHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 334 ~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
..+|++|++.+++|..++.... ......+..++.||+.||+|||+.||+||||||+|||++.+ +.+
T Consensus 77 ~~~~lv~e~~~~~l~~~l~~~~-----~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~---------~~~ 142 (330)
T cd07834 77 NDVYIVTELMETDLHKVIKSPQ-----PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSN---------CDL 142 (330)
T ss_pred cceEEEecchhhhHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC---------CCE
Confidence 4789999998888888886543 34456666677899999999999999999999999999876 579
Q ss_pred EEEeccCccccCCCCCc-ccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchH
Q psy14267 414 KIIDFGIACSLQDDKTS-VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTW 492 (553)
Q Consensus 414 kL~DFGla~~~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~ 492 (553)
+|+|||++......... .......++..|+|||++.+.. .++.++|+||||+++|+|++|..||......
T Consensus 143 ~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--------~~~~~sDi~slG~il~~l~~g~~pf~~~~~~- 213 (330)
T cd07834 143 KICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSS--------RYTKAIDIWSVGCIFAELLTRKPLFPGRDYI- 213 (330)
T ss_pred EEcccCceEeecccccccccccccccccCcCCceeeeccc--------CCCcchhHHHHHHHHHHHHcCCCCcCCCCHH-
Confidence 99999999887654311 1122456899999999997652 3688999999999999999999999765432
Q ss_pred HHHHHHHhhccccc-----------------------ccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 493 AKMLAIARHKDQIE-----------------------FKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 493 ~~~~~i~~~~~~~~-----------------------~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
..+..+........ ..........++..+.++|.+||+.+|++||++.+++.+
T Consensus 214 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 214 DQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred HHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11111111100000 000000112467899999999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=286.18 Aligned_cols=244 Identities=17% Similarity=0.278 Sum_probs=183.0
Q ss_pred ceEEEeee--eeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 257 QYQVLSLL--GKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 257 ~y~i~~~L--G~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
+|++.+.+ |.|+||.||++....++.. +|+|++....... .|+.+...+.+|+||+++++++.. ..
T Consensus 15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~--~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~--~~ 82 (267)
T PHA03390 15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKL--FVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTT--LK 82 (267)
T ss_pred hhccccceeecCCCceEEEEEEEcCCCcE--EEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEec--CC
Confidence 56666665 9999999999988777644 9999987654322 133333334468999999987754 45
Q ss_pred eEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 335 HLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 335 ~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
.++++||+. +++|.+++.... ...+..+..++.|++.||+|||+.|++||||||+||+++.+. +.+
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~--------~~~ 149 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKEG-----KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAK--------DRI 149 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCC--------CeE
Confidence 789999975 689999987653 344566777788999999999999999999999999997762 379
Q ss_pred EEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHH
Q psy14267 414 KIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWA 493 (553)
Q Consensus 414 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~ 493 (553)
+|+|||++....... ...|+..|+|||++.+. .++.++||||||+++|||++|..||........
T Consensus 150 ~l~dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~---------~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~ 214 (267)
T PHA03390 150 YLCDYGLCKIIGTPS------CYDGTLDYFSPEKIKGH---------NYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL 214 (267)
T ss_pred EEecCccceecCCCc------cCCCCCcccChhhhcCC---------CCCchhhHHHHHHHHHHHHHCCCCCCCCCcchh
Confidence 999999987664322 34589999999999765 367899999999999999999999985433211
Q ss_pred HHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q psy14267 494 KMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT-VGNSVTQ 545 (553)
Q Consensus 494 ~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt-~~ell~~ 545 (553)
....+..... ........++..+.++|.+||+.+|++||+ +++++++
T Consensus 215 ~~~~~~~~~~-----~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 215 DLESLLKRQQ-----KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred hHHHHHHhhc-----ccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 1112211111 111122267899999999999999999996 6988854
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=282.50 Aligned_cols=252 Identities=32% Similarity=0.493 Sum_probs=196.2
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceE
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHL 336 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~ 336 (553)
+|++.+.||+|+||.||++.+..++. .+|+|.+.+..... .....+.+|+++++++. |+||+++++++.+ ....
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~--~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~~ 74 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQ--FYALKEVDLGSMSQ-KEREDAVNEIRILASVN-HPNIISYKEAFLD--GNKL 74 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCC--EEEEEEEehhhccH-HHHHHHHHHHHHHHhCC-CCCchhhhhhhcc--CCEE
Confidence 48899999999999999998776654 49999998765443 33467889999999996 6999999987754 4678
Q ss_pred EEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 337 YVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 337 ~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
+++|++. +++|..++...... ........+..++.|++.||+|||+.|++||||+|+||+++.+ +.+||
T Consensus 75 ~~v~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~---------~~~kl 144 (256)
T cd08530 75 CIVMEYAPFGDLSKAISKRKKK-RKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVAN---------DLVKI 144 (256)
T ss_pred EEEehhcCCCCHHHHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecC---------CcEEE
Confidence 8899865 67899988764321 1234455566777899999999999999999999999999875 57999
Q ss_pred EeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHH
Q psy14267 416 IDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKM 495 (553)
Q Consensus 416 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~ 495 (553)
+|||++....... .....|++.|+|||.+.+. .++.++|+||||+++|||++|+.||...... ...
T Consensus 145 ~d~g~~~~~~~~~----~~~~~~~~~~~~Pe~~~~~---------~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~-~~~ 210 (256)
T cd08530 145 GDLGISKVLKKNM----AKTQIGTPHYMAPEVWKGR---------PYSYKSDIWSLGCLLYEMATFAPPFEARSMQ-DLR 210 (256)
T ss_pred eeccchhhhccCC----cccccCCccccCHHHHCCC---------CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHH
Confidence 9999998776542 1235688999999999765 3678999999999999999999999875432 111
Q ss_pred HHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 496 LAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 496 ~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
..+.. . .+.+ . ...++.+++++|.+||..+|++||++.+++++
T Consensus 211 ~~~~~-~---~~~~-~--~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 211 YKVQR-G---KYPP-I--PPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred HHHhc-C---CCCC-C--chhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 22211 1 1111 1 12567899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=287.56 Aligned_cols=252 Identities=26% Similarity=0.446 Sum_probs=195.8
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
.+.|++.+.||+|+||.||++.+...+ +.||+|++..... ..+.+.+|+++++++. |+||+++++++.. ..
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~--~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~ 88 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATG--KEVAIKKMRLRKQ----NKELIINEILIMKDCK-HPNIVDYYDSYLV--GD 88 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCC--cEEEEEEEecCch----hHHHHHHHHHHHHHCC-CCCeeEEEEEEEE--CC
Confidence 346899999999999999999887555 3499999976543 3467889999999995 5999999988765 46
Q ss_pred eEEEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 335 HLYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 335 ~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
..++++++.. ++|.+++.... .......+..++.|++.||+|||+.||+|+||||+||+++.+ +.+
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~---------~~~ 155 (286)
T cd06614 89 ELWVVMEYMDGGSLTDIITQNF----VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKD---------GSV 155 (286)
T ss_pred EEEEEEeccCCCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCC---------CCE
Confidence 7888888765 89999998754 133445566677899999999999999999999999999766 579
Q ss_pred EEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHH
Q psy14267 414 KIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWA 493 (553)
Q Consensus 414 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~ 493 (553)
+|+|||++........ ......++..|+|||.+.+. .++.++|+||||+++|+|++|..||...... .
T Consensus 156 ~l~d~~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~---------~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~-~ 223 (286)
T cd06614 156 KLADFGFAAQLTKEKS--KRNSVVGTPYWMAPEVIKRK---------DYGPKVDIWSLGIMCIEMAEGEPPYLREPPL-R 223 (286)
T ss_pred EECccchhhhhccchh--hhccccCCcccCCHhHhcCC---------CCCCccccHHHHHHHHHHHhCCCCCCCCCHH-H
Confidence 9999999876654322 12244588999999998755 3678999999999999999999999875443 2
Q ss_pred HHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 494 KMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 494 ~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
....+... .. +.......++..+.++|.+||+.+|.+||++.+++.+
T Consensus 224 ~~~~~~~~-~~----~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 224 ALFLITTK-GI----PPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred HHHHHHhc-CC----CCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 22222211 11 1112223478899999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=286.92 Aligned_cols=258 Identities=27% Similarity=0.431 Sum_probs=192.1
Q ss_pred eEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEE
Q psy14267 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLY 337 (553)
Q Consensus 258 y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~ 337 (553)
|++.+.||+|+||+||+|.....+. .||||.+....... ......+|+..++++.+|+||+.+++++.+ ....+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~--~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~--~~~~~ 74 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGE--LVAIKKMKKKFYSW--EECMNLREVKSLRKLNEHPNIVKLKEVFRE--NDELY 74 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCc--EEEEEEehhhccch--hHHHHHHHHHHHHhccCCCCchhHHHHhhc--CCcEE
Confidence 6788999999999999998866654 49999987553221 123456799999999757999999998754 67889
Q ss_pred EEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEe
Q psy14267 338 VLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIID 417 (553)
Q Consensus 338 iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~D 417 (553)
++||+++++|.+++..... .......++.++.|++.||.|||++||+|+||||+||+++.+ +.++|+|
T Consensus 75 lv~e~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~---------~~~~l~d 142 (283)
T cd07830 75 FVFEYMEGNLYQLMKDRKG---KPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGP---------EVVKIAD 142 (283)
T ss_pred EEEecCCCCHHHHHHhccc---ccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCC---------CCEEEee
Confidence 9999999999998876541 133456667777899999999999999999999999999876 5799999
Q ss_pred ccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHHH
Q psy14267 418 FGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLA 497 (553)
Q Consensus 418 FGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~~ 497 (553)
||++........ .....++..|+|||++.... .++.++|+||||+++|||++|.+||...... .....
T Consensus 143 ~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~--------~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~-~~~~~ 210 (283)
T cd07830 143 FGLAREIRSRPP---YTDYVSTRWYRAPEILLRST--------SYSSPVDIWALGCIMAELYTLRPLFPGSSEI-DQLYK 210 (283)
T ss_pred cccceeccCCCC---cCCCCCcccccCceeeecCc--------CcCCccchhhHHHHHHHHHhCCCccCCCChH-HHHHH
Confidence 999987654322 12445889999999986432 3688999999999999999999999764332 11111
Q ss_pred HHhhccc-----------------ccccc----cccC-CCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 498 IARHKDQ-----------------IEFKP----QLAN-NVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 498 i~~~~~~-----------------~~~~~----~~~~-~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
+...... ..+.. .... ....+.++.++|++||..+|++|||++|++.+
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 211 ICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred HHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 1110000 00000 0000 11236789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=287.52 Aligned_cols=249 Identities=25% Similarity=0.413 Sum_probs=190.0
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceE
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHL 336 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~ 336 (553)
.|...+.||+|++|.||++.+...+. .+|+|++.... ....+.+.+|+.+++.+. ||||+++++++.. ....
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~--~~~iK~~~~~~---~~~~~~~~~e~~~l~~~~-h~~vv~~~~~~~~--~~~~ 91 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGR--QVAVKKMDLRK---QQRRELLFNEVVIMRDYQ-HPNIVEMYSSYLV--GDEL 91 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCC--EEEEEEEeccc---hhHHHHHHHHHHHHHHcC-CCChheEEEEEEc--CCeE
Confidence 46667899999999999998766554 49999886543 223466889999999995 6999999987753 5577
Q ss_pred EEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 337 YVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 337 ~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
++++++. +++|.+++... ......+..++.|++.||+|||++||+||||||+||+++.+ +.++|
T Consensus 92 ~~v~e~~~~~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~---------~~~~l 156 (285)
T cd06648 92 WVVMEFLEGGALTDIVTHT------RMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSD---------GRVKL 156 (285)
T ss_pred EEEEeccCCCCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCC---------CcEEE
Confidence 8888875 67898888762 23345566677899999999999999999999999999776 57999
Q ss_pred EeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHH
Q psy14267 416 IDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKM 495 (553)
Q Consensus 416 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~ 495 (553)
+|||++........ ......|++.|+|||.+.+. .++.++|||||||++|||++|..||...... ..+
T Consensus 157 ~d~g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~---------~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~-~~~ 224 (285)
T cd06648 157 SDFGFCAQVSKEVP--RRKSLVGTPYWMAPEVISRL---------PYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL-QAM 224 (285)
T ss_pred cccccchhhccCCc--ccccccCCccccCHHHhcCC---------CCCCcccHHHHHHHHHHHHhCCCCCcCCCHH-HHH
Confidence 99999876543221 12245689999999998765 3678999999999999999999999764322 222
Q ss_pred HHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 496 LAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 496 ~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
..+... ..+.......++..+.++|.+||..+|++||++.+++++
T Consensus 225 ~~~~~~-----~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 225 KRIRDN-----LPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred HHHHhc-----CCCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 222211 111222223478899999999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=279.33 Aligned_cols=254 Identities=32% Similarity=0.531 Sum_probs=197.5
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceE
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHL 336 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~ 336 (553)
+|++.+.||.|+||.||++.+..++ ..||+|++...... ....+.+.+|++++++++ |+|++.+.+.+.. ....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~--~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-~~~~~~~~~~~~~--~~~~ 74 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDG--KLYVLKEIDLSNMS-EKEREDALNEVKILKKLN-HPNIIKYYESFEE--KGKL 74 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCC--cEEEEEEeecccCC-hHHHHHHHHHHHHHHhcC-CCChhheEEEEec--CCEE
Confidence 5899999999999999999887655 44999999876543 244577899999999996 6999999987754 3678
Q ss_pred EEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 337 YVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 337 ~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
++++++. +++|.+++..... .........+..++.+++.||+|||++|++|+||+|+||+++.+ +.++|
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~---------~~~~l 144 (258)
T cd08215 75 CIVMEYADGGDLSQKIKKQKK-EGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSN---------GLVKL 144 (258)
T ss_pred EEEEEecCCCcHHHHHHHhhc-cCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCC---------CcEEE
Confidence 8888876 4689998887531 11244566677777899999999999999999999999999775 57999
Q ss_pred EeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHH
Q psy14267 416 IDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKM 495 (553)
Q Consensus 416 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~ 495 (553)
+|||++........ ......|++.|+|||.+... .++.++|+||||+++|+|++|..||...... ...
T Consensus 145 ~d~~~~~~~~~~~~--~~~~~~~~~~y~~pe~~~~~---------~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-~~~ 212 (258)
T cd08215 145 GDFGISKVLSSTVD--LAKTVVGTPYYLSPELCQNK---------PYNYKSDIWSLGCVLYELCTLKHPFEGENLL-ELA 212 (258)
T ss_pred CCccceeecccCcc--eecceeeeecccChhHhccC---------CCCccccHHHHHHHHHHHHcCCCCCCCCcHH-HHH
Confidence 99999987655431 22345689999999998655 3678999999999999999999999765422 111
Q ss_pred HHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 496 LAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 496 ~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
..... .. ..+ ....++..+.++|.+||..+|++||++.+++++
T Consensus 213 ~~~~~-~~---~~~---~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 213 LKILK-GQ---YPP---IPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred HHHhc-CC---CCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 22111 11 111 112578999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=284.71 Aligned_cols=248 Identities=25% Similarity=0.420 Sum_probs=191.2
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceE
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHL 336 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~ 336 (553)
-|++.+.||.|+||.||++.+..++. .||||++..... ....+.+.+|+.++.++. ||||+++++++.. +..+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~--~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~--~~~~ 77 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQK--VVAIKIIDLEEA--EDEIEDIQQEITVLSQCD-SPYVTKYYGSYLK--DTKL 77 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCc--EEEEEEeccccc--hHHHHHHHHHHHHHHhcC-CCCEeEEEEEEEe--CCeE
Confidence 47888999999999999997766654 499999865432 233467889999999995 5999999987754 5678
Q ss_pred EEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 337 YVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 337 ~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
+++||++. ++|..++... ......+..++.|++.||.|||+.|++|+||||+||+++.+ +.++|
T Consensus 78 ~lv~e~~~~~~l~~~i~~~------~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~---------~~~~l 142 (277)
T cd06641 78 WIIMEYLGGGSALDLLEPG------PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEH---------GEVKL 142 (277)
T ss_pred EEEEEeCCCCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCC---------CCEEE
Confidence 89999764 6788887642 23455566777899999999999999999999999999766 57999
Q ss_pred EeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHH
Q psy14267 416 IDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKM 495 (553)
Q Consensus 416 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~ 495 (553)
+|||++..+..... ......|+..|+|||.+.+. .++.++|+|||||++|+|++|..||...... ...
T Consensus 143 ~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~---------~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~ 210 (277)
T cd06641 143 ADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQS---------AYDSKADIWSLGITAIELAKGEPPHSELHPM-KVL 210 (277)
T ss_pred eecccceecccchh--hhccccCCccccChhhhccC---------CCCchhhHHHHHHHHHHHHcCCCCCCccchH-HHH
Confidence 99999876654322 12245688999999998654 3678999999999999999999999764432 212
Q ss_pred HHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 496 LAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 496 ~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
..+.. .. .+. ....++.++.++|.+||..+|++||++.+++.+
T Consensus 211 ~~~~~-~~----~~~--~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 211 FLIPK-NN----PPT--LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred HHHhc-CC----CCC--CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 22111 11 111 112567899999999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0671|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=291.30 Aligned_cols=269 Identities=25% Similarity=0.364 Sum_probs=200.9
Q ss_pred EecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCC-----CceeEeee
Q psy14267 252 TLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGC-----PYVIKMHD 326 (553)
Q Consensus 252 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~h-----p~Iv~l~~ 326 (553)
+....+|.++.++|+|+||.|-.+.+..++.. ||||+++.- ....+..+-|+++|.++.++ .-++.+.+
T Consensus 85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~--vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~ 158 (415)
T KOG0671|consen 85 DILTNRYEIVDLLGEGTFGKVVECWDRETKEH--VALKIIKNV----DKYREAALIEIEVLQKINESDPNGKFRCVQMRD 158 (415)
T ss_pred cccccceehhhhhcCCcccceEEEeecCCCce--ehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeeh
Confidence 34467999999999999999999988887555 999999633 34557788999999999543 24677766
Q ss_pred EEEeCCCceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccc--
Q psy14267 327 YVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLK-- 404 (553)
Q Consensus 327 ~~~~~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~-- 404 (553)
|| +-.++++|++|..|.++.+++.+.+- .++....+..+++|++.+++|||+.+++|-||||+|||+.+....
T Consensus 159 wF--dyrghiCivfellG~S~~dFlk~N~y---~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~ 233 (415)
T KOG0671|consen 159 WF--DYRGHICIVFELLGLSTFDFLKENNY---IPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKT 233 (415)
T ss_pred hh--hccCceEEEEeccChhHHHHhccCCc---cccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEE
Confidence 55 45779999999999999999987543 356677788888999999999999999999999999998643211
Q ss_pred ---------eecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHH
Q psy14267 405 ---------IIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCIL 475 (553)
Q Consensus 405 ---------~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl 475 (553)
+.......|+|+|||.|+...... .+.+.|..|.|||++.+-+ ++..+||||+||||
T Consensus 234 ~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLG---------wS~pCDvWSiGCIL 299 (415)
T KOG0671|consen 234 YNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLG---------WSQPCDVWSIGCIL 299 (415)
T ss_pred eccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccC---------cCCccCceeeeeEE
Confidence 112234569999999997765543 2667899999999999886 78899999999999
Q ss_pred HHHHhCCCCCCCCCchHH--HHHHHHhhc----------------ccccccccccCC-------------------CCCC
Q psy14267 476 YNMIYGRTPYSHIPNTWA--KMLAIARHK----------------DQIEFKPQLANN-------------------VTIP 518 (553)
Q Consensus 476 ~elltG~~Pf~~~~~~~~--~~~~i~~~~----------------~~~~~~~~~~~~-------------------~~~s 518 (553)
+|+.+|...|....+.+. .|..+.... ..++++...... ...-
T Consensus 300 ~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~ 379 (415)
T KOG0671|consen 300 VELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEH 379 (415)
T ss_pred EEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHH
Confidence 999999999986554321 121111100 011111000000 0011
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 519 PTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 519 ~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
..|.+||++||..||.+|+|+.|++.|
T Consensus 380 ~~LfDLl~~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 380 VQLFDLLRRMLEFDPARRITLREALSH 406 (415)
T ss_pred hHHHHHHHHHHccCccccccHHHHhcC
Confidence 358999999999999999999999875
|
|
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=307.78 Aligned_cols=242 Identities=26% Similarity=0.391 Sum_probs=193.7
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
.+.|.+...+|.|+|+.|-.+.+..+... +++|++.+.. ....+|+.++....+||||+.+++.+ .+..
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~--~~vkii~~~~-------~~~~~e~~~~~~~~~h~niv~~~~v~--~~~~ 389 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQE--PAVKIISKRA-------DDNQDEIPISLLVRDHPNIVKSHDVY--EDGK 389 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccc--hhheeccccc-------cccccccchhhhhcCCCcceeeccee--cCCc
Confidence 45788889999999999999988877755 9999997762 22347888999999999999999877 4578
Q ss_pred eEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 335 HLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 335 ~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
+.++|||.. ++.+.+.+..... .. ..+..|+++|+.|++|||++|||||||||+|||++.+. +++
T Consensus 390 ~~~~v~e~l~g~ell~ri~~~~~-----~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~--------g~l 455 (612)
T KOG0603|consen 390 EIYLVMELLDGGELLRRIRSKPE-----FC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSA--------GHL 455 (612)
T ss_pred eeeeeehhccccHHHHHHHhcch-----hH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCC--------CcE
Confidence 899999964 4455555554332 11 34445678999999999999999999999999996221 679
Q ss_pred EEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHH
Q psy14267 414 KIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWA 493 (553)
Q Consensus 414 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~ 493 (553)
+|+|||.++..... ..+.+-|..|.|||++... .|+.++||||||++||+||+|+.||...++...
T Consensus 456 rltyFG~a~~~~~~-----~~tp~~t~~y~APEvl~~~---------~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~e 521 (612)
T KOG0603|consen 456 RLTYFGFWSELERS-----CDTPALTLQYVAPEVLAIQ---------EYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIE 521 (612)
T ss_pred EEEEechhhhCchh-----hcccchhhcccChhhhccC---------CCCcchhhHHHHHHHHHHHhCCCccccCCchHH
Confidence 99999999877665 3366789999999999865 389999999999999999999999998777634
Q ss_pred HHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 494 KMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 494 ~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
.+..+.. ..+. ..+|+++++||..||+.||.+||++.+++.+
T Consensus 522 i~~~i~~----~~~s------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 522 IHTRIQM----PKFS------ECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred HHHhhcC----Cccc------cccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 3333322 1122 3688999999999999999999999999765
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=287.94 Aligned_cols=261 Identities=22% Similarity=0.358 Sum_probs=193.4
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCC-CccceEEEEEEecCCcC-chhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSE-HEFKPLALKVVDLSDIT-DQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~-~~~~~vAvK~l~~~~~~-~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
+|++.+.||+|+||.||++..... .....||||++++.... .....+.+.+|++++.++.+||+|+.+++.+ ....
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~--~~~~ 78 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF--QTDT 78 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee--ecCC
Confidence 488999999999999999876532 23356999999764332 2234467889999999998899999998766 4456
Q ss_pred eEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 335 HLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 335 ~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
.++++||+. +++|..++.... ......+..++.|++.||+|||+.+++||||||+||+++.+ +.+
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~---------~~~ 144 (288)
T cd05583 79 KLHLILDYVNGGELFTHLYQRE-----HFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSE---------GHV 144 (288)
T ss_pred EEEEEEecCCCCcHHHHHhhcC-----CcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC---------CCE
Confidence 788999975 568888886542 23445566667799999999999999999999999999776 579
Q ss_pred EEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCc--h
Q psy14267 414 KIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN--T 491 (553)
Q Consensus 414 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~--~ 491 (553)
+|+|||++......... ......|+..|+|||.+.+... .++.++||||||+++|||++|..||..... .
T Consensus 145 ~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~-------~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~ 216 (288)
T cd05583 145 VLTDFGLSKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSG-------GHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS 216 (288)
T ss_pred EEEECcccccccccccc-ccccccCCccccCHHHhcCCCC-------CCcchhhhHHHHHHHHHHHhCCCCcccCcccch
Confidence 99999998776543221 1224568999999999865421 157889999999999999999999964321 1
Q ss_pred HHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q psy14267 492 WAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINN 548 (553)
Q Consensus 492 ~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~ 548 (553)
...+..... .. .......++..+.++|.+||+.||++|||+.++...|+.
T Consensus 217 ~~~~~~~~~-~~------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 217 QSEISRRIL-KS------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred HHHHHHHHH-cc------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 111111110 11 111123567899999999999999999998777665554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=283.31 Aligned_cols=249 Identities=29% Similarity=0.452 Sum_probs=190.1
Q ss_pred eeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEEEEEecC
Q psy14267 264 LGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEKG 343 (553)
Q Consensus 264 LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~iv~e~~ 343 (553)
||.|+||.||++++..++. .||+|++...........+.+.+|+++++++. ||||+++++.+ ......+++|++.
T Consensus 1 lg~g~~~~vy~~~~~~~~~--~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~--~~~~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGD--IYAIKVIKKADMIRKNQVDQVLTERDILSQAQ-SPYVVKLYYSF--QGKKNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECCCCC--EEEEEEecchhhhhhhHHHHHHHHHHHHHhCC-CcchhHHHHhe--ecCcEEEEEEecC
Confidence 6899999999998876654 49999998776555566688999999999996 69999998766 3466788999976
Q ss_pred -CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEeccCcc
Q psy14267 344 -DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIAC 422 (553)
Q Consensus 344 -~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGla~ 422 (553)
+++|.+++.... ......+..++.|++.||+|||+++|+||||+|+||+++.+ +.++|+|||++.
T Consensus 76 ~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~---------~~~~l~dfg~~~ 141 (265)
T cd05579 76 PGGDLASLLENVG-----SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSN---------GHLKLTDFGLSK 141 (265)
T ss_pred CCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCC---------CCEEEEecccch
Confidence 568999887654 23455666777899999999999999999999999999876 579999999987
Q ss_pred ccCCCCC------cccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHH
Q psy14267 423 SLQDDKT------SVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKML 496 (553)
Q Consensus 423 ~~~~~~~------~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~ 496 (553)
....... ........++..|+|||.+... .++.++||||||+++|||++|..||...... ....
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~---------~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-~~~~ 211 (265)
T cd05579 142 VGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQ---------GHSKTVDWWSLGCILYEFLVGIPPFHGETPE-EIFQ 211 (265)
T ss_pred hcccCcccccccccccccCcccCccccCHHHhcCC---------CCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-HHHH
Confidence 6544321 1122245688999999998755 2678999999999999999999999765432 2222
Q ss_pred HHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q psy14267 497 AIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQIN 547 (553)
Q Consensus 497 ~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~ 547 (553)
.+.. ....+ .....++..+.++|.+||+.+|++|||+.++.+.|+
T Consensus 212 ~~~~--~~~~~----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 212 NILN--GKIEW----PEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred HHhc--CCcCC----CccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 2221 11111 112235899999999999999999999954444443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=277.35 Aligned_cols=250 Identities=29% Similarity=0.549 Sum_probs=196.3
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceE
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHL 336 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~ 336 (553)
+|++.+.||+|++|.||++.+...+. .||+|.+....... ...+.+.+|++++.++. |++|+.+++++.. ....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~--~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~~ 74 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGD--FVAIKQISLEKIKE-EALKSIMQEIDLLKNLK-HPNIVKYIGSIET--SDSL 74 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCc--EEEEEEecccccCH-HHHHHHHHHHHHHHhCC-CCCccEEEEEEEe--CCEE
Confidence 48899999999999999998766554 49999998776543 44578999999999995 5999999887754 4678
Q ss_pred EEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 337 YVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 337 ~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
+++|++. +++|.+++.... ......+..++.|++.||.|||+.||+||||||+||+++.+ +.++|
T Consensus 75 ~~v~e~~~~~~L~~~~~~~~-----~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~---------~~~~l 140 (254)
T cd06627 75 YIILEYAENGSLRQIIKKFG-----PFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKD---------GVVKL 140 (254)
T ss_pred EEEEecCCCCcHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCC---------CCEEE
Confidence 8999975 568888887652 33455666677899999999999999999999999999765 57999
Q ss_pred EeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHH
Q psy14267 416 IDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKM 495 (553)
Q Consensus 416 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~ 495 (553)
+|||++......... .....++..|+|||.+.+.. ++.++|||+||+++|+|++|..||...... ...
T Consensus 141 ~d~~~~~~~~~~~~~--~~~~~~~~~y~~pe~~~~~~---------~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~-~~~ 208 (254)
T cd06627 141 ADFGVATKLNDVSKD--DASVVGTPYWMAPEVIEMSG---------ASTASDIWSLGCTVIELLTGNPPYYDLNPM-AAL 208 (254)
T ss_pred eccccceecCCCccc--ccccccchhhcCHhhhcCCC---------CCcchhHHHHHHHHHHHHhCCCCCCCccHH-HHH
Confidence 999999877654432 22456899999999987552 678999999999999999999999875532 222
Q ss_pred HHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 496 LAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 496 ~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
..... ... + .....++..+.++|.+||..+|++||++.+++.+
T Consensus 209 ~~~~~-~~~----~--~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 209 FRIVQ-DDH----P--PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred HHHhc-cCC----C--CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 22211 111 1 1122568899999999999999999999999853
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=294.78 Aligned_cols=258 Identities=20% Similarity=0.339 Sum_probs=184.6
Q ss_pred eeeeee--CceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEEEE
Q psy14267 262 SLLGKG--GSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVL 339 (553)
Q Consensus 262 ~~LG~G--~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~iv 339 (553)
..||+| +||+||+|++...+.. ||||++....... ...+.+.+|+.+++.+. ||||+++++++.. ...++++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~--vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~--~~~~~~v 77 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTL--VTVRITDLENCTE-EHLKALQNEVVLSHFFR-HPNIMTSWTVFTT--GSWLWVI 77 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcE--EEEEEeccccCCH-HHHHHHHHHHHHHHhCC-CCCcceEeeeEec--CCceEEE
Confidence 456766 9999999988777654 9999998765443 34578899999998885 5999999998754 5577888
Q ss_pred EecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEec
Q psy14267 340 MEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDF 418 (553)
Q Consensus 340 ~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DF 418 (553)
|++. +++|.+++...... ......+..++.|++.||+|||++||+||||||+|||++.+ +.++++||
T Consensus 78 ~e~~~~~~l~~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~---------~~~~~~~~ 145 (328)
T cd08226 78 SPFMAYGSANSLLKTYFPE---GMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGD---------GLVSLSGL 145 (328)
T ss_pred EecccCCCHHHHHHhhccc---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCC---------CcEEEech
Confidence 8864 46888888765322 24455566677899999999999999999999999999766 57999999
Q ss_pred cCccccCCCCCcc-----cccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHH
Q psy14267 419 GIACSLQDDKTSV-----HKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWA 493 (553)
Q Consensus 419 Gla~~~~~~~~~~-----~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~ 493 (553)
+.+.......... ......++..|+|||++.+... .++.++|||||||++|||++|..||........
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-------~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~ 218 (328)
T cd08226 146 SHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLY-------GYNVKSDIYSVGITACELATGRVPFQDMLRTQM 218 (328)
T ss_pred HHHhhhhccCccccccccccccccCccCccChhhhcCCCC-------CCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH
Confidence 8654432211110 0011235667999999975421 368899999999999999999999987544322
Q ss_pred HHHHHHhhcccccc-------------------------------------cc--cccCCCCCCHHHHHHHHHhcccCCC
Q psy14267 494 KMLAIARHKDQIEF-------------------------------------KP--QLANNVTIPPTLLQSMKLCLQKDPK 534 (553)
Q Consensus 494 ~~~~i~~~~~~~~~-------------------------------------~~--~~~~~~~~s~~l~~li~~cL~~dP~ 534 (553)
....+.. ...... .. .......++..+.+||++||..||+
T Consensus 219 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~ 297 (328)
T cd08226 219 LLQKLKG-PPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPE 297 (328)
T ss_pred HHHHhcC-CCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcc
Confidence 2111110 000000 00 0011123567899999999999999
Q ss_pred CCCCHHHHHHH
Q psy14267 535 ARPTVGNSVTQ 545 (553)
Q Consensus 535 ~RPt~~ell~~ 545 (553)
+|||+.+++++
T Consensus 298 ~Rpta~e~l~~ 308 (328)
T cd08226 298 KRPSASSLLSH 308 (328)
T ss_pred cCCCHHHHhhC
Confidence 99999999865
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=318.03 Aligned_cols=148 Identities=24% Similarity=0.427 Sum_probs=123.9
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|.++++||+|+||.||+|.+...+.. ||||++.+...........+..|+.+++.+. ||||+.+++++. ...+
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~--vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~--~~~~ 78 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKL--YAVKVVKKADMINKNMVHQVQAERDALALSK-SPFIVHLYYSLQ--SANN 78 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcE--EEEEEEehhhccCHHHHHHHHHHHHHHHhcC-CCCcCeEEEEEE--ECCE
Confidence 5799999999999999999988766654 9999998776666666788999999999885 599999987663 3568
Q ss_pred EEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
+|++||++ +++|..++..... .....++.++.||+.||+|||.++||||||||+||||+.+ +.+|
T Consensus 79 ~~lVmEy~~g~~L~~li~~~~~-----l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~---------g~vk 144 (669)
T cd05610 79 VYLVMEYLIGGDVKSLLHIYGY-----FDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNE---------GHIK 144 (669)
T ss_pred EEEEEeCCCCCCHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCC---------CCEE
Confidence 89999975 7889998876432 2344566777899999999999999999999999999766 5799
Q ss_pred EEeccCcc
Q psy14267 415 IIDFGIAC 422 (553)
Q Consensus 415 L~DFGla~ 422 (553)
|+|||+++
T Consensus 145 L~DFGls~ 152 (669)
T cd05610 145 LTDFGLSK 152 (669)
T ss_pred EEeCCCCc
Confidence 99999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=285.44 Aligned_cols=258 Identities=27% Similarity=0.429 Sum_probs=194.4
Q ss_pred eEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEE
Q psy14267 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLY 337 (553)
Q Consensus 258 y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~ 337 (553)
|++.+.||+|+||.||++....++. .||+|++.... ......+.+.+|+.+++++. |++|+++++++.+ ...++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~--~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~--~~~~~ 74 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGE--IVALKKIRLDN-EEEGIPSTALREISLLKELK-HPNIVKLLDVIHT--ERKLY 74 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCc--EEEEEEecccc-ccccccHHHHHHHHHHHhcC-CCCHHHHHhhhhc--CCceE
Confidence 6778899999999999998876654 49999998765 22334467889999999996 6999999988754 46889
Q ss_pred EEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEe
Q psy14267 338 VLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIID 417 (553)
Q Consensus 338 iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~D 417 (553)
++||+.+++|.+++.... .......+..++.|++.||+|||++||+||||+|+||+++.+ +.++|+|
T Consensus 75 ~v~e~~~~~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~---------~~~~l~d 141 (282)
T cd07829 75 LVFEYCDMDLKKYLDKRP----GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRD---------GVLKLAD 141 (282)
T ss_pred EEecCcCcCHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCC---------CCEEEec
Confidence 999998899999998753 134456666777899999999999999999999999999776 5799999
Q ss_pred ccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHHH
Q psy14267 418 FGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLA 497 (553)
Q Consensus 418 FGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~~ 497 (553)
||++......... .....++..|+|||.+.+.. .++.++|||||||++|||++|..||...... ..+..
T Consensus 142 ~g~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~--------~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-~~~~~ 210 (282)
T cd07829 142 FGLARAFGIPLRT--YTHEVVTLWYRAPEILLGSK--------HYSTAVDIWSVGCIFAEMITGKPLFPGDSEI-DQLFK 210 (282)
T ss_pred CCcccccCCCccc--cCccccCcCcCChHHhcCCc--------CCCccccHHHHHHHHHHHHhCCCCCCCccHH-HHHHH
Confidence 9999876543321 22344678899999986542 3678999999999999999999999764332 11111
Q ss_pred HHhhcc----------------cccccc-----cccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 498 IARHKD----------------QIEFKP-----QLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 498 i~~~~~----------------~~~~~~-----~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
+..... ...+.. .......++..+.++|++||..+|++||++.+++.+
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 211 IFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred HHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 111000 000000 001112347889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=290.10 Aligned_cols=259 Identities=19% Similarity=0.257 Sum_probs=182.4
Q ss_pred EEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEEEE
Q psy14267 260 VLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVL 339 (553)
Q Consensus 260 i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~iv 339 (553)
+++.+|. +|.||+++...++ +.||||++....... ...+.+.+|+.++++++ |+||+.+++++.. ....+++
T Consensus 6 i~~~~~~--~~~v~~~~~~~~~--~~~avK~~~~~~~~~-~~~~~~~~Ei~~l~~l~-h~~i~~~~~~~~~--~~~~~~~ 77 (314)
T cd08216 6 IGKCFED--LMIVHLAKHKPTN--TLVAVKKINLDSCSK-EDLKLLQQEIITSRQLQ-HPNILPYVTSFIV--DSELYVV 77 (314)
T ss_pred hhHhhcC--CceEEEEEecCCC--CEEEEEEEeccccch-hHHHHHHHHHHHHHhcC-Ccchhhhhheeec--CCeEEEE
Confidence 3344444 4555555555544 459999998764333 45678999999999996 5999999987744 5567888
Q ss_pred EecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEec
Q psy14267 340 MEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDF 418 (553)
Q Consensus 340 ~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DF 418 (553)
||++ +++|.+++...... ......+..++.|++.||+|||+++|+||||||+|||++.+ +.+||+||
T Consensus 78 ~e~~~~~~l~~~l~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~---------~~~kl~d~ 145 (314)
T cd08216 78 SPLMAYGSCEDLLKTHFPE---GLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGD---------GKVVLSGL 145 (314)
T ss_pred EeccCCCCHHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecC---------CceEEecC
Confidence 8875 47888888764322 23345566677899999999999999999999999999876 57999999
Q ss_pred cCccccCCCCCc-----ccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHH
Q psy14267 419 GIACSLQDDKTS-----VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWA 493 (553)
Q Consensus 419 Gla~~~~~~~~~-----~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~ 493 (553)
|.+..+...... .......++..|+|||++..... .++.++|||||||++|||++|..||........
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-------~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~ 218 (314)
T cd08216 146 RYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQ-------GYNEKSDIYSVGITACELANGHVPFKDMPATQM 218 (314)
T ss_pred ccceeeccccccccccccccccccccccccCHHHhcCCCC-------CCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 998765432221 11123457889999999875321 367899999999999999999999987654332
Q ss_pred HHHHHHhhccccc-------------------------ccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 494 KMLAIARHKDQIE-------------------------FKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 494 ~~~~i~~~~~~~~-------------------------~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
....+......+. ..........++.++.++|.+||..||++|||+++++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 219 LLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred HHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 2222211100000 000000011234678999999999999999999999875
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0200|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=312.01 Aligned_cols=270 Identities=23% Similarity=0.361 Sum_probs=212.8
Q ss_pred eEEecCcceEEEeeeeeeCceEEEEEeeeCCC-----ccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEe
Q psy14267 250 VITLNGKQYQVLSLLGKGGSSSVYLVGGTSEH-----EFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKM 324 (553)
Q Consensus 250 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l 324 (553)
.|++..++..+.+.||+|.||.|+++...... ....||||.++..... ...+.+..|+++|+.+.+|+||+.+
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~l 367 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNL 367 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhh
Confidence 78888888889999999999999998654221 2456999998765433 4468899999999999999999999
Q ss_pred eeEEEeCCCceEEEEEec-CCCCHHHHHHHcc---------cCCCC--chHHHHHHHHHHHHHHHHHHHhhCCcEecCCC
Q psy14267 325 HDYVYDTASKHLYVLMEK-GDTDLSKYMRNLN---------KMTTL--PNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLK 392 (553)
Q Consensus 325 ~~~~~~~~~~~~~iv~e~-~~~~L~~~l~~~~---------~~~~~--~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLK 392 (553)
++.+.. ...+++++|+ ..|+|..+++... ..... .......+.++.||+.||+||++.++|||||-
T Consensus 368 lG~~t~--~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLA 445 (609)
T KOG0200|consen 368 LGACTQ--DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLA 445 (609)
T ss_pred eeeecc--CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhh
Confidence 998855 5566666664 6799999999876 12222 26677888889999999999999999999999
Q ss_pred CCCEEEecCccceecCCCCeEEEEeccCccccCCCCCcccccCCc--cCCCccCcccccccCCCCCCCccCCCccchHHH
Q psy14267 393 PANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTAS--GTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWS 470 (553)
Q Consensus 393 p~NILl~~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~--Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwS 470 (553)
..||||..+ ..+||+|||+|+........... ... -...|||||.+... .|+.++||||
T Consensus 446 aRNVLi~~~---------~~~kIaDFGlar~~~~~~~y~~~-~~~~~LP~kWmApEsl~~~---------~ft~kSDVWS 506 (609)
T KOG0200|consen 446 ARNVLITKN---------KVIKIADFGLARDHYNKDYYRTK-SSAGTLPVKWMAPESLFDR---------VFTSKSDVWS 506 (609)
T ss_pred hhhEEecCC---------CEEEEccccceeccCCCCceEec-CCCCccceeecCHHHhccC---------cccccchhhH
Confidence 999999877 57999999999976554433211 111 24469999999864 4899999999
Q ss_pred HHHHHHHHHh-CCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 471 LGCILYNMIY-GRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 471 lGvvl~ellt-G~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
|||+|||+++ |..||.+.......+..+. ... ++..+..|+.++.++|+.||+.+|++||++.++++.|+..
T Consensus 507 fGI~L~EifsLG~~PYp~~~~~~~l~~~l~-~G~------r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 507 FGILLWEIFTLGGTPYPGIPPTEELLEFLK-EGN------RMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred HHHHHHHHhhCCCCCCCCCCcHHHHHHHHh-cCC------CCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 9999999996 9999998653333333222 222 2334457899999999999999999999999999999873
|
|
| >KOG0662|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=256.70 Aligned_cols=259 Identities=26% Similarity=0.382 Sum_probs=199.9
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceE
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHL 336 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~ 336 (553)
+|...++||+|+||+||+++...+.+. ||+|.+..++-. +..-...++|+.+|+.|+| .|||++++.. ..++.+
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~ei--valkrvrldddd-egvpssalreicllkelkh-knivrl~dvl--hsdkkl 76 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEI--VALKRVRLDDDD-EGVPSSALREICLLKELKH-KNIVRLHDVL--HSDKKL 76 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccce--EEEEEEeccCCC-CCCcHHHHHHHHHHHHhhh-cceeehhhhh--ccCcee
Confidence 577788999999999999988887765 999999887633 3445678999999999965 9999999866 457789
Q ss_pred EEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEE
Q psy14267 337 YVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKII 416 (553)
Q Consensus 337 ~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~ 416 (553)
-+|+|+|+.+|..+....+.. .....+..++.|++.||.|+|+++++||||||.|+||+.+ |.+||+
T Consensus 77 tlvfe~cdqdlkkyfdslng~----~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~n---------gelkla 143 (292)
T KOG0662|consen 77 TLVFEFCDQDLKKYFDSLNGD----LDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRN---------GELKLA 143 (292)
T ss_pred EEeHHHhhHHHHHHHHhcCCc----CCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccC---------CcEEec
Confidence 999999999999999987653 3345556666799999999999999999999999999887 789999
Q ss_pred eccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHH-hCCCCCCCCCchHHHH
Q psy14267 417 DFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI-YGRTPYSHIPNTWAKM 495 (553)
Q Consensus 417 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ell-tG~~Pf~~~~~~~~~~ 495 (553)
|||+|+.+.-+-... ...+-|.+|.+|.++.+.. -|+...|+||.||++.|+. .|++.|.+.... ..+
T Consensus 144 dfglarafgipvrcy--saevvtlwyrppdvlfgak--------ly~tsidmwsagcifaelanagrplfpg~dvd-dql 212 (292)
T KOG0662|consen 144 DFGLARAFGIPVRCY--SAEVVTLWYRPPDVLFGAK--------LYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-DQL 212 (292)
T ss_pred ccchhhhcCCceEee--eceeeeeeccCcceeeeee--------hhccchHhhhcchHHHHHhhcCCCCCCCCcHH-HHH
Confidence 999998876543221 2334699999999999774 4789999999999999998 588888875443 233
Q ss_pred HHHHhhcc-----cccccccccCC----------------CCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 496 LAIARHKD-----QIEFKPQLANN----------------VTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 496 ~~i~~~~~-----~~~~~~~~~~~----------------~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
..+..... ++.-...+++. ..+...=+++++++|.-+|.+|.++++++++
T Consensus 213 krif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 213 KRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred HHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 33322111 11110111110 1223345789999999999999999998865
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=273.96 Aligned_cols=239 Identities=28% Similarity=0.440 Sum_probs=188.0
Q ss_pred eeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEEEEEecC
Q psy14267 264 LGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEKG 343 (553)
Q Consensus 264 LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~iv~e~~ 343 (553)
||+|+||.||++.+...+ +.||+|++.+...........+..|+.+++++. |+||+.+++.+ .....++++|++.
T Consensus 1 lg~G~~~~v~~~~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~--~~~~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTG--KLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN-HPFIVKLHYAF--QTEEKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECCCC--cEEEEEEeehhhhcchHHHHHHHHHHHHHHHcC-CCcHHHHHHHe--ecCCeeEEEEecC
Confidence 799999999999876655 459999998876655556678999999999996 69999998766 4467889999987
Q ss_pred -CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEeccCcc
Q psy14267 344 -DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIAC 422 (553)
Q Consensus 344 -~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGla~ 422 (553)
+++|.+++.... ......+..++.|++.||.|||+.+++|+||||+||+++.+ +.++|+|||++.
T Consensus 76 ~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~---------~~~~l~d~~~~~ 141 (250)
T cd05123 76 PGGELFSHLSKEG-----RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDAD---------GHIKLTDFGLAK 141 (250)
T ss_pred CCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCC---------CcEEEeecCcce
Confidence 889999987653 23445566667799999999999999999999999999776 579999999997
Q ss_pred ccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHhhc
Q psy14267 423 SLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARHK 502 (553)
Q Consensus 423 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~~i~~~~ 502 (553)
....... ......++..|+|||.+.+. .++.++|+||||+++|+|++|..||...... .....+..
T Consensus 142 ~~~~~~~--~~~~~~~~~~~~~Pe~~~~~---------~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~-~~~~~~~~-- 207 (250)
T cd05123 142 ELSSEGS--RTNTFCGTPEYLAPEVLLGK---------GYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK-EIYEKILK-- 207 (250)
T ss_pred ecccCCC--cccCCcCCccccChHHhCCC---------CCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHhc--
Confidence 7654321 12345689999999998755 3678999999999999999999999765431 22222221
Q ss_pred ccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHH
Q psy14267 503 DQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGN 541 (553)
Q Consensus 503 ~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~e 541 (553)
.. ......++..+.++|++||..||++||++.+
T Consensus 208 ~~------~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 208 DP------LRFPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CC------CCCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 11 1222245789999999999999999999944
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG4250|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=306.11 Aligned_cols=269 Identities=22% Similarity=0.370 Sum_probs=197.0
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC----
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA---- 332 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~---- 332 (553)
.|..-+.||+|+||.||+++++.++.. ||||.+++.... ...++..+|+++|++|+ |+|||+++++-....
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~--vAvK~~~~~~~~--r~~e~~~~EieilkKLn-h~NIVk~f~iee~~~~~~~ 88 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRL--VAVKTFNKESSL--RPRERWCREIEILKKLN-HPNIVKLFDIEETKFLGLV 88 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccc--hhHHhhhhhccc--chHHHHHHHHHHHHHcC-chhhhhhcccCCccccCcc
Confidence 477788999999999999998888876 999999876533 34588999999999997 799999987643333
Q ss_pred CceEEEEEe-cCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCC
Q psy14267 333 SKHLYVLME-KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGN 411 (553)
Q Consensus 333 ~~~~~iv~e-~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~ 411 (553)
...-+++|| +.+|+|..++++.......+..+.. .+..++..||.|||++|||||||||.||++-... ....
T Consensus 89 ~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l--~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Ge-----dgq~ 161 (732)
T KOG4250|consen 89 TRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFL--DLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGE-----DGQS 161 (732)
T ss_pred cccceEEEeecCCCcHHHHhcCcccccCCCHHHHH--HHHHHHHHHHHHHHHcCceeccCCCCcEEEeecC-----CCce
Confidence 233355666 5678999999987766666655544 4456999999999999999999999999986543 1234
Q ss_pred eEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCch
Q psy14267 412 VLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNT 491 (553)
Q Consensus 412 ~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~ 491 (553)
.-||+|||.|+.+.+.. ...+..||+.|++||+..... .|+..+|.|||||++|+++||.+||......
T Consensus 162 IyKLtDfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~--------~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 162 IYKLTDFGAARELDDNS---LFTSLVGTEEYLHPELYERQK--------KYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred EEeeecccccccCCCCC---eeeeecCchhhcChHHHhhcc--------CcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 68999999999998766 345888999999999997522 4788999999999999999999999652211
Q ss_pred ---HHHHHHHHh-------------hcccccccccccCCCCCCHH----HHHHHHHhcccCCCCCC--CHHHHHHHHhc
Q psy14267 492 ---WAKMLAIAR-------------HKDQIEFKPQLANNVTIPPT----LLQSMKLCLQKDPKARP--TVGNSVTQINN 548 (553)
Q Consensus 492 ---~~~~~~i~~-------------~~~~~~~~~~~~~~~~~s~~----l~~li~~cL~~dP~~RP--t~~ell~~L~~ 548 (553)
...+..+.. ....+.+...++....++.. +-..+..+|..+|++|- ...+....+..
T Consensus 231 k~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~d 309 (732)
T KOG4250|consen 231 KNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDD 309 (732)
T ss_pred cccchhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHH
Confidence 111211111 12223333333333344443 45667778999999998 55555554443
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=282.86 Aligned_cols=248 Identities=25% Similarity=0.404 Sum_probs=188.2
Q ss_pred eEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEE
Q psy14267 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLY 337 (553)
Q Consensus 258 y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~ 337 (553)
|....+||+|+||.||++....++.. ||||.+.... ......+.+|+.+++++. |+||+++++++.. ..+.+
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~--v~iK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~--~~~~~ 93 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKL--VAVKKMDLRK---QQRRELLFNEVVIMRDYQ-HENVVEMYNSYLV--GDELW 93 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeE--EEEEEecccc---hhHHHHHHHHHHHHHhcC-CcchhheeeEEEe--CCEEE
Confidence 44457899999999999987766644 9999885432 233467899999999995 5999999987754 56889
Q ss_pred EEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEE
Q psy14267 338 VLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKII 416 (553)
Q Consensus 338 iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~ 416 (553)
++||+. +++|.+++... ......+..++.|++.||+|||+.||+||||||+||+++.+ +.++|+
T Consensus 94 lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~---------~~~~l~ 158 (292)
T cd06657 94 VVMEFLEGGALTDIVTHT------RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHD---------GRVKLS 158 (292)
T ss_pred EEEecCCCCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC---------CCEEEc
Confidence 999975 55777766432 23345566677899999999999999999999999999776 579999
Q ss_pred eccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHH
Q psy14267 417 DFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKML 496 (553)
Q Consensus 417 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~ 496 (553)
|||++........ ......|++.|+|||.+.+. .++.++|+||||+++|||++|..||...... ....
T Consensus 159 dfg~~~~~~~~~~--~~~~~~~~~~y~~pE~~~~~---------~~~~~~Dv~slGvil~el~tg~~p~~~~~~~-~~~~ 226 (292)
T cd06657 159 DFGFCAQVSKEVP--RRKSLVGTPYWMAPELISRL---------PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-KAMK 226 (292)
T ss_pred ccccceecccccc--cccccccCccccCHHHhcCC---------CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHH
Confidence 9999876543221 12245689999999998654 3678999999999999999999999764332 2222
Q ss_pred HHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 497 AIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 497 ~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
.+... ..+.+.....++..+.++|.+||..+|.+||++.+++.+
T Consensus 227 ~~~~~-----~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 227 MIRDN-----LPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred HHHhh-----CCcccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 22111 112222333578899999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=276.41 Aligned_cols=254 Identities=30% Similarity=0.420 Sum_probs=187.6
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcC--chhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDIT--DQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~--~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
+|.+.+.||+|+||.||++.+...... +++|+++..... .......+..|+.+++++. ||||+++++++.+ ..
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~ 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAE--ERLKVLKEIPVGELNPNETVQANQEAQLLSKLD-HPAIVKFHASFLE--RD 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCc--ceEEEeccccccccCcchHHHHHHHHHHHHhCC-CCcHHHHHHHHhc--CC
Confidence 588999999999999999987765433 666666543221 1122345778999999995 6999999987754 44
Q ss_pred eEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 335 HLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 335 ~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
..+++||+. +++|..++..... ......+..+..++.|++.||+|||+.|++|+||||+||+++.+ .+
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~~----------~~ 144 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELKH-TGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNN----------LL 144 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHhh-cccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeecC----------CE
Confidence 678888864 5688888765322 11234556667777899999999999999999999999999643 48
Q ss_pred EEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHH
Q psy14267 414 KIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWA 493 (553)
Q Consensus 414 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~ 493 (553)
+|+|||++......... .....|++.|+|||.+.+.. ++.++|+||||+++|+|++|..||..... ..
T Consensus 145 ~l~d~g~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~---------~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-~~ 212 (260)
T cd08222 145 KIGDFGVSRLLMGSCDL--ATTFTGTPYYMSPEALKHQG---------YDSKSDIWSLGCILYEMCCLAHAFEGQNF-LS 212 (260)
T ss_pred eecccCceeecCCCccc--ccCCCCCcCccCHHHHccCC---------CCchhhHHHHHHHHHHHHhCCCCCCCccH-HH
Confidence 99999999776543321 22456899999999986542 67789999999999999999999975332 12
Q ss_pred HHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 494 KMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 494 ~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
....+... . .+ .....++.++.++|.+||..+|++||++.+++++
T Consensus 213 ~~~~~~~~-~----~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 213 VVLRIVEG-P----TP--SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred HHHHHHcC-C----CC--CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 22222111 1 11 1122567899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0669|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=275.91 Aligned_cols=267 Identities=21% Similarity=0.300 Sum_probs=201.0
Q ss_pred cCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC-
Q psy14267 254 NGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA- 332 (553)
Q Consensus 254 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~- 332 (553)
....|+...+||+|.||+||+|+.+.++.. ||+|++-.+... +.+-...++|+++|..|+| +|++.++++|....
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kk--valkkvlmeneK-eGfpitalreikiL~~lkH-env~nliEic~tk~T 90 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKK--VALKKVLMENEK-EGFPITALREIKILQLLKH-ENVVNLIEICRTKAT 90 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccch--hHHHHHHHhccc-cCCcHHHHHHHHHHHHhcc-hhHHHHHHHHhhccC
Confidence 345688889999999999999988777655 899877654322 2334567899999999965 99999988764321
Q ss_pred -----CceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceec
Q psy14267 333 -----SKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIID 407 (553)
Q Consensus 333 -----~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~ 407 (553)
...+|+||.+|..+|..++.+... .++...|..++.+++.||.|+|...|+|||+|++|+||+.+
T Consensus 91 p~~r~r~t~ylVf~~cehDLaGlLsn~~v----r~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~d------ 160 (376)
T KOG0669|consen 91 PTNRDRATFYLVFDFCEHDLAGLLSNRKV----RFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKD------ 160 (376)
T ss_pred CcccccceeeeeHHHhhhhHHHHhcCccc----cccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCC------
Confidence 235899999999999998876532 34456677777899999999999999999999999999887
Q ss_pred CCCCeEEEEeccCccccCCCCC--cccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCC
Q psy14267 408 CIGNVLKIIDFGIACSLQDDKT--SVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY 485 (553)
Q Consensus 408 ~~~~~vkL~DFGla~~~~~~~~--~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf 485 (553)
+.+||+|||+|+.+..... ...+...+-|.+|++||.+.|.. .|+...|||..||+|.||++|.+-+
T Consensus 161 ---gilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r--------~yg~~iDiWgAgCimaeMwtrspim 229 (376)
T KOG0669|consen 161 ---GILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDR--------EYGPPIDIWGAGCIMAEMWTRSPIM 229 (376)
T ss_pred ---ceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhccc--------ccCCcchhHhHHHHHHHHHccCccc
Confidence 7899999999987754432 22344556799999999999875 5889999999999999999999999
Q ss_pred CCCCchHHHHHHHHhhccc-----------------cccccc----------ccCCCCCCHHHHHHHHHhcccCCCCCCC
Q psy14267 486 SHIPNTWAKMLAIARHKDQ-----------------IEFKPQ----------LANNVTIPPTLLQSMKLCLQKDPKARPT 538 (553)
Q Consensus 486 ~~~~~~~~~~~~i~~~~~~-----------------~~~~~~----------~~~~~~~s~~l~~li~~cL~~dP~~RPt 538 (553)
.+..+. +.+..+...-.. ++..|. .-....-+++..+||..+|..||.+|++
T Consensus 230 qgnteq-qql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ 308 (376)
T KOG0669|consen 230 QGNTEQ-QQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRID 308 (376)
T ss_pred cCChHH-HHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcc
Confidence 875443 222222221110 000110 0011222457889999999999999999
Q ss_pred HHHHHHHH
Q psy14267 539 VGNSVTQI 546 (553)
Q Consensus 539 ~~ell~~L 546 (553)
+.++++|.
T Consensus 309 ad~alnh~ 316 (376)
T KOG0669|consen 309 ADQALNHD 316 (376)
T ss_pred hHhhhchh
Confidence 99998874
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=302.97 Aligned_cols=272 Identities=17% Similarity=0.196 Sum_probs=168.4
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCC--CccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEE----
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSE--HEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYV---- 328 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~--~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~---- 328 (553)
.++|.+.++||+|+||.||+|.+..+ .....||||.+...... +....| . ++...+ .++..+...+
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-----e~~~~e-~-l~~~~~-~~~~~~~~~~~~~~ 202 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-----EIWMNE-R-VRRACP-NSCADFVYGFLEPV 202 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-----HHHHHH-H-HHhhch-hhHHHHHHhhhccc
Confidence 46799999999999999999988766 11244999987643211 111111 1 111111 2222221111
Q ss_pred EeCCCceEEEEEecC-CCCHHHHHHHcccCC---------------CCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCC
Q psy14267 329 YDTASKHLYVLMEKG-DTDLSKYMRNLNKMT---------------TLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLK 392 (553)
Q Consensus 329 ~~~~~~~~~iv~e~~-~~~L~~~l~~~~~~~---------------~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLK 392 (553)
.......++++|+|. +++|.+++....... ........+..++.||+.||+|||+++|||||||
T Consensus 203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLK 282 (566)
T PLN03225 203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVK 282 (566)
T ss_pred ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCC
Confidence 113455778888875 567888886542110 0011223455677899999999999999999999
Q ss_pred CCCEEEecCccceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCC-------------c
Q psy14267 393 PANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGN-------------T 459 (553)
Q Consensus 393 p~NILl~~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~-------------~ 459 (553)
|+||||+.+. +.+||+|||+|+.+...... .....+||+.|||||.+.......... .
T Consensus 283 P~NILl~~~~--------~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~ 353 (566)
T PLN03225 283 PQNIIFSEGS--------GSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQ 353 (566)
T ss_pred HHHEEEeCCC--------CcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhcc
Confidence 9999997642 57999999999876543322 223667999999999775433221100 1
Q ss_pred cCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHhhcccc---------ccccccc----CCCCCCHHHHHHHH
Q psy14267 460 YRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQI---------EFKPQLA----NNVTIPPTLLQSMK 526 (553)
Q Consensus 460 ~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~~i~~~~~~~---------~~~~~~~----~~~~~s~~l~~li~ 526 (553)
..++.++|||||||+||||+++..++..... .....+....... ...+.+. .....+.+..+||.
T Consensus 354 ~~~~~k~DVwSlGviL~el~~~~~~~~~~~~--~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~ 431 (566)
T PLN03225 354 LNLPDRFDIYSAGLIFLQMAFPNLRSDSNLI--QFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLK 431 (566)
T ss_pred ccCCCCcccHHHHHHHHHHHhCcCCCchHHH--HHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHH
Confidence 1245678999999999999998877653211 1111111100000 0000000 00112345679999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q psy14267 527 LCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 527 ~cL~~dP~~RPt~~ell~~ 545 (553)
+||++||++|||+.++++|
T Consensus 432 ~mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 432 SMMRFKGRQRISAKAALAH 450 (566)
T ss_pred HHccCCcccCCCHHHHhCC
Confidence 9999999999999999986
|
|
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=289.67 Aligned_cols=250 Identities=20% Similarity=0.348 Sum_probs=192.2
Q ss_pred cCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCC
Q psy14267 254 NGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTAS 333 (553)
Q Consensus 254 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~ 333 (553)
....|..++.||-|+||+|.+++..++... ||+|.+.|.++...+.+...+.|-.||....+ +.||+|+ +...+.
T Consensus 627 dKSmFvkik~iGvGAFGeV~Lv~KvDT~~l--YAmKTLrKaDVl~rnQvaHVKAERDILAEADn-~WVVrLy--ySFQDk 701 (1034)
T KOG0608|consen 627 DKSMFVKIKTIGVGAFGEVCLVRKVDTRAL--YAMKTLRKADVLMRNQVAHVKAERDILAEADN-EWVVRLY--YSFQDK 701 (1034)
T ss_pred cccceEEEeeecccccceeEEEeecchhhH--HHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCC-cceEEEE--EEeccC
Confidence 345799999999999999999998888655 99999999888777778889999999999855 9999995 444667
Q ss_pred ceEEEEEec-CCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCe
Q psy14267 334 KHLYVLMEK-GDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNV 412 (553)
Q Consensus 334 ~~~~iv~e~-~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~ 412 (553)
..+|+||+| .||++..+|-+.+ -+.+..+.++++++..|+++.|..|+|||||||+|||||.+ |.
T Consensus 702 dnLYFVMdYIPGGDmMSLLIrmg-----IFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrd---------GH 767 (1034)
T KOG0608|consen 702 DNLYFVMDYIPGGDMMSLLIRMG-----IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRD---------GH 767 (1034)
T ss_pred CceEEEEeccCCccHHHHHHHhc-----cCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccC---------Cc
Confidence 788888887 6789998888766 34456677778899999999999999999999999999988 78
Q ss_pred EEEEeccCccccCCC--------CCccc--------------------------------ccCCccCCCccCcccccccC
Q psy14267 413 LKIIDFGIACSLQDD--------KTSVH--------------------------------KDTASGTLNYMSPEAAGQTS 452 (553)
Q Consensus 413 vkL~DFGla~~~~~~--------~~~~~--------------------------------~~~~~Gt~~y~APE~l~~~~ 452 (553)
|||+|||||+-+.-. +.+.. ....+||+.|+|||++...+
T Consensus 768 IKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g 847 (1034)
T KOG0608|consen 768 IKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTG 847 (1034)
T ss_pred eeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccC
Confidence 999999998643210 00000 11456999999999998764
Q ss_pred CCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccC
Q psy14267 453 SSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKD 532 (553)
Q Consensus 453 ~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~d 532 (553)
|+.-.|+||.|||||||+.|++||.........+ .+++....+. +....+++++..++|.++.. +
T Consensus 848 ---------~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~-kv~nw~~~l~----~~~~~~ls~e~~~li~kLc~-s 912 (1034)
T KOG0608|consen 848 ---------YTQLCDWWSVGVILYEMLVGQPPFLADTPGETQY-KVINWRNFLH----IPYQGNLSKEALDLIQKLCC-S 912 (1034)
T ss_pred ---------ccccchhhHhhHHHHHHhhCCCCccCCCCCccee-eeeehhhccc----cccccccCHHHHHHHHHHhc-C
Confidence 6888999999999999999999997644331111 1111111222 22344788999999887443 4
Q ss_pred CCCCC
Q psy14267 533 PKARP 537 (553)
Q Consensus 533 P~~RP 537 (553)
++.|.
T Consensus 913 ad~RL 917 (1034)
T KOG0608|consen 913 ADSRL 917 (1034)
T ss_pred hhhhh
Confidence 55664
|
|
| >KOG1024|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=270.12 Aligned_cols=270 Identities=20% Similarity=0.304 Sum_probs=215.1
Q ss_pred EEecCcceEEEeeeeeeCceEEEEEeeeCCC---ccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeE
Q psy14267 251 ITLNGKQYQVLSLLGKGGSSSVYLVGGTSEH---EFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDY 327 (553)
Q Consensus 251 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~---~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~ 327 (553)
+.+...++++..++-+|+||.||.+-+++.+ ..+.|-+|.++.. ..+-.+..++.|...|..+. |||++.+.++
T Consensus 279 l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~s-H~nll~V~~V 355 (563)
T KOG1024|consen 279 LTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGAS-HPNLLSVLGV 355 (563)
T ss_pred hhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCc-CCCccceeEE
Confidence 4556678999999999999999998554332 2255777777543 23445678899999998884 7999999998
Q ss_pred EEeCCCceEEEEEecCCCCHHHHHHHcccCC---CCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccc
Q psy14267 328 VYDTASKHLYVLMEKGDTDLSKYMRNLNKMT---TLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLK 404 (553)
Q Consensus 328 ~~~~~~~~~~iv~e~~~~~L~~~l~~~~~~~---~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~ 404 (553)
.....+..++++-..+-|+|..+++...... ....+..++..++.|++.||+|||+.||||.||...|++|++.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~--- 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQ--- 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhh---
Confidence 8876666555555556789999998543221 2245566778888899999999999999999999999999887
Q ss_pred eecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCC
Q psy14267 405 IIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRT 483 (553)
Q Consensus 405 ~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~ 483 (553)
-+|||+|=.+++.+-+.+.+...........||+||.+... .|+.++|+||||++||||+| |+.
T Consensus 433 ------LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~---------~yssasDvWsfGVllWELmtlg~~ 497 (563)
T KOG1024|consen 433 ------LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNS---------HYSSASDVWSFGVLLWELMTLGKL 497 (563)
T ss_pred ------eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhh---------hhcchhhhHHHHHHHHHHHhcCCC
Confidence 47999999999999888887766666678899999999866 48999999999999999997 999
Q ss_pred CCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 484 PYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 484 Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
||..++..+....... ..++..+.+||+++..+|..||+..|++||++++++.-|.++
T Consensus 498 PyaeIDPfEm~~ylkd--------GyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 498 PYAEIDPFEMEHYLKD--------GYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred CccccCHHHHHHHHhc--------cceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 9999876533222211 223445568999999999999999999999999999988764
|
|
| >KOG0984|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=253.61 Aligned_cols=227 Identities=23% Similarity=0.377 Sum_probs=181.3
Q ss_pred EEecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEe
Q psy14267 251 ITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYD 330 (553)
Q Consensus 251 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~ 330 (553)
+++..+....+..||+|+||.|-+.++..++.. .|+|.+..... .++ .+++++|+.+.++...||++|.+++..+.
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~i--mAvKri~~tvn-~q~-q~r~L~dldi~~r~~~CPf~V~FyGa~~r 116 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTI--MAVKRIRATVN-SQE-QKRLLMDLDIIMRTVDCPFTVHFYGALFR 116 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeE--EEEeeehhhcC-hHH-HHHHHHhhhhhccCCCCCeEEEeehhhhc
Confidence 555666777788999999999999888888865 99999976653 333 47889999999999999999999886654
Q ss_pred CCCceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhC-CcEecCCCCCCEEEecCccceecCC
Q psy14267 331 TASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAA-GIIHSDLKPANFLFVGNVLKIIDCI 409 (553)
Q Consensus 331 ~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~-gIiHrDLKp~NILl~~~~~~~~~~~ 409 (553)
...++|.||....+|..+-++.-+. .....+..+-.++..++.||+|||++ .|||||+||.||||+.+
T Consensus 117 --egdvwIcME~M~tSldkfy~~v~~~-g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~-------- 185 (282)
T KOG0984|consen 117 --EGDVWICMELMDTSLDKFYRKVLKK-GGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYD-------- 185 (282)
T ss_pred --cccEEEeHHHhhhhHHHHHHHHHhc-CCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccC--------
Confidence 4568899999999988877654221 12333444555667999999999965 89999999999999887
Q ss_pred CCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy14267 410 GNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIP 489 (553)
Q Consensus 410 ~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~ 489 (553)
|+|||||||++..+.+.-. .+...|...|||||.+..+.. ...|+-++||||||++|.||.+++.||....
T Consensus 186 -GqVKiCDFGIsG~L~dSiA---kt~daGCkpYmaPEri~~e~n-----~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 186 -GQVKICDFGISGYLVDSIA---KTMDAGCKPYMAPERINPELN-----QKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred -CcEEEcccccceeehhhhH---HHHhcCCCccCChhhcCcccC-----cccceeehhhhhhhhhhhhhhhccccccccC
Confidence 7899999999988765432 223568889999999976643 2248999999999999999999999999988
Q ss_pred chHHHHHHHHhh
Q psy14267 490 NTWAKMLAIARH 501 (553)
Q Consensus 490 ~~~~~~~~i~~~ 501 (553)
..++.+.++...
T Consensus 257 tpF~qLkqvVee 268 (282)
T KOG0984|consen 257 TPFQQLKQVVEE 268 (282)
T ss_pred CHHHHHHHHhcC
Confidence 888888776643
|
|
| >KOG0668|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=259.26 Aligned_cols=257 Identities=27% Similarity=0.459 Sum_probs=198.1
Q ss_pred cCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCC
Q psy14267 254 NGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTAS 333 (553)
Q Consensus 254 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~ 333 (553)
..++|++++++|+|-|++||.+....+++. ++||+++.-. .+...+|+.||..|+++|||+.+++++.+...
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK--~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~S 107 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEK--CVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDIVKDPES 107 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCce--EEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhhhcCccc
Confidence 456899999999999999999988777765 9999997532 36788999999999999999999999988888
Q ss_pred ceEEEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCe
Q psy14267 334 KHLYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNV 412 (553)
Q Consensus 334 ~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~ 412 (553)
..-.+++|+.. .+...+... ++...+..++.+++.||.|+|+.||.|||+||.|++||... ..
T Consensus 108 ktpaLiFE~v~n~Dfk~ly~t--------l~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~--------rk 171 (338)
T KOG0668|consen 108 KTPSLIFEYVNNTDFKQLYPT--------LTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHEL--------RK 171 (338)
T ss_pred cCchhHhhhhccccHHHHhhh--------hchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhh--------ce
Confidence 87778888644 444333332 23455777888999999999999999999999999997664 56
Q ss_pred EEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchH
Q psy14267 413 LKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTW 492 (553)
Q Consensus 413 vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~ 492 (553)
++|+|+|||.++-++.. +...+.+..|--||++..-. .|+..-|+|||||++..|++.+.||-...+..
T Consensus 172 LrlIDWGLAEFYHp~~e---YnVRVASRyfKGPELLVdy~--------~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~ 240 (338)
T KOG0668|consen 172 LRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDYQ--------MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY 240 (338)
T ss_pred eeeeecchHhhcCCCce---eeeeeehhhcCCchheeech--------hccccHHHHHHHHHHHHHHhccCcccCCCCCH
Confidence 89999999988866543 34566788999999997543 36677899999999999999999986543333
Q ss_pred HHHHHHHhh-----------ccccccccccc------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q psy14267 493 AKMLAIARH-----------KDQIEFKPQLA------------------NNVTIPPTLLQSMKLCLQKDPKARPTVGNSV 543 (553)
Q Consensus 493 ~~~~~i~~~-----------~~~~~~~~~~~------------------~~~~~s~~l~~li~~cL~~dP~~RPt~~ell 543 (553)
+.+..++.- +..+.+++... +..-.++++.+|+.++|..|..+|+|++|++
T Consensus 241 DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam 320 (338)
T KOG0668|consen 241 DQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAM 320 (338)
T ss_pred HHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHh
Confidence 333332221 11222222221 1123468999999999999999999999998
Q ss_pred HH
Q psy14267 544 TQ 545 (553)
Q Consensus 544 ~~ 545 (553)
.|
T Consensus 321 ~H 322 (338)
T KOG0668|consen 321 AH 322 (338)
T ss_pred cC
Confidence 65
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=264.60 Aligned_cols=219 Identities=21% Similarity=0.305 Sum_probs=165.7
Q ss_pred eCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEEEEEecC-CC
Q psy14267 267 GGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEKG-DT 345 (553)
Q Consensus 267 G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~iv~e~~-~~ 345 (553)
|.||.||+|++..++.. ||+|.+.+... +.+|...+... .||||+++++++.. ....+++||+. ++
T Consensus 4 g~~~~v~~~~~~~~~~~--~~~K~i~~~~~--------~~~~~~~~~~~-~~~~i~~~~~~~~~--~~~~~lv~e~~~~~ 70 (237)
T cd05576 4 GVIDKVLLVMDTRTQQT--FILKGLRKSSE--------YSRERLTIIPH-CVPNMVCLHKYIVS--EDSVFLVLQHAEGG 70 (237)
T ss_pred cccceEEEEEEccCCcE--EEEEeecchhh--------hhhHHHHHHhc-CCCceeehhhheec--CCeEEEEEecCCCC
Confidence 89999999998877754 99999976431 22344444444 36999999987743 56788999975 57
Q ss_pred CHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEeccCccccC
Q psy14267 346 DLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQ 425 (553)
Q Consensus 346 ~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGla~~~~ 425 (553)
+|.+++..... .....+..++.|++.||+|||++||+||||||+||+++.+ +.++|+|||++....
T Consensus 71 ~L~~~l~~~~~-----l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~---------~~~~l~df~~~~~~~ 136 (237)
T cd05576 71 KLWSHISKFLN-----IPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDR---------GHIQLTYFSRWSEVE 136 (237)
T ss_pred CHHHHHHHhcC-----CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCC---------CCEEEecccchhccc
Confidence 89888876432 3455667777899999999999999999999999999876 569999999886654
Q ss_pred CCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHhhcccc
Q psy14267 426 DDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQI 505 (553)
Q Consensus 426 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~~i~~~~~~~ 505 (553)
.... ...++..|+|||.+.+. .++.++|+|||||++|||++|..||........ ....
T Consensus 137 ~~~~-----~~~~~~~y~aPE~~~~~---------~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~-------~~~~- 194 (237)
T cd05576 137 DSCD-----GEAVENMYCAPEVGGIS---------EETEACDWWSLGAILFELLTGKTLVECHPSGIN-------THTT- 194 (237)
T ss_pred cccc-----cCCcCccccCCcccCCC---------CCCchhhHHHHHHHHHHHHHCcchhhcCchhcc-------cccc-
Confidence 4221 34467789999998654 367899999999999999999998765322100 0001
Q ss_pred cccccccCCCCCCHHHHHHHHHhcccCCCCCCCH
Q psy14267 506 EFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTV 539 (553)
Q Consensus 506 ~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~ 539 (553)
+.....+++.++++|.+||+.||++||++
T Consensus 195 -----~~~~~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 195 -----LNIPEWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred -----cCCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence 11122467899999999999999999996
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1290|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.4e-31 Score=268.07 Aligned_cols=138 Identities=29% Similarity=0.447 Sum_probs=115.8
Q ss_pred ecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCC-------CceeEee
Q psy14267 253 LNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGC-------PYVIKMH 325 (553)
Q Consensus 253 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~h-------p~Iv~l~ 325 (553)
+.+.+|.++++||.|.|++||+|.+...+.+ ||+|+++-. +.+.+..+.||++|++++.+ .+||+|+
T Consensus 75 F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~--VAlKVvKSA----qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~Ll 148 (590)
T KOG1290|consen 75 FNGGRYHVQRKLGWGHFSTVWLAWDTQNKRY--VALKVVKSA----QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLL 148 (590)
T ss_pred ccCceEEEEEeccccccceeEEEeeccCCeE--EEEEEEehh----hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeee
Confidence 3457999999999999999999999988877 999999743 46667889999999998653 4899999
Q ss_pred eEEEeC--CCceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHh-hCCcEecCCCCCCEEEe
Q psy14267 326 DYVYDT--ASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIH-AAGIIHSDLKPANFLFV 399 (553)
Q Consensus 326 ~~~~~~--~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH-~~gIiHrDLKp~NILl~ 399 (553)
++|... ...|++||+|+.|..|+.+|....-. ......+..|++||+.||.||| +.||||-||||+|||+-
T Consensus 149 D~FkhsGpNG~HVCMVfEvLGdnLLklI~~s~Yr---Glpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 149 DHFKHSGPNGQHVCMVFEVLGDNLLKLIKYSNYR---GLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred ccceecCCCCcEEEEEehhhhhHHHHHHHHhCCC---CCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 988644 46799999999999999999876433 2334556677789999999999 57999999999999984
|
|
| >KOG1151|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=276.77 Aligned_cols=266 Identities=26% Similarity=0.435 Sum_probs=199.4
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCC----cCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEe
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSD----ITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYD 330 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~----~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~ 330 (553)
.++|-++.+||+|+|++||+|.+.....+ ||||+-.... ...+++.+...+|.+|.+.|. ||.||++++|+.-
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRY--vAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLD-HpRIVKlYDyfsl 538 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRY--VAVKIHQLNKNWRDEKKENYHKHACREYRIHKELD-HPRIVKLYDYFSL 538 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhhe--eeEeeehhccchhhHhhhhHHHHHHHHHhhhhccC-cceeeeeeeeeee
Confidence 46899999999999999999988877766 9999875443 233456677899999999995 5999999998866
Q ss_pred CCCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhC--CcEecCCCCCCEEEecCccceec
Q psy14267 331 TASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAA--GIIHSDLKPANFLFVGNVLKIID 407 (553)
Q Consensus 331 ~~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~--gIiHrDLKp~NILl~~~~~~~~~ 407 (553)
+.+ .++.|+||| |.+|.-|++...-+ ++..+..++.||+.||.||.+. .|||=||||.||||...
T Consensus 539 Dtd-sFCTVLEYceGNDLDFYLKQhklm-----SEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~G------ 606 (775)
T KOG1151|consen 539 DTD-SFCTVLEYCEGNDLDFYLKQHKLM-----SEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNG------ 606 (775)
T ss_pred ccc-cceeeeeecCCCchhHHHHhhhhh-----hHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecC------
Confidence 544 455666655 55777777766533 2334444555999999999965 69999999999999765
Q ss_pred CCCCeEEEEeccCccccCCCCCc-----ccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCC
Q psy14267 408 CIGNVLKIIDFGIACSLQDDKTS-----VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGR 482 (553)
Q Consensus 408 ~~~~~vkL~DFGla~~~~~~~~~-----~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~ 482 (553)
..-|.|||+||||++.+.+.... ..+....||.+|++||.+.-.. ++-+++.++||||+||++|.+++|+
T Consensus 607 tacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgk-----ePPKIsnKVDVWSvGVIFyQClYGr 681 (775)
T KOG1151|consen 607 TACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGK-----EPPKISNKVDVWSVGVIFYQCLYGR 681 (775)
T ss_pred cccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCC-----CCCccccceeeEeeehhhhhhhccC
Confidence 34478999999999998766543 1234567999999999986442 2236899999999999999999999
Q ss_pred CCCCCCCchHHHHHHHHhhc-ccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy14267 483 TPYSHIPNTWAKMLAIARHK-DQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVT 544 (553)
Q Consensus 483 ~Pf~~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~ 544 (553)
-||++.......+....... ....|++ -..++.+.+++|++||+.--+.|..+.+|..
T Consensus 682 KPFGhnqsQQdILqeNTIlkAtEVqFP~----KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 682 KPFGHNQSQQDILQENTILKATEVQFPP----KPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred CCCCCchhHHHHHhhhchhcceeccCCC----CCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 99998655434333221111 1112222 2357899999999999999999988877653
|
|
| >KOG1025|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-32 Score=289.45 Aligned_cols=257 Identities=23% Similarity=0.324 Sum_probs=203.2
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCc--cceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCC
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHE--FKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTAS 333 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~--~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~ 333 (553)
...+..++||+|+||+||++.+.-.++ +-+||||++..... .+.-++++.|+-+|.+|. ||||+++++++....
T Consensus 696 telkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~--~~~s~e~LdeAl~masld-Hpnl~RLLgvc~~s~- 771 (1177)
T KOG1025|consen 696 TELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTS--PKASIELLDEALRMASLD-HPNLLRLLGVCMLST- 771 (1177)
T ss_pred hhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCC--chhhHHHHHHHHHHhcCC-CchHHHHhhhcccch-
Confidence 356677899999999999987754433 35799999865432 233478999999999995 599999999886543
Q ss_pred ceEEEEEe-cCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCe
Q psy14267 334 KHLYVLME-KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNV 412 (553)
Q Consensus 334 ~~~~iv~e-~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~ 412 (553)
+.|+.+ +..|.|.+|++..... .-......|.+||++||.|||++++|||||-..||||..- ..
T Consensus 772 --~qlvtq~mP~G~LlDyvr~hr~~----igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP---------~h 836 (1177)
T KOG1025|consen 772 --LQLVTQLMPLGCLLDYVREHRDN----IGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSP---------NH 836 (1177)
T ss_pred --HHHHHHhcccchHHHHHHHhhcc----ccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCC---------Ce
Confidence 444444 4568899999985432 2334556667799999999999999999999999999665 57
Q ss_pred EEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCCCch
Q psy14267 413 LKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHIPNT 491 (553)
Q Consensus 413 vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~~~~ 491 (553)
|||.|||+|+.+.............-.+.|||-|.+... .|+.++|||||||++||+|| |.-||.+++..
T Consensus 837 vkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~---------~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~ 907 (1177)
T KOG1025|consen 837 VKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIR---------KYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE 907 (1177)
T ss_pred EEEEecchhhccCcccccccccccccCcHHHHHHHhhcc---------CCCchhhhhhhhhhHHHHHhcCCCccCCCCHH
Confidence 999999999999887766555555567899999999766 48999999999999999996 99999997653
Q ss_pred HHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q psy14267 492 WAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINN 548 (553)
Q Consensus 492 ~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~ 548 (553)
.+... ++...+++.+..++.++..+|.+||..|++.||+++++...+..
T Consensus 908 --eI~dl------le~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~ 956 (1177)
T KOG1025|consen 908 --EIPDL------LEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR 956 (1177)
T ss_pred --HhhHH------HhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence 22222 22334456666889999999999999999999999999988765
|
|
| >KOG1027|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-32 Score=294.83 Aligned_cols=254 Identities=24% Similarity=0.324 Sum_probs=188.9
Q ss_pred eEEEeeeeeeCceEE-EEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceE
Q psy14267 258 YQVLSLLGKGGSSSV-YLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHL 336 (553)
Q Consensus 258 y~i~~~LG~G~fG~V-y~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~ 336 (553)
|.-.+++|.|+-|+| |++. -+.+.||||.+-. +....+.+|+..|+....||||+++ ||.+.+..++
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~----ye~R~VAVKrll~------e~~~~A~rEi~lL~eSD~H~NviRy--yc~E~d~qF~ 578 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGV----YEGREVAVKRLLE------EFFDFAQREIQLLQESDEHPNVIRY--YCSEQDRQFL 578 (903)
T ss_pred eccHHHcccCCCCcEEEEEe----eCCceehHHHHhh------HhHHHHHHHHHHHHhccCCCceEEE--EeeccCCceE
Confidence 444568999998765 5542 2335699998843 3346678999999999999999999 5677888999
Q ss_pred EEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEE
Q psy14267 337 YVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKII 416 (553)
Q Consensus 337 ~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~ 416 (553)
||..|.|..+|.++++..... .........+....|++.||++||+.+||||||||.||||+... ......++|+
T Consensus 579 YIalELC~~sL~dlie~~~~d-~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~----~~~~~ra~iS 653 (903)
T KOG1027|consen 579 YIALELCACSLQDLIESSGLD-VEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPS----ADGTLRAKIS 653 (903)
T ss_pred EEEehHhhhhHHHHHhccccc-hhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccC----CCcceeEEec
Confidence 999999999999999985111 11111133445556999999999999999999999999997631 1122579999
Q ss_pred eccCccccCCCCCccc-ccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhC-CCCCCCCCchHHH
Q psy14267 417 DFGIACSLQDDKTSVH-KDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYG-RTPYSHIPNTWAK 494 (553)
Q Consensus 417 DFGla~~~~~~~~~~~-~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG-~~Pf~~~~~~~~~ 494 (553)
|||+++.+..+..... .....||-+|+|||++.... -+.++|||||||++|+.++| ..||+.......
T Consensus 654 DfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~---------~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~- 723 (903)
T KOG1027|consen 654 DFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDR---------KTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA- 723 (903)
T ss_pred ccccccccCCCcchhhcccCCCCcccccCHHHHhccc---------cCcccchhhcCceEEEEecCCccCCCchHHhhh-
Confidence 9999999987665433 34567999999999998763 46699999999999999985 999987433222
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
.|........ .+....++ +..+||.+|++.+|..||++.+++.|
T Consensus 724 --NIl~~~~~L~---~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 724 --NILTGNYTLV---HLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred --hhhcCcccee---eeccCchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 1222211111 01111111 89999999999999999999999865
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=314.15 Aligned_cols=250 Identities=18% Similarity=0.275 Sum_probs=177.6
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceE
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHL 336 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~ 336 (553)
.|....+||+|+||.||+|+....+. .||||.+..... ....|+++++++ +||||+++++++.+ ....
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~--~vavK~~~~~~~-------~~~~~~~~l~~l-~HpnIv~~~~~~~~--~~~~ 758 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGM--QFVVKEINDVNS-------IPSSEIADMGKL-QHPNIVKLIGLCRS--EKGA 758 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCc--EEEEEEccCCcc-------ccHHHHHHHhhC-CCCCcceEEEEEEc--CCCC
Confidence 45667789999999999998766654 499998864331 113468889999 56999999998854 4567
Q ss_pred EEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHh---hCCcEecCCCCCCEEEecCccceecCCCCe
Q psy14267 337 YVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIH---AAGIIHSDLKPANFLFVGNVLKIIDCIGNV 412 (553)
Q Consensus 337 ~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH---~~gIiHrDLKp~NILl~~~~~~~~~~~~~~ 412 (553)
+++|||+ +++|.++++. ..+..+..++.|++.||+||| +.+|+||||||+||+++.+. .
T Consensus 759 ~lv~Ey~~~g~L~~~l~~--------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~---------~ 821 (968)
T PLN00113 759 YLIHEYIEGKNLSEVLRN--------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKD---------E 821 (968)
T ss_pred EEEEeCCCCCcHHHHHhc--------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCC---------c
Confidence 8899975 6889998864 234455667789999999999 67999999999999998763 3
Q ss_pred EEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchH
Q psy14267 413 LKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTW 492 (553)
Q Consensus 413 vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~ 492 (553)
.++. ||.+...... ....||+.|||||++.+. .++.++|||||||+||||++|+.||.......
T Consensus 822 ~~~~-~~~~~~~~~~------~~~~~t~~y~aPE~~~~~---------~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~ 885 (968)
T PLN00113 822 PHLR-LSLPGLLCTD------TKCFISSAYVAPETRETK---------DITEKSDIYGFGLILIELLTGKSPADAEFGVH 885 (968)
T ss_pred eEEE-eccccccccC------CCccccccccCcccccCC---------CCCcccchhhHHHHHHHHHhCCCCCCcccCCC
Confidence 4544 6655433221 133688999999998765 47899999999999999999999995421111
Q ss_pred HHHHHHHhh-c----ccccccccccCCC----CCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q psy14267 493 AKMLAIARH-K----DQIEFKPQLANNV----TIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNPE 551 (553)
Q Consensus 493 ~~~~~i~~~-~----~~~~~~~~~~~~~----~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~~ 551 (553)
..+..+... . ......+.+.... ....++.+++.+||+.||++||+++|+++.|++...
T Consensus 886 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 886 GSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred CcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 111111110 0 0001112111111 122357789999999999999999999999998643
|
|
| >KOG3653|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=273.54 Aligned_cols=266 Identities=20% Similarity=0.262 Sum_probs=195.1
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhc-CCCceeEeeeEEEeCC-
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQ-GCPYVIKMHDYVYDTA- 332 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~-~hp~Iv~l~~~~~~~~- 332 (553)
.....+.++||+|.||.||+|.... +.||||++.. ...+.|.+|..|..... .|+||+++++.-....
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~~----~~VAVKifp~------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~ 278 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLDN----RLVAVKIFPE------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTA 278 (534)
T ss_pred CCchhhHHHhhcCccceeehhhccC----ceeEEEecCH------HHHHHHHhHHHHHhccCccchhHHHhhchhccCCc
Confidence 3457788999999999999986544 4599999853 33578999999976542 4799999977532222
Q ss_pred -CceEEEEEec-CCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhh---------CCcEecCCCCCCEEEecC
Q psy14267 333 -SKHLYVLMEK-GDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHA---------AGIIHSDLKPANFLFVGN 401 (553)
Q Consensus 333 -~~~~~iv~e~-~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~---------~gIiHrDLKp~NILl~~~ 401 (553)
...+.+|+++ ..|+|.+|+... ..++.....++..|++||+|||+ ..|+|||||+.||||..|
T Consensus 279 ~~~eywLVt~fh~kGsL~dyL~~n------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~D 352 (534)
T KOG3653|consen 279 DRMEYWLVTEFHPKGSLCDYLKAN------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKND 352 (534)
T ss_pred cccceeEEeeeccCCcHHHHHHhc------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccC
Confidence 2256677775 669999999886 34456666677799999999995 369999999999999888
Q ss_pred ccceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhC
Q psy14267 402 VLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYG 481 (553)
Q Consensus 402 ~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG 481 (553)
.+..|+|||||.++..+......-..+||.+|||||++.+.-.-.. ...-.+.||||+|.+||||++.
T Consensus 353 ---------lTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d---~~Afkr~DvYamgLVLWEi~SR 420 (534)
T KOG3653|consen 353 ---------LTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQD---RDAFKRIDVYAMGLVLWEIASR 420 (534)
T ss_pred ---------CcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhccccc---HHHHHHHHHHHHHHHHHHHHhh
Confidence 5789999999999886654433445789999999999987642110 1122579999999999999964
Q ss_pred C------------CCCC---CCCchHHHHHHH-HhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 482 R------------TPYS---HIPNTWAKMLAI-ARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 482 ~------------~Pf~---~~~~~~~~~~~i-~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
. +||+ +.....+.|... ...+....++..+... .....+++.+..||..|++.|.|+.-+.++
T Consensus 421 C~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h-~~~~~l~et~EeCWDhDaeARLTA~Cv~eR 499 (534)
T KOG3653|consen 421 CTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKH-AGMAVLCETIEECWDHDAEARLTAGCVEER 499 (534)
T ss_pred cccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcC-ccHHHHHHHHHHHcCCchhhhhhhHHHHHH
Confidence 2 3444 123334455443 3344444444444433 345689999999999999999999988888
Q ss_pred HhcC
Q psy14267 546 INNN 549 (553)
Q Consensus 546 L~~~ 549 (553)
+.+.
T Consensus 500 ~~~l 503 (534)
T KOG3653|consen 500 MAEL 503 (534)
T ss_pred HHHH
Confidence 7663
|
|
| >KOG0670|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-32 Score=277.56 Aligned_cols=209 Identities=24% Similarity=0.402 Sum_probs=173.3
Q ss_pred EEecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcC-----CCceeEee
Q psy14267 251 ITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG-----CPYVIKMH 325 (553)
Q Consensus 251 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~-----hp~Iv~l~ 325 (553)
.++...+|.+....|+|-|++|..|.+...+. .||||+|...+ -+.+.=++|++||++|.. --|+++|+
T Consensus 427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~--~vAiKIIRnNE----~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~ 500 (752)
T KOG0670|consen 427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQ--EVAIKIIRNNE----VMHKTGLKELEILKKLNDADPEDKFHCLRLF 500 (752)
T ss_pred hhhhcceeEEEeccccceeeeeeeccccCCCC--eeEEEEeecch----HHhhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence 34556799999999999999999998876665 49999998654 334666899999999953 24777776
Q ss_pred eEEEeCCCceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccce
Q psy14267 326 DYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKI 405 (553)
Q Consensus 326 ~~~~~~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~ 405 (553)
-.| .+.+|+|||+|....+|.+++...++...+. ...+..|+.|+..||..|-..||+|.||||+|||+++..
T Consensus 501 r~F--~hknHLClVFE~LslNLRevLKKyG~nvGL~--ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k--- 573 (752)
T KOG0670|consen 501 RHF--KHKNHLCLVFEPLSLNLREVLKKYGRNVGLH--IKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESK--- 573 (752)
T ss_pred HHh--hhcceeEEEehhhhchHHHHHHHhCccccee--ehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCc---
Confidence 655 4578999999999999999999987766554 445667788999999999999999999999999998774
Q ss_pred ecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCC
Q psy14267 406 IDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY 485 (553)
Q Consensus 406 ~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf 485 (553)
..+||||||.|......... -+.-+..|.|||++.|.+ |+...|+||.||+||||+||+..|
T Consensus 574 -----~iLKLCDfGSA~~~~eneit----PYLVSRFYRaPEIiLG~~---------yd~~iD~WSvgctLYElYtGkIlF 635 (752)
T KOG0670|consen 574 -----NILKLCDFGSASFASENEIT----PYLVSRFYRAPEIILGLP---------YDYPIDTWSVGCTLYELYTGKILF 635 (752)
T ss_pred -----ceeeeccCcccccccccccc----HHHHHHhccCcceeecCc---------ccCCccceeeceeeEEeeccceec
Confidence 67999999999887665432 233567899999999885 677899999999999999999999
Q ss_pred CCCCc
Q psy14267 486 SHIPN 490 (553)
Q Consensus 486 ~~~~~ 490 (553)
.+..+
T Consensus 636 pG~TN 640 (752)
T KOG0670|consen 636 PGRTN 640 (752)
T ss_pred CCCCc
Confidence 88554
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-30 Score=276.48 Aligned_cols=282 Identities=17% Similarity=0.184 Sum_probs=181.1
Q ss_pred cCcceEEEeeeeeeCceEEEEEeeeCC--------------CccceEEEEEEecCCcCch-h----------HHHHHHHH
Q psy14267 254 NGKQYQVLSLLGKGGSSSVYLVGGTSE--------------HEFKPLALKVVDLSDITDQ-S----------IADSYLNE 308 (553)
Q Consensus 254 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~--------------~~~~~vAvK~l~~~~~~~~-~----------~~~~~~~E 308 (553)
..++|++.++||+|+||+||++..... ...+.||||.+........ + ..+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 456899999999999999999864221 2224699999865431110 0 11234557
Q ss_pred HHHHHhhcCCCc----eeEeeeEEEeC------CCceEEEEEecC-CCCHHHHHHHcccCC-------------------
Q psy14267 309 VELLAKLQGCPY----VIKMHDYVYDT------ASKHLYVLMEKG-DTDLSKYMRNLNKMT------------------- 358 (553)
Q Consensus 309 ~~iL~~l~~hp~----Iv~l~~~~~~~------~~~~~~iv~e~~-~~~L~~~l~~~~~~~------------------- 358 (553)
+.++.++++++. ++.+++|+... .....++|||+. +++|.+++.......
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 788888876443 45666665432 124578888874 578888886432110
Q ss_pred CCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEeccCccccCCCCCcccccCCcc
Q psy14267 359 TLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASG 438 (553)
Q Consensus 359 ~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~G 438 (553)
.....+..+..++.|++.||+|||+.+|+||||||+|||++.+ +.+||+|||++......... ......+
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~---------~~~kL~DFGla~~~~~~~~~-~~~~g~~ 372 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVD---------GQVKIIDFGAAVDMCTGINF-NPLYGML 372 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCC---------CcEEEEeCcCccccccCCcc-CccccCC
Confidence 0112334566677899999999999999999999999999776 57999999999765443221 1112345
Q ss_pred CCCccCcccccccCCCCCC-------------CccCCCccchHHHHHHHHHHHHhCCC-CCCCCCchHHHHHHHH---h-
Q psy14267 439 TLNYMSPEAAGQTSSSGGG-------------NTYRITYKSDVWSLGCILYNMIYGRT-PYSHIPNTWAKMLAIA---R- 500 (553)
Q Consensus 439 t~~y~APE~l~~~~~~~~~-------------~~~~~s~~sDIwSlGvvl~elltG~~-Pf~~~~~~~~~~~~i~---~- 500 (553)
|+.|+|||++......+.. ..+....+.||||+||++|+|++|.+ ||.........+.... .
T Consensus 373 tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~ 452 (507)
T PLN03224 373 DPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNR 452 (507)
T ss_pred CcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHH
Confidence 8999999998643211100 00112235799999999999999986 7764321111111000 0
Q ss_pred hcccccccccccCCCCCCHHHHHHHHHhcccCC---CCCCCHHHHHHH
Q psy14267 501 HKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDP---KARPTVGNSVTQ 545 (553)
Q Consensus 501 ~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP---~~RPt~~ell~~ 545 (553)
.............+..+++..++|+.+||.++| .+|+|+.|+++|
T Consensus 453 ~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 453 WRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred HHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 000000111222344578899999999999876 689999999976
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-30 Score=248.13 Aligned_cols=239 Identities=29% Similarity=0.453 Sum_probs=184.0
Q ss_pred CceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEEEEEecCCC-C
Q psy14267 268 GSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEKGDT-D 346 (553)
Q Consensus 268 ~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~iv~e~~~~-~ 346 (553)
+||.||++....++. .+|+|++........ .+.+.+|+++++++ +|++|+.+++++.. ....++++++.++ +
T Consensus 1 ~~g~v~~~~~~~~~~--~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l-~~~~i~~~~~~~~~--~~~~~l~~e~~~~~~ 73 (244)
T smart00220 1 SFGKVYLARDKKTGK--LVAIKVIKKEKIKKK--RERILREISILKKL-KHPNIVRLYDVFED--EDKLYLVMEYCDGGD 73 (244)
T ss_pred CceEEEEEEECCCCc--EEEEEEecccccccH--HHHHHHHHHHHHhC-CCCcHHHHHhheee--CCEEEEEEeCCCCCC
Confidence 589999998876554 499999976654332 47889999999999 66999999987754 4678888987655 9
Q ss_pred HHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEeccCccccCC
Q psy14267 347 LSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQD 426 (553)
Q Consensus 347 L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGla~~~~~ 426 (553)
|..++..... .....+..++.+++.+|.|||+.+|+|+||+|.||+++.+ +.++|+|||++.....
T Consensus 74 L~~~~~~~~~-----~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~---------~~~~l~d~~~~~~~~~ 139 (244)
T smart00220 74 LFDLLKKRGR-----LSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDED---------GHVKLADFGLARQLDP 139 (244)
T ss_pred HHHHHHhccC-----CCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCC---------CcEEEccccceeeecc
Confidence 9998876542 3455666677899999999999999999999999999776 5799999999988765
Q ss_pred CCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHhhccccc
Q psy14267 427 DKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIE 506 (553)
Q Consensus 427 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~~i~~~~~~~~ 506 (553)
.. ......++..|++||.+.+. .++.++|||+||+++|+|++|..||............+......
T Consensus 140 ~~---~~~~~~~~~~~~~pE~~~~~---------~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~-- 205 (244)
T smart00220 140 GG---LLTTFVGTPEYMAPEVLLGK---------GYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPP-- 205 (244)
T ss_pred cc---ccccccCCcCCCCHHHHccC---------CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCC--
Confidence 43 12245688999999998744 36789999999999999999999997643332222222211111
Q ss_pred ccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy14267 507 FKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVT 544 (553)
Q Consensus 507 ~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~ 544 (553)
.. .....++.++.+++.+||..+|++||++.++++
T Consensus 206 ~~---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 206 FP---PPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred Cc---cccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 10 111127789999999999999999999999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG2052|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-30 Score=259.35 Aligned_cols=267 Identities=19% Similarity=0.314 Sum_probs=190.5
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhh-cCCCceeEeeeEEEeCCC
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKL-QGCPYVIKMHDYVYDTAS 333 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l-~~hp~Iv~l~~~~~~~~~ 333 (553)
.++..+++.||+|.||+||.+.+.... ||||++.-.+ .+.+.+|.+|++.. -.|+||+.+++.-....+
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wrGe~----VAVKiF~srd------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~g 279 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWRGED----VAVKIFSSRD------ERSWFRETEIYQTVMLRHENILGFIAADNKDNG 279 (513)
T ss_pred hheeEEEEEecCccccceeeccccCCc----eEEEEecccc------hhhhhhHHHHHHHHHhccchhhhhhhccccCCC
Confidence 357889999999999999988765433 9999996433 36788999997653 346999999764222211
Q ss_pred --ceEEEEEec-CCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhh--------CCcEecCCCCCCEEEecCc
Q psy14267 334 --KHLYVLMEK-GDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHA--------AGIIHSDLKPANFLFVGNV 402 (553)
Q Consensus 334 --~~~~iv~e~-~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~--------~gIiHrDLKp~NILl~~~~ 402 (553)
-.++++.+| ..|+|++||.+. .......+.++..++.||++||. ..|.|||||+.||||..+
T Consensus 280 s~TQLwLvTdYHe~GSL~DyL~r~------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn- 352 (513)
T KOG2052|consen 280 SWTQLWLVTDYHEHGSLYDYLNRN------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN- 352 (513)
T ss_pred ceEEEEEeeecccCCcHHHHHhhc------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccC-
Confidence 246777776 669999999874 33445566667799999999994 259999999999999887
Q ss_pred cceecCCCCeEEEEeccCccccCCCCC--cccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh
Q psy14267 403 LKIIDCIGNVLKIIDFGIACSLQDDKT--SVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY 480 (553)
Q Consensus 403 ~~~~~~~~~~vkL~DFGla~~~~~~~~--~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt 480 (553)
++..|+|+|||........ .......+||.+|||||++...-.. +...--..+||||||.+|||++-
T Consensus 353 --------~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~---~~Fesyk~ADIYafgLVlWEiar 421 (513)
T KOG2052|consen 353 --------GTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINM---KHFESYKRADIYAFGLVLWEIAR 421 (513)
T ss_pred --------CcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcCh---hhhhhhhHHHHHHHHHHHHHHHH
Confidence 6899999999987765432 2233467899999999999754321 11122357999999999999983
Q ss_pred -----C-----CCCCCCC---CchHHHHHHH-HhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q psy14267 481 -----G-----RTPYSHI---PNTWAKMLAI-ARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQI 546 (553)
Q Consensus 481 -----G-----~~Pf~~~---~~~~~~~~~i-~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L 546 (553)
| ++||.+. ++..+.|..+ ...+....+++.+.. ..+-..+.++|+.||..+|..|.|+--|.+.|
T Consensus 422 Rc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s-~~~l~~m~klMkeCW~~Np~aRltALriKKtl 500 (513)
T KOG2052|consen 422 RCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKS-DPALRVMAKLMKECWYANPAARLTALRIKKTL 500 (513)
T ss_pred HhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCccccc-CHHHHHHHHHHHHhhcCCchhhhHHHHHHHHH
Confidence 2 6888763 2333444433 222223333333322 12234678899999999999999998888887
Q ss_pred hcCC
Q psy14267 547 NNNP 550 (553)
Q Consensus 547 ~~~~ 550 (553)
.+..
T Consensus 501 ~~l~ 504 (513)
T KOG2052|consen 501 AKLS 504 (513)
T ss_pred HHHh
Confidence 7643
|
|
| >KOG1152|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=271.11 Aligned_cols=202 Identities=25% Similarity=0.467 Sum_probs=168.1
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhH-----HHHHHHHHHHHHhhc--CCCceeEeeeEE
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSI-----ADSYLNEVELLAKLQ--GCPYVIKMHDYV 328 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~-----~~~~~~E~~iL~~l~--~hp~Iv~l~~~~ 328 (553)
..|..++.+|+|+||.|++|.++... ..|+||.+.|+.+-.... +-..-.|++||..|. .|+||++++++|
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~--~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENN--YEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccceeeeeccccccceEEEeeecccc--eEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 46999999999999999999988774 459999998876432211 223567999999996 379999999988
Q ss_pred EeCCCceEEEEEec--CCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCcccee
Q psy14267 329 YDTASKHLYVLMEK--GDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKII 406 (553)
Q Consensus 329 ~~~~~~~~~iv~e~--~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~ 406 (553)
+++.++|++||. .+.+|.++++..+++.+ .....+++|++.|+++||++||||||||-+||.++.+
T Consensus 639 --Eddd~yyl~te~hg~gIDLFd~IE~kp~m~E-----~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~----- 706 (772)
T KOG1152|consen 639 --EDDDYYYLETEVHGEGIDLFDFIEFKPRMDE-----PEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSN----- 706 (772)
T ss_pred --ecCCeeEEEecCCCCCcchhhhhhccCccch-----HHHHHHHHHHHhccccccccCceecccccccEEEecC-----
Confidence 557899999995 44689999998876543 4455667899999999999999999999999999888
Q ss_pred cCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCC
Q psy14267 407 DCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYS 486 (553)
Q Consensus 407 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~ 486 (553)
|.+||+|||.|.....+.. .+++||..|.|||++.|..+ .+..-|||+||++||.+++..-||.
T Consensus 707 ----g~~klidfgsaa~~ksgpf----d~f~gtv~~aapevl~g~~y--------~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 707 ----GFVKLIDFGSAAYTKSGPF----DVFVGTVDYAAPEVLGGEKY--------LGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ----CeEEEeeccchhhhcCCCc----ceeeeeccccchhhhCCCcc--------CCCcchhhhhhheeeEEEeccCCCc
Confidence 7899999999987766554 37889999999999998865 3567899999999999999999987
Q ss_pred C
Q psy14267 487 H 487 (553)
Q Consensus 487 ~ 487 (553)
+
T Consensus 771 n 771 (772)
T KOG1152|consen 771 N 771 (772)
T ss_pred C
Confidence 5
|
|
| >KOG0664|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-32 Score=257.43 Aligned_cols=261 Identities=23% Similarity=0.314 Sum_probs=186.5
Q ss_pred EEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc---eE
Q psy14267 260 VLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK---HL 336 (553)
Q Consensus 260 i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~---~~ 336 (553)
-.+-||-|+||+||.+.+..++. .||+|.+..- +..-...+++.+|+++|.-.+| .||+..+++....+-. .+
T Consensus 57 PDRPIGYGAFGVVWsVTDPRdgr--rvalkK~pnv-fq~L~s~krvFre~kmLcfFkH-dNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 57 PDRPIGYGAFGVVWSVTDPRSGK--RVALKKMPNV-FQNLASCKRVFREIKMLSSFRH-DNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred CCCcccccceeEEEeccCCCCcc--chhHhhcchH-HHHHHHHHHHHHHHHHHHhhcc-ccHHHHHHhcCCCCchHHHHH
Confidence 34579999999999997766654 4999987532 2222334789999999999865 9999998876443332 35
Q ss_pred EEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEE
Q psy14267 337 YVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKII 416 (553)
Q Consensus 337 ~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~ 416 (553)
|++.|....+|...+-... .++...+..+.+||+.||.|||+.+|+||||||.|+|++++ ..+|||
T Consensus 133 YV~TELmQSDLHKIIVSPQ-----~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSN---------CvLKIC 198 (449)
T KOG0664|consen 133 YVLTELMQSDLHKIIVSPQ-----ALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSN---------CILKIC 198 (449)
T ss_pred HHHHHHHHhhhhheeccCC-----CCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccC---------ceEEec
Confidence 7788888888887766543 23334445555799999999999999999999999999888 789999
Q ss_pred eccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCch-----
Q psy14267 417 DFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNT----- 491 (553)
Q Consensus 417 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~----- 491 (553)
|||+|+........ ..+..+-|-+|.|||+++|.. +|+.++||||.||++.||+..+..|..-...
T Consensus 199 DFGLARvee~d~~~-hMTqEVVTQYYRAPEiLMGaR--------hYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~l 269 (449)
T KOG0664|consen 199 DFGLARTWDQRDRL-NMTHEVVTQYYRAPELLMGAR--------RYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQM 269 (449)
T ss_pred ccccccccchhhhh-hhHHHHHHHHhccHHHhhcch--------hhcCccceehhhHHHHHHHhhhhhhhccChHHHHHH
Confidence 99999877654332 222344688999999999886 5899999999999999999998888643221
Q ss_pred ---------HHHHHHHHhhcc-----cccccccccCCCCC------CHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q psy14267 492 ---------WAKMLAIARHKD-----QIEFKPQLANNVTI------PPTLLQSMKLCLQKDPKARPTVGNSVTQIN 547 (553)
Q Consensus 492 ---------~~~~~~i~~~~~-----~~~~~~~~~~~~~~------s~~l~~li~~cL~~dP~~RPt~~ell~~L~ 547 (553)
.+.|....++.. .....|.....+.+ .-+...++..+|..||..|.+..+.+.++-
T Consensus 270 ItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 270 IIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred HHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 111111111100 00112222222222 235778888999999999999999887754
|
|
| >KOG1165|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=239.92 Aligned_cols=267 Identities=21% Similarity=0.274 Sum_probs=214.8
Q ss_pred ecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC
Q psy14267 253 LNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA 332 (553)
Q Consensus 253 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~ 332 (553)
+-+-.|+++++||+|+||+++++...-+++. ||||.-..+.. .-++..|.+..+.|.+.+.|... |+++..
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~--VAIKfEPrkS~-----APQLrdEYr~YKlL~g~~GIP~v--YYFGqe 95 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEP--VAIKFEPRKSE-----APQLRDEYRTYKLLGGTEGIPQV--YYFGQE 95 (449)
T ss_pred EecccceeccccccCcceeeecccccccCce--EEEEeccccCC-----cchHHHHHHHHHHHcCCCCCCce--eeeccc
Confidence 3456899999999999999999988877755 99998765432 25678899999999999999988 667788
Q ss_pred CceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCe
Q psy14267 333 SKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNV 412 (553)
Q Consensus 333 ~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~ 412 (553)
..+-.+||+..|.+|.++++-+++ .+++..++++|.|++.-++|+|++.+|+|||||+|+||.... ......
T Consensus 96 G~~NiLVidLLGPSLEDLFD~CgR----~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~----~k~~n~ 167 (449)
T KOG1165|consen 96 GKYNILVIDLLGPSLEDLFDLCGR----RFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPG----TKDANV 167 (449)
T ss_pred cchhhhhhhhhCcCHHHHHHHhcC----cccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCC----CCCCce
Confidence 889999999999999999998876 456777888889999999999999999999999999997642 344578
Q ss_pred EEEEeccCccccCCCCCccc-----ccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCC
Q psy14267 413 LKIIDFGIACSLQDDKTSVH-----KDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSH 487 (553)
Q Consensus 413 vkL~DFGla~~~~~~~~~~~-----~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~ 487 (553)
|.|+|||+|+.+.+.....+ ..+..||.+||+-..+.|.. -+++.|+-|||-++++.|-|.+||.+
T Consensus 168 IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrE---------QSRRDDLEaLGHvFmYFLRGsLPWQG 238 (449)
T KOG1165|consen 168 IHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGRE---------QSRRDDLEALGHVFMYFLRGSLPWQG 238 (449)
T ss_pred EEEEeccchhhhcCccccccCccccccccccceeeeEeeccccch---------hhhhhhHHHhhhhhhhhccCCCcccc
Confidence 99999999999987765332 34677999999999988874 68999999999999999999999998
Q ss_pred CCch--HHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q psy14267 488 IPNT--WAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINN 548 (553)
Q Consensus 488 ~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~ 548 (553)
+... .+....|-..+....+.. -..++|.++...|+..-..+.++-|.++-+...+..
T Consensus 239 LKA~tnK~kYeKIGe~Kr~T~i~~---Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~d 298 (449)
T KOG1165|consen 239 LKADTNKEKYEKIGETKRSTPIEV---LCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDD 298 (449)
T ss_pred ccCcchHHHHHHhccccccCCHHH---HHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 6442 233333333332222222 223688999999999999999999999877665544
|
|
| >KOG0665|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=247.39 Aligned_cols=257 Identities=25% Similarity=0.378 Sum_probs=190.5
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCC--
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTAS-- 333 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~-- 333 (553)
.+|.-++.+|.|.- .|-.|.+.-.+ ++||+|.+... +......++..+|..++..+.| +||+.++.++.....
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~--~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~~-~nii~l~n~ftP~~~l~ 91 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLG--RPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVNH-KNIISLLNVFTPQKTLE 91 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhcc--CceehhhhcCc-cccCccchhhhhhhhhhhhhcc-cceeeeeeccCccccHH
Confidence 57888999999998 55555554444 55999988766 3334455889999999999955 999999987754332
Q ss_pred --ceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCC
Q psy14267 334 --KHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGN 411 (553)
Q Consensus 334 --~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~ 411 (553)
..+|++||+...+|..++.- ......+..+++|++.|+.|||+.||+||||||+||++..+ +
T Consensus 92 ~~~e~y~v~e~m~~nl~~vi~~-------elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~---------~ 155 (369)
T KOG0665|consen 92 EFQEVYLVMELMDANLCQVILM-------ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSD---------C 155 (369)
T ss_pred HHHhHHHHHHhhhhHHHHHHHH-------hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecch---------h
Confidence 35799999999999998873 22345566667899999999999999999999999999776 7
Q ss_pred eEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCc-
Q psy14267 412 VLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN- 490 (553)
Q Consensus 412 ~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~- 490 (553)
.+||.|||+|+..... ..-+-.+.|..|.|||++.+.. |...+||||+||++.||++|+..|.+...
T Consensus 156 ~lKi~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~---------~ke~vdiwSvGci~gEli~~~Vlf~g~d~i 223 (369)
T KOG0665|consen 156 TLKILDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMG---------YKENVDIWSVGCIMGELILGTVLFPGKDHI 223 (369)
T ss_pred heeeccchhhcccCcc---cccCchhheeeccCchheeccC---------CcccchhhhhhhHHHHHhhceEEecCchHH
Confidence 8999999999776544 1223567899999999998874 67899999999999999999998875221
Q ss_pred -hHHHHHHH-------------------------------HhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCC
Q psy14267 491 -TWAKMLAI-------------------------------ARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538 (553)
Q Consensus 491 -~~~~~~~i-------------------------------~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt 538 (553)
.|.++... .+.-....|.........-...+++++.+||..||++|.+
T Consensus 224 dQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Ris 303 (369)
T KOG0665|consen 224 DQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRIS 303 (369)
T ss_pred HHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhccc
Confidence 11111100 0001111122222222122346899999999999999999
Q ss_pred HHHHHHH
Q psy14267 539 VGNSVTQ 545 (553)
Q Consensus 539 ~~ell~~ 545 (553)
++++|.|
T Consensus 304 v~daL~H 310 (369)
T KOG0665|consen 304 VDDALRH 310 (369)
T ss_pred HHHHhcC
Confidence 9999975
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-30 Score=270.12 Aligned_cols=256 Identities=24% Similarity=0.347 Sum_probs=200.9
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
.++|+++.++|.|+||.||+|+++.+++. .|+|+++.....+ ..-..+|+-+++..+| |||+.+++-+.. ..
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~el--aavkvVkLep~dd---~~~iqqei~~~~dc~h-~nivay~gsylr--~d 85 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGEL--AAVKVVKLEPGDD---FSGIQQEIGMLRDCRH-PNIVAYFGSYLR--RD 85 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCch--hhheeeeccCCcc---ccccccceeeeecCCC-cChHHHHhhhhh--hc
Confidence 35799999999999999999999988876 9999998765333 4566789999998865 999999886643 55
Q ss_pred eEEEEEecCCC-CHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 335 HLYVLMEKGDT-DLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 335 ~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
.+.+.|||||+ +|.+.-. ...+..+.++..+.++.++||+|||++|-+|||||-.|||+++. +.|
T Consensus 86 klwicMEycgggslQdiy~-----~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~---------gDv 151 (829)
T KOG0576|consen 86 KLWICMEYCGGGSLQDIYH-----VTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDE---------GDV 151 (829)
T ss_pred CcEEEEEecCCCcccceee-----ecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeeccc---------Cce
Confidence 68899998765 4544322 23367788888888999999999999999999999999999776 679
Q ss_pred EEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHH
Q psy14267 414 KIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWA 493 (553)
Q Consensus 414 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~ 493 (553)
||+|||.+..+...- .....+.||++|||||+...+... -|...+|||++|++..|+---++|--.......
T Consensus 152 klaDfgvsaqitati--~KrksfiGtpywmapEvaaverkg------gynqlcdiwa~gitAiel~eLqpplfdlhpmr~ 223 (829)
T KOG0576|consen 152 KLADFGVSAQITATI--AKRKSFIGTPYWMAPEVAAVERKG------GYNQLCDIWALGITAIELGELQPPLFDLHPMRA 223 (829)
T ss_pred eecccCchhhhhhhh--hhhhcccCCccccchhHHHHHhcc------cccccccccccccchhhhhhcCCcccccchHHH
Confidence 999999987765432 234578899999999998654322 388999999999999999887777655433212
Q ss_pred HHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy14267 494 KMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVT 544 (553)
Q Consensus 494 ~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~ 544 (553)
.+. .......++.+.+....++.+.+|++.||.++|++||+++-+|.
T Consensus 224 l~L----mTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 224 LFL----MTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred HHH----hhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 111 12222345667777788999999999999999999999988775
|
|
| >KOG1167|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=249.30 Aligned_cols=259 Identities=24% Similarity=0.416 Sum_probs=187.7
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCC-CccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSE-HEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~-~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
..|.++.+||+|+|++||++.+... ...+.||+|.+....- ..+..+|+++|..+.++.||+.+.+++ ..++
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-----p~ri~~El~~L~~~gG~~ni~~~~~~~--rnnd 108 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-----PSRILNELEMLYRLGGSDNIIKLNGCF--RNND 108 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-----chHHHHHHHHHHHhccchhhhcchhhh--ccCC
Confidence 5699999999999999999977661 1224599999876542 367899999999999999999998766 4567
Q ss_pred eEEEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 335 HLYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 335 ~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
.+.++||+.+ .+..++..... ...+..+++.++.||.++|.+|||||||||.|+|.+... +.-
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~l~--------~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t--------~rg 172 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRSLS--------LAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRT--------QRG 172 (418)
T ss_pred eeEEEecccCccCHHHHHhcCC--------HHHHHHHHHHHHHHhhhhhccCccccCCCcccccccccc--------CCc
Confidence 7888888754 55666655433 456677788999999999999999999999999987664 456
Q ss_pred EEEeccCccccC-----------------C-CCCc------------------------ccccCCccCCCccCccccccc
Q psy14267 414 KIIDFGIACSLQ-----------------D-DKTS------------------------VHKDTASGTLNYMSPEAAGQT 451 (553)
Q Consensus 414 kL~DFGla~~~~-----------------~-~~~~------------------------~~~~~~~Gt~~y~APE~l~~~ 451 (553)
.|+|||||.... . .+.. .......||++|.|||++...
T Consensus 173 ~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~ 252 (418)
T KOG1167|consen 173 VLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRC 252 (418)
T ss_pred eEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhc
Confidence 899999987211 0 0000 001123499999999999877
Q ss_pred CCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHH------------HHHhhccc---cc----------
Q psy14267 452 SSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKML------------AIARHKDQ---IE---------- 506 (553)
Q Consensus 452 ~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~------------~i~~~~~~---~~---------- 506 (553)
+ .-+.++||||.||+++-++++..||-...++...+. ..+..... +.
T Consensus 253 ~--------~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~ 324 (418)
T KOG1167|consen 253 P--------RQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPEL 324 (418)
T ss_pred c--------CcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHH
Confidence 5 468899999999999999999999964332211111 11110001 00
Q ss_pred ------c---------c--ccccCCC-CCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 507 ------F---------K--PQLANNV-TIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 507 ------~---------~--~~~~~~~-~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
+ . -....+. ..+..+.+|+.+||..||.+|.|++++|.|
T Consensus 325 ~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 325 RVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred HhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 0 0 0111122 234588999999999999999999999875
|
|
| >KOG1164|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-26 Score=239.64 Aligned_cols=267 Identities=21% Similarity=0.243 Sum_probs=197.6
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhc---CCCceeEeeeEEEeCCC
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQ---GCPYVIKMHDYVYDTAS 333 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~---~hp~Iv~l~~~~~~~~~ 333 (553)
+|.+.++||+|+||.||++.+.... ...+|+|+......... ..+..|+.+|..+. +..++..+++.+. ...
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~-~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~-~~~ 93 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEK-NKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGR-STE 93 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCC-CeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEecc-CCC
Confidence 7999999999999999999887665 34589998876543221 25778999999887 3457777766553 456
Q ss_pred ceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 334 KHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 334 ~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
.+.||||...|.+|.++..... ...++...+..++.|++.+|++||+.|+|||||||+|+++..... .....+
T Consensus 94 ~~~~iVM~l~G~sL~dl~~~~~---~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~----~~~~~~ 166 (322)
T KOG1164|consen 94 DFNFIVMSLLGPSLEDLRKRNP---PGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSR----SEVRTL 166 (322)
T ss_pred ceeEEEEeccCccHHHHHHhCC---CCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCC----cccceE
Confidence 6889999999999999887665 234555666777789999999999999999999999999965420 111469
Q ss_pred EEEeccCcc--ccCCCCCc---cc---ccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCC
Q psy14267 414 KIIDFGIAC--SLQDDKTS---VH---KDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY 485 (553)
Q Consensus 414 kL~DFGla~--~~~~~~~~---~~---~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf 485 (553)
.|.|||+|+ .+...... .. ...+.||..|+++.++.+.. .+++.|+||+++++.||+.|.+||
T Consensus 167 ~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e---------~~r~DDles~~Y~l~el~~g~LPW 237 (322)
T KOG1164|consen 167 YLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIE---------QGRRDDLESLFYMLLELLKGSLPW 237 (322)
T ss_pred EEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCc---------cCCchhhhhHHHHHHHHhcCCCCC
Confidence 999999998 43222211 11 12355999999999998774 689999999999999999999999
Q ss_pred CCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q psy14267 486 SHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINN 548 (553)
Q Consensus 486 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~ 548 (553)
........ ...+........... .....+..+..++..+-..+...+|.+..+...|++
T Consensus 238 ~~~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~ 296 (322)
T KOG1164|consen 238 EALEMTDL-KSKFEKDPRKLLTDR---FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKD 296 (322)
T ss_pred ccccccch-HHHHHHHhhhhcccc---ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHH
Confidence 87654322 111111111111111 122456789999999999999999999999888765
|
|
| >KOG1163|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-27 Score=222.53 Aligned_cols=263 Identities=22% Similarity=0.279 Sum_probs=207.0
Q ss_pred cCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCC
Q psy14267 254 NGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTAS 333 (553)
Q Consensus 254 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~ 333 (553)
-+.+|+++++||.|+||.+|++.....++. ||||+-....-. .++..|.++.+.|++...|..+..|+ .+.
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~--VAiK~Es~~a~h-----pqL~yEskvY~iL~~g~GiP~i~~y~--~e~ 83 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEE--VAIKLESSKAKH-----PQLLYESKVYRILQGGVGIPHIRHYG--TEK 83 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCce--EEEEeecccCCC-----cchhHHHHHHHHhccCCCCchhhhhc--ccc
Confidence 356899999999999999999999888876 999987654322 45778999999999888888886544 567
Q ss_pred ceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 334 KHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 334 ~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
.+-.+||+..|.+|.+++.-+.+ .+++..+..++-|++.-++|+|.+++|||||||+|+|..-+ .....+
T Consensus 84 ~ynvlVMdLLGPsLEdLfnfC~R----~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlg------rh~~kl 153 (341)
T KOG1163|consen 84 DYNVLVMDLLGPSLEDLFNFCSR----RFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLG------RHCNKL 153 (341)
T ss_pred ccceeeeeccCccHHHHHHHHhh----hhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccc------cccceE
Confidence 78899999999999998876654 45667788888899999999999999999999999998544 333579
Q ss_pred EEEeccCccccCCCCCccc-----ccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy14267 414 KIIDFGIACSLQDDKTSVH-----KDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHI 488 (553)
Q Consensus 414 kL~DFGla~~~~~~~~~~~-----~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~ 488 (553)
.|+|||||+.+.+.....+ .....||.+|.+-..+.+.. -+++.|+-|+|++|..+.-|.+||.++
T Consensus 154 ~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~e---------qSRRDDmeSvgYvLmYfnrG~LPWQgl 224 (341)
T KOG1163|consen 154 YLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIE---------QSRRDDMESVGYVLMYFNRGSLPWQGL 224 (341)
T ss_pred EEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhh---------hhhhhhhhhhcceeeeeecCCCccccc
Confidence 9999999998876543322 23556999999988877653 578999999999999999999999986
Q ss_pred Cch--HHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q psy14267 489 PNT--WAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQIN 547 (553)
Q Consensus 489 ~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~ 547 (553)
... .++...+.+.+........ ..++|.++.-+|..|-..--++-|.+.-|.+.++
T Consensus 225 ka~tk~QKyEkI~EkK~s~~ie~L---C~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFr 282 (341)
T KOG1163|consen 225 KAATKKQKYEKISEKKMSTPIEVL---CKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFR 282 (341)
T ss_pred chhhHHHHHHHHHHhhcCCCHHHH---hCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHH
Confidence 542 3334444444333322222 2378899999999999999999999887766543
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-26 Score=220.37 Aligned_cols=213 Identities=34% Similarity=0.575 Sum_probs=172.7
Q ss_pred eeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEEEEEecC
Q psy14267 264 LGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEKG 343 (553)
Q Consensus 264 LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~iv~e~~ 343 (553)
||+|++|.||++....++ +.+++|++....... ..+.+.+|+++++.+.+ ++|+.+++++.. ....+++|++.
T Consensus 1 l~~g~~~~v~~~~~~~~~--~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~-~~i~~~~~~~~~--~~~~~~~~e~~ 73 (215)
T cd00180 1 LGEGGFGTVYLARDKKTG--KKVAIKIIKKEDSSS--LLEELLREIEILKKLNH-PNIVKLYGVFED--ENHLYLVMEYC 73 (215)
T ss_pred CCcCCceEEEEEEecCCC--cEEEEEEeccccchh--HHHHHHHHHHHHHhcCC-CCeeeEeeeeec--CCeEEEEEecC
Confidence 689999999999876544 449999997664332 34678999999999966 999999887744 46788999987
Q ss_pred C-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEec-CccceecCCCCeEEEEeccCc
Q psy14267 344 D-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVG-NVLKIIDCIGNVLKIIDFGIA 421 (553)
Q Consensus 344 ~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~-~~~~~~~~~~~~vkL~DFGla 421 (553)
+ ++|.+++.... .......++.++.+++.+|++||+.|++|+||+|.||+++. + +.++|+|||.+
T Consensus 74 ~~~~l~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~---------~~~~l~d~~~~ 140 (215)
T cd00180 74 EGGSLKDLLKENE----GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDN---------GKVKLADFGLS 140 (215)
T ss_pred CCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCC---------CcEEEecCCce
Confidence 6 89999887653 13345566677789999999999999999999999999987 4 57999999999
Q ss_pred cccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHhh
Q psy14267 422 CSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARH 501 (553)
Q Consensus 422 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~~i~~~ 501 (553)
........ ......+...|++||.+.... .++.++|+|+||++|++|
T Consensus 141 ~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~--------~~~~~~D~~~lg~~~~~l----------------------- 187 (215)
T cd00180 141 KLLTSDKS--LLKTIVGTPAYMAPEVLLGKG--------YYSEKSDIWSLGVILYEL----------------------- 187 (215)
T ss_pred EEccCCcc--hhhcccCCCCccChhHhcccC--------CCCchhhhHHHHHHHHHH-----------------------
Confidence 87755431 112445788999999986541 267899999999999998
Q ss_pred cccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q psy14267 502 KDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQI 546 (553)
Q Consensus 502 ~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L 546 (553)
..+.+++..||..+|++||++.++++++
T Consensus 188 -----------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -----------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -----------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 5789999999999999999999998754
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1345|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-28 Score=231.32 Aligned_cols=251 Identities=18% Similarity=0.292 Sum_probs=183.6
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
.+.|.|.+.||+|.||.+.+|+++.++.. +++|.+...- .....|.+|..---.|.+|.||+.-++..+...+
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~--ivlKavp~p~----tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d- 95 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTR--IVLKAVPRPQ----TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSD- 95 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceE--EEeeccCcch----hhHHHHHHHhccceeeccchhhhHHHHHHhhcCc-
Confidence 36799999999999999999999988865 9999987654 3357788998887788889999998886665544
Q ss_pred eEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEe-cCccceecCCCCe
Q psy14267 335 HLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFV-GNVLKIIDCIGNV 412 (553)
Q Consensus 335 ~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~-~~~~~~~~~~~~~ 412 (553)
+++.++|++ -|+|..-+...+ .-+.....++.|+++||+|+|++++||||||.+||||- .++ ..
T Consensus 96 ~YvF~qE~aP~gdL~snv~~~G------igE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df--------~r 161 (378)
T KOG1345|consen 96 AYVFVQEFAPRGDLRSNVEAAG------IGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADF--------YR 161 (378)
T ss_pred eEEEeeccCccchhhhhcCccc------ccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCc--------cE
Confidence 666777764 477776655432 23445566778999999999999999999999999984 333 57
Q ss_pred EEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCC----
Q psy14267 413 LKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHI---- 488 (553)
Q Consensus 413 vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~---- 488 (553)
|||||||+++.....-. ...-+-.|-+||+...... ..+...+.+|||.||+++|.+|||++||...
T Consensus 162 vKlcDFG~t~k~g~tV~-----~~~~~~~y~~pe~~~~~~n----e~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d 232 (378)
T KOG1345|consen 162 VKLCDFGLTRKVGTTVK-----YLEYVNNYHAPELCDTVVN----EKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD 232 (378)
T ss_pred EEeeecccccccCceeh-----hhhhhcccCCcHHHhhccc----cceEecccccchheeeeeeeeecCCCcchhhhccC
Confidence 99999999876543221 1223567889998865532 2345778899999999999999999999752
Q ss_pred CchHHHHHHHHhhcccccccccccCCC-CCCHHHHHHHHHhcccCCCCCCCHHH
Q psy14267 489 PNTWAKMLAIARHKDQIEFKPQLANNV-TIPPTLLQSMKLCLQKDPKARPTVGN 541 (553)
Q Consensus 489 ~~~~~~~~~i~~~~~~~~~~~~~~~~~-~~s~~l~~li~~cL~~dP~~RPt~~e 541 (553)
..-|..+....+... .++... .+++.+.++.++-|..+++.|--+.+
T Consensus 233 ~~Y~~~~~w~~rk~~------~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~ 280 (378)
T KOG1345|consen 233 KPYWEWEQWLKRKNP------ALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWT 280 (378)
T ss_pred chHHHHHHHhcccCc------cCchhhcccCHHHHHHHHHhcCCcccccchhHH
Confidence 122222222222211 222221 46788999999999999999944333
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-25 Score=216.46 Aligned_cols=200 Identities=31% Similarity=0.521 Sum_probs=159.5
Q ss_pred eEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEE
Q psy14267 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLY 337 (553)
Q Consensus 258 y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~ 337 (553)
|.+.+.||.|++|.||++.....+. .+|+|.+...... ...+.+.+|++.++++. |++++++++++.. ....+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~--~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~-~~~i~~~~~~~~~--~~~~~ 73 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGE--LVAVKVLKKEKTE--KQREEFLREIRILKKLK-HPNIVKLYGVFED--PEPLY 73 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCc--EEEEEeeccccch--HHHHHHHHHHHHHHhCC-CCChhhheeeeec--CCceE
Confidence 5788999999999999998876553 4999999876533 24578899999999995 5999999887643 45677
Q ss_pred EEEecCCC-CHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEE
Q psy14267 338 VLMEKGDT-DLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKII 416 (553)
Q Consensus 338 iv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~ 416 (553)
+++++..+ +|.+++...... .....+..++.+++.+|.+||+.+++|+||+|.||+++.+ +.++|+
T Consensus 74 ~v~e~~~~~~L~~~~~~~~~~----~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~---------~~~~l~ 140 (225)
T smart00221 74 LVMEYCEGGDLFDYLRKKGGK----LSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMD---------GLVKLA 140 (225)
T ss_pred EEEeccCCCCHHHHHHhcccC----CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC---------CCEEEe
Confidence 88887555 999988765431 3455666677799999999999999999999999999776 579999
Q ss_pred eccCccccCCCCCcccccCCccCCCccCccccc-ccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCC
Q psy14267 417 DFGIACSLQDDKTSVHKDTASGTLNYMSPEAAG-QTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSH 487 (553)
Q Consensus 417 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~-~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~ 487 (553)
|||++......... ......++..|++||.+. .. .++.++|+|+||+++|||++|+.||..
T Consensus 141 d~g~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~---------~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 141 DFGLARFIHRDLAA-LLKTVKGTPFYLAPEVLLGGK---------GYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred eCceeeEecCcccc-cccceeccCCcCCHhHhcCCC---------CCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 99999887654311 122456888999999984 22 367799999999999999999999976
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.9e-27 Score=270.38 Aligned_cols=204 Identities=17% Similarity=0.235 Sum_probs=137.9
Q ss_pred CceeEeeeEEE----e-CCCceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCC
Q psy14267 319 PYVIKMHDYVY----D-TASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKP 393 (553)
Q Consensus 319 p~Iv~l~~~~~----~-~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp 393 (553)
+||+.+++++. + .+...++.+||+.+++|.+++.... ..+....+..+++||+.||+|||++|||||||||
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP 108 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPD----RSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRP 108 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhccc----ccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCc
Confidence 45655555431 1 1123567788899999999997532 2355667778889999999999999999999999
Q ss_pred CCEEEecCccc-ee---------cCCCCeEEEEeccCccccCCCCC--------------cccccCCccCCCccCccccc
Q psy14267 394 ANFLFVGNVLK-II---------DCIGNVLKIIDFGIACSLQDDKT--------------SVHKDTASGTLNYMSPEAAG 449 (553)
Q Consensus 394 ~NILl~~~~~~-~~---------~~~~~~vkL~DFGla~~~~~~~~--------------~~~~~~~~Gt~~y~APE~l~ 449 (553)
+||||+....- +. ....+.+||+|||+++....... .......+||+.|||||++.
T Consensus 109 ~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~ 188 (793)
T PLN00181 109 SCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDN 188 (793)
T ss_pred hhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhc
Confidence 99999642100 00 01124578888888865321100 00111246899999999997
Q ss_pred ccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhc
Q psy14267 450 QTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCL 529 (553)
Q Consensus 450 ~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL 529 (553)
+. .|+.++|||||||+||||++|..|+.... ..+..+.... ..+.. ......+..++.+||
T Consensus 189 ~~---------~~~~~sDVwSlGviL~ELl~~~~~~~~~~---~~~~~~~~~~----~~~~~---~~~~~~~~~~~~~~L 249 (793)
T PLN00181 189 GS---------SSNCASDVYRLGVLLFELFCPVSSREEKS---RTMSSLRHRV----LPPQI---LLNWPKEASFCLWLL 249 (793)
T ss_pred cC---------CCCchhhhhhHHHHHHHHhhCCCchhhHH---HHHHHHHHhh----cChhh---hhcCHHHHHHHHHhC
Confidence 66 37889999999999999999998875421 1111111111 11111 112356778999999
Q ss_pred ccCCCCCCCHHHHHHH
Q psy14267 530 QKDPKARPTVGNSVTQ 545 (553)
Q Consensus 530 ~~dP~~RPt~~ell~~ 545 (553)
+.+|.+||++.|++++
T Consensus 250 ~~~P~~Rps~~eil~h 265 (793)
T PLN00181 250 HPEPSCRPSMSELLQS 265 (793)
T ss_pred CCChhhCcChHHHhhc
Confidence 9999999999999875
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-25 Score=208.25 Aligned_cols=167 Identities=19% Similarity=0.272 Sum_probs=122.5
Q ss_pred CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEeccCcccc
Q psy14267 345 TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSL 424 (553)
Q Consensus 345 ~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGla~~~ 424 (553)
|+|.++++.... .+.+..++.++.|++.||+|||+++ ||+|||++.+ +.+|+ ||++...
T Consensus 1 GsL~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~---------~~~~~--fG~~~~~ 59 (176)
T smart00750 1 VSLADILEVRGR----PLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWD---------GLLKL--DGSVAFK 59 (176)
T ss_pred CcHHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCc---------cceee--ccceEee
Confidence 578888876432 3456677788889999999999998 9999999776 56888 9998776
Q ss_pred CCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHhhccc
Q psy14267 425 QDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQ 504 (553)
Q Consensus 425 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~~i~~~~~~ 504 (553)
.... ..||+.|||||++.+. .++.++|||||||++|||++|..||.........+..+......
T Consensus 60 ~~~~-------~~g~~~y~aPE~~~~~---------~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 123 (176)
T smart00750 60 TPEQ-------SRVDPYFMAPEVIQGQ---------SYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPA 123 (176)
T ss_pred cccc-------CCCcccccChHHhcCC---------CCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhcc
Confidence 4422 2589999999999766 36789999999999999999999997643322222222222111
Q ss_pred ccccccccCCCCCCH--HHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 505 IEFKPQLANNVTIPP--TLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 505 ~~~~~~~~~~~~~s~--~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
.. .........++. ++.++|.+||..+|++||++.++++++...
T Consensus 124 ~~-~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 124 DD-PRDRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred CC-ccccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 11 000011112333 699999999999999999999999998653
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-22 Score=204.42 Aligned_cols=264 Identities=30% Similarity=0.462 Sum_probs=190.6
Q ss_pred eEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEE
Q psy14267 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLY 337 (553)
Q Consensus 258 y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~ 337 (553)
|.+.+.||.|+||.||++.+. ..+++|.+.............+.+|+.++..+.++++|+.+.+++ ......+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-----~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~--~~~~~~~ 74 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-----KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFF--QDEGSLY 74 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-----cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEE--ecCCEEE
Confidence 788999999999999999776 448999998776555445688999999999998877899998877 3344467
Q ss_pred EEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEE
Q psy14267 338 VLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKII 416 (553)
Q Consensus 338 iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~ 416 (553)
+++++. ++++..++...... ..........++.|++.++.|+|..+++||||||+||+++... ..++++
T Consensus 75 ~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~--------~~~~l~ 144 (384)
T COG0515 75 LVMEYVDGGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDG--------RVVKLI 144 (384)
T ss_pred EEEecCCCCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCC--------CeEEEe
Confidence 777764 46676555544311 1333455666677999999999999999999999999997762 268999
Q ss_pred eccCccccCCCCCcc----cccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCc--
Q psy14267 417 DFGIACSLQDDKTSV----HKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN-- 490 (553)
Q Consensus 417 DFGla~~~~~~~~~~----~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~-- 490 (553)
|||++..+....... ......||..|+|||.+.+.. ...++...|+|++|++++++++|..||.....
T Consensus 145 dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~------~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~ 218 (384)
T COG0515 145 DFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLS------LAYASSSSDIWSLGITLYELLTGLPPFEGEKNSS 218 (384)
T ss_pred ccCcceecCCCCccccccccccccccccccCCHHHhcCCC------CCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccc
Confidence 999998665544321 234678999999999997631 00367899999999999999999999876543
Q ss_pred -hHHHHHHHHhhcccccccccccCC--CCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 491 -TWAKMLAIARHKDQIEFKPQLANN--VTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 491 -~~~~~~~i~~~~~~~~~~~~~~~~--~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
.......+...... ......... ......+.+++..|+..+|..|.+..+....
T Consensus 219 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 219 ATSQTLKIILELPTP-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cHHHHHHHHHhcCCc-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 22222222221111 000000000 1112578999999999999999998877654
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.9e-23 Score=214.01 Aligned_cols=169 Identities=17% Similarity=0.127 Sum_probs=122.1
Q ss_pred cCcceEEEeeeeeeCceEEEEEeeeC-CCccceEEEEEEecCCc--CchhHHHHHHHHHHHHHhhcCCCcee-EeeeEEE
Q psy14267 254 NGKQYQVLSLLGKGGSSSVYLVGGTS-EHEFKPLALKVVDLSDI--TDQSIADSYLNEVELLAKLQGCPYVI-KMHDYVY 329 (553)
Q Consensus 254 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~~~~vAvK~l~~~~~--~~~~~~~~~~~E~~iL~~l~~hp~Iv-~l~~~~~ 329 (553)
....|.+.+.||+|+||+||+|.+.. ++. .||||++..... ......+.+.+|+++|+++.| ++|+ .++++
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~--~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h-~~iv~~l~~~-- 90 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGT--ARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRG-IGVVPQLLAT-- 90 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCe--EEEEEEecccccccccHHHHHHHHHHHHHHHhccC-CCCCcEEEEc--
Confidence 34679999999999999999998765 343 389998753311 123345678999999999976 6665 45431
Q ss_pred eCCCceEEEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCC-CCCCEEEecCccceec
Q psy14267 330 DTASKHLYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDL-KPANFLFVGNVLKIID 407 (553)
Q Consensus 330 ~~~~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDL-Kp~NILl~~~~~~~~~ 407 (553)
...|++||++. ++|. .+.. . . . ..++.+++.||+|||++||||||| ||+|||++.+
T Consensus 91 ----~~~~LVmE~~~G~~L~-~~~~---~---~--~---~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~------ 148 (365)
T PRK09188 91 ----GKDGLVRGWTEGVPLH-LARP---H---G--D---PAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPD------ 148 (365)
T ss_pred ----CCcEEEEEccCCCCHH-HhCc---c---c--h---HHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCC------
Confidence 24689999865 4554 2211 0 0 0 234568999999999999999999 9999999655
Q ss_pred CCCCeEEEEeccCccccCCCCCccc------ccCCccCCCccCcccccccC
Q psy14267 408 CIGNVLKIIDFGIACSLQDDKTSVH------KDTASGTLNYMSPEAAGQTS 452 (553)
Q Consensus 408 ~~~~~vkL~DFGla~~~~~~~~~~~------~~~~~Gt~~y~APE~l~~~~ 452 (553)
+.+||+|||+|+.+........ .....++..|+|||.+....
T Consensus 149 ---~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~ 196 (365)
T PRK09188 149 ---GEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRE 196 (365)
T ss_pred ---CCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhh
Confidence 5699999999998765432211 13556889999999987554
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.9e-23 Score=204.27 Aligned_cols=250 Identities=21% Similarity=0.314 Sum_probs=158.1
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcC---------CCceeEeeeE
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG---------CPYVIKMHDY 327 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~---------hp~Iv~l~~~ 327 (553)
.+.....||.|+|+.||.+.+..+++. +|||+............+.+.+|.-....+.+ |-.++..++.
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~--~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~ 90 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEE--FAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDL 90 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEE--EEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEE
T ss_pred EEEEccccccCCceEEEEEEEccCCce--EEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEE
Confidence 467788999999999999999888755 99999987765555566777777755544322 1122222222
Q ss_pred EEeC----------CCc-----eEEEEEecCCCCHHHHHHHcccCCCC--chHHHHHHHHHHHHHHHHHHHhhCCcEecC
Q psy14267 328 VYDT----------ASK-----HLYVLMEKGDTDLSKYMRNLNKMTTL--PNTMIIIIMHWYEMLLAVKEIHAAGIIHSD 390 (553)
Q Consensus 328 ~~~~----------~~~-----~~~iv~e~~~~~L~~~l~~~~~~~~~--~~~~~~i~~~~~qil~aL~yLH~~gIiHrD 390 (553)
.... +.. ..+++|+...++|..++......... .........+-.|++..+++||..|+||+|
T Consensus 91 ~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgd 170 (288)
T PF14531_consen 91 LRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGD 170 (288)
T ss_dssp EEETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST
T ss_pred EEEcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecc
Confidence 2211 111 24778888889998887653322222 222223333446999999999999999999
Q ss_pred CCCCCEEEecCccceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHH
Q psy14267 391 LKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWS 470 (553)
Q Consensus 391 LKp~NILl~~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwS 470 (553)
|||+|+|++.+ |.++|+||+.......... ....+..|.+||........+. ....++.+.|.|+
T Consensus 171 i~~~nfll~~~---------G~v~Lg~F~~~~r~g~~~~-----~~~~~~~~~PPe~~~~~~~~~~-~~~~~t~~~DaW~ 235 (288)
T PF14531_consen 171 IKPENFLLDQD---------GGVFLGDFSSLVRAGTRYR-----CSEFPVAFTPPELESCAGQFGQ-NNAPYTFATDAWQ 235 (288)
T ss_dssp -SGGGEEE-TT---------S-EEE--GGGEEETTEEEE-----GGGS-TTTS-HHHHHHHTSCHH-SEEEE-HHHHHHH
T ss_pred cceeeEEEcCC---------CCEEEcChHHHeecCceee-----ccCCCcccCChhhhhhhcccCc-ccceeeeccCHHH
Confidence 99999999887 7899999998766543221 1234578999998754311000 2235789999999
Q ss_pred HHHHHHHHHhCCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCC
Q psy14267 471 LGCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKAR 536 (553)
Q Consensus 471 lGvvl~elltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~R 536 (553)
||+++|.|++|..||....... .... .+....++|+.++.||+.+|+.+|++|
T Consensus 236 LG~~ly~lWC~~lPf~~~~~~~---------~~~~----~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 236 LGITLYSLWCGRLPFGLSSPEA---------DPEW----DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHHHHHSS-STCCCGGGS---------TSGG----GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHHHHHccCCCCCCCccc---------cccc----cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 9999999999999998643320 0111 233333789999999999999999987
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.6e-24 Score=236.15 Aligned_cols=259 Identities=24% Similarity=0.283 Sum_probs=181.2
Q ss_pred EEEeeeeeeCceEEEEEeeeCCCccceEEEEEEec---CCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 259 QVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDL---SDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 259 ~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~---~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
....++|.|++|.|+.+........ ++.|.... ...........+..|+.+-..+ +|||++..+..+.+...
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~--~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l-~h~~~~e~l~~~~~~~~-- 395 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKS--FPEKEFRVRVKPTESERKYNYNITSEFCIGSSL-SHPNIIETLDIVQEIDG-- 395 (601)
T ss_pred CccceeeecccCceEEEEecCCCcc--chhhhhhcccCCcccHHHHhhhhhhheeecccc-cCCchhhhHHHHhhccc--
Confidence 4567899999998887765443332 44444332 2222222323366677777777 45998777665543322
Q ss_pred EEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 336 LYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 336 ~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
.+..||++..+|..++....++. ...+-+++.|++.||.|||+.||.|||||++|+++..+ +.+||
T Consensus 396 ~~~~mE~~~~Dlf~~~~~~~~~~-----~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~---------g~lki 461 (601)
T KOG0590|consen 396 ILQSMEYCPYDLFSLVMSNGKLT-----PLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTEN---------GILKI 461 (601)
T ss_pred chhhhhcccHHHHHHHhcccccc-----hhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecC---------CceEE
Confidence 22339998889998888763332 34455666799999999999999999999999999877 68999
Q ss_pred EeccCccccCCCCCc--ccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHH
Q psy14267 416 IDFGIACSLQDDKTS--VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWA 493 (553)
Q Consensus 416 ~DFGla~~~~~~~~~--~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~ 493 (553)
+|||.+..+..+... ......+|+..|+|||++.+..+++ +..||||.|+++..|.+|+.||.-......
T Consensus 462 ~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydp--------r~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~ 533 (601)
T KOG0590|consen 462 IDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDP--------RAVDVWSCGIIYICMILGRFPWKVAKKSDN 533 (601)
T ss_pred eecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCc--------chhhhhhccceEEEEecCCCcccccccccc
Confidence 999999877655443 4445778999999999999887653 679999999999999999999975332211
Q ss_pred HHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy14267 494 KMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVT 544 (553)
Q Consensus 494 ~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~ 544 (553)
...........-........+..++...+.+|.+||+.||.+|.|+++|++
T Consensus 534 ~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 534 SFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred chhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 111111111111111111223357789999999999999999999999986
|
|
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.3e-23 Score=220.52 Aligned_cols=230 Identities=22% Similarity=0.374 Sum_probs=172.9
Q ss_pred eeeeeCceEEEEEeeeCC-CccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEEEEEe
Q psy14267 263 LLGKGGSSSVYLVGGTSE-HEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLME 341 (553)
Q Consensus 263 ~LG~G~fG~Vy~a~~~~~-~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~iv~e 341 (553)
++|.|+||.|++++.... ....-+|+|++++........ .....|..++..++.||.++.++..+ ..+..++++++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~-~~t~~er~il~~~~~~~f~v~lhyaf--qt~~kl~l~ld 77 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDR-THTKQERIILAFVHNTPFLVKLHYAF--QTDGKLYLILD 77 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccc-cccccHHHHHhhccCCCceeeeeeee--ccccchhHhhh
Confidence 479999999998754322 222448999998876554333 26778999999998899999997544 33444555555
Q ss_pred -cCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEeccC
Q psy14267 342 -KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGI 420 (553)
Q Consensus 342 -~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGl 420 (553)
..+++|...+.... .+.......+..+++.|++++|+.+|+|||+|++||+++.+ |.+++.|||+
T Consensus 78 ~~rgg~lft~l~~~~-----~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~---------Ghi~~tdfgl 143 (612)
T KOG0603|consen 78 FLRGGDLFTRLSKEV-----MFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLE---------GHIKLTDFGL 143 (612)
T ss_pred hcccchhhhccccCC-----chHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeeccc---------CccccCCchh
Confidence 45667665554433 33445555566799999999999999999999999999887 7899999999
Q ss_pred ccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHh
Q psy14267 421 ACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIAR 500 (553)
Q Consensus 421 a~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~~i~~ 500 (553)
++....... .|||..|||||++.+. ..++|+||||++++||++|..||.. ..+..+..
T Consensus 144 ske~v~~~~------~cgt~eymApEI~~gh-----------~~a~D~ws~gvl~felltg~~pf~~-----~~~~~Il~ 201 (612)
T KOG0603|consen 144 SKEAVKEKI------ACGTYEYRAPEIINGH-----------LSAADWWSFGVLAFELLTGTLPFGG-----DTMKRILK 201 (612)
T ss_pred hhHhHhhhh------cccchhhhhhHhhhcc-----------CCcccchhhhhhHHHHhhCCCCCch-----HHHHHHhh
Confidence 988766543 2899999999999833 5789999999999999999999987 33333322
Q ss_pred hcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCH
Q psy14267 501 HKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTV 539 (553)
Q Consensus 501 ~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~ 539 (553)
. . +.....++..+++++..++..+|..|.-.
T Consensus 202 ~--~------~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 202 A--E------LEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred h--c------cCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 1 1 22222566889999999999999999765
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.2e-21 Score=213.25 Aligned_cols=210 Identities=26% Similarity=0.518 Sum_probs=146.3
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
.+|..+++|-.|+||.||+++++.+... +|+|+ ++..+.-. + ||... ..|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqr--fa~ki-Nkq~lilR-------n---ilt~a-~npfvv------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQR--FAMKI-NKQNLILR-------N---ILTFA-GNPFVV------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccc--hhhcc-cccchhhh-------c---ccccc-CCccee-------------
Confidence 4699999999999999999998877744 99953 33321110 1 22222 223332
Q ss_pred EEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 336 LYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 336 ~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
||-...+...+.. + .+++.+++|||+.||+|||+||+|++|..- |.+|+
T Consensus 136 ---------gDc~tllk~~g~l---P----------vdmvla~Eylh~ygivhrdlkpdnllIT~m---------GhiKl 184 (1205)
T KOG0606|consen 136 ---------GDCATLLKNIGPL---P----------VDMVLAVEYLHSYGIVHRDLKPDNLLITSM---------GHIKL 184 (1205)
T ss_pred ---------chhhhhcccCCCC---c----------chhhHHhHhhccCCeecCCCCCCcceeeec---------ccccc
Confidence 2222233322211 1 155789999999999999999999999776 67999
Q ss_pred EeccCccccCCC--------C-----CcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCC
Q psy14267 416 IDFGIACSLQDD--------K-----TSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGR 482 (553)
Q Consensus 416 ~DFGla~~~~~~--------~-----~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~ 482 (553)
+|||+.+..--. . ........|||+.|+|||++...+ |...+|||++|+++||.+-|+
T Consensus 185 TDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqg---------ygkpvdwwamGiIlyeFLVgc 255 (1205)
T KOG0606|consen 185 TDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQG---------YGKPVDWWAMGIILYEFLVGC 255 (1205)
T ss_pred cchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhc---------cCCCccHHHHHHHHHHHheee
Confidence 999997642111 0 011123568999999999998775 788999999999999999999
Q ss_pred CCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCC
Q psy14267 483 TPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538 (553)
Q Consensus 483 ~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt 538 (553)
.||.+...+ +.+..+. .+.+.+... ...++++++++|.++|+.+|..|.-
T Consensus 256 vpffGdtpe-elfg~vi--sd~i~wpE~---dea~p~Ea~dli~~LL~qnp~~Rlg 305 (1205)
T KOG0606|consen 256 VPFFGDTPE-ELFGQVI--SDDIEWPEE---DEALPPEAQDLIEQLLRQNPLCRLG 305 (1205)
T ss_pred eeccCCCHH-HHHhhhh--hhhcccccc---CcCCCHHHHHHHHHHHHhChHhhcc
Confidence 999886554 3333333 223333322 3367899999999999999999963
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.8e-20 Score=175.76 Aligned_cols=190 Identities=15% Similarity=0.127 Sum_probs=134.1
Q ss_pred EEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchh-HHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEE
Q psy14267 259 QVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQS-IADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLY 337 (553)
Q Consensus 259 ~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~-~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~ 337 (553)
.+...|++|+||+||++.. .+ .+++.+.+......... ....+.+|+++|++|.++++|+.++++ ...+
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~--~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~------~~~~ 74 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GE--RKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW------DGRH 74 (218)
T ss_pred ccceeecCCCcceEEEeec--CC--ceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE------cCEE
Confidence 4567899999999998754 22 33776666544432111 123578999999999888999999774 2358
Q ss_pred EEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCC-CCCCEEEecCccceecCCCCeEEE
Q psy14267 338 VLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDL-KPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 338 iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDL-Kp~NILl~~~~~~~~~~~~~~vkL 415 (553)
++|++.. .+|...+.. .. ..++.|++.+|+++|++||||||| ||+|||++.+ +.++|
T Consensus 75 lvmeyI~G~~L~~~~~~------~~------~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~---------g~i~L 133 (218)
T PRK12274 75 LDRSYLAGAAMYQRPPR------GD------LAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQED---------GSPAV 133 (218)
T ss_pred EEEeeecCccHHhhhhh------hh------HHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCC---------CCEEE
Confidence 8899754 455432211 01 123458999999999999999999 7999999765 56999
Q ss_pred EeccCccccCCCCCc---cc--------ccCCccCCCccCcccccccCCCCCCCccCCC-ccchHHHHHHHHHHHHhCCC
Q psy14267 416 IDFGIACSLQDDKTS---VH--------KDTASGTLNYMSPEAAGQTSSSGGGNTYRIT-YKSDVWSLGCILYNMIYGRT 483 (553)
Q Consensus 416 ~DFGla~~~~~~~~~---~~--------~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s-~~sDIwSlGvvl~elltG~~ 483 (553)
+|||+|......... .. .....+++.|++|+...... ..+ .+.++++.|+-+|.++|+..
T Consensus 134 IDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~--------~~~~~~~~w~~~g~~~~~~~~~~~ 205 (218)
T PRK12274 134 IDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLK--------RTSWIRELWFATGKPVYRFVTRRV 205 (218)
T ss_pred EECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhc--------cchhHHHHHHHhcchHHHHHhccC
Confidence 999999865543321 00 11223788999998765432 123 56799999999999999999
Q ss_pred CCCC
Q psy14267 484 PYSH 487 (553)
Q Consensus 484 Pf~~ 487 (553)
+...
T Consensus 206 ~~~~ 209 (218)
T PRK12274 206 LHWE 209 (218)
T ss_pred Cccc
Confidence 8754
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.4e-20 Score=180.20 Aligned_cols=175 Identities=15% Similarity=0.202 Sum_probs=128.0
Q ss_pred cCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHH------HHHHHHHHHhhcCCCceeEeeeE
Q psy14267 254 NGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADS------YLNEVELLAKLQGCPYVIKMHDY 327 (553)
Q Consensus 254 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~------~~~E~~iL~~l~~hp~Iv~l~~~ 327 (553)
...+|++.++||.|+||.||++.. . .+.+|||++.......+....+ +.+|++.+.++. |++|..+.++
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~---~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~-~~GI~~~~d~ 103 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-D---YGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVR-SEGLASLNDF 103 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-C---CCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHH-HCCCCcceEe
Confidence 356899999999999999999755 2 2349999998766555555455 579999999995 5999999888
Q ss_pred EEeCC------CceEEEEEecCCC-CHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEec
Q psy14267 328 VYDTA------SKHLYVLMEKGDT-DLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVG 400 (553)
Q Consensus 328 ~~~~~------~~~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~ 400 (553)
+.... ....+++||+..| +|.++... . .. ...+++.+|..||+.|++||||||.||+++.
T Consensus 104 ~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~~-------~--~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~ 170 (232)
T PRK10359 104 YLLAERKTLRYAHTYIMLIEYIEGVELNDMPEI-------S--ED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSK 170 (232)
T ss_pred eeecccccccccCCeEEEEEEECCccHHHhhhc-------c--HH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeC
Confidence 66543 2357899998665 67665211 1 11 2348999999999999999999999999976
Q ss_pred CccceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHH
Q psy14267 401 NVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI 479 (553)
Q Consensus 401 ~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ell 479 (553)
+ + ++|+|||........... . .++... .|..++|+|+||+++..+.
T Consensus 171 ~---------g-i~liDfg~~~~~~e~~a~-d-------------~~vler---------~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 171 N---------G-LRIIDLSGKRCTAQRKAK-D-------------RIDLER---------HYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred C---------C-EEEEECCCcccccchhhH-H-------------HHHHHh---------HhcccccccceeEeehHHH
Confidence 5 5 999999987655322111 0 022222 2557899999999988664
|
|
| >KOG1240|consensus | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.4e-21 Score=210.96 Aligned_cols=262 Identities=19% Similarity=0.239 Sum_probs=174.9
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCC-cCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSD-ITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
+|...+.||++.|=+|.+|++..+ .|+||++-+.. ...-....+-+.|++ ..+..+||++.+.-. ...++.
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG----~vVvKVFvk~~p~~sL~~~~qrL~~ik--~~l~~~pn~lPfqk~--~~t~kA 95 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREG----LVVVKVFVKQDPTISLRPFKQRLEEIK--FALMKAPNCLPFQKV--LVTDKA 95 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCc----eEEEEEEeccCCCCCchHHHHHHHHHH--HHhhcCCcccchHHH--HHhhHH
Confidence 688999999999999998855433 29999997665 222222344455555 344456999887543 244566
Q ss_pred EEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 336 LYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 336 ~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
.||+-.|...+|++.+..++- ........++.|++.||..+|..||+|+|||.+||||+.= +=+.|
T Consensus 96 AylvRqyvkhnLyDRlSTRPF-----L~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSW---------NW~~L 161 (1431)
T KOG1240|consen 96 AYLVRQYVKHNLYDRLSTRPF-----LVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSW---------NWLYL 161 (1431)
T ss_pred HHHHHHHHhhhhhhhhccchH-----HHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeee---------chhhh
Confidence 678878888888887765542 2233444556799999999999999999999999999643 23789
Q ss_pred EeccCcccc--CCCC---CcccccCCccCCCccCcccccccC-CCCCCCcc-CCCccchHHHHHHHHHHHHh-CCCCCCC
Q psy14267 416 IDFGIACSL--QDDK---TSVHKDTASGTLNYMSPEAAGQTS-SSGGGNTY-RITYKSDVWSLGCILYNMIY-GRTPYSH 487 (553)
Q Consensus 416 ~DFGla~~~--~~~~---~~~~~~~~~Gt~~y~APE~l~~~~-~~~~~~~~-~~s~~sDIwSlGvvl~ellt-G~~Pf~~ 487 (553)
+||..-+.. .... ......+...-..|+|||.+-... ....++.. ..+++.||||+||+++||++ |++||.-
T Consensus 162 tDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L 241 (1431)
T KOG1240|consen 162 TDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL 241 (1431)
T ss_pred hcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH
Confidence 999764332 1111 111122333455899999987543 11122222 37899999999999999987 7999853
Q ss_pred CCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q psy14267 488 IPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINN 548 (553)
Q Consensus 488 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~ 548 (553)
..+...+.+. .......++.. -+..++.+|..|++.||++|.++++.|+.-+.
T Consensus 242 -----SQL~aYr~~~-~~~~e~~Le~I--ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 242 -----SQLLAYRSGN-ADDPEQLLEKI--EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred -----HHHHhHhccC-ccCHHHHHHhC--cCccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 2233322221 11111111111 13479999999999999999999999987655
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=1e-19 Score=173.74 Aligned_cols=142 Identities=16% Similarity=0.156 Sum_probs=98.0
Q ss_pred EeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchh-----------------------HHHHHHHHHHHHHhhcC
Q psy14267 261 LSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQS-----------------------IADSYLNEVELLAKLQG 317 (553)
Q Consensus 261 ~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~-----------------------~~~~~~~E~~iL~~l~~ 317 (553)
...||+|+||.||+|.+. ++ +.||||+++........ ......+|+++|.++.+
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g--~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 78 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NG--EERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVT 78 (190)
T ss_pred CCccccccceEEEEEECC-CC--CEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHH
Confidence 467999999999999875 33 55999999865322111 01223459999999964
Q ss_pred CCceeEeeeEEEeCCCceEEEEEecCCCC-HHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHH-hhCCcEecCCCCCC
Q psy14267 318 CPYVIKMHDYVYDTASKHLYVLMEKGDTD-LSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEI-HAAGIIHSDLKPAN 395 (553)
Q Consensus 318 hp~Iv~l~~~~~~~~~~~~~iv~e~~~~~-L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yL-H~~gIiHrDLKp~N 395 (553)
++|.....+.. .. .+++||+.+++ +...+.... ......+..++.|++.+|+|| |+.|||||||||+|
T Consensus 79 -~~v~~p~~~~~--~~--~~iVmE~i~g~~l~~~~~~~~-----~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~N 148 (190)
T cd05147 79 -AGIPCPEPILL--KS--HVLVMEFIGDDGWAAPRLKDA-----PLSESKARELYLQVIQIMRILYQDCRLVHADLSEYN 148 (190)
T ss_pred -CCCCCCcEEEe--cC--CEEEEEEeCCCCCcchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHH
Confidence 55533322221 11 27999987654 333222211 234556677778999999999 79999999999999
Q ss_pred EEEecCccceecCCCCeEEEEeccCccccC
Q psy14267 396 FLFVGNVLKIIDCIGNVLKIIDFGIACSLQ 425 (553)
Q Consensus 396 ILl~~~~~~~~~~~~~~vkL~DFGla~~~~ 425 (553)
||++. +.++|+|||+|....
T Consensus 149 Ili~~----------~~v~LiDFG~a~~~~ 168 (190)
T cd05147 149 LLYHD----------GKLYIIDVSQSVEHD 168 (190)
T ss_pred EEEEC----------CcEEEEEccccccCC
Confidence 99974 359999999997553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG4158|consensus | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.3e-19 Score=179.01 Aligned_cols=211 Identities=22% Similarity=0.318 Sum_probs=144.3
Q ss_pred hcCCCceeEeeeEEEeC-------------------------CCceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHH
Q psy14267 315 LQGCPYVIKMHDYVYDT-------------------------ASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIM 369 (553)
Q Consensus 315 l~~hp~Iv~l~~~~~~~-------------------------~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~ 369 (553)
|..|||||++..+|.+. +...+|++|.....+|.+|+-.... +....+.
T Consensus 272 La~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~~~------s~r~~~~ 345 (598)
T KOG4158|consen 272 LAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTRHR------SYRTGRV 345 (598)
T ss_pred cCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcCCC------chHHHHH
Confidence 34579999888766532 2356899999888899999876532 1223344
Q ss_pred HHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEeccCccccCCCCCcc----cccCCccCCCccCc
Q psy14267 370 HWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSV----HKDTASGTLNYMSP 445 (553)
Q Consensus 370 ~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~----~~~~~~Gt~~y~AP 445 (553)
++.|+++|+.|||.+||.|||||++||||.-+. ..-..+.|+|||.|-.-...+-.. ..-...|...-|||
T Consensus 346 ~laQlLEav~hL~~hgvAhRDlKSDNiL~Eldd-----D~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAP 420 (598)
T KOG4158|consen 346 ILAQLLEAVTHLHKHGVAHRDLKSDNILLELDD-----DEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAP 420 (598)
T ss_pred HHHHHHHHHHHHHHccchhhcccccceEEEecC-----CCCcEEEEcccceeeeccccccccccccccccCCCcceecch
Confidence 456999999999999999999999999996553 233678999999874433322111 12244588899999
Q ss_pred ccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHH
Q psy14267 446 EAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSM 525 (553)
Q Consensus 446 E~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li 525 (553)
|+....+.. ....--.++|.|+.|.+.||++...-||..-.. ..+ .... .+...-| .-...+++.+++++
T Consensus 421 Ei~ta~PGp---~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe--m~L-~~r~--Yqe~qLP--alp~~vpp~~rqlV 490 (598)
T KOG4158|consen 421 EIATAVPGP---NAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE--MLL-DTRT--YQESQLP--ALPSRVPPVARQLV 490 (598)
T ss_pred hhhhcCCCC---ceeeccchhhhhhhhhhHHHHhccCCcccccch--hee-chhh--hhhhhCC--CCcccCChHHHHHH
Confidence 998765421 211123589999999999999999999976211 111 0111 1111111 12337889999999
Q ss_pred HHhcccCCCCCCCHHHHHHHH
Q psy14267 526 KLCLQKDPKARPTVGNSVTQI 546 (553)
Q Consensus 526 ~~cL~~dP~~RPt~~ell~~L 546 (553)
...|+.||.+|++..=.-+.|
T Consensus 491 ~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 491 FDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHhcCCccccCCccHHHhHH
Confidence 999999999999876544443
|
|
| >KOG1166|consensus | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.9e-19 Score=199.71 Aligned_cols=264 Identities=19% Similarity=0.225 Sum_probs=173.6
Q ss_pred cceEEecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeE
Q psy14267 248 QDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDY 327 (553)
Q Consensus 248 ~~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~ 327 (553)
.....+.+..|.|.+.||+|+||.||+|.... .+.||||+-+.....+-..-.+++..++ ++-+ +.|..+...
T Consensus 690 ~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~---~~~~alK~e~P~~~WEfYI~~q~~~RLk-~~~~---~~~~~~~~a 762 (974)
T KOG1166|consen 690 NTEFEVGGEKFCISKEIGEGSYGSVYVATHSN---GKLVALKVEKPPNPWEFYICLQVMERLK-PQML---PSIMHISSA 762 (974)
T ss_pred cceeeecceeEEEEeeeccccceEEEEeecCC---CcEEEEEeecCCCceeeeehHHHHHhhc-hhhh---cchHHHHHH
Confidence 34567788999999999999999999997766 3559999988776544222223333233 2222 334444332
Q ss_pred EEeCCCceEEEEEec-CCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCcccee
Q psy14267 328 VYDTASKHLYVLMEK-GDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKII 406 (553)
Q Consensus 328 ~~~~~~~~~~iv~e~-~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~ 406 (553)
+... +-.+++++| ..|+|.+++.... ...+..++.+..|++..+++||..+|||+||||+|+||......-
T Consensus 763 ~~~~--~~S~lv~ey~~~Gtlld~~N~~~-----~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~- 834 (974)
T KOG1166|consen 763 HVFQ--NASVLVSEYSPYGTLLDLINTNK-----VMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICAD- 834 (974)
T ss_pred HccC--CcceeeeeccccccHHHhhccCC-----CCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCC-
Confidence 2222 233566665 6689999988332 344566666777999999999999999999999999996543221
Q ss_pred cCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCC
Q psy14267 407 DCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYS 486 (553)
Q Consensus 407 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~ 486 (553)
...-.++|+|||.+..+..-.........++|-.+-.+|+..|.+ ++.++|.|.|..+++-||+|+.--
T Consensus 835 -~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grp---------WtYq~DyfGlAa~~h~mLFG~y~q- 903 (974)
T KOG1166|consen 835 -SDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRP---------WTYQIDYFGLAATVHVMLFGKYME- 903 (974)
T ss_pred -CcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCC---------CchhhhhHHHHHHHHHHHHHHHHH-
Confidence 223458999999987654332222334566888999999998885 788999999999999999996421
Q ss_pred CCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q psy14267 487 HIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNP 550 (553)
Q Consensus 487 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~ 550 (553)
.. ....+.......+.. --+...+++..+|+.|-..=|...+|...|+.+.
T Consensus 904 -----------~~-~g~~~~~~~~~~Ry~-~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~ 954 (974)
T KOG1166|consen 904 -----------VK-NGSSWMVKTNFPRYW-KRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVL 954 (974)
T ss_pred -----------hc-CCcceeccccchhhh-hHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHH
Confidence 11 111111111111100 0123457777788855555588888888877653
|
|
| >KOG0195|consensus | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.2e-20 Score=174.87 Aligned_cols=254 Identities=14% Similarity=0.235 Sum_probs=185.3
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
....+..+|.+...|+.|++++..+. +++|+++..+.+.. ....|..|.-.|+-. .||||+.+++.+-. ..+
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrwqgnd----ivakil~vr~~t~r-isrdfneefp~lrif-shpnilpvlgacns--ppn 261 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRWQGND----IVAKILNVREVTAR-ISRDFNEEFPALRIF-SHPNILPVLGACNS--PPN 261 (448)
T ss_pred hhhhhhhhhccCCCcccccccccCcc----hhhhhhhhhhcchh-hcchhhhhCcceeee-cCCchhhhhhhccC--CCC
Confidence 34567778999999999998776554 78899988876653 336678888888777 56999999987733 344
Q ss_pred EEEEE-ecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCC--cEecCCCCCCEEEecCccceecCCCCe
Q psy14267 336 LYVLM-EKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAG--IIHSDLKPANFLFVGNVLKIIDCIGNV 412 (553)
Q Consensus 336 ~~iv~-e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~g--IiHrDLKp~NILl~~~~~~~~~~~~~~ 412 (553)
+.++. .+..++|+.++...... .....+...++.+|+.||+|||+.. |.---|.+..|+||++.. ..
T Consensus 262 lv~isq~mp~gslynvlhe~t~v---vvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedlt-------ar 331 (448)
T KOG0195|consen 262 LVIISQYMPFGSLYNVLHEQTSV---VVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLT-------AR 331 (448)
T ss_pred ceEeeeeccchHHHHHHhcCccE---EEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhh-------hh
Confidence 44443 44567899988765432 3334556667789999999999875 334468889999998853 23
Q ss_pred EEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchH
Q psy14267 413 LKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTW 492 (553)
Q Consensus 413 vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~ 492 (553)
+-.+|--++.... .....|.||+||.+..++.+. --+++|+|||.++||||.|...||.++++..
T Consensus 332 ismad~kfsfqe~---------gr~y~pawmspealqrkped~------n~raadmwsfaillwel~trevpfadlspme 396 (448)
T KOG0195|consen 332 ISMADTKFSFQEV---------GRAYSPAWMSPEALQRKPEDL------NIRAADMWSFAILLWELNTREVPFADLSPME 396 (448)
T ss_pred eecccceeeeecc---------ccccCcccCCHHHHhcCchhc------chhhhhHHHHHHHHHHhhccccccccCCchh
Confidence 4455544432211 223578999999999876542 3468899999999999999999999988764
Q ss_pred HHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 493 AKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 493 ~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
.-+. +.-......++| +++..+..||.-|++.||.+||.+..|+-.|+.-
T Consensus 397 cgmk-ialeglrv~ipp------gis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 397 CGMK-IALEGLRVHIPP------GISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred hhhh-hhhccccccCCC------CccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 4443 332333333344 7889999999999999999999999999888764
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=2e-18 Score=164.74 Aligned_cols=142 Identities=19% Similarity=0.211 Sum_probs=100.1
Q ss_pred EeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCch-----------------------hHHHHHHHHHHHHHhhcC
Q psy14267 261 LSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQ-----------------------SIADSYLNEVELLAKLQG 317 (553)
Q Consensus 261 ~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~-----------------------~~~~~~~~E~~iL~~l~~ 317 (553)
.+.||+|+||.||+|.+. ++ +.||||++........ .....+..|.+.+.++.+
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g--~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 78 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DG--EELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYE 78 (190)
T ss_pred CceeecCCCcEEEEEEcC-CC--CEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHh
Confidence 468999999999999876 33 4599999987632110 001234689999999965
Q ss_pred CCceeEeeeEEEeCCCceEEEEEecCCCC-HHH-HHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhh-CCcEecCCCCC
Q psy14267 318 CPYVIKMHDYVYDTASKHLYVLMEKGDTD-LSK-YMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHA-AGIIHSDLKPA 394 (553)
Q Consensus 318 hp~Iv~l~~~~~~~~~~~~~iv~e~~~~~-L~~-~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~-~gIiHrDLKp~ 394 (553)
++|.....+... ..+++||+.++. +.. .+... .........++.|++.+|.+||. .||+||||||+
T Consensus 79 -~~i~~p~~~~~~----~~~lVmE~~~g~~~~~~~l~~~------~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~ 147 (190)
T cd05145 79 -AGVPVPEPILLK----KNVLVMEFIGDDGSPAPRLKDV------PLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEY 147 (190)
T ss_pred -CCCCCceEEEec----CCEEEEEEecCCCchhhhhhhc------cCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChh
Confidence 666544333322 137999987664 322 23221 12234455667799999999999 99999999999
Q ss_pred CEEEecCccceecCCCCeEEEEeccCccccCC
Q psy14267 395 NFLFVGNVLKIIDCIGNVLKIIDFGIACSLQD 426 (553)
Q Consensus 395 NILl~~~~~~~~~~~~~~vkL~DFGla~~~~~ 426 (553)
|||++ + +.++|+|||+|.....
T Consensus 148 NIll~-~---------~~~~liDFG~a~~~~~ 169 (190)
T cd05145 148 NILYH-D---------GKPYIIDVSQAVELDH 169 (190)
T ss_pred hEEEE-C---------CCEEEEEcccceecCC
Confidence 99997 3 4699999999977654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.3e-18 Score=164.51 Aligned_cols=140 Identities=16% Similarity=0.162 Sum_probs=101.6
Q ss_pred EeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcC----CCceeEeeeEEEeCCC-ce
Q psy14267 261 LSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG----CPYVIKMHDYVYDTAS-KH 335 (553)
Q Consensus 261 ~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~----hp~Iv~l~~~~~~~~~-~~ 335 (553)
.+.||+|+||.||. +..... .+||++...... ..+.+.+|+.+++.+.| ||||+++++++..... ..
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~---k~IKv~~~~~~~---~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~ 78 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQ---RCIKIVYHRGDG---GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGY 78 (210)
T ss_pred cceecCCCceEEEE--CCCCcC---eEEEEEeccccc---hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeE
Confidence 46899999999995 444332 479988765422 23678999999999953 7999999998866542 34
Q ss_pred EE-EEEecCC---CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHH-HHHhhCCcEecCCCCCCEEEecCccceecCCC
Q psy14267 336 LY-VLMEKGD---TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAV-KEIHAAGIIHSDLKPANFLFVGNVLKIIDCIG 410 (553)
Q Consensus 336 ~~-iv~e~~~---~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL-~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~ 410 (553)
++ ++|++.| ++|.+++.+.. .... ..++.|++.++ +|||+++||||||||+|||++... ...
T Consensus 79 v~~~I~e~~G~~~~tL~~~l~~~~----~~e~----~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~-----~~~ 145 (210)
T PRK10345 79 VYDVIADFDGKPSITLTEFAEQCR----YEED----VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRIS-----ESE 145 (210)
T ss_pred EEEEEecCCCCcchhHHHHHHccc----ccHh----HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccC-----CCC
Confidence 44 6799755 79999996632 1211 12345788777 999999999999999999997542 122
Q ss_pred CeEEEEeccCc
Q psy14267 411 NVLKIIDFGIA 421 (553)
Q Consensus 411 ~~vkL~DFGla 421 (553)
..++|+||+.+
T Consensus 146 ~~~~LiDg~G~ 156 (210)
T PRK10345 146 VIPVVCDNIGE 156 (210)
T ss_pred CcEEEEECCCC
Confidence 47999995544
|
|
| >KOG1023|consensus | Back alignment and domain information |
|---|
Probab=99.74 E-value=7.4e-18 Score=178.77 Aligned_cols=220 Identities=20% Similarity=0.326 Sum_probs=159.0
Q ss_pred HhhcCCCceeEeeeEEEeCCCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCc-EecC
Q psy14267 313 AKLQGCPYVIKMHDYVYDTASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGI-IHSD 390 (553)
Q Consensus 313 ~~l~~hp~Iv~l~~~~~~~~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gI-iHrD 390 (553)
+.+. |.|+.++++.+++. ...+++.++| -|+|.+.+.... ..........+.++|+.||+|||.-.| .|+-
T Consensus 2 ~~l~-h~n~~~f~g~~~~~--~~~~~i~~~c~rGsl~D~i~~~~----~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~ 74 (484)
T KOG1023|consen 2 RQLD-HDNLNKFIGASVDG--PEMIVIWEYCSRGSLLDILSNED----IKLDYFFILSFIRDISKGLAYLHNSPIGYHGA 74 (484)
T ss_pred cccc-hhhhhhheeeEecC--CceEEEEeeecCccHHhHHhccc----cCccHHHHHHHHHHHHHHHHHHhcCcceeeee
Confidence 3453 59999999988775 5666666655 488999888733 244556666777899999999998776 9999
Q ss_pred CCCCCEEEecCccceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHH
Q psy14267 391 LKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWS 470 (553)
Q Consensus 391 LKp~NILl~~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwS 470 (553)
|++.|++++.. ..+||+|||+.................-...|.|||.+++..... .....+.+.||||
T Consensus 75 l~s~nClvd~~---------w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~--~~~~~~~~gdiYs 143 (484)
T KOG1023|consen 75 LKSSNCLVDSR---------WVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQS--LESALTQKGDIYS 143 (484)
T ss_pred eccccceeeee---------EEEEechhhhcccccccccccccchhHHHHhccCHHHhccccccc--ccccccccCCeeh
Confidence 99999999988 479999999987765311111111222466899999998753221 0012478899999
Q ss_pred HHHHHHHHHhCCCCCCCCCch---HHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q psy14267 471 LGCILYNMIYGRTPYSHIPNT---WAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQIN 547 (553)
Q Consensus 471 lGvvl~elltG~~Pf~~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~ 547 (553)
||++++|+++...||...... ...+..+.. .....+.|.+......++++..+++.||..+|++||+++.+...++
T Consensus 144 ~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~-~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~ 222 (484)
T KOG1023|consen 144 FGIIMYEILFRSGPFDLRNLVEDPDEIILRVKK-GGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLL 222 (484)
T ss_pred HHHHHHHHHhccCccccccccCChHHHHHHHHh-cCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhh
Confidence 999999999999999863322 223333333 2233344544433366678999999999999999999999999988
Q ss_pred cCCC
Q psy14267 548 NNPE 551 (553)
Q Consensus 548 ~~~~ 551 (553)
....
T Consensus 223 ~~~~ 226 (484)
T KOG1023|consen 223 TINK 226 (484)
T ss_pred hhcc
Confidence 7654
|
|
| >KOG1033|consensus | Back alignment and domain information |
|---|
Probab=99.71 E-value=9.4e-18 Score=175.09 Aligned_cols=246 Identities=22% Similarity=0.343 Sum_probs=158.2
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCcc-ceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEee--e----EEE
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEF-KPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMH--D----YVY 329 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~-~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~--~----~~~ 329 (553)
.+.+.+.++..++|.++..+....... .-++.|..+.+.. .......+++-.+.-..+|+..+..- . .+.
T Consensus 245 s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~---~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~ 321 (516)
T KOG1033|consen 245 SSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSL---CACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSK 321 (516)
T ss_pred cccccccccccccCCchhhhhcccchhhhhccchhhhccch---hhhhhhhhhhhheeccccCCcccccCCCCchhhhcc
Confidence 466677788888888875543333111 1134443333321 22345566777776666766655432 0 011
Q ss_pred eCC---CceEEEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccce
Q psy14267 330 DTA---SKHLYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKI 405 (553)
Q Consensus 330 ~~~---~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~ 405 (553)
... ..++||.|+.|. .+|.+++++....... .+..+..++.|++.|++| ++.+|||+||.||++..+
T Consensus 322 ~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~--s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d---- 392 (516)
T KOG1033|consen 322 RNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEER--SLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDD---- 392 (516)
T ss_pred ccccccccchhhhhhhhhhhhHHHHhhCCCccccc--chhHHHHHHHhhccchhh---ccchhhhccccccccccc----
Confidence 111 236889999765 6799999765544433 344556667799999999 999999999999998666
Q ss_pred ecCCCCeEEEEeccCccccCCCC----CcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-
Q psy14267 406 IDCIGNVLKIIDFGIACSLQDDK----TSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY- 480 (553)
Q Consensus 406 ~~~~~~~vkL~DFGla~~~~~~~----~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt- 480 (553)
..+||+|||+........ .........||..||+||.+.+. .|+.++||||||++|+||+.
T Consensus 393 -----~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~---------~y~~kvdIyaLGlil~EL~~~ 458 (516)
T KOG1033|consen 393 -----DQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQ---------QYSEKVDIYALGLILAELLIQ 458 (516)
T ss_pred -----hhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhh---------hhhhhcchhhHHHHHHHHHHH
Confidence 579999999988776544 11123356799999999999977 48999999999999999986
Q ss_pred CCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCH
Q psy14267 481 GRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTV 539 (553)
Q Consensus 481 G~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~ 539 (553)
=...+.. ...+..+... .+++.... +. +.-..|+.++|...|.+||++
T Consensus 459 f~T~~er----~~t~~d~r~g----~ip~~~~~--d~-p~e~~ll~~lls~~p~~RP~~ 506 (516)
T KOG1033|consen 459 FSTQFER----IATLTDIRDG----IIPPEFLQ--DY-PEEYTLLQQLLSPSPEERPSA 506 (516)
T ss_pred hccHHHH----HHhhhhhhcC----CCChHHhh--cC-cHHHHHHHHhcCCCcccCchH
Confidence 2222211 1112222211 11211111 12 355789999999999999943
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.1e-16 Score=157.98 Aligned_cols=149 Identities=17% Similarity=0.117 Sum_probs=102.5
Q ss_pred CcceEEEeeeeeeCceEEEEEe-eeCCCccceEEEEEEecCCcCc---------------------hhHHHHHHHHHHHH
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVG-GTSEHEFKPLALKVVDLSDITD---------------------QSIADSYLNEVELL 312 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~-~~~~~~~~~vAvK~l~~~~~~~---------------------~~~~~~~~~E~~iL 312 (553)
+.-|.+.+.||+|+||.||+|. +..++ +.||||++....... +.....+.+|+.++
T Consensus 27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g--~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L 104 (237)
T smart00090 27 GILSAIGGCISTGKEANVYHALDFDGSG--KERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNL 104 (237)
T ss_pred CchHHhCCeeccCcceeEEEEEecCCCC--cEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHH
Confidence 4468999999999999999997 44444 459999998653210 00113457899999
Q ss_pred HhhcC-CCceeEeeeEEEeCCCceEEEEEecCCC-CHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCC-cEec
Q psy14267 313 AKLQG-CPYVIKMHDYVYDTASKHLYVLMEKGDT-DLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAG-IIHS 389 (553)
Q Consensus 313 ~~l~~-hp~Iv~l~~~~~~~~~~~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~g-IiHr 389 (553)
.++.+ ...+..++++ . ..+++||+.++ +|...+.... ......+..++.|++.+|++||+.| |+||
T Consensus 105 ~~L~~~~i~~p~~~~~-----~-~~~lV~E~~~g~~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~ 173 (237)
T smart00090 105 QRLYEAGVPVPKPIAW-----R-RNVLVMEFIGGDGLPAPRLKDV-----EPEEEEEFELYDDILEEMRKLYKEGELVHG 173 (237)
T ss_pred HHHHhcCCCCCeeeEe-----c-CceEEEEEecCCcccccccccC-----CcchHHHHHHHHHHHHHHHHHHhcCCEEeC
Confidence 99965 1233344332 1 23788998766 3433321111 2223334566779999999999999 9999
Q ss_pred CCCCCCEEEecCccceecCCCCeEEEEeccCccccCC
Q psy14267 390 DLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQD 426 (553)
Q Consensus 390 DLKp~NILl~~~~~~~~~~~~~~vkL~DFGla~~~~~ 426 (553)
||||+||+++ + +.++|+|||+|.....
T Consensus 174 Dikp~NIli~-~---------~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 174 DLSEYNILVH-D---------GKVVIIDVSQSVELDH 200 (237)
T ss_pred CCChhhEEEE-C---------CCEEEEEChhhhccCC
Confidence 9999999997 3 4699999999865433
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.63 E-value=4.1e-15 Score=143.73 Aligned_cols=136 Identities=21% Similarity=0.246 Sum_probs=99.8
Q ss_pred eeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchh-----HHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceE
Q psy14267 262 SLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQS-----IADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHL 336 (553)
Q Consensus 262 ~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~-----~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~ 336 (553)
+.||+|++|.||++.. .+ ..|+||+.......... ...++.+|+.++..+.+ ++|.....++.+. ...
T Consensus 2 ~~l~~G~~~~vy~~~~--~~--~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~-~~i~~p~~~~~~~--~~~ 74 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LG--IKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARK-AGVNVPAVYFVDP--ENF 74 (211)
T ss_pred cccccCceEEEEEEee--CC--CceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHH-CCCCCCeEEEEeC--CCC
Confidence 5799999999999976 22 33899987644332211 12467899999999965 6666655554433 346
Q ss_pred EEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 337 YVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 337 ~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
+++||+. |.+|.+++..... ....++.+++.+|.+||+.|++|||++|.|||++ + +.++|
T Consensus 75 ~lv~e~~~G~~L~~~~~~~~~---------~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~---------~~~~l 135 (211)
T PRK14879 75 IIVMEYIEGEPLKDLINSNGM---------EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-G---------GKIYL 135 (211)
T ss_pred EEEEEEeCCcCHHHHHHhccH---------HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-C---------CCEEE
Confidence 7788875 6688888764321 3455567999999999999999999999999997 2 46899
Q ss_pred EeccCccc
Q psy14267 416 IDFGIACS 423 (553)
Q Consensus 416 ~DFGla~~ 423 (553)
+|||++..
T Consensus 136 iDf~~a~~ 143 (211)
T PRK14879 136 IDFGLAEF 143 (211)
T ss_pred EECCcccC
Confidence 99998865
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.62 E-value=5.7e-15 Score=141.50 Aligned_cols=133 Identities=24% Similarity=0.262 Sum_probs=94.8
Q ss_pred eeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCch-----hHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEE
Q psy14267 263 LLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQ-----SIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLY 337 (553)
Q Consensus 263 ~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~-----~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~ 337 (553)
.||+|+||.||++... + +.|++|+......... ....++.+|++++..+.+ +++.....++.. ....+
T Consensus 1 ~ig~G~~~~vy~~~~~--~--~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~-~~i~~p~~~~~~--~~~~~ 73 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL--G--LKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARK-AGVNTPVVYDVD--PDNKT 73 (199)
T ss_pred CCCCCceEEEEEeecC--C--ccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHH-CCCCCCEEEEEE--CCCCE
Confidence 4899999999999742 2 3489998655432221 123567899999999976 443333323333 33457
Q ss_pred EEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEE
Q psy14267 338 VLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKII 416 (553)
Q Consensus 338 iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~ 416 (553)
++||+. +++|.+++..... .++.+++.+|.+||+.|++|||++|.||+++ + +.++|+
T Consensus 74 lv~e~~~g~~l~~~~~~~~~------------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~---------~~~~li 131 (199)
T TIGR03724 74 IVMEYIEGKPLKDVIEEGND------------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-D---------DKLYLI 131 (199)
T ss_pred EEEEEECCccHHHHHhhcHH------------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-C---------CcEEEE
Confidence 888875 6778777654211 3456999999999999999999999999997 3 469999
Q ss_pred eccCcccc
Q psy14267 417 DFGIACSL 424 (553)
Q Consensus 417 DFGla~~~ 424 (553)
|||++...
T Consensus 132 Dfg~a~~~ 139 (199)
T TIGR03724 132 DFGLGKYS 139 (199)
T ss_pred ECCCCcCC
Confidence 99998653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.9e-17 Score=181.53 Aligned_cols=261 Identities=20% Similarity=0.275 Sum_probs=183.1
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceE
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHL 336 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~ 336 (553)
.|.+.+.||+|+|+.|-++....... ..+|+|.+.... .......+...|..+-+.+..|.|++.+++.. ......
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~-~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~--~~~~~~ 96 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPE-SSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS--SSPRSY 96 (601)
T ss_pred cccccccccccccchhhhhhhcCCCc-ceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCcc--CCCccc
Confidence 47788889999999998776543332 336777665544 23344466677888888887689999998765 344556
Q ss_pred EEEEec-CCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHh-hCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 337 YVLMEK-GDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIH-AAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 337 ~iv~e~-~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH-~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
++.+++ .++++..-+.... .. .......-.++.|+..++.|+| ..++.||||||+|.+++... ..+|
T Consensus 97 ~~~~~~s~g~~~f~~i~~~~-~~--~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~--------~~l~ 165 (601)
T KOG0590|consen 97 LLSLSYSDGGSLFSKISHPD-ST--GTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESG--------SALK 165 (601)
T ss_pred ccccCcccccccccccccCC-cc--CCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCC--------Cccc
Confidence 666665 4556655552111 10 1111223334569999999999 99999999999999997762 1789
Q ss_pred EEeccCccccCC-CCCcccccCCcc-CCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchH
Q psy14267 415 IIDFGIACSLQD-DKTSVHKDTASG-TLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTW 492 (553)
Q Consensus 415 L~DFGla~~~~~-~~~~~~~~~~~G-t~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~ 492 (553)
++|||+|..+.. .+........+| ++.|+|||...+..+ .....|+||.|+++.-+++|..||.......
T Consensus 166 ~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~--------~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~ 237 (601)
T KOG0590|consen 166 IADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAY--------RGPSVDVWSLGIVLSAMLTGELPWDFPSRKD 237 (601)
T ss_pred CCCchhhccccccCCcceeeecccCCCCCCCCcccccchhh--------cCCCcccccccccccccccCCCCcccccccc
Confidence 999999998877 444444456778 999999999987533 3578999999999999999999998643322
Q ss_pred HHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy14267 493 AKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVT 544 (553)
Q Consensus 493 ~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~ 544 (553)
.....+..... ......+..++....+++.+++..+|..|.+.+++..
T Consensus 238 ~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 238 GRYSSWKSNKG----RFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ccceeeccccc----ccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 11111111110 1123345578889999999999999999999887753
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=3.4e-15 Score=143.34 Aligned_cols=140 Identities=26% Similarity=0.187 Sum_probs=97.9
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCch-------------------hHHHHHHHHHHHHHhhcC
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQ-------------------SIADSYLNEVELLAKLQG 317 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~-------------------~~~~~~~~E~~iL~~l~~ 317 (553)
.|.+.+.||+|+||.||++... ++ +.||||++........ .....+..|..++.++.+
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 92 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DG--NPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYE 92 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CC--CEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHH
Confidence 4888899999999999999764 33 4599999875431100 011236789999999855
Q ss_pred CC--ceeEeeeEEEeCCCceEEEEEecCCC-CHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCC
Q psy14267 318 CP--YVIKMHDYVYDTASKHLYVLMEKGDT-DLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPA 394 (553)
Q Consensus 318 hp--~Iv~l~~~~~~~~~~~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~ 394 (553)
+ .+...++ ....+++||+..+ +|..+... .....++.+++.++.++|+.||+||||||+
T Consensus 93 -~~i~v~~~~~------~~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~ 154 (198)
T cd05144 93 -EGFPVPKPID------WNRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAYKHGIIHGDLSEF 154 (198)
T ss_pred -cCCCCCceee------cCCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcc
Confidence 4 3444332 1234788887554 55443220 112334568999999999999999999999
Q ss_pred CEEEecCccceecCCCCeEEEEeccCccccCC
Q psy14267 395 NFLFVGNVLKIIDCIGNVLKIIDFGIACSLQD 426 (553)
Q Consensus 395 NILl~~~~~~~~~~~~~~vkL~DFGla~~~~~ 426 (553)
||+|+.+ +.++|+|||++.....
T Consensus 155 Nill~~~---------~~~~liDfg~~~~~~~ 177 (198)
T cd05144 155 NILVDDD---------EKIYIIDWPQMVSTDH 177 (198)
T ss_pred cEEEcCC---------CcEEEEECCccccCCC
Confidence 9999765 5799999999966544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.59 E-value=8.9e-15 Score=138.63 Aligned_cols=140 Identities=20% Similarity=0.226 Sum_probs=91.5
Q ss_pred EeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHH---------------------HHHHHHHHHHhhcCC-
Q psy14267 261 LSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIAD---------------------SYLNEVELLAKLQGC- 318 (553)
Q Consensus 261 ~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~---------------------~~~~E~~iL~~l~~h- 318 (553)
.+.||+|+||.||+|.+. .+ +.||||++............ ....|...+.++.+.
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~--~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~ 78 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DG--EPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAG 78 (187)
T ss_pred CcccccccceeEEEEECC-CC--CEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcC
Confidence 467999999999999765 33 45999998765422211111 114677777777543
Q ss_pred CceeEeeeEEEeCCCceEEEEEecCCC-CHH-HHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhh-CCcEecCCCCCC
Q psy14267 319 PYVIKMHDYVYDTASKHLYVLMEKGDT-DLS-KYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHA-AGIIHSDLKPAN 395 (553)
Q Consensus 319 p~Iv~l~~~~~~~~~~~~~iv~e~~~~-~L~-~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~-~gIiHrDLKp~N 395 (553)
..+..++++ ...+++||+..+ .+. ..+...... .....++.+++.++.++|. .+|+||||||+|
T Consensus 79 ~~~~~~~~~------~~~~lv~e~~~g~~~~~~~l~~~~~~-------~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~N 145 (187)
T cd05119 79 VPVPKPIDL------NRHVLVMEFIGGDGIPAPRLKDVRLL-------EDPEELYDQILELMRKLYREAGLVHGDLSEYN 145 (187)
T ss_pred CCCCceEec------CCCEEEEEEeCCCCccChhhhhhhhc-------ccHHHHHHHHHHHHHHHhhccCcCcCCCChhh
Confidence 224444321 134788887665 111 111111100 2234556699999999999 999999999999
Q ss_pred EEEecCccceecCCCCeEEEEeccCccccCC
Q psy14267 396 FLFVGNVLKIIDCIGNVLKIIDFGIACSLQD 426 (553)
Q Consensus 396 ILl~~~~~~~~~~~~~~vkL~DFGla~~~~~ 426 (553)
|+++ + +.++|+|||.+.....
T Consensus 146 ili~-~---------~~~~liDfg~a~~~~~ 166 (187)
T cd05119 146 ILVD-D---------GKVYIIDVPQAVEIDH 166 (187)
T ss_pred EEEE-C---------CcEEEEECcccccccC
Confidence 9997 3 5699999999866544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.9e-14 Score=158.77 Aligned_cols=138 Identities=22% Similarity=0.220 Sum_probs=99.2
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcC-----chhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeC
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDIT-----DQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDT 331 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~-----~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~ 331 (553)
.|...+.||+|+||+||++...... +++|+....... .....+++.+|+++++++++ ++|+....+...
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~~~----~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~-~~i~~p~~~~~~- 407 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLGRD----AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARR-AGVPTPVIYDVD- 407 (535)
T ss_pred ccCccceeccCCcEEEEEEeecCcc----ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcc-cCCCeeEEEEEe-
Confidence 3566789999999999998664433 444443222211 11223578899999999965 777776555443
Q ss_pred CCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCC
Q psy14267 332 ASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIG 410 (553)
Q Consensus 332 ~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~ 410 (553)
....+++||+. +++|.+++.. ...++.+++.+|.|||+.||+||||||+|||++.
T Consensus 408 -~~~~~lv~E~~~g~~L~~~l~~-------------~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~~---------- 463 (535)
T PRK09605 408 -PEEKTIVMEYIGGKDLKDVLEG-------------NPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVRD---------- 463 (535)
T ss_pred -CCCCEEEEEecCCCcHHHHHHH-------------HHHHHHHHHHHHHHHHhCCCccCCCChHHEEEEC----------
Confidence 33456888875 6688877652 2344569999999999999999999999999943
Q ss_pred CeEEEEeccCcccc
Q psy14267 411 NVLKIIDFGIACSL 424 (553)
Q Consensus 411 ~~vkL~DFGla~~~ 424 (553)
+.++|+|||+++..
T Consensus 464 ~~~~liDFGla~~~ 477 (535)
T PRK09605 464 DRLYLIDFGLGKYS 477 (535)
T ss_pred CcEEEEeCcccccC
Confidence 36899999998653
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.54 E-value=8.4e-14 Score=137.72 Aligned_cols=139 Identities=19% Similarity=0.232 Sum_probs=94.1
Q ss_pred eeee-eeCceEEEEEeeeCCCccceEEEEEEecCCc----C------chhHHHHHHHHHHHHHhhcCCCc--eeEeeeEE
Q psy14267 262 SLLG-KGGSSSVYLVGGTSEHEFKPLALKVVDLSDI----T------DQSIADSYLNEVELLAKLQGCPY--VIKMHDYV 328 (553)
Q Consensus 262 ~~LG-~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~----~------~~~~~~~~~~E~~iL~~l~~hp~--Iv~l~~~~ 328 (553)
..|| .|+.|+||.++.. + ..++||.+....+ . ......++.+|+.++.+|.+ ++ ++..+++.
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~--~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~-~gi~vP~pl~~~ 111 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--G--VNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYE-AGLPVPRPIAAR 111 (239)
T ss_pred ceeecCCCCccEEEEEeC--C--ceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHh-CCCCCceeEeee
Confidence 3566 6777777777543 2 3489998865332 0 11223578899999999965 44 46666554
Q ss_pred EeCCCc--eEEEEEecCC--CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccc
Q psy14267 329 YDTASK--HLYVLMEKGD--TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLK 404 (553)
Q Consensus 329 ~~~~~~--~~~iv~e~~~--~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~ 404 (553)
...... ..+++|++.. .+|.+++.... .... .+.+++.+|.+||+.||+||||||+|||++.+
T Consensus 112 ~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~~------l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~--- 178 (239)
T PRK01723 112 VVRHGLFYRADILIERIEGARDLVALLQEAP------LSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPD--- 178 (239)
T ss_pred eeecCcceeeeEEEEecCCCCCHHHHHhcCC------CCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCC---
Confidence 333222 2258888655 47888775421 1111 13589999999999999999999999999765
Q ss_pred eecCCCCeEEEEeccCcccc
Q psy14267 405 IIDCIGNVLKIIDFGIACSL 424 (553)
Q Consensus 405 ~~~~~~~~vkL~DFGla~~~ 424 (553)
+.++|+|||.+...
T Consensus 179 ------~~v~LIDfg~~~~~ 192 (239)
T PRK01723 179 ------GKFWLIDFDRGELR 192 (239)
T ss_pred ------CCEEEEECCCcccC
Confidence 46999999987543
|
|
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.51 E-value=4.3e-14 Score=150.43 Aligned_cols=257 Identities=20% Similarity=0.237 Sum_probs=184.6
Q ss_pred cCcceEEEeeeee--eCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeC
Q psy14267 254 NGKQYQVLSLLGK--GGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDT 331 (553)
Q Consensus 254 ~~~~y~i~~~LG~--G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~ 331 (553)
....+.+.+.+|. |.+|.||.++.........+|+|.-+... .....-.+-++|+...+++..|++.++.+..+ .
T Consensus 112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~-s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~--e 188 (524)
T KOG0601|consen 112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPF-SPPLDSKRKLREFLSHHKIDSHENPVRDSPAW--E 188 (524)
T ss_pred hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCC-CCccccccccchhhcccccCccccccccCccc--c
Confidence 3456778899999 99999999877323333448988743322 11122245578888889998899999976655 5
Q ss_pred CCceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHH----HHHHHhhCCcEecCCCCCCEEEecCccceec
Q psy14267 332 ASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLL----AVKEIHAAGIIHSDLKPANFLFVGNVLKIID 407 (553)
Q Consensus 332 ~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~----aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~ 407 (553)
...++|+-+|.++.+|..+............ ++....+..+ ||.++|..+|+|-|+||+||++..+.
T Consensus 189 ~~~~lfiqtE~~~~sl~~~~~~~~~~~p~~~----l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~----- 259 (524)
T KOG0601|consen 189 GSGILFIQTELCGESLQSYCHTPCNFLPDNL----LWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDW----- 259 (524)
T ss_pred cCCcceeeeccccchhHHhhhcccccCCchh----hhhHHhhhhhcccccccccCCCcccccccchhheeccccc-----
Confidence 5778999999999999998887665443332 3333446677 99999999999999999999997762
Q ss_pred CCCCeEEEEeccCccccCCCCCcccc---cCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCC
Q psy14267 408 CIGNVLKIIDFGIACSLQDDKTSVHK---DTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTP 484 (553)
Q Consensus 408 ~~~~~vkL~DFGla~~~~~~~~~~~~---~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~P 484 (553)
...+++|||+...+......... ....|...|++||+..+. ++.++|||+||.++++..+|..+
T Consensus 260 ---~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l----------~~~~~di~sl~ev~l~~~l~~~~ 326 (524)
T KOG0601|consen 260 ---TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL----------ATFASDIFSLGEVILEAILGSHL 326 (524)
T ss_pred ---ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccc----------cchHhhhcchhhhhHhhHhhccc
Confidence 46899999999888776532111 122588899999999865 78999999999999999988766
Q ss_pred CCC-CCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy14267 485 YSH-IPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVT 544 (553)
Q Consensus 485 f~~-~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~ 544 (553)
... ....|..+.. ..++. +.....+.++...+..++..+|-.|++.+.+.+
T Consensus 327 ~~~g~~~~W~~~r~-------~~ip~--e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 327 PSVGKNSSWSQLRQ-------GYIPL--EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ccCCCCCCcccccc-------ccCch--hhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 543 2233332211 11111 111245567777999999999999999887764
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.8e-13 Score=123.26 Aligned_cols=133 Identities=24% Similarity=0.236 Sum_probs=98.3
Q ss_pred EEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCC-CceeEeeeEEEeCCCceEEE
Q psy14267 260 VLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGC-PYVIKMHDYVYDTASKHLYV 338 (553)
Q Consensus 260 i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~h-p~Iv~l~~~~~~~~~~~~~i 338 (553)
+++.||.|.++.||++.... +.+++|....... ...+.+|+.+++.+.++ .++..++.+. ......++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~----~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~--~~~~~~~~ 70 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD----EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASG--ESDGWSYL 70 (155)
T ss_pred cceecccccccceEEEEecC----CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEc--CCCCccEE
Confidence 45789999999999997644 3489999865432 35688999999999775 6777876654 33356788
Q ss_pred EEecCCCC-HHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhC---CcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 339 LMEKGDTD-LSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAA---GIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 339 v~e~~~~~-L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~---gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
+|++..+. +..+ .......++.+++.+|++||.. +++|+||+|+|||++.. +.++
T Consensus 71 v~e~~~g~~~~~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~---------~~~~ 129 (155)
T cd05120 71 LMEWIEGETLDEV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDG---------KILG 129 (155)
T ss_pred EEEecCCeecccC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECC---------cEEE
Confidence 88876543 3322 1122333456899999999984 79999999999999764 5799
Q ss_pred EEeccCcccc
Q psy14267 415 IIDFGIACSL 424 (553)
Q Consensus 415 L~DFGla~~~ 424 (553)
|+|||.+...
T Consensus 130 l~Df~~~~~~ 139 (155)
T cd05120 130 IIDWEYAGYG 139 (155)
T ss_pred EEecccccCC
Confidence 9999998643
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.17 E-value=2.9e-11 Score=128.97 Aligned_cols=255 Identities=20% Similarity=0.075 Sum_probs=166.1
Q ss_pred EecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeC
Q psy14267 252 TLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDT 331 (553)
Q Consensus 252 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~ 331 (553)
.....+|.++..||.|.|+.|+.+. +.......|++|.+.......... ..-+.|+.+...+.-|.+++.+..-+..
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~-~r~~~~~~Y~~ke~~~~l~~~~~d-i~sl~ev~l~~~l~~~~~~~g~~~~W~~- 337 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVS-KRPEGDCIYAAKELLNGLATFASD-IFSLGEVILEAILGSHLPSVGKNSSWSQ- 337 (524)
T ss_pred eeecCCcceeEEccCCccccceeee-ecCCCCceEeChhhhccccchHhh-hcchhhhhHhhHhhcccccCCCCCCccc-
Confidence 3445689999999999999999875 332233458999886654433222 3457888888888888888887654433
Q ss_pred CCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCC
Q psy14267 332 ASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIG 410 (553)
Q Consensus 332 ~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~ 410 (553)
....|+-.|++ ++++...+.- .. .......+.+..|++.++.++|++.++|+|+||+||++..+.
T Consensus 338 -~r~~~ip~e~~~~~s~~l~~~~-~~----~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~-------- 403 (524)
T KOG0601|consen 338 -LRQGYIPLEFCEGGSSSLRSVT-SQ----MLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG-------- 403 (524)
T ss_pred -cccccCchhhhcCcchhhhhHH-HH----hcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch--------
Confidence 33455777776 4444333311 11 111122233345999999999999999999999999997652
Q ss_pred CeEEEEeccCccccCCCCCcccccCCccCCCcc-CcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy14267 411 NVLKIIDFGIACSLQDDKTSVHKDTASGTLNYM-SPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIP 489 (553)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~-APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~ 489 (553)
..-+++|||..+.+.-... .....-+++ ..|++... +.+..+.|++|||..+.|.++|..--...
T Consensus 404 ~~~~~~~~~~~t~~~~~~~-----~~~~~~r~~p~~~~~~e~--------~~~~~~~~~~sl~~~~~e~~~~~~ls~~~- 469 (524)
T KOG0601|consen 404 FFSKLGDFGCWTRLAFSSG-----VFHHIDRLYPIAEILLED--------YPHLSKADIFSLGLSVDEAITGSPLSESG- 469 (524)
T ss_pred hhhhccccccccccceecc-----cccccccccccchhhccc--------cccccccccccccccccccccCcccCccc-
Confidence 4579999999875332222 222333444 25555433 24678999999999999999986432221
Q ss_pred chHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q psy14267 490 NTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINN 548 (553)
Q Consensus 490 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~ 548 (553)
..|. ......+.........+..+.+.++..++..||.+.++..+.+-
T Consensus 470 ~~~~-----------~i~~~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 470 VQSL-----------TIRSGDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred ccce-----------eeecccccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 1111 11122233333444788899999999999999999988776553
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.15 E-value=2.3e-11 Score=136.01 Aligned_cols=253 Identities=17% Similarity=0.202 Sum_probs=168.4
Q ss_pred cCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCC
Q psy14267 254 NGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTAS 333 (553)
Q Consensus 254 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~ 333 (553)
.-+.+.+.+-+-+|.++.++.+.-...+.. .++|+..+.........+....+-.++... ++|.++....- ....
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~--~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p-~~P~v~~~~~s--~~~r 876 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHT--RPSKVHGLAPKIRTNDYESIRSKSNILITP-RSPAVVRSFPS--FPCR 876 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccc--cchhhhccchhhccccccccCCccCccccC-CCCceecccCC--CCCC
Confidence 345688888999999999998866665544 677776665544433344455555554333 44777765322 1334
Q ss_pred ceEEEEEec-CCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCe
Q psy14267 334 KHLYVLMEK-GDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNV 412 (553)
Q Consensus 334 ~~~~iv~e~-~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~ 412 (553)
...+++|++ ++++|...++..+-..... .......+.++++|||...++|||+||.|+|+..+ +.
T Consensus 877 sP~~L~~~~~~~~~~~Skl~~~~~~saep-----aRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~---------gh 942 (1205)
T KOG0606|consen 877 SPLPLVGHYLNGGDLPSKLHNSGCLSAEP-----ARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYD---------GH 942 (1205)
T ss_pred CCcchhhHHhccCCchhhhhcCCCccccc-----ccchhHHHHhhhhccccchhhcccccccchhhccc---------CC
Confidence 567788775 5677877777665222211 12222378899999999999999999999998766 67
Q ss_pred EEEEeccCccccCC------C---------------CC--------cccccCCccCCCccCcccccccCCCCCCCccCCC
Q psy14267 413 LKIIDFGIACSLQD------D---------------KT--------SVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRIT 463 (553)
Q Consensus 413 vkL~DFGla~~~~~------~---------------~~--------~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s 463 (553)
.+++|||+...... . .. ........||+.|++||.+.+.. -.
T Consensus 943 ~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~---------hg 1013 (1205)
T KOG0606|consen 943 RPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR---------HG 1013 (1205)
T ss_pred cccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc---------CC
Confidence 89999984322110 0 00 00122456999999999998875 35
Q ss_pred ccchHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHH
Q psy14267 464 YKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVG 540 (553)
Q Consensus 464 ~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ 540 (553)
..+|+|++|++++|.++|.+||...... .....+..... +........+..+++++...+..+|.+|..+.
T Consensus 1014 s~ad~~~~g~~l~e~l~g~pp~na~tpq-~~f~ni~~~~~-----~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1014 SAADWWSSGVCLFEVLTGIPPFNAETPQ-QIFENILNRDI-----PWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CcchhhhhhhhhhhhhcCCCCCCCcchh-hhhhccccCCC-----CCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 6899999999999999999999874332 22222221111 11222335678999999999999999998765
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.14 E-value=2.6e-10 Score=122.57 Aligned_cols=144 Identities=17% Similarity=0.148 Sum_probs=90.7
Q ss_pred eeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCc---------------------------h----hHHH------H
Q psy14267 262 SLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITD---------------------------Q----SIAD------S 304 (553)
Q Consensus 262 ~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~---------------------------~----~~~~------~ 304 (553)
+.||.|++|.||+|+..++ +.||||+.+...... . +... .
T Consensus 123 ~plasaSigQVh~A~l~~G---~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eld 199 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDG---KEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELD 199 (437)
T ss_pred cceeeeehhheEEEEecCC---CEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHC
Confidence 5699999999999976533 459999986542100 0 0000 2
Q ss_pred HHHHHHHHHhhc----CCCceeEeeeEEEeCCCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHH-HH
Q psy14267 305 YLNEVELLAKLQ----GCPYVIKMHDYVYDTASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLL-AV 378 (553)
Q Consensus 305 ~~~E~~iL~~l~----~hp~Iv~l~~~~~~~~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~-aL 378 (553)
+.+|++.+.+++ ++++|.-.. ++. ......+++||+. |.+|.++........ ... .++.+++. .+
T Consensus 200 f~~Ea~n~~~~~~~~~~~~~v~vP~-v~~-~~~~~~vLvmE~i~G~~L~~~~~~~~~~~----~~~---~ia~~~~~~~l 270 (437)
T TIGR01982 200 LRREAANASELGENFKNDPGVYVPE-VYW-DRTSERVLTMEWIDGIPLSDIAALDEAGL----DRK---ALAENLARSFL 270 (437)
T ss_pred HHHHHHHHHHHHHhcCCCCCEEeCC-Eeh-hhcCCceEEEEeECCcccccHHHHHhcCC----CHH---HHHHHHHHHHH
Confidence 456666666654 345544332 222 2223458889976 456666554321110 111 12234444 47
Q ss_pred HHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEeccCccccCC
Q psy14267 379 KEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQD 426 (553)
Q Consensus 379 ~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGla~~~~~ 426 (553)
..+|..|++|+|+||.||+++.+ +.++|+|||++..+..
T Consensus 271 ~ql~~~g~~H~D~hPgNilv~~~---------g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 271 NQVLRDGFFHADLHPGNIFVLKD---------GKIIALDFGIVGRLSE 309 (437)
T ss_pred HHHHhCCceeCCCCcccEEECCC---------CcEEEEeCCCeeECCH
Confidence 88999999999999999999765 5799999999987764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.13 E-value=2.4e-10 Score=106.15 Aligned_cols=127 Identities=20% Similarity=0.156 Sum_probs=86.0
Q ss_pred EeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEEEEE
Q psy14267 261 LSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLM 340 (553)
Q Consensus 261 ~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~iv~ 340 (553)
++.|+.|.++.||+++.. .+.|++|+....... ...+.+|+.+++.+.+...+.+++.+ +.. ..+++|
T Consensus 3 ~~~l~~G~~~~vy~~~~~----~~~~~lK~~~~~~~~----~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~--~~~lv~ 70 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA----NKKYVVRIPGNGTEL----LINRENEAENSKLAAEAGIGPKLYYF--DPE--TGVLIT 70 (170)
T ss_pred eeecCCcccCceEEEEEC----CeEEEEEeCCCCccc----ccCHHHHHHHHHHHHHhCCCCceEEE--eCC--CCeEEE
Confidence 467899999999998654 234999987544211 12457899999988664444555443 222 236788
Q ss_pred ecCCC-CHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCc-----EecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 341 EKGDT-DLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGI-----IHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 341 e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gI-----iHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
|+..+ ++... . . . ....+.+++.+|+.||..++ +|+|++|.||+++. +.++
T Consensus 71 e~i~G~~l~~~-----~--~-~-----~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~~----------~~~~ 127 (170)
T cd05151 71 EFIEGSELLTE-----D--F-S-----DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLDD----------GRLW 127 (170)
T ss_pred EecCCCccccc-----c--c-c-----CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEEC----------CeEE
Confidence 87554 33221 0 0 0 11223589999999999985 99999999999973 3589
Q ss_pred EEeccCcc
Q psy14267 415 IIDFGIAC 422 (553)
Q Consensus 415 L~DFGla~ 422 (553)
|+|||.+.
T Consensus 128 liDf~~a~ 135 (170)
T cd05151 128 LIDWEYAG 135 (170)
T ss_pred EEeccccc
Confidence 99999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.2e-09 Score=104.28 Aligned_cols=142 Identities=18% Similarity=0.174 Sum_probs=91.8
Q ss_pred eeeeeeCceEEEEEeeeCC----CccceEEEEEEecCCc--C--------c---------hhHHHH----HHHHHHHHHh
Q psy14267 262 SLLGKGGSSSVYLVGGTSE----HEFKPLALKVVDLSDI--T--------D---------QSIADS----YLNEVELLAK 314 (553)
Q Consensus 262 ~~LG~G~fG~Vy~a~~~~~----~~~~~vAvK~l~~~~~--~--------~---------~~~~~~----~~~E~~iL~~ 314 (553)
..||.|-=+.||.|..... .....+|||+.+.... . + .+..+. ..+|.+.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 5789999999999965431 0234599999875321 0 0 011222 3489999999
Q ss_pred hcCC-CceeEeeeEEEeCCCceEEEEEecCCCC-HH-HHHHHcccCCCCchHHHHHHHHHHHHHHHHHHH-hhCCcEecC
Q psy14267 315 LQGC-PYVIKMHDYVYDTASKHLYVLMEKGDTD-LS-KYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEI-HAAGIIHSD 390 (553)
Q Consensus 315 l~~h-p~Iv~l~~~~~~~~~~~~~iv~e~~~~~-L~-~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yL-H~~gIiHrD 390 (553)
+... -.+..++++ ..-+++||+.+++ +. ..++.. .........++.+++.+|.+| |..||||+|
T Consensus 83 l~~~Gv~vP~pi~~------~~~~lvME~Ig~~~~~~~~Lkd~------~~~~~~~~~i~~~i~~~l~~l~H~~glVHGD 150 (197)
T cd05146 83 MQKAGIPCPEVVVL------KKHVLVMSFIGDDQVPAPKLKDA------KLNDEEMKNAYYQVLSMMKQLYKECNLVHAD 150 (197)
T ss_pred HHHcCCCCCeEEEe------cCCEEEEEEcCCCCccchhhhcc------ccCHHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 8653 455555542 2347889987653 21 112211 111122233446999999998 899999999
Q ss_pred CCCCCEEEecCccceecCCCCeEEEEeccCccccC
Q psy14267 391 LKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQ 425 (553)
Q Consensus 391 LKp~NILl~~~~~~~~~~~~~~vkL~DFGla~~~~ 425 (553)
|++.|||++.+ .+.|+|||.|....
T Consensus 151 Ls~~NIL~~~~----------~v~iIDF~qav~~~ 175 (197)
T cd05146 151 LSEYNMLWHDG----------KVWFIDVSQSVEPT 175 (197)
T ss_pred CCHHHEEEECC----------cEEEEECCCceeCC
Confidence 99999999643 58999999886554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.01 E-value=2.7e-09 Score=116.45 Aligned_cols=154 Identities=14% Similarity=0.213 Sum_probs=89.0
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcC---------------------------ch----hHHHH-
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDIT---------------------------DQ----SIADS- 304 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~---------------------------~~----~~~~~- 304 (553)
.|.. +.||+|++|.||.|+.+++++ .||||++.+.... .. +..+.
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~--~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGR--EVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCC--EEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 4665 789999999999998876554 4999999765210 00 11122
Q ss_pred -----HHHHHHHHHhhcC---CCceeEeeeEEEeCCCceEEEEEecCC-CCHHHH--HHHcccCCCCchHHHHHHHHHHH
Q psy14267 305 -----YLNEVELLAKLQG---CPYVIKMHDYVYDTASKHLYVLMEKGD-TDLSKY--MRNLNKMTTLPNTMIIIIMHWYE 373 (553)
Q Consensus 305 -----~~~E~~iL~~l~~---hp~Iv~l~~~~~~~~~~~~~iv~e~~~-~~L~~~--l~~~~~~~~~~~~~~~i~~~~~q 373 (553)
+.+|+..+.+++. +...+.+-.++.+ -....+++||+.. +.+.++ +...+ ..........+..+
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d-~st~~VLvmE~i~G~~l~d~~~l~~~g-~d~~~la~~~v~~~--- 272 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWD-YCSETVMVMERMYGIPVSDVAALRAAG-TDMKLLAERGVEVF--- 272 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecc-cCCCceEEEeeecCccHHhHHHHHhcC-CCHHHHHHHHHHHH---
Confidence 3455555555531 1222222222222 2334578899755 456543 22211 11111222222222
Q ss_pred HHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEeccCccccCCC
Q psy14267 374 MLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDD 427 (553)
Q Consensus 374 il~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGla~~~~~~ 427 (553)
+.-++..|++|+|+||.||+++.+. ...+.++++|||++..+...
T Consensus 273 ----~~Qif~~GffHaDpHPGNIlv~~~g-----~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 273 ----FTQVFRDGFFHADMHPGNIFVSYDP-----PENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred ----HHHHHhCCeeeCCCChHHeEEecCC-----CCCCeEEEEecceEEECCHH
Confidence 3344569999999999999998762 11247999999999877553
|
|
| >KOG1243|consensus | Back alignment and domain information |
|---|
Probab=99.00 E-value=1.3e-08 Score=109.98 Aligned_cols=162 Identities=15% Similarity=0.306 Sum_probs=113.1
Q ss_pred ceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEEEEEecCCCCHHHHHHHcccCCCCchH
Q psy14267 284 KPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNT 363 (553)
Q Consensus 284 ~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~ 363 (553)
.+|.|.+.+.... .......+-++-|+.++| |+|+++++.+ +.+..+|++.|... -|..++.+..
T Consensus 38 ~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRH-P~Il~yL~t~--e~~~~~ylvTErV~-Pl~~~lk~l~-------- 102 (690)
T KOG1243|consen 38 GPVSVFVYKRSNG---EVTELAKRAVKRLKTLRH-PNILSYLDTT--EEEGTLYLVTERVR-PLETVLKELG-------- 102 (690)
T ss_pred CceEEEEEeCCCc---hhhHHHHHHHHHhhhccC-chhhhhhhhh--cccCceEEEeeccc-cHHHHHHHhH--------
Confidence 3477777765542 333556777888999976 9999998865 34568999999653 2555666554
Q ss_pred HHHHHHHHHHHHHHHHHHh-hCCcEecCCCCCCEEEecCccceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCc
Q psy14267 364 MIIIIMHWYEMLLAVKEIH-AAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNY 442 (553)
Q Consensus 364 ~~~i~~~~~qil~aL~yLH-~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y 442 (553)
...+...+.||+.||.||| +.+++|++|.-+.|+|+.. |..||++|-++.....-.. ......--..|
T Consensus 103 ~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~---------GeWkLggle~v~~~~~~~~--~~~~~~~~~s~ 171 (690)
T KOG1243|consen 103 KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNES---------GEWKLGGLELVSKASGFNA--PAKSLYLIESF 171 (690)
T ss_pred HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCC---------CcEEEeeeEEEeccccCCc--ccccchhhhcc
Confidence 2334444569999999997 7889999999999999776 6799999998865543332 11111122245
Q ss_pred cCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCC
Q psy14267 443 MSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGR 482 (553)
Q Consensus 443 ~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~ 482 (553)
..|+.+... ....|.|.|||+++|++.|.
T Consensus 172 ~~P~~~~~s-----------~~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 172 DDPEEIDPS-----------EWSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred cChhhcCcc-----------ccchhhhhHHHHHHHHhCcc
Confidence 667665322 13479999999999999993
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.98 E-value=1.2e-08 Score=104.58 Aligned_cols=263 Identities=17% Similarity=0.246 Sum_probs=159.9
Q ss_pred EEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeE----EEeCC-C
Q psy14267 259 QVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDY----VYDTA-S 333 (553)
Q Consensus 259 ~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~----~~~~~-~ 333 (553)
...+.||+|+-+.+|-... .+..+-|+..+.-...+ .+-+..|.+...||-+..-+.+ .++.. .
T Consensus 14 ~~gr~LgqGgea~ly~l~e-----~~d~VAKIYh~Pppa~~------aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~ 82 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGE-----VRDQVAKIYHAPPPAAQ------AQKVAELAATPDAPLLNYRVAWPQATLHGGRRG 82 (637)
T ss_pred CCCccccCCccceeeecch-----hhchhheeecCCCchHH------HHHHHHhccCCCCcchhhhhcccHHHhhCCCcc
Confidence 3456799999999995422 22345588766543321 1234445565555544331111 11122 2
Q ss_pred ceEEEEEecCC--CCHHHHHHHc-ccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCC
Q psy14267 334 KHLYVLMEKGD--TDLSKYMRNL-NKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIG 410 (553)
Q Consensus 334 ~~~~iv~e~~~--~~L~~~l~~~-~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~ 410 (553)
..+-++|+... ..+..+..-. .+..-....+......++.++.+.+-||+.|.+-+|+.++|+|+.++
T Consensus 83 ~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~--------- 153 (637)
T COG4248 83 KVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDD--------- 153 (637)
T ss_pred ceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecC---------
Confidence 33556676433 2333333322 22223345566677788899999999999999999999999999776
Q ss_pred CeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhC-CCCCCCCC
Q psy14267 411 NVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYG-RTPYSHIP 489 (553)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG-~~Pf~~~~ 489 (553)
+.|.|.|-..-... ..+. .....+|.+.|.+||.-.-....+. .-+...|.|.||++++++|.| +.||.++.
T Consensus 154 ~~V~LVdsDsfqi~-~ng~--~~~cpVg~~eftPPElQ~~~sf~g~----~r~~~hD~FGLavLiF~lL~ggrHPysGI~ 226 (637)
T COG4248 154 SKVVLVDSDSFQIN-ANGT--LHLCPVGVSEFTPPELQTLPSFVGF----ERTANHDNFGLAVLIFHLLFGGRHPYSGIP 226 (637)
T ss_pred ceEEEEcccceeec-cCCc--eEecccCccccCCHHHhcccccccc----CCCccccchhHHHHHHHHHhcCCCCCCccc
Confidence 56788874322111 1111 2235679999999998763333221 246679999999999999986 99998743
Q ss_pred c-------hHHHHH-----HHHhhcccccccccccCCCCCCHHHHHHHHHhccc--CCCCCCCHHHHHHHHhc
Q psy14267 490 N-------TWAKML-----AIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQK--DPKARPTVGNSVTQINN 548 (553)
Q Consensus 490 ~-------~~~~~~-----~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~--dP~~RPt~~ell~~L~~ 548 (553)
. .+..+. .-.....-..-.|....+.-+++++..+..+|+.. ++.-|||++..+..|..
T Consensus 227 ~~~~ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~a 299 (637)
T COG4248 227 LISDAPNPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDA 299 (637)
T ss_pred ccCCCCCcchhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Confidence 2 111111 00001111111222333456789999999999876 35689999998887764
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.94 E-value=1.4e-08 Score=94.37 Aligned_cols=133 Identities=23% Similarity=0.277 Sum_probs=88.5
Q ss_pred eeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchh-----HHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceE
Q psy14267 262 SLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQS-----IADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHL 336 (553)
Q Consensus 262 ~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~-----~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~ 336 (553)
..|++|+=+.+|++..... ++.+|.=.++.....+ ...+..+|+++|.+++. -.|....=|.++ ....
T Consensus 2 ~~i~~GAEa~i~~~~~~g~----~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~-~GV~~P~v~dvD--~~~~ 74 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGL----PAVVKERIPKRYRHPELDEKLRRERTRREARILAKARE-AGVPVPIVYDVD--PDNG 74 (204)
T ss_pred chhhCCcceeEEeeeccCc----ceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHH-cCCCCCeEEEEc--CCCC
Confidence 3578899999998755332 2566654443322222 23467899999999865 333333223333 4455
Q ss_pred EEEEecCCCCH-HHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 337 YVLMEKGDTDL-SKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 337 ~iv~e~~~~~L-~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
.|+||+.+|.+ .+++.... ..++..+-.-+.-||..||||+||.++||++..+ .+.+
T Consensus 75 ~I~me~I~G~~lkd~l~~~~------------~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~----------~i~~ 132 (204)
T COG3642 75 LIVMEYIEGELLKDALEEAR------------PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG----------RIYF 132 (204)
T ss_pred EEEEEEeCChhHHHHHHhcc------------hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC----------cEEE
Confidence 78899866654 44665531 2223467777889999999999999999999765 3899
Q ss_pred EeccCccc
Q psy14267 416 IDFGIACS 423 (553)
Q Consensus 416 ~DFGla~~ 423 (553)
+||||+..
T Consensus 133 IDfGLg~~ 140 (204)
T COG3642 133 IDFGLGEF 140 (204)
T ss_pred EECCcccc
Confidence 99999853
|
|
| >KOG1266|consensus | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.5e-09 Score=107.91 Aligned_cols=205 Identities=18% Similarity=0.230 Sum_probs=126.3
Q ss_pred HHhhcCCCceeEeeeEEEeCCC----ceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhC--C
Q psy14267 312 LAKLQGCPYVIKMHDYVYDTAS----KHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAA--G 385 (553)
Q Consensus 312 L~~l~~hp~Iv~l~~~~~~~~~----~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~--g 385 (553)
|-++- |-|||+++.|+.+... ..+|+..++..+++..+|++..+... .........+.-||+.||.|||+. .
T Consensus 121 llqlv-HsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~-a~~~~~wkkw~tqIlsal~yLhs~~Pp 198 (458)
T KOG1266|consen 121 LLQLV-HSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQK-ALFQKAWKKWCTQILSALSYLHSCDPP 198 (458)
T ss_pred HHHHH-HHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhh-hhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence 33443 4779999988755432 23455555677899999987654322 222333445566999999999965 6
Q ss_pred cEecCCCCCCEEEecCccceecCCCCeEEEEeccCccccC--CCCCcccccCCccCCCccCcccccccCCCCCCCccCCC
Q psy14267 386 IIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQ--DDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRIT 463 (553)
Q Consensus 386 IiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGla~~~~--~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s 463 (553)
|+|+++..+-|++..+ +.|||+--.-..... .......+..-.+-++|.|||.=... ..+
T Consensus 199 iihgnlTc~tifiq~n---------gLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~t---------n~~ 260 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHN---------GLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTT---------NTT 260 (458)
T ss_pred cccCCcchhheeecCC---------ceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCccc---------ccc
Confidence 9999999999999766 456665321111000 00001112233467889999874332 457
Q ss_pred ccchHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q psy14267 464 YKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSV 543 (553)
Q Consensus 464 ~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell 543 (553)
-++|||+||++.+||..|..--.+.......-..+. ...+. ++ ..--++++.+|++-+|..||++++++
T Consensus 261 ~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia----~~i~~--le-----n~lqr~~i~kcl~~eP~~rp~ar~ll 329 (458)
T KOG1266|consen 261 GASDIYKFGMCALEMAILEIQSTNSESKVEVEENIA----NVIIG--LE-----NGLQRGSITKCLEGEPNGRPDARLLL 329 (458)
T ss_pred cchhhhhhhHHHHHHHHheeccCCCcceeehhhhhh----hheee--cc-----CccccCcCcccccCCCCCCcchhhhh
Confidence 789999999999999987654333211100000111 00000 01 12235789999999999999999998
Q ss_pred HHHh
Q psy14267 544 TQIN 547 (553)
Q Consensus 544 ~~L~ 547 (553)
-|.-
T Consensus 330 fHpl 333 (458)
T KOG1266|consen 330 FHPL 333 (458)
T ss_pred cCce
Confidence 7654
|
|
| >KOG3087|consensus | Back alignment and domain information |
|---|
Probab=98.84 E-value=5.4e-08 Score=90.09 Aligned_cols=149 Identities=18% Similarity=0.141 Sum_probs=98.2
Q ss_pred EEeeeeeeCceEEEEEeeeCCCccceEEEEEEecC-----CcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 260 VLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLS-----DITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 260 i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~-----~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
.+.+|-+|+=+.|+.+.... +.+.||.-..+ .+..+-..++..+|+++|.+++- -.|.-..=++.+...
T Consensus 11 ~l~likQGAEArv~~~~~~G----e~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~-~GI~~P~l~~~D~~~- 84 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSG----EAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRA-LGIPAPRLIFIDTYG- 84 (229)
T ss_pred cceeeeccceeeEeeeccCC----ceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHH-hCCCCceEEEEecCC-
Confidence 56678899999999774432 22555543222 23334445678999999999864 233222224544433
Q ss_pred eEEEEEecCCC--CHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCe
Q psy14267 335 HLYVLMEKGDT--DLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNV 412 (553)
Q Consensus 335 ~~~iv~e~~~~--~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~ 412 (553)
-.|+||+.+| ++.+++...-........ ....+.+|-+.+.-||..+|||+||..+||+|.++.. .-.
T Consensus 85 -~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~---~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~------~~~ 154 (229)
T KOG3087|consen 85 -GQIYMEFIDGASTVKDFILSTMEDESEDEG---LAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGN------QIT 154 (229)
T ss_pred -CeEEEEeccchhHHHHHHHHHccCcccchh---HHHHHHHHHHHHHHhhhCCeecccccccceEEecCCC------cCc
Confidence 3677887776 788888765433222222 1344568888999999999999999999999987642 234
Q ss_pred EEEEeccCcccc
Q psy14267 413 LKIIDFGIACSL 424 (553)
Q Consensus 413 vkL~DFGla~~~ 424 (553)
+.|+|||++...
T Consensus 155 ~~lIdfgls~~s 166 (229)
T KOG3087|consen 155 PILIDFGLSSVS 166 (229)
T ss_pred eEEEeecchhcc
Confidence 689999997543
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.63 E-value=2.2e-07 Score=88.26 Aligned_cols=101 Identities=26% Similarity=0.231 Sum_probs=60.7
Q ss_pred HHHHHHHHHHHhhcCC-CceeEeeeEEEeCCCceEEEEEecCC--CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHH
Q psy14267 303 DSYLNEVELLAKLQGC-PYVIKMHDYVYDTASKHLYVLMEKGD--TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVK 379 (553)
Q Consensus 303 ~~~~~E~~iL~~l~~h-p~Iv~l~~~~~~~~~~~~~iv~e~~~--~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~ 379 (553)
....+|.++|.++... -++.+++++. ..+++||+.+ |.....+....... .....++.+++..+.
T Consensus 53 ~~~~~E~~~L~~l~~~Gv~vP~p~~~~------~~~ivME~I~~~G~~~~~l~~~~~~~------~~~~~~~~~il~~~~ 120 (188)
T PF01163_consen 53 EWAKKEFRNLKRLYEAGVPVPKPYDYN------RNVIVMEYIGEDGVPLPRLKDVDLSP------EEPKELLEEILEEII 120 (188)
T ss_dssp HHHHHHHHHHHHCCCTT-SS--EEEEE------TTEEEEE--EETTEEGGCHHHCGGGG------STHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHCCccCCcEEEEe------CCEEEEEecCCCccchhhHHhccccc------hhHHHHHHHHHHHHH
Confidence 4568999999999763 2566665432 2368899866 54333333332110 112222346777555
Q ss_pred H-HhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEeccCccccC
Q psy14267 380 E-IHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQ 425 (553)
Q Consensus 380 y-LH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGla~~~~ 425 (553)
. +|..||||+||.+.|||++.+ .+.|+|||.+....
T Consensus 121 ~~~~~~givHGDLs~~NIlv~~~----------~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 121 KMLHKAGIVHGDLSEYNILVDDG----------KVYIIDFGQAVDSS 157 (188)
T ss_dssp HHHHCTTEEESS-STTSEEEETT----------CEEE--GTTEEETT
T ss_pred HHHHhcCceecCCChhhEEeecc----------eEEEEecCcceecC
Confidence 4 579999999999999999765 48999999986654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741|consensus | Back alignment and domain information |
|---|
Probab=98.62 E-value=2.6e-06 Score=89.97 Aligned_cols=218 Identities=17% Similarity=0.191 Sum_probs=145.5
Q ss_pred eEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeC--CCceEEEEEec--CCC
Q psy14267 270 SSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDT--ASKHLYVLMEK--GDT 345 (553)
Q Consensus 270 G~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~--~~~~~~iv~e~--~~~ 345 (553)
.+.|++....++.. |++|.+........ ..-..-+++|+++.| .|||.+.+++... ++..+++++.| +.+
T Consensus 290 ~Ttyk~~s~~DG~~--YvLkRlhg~r~~~~---nk~t~lve~wkkl~h-~NvV~frevf~t~tF~D~SlvlvYDYyP~s~ 363 (655)
T KOG3741|consen 290 ITTYKATSNVDGNA--YVLKRLHGDRDQST---NKDTSLVEAWKKLCH-TNVVPFREVFLTYTFGDLSLVLVYDYYPSSP 363 (655)
T ss_pred ceeEeeeeccCCce--eeeeeeccccccCc---ccchHHHHHHHHhcc-CceeehhhhhhhhccCcceEEEEEecCCCCc
Confidence 56788877777765 99999944332111 122355778999965 9999999877522 23456666665 445
Q ss_pred CHHHHHHHcccCC----------CCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 346 DLSKYMRNLNKMT----------TLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 346 ~L~~~l~~~~~~~----------~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
+|.++.-...... .....+..+|.++.|+..||.+||+.|..-+-|.+.+||++.+ ..|+|
T Consensus 364 TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~---------~RIri 434 (655)
T KOG3741|consen 364 TLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGK---------MRIRI 434 (655)
T ss_pred hHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCc---------ceEEE
Confidence 6776654332222 2345567788888999999999999999999999999999776 35888
Q ss_pred EeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH-
Q psy14267 416 IDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK- 494 (553)
Q Consensus 416 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~- 494 (553)
...|+...+..... |-+.+ -.+-|.=.||.+++.|.||..=-.........
T Consensus 435 S~C~i~Dvl~~d~~----------------~~le~------------~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~ 486 (655)
T KOG3741|consen 435 SGCGIMDVLQEDPT----------------EPLES------------QQQNDLRDLGLLLLALATGTENSNRTDSTQSSH 486 (655)
T ss_pred ecccceeeecCCCC----------------cchhH------------HhhhhHHHHHHHHHHHhhcccccccccchHHHH
Confidence 87777655433321 12221 24679999999999999996531111111000
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQI 546 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L 546 (553)
+..+ . ..++.+++++|......++++ -++.+++.++
T Consensus 487 ~~~I---------~------~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 487 LTRI---------T------TTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred HHHh---------h------hhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence 1111 1 146789999999999998887 6888887665
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.57 E-value=2.9e-07 Score=88.95 Aligned_cols=79 Identities=23% Similarity=0.224 Sum_probs=50.0
Q ss_pred eeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCC-CceeEeeeEEEeCC-CceEEEE
Q psy14267 262 SLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGC-PYVIKMHDYVYDTA-SKHLYVL 339 (553)
Q Consensus 262 ~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~h-p~Iv~l~~~~~~~~-~~~~~iv 339 (553)
+.||.|.++.||+++... .+.+++|+....... .....+.+|+++++.+.++ ..+.+++.+..... ....+++
T Consensus 4 ~~l~~G~~n~~~~v~~~~---g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v 78 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG---GRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYV 78 (223)
T ss_pred eecCCCccceEEEEEecC---CcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEE
Confidence 568999999999987643 234899987654321 1235678999999999763 23455544332211 1245788
Q ss_pred EecCCC
Q psy14267 340 MEKGDT 345 (553)
Q Consensus 340 ~e~~~~ 345 (553)
|++..|
T Consensus 79 ~e~i~G 84 (223)
T cd05154 79 MERVDG 84 (223)
T ss_pred EEEeCC
Confidence 886543
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.53 E-value=2.4e-06 Score=85.83 Aligned_cols=115 Identities=18% Similarity=0.150 Sum_probs=73.6
Q ss_pred HHHHHHHHHHhhcCC-CceeEeeeEEEeCC---CceEEEEEecCCC--CHHHHHHHcccCCCCchHHHHHHHHHHHHHHH
Q psy14267 304 SYLNEVELLAKLQGC-PYVIKMHDYVYDTA---SKHLYVLMEKGDT--DLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLA 377 (553)
Q Consensus 304 ~~~~E~~iL~~l~~h-p~Iv~l~~~~~~~~---~~~~~iv~e~~~~--~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~a 377 (553)
.+.+|...+.+|... -.++.++++..... ....++++|+.++ +|.+++...... .........++.+++..
T Consensus 74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~---~~~~~~~~~ll~~la~~ 150 (268)
T PRK15123 74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATN---PPDPRLKRMLIKRVATM 150 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhccc---CCCHHHHHHHHHHHHHH
Confidence 478999998888431 12223333332221 2346788887665 688887643211 11123333455689999
Q ss_pred HHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEeccCccc
Q psy14267 378 VKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACS 423 (553)
Q Consensus 378 L~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGla~~ 423 (553)
+.-||..||+|+|+++.||||+.+.. .......+.|+||+.+..
T Consensus 151 i~~LH~~Gi~HgDL~~~NiLl~~~~~--~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 151 VRDMHAAGINHRDCYICHFLLHLPFP--GREEDLKLSVIDLHRAQI 194 (268)
T ss_pred HHHHHHCcCccCCCChhhEEEecccc--CCCCCceEEEEECCcccc
Confidence 99999999999999999999975200 001235799999998753
|
|
| >KOG2137|consensus | Back alignment and domain information |
|---|
Probab=98.50 E-value=5.9e-08 Score=105.46 Aligned_cols=148 Identities=21% Similarity=0.299 Sum_probs=102.2
Q ss_pred HHHHHHHHHh-hCCcEecCCCCCCEEEecCccceecCCCCeEEEEeccCccccCCCCCcc-c-c-----cCCccCCCccC
Q psy14267 373 EMLLAVKEIH-AAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSV-H-K-----DTASGTLNYMS 444 (553)
Q Consensus 373 qil~aL~yLH-~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~-~-~-----~~~~Gt~~y~A 444 (553)
+++.||.|+| +.++||+.|.|++|.++.+ +..||+.|+++....++.... . + ....-...|.|
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~---------~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~a 177 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNAN---------GDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLA 177 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccC---------cceeeccchhhhccCCCCccccccCCCCCChhhccCccccc
Confidence 5669999999 5689999999999999877 679999999986655422210 0 0 01124679999
Q ss_pred cccccccCCCCCCCccCCCccchHHHHHHHHHHHH-hCCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHH
Q psy14267 445 PEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI-YGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQ 523 (553)
Q Consensus 445 PE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ell-tG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~ 523 (553)
||.+... ..+.++|+||||+++|.+. .|+.-+...... ........... .........+|.++++
T Consensus 178 pE~~~~~---------~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~--~~~~~~~~~~~---~~~~~~s~~~p~el~~ 243 (700)
T KOG2137|consen 178 PEYLLGT---------TNTPASDVFSLGVLIYTIYNGGKSIIAANGGL--LSYSFSRNLLN---AGAFGYSNNLPSELRE 243 (700)
T ss_pred chhhccc---------cccccccceeeeeEEEEEecCCcchhhccCCc--chhhhhhcccc---cccccccccCcHHHHH
Confidence 9999874 3578999999999999998 565555432211 11111111111 1111222478999999
Q ss_pred HHHHhcccCCCCCCCHHHHH
Q psy14267 524 SMKLCLQKDPKARPTVGNSV 543 (553)
Q Consensus 524 li~~cL~~dP~~RPt~~ell 543 (553)
-|.+++..+..-||++.++.
T Consensus 244 ~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 244 SLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred HHHHHhcCCcccCcchhhhh
Confidence 99999999999999766554
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.42 E-value=4.5e-06 Score=80.72 Aligned_cols=111 Identities=18% Similarity=0.146 Sum_probs=74.6
Q ss_pred HHHHHHHHHHHhhcCC-CceeEeeeEEEeCC--CceEEEEEecCCC--CHHHHHHHcccCCCCchHHHHHHHHHHHHHHH
Q psy14267 303 DSYLNEVELLAKLQGC-PYVIKMHDYVYDTA--SKHLYVLMEKGDT--DLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLA 377 (553)
Q Consensus 303 ~~~~~E~~iL~~l~~h-p~Iv~l~~~~~~~~--~~~~~iv~e~~~~--~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~a 377 (553)
.++.+|...+..|... -.+...+++..... ....+++++...+ +|.+++...... .......++.+++..
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~-----~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQL-----DPSQRRELLRALARL 130 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhccc-----chhhHHHHHHHHHHH
Confidence 4678888888777531 22334444443322 1345778886543 688888764331 112233445689999
Q ss_pred HHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEeccCcccc
Q psy14267 378 VKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSL 424 (553)
Q Consensus 378 L~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGla~~~ 424 (553)
+.-||+.||+|+|+++.|||++.+. ....+.|+||+-++..
T Consensus 131 i~~lH~~gi~H~Dl~~~NILv~~~~------~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 131 IAKLHDAGIYHGDLNPSNILVDPDD------GQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHHCcCCCCCCCcccEEEeCCC------CceeEEEEcchhceeC
Confidence 9999999999999999999998773 2246999999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.23 E-value=2.3e-05 Score=75.25 Aligned_cols=146 Identities=13% Similarity=0.052 Sum_probs=90.0
Q ss_pred eeeeCceEEEEEeeeCCCccceEEEEEEecCC---cCchhHHHHHHHHHHHHHhhcCC-CceeEeeeEE--EeCCCceEE
Q psy14267 264 LGKGGSSSVYLVGGTSEHEFKPLALKVVDLSD---ITDQSIADSYLNEVELLAKLQGC-PYVIKMHDYV--YDTASKHLY 337 (553)
Q Consensus 264 LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~~~~E~~iL~~l~~h-p~Iv~l~~~~--~~~~~~~~~ 337 (553)
-|+||-+.|+....... .+-+|.-...- ..-..-...|.+|...|.+|... -.+..+.... ........+
T Consensus 26 ~~rgG~SgV~r~~~~g~----~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~ 101 (216)
T PRK09902 26 YRRNGMSGVQCVERNGK----KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRAL 101 (216)
T ss_pred cCCCCcceEEEEEeCCc----EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEE
Confidence 56678888876543222 25666553110 00011236789999999988542 1244443111 112233468
Q ss_pred EEEecCC--CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 338 VLMEKGD--TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 338 iv~e~~~--~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
+|++..+ .+|.+++...... +........++.+++.++.-||+.|+.|+|+-+.|||++.+. .-.|++
T Consensus 102 LVTe~L~g~~~L~~~l~~~~~~---~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g-------~~~v~l 171 (216)
T PRK09902 102 LVTEDMAGFISIADWYAQHAVS---PYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEG-------KAEAGF 171 (216)
T ss_pred EEEEeCCCCccHHHHHhcCCcC---CcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCC-------CeeEEE
Confidence 8888655 6888887654321 112222334456999999999999999999999999997541 124999
Q ss_pred EeccCccc
Q psy14267 416 IDFGIACS 423 (553)
Q Consensus 416 ~DFGla~~ 423 (553)
+||--++.
T Consensus 172 IDlEk~r~ 179 (216)
T PRK09902 172 LDLEKSRR 179 (216)
T ss_pred EEhhccch
Confidence 99976543
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.14 E-value=1.6e-05 Score=78.43 Aligned_cols=140 Identities=21% Similarity=0.119 Sum_probs=90.7
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcC-----------------c--hhHHHHHHHHHHHHHhhcC
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDIT-----------------D--QSIADSYLNEVELLAKLQG 317 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~-----------------~--~~~~~~~~~E~~iL~~l~~ 317 (553)
-+.++..||-|-=+.||.+.+.. ..++|||.=+..... . --....+.+|.++|.+|..
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~~---g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~ 168 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDPK---GRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYP 168 (304)
T ss_pred HHhhccccccCccceEEEEECCC---CCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhh
Confidence 46677899999999999996653 345899975432100 0 0112346789999999965
Q ss_pred C-CceeEeeeEEEeCCCceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCE
Q psy14267 318 C-PYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANF 396 (553)
Q Consensus 318 h-p~Iv~l~~~~~~~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NI 396 (553)
. -.|...++ -+...++||+..|....-++- . . ...-.++..|+.-+..+-..||||+|+.+=||
T Consensus 169 ~G~~VP~P~~------~nRHaVvMe~ieG~eL~~~r~---~---~---en~~~il~~il~~~~~~~~~GiVHGDlSefNI 233 (304)
T COG0478 169 EGVKVPKPIA------WNRHAVVMEYIEGVELYRLRL---D---V---ENPDEILDKILEEVRKAYRRGIVHGDLSEFNI 233 (304)
T ss_pred cCCCCCCccc------cccceeeeehcccceeecccC---c---c---cCHHHHHHHHHHHHHHHHHcCccccCCchheE
Confidence 3 35666654 235688999876632211110 0 1 11111223556656655689999999999999
Q ss_pred EEecCccceecCCCCeEEEEeccCccc
Q psy14267 397 LFVGNVLKIIDCIGNVLKIIDFGIACS 423 (553)
Q Consensus 397 Ll~~~~~~~~~~~~~~vkL~DFGla~~ 423 (553)
|++++ |.+.++||-.+..
T Consensus 234 lV~~d---------g~~~vIDwPQ~v~ 251 (304)
T COG0478 234 LVTED---------GDIVVIDWPQAVP 251 (304)
T ss_pred EEecC---------CCEEEEeCccccc
Confidence 99887 5689999976643
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.10 E-value=4.8e-05 Score=74.32 Aligned_cols=141 Identities=18% Similarity=0.165 Sum_probs=88.5
Q ss_pred eeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCch--------------------hH-HHHHHHHHHHHHhhcC-CC
Q psy14267 262 SLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQ--------------------SI-ADSYLNEVELLAKLQG-CP 319 (553)
Q Consensus 262 ~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~--------------------~~-~~~~~~E~~iL~~l~~-hp 319 (553)
..|..|--+.||+|.. +....+|||+.+..-..-. .. .....+|...|+++.. +-
T Consensus 54 g~istGKEA~Vy~a~~---~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGV 130 (268)
T COG1718 54 GCISTGKEANVYLAET---GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGV 130 (268)
T ss_pred eeecCCcceEEEeecc---CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCC
Confidence 4677888889999854 3334599999976432111 11 1234678888888854 23
Q ss_pred ceeEeeeEEEeCCCceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhh-CCcEecCCCCCCEEE
Q psy14267 320 YVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHA-AGIIHSDLKPANFLF 398 (553)
Q Consensus 320 ~Iv~l~~~~~~~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~-~gIiHrDLKp~NILl 398 (553)
.+.+.+.+. .-.++||+.|... ...+.+...+........++.++++.|.-|-. .++||+||..=|||+
T Consensus 131 rvP~Pi~~~------~nVLvMEfIg~~g----~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~ 200 (268)
T COG1718 131 RVPEPIAFR------NNVLVMEFIGDDG----LPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILV 200 (268)
T ss_pred CCCCceeec------CCeEEEEeccCCC----CCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEE
Confidence 444444322 3478899866541 11122222221111333444588888888876 999999999999999
Q ss_pred ecCccceecCCCCeEEEEeccCccccC
Q psy14267 399 VGNVLKIIDCIGNVLKIIDFGIACSLQ 425 (553)
Q Consensus 399 ~~~~~~~~~~~~~~vkL~DFGla~~~~ 425 (553)
.. +.+.|+|||.|....
T Consensus 201 ~~----------~~p~iID~~QaV~~~ 217 (268)
T COG1718 201 HD----------GEPYIIDVSQAVTID 217 (268)
T ss_pred EC----------CeEEEEECccccccC
Confidence 74 468999999886554
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.00045 Score=65.98 Aligned_cols=131 Identities=25% Similarity=0.362 Sum_probs=87.8
Q ss_pred cceEEEeeeeeeCc-eEEEEEeeeCCCccceEEEEEEec---CC-------cCc--------hhHHHHHHHHHHHHHhhc
Q psy14267 256 KQYQVLSLLGKGGS-SSVYLVGGTSEHEFKPLALKVVDL---SD-------ITD--------QSIADSYLNEVELLAKLQ 316 (553)
Q Consensus 256 ~~y~i~~~LG~G~f-G~Vy~a~~~~~~~~~~vAvK~l~~---~~-------~~~--------~~~~~~~~~E~~iL~~l~ 316 (553)
..++.++.||.|.- |.||+++-... .||||++.. .. ... .....-|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~----~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLk 112 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGR----IYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLK 112 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCe----EEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHH
Confidence 67999999999999 99999865432 499999332 11 110 023346889999988886
Q ss_pred CC--Cce--eEeeeEEEeCC----------------CceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHH
Q psy14267 317 GC--PYV--IKMHDYVYDTA----------------SKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLL 376 (553)
Q Consensus 317 ~h--p~I--v~l~~~~~~~~----------------~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~ 376 (553)
.+ .++ ++.+||..-.. .....||.++....- .. ....+.+|++
T Consensus 113 e~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~----~~~~~~~~~~ 175 (207)
T PF13095_consen 113 EAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PL----QIRDIPQMLR 175 (207)
T ss_pred hccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------cc----chhHHHHHHH
Confidence 53 445 88888764431 112345555443221 01 1122348899
Q ss_pred HHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEeccCc
Q psy14267 377 AVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIA 421 (553)
Q Consensus 377 aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGla 421 (553)
-|..+|..||+-+|+|+.|.. .-||+|||.+
T Consensus 176 dl~~~~k~gI~~~Dv~~~ny~--------------~G~lvDfs~~ 206 (207)
T PF13095_consen 176 DLKILHKLGIVPRDVKPRNYR--------------GGKLVDFSSS 206 (207)
T ss_pred HHHHHHHCCeeeccCcccccc--------------CCEEEecccC
Confidence 999999999999999999987 1389999964
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=97.81 E-value=4.8e-06 Score=89.96 Aligned_cols=186 Identities=22% Similarity=0.201 Sum_probs=123.0
Q ss_pred eEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCc-eeEeeeEEEeCCCceE
Q psy14267 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPY-VIKMHDYVYDTASKHL 336 (553)
Q Consensus 258 y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~-Iv~l~~~~~~~~~~~~ 336 (553)
+....-+++|+++++|+.+....+.. ..+.+... ....-++++|.++++ || ++..+ ...+.+.+.
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL---~h~fvs~~--------l~~rl~~eLLdK~n~-P~~~v~~~--~d~~~E~~~ 309 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLL---QHPFVSQT--------LSRRLAIELLDKVNN-PNPVVRYL--EDYDGEDYL 309 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhhe---eceeeccc--------hhhHHHHHHHHHccC-CCCccccc--ccCCccccc
Confidence 45566789999999998755444322 24444322 234568889999966 87 44332 223446678
Q ss_pred EEEEecCCCC--HHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 337 YVLMEKGDTD--LSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 337 ~iv~e~~~~~--L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
.+.|+++++. ....+. .....+...++....+.-+.+|++||+.-=+||| ||+..++ .++
T Consensus 310 ~i~~~i~s~~rs~~~~~~----~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~~----------~~~ 371 (829)
T KOG0576|consen 310 WIPMRICSTGRSSALEMT----VSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSEE----------EVK 371 (829)
T ss_pred chhhhhhcCCccccccCC----hhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccccc----------ccc
Confidence 8888877653 110000 0000111222333334556789999988779999 8887554 479
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCC
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSH 487 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~ 487 (553)
++||+....+.... ...+..+++.|+|||+..+.. +....|.|++|+-..++.-|.+|-..
T Consensus 372 ~~~~~v~~~L~~~~---~~~t~~~~~~~~~pev~~~~~---------~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 372 LLDFAVPPQLTRTM---KPRTAIGTPEPLAPEVIQENT---------IDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred cccccCCcccCccc---ccccCCCCCCCCCchhhcccc---------cccCCCccCCCcchhhcCCCCCCCCC
Confidence 99999987776543 234778999999999988764 56789999999988888888877644
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00034 Score=67.76 Aligned_cols=76 Identities=22% Similarity=0.199 Sum_probs=49.7
Q ss_pred EeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCC-ceeEeeeEEEeCC-CceEEE
Q psy14267 261 LSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCP-YVIKMHDYVYDTA-SKHLYV 338 (553)
Q Consensus 261 ~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp-~Iv~l~~~~~~~~-~~~~~i 338 (553)
++.|+.|..+.||++.... +.+++|+.... .....+.+|..+++.|..+- .+..++.+..... ....++
T Consensus 2 i~~l~~G~~n~~~~v~~~~----~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~ 72 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD----GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYL 72 (239)
T ss_dssp EEEEEESSSSEEEEEEETT----SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEE
T ss_pred CccCCCCCeeeEEEEEECC----cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceE
Confidence 5689999999999986544 24899986432 33467789999998886542 2556654332222 335688
Q ss_pred EEecCCC
Q psy14267 339 LMEKGDT 345 (553)
Q Consensus 339 v~e~~~~ 345 (553)
+|++..|
T Consensus 73 ~~~~i~g 79 (239)
T PF01636_consen 73 LMEYIPG 79 (239)
T ss_dssp EEEEESS
T ss_pred EEEEecc
Confidence 8887554
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00043 Score=66.94 Aligned_cols=141 Identities=19% Similarity=0.189 Sum_probs=82.9
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHH------HHHHHHHHHhhcC--CCceeEeee
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADS------YLNEVELLAKLQG--CPYVIKMHD 326 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~------~~~E~~iL~~l~~--hp~Iv~l~~ 326 (553)
..+|.+.+++-......|.+.+-.. +.+.+|.........+..... +.+++..+.++.. ....+.++.
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei~~----~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEIDG----KKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEECC----cEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 3578888888888878887763322 338999876544332222222 2344444444432 122222211
Q ss_pred EEEeC---CCceEEEEEecCCC-CHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCc
Q psy14267 327 YVYDT---ASKHLYVLMEKGDT-DLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNV 402 (553)
Q Consensus 327 ~~~~~---~~~~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~ 402 (553)
...-. -....+++||+.+| .|.++..- .. .++..+.++|.-||+.|++|+|..|.|+++..+
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~i-------~e------~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~- 171 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIEDI-------DE------DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN- 171 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchhc-------CH------HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-
Confidence 11111 12345678998655 34332210 00 112367888999999999999999999999765
Q ss_pred cceecCCCCeEEEEeccCcc
Q psy14267 403 LKIIDCIGNVLKIIDFGIAC 422 (553)
Q Consensus 403 ~~~~~~~~~~vkL~DFGla~ 422 (553)
.++++||+..+
T Consensus 172 ---------~i~iID~~~k~ 182 (229)
T PF06176_consen 172 ---------GIRIIDTQGKR 182 (229)
T ss_pred ---------cEEEEECcccc
Confidence 38999998653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00028 Score=65.59 Aligned_cols=132 Identities=26% Similarity=0.227 Sum_probs=86.3
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceE
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHL 336 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~ 336 (553)
..++.+.||+|++|.||++++... .+|+|+-..+. ....+..|+++|..+...-.-.+++.|. . .
T Consensus 23 ~~~v~~~L~KG~~s~Vyl~~~~~~----~~a~Kvrr~ds-----~r~~l~kEakiLeil~g~~~~p~vy~yg--~----~ 87 (201)
T COG2112 23 ELRVEKELAKGTTSVVYLGEWRGG----EVALKVRRRDS-----PRRNLEKEAKILEILAGEGVTPEVYFYG--E----D 87 (201)
T ss_pred hhhhhhhhhcccccEEEEeeccCc----eEEEEEecCCc-----chhhHHHHHHHHHHhhhcCCCceEEEec--h----h
Confidence 345667899999999999876544 38999876553 2366889999999987644444554332 2 2
Q ss_pred EEEEecCCC-CHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCC--CCEEEecCccceecCCCCeE
Q psy14267 337 YVLMEKGDT-DLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKP--ANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 337 ~iv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp--~NILl~~~~~~~~~~~~~~v 413 (553)
++.||+..| .|........ ...+ ..++++---|-..||-|..|.- .||++... .+
T Consensus 88 ~i~me~i~G~~L~~~~~~~~--------rk~l----~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~----------~~ 145 (201)
T COG2112 88 FIRMEYIDGRPLGKLEIGGD--------RKHL----LRVLEKAYKLDRLGIEHGELSRPWKNVLVNDR----------DV 145 (201)
T ss_pred hhhhhhhcCcchhhhhhccc--------HHHH----HHHHHHHHHHHHhccchhhhcCCceeEEecCC----------cE
Confidence 445888665 5655433210 1122 2556665556678999999974 45665442 48
Q ss_pred EEEeccCccccC
Q psy14267 414 KIIDFGIACSLQ 425 (553)
Q Consensus 414 kL~DFGla~~~~ 425 (553)
.|+||.-|+...
T Consensus 146 ~iIDFd~At~k~ 157 (201)
T COG2112 146 YIIDFDSATFKK 157 (201)
T ss_pred EEEEccchhhcc
Confidence 999999886443
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.0008 Score=66.02 Aligned_cols=71 Identities=17% Similarity=0.119 Sum_probs=45.7
Q ss_pred eeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCc-eeEeeeEEEeCCCceEEEEE
Q psy14267 262 SLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPY-VIKMHDYVYDTASKHLYVLM 340 (553)
Q Consensus 262 ~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~-Iv~l~~~~~~~~~~~~~iv~ 340 (553)
..||.|..+.||+. . +. .+++|+..... ......+|.+++..+....- +.+.+++. .......++|
T Consensus 7 ~~i~~G~t~~~y~~---~-~~--~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~--~~~~~~glv~ 73 (226)
T TIGR02172 7 TQTGEGGNGESYTH---K-TG--KWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLV--EDGGRLGLIY 73 (226)
T ss_pred eeecCCCCcceeEe---c-CC--CEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEE--ecCCeeeeee
Confidence 46899999999974 1 22 37888875422 12456889999998865322 45554443 3344566788
Q ss_pred ecCCC
Q psy14267 341 EKGDT 345 (553)
Q Consensus 341 e~~~~ 345 (553)
++..|
T Consensus 74 e~i~G 78 (226)
T TIGR02172 74 ELIVG 78 (226)
T ss_pred eecCC
Confidence 87665
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00043 Score=75.60 Aligned_cols=143 Identities=17% Similarity=0.190 Sum_probs=85.1
Q ss_pred eeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcC---------------------------ch----hHHH------H
Q psy14267 262 SLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDIT---------------------------DQ----SIAD------S 304 (553)
Q Consensus 262 ~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~---------------------------~~----~~~~------~ 304 (553)
.-|+.++-|-||.|+.++ ++.||||+....-.. -. +..+ .
T Consensus 131 ~PiAsASIaQVH~A~L~s---G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElD 207 (517)
T COG0661 131 EPIASASIAQVHRAVLKS---GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELD 207 (517)
T ss_pred CchhhhhHhhheeEEecC---CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhC
Confidence 469999999999998876 345999999765310 00 1111 2
Q ss_pred HHHHHHHHHhhc----CCCceeEeeeEEEeCCCceEEEEEecCCC-CHHHH--HHHcccCCCCchHHHHHHHHHHHHHH-
Q psy14267 305 YLNEVELLAKLQ----GCPYVIKMHDYVYDTASKHLYVLMEKGDT-DLSKY--MRNLNKMTTLPNTMIIIIMHWYEMLL- 376 (553)
Q Consensus 305 ~~~E~~iL~~l~----~hp~Iv~l~~~~~~~~~~~~~iv~e~~~~-~L~~~--l~~~~~~~~~~~~~~~i~~~~~qil~- 376 (553)
+.+|+..+.+++ +.+.|.-.. +++ +-...-+++||+.+| .+.+. ++..+ . . ...+. ..++.
T Consensus 208 y~~EA~n~~~~~~nf~~~~~v~VP~-V~w-e~t~~~VLtmE~i~Gi~i~d~~~l~~~g-~---d--~k~ia---~~~~~~ 276 (517)
T COG0661 208 YRREAANAERFRENFKDDPDVYVPK-VYW-EYTTRRVLTMEWIDGIKISDIAALKSAG-I---D--RKELA---ELLVRA 276 (517)
T ss_pred HHHHHHHHHHHHHHcCCCCCeEece-eeh-hccCCcEEEEEeeCCEecccHHHHHhcC-C---C--HHHHH---HHHHHH
Confidence 456666666553 234443332 121 223445788887655 34443 33311 1 1 11111 11221
Q ss_pred HHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEeccCccccCCC
Q psy14267 377 AVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDD 427 (553)
Q Consensus 377 aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGla~~~~~~ 427 (553)
-+..+-..|+.|.|..|.||+++.+ +.+.+.|||+...+.+.
T Consensus 277 f~~q~~~dgffHaDpHpGNi~v~~~---------g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 277 FLRQLLRDGFFHADPHPGNILVRSD---------GRIVLLDFGIVGRLDPK 318 (517)
T ss_pred HHHHHHhcCccccCCCccceEEecC---------CcEEEEcCcceecCCHH
Confidence 2334445899999999999999887 67999999998776554
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.0015 Score=62.56 Aligned_cols=136 Identities=18% Similarity=0.218 Sum_probs=85.1
Q ss_pred eeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcC-------------chhHHHHHHHHHHHHHhhc-----CCCceeE
Q psy14267 262 SLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDIT-------------DQSIADSYLNEVELLAKLQ-----GCPYVIK 323 (553)
Q Consensus 262 ~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~-------------~~~~~~~~~~E~~iL~~l~-----~hp~Iv~ 323 (553)
..||+|+.-.||. +..... .+||++...... .....++..+|+.-...+. .+.+|.+
T Consensus 7 ~~i~~G~~R~cy~--HP~dp~---~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r 81 (199)
T PF10707_consen 7 DLIAQGGERDCYQ--HPDDPN---LCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR 81 (199)
T ss_pred cccccCCCceEEE--CCCCCC---eEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence 4799999999995 233332 699999876610 1122356677877776665 2578999
Q ss_pred eeeEEEeCCCceEEEEEe----cC---CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCE
Q psy14267 324 MHDYVYDTASKHLYVLME----KG---DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANF 396 (553)
Q Consensus 324 l~~~~~~~~~~~~~iv~e----~~---~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NI 396 (553)
++|+..... -.-+++| .. ..+|.+++.+..- . . .+. ..+-+-.+||-+.+|+.+||+|.||
T Consensus 82 ~~G~veT~~--G~Glv~e~I~d~dG~~s~TL~~~l~~~~~----~--~-~~~---~~L~~f~~~l~~~~Iv~~dl~~~NI 149 (199)
T PF10707_consen 82 FYGFVETNL--GLGLVVELIRDADGNISPTLEDYLKEGGL----T--E-ELR---QALDEFKRYLLDHHIVIRDLNPHNI 149 (199)
T ss_pred EeEEEecCC--ceEEEEEEEECCCCCcCccHHHHHHcCCc----c--H-HHH---HHHHHHHHHHHHcCCeecCCCcccE
Confidence 988764332 2333333 22 2468888754321 1 1 111 1233445788999999999999999
Q ss_pred EEecCccceecCCCCeEEEEe-cc
Q psy14267 397 LFVGNVLKIIDCIGNVLKIID-FG 419 (553)
Q Consensus 397 Ll~~~~~~~~~~~~~~vkL~D-FG 419 (553)
++..+.. ....+.|+| ||
T Consensus 150 v~~~~~~-----~~~~lvlIDG~G 168 (199)
T PF10707_consen 150 VVQRRDS-----GEFRLVLIDGLG 168 (199)
T ss_pred EEEecCC-----CceEEEEEeCCC
Confidence 9987632 112678888 44
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.0012 Score=76.99 Aligned_cols=85 Identities=19% Similarity=0.179 Sum_probs=53.7
Q ss_pred EEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCce--eEeeeEEEeCC-CceE
Q psy14267 260 VLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYV--IKMHDYVYDTA-SKHL 336 (553)
Q Consensus 260 i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~I--v~l~~~~~~~~-~~~~ 336 (553)
.++.|+.|.++.+|++..........+++|+........ ....+.+|+++|+.|..+.+| .+++.++.+.. ....
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~--~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~ 119 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ--SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA 119 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc--cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence 356789999999999876543322347777764432211 124678999999999644444 66655543321 2356
Q ss_pred EEEEecCCCC
Q psy14267 337 YVLMEKGDTD 346 (553)
Q Consensus 337 ~iv~e~~~~~ 346 (553)
|++||+..|.
T Consensus 120 flVME~v~G~ 129 (822)
T PLN02876 120 FYIMEYLEGR 129 (822)
T ss_pred eEEEEecCCc
Confidence 7899986654
|
|
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.00059 Score=78.86 Aligned_cols=243 Identities=17% Similarity=0.170 Sum_probs=138.1
Q ss_pred eeeeCceEEEEEeeeCCCc--cceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce--EEEE
Q psy14267 264 LGKGGSSSVYLVGGTSEHE--FKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH--LYVL 339 (553)
Q Consensus 264 LG~G~fG~Vy~a~~~~~~~--~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~--~~iv 339 (553)
|..-.+|+|++.++...-. ..++-++.-...-......+.....|+..+.++.| +|++.++.|........ +.+.
T Consensus 186 ls~~~~~~l~l~k~~~~~qs~~~~~~~s~~~~~~~~~k~~i~~~E~e~~~l~k~~~-~n~~~~~~~~le~~~~g~~~~v~ 264 (1351)
T KOG1035|consen 186 LSHLTQGTLLLVKWVEQAQSLSEPIEISHDYESTPCGKKEIQTTEIELESLSKIAH-DNLGGYFVYGLERLFRGIVLDVL 264 (1351)
T ss_pred eccccCceEEEEehhhhHHhhcCcccccCcccCccchHHHHHHHHHHHHHHHhhcc-ccccceeEEeehhhcchHHHHHH
Confidence 6677888998876643211 11222222111111122233444556666777754 99999987765443222 1112
Q ss_pred Ee-cCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEE--
Q psy14267 340 ME-KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKII-- 416 (553)
Q Consensus 340 ~e-~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~-- 416 (553)
-+ +...++...+..... ........+..+++.||+|+|+....|.=|-..-..-... ...+.+.+.
T Consensus 265 ~~~~s~~~~~~~~q~v~~-----i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~~~~~------~~e~~~~~sl~ 333 (1351)
T KOG1035|consen 265 QEICSKVELRSLLQSVGS-----IPLETLRILHQKLLEGLAYLHSLSLEHVVLSASSSKESTV------DGEGVVAISLS 333 (1351)
T ss_pred HhhcCccchHHHHhhccc-----cCHHHHHHHHHHHhhhHHHHHHhccceeEEeccccccccc------Cccceeecchh
Confidence 22 234456666655432 2233444455699999999999854444333331111110 112445666
Q ss_pred eccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHH
Q psy14267 417 DFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKML 496 (553)
Q Consensus 417 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~ 496 (553)
||+....+....... ...-+..|.++|....... ...+..|+|.+|.....+..|..+-..... .
T Consensus 334 ~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~~-------~~~r~~dL~~lgll~~~~~~~~~i~~~~~~----~- 398 (1351)
T KOG1035|consen 334 DFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENTA-------KKSRLTDLWCLGLLLLQLSQGEDISEKSAV----P- 398 (1351)
T ss_pred hhcccccCCCcccch---hhcCccccccccccccccc-------hhhhhhHHHHHHHHHhhhhhcCcccccccc----h-
Confidence 888887766544321 2334567788888765432 345668999999999999887654322100 0
Q ss_pred HHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q psy14267 497 AIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQI 546 (553)
Q Consensus 497 ~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L 546 (553)
..+... .....+.+.+.+|+.-+.++|+++.+++.+.
T Consensus 399 ------------~~~l~~-~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 399 ------------VSLLDV-LSTSELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred ------------hhhhcc-ccchhhhhhhhhhcchhhhhccchhhhhhch
Confidence 000000 1112678889999999999999999998865
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.002 Score=63.61 Aligned_cols=70 Identities=24% Similarity=0.247 Sum_probs=42.9
Q ss_pred eeeeCc-eEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEEEEEec
Q psy14267 264 LGKGGS-SSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEK 342 (553)
Q Consensus 264 LG~G~f-G~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~iv~e~ 342 (553)
|-.|.. ..||++.... ..+.||+..... ...+.+|+++++.+..+--+.+++++.. ....-+++|++
T Consensus 6 ~~~g~~~~~v~~~~~~~----~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~--~~~~~~lv~e~ 73 (244)
T cd05150 6 VTEGQSGATVYRLDGKN----PGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGS--DDGRAWLLTSA 73 (244)
T ss_pred cCCCCCcCeEEEEcCCC----CcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEe--cCCccEEEEEe
Confidence 334444 8899884422 347888875432 2356789999999876544556655443 23445778886
Q ss_pred CCC
Q psy14267 343 GDT 345 (553)
Q Consensus 343 ~~~ 345 (553)
..|
T Consensus 74 i~G 76 (244)
T cd05150 74 VPG 76 (244)
T ss_pred eCC
Confidence 544
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF00130 C1_1: Phorbol esters/diacylglycerol binding domain (C1 domain); InterPro: IPR002219 Diacylglycerol (DAG) is an important second messenger | Back alignment and domain information |
|---|
Probab=97.39 E-value=4.2e-05 Score=56.88 Aligned_cols=32 Identities=19% Similarity=0.148 Sum_probs=27.7
Q ss_pred hhhHhhhhh---hccccccccccccccCCCCCCCC
Q psy14267 105 AQSVEKIVL---NNINYRVDQCKKNLNYDPSIKTP 136 (553)
Q Consensus 105 ~~~~~~~~~---~~~g~rC~~Cg~kfh~~C~~~vp 136 (553)
-|++|+-.| ++|||+|..|++.+|+.|..+||
T Consensus 13 ~C~~C~~~i~g~~~~g~~C~~C~~~~H~~C~~~~~ 47 (53)
T PF00130_consen 13 YCDVCGKFIWGLGKQGYRCSWCGLVCHKKCLSKVP 47 (53)
T ss_dssp B-TTSSSBECSSSSCEEEETTTT-EEETTGGCTSS
T ss_pred CCcccCcccCCCCCCeEEECCCCChHhhhhhhhcC
Confidence 478888777 89999999999999999999999
|
Phorbol esters (PE) are analogues of DAG and potent tumour promoters that cause a variety of physiological changes when administered to both cells and tissues. DAG activates a family of serine/threonine protein kinases, collectively known as protein kinase C (PKC) []. Phorbol esters can directly stimulate PKC. The N-terminal region of PKC, known as C1, has been shown [] to bind PE and DAG in a phospholipid and zinc-dependent fashion. The C1 region contains one or two copies (depending on the isozyme of PKC) of a cysteine-rich domain, which is about 50 amino-acid residues long, and which is essential for DAG/PE-binding. The DAG/PE-binding domain binds two zinc ions; the ligands of these metal ions are probably the six cysteines and two histidines that are conserved in this domain.; GO: 0035556 intracellular signal transduction; PDB: 1RFH_A 2FNF_X 3PFQ_A 1PTQ_A 1PTR_A 2VRW_B 1XA6_A 2ENN_A 1TBN_A 1TBO_A .... |
| >cd00029 C1 Protein kinase C conserved region 1 (C1) | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.00017 Score=52.68 Aligned_cols=31 Identities=19% Similarity=0.174 Sum_probs=29.3
Q ss_pred hhHhhhhhh---ccccccccccccccCCCCCCCC
Q psy14267 106 QSVEKIVLN---NINYRVDQCKKNLNYDPSIKTP 136 (553)
Q Consensus 106 ~~~~~~~~~---~~g~rC~~Cg~kfh~~C~~~vp 136 (553)
|+++.-.|| .|||+|..|++.+|+.|..+|+
T Consensus 14 C~~C~~~i~~~~~~~~~C~~C~~~~H~~C~~~v~ 47 (50)
T cd00029 14 CDVCRKSIWGLFKQGLRCSWCKVKCHKKCADKVP 47 (50)
T ss_pred hhhcchhhhccccceeEcCCCCCchhhhhhccCC
Confidence 899998888 6999999999999999999998
|
Cysteine-rich zinc binding domain. Some members of this domain family bind phorbol esters and diacylglycerol, some are reported to bind RasGTP. May occur in tandem arrangement. Diacylglycerol (DAG) is a second messenger, released by activation of Phospholipase D. Phorbol Esters (PE) can act as analogues of DAG and mimic its downstream effects in, for example, tumor promotion. Protein Kinases C are activated by DAG/PE, this activation is mediated by their N-terminal conserved region (C1). DAG/PE binding may be phospholipid dependent. C1 domains may also mediate DAG/PE signals in chimaerins (a family of Rac GTPase activating proteins), RasGRPs (exchange factors for Ras/Rap1), and Munc13 isoforms (scaffolding proteins involved in exocytosis). |
| >KOG1235|consensus | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.0073 Score=66.03 Aligned_cols=145 Identities=18% Similarity=0.177 Sum_probs=84.7
Q ss_pred eeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCc----------------------------hhHHH------HHHH
Q psy14267 262 SLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITD----------------------------QSIAD------SYLN 307 (553)
Q Consensus 262 ~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~----------------------------~~~~~------~~~~ 307 (553)
+-||.-+.|.||.|+.+. ++.||||+-+..--.. .+..+ .|.+
T Consensus 167 ~piaaASlaQVhrA~L~~---G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~ 243 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN---GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTK 243 (538)
T ss_pred chhhhcchhheEEEEecC---CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHH
Confidence 469999999999998776 3459999986542100 01111 2455
Q ss_pred HHHHHHhhcC---CCc------eeEeeeEEEeCCCceEEEEEecCCC---CHHHHHHHcccCCCCchHHHHHHHHHHHHH
Q psy14267 308 EVELLAKLQG---CPY------VIKMHDYVYDTASKHLYVLMEKGDT---DLSKYMRNLNKMTTLPNTMIIIIMHWYEML 375 (553)
Q Consensus 308 E~~iL~~l~~---hp~------Iv~l~~~~~~~~~~~~~iv~e~~~~---~L~~~l~~~~~~~~~~~~~~~i~~~~~qil 375 (553)
|++...+.++ +-. |.+++ . .-....+++||+++| +-.+++++.+-. +. .+.. .+.
T Consensus 244 EA~Nae~~~~~f~~~~~~~~V~VP~Vy---~-~~st~RVLtME~~~G~~i~Dl~~i~~~gi~---~~---~i~~---~l~ 310 (538)
T KOG1235|consen 244 EAKNAERFRENFKDFSLLTYVLVPKVY---W-DLSTKRVLTMEYVDGIKINDLDAIDKRGIS---PH---DILN---KLV 310 (538)
T ss_pred HHHhHHHHHHHHHhcccccceeCCeeh---h-hcCcceEEEEEecCCccCCCHHHHHHcCCC---HH---HHHH---HHH
Confidence 5555444321 122 33331 1 223456889998765 223455554321 11 1111 222
Q ss_pred HH-HHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEeccCccccCCC
Q psy14267 376 LA-VKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDD 427 (553)
Q Consensus 376 ~a-L~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGla~~~~~~ 427 (553)
++ ++-|-..|++|.|-.|.||++..+. ..+..+.+.|||+...+...
T Consensus 311 ~~~~~qIf~~GffHaDPHPGNilv~~~~-----~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 311 EAYLEQIFKTGFFHADPHPGNILVRPNP-----EGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred HHHHHHHHhcCCccCCCCCCcEEEecCC-----CCCccEEEEcccccccccHH
Confidence 22 2334467899999999999998541 23467999999998776543
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.0054 Score=58.37 Aligned_cols=103 Identities=24% Similarity=0.211 Sum_probs=70.4
Q ss_pred HHHHHHHHhhcCCCceeEeeeEEEeCCCceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhh--
Q psy14267 306 LNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHA-- 383 (553)
Q Consensus 306 ~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~-- 383 (553)
..|.-+|+.+.+.+++.+++|+| +++|++.....+.+......... -....+...+.++.++++.+++|+.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C-----G~~~v~E~~~~~~~~~~~~~l~~--~~~~~w~~R~~iA~~lL~~l~~l~~~~ 79 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC-----GRFYVVEYVGAGSLYGIYRPLSQ--FLQSPWEQRAKIALQLLELLEELDHGP 79 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC-----CCEEEEEeecCcccccccccccc--ccccCHHHHHHHHHHHHHHHHHHhcCC
Confidence 35888899998878999999977 23444433343433321000000 0123456667778899999999986
Q ss_pred -CCcEecCCCCCCEEEecCccceecCCCCeEEEEeccCcccc
Q psy14267 384 -AGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSL 424 (553)
Q Consensus 384 -~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGla~~~ 424 (553)
..+.-.|++++|+-++++ +.+|++|...+...
T Consensus 80 ~~~~~lcDv~~~nfgv~~~---------~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 80 LGFFYLCDVSPDNFGVNDD---------GRLKLIDLDDVFVE 112 (188)
T ss_pred CCcEEEeecchHHeEEeCC---------CcEEEEechhcchh
Confidence 458889999999999876 57999999876544
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG4236|consensus | Back alignment and domain information |
|---|
Probab=96.61 E-value=0.0017 Score=69.07 Aligned_cols=34 Identities=18% Similarity=0.294 Sum_probs=29.9
Q ss_pred hhHhhhhh---hccccccccccccccCCCCCCCC--CCC
Q psy14267 106 QSVEKIVL---NNINYRVDQCKKNLNYDPSIKTP--CKD 139 (553)
Q Consensus 106 ~~~~~~~~---~~~g~rC~~Cg~kfh~~C~~~vp--c~d 139 (553)
||-|--+| .|||.+|.-||.+||++|+.|.| |.-
T Consensus 159 CD~CGEmL~GLvrQGlKC~gCglNyHKRCa~kipNNCsG 197 (888)
T KOG4236|consen 159 CDFCGEMLFGLVRQGLKCEGCGLNYHKRCAFKIPNNCSG 197 (888)
T ss_pred HHHHHHHHHHHHHccccccCCCCcHhhhhhhcCCCCCCc
Confidence 77777665 59999999999999999999999 755
|
|
| >smart00109 C1 Protein kinase C conserved region 1 (C1) domains (Cysteine-rich domains) | Back alignment and domain information |
|---|
Probab=96.58 E-value=0.0004 Score=50.37 Aligned_cols=31 Identities=19% Similarity=0.177 Sum_probs=28.8
Q ss_pred hhHhhhhhhc--cccccccccccccCCCCCCCC
Q psy14267 106 QSVEKIVLNN--INYRVDQCKKNLNYDPSIKTP 136 (553)
Q Consensus 106 ~~~~~~~~~~--~g~rC~~Cg~kfh~~C~~~vp 136 (553)
|+++.-.|+. |||+|..|++.+|++|..+|+
T Consensus 14 C~~C~~~i~~~~~~~~C~~C~~~~H~~C~~~v~ 46 (49)
T smart00109 14 CCVCRKSIWGSFQGLRCSWCKVKCHKKCAEKVP 46 (49)
T ss_pred ccccccccCcCCCCcCCCCCCchHHHHHHhhcC
Confidence 8899888887 799999999999999999987
|
Some bind phorbol esters and diacylglycerol. Some bind RasGTP. Zinc-binding domains. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.53 E-value=0.035 Score=54.27 Aligned_cols=61 Identities=11% Similarity=0.091 Sum_probs=36.5
Q ss_pred EeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeee
Q psy14267 261 LSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHD 326 (553)
Q Consensus 261 ~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~ 326 (553)
++.|..|-...||++..... ..+.|++|+..... . .. -...+|+.+++.+.....+.++++
T Consensus 3 i~~l~gG~tN~~~~v~~~~~-~~~~~vlR~~~~~~--~-~~-~d~~~E~~~~~~l~~~gl~P~v~~ 63 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKED-NQDAVLVRVYGNKT--E-LI-IDRERELRIHKLLSKHGLAPKLYA 63 (235)
T ss_pred EEEcCCcccceEEEEEcCCC-CCCeEEEEEccCCc--c-ce-ecHHHHHHHHHHHHhCCCCCeEEE
Confidence 45688888999998854320 12348889765321 1 11 123478999988865444555543
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.49 E-value=0.06 Score=57.22 Aligned_cols=78 Identities=22% Similarity=0.143 Sum_probs=49.4
Q ss_pred EeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCc--Cc--hhHHHHHHHHHHHHHhhcCC--CceeEeeeEEEeCCCc
Q psy14267 261 LSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDI--TD--QSIADSYLNEVELLAKLQGC--PYVIKMHDYVYDTASK 334 (553)
Q Consensus 261 ~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~--~~--~~~~~~~~~E~~iL~~l~~h--p~Iv~l~~~~~~~~~~ 334 (553)
.+.||.|.+..||.+...+.. +.|.||.-..... .+ .-..++...|.+.|+.+... .++.+++.+ + ..
T Consensus 31 ~~elggGn~N~VyrV~~~~g~--~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D--~~ 104 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGG--KSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--D--EE 104 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCC--eEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--C--CC
Confidence 357999999999999765432 2489997532110 01 12346788899998887532 456666543 3 34
Q ss_pred eEEEEEecCC
Q psy14267 335 HLYVLMEKGD 344 (553)
Q Consensus 335 ~~~iv~e~~~ 344 (553)
..+++||+.+
T Consensus 105 ~~~lVME~L~ 114 (401)
T PRK09550 105 LAVTVMEDLS 114 (401)
T ss_pred CCEEEEecCC
Confidence 4678888754
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.48 E-value=0.04 Score=55.95 Aligned_cols=76 Identities=16% Similarity=0.059 Sum_probs=43.6
Q ss_pred EEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCC-ceeEeeeE----EEeCCCc
Q psy14267 260 VLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCP-YVIKMHDY----VYDTASK 334 (553)
Q Consensus 260 i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp-~Iv~l~~~----~~~~~~~ 334 (553)
-++.|..|....+|++.... ..+++|+.... . ......|+.++..|..+- .+..++.. .......
T Consensus 18 ~i~~i~~G~~n~~y~v~~~~----~~~vLr~~~~~--~----~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~ 87 (296)
T cd05153 18 SFEGISAGIENTNYFVTTDS----GRYVLTLFEKV--S----AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAG 87 (296)
T ss_pred heecccCccccceEEEEeCC----CcEEEEEcCCC--C----hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCC
Confidence 35678888888999875422 23899987541 1 245677888888885431 24444321 0111123
Q ss_pred eEEEEEecCCC
Q psy14267 335 HLYVLMEKGDT 345 (553)
Q Consensus 335 ~~~iv~e~~~~ 345 (553)
..++++++..|
T Consensus 88 ~~~~l~~~i~G 98 (296)
T cd05153 88 KPAALVEFLAG 98 (296)
T ss_pred ceEEEEEeCCC
Confidence 45677776443
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=96.42 E-value=0.026 Score=55.41 Aligned_cols=30 Identities=33% Similarity=0.541 Sum_probs=24.3
Q ss_pred CCcEecCCCCCCEEEecCccceecCCCCeEEEEeccCcc
Q psy14267 384 AGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIAC 422 (553)
Q Consensus 384 ~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGla~ 422 (553)
.+++|+|+.+.|||++.+ ...-|+||+.|.
T Consensus 164 ~~l~HGD~~~~Nvlv~~~---------~i~giIDw~~a~ 193 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDG---------RLSAVIDFGCLG 193 (235)
T ss_pred ceEEeCCCCCCcEEEECC---------CEEEEEeCcccC
Confidence 358999999999999754 345799999763
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1826|consensus | Back alignment and domain information |
|---|
Probab=96.38 E-value=0.0012 Score=77.99 Aligned_cols=159 Identities=13% Similarity=-0.016 Sum_probs=99.7
Q ss_pred HHHHHHHHhhcCCCceeEeeeEEEeCCCceEEEEEec-CCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhC
Q psy14267 306 LNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEK-GDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAA 384 (553)
Q Consensus 306 ~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~iv~e~-~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~ 384 (553)
..|...++...| +++.....=..+......+..+++ .+|.+...+-+...... +.....+.+...+.+.+..-+|+.
T Consensus 1277 l~e~de~~~~~h-~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~-~ld~~~v~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1277 LSERDELREAKH-YLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESP-DLDRSPVHLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred hhhhhhhhhhhc-eeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCC-cchhchHHHHHHHHHhccchhhhc
Confidence 344444444544 666554332222333345666664 45677777665433221 222222222222336666666643
Q ss_pred -----CcEecCCCCCCEEEecCccceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCc
Q psy14267 385 -----GIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNT 459 (553)
Q Consensus 385 -----gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~ 459 (553)
-.+|++||+-|.+|..+ ..||++++|+.+...+... ......+++.|+++++...-
T Consensus 1355 tnlg~T~v~~~Lkf~lpmIVtn---------y~v~~gk~gLdKIknp~~s--f~Gl~l~sp~~v~qli~N~i-------- 1415 (2724)
T KOG1826|consen 1355 TNLGNTNVSKSLKFTLPMIVTN---------YNVKLGKGGLDKIKNPVLS--FFGLELCSPIYVLQLIKNEI-------- 1415 (2724)
T ss_pred ccCCccchhhhhhhhccceecC---------CcccccccccccccCchHh--hhhhhhCCHHHHHHHHHHHH--------
Confidence 27999999999999887 4689999999984333221 23356688999999987544
Q ss_pred cCCCccchHHHHHHHHHHHHhCCCCCC
Q psy14267 460 YRITYKSDVWSLGCILYNMIYGRTPYS 486 (553)
Q Consensus 460 ~~~s~~sDIwSlGvvl~elltG~~Pf~ 486 (553)
.++.++|+|..|+.+|++--|..+|-
T Consensus 1416 -k~t~rsdilr~s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1416 -KFTKRSDILRRSLSLYLRSDGNAYFI 1441 (2724)
T ss_pred -hhhhHHHHHHHHHHHHHHhcccHHHH
Confidence 47788999999999999998887773
|
|
| >KOG1093|consensus | Back alignment and domain information |
|---|
Probab=96.33 E-value=0.0082 Score=64.33 Aligned_cols=164 Identities=23% Similarity=0.325 Sum_probs=94.8
Q ss_pred HHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHh
Q psy14267 303 DSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIH 382 (553)
Q Consensus 303 ~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH 382 (553)
.+.+-..++++.+.| +++..++++...... ..++|||+++.+|.+.+.... .. ..+++
T Consensus 27 ~~ilgr~~~lktl~~-~~l~~yl~~~r~~~~-r~IVV~e~~~~Sled~~~~~~-l~---------------~~s~~---- 84 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQH-DNLCQYLDFSRGKHE-RVIVVMEHYTMSLEDILKTGN-LK---------------DESLL---- 84 (725)
T ss_pred HHHhhhhHHHHhhcC-ccceeeEeeecCccc-eEEEEehhhccchHHHHHhcc-cc---------------hhhhc----
Confidence 456667788888865 999998876544444 489999999999999887653 10 11111
Q ss_pred hCCcEecCCCCCCEEEecCccceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCC
Q psy14267 383 AAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRI 462 (553)
Q Consensus 383 ~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~ 462 (553)
.+++.| . +.++++| .++.. | |-. .
T Consensus 85 ~~~~~~-----~----------------~~~~~td-~~~t~------------------~--~~~--------------~ 108 (725)
T KOG1093|consen 85 AHGVLH-----L----------------NIIYITD-HFLTK------------------Y--PSP--------------I 108 (725)
T ss_pred ccccce-----e----------------hhhhccc-ccccc------------------C--CCC--------------C
Confidence 222222 1 1245555 11100 0 101 1
Q ss_pred CccchHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHhhcccccc-cccc--cCCCCCCHHHHHHHHHhcccCCCCCCCH
Q psy14267 463 TYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEF-KPQL--ANNVTIPPTLLQSMKLCLQKDPKARPTV 539 (553)
Q Consensus 463 s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~~i~~~~~~~~~-~~~~--~~~~~~s~~l~~li~~cL~~dP~~RPt~ 539 (553)
.+++||||+|.++.||..|..-|..............-....... .-.. .....++..+.++.+.|+-..|..||..
T Consensus 109 ~pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~ 188 (725)
T KOG1093|consen 109 GPKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLP 188 (725)
T ss_pred CcchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccch
Confidence 248999999999999999987776533321111000000000000 0000 0111466788999999999999999976
Q ss_pred HHHHH
Q psy14267 540 GNSVT 544 (553)
Q Consensus 540 ~ell~ 544 (553)
.++.+
T Consensus 189 ~~~~k 193 (725)
T KOG1093|consen 189 MELSK 193 (725)
T ss_pred hHHhc
Confidence 66543
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.30 E-value=0.049 Score=55.80 Aligned_cols=147 Identities=23% Similarity=0.210 Sum_probs=76.8
Q ss_pred eEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCC-CceeEeeeE----EEeCC
Q psy14267 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGC-PYVIKMHDY----VYDTA 332 (553)
Q Consensus 258 y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~h-p~Iv~l~~~----~~~~~ 332 (553)
...++.|+.|....+|+++.. .+ .+++|+..... . .+....|++++..|..+ -.|.+++.. .....
T Consensus 24 ~~~i~~~~~G~~n~~y~v~t~-~~---~~vLK~~~~~~-~----~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~ 94 (307)
T TIGR00938 24 LLSLKGIAEGVENSNYLLTTD-VG---RYILTLYEKRV-K----AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTL 94 (307)
T ss_pred ceeccccCCccccceEEEEeC-CC---cEEEEEecCCC-C----HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhc
Confidence 444667888888999988532 22 37889775421 1 13455677887777432 113444321 01111
Q ss_pred CceEEEEEecCCCC------HH------HH---HHHc-ccCCC-----Cc-hHHHHHH------------HHHHHHHHHH
Q psy14267 333 SKHLYVLMEKGDTD------LS------KY---MRNL-NKMTT-----LP-NTMIIII------------MHWYEMLLAV 378 (553)
Q Consensus 333 ~~~~~iv~e~~~~~------L~------~~---l~~~-~~~~~-----~~-~~~~~i~------------~~~~qil~aL 378 (553)
....++++++..|. .. .. +... ..... .. ..+.... .....+...+
T Consensus 95 ~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~ 174 (307)
T TIGR00938 95 AGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKEL 174 (307)
T ss_pred CCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHH
Confidence 34567788764441 11 11 1111 11100 00 0100000 0011233345
Q ss_pred HHHh-------hCCcEecCCCCCCEEEecCccceecCCCCeEEEEeccCcc
Q psy14267 379 KEIH-------AAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIAC 422 (553)
Q Consensus 379 ~yLH-------~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGla~ 422 (553)
+++. ..+++|+|+.+.||+++.+ +.+.|+||+.+.
T Consensus 175 ~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~---------~~~~vIDfd~~~ 216 (307)
T TIGR00938 175 DYLDKFWPRDLPRGVIHADLFPDNVLFDGD---------SVKGVIDFYFAC 216 (307)
T ss_pred HHHHhhhhhcCCCccCCCCCCcCcEEEECC---------ceEEEeeccccc
Confidence 5554 3689999999999999776 456899999873
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.15 E-value=0.098 Score=53.78 Aligned_cols=30 Identities=47% Similarity=0.808 Sum_probs=25.0
Q ss_pred CCcEecCCCCCCEEEecCccceecCCCCeEEEEeccCcc
Q psy14267 384 AGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIAC 422 (553)
Q Consensus 384 ~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGla~ 422 (553)
.++||+|+.|.|||++.+ ..+-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~---------~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGD---------RLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECC---------ceEEEEeccccc
Confidence 489999999999999755 345799999874
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.91 E-value=0.13 Score=52.61 Aligned_cols=79 Identities=8% Similarity=-0.023 Sum_probs=51.4
Q ss_pred eEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCC--CceeEeeeEEEeC-CCc
Q psy14267 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGC--PYVIKMHDYVYDT-ASK 334 (553)
Q Consensus 258 y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~h--p~Iv~l~~~~~~~-~~~ 334 (553)
-.-.+.||.|..+.||.....+. .+.+|..+ .. .. ...+..|...|+.|... -.|.++++++.+. ...
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~~~----~~~~k~~~-~~-~~---~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g 86 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDSQG----NPMPLMAR-SF-ST---PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPG 86 (297)
T ss_pred hheeeecCCccceeEEEEEcCCC----CEEEEEec-cc-cc---chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCC
Confidence 34456899999999998743322 26777743 21 11 24678999999998664 3577777655432 234
Q ss_pred eEEEEEecCCC
Q psy14267 335 HLYVLMEKGDT 345 (553)
Q Consensus 335 ~~~iv~e~~~~ 345 (553)
.-+++||+..+
T Consensus 87 ~~~LVmE~i~G 97 (297)
T PRK10593 87 PDVLLLERLRG 97 (297)
T ss_pred CeEEEEeccCC
Confidence 57888987543
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=95.73 E-value=0.11 Score=51.68 Aligned_cols=29 Identities=28% Similarity=0.478 Sum_probs=24.2
Q ss_pred CcEecCCCCCCEEEecCccceecCCCCeEEEEeccCccc
Q psy14267 385 GIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACS 423 (553)
Q Consensus 385 gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGla~~ 423 (553)
.++|+|+.|.||+++.+ + +.|+||..|..
T Consensus 147 ~l~H~Dl~~~Nil~~~~---------~-~~lIDwE~a~~ 175 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQ---------G-LKLIDWEYASD 175 (256)
T ss_pred eeecCCCCcCcEEEeCC---------C-CEEEeccccCc
Confidence 58999999999999765 3 68999988743
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG2268|consensus | Back alignment and domain information |
|---|
Probab=95.69 E-value=0.01 Score=60.30 Aligned_cols=139 Identities=22% Similarity=0.285 Sum_probs=85.2
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcC-----ch------------hH--HHHHHHHHHHHHhhcC
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDIT-----DQ------------SI--ADSYLNEVELLAKLQG 317 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~-----~~------------~~--~~~~~~E~~iL~~l~~ 317 (553)
-+.++..||-|-=+-||++.+... .+.++|+-...... .. -. .-...+|...|+.|..
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G---~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e 169 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEG---NPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYE 169 (465)
T ss_pred hhhhccccccccccceEEEecCCC---CchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHH
Confidence 466788899999999998855433 34677754332210 00 00 1135789999999866
Q ss_pred CC-ceeEeeeEEEeCCCceEEEEEecCCC-CHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCC
Q psy14267 318 CP-YVIKMHDYVYDTASKHLYVLMEKGDT-DLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPAN 395 (553)
Q Consensus 318 hp-~Iv~l~~~~~~~~~~~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~N 395 (553)
|- -|...++ ....+++|++..+ .|... +... ....+...++.-+-.|..+|+||+|..-=|
T Consensus 170 ~gfpVPkpiD------~~RH~Vvmelv~g~Pl~~v-~~v~----------d~~~ly~~lm~~Iv~la~~GlIHgDFNEFN 232 (465)
T KOG2268|consen 170 RGFPVPKPID------HNRHCVVMELVDGYPLRQV-RHVE----------DPPTLYDDLMGLIVRLANHGLIHGDFNEFN 232 (465)
T ss_pred cCCCCCCccc------ccceeeHHHhhcccceeee-eecC----------ChHHHHHHHHHHHHHHHHcCceecccchhe
Confidence 43 2334433 2355788886543 22221 1111 011112255556678889999999999999
Q ss_pred EEEecCccceecCCCCeEEEEeccCcccc
Q psy14267 396 FLFVGNVLKIIDCIGNVLKIIDFGIACSL 424 (553)
Q Consensus 396 ILl~~~~~~~~~~~~~~vkL~DFGla~~~ 424 (553)
|+|+.+ +.++++||-.+...
T Consensus 233 imv~dd---------~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 233 IMVKDD---------DKIVVIDFPQMVST 252 (465)
T ss_pred eEEecC---------CCEEEeechHhhcc
Confidence 999866 56899999865443
|
|
| >KOG2270|consensus | Back alignment and domain information |
|---|
Probab=95.61 E-value=0.11 Score=54.06 Aligned_cols=144 Identities=16% Similarity=0.183 Sum_probs=86.4
Q ss_pred EEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCc----------------------CchhHHH-HHHHHHHHHHhh
Q psy14267 259 QVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDI----------------------TDQSIAD-SYLNEVELLAKL 315 (553)
Q Consensus 259 ~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~----------------------~~~~~~~-~~~~E~~iL~~l 315 (553)
.+...|..|--+-||.|...... .+|||+.+...+ +....++ .+.+|++.|++|
T Consensus 147 ~inGCiSTGKEANVYHat~~dG~---~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl 223 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEEDGS---EFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRL 223 (520)
T ss_pred ecccccccCccceeEeeecCCCc---eEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHH
Confidence 34457888999999998655443 389999875421 1122222 245788889998
Q ss_pred cCCCceeEeeeEEEeCCCceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHH-hhCCcEecCCCCC
Q psy14267 316 QGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEI-HAAGIIHSDLKPA 394 (553)
Q Consensus 316 ~~hp~Iv~l~~~~~~~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yL-H~~gIiHrDLKp~ 394 (553)
.. ..|...--+.. ...++||+++|.+-+-. +++.....+...+..+..+++.-|.-| |..++||.||.-=
T Consensus 224 ~~-aGIP~PePIlL----k~hVLVM~FlGrdgw~a----PkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEf 294 (520)
T KOG2270|consen 224 NN-AGIPCPEPILL----KNHVLVMEFLGRDGWAA----PKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEF 294 (520)
T ss_pred Hh-cCCCCCCceee----ecceEeeeeccCCCCcC----cccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhh
Confidence 54 33332221111 12478899877542211 111111222222333334666666655 4779999999999
Q ss_pred CEEEecCccceecCCCCeEEEEeccCcccc
Q psy14267 395 NFLFVGNVLKIIDCIGNVLKIIDFGIACSL 424 (553)
Q Consensus 395 NILl~~~~~~~~~~~~~~vkL~DFGla~~~ 424 (553)
|+|+.. |.+.|+|-+.+...
T Consensus 295 N~Lyhd----------G~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 295 NLLYHD----------GKLYIIDVSQSVEH 314 (520)
T ss_pred hheEEC----------CEEEEEEccccccC
Confidence 999865 46899999877543
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=95.14 E-value=0.31 Score=49.60 Aligned_cols=62 Identities=23% Similarity=0.185 Sum_probs=36.2
Q ss_pred EeeeeeeCceEEEEEeeeCC----CccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeee
Q psy14267 261 LSLLGKGGSSSVYLVGGTSE----HEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHD 326 (553)
Q Consensus 261 ~~~LG~G~fG~Vy~a~~~~~----~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~ 326 (553)
++.|..|-...||++..... ...+.|++|+...... ......+|.+++..+...-...+++.
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~----~~~~r~~E~~~~~~l~~~g~~P~~~~ 68 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE----LLIDRERELVVFARLSERNLGPKLYG 68 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc----ceechHHHHHHHHHHHhCCCCCceEE
Confidence 34566777788998864331 1124588998654321 11344688888888865433334433
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=94.44 E-value=0.34 Score=50.70 Aligned_cols=75 Identities=17% Similarity=0.145 Sum_probs=44.8
Q ss_pred eeeeeCceEEEEEeeeCCCccceEEEEEEecCC--c--CchhHHHHHHHHHHHHHhhcC-CC-ceeEeeeEEEeCCCceE
Q psy14267 263 LLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSD--I--TDQSIADSYLNEVELLAKLQG-CP-YVIKMHDYVYDTASKHL 336 (553)
Q Consensus 263 ~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~--~--~~~~~~~~~~~E~~iL~~l~~-hp-~Iv~l~~~~~~~~~~~~ 336 (553)
.||-|....||++...... +.|+||.-.... . .-.-..++..-|...|+.... .| .+.+++ +++ ....
T Consensus 2 EigdGnlN~VfrV~~~~g~--~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy--~~D--~e~~ 75 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGD--RAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIF--HFD--TEMA 75 (370)
T ss_pred cCCCCceEEEEEEEcCCCC--eeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEE--EEc--cccc
Confidence 5799999999999764221 348888653211 0 102234667788888877644 23 456663 333 3345
Q ss_pred EEEEecC
Q psy14267 337 YVLMEKG 343 (553)
Q Consensus 337 ~iv~e~~ 343 (553)
.++||+.
T Consensus 76 ~~vMEdL 82 (370)
T TIGR01767 76 VTVMEDL 82 (370)
T ss_pred eehHhhC
Confidence 6777765
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=94.36 E-value=0.012 Score=61.10 Aligned_cols=36 Identities=14% Similarity=0.044 Sum_probs=31.4
Q ss_pred hhhHhhhhhh---ccccccccccccccCCCCCCCC--CCCc
Q psy14267 105 AQSVEKIVLN---NINYRVDQCKKNLNYDPSIKTP--CKDA 140 (553)
Q Consensus 105 ~~~~~~~~~~---~~g~rC~~Cg~kfh~~C~~~vp--c~d~ 140 (553)
-|+-||=.|| +|||+||+|-|.+|++|..=|. |.-.
T Consensus 58 fCsHCkDFiwGfgKQGfQCqvC~fvvHkrChefVtF~CPGa 98 (683)
T KOG0696|consen 58 FCSHCKDFIWGFGKQGFQCQVCCFVVHKRCHEFVTFSCPGA 98 (683)
T ss_pred hhhhhhhheeccccCceeeeEEeehhhhhhcceEEEECCCC
Confidence 4888998876 8999999999999999999887 6654
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=94.25 E-value=1.1 Score=45.33 Aligned_cols=31 Identities=29% Similarity=0.472 Sum_probs=24.4
Q ss_pred CcEecCCCCCCEEEecCccceecCCCCeEEEEeccCccc
Q psy14267 385 GIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACS 423 (553)
Q Consensus 385 gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGla~~ 423 (553)
.+||+|+.+.|||++.+ +...-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~--------~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDED--------ARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCC--------CCEEEEECcHhccc
Confidence 48999999999999753 13467999998743
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.17 E-value=0.15 Score=52.97 Aligned_cols=77 Identities=14% Similarity=0.182 Sum_probs=50.6
Q ss_pred CCCceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHh-hCCcEecCCCCCCEEEecCccceecCC
Q psy14267 331 TASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIH-AAGIIHSDLKPANFLFVGNVLKIIDCI 409 (553)
Q Consensus 331 ~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH-~~gIiHrDLKp~NILl~~~~~~~~~~~ 409 (553)
.+..+.|++|++.|+.+...--. ....+..++.+.+..++-+. .-..-|||+.-.||||+ +
T Consensus 296 de~~y~yl~~kdhgt~is~ik~~---------~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~-------- 357 (488)
T COG5072 296 DETLYLYLHFKDHGTPISIIKAD---------RSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-E-------- 357 (488)
T ss_pred CCceEEEEEEecCCceeeeeecc---------cHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-c--------
Confidence 45668899999988876432111 12233333345554444443 33688999999999998 3
Q ss_pred CCeEEEEeccCccccCC
Q psy14267 410 GNVLKIIDFGIACSLQD 426 (553)
Q Consensus 410 ~~~vkL~DFGla~~~~~ 426 (553)
|+|.|+||-+++.-.+
T Consensus 358 -GnvtLIDfklsRl~~~ 373 (488)
T COG5072 358 -GNVTLIDFKLSRLSYS 373 (488)
T ss_pred -CceEEEEeeeeecccC
Confidence 5799999999984433
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=94.14 E-value=0.71 Score=49.21 Aligned_cols=78 Identities=13% Similarity=0.060 Sum_probs=47.2
Q ss_pred EEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCc-Cch---hHHHHHHHHHHHHHhhcCC--CceeEeeeEEEeCCC
Q psy14267 260 VLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDI-TDQ---SIADSYLNEVELLAKLQGC--PYVIKMHDYVYDTAS 333 (553)
Q Consensus 260 i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~-~~~---~~~~~~~~E~~iL~~l~~h--p~Iv~l~~~~~~~~~ 333 (553)
..+.||-|....||++.+. + +.|+||.-..... ... ....+...|+..|+.+... ..|.+++.++ .
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~--~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~d--e-- 107 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--S--GSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFD--R-- 107 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--C--ccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEEC--C--
Confidence 3567899999999998652 2 2388887652211 110 1245667778888776421 3666665443 2
Q ss_pred ceEEEEEecCCC
Q psy14267 334 KHLYVLMEKGDT 345 (553)
Q Consensus 334 ~~~~iv~e~~~~ 345 (553)
...+++||+..+
T Consensus 108 d~~vlvME~L~~ 119 (418)
T PLN02756 108 TMALIGMRYLEP 119 (418)
T ss_pred CCCEEEEeecCC
Confidence 334667887644
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=93.98 E-value=0.59 Score=47.89 Aligned_cols=29 Identities=24% Similarity=0.355 Sum_probs=24.8
Q ss_pred CcEecCCCCCCEEEecCccceecCCCCeEEEEeccCcc
Q psy14267 385 GIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIAC 422 (553)
Q Consensus 385 gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGla~ 422 (553)
+++|+|+.+.|||++.+ +.+.|+||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~---------~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDET---------RGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCC---------CCEEEEEhhhcc
Confidence 79999999999999765 458899998764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.64 E-value=0.66 Score=48.12 Aligned_cols=28 Identities=50% Similarity=0.751 Sum_probs=24.0
Q ss_pred cEecCCCCCCEEEecCccceecCCCCeEEEEeccCc
Q psy14267 386 IIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIA 421 (553)
Q Consensus 386 IiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGla 421 (553)
+||+|+-|.|||++.+. ..+.++||+-|
T Consensus 199 iIH~D~~~~NVl~d~~~--------~~~g~iDFdDa 226 (331)
T COG2334 199 IIHGDLHPDNVLFDDDT--------DVSGFIDFDDA 226 (331)
T ss_pred eeecCCCccceeEcCCC--------CeeeEEEcccc
Confidence 99999999999998773 14789999976
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.57 E-value=0.11 Score=53.05 Aligned_cols=38 Identities=26% Similarity=0.380 Sum_probs=25.7
Q ss_pred HHHHHHHHHHHHHHHHHhh----CCcEecCCCCCCEEEecCc
Q psy14267 365 IIIIMHWYEMLLAVKEIHA----AGIIHSDLKPANFLFVGNV 402 (553)
Q Consensus 365 ~~i~~~~~qil~aL~yLH~----~gIiHrDLKp~NILl~~~~ 402 (553)
.-+..++.||+.-.-.+-+ .+.+|-||||+||||-+..
T Consensus 279 ~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~ 320 (444)
T PHA03111 279 EYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSD 320 (444)
T ss_pred HHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCC
Confidence 3455556677754434433 3599999999999996553
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=93.36 E-value=0.13 Score=52.87 Aligned_cols=61 Identities=20% Similarity=0.183 Sum_probs=35.9
Q ss_pred HHHHHHHHHHHHHHHHHh----hCCcEecCCCCCCEEEecCccceec---------CCCCeEEEEeccCccccC
Q psy14267 365 IIIIMHWYEMLLAVKEIH----AAGIIHSDLKPANFLFVGNVLKIID---------CIGNVLKIIDFGIACSLQ 425 (553)
Q Consensus 365 ~~i~~~~~qil~aL~yLH----~~gIiHrDLKp~NILl~~~~~~~~~---------~~~~~vkL~DFGla~~~~ 425 (553)
.-+..++.||+.-.--+- -.+.+|-||||+||||-+....+.- .+.-..+|.||.++....
T Consensus 275 ~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~~ 348 (434)
T PF05445_consen 275 EYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVAN 348 (434)
T ss_pred HHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhcc
Confidence 334555567664321122 3469999999999999654322211 122346788888876543
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=92.98 E-value=1.9 Score=45.03 Aligned_cols=62 Identities=6% Similarity=0.011 Sum_probs=36.9
Q ss_pred eeeeeeCceEEEEEeeeCC--CccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeE
Q psy14267 262 SLLGKGGSSSVYLVGGTSE--HEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDY 327 (553)
Q Consensus 262 ~~LG~G~fG~Vy~a~~~~~--~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~ 327 (553)
..|-.|-...+|++..... ...+.|++|+..... ...+++ .+|..+++.+.....-.+++++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~idR-~~E~~~~~~l~~~gl~P~~~~~ 105 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFDR-DDEIRTFECMSRHGQGPRLLGR 105 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeech-HHHHHHHHHHHHcCCCCceEEE
Confidence 3555588889998864321 122458899875432 222333 6799998888664444444443
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=92.92 E-value=1.7 Score=44.74 Aligned_cols=33 Identities=18% Similarity=0.361 Sum_probs=27.1
Q ss_pred CcEecCCCCCCEEEecCccceecCCCCeEEEEeccCccccCC
Q psy14267 385 GIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQD 426 (553)
Q Consensus 385 gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGla~~~~~ 426 (553)
.++|+|+.+.||+|+.+. -+-|.||+++..-.+
T Consensus 199 ~lvHGD~~~gNlii~~~~---------~~gVlDwe~~~lGDP 231 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGR---------PTGVLDWELATLGDP 231 (321)
T ss_pred eeeeCCcccCCEEEeCCC---------eeEEEeccccccCCc
Confidence 489999999999998773 388999999865433
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.73 E-value=1.7 Score=44.99 Aligned_cols=28 Identities=25% Similarity=0.335 Sum_probs=22.8
Q ss_pred CCcEecCCCCCCEEEecCccceecCCCCeEEEEeccCcc
Q psy14267 384 AGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIAC 422 (553)
Q Consensus 384 ~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGla~ 422 (553)
.++||+|+-+.|||++ + .+.|+||+-+.
T Consensus 196 ~~liHgD~h~~NvL~~-d----------~~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D----------GPHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhcccc-C----------CcEEEeCCCCC
Confidence 4689999999999984 2 25799999764
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=92.24 E-value=0.92 Score=47.07 Aligned_cols=31 Identities=26% Similarity=0.376 Sum_probs=25.1
Q ss_pred cEecCCCCCCEEEecCccceecCCCCeEEEEeccCcccc
Q psy14267 386 IIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSL 424 (553)
Q Consensus 386 IiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGla~~~ 424 (553)
.+|.|+-+.|||++++. +.++|+||..|..-
T Consensus 184 ~CHnDl~~~NiL~~~~~--------~~l~lID~EYag~n 214 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDE--------GKLYFIDFEYGSYS 214 (330)
T ss_pred EEECCCCcccEEEeCCC--------CcEEEEcccccCCC
Confidence 78999999999996542 46999999987543
|
|
| >PF07649 C1_3: C1-like domain; InterPro: IPR011424 This short domain is rich in cysteines and histidines | Back alignment and domain information |
|---|
Probab=92.08 E-value=0.021 Score=36.96 Aligned_cols=26 Identities=15% Similarity=0.238 Sum_probs=11.9
Q ss_pred hhHhhhhhhc-cccccccccccccCCC
Q psy14267 106 QSVEKIVLNN-INYRVDQCKKNLNYDP 131 (553)
Q Consensus 106 ~~~~~~~~~~-~g~rC~~Cg~kfh~~C 131 (553)
|++++..+.. ..|+|.+|.|.+|..|
T Consensus 3 C~~C~~~~~~~~~Y~C~~Cdf~lH~~C 29 (30)
T PF07649_consen 3 CDACGKPIDGGWFYRCSECDFDLHEEC 29 (30)
T ss_dssp -TTTS----S--EEE-TTT-----HHH
T ss_pred CCcCCCcCCCCceEECccCCCccChhc
Confidence 5677777776 7999999999999887
|
The pattern of conservation is similar to that found in IPR002219 from INTERPRO. C1 domains are protein kinase C-like zinc finger structures. Diacylglycerol (DAG) kinases (DGKs) have a two or three commonly conserved cysteine-rich C1 domains []. DGKs modulate the balance between the two signaling lipids, DAG and phosphatidic acid (PA), by phosphorylating DAG to yield PA []. The PKD (protein kinase D) family are novel DAG receptors. They have twin C1 domains, designated C1a and C1b, which bind DAG or phorbol esters. Individual C1 domains differ in ligand-binding activity and selectivity []. ; GO: 0047134 protein-disulfide reductase activity, 0055114 oxidation-reduction process; PDB: 1V5N_A. |
| >PF13240 zinc_ribbon_2: zinc-ribbon domain | Back alignment and domain information |
|---|
Probab=92.00 E-value=0.061 Score=32.58 Aligned_cols=17 Identities=6% Similarity=0.063 Sum_probs=14.3
Q ss_pred cccccc------ccccCCCCCCC
Q psy14267 119 RVDQCK------KNLNYDPSIKT 135 (553)
Q Consensus 119 rC~~Cg------~kfh~~C~~~v 135 (553)
+|+.|| -+||++|+.++
T Consensus 1 ~Cp~CG~~~~~~~~fC~~CG~~l 23 (23)
T PF13240_consen 1 YCPNCGAEIEDDAKFCPNCGTPL 23 (23)
T ss_pred CCcccCCCCCCcCcchhhhCCcC
Confidence 589999 78999998875
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 553 | ||||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-41 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-41 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-41 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-41 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 5e-41 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-41 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 7e-41 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-40 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-18 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-16 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 7e-16 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-15 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 5e-15 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-15 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-15 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-15 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-15 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 6e-15 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 7e-15 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-15 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-14 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-14 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 5e-14 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-14 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 7e-14 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 8e-14 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-14 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 9e-14 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 9e-14 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-13 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-13 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-13 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-13 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-13 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-13 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-13 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 8e-13 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-12 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-12 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-12 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-12 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-12 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 5e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-12 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 7e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 8e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 9e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-11 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-11 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-11 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-11 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-11 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-11 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-11 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-11 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-11 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-11 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-11 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-11 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-11 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 7e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-11 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 7e-11 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 7e-11 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 8e-11 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 8e-11 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 9e-11 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-10 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-10 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-10 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-10 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-10 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-10 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-10 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-10 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-10 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-10 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-10 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-10 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-10 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-10 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-10 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-10 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-10 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-10 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-10 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-10 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-10 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-10 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-10 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-10 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-10 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-10 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-10 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-10 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-10 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-10 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-10 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-10 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-10 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-10 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-10 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-10 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-10 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 5e-10 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 5e-10 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-10 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-10 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 6e-10 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 6e-10 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 6e-10 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-10 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-10 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 7e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-10 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 7e-10 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-10 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 7e-10 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-10 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 7e-10 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 7e-10 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 7e-10 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 7e-10 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 8e-10 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 8e-10 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-10 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-10 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 8e-10 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 8e-10 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 8e-10 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 8e-10 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 8e-10 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 8e-10 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 8e-10 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 9e-10 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 9e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 9e-10 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 9e-10 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-10 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 9e-10 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 9e-10 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 9e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-10 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 9e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 9e-10 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-09 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-09 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-09 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-09 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-09 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-09 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-09 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-09 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-09 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-09 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-09 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-09 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 1e-09 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 1e-09 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 1e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-09 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-09 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-09 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 1e-09 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 1e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-09 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 1e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-09 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-09 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 1e-09 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-09 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-09 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 1e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-09 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 1e-09 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 1e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-09 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 1e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-09 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-09 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-09 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-09 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-09 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-09 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 2e-09 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-09 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-09 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-09 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-09 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-09 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-09 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-09 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-09 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-09 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-09 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-09 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-09 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-09 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-09 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-09 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-09 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-09 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-09 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-09 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-09 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-09 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-09 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-09 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-09 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-09 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-09 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-09 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-09 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 4e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-09 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-09 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-09 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 4e-09 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 4e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-09 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 4e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-09 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-09 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 5e-09 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 5e-09 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-09 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-09 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 5e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 5e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-09 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-09 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 6e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 6e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 6e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 6e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 6e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-09 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 6e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 6e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 6e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 6e-09 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 6e-09 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 6e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 6e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 6e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 6e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 6e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 6e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 6e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 6e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 7e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 7e-09 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 7e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 7e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 7e-09 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 7e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 7e-09 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 7e-09 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 7e-09 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 7e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 7e-09 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 7e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 8e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 8e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 8e-09 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 8e-09 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 8e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 8e-09 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 8e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 8e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 8e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 8e-09 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-09 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 9e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-08 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 1e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-08 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-08 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 1e-08 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-08 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-08 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-08 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-08 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-08 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-08 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-08 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-08 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-08 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-08 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-08 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-08 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-08 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-08 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-08 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-08 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-08 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-08 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-08 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-08 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-08 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-08 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-08 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-08 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-08 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-08 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-08 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-08 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-08 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-08 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-08 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-08 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-08 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-08 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-08 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-08 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-08 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-08 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-08 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-08 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-08 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-08 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 5e-08 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-08 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 5e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-08 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 5e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-08 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-08 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-08 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 5e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 5e-08 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 5e-08 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 5e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 6e-08 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-08 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 6e-08 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 6e-08 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-08 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 6e-08 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 6e-08 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-08 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-08 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 6e-08 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 6e-08 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 6e-08 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 6e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-08 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 6e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 6e-08 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 7e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 7e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 7e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 7e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 7e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 7e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 7e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 7e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 7e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 7e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 7e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 7e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 8e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 8e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 8e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 8e-08 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 8e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 8e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 8e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 8e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 9e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 9e-08 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 9e-08 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 9e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 9e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 9e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-08 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-07 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-07 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-07 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-07 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-07 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-07 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-07 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-07 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-07 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-07 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-07 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-07 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-07 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-07 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-07 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-07 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-07 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-07 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-07 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-07 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-07 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-07 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-07 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-07 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-07 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-07 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-07 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-07 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-07 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-07 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-07 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-07 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-07 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-07 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-07 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 4e-07 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-07 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 4e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-07 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-07 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 4e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-07 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 4e-07 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 4e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 4e-07 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 4e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-07 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-07 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 5e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-07 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-07 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-07 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-07 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 5e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-07 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-07 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-07 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 6e-07 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 6e-07 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 6e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 6e-07 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 6e-07 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 6e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 6e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-07 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 6e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 6e-07 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 7e-07 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 7e-07 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 7e-07 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 7e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 7e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 7e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-07 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 7e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 7e-07 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 7e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 8e-07 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 8e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 8e-07 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 8e-07 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-07 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 8e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 9e-07 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 9e-07 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 9e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 9e-07 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 9e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 9e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 9e-07 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 9e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 9e-07 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-06 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-06 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-06 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-06 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-06 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-06 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-06 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-06 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-06 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-06 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-06 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-06 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-06 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-06 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-06 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-06 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-06 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-06 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-06 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-06 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-06 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-06 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-06 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-06 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-06 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-06 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-06 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-06 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-06 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-06 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-06 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-06 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-06 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-06 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-06 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-06 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-06 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-06 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-06 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-06 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-06 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-06 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-06 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-06 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-06 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-06 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-06 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-06 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-06 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-06 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-06 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-06 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-06 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-06 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-06 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-06 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-06 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-06 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-06 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-06 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-06 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-06 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-06 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-06 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 3e-06 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-06 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-06 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-06 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-06 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-06 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-06 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-06 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 5e-06 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 5e-06 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-06 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-06 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-06 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 6e-06 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-06 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 6e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 7e-06 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 7e-06 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 7e-06 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 8e-06 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 8e-06 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-06 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 9e-06 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 9e-06 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-06 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-05 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-05 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-05 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-05 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-05 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-05 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 1e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-05 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 1e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-05 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-05 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 2e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-05 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-05 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-05 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-05 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-05 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-05 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-05 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-05 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-05 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-05 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-05 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-05 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-05 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-05 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-05 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-05 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-05 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-05 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-05 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-05 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-05 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 6e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 7e-05 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 7e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 7e-05 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 7e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-05 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 7e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-05 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 8e-05 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 8e-05 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-05 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 8e-05 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 8e-05 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 8e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 9e-05 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 9e-05 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-05 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 9e-05 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 9e-05 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-04 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-04 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-04 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-04 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-04 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-04 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-04 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-04 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-04 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-04 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-04 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-04 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-04 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-04 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-04 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-04 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-04 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-04 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-04 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-04 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-04 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 4e-04 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 4e-04 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 5e-04 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-04 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 5e-04 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 5e-04 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-04 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 5e-04 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-04 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-04 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 6e-04 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-04 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-04 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 7e-04 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 7e-04 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 7e-04 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-04 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 7e-04 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-04 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 8e-04 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-04 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 8e-04 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 8e-04 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 8e-04 | ||
| 2csn_A | 297 | Binary Complex Of Casein Kinase-1 With Cki7 Length | 9e-04 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 9e-04 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 9e-04 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 9e-04 |
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 278 bits (713), Expect = 5e-90
Identities = 112/292 (38%), Positives = 161/292 (55%), Gaps = 30/292 (10%)
Query: 251 ITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVE 310
+++ G+ Y +L +G GGSS V+ V + + A+K V+L + D DSY NE+
Sbjct: 23 MSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIY---AIKYVNLEEA-DNQTLDSYRNEIA 78
Query: 311 LLAKLQG-CPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIM 369
L KLQ +I+++DY +++Y++ME G+ DL+ +++ +
Sbjct: 79 YLNKLQQHSDKIIRLYDYEIT--DQYIYMVMECGNIDLNSWLKKKKSID-----PWERKS 131
Query: 370 HWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKT 429
+W ML AV IH GI+HSDLKPANFL V +LK+ID FGIA +Q D T
Sbjct: 132 YWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLID----------FGIANQMQPDTT 181
Query: 430 SVHKDTASGTLNYMSPEA--AGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSH 487
SV KD+ GT+NYM PEA +S G + +I+ KSDVWSLGCILY M YG+TP+
Sbjct: 182 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 241
Query: 488 IPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTV 539
I N +K+ AI +IEF L +K CL++DPK R ++
Sbjct: 242 IINQISKLHAIIDPNHEIEFPD------IPEKDLQDVLKCCLKRDPKQRISI 287
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 278 bits (713), Expect = 6e-89
Identities = 117/333 (35%), Positives = 176/333 (52%), Gaps = 30/333 (9%)
Query: 210 PLSVNSTKSSDPSVSKETIKPAKPQITTSNAKKSVETSQDVITLNGKQYQVLSLLGKGGS 269
+ S + E P + T + K+ ++ + I++ G+ Y +L +G GGS
Sbjct: 10 LVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGS 69
Query: 270 SSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG-CPYVIKMHDYV 328
S V+ V + + A+K V+L + +Q++ DSY NE+ L KLQ +I+++DY
Sbjct: 70 SKVFQVLNEKKQIY---AIKYVNLEEADNQTL-DSYRNEIAYLNKLQQHSDKIIRLYDYE 125
Query: 329 YDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIH 388
+++Y++ME G+ DL+ +++ + +W ML AV IH GI+H
Sbjct: 126 IT--DQYIYMVMECGNIDLNSWLKKKKSID-----PWERKSYWKNMLEAVHTIHQHGIVH 178
Query: 389 SDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEA- 447
SDLKPANFL V +LK+ID FGIA +Q D TSV KD+ G +NYM PEA
Sbjct: 179 SDLKPANFLIVDGMLKLID----------FGIANQMQPDTTSVVKDSQVGAVNYMPPEAI 228
Query: 448 -AGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIE 506
+S G + +I+ KSDVWSLGCILY M YG+TP+ I N +K+ AI +IE
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE 288
Query: 507 FKPQLANNVTIPPTLLQSMKLCLQKDPKARPTV 539
F L +K CL++DPK R ++
Sbjct: 289 FPD------IPEKDLQDVLKCCLKRDPKQRISI 315
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 274 bits (703), Expect = 4e-88
Identities = 113/294 (38%), Positives = 165/294 (56%), Gaps = 30/294 (10%)
Query: 249 DVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNE 308
+ I++ G+ Y +L +G GGSS V+ V + + A+K V+L + +Q++ DSY NE
Sbjct: 2 ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIY---AIKYVNLEEADNQTL-DSYRNE 57
Query: 309 VELLAKLQG-CPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIII 367
+ L KLQ +I+++DY +++Y++ME G+ DL+ +++ +
Sbjct: 58 IAYLNKLQQHSDKIIRLYDYEIT--DQYIYMVMECGNIDLNSWLKKKKSID-----PWER 110
Query: 368 IMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDD 427
+W ML AV IH GI+HSDLKPANFL V +LK+ID FGIA +Q D
Sbjct: 111 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLID----------FGIANQMQPD 160
Query: 428 KTSVHKDTASGTLNYMSPEA--AGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY 485
TSV KD+ GT+NYM PEA +S G + +I+ KSDVWSLGCILY M YG+TP+
Sbjct: 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 220
Query: 486 SHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTV 539
I N +K+ AI +IEF L +K CL++DPK R ++
Sbjct: 221 QQIINQISKLHAIIDPNHEIEFPD------IPEKDLQDVLKCCLKRDPKQRISI 268
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 2e-50
Identities = 67/316 (21%), Positives = 119/316 (37%), Gaps = 50/316 (15%)
Query: 250 VITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEV 309
++ ++ K Y + LG+GG S V LV G + ALK + + D+ A E
Sbjct: 23 MVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDG--HFYALKRILCHEQQDREEA---QREA 77
Query: 310 ELLAKLQGCPYVIKMHDYVYD--TASKHLYVLME---KGDTDLSKYM-RNLNKMTTLPNT 363
++ P ++++ Y A ++L+ +G L + R +K L
Sbjct: 78 DMHRLF-NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGT--LWNEIERLKDKGNFLTED 134
Query: 364 MIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACS 423
I+ ++ + ++ IHA G H DLKP N L ++D G
Sbjct: 135 QILWLL--LGICRGLEAIHAKGYAHRDLKPTNILLGDE---------GQPVLMDLGSMNQ 183
Query: 424 LQDDKTSVHK-------DTASGTLNYMSPEAAGQTSSSGGGNTYR-ITYKSDVWSLGCIL 475
+ T++Y +PE ++ I ++DVWSLGC+L
Sbjct: 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFS-------VQSHCVIDERTDVWSLGCVL 236
Query: 476 YNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKA 535
Y M++G PY + + +++ I P+ L Q + + DP
Sbjct: 237 YAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRH------SSALWQLLNSMMTVDPHQ 290
Query: 536 RPTVGNSVTQINNNPE 551
RP + + + E
Sbjct: 291 RP----HIPLLLSQLE 302
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 2e-48
Identities = 79/306 (25%), Positives = 126/306 (41%), Gaps = 53/306 (17%)
Query: 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKL 315
+ Y+VL +G G + + + K L K +D +T+ ++EV LL +L
Sbjct: 6 EDYEVLYTIGTGSYGRCQKI--RRKSDGKILVWKELDYGSMTEAEKQML-VSEVNLLREL 62
Query: 316 QGCPYVIKMHDYVYDTASKHLYVLME---KGDTDLSKYMRNLNKM-TTLPNTMIIIIMHW 371
+ P +++ +D + D + LY++ME GD L+ + K L ++ +M
Sbjct: 63 K-HPNIVRYYDRIIDRTNTTLYIVMEYCEGGD--LASVITKGTKERQYLDEEFVLRVM-- 117
Query: 372 YEMLLAVKEIH-----AAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQD 426
++ LA+KE H ++H DLKPAN G +K+ DFG+A L
Sbjct: 118 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK---------QNVKLGDFGLARIL-- 166
Query: 427 DKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYS 486
+ + T GT YMSPE +Y KSD+WSLGC+LY + P+
Sbjct: 167 NHDTSFAKTFVGTPYYMSPEQMN-------RMSY--NEKSDIWSLGCLLYELCALMPPF- 216
Query: 487 HIPNTWAKMLAIAR--HKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVT 544
T +A + + P L + + L RP SV
Sbjct: 217 ----TAFSQKELAGKIREGKFRRIPY-----RYSDELNEIITRMLNLKDYHRP----SVE 263
Query: 545 QINNNP 550
+I NP
Sbjct: 264 EILENP 269
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 7e-48
Identities = 64/298 (21%), Positives = 117/298 (39%), Gaps = 46/298 (15%)
Query: 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKL 315
++Y L +G+G LV S + + +K +++S ++ + +S EV +LA +
Sbjct: 24 EKYVRLQKIGEGSFGKAILV--KSTEDGRQYVIKEINISRMSSKEREES-RREVAVLANM 80
Query: 316 QGCPYVIKMHDYVYDTASKHLYVLME---KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWY 372
+ P +++ + + + LY++M+ GD L K + I+
Sbjct: 81 K-HPNIVQYRESFEE--NGSLYIVMDYCEGGD--LFKRINAQKG-VLFQEDQILDWF--V 132
Query: 373 EMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVH 432
++ LA+K +H I+H D+K N + +++ DFGIA L + T
Sbjct: 133 QICLALKHVHDRKILHRDIKSQNIFLTKD---------GTVQLGDFGIARVL--NSTVEL 181
Query: 433 KDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTW 492
GT Y+SPE Y KSD+W+LGC+LY + + + +
Sbjct: 182 ARACIGTPYYLSPEICE-------NKPY--NNKSDIWALGCVLYELCTLKHAF-EAGSMK 231
Query: 493 AKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNP 550
+L I L + +++P+ RP SV I
Sbjct: 232 NLVLKI--ISGSFPPVSL-----HYSYDLRSLVSQLFKRNPRDRP----SVNSILEKG 278
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 3e-47
Identities = 67/318 (21%), Positives = 129/318 (40%), Gaps = 64/318 (20%)
Query: 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKL 315
++ + LG+GG V+ ++ + A+K + L + + + EV+ LAKL
Sbjct: 5 TDFEPIQCLGRGGFGVVFEA--KNKVDDCNYAIKRIRLPNRELAR--EKVMREVKALAKL 60
Query: 316 QGCPYVIKMHDYVYD----------TASKHLYVLME---KGDTDLSKYMRNLNKMTTLPN 362
+ P +++ + + + +LY+ M+ K + L +M +
Sbjct: 61 E-HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKEN--LKDWMNGRCTIEERER 117
Query: 363 TMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIAC 422
++ + I ++ AV+ +H+ G++H DLKP+N F + +V+K+ DFG+
Sbjct: 118 SVCLHIF--LQIAEAVEFLHSKGLMHRDLKPSNIFFTMD---------DVVKVGDFGLVT 166
Query: 423 SLQDDKTSVHKDTAS----------GTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLG 472
++ D+ T GT YMSPE GN+Y ++K D++SLG
Sbjct: 167 AMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQI-------HGNSY--SHKVDIFSLG 217
Query: 473 CILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKD 532
IL+ ++ + +T + + ++F P P ++ L
Sbjct: 218 LILFELL-------YPFSTQMERVRTLTDVRNLKFPPLFTQ---KYPCEYVMVQDMLSPS 267
Query: 533 PKARPTVGNSVTQINNNP 550
P RP I N
Sbjct: 268 PMERP----EAINIIENA 281
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 4e-47
Identities = 74/320 (23%), Positives = 136/320 (42%), Gaps = 43/320 (13%)
Query: 224 SKETIKPAKPQITTSNAKKSVETSQDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEF 283
S+ P PQ A + + +++ +G+G S VY +
Sbjct: 5 SQGMQGPPVPQFQPQKALRPDMGYNTL-----ANFRIEKKIGRGQFSEVYRAACLLDGVP 59
Query: 284 KPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLME-- 341
+ALK V + D+ D + E++LL +L P VIK + + L +++E
Sbjct: 60 --VALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIE--DNELNIVLELA 114
Query: 342 -KGDTDLSKYMRNLNKM-TTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFV 399
GD LS+ +++ K +P + ++ A++ +H+ ++H D+KPAN
Sbjct: 115 DAGD--LSRMIKHFKKQKRLIPERTVWKYF--VQLCSALEHMHSRRVMHRDIKPANVFIT 170
Query: 400 GNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNT 459
V+K+ D G+ + + GT YMSPE +
Sbjct: 171 AT---------GVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPERIHENG------- 212
Query: 460 YRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPP 519
Y +KSD+WSLGC+LY M ++P+ + ++ + +Q ++ P +++
Sbjct: 213 Y--NFKSDIWSLGCLLYEMAALQSPFYGDKMN---LYSLCKKIEQCDYPPLPSDH--YSE 265
Query: 520 TLLQSMKLCLQKDPKARPTV 539
L Q + +C+ DP+ RP V
Sbjct: 266 ELRQLVNMCINPDPEKRPDV 285
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 1e-46
Identities = 62/317 (19%), Positives = 117/317 (36%), Gaps = 78/317 (24%)
Query: 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAK 314
G ++ + L+G GG V+ + K +K V ++ + EV+ LAK
Sbjct: 10 GMDFKEIELIGSGGFGQVFKA--KHRIDGKTYVIKRVKYNN-------EKAEREVKALAK 60
Query: 315 LQGCPYVIKMHDYVYD--------------TASKHLYVLME---KGDTDLSKYMRNLNKM 357
L ++ + + +K L++ ME KG L +++ +
Sbjct: 61 LD-HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGT--LEQWIEK-RRG 116
Query: 358 TTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIID 417
L + + + ++ V IH+ +I+ DLKP+N V +KI D
Sbjct: 117 EKLDKVLALELF--EQITKGVDYIHSKKLINRDLKPSNIFLVDT---------KQVKIGD 165
Query: 418 FGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYN 477
FG+ SL++D + + GTL YMSPE Y + D+++LG IL
Sbjct: 166 FGLVTSLKNDGK---RTRSKGTLRYMSPEQIS-------SQDY--GKEVDLYALGLILAE 213
Query: 478 MIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTL---LQSM-KLCLQKDP 533
+++ + + + I +++ + L K P
Sbjct: 214 LLHVCDTAFETSKFFTDL-----------------RDGIISDIFDKKEKTLLQKLLSKKP 256
Query: 534 KARPTVGNSVTQINNNP 550
+ RP + ++I
Sbjct: 257 EDRP----NTSEILRTL 269
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 165 bits (418), Expect = 4e-46
Identities = 49/365 (13%), Positives = 103/365 (28%), Gaps = 59/365 (16%)
Query: 199 KKNESTPVFKRPLSVNSTKSSDPSVSKETIKPAKPQITTSNAKKSVETSQDVITLNGKQY 258
K+ E + R ++ + +V+ S + ++
Sbjct: 16 KREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQG-----------ERKL 64
Query: 259 QVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKL--- 315
+++ L G S V+LV + ALKV + +S + A+L
Sbjct: 65 KLVEPLRVGDRSVVFLV--RDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 316 --------------------QGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLN 355
Q P ++ D A + +LM DL L+
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 356 KMTTLPNTMIIIIMHWY--EMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413
+ I+ +H +++ + + G++H P N + + G +
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPD--------GRL- 233
Query: 414 KIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGC 473
+ D + +S + Y E +T T+ + W LG
Sbjct: 234 MLGDVSALWKVGTRGP-----ASSVPVTYAPREFLN-------ASTATFTHALNAWQLGL 281
Query: 474 ILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDP 533
+Y + P+ + + + +P + + L D
Sbjct: 282 SIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDR 341
Query: 534 KARPT 538
+ R
Sbjct: 342 RRRLL 346
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 8e-44
Identities = 68/314 (21%), Positives = 111/314 (35%), Gaps = 63/314 (20%)
Query: 250 VITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEV 309
+ L + +V +L +GG + VY + ALK + ++ + EV
Sbjct: 22 TVELGELRLRVRRVLAEGGFAFVYEAQDVGSG--REYALKRLLSNEEEKNRAI---IQEV 76
Query: 310 ELLAKLQGCPYVIKMHDY------VYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNT 363
+ KL G P +++ DT +L E L ++++ + L
Sbjct: 77 CFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCD 136
Query: 364 MIIIIMHWYEMLLAVKEIHAAG--IIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIA 421
++ I Y+ AV+ +H IIH DLK N L +K+ DFG A
Sbjct: 137 TVLKIF--YQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQ---------GTIKLCDFGSA 185
Query: 422 CSLQDDKTSVHKD----------TASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSL 471
++ T + T Y +PE N I K D+W+L
Sbjct: 186 TTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEII-----DLYSNFP-IGEKQDIWAL 239
Query: 472 GCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKL---- 527
GCILY + + + P+ L I K +IPP Q
Sbjct: 240 GCILYLLCFRQHPFED-----GAKLRIVNGK------------YSIPPHDTQYTVFHSLI 282
Query: 528 --CLQKDPKARPTV 539
LQ +P+ R ++
Sbjct: 283 RAMLQVNPEERLSI 296
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 1e-43
Identities = 64/333 (19%), Positives = 115/333 (34%), Gaps = 44/333 (13%)
Query: 210 PLSVNSTKSSDPSVSKETIKPAKPQITTSNAKKSVETSQD---VITLNGKQYQVLSLLGK 266
V+ + S ++P + ++ D + + +Q LS LG
Sbjct: 8 SSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGH 67
Query: 267 GGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHD 326
G V+ V S+ + + A+K + A L EV K+ P +++
Sbjct: 68 GSYGEVFKV--RSKEDGRLYAVKRSMSPFRGPKDRARK-LAEVGSHEKVGQHPCCVRLEQ 124
Query: 327 YVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGI 386
+ LY+ E L ++ +LP + + + LLA+ +H+ G+
Sbjct: 125 AWEE--GGILYLQTELCGPSLQQHCEAWGA--SLPEAQVWGYL--RDTLLALAHLHSQGL 178
Query: 387 IHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPE 446
+H D+KPAN K+ DFG+ L + G YM+PE
Sbjct: 179 VHLDVKPANIFLGPR---------GRCKLGDFGLLVELGTAGA---GEVQEGDPRYMAPE 226
Query: 447 AAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIE 506
+Y +DV+SLG + + W ++ Q
Sbjct: 227 LL--------QGSY--GTAADVFSLGLTILEVACNMELPHGGEG-WQQLR-------QGY 268
Query: 507 FKPQLANNVTIPPTLLQSMKLCLQKDPKARPTV 539
P+ ++ L + + L+ DPK R T
Sbjct: 269 LPPEFTAGLS--SELRSVLVMMLEPDPKLRATA 299
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 5e-43
Identities = 71/309 (22%), Positives = 117/309 (37%), Gaps = 63/309 (20%)
Query: 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQ 316
++ +++LG+G V + + A+K + ++ +I L+EV LLA L
Sbjct: 7 DFEEIAVLGQGAFGQVVKARNALDSRY--YAIKKIRHTEEKLSTI----LSEVMLLASLN 60
Query: 317 GCPYVIKMHD-----------YVYDTASKHLYVLME---KGDTDLSKYMRNLNKMTTLPN 362
YV++ + L++ ME G L + + N
Sbjct: 61 -HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGT--LYDLIHSENLN--QQR 115
Query: 363 TMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIAC 422
+ ++L A+ IH+ GIIH DLKP N + NV KI DFG+A
Sbjct: 116 DEYWRLFR--QILEALSYIHSQGIIHRDLKPMNIFIDES--------RNV-KIGDFGLAK 164
Query: 423 SLQDDKTSVHKD------------TASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWS 470
++ + D +A GT Y++ E T K D++S
Sbjct: 165 NVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYN--------EKIDMYS 216
Query: 471 LGCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQ 530
LG I + MIY + N K+ ++ IEF P +N + ++L +
Sbjct: 217 LGIIFFEMIYPFSTGMERVNILKKLRSV-----SIEFPPDFDDN--KMKVEKKIIRLLID 269
Query: 531 KDPKARPTV 539
DP RP
Sbjct: 270 HDPNKRPGA 278
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 9e-41
Identities = 43/298 (14%), Positives = 104/298 (34%), Gaps = 48/298 (16%)
Query: 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKL 315
++ L +G G SV+ + A+K ++ L EV A L
Sbjct: 11 TEFHELEKIGSGEFGSVFKCVKRLDGCI--YAIKRSKKPLAGSVDEQNA-LREVYAHAVL 67
Query: 316 QGCPYVIKMHDYVYDTASKHLYVLME---KGDTDLSKYMRNLNK-MTTLPNTMIIIIMHW 371
+V++ + H+ + E G L+ + + M+ + ++
Sbjct: 68 GQHSHVVRYFSAWAE--DDHMLIQNEYCNGGS--LADAISENYRIMSYFKEAELKDLL-- 121
Query: 372 YEMLLAVKEIHAAGIIHSDLKPAN-FLFVGNVLKIIDCIGN---------VLKIIDFGIA 421
++ ++ IH+ ++H D+KP+N F+ ++ G+ + KI D G
Sbjct: 122 LQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV 181
Query: 422 CSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYG 481
+ + G +++ E + + + K+D+++L +
Sbjct: 182 TRISSPQVEE------GDSRFLANEVLQENYT------H--LPKADIFALALTVVCAAGA 227
Query: 482 RTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTV 539
+ + I + + P++ + + +K+ + DP+ RP+
Sbjct: 228 EPLPRNGD----QWHEIRQGR-----LPRIPQV--LSQEFTELLKVMIHPDPERRPSA 274
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 5e-40
Identities = 42/319 (13%), Positives = 98/319 (30%), Gaps = 60/319 (18%)
Query: 250 VITLNGKQYQVLS---LLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYL 306
V + G++ + L +LG+ + T + + + V ++ +
Sbjct: 69 VESELGERPRTLVRGTVLGQEDPYAYLEA--TDQETGESFEVHVPYFTERPPSNAIKQMK 126
Query: 307 NEVELLAKLQ------------------------GCPYVIKMHDYVYDTASKHLYVLMEK 342
EV L L+ +I++ D + L +
Sbjct: 127 EEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPR 186
Query: 343 GDTDLSKYMRNLNKMTTLPNTMIIIIMHWY--EMLLAVKEIHAAGIIHSDLKPANFLFVG 400
++L + L ++ +++ +++ + +H G++H+ L+P + +
Sbjct: 187 MQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIV--- 243
Query: 401 NVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPE-AAGQTSSSGGGNT 459
+D G V + F + G + PE A + G +
Sbjct: 244 -----LDQRGGV-FLTGFEHLVRDGASAV-----SPIGRG-FAPPETTAERMLPFGQHHP 291
Query: 460 YRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPP 519
+T+ D W+LG +Y + P + I + IP
Sbjct: 292 TLMTFAFDTWTLGLAIYWIWCADLPNTD-DAALGGSEWI------------FRSCKNIPQ 338
Query: 520 TLLQSMKLCLQKDPKARPT 538
+ ++ L+ + R
Sbjct: 339 PVRALLEGFLRYPKEDRLL 357
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 148 bits (374), Expect = 6e-40
Identities = 50/359 (13%), Positives = 100/359 (27%), Gaps = 69/359 (19%)
Query: 209 RPLSVNSTKSSDPSVSKETIKPAKPQITTSNAKKSVETSQDVITLNGKQYQVLSLLGKGG 268
R S ++D VS +P S + + ++LG+
Sbjct: 37 RTTSEYMQSAADSLVSTSLWNTGQPFRVES-----------ELGERPRTLVRGTVLGQED 85
Query: 269 SSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKL------------- 315
+ E + V ++ + EV L L
Sbjct: 86 PYAYLEATDQETGE--SFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHL 143
Query: 316 -----------QGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTM 364
+I++ D + L + ++L + L ++ ++
Sbjct: 144 RFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSL 203
Query: 365 IIIIMHWY--EMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIAC 422
+ +++ + +H G++H+ L+P + + G V + F
Sbjct: 204 VHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQR--------GGV-FLTGFEHLV 254
Query: 423 SLQDDKTSVHKDTASGTLNYMSPE--AAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY 480
S + + PE A T S +T+ D W+LG ++Y +
Sbjct: 255 RDGARVVSS------VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308
Query: 481 GRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTV 539
P + I R I PQ LL+ L+ + R
Sbjct: 309 ADLPITK-DAALGGSEWIFRSCKNI---PQPVRA------LLEGF---LRYPKEDRLLP 354
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-38
Identities = 59/304 (19%), Positives = 110/304 (36%), Gaps = 33/304 (10%)
Query: 238 SNAKKSVETSQDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDIT 297
S + + V+ + + +LG G ++ G + + +A+K + +
Sbjct: 6 SLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRG---MFDNRDVAVKRILPECFS 62
Query: 298 DQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKM 357
EV+LL + P VI+ D + Y+ +E L +Y+ K
Sbjct: 63 FAD------REVQLLRESDEHPNVIRYFCTEKD--RQFQYIAIELCAATLQEYV--EQKD 112
Query: 358 TTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIID 417
I ++ + + +H+ I+H DLKP N L I D
Sbjct: 113 FAHLGLEPITLL--QQTTSGLAHLHSLNIVHRDLKPHNILISMPN----AHGKIKAMISD 166
Query: 418 FGIACSLQDDKTSVHK-DTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILY 476
FG+ L + S + GT +++PE + TY D++S GC+ Y
Sbjct: 167 FGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKE------NPTYTVDIFSAGCVFY 220
Query: 477 NMI-YGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKA 535
+I G P+ + + I ++ + I L++ M + DP+
Sbjct: 221 YVISEGSHPFG---KSLQRQANILLGACSLDCLHPEKHEDVIARELIEKM---IAMDPQK 274
Query: 536 RPTV 539
RP+
Sbjct: 275 RPSA 278
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-38
Identities = 57/308 (18%), Positives = 116/308 (37%), Gaps = 43/308 (13%)
Query: 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKL 315
+ + +LG+G +++V+ G + A+KV + D + E E+L KL
Sbjct: 9 HLWLLSDILGQGATANVFR--GRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKL 64
Query: 316 QGCPYVIKMHDYVYDTASKHLYVLME---KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWY 372
++K+ +T ++H ++ME G L + + LP + +I++
Sbjct: 65 NH-KNIVKLFAIEEETTTRHKVLIMEFCPCGS--LYTVLEEPSNAYGLPESEFLIVLR-- 119
Query: 373 EMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVH 432
+++ + + GI+H ++KP N + V +V K+ DFG A L+DD+
Sbjct: 120 DVVGGMNHLRENGIVHRNIKPGNIMRVIGEDG-----QSVYKLTDFGAARELEDDEQF-- 172
Query: 433 KDTASGTLNYMSPEA-AGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY--SHIP 489
+ GT Y+ P+ Y D+WS+G Y+ G P+ P
Sbjct: 173 -VSLYGTEEYLHPDMYERAVLRKDHQKKY--GATVDLWSIGVTFYHAATGSLPFRPFEGP 229
Query: 490 NTWAKML--------------AIARHKDQIEFKPQLANNVTIPPTLLQSMK----LCLQK 531
+++ I++ + + ++ L + L+
Sbjct: 230 RRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEA 289
Query: 532 DPKARPTV 539
D +
Sbjct: 290 DQEKCWGF 297
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 8e-38
Identities = 68/362 (18%), Positives = 124/362 (34%), Gaps = 72/362 (19%)
Query: 187 SVRSASDQSLSQKKNESTPVFKRPLSVN-STKSSDPSVSKETIKPAKPQITTSNAKKSVE 245
SV S SL+ + + + T+ ++ + E +KP +
Sbjct: 4 SVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEV------ 57
Query: 246 TSQDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSY 305
+G+G V+ + A+K V L +
Sbjct: 58 ----------HWMTHQPRVGRGSFGEVHRMKDKQTGFQ--CAVKKVRLEVFRVE------ 99
Query: 306 LNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRN------LNKMTT 359
E+ A L P ++ ++ V + + + ME + + +M
Sbjct: 100 --ELVACAGLS-SPRIVPLYGAVRE--GPWVNIFME--------LLEGGSLGQLIKQMGC 146
Query: 360 LPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFG 419
LP + + + L ++ +H I+H D+K N L + G+ + DFG
Sbjct: 147 LPEDRALYYL--GQALEGLEYLHTRRILHGDVKADNVL--------LSSDGSRAALCDFG 196
Query: 420 IACSLQDD---KTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILY 476
A LQ D K+ + D GT +M+PE K D+WS C++
Sbjct: 197 HALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD---------AKVDIWSSCCMML 247
Query: 477 NMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKAR 536
+M+ G P++ L IA E P + P Q+++ L+K+P R
Sbjct: 248 HMLNGCHPWTQY-FRGPLCLKIAS-----EPPPIREIPPSCAPLTAQAIQEGLRKEPVHR 301
Query: 537 PT 538
+
Sbjct: 302 AS 303
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 143 bits (361), Expect = 2e-37
Identities = 58/298 (19%), Positives = 117/298 (39%), Gaps = 34/298 (11%)
Query: 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEF--KPLALKVVDLSDITDQSIADSYLNEVELL 312
+LG G S +V + F +P+A+K + + D L E++LL
Sbjct: 14 KNLVVSEKILGYGSSGTVVF-----QGSFQGRPVAVKRMLIDFC------DIALMEIKLL 62
Query: 313 AKLQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYM----RNLNKMTTLPNTMIIII 368
+ P VI+ + + LY+ +E + +L + + + I +
Sbjct: 63 TESDDHPNVIRYYCSETT--DRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISL 120
Query: 369 MHWYEMLLAVKEIHAAGIIHSDLKPANFLF----VGNVLKIIDCIGNVLKIIDFGIACSL 424
+ ++ V +H+ IIH DLKP N L + + I DFG+ L
Sbjct: 121 L--RQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL 178
Query: 425 QDDKTSVHKD--TASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI-YG 481
++S + SGT + +PE ++++ T D++S+GC+ Y ++ G
Sbjct: 179 DSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRL--TRSIDIFSMGCVFYYILSKG 236
Query: 482 RTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTV 539
+ P+ + + ++ D+++ + ++ + + DP RPT
Sbjct: 237 KHPFGDKYSRESNIIRGIFSLDEMKCLH----DRSLIAEATDLISQMIDHDPLKRPTA 290
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 9e-37
Identities = 65/301 (21%), Positives = 126/301 (41%), Gaps = 41/301 (13%)
Query: 247 SQDVITLNGK-------QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQ 299
+T+ G+ + L +G G V+ + +A+K + S ++
Sbjct: 9 QTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHV--IAVKQMRRS--GNK 64
Query: 300 SIADSYLNEVELLAKLQGCPYVIKMHD-YVYDTASKHLYVLMEKGDTDLSKYMRNLNKMT 358
L +++++ K CPY+++ ++ +T +++ ME T K + +
Sbjct: 65 EENKRILMDLDVVLKSHDCPYIVQCFGTFITNTD---VFIAMELMGTCAEKLKKRMQG-- 119
Query: 359 TLPNTMIIIIMHWYEMLLAVKEIHAA-GIIHSDLKPANFLFVGNVLKIIDCIGNVLKIID 417
+P ++ + ++ A+ + G+IH D+KP+N L +D G + K+ D
Sbjct: 120 PIPERILGKMT--VAIVKALYYLKEKHGVIHRDVKPSNIL--------LDERGQI-KLCD 168
Query: 418 FGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYN 477
FGI+ L D KD ++G YM+PE + Y ++DVWSLG L
Sbjct: 169 FGISGRLVD---DKAKDRSAGCAAYMAPERIDPPDPTKPD--Y--DIRADVWSLGISLVE 221
Query: 478 MIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARP 537
+ G+ PY + + + + + + P L ++ +K CL KD + RP
Sbjct: 222 LATGQFPYKNCKTDFEVLTKVLQEE-----PPLLPGHMGFSGDFQSFVKDCLTKDHRKRP 276
Query: 538 T 538
Sbjct: 277 K 277
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-36
Identities = 58/308 (18%), Positives = 117/308 (37%), Gaps = 43/308 (13%)
Query: 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKL 315
+ + +LG+G +++V+ G + A+KV + D + E E+L KL
Sbjct: 9 HLWLLSDILGQGATANVFR--GRHKKTGDLFAIKVFNNISFLRPV--DVQMREFEVLKKL 64
Query: 316 QGCPYVIKMHDYVYDTASKHLYVLME---KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWY 372
++K+ +T ++H ++ME G L + + LP + +I++
Sbjct: 65 N-HKNIVKLFAIEEETTTRHKVLIMEFCPCGS--LYTVLEEPSNAYGLPESEFLIVLR-- 119
Query: 373 EMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVH 432
+++ + + GI+H ++KP N + V +V K+ DFG A L+DD+ V
Sbjct: 120 DVVGGMNHLRENGIVHRNIKPGNIMRVIGEDG-----QSVYKLTDFGAARELEDDEQFV- 173
Query: 433 KDTASGTLNYMSPEA-AGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY--SHIP 489
+ GT Y+ P+ Y D+WS+G Y+ G P+ P
Sbjct: 174 --SLYGTEEYLHPDMYERAVLRKDHQKKY--GATVDLWSIGVTFYHAATGSLPFRPFEGP 229
Query: 490 NTWAKML--------------AIARHKDQIEFKPQLANNVTIPPTLLQSMK----LCLQK 531
+++ I++ + + ++ L + L+
Sbjct: 230 RRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEA 289
Query: 532 DPKARPTV 539
D +
Sbjct: 290 DQEKCWGF 297
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 5e-36
Identities = 66/307 (21%), Positives = 115/307 (37%), Gaps = 40/307 (13%)
Query: 235 ITTSNAKKSVETSQDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLS 294
+T + + + + +LGKG VY S +A+K +
Sbjct: 3 RSTEEGDCESDLLEYDYEYD--ENGDRVVLGKGTYGIVYAGRDLSNQVR--IAIKEIPER 58
Query: 295 DITD-QSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLME--KGDTDLSKYM 351
D Q + + E+ L L+ +++ + + + + ME G + LS +
Sbjct: 59 DSRYSQPLHE----EIALHKHLK-HKNIVQYLGSFSE--NGFIKIFMEQVPGGS-LSALL 110
Query: 352 RNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGN 411
R+ I ++L +K +H I+H D+K N L I+
Sbjct: 111 RSKWGPLKDNEQTIGFYT--KQILEGLKYLHDNQIVHRDIKGDNVL--------INTYSG 160
Query: 412 VLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSL 471
VLKI DFG + L +T +GTL YM+PE + G +D+WSL
Sbjct: 161 VLKISDFGTSKRLAGINP--CTETFTGTLQYMAPEIIDKGPRGYGK-------AADIWSL 211
Query: 472 GCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQK 531
GC + M G+ P+ + A M + K P++ +++ + C +
Sbjct: 212 GCTIIEMATGKPPFYELGEPQAAMFKVGMFKV----HPEIPESMS--AEAKAFILKCFEP 265
Query: 532 DPKARPT 538
DP R
Sbjct: 266 DPDKRAC 272
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 6e-36
Identities = 72/332 (21%), Positives = 135/332 (40%), Gaps = 63/332 (18%)
Query: 221 PSVSKETIKPAKPQITTSNAKKSVETSQDVI-TLNGKQYQVLSLLGKGGSSSVYLVGGTS 279
K + + A + E + ++ + ++Y LGKGG + + +
Sbjct: 5 ADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFE--ISD 62
Query: 280 EHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVL 339
+ A K+V S + + E+ + L +V+ H + D + ++V+
Sbjct: 63 ADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH-QHVVGFHGFFED--NDFVFVV 119
Query: 340 ME---KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANF 396
+E + L + + +T P + +++L + +H +IH DLK N
Sbjct: 120 LELCRRRS--LLELHKRRKALT-EPEARYYL----RQIVLGCQYLHRNRVIHRDLKLGNL 172
Query: 397 LFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGG 456
++ +KI DFG+A ++ D K GT NY++PE
Sbjct: 173 F--------LNEDLE-VKIGDFGLATKVEYD--GERKKVLCGTPNYIAPEVLS------- 214
Query: 457 GNTYRITYKSDVWSLGCILYNMIYGRTPY--SHIPNTWAKMLAIARHKDQIEFKPQLANN 514
+ +++ DVWS+GCI+Y ++ G+ P+ S + T+ + I + N
Sbjct: 215 KKGH--SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLR---IKK------------NE 257
Query: 515 VTIPP-------TLLQSMKLCLQKDPKARPTV 539
+IP +L+Q M LQ DP ARPT+
Sbjct: 258 YSIPKHINPVAASLIQKM---LQTDPTARPTI 286
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 7e-36
Identities = 70/294 (23%), Positives = 129/294 (43%), Gaps = 41/294 (13%)
Query: 251 ITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKP----LALKVVDLSDITDQSIADSYL 306
+ + + + LG+G V + P +A+K + + + L
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKM------RHVPSGQIMAVKRIRAT--VNSQEQKRLL 53
Query: 307 NEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSK-YMRNLNKMTTLPNTMI 365
++++ + CP+ + + ++ +++ ME DT L K Y + ++K T+P ++
Sbjct: 54 MDLDISMRTVDCPFTVTFYGALFREG--DVWICMELMDTSLDKFYKQVIDKGQTIPEDIL 111
Query: 366 IIIMHWYEMLLAVKEIHAAG-IIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSL 424
I ++ A++ +H+ +IH D+KP+N L I+ +G V K+ DFGI+ L
Sbjct: 112 GKIA--VSIVKALEHLHSKLSVIHRDVKPSNVL--------INALGQV-KMCDFGISGYL 160
Query: 425 QDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTP 484
D V KD +G YM+PE + + Y + KSD+WSLG + + R P
Sbjct: 161 VD---DVAKDIDAGCKPYMAPE---RINPELNQKGY--SVKSDIWSLGITMIELAILRFP 212
Query: 485 YSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
Y + ++ + E PQL + + CL+K+ K RPT
Sbjct: 213 YDSWGTPFQQLKQVVE-----EPSPQLPAD-KFSAEFVDFTSQCLKKNSKERPT 260
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 2e-35
Identities = 70/298 (23%), Positives = 126/298 (42%), Gaps = 62/298 (20%)
Query: 254 NGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLA 313
+ ++Y LGKGG + + + + A K+V S + + E+ +
Sbjct: 13 SRRRYVRGRFLGKGGFAKCFE--ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 70
Query: 314 KLQGCPYVIKMHDYVYDTASKHLYVLME---KGDTDLSKYMRNLNKMTTLPNTMIIIIMH 370
L +V+ H + D + ++V++E + L + + +T P +
Sbjct: 71 SLA-HQHVVGFHGFFED--NDFVFVVLELCRRRS--LLELHKRRKALTE-PEARYYL--- 121
Query: 371 WYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTS 430
+++L + +H +IH DLK N ++ V KI DFG+A ++ D
Sbjct: 122 -RQIVLGCQYLHRNRVIHRDLKLGNLF--------LNEDLEV-KIGDFGLATKVEYD--G 169
Query: 431 VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY--SHI 488
K GT NY++PE + +++ DVWS+GCI+Y ++ G+ P+ S +
Sbjct: 170 ERKKVLCGTPNYIAPEVLS-------KKGH--SFEVDVWSIGCIMYTLLVGKPPFETSCL 220
Query: 489 PNTWAKMLAIARHKDQIEFKPQLANNVTIPP-------TLLQSMKLCLQKDPKARPTV 539
T+ + I + N +IP +L+Q M LQ DP ARPT+
Sbjct: 221 KETYLR---IKK------------NEYSIPKHINPVAASLIQKM---LQTDPTARPTI 260
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-35
Identities = 73/307 (23%), Positives = 143/307 (46%), Gaps = 65/307 (21%)
Query: 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKL 315
+ ++V +LLGKG + VY S H +A+K++D + + NEV++ +L
Sbjct: 11 EDFKVGNLLGKGSFAGVYRA--ESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL 68
Query: 316 QGCPYVIKMHDYVYDTASKHLYVLME---KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWY 372
+ P ++++++Y D S ++Y+++E G+ +++Y++N K + + +
Sbjct: 69 KH-PSILELYNYFED--SNYVYLVLEMCHNGE--MNRYLKNRVKPFSENEARHFM----H 119
Query: 373 EMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVH 432
+++ + +H+ GI+H DL +N L + N +KI DFG+A L+
Sbjct: 120 QIITGMLYLHSHGILHRDLTLSNLL--------LTRNMN-IKIADFGLATQLKMP--HEK 168
Query: 433 KDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY--SHIPN 490
T GT NY+SPE A + + +SDVWSLGC+ Y ++ GR P+ + N
Sbjct: 169 HYTLCGTPNYISPEIAT-------RSAH--GLESDVWSLGCMFYTLLIGRPPFDTDTVKN 219
Query: 491 TWAKMLAIARHKDQIEFKPQLANNVTIPPT-------LLQSMKLCLQKDPKARPTVGNSV 543
T K + + +P L+ + L+++P R + +
Sbjct: 220 TLNK---VVL------------ADYEMPSFLSIEAKDLIHQL---LRRNPADRLS----L 257
Query: 544 TQINNNP 550
+ + ++P
Sbjct: 258 SSVLDHP 264
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 5e-35
Identities = 72/314 (22%), Positives = 120/314 (38%), Gaps = 45/314 (14%)
Query: 231 AKPQITTSNAKKSVETSQDVITLNGKQ---YQVLSLLGKGGSSSVYLVGGTSEHEFKP-- 285
++ + + G Q Y++ L+G+GG VY +E +
Sbjct: 6 HHHHHSSGLVPRGSHMDGTAESREGTQFGPYRLRRLVGRGGMGDVYE----AEDTVRERI 61
Query: 286 LALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLME--KG 343
+ALK++ + +D E +LQ P+V+ +HD+ LYV M G
Sbjct: 62 VALKLMSETLSSDPVFRTRMQREARTAGRLQE-PHVVPIHDF--GEIDGQLYVDMRLING 118
Query: 344 DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVL 403
DL+ +R + P + I+ ++ A+ HAAG H D+KP N L
Sbjct: 119 -VDLAAMLRRQGPLA--PPRAVAIVR---QIGSALDAAHAAGATHRDVKPENIL------ 166
Query: 404 KIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRIT 463
+ ++DFGIA + D+ GTL YM+PE S T
Sbjct: 167 --VSADDFA-YLVDFGIASAT-TDEKLTQLGNTVGTLYYMAPERF-----SES----HAT 213
Query: 464 YKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQ 523
Y++D+++L C+LY + G PY L++ IP
Sbjct: 214 YRADIYALTCVLYECLTGSPPYQ------GDQLSVMGAHINQAIPRPSTVRPGIPVAFDA 267
Query: 524 SMKLCLQKDPKARP 537
+ + K+P+ R
Sbjct: 268 VIARGMAKNPEDRY 281
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 5e-35
Identities = 74/314 (23%), Positives = 136/314 (43%), Gaps = 45/314 (14%)
Query: 235 ITTSNAKKSVETSQDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKP----LALKV 290
++ ++ K + + + + L +G+G SV + KP +A+K
Sbjct: 1 MSIESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKM------VHKPSGQIMAVKR 54
Query: 291 VDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHD-YVYDTASKHLYVLMEKGDTDLSK 349
+ + D+ L +++++ + CPY+++ + + ++ ME T K
Sbjct: 55 IRST--VDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGD---CWICMELMSTSFDK 109
Query: 350 YMRNLNKMT--TLPNTMIIIIMHWYEMLLAVKEIHAAG-IIHSDLKPANFLFVGNVLKII 406
+ + + + +P ++ I + A+ + IIH D+KP+N L +
Sbjct: 110 FYKYVYSVLDDVIPEEILGKIT--LATVKALNHLKENLKIIHRDIKPSNIL--------L 159
Query: 407 DCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKS 466
D GN+ K+ DFGI+ L D S+ K +G YM+PE + S Y +S
Sbjct: 160 DRSGNI-KLCDFGISGQLVD---SIAKTRDAGCRPYMAPE---RIDPSASRQGY--DVRS 210
Query: 467 DVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTI--PPTLLQS 524
DVWSLG LY + GR PY + + ++ + + PQL+N+ P+ +
Sbjct: 211 DVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK-----GDPPQLSNSEEREFSPSFINF 265
Query: 525 MKLCLQKDPKARPT 538
+ LCL KD RP
Sbjct: 266 VNLCLTKDESKRPK 279
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 8e-35
Identities = 67/298 (22%), Positives = 126/298 (42%), Gaps = 54/298 (18%)
Query: 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG 317
+++ LGKG +VYL + LALKV+ + + + EVE+ + L+
Sbjct: 11 FEIGRPLGKGKFGNVYLA--REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 318 CPYVIKMHDYVYDTASKHLYVLME---KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEM 374
P +++++ Y +D + +Y+++E G + + ++ L+K T I E+
Sbjct: 69 -PNILRLYGYFHD--ATRVYLILEYAPLGT--VYRELQKLSKFDE-QRTATYI----TEL 118
Query: 375 LLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKD 434
A+ H+ +IH D+KP N L + G LKI DFG + +
Sbjct: 119 ANALSYCHSKRVIHRDIKPENLL--------LGSAGE-LKIADFGWSVHAPSSRR----T 165
Query: 435 TASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY--SHIPNTW 492
GTL+Y+ PE G + K D+WSLG + Y + G+ P+ + T+
Sbjct: 166 DLCGTLDYLPPEMIE-------GRMH--DEKVDLWSLGVLCYEFLVGKPPFEANTYQETY 216
Query: 493 AKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNP 550
++ + + F + L+ + L+ +P RP + ++ +P
Sbjct: 217 KRIS-----RVEFTFPDFVTEGAR---DLISRL---LKHNPSQRPM----LREVLEHP 259
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-33
Identities = 72/290 (24%), Positives = 117/290 (40%), Gaps = 54/290 (18%)
Query: 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKL 315
K+ +V ++G+G V K +A+K I +S +++ E+ L+++
Sbjct: 8 KEIEVEEVVGRGAFGVVCK--AK--WRAKDVAIKQ-----IESESERKAFIVELRQLSRV 58
Query: 316 QGCPYVIKMHDYVYDTASKHLYVLME---KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWY 372
P ++K+ Y + ++ME G L + + +
Sbjct: 59 N-HPNIVKL----YGACLNPVCLVMEYAEGGS--LYNVLHGAEPLPYYTAAHAMSWC--L 109
Query: 373 EMLLAVKEIHA---AGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKT 429
+ V +H+ +IH DLKP N L V G VLKI DFG AC +Q T
Sbjct: 110 QCSQGVAYLHSMQPKALIHRDLKPPNLLLVAG--------GTVLKICDFGTACDIQTHMT 161
Query: 430 SVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIP 489
+ G+ +M+PE G+ Y + K DV+S G IL+ +I R P+ I
Sbjct: 162 N-----NKGSAAWMAPEVFE-------GSNY--SEKCDVFSWGIILWEVITRRKPFDEIG 207
Query: 490 NT-WAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
+ M A+ +P L N +P + M C KDP RP+
Sbjct: 208 GPAFRIMWAVHNGT-----RPPLIKN--LPKPIESLMTRCWSKDPSQRPS 250
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 7e-33
Identities = 61/348 (17%), Positives = 116/348 (33%), Gaps = 97/348 (27%)
Query: 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKL 315
++ + +G+GG V+ ++ + A+K + L + + + EV+ LAKL
Sbjct: 6 TDFEPIQCMGRGGFGVVFEA--KNKVDDCNYAIKRIRLPNRELAR--EKVMREVKALAKL 61
Query: 316 QGCPYVIKMHD-----------------------YVYDTASKHLYVLMEKGDTDLSKYMR 352
+ P +++ + + +S + +
Sbjct: 62 E-HPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFST 120
Query: 353 NLNKMTTLP---NTMIIIIM-------------------------HWY---EMLLAVKEI 381
P + I M + ++ AV+ +
Sbjct: 121 KNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFL 180
Query: 382 HAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTAS---- 437
H+ G++H DLKP+N F + +V+K+ DFG+ ++ D+ T
Sbjct: 181 HSKGLMHRDLKPSNIFFTMD---------DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 231
Query: 438 ------GTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNT 491
GT YMSPE Q GN Y ++K D++SLG IL+ ++Y +
Sbjct: 232 THTGQVGTKLYMSPE---QIH----GNNY--SHKVDIFSLGLILFELLYSFSTQMERVRI 282
Query: 492 WAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTV 539
+ ++F P ++ L P RP
Sbjct: 283 ITDV-------RNLKFPLLFTQ---KYPQEHMMVQDMLSPSPTERPEA 320
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-32
Identities = 79/289 (27%), Positives = 130/289 (44%), Gaps = 52/289 (17%)
Query: 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKL 315
+ + L +GKG V+ G K +A+K++DL + D+ + E+ +L++
Sbjct: 22 ELFTKLEKIGKGSFGEVFK--GIDNRTQKVVAIKIIDLEEAEDE--IEDIQQEITVLSQC 77
Query: 316 QGCPYVIKMHD-YVYDTASKHLYVLMEKGDTDLSKYM-----RNLNKMTTLPNTMIIIIM 369
PYV K + Y+ DT L+++ME Y+ +L + L T I I+
Sbjct: 78 D-SPYVTKYYGSYLKDT---KLWIIME--------YLGGGSALDLLEPGPLDETQIATIL 125
Query: 370 HWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKT 429
E+L + +H+ IH D+K AN L + G V K+ DFG+A L D T
Sbjct: 126 R--EILKGLDYLHSEKKIHRDIKAANVL--------LSEHGEV-KLADFGVAGQLTD--T 172
Query: 430 SVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIP 489
+ ++T GT +M+PE Q + Y K+D+WSLG + G P+S +
Sbjct: 173 QIKRNTFVGTPFWMAPEVIKQ-------SAY--DSKADIWSLGITAIELARGEPPHSELH 223
Query: 490 NTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
+ I ++ P L N + L + ++ CL K+P RPT
Sbjct: 224 PMKV-LFLIPKNN-----PPTLEGNYS--KPLKEFVEACLNKEPSFRPT 264
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 54/339 (15%), Positives = 106/339 (31%), Gaps = 38/339 (11%)
Query: 220 DPSVSKETIKPAKPQITTS------NAKKSVETSQDVITLNGKQYQVLSLLGKGGSSSVY 273
D + + + +++ K + L K V LLG+G + VY
Sbjct: 23 DDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVY 82
Query: 274 LV---GGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYD 330
+ LKV ++ + I ++ K +K +
Sbjct: 83 EATQGDLNDAKNKQKFVLKVQKPANPWEFYI----GTQLMERLKPSMQHMFMKFYSAHLF 138
Query: 331 TASKHLYVLME--KGDT--DLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGI 386
++ E T + +N + +P ++I ML ++++H I
Sbjct: 139 --QNGSVLVGELYSYGTLLNAINLYKNTPE-KVMPQGLVISFAM--RMLYMIEQVHDCEI 193
Query: 387 IHSDLKPANFLFVGNVLKIIDC--IGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMS 444
IH D+KP NF+ L+ D + L +ID G + ++ T +
Sbjct: 194 IHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQC 253
Query: 445 PEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQ 504
E + Y+ D + + +Y M++G K + R
Sbjct: 254 VEML-------SNKPW--NYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPH 304
Query: 505 IE-----FKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
++ F L L ++ L+K + T
Sbjct: 305 LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYT 343
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-32
Identities = 83/347 (23%), Positives = 129/347 (37%), Gaps = 63/347 (18%)
Query: 214 NSTKSSDPSVSKETIKPAKPQITTSNAKKSVETSQDVITLNGKQYQVLSLLGKGGSSSVY 273
S+ S + + + ++ L QYQV LLG GG SVY
Sbjct: 2 GSSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLES-QYQVGPLLGSGGFGSVY 60
Query: 274 LVGGTSEHEFKPLALKVVDLSDITDQSIADSYLN---EVELLAKLQ-GCPYVIKMHDYVY 329
G + P+A+K V+ I+D + EV LL K+ G VI++ D +
Sbjct: 61 S--GIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD-WF 117
Query: 330 DTASKHLYVLME--KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGII 387
+ +++E + DL ++ + + ++L AV+ H G++
Sbjct: 118 ER-PDSFVLILERPEPVQDLFDFITERGAL---QEELARSFFW--QVLEAVRHCHNCGVL 171
Query: 388 HSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEA 447
H D+K N L ID LK+IDFG L+D GT Y PE
Sbjct: 172 HRDIKDENIL--------IDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEW 219
Query: 448 AGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEF 507
+ Y + VWSLG +LY+M+ G P+ H ++I
Sbjct: 220 IR-------YHRYHGR-SAAVWSLGILLYDMVCGDIPF--------------EHDEEI-- 255
Query: 508 KPQLANNVTIPPTL-LQSMKL---CLQKDPKARPTVGNSVTQINNNP 550
+ V + + L CL P RPT +I N+P
Sbjct: 256 ---IRGQVFFRQRVSSECQHLIRWCLALRPSDRPT----FEEIQNHP 295
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 6e-32
Identities = 68/301 (22%), Positives = 113/301 (37%), Gaps = 60/301 (19%)
Query: 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAK 314
++++ L+G G VY G + A+KV+D++ ++ I E+ +L K
Sbjct: 23 AGIFELVELVGNGTYGQVYK--GRHVKTGQLAAIKVMDVTGDEEEEI----KQEINMLKK 76
Query: 315 LQGCPYVIKMHD-YVYDTASKH---LYVLMEKGD----TDLSKYMRNLNKMTTLPNTMII 366
+ + ++ L+++ME TDL K + TL I
Sbjct: 77 YSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG----NTLKEEWIA 132
Query: 367 IIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQD 426
I E+L + +H +IH D+K N L + V K++DFG++ L
Sbjct: 133 YICR--EILRGLSHLHQHKVIHRDIKGQNVL--------LTENAEV-KLVDFGVSAQLDR 181
Query: 427 DKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYS 486
T ++T GT +M+PE + Y +KSD+WSLG M G P
Sbjct: 182 --TVGRRNTFIGTPYWMAPEVIACDENPDAT--Y--DFKSDLWSLGITAIEMAEGAPPLC 235
Query: 487 HIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQS---------MKLCLQKDPKARP 537
+ A + I R+ P L ++ CL K+ RP
Sbjct: 236 DMHPMRA-LFLIPRNP---------------APRLKSKKWSKKFQSFIESCLVKNHSQRP 279
Query: 538 T 538
Sbjct: 280 A 280
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 7e-32
Identities = 56/292 (19%), Positives = 110/292 (37%), Gaps = 61/292 (20%)
Query: 252 TLNGKQYQVLSLLGKGGSSSVYLVGGTSEH-EFKPLALKVVDLSDITDQSIADSYLNEVE 310
+ G QY+V + GG +YL + +P+ LK L D + E +
Sbjct: 77 IVAG-QYEVKGCIAHGGLGWIYL--ALDRNVNGRPVVLKG--LVHSGDAEAQAMAMAERQ 131
Query: 311 LLAKLQGCPYVIKMHDYVYD---TASKHLYVLME--KGDTDLSKYMRNLNKMTTLPNTMI 365
LA++ P ++++ ++V Y++ME G + L + LP
Sbjct: 132 FLAEVVH-PSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQS-LKRSKGQ-----KLPVAEA 184
Query: 366 IIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQ 425
I + E+L A+ +H+ G++++DLKP N + + LK+ID G +
Sbjct: 185 IAYLL--EILPALSYLHSIGLVYNDLKPENIM--------LT--EEQLKLIDLGAVSRI- 231
Query: 426 DDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY 485
+ GT + +PE G T +D++++G L +
Sbjct: 232 -NSFG----YLYGTPGFQAPEIV------RTGPTVA----TDIYTVGRTLAALTLDLPTR 276
Query: 486 SHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARP 537
+ R+ D + P+ + + + ++ + DP+ R
Sbjct: 277 N------------GRYVDGL---PEDDPVLKTYDSYGRLLRRAIDPDPRQRF 313
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 8e-32
Identities = 72/290 (24%), Positives = 122/290 (42%), Gaps = 41/290 (14%)
Query: 252 TLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVEL 311
+N + Y+++ LG GG S+VYL +A+K + + + + EV
Sbjct: 8 IINER-YKIVDKLGGGGMSTVYL--AEDTILNIKVAIKAIFIPPREKEETLKRFEREVHN 64
Query: 312 LAKLQGCPYVIKMHDYVYDTASKHLYVLME--KGDTDLSKYMRNLNKMTTLPNTMIIIIM 369
++L ++ M D + Y++ME +G T LS+Y+ + L I
Sbjct: 65 SSQLSH-QNIVSMIDVDEED--DCYYLVMEYIEGPT-LSEYIESHGP---LSVDTAINFT 117
Query: 370 HWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKT 429
+ ++L +K H I+H D+KP N L ID + KI DFGIA +L + +
Sbjct: 118 N--QILDGIKHAHDMRIVHRDIKPQNIL--------IDSNKTL-KIFDFGIAKAL-SETS 165
Query: 430 SVHKDTASGTLNYMSPE-AAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHI 488
+ GT+ Y SPE A G+ +D++S+G +LY M+ G P++
Sbjct: 166 LTQTNHVLGTVQYFSPEQAKGEA----------TDECTDIYSIGIVLYEMLVGEPPFNG- 214
Query: 489 PNTWAKMLAIA-RHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARP 537
++IA +H IP +L + +KD R
Sbjct: 215 ----ETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRY 260
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 8e-32
Identities = 60/294 (20%), Positives = 110/294 (37%), Gaps = 48/294 (16%)
Query: 254 NGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLA 313
+G+ + +G+G +VY G +A + +T + E E+L
Sbjct: 24 DGRFLKFDIEIGRGSFKTVYK--GLDTETTVEVAWCELQDRKLTKSER-QRFKEEAEMLK 80
Query: 314 KLQGCPYVIKMHDYVYDTAS--KHLYVLME---KGDTDLSKYMRNLNKMTTLPNTMIIII 368
LQ P +++ +D T K + ++ E G L Y++ M I ++
Sbjct: 81 GLQ-HPNIVRFYDSWESTVKGKKCIVLVTELMTSGT--LKTYLKRFKVMK------IKVL 131
Query: 369 MHW-YEMLLAVKEIHAAG--IIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQ 425
W ++L ++ +H IIH DLK N G G+V KI D G+A +
Sbjct: 132 RSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGP-------TGSV-KIGDLGLATLKR 183
Query: 426 DDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY 485
GT +M+PE Y DV++ G + M PY
Sbjct: 184 ASFAK----AVIGTPEFMAPEM--------YEEKY--DESVDVYAFGMCMLEMATSEYPY 229
Query: 486 SHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTV 539
S N A++ + ++A P + + ++ C++++ R ++
Sbjct: 230 SECQNA-AQIYRRVTSGVKPASFDKVAI-----PEVKEIIEGCIRQNKDERYSI 277
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 74/304 (24%), Positives = 128/304 (42%), Gaps = 50/304 (16%)
Query: 252 TLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVEL 311
++N Y++ ++G G ++ V + + +A+K ++L D L E++
Sbjct: 11 SINRDDYELQEVIGSGATAVVQA--AYCAPKKEKVAIKRINLEKCQTS--MDELLKEIQA 66
Query: 312 LAKLQGCPYVIKMHD-YVYDTASKHLYVLME---KGD-TDLSK--YMRNLNKMTTLPNTM 364
+++ P ++ + +V L+++M+ G D+ K + +K L +
Sbjct: 67 MSQCH-HPNIVSYYTSFVVKD---ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST 122
Query: 365 IIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSL 424
I I+ E+L ++ +H G IH D+K N L + G+V +I DFG++ L
Sbjct: 123 IATILR--EVLEGLEYLHKNGQIHRDVKAGNIL--------LGEDGSV-QIADFGVSAFL 171
Query: 425 ---QDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYG 481
D + + T GT +M+PE Q Y +K+D+WS G + G
Sbjct: 172 ATGGDITRNKVRKTFVGTPCWMAPEVMEQ------VRGY--DFKADIWSFGITAIELATG 223
Query: 482 RTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTL------LQSM-KLCLQKDPK 534
PY P ML ++ P L V L + M LCLQKDP+
Sbjct: 224 AAPYHKYPPMKVLML-TLQND-----PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPE 277
Query: 535 ARPT 538
RPT
Sbjct: 278 KRPT 281
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 60/296 (20%), Positives = 107/296 (36%), Gaps = 58/296 (19%)
Query: 259 QVLSLLGKGGSSSVYL------VGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELL 312
++ L+GKG VY V A++++D+ + + + EV
Sbjct: 36 EIGELIGKGRFGQVYHGRWHGEV-----------AIRLIDIERDNEDQLKA-FKREVMAY 83
Query: 313 AKLQGCPYVIKMHDYVYDTASKHLYVLME--KGDTDLSKYMRNLNKMTTLPNTMIIII-- 368
+ + V+ + HL ++ KG T L +R+ + + T I
Sbjct: 84 RQTRH-ENVVLFMGAC--MSPPHLAIITSLCKGRT-LYSVVRDAKIVLDVNKTRQIAQEI 139
Query: 369 ---MHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQ 425
M + +HA GI+H DLK N +F N + I DFG+
Sbjct: 140 VKGMGY---------LHAKGILHKDLKSKN-VFYDN---------GKVVITDFGLFSISG 180
Query: 426 DDKTSVHKD---TASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGR 482
+ +D +G L +++PE Q S + + SDV++LG I Y +
Sbjct: 181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE 240
Query: 483 TPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
P+ P + + KP L+ + + + C + + RPT
Sbjct: 241 WPFKTQPAEAI-IWQMGTGM-----KPNLSQI-GMGKEISDILLFCWAFEQEERPT 289
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-31
Identities = 69/289 (23%), Positives = 118/289 (40%), Gaps = 49/289 (16%)
Query: 259 QVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGC 318
V +G G +VY G + +A+K+++++ T Q + + NEV +L K +
Sbjct: 27 TVGQRIGSGSFGTVYK--GKWHGD---VAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRH- 79
Query: 319 PYVIKMHDYVYDTASKHLYV---LMEKGDTDLSKYMRNLNKMTTLPNTMIIII-----MH 370
++ Y L + E L ++ + + I M
Sbjct: 80 VNILLFMGYSTAP---QLAIVTQWCEGSS--LYHHLHASETKFEMKKLIDIARQTARGMD 134
Query: 371 WYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTS 430
+ +HA IIH DLK N +F+ N +KI DFG+A S
Sbjct: 135 Y---------LHAKSIIHRDLKSNN-IFLHE--------DNTVKIGDFGLATEKSRWSGS 176
Query: 431 VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN 490
+ SG++ +M+PE S N Y +++SDV++ G +LY ++ G+ PYS+I N
Sbjct: 177 HQFEQLSGSILWMAPEVIRMQDS----NPY--SFQSDVYAFGIVLYELMTGQLPYSNINN 230
Query: 491 TWAKMLAIARHKDQIEFKPQLANN-VTIPPTLLQSMKLCLQKDPKARPT 538
+ + R P L+ P + + M CL+K RP+
Sbjct: 231 RDQIIEMVGRGS----LSPDLSKVRSNCPKRMKRLMAECLKKKRDERPS 275
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 2e-31
Identities = 67/298 (22%), Positives = 123/298 (41%), Gaps = 54/298 (18%)
Query: 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG 317
+ + LGKG +VYL +ALKV+ S + + + E+E+ + L+
Sbjct: 16 FDIGRPLGKGKFGNVYLAREKQNKFI--MALKVLFKSQLEKEGVEHQLRREIEIQSHLR- 72
Query: 318 CPYVIKMHDYVYDTASKHLYVLME---KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEM 374
P +++M++Y +D K +Y+++E +G+ L K ++ + + + E+
Sbjct: 73 HPNILRMYNYFHD--RKRIYLMLEFAPRGE--LYKELQKHGRFDE-QRSATFM----EEL 123
Query: 375 LLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKD 434
A+ H +IH D+KP N L + G LKI DFG + +
Sbjct: 124 ADALHYCHERKVIHRDIKPENLL--------MGYKGE-LKIADFGWSVHAPSLRR----R 170
Query: 435 TASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY--SHIPNTW 492
T GTL+Y+ PE G T+ K D+W G + Y + G P+ T
Sbjct: 171 TMCGTLDYLPPEMIE-------GKTH--DEKVDLWCAGVLCYEFLVGMPPFDSPSHTETH 221
Query: 493 AKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNP 550
+++ ++F P L++ L+ + L+ P R + + +P
Sbjct: 222 RRIV-----NVDLKFPPFLSDGSK---DLISKL---LRYHPPQRLP----LKGVMEHP 264
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 73/336 (21%), Positives = 133/336 (39%), Gaps = 56/336 (16%)
Query: 211 LSVNSTKSSDPSVSKETIKPAKPQITTSNAKKSVETSQDVITLN--GKQYQVLSLLGKGG 268
+ + SS + E + +T K ++ + V+ +G+G
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQSGVVTHEQFKAAL---RMVVDQGDPRLLLDSYVKIGEGS 57
Query: 269 SSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHD-Y 327
+ V L +H + +A+K++DL + + NEV ++ Q V++M+ Y
Sbjct: 58 TGIVCL--AREKHSGRQVAVKMMDLRKQQRR---ELLFNEVVIMRDYQ-HFNVVEMYKSY 111
Query: 328 VYDTASKHLYVLMEKGDTDLSKYM-----RNLNKMTTLPNTMIIIIMHWYEMLLAVKEIH 382
+ L+VLME ++ ++ L I + +L A+ +H
Sbjct: 112 LVGE---ELWVLME--------FLQGGALTDIVSQVRLNEEQIATVCE--AVLQALAYLH 158
Query: 383 AAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNY 442
A G+IH D+K + L + G V K+ DFG + D + + GT +
Sbjct: 159 AQGVIHRDIKSDSILLTLD--------GRV-KLSDFGFCAQISKDVP--KRKSLVGTPYW 207
Query: 443 MSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARHK 502
M+PE ++ Y + D+WSLG ++ M+ G PY A M +
Sbjct: 208 MAPEVISRSL-------Y--ATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA-MKRLRDSP 257
Query: 503 DQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
P+L N+ + P L ++ L +DP+ R T
Sbjct: 258 -----PPKLKNSHKVSPVLRDFLERMLVRDPQERAT 288
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-31
Identities = 76/344 (22%), Positives = 131/344 (38%), Gaps = 75/344 (21%)
Query: 222 SVSKETIKPAKPQITTSNAKKSVETSQDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEH 281
++K P P T + + +Y++ LLGKGG +V+ G
Sbjct: 2 MLTKPLQGPPAPPGTPTPPPGGKDREAFE-----AEYRLGPLLGKGGFGTVFA--GHRLT 54
Query: 282 EFKPLALKVVDLSDITDQSIADSYLN---EVELLAKL---QGCPYVIKMHDYVYDTASKH 335
+ +A+KV+ + + S + EV LL K+ G P VI++ D ++T +
Sbjct: 55 DRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD-WFET-QEG 112
Query: 336 LYVLMEKGDT--DLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKP 393
+++E+ DL Y+ + +++ A++ H+ G++H D+K
Sbjct: 113 FMLVLERPLPAQDLFDYITEKGPLGE---GPSRCFFG--QVVAAIQHCHSRGVVHRDIKD 167
Query: 394 ANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSS 453
N L ID K+IDFG L D+ GT Y PE
Sbjct: 168 ENIL--------IDLRRGCAKLIDFGSGALLHDE----PYTDFDGTRVYSPPEWI----- 210
Query: 454 SGGGNTYRITY---KSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQ 510
S Y + VWSLG +LY+M+ G P+ +I
Sbjct: 211 SRHQ------YHALPATVWSLGILLYDMVCGDIPF--------------ERDQEI----- 245
Query: 511 LANNVTIPPTL---LQSM-KLCLQKDPKARPTVGNSVTQINNNP 550
L + P + ++ + CL P +RP+ + +I +P
Sbjct: 246 LEAELHFPAHVSPDCCALIRRCLAPKPSSRPS----LEEILLDP 285
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-31
Identities = 76/292 (26%), Positives = 128/292 (43%), Gaps = 40/292 (13%)
Query: 252 TLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVEL 311
L+ + Y++ +LG GG S V+L + + +A+KV+ D S + E +
Sbjct: 9 HLSDR-YELGEILGFGGMSEVHL--ARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQN 65
Query: 312 LAKLQGCPYVIKMHDY--VYDTASKHLYVLME--KGDTDLSKYMRNLNKMTTLPNTMIII 367
A L P ++ ++D A Y++ME G T L ++ + I
Sbjct: 66 AAALNH-PAIVAVYDTGEAETPAGPLPYIVMEYVDGVT-LRDI---VHTEGPMTPKRAIE 120
Query: 368 IMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDD 427
++ + A+ H GIIH D+KPAN + I V K++DFGIA ++ D
Sbjct: 121 VIA--DACQALNFSHQNGIIHRDVKPANIM--------ISATNAV-KVMDFGIARAIADS 169
Query: 428 KTSV-HKDTASGTLNYMSPE-AAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY 485
SV GT Y+SPE A G + + +SDV+SLGC+LY ++ G P+
Sbjct: 170 GNSVTQTAAVIGTAQYLSPEQARGDS----------VDARSDVYSLGCVLYEVLTGEPPF 219
Query: 486 SHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARP 537
+ +++A + + P A + + L + L K+P+ R
Sbjct: 220 TG-----DSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRY 266
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-31
Identities = 60/289 (20%), Positives = 115/289 (39%), Gaps = 43/289 (14%)
Query: 259 QVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIA----DSYLNEVELLAK 314
+ +GKGG V+ G + +A+K + L D ++ + EV +++
Sbjct: 22 EYEKQIGKGGFGLVHK--GRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSN 79
Query: 315 LQGCPYVIKMHDYVYDTASKHLYVLME---KGDTDLSKYMRNLNKMTTLPNTMIIIIMHW 371
L P ++K+ Y ++ME GD L + + K + ++ + +M
Sbjct: 80 LN-HPNIVKL----YGLMHNPPRMVMEFVPCGD--LYHRLLD--KAHPIKWSVKLRLM-- 128
Query: 372 YEMLLAVKEIHAAG--IIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKT 429
++ L ++ + I+H DL+ N + + + K+ DFG++ +
Sbjct: 129 LDIALGIEYMQNQNPPIVHRDLRSPNIF----LQSLDENAPVCAKVADFGLSQQSVHSVS 184
Query: 430 SVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIP 489
G +M+PE +Y T K+D +S ILY ++ G P+
Sbjct: 185 G-----LLGNFQWMAPETI-----GAEEESY--TEKADTYSFAMILYTILTGEGPFDEYS 232
Query: 490 NTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
K + + R + +P + + PP L ++LC DPK RP
Sbjct: 233 YGKIKFINMIREEGL---RPTIPED--CPPRLRNVIELCWSGDPKKRPH 276
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 65/289 (22%), Positives = 122/289 (42%), Gaps = 51/289 (17%)
Query: 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKL 315
K+Y +G+G S +VY + +A++ ++L + + +NE+ ++ +
Sbjct: 20 KKYTRFEKIGQGASGTVYT--AMDVATGQEVAIRQMNLQQQPKKEL---IINEILVMREN 74
Query: 316 QGCPYVIKMHD-YVYDTASKHLYVLMEKGDTDLSKYM-----RNLNKMTTLPNTMIIIIM 369
+ P ++ D Y+ L+V+ME Y+ ++ T + I +
Sbjct: 75 K-NPNIVNYLDSYLVGD---ELWVVME--------YLAGGSLTDVVTETCMDEGQIAAVC 122
Query: 370 HWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKT 429
E L A++ +H+ +IH D+K N L + G+V K+ DFG + +++
Sbjct: 123 R--ECLQALEFLHSNQVIHRDIKSDNIL--------LGMDGSV-KLTDFGFCAQITPEQS 171
Query: 430 SVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIP 489
+ T GT +M+PE + + Y K D+WSLG + MI G PY +
Sbjct: 172 --KRSTMVGTPYWMAPEVVTRKA-------Y--GPKVDIWSLGIMAIEMIEGEPPYLNEN 220
Query: 490 NTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
A + IA + P+L N + + CL+ D + R +
Sbjct: 221 PLRA-LYLIATNG-----TPELQNPEKLSAIFRDFLNRCLEMDVEKRGS 263
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 70/347 (20%), Positives = 121/347 (34%), Gaps = 64/347 (18%)
Query: 206 VFKRPLSVNSTKSSDPSVSKETIKPAKPQITTSNAKKSVETSQDVITLN-GKQYQVLSLL 264
+ + + ++ + P + + K + ++ + K + L +
Sbjct: 3 YYHHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREI 62
Query: 265 GKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKM 324
G G +VY + +A+K + S + EV L KL+ P I+
Sbjct: 63 GHGSFGAVYF--ARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQY 119
Query: 325 HD-YVYDTASKHLYVLME---KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKE 380
Y+ + +++ME +DL + K L I + H L +
Sbjct: 120 RGCYLREH---TAWLVMEYCLGSASDL---LEVHKK--PLQEVEIAAVTH--GALQGLAY 169
Query: 381 IHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTL 440
+H+ +IH D+K N L + G V K+ DFG A + + V GT
Sbjct: 170 LHSHNMIHRDVKAGNIL--------LSEPGLV-KLGDFGSASIMAPANSFV------GTP 214
Query: 441 NYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIAR 500
+M+PE Y K DVWSLG + + P ++ A + IA+
Sbjct: 215 YWMAPEVILAMDEGQ----Y--DGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQ 267
Query: 501 HKDQIEFKPQLANNVTIPPTLLQS---------MKLCLQKDPKARPT 538
++ P L + CLQK P+ RPT
Sbjct: 268 NE---------------SPALQSGHWSEYFRNFVDSCLQKIPQDRPT 299
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-30
Identities = 69/353 (19%), Positives = 125/353 (35%), Gaps = 81/353 (22%)
Query: 236 TTSNAKKSVETSQDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVD--- 292
K V+ I Y+++ L +G + + L E + K ALK +
Sbjct: 15 NLIYLNKYVKEKDKYIN----DYRIIRTLNQGKFNKIILC----EKDNKFYALKKYEKSL 66
Query: 293 -----------LSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLME 341
I+ +S D + NE++++ ++ Y + + + +Y++ E
Sbjct: 67 LEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKN-EYCLTCEGIITN--YDEVYIIYE 123
Query: 342 ---KGDTDLSKYMRNLNKMTT-----LPNTMIIIIMHWYEMLLAVKEIHAA-GIIHSDLK 392
+ K+ + +P +I I+ +L + IH I H D+K
Sbjct: 124 YMENDS--ILKFDEYFFVLDKNYTCFIPIQVIKCIIK--SVLNSFSYIHNEKNICHRDVK 179
Query: 393 PANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEA-AGQT 451
P+N L +D G V K+ DFG + + D K + GT +M PE + ++
Sbjct: 180 PSNIL--------MDKNGRV-KLSDFGESEYMVDKKI----KGSRGTYEFMPPEFFSNES 226
Query: 452 SSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY---SHIPNTWAKMLA--------IAR 500
S +G K D+WSLG LY M Y P+ + + +
Sbjct: 227 SYNG--------AKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNH 278
Query: 501 HKDQIEFKPQLANNVTIPPT---LLQSMKLCLQKDPKARPTVGNSVTQINNNP 550
+ K +N + L+ L+K+P R T +
Sbjct: 279 FLYPLTNKKSTCSNNFLSNEDIDFLKLF---LRKNPAERIT----SEDALKHE 324
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 5e-30
Identities = 64/286 (22%), Positives = 115/286 (40%), Gaps = 39/286 (13%)
Query: 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKL 315
+Y+ +LGKG V L + + A+KV+ + ++ +S L EV+LL +L
Sbjct: 26 DRYKGQRVLGKGSFGEVILC--KDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 316 QGCPYVIKMHDYVYDTASKHLYVLME--KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYE 373
P ++K+++ ++ + Y++ E G + + I+ +
Sbjct: 84 DH-PNIMKLYE-FFED-KGYFYLVGEVYTGGELFDE----IISRKRFSEVDAARII--RQ 134
Query: 374 MLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHK 433
+L + +H I+H DLKP N L ++IIDFG++ + K
Sbjct: 135 VLSGITYMHKNKIVHRDLKPENLLLE------SKSKDANIRIIDFGLSTHFEASKKMK-- 186
Query: 434 DTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWA 493
GT Y++PE K DVWS G ILY ++ G P+ + N +
Sbjct: 187 -DKIGTAYYIAPEVLHG----------TYDEKCDVWSTGVILYILLSGCPPF-NGANEYD 234
Query: 494 KMLAIARHKDQIEFKPQLANNVTIPP-TLLQSMKLCLQKDPKARPT 538
+ + + K F+ V+ L++ M L P R +
Sbjct: 235 ILKKVEKGK--YTFELPQWKKVSESAKDLIRKM---LTYVPSMRIS 275
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-30
Identities = 78/376 (20%), Positives = 152/376 (40%), Gaps = 78/376 (20%)
Query: 194 QSLSQKKNESTPVFKRPLSVNSTKSSDPSVSKETIKPAKPQITTSNAKKSVETSQDVITL 253
+ L E F R L + ++S++ + + A+P+ T + +S+ ++
Sbjct: 27 RHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDW 86
Query: 254 N-----GKQYQVLSLLGKGGSSSVYLVGGTSEHEF--KPLALKVVD-----LSDITDQSI 301
++Y ++G+G SS V H A+K+++ LS + +
Sbjct: 87 AAAKEFYQKYDPKDVIGRGVSSVVRRC----VHRATGHEFAVKIMEVTAERLSPEQLEEV 142
Query: 302 ADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLME-------------KG---DT 345
++ E +L ++ G P++I + D Y++ S ++++ + K +
Sbjct: 143 REATRRETHILRQVAGHPHIITLID-SYES-SSFMFLVFDLMRKGELFDYLTEKVALSEK 200
Query: 346 DLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKI 405
+ MR+ +L AV +HA I+H DLKP N L N+
Sbjct: 201 ETRSIMRS--------------------LLEAVSFLHANNIVHRDLKPENILLDDNMQ-- 238
Query: 406 IDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYK 465
+++ DFG +C L+ + ++ GT Y++PE + S Y +
Sbjct: 239 -------IRLSDFGFSCHLEPGE--KLRELC-GTPGYLAPEIL-KCSMDETHPGY--GKE 285
Query: 466 SDVWSLGCILYNMIYGRTPYSHIPNTWAKML-AIARHKDQIEFKPQLANNVTIPPT-LLQ 523
D+W+ G IL+ ++ G P+ H ML I + +F ++ + L+
Sbjct: 286 VDLWACGVILFTLLAGSPPFWH--RRQILMLRMIMEGQ--YQFSSPEWDDRSSTVKDLIS 341
Query: 524 SMKLCLQKDPKARPTV 539
+ LQ DP+AR T
Sbjct: 342 RL---LQVDPEARLTA 354
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 8e-30
Identities = 67/285 (23%), Positives = 119/285 (41%), Gaps = 38/285 (13%)
Query: 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKL 315
+ YQ + LG G V L + A+K++ + ++ S + L EV +L L
Sbjct: 37 EMYQRVKKLGSGAYGEVLLC--RDKVTHVERAIKIIRKTSVSTSSNSK-LLEEVAVLKLL 93
Query: 316 QGCPYVIKMHDYVYDTASKHLYVLME--KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYE 373
P ++K++D ++ ++ Y++ME KG + + +I+ +
Sbjct: 94 DH-PNIMKLYD-FFED-KRNYYLVMECYKGGELFDE----IIHRMKFNEVDAAVII--KQ 144
Query: 374 MLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHK 433
+L V +H I+H DLKP N L ++KI+DFG++ ++ K
Sbjct: 145 VLSGVTYLHKHNIVHRDLKPENLLLE------SKEKDALIKIVDFGLSAVFENQKKMK-- 196
Query: 434 DTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWA 493
GT Y++PE + + K DVWS+G IL+ ++ G P+ T
Sbjct: 197 -ERLGTAYYIAPEVLRK----------KYDEKCDVWSIGVILFILLAGYPPFGG--QTDQ 243
Query: 494 KMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
++L K + F NV+ +K LQ D + R +
Sbjct: 244 EILRKVE-KGKYTFDSPEWKNVS--EGAKDLIKQMLQFDSQRRIS 285
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 9e-30
Identities = 72/298 (24%), Positives = 124/298 (41%), Gaps = 62/298 (20%)
Query: 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKL 315
+ ++++ LG G VY ++ A KV++ + + Y+ E+E+LA
Sbjct: 19 EVWEIVGELGDGAFGKVYK--AKNKETGALAAAKVIETKSEEEL---EDYIVEIEILATC 73
Query: 316 QGCPYVIKMHD-YVYDTASKHLYVLMEKGD----TDLSKYMRNLNKMTTLPNTMIIIIMH 370
PY++K+ Y +D L++++E + M L++ L I ++
Sbjct: 74 D-HPYIVKLLGAYYHDG---KLWIMIEFCPGGAVDAI---MLELDR--GLTEPQIQVVCR 124
Query: 371 WYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTS 430
+ML A+ +H+ IIH DLK N L + G++ ++ DFG++ T
Sbjct: 125 --QMLEALNFLHSKRIIHRDLKAGNVL--------MTLEGDI-RLADFGVSAKNLK--TL 171
Query: 431 VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN 490
+D+ GT +M+PE + Y YK+D+WSLG L M P+ +
Sbjct: 172 QKRDSFIGTPYWMAPEVVMCETMKDTP--Y--DYKADIWSLGITLIEMAQIEPPHHELNP 227
Query: 491 TWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKL----------CLQKDPKARPT 538
+L IA+ PPTLL K L K+P+ RP+
Sbjct: 228 MRV-LLKIAKSD---------------PPTLLTPSKWSVEFRDFLKIALDKNPETRPS 269
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-29
Identities = 66/324 (20%), Positives = 118/324 (36%), Gaps = 82/324 (25%)
Query: 237 TSNAKKSVETSQDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDI 296
S+ ++++ ++Y ++ +LGKG V + A+KV++ +
Sbjct: 7 HSSGRENLYFQGTF----AERYNIVCMLGKGSFGEVLKC--KDRITQQEYAVKVINKASA 60
Query: 297 TDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEK---GD--------- 344
++ + L EVELL KL P ++K+ + + + S Y++ E G+
Sbjct: 61 KNKDTST-ILREVELLKKLDH-PNIMKLFE-ILED-SSSFYIVGELYTGGELFDEIIKRK 116
Query: 345 ----TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVG 400
D ++ ++ ++ + +H I+H DLKP N L
Sbjct: 117 RFSEHDAARIIK--------------------QVFSGITYMHKHNIVHRDLKPENILLE- 155
Query: 401 NVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTY 460
+KIIDFG++ Q + GT Y++PE
Sbjct: 156 -----SKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG---------- 197
Query: 461 RITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK-----MLAIARHKDQIEFKPQLANNV 515
K DVWS G ILY ++ G P+ + K + + K F +
Sbjct: 198 TYDEKCDVWSAGVILYILLSGTPPF------YGKNEYDILKRVETGK--YAFDLPQWRTI 249
Query: 516 TIPP-TLLQSMKLCLQKDPKARPT 538
+ L++ M L P R T
Sbjct: 250 SDDAKDLIRKM---LTFHPSLRIT 270
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 78/365 (21%), Positives = 132/365 (36%), Gaps = 76/365 (20%)
Query: 198 QKKNESTPVFKRPLSVNSTKSSDPSVSKETIKPAKPQITTSNAKKSVETSQDVITLNGKQ 257
+P P + P++ +P P Q
Sbjct: 3 SNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDD 62
Query: 258 YQVLS-LLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQ 316
Y+V S +LG G + V + ++ + ALK++ D EVEL +
Sbjct: 63 YKVTSQVLGLGINGKVLQI--FNKRTQEKFALKMLQ--DCPKAR------REVELHWRAS 112
Query: 317 GCPYVIKMHDYVYDTAS---KHLYVLME-------------KGDT-----DLSKYMRNLN 355
CP+++++ D VY+ K L ++ME +GD + S+ M+
Sbjct: 113 QCPHIVRIVD-VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK--- 168
Query: 356 KMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415
+ A++ +H+ I H D+KP N L+ K + I LK+
Sbjct: 169 -----------------SIGEAIQYLHSINIAHRDVKPENLLYTS---KRPNAI---LKL 205
Query: 416 IDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCIL 475
DFG A + T T Y++PE G Y D+WSLG I+
Sbjct: 206 TDFGFAKETTSHNSLT---TPCYTPYYVAPEVLGPEK-------Y--DKSCDMWSLGVIM 253
Query: 476 YNMIYGRTP-YSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPP-TLLQSMKLCLQKDP 533
Y ++ G P YS+ + + Q EF + V+ L++++ L+ +P
Sbjct: 254 YILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNL---LKTEP 310
Query: 534 KARPT 538
R T
Sbjct: 311 TQRMT 315
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-29
Identities = 70/320 (21%), Positives = 108/320 (33%), Gaps = 61/320 (19%)
Query: 257 QYQVLSLLGKGGSSSVYLVGGTSEHEF--KPLALKVVDLSDITDQSIADSYLNEVELLAK 314
+++ LG GG V H+ + +A+K + + E++++ K
Sbjct: 15 PWEMKERLGTGGFGYVLRW----IHQDTGEQVAIKQCRQELSPKNR--ERWCLEIQIMKK 68
Query: 315 LQGCPYVIKMHDYVYDTASK-----HLYVLME---KGDTDLSKYMRNLNKMTTLPNTMII 366
L P V+ + V D K + ME GD L KY+ L I
Sbjct: 69 LN-HPNVVSARE-VPDGLQKLAPNDLPLLAMEYCEGGD--LRKYLNQFENCCGLKEGPIR 124
Query: 367 IIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQD 426
++ ++ A++ +H IIH DLKP N + ++I KIID G A L
Sbjct: 125 TLLS--DISSALRYLHENRIIHRDLKPENIVLQPGPQRLI------HKIIDLGYAKELDQ 176
Query: 427 DKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY- 485
+ GTL Y++PE Y T D WS G + + I G P+
Sbjct: 177 GELC---TEFVGTLQYLAPELLE-------QKKY--TVTVDYWSFGTLAFECITGFRPFL 224
Query: 486 -SHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLC--------------LQ 530
+ P W + + + I L V L L L
Sbjct: 225 PNWQPVQWHGKV-REKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLM 283
Query: 531 KDPKARPTVGNSVTQINNNP 550
+ R T Q N
Sbjct: 284 WHQRQRGT----DPQNPNVG 299
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 6e-29
Identities = 74/314 (23%), Positives = 127/314 (40%), Gaps = 52/314 (16%)
Query: 232 KPQITTSNAKKSVETSQDVITLN-GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKV 290
Q+ ++ + +D +T + + VL LG+G SVY + +A+K
Sbjct: 4 TVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQ--IVAIKQ 61
Query: 291 VDL-SDITDQSIADSYLNEVELLAKLQGCPYVIKMHD-YVYDTASKHLYVLMEKGD---- 344
V + SD+ + + E+ ++ + P+V+K + Y +T L+++ME
Sbjct: 62 VPVESDLQE------IIKEISIMQQCD-SPHVVKYYGSYFKNT---DLWIVMEYCGAGSV 111
Query: 345 TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLK 404
+D+ + TL I I+ L ++ +H IH D+K N L
Sbjct: 112 SDIIRLRNK-----TLTEDEIATILQ--STLKGLEYLHFMRKIHRDIKAGNIL------- 157
Query: 405 IIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITY 464
++ G+ K+ DFG+A L D T ++T GT +M+PE + Y
Sbjct: 158 -LNTEGHA-KLADFGVAGQLTD--TMAKRNTVIGTPFWMAPEVIQE-------IGY--NC 204
Query: 465 KSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQS 524
+D+WSLG M G+ PY+ I A + I + P
Sbjct: 205 VADIWSLGITAIEMAEGKPPYADIHPMRA-IFMIPTNP-----PPTFRKPELWSDNFTDF 258
Query: 525 MKLCLQKDPKARPT 538
+K CL K P+ R T
Sbjct: 259 VKQCLVKSPEQRAT 272
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 68/300 (22%), Positives = 115/300 (38%), Gaps = 67/300 (22%)
Query: 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKL 315
Y+V +G G S + A+K++D S E+E+L +
Sbjct: 22 DGYEVKEDIGVGSYSVCKRC--IHKATNMEFAVKIIDKS-------KRDPTEEIEILLRY 72
Query: 316 QGCPYVIKMHDYVYDTASKHLYVLME-------------KG---DTDLSKYMRNLNKMTT 359
P +I + D VYD K++YV+ E + + + S + +
Sbjct: 73 GQHPNIITLKD-VYDD-GKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTI----- 125
Query: 360 LPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFG 419
V+ +HA G++H DLKP+N L+V ++I DFG
Sbjct: 126 ---------------TKTVEYLHAQGVVHRDLKPSNILYVDE-----SGNPESIRICDFG 165
Query: 420 IACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI 479
A L+ + + T T N+++PE + Y D+WSLG +LY M+
Sbjct: 166 FAKQLRAENGLLM--TPCYTANFVAPEVLERQG-------Y--DAACDIWSLGVLLYTML 214
Query: 480 YGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPP-TLLQSMKLCLQKDPKARPT 538
G TP+++ P+ + + + N+V+ L+ M L DP R T
Sbjct: 215 TGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKM---LHVDPHQRLT 271
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-28
Identities = 65/295 (22%), Positives = 113/295 (38%), Gaps = 59/295 (20%)
Query: 259 QVLSLLGKGGSSSVYLVG---GTSEHEFKPLALKVVDLSDITDQS-IADSYLNEVELLAK 314
+ ++G GG VY G +A+K D S ++ E +L A
Sbjct: 10 TLEEIIGIGGFGKVYR-AFWIGD------EVAVKAARHDPDEDISQTIENVRQEAKLFAM 62
Query: 315 LQGCPYVIKMHDYVYDTASKHLYVLME---KGDTDLSKYMRNLNKMTTLPNTMIIII--- 368
L+ P +I + +L ++ME G L++ + K + +
Sbjct: 63 LKH-PNIIALRGVC--LKEPNLCLVMEFARGGP--LNRVLSG--KRIPPDILVNWAVQIA 115
Query: 369 --MHWYEMLLAVKEIHAAG---IIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACS 423
M++ +H IIH DLK +N L + ++ D +LKI DFG+A
Sbjct: 116 RGMNY---------LHDEAIVPIIHRDLKSSNIL-ILQKVENGDLSNKILKITDFGLARE 165
Query: 424 LQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRT 483
+A+G +M+PE + + + SDVWS G +L+ ++ G
Sbjct: 166 WHRTTKM----SAAGAYAWMAPEVIR-------ASMF--SKGSDVWSYGVLLWELLTGEV 212
Query: 484 PYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
P+ I LA+A + + + P + M+ C DP +RP+
Sbjct: 213 PFRGIDG-----LAVAYGVAMNKLALPIPST--CPEPFAKLMEDCWNPDPHSRPS 260
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 60/325 (18%), Positives = 115/325 (35%), Gaps = 66/325 (20%)
Query: 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIAD--SYLNEVELLA 313
K+Y + +G+G V + A+K+++ + I + D EV L+
Sbjct: 26 KKYHLKGAIGQGSYGVVRVAIENQTRA--IRAIKIMNKNKIRQINPKDVERIKTEVRLMK 83
Query: 314 KLQGCPYVIKMHDYVYDTASKHLYVLME-------------KGDTDLSKYMRNLNKMTTL 360
KL P + ++++ VY+ +++ ++ME D K ++ K
Sbjct: 84 KLHH-PNIARLYE-VYED-EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQIC 140
Query: 361 PNTMIIIIMHWYE-----------------------MLLAVKEIHAAGIIHSDLKPANFL 397
P + A+ +H GI H D+KP NFL
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFL 200
Query: 398 FVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKD--TASGTLNYMSPEAAGQTSSSG 455
F N +K++DFG++ + T +GT +++PE
Sbjct: 201 FSTNK-------SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVL------- 246
Query: 456 GGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNV 515
K D WS G +L+ ++ G P+ A ++ ++ F+ N +
Sbjct: 247 NTTNESYGPKCDAWSAGVLLHLLLMGAVPFPG--VNDADTISQVL-NKKLCFENPNYNVL 303
Query: 516 TIPP-TLLQSMKLCLQKDPKARPTV 539
+ LL ++ L ++ R
Sbjct: 304 SPLARDLLSNL---LNRNVDERFDA 325
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-28
Identities = 73/336 (21%), Positives = 133/336 (39%), Gaps = 71/336 (21%)
Query: 243 SVETSQDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIA 302
S +S D + LN QY + +GKG V L +E++ A+KV+ + Q+
Sbjct: 2 SSGSSGDCVQLN--QYTLKDEIGKGSYGVVKL--AYNENDNTYYAMKVLSKKKLIRQAGF 57
Query: 303 DSYLNEVELLAKLQGC----------------------PYVIKMHDYVYDTASK-HLYVL 339
GC P V+K+ + V D ++ HLY++
Sbjct: 58 PRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVE-VLDDPNEDHLYMV 116
Query: 340 MEKGDTDLSKYMRN---LNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANF 396
E + + T P + ++ +++ ++ +H IIH D+KP+N
Sbjct: 117 FE--------LVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNL 168
Query: 397 LFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGG 456
L + G++ KI DFG++ + + GT +M+PE+ S
Sbjct: 169 L--------VGEDGHI-KIADFGVSNEFKGSDALLS--NTVGTPAFMAPESL-----SET 212
Query: 457 GNTYRITYKSDVWSLGCILYNMIYGRTPY--SHIPNTWAKMLAIARHKDQIEFKPQLANN 514
+ DVW++G LY ++G+ P+ I +K I + +P +A +
Sbjct: 213 RKIFS-GKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSK---IKSQALEFPDQPDIAED 268
Query: 515 VTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNP 550
+ L+ M L K+P++R V +I +P
Sbjct: 269 LK---DLITRM---LDKNPESRIV----VPEIKLHP 294
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 68/308 (22%), Positives = 122/308 (39%), Gaps = 70/308 (22%)
Query: 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIAD------SYLNEV 309
+ Y+ +LG+G SS V + K A+K++D++ S + + L EV
Sbjct: 17 ENYEPKEILGRGVSSVVRRC--IHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 74
Query: 310 ELLAKLQGCPYVIKMHDYVYDTASKHLYVLME-------------KG---DTDLSKYMRN 353
++L K+ G P +I++ D Y+T + +++ + K + + K MR
Sbjct: 75 DILRKVSGHPNIIQLKD-TYET-NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 132
Query: 354 LNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413
+L + +H I+H DLKP N L ++ +
Sbjct: 133 --------------------LLEVICALHKLNIVHRDLKPENILLDDDMN---------I 163
Query: 414 KIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGC 473
K+ DFG +C L ++ GT +Y++PE + S + Y + D+WS G
Sbjct: 164 KLTDFGFSCQLDPG--EKLREVC-GTPSYLAPEII-ECSMNDNHPGY--GKEVDMWSTGV 217
Query: 474 ILYNMIYGRTPYSHIPNTWAKML-AIARHKDQIEFKPQLANNVTIPP-TLLQSMKLCLQK 531
I+Y ++ G P+ H ML I +F ++ + L+ L
Sbjct: 218 IMYTLLAGSPPFWH--RKQMLMLRMIMSGN--YQFGSPEWDDYSDTVKDLVSRF---LVV 270
Query: 532 DPKARPTV 539
P+ R T
Sbjct: 271 QPQKRYTA 278
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-28
Identities = 67/331 (20%), Positives = 111/331 (33%), Gaps = 61/331 (18%)
Query: 229 KPAKPQITTSNAKKSVETSQDVITLN----GKQYQVLSLLGKGGSSSVYLVGGTSEHEFK 284
+ + G+ Y + LG G V L ++
Sbjct: 5 HHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLC--KEKNGHS 62
Query: 285 PLALKVVDLSDITDQSIADSY----------LNEVELLAKLQGCPYVIKMHDYVYDTASK 334
A+KV+ S +D NE+ LL L P +IK+ D D K
Sbjct: 63 EKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDH-PNIIKLFDVFED--KK 119
Query: 335 HLYVLME--KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLK 392
+ Y++ E +G + + IM ++L + +H I+H D+K
Sbjct: 120 YFYLVTEFYEGGELFEQ----IINRHKFDECDAANIM--KQILSGICYLHKHNIVHRDIK 173
Query: 393 PANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTS 452
P N L +KI+DFG++ D GT Y++PE +
Sbjct: 174 PENILLENK------NSLLNIKIVDFGLSSFFSKDYKLR---DRLGTAYYIAPEVLKK-- 222
Query: 453 SSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK-----MLAIARHKDQIEF 507
+ K DVWS G I+Y ++ G P+ + + + + K F
Sbjct: 223 --------KYNEKCDVWSCGVIMYILLCGYPPF------GGQNDQDIIKKVEKGK--YYF 266
Query: 508 KPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
N++ + +KL L D R T
Sbjct: 267 DFNDWKNIS--DEAKELIKLMLTYDYNKRCT 295
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 115 bits (288), Expect = 4e-28
Identities = 64/340 (18%), Positives = 114/340 (33%), Gaps = 90/340 (26%)
Query: 254 NGKQYQVLSLLGKGGSS--SVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVEL 311
G Y++L+++GKG +V L E+ + ++ ++L +++ + E+ +
Sbjct: 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEY--VTVRRINLEACSNEMV-TFLQGELHV 79
Query: 312 LAKLQGCPYVIKMHD-YVYDTASKHLYVLME---KGD-TDLSKYMRNLNKMTTLPNTMII 366
P ++ ++ D L+V+ G DL + M + I
Sbjct: 80 SKLFN-HPNIVPYRATFIADN---ELWVVTSFMAYGSAKDLICT----HFMDGMNELAIA 131
Query: 367 IIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQD 426
I+ +L A+ IH G +H +K ++ L I G V + S+
Sbjct: 132 YIL--QGVLKALDYIHHMGYVHRSVKASHIL--------ISVDGKV-YLSGLRSNLSMIS 180
Query: 427 D---KTSVHKDTAS--GTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYG 481
+ VH L ++SPE Q Y KSD++S+G + G
Sbjct: 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQ-----GY--DAKSDIYSVGITACELANG 233
Query: 482 RTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSM---------------- 525
P+ +P T +L P L + TIP L
Sbjct: 234 HVPFKDMPATQM-LLEKLNGT-----VPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTT 287
Query: 526 ---------------------------KLCLQKDPKARPT 538
+ CLQ++P ARP+
Sbjct: 288 STPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPS 327
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 68/319 (21%), Positives = 118/319 (36%), Gaps = 71/319 (22%)
Query: 254 NGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLA 313
N YQ++ LG+G S V+ + +E + +K++ E+++L
Sbjct: 34 NQDDYQLVRKLGRGKYSEVFEAINITNNE--KVVVKILKPVK------KKKIKREIKILE 85
Query: 314 KLQGCPYVIKMHDYVYDTASKHL-YVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWY 372
L+G P +I + D V D S+ V +TD + + TL + I M Y
Sbjct: 86 NLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ------TLTDYDIRFYM--Y 137
Query: 373 EMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVH 432
E+L A+ H+ GI+H D+KP N + ID L++ID+G+A +
Sbjct: 138 EILKALDYCHSMGIMHRDVKPHNVM--------IDHEHRKLRLIDWGLAEFYHPGQEYNV 189
Query: 433 KDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY----SHI 488
+ + + PE Y Y D+WSLGC+L +MI+ + P+ +
Sbjct: 190 R---VASRYFKGPELL------VDYQMY--DYSLDMWSLGCMLASMIFRKEPFFHGHDNY 238
Query: 489 --------------PNTWAKMLAIARHKDQIEFKPQL-----------ANNVTIPPT--- 520
+ I + + N + P
Sbjct: 239 DQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALD 298
Query: 521 LLQSMKLCLQKDPKARPTV 539
L + L+ D ++R T
Sbjct: 299 FLDKL---LRYDHQSRLTA 314
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 53/292 (18%), Positives = 111/292 (38%), Gaps = 58/292 (19%)
Query: 259 QVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGC 318
+ +G G +V+ +A+K++ D + + + +L EV ++ +L+
Sbjct: 40 NIKEKIGAGSFGTVHR--AEWHG--SDVAVKILMEQDFHAERVNE-FLREVAIMKRLRH- 93
Query: 319 PYVIKMHDYVYDTASKHLYVLME---KGDTDLSKYMRNLNKMTTLPNTMIIII------- 368
P ++ V T +L ++ E +G L + + L + +
Sbjct: 94 PNIVLFMGAV--TQPPNLSIVTEYLSRGS--LYRLLHKSGAREQLDERRRLSMAYDVAKG 149
Query: 369 MHWYEMLLAVKEIHAAG--IIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQD 426
M++ +H I+H +LK N L +K+ DFG++
Sbjct: 150 MNY---------LHNRNPPIVHRNLKSPNLLVDKK---------YTVKVCDFGLSRLKAS 191
Query: 427 DKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYS 486
T + +A+GT +M+PE KSDV+S G IL+ + + P+
Sbjct: 192 --TFLSSKSAAGTPEWMAPEVLR-------DEPS--NEKSDVYSFGVILWELATLQQPWG 240
Query: 487 HIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
++ + A+ + ++ N + P + ++ C +P RP+
Sbjct: 241 NLNPAQV-VAAVGFKC----KRLEIPRN--LNPQVAAIIEGCWTNEPWKRPS 285
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 8e-27
Identities = 71/296 (23%), Positives = 116/296 (39%), Gaps = 71/296 (23%)
Query: 264 LGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIK 323
LG+G S + + A+K++ + E+ L +G P ++K
Sbjct: 19 LGEGSFSICRKC--VHKKSNQAFAVKIISKRMEANTQ------KEITALKLCEGHPNIVK 70
Query: 324 MHDYVYDTASKHLYVLME-------------KG---DTDLSKYMRNLNKMTTLPNTMIII 367
+H+ V+ H +++ME K +T+ S MR
Sbjct: 71 LHE-VFHD-QLHTFLVMELLNGGELFERIKKKKHFSETEASYIMR--------------- 113
Query: 368 IMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDD 427
+++ AV +H G++H DLKP N LF + + +KIIDFG A D
Sbjct: 114 -----KLVSAVSHMHDVGVVHRDLKPENLLFTD---ENDNLE---IKIIDFGFARLKPPD 162
Query: 428 KTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY-- 485
+ T TL+Y +PE Q N Y D+WSLG ILY M+ G+ P+
Sbjct: 163 NQPLK--TPCFTLHYAAPELLNQ-------NGY--DESCDLWSLGVILYTMLSGQVPFQS 211
Query: 486 ---SHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
S + +++ + K F+ + NV+ L ++ L DP R
Sbjct: 212 HDRSLTCTSAVEIMKKIK-KGDFSFEGEAWKNVSQEAKDL--IQGLLTVDPNKRLK 264
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 44/295 (14%), Positives = 91/295 (30%), Gaps = 65/295 (22%)
Query: 259 QVLSLLGKGGSSSVYLVG---GTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKL 315
L+ L + S ++ G G + +KV+ + D + + D + E L
Sbjct: 13 NFLTKLNENHSGELWK-GRWQGN------DIVVKVLKVRDWSTRKSRD-FNEECPRLRIF 64
Query: 316 QGCPYVIKMHDYVYDTASKHLYVLME---KGDTDLSKYMRNLNKMTTLPNTMIIII---- 368
P V+ + + H ++ G L + + + +
Sbjct: 65 SH-PNVLPVLGACQSPPAPHPTLITHWMPYGS--LYNVLHE-GTNFVVDQSQAVKFALDM 120
Query: 369 ---MHWYEMLLAVKEIHAAG--IIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACS 423
M + +H I L + + + +I + S
Sbjct: 121 ARGMAF---------LHTLEPLIPRHALNSRSVMIDED---------MTARISMADVKFS 162
Query: 424 LQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRT 483
Q +++PEA + +D+WS +L+ ++
Sbjct: 163 FQSP-------GRMYAPAWVAPEALQKKPED------TNRRSADMWSFAVLLWELVTREV 209
Query: 484 PYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
P++ + N M +A + P I P + + MK+C+ +DP RP
Sbjct: 210 PFADLSNMEIGM-KVALEGLRPTIPP------GISPHVSKLMKICMNEDPAKRPK 257
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 59/305 (19%), Positives = 123/305 (40%), Gaps = 51/305 (16%)
Query: 240 AKKSVETSQDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQ 299
+ V + + + +++L +GKG V +V K A+K ++ ++
Sbjct: 1 SMPPVFDENEDVNFD--HFEILRAIGKGSFGKVCIV--QKNDTKKMYAMKYMNKQKCVER 56
Query: 300 SIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMR------N 353
+ + E++++ L+ P+++ + Y + ++++++ + +
Sbjct: 57 NEVRNVFKELQIMQGLE-HPFLVNLW-YSFQDEED-MFMVVD--------LLLGGDLRYH 105
Query: 354 LNKMTTLPNTMIIIIMHWY--EMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGN 411
L + + + + E+++A+ + IIH D+KP N L +D G+
Sbjct: 106 LQQNVHFKEETVKL----FICELVMALDYLQNQRIIHRDMKPDNIL--------LDEHGH 153
Query: 412 VLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSL 471
V I DF IA L + T +GT YM+PE +G Y ++ D WSL
Sbjct: 154 V-HITDFNIAAMLPRETQI---TTMAGTKPYMAPEMFSSRKGAG----Y--SFAVDWWSL 203
Query: 472 GCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQK 531
G Y ++ GR PY +T +K + + + ++ +K L+
Sbjct: 204 GVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPS------AWSQEMVSLLKKLLEP 257
Query: 532 DPKAR 536
+P R
Sbjct: 258 NPDQR 262
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 70/306 (22%), Positives = 115/306 (37%), Gaps = 75/306 (24%)
Query: 256 KQYQVLS-LLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAK 314
YQ+ +LG G + V + ALK+ + D A EV+ +
Sbjct: 28 DDYQLSKQVLGLGVNGKVLEC--FHRRTGQKCALKL-----LYDSPKA---RQEVDHHWQ 77
Query: 315 LQGCPYVIKMHDYVYDTAS---KHLYVLME-------------KGDT-----DLSKYMRN 353
G P+++ + D VY+ + L ++ME +GD + ++ MR
Sbjct: 78 ASGGPHIVCILD-VYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMR- 135
Query: 354 LNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413
++ A++ +H+ I H D+KP N L+ K D + L
Sbjct: 136 -------------------DIGTAIQFLHSHNIAHRDVKPENLLYTS---KEKDAV---L 170
Query: 414 KIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGC 473
K+ DFG A + T T Y++PE G Y D+WSLG
Sbjct: 171 KLTDFGFAKETTQNALQ----TPCYTPYYVAPEVLGPEK-------Y--DKSCDMWSLGV 217
Query: 474 ILYNMIYGRTP-YSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKD 532
I+Y ++ G P YS+ + + Q F + V+ L ++L L+ D
Sbjct: 218 IMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQL--IRLLLKTD 275
Query: 533 PKARPT 538
P R T
Sbjct: 276 PTERLT 281
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 64/323 (19%), Positives = 117/323 (36%), Gaps = 71/323 (21%)
Query: 253 LNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELL 312
L ++ +S LG G V+ V +A K++ L +I + + E+++L
Sbjct: 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLV--MARKLIHLE--IKPAIRNQIIRELQVL 85
Query: 313 AKLQGCPYVIKMHDYVYDTASKHLYVLMEKGDTD-LSKYMRNLNKMTTLPNTMIIIIMHW 371
+ PY++ + Y + + ME D L + ++ K +P ++ +
Sbjct: 86 HECN-SPYIVGFYGAFYS--DGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVS-- 137
Query: 372 YEMLLAVKEIHAAG-IIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTS 430
++ + + I+H D+KP+N L ++ G + K+ DFG++ L D
Sbjct: 138 IAVIKGLTYLREKHKIMHRDVKPSNIL--------VNSRGEI-KLCDFGVSGQLIDSMA- 187
Query: 431 VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN 490
++ GT +YMSPE G Y + +SD+WS+G L M GR P
Sbjct: 188 ---NSFVGTRSYMSPERLQ-------GTHY--SVQSDIWSMGLSLVEMAVGRYPIPPPDA 235
Query: 491 TWAKMLAIARHKDQIEFKPQLANNVTI--------------------------PPTLLQS 524
+++ + + P PP L
Sbjct: 236 KELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSG 295
Query: 525 ---------MKLCLQKDPKARPT 538
+ CL K+P R
Sbjct: 296 VFSLEFQDFVNKCLIKNPAERAD 318
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 69/343 (20%), Positives = 136/343 (39%), Gaps = 66/343 (19%)
Query: 220 DPSVSKETIKPAKPQITTSNAKKSVETSQDVITLNGKQYQVLSLLGKGGSSSVYLVGGTS 279
D + ++ Q + + +D ++ +LG+G S+V L
Sbjct: 2 DGTAAEPRPGAGSLQHAQPPPQPRKKRPED--------FKFGKILGEGSFSTVVLA--RE 51
Query: 280 EHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVL 339
+ A+K+++ I ++ E +++++L P+ +K++ + + K LY
Sbjct: 52 LATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLY-FTFQDDEK-LYFG 108
Query: 340 MEKGDTDLSKYMRN------LNKMTTLPNTMIIIIMHWY--EMLLAVKEIHAAGIIHSDL 391
+ Y +N + K+ + T +Y E++ A++ +H GIIH DL
Sbjct: 109 LS--------YAKNGELLKYIRKIGSFDETC----TRFYTAEIVSALEYLHGKGIIHRDL 156
Query: 392 KPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQT 451
KP N L ++ ++ +I DFG A L + ++ GT Y+SPE
Sbjct: 157 KPENIL--------LNEDMHI-QITDFGTAKVLSPESKQARANSFVGTAQYVSPELL--- 204
Query: 452 SSSGGGNTYRITYKSDVWSLGCILYNMIYGRTP-YSHIPN-TWAKMLAIARHKDQIEFKP 509
+ + SD+W+LGCI+Y ++ G P + + K++ K + +F
Sbjct: 205 TEKSACKS------SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII-----KLEYDFPE 253
Query: 510 QLANNVTIPPTLLQSMKLCLQKDPKARPTVG--NSVTQINNNP 550
+ L++ KL L D R + +P
Sbjct: 254 KFFPKAR---DLVE--KL-LVLDATKRLGCEEMEGYGPLKAHP 290
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 9e-26
Identities = 60/310 (19%), Positives = 108/310 (34%), Gaps = 74/310 (23%)
Query: 263 LLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVI 322
+LG+G + V + + A+K+++ + EVE+L + QG V+
Sbjct: 20 VLGEGAHARVQTC--INLITSQEYAVKIIEKQPGHIR---SRVFREVEMLYQCQGHRNVL 74
Query: 323 KMHDYVYDTASKHLYVLMEK---GD-------------TDLSKYMRNLNKMTTLPNTMII 366
++ + ++ Y++ EK G + S ++++
Sbjct: 75 ELIE-FFEE-EDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDV------------ 120
Query: 367 IIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQD 426
A+ +H GI H DLKP N L + +KI DF + ++
Sbjct: 121 --------ASALDFLHNKGIAHRDLKPENILCEHP------NQVSPVKICDFDLGSGIKL 166
Query: 427 DKTSVHKD-----TASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYG 481
+ T G+ YM+PE S Y + D+WSLG ILY ++ G
Sbjct: 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASI--Y--DKRCDLWSLGVILYILLSG 222
Query: 482 RTP-YSHIPNTWAKMLAIARHKDQ-----------IEFKPQLANNVTIPP-TLLQSMKLC 528
P + A Q EF + +++ L+ +
Sbjct: 223 YPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKL--- 279
Query: 529 LQKDPKARPT 538
L +D K R +
Sbjct: 280 LVRDAKQRLS 289
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 76/311 (24%), Positives = 114/311 (36%), Gaps = 78/311 (25%)
Query: 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEF--KPLALKVVDLSDIT-----DQSIADSYLNE 308
+Y + LG G V L K +A+K++ + A + E
Sbjct: 10 DEYIMSKTLGSGACGEVKLA----FERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 309 VELLAKLQGCPYVIKMHDYVYDTASKHLYVLME-------------KG---DTDLSKYMR 352
+E+L KL P +IK+ + +D + Y+++E + Y
Sbjct: 66 IEILKKLNH-PCIIKIKN-FFDA--EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 121
Query: 353 NLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNV 412
MLLAV+ +H GIIH DLKP N L +
Sbjct: 122 Q--------------------MLLAVQYLHENGIIHRDLKPENVLLSSQ------EEDCL 155
Query: 413 LKIIDFGIACSLQDD---KTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVW 469
+KI DFG + L + +T GT Y++PE ++G D W
Sbjct: 156 IKITDFGHSKILGETSLMRTLC------GTPTYLAPEVLVSVGTAGYNR------AVDCW 203
Query: 470 SLGCILYNMIYGRTPYSHIPNTWAKML-AIARHKDQIEFKPQLANNVTIPPTLLQSMKLC 528
SLG IL+ + G P+S T + I K F P++ V+ L +K
Sbjct: 204 SLGVILFICLSGYPPFSE-HRTQVSLKDQITSGK--YNFIPEVWAEVSEKALDL--VKKL 258
Query: 529 LQKDPKARPTV 539
L DPKAR T
Sbjct: 259 LVVDPKARFTT 269
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 79/294 (26%), Positives = 126/294 (42%), Gaps = 44/294 (14%)
Query: 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVD-----LSDITDQSIADSYLNEVE 310
+Y + LG G V L K +A++++ + + A + E+E
Sbjct: 135 DEYIMSKTLGSGACGEVKLA--FERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIE 192
Query: 311 LLAKLQGCPYVIKMHDYVYDTASKHLYVLMEK---GDTDLSKYMRNLNKMTTLPNTMIII 367
+L KL P +IK+ + +D + Y+++E G+ L + ++ +
Sbjct: 193 ILKKLNH-PCIIKIKN-FFDA--EDYYIVLELMEGGE--LFDKVVGNKRLKE-ATCKLYF 245
Query: 368 IMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDD 427
Y+MLLAV+ +H GIIH DLKP N L + DC+ +KI DFG + L +
Sbjct: 246 ----YQMLLAVQYLHENGIIHRDLKPENVLLSS---QEEDCL---IKITDFGHSKILGET 295
Query: 428 KTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSH 487
T GT Y++PE ++G Y D WSLG IL+ + G P+S
Sbjct: 296 SLM---RTLCGTPTYLAPEVLVSVGTAG----Y--NRAVDCWSLGVILFICLSGYPPFSE 346
Query: 488 IPNTWAKML-AIARHKDQIEFKPQLANNVTIPPT-LLQSMKLCLQKDPKARPTV 539
T + I K F P++ V+ L++ + L DPKAR T
Sbjct: 347 -HRTQVSLKDQITSGK--YNFIPEVWAEVSEKALDLVKKL---LVVDPKARFTT 394
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 68/300 (22%), Positives = 114/300 (38%), Gaps = 68/300 (22%)
Query: 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKL 315
++Y ++ +LGKG V + A+KV++ + ++ + L EVELL KL
Sbjct: 22 ERYNIVCMLGKGSFGEVLKC--KDRITQQEYAVKVINKASAKNKDTST-ILREVELLKKL 78
Query: 316 QGCPYVIKMHDYVYDTASKHLYVLME-------------KG---DTDLSKYMRNLNKMTT 359
P ++K+ + + + S Y++ E + + D ++ ++
Sbjct: 79 DH-PNIMKLFE-ILED-SSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQ------ 129
Query: 360 LPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFG 419
+ + +H I+H DLKP N L K DC +KIIDFG
Sbjct: 130 --------------VFSGITYMHKHNIVHRDLKPENILLES---KEKDCD---IKIIDFG 169
Query: 420 IACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI 479
++ Q + GT Y++PE TY K DVWS G ILY ++
Sbjct: 170 LSTCFQQNTK---MKDRIGTAYYIAPEVLRG--------TY--DEKCDVWSAGVILYILL 216
Query: 480 YGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPP-TLLQSMKLCLQKDPKARPT 538
G P+ +L + F ++ L++ M L P R T
Sbjct: 217 SGTPPFYG--KNEYDILKRVE-TGKYAFDLPQWRTISDDAKDLIRKM---LTFHPSLRIT 270
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 64/307 (20%), Positives = 117/307 (38%), Gaps = 84/307 (27%)
Query: 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKL 315
+ Y + + +G+G V + + A K + + D D + E+E++ L
Sbjct: 9 QYYTLENTIGRGSWGEVKIA--VQKGTRIRRAAKKIPKYFVEDV---DRFKQEIEIMKSL 63
Query: 316 QGCPYVIKMHDYVYDTASKHLYVLME-------------KG---DTDLSKYMRNLNKMTT 359
P +I++++ ++ + +Y++ME K ++D ++ M++
Sbjct: 64 DH-PNIIRLYE-TFED-NTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKD------ 114
Query: 360 LPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFG 419
+L AV H + H DLKP NFLF+ + + LK+IDFG
Sbjct: 115 --------------VLSAVAYCHKLNVAHRDLKPENFLFLTD------SPDSPLKLIDFG 154
Query: 420 IACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI 479
+A + K + + GT Y+SP+ Y + D WS G ++Y ++
Sbjct: 155 LAARFKPGK--MMRTKV-GTPYYVSPQVLEG--------LY--GPECDEWSAGVMMYVLL 201
Query: 480 YGRTPY--SHIPNTWAKMLAIARHKDQIEFKPQLANNVT------IPPTLLQSMKLCLQK 531
G P+ K+ + F + NV+ I + L K
Sbjct: 202 CGYPPFSAPTDSEVMLKIR-----EGTFTFPEKDWLNVSPQAESLI--------RRLLTK 248
Query: 532 DPKARPT 538
PK R T
Sbjct: 249 SPKQRIT 255
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 68/305 (22%), Positives = 126/305 (41%), Gaps = 56/305 (18%)
Query: 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLN-EVELLAKL 315
+Y + LLG+G V A+K++ + ++ + E++LL +
Sbjct: 6 KYLMGDLLGEGSYGKVKE--VLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLL-RR 62
Query: 316 QGCPYVIKMHDYVYDTASKHLYVLME---KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWY 372
VI++ D +Y+ + +Y++ME G ++ + + + H Y
Sbjct: 63 LRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE-KRFP-------VCQAHGY 114
Query: 373 --EMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTS 430
+++ ++ +H+ GI+H D+KP N L + G LKI G+A +L
Sbjct: 115 FCQLIDGLEYLHSQGIVHKDIKPGNLL--------LTTGGT-LKISALGVAEALHPFAAD 165
Query: 431 VHKDTASGTLNYMSPE-AAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY--SH 487
T+ G+ + PE A G + SG +K D+WS G LYN+ G P+ +
Sbjct: 166 DTCRTSQGSPAFQPPEIANGLDTFSG--------FKVDIWSAGVTLYNITTGLYPFEGDN 217
Query: 488 IPNTWAKMLAIARHKDQI--EFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545
I + I + I + P L++ LL+ M L+ +P R + + Q
Sbjct: 218 IYKLFEN---IGKGSYAIPGDCGPPLSD-------LLKGM---LEYEPAKRFS----IRQ 260
Query: 546 INNNP 550
I +
Sbjct: 261 IRQHS 265
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-24
Identities = 62/390 (15%), Positives = 129/390 (33%), Gaps = 71/390 (18%)
Query: 167 ENVVPDNE-KFKGPTQTKSVFSVRSASDQSLSQKKNESTPVFKRPLSVNSTKSSDPSVSK 225
E + + +F+ + K S + +E +
Sbjct: 70 EGLRAGKQYEFRIIAENKHGQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVS 129
Query: 226 ETIKPAKPQITTSNAKKSVETSQDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKP 285
I + VE D + Y + LG G V+ V T
Sbjct: 130 SNYDNYVFDIWKQYYPQPVEIKHDHVL---DHYDIHEELGTGAFGVVHRV--TERATGNN 184
Query: 286 LALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEKGDT 345
A K V +D+ ++ E++ ++ L+ P ++ +HD ++ + ++ E
Sbjct: 185 FAAKFVMTPHESDK---ETVRKEIQTMSVLRH-PTLVNLHD-AFEDD-NEMVMIYE---- 234
Query: 346 DLSKYM-------RNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLF 398
+M + ++ + + M ++ + +H +H DLKP N +F
Sbjct: 235 ----FMSGGELFEKVADEHNKMSEDEAVEYMR--QVCKGLCHMHENNYVHLDLKPENIMF 288
Query: 399 VGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGN 458
N LK+IDFG+ L ++ +GT + +PE A
Sbjct: 289 T-------TKRSNELKLIDFGLTAHLDPKQSV---KVTTGTAEFAAPEVAEGKP------ 332
Query: 459 TYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK-----MLAIARHKDQIEFKPQLAN 513
+ Y +D+WS+G + Y ++ G +P+ + + + +
Sbjct: 333 ---VGYYTDMWSVGVLSYILLSGLSPF------GGENDDETLRNVKSCD--WNMDDSAFS 381
Query: 514 NVTIPPTLLQS----MKLCLQKDPKARPTV 539
++ + ++ L DP R T+
Sbjct: 382 GIS------EDGKDFIRKLLLADPNTRMTI 405
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 43/282 (15%), Positives = 78/282 (27%), Gaps = 64/282 (22%)
Query: 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG 317
Y++L G + + +AL VD + + L+ L+++
Sbjct: 33 YRLLIFHGGVPPLQFWQ--ALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID- 89
Query: 318 CPYVIKMHDYVYDTASKHLYVLME--KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEML 375
P V ++ D V+ A V+ E +G + L + + P I + +
Sbjct: 90 KPGVARVLDVVHTRA--GGLVVAEWIRGGS-LQEVADT----SPSPVGAIRAMQ---SLA 139
Query: 376 LAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDT 435
A H AG+ S P+ + G+V +
Sbjct: 140 AAADAAHRAGVALSIDHPSRVR--------VSIDGDV-VLAYPA---------------- 174
Query: 436 ASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKM 495
M + D+ +G LY ++ R P
Sbjct: 175 ------TMPDA----------------NPQDDIRGIGASLYALLVNRWPLP--EAGVRSG 210
Query: 496 LAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARP 537
LA A + + IP + +Q D R
Sbjct: 211 LAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIRS 252
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 69/312 (22%), Positives = 126/312 (40%), Gaps = 56/312 (17%)
Query: 237 TSNAKKSVETSQDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDI 296
S+ ++++ + + LG G V+LV +K ++
Sbjct: 7 HSSGRENLYFQGTI----DDLFIFKRKLGSGAFGDVHLV--EERSSGLERVIKTINKDRS 60
Query: 297 TDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLME--KGDTDLSKYMRNL 354
+ E+E+L L P +IK+ + V++ ++Y++ME +G L + +
Sbjct: 61 QVP--MEQIEAEIEVLKSLDH-PNIIKIFE-VFED-YHNMYIVMETCEGGELLERIVSAQ 115
Query: 355 NKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414
+ L + +M +M+ A+ H+ ++H DLKP N LF + +K
Sbjct: 116 ARGKALSEGYVAELMK--QMMNALAYFHSQHVVHKDLKPENILFQDT------SPHSPIK 167
Query: 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCI 474
IIDFG+A + D+ S A+GT YM+PE +T+K D+WS G +
Sbjct: 168 IIDFGLAELFKSDEHS---TNAAGTALYMAPEVF----------KRDVTFKCDIWSAGVV 214
Query: 475 LYNMIYGRTPYSHIPNTWAK-----MLAIARHKDQIEFKPQLANNVTIPPT---LLQSMK 526
+Y ++ G P+ + + + + P LL+ M
Sbjct: 215 MYFLLTGCLPF------TGTSLEEVQQKATYKE--PNYAVECRP---LTPQAVDLLKQM- 262
Query: 527 LCLQKDPKARPT 538
L KDP+ RP+
Sbjct: 263 --LTKDPERRPS 272
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 63/309 (20%), Positives = 111/309 (35%), Gaps = 76/309 (24%)
Query: 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIAD--SYLNEVELLA 313
Y++ ++GKG S V + + A+K+VD++ T E +
Sbjct: 24 DVYELCEVIGKGPFSVVRRC--INRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICH 81
Query: 314 KLQGCPYVIKMHDYVYDTASKHLYVLME-------------KGDT-------DLSKYMRN 353
L+ P+++++ + Y + LY++ E + D S YMR
Sbjct: 82 MLKH-PHIVELLE-TYSS-DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQ 138
Query: 354 LNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413
+L A++ H IIH D+KP L K +
Sbjct: 139 --------------------ILEALRYCHDNNIIHRDVKPHCVLLAS---KENSAP---V 172
Query: 414 KIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGC 473
K+ FG+A L + GT ++M+PE Y DVW G
Sbjct: 173 KLGGFGVAIQLGESGLVAG--GRVGTPHFMAPEVV-------KREPY--GKPVDVWGCGV 221
Query: 474 ILYNMIYGRTPYSHIPNTWAKMLAIARH--KDQIEFKPQLANNVTIPP-TLLQSMKLCLQ 530
IL+ ++ G P+ + + K + + P+ ++++ L++ M L
Sbjct: 222 ILFILLSGCLPF------YGTKERLFEGIIKGKYKMNPRQWSHISESAKDLVRRM---LM 272
Query: 531 KDPKARPTV 539
DP R TV
Sbjct: 273 LDPAERITV 281
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 82/326 (25%), Positives = 142/326 (43%), Gaps = 55/326 (16%)
Query: 223 VSKETIKPAKPQITTSNAKKSVETSQDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHE 282
+ ++ K + K + + + Y+V+ ++G+G V LV S +
Sbjct: 36 LDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRK 95
Query: 283 FKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLME- 341
A+K++ ++ +S + + E +++A P+V+++ Y + ++LY++ME
Sbjct: 96 V--YAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLF-YAFQD-DRYLYMVMEY 150
Query: 342 --KGD--TDLSKYMRNLNKMTTLPNTMIIIIMHWY--EMLLAVKEIHAAGIIHSDLKPAN 395
GD +S Y +P Y E++LA+ IH+ G IH D+KP N
Sbjct: 151 MPGGDLVNLMSNY--------DVPEKWARF----YTAEVVLALDAIHSMGFIHRDVKPDN 198
Query: 396 FLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSG 455
L +D G++ K+ DFG + + V DTA GT +Y+SPE S G
Sbjct: 199 ML--------LDKSGHL-KLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEV---LKSQG 245
Query: 456 GGNTYRITYKSDVWSLGCILYNMIYGRTP-YSHIPN-TWAKMLAIARHKDQIEFKPQLAN 513
G Y + D WS+G LY M+ G TP Y+ T++K I HK+ + F
Sbjct: 246 GDGYY--GRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK---IMNHKNSLTFPD---- 296
Query: 514 NVTIPPT---LLQSMKLCLQKDPKAR 536
+ I L+ + D + R
Sbjct: 297 DNDISKEAKNLICA----FLTDREVR 318
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-24
Identities = 85/380 (22%), Positives = 148/380 (38%), Gaps = 68/380 (17%)
Query: 172 DNEKFKGPTQTKSVFSVRSASDQSLSQKKNESTPVFKRPLSVNSTKSSDPSVSKETIKPA 231
D K FS + K + P +P ++ V ++ I+
Sbjct: 110 DTYIMKELLACSHPFSKSAIEHVQGHLVKKQVPPDLFQPYIEEICQNLRGDVFQKFIESD 169
Query: 232 KPQITTSNAKKSVETSQDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVV 291
K K+VE +T+N + V ++G+GG VY + A+K +
Sbjct: 170 KFTRFCQ--WKNVE-LNIHLTMN--DFSVHRIIGRGGFGEVYGCRKADTGKM--YAMKCL 222
Query: 292 DLSDITDQSIADSYLNEVELLAKLQG--CPYVIKMHDYVYDTASKHLYVLMEKGDTDLSK 349
D I + LNE +L+ + CP+++ M Y + T K L +++
Sbjct: 223 DKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS-YAFHTPDK-LSFILD-------- 272
Query: 350 YMR------NLNKMTTLPNTMIIIIMHWY--EMLLAVKEIHAAGIIHSDLKPANFLFVGN 401
M +L++ + Y E++L ++ +H +++ DLKPAN L
Sbjct: 273 LMNGGDLHYHLSQHGVFSEADMRF----YAAEIILGLEHMHNRFVVYRDLKPANIL---- 324
Query: 402 VLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYR 461
+D G+V +I D G+AC K + GT YM+PE + G Y
Sbjct: 325 ----LDEHGHV-RISDLGLACDFSKKKPH----ASVGTHGYMAPEVLQK------GVAY- 368
Query: 462 ITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIE-FKPQLANNVTIPPT 520
+D +SLGC+L+ ++ G +P+ KD+ E + L V +P +
Sbjct: 369 -DSSADWFSLGCMLFKLLRGHSPFRQHKT-----------KDKHEIDRMTLTMAVELPDS 416
Query: 521 LLQSMK-LC---LQKDPKAR 536
++ L LQ+D R
Sbjct: 417 FSPELRSLLEGLLQRDVNRR 436
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 72/315 (22%), Positives = 119/315 (37%), Gaps = 85/315 (26%)
Query: 257 QYQVLSLLGKGGSSSVYLVGGTSEHEF--KPLALKVVDLSDITDQSIADSYLNEVELLAK 314
Y++L +GKG + V L + H + +A+K++D + + S+ + EV ++
Sbjct: 16 NYRLLKTIGKGNFAKVKL----ARHILTGREVAIKIIDKTQLNPTSLQKLF-REVRIMKI 70
Query: 315 LQGCPYVIKMHDYVYDTASKHLYVLMEKGDT-DLSKYMRNLNKMTTLPNTMIIIIMHWYE 373
L P ++K+ + V +T K LY++ME ++ Y+ +M E
Sbjct: 71 LNH-PNIVKLFE-VIET-EKTLYLIMEYASGGEVFDYLVAHGRMK--------------E 113
Query: 374 ---------MLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSL 424
++ AV+ H I+H DLK N L +D N+ KI DFG +
Sbjct: 114 KEARSKFRQIVSAVQYCHQKRIVHRDLKAENLL--------LDADMNI-KIADFGFSNEF 164
Query: 425 QDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTP 484
D G Y +PE G + DVWSLG ILY ++ G P
Sbjct: 165 TVGG---KLDAFCGAPPYAAPELFQGKKYDG--------PEVDVWSLGVILYTLVSGSLP 213
Query: 485 Y--SHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPP-------TLLQSMKLCLQKDPKA 535
+ ++ ++ L IP LL+ L +P
Sbjct: 214 FDGQNLKELRERV---------------LRGKYRIPFYMSTDCENLLKRF---LVLNPIK 255
Query: 536 RPTVGNSVTQINNNP 550
R T + QI +
Sbjct: 256 RGT----LEQIMKDR 266
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 62/313 (19%), Positives = 120/313 (38%), Gaps = 78/313 (24%)
Query: 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEF--KPLALKVVDLSDITDQSIADSYLN-----E 308
++Y +S LG G V+ + + K + +K + + + + E
Sbjct: 24 QKYSTMSPLGSGAFGFVWT----AVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLE 79
Query: 309 VELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEKGDT--DLSKYMRNLNKMTTLPNTMII 366
+ +L++++ +IK+ D +++ ++MEK + DL ++ ++
Sbjct: 80 IAILSRVEH-ANIIKVLD-IFEN-QGFFQLVMEKHGSGLDLFAFIDRHPRLD-------- 128
Query: 367 IIMHWYE---------MLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIID 417
E ++ AV + IIH D+K N + I + K+ID
Sbjct: 129 ------EPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIV--------IAEDFTI-KLID 173
Query: 418 FGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYN 477
FG A L+ K T GT+ Y +PE GN YR + ++WSLG LY
Sbjct: 174 FGSAAYLERGK---LFYTFCGTIEYCAPEVLM-------GNPYR-GPELEMWSLGVTLYT 222
Query: 478 MIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARP 537
+++ P+ + T + +L + L+ + LQ P+ R
Sbjct: 223 LVFEENPFCELEETVEAAIHPPYL-----VSKELMS-------LVSGL---LQPVPERRT 267
Query: 538 TVGNSVTQINNNP 550
T + ++ +P
Sbjct: 268 T----LEKLVTDP 276
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 4e-24
Identities = 70/293 (23%), Positives = 126/293 (43%), Gaps = 39/293 (13%)
Query: 224 SKETIKPAKPQITTSNAKKSVETSQDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEF 283
+ K + + + L +++L ++G+G S V +V +
Sbjct: 29 GASELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQV 88
Query: 284 KPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLME-- 341
A+K+++ D+ + + E ++L ++ ++H + + +LY++ME
Sbjct: 89 --YAMKIMNKWDMLKRGEVSCFREERDVLVNGD-RRWITQLH-FAFQD-ENYLYLVMEYY 143
Query: 342 -KGD--TDLSKYMRNLNKMTTLPNTMIIIIMHWY--EMLLAVKEIHAAGIIHSDLKPANF 396
GD T LSK+ +P M Y E+++A+ +H G +H D+KP N
Sbjct: 144 VGGDLLTLLSKFGE------RIPAEMARF----YLAEIVMAIDSVHRLGYVHRDIKPDNI 193
Query: 397 LFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGG 456
L +D G++ ++ DFG L+ D T V A GT +Y+SPE G
Sbjct: 194 L--------LDRCGHI-RLADFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPG 243
Query: 457 GNTYRITYKSDVWSLGCILYNMIYGRTP-YSHIPN-TWAKMLAIARHKDQIEF 507
+Y + D W+LG Y M YG+TP Y+ T+ K I +K+ +
Sbjct: 244 TGSY--GPECDWWALGVFAYEMFYGQTPFYADSTAETYGK---IVHYKEHLSL 291
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 7e-24
Identities = 68/302 (22%), Positives = 115/302 (38%), Gaps = 69/302 (22%)
Query: 256 KQYQVLSLLGKGGSSSVYL-VGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAK 314
Y V LGKG S V V T+ EF A K+++ ++ + E + K
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEF---AAKIINTKKLSARDFQK-LEREARICRK 61
Query: 315 LQGCPYVIKMHDYVYDTASKHLYVLME-------------KG---DTDLSKYMRNLNKMT 358
LQ P ++++HD Y++ + + + D S ++
Sbjct: 62 LQH-PNIVRLHD-SIQE-ESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ----- 113
Query: 359 TLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDF 418
+L ++ H+ GI+H +LKP N L G +K+ DF
Sbjct: 114 ---------------ILESIAYCHSNGIVHRNLKPENLLLASK------AKGAAVKLADF 152
Query: 419 GIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNM 478
G+A + D + A GT Y+SPE + Y + D+W+ G ILY +
Sbjct: 153 GLAIEVNDSE--AWHGFA-GTPGYLSPEVL-------KKDPY--SKPVDIWACGVILYIL 200
Query: 479 IYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPP-TLLQSMKLCLQKDPKARP 537
+ G P+ ++ A + ++ + VT +L+ SM L +PK R
Sbjct: 201 LVGYPPFWD--EDQHRLYAQIK-AGAYDYPSPEWDTVTPEAKSLIDSM---LTVNPKKRI 254
Query: 538 TV 539
T
Sbjct: 255 TA 256
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 8e-24
Identities = 70/318 (22%), Positives = 138/318 (43%), Gaps = 40/318 (12%)
Query: 224 SKETIKPAKPQITTSNAKKSVETSQDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEF 283
+ ++ K + K + + L+ + +++L ++G+G V +V + +
Sbjct: 42 NNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKV 101
Query: 284 KPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLME-- 341
A+K+++ ++ ++ + E ++L ++ +H Y + + LY++M+
Sbjct: 102 --FAMKILNKWEMLKRAETACFREERDVLVNGD-SKWITTLH-YAFQDDNN-LYLVMDYY 156
Query: 342 -KGD--TDLSKYMRNLNKMTTLPNTMIIIIMHWY--EMLLAVKEIHAAGIIHSDLKPANF 396
GD T LSK+ LP M Y EM++A+ +H +H D+KP N
Sbjct: 157 VGGDLLTLLSKFED------RLPEEMARF----YLAEMVIAIDSVHQLHYVHRDIKPDNI 206
Query: 397 LFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGG 456
L +D G++ ++ DFG C + +V A GT +Y+SPE + GG
Sbjct: 207 L--------MDMNGHI-RLADFGS-CLKLMEDGTVQSSVAVGTPDYISPEIL--QAMEGG 254
Query: 457 GNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVT 516
Y + D WSLG +Y M+YG TP+ + + I HK++ +F Q+ +
Sbjct: 255 KGRY--GPECDWWSLGVCMYEMLYGETPF-YAESLVETYGKIMNHKERFQFPTQVTD--- 308
Query: 517 IPPTLLQSMKLCLQKDPK 534
+ ++ +
Sbjct: 309 VSENAKDLIRRLICSREH 326
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 61/296 (20%), Positives = 103/296 (34%), Gaps = 65/296 (21%)
Query: 264 LGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIK 323
LGKG T + + +K L +++ +L EV+++ L+ P V+K
Sbjct: 18 LGKGCFGQAIK--VTHRETGEVMVMKE--LIRFDEETQRT-FLKEVKVMRCLEH-PNVLK 71
Query: 324 MHDYVYDTASKHLYV---LMEKGDTDLSKYMRNLNKMTTLPNTMIIII-----MHWYEML 375
+ K L ++ G L +++++ + M +
Sbjct: 72 FIGVL--YKDKRLNFITEYIKGGT--LRGIIKSMDSQYPWSQRVSFAKDIASGMAY---- 123
Query: 376 LAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVH--- 432
+H+ IIH DL N L N + + DFG+A + D+KT
Sbjct: 124 -----LHSMNIIHRDLNSHNCLVREN---------KNVVVADFGLARLMVDEKTQPEGLR 169
Query: 433 ---------KDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRT 483
+ T G +M+PE G +Y K DV+S G +L +I
Sbjct: 170 SLKKPDRKKRYTVVGNPYWMAPEMIN-------GRSY--DEKVDVFSFGIVLCEIIGRVN 220
Query: 484 PYSHI-PNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
P T L + D+ + P PP+ C DP+ RP+
Sbjct: 221 ADPDYLPRTMDFGLNVRGFLDR--YCPP-----NCPPSFFPITVRCCDLDPEKRPS 269
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 69/329 (20%), Positives = 121/329 (36%), Gaps = 75/329 (22%)
Query: 233 PQITTSNAKKSVETSQDVITLNG----KQYQVLSLLGKGGSSSVYL-VGGTSEHEFKPLA 287
P + + + + + + Y V LGKG S V V T+ EF A
Sbjct: 2 PHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEF---A 58
Query: 288 LKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLME------ 341
K+++ ++ + E + KLQ P ++++HD Y++ +
Sbjct: 59 AKIINTKKLSARDFQK-LEREARICRKLQH-PNIVRLHD-SIQE-ESFHYLVFDLVTGGE 114
Query: 342 -------KG---DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDL 391
+ + D S ++ +L ++ H+ GI+H +L
Sbjct: 115 LFEDIVAREFYSEADASHCIQQ--------------------ILESIAYCHSNGIVHRNL 154
Query: 392 KPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQT 451
KP N L G +K+ DFG+A + D + A GT Y+SPE
Sbjct: 155 KPENLLLASK------AKGAAVKLADFGLAIEVNDSE--AWHGFA-GTPGYLSPEVL--- 202
Query: 452 SSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKML-AIARHKDQIEFKPQ 510
+ Y + D+W+ G ILY ++ G P+ ++ I ++
Sbjct: 203 ----KKDPY--SKPVDIWACGVILYILLVGYPPFWD--EDQHRLYAQIK--AGAYDYPSP 252
Query: 511 LANNVTIPP-TLLQSMKLCLQKDPKARPT 538
+ VT +L+ SM L +PK R T
Sbjct: 253 EWDTVTPEAKSLIDSM---LTVNPKKRIT 278
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-23
Identities = 61/305 (20%), Positives = 109/305 (35%), Gaps = 76/305 (24%)
Query: 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKL 315
++YQ+ LGKG S V + A +++ ++ + E + L
Sbjct: 11 EEYQLFEELGKGAFSVVRRC--VKVLAGQEYAAMIINTKKLSARDHQKLE-REARICRLL 67
Query: 316 QGCPYVIKMHDYVYDTASKHLYVLME-------------KG---DTDLSKYMRNLNKMTT 359
+ P ++++HD H Y++ + + + D S ++
Sbjct: 68 KH-PNIVRLHD-SISE-EGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQ------ 118
Query: 360 LPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFG 419
+L AV H G++H +LKP N L G +K+ DFG
Sbjct: 119 --------------ILEAVLHCHQMGVVHRNLKPENLLLASK------LKGAAVKLADFG 158
Query: 420 IACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI 479
+A ++ ++ + +GT Y+SPE + Y D+W+ G ILY ++
Sbjct: 159 LAIEVEGEQQAWF--GFAGTPGYLSPEVL-------RKDPY--GKPVDLWACGVILYILL 207
Query: 480 YGRTPYSHIPNTWAK-----MLAIARHKDQIEFKPQLANNVTIPP-TLLQSMKLCLQKDP 533
G P+ W + I +F + VT L+ M L +P
Sbjct: 208 VGYPPF------WDEDQHRLYQQIK--AGAYDFPSPEWDTVTPEAKDLINKM---LTINP 256
Query: 534 KARPT 538
R T
Sbjct: 257 SKRIT 261
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 54/309 (17%), Positives = 109/309 (35%), Gaps = 78/309 (25%)
Query: 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVD---LSDITDQSIADSYLNEVELL 312
Y + LG G + V + A K + + EV +L
Sbjct: 12 DFYDIGEELGSGQFAIVKKC--REKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69
Query: 313 AKLQGCPYVIKMHDYVYDTASKHLYVLME-------------KG---DTDLSKYMRNLNK 356
++ VI +HD VY+ + +++E K + + + +++ +
Sbjct: 70 RQVLH-HNVITLHD-VYEN-RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI-- 124
Query: 357 MTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKII 416
L V +H I H DLKP N + + + +K+I
Sbjct: 125 ------------------LDGVNYLHTKKIAHFDLKPENIMLLDK-----NIPIPHIKLI 161
Query: 417 DFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILY 476
DFG+A ++D K+ GT +++PE + ++D+WS+G I Y
Sbjct: 162 DFGLAHEIEDGV--EFKNIF-GTPEFVAPEIVNYEP---------LGLEADMWSIGVITY 209
Query: 477 NMIYGRTPYSHIPNTWAK-----MLAIARHKDQIEFKPQLANNVTIPPT-LLQSMKLCLQ 530
++ G +P+ + I +F + ++ + ++ + L
Sbjct: 210 ILLSGASPF------LGDTKQETLANITSVS--YDFDEEFFSHTSELAKDFIRKL---LV 258
Query: 531 KDPKARPTV 539
K+ + R T+
Sbjct: 259 KETRKRLTI 267
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 75/356 (21%), Positives = 130/356 (36%), Gaps = 72/356 (20%)
Query: 215 STKSSDPSVSKETIKPAKPQITTSNAKKSVETSQDVITLNGKQYQVLSLLGKGGSSSVYL 274
S S+ ++ + P S + + + Y ++G G V+
Sbjct: 2 SFTMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREI---AYTNCKVIGNGSFGVVFQ 58
Query: 275 VGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334
E A+K V L D + E++++ ++ P V+ + + Y K
Sbjct: 59 AKLVESDEV---AIKKV-LQDKRFK------NRELQIMRIVK-HPNVVDLKAFFYSNGDK 107
Query: 335 H----LYVLMEKGDTDLSKYMRNLNKMT-TLPNTMIIIIMHWYEMLLAVKEIHAAGIIHS 389
L +++E + + R+ K+ T+P +I + M Y++L ++ IH+ GI H
Sbjct: 108 KDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYM--YQLLRSLAYIHSIGICHR 165
Query: 390 DLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAG 449
D+KP N L +D VLK+IDFG A L + +V + Y +PE
Sbjct: 166 DIKPQNLL--------LDPPSGVLKLIDFGSAKILIAGEPNVSYIC---SRYYRAPELIF 214
Query: 450 QTSSSGGGNTYRITYKSDVWSLGCILYNMIYGR--------------------TPYSHIP 489
G Y T D+WS GC++ ++ G+ TP
Sbjct: 215 ------GATNY--TTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTP---SR 263
Query: 490 NTWAKMLAIARHKDQIEFKPQLANNVTIPPT------LLQSMKLCLQKDPKARPTV 539
M + +P + V P T L+ + L+ P AR T
Sbjct: 264 EQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRL---LEYTPSARLTA 316
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 3e-23
Identities = 65/335 (19%), Positives = 129/335 (38%), Gaps = 83/335 (24%)
Query: 229 KPAKPQITTSN-AKKSVETSQDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLA 287
+ + T N +S+E + L K+ LG+G + V S+ + A
Sbjct: 7 HSSGVDLGTENLYFQSMENFNNFYILTSKE------LGRGKFAVVRQC--ISKSTGQEYA 58
Query: 288 LKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLME------ 341
K + A+ L+E+ +L + CP VI +H+ VY+ + + +++E
Sbjct: 59 AKFLKKRRRGQDCRAE-ILHEIAVLELAKSCPRVINLHE-VYEN-TSEIILILEYAAGGE 115
Query: 342 -------KGDTDLS-----KYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHS 389
+ +S + ++ ++L V +H I+H
Sbjct: 116 IFSLCLPELAEMVSENDVIRLIK--------------------QILEGVYYLHQNNIVHL 155
Query: 390 DLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAG 449
DLKP N L +KI+DFG++ + ++ GT Y++PE
Sbjct: 156 DLKPQNILLSSI------YPLGDIKIVDFGMSRKIGHAC--ELREIM-GTPEYLAPEILN 206
Query: 450 QTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK-----MLAIARHKDQ 504
IT +D+W++G I Y ++ +P+ + L I+ +
Sbjct: 207 YDP---------ITTATDMWNIGIIAYMLLTHTSPF------VGEDNQETYLNIS--QVN 249
Query: 505 IEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTV 539
+++ + ++V+ T ++ L K+P+ RPT
Sbjct: 250 VDYSEETFSSVSQLATDF--IQSLLVKNPEKRPTA 282
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 4e-23
Identities = 60/312 (19%), Positives = 111/312 (35%), Gaps = 84/312 (26%)
Query: 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVD---LSDITDQSIADSYLNEVELL 312
Y LG G + V + A K + + EV +L
Sbjct: 11 DYYDTGEELGSGQFAVVKKC--REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 313 AKLQGCPYVIKMHDYVYDTASKHLYVLME-------------KG---DTDLSKYMRNLNK 356
++Q P VI +H+ VY+ + +++E K + + +++++
Sbjct: 69 KEIQ-HPNVITLHE-VYENK-TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ--- 122
Query: 357 MTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKII 416
+L V +H+ I H DLKP N + + + +KII
Sbjct: 123 -----------------ILNGVYYLHSLQIAHFDLKPENIMLLDR-----NVPKPRIKII 160
Query: 417 DFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILY 476
DFG+A + K+ GT +++PE + ++D+WS+G I Y
Sbjct: 161 DFGLAHKIDFGN--EFKNIF-GTPEFVAPEIVNYEP---------LGLEADMWSIGVITY 208
Query: 477 NMIYGRTPYSHIPNTWAK-----MLAIARHKDQIEFKPQLANNVTIPPTLLQSMK----L 527
++ G +P+ + ++ EF+ + +N + K
Sbjct: 209 ILLSGASPF------LGDTKQETLANVSAVN--YEFEDEYFSNTS------ALAKDFIRR 254
Query: 528 CLQKDPKARPTV 539
L KDPK R T+
Sbjct: 255 LLVKDPKKRMTI 266
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 4e-23
Identities = 74/309 (23%), Positives = 124/309 (40%), Gaps = 86/309 (27%)
Query: 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKL 315
K + + +LG G S V+LV K ALK + S S NE+ +L K+
Sbjct: 9 KTFIFMEVLGSGAFSEVFLV--KQRLTGKLFALKCIKKSPAFRD---SSLENEIAVLKKI 63
Query: 316 QGCPYVIKMHDYVYDTASKHLYVLME-------------KG---DTDLSKYMRNLNKMTT 359
+ ++ + D +Y++ + H Y++M+ +G + D S ++
Sbjct: 64 KH-ENIVTLED-IYES-TTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQ------ 114
Query: 360 LPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFG 419
+L AVK +H GI+H DLKP N L++ + + I DFG
Sbjct: 115 --------------VLSAVKYLHENGIVHRDLKPENLLYLTP------EENSKIMITDFG 154
Query: 420 IACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI 479
++ Q+ S TA GT Y++PE Q Y + D WS+G I Y ++
Sbjct: 155 LSKMEQNGIMS----TACGTPGYVAPEVLAQKP-------Y--SKAVDCWSIGVITYILL 201
Query: 480 YGRTPYSHIPNTWAK-----MLAIARHKDQIEFKPQLANNVTIPPTLLQSMK----LCLQ 530
G P+ + + I + EF+ ++++ +S K L+
Sbjct: 202 CGYPPF------YEETESKLFEKIK--EGYYEFESPFWDDIS------ESAKDFICHLLE 247
Query: 531 KDPKARPTV 539
KDP R T
Sbjct: 248 KDPNERYTC 256
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 4e-23
Identities = 80/409 (19%), Positives = 151/409 (36%), Gaps = 58/409 (14%)
Query: 143 LSEDILATRKKYPFLVSSTSSLDKENVVPDNEKFKGPTQTKSVFSVRSASDQSLSQKKNE 202
L + ATR + V+ + + V PD+++ F + D +
Sbjct: 66 LFREFCATRPELSRCVAFLDGVAEYEVTPDDKRKACGRNLTQNFLSHTGPDLIPEVPRQL 125
Query: 203 STPVFKRPLSVNSTKSSDPSVSKETIKPAKPQITTSNAKKSVETSQDVITLNGKQYQ--- 259
T +R + + +E + ++ + +++ L K +
Sbjct: 126 VTNCTQRL-----EQGPCKDLFQELTRLTHEYLSVAPFADYLDSIYFNRFLQWKWLERQP 180
Query: 260 -------VLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELL 312
+LGKGG V + + A K ++ I + LNE ++L
Sbjct: 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKM--YACKKLEKKRIKKRKGEAMALNEKQIL 238
Query: 313 AKLQGCPYVIKMHDYVYDTASKHLYVLME--KGDTDLSKYMRNLNKMTTLPNTMIIIIMH 370
K+ +V+ + Y Y+T L +++ G DL ++ ++ + +
Sbjct: 239 EKVN-SRFVVSLA-YAYETKD-ALCLVLTLMNGG-DLKFHIYHMGQAGFPEARAVF---- 290
Query: 371 WY--EMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDK 428
Y E+ ++++H I++ DLKP N L +D G++ +I D G+A + + +
Sbjct: 291 -YAAEICCGLEDLHRERIVYRDLKPENIL--------LDDHGHI-RISDLGLAVHVPEGQ 340
Query: 429 TSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTP-YSH 487
T GT+ YM+PE Y T+ D W+LGC+LY MI G++P
Sbjct: 341 TI---KGRVGTVGYMAPEVVK-------NERY--TFSPDWWALGCLLYEMIAGQSPFQQR 388
Query: 488 IPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKAR 536
+ + + E+ + P L KDP R
Sbjct: 389 KKKIKREEVERLVKEVPEEYSERF------SPQARSLCSQLLCKDPAER 431
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 9e-23
Identities = 76/305 (24%), Positives = 125/305 (40%), Gaps = 65/305 (21%)
Query: 257 QYQVLSLLGKGGSSSVYLVGGTSEHEF--KPLALKVVDLSDITDQSIADSYLNEVELLAK 314
Y + LG+G V L + H + +ALK + + + E+ L K
Sbjct: 10 PYIIRETLGEGSFGKVKL----ATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYL-K 64
Query: 315 LQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEM 374
L P++IK++D V T + +++E +L Y+ +MT + ++
Sbjct: 65 LLRHPHIIKLYD-VITT-PTDIVMVIEYAGGELFDYIVEKKRMTE-----DEGRRFFQQI 117
Query: 375 LLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKD 434
+ A++ H I+H DLKP N L +D NV KI DFG++ + D
Sbjct: 118 ICAIEYCHRHKIVHRDLKPENLL--------LDDNLNV-KIADFGLSNIMTDGN---FLK 165
Query: 435 TASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY--SHIPNTW 492
T+ G+ NY +PE G Y + DVWS G +LY M+ GR P+ IPN +
Sbjct: 166 TSCGSPNYAAPEVIN-------GKLYAGP-EVDVWSCGIVLYVMLVGRLPFDDEFIPNLF 217
Query: 493 AKMLAIARHKDQIEFKPQLANNVTIPP-------TLLQSMKLCLQKDPKARPTVGNSVTQ 545
K+ + +P +L++ M + DP R T + +
Sbjct: 218 KKV---------------NSCVYVMPDFLSPGAQSLIRRM---IVADPMQRIT----IQE 255
Query: 546 INNNP 550
I +P
Sbjct: 256 IRRDP 260
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 47/312 (15%), Positives = 103/312 (33%), Gaps = 92/312 (29%)
Query: 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKL 315
++Y + LG+G V+ K K V + + E+ +L
Sbjct: 5 EKYMIAEDLGRGEFGIVHRC--VETSSKKTYMAKFVKVKGTDQVLV----KKEISILNIA 58
Query: 316 QGCPYVIKMHDYVYDTASKHLYVLME-------------KGDT----DLSKYMRNLNKMT 358
++ +H+ +++ + L ++ E ++ Y+
Sbjct: 59 -RHRNILHLHE-SFESM-EELVMIFEFISGLDIFERINTSAFELNEREIVSYVH------ 109
Query: 359 TLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDF 418
++ A++ +H+ I H D++P N ++ + +KII+F
Sbjct: 110 --------------QVCEALQFLHSHNIGHFDIRPENIIYQTRR-------SSTIKIIEF 148
Query: 419 GIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNM 478
G A L+ + Y +PE ++ +D+WSLG ++Y +
Sbjct: 149 GQARQLKPGD--NFRLLF-TAPEYYAPEVHQHDV---------VSTATDMWSLGTLVYVL 196
Query: 479 IYGRTPYSHIPNTWAK-----MLAIARHKDQIEFKPQLANNVT------IPPTLLQSMKL 527
+ G P+ A+ + I + F + ++ +
Sbjct: 197 LSGINPF------LAETNQQIIENIMNAE--YTFDEEAFKEISIEAMDFV--------DR 240
Query: 528 CLQKDPKARPTV 539
L K+ K+R T
Sbjct: 241 LLVKERKSRMTA 252
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 1e-22
Identities = 59/309 (19%), Positives = 119/309 (38%), Gaps = 78/309 (25%)
Query: 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVD---LSDITDQSIADSYLNEVELL 312
Y++ LG G + V + K A K + LS + EV +L
Sbjct: 5 DHYEMGEELGSGQFAIVRKC--RQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNIL 62
Query: 313 AKLQGCPYVIKMHDYVYDTASKHLYVLME-------------KG---DTDLSKYMRNLNK 356
+++ P +I +HD +++ + +++E K + + +++++ +
Sbjct: 63 REIRH-PNIITLHD-IFEN-KTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI-- 117
Query: 357 MTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKII 416
L V +H+ I H DLKP N + + + +K+I
Sbjct: 118 ------------------LDGVHYLHSKRIAHFDLKPENIMLLDK-----NVPNPRIKLI 154
Query: 417 DFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILY 476
DFGIA ++ K+ GT +++PE + ++D+WS+G I Y
Sbjct: 155 DFGIAHKIEAGN--EFKNIF-GTPEFVAPEIVNYEP---------LGLEADMWSIGVITY 202
Query: 477 NMIYGRTPYSHIPNTWAK-----MLAIARHKDQIEFKPQLANNVTIPP-TLLQSMKLCLQ 530
++ G +P+ + + I+ +F + +N + ++ + L
Sbjct: 203 ILLSGASPF------LGETKQETLTNIS--AVNYDFDEEYFSNTSELAKDFIRRL---LV 251
Query: 531 KDPKARPTV 539
KDPK R T+
Sbjct: 252 KDPKRRMTI 260
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 1e-22
Identities = 73/355 (20%), Positives = 127/355 (35%), Gaps = 87/355 (24%)
Query: 214 NSTKSSDPSVSKETIKPAKPQITTSNAKKSVETSQDVITLNGKQ-------YQVLSLLGK 266
+ SS + E + T++A + ++G ++V S LG+
Sbjct: 4 HHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGR 63
Query: 267 GGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHD 326
G +S VY + KP ALKV + E+ +L +L P +IK+ +
Sbjct: 64 GATSIVYRC--KQKGTQKPYALKV-----LKKTVDKKIVRTEIGVLLRLS-HPNIIKLKE 115
Query: 327 YVYDTASKHLYVLME-------------KG---DTDLSKYMRNLNKMTTLPNTMIIIIMH 370
+++T + +++E KG + D + ++
Sbjct: 116 -IFET-PTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQ----------------- 156
Query: 371 WYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTS 430
+L AV +H GI+H DLKP N L+ LKI DFG++ ++
Sbjct: 157 ---ILEAVAYLHENGIVHRDLKPENLLYATP------APDAPLKIADFGLSKIVEHQV-- 205
Query: 431 VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN 490
+ K GT Y +PE + Y + D+WS+G I Y ++ G P+
Sbjct: 206 LMKTVC-GTPGYCAPEILRGCA-------Y--GPEVDMWSVGIITYILLCGFEPFYDERG 255
Query: 491 TWAKMLAIARHKDQIEFKPQLANNVT------IPPTLLQSMKLCLQKDPKARPTV 539
I + F + V+ + + + DPK R T
Sbjct: 256 DQFMFRRI--LNCEYYFISPWWDEVSLNAKDLV--------RKLIVLDPKKRLTT 300
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-22
Identities = 54/309 (17%), Positives = 109/309 (35%), Gaps = 78/309 (25%)
Query: 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVD---LSDITDQSIADSYLNEVELL 312
Y + LG G + V + A K + + EV +L
Sbjct: 12 DFYDIGEELGSGQFAIVKKC--REKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSIL 69
Query: 313 AKLQGCPYVIKMHDYVYDTASKHLYVLME-------------KG---DTDLSKYMRNLNK 356
++ P +I +HD VY+ + +++E K + + + +++ +
Sbjct: 70 RQVL-HPNIITLHD-VYEN-RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI-- 124
Query: 357 MTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKII 416
L V +H I H DLKP N + + + +K+I
Sbjct: 125 ------------------LDGVNYLHTKKIAHFDLKPENIMLLDK-----NIPIPHIKLI 161
Query: 417 DFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILY 476
DFG+A ++D K+ GT +++PE + ++D+WS+G I Y
Sbjct: 162 DFGLAHEIEDGV--EFKNIF-GTPEFVAPEIVNYEP---------LGLEADMWSIGVITY 209
Query: 477 NMIYGRTPYSHIPNTWAK-----MLAIARHKDQIEFKPQLANNVTIPP-TLLQSMKLCLQ 530
++ G +P+ + I +F + + + ++ + L
Sbjct: 210 ILLSGASPF------LGDTKQETLANITAVS--YDFDEEFFSQTSELAKDFIRKL---LV 258
Query: 531 KDPKARPTV 539
K+ + R T+
Sbjct: 259 KETRKRLTI 267
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 2e-22
Identities = 53/246 (21%), Positives = 99/246 (40%), Gaps = 41/246 (16%)
Query: 252 TLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVV-DLSDITDQSIADSYLNEVE 310
+Y ++ LG G S+V+L + +A+K+V T+ + +E++
Sbjct: 15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTH--VAMKIVRGDKVYTEAA-----EDEIK 67
Query: 311 LLAKL----------QGCPYVIKMHD--YVYDTASKHLYVLMEKGDTDLSKYMRNLNKMT 358
LL ++ G +++K+ D H+ ++ E +L ++ +
Sbjct: 68 LLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKK-YEHR 126
Query: 359 TLPNTMIIIIMHWYEMLLAVKEIHA-AGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIID 417
+P + I ++LL + +H GIIH+D+KP N L +KI D
Sbjct: 127 GIPLIYVKQIS--KQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL---IQIKIAD 181
Query: 418 FGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYN 477
G AC + T+ + T Y SPE G + +D+WS C+++
Sbjct: 182 LGNACWYDEHYTNSIQ-----TREYRSPEVLL-------GAPW--GCGADIWSTACLIFE 227
Query: 478 MIYGRT 483
+I G
Sbjct: 228 LITGDF 233
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 2e-22
Identities = 66/359 (18%), Positives = 126/359 (35%), Gaps = 100/359 (27%)
Query: 218 SSDPSVSKETIKPAKPQITTSNAKKSVETS------QDVITLNG---KQYQVLSLLGKGG 268
S ++ ++ K E Q V G Y +L LG G
Sbjct: 4 SHHHHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGA 63
Query: 269 SSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYV 328
V+ + + K ++ D+ + NE+ ++ +L P +I +HD
Sbjct: 64 FGVVHRC--VEKATGRVFVAKFINTPYPLDK---YTVKNEISIMNQLHH-PKLINLHD-A 116
Query: 329 YDTASKHLYVLME-------------KGDT----DLSKYMRNLNKMTTLPNTMIIIIMHW 371
++ + +++E + ++ YMR
Sbjct: 117 FED-KYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMR------------------- 156
Query: 372 YEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSV 431
+ +K +H I+H D+KP N + + +KIIDFG+A L D+ +
Sbjct: 157 -QACEGLKHMHEHSIVHLDIKPENIMCETKK-------ASSVKIIDFGLATKLNPDE--I 206
Query: 432 HKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNT 491
K T T + +PE + + + +D+W++G + Y ++ G +P+
Sbjct: 207 VKVTT-ATAEFAAPEIVDREP---------VGFYTDMWAIGVLGYVLLSGLSPF------ 250
Query: 492 WAK-----MLAIARHKDQIEFKPQLANNVT------IPPTLLQSMKLCLQKDPKARPTV 539
+ + + R EF ++V+ I K LQK+P+ R TV
Sbjct: 251 AGEDDLETLQNVKRCD--WEFDEDAFSSVSPEAKDFI--------KNLLQKEPRKRLTV 299
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 3e-22
Identities = 75/309 (24%), Positives = 121/309 (39%), Gaps = 72/309 (23%)
Query: 257 QYQVLSLLGKGGSSSVYLVGGTSEHEF--KPLALKVVDLSDITDQSIADSYLNEVELLAK 314
Y + LG G V + EH+ +A+K+++ I + E++ L K
Sbjct: 12 HYVLGDTLGVGTFGKVKI----GEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNL-K 66
Query: 315 LQGCPYVIKMHDYVYDTASKHLYVLME--KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWY 372
L P++IK++ V T +++ME G +L Y+ ++ +
Sbjct: 67 LFRHPHIIKLYQ-VIST-PTDFFMVMEYVSGG-ELFDYICKHGRVE-------EMEARRL 116
Query: 373 --EMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTS 430
++L AV H ++H DLKP N L +D N KI DFG++ + D +
Sbjct: 117 FQQILSAVDYCHRHMVVHRDLKPENVL--------LDAHMN-AKIADFGLSNMMSDGE-- 165
Query: 431 VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY--SHI 488
T+ G+ NY +PE +G + D+WS G ILY ++ G P+ H+
Sbjct: 166 -FLRTSCGSPNYAAPEVISGRLYAG--------PEVDIWSCGVILYALLCGTLPFDDEHV 216
Query: 489 PNTWAKMLAIARHKDQIEFKPQLANNVTIPP-------TLLQSMKLCLQKDPKARPTVGN 541
P + K+ IP TLL M LQ DP R T
Sbjct: 217 PTLFKKI---------------RGGVFYIPEYLNRSVATLLMHM---LQVDPLKRAT--- 255
Query: 542 SVTQINNNP 550
+ I +
Sbjct: 256 -IKDIREHE 263
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 8e-22
Identities = 73/417 (17%), Positives = 151/417 (36%), Gaps = 73/417 (17%)
Query: 142 QLSEDILATRKKYPFLVSSTSSLDKENVVPDNEKFKGPTQTKSVFSVRSASDQSLSQKKN 201
+L + L T +++ + ++ + D + + ++ L +
Sbjct: 70 RLFQQFLRTHEQHGPALQLWKDIEDYDTADDALRPQ---------KAQALRAAYLEPQAQ 120
Query: 202 ESTPVFKRPLSVNSTKSSDPSVSKETIKPAKPQITTSNAKKSVETSQDVITLNGKQYQ-- 259
+ + + + ++ + + ++ +++ + L K +
Sbjct: 121 LFCSFLDAETVARARAGAGDGLFQPLLRAVLAHLGQAPFQEFLDSLYFLRFLQWKWLEAQ 180
Query: 260 --------VLSLLGKGGSSSVYLVG--GTSEHEFKPLALKVVDLSDITDQSIADSYLNEV 309
+LG+GG V+ T + A K ++ + + + E
Sbjct: 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKL----YACKKLNKKRLKKRKGYQGAMVEK 236
Query: 310 ELLAKLQGCPYVIKMHDYVYDTASKHLYVLME---KGDTDLSKYMRNLNKMTTLPNTMII 366
++LAK+ +++ + Y ++T + L ++M GD ++ +
Sbjct: 237 KILAKVH-SRFIVSLA-YAFETKT-DLCLVMTIMNGGD-----IRYHIYNVDEDNPGFQE 288
Query: 367 IIMHWY--EMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSL 424
+Y +++ ++ +H II+ DLKP N L +D GNV +I D G+A L
Sbjct: 289 PRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVL--------LDDDGNV-RISDLGLAVEL 339
Query: 425 QDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTP 484
+ +T +GT +M+PE G Y + D ++LG LY MI R P
Sbjct: 340 KAGQTKTK--GYAGTPGFMAPELLL-------GEEY--DFSVDYFALGVTLYEMIAARGP 388
Query: 485 -YSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMK-LC---LQKDPKAR 536
+ ++ + L VT P + K C LQKDP+ R
Sbjct: 389 FRARGEKV---------ENKEL-KQRVLEQAVTYPDKFSPASKDFCEALLQKDPEKR 435
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 1e-21
Identities = 78/368 (21%), Positives = 132/368 (35%), Gaps = 77/368 (20%)
Query: 209 RPLSVNSTKSSDPSVSKETIKPAKPQITTSNAKKSVETSQDVITLNGKQ---YQVLSLLG 265
RP + + +S P K +K + + + Q Y ++G
Sbjct: 4 RPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIG 63
Query: 266 KGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMH 325
G VY E +A+K V L D E++++ KL ++++
Sbjct: 64 NGSFGVVYQAKLCDSGE--LVAIKKV-LQD------KRFKNRELQIMRKLD-HCNIVRLR 113
Query: 326 DYVYDTASK----HLYVLMEKGDTDLSKYMRNLNKMT-TLPNTMIIIIMHWYEMLLAVKE 380
+ Y + K +L ++++ + + R+ ++ TLP + + M Y++ ++
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM--YQLFRSLAY 171
Query: 381 IHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTL 440
IH+ GI H D+KP N L +D VLK+ DFG A L + +V +
Sbjct: 172 IHSFGICHRDIKPQNLL--------LDPDTAVLKLCDFGSAKQLVRGEPNVSYIC---SR 220
Query: 441 NYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGR------------------ 482
Y +PE G Y T DVWS GC+L ++ G+
Sbjct: 221 YYRAPELI------FGATDY--TSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 272
Query: 483 --TPYSHIPNTWAKMLA---------IARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQK 531
TP +M I H F+P+ PP + L+
Sbjct: 273 LGTP---TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRT------PPEAIALCSRLLEY 323
Query: 532 DPKARPTV 539
P AR T
Sbjct: 324 TPTARLTP 331
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 3e-21
Identities = 77/333 (23%), Positives = 135/333 (40%), Gaps = 69/333 (20%)
Query: 215 STKSSDPSVSKETIKPAKPQITTSNAKKSVETSQDVITLNGKQYQVLSLLGKGGSSSVYL 274
+ K S+ KE + AK KK SQ+ L+ Q+ + LG G V L
Sbjct: 6 AKKGSEQESVKEFLAKAKEDFL----KKWETPSQNTAQLD--QFDRIKTLGTGSFGRVML 59
Query: 275 VGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334
V + A+K++D + + LNE +L + P+++K+ + + S
Sbjct: 60 V--KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLE-FSFKDNSN 115
Query: 335 HLYVLMEKGDTDLSKYMR------NLNKMTTLPNTMIIIIMHWY--EMLLAVKEIHAAGI 386
LY++ME Y+ +L ++ +Y +++L + +H+ +
Sbjct: 116 -LYMVME--------YVAGGEMFSHLRRIGRFSEPH----ARFYAAQIVLTFEYLHSLDL 162
Query: 387 IHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPE 446
I+ DLKP N L ID G + ++ DFG +T T GT ++PE
Sbjct: 163 IYRDLKPENLL--------IDQQGYI-QVTDFGF-AKRVKGRTW----TLCGTPEALAPE 208
Query: 447 AAGQTSSSGGGNTYRITYKS-DVWSLGCILYNMIYGRTP-YSHIPN-TWAKMLAIARHKD 503
S G K+ D W+LG ++Y M G P ++ P + K++
Sbjct: 209 I---ILSKGYN-------KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV-----SG 253
Query: 504 QIEFKPQLANNVTIPPTLLQSMKLCLQKDPKAR 536
++ F ++++ LL+ L LQ D R
Sbjct: 254 KVRFPSHFSSDLK---DLLR--NL-LQVDLTKR 280
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 3e-21
Identities = 68/324 (20%), Positives = 121/324 (37%), Gaps = 100/324 (30%)
Query: 239 NAKKSVETSQDVITLNGKQYQVLS-LLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDIT 297
+ K ++ ++ I Y+V S +LG G + V + ++ + ALK++ D
Sbjct: 3 HVKSGLQIKKNAII---DDYKVTSQVLGLGINGKVLQI--FNKRTQEKFALKMLQ--DCP 55
Query: 298 DQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTAS---KHLYVLME------------- 341
EVEL + CP+++++ D VY+ K L ++ME
Sbjct: 56 KAR------REVELHWRASQCPHIVRIVD-VYENLYAGRKCLLIVMECLDGGELFSRIQD 108
Query: 342 KGDT-----DLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANF 396
+GD + S+ M++ + A++ +H+ I H D+KP N
Sbjct: 109 RGDQAFTEREASEIMKS--------------------IGEAIQYLHSINIAHRDVKPENL 148
Query: 397 LFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGG 456
L+ +LK+ DFG A E G+
Sbjct: 149 LYTSK------RPNAILKLTDFGFA-----------------------KETTGE------ 173
Query: 457 GNTYRITYKSDVWSLGCILYNMIYGRTP-YSHIPNTWAKMLAIARHKDQIEFKPQLANNV 515
Y D+WSLG I+Y ++ G P YS+ + + Q EF + V
Sbjct: 174 --KY--DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 229
Query: 516 TIPP-TLLQSMKLCLQKDPKARPT 538
+ L++++ L+ +P R T
Sbjct: 230 SEEVKMLIRNL---LKTEPTQRMT 250
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 6e-21
Identities = 69/287 (24%), Positives = 114/287 (39%), Gaps = 42/287 (14%)
Query: 215 STKSSDPSVSKETIKPAKPQITTSNAKKSVETSQDVITLNGKQYQVLSLLGKGGSSSVYL 274
+ +VS + + + S+ + +Y++ L+G G V
Sbjct: 12 HNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCE 71
Query: 275 VGGTSEHEFKPLALKVVDL--SDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA 332
E +A+K + D+ D L E+ +L +L +V+K+ D V
Sbjct: 72 AYDKLEKR--VVAIKKILRVFEDLIDCKRI---LREIAILNRLN-HDHVVKVLDIVIPKD 125
Query: 333 S---KHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHS 389
LYV++E D+D K R L I ++ Y +L+ VK +H+AGI+H
Sbjct: 126 VEKFDELYVVLEIADSDFKKLFR---TPVYLTELHIKTLL--YNLLVGVKYVHSAGILHR 180
Query: 390 DLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAG 449
DLKPAN L N DC +K+ DFG+A ++ + + S + M+
Sbjct: 181 DLKPANCLV--NQ----DC---SVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFP 231
Query: 450 QTSSSGGGNT-------YR---I-------TYKSDVWSLGCILYNMI 479
T + T YR + T DVWS+GCI ++
Sbjct: 232 HTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 9e-21
Identities = 67/388 (17%), Positives = 142/388 (36%), Gaps = 80/388 (20%)
Query: 170 VPDNEKFKGPTQTKSVFSVRSASDQSLSQKKNESTPVFKRPLSVNSTKSSDPSVSKETIK 229
V + K+ S S + +++ + + + V S ++S +V
Sbjct: 12 VDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADL-TERMPVKSKRTSALAVDIPAPP 70
Query: 230 PAKPQITTSNAKKSVETSQDVITLNGKQYQVLSL--LGKGGSSSVYLVGGTSEHEFKPLA 287
+ + +V Y V LG G V+ T+ LA
Sbjct: 71 APFDHRIVTAKQGAVN----------SFYTVSKTEILGGGRFGQVHKCEETATG--LKLA 118
Query: 288 LKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDL 347
K++ + D+ + NE+ ++ +L +I+++D +++ + ++ME
Sbjct: 119 AKIIKTRGMKDK---EEVKNEISVMNQLDH-ANLIQLYD-AFES-KNDIVLVME------ 166
Query: 348 SKYM-------RNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVG 400
Y+ R +++ L I+ M ++ ++ +H I+H DLKP N L V
Sbjct: 167 --YVDGGELFDRIIDESYNLTELDTILFMK--QICEGIRHMHQMYILHLDLKPENILCVN 222
Query: 401 NVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTY 460
+KIIDFG+A + + K GT +++PE
Sbjct: 223 RD-------AKQIKIIDFGLARRYKPRE--KLKVNF-GTPEFLAPEVVNYDF-------- 264
Query: 461 RITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK-----MLAIARHKDQIEFKPQLANNV 515
+++ +D+WS+G I Y ++ G +P+ + I + + + + ++
Sbjct: 265 -VSFPTDMWSVGVIAYMLLSGLSPF------LGDNDAETLNNILACR--WDLEDEEFQDI 315
Query: 516 TIPPTLLQSMK----LCLQKDPKARPTV 539
+ + K L K+ R +
Sbjct: 316 S------EEAKEFISKLLIKEKSWRISA 337
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 1e-20
Identities = 63/307 (20%), Positives = 111/307 (36%), Gaps = 64/307 (20%)
Query: 257 QYQVLSLLGKGGSSSVYLVGGTSEHEF--KPLALKVVDLSDITDQSIADSYLNEVELLAK 314
+ ++ LG+G V L + + +A+K+VD+ D ++ E+ + K
Sbjct: 8 DWDLVQTLGEGAYGEVQLA----VNRVTEEAVAVKIVDMKRAVD--CPENIKKEICIN-K 60
Query: 315 LQGCPYVIKMHDYVYDTASKHLYVLME--KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWY 372
+ V+K + Y+ +E G +L + M
Sbjct: 61 MLNHENVVKFYG-HRRE-GNIQYLFLEYCSGG-ELFDRIEPDIGMP-------------- 103
Query: 373 E---------MLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACS 423
E ++ V +H GI H D+KP N L +D N LKI DFG+A
Sbjct: 104 EPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLL--------LDERDN-LKISDFGLATV 154
Query: 424 LQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRT 483
+ + + GTL Y++PE + DVWS G +L M+ G
Sbjct: 155 FRYNNRERLLNKMCGTLPYVAPELL-------KRREFH-AEPVDVWSCGIVLTAMLAGEL 206
Query: 484 PYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSV 543
P+ ++ + K + ++ + LL + L ++P AR T +
Sbjct: 207 PWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL---ALLHKI---LVENPSARIT----I 256
Query: 544 TQINNNP 550
I +
Sbjct: 257 PDIKKDR 263
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 4e-20
Identities = 66/286 (23%), Positives = 103/286 (36%), Gaps = 67/286 (23%)
Query: 287 ALKVV--DLSDITDQSIADSYLNEVELLAKLQGC--PYVIKMHDYVYDTASKH---LYVL 339
ALK V + S + EV LL +L+ P V+++ D + + + ++
Sbjct: 38 ALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLV 97
Query: 340 MEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFV 399
E D DL Y+ LP I +M + L + +HA I+H DLKP N L
Sbjct: 98 FEHVDQDLRTYLDKAPP-PGLPAETIKDLM--RQFLRGLDFLHANCIVHRDLKPENIL-- 152
Query: 400 GNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEA-AGQTSSSGGGN 458
+ G +K+ DFG+A TL Y +PE T ++
Sbjct: 153 ------VTSGGT-VKLADFGLARIYSYQMALTPVVV---TLWYRAPEVLLQSTYATP--- 199
Query: 459 TYRITYKSDVWSLGCILYNMIYGRTPY----------SHI------PN--TWAKMLAIAR 500
D+WS+GCI M + P I P W + +++ R
Sbjct: 200 -------VDMWSVGCIFAEMFRRK-PLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPR 251
Query: 501 HKDQIEFKPQLANNV-----TIPPT---LLQSMKLCLQKDPKARPT 538
F P+ V + + LL M L +P R +
Sbjct: 252 GA----FPPRGPRPVQSVVPEMEESGAQLLLEM---LTFNPHKRIS 290
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 5e-20
Identities = 51/246 (20%), Positives = 104/246 (42%), Gaps = 43/246 (17%)
Query: 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDI-TDQSIADSYLNEVELLA 313
++Y+++ LGKG V+ E +A+K + D + + A E+ +L
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGE--VVAVK--KIFDAFQNSTDAQRTFREIMILT 63
Query: 314 KLQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYE 373
+L G ++ + + + + +Y++ + +TDL +R L ++ Y+
Sbjct: 64 ELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIR----ANILEPVHKQYVV--YQ 117
Query: 374 MLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHK 433
++ +K +H+ G++H D+KP N+L +C +K+ DFG++ S + + +
Sbjct: 118 LIKVIKYLHSGGLLHRDMKP------SNILLNAEC---HVKVADFGLSRSFVNIRRVTNN 168
Query: 434 DTASGTLNYMSPEAAGQT-----------------SSSGGGNTYRITYKSDVWSLGCILY 476
S N + + S+ Y T D+WSLGCIL
Sbjct: 169 IPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTK----Y--TKGIDMWSLGCILG 222
Query: 477 NMIYGR 482
++ G+
Sbjct: 223 EILCGK 228
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 7e-20
Identities = 55/332 (16%), Positives = 109/332 (32%), Gaps = 73/332 (21%)
Query: 243 SVETSQDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIA 302
V+ + + Q+L + +G V+ +E+ +A+K+ + D
Sbjct: 11 GVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEY----VAVKIFPIQD------K 60
Query: 303 DSYLNEVE--LLAKLQGCPYVIKMHDYV-----YDTASKHL-------YVLMEKGDTDLS 348
S+ NE E L ++ H+ + + + EKG LS
Sbjct: 61 QSWQNEYEVYSLPGMK--------HENILQFIGAEKRGTSVDVDLWLITAFHEKGS--LS 110
Query: 349 KYMRNLNKMTTLP-NTMIIIIM-------HWYEMLLAVKEIHAAGIIHSDLKPANFLFVG 400
+++ + N + I + +E + +K+ H I H D+K N L
Sbjct: 111 DFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVL--- 163
Query: 401 NVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTY 460
+ I DFG+A + K++ GT YM+PE
Sbjct: 164 -----LKNNLTA-CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVL----EGAINFQR 213
Query: 461 RITYKSDVWSLGCILYNMIYGRTPYSHIP--------------NTWAKMLAIARHKDQIE 506
+ D++++G +L+ + T + M + HK +
Sbjct: 214 DAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRP 273
Query: 507 FKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
L ++++ C D +AR +
Sbjct: 274 VLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 8e-20
Identities = 57/241 (23%), Positives = 93/241 (38%), Gaps = 42/241 (17%)
Query: 249 DVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVV-DLSDITDQSIADSYLN 307
D + +Y+VL ++GKG V H+ +ALK+V + Q+
Sbjct: 93 DHV---AYRYEVLKVIGKGSFGQVVKAYDHKVHQH--VALKMVRNEKRFHRQA-----AE 142
Query: 308 EVELLAKLQ-----GCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPN 362
E+ +L L+ VI M + H+ + E +L + ++ NK
Sbjct: 143 EIRILEHLRKQDKDNTMNVIHMLENFTF--RNHICMTFELLSMNLYELIKK-NKFQGFSL 199
Query: 363 TMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIAC 422
++ H +L + +H IIH DLKP N L + +K+IDFG +C
Sbjct: 200 PLVRKFAH--SILQCLDALHKNRIIHCDLKPENILLK-------QQGRSGIKVIDFGSSC 250
Query: 423 SLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGR 482
+ + + Y +PE G Y D+WSLGCIL ++ G
Sbjct: 251 YEHQRVYTYIQ-----SRFYRAPEVI-------LGARY--GMPIDMWSLGCILAELLTGY 296
Query: 483 T 483
Sbjct: 297 P 297
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 90.7 bits (225), Expect = 9e-20
Identities = 69/378 (18%), Positives = 120/378 (31%), Gaps = 113/378 (29%)
Query: 252 TLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVEL 311
NG+ Y V+ LG G S+V+L +F +A+KVV + + ++ L+E+ L
Sbjct: 34 LFNGR-YHVIRKLGWGHFSTVWLSWDIQGKKF--VAMKVV----KSAEHYTETALDEIRL 86
Query: 312 LAKLQ-------GCPYVIKMHDYVYDTAS--KHLYVLMEKGDTDLSKYMRNLNKMTTLPN 362
L ++ V+++ D + H+ ++ E L K++ + LP
Sbjct: 87 LKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIK-SNYQGLPL 145
Query: 363 TMIIIIMHWYEMLLAVKEIHA-AGIIHSDLKPANFLFVGNVLKIIDCIGNV--------- 412
+ I+ +L + +H IIH+D+KP N L N I
Sbjct: 146 PCVKKIIQQ--VLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAP 203
Query: 413 -------------------------------LKIIDFGIACSLQDDKTSVHKDTASGTLN 441
+KI D G AC + T + T
Sbjct: 204 PPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ-----TRQ 258
Query: 442 YMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYS-HIPNTW-------A 493
Y S E + +D+WS C+ + + G + H + A
Sbjct: 259 YRSLEVLIGSG---------YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIA 309
Query: 494 KMLAI---------ARHKDQIEF---KPQLANNVTIPPTLLQS----------------- 524
++ + K EF K L + + P L
Sbjct: 310 LIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFT 369
Query: 525 --MKLCLQKDPKARPTVG 540
+ L+ P+ R T
Sbjct: 370 DFLLPMLELIPEKRATAA 387
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 72/343 (20%), Positives = 144/343 (41%), Gaps = 58/343 (16%)
Query: 209 RPLSVNSTKSSDPSVSKETIKPAKPQITTSNAKKSVETSQDVITLNGKQYQVLSLLGKGG 268
+S ++ S + ++ + + + +++L +LG G
Sbjct: 9 EEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIE--NFELLKVLGTGA 66
Query: 269 SSSVYLVGGTSEHEFKPL-ALKVVDLSDI-TDQSIADSYLNEVELLAKLQGCPYVIKMHD 326
V+LV S H+ L A+KV+ + I + E ++L ++ P+++ +H
Sbjct: 67 YGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLH- 125
Query: 327 YVYDTASKHLYVLME--KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWY--EMLLAVKEIH 382
Y + T +K L+++++ G +L +L++ + I Y E++LA++ +H
Sbjct: 126 YAFQTETK-LHLILDYINGG-EL---FTHLSQRERFTEHEVQI----YVGEIVLALEHLH 176
Query: 383 AAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIA---CSLQDDKTSVHKDTASGT 439
GII+ D+K N L +D G+V + DFG++ + + ++ GT
Sbjct: 177 KLGIIYRDIKLENIL--------LDSNGHV-VLTDFGLSKEFVADETERAY----DFCGT 223
Query: 440 LNYMSPEAAGQTSSSGGGNTYRITYKS-DVWSLGCILYNMIYGRTPYSHIPNTWAKMLAI 498
+ YM+P+ + SG K+ D WSLG ++Y ++ G +P++
Sbjct: 224 IEYMAPDIV-RGGDSGHD-------KAVDWWSLGVLMYELLTGASPFT----------VD 265
Query: 499 ARHKDQIE-FKPQLANNVTIPPTLLQS----MKLCLQKDPKAR 536
Q E + L + P + ++ L KDPK R
Sbjct: 266 GEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKR 308
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 2e-19
Identities = 73/308 (23%), Positives = 122/308 (39%), Gaps = 70/308 (22%)
Query: 257 QYQVLSLLGKGGSSSVYLVGGTSEHEF--KPLALKVVDLSDITDQSIADSYLNEVELLAK 314
Y + LG G V + +HE +A+K+++ I + E++ L K
Sbjct: 17 HYILGDTLGVGTFGKVKV----GKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNL-K 71
Query: 315 LQGCPYVIKMHDYVYDTASKHLYVLME---KGDTDLSKYMRNLNKMTTLPNTMIIIIMHW 371
L P++IK++ V T ++++ME G+ L Y+ ++ + +
Sbjct: 72 LFRHPHIIKLYQ-VIST-PSDIFMVMEYVSGGE--LFDYICKNGRLDEKESRRLF----- 122
Query: 372 YEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSV 431
++L V H ++H DLKP N L +D N KI DFG++ + D +
Sbjct: 123 QQILSGVDYCHRHMVVHRDLKPENVL--------LDAHMNA-KIADFGLSNMMSDGE--- 170
Query: 432 HKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY--SHIP 489
T+ G+ NY +PE G Y + D+WS G ILY ++ G P+ H+P
Sbjct: 171 FLRTSCGSPNYAAPEVIS-------GRLYAGP-EVDIWSSGVILYALLCGTLPFDDDHVP 222
Query: 490 NTWAKMLAIARHKDQIEFKPQLANNVTIPP-------TLLQSMKLCLQKDPKARPTVGNS 542
+ K+ P +LL+ M LQ DP R T
Sbjct: 223 TLFKKI---------------CDGIFYTPQYLNPSVISLLKHM---LQVDPMKRAT---- 260
Query: 543 VTQINNNP 550
+ I +
Sbjct: 261 IKDIREHE 268
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 67/317 (21%), Positives = 115/317 (36%), Gaps = 84/317 (26%)
Query: 257 QYQVLSLLGKGGSSSVYLVGGTSEHEF--KPLALKVVDLSDITDQSIADSYLNEVELLAK 314
+Y + +G G L+ + + +A+K ++ D+++ E+ +
Sbjct: 21 RYDFVKDIGSGNFGVARLM----RDKLTKELVAVKYIERGAAIDENVQ----REIINH-R 71
Query: 315 LQGCPYVIKMHDYVYDTASKHLYVLME--KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWY 372
P +++ + V T HL ++ME G +L + + N + +
Sbjct: 72 SLRHPNIVRFKE-VILT-PTHLAIIMEYASGG-ELYERICNAGRFS-------------- 114
Query: 373 E---------MLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACS 423
E +L V H+ I H DLK N L G+ LKI DFG + S
Sbjct: 115 EDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPA------PR-LKICDFGYSKS 167
Query: 424 LQDD---KTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY 480
K++V GT Y++PE + G +DVWS G LY M+
Sbjct: 168 SVLHSQPKSTV------GTPAYIAPEVLLRQEYDGK--------IADVWSCGVTLYVMLV 213
Query: 481 GRTPY--SHIPNTWAKMLA-IARHK----DQIEFKPQLANNVTIPPTLLQSMKLCLQKDP 533
G P+ P + K + I K D I P+ + L+ + DP
Sbjct: 214 GAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCH-------LISRI---FVADP 263
Query: 534 KARPTVGNSVTQINNNP 550
R + + +I +
Sbjct: 264 ATRIS----IPEIKTHS 276
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 2e-19
Identities = 76/307 (24%), Positives = 129/307 (42%), Gaps = 64/307 (20%)
Query: 247 SQDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYL 306
+ D + L + +L ++G+G + V LV A+KVV + D D
Sbjct: 2 AMDPLGLQ--DFDLLRVIGRGSYAKVLLVRLKKTDRI--YAMKVVKKELVNDDEDIDWVQ 57
Query: 307 NEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLME--KGDTDLSKYMRNLNKMTTLPNTM 364
E + + P+++ +H + T S+ L+ ++E G DL M ++ + LP
Sbjct: 58 TEKHVFEQASNHPFLVGLH-SCFQTESR-LFFVIEYVNGG-DL---MFHMQRQRKLPEEH 111
Query: 365 IIIIMHWY--EMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIAC 422
Y E+ LA+ +H GII+ DLK N L +D G++ K+ D+G+ C
Sbjct: 112 ARF----YSAEISLALNYLHERGIIYRDLKLDNVL--------LDSEGHI-KLTDYGM-C 157
Query: 423 SL---QDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKS-----DVWSLGCI 474
D TS T GT NY++PE + + D W+LG +
Sbjct: 158 KEGLRPGDTTS----TFCGTPNYIAPEI--------------LRGEDYGFSVDWWALGVL 199
Query: 475 LYNMIYGRTPYSHIPNTWAKMLAIARHKDQIE-FKPQLANNVTIPPTLLQS----MKLCL 529
++ M+ GR+P+ + ++ + F+ L + IP +L +K L
Sbjct: 200 MFEMMAGRSPFDIVGSS-----DNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFL 254
Query: 530 QKDPKAR 536
KDPK R
Sbjct: 255 NKDPKER 261
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 64/336 (19%), Positives = 121/336 (36%), Gaps = 73/336 (21%)
Query: 216 TKSSDPSVSKETIKPAKPQITTSNAKKSVETSQDVITLNGKQYQVLSLLGKGGSSSVYLV 275
+ P K + + K + + + L + +G+G V+
Sbjct: 86 LSTQQPLTKKSGVVLHRAV-----PKDKWVLNHEDLVLGEQ-------IGRGNFGEVFS- 132
Query: 276 GGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335
G + +A+K + A +L E +L + P ++++ T +
Sbjct: 133 -GRLRADNTLVAVKSCR-ETLPPDLKAK-FLQEARILKQYS-HPNIVRLIGVC--TQKQP 186
Query: 336 LYV---LMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKE----IHAAGIIH 388
+Y+ L++ GD ++R + T++ +M+ + + IH
Sbjct: 187 IYIVMELVQGGD--FLTFLRTEGARLRVK-TLL-------QMVGDAAAGMEYLESKCCIH 236
Query: 389 SDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAA 448
DL N L V NVLKI DFG++ D + + + +PEA
Sbjct: 237 RDLAARNCL-VTE--------KNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEAL 287
Query: 449 GQTSSSGGGNTYRITYKSDVWSLGCILYNMI-YGRTPYSHIPNTWAKMLAIARHKDQIEF 507
N R + +SDVWS G +L+ G +PY ++ N + + +E
Sbjct: 288 ---------NYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTR--------EFVEK 330
Query: 508 -----KPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
P+L P + + M+ C +P RP+
Sbjct: 331 GGRLPCPELC-----PDAVFRLMEQCWAYEPGQRPS 361
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 63/311 (20%), Positives = 109/311 (35%), Gaps = 72/311 (23%)
Query: 257 QYQVLSLLGKGGSSSVYLVGGTSEHEF--KPLALKVVDLSDITDQSIADSYLNEVELLAK 314
+ ++ LG+G V L + + +A+K+VD+ D ++ E+ + K
Sbjct: 8 DWDLVQTLGEGAYGEVQLA----VNRVTEEAVAVKIVDMKRAVD--CPENIKKEICIN-K 60
Query: 315 LQGCPYVIKMHDYVYDTASKHLYVLME--KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWY 372
+ V+K + Y+ +E G +L + M
Sbjct: 61 MLNHENVVKFYG-HRRE-GNIQYLFLEYCSGG-ELFDRIEPDIGMP-------------- 103
Query: 373 E---------MLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACS 423
E ++ V +H GI H D+KP N L +D N LKI DFG+A
Sbjct: 104 EPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLL--------LDERDN-LKISDFGLATV 154
Query: 424 LQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRT 483
+ + + GTL Y++PE + DVWS G +L M+ G
Sbjct: 155 FRYNNRERLLNKMCGTLPYVAPELL-------KRREFH-AEPVDVWSCGIVLTAMLAGEL 206
Query: 484 PYSHIPNTWAKMLAIARHKDQI----EFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTV 539
P+ ++ + K + + LL + L ++P AR T
Sbjct: 207 PWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA-------LLHKI---LVENPSARIT- 255
Query: 540 GNSVTQINNNP 550
+ I +
Sbjct: 256 ---IPDIKKDR 263
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 3e-19
Identities = 58/262 (22%), Positives = 106/262 (40%), Gaps = 43/262 (16%)
Query: 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAK 314
G +Y++ +G G +YL GT + +A+K+ + Q E ++
Sbjct: 8 GNRYRLGRKIGSGSFGDIYL--GTDIAAGEEVAIKLECVKTKHPQ-----LHIESKIYKM 60
Query: 315 LQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEM 374
+QG + + + + ++ME L ++ +L +++ +M
Sbjct: 61 MQGGVGIPTIRWCGAE--GDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLAD----QM 114
Query: 375 LLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVH-- 432
+ ++ IH+ IH D+KP NFL +G + GN++ IIDFG+A +D +T H
Sbjct: 115 ISRIEYIHSKNFIHRDVKPDNFL-MG-----LGKKGNLVYIIDFGLAKKYRDARTHQHIP 168
Query: 433 -KDTAS--GTLNYMSPEA-AGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY---GRTPY 485
++ + GT Y S G S + D+ SLG Y ++Y G P+
Sbjct: 169 YRENKNLTGTARYASINTHLGIEQS----------RRDDLESLG---YVLMYFNLGSLPW 215
Query: 486 SHI--PNTWAKMLAIARHKDQI 505
+ K I+ K
Sbjct: 216 QGLKAATKRQKYERISEKKMST 237
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 3e-19
Identities = 67/325 (20%), Positives = 112/325 (34%), Gaps = 74/325 (22%)
Query: 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAK 314
G +Y L LG GG+ V+ + +A+K + L+D L E++++ +
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDK--RVAIKKIVLTDPQS---VKHALREIKIIRR 64
Query: 315 LQGCPYVIKMHD------------YVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPN 362
L ++K+ + T +Y++ E +TDL+ + L
Sbjct: 65 LDH-DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLE----QGPLLE 119
Query: 363 TMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIAC 422
+ M Y++L +K IH+A ++H DLKPAN + D VLKI DFG+A
Sbjct: 120 EHARLFM--YQLLRGLKYIHSANVLHRDLKPANLF-----INTEDL---VLKIGDFGLAR 169
Query: 423 SLQDDKTSVHKDTAS-GTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYG 481
+ + + T Y SP N Y T D+W+ GCI M+ G
Sbjct: 170 IMDPHYSHKGHLSEGLVTKWYRSPRLL------LSPNNY--TKAIDMWAAGCIFAEMLTG 221
Query: 482 R--------------------TP----YSHIPNTWAKMLAIARHKDQIEFKPQLANNVTI 517
+ + + + + L I
Sbjct: 222 KTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPG---I 278
Query: 518 PPT---LLQSMKLCLQKDPKARPTV 539
L+ + L P R T
Sbjct: 279 SREAVDFLEQI---LTFSPMDRLTA 300
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 5e-19
Identities = 75/349 (21%), Positives = 134/349 (38%), Gaps = 73/349 (20%)
Query: 219 SDPSVSKETIKPAKPQITTSNAKKSVETSQDVITLNGKQYQVLSLLGKGGSSSVYLVGGT 278
S P + P S +S + + L ++GKG V L
Sbjct: 3 SQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKPS--DFHFLKVIGKGSFGKVLLARHK 60
Query: 279 SEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYV 338
+E F A+KV+ I + ++E +L K P+++ +H + + TA K LY
Sbjct: 61 AEEVF--YAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH-FSFQTADK-LYF 116
Query: 339 LME--KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWY--EMLLAVKEIHAAGIIHSDLKPA 394
+++ G +L +L + Y E+ A+ +H+ I++ DLKP
Sbjct: 117 VLDYINGG-EL---FYHLQRERCFLEPRARF----YAAEIASALGYLHSLNIVYRDLKPE 168
Query: 395 NFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSV-HKDTAS---GTLNYMSPEAAGQ 450
N L +D G++ + DFG+ K ++ H T S GT Y++PE
Sbjct: 169 NIL--------LDSQGHI-VLTDFGLC------KENIEHNSTTSTFCGTPEYLAPEV--- 210
Query: 451 TSSSGGGNTYRITYKS-----DVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQI 505
+ + D W LG +LY M+YG P+ +R+ ++
Sbjct: 211 -----------LHKQPYDRTVDWWCLGAVLYEMLYGLPPFY------------SRNTAEM 247
Query: 506 EFKPQLANNVTIPPTLLQS----MKLCLQKDPKARPTVGNSVTQINNNP 550
+ L + + P + S ++ LQKD R + +I ++
Sbjct: 248 -YDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHV 295
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 5e-19
Identities = 74/336 (22%), Positives = 136/336 (40%), Gaps = 64/336 (19%)
Query: 218 SSDPSVSKETIKPAKPQITTSNAKKSVETSQDVITLNGKQYQVLSLLGKGGSSSVYLVGG 277
+++ + + + + + + + L + +L ++G+G + V LV
Sbjct: 16 TTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQ--DFDLLRVIGRGSYAKVLLVRL 73
Query: 278 TSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLY 337
A++VV + D D E + + P+++ +H + T S+ L+
Sbjct: 74 KKTDRI--YAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH-SCFQTESR-LF 129
Query: 338 VLME--KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWY--EMLLAVKEIHAAGIIHSDLKP 393
++E G DL M ++ + LP Y E+ LA+ +H GII+ DLK
Sbjct: 130 FVIEYVNGG-DL---MFHMQRQRKLPEEHARF----YSAEISLALNYLHERGIIYRDLKL 181
Query: 394 ANFLFVGNVLKIIDCIGNVLKIIDFGIACSL---QDDKTSVHKDTASGTLNYMSPEAAGQ 450
N L +D G++ K+ D+G+ C D TS T GT NY++PE
Sbjct: 182 DNVL--------LDSEGHI-KLTDYGM-CKEGLRPGDTTS----TFCGTPNYIAPEI--- 224
Query: 451 TSSSGGGNTYRITYKS-----DVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQI 505
+ + D W+LG +++ M+ GR+P+ + ++ +
Sbjct: 225 -----------LRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSS-----DNPDQNTED 268
Query: 506 E-FKPQLANNVTIPPTLLQS----MKLCLQKDPKAR 536
F+ L + IP +L +K L KDPK R
Sbjct: 269 YLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKER 304
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 5e-19
Identities = 75/288 (26%), Positives = 124/288 (43%), Gaps = 57/288 (19%)
Query: 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQ 316
+Q+L LG G V+L+ S H + A+KV+ + + +E +L+ +
Sbjct: 7 DFQILRTLGTGSFGRVHLI--RSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 64
Query: 317 GCPYVIKMHDYVYDTASKHLYVLMEK---GD--TDLSKYMRNLNKMTTLPNTMIIIIMHW 371
P++I+M + A + ++++M+ G+ + L K R N +
Sbjct: 65 -HPFIIRMW-GTFQDAQQ-IFMIMDYIEGGELFSLLRKSQRFPNPVAKF----------- 110
Query: 372 Y--EMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKT 429
Y E+ LA++ +H+ II+ DLKP N L +D G++ KI DFG D T
Sbjct: 111 YAAEVCLALEYLHSKDIIYRDLKPENIL--------LDKNGHI-KITDFGF-AKYVPDVT 160
Query: 430 SVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKS-DVWSLGCILYNMIYGRTPYSHI 488
T GT +Y++PE S+ KS D WS G ++Y M+ G TP+
Sbjct: 161 Y----TLCGTPDYIAPEV---VSTKPYN-------KSIDWWSFGILIYEMLAGYTPFYD- 205
Query: 489 PNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKAR 536
NT I + + F P +V LL +L + +D R
Sbjct: 206 SNTMKTYEKILNAE--LRFPPFFNEDVK---DLLS--RL-ITRDLSQR 245
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 5e-19
Identities = 66/306 (21%), Positives = 117/306 (38%), Gaps = 82/306 (26%)
Query: 259 QVLSLLGKGGSSSVY--LVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQ 316
++G G VY ++ +S + P+A+K L + +L E ++ +
Sbjct: 47 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKT--LKAGYTEKQRVDFLGEAGIMGQFS 104
Query: 317 GCPYVIKMHDYVYDTASKHLYV---LMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYE 373
+I++ + + K + + ME G L K++R + ++ +
Sbjct: 105 -HHNIIRLEGVI--SKYKPMMIITEYMENGA--LDKFLREKDGEFSVLQLV--------G 151
Query: 374 MLLAVKEIHAAG--------IIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQ 425
ML + AAG +H DL N L V + V K+ DFG++ L+
Sbjct: 152 MLRGI----AAGMKYLANMNYVHRDLAARNIL-VNS--------NLVCKVSDFGLSRVLE 198
Query: 426 DDKTSVHKDTASGT---LNYMSPEAAGQTSSSGGGNTYRI-TYKSDVWSLGCILYNMI-Y 480
DD + + T SG + + +PEA +YR T SDVWS G +++ ++ Y
Sbjct: 199 DDPEATY--TTSGGKIPIRWTAPEAI----------SYRKFTSASDVWSFGIVMWEVMTY 246
Query: 481 GRTPYSHIPNTWAKMLAIARHKDQIEF--------KPQLANNVTIPPTLLQSMKLCLQKD 532
G PY + N + ++ P P + Q M C Q++
Sbjct: 247 GERPYWELSN-----------HEVMKAINDGFRLPTPMDC-----PSAIYQLMMQCWQQE 290
Query: 533 PKARPT 538
RP
Sbjct: 291 RARRPK 296
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 86.4 bits (215), Expect = 5e-19
Identities = 54/200 (27%), Positives = 89/200 (44%), Gaps = 29/200 (14%)
Query: 287 ALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEKGDTD 346
ALK V L D D+ + S L E+ LL +L+ ++++HD ++ K L ++ E D D
Sbjct: 31 ALKRVRL-DDDDEGVPSSALREICLLKELK-HKNIVRLHDVLHS--DKKLTLVFEFCDQD 86
Query: 347 LSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKII 406
L KY + N L ++ + +++L + H+ ++H DLKP N L I
Sbjct: 87 LKKYFDSCN--GDLDPEIVKSFL--FQLLKGLGFCHSRNVLHRDLKPQNLL--------I 134
Query: 407 DCIGNVLKIIDFGIACSLQD-DKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYK 465
+ G LK+ +FG+A + + + TL Y P+ G Y +
Sbjct: 135 NRNGE-LKLANFGLARAFGIPVRCYSAEVV---TLWYRPPDVL------FGAKLY--STS 182
Query: 466 SDVWSLGCILYNMIYGRTPY 485
D+WS GCI + P
Sbjct: 183 IDMWSAGCIFAELANAGRPL 202
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 7e-19
Identities = 61/283 (21%), Positives = 106/283 (37%), Gaps = 64/283 (22%)
Query: 287 ALKVVDLSDITDQSIADSYLNEVELLAKLQGC--PYVIKMHDYVYDTASKH---LYVLME 341
ALK V + ++ + S + EV +L L+ P V+++ D + + L ++ E
Sbjct: 41 ALKRVRV-QTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFE 99
Query: 342 KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGN 401
D DL+ Y+ + + +P I +M +++L + +H+ ++H DLKP N L
Sbjct: 100 HVDQDLTTYLDKVPE-PGVPTETIKDMM--FQLLRGLDFLHSHRVVHRDLKPQNIL---- 152
Query: 402 VLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEA-AGQTSSSGGGNTY 460
+ G +K+ DFG+A TL Y +PE + ++
Sbjct: 153 ----VTSSGQ-IKLADFGLARIYSFQMALTSVVV---TLWYRAPEVLLQSSYATP----- 199
Query: 461 RITYKSDVWSLGCILYNMIYGR--------------------TPYSHIPNTWAKMLAIAR 500
D+WS+GCI M + P W + +A+ R
Sbjct: 200 -----VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG---EEDWPRDVALPR 251
Query: 501 HKDQIEFKPQ-LANNVT-IPPT---LLQSMKLCLQKDPKARPT 538
Q + VT I LL L +P R +
Sbjct: 252 QA-FHSKSAQPIEKFVTDIDELGKDLLLKC---LTFNPAKRIS 290
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 8e-19
Identities = 69/343 (20%), Positives = 124/343 (36%), Gaps = 75/343 (21%)
Query: 234 QITTSNAKKSVETSQDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDL 293
++ + A + E S+ + ++QV + G+G +V L S +A+K V
Sbjct: 5 MMSLNAAAAADERSRKEM----DRFQVERMAGQGTFGTVQLGKEKSTGM--SVAIKKV-- 56
Query: 294 SDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH-----LYVLMEKGDTDLS 348
I D + L ++ LA L P ++++ Y Y + L V+ME L
Sbjct: 57 --IQDPRFRNRELQIMQDLAVLHH-PNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLH 113
Query: 349 KYMRNLNKM-TTLPNTMIIIIMHWYEMLLAVKEIH--AAGIIHSDLKPANFLFVGNVLKI 405
+ RN + P +I + + ++++ ++ +H + + H D+KP N L
Sbjct: 114 RCCRNYYRRQVAPPPILIKVFL--FQLIRSIGCLHLPSVNVCHRDIKPHNVL-------- 163
Query: 406 IDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYK 465
++ LK+ DFG A L + +V + Y +PE G Y T
Sbjct: 164 VNEADGTLKLCDFGSAKKLSPSEPNVAYIC---SRYYRAPELI------FGNQHY--TTA 212
Query: 466 SDVWSLGCILYNMIYGR--------------------TPYSHIPNTWAKMLA-IARHKD- 503
D+WS+GCI M+ G P K+
Sbjct: 213 VDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPS---REVLRKLNPSHTDVDLY 269
Query: 504 QIEFKP---QLANNVTIPPT----LLQSMKLCLQKDPKARPTV 539
+ P +++ LL ++ LQ P+ R
Sbjct: 270 NSKGIPWSNVFSDHSLKDAKEAYDLLSAL---LQYLPEERMKP 309
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 9e-19
Identities = 76/311 (24%), Positives = 124/311 (39%), Gaps = 65/311 (20%)
Query: 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKL 315
+ Y L LG+G ++VY G S+ +ALK + L ++ + + EV LL L
Sbjct: 2 ETYIKLDKLGEGTYATVYK--GKSKLTDNLVALKEIRLEH--EEGAPCTAIREVSLLKDL 57
Query: 316 QGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEML 375
+ ++ +HD ++ K L ++ E D DL +Y+ + + + N + + +L
Sbjct: 58 K-HANIVTLHDIIHT--EKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQ----LL 110
Query: 376 LAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQD-DKTSVHKD 434
+ H ++H DLKP N L I+ G LK+ DFG+A + KT ++
Sbjct: 111 RGLAYCHRQKVLHRDLKPQNLL--------INERGE-LKLADFGLARAKSIPTKTYDNEV 161
Query: 435 TASGTLNYMSPEA-AGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY-------- 485
TL Y P+ G T S D+W +GCI Y M GR P
Sbjct: 162 V---TLWYRPPDILLGSTDYSTQ---------IDMWGVGCIFYEMATGR-PLFPGSTVEE 208
Query: 486 --SHI------PN--TWAKMLAIARHKDQIEFKPQLANNV-----TIPPT---LLQSMKL 527
I P TW +L+ K + A + + LL +
Sbjct: 209 QLHFIFRILGTPTEETWPGILSNEEFK-TYNYPKYRAEALLSHAPRLDSDGADLLTKL-- 265
Query: 528 CLQKDPKARPT 538
LQ + + R +
Sbjct: 266 -LQFEGRNRIS 275
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 1e-18
Identities = 50/199 (25%), Positives = 83/199 (41%), Gaps = 27/199 (13%)
Query: 290 VVDLSDI-----TDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEKGD 344
++ L D ++ ++ L V + +K+L V+ME
Sbjct: 62 IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121
Query: 345 TDLSKYMRNLNKM-TTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVL 403
L K +++ + ++P +I I + Y++ AV IH+ GI H D+KP N L
Sbjct: 122 DTLHKVLKSFIRSGRSIPMNLISIYI--YQLFRAVGFIHSLGICHRDIKPQNLL------ 173
Query: 404 KIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRIT 463
++ N LK+ DFG A L + SV + Y +PE G Y T
Sbjct: 174 --VNSKDNTLKLCDFGSAKKLIPSEPSVAYIC---SRFYRAPELM------LGATEY--T 220
Query: 464 YKSDVWSLGCILYNMIYGR 482
D+WS+GC+ +I G+
Sbjct: 221 PSIDLWSIGCVFGELILGK 239
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 1e-18
Identities = 53/204 (25%), Positives = 83/204 (40%), Gaps = 29/204 (14%)
Query: 289 KVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLS 348
K L I I+ S E+ LL +L+ P VI + A + +++L + + DL
Sbjct: 49 KDYALKQIEGTGISMSACREIALLRELK-HPNVISLQKVFLSHADRKVWLLFDYAEHDLW 107
Query: 349 KYMRNL------NKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNV 402
++ K LP M+ ++ Y++L + +HA ++H DLKPAN L V
Sbjct: 108 HIIKFHRASKANKKPVQLPRGMVKSLL--YQILDGIHYLHANWVLHRDLKPANIL----V 161
Query: 403 LKIIDCIGNVLKIIDFGIACSLQD-DKTSVHKDTASGTLNYMSPEAAGQTSSSG---GGN 458
+ G +KI D G A K D T Y +PE G
Sbjct: 162 MGEGPERG-RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE---------LLLGAR 211
Query: 459 TYRITYKSDVWSLGCILYNMIYGR 482
Y T D+W++GCI ++
Sbjct: 212 HY--TKAIDIWAIGCIFAELLTSE 233
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 2e-18
Identities = 65/313 (20%), Positives = 108/313 (34%), Gaps = 69/313 (22%)
Query: 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQ 316
+Y+ + +G+G V+ + + +A+K S+ D I L E+ +L +L+
Sbjct: 4 KYEKIGKIGEGSYGVVFK--CRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLK 60
Query: 317 GCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLL 376
P ++ + + + L+++ E D + + + +P ++ I ++ L
Sbjct: 61 -HPNLVNLLEVFRR--KRRLHLVFEYCDHTVLHELDRYQRG--VPEHLVKSIT--WQTLQ 113
Query: 377 AVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTA 436
AV H IH D+KP N L I V+K+ DFG A L + D
Sbjct: 114 AVNFCHKHNCIHRDVKPENIL--------ITKHS-VIKLCDFGFARLL-----TGPSDYY 159
Query: 437 SG---TLNYMSPEA-AGQTSSSGGGNTYRITYKS--DVWSLGCILYNMIYGR-------- 482
T Y SPE G T Y DVW++GC+ ++ G
Sbjct: 160 DDEVATRWYRSPELLVGDT-----------QYGPPVDVWAIGCVFAELLSGVPLWPGKSD 208
Query: 483 ------------TPYSHIPNTWAKMLAIARHKDQIEFKPQLANNV-----TIPPTLLQSM 525
IP P+ + I L +
Sbjct: 209 VDQLYLIRKTLGDL---IPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLL 265
Query: 526 KLCLQKDPKARPT 538
K CL DP R T
Sbjct: 266 KGCLHMDPTERLT 278
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 88.2 bits (218), Expect = 2e-18
Identities = 84/467 (17%), Positives = 162/467 (34%), Gaps = 64/467 (13%)
Query: 89 NQLGKSSTNLKTNFQHAQSVEKIVLNNINYRVDQCKKNLNYDPSIKTPCKDASQLSEDIL 148
+ + + ++ K L DP ++ K + S
Sbjct: 163 IYIQAHIDREVLIVVVRDAKNLVPMDPNGLSDPYVKLKLIPDPKSESKQKTKTIKSSLNP 222
Query: 149 ATRKKYPFLVSSTSSLDKENVVP------DNEKFKGPTQTKSVFSVRSASDQSLSQKKNE 202
+ + F + + + +V F G ++ D E
Sbjct: 223 EWNETFRFQLKESDKDRRLSVEIWDWDLTSRNDFMGSLSFGISELQKAGVDGWFKLLSQE 282
Query: 203 STPVFKRPLSVNSTKSSDPSVSKETIKPAKPQITTSNAKKSVETSQDVITLNGKQY---- 258
F P+ ++ ++ K K + S+ N +
Sbjct: 283 EGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTD 342
Query: 259 -QVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG 317
L +LGKG V L E A+K++ + + + E +LA
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGTDEL--YAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400
Query: 318 CPYVIKMHDYVYDTASKHLYVLME--KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEML 375
P++ ++H + T LY +ME G DL +++ P+ + E+
Sbjct: 401 PPFLTQLH-SCFQTMD-RLYFVMEYVNGG-DLMYHIQQ-VGRFKEPHAVFYAA----EIA 452
Query: 376 LAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIAC--SLQDDKTSVHK 433
+ + + + GII+ DLK N + +D G++ KI DFG+ C ++ D T+
Sbjct: 453 IGLFFLQSKGIIYRDLKLDNVM--------LDSEGHI-KIADFGM-CKENIWDGVTT--- 499
Query: 434 DTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWA 493
T GT +Y++PE Y D W+ G +LY M+ G+ P+
Sbjct: 500 KTFCGTPDYIAPEII-------AYQPY--GKSVDWWAFGVLLYEMLAGQAPFE------- 543
Query: 494 KMLAIARHKDQIEFKPQLANNVTIPPTL-LQSMKLC---LQKDPKAR 536
+D++ F+ + +NV P ++ +++ +C + K P R
Sbjct: 544 -----GEDEDEL-FQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKR 584
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 3e-18
Identities = 63/235 (26%), Positives = 100/235 (42%), Gaps = 40/235 (17%)
Query: 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDI-TDQSIADSYLNEVELLA 313
K+YQ L +G G V +A+K LS +Q+ A E+ L+
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILER--NVAIK--KLSRPFQNQTHAKRAYRELVLMK 79
Query: 314 KLQGCPYVIKMHDYVYDTAS----KHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIM 369
+ +I + + S + +Y++ME D +L + ++ L + + ++
Sbjct: 80 CVN-HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ-----MELDHERMSYLL 133
Query: 370 HWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKT 429
Y+ML +K +H+AGIIH DLKP N++ DC LKI+DFG+A +
Sbjct: 134 --YQMLCGIKHLHSAGIIHRDLKP------SNIVVKSDC---TLKILDFGLARTAGTSFM 182
Query: 430 SVHKDTAS-GTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRT 483
T T Y +PE G Y D+WS+GCI+ MI G
Sbjct: 183 M----TPYVVTRYYRAPEV-------ILGMGY--KENVDIWSVGCIMGEMIKGGV 224
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 3e-18
Identities = 58/293 (19%), Positives = 112/293 (38%), Gaps = 63/293 (21%)
Query: 259 QVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGC 318
+ LG G VY G + +A+K + D + +L E ++ +++
Sbjct: 223 TMKHKLGGGQYGEVYE--GVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIK-H 275
Query: 319 PYVIKMHDYVYDTASKHLYV---LMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEML 375
P ++++ T Y+ M G+ L Y+R N+ ++ M
Sbjct: 276 PNLVQLLGVC--TREPPFYIITEFMTYGN--LLDYLRECNRQEVSAVVLL-------YMA 324
Query: 376 LAVKE----IHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSV 431
+ + IH +L N L VG +++K+ DFG++ + D +
Sbjct: 325 TQISSAMEYLEKKNFIHRNLAARNCL-VGE--------NHLVKVADFGLSRLMTGDTYTA 375
Query: 432 HKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI-YGRTPYSHIPN 490
H A + + +PE+ + + KSDVW+ G +L+ + YG +PY I
Sbjct: 376 HAG-AKFPIKWTAPESL---------AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 425
Query: 491 TWAKMLAIARHKDQIE-----FKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
+ + +E +P+ P + + M+ C Q +P RP+
Sbjct: 426 SQVY--------ELLEKDYRMERPEGC-----PEKVYELMRACWQWNPSDRPS 465
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 4e-18
Identities = 71/346 (20%), Positives = 129/346 (37%), Gaps = 66/346 (19%)
Query: 208 KRPLSVNSTKSSDPSVSKETIKPAKPQITTSNAKKSVETSQDVITLNGKQY-----QVLS 262
+R + ++ + K+ + + + E + + + + L
Sbjct: 95 EREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLK 154
Query: 263 LLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVI 322
LLGKG V LV + + A+K++ I + L E +L + P++
Sbjct: 155 LLGKGTFGKVILVKEKATGRY--YAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLT 211
Query: 323 KMHDYVYDTASKHLYVLME--KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWY--EMLLAV 378
+ Y + T L +ME G +L +L++ +Y E++ A+
Sbjct: 212 ALK-YSFQTHD-RLCFVMEYANGG-EL---FFHLSRERVFSEDR----ARFYGAEIVSAL 261
Query: 379 KEIHAA-GIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSL---QDDKTSVHKD 434
+H+ +++ DLK N + +D G++ KI DFG+ C
Sbjct: 262 DYLHSEKNVVYRDLKLENLM--------LDKDGHI-KITDFGL-CKEGIKDGATMK---- 307
Query: 435 TASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494
T GT Y++PE N Y D W LG ++Y M+ GR P+
Sbjct: 308 TFCGTPEYLAPEVLE-------DNDY--GRAVDWWGLGVVMYEMMCGRLPFY-------- 350
Query: 495 MLAIARHKDQIEFKPQLANNVTIPPTL----LQSMKLCLQKDPKAR 536
+ +++ F+ L + P TL + L+KDPK R
Sbjct: 351 ----NQDHEKL-FELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQR 391
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 4e-18
Identities = 69/319 (21%), Positives = 128/319 (40%), Gaps = 69/319 (21%)
Query: 233 PQITTSNAKKSVETSQDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVD 292
P+ ++ S + + ++ ++ + +LGKG V L + A+KV+
Sbjct: 2 PKESSKEGNGIGVNSSNRLGID--NFEFIRVLGKGSFGKVMLARVKETGDL--YAVKVLK 57
Query: 293 LSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLME--KGDTDLSKY 350
I + + E +L+ + P++ ++ + T + L+ +ME G DL
Sbjct: 58 KDVILQDDDVECTMTEKRILSLARNHPFLTQLF-CCFQTPDR-LFFVMEFVNGG-DL--- 111
Query: 351 MRNLNKMTTLPNTMIIIIMHWY--EMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDC 408
M ++ K Y E++ A+ +H GII+ DLK N L +D
Sbjct: 112 MFHIQKSRRFDEARARF----YAAEIISALMFLHDKGIIYRDLKLDNVL--------LDH 159
Query: 409 IGNVLKIIDFGIAC--SLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKS 466
G+ K+ DFG+ C + + T+ T GT +Y++PE +
Sbjct: 160 EGHC-KLADFGM-CKEGICNGVTT---ATFCGTPDYIAPEI--------------LQEML 200
Query: 467 -----DVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTL 521
D W++G +LY M+ G P+ A ++D + F+ L + V P L
Sbjct: 201 YGPAVDWWAMGVLLYEMLCGHAPFE------------AENEDDL-FEAILNDEVVYPTWL 247
Query: 522 LQS----MKLCLQKDPKAR 536
+ +K + K+P R
Sbjct: 248 HEDATGILKSFMTKNPTMR 266
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 5e-18
Identities = 55/260 (21%), Positives = 89/260 (34%), Gaps = 80/260 (30%)
Query: 303 DSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYV---LMEKGDTDLSKYMRNLNKMTT 359
D + E + + KL P ++K + + +Y+ + G L Y+R+ K
Sbjct: 48 DEFFQEAQTMMKLS-HPKLVKFYGVC--SKEYPIYIVTEYISNGC--LLNYLRSHGKGLE 102
Query: 360 LPNTMIIIIMHWYEMLLAVKEIHAAG--------IIHSDLKPANFLFVGNVLKIIDCIGN 411
++ EM V G IH DL N L V
Sbjct: 103 PS-QLL-------EMCYDV----CEGMAFLESHQFIHRDLAARNCL-VDR--------DL 141
Query: 412 VLKIIDFGIACSLQDDKTSVHKDTASGTL---NYMSPEAAGQTSSSGGGNTYRI-TYKSD 467
+K+ DFG+ + DD+ GT + +PE Y + KSD
Sbjct: 142 CVKVSDFGMTRYVLDDQYVSS----VGTKFPVKWSAPEVF----------HYFKYSSKSD 187
Query: 468 VWSLGCILYNMI-YGRTPYSHIPNTWAKMLAIARHKDQIEF--------KPQLANNVTIP 518
VW+ G +++ + G+ PY N + + +P LA
Sbjct: 188 VWAFGILMWEVFSLGKMPYDLYTN-----------SEVVLKVSQGHRLYRPHLA-----S 231
Query: 519 PTLLQSMKLCLQKDPKARPT 538
T+ Q M C + P+ RPT
Sbjct: 232 DTIYQIMYSCWHELPEKRPT 251
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 6e-18
Identities = 71/313 (22%), Positives = 125/313 (39%), Gaps = 67/313 (21%)
Query: 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVV--DLSDITDQSIADSYLNEVELLA 313
K+Y+ L LG+G ++VY ++ + +A+K + I + L E++LL
Sbjct: 10 KRYEKLDFLGEGQFATVYK--ARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQ 67
Query: 314 KLQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYE 373
+L P +I + D ++ ++ + +TDL +++ + + T + ++M
Sbjct: 68 ELS-HPNIIGLLDAF--GHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLM---- 120
Query: 374 MLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQD-DKTSVH 432
L ++ +H I+H DLKP N L +D G VLK+ DFG+A S ++ H
Sbjct: 121 TLQGLEYLHQHWILHRDLKPNNLL--------LDENG-VLKLADFGLAKSFGSPNRAYTH 171
Query: 433 KDTASGTLNYMSPEA-AGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY------ 485
+ T Y +PE G G D+W++GCIL ++ P+
Sbjct: 172 QVV---TRWYRAPELLFGARMYGVG---------VDMWAVGCILAELLLRV-PFLPGDSD 218
Query: 486 ----SHI------PN--TWAKMLAIARHKDQIEFKPQLANNV-----TIPPT---LLQSM 525
+ I P W M D + FK + L+Q +
Sbjct: 219 LDQLTRIFETLGTPTEEQWPDM---CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGL 275
Query: 526 KLCLQKDPKARPT 538
+P AR T
Sbjct: 276 ---FLFNPCARIT 285
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 7e-18
Identities = 65/305 (21%), Positives = 113/305 (37%), Gaps = 81/305 (26%)
Query: 259 QVLSLLGKGGSSSVYL-VGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG 317
+ ++G G S V P+A+K L + +L+E ++ +
Sbjct: 52 HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKA--LKAGYTERQRRDFLSEASIMGQFD- 108
Query: 318 CPYVIKMHDYVYDTASKHLYV---LMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEM 374
P +I++ V T + + ME G L ++R + T+ ++
Sbjct: 109 HPNIIRLEGVV--TRGRLAMIVTEYMENGS--LDTFLRTHDGQFTIM-----------QL 153
Query: 375 LLAVKEIHAAG--------IIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQD 426
+ ++ + AG +H DL N L V + V K+ DFG++ L+D
Sbjct: 154 VGMLRGV-GAGMRYLSDLGYVHRDLAARNVL-VDS--------NLVCKVSDFGLSRVLED 203
Query: 427 DKTSVHKDTASGT---LNYMSPEAAGQTSSSGGGNTYRI-TYKSDVWSLGCILYNMI-YG 481
D + + T +G + + +PEA +R + SDVWS G +++ ++ YG
Sbjct: 204 DPDAAY--TTTGGKIPIRWTAPEAI----------AFRTFSSASDVWSFGVVMWEVLAYG 251
Query: 482 RTPYSHIPNTWAKMLAIARHKDQIEF--------KPQLANNVTIPPTLLQSMKLCLQKDP 533
PY ++ N +D I P P L Q M C KD
Sbjct: 252 ERPYWNMTN-----------RDVISSVEEGYRLPAPMGC-----PHALHQLMLDCWHKDR 295
Query: 534 KARPT 538
RP
Sbjct: 296 AQRPR 300
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 7e-18
Identities = 79/319 (24%), Positives = 114/319 (35%), Gaps = 75/319 (23%)
Query: 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDI-TDQSIADSYLNEVELLA 313
K Y + +G G SV E +A+K LS + A E+ LL
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGE--KVAIK--KLSRPFQSEIFAKRAYRELLLLK 78
Query: 314 KLQGCPYVIKMHDYVYDTAS----KHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIM 369
+Q VI + D +S Y++M TDL K M I ++
Sbjct: 79 HMQH-ENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMG-----LKFSEEKIQYLV 132
Query: 370 HWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKT 429
Y+ML +K IH+AG++H DLKP GN+ DC LKI+DFG+A + T
Sbjct: 133 --YQMLKGLKYIHSAGVVHRDLKP------GNLAVNEDC---ELKILDFGLARHADAEMT 181
Query: 430 S-VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGR------ 482
V T Y +PE Y D+WS+GCI+ M+ G+
Sbjct: 182 GYV------VTRWYRAPEVI------LSWMHY--NQTVDIWSVGCIMAEMLTGKTLFKGK 227
Query: 483 --------------TP----YSHIPNTWAK-MLAIARHKDQIEFKPQLANNVTIPPT--- 520
P + + AK + + +F P
Sbjct: 228 DYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPR---ASPQAAD 284
Query: 521 LLQSMKLCLQKDPKARPTV 539
LL+ M L+ D R T
Sbjct: 285 LLEKM---LELDVDKRLTA 300
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 9e-18
Identities = 72/280 (25%), Positives = 112/280 (40%), Gaps = 62/280 (22%)
Query: 287 ALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEKGDTD 346
ALK + L D D+ I + + E+ LL +L P ++ + D ++ + L ++ E + D
Sbjct: 49 ALKRIRL-DAEDEGIPSTAIREISLLKELH-HPNIVSLIDVIHS--ERCLTLVFEFMEKD 104
Query: 347 LSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKII 406
L K + L ++ I I + Y++L V H I+H DLKP N L I
Sbjct: 105 LKKVLDENKTG--LQDSQIKIYL--YQLLRGVAHCHQHRILHRDLKPQNLL--------I 152
Query: 407 DCIGNVLKIIDFGIACSLQD-DKTSVHKDTASGTLNYMSPEA-AGQTSSSGGGNTYRITY 464
+ G LK+ DFG+A + ++ H+ TL Y +P+ G S
Sbjct: 153 NSDGA-LKLADFGLARAFGIPVRSYTHEVV---TLWYRAPDVLMGSKKYSTS-------- 200
Query: 465 KSDVWSLGCILYNMIYGRTPY----------SHI------PN--TWAKMLAIARHKDQIE 506
D+WS+GCI MI G+ P I PN W ++ + K Q
Sbjct: 201 -VDIWSIGCIFAEMITGK-PLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWK-QRT 257
Query: 507 FKPQLANNV-----TIPPT---LLQSMKLCLQKDPKARPT 538
F+ LL +M L DP R +
Sbjct: 258 FQVFEKKPWSSIIPGFCQEGIDLLSNM---LCFDPNKRIS 294
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 9e-18
Identities = 68/235 (28%), Positives = 96/235 (40%), Gaps = 40/235 (17%)
Query: 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDI-TDQSIADSYLNEVELLA 313
Y+ L +G G +V +A+K L + A E+ LL
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGA--KVAIK--KLYRPFQSELFAKRAYRELRLLK 79
Query: 314 KLQGCPYVIKMHDYVYDTAS----KHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIM 369
++ VI + D + Y++M TDL K M+ L I ++
Sbjct: 80 HMRH-ENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK----HEKLGEDRIQFLV 134
Query: 370 HWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKT 429
Y+ML ++ IHAAGIIH DLKP GN+ DC LKI+DFG+A + T
Sbjct: 135 --YQMLKGLRYIHAAGIIHRDLKP------GNLAVNEDC---ELKILDFGLARQADSEMT 183
Query: 430 S-VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRT 483
V T Y +PE Y T D+WS+GCI+ MI G+T
Sbjct: 184 GYV------VTRWYRAPEVI------LNWMRY--TQTVDIWSVGCIMAEMITGKT 224
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 9e-18
Identities = 73/326 (22%), Positives = 115/326 (35%), Gaps = 76/326 (23%)
Query: 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVD-LSDITDQSIADSYLNEVELLA 313
+Q+ SLLG+G V E +A+K ++ A L E+++L
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGE--IVAIKKIEPFDKPLF---ALRTLREIKILK 64
Query: 314 KLQGCPYVIKMHDYVYDTAS---KHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMH 370
+ +I + + + +Y++ E TDL + + L + I +
Sbjct: 65 HFKH-ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIST----QMLSDDHIQYFI- 118
Query: 371 WYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTS 430
Y+ L AVK +H + +IH DLKP N+L +C LK+ DFG+A + +
Sbjct: 119 -YQTLRAVKVLHGSNVIHRDLKP------SNLLINSNC---DLKVCDFGLARIIDESAAD 168
Query: 431 VHKDTASG--------TLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGR 482
+ T T Y +PE Y + DVWS GCIL + R
Sbjct: 169 NSEPTGQQSGMVEFVATRWYRAPEVM------LTSAKY--SRAMDVWSCGCILAELFLRR 220
Query: 483 --------------------TPYSH-----IPNTWAK-MLAIARHKDQIEFKPQLANNVT 516
TP+S I + A+ + +
Sbjct: 221 PIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPR--- 277
Query: 517 IPPT---LLQSMKLCLQKDPKARPTV 539
+ P LLQ M L DP R T
Sbjct: 278 VNPKGIDLLQRM---LVFDPAKRITA 300
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 63/235 (26%), Positives = 97/235 (41%), Gaps = 40/235 (17%)
Query: 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDL--SDITDQSIADSYLNEVELL 312
++YQ LS +G G SV T +A+K + I A E+ LL
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGL--RVAVKKLSRPFQSIIH---AKRTYRELRLL 82
Query: 313 AKLQGCPYVIKMHDYVYDTAS----KHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIII 368
++ VI + D S +Y++ DL+ ++ L + + +
Sbjct: 83 KHMKH-ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----QKLTDDHVQFL 137
Query: 369 MHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDK 428
+ Y++L +K IH+A IIH DLKP N+ DC LKI+DFG+A D+
Sbjct: 138 I--YQILRGLKYIHSADIIHRDLKP------SNLAVNEDC---ELKILDFGLARHTADEM 186
Query: 429 TSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRT 483
T T Y +PE Y D+WS+GCI+ ++ GRT
Sbjct: 187 TGYV-----ATRWYRAPEIM------LNWMHY--NQTVDIWSVGCIMAELLTGRT 228
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 1e-17
Identities = 52/262 (19%), Positives = 105/262 (40%), Gaps = 41/262 (15%)
Query: 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAK 314
G ++V +G G + L G + + + +A+K+ + S A E +
Sbjct: 8 GPNFRVGKKIGCGNFGELRL--GKNLYTNEYVAIKLEPMK-----SRAPQLHLEYRFYKQ 60
Query: 315 LQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEM 374
L + +++ + K+ +++E L ++ +L ++I I ++
Sbjct: 61 LGSGDGIPQVYYFGPC--GKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAI----QL 114
Query: 375 LLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVH-- 432
+ ++ +H+ +I+ D+KP NFL +G + + V+ IIDF +A D +T H
Sbjct: 115 ISRMEYVHSKNLIYRDVKPENFL-IG---RPGNKTQQVIHIIDFALAKEYIDPETKKHIP 170
Query: 433 -KDTAS--GTLNYMSPEA-AGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY---GRTPY 485
++ S GT YMS G+ S + D+ +LG + +Y G P+
Sbjct: 171 YREHKSLTGTARYMSINTHLGKEQS----------RRDDLEALG---HMFMYFLRGSLPW 217
Query: 486 SHI--PNTWAKMLAIARHKDQI 505
+ + I K
Sbjct: 218 QGLKADTLKERYQKIGDTKRAT 239
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 79/317 (24%), Positives = 126/317 (39%), Gaps = 66/317 (20%)
Query: 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAK 314
G +Y LS +G+G V +A+K +S Q+ L E+++L +
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKV--RVAIK--KISPFEHQTYCQRTLREIKILLR 81
Query: 315 LQGCPYVIKMHDYVYDTAS---KHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHW 371
+ +I ++D + K +Y++ + +TDL K ++ L N I +
Sbjct: 82 FRH-ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK----TQHLSNDHICYFL-- 134
Query: 372 YEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSV 431
Y++L +K IH+A ++H DLKP N+L C LKI DFG+A D
Sbjct: 135 YQILRGLKYIHSANVLHRDLKP------SNLLLNTTC---DLKICDFGLARVADPDHDHT 185
Query: 432 HKDTAS-GTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGR-------- 482
T T Y +PE Y T D+WS+GCIL M+ R
Sbjct: 186 GFLTEYVATRWYRAPEIM------LNSKGY--TKSIDIWSVGCILAEMLSNRPIFPGKHY 237
Query: 483 ------------TP----YSHIPNTWAK-MLAIARHKDQIEFK---PQLANNVTIPPTLL 522
+P + I N A+ L HK+++ + P A++ + LL
Sbjct: 238 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPN-ADSKAL--DLL 294
Query: 523 QSMKLCLQKDPKARPTV 539
M L +P R V
Sbjct: 295 DKM---LTFNPHKRIEV 308
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 72/316 (22%), Positives = 130/316 (41%), Gaps = 69/316 (21%)
Query: 236 TTSNAKKSVETSQDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSD 295
T + +K ++D + L + L +LGKG V L E A+K++
Sbjct: 2 TNTVSKFDNNGNRDRMKLT--DFNFLMVLGKGSFGKVMLSERKGTDEL--YAVKILKKDV 57
Query: 296 ITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLME--KGDTDLSKYMRN 353
+ + + E +LA P++ ++H + T LY +ME G DL M +
Sbjct: 58 VIQDDDVECTMVEKRVLALPGKPPFLTQLH-SCFQTMD-RLYFVMEYVNGG-DL---MYH 111
Query: 354 LNKMTTLPNTMIIIIMHWY--EMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGN 411
+ ++ + Y E+ + + + + GII+ DLK N + +D G+
Sbjct: 112 IQQVGRFKEPHAVF----YAAEIAIGLFFLQSKGIIYRDLKLDNVM--------LDSEGH 159
Query: 412 VLKIIDFGIAC--SLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKS--- 466
+ KI DFG+ C ++ D T+ T GT +Y++PE I Y+
Sbjct: 160 I-KIADFGM-CKENIWDGVTT---KTFCGTPDYIAPEI--------------IAYQPYGK 200
Query: 467 --DVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQS 524
D W+ G +LY M+ G+ P+ +D++ F+ + +NV P ++ +
Sbjct: 201 SVDWWAFGVLLYEMLAGQAPFE------------GEDEDEL-FQSIMEHNVAYPKSMSKE 247
Query: 525 ----MKLCLQKDPKAR 536
K + K P R
Sbjct: 248 AVAICKGLMTKHPGKR 263
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 1e-17
Identities = 59/298 (19%), Positives = 107/298 (35%), Gaps = 83/298 (27%)
Query: 264 LGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIK 323
LG G VY G + +A+K + D + +L E ++ +++ P +++
Sbjct: 21 LGGGQYGEVYE--GVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIK-HPNLVQ 73
Query: 324 MHDYVYDTASKHLYV---LMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKE 380
+ T Y+ M G+ L Y+R N+ ++ M +
Sbjct: 74 LLGVC--TREPPFYIITEFMTYGN--LLDYLRECNRQEVSAVVLL-------YMATQI-- 120
Query: 381 IHAAG--------IIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVH 432
++ IH DL N L VG +++K+ DFG++ + D +
Sbjct: 121 --SSAMEYLEKKNFIHRDLAARNCL-VGE--------NHLVKVADFGLSRLMTGD---TY 166
Query: 433 KDTASGTL--NYMSPEAAGQTSSSGGGNTYRI-TYKSDVWSLGCILYNMI-YGRTPYSHI 488
A + +PE+ Y + KSDVW+ G +L+ + YG +PY I
Sbjct: 167 TAHAGAKFPIKWTAPESL----------AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 216
Query: 489 PNTWAKMLAIARHKDQIEF--------KPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
E +P+ P + + M+ C Q +P RP+
Sbjct: 217 DL-----------SQVYELLEKDYRMERPEGC-----PEKVYELMRACWQWNPSDRPS 258
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 1e-17
Identities = 66/290 (22%), Positives = 116/290 (40%), Gaps = 60/290 (20%)
Query: 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG 317
+ L LLGKG V LV + + A+K++ I + + E +L +
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRY--YAMKILRKEVIIAKDEVAHTVTESRVLQNTR- 63
Query: 318 CPYVIKMHDYVYDTASKHLYVLME--KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWY--E 373
P++ + Y + T + L +ME G +L +L++ +Y E
Sbjct: 64 HPFLTALK-YAFQTHDR-LCFVMEYANGG-EL---FFHLSRERVFTEER----ARFYGAE 113
Query: 374 MLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSL---QDDKTS 430
++ A++ +H+ +++ D+K N + +D G++ KI DFG+ C
Sbjct: 114 IVSALEYLHSRDVVYRDIKLENLM--------LDKDGHI-KITDFGL-CKEGISDGATMK 163
Query: 431 VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN 490
T GT Y++PE N Y D W LG ++Y M+ GR P+
Sbjct: 164 ----TFCGTPEYLAPEVL-------EDNDY--GRAVDWWGLGVVMYEMMCGRLPFY---- 206
Query: 491 TWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQS----MKLCLQKDPKAR 536
+ +++ F+ L + P TL + L+KDPK R
Sbjct: 207 --------NQDHERL-FELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 247
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 1e-17
Identities = 52/268 (19%), Positives = 103/268 (38%), Gaps = 37/268 (13%)
Query: 246 TSQDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSY 305
+ Q+ + G Y+V +G+G ++ GT+ + +A+K +S A
Sbjct: 2 SGQNNVV--GVHYKVGRRIGEGSFGVIFE--GTNLLNNQQVAIKFEPR-----RSDAPQL 52
Query: 306 LNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMI 365
+E L GC + ++ + + H ++++ L + + ++ +
Sbjct: 53 RDEYRTYKLLAGCTGIPNVYYFGQE--GLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAM 110
Query: 366 IIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQ 425
+ML V+ IH +++ D+KP NFL K N++ ++DFG+ +
Sbjct: 111 AAK----QMLARVQSIHEKSLVYRDIKPDNFLIGRPNSK----NANMIYVVDFGMVKFYR 162
Query: 426 DDKTSVH---KDTAS--GTLNYMSPEA-AGQTSSSGGGNTYRITYKSDVWSLGCILYNMI 479
D T H ++ + GT YMS G+ S + D+ +LG + +
Sbjct: 163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQS----------RRDDLEALGHVFMYFL 212
Query: 480 YGRTPYSHI--PNTWAKMLAIARHKDQI 505
G P+ + K I K
Sbjct: 213 RGSLPWQGLKAATNKQKYERIGEKKQST 240
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 1e-17
Identities = 52/197 (26%), Positives = 88/197 (44%), Gaps = 29/197 (14%)
Query: 287 ALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEKGDTD 346
ALK + L + D+ I + + E+ +L +L+ ++K++D ++ K L ++ E D D
Sbjct: 30 ALKKIRL-EKEDEGIPSTTIREISILKELK-HSNIVKLYDVIHT--KKRLVLVFEHLDQD 85
Query: 347 LSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKII 406
L K + L + + ++L + H ++H DLKP N L I
Sbjct: 86 LKKLLDVCE--GGLESVTAKSFL--LQLLNGIAYCHDRRVLHRDLKPQNLL--------I 133
Query: 407 DCIGNVLKIIDFGIACSLQD-DKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYK 465
+ G LKI DFG+A + + H+ TL Y +P+ G Y +
Sbjct: 134 NREGE-LKIADFGLARAFGIPVRKYTHEIV---TLWYRAPDVL------MGSKKY--STT 181
Query: 466 SDVWSLGCILYNMIYGR 482
D+WS+GCI M+ G
Sbjct: 182 IDIWSVGCIFAEMVNGT 198
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 58/294 (19%), Positives = 101/294 (34%), Gaps = 53/294 (18%)
Query: 264 LGKGGSSSVYL--VGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYV 321
LGKG SV L ++ +A+K L D + E+++L L ++
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQ--LQHSGPDQQRD-FQREIQILKALH-SDFI 86
Query: 322 IKMHDYVYDTASKHLYV---LMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAV 378
+K Y + L + + G L +++ ++ + ++ +
Sbjct: 87 VKYRGVSYGPGRQSLRLVMEYLPSGC--LRDFLQR-HRARLDASRLL-------LYSSQI 136
Query: 379 KE----IHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKD 434
+ + + +H DL N L V + +KI DFG+A L DK +
Sbjct: 137 CKGMEYLGSRRCVHRDLAARNIL-VES--------EAHVKIADFGLAKLLPLDK-DYYVV 186
Query: 435 TASGTL--NYMSPEAAGQTSSSGGGNTYRI-TYKSDVWSLGCILYNMI-YGRTPYSHIPN 490
G + +PE+ + I + +SDVWS G +LY + Y S
Sbjct: 187 REPGQSPIFWYAPESL----------SDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAE 236
Query: 491 TWAKMLAIARHKDQIEFKPQLANN------VTIPPTLLQSMKLCLQKDPKARPT 538
M L P + + MKLC P+ RP+
Sbjct: 237 FLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPS 290
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 61/255 (23%), Positives = 105/255 (41%), Gaps = 39/255 (15%)
Query: 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSI-ADSYLNEVELLA 313
Y + L+G+G VYL + + +A+K ++ + + I L E+ +L
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEK--NVAIK--KVNRMFEDLIDCKRILREITILN 80
Query: 314 KLQGCPYVIKMHDYVYDTAS---KHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMH 370
+L+ Y+I+++D + LY+++E D+DL K + +T I I+
Sbjct: 81 RLK-SDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLT---EEHIKTIL- 135
Query: 371 WYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTS 430
Y +LL IH +GIIH DLKPAN L N DC +K+ DFG+A ++ +K +
Sbjct: 136 -YNLLLGENFIHESGIIHRDLKPANCLL--NQ----DC---SVKVCDFGLARTINSEKDT 185
Query: 431 VHKDTASGTLNYMSPEAAGQTSSSG--------------GGNTYRITYKSDVWSLGCILY 476
+ + + Y T D+WS GCI
Sbjct: 186 NIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENY--TKSIDIWSTGCIFA 243
Query: 477 NMIYGRTPYSHIPNT 491
++ + + P
Sbjct: 244 ELLNMLQSHINDPTN 258
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 48/261 (18%), Positives = 98/261 (37%), Gaps = 64/261 (24%)
Query: 249 DVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVV-DLSDITDQSIADSYLN 307
DV++ +Y+++ LG+G V + +A+K+V ++ + + +
Sbjct: 10 DVLS---ARYEIVDTLGEGAFGKVVECIDHKAGG-RHVAVKIVKNVDRYCEAA-----RS 60
Query: 308 EVELLAKLQ-----GCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPN 362
E+++L L ++M ++ H+ ++ E +++ N
Sbjct: 61 EIQVLEHLNTTDPNSTFRCVQMLEWFEH--HGHICIVFELLGLSTYDFIKE-NGFLPFRL 117
Query: 363 TMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNV---------- 412
I + + ++ +V +H+ + H+DLKP N LFV +
Sbjct: 118 DHIRKMAY--QICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPD 175
Query: 413 LKIIDFGIACSLQDDKTSV----HKDTASGTLNYMSPEAAGQTSSSGGGNTYRI------ 462
+K++DFG A + +++ H Y +PE +
Sbjct: 176 IKVVDFGSATYDDEHHSTLVSTRH---------YRAPE---------------VILALGW 211
Query: 463 TYKSDVWSLGCILYNMIYGRT 483
+ DVWS+GCIL G T
Sbjct: 212 SQPCDVWSIGCILIEYYLGFT 232
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 2e-17
Identities = 74/317 (23%), Positives = 139/317 (43%), Gaps = 66/317 (20%)
Query: 234 QITTSNAKKSVETSQDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPL-ALKVVD 292
I V+ + + Q+++L +LG+G V+LV S + + L A+KV+
Sbjct: 4 SIKEIAITHHVKEGHEKADPS--QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLK 61
Query: 293 LSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLME---KGD--TDL 347
+ + + + E ++L ++ P+++K+H Y + T K LY++++ GD T L
Sbjct: 62 KATLKVRDRVRT-KMERDILVEVN-HPFIVKLH-YAFQTEGK-LYLILDFLRGGDLFTRL 117
Query: 348 SKYMRNLNKMTTLPNTMIIIIMHWY--EMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKI 405
SK M T + Y E+ LA+ +H+ GII+ DLKP N L
Sbjct: 118 SK-----EVMFTEEDVKF------YLAELALALDHLHSLGIIYRDLKPENIL-------- 158
Query: 406 IDCIGNVLKIIDFGIAC--SLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRIT 463
+D G++ K+ DFG+ S+ +K + + GT+ YM+PE + T
Sbjct: 159 LDEEGHI-KLTDFGL-SKESIDHEKKA---YSFCGTVEYMAPEVV-------NRRGH--T 204
Query: 464 YKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQ 523
+D WS G +++ M+ G P+ + + + L + +P L
Sbjct: 205 QSADWWSFGVLMFEMLTGTLPFQ------------GKDRKET-MTMILKAKLGMPQFLSP 251
Query: 524 S----MKLCLQKDPKAR 536
+++ +++P R
Sbjct: 252 EAQSLLRMLFKRNPANR 268
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 2e-17
Identities = 68/323 (21%), Positives = 120/323 (37%), Gaps = 87/323 (26%)
Query: 240 AKKSVETSQDVITLNGKQYQVLSLLGKGGSSSVYLVGGT--SEHEFKPLALKVVDLSDIT 297
K V + ++TL K+ LG G +V G + K +A+K++ ++
Sbjct: 7 RPKEVYLDRKLLTLEDKE------LGSGNFGTVKK--GYYQMKKVVKTVAVKILK-NEAN 57
Query: 298 DQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYV--LMEKGDTDLSKYMRNLN 355
D ++ D L E ++ +L PY+++M A + V + E G L+KY++ N
Sbjct: 58 DPALKDELLAEANVMQQLDN-PYIVRMIGIC--EAESWMLVMEMAELGP--LNKYLQQ-N 111
Query: 356 KMTTLPNTMIIIIMHWYEMLLAVKEIHAAG--------IIHSDLKPANFLFVGNVLKIID 407
+ N + E++ V + G +H DL N L +
Sbjct: 112 RHVKDKNII--------ELVHQV----SMGMKYLEESNFVHRDLAARNVL-LVT------ 152
Query: 408 CIGNVLKIIDFGIACSLQDDKTSVHKDTASGT---LNYMSPEAAGQTSSSGGGNTYRITY 464
+ KI DFG++ +L+ D+ + + + +PE N Y+ +
Sbjct: 153 --QHYAKISDFGLSKALRADENYYK--AQTHGKWPVKWYAPECI---------NYYKFSS 199
Query: 465 KSDVWSLGCILYNMI-YGRTPYSHIPNTWAKMLAIARHKDQIEF--------KPQLANNV 515
KSDVWS G +++ YG+ PY + + P
Sbjct: 200 KSDVWSFGVLMWEAFSYGQKPYRGMKG-----------SEVTAMLEKGERMGCPAGC--- 245
Query: 516 TIPPTLLQSMKLCLQKDPKARPT 538
P + M LC D + RP
Sbjct: 246 --PREMYDLMNLCWTYDVENRPG 266
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 49/261 (18%), Positives = 99/261 (37%), Gaps = 64/261 (24%)
Query: 249 DVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVV-DLSDITDQSIADSYLN 307
D + ++Y+++ LG+G V + + +ALK++ ++ + +
Sbjct: 15 DWLQ---ERYEIVGNLGEGTFGKVVECLDHARGK-SQVALKIIRNVGKYREAA-----RL 65
Query: 308 EVELLAKLQ-----GCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPN 362
E+ +L K++ + M D+ H+ + E + ++++ N P
Sbjct: 66 EINVLKKIKEKDKENKFLCVLMSDWFNFH--GHMCIAFELLGKNTFEFLKE-NNFQPYPL 122
Query: 363 TMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNV---------- 412
+ + Y++ A++ +H + H+DLKP N LFV + + +
Sbjct: 123 PHVRHMA--YQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTS 180
Query: 413 LKIIDFGIACSLQDDKTSV----HKDTASGTLNYMSPEAAGQTSSSGGGNTYRI------ 462
+++ DFG A + T++ H Y PE +
Sbjct: 181 IRVADFGSATFDHEHHTTIVATRH---------YRPPE---------------VILELGW 216
Query: 463 TYKSDVWSLGCILYNMIYGRT 483
DVWS+GCIL+ G T
Sbjct: 217 AQPCDVWSIGCILFEYYRGFT 237
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 3e-17
Identities = 67/278 (24%), Positives = 106/278 (38%), Gaps = 80/278 (28%)
Query: 285 PLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYV---LME 341
+A+K L + +L E ++ + P +I++ V T SK + + ME
Sbjct: 75 SVAIKT--LKVGYTEKQRRDFLGEASIMGQFD-HPNIIRLEGVV--TKSKPVMIVTEYME 129
Query: 342 KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAG--------IIHSDLKP 393
G L ++R + T+ +++ ++ I A+G +H DL
Sbjct: 130 NGS--LDSFLRKHDAQFTVI-----------QLVGMLRGI-ASGMKYLSDMGYVHRDLAA 175
Query: 394 ANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGT---LNYMSPEAAGQ 450
N L + + V K+ DFG+ L+DD + + T G + + SPEA
Sbjct: 176 RNIL-INS--------NLVCKVSDFGLGRVLEDDPEAAY--TTRGGKIPIRWTSPEAI-- 222
Query: 451 TSSSGGGNTYRI-TYKSDVWSLGCILYNMI-YGRTPYSHIPNTWAKMLAIARHKDQIEF- 507
YR T SDVWS G +L+ ++ YG PY + N +D I+
Sbjct: 223 --------AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-----------QDVIKAV 263
Query: 508 -------KPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
P P L Q M C QKD RP
Sbjct: 264 DEGYRLPPPMDC-----PAALYQLMLDCWQKDRNNRPK 296
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 3e-17
Identities = 50/262 (19%), Positives = 89/262 (33%), Gaps = 66/262 (25%)
Query: 308 EVELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIII 367
E++LL +L+ ++ + + K Y++ E D + + L ++
Sbjct: 74 EIKLLKQLR-HENLVNLLEVCKK--KKRWYLVFEFVDHTILDDLELFPN--GLDYQVVQK 128
Query: 368 IMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDD 427
+ ++++ + H+ IIH D+KP N L + G V+K+ DFG A +L
Sbjct: 129 YL--FQIINGIGFCHSHNIIHRDIKPENIL--------VSQSG-VVKLCDFGFARTL--- 174
Query: 428 KTSVHKDTASG---TLNYMSPEA-AGQTSSSGGGNTYRITYKS--DVWSLGCILYNMIYG 481
+ + T Y +PE G Y DVW++GC++ M G
Sbjct: 175 --AAPGEVYDDEVATRWYRAPELLVGDV-----------KYGKAVDVWAIGCLVTEMFMG 221
Query: 482 R--------------------TPYSHIPNTWAKMLAIARHKD----QIEFKPQLANNV-T 516
IP +I+ + L
Sbjct: 222 EPLFPGDSDIDQLYHIMMCLGNL---IPRHQELFNKNPVFAGVRLPEIKEREPLERRYPK 278
Query: 517 IPPTLLQSMKLCLQKDPKARPT 538
+ ++ K CL DP RP
Sbjct: 279 LSEVVIDLAKKCLHIDPDKRPF 300
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 83.0 bits (205), Expect = 4e-17
Identities = 60/237 (25%), Positives = 100/237 (42%), Gaps = 44/237 (18%)
Query: 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDI-TDQSIADSYLNEVELLA 313
K+YQ L +G G V +A+K LS +Q+ A E+ L+
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDR--NVAIK--KLSRPFQNQTHAKRAYRELVLMK 116
Query: 314 KLQGCPYVIKMHDYVYDTAS----KHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIM 369
+ +I + + + + +Y++ME D +L + ++ L + + ++
Sbjct: 117 CVN-HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ-----MELDHERMSYLL 170
Query: 370 HWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKT 429
Y+ML +K +H+AGIIH DLKP N++ DC LKI+DFG+A +
Sbjct: 171 --YQMLCGIKHLHSAGIIHRDLKP------SNIVVKSDC---TLKILDFGLARTAGTSFM 219
Query: 430 ---SVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRT 483
V T Y +PE G Y D+WS+GCI+ M+ +
Sbjct: 220 MTPYV------VTRYYRAPEVI-------LGMGY--KENVDIWSVGCIMGEMVRHKI 261
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 4e-17
Identities = 50/266 (18%), Positives = 86/266 (32%), Gaps = 70/266 (26%)
Query: 249 DVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVV-DLSDITDQSIADSYLN 307
++ + V+ +G G V L ++ A+KVV ++ T +
Sbjct: 31 MLLN---NAFLVIRKMGDGTFGRVLLCQHIDNKKY--YAVKVVRNIKKYTRSA-----KI 80
Query: 308 EVELLAKLQGCP----YVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNT 363
E ++L K+Q ++K H H+ ++ E L + + N
Sbjct: 81 EADILKKIQNDDINNNNIVKYHGKFMYY--DHMCLIFEPLGPSLYEIITR-NNYNGFHIE 137
Query: 364 MIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIG------------- 410
I + E+L A+ + + H+DLKP N L +
Sbjct: 138 DIKLYC--IEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYR 195
Query: 411 ---NVLKIIDFGIACSLQDDKTSV----HKDTASGTLNYMSPEAAGQTSSSGGGNTYRI- 462
+K+IDFG A D S+ Y +PE +
Sbjct: 196 TKSTGIKLIDFGCATFKSDYHGSIINTRQ---------YRAPE---------------VI 231
Query: 463 -----TYKSDVWSLGCILYNMIYGRT 483
SD+WS GC+L + G
Sbjct: 232 LNLGWDVSSDMWSFGCVLAELYTGSL 257
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 4e-17
Identities = 64/295 (21%), Positives = 120/295 (40%), Gaps = 69/295 (23%)
Query: 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG 317
+ + +LGKG V+L ++F A+K + + + + E +L+
Sbjct: 19 FILHKMLGKGSFGKVFLAEFKKTNQF--FAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76
Query: 318 CPYVIKMHDYVYDTASKHLYVLME--KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWY--E 373
P++ M + T +L+ +ME G DL M ++ + Y E
Sbjct: 77 HPFLTHMF-CTFQTKE-NLFFVMEYLNGG-DL---MYHIQSCHKFDLSRATF----YAAE 126
Query: 374 MLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSL---QDDKTS 430
++L ++ +H+ GI++ DLK N L +D G++ KI DFG+ C D KT+
Sbjct: 127 IILGLQFLHSKGIVYRDLKLDNIL--------LDKDGHI-KIADFGM-CKENMLGDAKTN 176
Query: 431 VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKS-----DVWSLGCILYNMIYGRTPY 485
T GT +Y++PE + + D WS G +LY M+ G++P+
Sbjct: 177 ----TFCGTPDYIAPEI--------------LLGQKYNHSVDWWSFGVLLYEMLIGQSPF 218
Query: 486 SHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQS----MKLCLQKDPKAR 536
+ ++++ F +N P L + + ++P+ R
Sbjct: 219 H------------GQDEEEL-FHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKR 260
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 6e-17
Identities = 63/307 (20%), Positives = 112/307 (36%), Gaps = 80/307 (26%)
Query: 264 LGKGGSSSVYL--VGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYV 321
LG+G V L T++ + +A+K + +D Q + + E+++L L ++
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALK-ADAGPQHRSG-WKQEIDILRTLY-HEHI 95
Query: 322 IKMHDYVYDTASKHLYVLME---KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAV 378
IK D + L ++ME G L Y+ + + ++LL
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGS--LRDYLPR-HSIG------------LAQLLLFA 140
Query: 379 KEIHAAG--------IIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTS 430
++I G IH DL N L + N ++KI DFG+A ++ +
Sbjct: 141 QQI-CEGMAYLHAQHYIHRDLAARNVL-LDN--------DRLVKIGDFGLAKAVPEGH-E 189
Query: 431 VHKDTASGTL--NYMSPEAAGQTSSSGGGNTYRI-TYKSDVWSLGCILYNMI-YGRTPYS 486
++ G + +PE Y SDVWS G LY ++ + + S
Sbjct: 190 YYRVREDGDSPVFWYAPECL----------KEYKFYYASDVWSFGVTLYELLTHCDSSQS 239
Query: 487 HIPNTWAKMLAIARHKDQIEFKPQLANNVTI---------------PPTLLQSMKLCLQK 531
P + +++ IA+ Q+ P + MK C +
Sbjct: 240 P-PTKFLELIGIAQ--------GQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWET 290
Query: 532 DPKARPT 538
+ RPT
Sbjct: 291 EASFRPT 297
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 6e-17
Identities = 57/237 (24%), Positives = 91/237 (38%), Gaps = 41/237 (17%)
Query: 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVV-DLSDITDQSIADSYLNEVELLA 313
+Y++ SL+GKG V E E+ +A+K++ + +Q+ EV LL
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEW--VAIKIIKNKKAFLNQA-----QIEVRLLE 105
Query: 314 KLQ-----GCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIII 368
+ Y++ + + HL ++ E +L +RN + +
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMF--RNHLCLVFEMLSYNLYDLLRN-TNFRGVSLNLTRKF 162
Query: 369 MHWYEMLLAVKEIHA--AGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQD 426
+M A+ + IIH DLKP N L + + +KI+DFG +C L
Sbjct: 163 A--QQMCTALLFLATPELSIIHCDLKPENILLC-------NPKRSAIKIVDFGSSCQLGQ 213
Query: 427 DKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRT 483
+ + Y SPE G Y D+WSLGCIL M G
Sbjct: 214 RIYQYIQ-----SRFYRSPEVLL-------GMPY--DLAIDMWSLGCILVEMHTGEP 256
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 6e-17
Identities = 60/277 (21%), Positives = 113/277 (40%), Gaps = 52/277 (18%)
Query: 214 NSTKSSDPSVSKETIKPAKPQITTSNAKKSVETSQDVITLNGKQYQVLSLLGKGGSSSVY 273
+ ++ +T P ++ + + S++ +Y+ ++ LG+G VY
Sbjct: 3 HHHHHHMGTLEAQTQGPGSMSVSAAPSATSID-----------RYRRITKLGEGTYGEVY 51
Query: 274 LVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTAS 333
+ +A+K + L + ++ + + + EV LL +LQ +I++ + +
Sbjct: 52 K--AIDTVTNETVAIKRIRL-EHEEEGVPGTAIREVSLLKELQ-HRNIIELKSVI--HHN 105
Query: 334 KHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKP 393
L+++ E + DL KYM +K + +I + Y+++ V H+ +H DLKP
Sbjct: 106 HRLHLIFEYAENDLKKYM---DKNPDVSMRVIKSFL--YQLINGVNFCHSRRCLHRDLKP 160
Query: 394 ANFLFVGNVLKIIDCIGN----VLKIIDFGIACSLQD-DKTSVHKDTASGTLNYMSPEA- 447
N L + VLKI DFG+A + + H+ TL Y PE
Sbjct: 161 QNLL--------LSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII---TLWYRPPEIL 209
Query: 448 AGQTSSSGGGNTYRITYKS--DVWSLGCILYNMIYGR 482
G Y + D+WS+ CI M+
Sbjct: 210 LGSR-----------HYSTSVDIWSIACIWAEMLMKT 235
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 7e-17
Identities = 69/323 (21%), Positives = 113/323 (34%), Gaps = 79/323 (24%)
Query: 264 LGKGGSSSVYL--VGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYV 321
LGKG SV + ++ + +A+K L T++ + D + E+E+L LQ +
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKK--LQHSTEEHLRD-FEREIEILKSLQ-HDNI 73
Query: 322 IKMHDYVYDTASKHLYV---LMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAV 378
+K Y ++L + + G L Y++ +K ++ + +
Sbjct: 74 VKYKGVCYSAGRRNLKLIMEYLPYGS--LRDYLQK-HKERIDHIKLL-------QYTSQI 123
Query: 379 KEIHAAG--------IIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTS 430
G IH DL N L V N N +KI DFG+ L DK
Sbjct: 124 ----CKGMEYLGTKRYIHRDLATRNIL-VEN--------ENRVKIGDFGLTKVLPQDK-E 169
Query: 431 VHKDTASGTL--NYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI-YGRTPYSH 487
K G + +PE+ + + SDVWS G +LY + Y S
Sbjct: 170 FFKVKEPGESPIFWYAPESL---------TESKFSVASDVWSFGVVLYELFTYIEKSKSP 220
Query: 488 IPNTWAKMLAIARHKDQIEFKPQLANNVTI---------------PPTLLQSMKLCLQKD 532
P + +M+ + Q+ I P + M C +
Sbjct: 221 -PAEFMRMIGNDKQ-------GQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNN 272
Query: 533 PKARPT---VGNSVTQINNNPEG 552
RP+ + V QI +N G
Sbjct: 273 VNQRPSFRDLALRVDQIRDNMAG 295
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 9e-17
Identities = 63/325 (19%), Positives = 109/325 (33%), Gaps = 85/325 (26%)
Query: 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVEL--LA 313
+ +L +GKG V+ G+ + E +A+K+ D S+ E EL
Sbjct: 8 RDITLLECVGKGRYGEVWR--GSWQGE--NVAVKIFSSRDE------KSWFRETELYNTV 57
Query: 314 KLQGCPYVIKMHDYV-----YDTASKHLYV-------LMEKGDTDLSKYMRNLNKMTTLP 361
L+ H+ + D S+H E G L Y++ TTL
Sbjct: 58 MLR--------HENILGFIASDMTSRHSSTQLWLITHYHEMGS--LYDYLQL----TTLD 103
Query: 362 NTMIIIIMHWYEMLLAVKEIHAA--------GIIHSDLKPANFLFVGNVLKIIDCIGNVL 413
+ I+ + + +H I H DLK N L N
Sbjct: 104 TVSCLRIV--LSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKN---------GQC 152
Query: 414 KIIDFGIACSLQDDKTSVHKDTAS----GTLNYMSPEAAGQTSSSGGGNTYRITYKSDVW 469
I D G+A +++ D + GT YM+PE + + + + D+W
Sbjct: 153 CIADLGLAV--MHSQSTNQLDVGNNPRVGTKRYMAPEV---LDETIQVDCFDSYKRVDIW 207
Query: 470 SLGCILYNMIYGRTPYSHIPN-------------TWAKMLAIARHKDQ---IEFKPQLAN 513
+ G +L+ + + + ++ M + Q I P
Sbjct: 208 AFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNI---PNRWF 264
Query: 514 NVTIPPTLLQSMKLCLQKDPKARPT 538
+ +L + MK C ++P AR T
Sbjct: 265 SDPTLTSLAKLMKECWYQNPSARLT 289
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 1e-16
Identities = 58/249 (23%), Positives = 103/249 (41%), Gaps = 58/249 (23%)
Query: 303 DSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYV---LMEKGDTDLSKYMRNLNKMTT 359
+++L E +++ KL+ +++++ V + + +Y+ M KG L +++
Sbjct: 224 EAFLQEAQVMKKLR-HEKLVQLYAVVSE---EPIYIVTEYMSKGS--LLDFLKGETGKYL 277
Query: 360 LPNTMIIIIMHWYEMLLAVKE----IHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415
++ +M + + +H DL+ AN L VG V K+
Sbjct: 278 RLPQLV-------DMAAQIASGMAYVERMNYVHRDLRAANIL-VGE--------NLVCKV 321
Query: 416 IDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCIL 475
DFG+A ++D++ + + + + +PEAA R T KSDVWS G +L
Sbjct: 322 ADFGLARLIEDNEYTARQGA-KFPIKWTAPEAA---------LYGRFTIKSDVWSFGILL 371
Query: 476 YNMI-YGRTPYSHIPNTWAKMLAIARHKDQIE-----FKPQLANNVTIPPTLLQSMKLCL 529
+ GR PY + N DQ+E P P +L M C
Sbjct: 372 TELTTKGRVPYPGMVNREVL--------DQVERGYRMPCPPEC-----PESLHDLMCQCW 418
Query: 530 QKDPKARPT 538
+K+P+ RPT
Sbjct: 419 RKEPEERPT 427
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 51/316 (16%), Positives = 103/316 (32%), Gaps = 67/316 (21%)
Query: 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVE--LLA 313
+ + +GKG V+ G E +A+K+ + S+ E E
Sbjct: 42 RTIVLQESIGKGRFGEVWR--GKWRGE--EVAVKIFSSREE------RSWFREAEIYQTV 91
Query: 314 KLQGCPYVIKM--HDYVYDTASKHLYVLMEKGDTDLSKYMRN------LNKMTTLPNTMI 365
L+ ++ D + L+++ + Y + LN+ T MI
Sbjct: 92 MLR-HENILGFIAADNKDNGTWTQLWLVSD--------YHEHGSLFDYLNRYTVTVEGMI 142
Query: 366 III------MHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFG 419
+ + M + V I H DLK N L N I D G
Sbjct: 143 KLALSTASGLAHLHMEI-VGTQGKPAIAHRDLKSKNILVKKN---------GTCCIADLG 192
Query: 420 IACSLQDDKTSVHKDTAS----GTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCIL 475
+A D + D A GT YM+PE + + +++ ++D++++G +
Sbjct: 193 LAVRH--DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFK---RADIYAMGLVF 247
Query: 476 YNMIYGRTPYSHIPNT---WAKMLAIARHKDQIEFK----------PQLANNVTIPPTLL 522
+ + + + + ++ +++ P + +
Sbjct: 248 WEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMA 307
Query: 523 QSMKLCLQKDPKARPT 538
+ M+ C + AR T
Sbjct: 308 KIMRECWYANGAARLT 323
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 1e-16
Identities = 57/327 (17%), Positives = 116/327 (35%), Gaps = 93/327 (28%)
Query: 238 SNAKKSVETSQDVITLNGKQYQVLSLLGKGGSSSVYL-VGGTSEHEFKPLALKVVDLSDI 296
++ + E ++ I L +G+G V+ + + E+ +A+K +
Sbjct: 4 GSSTRDYEIQRERIELGRC-------IGEGQFGDVHQGIYMSPENPALAVAIKT--CKNC 54
Query: 297 TDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH-LYV---LMEKGDTDLSKYMR 352
T S+ + +L E + + P+++K+ + +++ +++ L G+ L +++
Sbjct: 55 TSDSVREKFLQEALTMRQFD-HPHIVKLIGVI----TENPVWIIMELCTLGE--LRSFLQ 107
Query: 353 NLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAG--------IIHSDLKPANFLFVGNVLK 404
L + + + + +H D+ N L V +
Sbjct: 108 VRKYSLDLASLI--------LYAYQL----STALAYLESKRFVHRDIAARNVL-VSS--- 151
Query: 405 IIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTL---NYMSPEAAGQTSSSGGGNTYR 461
+ +K+ DFG++ ++D AS +M+PE+ +R
Sbjct: 152 -----NDCVKLGDFGLSRYMEDSTYY----KASKGKLPIKWMAPESI----------NFR 192
Query: 462 I-TYKSDVWSLGCILYNMI-YGRTPYSHIPNTWAKMLAIARHKDQIEF--------KPQL 511
T SDVW G ++ ++ +G P+ + N D I P
Sbjct: 193 RFTSASDVWMFGVCMWEILMHGVKPFQGVKN-----------NDVIGRIENGERLPMPPN 241
Query: 512 ANNVTIPPTLLQSMKLCLQKDPKARPT 538
PPTL M C DP RP
Sbjct: 242 C-----PPTLYSLMTKCWAYDPSRRPR 263
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-16
Identities = 47/260 (18%), Positives = 88/260 (33%), Gaps = 80/260 (30%)
Query: 303 DSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYV---LMEKGDTDLSKYMRNLNKMTT 359
D ++ E +++ L +++++ T + +++ M G L Y+R +
Sbjct: 64 DEFIEEAKVMMNLS-HEKLVQLYGVC--TKQRPIFIITEYMANGC--LLNYLREMRHRFQ 118
Query: 360 LPNTMIIIIMHWYEMLLAVKEIHAAG--------IIHSDLKPANFLFVGNVLKIIDCIGN 411
++ EM V +H DL N L V +
Sbjct: 119 TQ-QLL-------EMCKDV----CEAMEYLESKQFLHRDLAARNCL-VND--------QG 157
Query: 412 VLKIIDFGIACSLQDDKTSVHKDTASGTL---NYMSPEAAGQTSSSGGGNTYRI-TYKSD 467
V+K+ DFG++ + DD+ + G+ + PE Y + KSD
Sbjct: 158 VVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVL----------MYSKFSSKSD 203
Query: 468 VWSLGCILYNMI-YGRTPYSHIPNTWAKMLAIARHKDQIEF--------KPQLANNVTIP 518
+W+ G +++ + G+ PY N + E +P LA
Sbjct: 204 IWAFGVLMWEIYSLGKMPYERFTN-----------SETAEHIAQGLRLYRPHLA-----S 247
Query: 519 PTLLQSMKLCLQKDPKARPT 538
+ M C + RPT
Sbjct: 248 EKVYTIMYSCWHEKADERPT 267
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 2e-16
Identities = 61/342 (17%), Positives = 121/342 (35%), Gaps = 84/342 (24%)
Query: 244 VETSQDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIAD 303
+E + +L+ ++L L+G+G +VY G+ + P+A+KV ++
Sbjct: 1 MEAAASEPSLDLDNLKLLELIGRGRYGAVYK--GSLDER--PVAVKVFSFANR------Q 50
Query: 304 SYLNEVE--LLAKLQGCPYVIKMHD----------YVYDTASKHLYVLMEKGDTDLSKYM 351
+++NE + ++ HD V ++ME Y
Sbjct: 51 NFINEKNIYRVPLME--------HDNIARFIVGDERVTADGRMEYLLVME--------YY 94
Query: 352 RN------LNKMTTLPNTMIIII------MHWYEMLLAVKEIHAAGIIHSDLKPANFLFV 399
N L+ T+ + + + + L + + I H DL N L
Sbjct: 95 PNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVL-- 152
Query: 400 GNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTAS------GTLNYMSPEAAGQTSS 453
+ G I DFG++ L ++ + + GT+ YM+PE +
Sbjct: 153 ------VKNDGTC-VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVN 205
Query: 454 SGGGNTYRITYKSDVWSLGCILYNMIYGRT---PYSHIPN-------------TWAKMLA 497
+ + D+++LG I + + T P +P T+ M
Sbjct: 206 LRDXESA--LKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQV 263
Query: 498 IARHKDQI-EFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
+ + Q +F N +L ++++ C +D +AR T
Sbjct: 264 LVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLT 305
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 2e-16
Identities = 59/260 (22%), Positives = 100/260 (38%), Gaps = 80/260 (30%)
Query: 303 DSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYV---LMEKGDTDLSKYMRNLNKMTT 359
+ ++ E E++ KL P +++++ + + ME G LS Y+R +
Sbjct: 48 EDFIEEAEVMMKLS-HPKLVQLYGVC--LEQAPICLVTEFMEHGC--LSDYLRT-QRGLF 101
Query: 360 LPNTMIIIIMHWYEMLLAVKEIHAAG--------IIHSDLKPANFLFVGNVLKIIDCIGN 411
T++ M L V G +IH DL N L VG
Sbjct: 102 AAETLL-------GMCLDV----CEGMAYLEEACVIHRDLAARNCL-VGE--------NQ 141
Query: 412 VLKIIDFGIACSLQDDKTSVHKDTASGTL---NYMSPEAAGQTSSSGGGNTYRI-TYKSD 467
V+K+ DFG+ + DD+ + +GT + SPE ++ + KSD
Sbjct: 142 VIKVSDFGMTRFVLDDQYTSS----TGTKFPVKWASPEVF----------SFSRYSSKSD 187
Query: 468 VWSLGCILYNMI-YGRTPYSHIPNTWAKMLAIARHKDQIEF--------KPQLANNVTIP 518
VWS G +++ + G+ PY + N + +E KP+LA
Sbjct: 188 VWSFGVLMWEVFSEGKIPYENRSN-----------SEVVEDISTGFRLYKPRLA-----S 231
Query: 519 PTLLQSMKLCLQKDPKARPT 538
+ Q M C ++ P+ RP
Sbjct: 232 THVYQIMNHCWRERPEDRPA 251
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 3e-16
Identities = 49/180 (27%), Positives = 80/180 (44%), Gaps = 31/180 (17%)
Query: 308 EVELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTT---LPNTM 364
E+ L+ +L+ +++++D ++ L ++ E D DL KYM + T L +
Sbjct: 53 EISLMKELK-HENIVRLYDVIHT--ENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNL 109
Query: 365 IIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSL 424
+ +++L + H I+H DLKP N L I+ G LK+ DFG+A +
Sbjct: 110 VKYFQ--WQLLQGLAFCHENKILHRDLKPQNLL--------INKRGQ-LKLGDFGLARAF 158
Query: 425 QD-DKTSVHKDTASGTLNYMSPEA-AGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGR 482
T + TL Y +P+ G + S D+WS GCIL MI G+
Sbjct: 159 GIPVNTFSSEVV---TLWYRAPDVLMGSRTYSTS---------IDIWSCGCILAEMITGK 206
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 3e-16
Identities = 63/302 (20%), Positives = 107/302 (35%), Gaps = 88/302 (29%)
Query: 264 LGKGGSSSVYLVGGT---SEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPY 320
LG+G VY G + E +A+K + +++E ++ L P+
Sbjct: 20 LGEGFFGEVYE--GVYTNHKGEKINVAVKT--CKKDCTLDNKEKFMSEAVIMKNLD-HPH 74
Query: 321 VIKMHDYVYDTASKH-LYV---LMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLL 376
++K+ + + ++ L G+ L Y+ NK + T++ L
Sbjct: 75 IVKLIGII----EEEPTWIIMELYPYGE--LGHYLER-NKNSLKVLTLV-------LYSL 120
Query: 377 AVKEIHAAG--------IIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDK 428
+ +H D+ N L V + +K+ DFG++ ++D+
Sbjct: 121 QI----CKAMAYLESINCVHRDIAVRNIL-VAS--------PECVKLGDFGLSRYIEDED 167
Query: 429 TSVHKDTASGTL---NYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI-YGRTP 484
AS T +MSPE+ N R T SDVW ++ ++ +G+ P
Sbjct: 168 YY----KASVTRLPIKWMSPESI---------NFRRFTTASDVWMFAVCMWEILSFGKQP 214
Query: 485 YSHIPNTWAKMLAIARHKDQIEF--------KPQLANNVTIPPTLLQSMKLCLQKDPKAR 536
+ + N KD I KP L PP L M C DP R
Sbjct: 215 FFWLEN-----------KDVIGVLEKGDRLPKPDLC-----PPVLYTLMTRCWDYDPSDR 258
Query: 537 PT 538
P
Sbjct: 259 PR 260
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 4e-16
Identities = 67/297 (22%), Positives = 110/297 (37%), Gaps = 73/297 (24%)
Query: 264 LGKGGSSSVYL-VGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVI 322
+GKG VY A+K LS IT+ +++L E L+ L P V+
Sbjct: 29 IGKGHFGVVYHGEYIDQAQNRIQCAIKS--LSRITEMQQVEAFLREGLLMRGLN-HPNVL 85
Query: 323 KMHDYVYDTASKHLYV--LMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKE 380
+ + + M GD L +++R+ + T+ +++ +
Sbjct: 86 ALIGIMLPPEGLPHVLLPYMCHGD--LLQFIRSPQRNPTVK-----------DLISFGLQ 132
Query: 381 IHAAG--------IIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVH 432
+ A G +H DL N + + +K+ DFG+A + D +
Sbjct: 133 V-ARGMEYLAEQKFVHRDLAARNCM-LDE--------SFTVKVADFGLARDILDREYYSV 182
Query: 433 KDTASGTL--NYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI-YGRTPYSHIP 489
+ L + + E+ TYR T KSDVWS G +L+ ++ G PY HI
Sbjct: 183 QQHRHARLPVKWTALESL---------QTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID 233
Query: 490 NTWAKMLAIARHKDQIEF--------KPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
D F +P+ P +L Q M+ C + DP RPT
Sbjct: 234 P-----------FDLTHFLAQGRRLPQPE-----YCPDSLYQVMQQCWEADPAVRPT 274
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 4e-16
Identities = 74/336 (22%), Positives = 125/336 (37%), Gaps = 72/336 (21%)
Query: 216 TKSSDPSVSKETIKPAKPQITTSNAKKSVETSQDVITLNGKQYQVLSLLGKGGSSSVYLV 275
K +D K ++ + K + E ++ + L K LG G V++
Sbjct: 155 KKGNDGLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKK-------LGAGQFGEVWMA 207
Query: 276 GGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335
+A+K + +++L E ++ LQ ++K+H V +
Sbjct: 208 TYNKHT---KVAVKTM----KPGSMSVEAFLAEANVMKTLQ-HDKLVKLHAVVTK---EP 256
Query: 336 LYV---LMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKE----IHAAGIIH 388
+Y+ M KG L ++++ +I + + E I IH
Sbjct: 257 IYIITEFMAKGS--LLDFLKSDEGSKQPLPKLI-------DFSAQIAEGMAFIEQRNYIH 307
Query: 389 SDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAA 448
DL+ AN L V V KI DFG+A ++D++ + + A + + +PEA
Sbjct: 308 RDLRAANIL-VSA--------SLVCKIADFGLARVIEDNEYTAREG-AKFPIKWTAPEAI 357
Query: 449 GQTSSSGGGNTYRITYKSDVWSLGCILYNMI-YGRTPYSHIPNTWAKMLAIARHKDQIE- 506
N T KSDVWS G +L ++ YGR PY + N +E
Sbjct: 358 ---------NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--------PEVIRALER 400
Query: 507 ----FKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
+P+ P L M C + P+ RPT
Sbjct: 401 GYRMPRPENC-----PEELYNIMMRCWKNRPEERPT 431
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 4e-16
Identities = 67/299 (22%), Positives = 120/299 (40%), Gaps = 59/299 (19%)
Query: 264 LGKGGSSSVY---LVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPY 320
LG G V G +A+K+ L + ++ ++E+++L+ L
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKM--LKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 321 VIKMHDYVYDTASKHLYVLME---KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLA 377
++ + T V+ E GD L ++R + + + + IM E+ L
Sbjct: 89 IVNLLGAC--TIGGPTLVITEYCCYGD--LLNFLRR-KRDSFICSKTSPAIMEDDELALD 143
Query: 378 VKEIH------AAG--------IIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACS 423
++++ A G IH DL N L + + G + KI DFG+A
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL-LTH--------GRITKICDFGLARD 194
Query: 424 LQDDKTSVHKDTASGTL--NYMSPEAAGQTSSSGGGNTYRI-TYKSDVWSLGCILYNMI- 479
+++D S + + L +M+PE+ + T++SDVWS G L+ +
Sbjct: 195 IKND--SNYVVKGNARLPVKWMAPESI----------FNCVYTFESDVWSYGIFLWELFS 242
Query: 480 YGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
G +PY +P +K + + ++ P+ A P + MK C DP RPT
Sbjct: 243 LGSSPYPGMP-VDSKFYKMIKEGFRML-SPEHA-----PAEMYDIMKTCWDADPLKRPT 294
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 4e-16
Identities = 72/340 (21%), Positives = 118/340 (34%), Gaps = 76/340 (22%)
Query: 230 PAKPQITTSNAKKSVETSQDVITLNGKQYQVLSLLGKGGSSSVYL--VGGTSEHEFKPLA 287
P + A S +D + + L LGKG SV + ++ + +A
Sbjct: 15 PTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVA 74
Query: 288 LKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLME---KGD 344
+K L T++ + D + E+E+L LQ ++K Y ++L ++ME G
Sbjct: 75 VKK--LQHSTEEHLRD-FEREIEILKSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGS 130
Query: 345 TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAG--------IIHSDLKPANF 396
L Y++ + ++L +I G IH DL N
Sbjct: 131 --LRDYLQKHKERIDHI-----------KLLQYTSQI-CKGMEYLGTKRYIHRDLATRNI 176
Query: 397 LFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTL--NYMSPEAAGQTSSS 454
L V N N +KI DFG+ L DK +K G + +PE+
Sbjct: 177 L-VEN--------ENRVKIGDFGLTKVLPQDK-EYYKVKEPGESPIFWYAPESL------ 220
Query: 455 GGGNTYRITYKSDVWSLGCILYNMI-YGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLAN 513
+ + SDVWS G +LY + Y S P + +M+ + Q+
Sbjct: 221 ---TESKFSVASDVWSFGVVLYELFTYIEKSKSP-PAEFMRMIGNDKQ-------GQMIV 269
Query: 514 NVTI---------------PPTLLQSMKLCLQKDPKARPT 538
I P + M C + RP+
Sbjct: 270 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPS 309
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 5e-16
Identities = 59/314 (18%), Positives = 101/314 (32%), Gaps = 63/314 (20%)
Query: 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVE--LLA 313
KQ Q++ +GKG V++ G E +A+KV ++ S+ E E
Sbjct: 37 KQIQMVKQIGKGRYGEVWM--GKWRGE--KVAVKVFFTTEE------ASWFRETEIYQTV 86
Query: 314 KLQGCPYVIKM--HDYVYDTASKHLYV---LMEKGDTDLSKYMRNLNKMTTLPNTMIIII 368
++ ++ D + LY+ E G L Y L T +M+ +
Sbjct: 87 LMR-HENILGFIAADIKGTGSWTQLYLITDYHENGS--LYDY---LKSTTLDAKSMLKLA 140
Query: 369 M---------HWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFG 419
H K I H DLK N L N I D G
Sbjct: 141 YSSVSGLCHLHTEIFSTQGK----PAIAHRDLKSKNILVKKN---------GTCCIADLG 187
Query: 420 IACSLQDDKTSVHKDTAS--GTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYN 477
+A D V + GT YM PE ++ + +Y +D++S G IL+
Sbjct: 188 LAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYI---MADMYSFGLILWE 244
Query: 478 MIYGRTPYSHIPNT---WAKMLAIARHKDQIEFK----------PQLANNVTIPPTLLQS 524
+ + + ++ + + P ++ + +
Sbjct: 245 VARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKL 304
Query: 525 MKLCLQKDPKARPT 538
M C +P +R T
Sbjct: 305 MTECWAHNPASRLT 318
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 5e-16
Identities = 72/310 (23%), Positives = 134/310 (43%), Gaps = 60/310 (19%)
Query: 239 NAKKSVETSQDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPL-ALKVVDLSDI- 296
+++ SV + I +++L +LGKGG V+ V + + A+KV+ + I
Sbjct: 2 SSETSVNRGPEKIRPE--CFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIV 59
Query: 297 TDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLME--KGDTDLSKYMRNL 354
+ E +L +++ P+++ + Y + T K LY+++E G +L L
Sbjct: 60 RNAKDTAHTKAERNILEEVK-HPFIVDLI-YAFQTGGK-LYLILEYLSGG-EL---FMQL 112
Query: 355 NKMTTLPNTMIIIIMHWY--EMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNV 412
+ Y E+ +A+ +H GII+ DLKP N + ++ G+V
Sbjct: 113 EREGIFMEDTACF----YLAEISMALGHLHQKGIIYRDLKPENIM--------LNHQGHV 160
Query: 413 LKIIDFGIAC--SLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWS 470
K+ DFG+ C S+ D + T GT+ YM+PE + + D WS
Sbjct: 161 -KLTDFGL-CKESIHDGTVT---HTFCGTIEYMAPEIL-------MRSGH--NRAVDWWS 206
Query: 471 LGCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQS----MK 526
LG ++Y+M+ G P++ ++ + L + +PP L Q +K
Sbjct: 207 LGALMYDMLTGAPPFT------------GENRKKT-IDKILKCKLNLPPYLTQEARDLLK 253
Query: 527 LCLQKDPKAR 536
L+++ +R
Sbjct: 254 KLLKRNAASR 263
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 5e-16
Identities = 52/306 (16%), Positives = 98/306 (32%), Gaps = 76/306 (24%)
Query: 264 LGKGGSSSVYL--VGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYV 321
LG+G V L ++ + +A+K + + IAD E+E+L L +
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLK-PESGGNHIAD-LKKEIEILRNLY-HENI 85
Query: 322 IKMHDYVYDTASKHLYV---LMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAV 378
+K + + + + G L +Y+ NK + + + +
Sbjct: 86 VKYKGICTEDGGNGIKLIMEFLPSGS--LKEYLPK-NKNKINLKQQL-------KYAVQI 135
Query: 379 KEIHAAG--------IIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTS 430
G +H DL N L V + + +KI DFG+ +++ DK
Sbjct: 136 ----CKGMDYLGSRQYVHRDLAARNVL-VES--------EHQVKIGDFGLTKAIETDK-E 181
Query: 431 VHKDTASGTL--NYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI-YGRTPYSH 487
+ + +PE + SDVWS G L+ ++ Y + S
Sbjct: 182 YYTVKDDRDSPVFWYAPECL---------MQSKFYIASDVWSFGVTLHELLTYCDSDSSP 232
Query: 488 IPNTWAKMLAIARHKDQIEFKPQLANNVTI---------------PPTLLQSMKLCLQKD 532
+ + Q+ + P + Q M+ C +
Sbjct: 233 MALFLKMIGP---------THGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQ 283
Query: 533 PKARPT 538
P R +
Sbjct: 284 PSNRTS 289
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 5e-16
Identities = 53/243 (21%), Positives = 87/243 (35%), Gaps = 45/243 (18%)
Query: 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDIT--------DQSIADSYL 306
Y V + G +V + E P+A+K V + D + L
Sbjct: 21 QSPYTVQRFISSGSYGAVCAG---VDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVL 77
Query: 307 NEVELLAKLQGCPYVIKMHDYVYDTAS---KHLYVLMEKGDTDLSKYMRNLNKMTTLPNT 363
E+ LL P ++ + D LY++ E TDL++ + + + +
Sbjct: 78 REIRLLNHFH-HPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHD--QRIVISPQ 134
Query: 364 MIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACS 423
I M Y +LL + +H AG++H DL P GN+L + + I DF +A
Sbjct: 135 HIQYFM--YHILLGLHVLHEAGVVHRDLHP------GNILLADNN---DITICDFNLARE 183
Query: 424 LQDDKTS---VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY 480
D V Y +PE + T D+WS GC++ M
Sbjct: 184 DTADANKTHYV------THRWYRAPELV------MQFKGF--TKLVDMWSAGCVMAEMFN 229
Query: 481 GRT 483
+
Sbjct: 230 RKA 232
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 7e-16
Identities = 69/293 (23%), Positives = 118/293 (40%), Gaps = 57/293 (19%)
Query: 264 LGKGGSSSVY---LVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPY 320
LG+G VY G + +A+K V+ + + + +LNE ++ + C +
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIE-FLNEASVMKEFN-CHH 89
Query: 321 VIKMHDYVYDTASKHLYV---LMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLA 377
V+++ V + + V LM +GD L Y+R+L + + +M+
Sbjct: 90 VVRLLGVV--SQGQPTLVIMELMTRGD--LKSYLRSLRPAMANNPVLAPPSLS--KMIQM 143
Query: 378 VKEIHAAG--------IIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKT 429
EI A G +H DL N + V +KI DFG+ + + T
Sbjct: 144 AGEI-ADGMAYLNANKFVHRDLAARNCM-VAE--------DFTVKIGDFGMTRDIYE--T 191
Query: 430 SVHKDTASGTL--NYMSPEAAGQTSSSGGGNTYRI-TYKSDVWSLGCILYNMI-YGRTPY 485
++ G L +MSPE+ + T SDVWS G +L+ + PY
Sbjct: 192 DYYRKGGKGLLPVRWMSPESL----------KDGVFTTYSDVWSFGVVLWEIATLAEQPY 241
Query: 486 SHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
+ N ++L ++ KP P L + M++C Q +PK RP+
Sbjct: 242 QGLSN--EQVLRFVMEGGLLD-KPDNC-----PDMLFELMRMCWQYNPKMRPS 286
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 8e-16
Identities = 64/305 (20%), Positives = 108/305 (35%), Gaps = 75/305 (24%)
Query: 264 LGKGGSSSVY---LVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPY 320
LG+ VY L G + + +A+K + + + +E L A+LQ P
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK-DKAEGPLREE-FRHEAMLRARLQ-HPN 73
Query: 321 VIKMHDYVYDTASKHLYV---LMEKGDTDLSKYMRN----LNKMTTLPNTMIIIIMHWYE 373
V+ + V T + L + GD L +++ + +T + + + +
Sbjct: 74 VVCLLGVV--TKDQPLSMIFSYCSHGD--LHEFLVMRSPHSDVGSTDDDRTVKSALEPPD 129
Query: 374 MLLAVKEIHAAG--------IIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQ 425
+ V +I AAG ++H DL N L V + +KI D G+ +
Sbjct: 130 FVHLVAQI-AAGMEYLSSHHVVHKDLATRNVL-VYD--------KLNVKISDLGLFREVY 179
Query: 426 DDKTSVHKDTASGTL--NYMSPEAAGQTSSSGGGNTYRI-TYKSDVWSLGCILYNMI-YG 481
+K + L +M+PEA Y + SD+WS G +L+ + YG
Sbjct: 180 A--ADYYKLLGNSLLPIRWMAPEAI----------MYGKFSIDSDIWSYGVVLWEVFSYG 227
Query: 482 RTPYSHIPNTWAKMLAIARHKDQIEF--------KPQLANNVTIPPTLLQSMKLCLQKDP 533
PY N +D +E P P + M C + P
Sbjct: 228 LQPYCGYSN-----------QDVVEMIRNRQVLPCPD-----DCPAWVYALMIECWNEFP 271
Query: 534 KARPT 538
RP
Sbjct: 272 SRRPR 276
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 8e-16
Identities = 71/305 (23%), Positives = 118/305 (38%), Gaps = 76/305 (24%)
Query: 264 LGKGGSSSVYL---VGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPY 320
LG+G V+L + + +A+K L D T + D + E ELL LQ +
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKA--LKDPTLAARKD-FQREAELLTNLQ-HEH 78
Query: 321 VIKMHDYVYDTASKHLYV---LMEKGDTDLSKYMR----NLNKMTTLPNTMIIIIMHWYE 373
++K + L + M+ GD L+K++R + + + +
Sbjct: 79 IVKFYGVC--GDGDPLIMVFEYMKHGD--LNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 374 MLLAVKEIHAAG--------IIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQ 425
ML +I A+G +H DL N L VG ++KI DFG++ +
Sbjct: 135 MLHIASQI-ASGMVYLASQHFVHRDLATRNCL-VGA--------NLLVKIGDFGMSRDVY 184
Query: 426 DDKTSVHKDTASGTL--NYMSPEAAGQTSSSGGGNTYRI-TYKSDVWSLGCILYNMI-YG 481
++ L +M PE+ YR T +SDVWS G IL+ + YG
Sbjct: 185 ST--DYYRVGGHTMLPIRWMPPESI----------MYRKFTTESDVWSFGVILWEIFTYG 232
Query: 482 RTPYSHIPNTWAKMLAIARHKDQIEF--------KPQLANNVTIPPTLLQSMKLCLQKDP 533
+ P+ + NT + IE +P++ P + M C Q++P
Sbjct: 233 KQPWFQLSNT-----------EVIECITQGRVLERPRVC-----PKEVYDVMLGCWQREP 276
Query: 534 KARPT 538
+ R
Sbjct: 277 QQRLN 281
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 47/337 (13%), Positives = 109/337 (32%), Gaps = 57/337 (16%)
Query: 218 SSDPSVSKETIKPAKPQITTSNAKKSVETSQDVITLNGKQYQVLSLLGKGGSSSVYLV-- 275
SS + E + + + +++ T + +G+Q+++ S + +Y
Sbjct: 8 SSGVDLGTENLYFQS----MTTSLEALPTGTVLTDKSGRQWKLKSFQTRDNQGILYEAAP 63
Query: 276 ----GGTSEHEFKPLALKVVDLSDITDQSIADSYLN-----EVELLAKLQGCPY--VIKM 324
S + + +LK+ D D + + + +V KL P +
Sbjct: 64 TSTLTCDSGPQKQKFSLKL-DAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTC 122
Query: 325 HDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMT-TLPNTMIIIIMHWYEMLLAVKEIHA 383
+ K+ ++++ L + K + + + + +L A++ +H
Sbjct: 123 MGFGVHQ-DKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVAC----RLLDALEFLHE 177
Query: 384 AGIIHSDLKPANFLF-VGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVH-----KDTAS 437
+H ++ N + + + + +G A V +
Sbjct: 178 NEYVHGNVTAENIFVDPED--------QSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHE 229
Query: 438 GTLNYMSPEA-AGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY---GRTPYSHI--PNT 491
G L ++S + G S R +SD+ SLG Y M+ G P+++
Sbjct: 230 GDLEFISMDLHKGCGPS-------R---RSDLQSLG---YCMLKWLYGFLPWTNCLPNTE 276
Query: 492 WAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLC 528
F + + TL + +K+
Sbjct: 277 DIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVV 313
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 78.5 bits (193), Expect = 1e-15
Identities = 55/259 (21%), Positives = 106/259 (40%), Gaps = 37/259 (14%)
Query: 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAK 314
G ++++ +G G +YL GT+ + +A+K+ ++ Q L E ++
Sbjct: 6 GNKFRLGRKIGSGSFGEIYL--GTNIQTNEEVAIKLENVKTKHPQ-----LLYESKIYRI 58
Query: 315 LQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEM 374
LQG + + + + + ++M+ L ++ +L +++ +M
Sbjct: 59 LQGGTGIPNVRWFGVE--GDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLAD----QM 112
Query: 375 LLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVH-- 432
+ V+ +H+ +H D+KP NFL +G + N + IIDFG+A +D T H
Sbjct: 113 INRVEFVHSKSFLHRDIKPDNFL-MGLGRR-----ANQVYIIDFGLAKKYRDTSTHQHIP 166
Query: 433 -KDTAS--GTLNYMSPEA-AGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHI 488
++ + GT Y S G S + D+ SLG +L + G P+ +
Sbjct: 167 YRENKNLTGTARYASVNTHLGIEQS----------RRDDLESLGYVLMYFLRGSLPWQGL 216
Query: 489 --PNTWAKMLAIARHKDQI 505
K I+ K
Sbjct: 217 KAGTKKQKYEKISEKKVAT 235
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 1e-15
Identities = 46/307 (14%), Positives = 99/307 (32%), Gaps = 92/307 (29%)
Query: 264 LGKGGSSSVYL-----VGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGC 318
LG+G + ++ VG + + LKV+D ++ ++S+ +++KL
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLD---KAHRNYSESFFEAASMMSKLS-H 71
Query: 319 PYVIKMHDYVYDTASKHLYV---LMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEML 375
+++ + + ++ G L Y++ NK + E+
Sbjct: 72 KHLVLNYGVC--VCGDENILVQEFVKFGS--LDTYLKK-NKNCINILWKL-------EVA 119
Query: 376 LAVKEIHAAG--------IIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDD 427
+ AA +IH ++ N L + +K+ D GI+ ++
Sbjct: 120 KQL----AAAMHFLEENTLIHGNVCAKNIL-LIREEDRKTGNPPFIKLSDPGISITVLPK 174
Query: 428 KTSVHKDTASGTLNY-------MSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI- 479
+ + PE N + +D WS G L+ +
Sbjct: 175 -------------DILQERIPWVPPECIE--------NPKNLNLATDKWSFGTTLWEICS 213
Query: 480 YGRTPYSHIPNTWAKMLAIARHKDQIEF--------KPQLANNVTIPPTLLQSMKLCLQK 531
G P S + + + +++F P+ L + C+
Sbjct: 214 GGDKPLSALDS-----------QRKLQFYEDRHQLPAPK-------AAELANLINNCMDY 255
Query: 532 DPKARPT 538
+P RP+
Sbjct: 256 EPDHRPS 262
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 78.4 bits (193), Expect = 2e-15
Identities = 58/249 (23%), Positives = 103/249 (41%), Gaps = 58/249 (23%)
Query: 303 DSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYV---LMEKGDTDLSKYMRNLNKMTT 359
+++L E +++ KL+ +++++ V + + +Y+ M KG L +++
Sbjct: 307 EAFLQEAQVMKKLR-HEKLVQLYAVVSE---EPIYIVTEYMSKGS--LLDFLKGETGKYL 360
Query: 360 LPNTMIIIIMHWYEMLLAVKE----IHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415
++ +M + + +H DL+ AN L VG V K+
Sbjct: 361 RLPQLV-------DMAAQIASGMAYVERMNYVHRDLRAANIL-VGE--------NLVCKV 404
Query: 416 IDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCIL 475
DFG+A ++D++ + + + + +PEAA R T KSDVWS G +L
Sbjct: 405 ADFGLARLIEDNEYTARQGA-KFPIKWTAPEAA---------LYGRFTIKSDVWSFGILL 454
Query: 476 YNMI-YGRTPYSHIPNTWAKMLAIARHKDQIE-----FKPQLANNVTIPPTLLQSMKLCL 529
+ GR PY + N DQ+E P P +L M C
Sbjct: 455 TELTTKGRVPYPGMVNREVL--------DQVERGYRMPCPPEC-----PESLHDLMCQCW 501
Query: 530 QKDPKARPT 538
+K+P+ RPT
Sbjct: 502 RKEPEERPT 510
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 2e-15
Identities = 55/293 (18%), Positives = 102/293 (34%), Gaps = 65/293 (22%)
Query: 264 LGKGGSSSVYLVGGT---SEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPY 320
LG G V G + +A+K + ++ D ++ EV + L
Sbjct: 26 LGDGSFGVVRR--GEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRN 82
Query: 321 VIKMHDYVYDTASKHLYV---LMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLA 377
+I+++ V + + + L G L +R ++ L T+ +
Sbjct: 83 LIRLYGVV---LTPPMKMVTELAPLGS--LLDRLRK-HQGHFLLGTLS-------RYAVQ 129
Query: 378 VKEIHAAG--------IIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKT 429
V A G IH DL N L + +++KI DFG+ +L +
Sbjct: 130 V----AEGMGYLESKRFIHRDLAARNLL-LAT--------RDLVKIGDFGLMRALPQNDD 176
Query: 430 SVHKDTASGT---LNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI-YGRTPY 485
+ +PE+ T ++ SD W G L+ M YG+ P+
Sbjct: 177 HYV--MQEHRKVPFAWCAPESL---------KTRTFSHASDTWMFGVTLWEMFTYGQEPW 225
Query: 486 SHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
+ + + I + +++ +P+ P + M C P+ RPT
Sbjct: 226 IGLNGSQI-LHKIDKEGERLP-RPEDC-----PQDIYNVMVQCWAHKPEDRPT 271
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 62/385 (16%), Positives = 124/385 (32%), Gaps = 82/385 (21%)
Query: 177 KGPTQTKSVFSVRSASDQSLSQKKNESTPVFKRPLSVNSTKSSDPSVSKETIKPAKPQIT 236
+ + + R + E + + + + + P++
Sbjct: 17 RRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELV 76
Query: 237 TSNAKKSVETSQDVITLNGKQYQVLSLLGKGGSSSVYL-VGGTSEHEFKPLALKVVDLSD 295
+ + S ++ ++G+G VY ++ + A+K L+
Sbjct: 77 QAVQHVVIGPSSLIVHF-------NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS--LNR 127
Query: 296 ITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYV--LMEKGDTDLSKYMRN 353
ITD +L E ++ P V+ + + L V M+ GD L ++RN
Sbjct: 128 ITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGD--LRNFIRN 184
Query: 354 LNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAG--------IIHSDLKPANFLFVGNVLKI 405
T+ +++ ++ A G +H DL N + +
Sbjct: 185 ETHNPTVK-----------DLIGFGLQV-AKGMKFLASKKFVHRDLAARNCM-LDE---- 227
Query: 406 IDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTL--NYMSPEAAGQTSSSGGGNTYRI- 462
+K+ DFG+A + D + + L +M+ E+ +
Sbjct: 228 ----KFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL----------QTQKF 273
Query: 463 TYKSDVWSLGCILYNMI-YGRTPYSHIPNTWAKMLAIARHKDQIEF--------KPQLAN 513
T KSDVWS G +L+ ++ G PY + D + +P+
Sbjct: 274 TTKSDVWSFGVLLWELMTRGAPPYPDVNT-----------FDITVYLLQGRRLLQPEYC- 321
Query: 514 NVTIPPTLLQSMKLCLQKDPKARPT 538
P L + M C + RP+
Sbjct: 322 ----PDPLYEVMLKCWHPKAEMRPS 342
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 47/254 (18%), Positives = 89/254 (35%), Gaps = 61/254 (24%)
Query: 253 LNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELL 312
+ G Q+ + +G GG +YL ++ + A VV + + + +E++
Sbjct: 34 MEGNQWVLGKKIGSGGFGLIYL--AFPTNKPEKDARHVVKVEYQENGPL----FSELKFY 87
Query: 313 AKLQGCPYVIKMHDYVYDTA----------------SKHLYVLMEKGDTDLSKYMRNLNK 356
++ + K + + +++ME+ DL K
Sbjct: 88 QRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGT 147
Query: 357 M---TTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLF-VGNVLKIIDCIGNV 412
T L + I ML ++ IH +H D+K AN L N +
Sbjct: 148 FKKSTVL---QLGI-----RMLDVLEYIHENEYVHGDIKAANLLLGYKN--------PDQ 191
Query: 413 LKIIDFGIACSLQDDKTSVH-----KDTASGTLNYMSPEA-AGQTSSSGGGNTYRITYKS 466
+ + D+G++ + + +GT+ + S +A G S R +S
Sbjct: 192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALS-------R---RS 241
Query: 467 DVWSLGCILYNMIY 480
DV LG Y M+
Sbjct: 242 DVEILG---YCMLR 252
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 65/314 (20%), Positives = 118/314 (37%), Gaps = 81/314 (25%)
Query: 264 LGKGGSSSVY--LVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYV 321
LG G +VY L E P+A+K L + T L+E ++A + P+V
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKE--LREATSPKANKEILDEAYVMASVD-NPHV 79
Query: 322 IKMHDYVYDTASKHLYV---LMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAV 378
++ + + + LM G L Y+R +K ++ + +
Sbjct: 80 CRLLGIC---LTSTVQLITQLMPFGC--LLDYVRE-HKDNIGSQYLL-------NWCVQI 126
Query: 379 KEIHAAG--------IIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTS 430
A G ++H DL N L V +KI DFG+A L ++
Sbjct: 127 ----AKGMNYLEDRRLVHRDLAARNVL-VKT--------PQHVKITDFGLAKLLGAEEKE 173
Query: 431 VHKDTASGT---LNYMSPEAAGQTSSSGGGNTYRI-TYKSDVWSLGCILYNMI-YGRTPY 485
A G + +M+ E+ +RI T++SDVWS G ++ ++ +G PY
Sbjct: 174 Y---HAEGGKVPIKWMALESI----------LHRIYTHQSDVWSYGVTVWELMTFGSKPY 220
Query: 486 SHIPNTWAKMLAIARHKDQIEF-----KPQLANNVTIPPTLLQSMKLCLQKDPKARPT-- 538
IP +++ +E +P + + M+ C D +RP
Sbjct: 221 DGIPA--SEIS------SILEKGERLPQPPIC-----TIDVYMIMRKCWMIDADSRPKFR 267
Query: 539 -VGNSVTQINNNPE 551
+ +++ +P+
Sbjct: 268 ELIIEFSKMARDPQ 281
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 2e-15
Identities = 62/257 (24%), Positives = 106/257 (41%), Gaps = 74/257 (28%)
Query: 303 DSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH-LYV---LMEKGDTDLSKYMRNLNKMT 358
D++L E L+ +LQ +++++ V ++ +Y+ ME G L +++ + +
Sbjct: 53 DAFLAEANLMKQLQ-HQRLVRLYAVV----TQEPIYIITEYMENGS--LVDFLKTPSGIK 105
Query: 359 TLPNTMIIIIMHWYEMLLAVKE----IHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414
N ++ +M + E I IH DL+ AN L V + K
Sbjct: 106 LTINKLL-------DMAAQIAEGMAFIEERNYIHRDLRAANIL-VSD--------TLSCK 149
Query: 415 IIDFGIACSLQDDKTSVHKDTASGTL---NYMSPEAAGQTSSSGGGNTYRI-TYKSDVWS 470
I DFG+A ++D++ + G + +PEA Y T KSDVWS
Sbjct: 150 IADFGLARLIEDNEYTAR----EGAKFPIKWTAPEAI----------NYGTFTIKSDVWS 195
Query: 471 LGCILYNMI-YGRTPYSHIPNTWAKMLAIARHKDQIEF--------KPQLANNVTIPPTL 521
G +L ++ +GR PY + N + I+ +P P L
Sbjct: 196 FGILLTEIVTHGRIPYPGMTN-----------PEVIQNLERGYRMVRPDNC-----PEEL 239
Query: 522 LQSMKLCLQKDPKARPT 538
Q M+LC ++ P+ RPT
Sbjct: 240 YQLMRLCWKERPEDRPT 256
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 3e-15
Identities = 60/304 (19%), Positives = 118/304 (38%), Gaps = 65/304 (21%)
Query: 264 LGKGGSSSVY---LVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPY 320
LG+G V + +A+K+ L + S L+E +L ++ P+
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKM--LKENASPSELRDLLSEFNVLKQV-NHPH 87
Query: 321 VIKMHDYVYDTASKHLYVLME---KGDTDLSKYMRN-----LNKMTTLPNTMIIIIMHWY 372
VIK++ + L +++E G L ++R + + + + H
Sbjct: 88 VIKLYGAC--SQDGPLLLIVEYAKYGS--LRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143
Query: 373 EMLLAVKEIH------AAG--------IIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDF 418
E L + ++ + G ++H DL N L V G +KI DF
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNIL-VAE--------GRKMKISDF 194
Query: 419 GIACSLQDDKTSVHKDTASGTL--NYMSPEAAGQTSSSGGGNTYRI-TYKSDVWSLGCIL 475
G++ + ++ + + G + +M+ E+ I T +SDVWS G +L
Sbjct: 195 GLSRDVYEE--DSYVKRSQGRIPVKWMAIESL----------FDHIYTTQSDVWSFGVLL 242
Query: 476 YNMI-YGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPK 534
+ ++ G PY IP ++ + + ++E +P + + M C +++P
Sbjct: 243 WEIVTLGGNPYPGIPP--ERLFNLLKTGHRME-RPDNC-----SEEMYRLMLQCWKQEPD 294
Query: 535 ARPT 538
RP
Sbjct: 295 KRPV 298
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 4e-15
Identities = 69/296 (23%), Positives = 125/296 (42%), Gaps = 59/296 (19%)
Query: 264 LGKGGSSSVY---LVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPY 320
LG+G V+ E + +A+K L + ++ + D + E ELL LQ +
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKA--LKEASESARQD-FQREAELLTMLQ-HQH 104
Query: 321 VIKMHDYVYDTASKHLYV---LMEKGDTDLSKYMRNL---NKMTTLPNTMIIIIMHWYEM 374
+++ T + L + M GD L++++R+ K+ + + ++
Sbjct: 105 IVRFFGVC--TEGRPLLMVFEYMRHGD--LNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 375 LLAVKEIHAAG--------IIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQD 426
L ++ AAG +H DL N L VG G V+KI DFG++ +
Sbjct: 161 LAVASQV-AAGMVYLAGLHFVHRDLATRNCL-VGQ--------GLVVKIGDFGMSRDIYS 210
Query: 427 DKTSVHKDTASGTL--NYMSPEAAGQTSSSGGGNTYRI-TYKSDVWSLGCILYNMI-YGR 482
T ++ L +M PE+ YR T +SDVWS G +L+ + YG+
Sbjct: 211 --TDYYRVGGRTMLPIRWMPPESI----------LYRKFTTESDVWSFGVVLWEIFTYGK 258
Query: 483 TPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
P+ + N + + ++E +P+ PP + M+ C Q++P+ R +
Sbjct: 259 QPWYQLSN--TEAIDCITQGRELE-RPRAC-----PPEVYAIMRGCWQREPQQRHS 306
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 4e-15
Identities = 53/331 (16%), Positives = 109/331 (32%), Gaps = 49/331 (14%)
Query: 222 SVSKETIKPAKPQITTSNAKKSVETSQDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEH 281
S+ + + + + + + + + ++V +G+GG +YL S
Sbjct: 1 SMRVKAAQAGRQSSAKRHLAEQFAVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSE 60
Query: 282 EFKPLALKVVDLSDITD----------QSIADSYLNEVELLAKLQGCPYVIKMHDY-VYD 330
A VV + + Q A + + + V K ++D
Sbjct: 61 SVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHD 120
Query: 331 TASKHLYVL-MEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHS 389
K + M++ +DL K K + + + + +L ++ IH +H
Sbjct: 121 KNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSL----RILDILEYIHEHEYVHG 176
Query: 390 DLKPANFLF-VGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVH-----KDTASGTLNYM 443
D+K +N L N + + ++D+G+A + K GT+ +
Sbjct: 177 DIKASNLLLNYKN--------PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFT 228
Query: 444 SPEA-AGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY---GRTPYSHI--PNTWAKMLA 497
S +A G S R + D+ LG Y MI G P+ + +
Sbjct: 229 SIDAHNGVAPS-------R---RGDLEILG---YCMIQWLTGHLPWEDNLKDPKYVRDSK 275
Query: 498 IARHKDQIEFKPQLANNVTIPPTLLQSMKLC 528
I ++ + P + + M+
Sbjct: 276 IRYRENIASLMDKCFPAANAPGEIAKYMETV 306
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 5e-15
Identities = 56/257 (21%), Positives = 91/257 (35%), Gaps = 82/257 (31%)
Query: 306 LNEVELLAKLQGCPYVIKMHDYVYDTASK-HLYV---LMEKGDTDLSKYMRNLNKMTTLP 361
L E ++ +L+ ++++ + K LY+ M KG L Y+R+ +
Sbjct: 62 LAEASVMTQLR-HSNLVQLLGVI--VEEKGGLYIVTEYMAKGS--LVDYLRSRGRSVLGG 116
Query: 362 NTMIIIIMHWYEMLLAVKEIHAAG--------IIHSDLKPANFLFVGNVLKIIDCIGNVL 413
+ ++ + L V +H DL N L V NV
Sbjct: 117 DCLL-------KFSLDV----CEAMEYLEGNNFVHRDLAARNVL-VSE--------DNVA 156
Query: 414 KIIDFGIACSLQDDKTSVHKDTASGTL--NYMSPEAAGQTSSSGGGNTYRI-TYKSDVWS 470
K+ DFG+ ++ +G L + +PEA + + KSDVWS
Sbjct: 157 KVSDFGLT---KE----ASSTQDTGKLPVKWTAPEAL----------REKKFSTKSDVWS 199
Query: 471 LGCILYNMI-YGRTPYSHIPNTWAKMLAIARHKDQIEF--------KPQLANNVTIPPTL 521
G +L+ + +GR PY IP KD + P PP +
Sbjct: 200 FGILLWEIYSFGRVPYPRIPL-----------KDVVPRVEKGYKMDAPDGC-----PPAV 243
Query: 522 LQSMKLCLQKDPKARPT 538
+ MK C D RP+
Sbjct: 244 YEVMKNCWHLDAAMRPS 260
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 6e-15
Identities = 79/365 (21%), Positives = 144/365 (39%), Gaps = 70/365 (19%)
Query: 206 VFKRPLSVNSTKSSDPSVSKETIKPAKPQITTSNAKKSVETSQDVITLNGK------QYQ 259
+R ++V++ SS + + ++ +T++ S+ + + K +
Sbjct: 25 PLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLT 84
Query: 260 VLSLLGKGGSSSVYL-----VGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAK 314
+ LG+G V + + E +A+K+ L D + ++E+E++
Sbjct: 85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKM--LKDDATEKDLSDLVSEMEMMKM 142
Query: 315 LQGCPYVIKMHDYVYDTASKHLYVLME---KGDTDLSKYMRNLNKMTTLPNTMIIIIMHW 371
+ +I + T LYV++E KG+ L +Y+R + I
Sbjct: 143 IGKHKNIINLLGAC--TQDGPLYVIVEYASKGN--LREYLRARRPPGMEYSYDI---NRV 195
Query: 372 YEMLLAVKEIH------AAG--------IIHSDLKPANFLFVGNVLKIIDCIGNVLKIID 417
E + K++ A G IH DL N L V NV+KI D
Sbjct: 196 PEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL-VTE--------NNVMKIAD 246
Query: 418 FGIACSLQDDKTSVHKDTASGTL--NYMSPEAAGQTSSSGGGNTYRI-TYKSDVWSLGCI 474
FG+A + + +K T +G L +M+PEA R+ T++SDVWS G +
Sbjct: 247 FGLARDINNI--DYYKKTTNGRLPVKWMAPEAL----------FDRVYTHQSDVWSFGVL 294
Query: 475 LYNMI-YGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDP 533
++ + G +PY IP ++ + + +++ KP L M+ C P
Sbjct: 295 MWEIFTLGGSPYPGIPV--EELFKLLKEGHRMD-KPANC-----TNELYMMMRDCWHAVP 346
Query: 534 KARPT 538
RPT
Sbjct: 347 SQRPT 351
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 76.5 bits (188), Expect = 7e-15
Identities = 72/417 (17%), Positives = 139/417 (33%), Gaps = 84/417 (20%)
Query: 143 LSEDILATRKKYPFLVSSTSSLDKENVVPDNEKFKGPTQTKSVFSVRSASDQSLSQKKNE 202
L + + + K L+ + + PT ++ + + +
Sbjct: 232 LWQLVEYLKLKADGLIYCLKEACPNSSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDG 291
Query: 203 STPVFKRPLSVNSTKSSDPSVSKETIKPAKPQITTSNAKKSVETSQDVITLNGKQYQVLS 262
TP P + S P ++ + K + +D + + +
Sbjct: 292 YTP---EPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIE----- 343
Query: 263 LLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVI 322
LG G SV + +A+KV L T+++ + + E +++ +L PY++
Sbjct: 344 -LGCGNFGSVRQGVYRMRKKQIDVAIKV--LKQGTEKADTEEMMREAQIMHQLDN-PYIV 399
Query: 323 KMHDYVYDTASKHLYV--LMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKE 380
++ A + V + G L K++ + + N E+L V
Sbjct: 400 RLIGVC--QAEALMLVMEMAGGGP--LHKFLVGKREEIPVSNVA--------ELLHQV-- 445
Query: 381 IHAAG--------IIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVH 432
+ G +H +L N L + N + KI DFG++ +L D S +
Sbjct: 446 --SMGMKYLEEKNFVHRNLAARNVL-LVN--------RHYAKISDFGLSKALGADD-SYY 493
Query: 433 KDTASGTL--NYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI-YGRTPYSHIP 489
++G + +PE N + + +SDVWS G ++ + YG+ PY +
Sbjct: 494 TARSAGKWPLKWYAPECI---------NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 544
Query: 490 NTWAKMLAIARHKDQIEF--------KPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
+ + F P PP L M C + RP
Sbjct: 545 G-----------PEVMAFIEQGKRMECPPEC-----PPELYALMSDCWIYKWEDRPD 585
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 7e-15
Identities = 58/270 (21%), Positives = 93/270 (34%), Gaps = 69/270 (25%)
Query: 308 EVELLAKLQGCPYVIKMHDYVYDTASKH------LYVLMEKGDTDLSKYMRNLNKMTTLP 361
E+++L L+ V+ + + AS + +Y++ + + DL+ + N+ TL
Sbjct: 66 EIKILQLLK-HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLS 124
Query: 362 NTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIA 421
I +M +L + IH I+H D+K AN L I G VLK+ DFG+A
Sbjct: 125 E--IKRVM--QMLLNGLYYIHRNKILHRDMKAANVL--------ITRDG-VLKLADFGLA 171
Query: 422 CSLQDDKTSVHKDTASG--TLNYMSPEA-AGQTSSSGGGNTYRITYKSDVWSLGCILYNM 478
+ K S + TL Y PE G+ Y D+W GCI+ M
Sbjct: 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGER-------DY--GPPIDLWGAGCIMAEM 222
Query: 479 IYGR--------------------TPYSHIPNTWAKMLAIARHKDQIEFKPQLANNV--- 515
+ P W + +++E V
Sbjct: 223 WTRSPIMQGNTEQHQLALISQLCGSI---TPEVWPNVDNY-ELYEKLELVKGQKRKVKDR 278
Query: 516 ----TIPPT---LLQSMKLCLQKDPKARPT 538
P L+ + L DP R
Sbjct: 279 LKAYVRDPYALDLIDKL---LVLDPAQRID 305
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 63/297 (21%), Positives = 110/297 (37%), Gaps = 56/297 (18%)
Query: 264 LGKGGSSSVY---LVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPY 320
LG+G V G + +A+K+ L + S + ++E+++L +
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKM--LKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 321 VIKMHDYVYDTASKHLYVLME---KGDTDLSKYMRN----LNKMTTLPNTMIIIIMHWYE 373
V+ + L V++E G+ LS Y+R+ P + +
Sbjct: 93 VVNLLGACTKP-GGPLMVIVEFCKFGN--LSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 374 MLLAVKEIHAAG--------IIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQ 425
++ ++ A G IH DL N L + NV+KI DFG+A +
Sbjct: 150 LICYSFQV-AKGMEFLASRKCIHRDLAARNIL-LSE--------KNVVKICDFGLARDIY 199
Query: 426 DDKTSVHKDTASGTL--NYMSPEAAGQTSSSGGGNTYRI-TYKSDVWSLGCILYNMI-YG 481
D + L +M+PE R+ T +SDVWS G +L+ + G
Sbjct: 200 KD--PDYVRKGDARLPLKWMAPETI----------FDRVYTIQSDVWSFGVLLWEIFSLG 247
Query: 482 RTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
+PY + + + ++ P P + Q+M C +P RPT
Sbjct: 248 ASPYPGVK-IDEEFCRRLKEGTRMR-APDYT-----TPEMYQTMLDCWHGEPSQRPT 297
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 3e-14
Identities = 61/299 (20%), Positives = 106/299 (35%), Gaps = 81/299 (27%)
Query: 264 LGKGGSSSVYLVGGT--SEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYV 321
LG G SV G + +A+KV L T+++ + + E +++ +L PY+
Sbjct: 18 LGCGNFGSVRQ--GVYRMRKKQIDVAIKV--LKQGTEKADTEEMMREAQIMHQLDN-PYI 72
Query: 322 IKMHDYVYDTASKHLYV--LMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVK 379
+++ A + V + G L K++ + + + E+L V
Sbjct: 73 VRLIGVC--QAEALMLVMEMAGGGP--LHKFLVG-KREEIPVSNVA-------ELLHQV- 119
Query: 380 EIHAAG--------IIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSV 431
+ G +H DL N L + N + KI DFG++ +L D +
Sbjct: 120 ---SMGMKYLEEKNFVHRDLAARNVL-LVN--------RHYAKISDFGLSKALGADDSYY 167
Query: 432 HKDTASGT---LNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI-YGRTPYSH 487
S L + +PE N + + +SDVWS G ++ + YG+ PY
Sbjct: 168 T--ARSAGKWPLKWYAPECI---------NFRKFSSRSDVWSYGVTMWEALSYGQKPYKK 216
Query: 488 IPNTWAKMLAIARHKDQIEF--------KPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
+ + + F P PP L M C + RP
Sbjct: 217 MKG-----------PEVMAFIEQGKRMECPPEC-----PPELYALMSDCWIYKWEDRPD 259
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 3e-14
Identities = 61/328 (18%), Positives = 112/328 (34%), Gaps = 75/328 (22%)
Query: 234 QITTSNAKKSVETSQDVITLNGKQYQVLSLLGKGGSSSVYL-VGGTSEHEFKPLALKVVD 292
++ N + VI + ++G+G VY ++ + A+K
Sbjct: 3 DLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS-- 60
Query: 293 LSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYV--LMEKGDTDLSKY 350
L+ ITD +L E ++ P V+ + + L V M+ GD L +
Sbjct: 61 LNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGD--LRNF 117
Query: 351 MRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAG--------IIHSDLKPANFLFVGNV 402
+RN T+ +++ ++ A G +H DL N + +
Sbjct: 118 IRNETHNPTVK-----------DLIGFGLQV-AKGMKYLASKKFVHRDLAARNCM-LDE- 163
Query: 403 LKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTL--NYMSPEAAGQTSSSGGGNTY 460
+K+ DFG+A + D + + L +M+ E+
Sbjct: 164 -------KFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL----------QT 206
Query: 461 RI-TYKSDVWSLGCILYNMI-YGRTPYSHIPNTWAKMLAIARHKDQIEF--------KPQ 510
+ T KSDVWS G +L+ ++ G PY + D + +P+
Sbjct: 207 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-----------FDITVYLLQGRRLLQPE 255
Query: 511 LANNVTIPPTLLQSMKLCLQKDPKARPT 538
P L + M C + RP+
Sbjct: 256 YC-----PDPLYEVMLKCWHPKAEMRPS 278
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 4e-14
Identities = 65/293 (22%), Positives = 114/293 (38%), Gaps = 57/293 (19%)
Query: 264 LGKGGSSSVY---LVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPY 320
LG G VY + G ++ +A+K + ++Q D +L E +++K
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP-EVCSEQDELD-FLMEALIISKFN-HQN 94
Query: 321 VIKMHDYVYDTASKHLYV---LMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLA 377
+++ S ++ LM GD L ++R + P+++ ++ ++L
Sbjct: 95 IVRCIGVS--LQSLPRFILMELMAGGD--LKSFLRETRPRPSQPSSLAML-----DLLHV 145
Query: 378 VKEIHAAG--------IIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKT 429
++I A G IH D+ N L + G V KI DFG+A +
Sbjct: 146 ARDI-ACGCQYLEENHFIHRDIAARNCL----LTCPGP--GRVAKIGDFGMARDIYR--A 196
Query: 430 SVHKDTASGTL--NYMSPEAAGQTSSSGGGNTYRI-TYKSDVWSLGCILYNMI-YGRTPY 485
S ++ L +M PEA I T K+D WS G +L+ + G PY
Sbjct: 197 SYYRKGGCAMLPVKWMPPEAF----------MEGIFTSKTDTWSFGVLLWEIFSLGYMPY 246
Query: 486 SHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
N ++L +++ P+ P + + M C Q P+ RP
Sbjct: 247 PSKSN--QEVLEFVTSGGRMD-PPK-----NCPGPVYRIMTQCWQHQPEDRPN 291
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 4e-14
Identities = 47/217 (21%), Positives = 83/217 (38%), Gaps = 26/217 (11%)
Query: 323 KMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIH 382
+ D + + S +E+ + + T+ +I + +++ ++ +
Sbjct: 151 RRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA 210
Query: 383 AAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNY 442
+ IH DL N L + NV+KI DFG+A + D V K A L +
Sbjct: 211 SRKCIHRDLAARNIL-LSE--------KNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 261
Query: 443 MSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI-YGRTPYSHIPNTWAKMLAIARH 501
M+PE T +SDVWS G +L+ + G +PY + + +
Sbjct: 262 MAPET---------IFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-DEEFCRRLKE 311
Query: 502 KDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
++ P P + Q+M C +P RPT
Sbjct: 312 GTRMR-APDYT-----TPEMYQTMLDCWHGEPSQRPT 342
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 4e-14
Identities = 71/299 (23%), Positives = 123/299 (41%), Gaps = 60/299 (20%)
Query: 264 LGKGGSSSVYL-----VGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGC 318
LG+G V + + E +A+K+ L D + ++E+E++ +
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM--LKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 319 PYVIKMHDYVYDTASKHLYVLME---KGDTDLSKYMRNLNKMTTLPNTMIIII----MHW 371
+I + T LYV++E KG+ L +Y+R + I + M +
Sbjct: 101 KNIINLLGAC--TQDGPLYVIVEYASKGN--LREYLRARRPPGMEYSYDINRVPEEQMTF 156
Query: 372 YEMLLAVKEIHAAG--------IIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACS 423
+++ ++ A G IH DL N L V NV+KI DFG+A
Sbjct: 157 KDLVSCTYQL-ARGMEYLASQKCIHRDLAARNVL-VTE--------NNVMKIADFGLARD 206
Query: 424 LQDDKTSVHKDTASGTL--NYMSPEAAGQTSSSGGGNTYRI-TYKSDVWSLGCILYNMI- 479
+ + +K T +G L +M+PEA R+ T++SDVWS G +++ +
Sbjct: 207 INNI--DYYKKTTNGRLPVKWMAPEAL----------FDRVYTHQSDVWSFGVLMWEIFT 254
Query: 480 YGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
G +PY IP ++ + + +++ KP L M+ C P RPT
Sbjct: 255 LGGSPYPGIPV--EELFKLLKEGHRMD-KPANC-----TNELYMMMRDCWHAVPSQRPT 305
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 4e-14
Identities = 65/293 (22%), Positives = 113/293 (38%), Gaps = 57/293 (19%)
Query: 264 LGKGGSSSVY---LVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPY 320
LG G VY + G ++ +A+K + ++Q D +L E +++K
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP-EVCSEQDELD-FLMEALIISKFN-HQN 135
Query: 321 VIKMHDYVYDTASKHLYV---LMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLA 377
+++ S ++ LM GD L ++R + P+++ ++ ++L
Sbjct: 136 IVRCIGVS--LQSLPRFILLELMAGGD--LKSFLRETRPRPSQPSSLAML-----DLLHV 186
Query: 378 VKEIHAAG--------IIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKT 429
++I A G IH D+ A N L G V KI DFG+A +
Sbjct: 187 ARDI-ACGCQYLEENHFIHRDIA-AR-----NCLLTCPGPGRVAKIGDFGMARDIYR--A 237
Query: 430 SVHKDTASGTL--NYMSPEAAGQTSSSGGGNTYRI-TYKSDVWSLGCILYNMI-YGRTPY 485
++ L +M PEA I T K+D WS G +L+ + G PY
Sbjct: 238 GYYRKGGCAMLPVKWMPPEAF----------MEGIFTSKTDTWSFGVLLWEIFSLGYMPY 287
Query: 486 SHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
N ++L +++ P+ P + + M C Q P+ RP
Sbjct: 288 PSKSN--QEVLEFVTSGGRMD-PPK-----NCPGPVYRIMTQCWQHQPEDRPN 332
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 5e-14
Identities = 68/303 (22%), Positives = 120/303 (39%), Gaps = 62/303 (20%)
Query: 264 LGKGGSSSVY---LVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPY 320
LG G V G + +A+K+ L + D S ++ ++E++++ +L
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKM--LKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 321 VIKMHDYVYDTASKHLYVLME---KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEM--- 374
++ + T S +Y++ E GD L Y+R+ + + E
Sbjct: 111 IVNLLGAC--TLSGPIYLIFEYCCYGD--LLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166
Query: 375 -LLAVKEIH------AAG--------IIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFG 419
+L +++ A G +H DL N L V + G V+KI DFG
Sbjct: 167 NVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVL-VTH--------GKVVKICDFG 217
Query: 420 IACSLQDDKTSVHKDTASGTL--NYMSPEAAGQTSSSGGGNTYRI-TYKSDVWSLGCILY 476
+A + D S + + L +M+PE+ I T KSDVWS G +L+
Sbjct: 218 LARDIMSD--SNYVVRGNARLPVKWMAPESL----------FEGIYTIKSDVWSYGILLW 265
Query: 477 NMI-YGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKA 535
+ G PY IP A + ++ +++ +P A + M+ C D +
Sbjct: 266 EIFSLGVNPYPGIP-VDANFYKLIQNGFKMD-QPFYA-----TEEIYIIMQSCWAFDSRK 318
Query: 536 RPT 538
RP+
Sbjct: 319 RPS 321
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 6e-14
Identities = 46/271 (16%), Positives = 102/271 (37%), Gaps = 68/271 (25%)
Query: 285 PLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYV---LME 341
P+ +KV + D + + + + + + L +++++ L + +
Sbjct: 44 PVCIKV--IEDKSGRQSFQAVTDHMLAIGSLD-HAHIVRLLGLC---PGSSLQLVTQYLP 97
Query: 342 KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAG--------IIHSDLKP 393
G L ++R ++ P ++ + + A G ++H +L
Sbjct: 98 LGS--LLDHVRQ-HRGALGPQLLL-------NWGVQI----AKGMYYLEEHGMVHRNLAA 143
Query: 394 ANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSS 453
N L + + + +++ DFG+A L D + A + +M+ E+
Sbjct: 144 RNVL-LKS--------PSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESI----- 189
Query: 454 SGGGNTYRITYKSDVWSLGCILYNMI-YGRTPYSHIPNTWAKMLAIARHKDQIEF----- 507
+ + T++SDVWS G ++ ++ +G PY+ + A++ D +E
Sbjct: 190 ----HFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL--AEVP------DLLEKGERLA 237
Query: 508 KPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
+PQ+ + M C D RPT
Sbjct: 238 QPQIC-----TIDVYMVMVKCWMIDENIRPT 263
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 7e-14
Identities = 57/300 (19%), Positives = 106/300 (35%), Gaps = 70/300 (23%)
Query: 264 LGKGGSSSVYLVGGT---SEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPY 320
LGKG SV + F +A+K++ I I + +L E + + P+
Sbjct: 31 LGKGEFGSVRE--AQLKQEDGSFVKVAVKMLKADIIASSDIEE-FLREAACMKEFD-HPH 86
Query: 321 VIKMH----DYVYDTASKHLYVLME---KGDTDLSKYMRNL---NKMTTLPNTMIIIIMH 370
V K+ V++ GD L ++ LP ++ M
Sbjct: 87 VAKLVGVSLRSRAKGRLPIPMVILPFMKHGD--LHAFLLASRIGENPFNLPLQTLVRFMV 144
Query: 371 WYEMLLAVKEIHAAG--------IIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIAC 422
+I A G IH DL N + + + + DFG++
Sbjct: 145 ---------DI-ACGMEYLSSRNFIHRDLAARNCM-LAE--------DMTVCVADFGLSR 185
Query: 423 SLQDDKTSVHKDTASGTL--NYMSPEAAGQTSSSGGGNTYRI-TYKSDVWSLGCILYNMI 479
+ ++ + L +++ E+ + T SDVW+ G ++ ++
Sbjct: 186 KIYS--GDYYRQGCASKLPVKWLALESL----------ADNLYTVHSDVWAFGVTMWEIM 233
Query: 480 -YGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
G+TPY+ I N A++ ++++ +P + M C DPK RP+
Sbjct: 234 TRGQTPYAGIEN--AEIYNYLIGGNRLK-QPPEC-----MEEVYDLMYQCWSADPKQRPS 285
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 8e-14
Identities = 68/299 (22%), Positives = 117/299 (39%), Gaps = 60/299 (20%)
Query: 264 LGKGGSSSVYL-----VGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGC 318
LG+G V L + + +A+K+ L + ++E+E++ +
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM--LKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 319 PYVIKMHDYVYDTASKHLYVLME---KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWY--- 372
+I + T LYV++E KG+ L +Y++ +
Sbjct: 135 KNIINLLGAC--TQDGPLYVIVEYASKGN--LREYLQARRPPGLEYSYNPSHNPEEQLSS 190
Query: 373 -EMLLAVKEIHAAG--------IIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACS 423
+++ ++ A G IH DL N L V NV+KI DFG+A
Sbjct: 191 KDLVSCAYQV-ARGMEYLASKKCIHRDLAARNVL-VTE--------DNVMKIADFGLARD 240
Query: 424 LQDDKTSVHKDTASGTL--NYMSPEAAGQTSSSGGGNTYRI-TYKSDVWSLGCILYNMI- 479
+ +K T +G L +M+PEA RI T++SDVWS G +L+ +
Sbjct: 241 IHHI--DYYKKTTNGRLPVKWMAPEAL----------FDRIYTHQSDVWSFGVLLWEIFT 288
Query: 480 YGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
G +PY +P ++ + + +++ KP L M+ C P RPT
Sbjct: 289 LGGSPYPGVPV--EELFKLLKEGHRMD-KPSNC-----TNELYMMMRDCWHAVPSQRPT 339
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 8e-14
Identities = 55/250 (22%), Positives = 101/250 (40%), Gaps = 50/250 (20%)
Query: 306 LNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLME---KGDTDLSKYMRNLNKMTTL-- 360
++E+++++ L ++ + T + V+ E GD L ++R +++
Sbjct: 97 MSELKIMSHLGQHENIVNLLGAC--THGGPVLVITEYCCYGD--LLNFLRRKSRVLETDP 152
Query: 361 PNTMIIIIMHWYEMLLAVKEIHAAG--------IIHSDLKPANFLFVGNVLKIIDCIGNV 412
+ ++L ++ A G IH D+ N L + N G+V
Sbjct: 153 AFAIANSTASTRDLLHFSSQV-AQGMAFLASKNCIHRDVAARNVL-LTN--------GHV 202
Query: 413 LKIIDFGIACSLQDDKTSVHKDTASGTL--NYMSPEAAGQTSSSGGGNTYRI-TYKSDVW 469
KI DFG+A + +D S + + L +M+PE+ + T +SDVW
Sbjct: 203 AKIGDFGLARDIMND--SNYIVKGNARLPVKWMAPESI----------FDCVYTVQSDVW 250
Query: 470 SLGCILYNMI-YGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLC 528
S G +L+ + G PY I +K + + Q+ +P A P + M+ C
Sbjct: 251 SYGILLWEIFSLGLNPYPGIL-VNSKFYKLVKDGYQMA-QPAFA-----PKNIYSIMQAC 303
Query: 529 LQKDPKARPT 538
+P RPT
Sbjct: 304 WALEPTHRPT 313
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 58/301 (19%), Positives = 116/301 (38%), Gaps = 63/301 (20%)
Query: 259 QVLSLLGKGGSSSVYLVGGT---SEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKL 315
+ +LG+G SV G + +A+K + L + + + I + +L+E +
Sbjct: 37 ILGKILGEGEFGSVME--GNLKQEDGTSLKVAVKTMKLDNSSQREIEE-FLSEAACMKDF 93
Query: 316 QGCPYVIKMHDYVYD---TASKHLYVLME---KGDTDLSKYMRNLNKMTTLPNTMIIIIM 369
P VI++ + V++ GD L Y+ +++ T P + +
Sbjct: 94 S-HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGD--LHTYLLY-SRLETGPKHIPLQ-- 147
Query: 370 HWYEMLLAVKEIHAAG--------IIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIA 421
+L + +I A G +H DL N + + + + + DFG++
Sbjct: 148 ---TLLKFMVDI-ALGMEYLSNRNFLHRDLAARNCM-LRD--------DMTVCVADFGLS 194
Query: 422 CSLQDDKTSVHKDTASGTL--NYMSPEAAGQTSSSGGGNTYRI-TYKSDVWSLGCILYNM 478
+ ++ + +++ E+ R+ T KSDVW+ G ++ +
Sbjct: 195 KKIYS--GDYYRQGRIAKMPVKWIAIESL----------ADRVYTSKSDVWAFGVTMWEI 242
Query: 479 I-YGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARP 537
G TPY + N +M H +++ +P+ L + M C + DP RP
Sbjct: 243 ATRGMTPYPGVQN--HEMYDYLLHGHRLK-QPEDC-----LDELYEIMYSCWRTDPLDRP 294
Query: 538 T 538
T
Sbjct: 295 T 295
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 3e-13
Identities = 53/276 (19%), Positives = 97/276 (35%), Gaps = 79/276 (28%)
Query: 285 PLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYV--LMEK 342
+A+K + T S+ + +L E + + P+++K+ + T + + L
Sbjct: 420 AVAIKT--CKNCTSDSVREKFLQEALTMRQFD-HPHIVKLIGVI--TENPVWIIMELCTL 474
Query: 343 GDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAG--------IIHSDLKPA 394
G+ L +++ K + ++I + + +H D+
Sbjct: 475 GE--LRSFLQV-RKFSLDLASLI-------LYAYQL----STALAYLESKRFVHRDIAAR 520
Query: 395 NFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTL---NYMSPEAAGQT 451
N L V + + +K+ DFG++ ++D AS +M+PE+
Sbjct: 521 NVL-VSS--------NDCVKLGDFGLSRYMEDSTYY----KASKGKLPIKWMAPESI--- 564
Query: 452 SSSGGGNTYRITYKSDVWSLGCILYNMI-YGRTPYSHIPNTWAKMLAIARHKDQIEF--- 507
N R T SDVW G ++ ++ +G P+ + N D I
Sbjct: 565 ------NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-----------NDVIGRIEN 607
Query: 508 -----KPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
P PPTL M C DP RP
Sbjct: 608 GERLPMPPNC-----PPTLYSLMTKCWAYDPSRRPR 638
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 4e-13
Identities = 66/329 (20%), Positives = 111/329 (33%), Gaps = 88/329 (26%)
Query: 229 KPAKPQITTSNAKKSVETSQDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFK--PL 286
+ + + L +GKG V +++ +
Sbjct: 173 MEGTVAAQDEFYRSGWALNMKELKLLQT-------IGKGEFGDVM------LGDYRGNKV 219
Query: 287 ALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK-HLYV---LMEK 342
A+K I + + A ++L E ++ +L+ ++++ + K LY+ M K
Sbjct: 220 AVKC-----IKNDATAQAFLAEASVMTQLR-HSNLVQLLGVI--VEEKGGLYIVTEYMAK 271
Query: 343 GDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKE----IHAAGIIHSDLKPANFLF 398
G L Y+R+ + + ++ + L V E + +H DL N L
Sbjct: 272 GS--LVDYLRSRGRSVLGGDCLL-------KFSLDVCEAMEYLEGNNFVHRDLAARNVL- 321
Query: 399 VGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNY--MSPEAAGQTSSSGG 456
V NV K+ DFG+ +G L +PEA
Sbjct: 322 VSE--------DNVAKVSDFGLTKE-------ASSTQDTGKLPVKWTAPEAL-------- 358
Query: 457 GNTYRI-TYKSDVWSLGCILYNMI-YGRTPYSHIPNTWAKMLAIARHKDQIE-----FKP 509
+ + KSDVWS G +L+ + +GR PY IP ++E P
Sbjct: 359 --REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV--------PRVEKGYKMDAP 408
Query: 510 QLANNVTIPPTLLQSMKLCLQKDPKARPT 538
PP + MK C D RPT
Sbjct: 409 DGC-----PPAVYDVMKNCWHLDAATRPT 432
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 5e-13
Identities = 61/294 (20%), Positives = 107/294 (36%), Gaps = 70/294 (23%)
Query: 264 LGKGGSSSVY--LVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYV 321
LG G +VY L E P+A+K L + T L+E ++A + P+V
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKE--LREATSPKANKEILDEAYVMASVD-NPHV 79
Query: 322 IKMHDYVYDTASKHLYV---LMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAV 378
++ + + + LM G L Y+R +K ++ + +
Sbjct: 80 CRLLGIC---LTSTVQLITQLMPFGC--LLDYVRE-HKDNIGSQYLL-------NWCVQI 126
Query: 379 KEIHAAG--------IIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTS 430
A G ++H DL N L V +KI DFG+A L ++
Sbjct: 127 ----AKGMNYLEDRRLVHRDLAARNVL-VKT--------PQHVKITDFGLAKLLGAEEKE 173
Query: 431 VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI-YGRTPYSHIP 489
H + + +M+ E+ T++SDVWS G ++ ++ +G PY IP
Sbjct: 174 YHAEGGKVPIKWMALESI---------LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 224
Query: 490 NTWAKMLAIARHKDQIEF-----KPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
+++ +E +P + + M C D +RP
Sbjct: 225 A--SEIS------SILEKGERLPQPPIC-----TIDVYMIMVKCWMIDADSRPK 265
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 6e-13
Identities = 60/263 (22%), Positives = 99/263 (37%), Gaps = 61/263 (23%)
Query: 297 TDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYV---LMEKGDTDLSKYMRN 353
+ D + E+E+L KL P +I + +LY+ G+ L ++R
Sbjct: 65 SKDDHRD-FAGELEVLCKLGHHPNIINLLGAC--EHRGYLYLAIEYAPHGN--LLDFLRK 119
Query: 354 LNKMTTLPNTMIIIIMHWYEMLLAVKEIH------AAG--------IIHSDLKPANFLFV 399
+ T P I + L+ +++ A G IH DL N L V
Sbjct: 120 SRVLETDPAFAI---ANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNIL-V 175
Query: 400 GNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTL--NYMSPEAAGQTSSSGGG 457
G V KI DFG++ + V+ G L +M+ E+
Sbjct: 176 GE--------NYVAKIADFGLS---RGQ--EVYVKKTMGRLPVRWMAIESL--------- 213
Query: 458 NTYRI-TYKSDVWSLGCILYNMI-YGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNV 515
Y + T SDVWS G +L+ ++ G TPY + A++ ++E KP
Sbjct: 214 -NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--AELYEKLPQGYRLE-KPLNC--- 266
Query: 516 TIPPTLLQSMKLCLQKDPKARPT 538
+ M+ C ++ P RP+
Sbjct: 267 --DDEVYDLMRQCWREKPYERPS 287
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 1e-12
Identities = 68/308 (22%), Positives = 111/308 (36%), Gaps = 82/308 (26%)
Query: 262 SLLGKGGSSSVY--LVGGTSEHEFKPLALKVVDLSDITDQSIA---DSYLNEVELLAKLQ 316
+ +G+GG VY V T +A+K L+ + D + + E++++AK Q
Sbjct: 37 NKMGEGGFGVVYKGYVNNT------TVAVKK--LAAMVDITTEELKQQFDQEIKVMAKCQ 88
Query: 317 GCPYVIKMHDYVYDTASKHL-YVLMEKGDTDLSKYMRNLNKMTTLP-NTMIIIIMHWYEM 374
++++ + D L YV M G L + L+ L + I
Sbjct: 89 H-ENLVELLGFSSDGDDLCLVYVYMPNGS--LLDRLSCLDGTPPLSWHMRCKIA------ 139
Query: 375 LLAVKEI---HAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL------KIIDFGIA-CSL 424
A I H IH D+K AN L L KI DFG+A S
Sbjct: 140 QGAANGINFLHENHHIHRDIKSANIL---------------LDEAFTAKISDFGLARASE 184
Query: 425 QDDKTSVHKDTA-SGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRT 483
+ +T + GT YM+PEA G IT KSD++S G +L +I G
Sbjct: 185 KFAQT--VMTSRIVGTTAYMAPEA-----LRG-----EITPKSDIYSFGVVLLEIITGLP 232
Query: 484 PYSHIPN-----TWAKMLAIARHKDQIEFK----PQLANNVTIPPTLLQSM----KLCLQ 530
+ + ++ + ++ + T +++M CL
Sbjct: 233 AVDEHREPQLLLDIKEEI----EDEEKTIEDYIDKKMND---ADSTSVEAMYSVASQCLH 285
Query: 531 KDPKARPT 538
+ RP
Sbjct: 286 EKKNKRPD 293
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 65/304 (21%), Positives = 118/304 (38%), Gaps = 65/304 (21%)
Query: 264 LGKGGSSSVY---LVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPY 320
+G+G V+ G F +A+K++ + + AD + E L+A+ P
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK-EEASADMQAD-FQREAALMAEFD-NPN 111
Query: 321 VIKMHDYVYDTASKHLYVLME---KGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLA 377
++K+ K + +L E GD L++++R+++ T + +
Sbjct: 112 IVKLLGVC--AVGKPMCLLFEYMAYGD--LNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 167
Query: 378 VKEIH-----------AAG--------IIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDF 418
+ AAG +H DL N L VG V+KI DF
Sbjct: 168 PPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCL-VGE--------NMVVKIADF 218
Query: 419 GIACSLQDDKTSVHKDTASGTL--NYMSPEAAGQTSSSGGGNTYRI-TYKSDVWSLGCIL 475
G++ ++ +K + + +M PE+ Y T +SDVW+ G +L
Sbjct: 219 GLSRNIYS--ADYYKADGNDAIPIRWMPPESI----------FYNRYTTESDVWAYGVVL 266
Query: 476 YNMI-YGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPK 534
+ + YG PY + + +++ R + + P+ P L M+LC K P
Sbjct: 267 WEIFSYGLQPYYGMAH--EEVIYYVRDGNILA-CPENC-----PLELYNLMRLCWSKLPA 318
Query: 535 ARPT 538
RP+
Sbjct: 319 DRPS 322
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 5e-12
Identities = 79/307 (25%), Positives = 119/307 (38%), Gaps = 75/307 (24%)
Query: 262 SLLGKGGSSSVY---LVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGC 318
L+G G VY L G +ALK + + Q I + + E+E L+ +
Sbjct: 45 FLIGHGVFGKVYKGVLRDGA------KVALKR--RTPESSQGIEE-FETEIETLSFCRH- 94
Query: 319 PYVIKMHDYVYDTASKHL-YVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLA 377
P+++ + + + L Y ME G+ L +++ + T + M W + L
Sbjct: 95 PHLVSLIGFCDERNEMILIYKYMENGN--LKRHLYGSDLPT--------MSMSWEQRL-- 142
Query: 378 VKEI-----------HAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIA-CSLQ 425
EI H IIH D+K N L N V KI DFGI+ +
Sbjct: 143 --EICIGAARGLHYLHTRAIIHRDVKSINILLDEN---------FVPKITDFGISKKGTE 191
Query: 426 DDKTSVHKDTA-SGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTP 484
D+T H T GTL Y+ PE R+T KSDV+S G +L+ ++ R+
Sbjct: 192 LDQT--HLSTVVKGTLGYIDPEYF---------IKGRLTEKSDVYSFGVVLFEVLCARSA 240
Query: 485 YSHIPNT-------WAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSM----KLCLQKDP 533
WA +QI P LA+ I P L+ CL
Sbjct: 241 IVQSLPREMVNLAEWAVESHNNGQLEQI-VDPNLADK--IRPESLRKFGDTAVKCLALSS 297
Query: 534 KARPTVG 540
+ RP++G
Sbjct: 298 EDRPSMG 304
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 7e-12
Identities = 64/321 (19%), Positives = 108/321 (33%), Gaps = 104/321 (32%)
Query: 263 LLGKGGSSSVY---LVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCP 319
+LG+GG VY L GT +A+K L + Q + EVE+++
Sbjct: 37 ILGRGGFGKVYKGRLADGT------LVAVKR--LKEERTQGGELQFQTEVEMISMAVH-R 87
Query: 320 YVIKMHDY---------VYD-----TASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMI 365
++++ + VY + + L + L R
Sbjct: 88 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRER-PESQPPLDWPKR-----------QR 135
Query: 366 III--------MHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL---- 413
I + +H + IIH D+K AN L L
Sbjct: 136 IALGSARGLAYLH---------DHCDPKIIHRDVKAANIL---------------LDEEF 171
Query: 414 --KIIDFGIACSLQDDKTSVHKDTA-SGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWS 470
+ DFG+A + T H TA GT+ +++PE +T + + K+DV+
Sbjct: 172 EAVVGDFGLAKLMDYKDT--HVTTAVRGTIGHIAPEYL---------STGKSSEKTDVFG 220
Query: 471 LGCILYNMIYGRTP--YSHIPN-------TWAKMLAIARHKDQIEFKPQLANNVTIPPTL 521
G +L +I G+ + + N W K L + + + L N
Sbjct: 221 YGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEAL-VDVDLQGNY--KDEE 277
Query: 522 LQSM----KLCLQKDPKARPT 538
++ + LC Q P RP
Sbjct: 278 VEQLIQVALLCTQSSPMERPK 298
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 61.8 bits (149), Expect = 4e-10
Identities = 60/430 (13%), Positives = 126/430 (29%), Gaps = 104/430 (24%)
Query: 30 FDIQFSNPVR--RIGRRNRSTATLKPLEN---QENPTPSSLFPSNSSESQTHPVNPGAAG 84
+ + + N L+ L+ Q +P +S S+ S + ++ A
Sbjct: 176 VQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSR--SDHSSNIKLRIHSIQAE 233
Query: 85 LSFLNQLGKSSTNLKTNFQHAQSVEKIVLNNINYR--VD----QCKKNLNYDPSIKTPCK 138
L L LK+ + + +VL N+ + C K L + T +
Sbjct: 234 LRRL---------LKSK-PYENCL--LVLLNVQNAKAWNAFNLSC-KIL-----LTT--R 273
Query: 139 DASQLSEDILATRKKYPFLVSSTSSLDKENVVPDNEKFKGPTQTKSVFS-VRSASDQSLS 197
+++ + A + L + +L + + KS+ Q L
Sbjct: 274 FKQ-VTDFLSAATTTHISLDHHSMTLTPD-------------EVKSLLLKYLDCRPQDLP 319
Query: 198 QKKNESTPVFKRPLSVNSTKSSDPSVSKETIKPAKPQITTSNAKKSVETSQDVITLNG-- 255
++ + P R LS+ + D T K + +E+S +V+
Sbjct: 320 REVLTTNP---RRLSIIAESIRDG---LATWDNWK-HVNCDKLTTIIESSLNVLEPAEYR 372
Query: 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLA-LKVV--DLSDITDQSIADSYLNEVELL 312
K + LS+ S ++ P L ++ D+ + + L
Sbjct: 373 KMFDRLSVFPP----SAHI----------PTILLSLIWFDVIKSDVMVVVNKLHK--YSL 416
Query: 313 AKLQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKY--MRNLNKMTTLPNTMIIIIMH 370
+ Q I + +Y L + + Y + + +P + +
Sbjct: 417 VEKQPKESTISIPS-IYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPY---LDQY 472
Query: 371 WYEMLLAVKEIHAAGIIHSDLKPA------NFLFVGNVLKIIDCIGNVLKIIDFGIACSL 424
+Y + H I H + +F F+ KI A +
Sbjct: 473 FYSHI----GHHLKNIEHPERMTLFRMVFLDFRFLEQ------------KIRHDSTAWNA 516
Query: 425 QDDKTSVHKD 434
+ +
Sbjct: 517 SGSILNTLQQ 526
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 58.3 bits (140), Expect = 5e-09
Identities = 80/522 (15%), Positives = 140/522 (26%), Gaps = 202/522 (38%)
Query: 103 QHAQSVEKIVLNNINYRVDQCKKNLNYDPSIKTPCKDASQLSEDILATRKKYPFLVSSTS 162
+H + I+ D N + CKD + + IL ++++ ++ S
Sbjct: 13 EHQYQYKDILSVF----EDAFVDNFD--------CKDVQDMPKSIL-SKEEIDHIIMS-- 57
Query: 163 SLDKENVVPDNEKFKGPTQTKSVFSVRSASDQSLSQKKNESTPVF-KRPLSVN------- 214
D + T +F L K+ E F + L +N
Sbjct: 58 --------KDAV-----SGTLRLFWT-------LLSKQEEMVQKFVEEVLRINYKFLMSP 97
Query: 215 -STKSSDPSVSKETIKPAKPQITTSN---AKKSVETSQDVITLNGKQYQV-----LSLLG 265
T+ PS+ + ++ N AK +V Q + L ++ + + G
Sbjct: 98 IKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDG 157
Query: 266 KGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADS---YLN------EVELLAKLQ 316
GS G T +AL V Q D +LN +L LQ
Sbjct: 158 VLGS------GKTW------VALDV--CLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQ 203
Query: 317 GCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLL 376
L ++ T S + N I + +H + L
Sbjct: 204 ------------------KLLYQIDPNWTSRSDHSSN-----------IKLRIHSIQAEL 234
Query: 377 AVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNV--LKIID-FGIACSLQDDKTSVHK 433
+ + + + N L ++ NV K + F ++C K +
Sbjct: 235 --RRL----LKSKPYE--------NCLLVLL---NVQNAKAWNAFNLSC-----KILL-- 270
Query: 434 DTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLG-------CILY-NMIYGRTP- 484
T T T T I+ +L + Y + P
Sbjct: 271 -T---TRF------KQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPR 320
Query: 485 ----------------YSHIPNTWA--KMLAIARHKDQIE-----FKP--------QLA- 512
TW K + + IE +P +L+
Sbjct: 321 EVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSV 380
Query: 513 --NNVTIPPTLLQSM------------------KLCLQKDPK 534
+ IP LL + ++K PK
Sbjct: 381 FPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPK 422
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.1 bits (116), Expect = 4e-06
Identities = 79/557 (14%), Positives = 164/557 (29%), Gaps = 170/557 (30%)
Query: 101 NFQHAQSVEKIVLNNINYRVDQCKKNLNYDPSI-----------KTPCKDASQLSEDILA 149
+ + Q + K +L+ ++ + ++ + + E++L
Sbjct: 34 DCKDVQDMPKSILSK-----EEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVL- 87
Query: 150 TRKKYPFLVSSTSSLDKENVVP-------------DNEKF-KGP-TQTKSVFSVRSASDQ 194
R Y FL+S + ++ + DN+ F K ++ + +R A
Sbjct: 88 -RINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQAL-L 145
Query: 195 SLSQKKNESTPVFKRPLSVN----STKSSDPSVSKETIKPAKPQ---------ITTSNAK 241
L KN + ++ S K+ V+ + K Q + N
Sbjct: 146 ELRPAKN---------VLIDGVLGSGKT---WVALDVCLSYKVQCKMDFKIFWLNLKNCN 193
Query: 242 KS---VETSQDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPL--------ALKV 290
+E Q ++ + S SS++ L + + E + L L V
Sbjct: 194 SPETVLEMLQKLLYQIDPNWTSRSD----HSSNIKLRIHSIQAELRRLLKSKPYENCLLV 249
Query: 291 VDLSDITDQSIADSYLNEVELLAKLQGCPYVI-----KMHDYVYDTASKHLYV-LMEKGD 344
+ ++ + +++ C ++ ++ D++ + H+ +
Sbjct: 250 LL--NVQNAKAWNAFNL---------SCKILLTTRFKQVTDFLSAATTTHISLDHHSMTL 298
Query: 345 TD------LSKYMRNLN-KMTTLPNTM-------IIII--------MHW--YEMLLAVKE 380
T L KY L+ + LP + + II W ++ + K
Sbjct: 299 TPDEVKSLLLKY---LDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKL 355
Query: 381 IHAAGIIHSDLKPANF--------LFVGNVLKIIDCIGNVLKII--------DFGIACSL 424
+ L+PA + +F + I +L +I + L
Sbjct: 356 TTIIESSLNVLEPAEYRKMFDRLSVFPPSA-HIPT---ILLSLIWFDVIKSDVMVVVNKL 411
Query: 425 QDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGG-------NTYRITYKSDVWSLGCILYN 477
+ V K T++ S + + Y I D L Y
Sbjct: 412 H-KYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLI-PPYL 469
Query: 478 MIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSM-----KLCLQKD 532
Y YSH I H IE +T+ + K+
Sbjct: 470 DQYF---YSH----------IGHHLKNIE----HPERMTLFRMVFLDFRFLEQKIRHDST 512
Query: 533 P-KARPTVGNSVTQINN 548
A ++ N++ Q+
Sbjct: 513 AWNASGSILNTLQQLKF 529
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 46.9 bits (111), Expect = 7e-06
Identities = 35/168 (20%), Positives = 54/168 (32%), Gaps = 42/168 (25%)
Query: 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYL----------- 306
+ L+G+G S+V+ +F +K + + + + +
Sbjct: 92 DAIGKLMGEGKESAVFNCYS---EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAI 148
Query: 307 ----NEVELLAKLQG--CPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTL 360
NE L KLQG P V VLME D L
Sbjct: 149 RSARNEFRALQKLQGLAVPKVYAWEGNA---------VLMELIDAK------------EL 187
Query: 361 PNTMIIIIMHWYEMLL-AVKEIHAAGIIHSDLKPANFLFVGNVLKIID 407
+ +M+L V + + GI+H DL N L + IID
Sbjct: 188 YRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEGIWIID 235
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 43.3 bits (101), Expect = 1e-04
Identities = 39/240 (16%), Positives = 70/240 (29%), Gaps = 57/240 (23%)
Query: 253 LNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITD-----QSIADSYLN 307
L ++ Q +G+G V+ + P+A+K++ + Q + L
Sbjct: 17 LPTEKLQRCEKIGEGVFGEVFQT----IADHTPVAIKIIAIEGPDLVNGSHQKTFEEILP 72
Query: 308 EVELLAKLQG--------CPYVIKMHD------------------------------YVY 329
E+ + +L I ++ +
Sbjct: 73 EIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFF 132
Query: 330 DTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHS 389
+ + E G DL + L+ + T I+H LAV E + H
Sbjct: 133 KDDQLFIVLEFEFGGIDLEQMRTKLSSLAT-----AKSILHQLTASLAVAE-ASLRFEHR 186
Query: 390 DLKPANFLFVGNVLKIIDCI--GNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEA 447
DL N L LK + G I G+ S+ D S + G + +
Sbjct: 187 DLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLS--RLERDGIVVFCDVSM 244
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* Length = 258 | Back alignment and structure |
|---|
Score = 40.8 bits (95), Expect = 7e-04
Identities = 24/181 (13%), Positives = 54/181 (29%), Gaps = 40/181 (22%)
Query: 254 NGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKV----------VDLSDITDQSIAD 303
G + ++ G ++V+ G + + +A+K+ +D D+
Sbjct: 45 KGYITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDM 104
Query: 304 SYLN-----------EVELLAKLQG----CPYVIKMHDYVYDTASKHLYVLMEKGDTDLS 348
++ E L + + P V +LME D
Sbjct: 105 RRISPKEKVFIWTEKEFRNLERAKEAGVSVPQPYTYMKNV---------LLMEFIGEDEL 155
Query: 349 KYMRNLNKMTTLPNTMIIIIMHWYEMLLA--VKEIHAAGIIHSDLKPANFLFVGNVLKII 406
+ L + + ++ + A ++H+DL N + + + I
Sbjct: 156 PAPTLVELGRELKELDVE---GIFNDVVENVKRLYQEAELVHADLSEYNIM-YIDKVYFI 211
Query: 407 D 407
D
Sbjct: 212 D 212
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 553 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.86 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.79 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.6 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.04 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.9 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.72 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.69 | |
| 1kbe_A | 49 | Kinase suppressor of RAS; KSR, cysteine-rich domai | 98.3 | |
| 1faq_A | 52 | RAF-1; transferase, serine/threonine-protein kinas | 98.21 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.05 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.97 | |
| 2fnf_X | 72 | Putative RAS effector NORE1; zinc, signal transduc | 97.94 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.84 | |
| 2enz_A | 65 | NPKC-theta, protein kinase C theta type; zinc bind | 97.84 | |
| 2eli_A | 85 | Protein kinase C alpha type; PKC-alpha, PKC-A, str | 97.78 | |
| 1rfh_A | 59 | RAS association (ralgds/AF-6) domain family 5; zin | 97.78 | |
| 1ptq_A | 50 | Protein kinase C delta type; phosphotransferase; 1 | 97.76 | |
| 2enn_A | 77 | NPKC-theta, protein kinase C theta type; zinc bind | 97.72 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.67 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.66 | |
| 2yuu_A | 83 | NPKC-delta, protein kinase C delta type; metal bin | 97.65 | |
| 1y8f_A | 66 | UNC-13 homolog A, MUNC13-1; cysteine-rich domain, | 97.61 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.6 | |
| 3uej_A | 65 | NPKC-delta, protein kinase C delta type; proteine | 97.56 | |
| 2db6_A | 74 | SH3 and cysteine rich domain 3; STAC3, C1 domain, | 97.54 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.53 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.21 | |
| 4b6d_A | 61 | RAC GTPase-activating protein 1; signaling protein | 97.18 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 96.71 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.67 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.54 | |
| 2row_A | 84 | RHO-associated protein kinase 2; ATP-binding, coil | 96.53 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 96.51 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.37 | |
| 2vrw_B | 406 | P95VAV, VAV1, proto-oncogene VAV; lipoprotein, GTP | 96.35 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.23 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.03 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 95.99 | |
| 3ky9_A | 587 | Proto-oncogene VAV; calponin homology domain, DBL | 95.78 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 95.35 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 95.07 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 94.77 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 93.66 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.2 | |
| 2ct0_A | 74 | Non-SMC element 1 homolog; ring domain, structural | 87.7 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 85.08 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 84.27 | |
| 1r79_A | 84 | Diacylglycerol kinase, delta; C1 domain, cystein-r | 84.11 | |
| 3nw0_A | 238 | Non-structural maintenance of chromosomes element | 83.53 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 80.61 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-53 Score=434.10 Aligned_cols=270 Identities=22% Similarity=0.328 Sum_probs=208.8
Q ss_pred cceEEecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeE
Q psy14267 248 QDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDY 327 (553)
Q Consensus 248 ~~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~ 327 (553)
...|++..+++++.++||+|+||+||+|+... .||||+++..... ....+.|.+|+.+|++++ |||||+++++
T Consensus 28 ~~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~-----~vAvK~~~~~~~~-~~~~~~f~~E~~il~~l~-HpNIV~l~g~ 100 (307)
T 3omv_A 28 SYYWEIEASEVMLSTRIGSGSFGTVYKGKWHG-----DVAVKILKVVDPT-PEQFQAFRNEVAVLRKTR-HVNILLFMGY 100 (307)
T ss_dssp -CCCBCCTTSCCEEEECCCCSSSEEEEEESSS-----EEEEEECCCSSCC-HHHHHHHHHHHHHHTTCC-CTTBCCEEEE
T ss_pred CcCcEEcHHHeEEeeEEeeCCCcEEEEEEECC-----cEEEEEEEecCCC-HHHHHHHHHHHHHHHhCC-CCCEeeEEEE
Confidence 34578888999999999999999999996532 3899999766544 345688999999999995 5999999997
Q ss_pred EEeCCCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCcccee
Q psy14267 328 VYDTASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKII 406 (553)
Q Consensus 328 ~~~~~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~ 406 (553)
+. ...++|||||+ +|+|.+++..... .+.+..++.++.||+.||+|||+++||||||||+||||+.+
T Consensus 101 ~~---~~~~~iVmEy~~gGsL~~~l~~~~~----~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~----- 168 (307)
T 3omv_A 101 MT---KDNLAIVTQWCEGSSLYKHLHVQET----KFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEG----- 168 (307)
T ss_dssp EC---SSSCEEEEECCSSCBHHHHHHTSCC----CCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETT-----
T ss_pred EE---CCeEEEEEEcCCCCCHHHHHhhcCC----CCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCC-----
Confidence 63 23578999976 5799999976432 34566677788899999999999999999999999999887
Q ss_pred cCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCC
Q psy14267 407 DCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYS 486 (553)
Q Consensus 407 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~ 486 (553)
+.+||+|||+|+..............+||+.|||||++.+.... .|+.++|||||||+||||+||+.||.
T Consensus 169 ----~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~------~y~~ksDVwS~Gvvl~Elltg~~Pf~ 238 (307)
T 3omv_A 169 ----LTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNN------PFSFQSDVYSYGIVLYELMTGELPYS 238 (307)
T ss_dssp ----EEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSC------CCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred ----CcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCC------CCCcHHHhHhHHHHHHHHHHCCCCCC
Confidence 57999999999887654443344567899999999999755321 48999999999999999999999998
Q ss_pred CCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 487 HIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 487 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
+..+.......+......... ...+..+++++.+||.+||+.||++|||+.||+++|+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~p~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 239 HINNRDQIIFMVGRGYASPDL---SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp TCCCHHHHHHHHHTTCCCCCS---TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred CCChHHHHHHHHhcCCCCCCc---ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 876654444444332222111 122347899999999999999999999999999988753
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-53 Score=428.21 Aligned_cols=251 Identities=25% Similarity=0.369 Sum_probs=192.4
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|++++.||+|+||+||+|+++.++.. ||||++.+.........+++.+|+++|++++ ||||+++++++. ....
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~--vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~--~~~~ 87 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQK--VALKIINKKVLAKSDMQGRIEREISYLRLLR-HPHIIKLYDVIK--SKDE 87 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCE--EEEEEEECC------CHHHHHHHHHHHHHCC-CTTBCCEEEEEE--CSSE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCE--EEEEEEeHHHcCCHHHHHHHHHHHHHHHHCC-CCCCCeEEEEEE--ECCE
Confidence 4799999999999999999998877654 9999999887666666678999999999995 699999999874 4678
Q ss_pred EEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 336 LYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 336 ~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
+|++||+++|+|.+++.+... +.+..+..++.||+.||+|||++|||||||||+||||+.+ +.+||
T Consensus 88 ~~ivmEy~~g~L~~~l~~~~~-----l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~---------~~vkl 153 (275)
T 3hyh_A 88 IIMVIEYAGNELFDYIVQRDK-----MSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEH---------LNVKI 153 (275)
T ss_dssp EEEEEECCCEEHHHHHHHSCS-----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTT---------CCEEE
T ss_pred EEEEEeCCCCCHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCC---------CCEEE
Confidence 999999999999999987653 4456677788899999999999999999999999999876 67999
Q ss_pred EeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHH
Q psy14267 416 IDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKM 495 (553)
Q Consensus 416 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~ 495 (553)
+|||+|+....... ..+.+||+.|||||++.+..+ ++.++|||||||+||||++|+.||.+... ...+
T Consensus 154 ~DFGla~~~~~~~~---~~~~~GT~~Y~APE~~~~~~y--------~~~~~DiwSlGvily~lltg~~PF~~~~~-~~~~ 221 (275)
T 3hyh_A 154 ADFGLSNIMTDGNF---LKTSCGSPNYAAPEVISGKLY--------AGPEVDVWSCGVILYVMLCRRLPFDDESI-PVLF 221 (275)
T ss_dssp CCSSCC------------------CTTSCHHHHSSSSC--------CCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHH
T ss_pred eecCCCeecCCCCc---cCCeeECcccCChhhhcCCCC--------CCChhhhHHHHHHHHHHHHCCCCCCCCCH-HHHH
Confidence 99999987654332 236789999999999987642 36899999999999999999999987433 2333
Q ss_pred HHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 496 LAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 496 ~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
..+.... ..+ +..+++++++||.+||++||++|||+.|+++|
T Consensus 222 ~~i~~~~--~~~------p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 222 KNISNGV--YTL------PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp HHHHHTC--CCC------CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred HHHHcCC--CCC------CCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 3333322 111 23578999999999999999999999999985
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-54 Score=439.64 Aligned_cols=252 Identities=24% Similarity=0.396 Sum_probs=209.8
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|+++++||+|+||+||+|+++.++.. ||||++.+.........+.+.+|+++|++|. |||||++++++. +...
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~--~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~--~~~~ 106 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSRE--YAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQ--DDEK 106 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCE--EEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEE--CSSE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCE--EEEEEEEHHHCCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEE--eCCE
Confidence 4799999999999999999999887755 9999998766544455688999999999995 699999998874 4678
Q ss_pred EEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
+|++|||+ +|+|.+++++... +.+..+..++.||+.||+|||++|||||||||+||||+.+ +.+|
T Consensus 107 ~yivmEy~~gG~L~~~i~~~~~-----l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~---------g~vK 172 (311)
T 4aw0_A 107 LYFGLSYAKNGELLKYIRKIGS-----FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED---------MHIQ 172 (311)
T ss_dssp EEEEECCCTTEEHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT---------SCEE
T ss_pred EEEEEecCCCCCHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCC---------CCEE
Confidence 99999986 5699999987653 4456677788899999999999999999999999999876 6799
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||+|+.+..........+.+||+.|||||++.+.. |+.++|||||||+||||++|++||.+.+. ...
T Consensus 173 l~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~---------y~~~~DiWSlGvilyeml~G~~PF~~~~~-~~~ 242 (311)
T 4aw0_A 173 ITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS---------ACKSSDLWALGCIIYQLVAGLPPFRAGNE-GLI 242 (311)
T ss_dssp ECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSC---------BCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHH
T ss_pred EEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCC---------CCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHH
Confidence 99999999886655444456789999999999998763 78999999999999999999999987433 344
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVT 544 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~ 544 (553)
+..+.... ..++ ..+++++++||.+||.+||++|||++|++.
T Consensus 243 ~~~i~~~~--~~~p------~~~s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 243 FAKIIKLE--YDFP------EKFFPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp HHHHHHTC--CCCC------TTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred HHHHHcCC--CCCC------cccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 44444332 2222 367899999999999999999999998743
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-53 Score=440.91 Aligned_cols=253 Identities=23% Similarity=0.401 Sum_probs=201.7
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|++++.||+|+||+||+|+++.++.. ||||++.+..... ...+++.+|+++|++|+ |||||++++++.+ ...
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~--vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~--~~~ 97 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQ--YVIKEINISRMSS-KEREESRREVAVLANMK-HPNIVQYRESFEE--NGS 97 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCE--EEEEEEECTTSCH-HHHHHHHHHHHHHHHCC-CTTBCCEEEEEEE--TTE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCE--EEEEEEehHHCCH-HHHHHHHHHHHHHHHCC-CCCCCcEEEEEEE--CCE
Confidence 5899999999999999999998877755 9999998876554 44688999999999995 5999999998754 678
Q ss_pred EEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
+||||||+ +|+|.+++...... ...+..++.++.||+.||+|||++|||||||||+||||+.+ +.||
T Consensus 98 ~yiVmEy~~gg~L~~~i~~~~~~---~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~---------g~vK 165 (350)
T 4b9d_A 98 LYIVMDYCEGGDLFKRINAQKGV---LFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKD---------GTVQ 165 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHTTTC---CCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTT---------CCEE
T ss_pred EEEEEeCCCCCcHHHHHHHcCCC---CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCC---------CCEE
Confidence 99999986 57999999865432 33455667778899999999999999999999999999876 6799
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||+|+.+..... ...+.+||+.|||||++.+.. |+.++|||||||+||||++|+.||.+.... ..
T Consensus 166 l~DFGla~~~~~~~~--~~~~~~GT~~YmAPE~l~~~~---------y~~~~DiwSlGvilyemltG~~PF~~~~~~-~~ 233 (350)
T 4b9d_A 166 LGDFGIARVLNSTVE--LARACIGTPYYLSPEICENKP---------YNNKSDIWALGCVLYELCTLKHAFEAGSMK-NL 233 (350)
T ss_dssp ECSTTEESCCCHHHH--HHHHHHSCCTTCCHHHHTTCC---------CCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-HH
T ss_pred EcccccceeecCCcc--cccccCCCccccCHHHHCCCC---------CCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-HH
Confidence 999999987654221 223568999999999998763 789999999999999999999999875432 34
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
+..+..... . ..+..+++++++||.+||++||++|||+.|+++|
T Consensus 234 ~~~i~~~~~----~---~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 234 VLKIISGSF----P---PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp HHHHHHTCC----C---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHcCCC----C---CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 444433221 1 1233689999999999999999999999999875
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-52 Score=423.86 Aligned_cols=252 Identities=21% Similarity=0.308 Sum_probs=201.8
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeC--CCc
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDT--ASK 334 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~--~~~ 334 (553)
-|++.++||+|+||+||+|.+..++.. ||||++....... ...+++.+|+++|++|+ |||||++++++.+. ...
T Consensus 27 ~~~~~~~iG~G~fg~Vy~a~~~~~~~~--vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~~~ 102 (290)
T 3fpq_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVE--VAWCELQDRKLTK-SERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCE--EEEEEEEGGGSCH-HHHHHHHHHHHHHHTCC-CTTBCCEEEEEEEEETTEE
T ss_pred eEEeeeEEecCcCcEEEEEEECCCCeE--EEEEEEchhhCCH-HHHHHHHHHHHHHHhCC-CCCCCcEEEEEeeccCCCc
Confidence 358888999999999999998877654 9999998765544 44578999999999995 59999999987653 356
Q ss_pred eEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCC--cEecCCCCCCEEEecCccceecCCCC
Q psy14267 335 HLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAG--IIHSDLKPANFLFVGNVLKIIDCIGN 411 (553)
Q Consensus 335 ~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~g--IiHrDLKp~NILl~~~~~~~~~~~~~ 411 (553)
.+||+||++ +|+|.+++.+... ..+..+..++.||+.||+|||++| ||||||||+||||+... +
T Consensus 103 ~~~lvmEy~~gg~L~~~l~~~~~-----l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~--------g 169 (290)
T 3fpq_A 103 CIVLVTELMTSGTLKTYLKRFKV-----MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPT--------G 169 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTT--------S
T ss_pred EEEEEEeCCCCCCHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCC--------C
Confidence 789999986 5799999987543 345666777889999999999998 99999999999997532 5
Q ss_pred eEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCch
Q psy14267 412 VLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNT 491 (553)
Q Consensus 412 ~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~ 491 (553)
.+||+|||+|+...... ..+.+||+.|||||++.+ .|+.++|||||||+||||++|+.||.+..+.
T Consensus 170 ~vKl~DFGla~~~~~~~----~~~~~GTp~YmAPE~~~~----------~y~~~~DiwSlGvilyelltg~~Pf~~~~~~ 235 (290)
T 3fpq_A 170 SVKIGDLGLATLKRASF----AKAVIGTPEFMAPEMYEE----------KYDESVDVYAFGMCMLEMATSEYPYSECQNA 235 (290)
T ss_dssp CEEECCTTGGGGCCTTS----BEESCSSCCCCCGGGGGT----------CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH
T ss_pred CEEEEeCcCCEeCCCCc----cCCcccCccccCHHHcCC----------CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH
Confidence 79999999998654322 236789999999999864 2789999999999999999999999876554
Q ss_pred HHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 492 WAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 492 ~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
......+........+ +..+++++++||.+||++||++|||+.|+++|
T Consensus 236 ~~~~~~i~~~~~~~~~------~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 236 AQIYRRVTSGVKPASF------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp HHHHHHHTTTCCCGGG------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHcCCCCCCC------CccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 4443333322211111 12567899999999999999999999999875
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=434.17 Aligned_cols=250 Identities=24% Similarity=0.399 Sum_probs=205.6
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
+.|+++++||+|+||+||+|+++.++.. ||||++.+..... .+.+.+|+.+|++|+ |||||++++++.+ ...
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~--vAiK~i~~~~~~~---~~~~~~Ei~il~~l~-HpnIV~l~~~~~~--~~~ 145 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKL--VAVKKMDLRKQQR---RELLFNEVVIMRDYQ-HENVVEMYNSYLV--GDE 145 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCE--EEEEEEEGGGCSS---GGGGHHHHHHHHHCC-CTTBCCEEEEEEE--TTE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCE--EEEEEEecCchhH---HHHHHHHHHHHHhCC-CCCCCcEEEEEEE--CCE
Confidence 4699999999999999999999887755 9999998765433 356789999999995 6999999998855 568
Q ss_pred EEEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
+||||||+. |+|.+++.+. .+.+..+..++.||+.||+|||++|||||||||+||||+.+ +.+|
T Consensus 146 ~~ivmEy~~gg~L~~~l~~~------~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~---------g~vK 210 (346)
T 4fih_A 146 LWVVMEFLEGGALTDIVTHT------RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHD---------GRVK 210 (346)
T ss_dssp EEEEECCCTTEEHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---------CCEE
T ss_pred EEEEEeCCCCCcHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCC---------CCEE
Confidence 999999864 6899888753 24466677788899999999999999999999999999876 6799
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||+|+.+..... ...+.+||+.|||||++.+. .|+.++|||||||+||||++|++||.+... ...
T Consensus 211 l~DFGla~~~~~~~~--~~~~~~GTp~YmAPEvl~~~---------~y~~~~DiWSlGvilyeml~G~~PF~~~~~-~~~ 278 (346)
T 4fih_A 211 LSDFGFCAQVSKEVP--RRKSLVGTPYWMAPELISRL---------PYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-LKA 278 (346)
T ss_dssp ECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTC---------CBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-HHH
T ss_pred EecCcCceecCCCCC--cccccccCcCcCCHHHHCCC---------CCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-HHH
Confidence 999999988765433 23478999999999999766 378999999999999999999999987543 233
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
+..+... ..+.+..+..+++++++||.+||.+||++|||+.|+++|
T Consensus 279 ~~~i~~~-----~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 279 MKMIRDN-----LPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp HHHHHHS-----SCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHcC-----CCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 3333322 122333444789999999999999999999999999875
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=435.92 Aligned_cols=275 Identities=23% Similarity=0.322 Sum_probs=221.3
Q ss_pred cceEEecCcceEEEeeeeeeCceEEEEEeeeCCC---ccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEe
Q psy14267 248 QDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEH---EFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKM 324 (553)
Q Consensus 248 ~~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~---~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l 324 (553)
...|++..++|++++.||+|+||+||+|.+...+ ..+.||||+++.... ....+.+.+|+++|.++.||||||++
T Consensus 56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~--~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--hHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 3457888899999999999999999999876543 235699999976542 33457899999999999999999999
Q ss_pred eeEEEeCCCceEEEEEecC-CCCHHHHHHHcccC-----------CCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCC
Q psy14267 325 HDYVYDTASKHLYVLMEKG-DTDLSKYMRNLNKM-----------TTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLK 392 (553)
Q Consensus 325 ~~~~~~~~~~~~~iv~e~~-~~~L~~~l~~~~~~-----------~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLK 392 (553)
++++... ...++|||||+ +|+|.++++..... ....+++..++.++.||+.||+|||+++|||||||
T Consensus 134 ~g~~~~~-~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK 212 (353)
T 4ase_A 134 LGACTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLA 212 (353)
T ss_dssp EEEECCT-TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred EEEEEec-CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccC
Confidence 9977443 45678999975 57999999875431 12235667778888999999999999999999999
Q ss_pred CCCEEEecCccceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHH
Q psy14267 393 PANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLG 472 (553)
Q Consensus 393 p~NILl~~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlG 472 (553)
|+||||+.+ +.+||+|||+|+.+............+||+.|||||++.+. .|+.++||||||
T Consensus 213 ~~NILl~~~---------~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~---------~y~~ksDVwS~G 274 (353)
T 4ase_A 213 ARNILLSEK---------NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR---------VYTIQSDVWSFG 274 (353)
T ss_dssp GGGEEECGG---------GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC---------CCCHHHHHHHHH
T ss_pred ccceeeCCC---------CCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcC---------CCCCcccEeehH
Confidence 999999877 57999999999987665544444567899999999999876 489999999999
Q ss_pred HHHHHHHh-CCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q psy14267 473 CILYNMIY-GRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNP 550 (553)
Q Consensus 473 vvl~ellt-G~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~ 550 (553)
|+||||+| |..||.+..........+... .... .+..+++++.++|.+||+.||++|||+.||+++|+++.
T Consensus 275 v~l~El~t~G~~Pf~~~~~~~~~~~~i~~g-~~~~------~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ll 346 (353)
T 4ase_A 275 VLLWEIFSLGASPYPGVKIDEEFCRRLKEG-TRMR------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 346 (353)
T ss_dssp HHHHHHTTTSCCSSTTCCCSHHHHHHHHHT-CCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHhCCCCCCCCCCHHHHHHHHHHcC-CCCC------CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 99999998 999998865543333333322 2222 22367899999999999999999999999999998753
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-52 Score=426.93 Aligned_cols=266 Identities=21% Similarity=0.359 Sum_probs=203.4
Q ss_pred EecCcceEEEeeeeeeCceEEEEEeeeC---CCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEE
Q psy14267 252 TLNGKQYQVLSLLGKGGSSSVYLVGGTS---EHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYV 328 (553)
Q Consensus 252 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~---~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~ 328 (553)
.+..++|.+.++||+|+||+||+|+... ....+.||||+++... ....++|.+|+++|++|+ |||||++++++
T Consensus 37 ~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~-HpnIV~l~g~~ 112 (329)
T 4aoj_A 37 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTMLQ-HQHIVRFFGVC 112 (329)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS---HHHHHHHHHHHHHHTTCC-CTTBCCEEEEE
T ss_pred ccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCC-CCCCCcEEEEE
Confidence 3455689999999999999999998653 2234569999997543 345678999999999995 69999999987
Q ss_pred EeCCCceEEEEEecC-CCCHHHHHHHcccC----------CCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEE
Q psy14267 329 YDTASKHLYVLMEKG-DTDLSKYMRNLNKM----------TTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFL 397 (553)
Q Consensus 329 ~~~~~~~~~iv~e~~-~~~L~~~l~~~~~~----------~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NIL 397 (553)
. ....++|||||+ +|+|.++++..... ...++.+..++.++.||+.||+|||+++||||||||+|||
T Consensus 113 ~--~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NIL 190 (329)
T 4aoj_A 113 T--EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCL 190 (329)
T ss_dssp C--SSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred E--ECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEE
Confidence 4 456789999975 58999999865422 1234567778888899999999999999999999999999
Q ss_pred EecCccceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHH
Q psy14267 398 FVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYN 477 (553)
Q Consensus 398 l~~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~e 477 (553)
|+.+ +.+||+|||+|+..............+||+.|||||++.+. .|+.++|||||||+|||
T Consensus 191 l~~~---------~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~---------~~~~~sDvwS~Gvvl~E 252 (329)
T 4aoj_A 191 VGQG---------LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR---------KFTTESDVWSFGVVLWE 252 (329)
T ss_dssp EETT---------TEEEECCCC----------------CCCCGGGCCHHHHTTC---------CCCHHHHHHHHHHHHHH
T ss_pred ECCC---------CcEEEcccccceeccCCCcceecCcccccccccChhhhcCC---------CCCccccccchHHHHHH
Confidence 9887 68999999999877655443333456799999999999876 47899999999999999
Q ss_pred HHh-CCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 478 MIY-GRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 478 llt-G~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
|+| |+.||.+..+. +.+..+.... .. ..+..+++++.+||.+||+.||++|||+.||+++|+.+
T Consensus 253 llt~G~~Pf~~~~~~-~~~~~i~~g~-~~------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l 317 (329)
T 4aoj_A 253 IFTYGKQPWYQLSNT-EAIDCITQGR-EL------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 317 (329)
T ss_dssp HHTTSCCTTCSSCHH-HHHHHHHHTC-CC------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHH
T ss_pred HHcCCCCCCCCCCHH-HHHHHHHcCC-CC------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 998 99999886654 3333333322 22 22346899999999999999999999999999999864
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-52 Score=424.66 Aligned_cols=266 Identities=22% Similarity=0.326 Sum_probs=210.5
Q ss_pred EecCcceEEEeeeeeeCceEEEEEeeeCC---CccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEE
Q psy14267 252 TLNGKQYQVLSLLGKGGSSSVYLVGGTSE---HEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYV 328 (553)
Q Consensus 252 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~---~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~ 328 (553)
.+..++|.+.+.||+|+||+||+|++... .....||||+++... ....++|.+|+++|++|+ |||||++++++
T Consensus 9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~-HpnIV~l~g~~ 84 (299)
T 4asz_A 9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQ-HEHIVKFYGVC 84 (299)
T ss_dssp BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC---HHHHHHHHHHHHHHTTCC-CTTBCCEEEEE
T ss_pred ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC---hHHHHHHHHHHHHHHhCC-CCCCccEEEEE
Confidence 35567899999999999999999987532 233569999997542 344578999999999995 69999999987
Q ss_pred EeCCCceEEEEEecC-CCCHHHHHHHcc--------cCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEe
Q psy14267 329 YDTASKHLYVLMEKG-DTDLSKYMRNLN--------KMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFV 399 (553)
Q Consensus 329 ~~~~~~~~~iv~e~~-~~~L~~~l~~~~--------~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~ 399 (553)
. ....+++||||+ +|+|.++++... ......+++..++.++.||+.||+|||+++||||||||+||||+
T Consensus 85 ~--~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~ 162 (299)
T 4asz_A 85 V--EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG 162 (299)
T ss_dssp C--SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred e--eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEEC
Confidence 4 456789999975 589999998753 12233456777788889999999999999999999999999998
Q ss_pred cCccceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHH
Q psy14267 400 GNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI 479 (553)
Q Consensus 400 ~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ell 479 (553)
.+ +.+||+|||+|+..............+||+.|||||++.+. .|+.++|||||||+||||+
T Consensus 163 ~~---------~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~---------~~~~k~DVwS~Gvvl~Ell 224 (299)
T 4asz_A 163 EN---------LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR---------KFTTESDVWSLGVVLWEIF 224 (299)
T ss_dssp GG---------GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHC---------CCCHHHHHHHHHHHHHHHH
T ss_pred CC---------CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCC---------CCCchhhHHHHHHHHHHHH
Confidence 77 57999999999877554433333355799999999999876 4889999999999999999
Q ss_pred h-CCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 480 Y-GRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 480 t-G~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
| |+.||.+.... +.+..+.... . ...+..+|+++.+||.+||+.||++|||+++|+..|+++
T Consensus 225 t~G~~Pf~~~~~~-~~~~~i~~~~-~------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~ 287 (299)
T 4asz_A 225 TYGKQPWYQLSNN-EVIECITQGR-V------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL 287 (299)
T ss_dssp TTTCCTTTTSCHH-HHHHHHHHTC-C------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCCCCCCCHH-HHHHHHHcCC-C------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 8 99999986553 3333343322 1 122336899999999999999999999999999999864
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-52 Score=442.36 Aligned_cols=250 Identities=24% Similarity=0.398 Sum_probs=206.7
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
+.|+++++||+|+||+||+|+++.++.. ||||++.+..... .+.+.+|+.+|++|+ |||||++++++.+ ...
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~--vAiK~i~~~~~~~---~~~~~~Ei~il~~l~-HpnIV~l~~~~~~--~~~ 222 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKL--VAVKKMDLRKQQR---RELLFNEVVIMRDYQ-HENVVEMYNSYLV--GDE 222 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCE--EEEEEEESTTCSS---GGGHHHHHHHHHHCC-CTTBCCEEEEEEE--TTE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCE--EEEEEEeccchhH---HHHHHHHHHHHHhCC-CCCCCceEEEEEE--CCE
Confidence 5699999999999999999999887755 9999998765443 356789999999995 6999999998865 568
Q ss_pred EEEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
+||||||+. |+|.+++... .+.+..+..++.||+.||+|||++|||||||||+||||+.+ +.||
T Consensus 223 ~~iVmEy~~gG~L~~~i~~~------~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~---------g~vK 287 (423)
T 4fie_A 223 LWVVMEFLEGGALTDIVTHT------RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHD---------GRVK 287 (423)
T ss_dssp EEEEEECCTTEEHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTT---------CCEE
T ss_pred EEEEEeCCCCCcHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCC---------CCEE
Confidence 999999864 6899888653 24456777788899999999999999999999999999876 6799
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||+|+.+..... ...+.+||+.|||||++.+. .|+.++|||||||+||||++|++||.+.... ..
T Consensus 288 l~DFGla~~~~~~~~--~~~~~~GTp~YmAPEvl~~~---------~y~~~~DiWSlGvilyeml~G~~PF~~~~~~-~~ 355 (423)
T 4fie_A 288 LSDFGFCAQVSKEVP--RRKSLVGTPYWMAPELISRL---------PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-KA 355 (423)
T ss_dssp ECCCTTCEECCSSCC--CBCCCEECTTTCCHHHHTTC---------CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-HH
T ss_pred EecCccceECCCCCc--cccccccCcCcCCHHHHCCC---------CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-HH
Confidence 999999988765433 23478899999999999866 3789999999999999999999999875432 33
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
+..+... ..+.+..+..+++++++||.+||.+||++|||+.||++|
T Consensus 356 ~~~i~~~-----~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 356 MKMIRDN-----LPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp HHHHHHS-----CCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHcC-----CCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 3333322 123344455789999999999999999999999999875
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-52 Score=424.01 Aligned_cols=269 Identities=18% Similarity=0.251 Sum_probs=211.4
Q ss_pred EecCcceEEEeeeeeeCceEEEEEeeeC---CCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEE
Q psy14267 252 TLNGKQYQVLSLLGKGGSSSVYLVGGTS---EHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYV 328 (553)
Q Consensus 252 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~---~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~ 328 (553)
++...++++.++||+|+||+||+|+... ....+.||||+++... .....+.|.+|+.+|++|+ |||||++++++
T Consensus 22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~-HpNIV~l~g~~ 98 (308)
T 4gt4_A 22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQ-HPNVVCLLGVV 98 (308)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCC-CCCCCCcceEE
Confidence 3455679999999999999999998642 2334569999997543 2234578999999999995 59999999987
Q ss_pred EeCCCceEEEEEecC-CCCHHHHHHHcccCC-----------CCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCE
Q psy14267 329 YDTASKHLYVLMEKG-DTDLSKYMRNLNKMT-----------TLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANF 396 (553)
Q Consensus 329 ~~~~~~~~~iv~e~~-~~~L~~~l~~~~~~~-----------~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NI 396 (553)
. ....+++||||+ +|+|.+++....... ...+.+..++.++.||+.||+|||+++||||||||+||
T Consensus 99 ~--~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NI 176 (308)
T 4gt4_A 99 T--KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNV 176 (308)
T ss_dssp C--SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred E--ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccce
Confidence 4 456788999975 579999997643221 12355666777888999999999999999999999999
Q ss_pred EEecCccceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHH
Q psy14267 397 LFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILY 476 (553)
Q Consensus 397 Ll~~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ 476 (553)
||+.+ +.+||+|||+|+..............+||+.|||||++.+. .|+.++|||||||+||
T Consensus 177 Ll~~~---------~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~---------~~s~ksDVwSfGvvl~ 238 (308)
T 4gt4_A 177 LVYDK---------LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG---------KFSIDSDIWSYGVVLW 238 (308)
T ss_dssp EECGG---------GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHC---------CCCHHHHHHHHHHHHH
T ss_pred EECCC---------CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCC---------CCCccchhhhHHHHHH
Confidence 99877 57999999999877554433334466899999999999866 4899999999999999
Q ss_pred HHHh-CCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q psy14267 477 NMIY-GRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNPE 551 (553)
Q Consensus 477 ellt-G~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~~ 551 (553)
||+| |..||.+.... +.+..+... .. .+.+..+|.++.+||.+||+.||++|||+.||+++|+.+.+
T Consensus 239 El~t~g~~Pf~~~~~~-~~~~~i~~~-~~------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~n 306 (308)
T 4gt4_A 239 EVFSYGLQPYCGYSNQ-DVVEMIRNR-QV------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGN 306 (308)
T ss_dssp HHHTTTCCTTTTCCHH-HHHHHHHTT-CC------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC
T ss_pred HHHhCCCCCCCCCCHH-HHHHHHHcC-CC------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccC
Confidence 9998 89999986553 333333322 11 12234789999999999999999999999999999998765
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-52 Score=426.95 Aligned_cols=253 Identities=21% Similarity=0.265 Sum_probs=200.8
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
...|++.++||+|+||+||+|+++.++.. ||||+++++... .+|+.+|++|+ |||||++++++.+ ..
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~--vAiK~i~~~~~~--------~~E~~il~~l~-HpnIV~l~~~~~~--~~ 123 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQ--CAVKKVRLEVFR--------VEELVACAGLS-SPRIVPLYGAVRE--GP 123 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCE--EEEEEEETTTCC--------THHHHTTTTCC-CTTBCCEEEEEEE--TT
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCE--EEEEEECHHHhH--------HHHHHHHHhCC-CCCCCcEEEEEEE--CC
Confidence 35699999999999999999998887755 999999876432 36999999995 6999999998754 56
Q ss_pred eEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 335 HLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 335 ~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
.+||+|||+ +++|.+++++... +.+..+..++.||+.||+|||++|||||||||+||||+.+. ..+
T Consensus 124 ~~~ivmEy~~gg~L~~~l~~~~~-----l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g--------~~v 190 (336)
T 4g3f_A 124 WVNIFMELLEGGSLGQLIKQMGC-----LPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDG--------SRA 190 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTS--------CCE
T ss_pred EEEEEEeccCCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCC--------CEE
Confidence 899999986 5799999987653 44566777888999999999999999999999999997662 369
Q ss_pred EEEeccCccccCCCCCc---ccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCc
Q psy14267 414 KIIDFGIACSLQDDKTS---VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN 490 (553)
Q Consensus 414 kL~DFGla~~~~~~~~~---~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~ 490 (553)
||+|||+|+.+...... ......+||+.|||||++.+.. |+.++|||||||+||||++|++||.+...
T Consensus 191 Kl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~---------y~~~~DiwSlGvilyemltG~~Pf~~~~~ 261 (336)
T 4g3f_A 191 ALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP---------CDAKVDIWSSCCMMLHMLNGCHPWTQYFR 261 (336)
T ss_dssp EECCCTTCEEC------------CCCCCCGGGCCHHHHTTCC---------CCTHHHHHHHHHHHHHHHHSSCSSTTTCC
T ss_pred EEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCC---------CCcHHHHHHHHHHHHHHHHCcCCCCCCCH
Confidence 99999999987654321 1223568999999999998763 78899999999999999999999987443
Q ss_pred hHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q psy14267 491 TWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINN 548 (553)
Q Consensus 491 ~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~ 548 (553)
. ..+..+...... ....+..+++++++||.+||++||++|||+.||+++|..
T Consensus 262 ~-~~~~~i~~~~~~-----~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~ 313 (336)
T 4g3f_A 262 G-PLCLKIASEPPP-----IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK 313 (336)
T ss_dssp S-CCHHHHHHSCCG-----GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred H-HHHHHHHcCCCC-----chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 2 222333322211 112234789999999999999999999999999998864
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=419.55 Aligned_cols=253 Identities=24% Similarity=0.408 Sum_probs=195.5
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCC-CccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCC
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSE-HEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTAS 333 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~-~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~ 333 (553)
.++|++++.||+|+||+||+|++... ...+.||||++++....... ..++.+|+++|++|. |||||++++++.+ .
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~-~~~~~~E~~il~~l~-HpnIv~l~~~~~~--~ 98 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-RVRTKMERDILVEVN-HPFIVKLHYAFQT--E 98 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE-CC------CCCCCCC-CTTEECEEEEEEE--T
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH-HHHHHHHHHHHHHCC-CCCCCeEEEEEEE--C
Confidence 35799999999999999999987543 33456999999876544322 246789999999995 6999999998754 5
Q ss_pred ceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCe
Q psy14267 334 KHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNV 412 (553)
Q Consensus 334 ~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~ 412 (553)
..+|++|||+ +|+|.+++.+.. .+.+..+..++.||+.||+|||++|||||||||+||||+.+ +.
T Consensus 99 ~~~~ivmEy~~gg~L~~~l~~~~-----~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~---------g~ 164 (304)
T 3ubd_A 99 GKLYLILDFLRGGDLFTRLSKEV-----MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEE---------GH 164 (304)
T ss_dssp TEEEEEECCCTTCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTT---------SC
T ss_pred CEEEEEEEcCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCC---------CC
Confidence 6899999986 579999998765 34456677788899999999999999999999999999877 67
Q ss_pred EEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchH
Q psy14267 413 LKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTW 492 (553)
Q Consensus 413 vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~ 492 (553)
+||+|||+|+....... ...+.+||+.|||||++.+.. |+.++|||||||+||||++|++||.+.+..
T Consensus 165 vKl~DFGla~~~~~~~~--~~~~~~GT~~YmAPE~~~~~~---------y~~~~DiwSlGvilyemltG~~PF~~~~~~- 232 (304)
T 3ubd_A 165 IKLTDFGLSKESIDHEK--KAYSFCGTVEYMAPEVVNRRG---------HTQSADWWSFGVLMFEMLTGTLPFQGKDRK- 232 (304)
T ss_dssp EEEESSEEEEC-----C--CCCSCCCCGGGCCHHHHHTSC---------CCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-
T ss_pred EEecccccceeccCCCc--cccccccCcccCCHHHhccCC---------CCCCCcccchHHHHHHHHhCCCCCCCcCHH-
Confidence 99999999987654332 234678999999999998763 788999999999999999999999875432
Q ss_pred HHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q psy14267 493 AKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTV-----GNSVTQ 545 (553)
Q Consensus 493 ~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~-----~ell~~ 545 (553)
+.+..+.... ..+ +..+|+++++||.+||++||++|||+ +|+++|
T Consensus 233 ~~~~~i~~~~--~~~------p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 233 ETMTMILKAK--LGM------PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp HHHHHHHHCC--CCC------CTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred HHHHHHHcCC--CCC------CCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 3444444322 122 23688999999999999999999984 566653
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=426.81 Aligned_cols=264 Identities=24% Similarity=0.333 Sum_probs=207.1
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeC---
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDT--- 331 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~--- 331 (553)
+++|++++.||+|+||+||+|+++.++.. ||||++++.... ....+++++|+++|++|+ |||||++++++...
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~--vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~ 128 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQ--VAIKKIPNAFDV-VTNAKRTLRELKILKHFK-HDNIIAIKDILRPTVPY 128 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCE--EEEEEETTTTSS-HHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSSCT
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCE--EEEEEECccccc-hHHHHHHHHHHHHHHhcC-CCCcceEeeeeeccccc
Confidence 46899999999999999999999887755 999999766533 344578999999999995 69999999876543
Q ss_pred -CCceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCC
Q psy14267 332 -ASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIG 410 (553)
Q Consensus 332 -~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~ 410 (553)
....+|||||+++|+|.+++.... .+.+..+..+++||+.||+|||++|||||||||+||||+.+
T Consensus 129 ~~~~~~~ivmE~~~g~L~~~i~~~~-----~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~--------- 194 (398)
T 4b99_A 129 GEFKSVYVVLDLMESDLHQIIHSSQ-----PLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNEN--------- 194 (398)
T ss_dssp TTCCCEEEEEECCSEEHHHHHTSSS-----CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT---------
T ss_pred ccCCEEEEEEeCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCC---------
Confidence 346899999999999999987643 34566778888999999999999999999999999999876
Q ss_pred CeEEEEeccCccccCCCCC--cccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy14267 411 NVLKIIDFGIACSLQDDKT--SVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHI 488 (553)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~--~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~ 488 (553)
+.+||+|||+|+.+..... .....+.+||+.|||||++.+.. .|+.++|||||||++|||++|++||.+.
T Consensus 195 ~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~--------~~~~~~DiWSlG~il~ell~G~~pF~g~ 266 (398)
T 4b99_A 195 CELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLH--------EYTQAIDLWSVGCIFGEMLARRQLFPGK 266 (398)
T ss_dssp CCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCS--------CCCTHHHHHHHHHHHHHHHHTSCSSCCS
T ss_pred CCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCC--------CCCChhheehhHHHHHHHHHCCCCCCCC
Confidence 6799999999987754321 22334778999999999998653 3689999999999999999999999875
Q ss_pred CchHHHHHHHHhhcccccc------------------cccc-----cCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 489 PNTWAKMLAIARHKDQIEF------------------KPQL-----ANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 489 ~~~~~~~~~i~~~~~~~~~------------------~~~~-----~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
+.. ..+..+......... .... .....+++++++||.+||.+||++|||+.|+++|
T Consensus 267 ~~~-~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 267 NYV-HQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp SHH-HHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred CHH-HHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 443 333333322111110 0000 0112568999999999999999999999999875
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-50 Score=410.25 Aligned_cols=255 Identities=24% Similarity=0.440 Sum_probs=187.5
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCC--
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTAS-- 333 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~-- 333 (553)
.+|++++.||+|+||+||+|+++.++.. ||||++++.. .+...+++.+|+++|++|+ |||||++++++.+...
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~--vAiK~i~~~~--~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~~ 79 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCN--YAIKRIRLPN--RELAREKVMREVKALAKLE-HPGIVRYFNAWLEKNTTE 79 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCE--EEEEEEEECS--SHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEEC---
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCE--EEEEEEeccC--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEecCccc
Confidence 3699999999999999999998877754 9999998654 3344578999999999995 6999999998865432
Q ss_pred --------ceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccc
Q psy14267 334 --------KHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLK 404 (553)
Q Consensus 334 --------~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~ 404 (553)
.++|++||++ +++|.+++......... ....++.++.||+.||+|||++|||||||||+||||+.+
T Consensus 80 ~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~--~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~--- 154 (299)
T 4g31_A 80 KLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEER--ERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMD--- 154 (299)
T ss_dssp -------CEEEEEEEECCCSCCHHHHHHTCCSGGGS--CHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---
T ss_pred cccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChh--HHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCC---
Confidence 3589999986 57999999875433322 234456677899999999999999999999999999876
Q ss_pred eecCCCCeEEEEeccCccccCCCCCc----------ccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHH
Q psy14267 405 IIDCIGNVLKIIDFGIACSLQDDKTS----------VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCI 474 (553)
Q Consensus 405 ~~~~~~~~vkL~DFGla~~~~~~~~~----------~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvv 474 (553)
+.+||+|||+|+.+...... ....+.+||+.|||||++.+. .|+.++|||||||+
T Consensus 155 ------~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~---------~y~~~~DiwSlGvi 219 (299)
T 4g31_A 155 ------DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN---------SYSHKVDIFSLGLI 219 (299)
T ss_dssp ------CCEEECCCCCC--------------------------CCCTTSCHHHHTTC---------CCCTHHHHHHHHHH
T ss_pred ------CcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCC---------CCCCHHHHHHHHHH
Confidence 67999999999887543221 112356799999999999876 37899999999999
Q ss_pred HHHHHhCCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 475 LYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 475 l~elltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
||||++ ||.........+..+... .+++... ..++.+.+||++||+.||++|||+.|++++
T Consensus 220 lyell~---Pf~~~~~~~~~~~~~~~~----~~p~~~~---~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 220 LFELLY---PFSTQMERVRTLTDVRNL----KFPPLFT---QKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HHHHHS---CCSSHHHHHHHHHHHHTT----CCCHHHH---HHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHcc---CCCCccHHHHHHHHHhcC----CCCCCCc---ccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 999996 786532222222222221 1222111 345678899999999999999999999874
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=444.97 Aligned_cols=254 Identities=22% Similarity=0.342 Sum_probs=204.7
Q ss_pred ecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC
Q psy14267 253 LNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA 332 (553)
Q Consensus 253 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~ 332 (553)
+...+|+++++||+|+||+||+|++..++.. ||||++++.........+.+..|..+|..+.+||+|+.+++++ ..
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~--vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~--~~ 413 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDEL--YAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF--QT 413 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCE--EEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEEC--BC
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcE--EEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEE--Ee
Confidence 4457899999999999999999998877655 9999998754433344577899999999998899999998766 45
Q ss_pred CceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCC
Q psy14267 333 SKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGN 411 (553)
Q Consensus 333 ~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~ 411 (553)
...+|++||++ +++|..++..... +.+..++.++.||+.||+|||++|||||||||+||||+.+ +
T Consensus 414 ~~~~~lV~E~~~gg~L~~~l~~~~~-----~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~---------g 479 (674)
T 3pfq_A 414 MDRLYFVMEYVNGGDLMYHIQQVGR-----FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSE---------G 479 (674)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSS---------S
T ss_pred CCEEEEEEeCcCCCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCC---------C
Confidence 67899999976 5799999987643 3456677788899999999999999999999999999877 6
Q ss_pred eEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCch
Q psy14267 412 VLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNT 491 (553)
Q Consensus 412 ~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~ 491 (553)
.+||+|||+|+....... .....+||+.|||||++.+. .|+.++|||||||+||||++|..||.+....
T Consensus 480 ~ikL~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~---------~~~~~~DvwSlGvilyelltG~~Pf~~~~~~ 548 (674)
T 3pfq_A 480 HIKIADFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQ---------PYGKSVDWWAFGVLLYEMLAGQAPFEGEDED 548 (674)
T ss_dssp CEEECCCTTCEECCCTTC--CBCCCCSCSSSCCHHHHTCC---------CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred cEEEeecceeeccccCCc--ccccccCCCcccCHhhhcCC---------CCCccceEechHHHHHHHHcCCCCCCCCCHH
Confidence 799999999987544332 23467899999999999766 3789999999999999999999999875432
Q ss_pred HHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q psy14267 492 WAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTV-----GNSVT 544 (553)
Q Consensus 492 ~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~-----~ell~ 544 (553)
.....+... ...++ ..+++++++||++||++||++||++ +||++
T Consensus 549 -~~~~~i~~~--~~~~p------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 549 -ELFQSIMEH--NVAYP------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp -HHHHHHHSS--CCCCC------TTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred -HHHHHHHhC--CCCCC------ccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 333333322 22222 2678999999999999999999997 66654
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-49 Score=408.87 Aligned_cols=260 Identities=21% Similarity=0.333 Sum_probs=199.4
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeC-CCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCC
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTS-EHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTAS 333 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~ 333 (553)
.++|+++++||+|+||+||+|+++. ....+.||||++.+.. ...++.+|+++|+++.+||||+++++++.+ .
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~--~ 92 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRK--N 92 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEE--T
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEE--C
Confidence 3579999999999999999998753 3444669999986543 235678999999999889999999987754 6
Q ss_pred ceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCe
Q psy14267 334 KHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNV 412 (553)
Q Consensus 334 ~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~ 412 (553)
.++|++||++ +++|.+++.. +.+..+..+++||+.||+|||++|||||||||+||||+.+. +.
T Consensus 93 ~~~~lvmE~~~g~~L~~~~~~--------l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~--------~~ 156 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDILNS--------LSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRL--------KK 156 (361)
T ss_dssp TEEEEEEECCCCCCHHHHHTT--------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTT--------TE
T ss_pred CEEEEEEeCCCcccHHHHHcC--------CCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCC--------Ce
Confidence 6899999987 5789888742 34556777888999999999999999999999999997663 57
Q ss_pred EEEEeccCccccCCCCCc--------------------------ccccCCccCCCccCcccccccCCCCCCCccCCCccc
Q psy14267 413 LKIIDFGIACSLQDDKTS--------------------------VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKS 466 (553)
Q Consensus 413 vkL~DFGla~~~~~~~~~--------------------------~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~s 466 (553)
+||+|||+|+........ ....+.+||+.|||||++.+.. .|+.++
T Consensus 157 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~--------~y~~~~ 228 (361)
T 4f9c_A 157 YALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCP--------NQTTAI 228 (361)
T ss_dssp EEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCS--------CCCTHH
T ss_pred EEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCC--------CCCCcc
Confidence 999999999866443211 1123567999999999997653 378999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHhhccc------------------------------------------
Q psy14267 467 DVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQ------------------------------------------ 504 (553)
Q Consensus 467 DIwSlGvvl~elltG~~Pf~~~~~~~~~~~~i~~~~~~------------------------------------------ 504 (553)
||||+||++|||++|+.||....+....+..+......
T Consensus 229 DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~ 308 (361)
T 4f9c_A 229 DMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKL 308 (361)
T ss_dssp HHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC---------
T ss_pred chhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccc
Confidence 99999999999999999997655544444333221000
Q ss_pred ----ccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 505 ----IEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 505 ----~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
.........+..+++++++||++||..||++|||++|+++|
T Consensus 309 ~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~H 353 (361)
T 4f9c_A 309 TSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLH 353 (361)
T ss_dssp -------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred ccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00001122345688999999999999999999999999875
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=395.56 Aligned_cols=265 Identities=16% Similarity=0.230 Sum_probs=190.4
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHH--HHHHHHHhhcCCCceeEeeeEEEeCCC
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYL--NEVELLAKLQGCPYVIKMHDYVYDTAS 333 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~--~E~~iL~~l~~hp~Iv~l~~~~~~~~~ 333 (553)
++|.+.++||+|+||+||+|++. + +.||||+++... .+.+. .|+..+.++ +|||||++++++.....
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~--g--~~VAvK~l~~~~------~~~~~~e~Ei~~~~~l-~HpNIv~l~g~~~~~~~ 71 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR--G--EEVAVKIFSSRE------ERSWFREAEIYQTVML-RHENILGFIAADNKDNG 71 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET--T--EEEEEEEECGGG------HHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECS
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC--C--EEEEEEEECccc------hhhHHHHHHHHHHhcC-CCCCCCcEEEEEEecCC
Confidence 46899999999999999999763 3 459999996532 13333 455555667 46999999999876543
Q ss_pred --ceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhC--------CcEecCCCCCCEEEecCc
Q psy14267 334 --KHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAA--------GIIHSDLKPANFLFVGNV 402 (553)
Q Consensus 334 --~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~--------gIiHrDLKp~NILl~~~~ 402 (553)
..+|+||||+ +|+|.++++... ..+..++.++.|++.||+|||++ +||||||||+||||+.+
T Consensus 72 ~~~~~~lV~Ey~~~gsL~~~l~~~~------l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~- 144 (303)
T 3hmm_A 72 TWTQLWLVSDYHEHGSLFDYLNRYT------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN- 144 (303)
T ss_dssp SSEEEEEEEECCTTCBHHHHHHHCC------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTT-
T ss_pred CceEEEEEecCCCCCcHHHHHHhCC------CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCC-
Confidence 3689999986 589999997642 34556667778999999999987 99999999999999887
Q ss_pred cceecCCCCeEEEEeccCccccCCCCCcc--cccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh
Q psy14267 403 LKIIDCIGNVLKIIDFGIACSLQDDKTSV--HKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY 480 (553)
Q Consensus 403 ~~~~~~~~~~vkL~DFGla~~~~~~~~~~--~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt 480 (553)
+.+||+|||+|+......... .....+||+.|||||++.+.... ....++.++|||||||+||||+|
T Consensus 145 --------~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~---~~~~~~~k~DVwS~Gvvl~El~t 213 (303)
T 3hmm_A 145 --------GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM---KHFESFKRADIYAMGLVFWEIAR 213 (303)
T ss_dssp --------SCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCT---TCHHHHHHHHHHHHHHHHHHHHH
T ss_pred --------CCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccc---cCCccChhHhhhhHHHHHHHHHH
Confidence 679999999998876544322 22346799999999999765311 12247889999999999999999
Q ss_pred CCCCCCC----------CC---chHHHHHH-HHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q psy14267 481 GRTPYSH----------IP---NTWAKMLA-IARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQI 546 (553)
Q Consensus 481 G~~Pf~~----------~~---~~~~~~~~-i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L 546 (553)
|..||.. .. .....+.. +........++... ....+++.+.+||.+||+.||++|||+.||++.|
T Consensus 214 g~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L 292 (303)
T 3hmm_A 214 RCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRW-QSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292 (303)
T ss_dssp TBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGG-GSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHH
T ss_pred CCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCccc-cchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHH
Confidence 9776542 11 11122222 11111111111111 1123446789999999999999999999999999
Q ss_pred hcCC
Q psy14267 547 NNNP 550 (553)
Q Consensus 547 ~~~~ 550 (553)
+++.
T Consensus 293 ~~l~ 296 (303)
T 3hmm_A 293 SQLS 296 (303)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 8753
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-48 Score=426.31 Aligned_cols=253 Identities=22% Similarity=0.359 Sum_probs=198.0
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhc--CCCceeEeeeEEEeCC
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQ--GCPYVIKMHDYVYDTA 332 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~--~hp~Iv~l~~~~~~~~ 332 (553)
-++|+++++||+|+||+||+|+++.++.. ||||++.+..+........+.+|..++..+. +|||||++++++. +
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~--~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~--~ 263 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKM--YAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH--T 263 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCE--EEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE--C
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCE--EEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEE--E
Confidence 35899999999999999999999887755 9999998765443333345556655444332 5799999988774 4
Q ss_pred CceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCC
Q psy14267 333 SKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGN 411 (553)
Q Consensus 333 ~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~ 411 (553)
...+|+||||+ ||+|..++.+... +.+..+..+++||+.||+|||++|||||||||+||||+.+ +
T Consensus 264 ~~~lylVmEy~~GGdL~~~l~~~~~-----l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~---------G 329 (689)
T 3v5w_A 264 PDKLSFILDLMNGGDLHYHLSQHGV-----FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH---------G 329 (689)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHCC-----CCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTT---------S
T ss_pred CCEEEEEEecCCCCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCC---------C
Confidence 67899999975 5799999987653 4466777888999999999999999999999999999877 6
Q ss_pred eEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCc-
Q psy14267 412 VLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN- 490 (553)
Q Consensus 412 ~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~- 490 (553)
.|||+|||+|+.+..... .+.+||+.|||||++.... .|+.++|||||||+||||++|.+||.+...
T Consensus 330 ~vKL~DFGlA~~~~~~~~----~t~~GTp~YmAPEvl~~~~--------~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~ 397 (689)
T 3v5w_A 330 HVRISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGV--------AYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 397 (689)
T ss_dssp CEEECCCTTCEECSSCCC----CSCCSCGGGCCHHHHSTTC--------CCCTHHHHHHHHHHHHHHHHSSCTTCGGGCC
T ss_pred CEEecccceeeecCCCCC----CCccCCcCccCHHHHhCCC--------CCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 899999999988765432 3679999999999996432 378999999999999999999999976322
Q ss_pred -hHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q psy14267 491 -TWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT-----VGNSVTQ 545 (553)
Q Consensus 491 -~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt-----~~ell~~ 545 (553)
.......+.. ... ..+..+++++++||.+||.+||++|++ ++||++|
T Consensus 398 ~~~~i~~~i~~--~~~------~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 398 DKHEIDRMTLT--MAV------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp CHHHHHHHHHH--CCC------CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred HHHHHHHhhcC--CCC------CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 2122222221 111 122368899999999999999999998 6777654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=414.97 Aligned_cols=254 Identities=20% Similarity=0.334 Sum_probs=206.9
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|++++.||+|+||+||+|.++.++.. ||||++.+... ...+.+.+|+.+|++|+ ||||+++++++. ....
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~--~AiK~i~~~~~---~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~--~~~~ 228 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNN--FAAKFVMTPHE---SDKETVRKEIQTMSVLR-HPTLVNLHDAFE--DDNE 228 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCE--EEEEEEECCSH---HHHHHHHHHHHHHHHTC-CTTBCCEEEEEE--CSSE
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCE--EEEEEEeccch---hhHHHHHHHHHHHHhCC-CCCCCeEEEEEE--ECCE
Confidence 5799999999999999999999887765 99999987542 33467889999999995 699999999874 4678
Q ss_pred EEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
+||+||++ +|+|.+++..... .+.+..+..+++||+.||+|||++|||||||||+||||+.+. .+.+|
T Consensus 229 ~~iv~E~~~gg~L~~~i~~~~~----~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~-------~~~vK 297 (573)
T 3uto_A 229 MVMIYEFMSGGELFEKVADEHN----KMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKR-------SNELK 297 (573)
T ss_dssp EEEEEECCCCCBHHHHHTCTTS----CEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSS-------CCCEE
T ss_pred EEEEEeecCCCcHHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCC-------CCCEE
Confidence 99999976 5799998864322 355677788889999999999999999999999999997542 25799
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||+|+.+..... ..+.+||+.|||||++.+.. |+.++|||||||+||||++|.+||.+.... ..
T Consensus 298 l~DFG~a~~~~~~~~---~~~~~GT~~y~APEv~~~~~---------y~~~~DiWSlGvilyeml~G~~Pf~~~~~~-~~ 364 (573)
T 3uto_A 298 LIDFGLTAHLDPKQS---VKVTTGTAEFAAPEVAEGKP---------VGYYTDMWSVGVLSYILLSGLSPFGGENDD-ET 364 (573)
T ss_dssp ECCCSSCEECCTTSE---EEEECSSGGGCCHHHHTTCC---------BCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-HH
T ss_pred EeeccceeEccCCCc---eeeeEECccccCHHHhCCCC---------CCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-HH
Confidence 999999998865443 23668999999999998763 789999999999999999999999875443 34
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
+..+...... +. ...+..+++++++||.+||++||++|||+.|+++|
T Consensus 365 ~~~i~~~~~~--~~--~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 365 LRNVKSCDWN--MD--DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp HHHHHTTCCC--CC--SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHhCCCC--CC--cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 4444433222 11 12234689999999999999999999999999985
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=370.52 Aligned_cols=269 Identities=42% Similarity=0.669 Sum_probs=204.1
Q ss_pred eEEecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCC-CceeEeeeEE
Q psy14267 250 VITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGC-PYVIKMHDYV 328 (553)
Q Consensus 250 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~h-p~Iv~l~~~~ 328 (553)
.+.+.+++|++++.||+|+||.||++.+.. .+.||||++...... ....+.+.+|+.+|+++.|| |||+++++++
T Consensus 3 ~i~~~~~~y~i~~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 78 (343)
T 3dbq_A 3 CISVKGRIYSILKQIGSGGSSKVFQVLNEK---KQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 78 (343)
T ss_dssp CEESSSCEEEEEEEESCCSSEEEEEEECTT---SCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred eeeeecCEEEEEEEEecCCCeEEEEEEeCC---CCEEEEEEeeccccc-hHHHHHHHHHHHHHHhhhhcCCceEEEeeeE
Confidence 356778899999999999999999997743 345999999876543 34557899999999999864 9999999877
Q ss_pred EeCCCceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecC
Q psy14267 329 YDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDC 408 (553)
Q Consensus 329 ~~~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~ 408 (553)
. ....++++||+.+++|.+++.... ......+..++.||+.||+|||++|||||||||+||||+.
T Consensus 79 ~--~~~~~~lv~e~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~~-------- 143 (343)
T 3dbq_A 79 I--TDQYIYMVMECGNIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-------- 143 (343)
T ss_dssp E--CSSEEEEEECCCSEEHHHHHHHSC-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET--------
T ss_pred e--eCCEEEEEEeCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEEC--------
Confidence 4 466899999999999999998754 2334556677789999999999999999999999999964
Q ss_pred CCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCC--CCccCCCccchHHHHHHHHHHHHhCCCCCC
Q psy14267 409 IGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGG--GNTYRITYKSDVWSLGCILYNMIYGRTPYS 486 (553)
Q Consensus 409 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~--~~~~~~s~~sDIwSlGvvl~elltG~~Pf~ 486 (553)
+.+||+|||+++..............+||+.|+|||++.+...... .....++.++|||||||+||||++|..||.
T Consensus 144 --~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 221 (343)
T 3dbq_A 144 --GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 221 (343)
T ss_dssp --TEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred --CcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcch
Confidence 4699999999988765544333346679999999999965221100 001247899999999999999999999998
Q ss_pred CCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 487 HIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 487 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
...+....+..+........+ ....+.++.+||.+||+.||++|||+.+++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~------~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 222 QIINQISKLHAIIDPNHEIEF------PDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp TCCSHHHHHHHHHCTTSCCCC------CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhhHHHHHHHHhcCCcccCC------cccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 866654444444332222222 22457899999999999999999999999876
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=374.84 Aligned_cols=269 Identities=22% Similarity=0.348 Sum_probs=211.8
Q ss_pred EEecCcceEEEeeeeeeCceEEEEEeeeCC-----CccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEee
Q psy14267 251 ITLNGKQYQVLSLLGKGGSSSVYLVGGTSE-----HEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMH 325 (553)
Q Consensus 251 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~-----~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~ 325 (553)
+.+..++|++++.||+|+||.||+|++... .....||||+++... .....+.+.+|+.+|+++.+||||++++
T Consensus 76 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 153 (370)
T 2psq_A 76 WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLL 153 (370)
T ss_dssp TBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEE
T ss_pred ccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence 345567899999999999999999987532 233569999997653 3445678999999999997779999999
Q ss_pred eEEEeCCCceEEEEEecC-CCCHHHHHHHcccC-----------CCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCC
Q psy14267 326 DYVYDTASKHLYVLMEKG-DTDLSKYMRNLNKM-----------TTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKP 393 (553)
Q Consensus 326 ~~~~~~~~~~~~iv~e~~-~~~L~~~l~~~~~~-----------~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp 393 (553)
+++ .....+|++||++ +++|.+++...... ......+..++.++.||+.||+|||++|||||||||
T Consensus 154 ~~~--~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp 231 (370)
T 2psq_A 154 GAC--TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAA 231 (370)
T ss_dssp EEE--CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCG
T ss_pred EEE--ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccch
Confidence 877 4456788899976 56999999875421 122345666777888999999999999999999999
Q ss_pred CCEEEecCccceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHH
Q psy14267 394 ANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGC 473 (553)
Q Consensus 394 ~NILl~~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGv 473 (553)
+||||+.+ +.+||+|||+++...............||+.|+|||++.+. .++.++|||||||
T Consensus 232 ~NIll~~~---------~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~---------~~~~~~DvwslG~ 293 (370)
T 2psq_A 232 RNVLVTEN---------NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR---------VYTHQSDVWSFGV 293 (370)
T ss_dssp GGEEECTT---------CCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTC---------CCCHHHHHHHHHH
T ss_pred hhEEECCC---------CCEEEccccCCcccCcccceecccCCCcccceECHhHhcCC---------CCCcHHHHHHHHH
Confidence 99999776 67999999999877654433333355678999999999765 3789999999999
Q ss_pred HHHHHHh-CCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 474 ILYNMIY-GRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 474 vl~ellt-G~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
+||||++ |..||.+.... .....+.. .... .....++.++.++|.+||+.||++||++.|++++|+++
T Consensus 294 il~ellt~g~~p~~~~~~~-~~~~~~~~-~~~~------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i 362 (370)
T 2psq_A 294 LMWEIFTLGGSPYPGIPVE-ELFKLLKE-GHRM------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362 (370)
T ss_dssp HHHHHHTTSCCSSTTCCGG-GHHHHHHT-TCCC------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHcCCCCCCCCCCHH-HHHHHHhc-CCCC------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 9999999 99999876543 22222222 1111 12236789999999999999999999999999999875
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=377.75 Aligned_cols=269 Identities=42% Similarity=0.682 Sum_probs=205.2
Q ss_pred eEEecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcC-CCceeEeeeEE
Q psy14267 250 VITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG-CPYVIKMHDYV 328 (553)
Q Consensus 250 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~-hp~Iv~l~~~~ 328 (553)
...+.+..|++++.||+|+||.||+|.+.. + +.||||++.+.... ....+.+.+|+.+|+++.+ ||||+++++++
T Consensus 50 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~--~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~ 125 (390)
T 2zmd_A 50 CISVKGRIYSILKQIGSGGSSKVFQVLNEK-K--QIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 125 (390)
T ss_dssp CEEETTEEEEEEEEEECCSSEEEEEEECTT-C--CEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred cccccCCceEEEEEEccCCCeEEEEEEcCC-C--CEEEEEEEeccccc-HHHHHHHHHHHHHHHHcccCCCeEEEEEEEE
Confidence 456677889999999999999999997654 3 45999999876543 3456889999999999985 79999999877
Q ss_pred EeCCCceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecC
Q psy14267 329 YDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDC 408 (553)
Q Consensus 329 ~~~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~ 408 (553)
.. ...+|++||+.+++|.+++.... ......++.++.||+.||+|||++|||||||||+||||+.
T Consensus 126 ~~--~~~~~lv~E~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~-------- 190 (390)
T 2zmd_A 126 IT--DQYIYMVMECGNIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-------- 190 (390)
T ss_dssp EC--SSEEEEEEECCSEEHHHHHHHCS-----SCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESS--------
T ss_pred ec--CCEEEEEEecCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEEC--------
Confidence 54 56799999999999999998754 2334456667789999999999999999999999999953
Q ss_pred CCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCC--CCCccCCCccchHHHHHHHHHHHHhCCCCCC
Q psy14267 409 IGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSG--GGNTYRITYKSDVWSLGCILYNMIYGRTPYS 486 (553)
Q Consensus 409 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~--~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~ 486 (553)
+.+||+|||+++.+............+||+.|+|||++.+..... +.....++.++|||||||+||||++|..||.
T Consensus 191 --~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~ 268 (390)
T 2zmd_A 191 --GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 268 (390)
T ss_dssp --SCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred --CeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcch
Confidence 469999999998876544333334667999999999997532110 0011247899999999999999999999998
Q ss_pred CCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 487 HIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 487 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
...+....+..+........+. ...+.++.+||.+||..||++|||+.|++++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 269 QIINQISKLHAIIDPNHEIEFP------DIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp TCCCHHHHHHHHHCTTSCCCCC------CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhHHHHHHHHHhCccccCCCC------ccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 7655544444444332222222 2457899999999999999999999999875
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=378.36 Aligned_cols=250 Identities=24% Similarity=0.380 Sum_probs=197.5
Q ss_pred cCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCC
Q psy14267 254 NGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTAS 333 (553)
Q Consensus 254 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~ 333 (553)
..++|+++++||+|+||+||+|+++.++.. ||||++++.........+.+.+|+.+|.++.+||||+++++++. ..
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~--~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~--~~ 125 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRI--YAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ--TE 125 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEE--EEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEE--CS
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCE--EEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEE--EC
Confidence 446899999999999999999998877654 99999998766655556778999999999978899999998774 46
Q ss_pred ceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCe
Q psy14267 334 KHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNV 412 (553)
Q Consensus 334 ~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~ 412 (553)
..++++||++ +++|..++..... +....+..++.||+.||+|||++|||||||||+||||+.+ +.
T Consensus 126 ~~~~lV~E~~~gg~L~~~l~~~~~-----l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~---------g~ 191 (396)
T 4dc2_A 126 SRLFFVIEYVNGGDLMFHMQRQRK-----LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE---------GH 191 (396)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT---------SC
T ss_pred CEEEEEEEcCCCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCC---------CC
Confidence 6889999976 5699998887543 4456677778899999999999999999999999999877 67
Q ss_pred EEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCc--
Q psy14267 413 LKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN-- 490 (553)
Q Consensus 413 vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~-- 490 (553)
+||+|||+|+....... .....+||+.|+|||++.+. .++.++|||||||+||||++|..||.....
T Consensus 192 ikL~DFGla~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~---------~~~~~~DiwslGvllyell~G~~Pf~~~~~~~ 260 (396)
T 4dc2_A 192 IKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGE---------DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 260 (396)
T ss_dssp EEECCCTTCBCCCCTTC--CBCCCCBCGGGCCHHHHTTC---------CBCTHHHHHHHHHHHHHHHHSSCSSTTTTC--
T ss_pred EEEeecceeeecccCCC--ccccccCCcccCCchhhcCC---------CCChHHHHHHHHHHHHHHHhCCCCCccccccc
Confidence 99999999986433322 23477899999999999876 378999999999999999999999964221
Q ss_pred -----hHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCH
Q psy14267 491 -----TWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTV 539 (553)
Q Consensus 491 -----~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~ 539 (553)
....+..... ...+.+ ...++.++++||++||+.||++||++
T Consensus 261 ~~~~~~~~~~~~~i~-~~~~~~------p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 261 NPDQNTEDYLFQVIL-EKQIRI------PRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp ----CCHHHHHHHHH-HCCCCC------CTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred ccchhhHHHHHHHHh-ccccCC------CCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 1111211111 111222 23578999999999999999999996
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=375.10 Aligned_cols=263 Identities=21% Similarity=0.345 Sum_probs=197.2
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|++++.||+|+||.||+|.+..++.. ||||++.... ......+++.+|+.+|+++.+||||+++++++.......
T Consensus 9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~--vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 9 RKYELVKKLGKGAYGIVWKSIDRRTGEV--VAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp TTEEEEEC-------CEEEEEETTTCCE--EEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred CceEEEEEeeeCCCeEEEEEEECCCCCE--EEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 5899999999999999999988877655 9999996543 334556788999999999987899999999987776778
Q ss_pred EEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 336 LYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 336 ~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
+|++||+++++|..+++.. ......+..++.||+.||+|||+.|||||||||+||||+.+ +.+||
T Consensus 86 ~~lv~e~~~~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~---------~~~kl 150 (388)
T 3oz6_A 86 VYLVFDYMETDLHAVIRAN------ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAE---------CHVKV 150 (388)
T ss_dssp EEEEEECCSEEHHHHHHHT------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT---------CCEEE
T ss_pred EEEEecccCcCHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCC---------CCEEe
Confidence 9999999999999998763 23345566677899999999999999999999999999876 67999
Q ss_pred EeccCccccCCCCC-------------------cccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHH
Q psy14267 416 IDFGIACSLQDDKT-------------------SVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILY 476 (553)
Q Consensus 416 ~DFGla~~~~~~~~-------------------~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ 476 (553)
+|||+|+.+..... .......+||+.|+|||++.+.. .++.++|||||||+||
T Consensus 151 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--------~~~~~~DiwSlG~il~ 222 (388)
T 3oz6_A 151 ADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGST--------KYTKGIDMWSLGCILG 222 (388)
T ss_dssp CCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCC--------CCCTHHHHHHHHHHHH
T ss_pred cCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCC--------CCCChhhHHHHHHHHH
Confidence 99999987643211 11123567999999999997632 4789999999999999
Q ss_pred HHHhCCCCCCCCCchHHHHHHHHhhcccccc-----------------------------c----------ccccCCCCC
Q psy14267 477 NMIYGRTPYSHIPNTWAKMLAIARHKDQIEF-----------------------------K----------PQLANNVTI 517 (553)
Q Consensus 477 elltG~~Pf~~~~~~~~~~~~i~~~~~~~~~-----------------------------~----------~~~~~~~~~ 517 (553)
||++|++||.+.... ..+..+......... . ........+
T Consensus 223 ell~g~~pf~~~~~~-~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (388)
T 3oz6_A 223 EILCGKPIFPGSSTM-NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADC 301 (388)
T ss_dssp HHHHSSCSCCCSSHH-HHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCC
T ss_pred HHHhCCCCCCCCCHH-HHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccC
Confidence 999999999875443 222222211110000 0 000112267
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 518 PPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 518 s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
++++.+||.+||..||++|||+.|+++|
T Consensus 302 ~~~~~dll~~~L~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 302 NEEALDLLDKLLQFNPNKRISANDALKH 329 (388)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CHHHHHHHHHhhccCcccCCCHHHHhCC
Confidence 8999999999999999999999999987
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=371.41 Aligned_cols=254 Identities=21% Similarity=0.305 Sum_probs=199.9
Q ss_pred cCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCC
Q psy14267 254 NGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTAS 333 (553)
Q Consensus 254 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~ 333 (553)
..++|+++++||+|+||+||+|+++.++.. ||||++.+.........+.+.+|+.+|+.+.+||||+++++++. ..
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~--~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~--~~ 96 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDL--YAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQ--TP 96 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCE--EEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEE--CS
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCE--EEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEE--eC
Confidence 346899999999999999999998877654 99999987654444556778999999999988899999998774 46
Q ss_pred ceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCe
Q psy14267 334 KHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNV 412 (553)
Q Consensus 334 ~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~ 412 (553)
..+|++||++ +++|..++..... +....+..++.||+.||+|||++|||||||||+||||+.+ +.
T Consensus 97 ~~~~lv~E~~~gg~L~~~l~~~~~-----~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~---------g~ 162 (353)
T 3txo_A 97 DRLFFVMEFVNGGDLMFHIQKSRR-----FDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHE---------GH 162 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT---------SC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCC---------CC
Confidence 6899999976 5699999887643 4456677778899999999999999999999999999876 67
Q ss_pred EEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchH
Q psy14267 413 LKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTW 492 (553)
Q Consensus 413 vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~ 492 (553)
+||+|||+|+....... .....+||+.|+|||++.+. .++.++|||||||+||||++|..||......
T Consensus 163 ikL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~ell~G~~Pf~~~~~~- 230 (353)
T 3txo_A 163 CKLADFGMCKEGICNGV--TTATFCGTPDYIAPEILQEM---------LYGPAVDWWAMGVLLYEMLCGHAPFEAENED- 230 (353)
T ss_dssp EEECCCTTCBCSCC-----------CCGGGCCHHHHHHH---------HCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH-
T ss_pred EEEccccceeecccCCc--cccccCCCcCeEChhhcCCC---------CcCCccCCCcchHHHHHHHhCCCCCCCCCHH-
Confidence 99999999986543322 23467899999999999866 3788999999999999999999999875443
Q ss_pred HHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q psy14267 493 AKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTV------GNSVTQ 545 (553)
Q Consensus 493 ~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~------~ell~~ 545 (553)
.....+.... ..+ ...++.++.+||++||.+||++||++ .+|++|
T Consensus 231 ~~~~~i~~~~--~~~------p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 231 DLFEAILNDE--VVY------PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp HHHHHHHHCC--CCC------CTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred HHHHHHHcCC--CCC------CCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 3333333221 122 22578999999999999999999998 677653
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=363.54 Aligned_cols=250 Identities=24% Similarity=0.359 Sum_probs=203.2
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|++++.||+|+||.||+|++..++.. ||||++.+.... ....+++.+|+++|+++. ||||+++++++. ....
T Consensus 15 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~--vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~--~~~~ 88 (328)
T 3fe3_A 15 GNYRLLKTIGKGNFAKVKLARHILTGRE--VAIKIIDKTQLN-PTSLQKLFREVRIMKILN-HPNIVKLFEVIE--TEKT 88 (328)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCE--EEEEEEEGGGSC-HHHHHHHHHHHHHHHHCC-CTTBCCEEEEEE--CSSE
T ss_pred CCEEEEEEEeeCCCEEEEEEEECCCCCE--EEEEEEEhhcCC-HHHHHHHHHHHHHHHhCC-CCCEeeEEEEEE--ECCE
Confidence 4799999999999999999988777654 999999876544 345578999999999995 699999998774 4668
Q ss_pred EEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
++++||++ +++|.+++..... .....+..++.||+.||+|||++||+||||||+||||+.+ +.+|
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~-----l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~---------~~~k 154 (328)
T 3fe3_A 89 LYLIMEYASGGEVFDYLVAHGR-----MKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDAD---------MNIK 154 (328)
T ss_dssp EEEEECCCTTCBHHHHHHHHCC-----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT---------SCEE
T ss_pred EEEEEECCCCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCC---------CCEE
Confidence 89999986 6799999977643 3455666777899999999999999999999999999776 5799
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||++........ ....+||+.|+|||++.+..+ .+.++|||||||++|||++|..||.+.... ..
T Consensus 155 l~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~--------~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~ 222 (328)
T 3fe3_A 155 IADFGFSNEFTVGGK---LDAFCGAPPYAAPELFQGKKY--------DGPEVDVWSLGVILYTLVSGSLPFDGQNLK-EL 222 (328)
T ss_dssp ECSTTCCGGGSSSCG---GGTTSSSGGGCCHHHHHTCCC--------CSHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HH
T ss_pred EeeccCceecCCCCc---cccccCCcceeCcccccCCCc--------CCchhhhhhhHHHHHHHHhCCCCCCCCCHH-HH
Confidence 999999987765432 236789999999999986642 357999999999999999999999875432 22
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
...+..... .....+++++.+||++||..||++|||++|++++
T Consensus 223 ~~~i~~~~~--------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 223 RERVLRGKY--------RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp HHHHHHCCC--------CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred HHHHHhCCC--------CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 223332221 1122578999999999999999999999999875
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=367.44 Aligned_cols=254 Identities=24% Similarity=0.372 Sum_probs=203.1
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
.++|++++.||+|+||.||+|+++.++.. ||||++.+.........+.+.+|+.+|+++.+||||+++++++. ...
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~--~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~--~~~ 83 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRI--YAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ--TES 83 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEE--EEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE--CSS
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCE--EEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEE--eCC
Confidence 46899999999999999999988777654 99999998776666777889999999999877899999998774 466
Q ss_pred eEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 335 HLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 335 ~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
.+|++||++ +++|..++..... +....+..++.||+.||+|||++||+||||||+||||+.+ +.+
T Consensus 84 ~~~lv~e~~~gg~L~~~l~~~~~-----l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~---------g~~ 149 (345)
T 3a8x_A 84 RLFFVIEYVNGGDLMFHMQRQRK-----LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE---------GHI 149 (345)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT---------SCE
T ss_pred EEEEEEeCCCCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCC---------CCE
Confidence 899999986 5799999887542 3456677778899999999999999999999999999776 679
Q ss_pred EEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCc---
Q psy14267 414 KIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN--- 490 (553)
Q Consensus 414 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~--- 490 (553)
||+|||+++....... .....+||+.|+|||++.+. .++.++|||||||+||||++|..||.....
T Consensus 150 kL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~ 218 (345)
T 3a8x_A 150 KLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGE---------DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN 218 (345)
T ss_dssp EECCGGGCBCSCCTTC--CBCCCCSCGGGCCHHHHTTC---------CBCTHHHHHHHHHHHHHHHHSSCTTTTTTC---
T ss_pred EEEeccccccccCCCC--cccccCCCccccCccccCCC---------CCChHHhHHHHHHHHHHHHhCCCCcCCcccccc
Confidence 9999999986543322 23467899999999999865 378999999999999999999999975211
Q ss_pred ----hHHHH-HHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q psy14267 491 ----TWAKM-LAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTV------GNSVTQ 545 (553)
Q Consensus 491 ----~~~~~-~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~------~ell~~ 545 (553)
....+ ..+... ...+ ...++.++++||++||+.||++||++ .++++|
T Consensus 219 ~~~~~~~~~~~~i~~~--~~~~------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 219 PDQNTEDYLFQVILEK--QIRI------PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp ----CHHHHHHHHHHC--CCCC------CTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred cccccHHHHHHHHHcC--CCCC------CCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 11112 122211 1112 23678999999999999999999996 566543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=358.05 Aligned_cols=251 Identities=23% Similarity=0.371 Sum_probs=201.4
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
.++|++++.||+|+||+||+|.+..++.. ||||++....... .+.+.+|+.+++++. ||||+++++++.. ..
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~~~~~~---~~~~~~E~~~l~~l~-hp~iv~~~~~~~~--~~ 90 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQE--VAIRQMNLQQQPK---KELIINEILVMRENK-NPNIVNYLDSYLV--GD 90 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCE--EEEEEEEGGGCSC---HHHHHHHHHHHHHCC-CTTBCCEEEEEEE--TT
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcE--EEEEEeecccccH---HHHHHHHHHHHhcCC-CCCCCeEeEEEEE--CC
Confidence 45799999999999999999988766644 9999998665333 366889999999995 5999999998754 55
Q ss_pred eEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 335 HLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 335 ~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
.++++||++ +++|.+++.... .....+..++.|++.||+|||++||+||||||+||||+.+ +.+
T Consensus 91 ~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~---------~~~ 155 (297)
T 3fxz_A 91 ELWVVMEYLAGGSLTDVVTETC------MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD---------GSV 155 (297)
T ss_dssp EEEEEEECCTTCBHHHHHHHSC------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---------CCE
T ss_pred EEEEEEECCCCCCHHHHHhhcC------CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCC---------CCE
Confidence 789999976 789999987642 3455667778899999999999999999999999999776 579
Q ss_pred EEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHH
Q psy14267 414 KIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWA 493 (553)
Q Consensus 414 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~ 493 (553)
||+|||++........ ......||+.|+|||++.+. .++.++|||||||++|||++|..||........
T Consensus 156 kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~ 224 (297)
T 3fxz_A 156 KLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRK---------AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA 224 (297)
T ss_dssp EECCCTTCEECCSTTC--CBCCCCSCGGGCCHHHHHCS---------CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred EEeeCCCceecCCccc--ccCCccCCcCccChhhhcCC---------CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9999999987765433 23356799999999999765 378899999999999999999999987554322
Q ss_pred HHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 494 KMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 494 ~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
........... ......++..+.+||.+||+.||++|||+.|++++
T Consensus 225 ~~~~~~~~~~~------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 225 LYLIATNGTPE------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp HHHHHHHCSCC------CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHhCCCCC------CCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 22222221111 12223678999999999999999999999999874
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=363.62 Aligned_cols=252 Identities=23% Similarity=0.343 Sum_probs=201.8
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
.++|++++.||+|+||+||+|+++.++.. ||||++++...........+.+|+.+|+++. ||||+++++++. ...
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~--vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~--~~~ 78 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRY--YAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQ--THD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCE--EEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-CTTBCCEEEEEE--CSS
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCE--EEEEEEeHHHhhhhhHHHHHHHHHHHHHhCC-CCcCcceEEEEE--eCC
Confidence 46899999999999999999988776654 9999998754333344577899999999995 699999988774 456
Q ss_pred eEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 335 HLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 335 ~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
.++++||++ +++|..++.... .+....+..++.||+.||+|||++|||||||||+||||+.+ +.+
T Consensus 79 ~~~lv~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~---------g~v 144 (337)
T 1o6l_A 79 RLCFVMEYANGGELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD---------GHI 144 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT---------SCE
T ss_pred EEEEEEeCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCC---------CCE
Confidence 889999986 568998887654 23455667777899999999999999999999999999776 679
Q ss_pred EEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHH
Q psy14267 414 KIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWA 493 (553)
Q Consensus 414 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~ 493 (553)
||+|||+++....... .....+||+.|+|||++.+. .++.++|||||||++|||++|..||...... .
T Consensus 145 kL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-~ 212 (337)
T 1o6l_A 145 KITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDN---------DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-R 212 (337)
T ss_dssp EECCCTTCBCSCCTTC--CBCCCEECGGGCCGGGGSSS---------CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-H
T ss_pred EEeeccchhhcccCCC--cccccccChhhCChhhhcCC---------CCCchhhcccchhHHHHHhcCCCCCCCCCHH-H
Confidence 9999999986543322 23367899999999999765 3788999999999999999999999875432 2
Q ss_pred HHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q psy14267 494 KMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARP-----TVGNSVTQ 545 (553)
Q Consensus 494 ~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RP-----t~~ell~~ 545 (553)
....+... ...+ ...+++++++||.+||+.||++|| ++.+|++|
T Consensus 213 ~~~~i~~~--~~~~------p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 213 LFELILME--EIRF------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHHHHHHC--CCCC------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHHHHcC--CCCC------CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 22333222 1122 226789999999999999999999 89999875
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=366.61 Aligned_cols=272 Identities=16% Similarity=0.211 Sum_probs=201.0
Q ss_pred EEecCcceEEEeeeeeeCceEEEEEeeeCCC---ccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcC----------
Q psy14267 251 ITLNGKQYQVLSLLGKGGSSSVYLVGGTSEH---EFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG---------- 317 (553)
Q Consensus 251 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~---~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~---------- 317 (553)
..+..++|++++.||+|+||.||+|.+..+. ..+.||||++.... ..+.+|+++++++.+
T Consensus 30 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~~~~~~~~~~~~e~~~~ 102 (364)
T 3op5_A 30 TDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN-------GPLFTELKFYQRAAKPEQIQKWIRT 102 (364)
T ss_dssp ECTTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTC-------HHHHHHHHHHHHHCCHHHHHHHHHH
T ss_pred eccCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccc-------hhHHHHHHHHHhhhhhHHHHHHHHH
Confidence 3456679999999999999999999886653 23569999997653 233445554444433
Q ss_pred ----CCceeEeeeEEEeCCC--ceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCC
Q psy14267 318 ----CPYVIKMHDYVYDTAS--KHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDL 391 (553)
Q Consensus 318 ----hp~Iv~l~~~~~~~~~--~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDL 391 (553)
||||+++++++..... .+++++||+++++|.+++..... .+.+..++.++.||+.||+|||++|||||||
T Consensus 103 ~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~----~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDl 178 (364)
T 3op5_A 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAK----RFSRKTVLQLSLRILDILEYIHEHEYVHGDI 178 (364)
T ss_dssp TTCSCCCSCCEEEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred hhccCCCCCeEEeeeeeccCCcceEEEEEeCCCCCHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCCeEEecC
Confidence 7999999998866433 57899999999999999987532 3456667778889999999999999999999
Q ss_pred CCCCEEEecCccceecCCCCeEEEEeccCccccCCCCCcc-----cccCCccCCCccCcccccccCCCCCCCccCCCccc
Q psy14267 392 KPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSV-----HKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKS 466 (553)
Q Consensus 392 Kp~NILl~~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~-----~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~s 466 (553)
||+||||+.+. .+.+||+|||+++.+....... .....+||+.|+|||++.+. .++.++
T Consensus 179 kp~Nill~~~~-------~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~ 242 (364)
T 3op5_A 179 KASNLLLNYKN-------PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGV---------APSRRG 242 (364)
T ss_dssp CGGGEEEESSC-------TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTC---------CCCHHH
T ss_pred CHHHEEEecCC-------CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCC---------CCCchh
Confidence 99999998321 2679999999998765432211 11345699999999999766 378999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHh-hccc-ccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy14267 467 DVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIAR-HKDQ-IEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVT 544 (553)
Q Consensus 467 DIwSlGvvl~elltG~~Pf~~~~~~~~~~~~i~~-~~~~-~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~ 544 (553)
|||||||+||||++|..||.+............. .... ..+...+.....++.++.++|..||..||++||++.+|++
T Consensus 243 Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 243 DLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred hHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 9999999999999999999863322122111111 1111 1111111122467899999999999999999999999999
Q ss_pred HHhcC
Q psy14267 545 QINNN 549 (553)
Q Consensus 545 ~L~~~ 549 (553)
.|++.
T Consensus 323 ~l~~~ 327 (364)
T 3op5_A 323 ILLQG 327 (364)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99864
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=364.46 Aligned_cols=273 Identities=23% Similarity=0.329 Sum_probs=213.4
Q ss_pred ceEEecCcceEEEeeeeeeCceEEEEEeeeC---CCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEee
Q psy14267 249 DVITLNGKQYQVLSLLGKGGSSSVYLVGGTS---EHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMH 325 (553)
Q Consensus 249 ~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~---~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~ 325 (553)
..|++..++|++++.||+|+||.||+|++.. ....+.||||+++... .....+.+.+|+++|+++.+||||++++
T Consensus 15 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 15 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 3456777899999999999999999998542 2334669999997653 2334578999999999998899999999
Q ss_pred eEEEeCCCceEEEEEecC-CCCHHHHHHHcccCC----------------------------------------------
Q psy14267 326 DYVYDTASKHLYVLMEKG-DTDLSKYMRNLNKMT---------------------------------------------- 358 (553)
Q Consensus 326 ~~~~~~~~~~~~iv~e~~-~~~L~~~l~~~~~~~---------------------------------------------- 358 (553)
+++... ...++++||++ +++|.+++.......
T Consensus 93 ~~~~~~-~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 93 GACTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEECST-TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeecC-CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 977543 44578888876 569999998754310
Q ss_pred ---------------CCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEeccCccc
Q psy14267 359 ---------------TLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACS 423 (553)
Q Consensus 359 ---------------~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGla~~ 423 (553)
.....+..++.++.||+.||+|||++|||||||||+||||+.+ +.+||+|||+++.
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~---------~~~kl~Dfg~a~~ 242 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK---------NVVKICDFGLARD 242 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG---------GCEEECCCGGGSC
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCC---------CcEEEEeccceee
Confidence 1115566777888899999999999999999999999999876 5799999999987
Q ss_pred cCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHhhc
Q psy14267 424 LQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHIPNTWAKMLAIARHK 502 (553)
Q Consensus 424 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~i~~~~ 502 (553)
..............||+.|+|||++.+. .++.++|||||||++|||++ |..||.+..........+...
T Consensus 243 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~---------~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~- 312 (359)
T 3vhe_A 243 IYKDPDYVRKGDARLPLKWMAPETIFDR---------VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG- 312 (359)
T ss_dssp TTSCTTCEEC--CEECGGGCCHHHHHHC---------CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHT-
T ss_pred ecccccchhccccCCCceeEChhhhcCC---------CCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcC-
Confidence 7555444344466789999999999765 47899999999999999998 999998765443333333222
Q ss_pred ccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 503 DQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 503 ~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
.... ....+++++.++|.+||+.||++|||+.+++++|+++
T Consensus 313 ~~~~------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 353 (359)
T 3vhe_A 313 TRMR------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353 (359)
T ss_dssp CCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCC------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 1111 1235789999999999999999999999999999875
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=354.34 Aligned_cols=265 Identities=26% Similarity=0.387 Sum_probs=206.8
Q ss_pred cCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCC
Q psy14267 254 NGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTAS 333 (553)
Q Consensus 254 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~ 333 (553)
..++|++++.||+|+||.||+|++...+.. ||||++...........+++.+|+.+++++. ||||+++++++ ...
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~--~~~ 83 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIK--VAIKAIFIPPREKEETLKRFEREVHNSSQLS-HQNIVSMIDVD--EED 83 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSE--EEEEEEECCSSCCHHHHHHHHHHHHHHTTCC-BTTBCCEEEEE--ECS
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCe--EEEEEeccCccccHHHHHHHHHHHHHHhcCC-CCCCceEEEee--eeC
Confidence 346899999999999999999988776644 9999998777666677789999999999995 59999999876 446
Q ss_pred ceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCe
Q psy14267 334 KHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNV 412 (553)
Q Consensus 334 ~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~ 412 (553)
..++++||++ +++|.+++.... ......++.++.|++.||+|||++||+||||||+|||++.+ +.
T Consensus 84 ~~~~lv~e~~~g~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~---------~~ 149 (294)
T 4eqm_A 84 DCYYLVMEYIEGPTLSEYIESHG-----PLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSN---------KT 149 (294)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---------SC
T ss_pred CeEEEEEeCCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC---------CC
Confidence 7889999986 569999998754 24456667778899999999999999999999999999776 57
Q ss_pred EEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchH
Q psy14267 413 LKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTW 492 (553)
Q Consensus 413 vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~ 492 (553)
+||+|||+++........ ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.....
T Consensus 150 ~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~---------~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~ 219 (294)
T 4eqm_A 150 LKIFDFGIAKALSETSLT-QTNHVLGTVQYFSPEQAKGE---------ATDECTDIYSIGIVLYEMLVGEPPFNGETAVS 219 (294)
T ss_dssp EEECCCSSSTTC--------------CCSSCCHHHHHTC---------CCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH
T ss_pred EEEEeCCCcccccccccc-ccCccccCccccCHhHhcCC---------CCCchHhHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 999999999876543321 22356799999999999765 36789999999999999999999998765433
Q ss_pred HHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCC-CHHHHHHHHhcCCC
Q psy14267 493 AKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARP-TVGNSVTQINNNPE 551 (553)
Q Consensus 493 ~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RP-t~~ell~~L~~~~~ 551 (553)
.....+.... . .........+++.+.++|.+||+.||++|| +++++.+.|+.+..
T Consensus 220 ~~~~~~~~~~--~--~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 220 IAIKHIQDSV--P--NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp HHHHHHSSCC--C--CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred HHHHHhhccC--C--CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 2222221111 1 111122346889999999999999999998 99999999998754
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-43 Score=351.71 Aligned_cols=261 Identities=24% Similarity=0.344 Sum_probs=204.0
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|++++.||+|+||+||+|++..++.. ||||++...... ....+.+.+|+.+|+++. ||||+++++++.+ ...
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~--~~~ 75 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEI--VALKRVRLDDDD-EGVPSSALREICLLKELK-HKNIVRLHDVLHS--DKK 75 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCE--EEEEEEESSCSS-TTHHHHHHHHHHHHTTCC-CTTBCCEEEEEEE--TTE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCce--EEEEeeeccCCc-CCcchHHHHHHHHHhcCC-CCCEeeEEeEEEe--CCE
Confidence 4799999999999999999988777654 999999876643 344578899999999995 5999999998754 568
Q ss_pred EEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 336 LYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 336 ~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
++++||++++++..++..... ......+..++.|++.||+|||++||+||||||+||||+.+ +.+||
T Consensus 76 ~~lv~e~~~~~l~~~~~~~~~----~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~---------~~~kl 142 (292)
T 3o0g_A 76 LTLVFEFCDQDLKKYFDSCNG----DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRN---------GELKL 142 (292)
T ss_dssp EEEEEECCSEEHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---------SCEEE
T ss_pred EEEEEecCCCCHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC---------CCEEE
Confidence 999999999999888876432 34456677778899999999999999999999999999876 57999
Q ss_pred EeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHH
Q psy14267 416 IDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKM 495 (553)
Q Consensus 416 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~ 495 (553)
+|||+++....... ......||+.|+|||++.+.. .++.++|||||||++|||++|..||.........+
T Consensus 143 ~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~--------~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~ 212 (292)
T 3o0g_A 143 ANFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAK--------LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL 212 (292)
T ss_dssp CCCTTCEECCSCCS--CCCSCCSCGGGCCHHHHTTCS--------CCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHH
T ss_pred eecccceecCCccc--cccCCccccCCcChHHHcCCC--------CcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHH
Confidence 99999987754332 223567899999999997653 36899999999999999999888865544443444
Q ss_pred HHHHhhcccccc---------------------cccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 496 LAIARHKDQIEF---------------------KPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 496 ~~i~~~~~~~~~---------------------~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
..+......... .........++.++++||.+||+.||++|||++|+++|
T Consensus 213 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 213 KRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp HHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 443322111100 00001112578899999999999999999999999875
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=365.72 Aligned_cols=254 Identities=22% Similarity=0.331 Sum_probs=202.7
Q ss_pred cCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCC
Q psy14267 254 NGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTAS 333 (553)
Q Consensus 254 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~ 333 (553)
...+|+++++||+|+||.||+|++..++. .||||++++.........+.+.+|..+|..+.+||+|+.+++++. ..
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~--~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~--~~ 93 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDE--LYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ--TM 93 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEE--EEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEE--CS
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCC--EEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEE--cC
Confidence 44689999999999999999998876654 499999987644333445778999999999888899999988774 46
Q ss_pred ceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCe
Q psy14267 334 KHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNV 412 (553)
Q Consensus 334 ~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~ 412 (553)
..+|++||++ +++|..++..... +....++.++.||+.||+|||++|||||||||+||||+.+ +.
T Consensus 94 ~~~~lv~E~~~gg~L~~~l~~~~~-----~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~---------g~ 159 (353)
T 2i0e_A 94 DRLYFVMEYVNGGDLMYHIQQVGR-----FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSE---------GH 159 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT---------SC
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCC---------Cc
Confidence 6899999986 5799999987543 3456677778899999999999999999999999999876 67
Q ss_pred EEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchH
Q psy14267 413 LKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTW 492 (553)
Q Consensus 413 vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~ 492 (553)
+||+|||+|+....... .....+||+.|+|||++.+.. ++.++|||||||++|||++|..||......
T Consensus 160 vkL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~---------~~~~~DiwslG~il~ell~G~~Pf~~~~~~- 227 (353)
T 2i0e_A 160 IKIADFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQP---------YGKSVDWWAFGVLLYEMLAGQAPFEGEDED- 227 (353)
T ss_dssp EEECCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCC---------BSTHHHHHHHHHHHHHHHHSSCSSCCSSHH-
T ss_pred EEEEeCCcccccccCCc--ccccccCCccccChhhhcCCC---------cCCcccccchHHHHHHHHcCCCCCCCCCHH-
Confidence 99999999986543322 234678999999999997653 788999999999999999999999875432
Q ss_pred HHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q psy14267 493 AKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT-----VGNSVTQ 545 (553)
Q Consensus 493 ~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt-----~~ell~~ 545 (553)
.....+.... ..++ ..++.++++||++||..||++||+ +++|++|
T Consensus 228 ~~~~~i~~~~--~~~p------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 228 ELFQSIMEHN--VAYP------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp HHHHHHHHCC--CCCC------TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred HHHHHHHhCC--CCCC------CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 3333333221 2222 267899999999999999999995 5666654
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=353.02 Aligned_cols=266 Identities=22% Similarity=0.310 Sum_probs=201.8
Q ss_pred ecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcC--chhHHHHHHHHHHHHHhhc--CCCceeEeeeEE
Q psy14267 253 LNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDIT--DQSIADSYLNEVELLAKLQ--GCPYVIKMHDYV 328 (553)
Q Consensus 253 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~--~~~~~~~~~~E~~iL~~l~--~hp~Iv~l~~~~ 328 (553)
+..++|++++.||+|+||+||+|++..++.. ||||++...... .......+.+|+.+++++. .||||+++++++
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~ 83 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHF--VALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVC 83 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCE--EEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcE--EEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeee
Confidence 3456899999999999999999988776654 999999754321 1112245678888888876 479999999988
Q ss_pred EeCCCc---eEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccce
Q psy14267 329 YDTASK---HLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKI 405 (553)
Q Consensus 329 ~~~~~~---~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~ 405 (553)
...... .++++||+++++|.+++...... ......+..++.||+.||+|||++||+||||||+||||+.+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~---- 156 (308)
T 3g33_A 84 ATSRTDREIKVTLVFEHVDQDLRTYLDKAPPP---GLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSG---- 156 (308)
T ss_dssp EECCSSSEEEEEEEEECCCCBHHHHHHTCCTT---CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTT----
T ss_pred eccCCCCceeEEEEehhhhcCHHHHHhhccCC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCC----
Confidence 765432 67999999999999999875432 24566677778899999999999999999999999999776
Q ss_pred ecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCC
Q psy14267 406 IDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY 485 (553)
Q Consensus 406 ~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf 485 (553)
+.+||+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|..||
T Consensus 157 -----~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~~l~~g~~pf 219 (308)
T 3g33_A 157 -----GTVKLADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQS---------TYATPVDMWSVGCIFAEMFRRKPLF 219 (308)
T ss_dssp -----SCEEECSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTS---------CCCSTHHHHHHHHHHHHTTTSSCSC
T ss_pred -----CCEEEeeCccccccCCCcc---cCCccccccccCchHHcCC---------CCCchHHHHHHHHHHHHHHhCCCCC
Confidence 5799999999987654332 2356799999999999765 3788999999999999999999999
Q ss_pred CCCCchHHHHHHHHhhccccc---cccc----------------ccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 486 SHIPNTWAKMLAIARHKDQIE---FKPQ----------------LANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 486 ~~~~~~~~~~~~i~~~~~~~~---~~~~----------------~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
...... ..+..+........ +... ......+++++.+||.+||+.||++|||+.|+++|
T Consensus 220 ~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 220 CGNSEA-DQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CCSSHH-HHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCHH-HHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 875543 23333222111100 0000 00113578999999999999999999999999875
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=356.42 Aligned_cols=266 Identities=19% Similarity=0.297 Sum_probs=198.3
Q ss_pred cceEEecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeE
Q psy14267 248 QDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDY 327 (553)
Q Consensus 248 ~~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~ 327 (553)
...+++...+|++.+.||+|+||+||+|++. + +.||||++....... ...+.+.+|+++|++++ ||||++++++
T Consensus 29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~--~--~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~-hp~iv~~~~~ 102 (309)
T 3p86_A 29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEWH--G--SDVAVKILMEQDFHA-ERVNEFLREVAIMKRLR-HPNIVLFMGA 102 (309)
T ss_dssp ---CBCCGGGEEEEEEEEECSSEEEEEEEET--T--EEEEEEEECCCCCSH-HHHHHHHHHHHHHHHCC-CTTBCCEEEE
T ss_pred cccccCChhHceeeeEeecCCCeEEEEEEEC--C--CcEEEEEecCCCCCH-HHHHHHHHHHHHHHhCC-CCCEeeEEEE
Confidence 3345566789999999999999999999653 3 349999998765443 44578999999999996 6999999987
Q ss_pred EEeCCCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCC--cEecCCCCCCEEEecCccc
Q psy14267 328 VYDTASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAG--IIHSDLKPANFLFVGNVLK 404 (553)
Q Consensus 328 ~~~~~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~g--IiHrDLKp~NILl~~~~~~ 404 (553)
+ .....++++||++ +++|.+++....... ......++.++.||+.||+|||++| ||||||||+||||+.+
T Consensus 103 ~--~~~~~~~lv~e~~~~~~L~~~l~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~--- 175 (309)
T 3p86_A 103 V--TQPPNLSIVTEYLSRGSLYRLLHKSGARE--QLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKK--- 175 (309)
T ss_dssp E--CSTTCCEEEEECCTTCBHHHHHHSTTHHH--HSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTT---
T ss_pred E--EECCceEEEEecCCCCcHHHHHhhcCCCC--CCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCC---
Confidence 7 4456688999976 569999987643211 2345566777789999999999999 9999999999999776
Q ss_pred eecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCC
Q psy14267 405 IIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTP 484 (553)
Q Consensus 405 ~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~P 484 (553)
+.+||+|||+++....... ......||+.|+|||++.+.. ++.++|||||||++|||++|..|
T Consensus 176 ------~~~kL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~---------~~~~~DiwslG~il~elltg~~P 238 (309)
T 3p86_A 176 ------YTVKVCDFGLSRLKASTFL--SSKSAAGTPEWMAPEVLRDEP---------SNEKSDVYSFGVILWELATLQQP 238 (309)
T ss_dssp ------CCEEECCCC-------------------CCTTSCHHHHTTCC---------CCTTHHHHHHHHHHHHHHHCCCT
T ss_pred ------CcEEECCCCCCcccccccc--ccccCCCCccccChhhhcCCC---------CCchhhHHHHHHHHHHHHhCCCC
Confidence 5799999999976544322 123567999999999998663 68899999999999999999999
Q ss_pred CCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q psy14267 485 YSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNP 550 (553)
Q Consensus 485 f~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~ 550 (553)
|...... .....+....... .....+++++.+||.+||..||++|||+.++++.|+.+.
T Consensus 239 f~~~~~~-~~~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~ 297 (309)
T 3p86_A 239 WGNLNPA-QVVAAVGFKCKRL------EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLI 297 (309)
T ss_dssp TTTSCHH-HHHHHHHHSCCCC------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCHH-HHHHHHHhcCCCC------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 9876543 2222222222222 222368899999999999999999999999999998754
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=363.56 Aligned_cols=268 Identities=21% Similarity=0.343 Sum_probs=212.2
Q ss_pred EecCcceEEEeeeeeeCceEEEEEeeeCCC-----ccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeee
Q psy14267 252 TLNGKQYQVLSLLGKGGSSSVYLVGGTSEH-----EFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHD 326 (553)
Q Consensus 252 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~ 326 (553)
++..++|++++.||+|+||.||+|++...+ ....||||+++... .....+++.+|+++++++..||||+++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 142 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLG 142 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhhee
Confidence 455678999999999999999999875432 22469999997653 33455789999999999977899999998
Q ss_pred EEEeCCCceEEEEEecC-CCCHHHHHHHcccC-----------CCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCC
Q psy14267 327 YVYDTASKHLYVLMEKG-DTDLSKYMRNLNKM-----------TTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPA 394 (553)
Q Consensus 327 ~~~~~~~~~~~iv~e~~-~~~L~~~l~~~~~~-----------~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~ 394 (553)
++ .....++++||++ +++|.+++...... ....+.+..++.++.||+.||+|||++|||||||||+
T Consensus 143 ~~--~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~ 220 (382)
T 3tt0_A 143 AC--TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 220 (382)
T ss_dssp EE--CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred ee--ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcc
Confidence 77 4456788999986 56999999876421 1123566777788889999999999999999999999
Q ss_pred CEEEecCccceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHH
Q psy14267 395 NFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCI 474 (553)
Q Consensus 395 NILl~~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvv 474 (553)
||||+.+ +.+||+|||+|+...............||+.|+|||++.+. .++.++|||||||+
T Consensus 221 NIll~~~---------~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~---------~~~~~~DiwslG~i 282 (382)
T 3tt0_A 221 NVLVTED---------NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR---------IYTHQSDVWSFGVL 282 (382)
T ss_dssp GEEECTT---------CCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSC---------CCCHHHHHHHHHHH
T ss_pred eEEEcCC---------CcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCC---------CCCchhHHHHHHHH
Confidence 9999776 57999999999877654433333455688999999999765 37899999999999
Q ss_pred HHHHHh-CCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 475 LYNMIY-GRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 475 l~ellt-G~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
+|||++ |..||...... .....+. ..... .....+++++.++|.+||+.||++|||+.+|+++|+++
T Consensus 283 l~ellt~g~~p~~~~~~~-~~~~~~~-~~~~~------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 350 (382)
T 3tt0_A 283 LWEIFTLGGSPYPGVPVE-ELFKLLK-EGHRM------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350 (382)
T ss_dssp HHHHHTTSCCSSTTCCHH-HHHHHHH-TTCCC------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHhCCCCCCCCCCHH-HHHHHHH-cCCCC------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 999999 99999875543 2222222 22111 12236889999999999999999999999999999874
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=365.42 Aligned_cols=254 Identities=21% Similarity=0.325 Sum_probs=202.0
Q ss_pred ecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC
Q psy14267 253 LNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA 332 (553)
Q Consensus 253 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~ 332 (553)
+..++|++.+.||+|+||.||+|+++.++.. ||||++++.........+.+..|..+|.++.+||||+++++++. .
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~--vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~--~ 89 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQF--FAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ--T 89 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEE--EEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE--C
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCE--EEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEE--e
Confidence 3456899999999999999999998777654 99999987543333345678899999998877899999988774 4
Q ss_pred CceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCC
Q psy14267 333 SKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGN 411 (553)
Q Consensus 333 ~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~ 411 (553)
...+|++||++ +++|..++..... +....+..++.||+.||+|||++|||||||||+||||+.+ +
T Consensus 90 ~~~~~lv~E~~~gg~L~~~l~~~~~-----~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~---------g 155 (345)
T 1xjd_A 90 KENLFFVMEYLNGGDLMYHIQSCHK-----FDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKD---------G 155 (345)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT---------S
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCC---------C
Confidence 66899999986 6799999987543 3455666778899999999999999999999999999876 6
Q ss_pred eEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCch
Q psy14267 412 VLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNT 491 (553)
Q Consensus 412 ~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~ 491 (553)
.+||+|||+|+....... .....+||+.|+|||++.+. .++.++|||||||++|||++|..||.+....
T Consensus 156 ~vkL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 224 (345)
T 1xjd_A 156 HIKIADFGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQ---------KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE 224 (345)
T ss_dssp CEEECCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTC---------CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred CEEEeEChhhhhcccCCC--cccCCCCCcccCChhhhcCC---------CCCChhhhHHHHHHHHHHhcCCCCCCCCCHH
Confidence 799999999986543322 23467899999999999865 3789999999999999999999999875432
Q ss_pred HHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHH-HHHH
Q psy14267 492 WAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVG-NSVT 544 (553)
Q Consensus 492 ~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~-ell~ 544 (553)
.....+.... ..+ ...++.++++||.+||..||++||++. +|++
T Consensus 225 -~~~~~i~~~~--~~~------p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 225 -ELFHSIRMDN--PFY------PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp -HHHHHHHHCC--CCC------CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -HHHHHHHhCC--CCC------CcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 3333333221 111 125789999999999999999999997 6653
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=368.87 Aligned_cols=256 Identities=20% Similarity=0.378 Sum_probs=201.4
Q ss_pred ecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC
Q psy14267 253 LNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA 332 (553)
Q Consensus 253 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~ 332 (553)
+..++|++++.||+|+||.||+|++..++.. ||||++.+.........+.+.+|+.+|+++ +||||+.+++++. .
T Consensus 12 v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~--~AiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~--~ 86 (384)
T 4fr4_A 12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKM--YAMKYMNKQKCVERNEVRNVFKELQIMQGL-EHPFLVNLWYSFQ--D 86 (384)
T ss_dssp CCGGGEEEEEEEECCTTCCEEEEEETTTCCE--EEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEE--C
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCE--EEEEEEehhhcccHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEE--e
Confidence 3456899999999999999999988877654 999999876544444567889999999999 4699999988774 4
Q ss_pred CceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCC
Q psy14267 333 SKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGN 411 (553)
Q Consensus 333 ~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~ 411 (553)
...+|++||++ +++|..++.... .+....+..++.||+.||+|||++|||||||||+||||+.+ +
T Consensus 87 ~~~~~lv~e~~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~---------g 152 (384)
T 4fr4_A 87 EEDMFMVVDLLLGGDLRYHLQQNV-----HFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEH---------G 152 (384)
T ss_dssp SSEEEEEECCCTTEEHHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---------S
T ss_pred CCEEEEEEecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCC---------C
Confidence 56789999976 678998887643 24456677778899999999999999999999999999776 6
Q ss_pred eEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCc-
Q psy14267 412 VLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN- 490 (553)
Q Consensus 412 ~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~- 490 (553)
.+||+|||+|+.+..... ....+||+.|+|||++...... .++.++|||||||+||||++|..||.....
T Consensus 153 ~vkL~DFG~a~~~~~~~~---~~~~~gt~~Y~aPE~~~~~~~~------~~~~~~DiwSlG~il~elltG~~Pf~~~~~~ 223 (384)
T 4fr4_A 153 HVHITDFNIAAMLPRETQ---ITTMAGTKPYMAPEMFSSRKGA------GYSFAVDWWSLGVTAYELLRGRRPYHIRSST 223 (384)
T ss_dssp CEEECCCTTCEECCTTCC---BCCCCSCGGGCCGGGTCCCSSC------CBCTTHHHHHHHHHHHHHHHSSCSSCCCTTS
T ss_pred CEEEeccceeeeccCCCc---eeccCCCccccCCeeeccCCCC------CCCccceeechHHHHHHHHhCCCCCCCCCCc
Confidence 799999999987754432 3367899999999999753211 378999999999999999999999975322
Q ss_pred -hHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCC-HHHHHH
Q psy14267 491 -TWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT-VGNSVT 544 (553)
Q Consensus 491 -~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt-~~ell~ 544 (553)
.......+.. .... ....++..+.+||.+||+.||++||+ ++++++
T Consensus 224 ~~~~~~~~~~~--~~~~------~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 224 SSKEIVHTFET--TVVT------YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp CHHHHHHHHHH--CCCC------CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred cHHHHHHHHhh--cccC------CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 1122222211 1111 22367899999999999999999998 666654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=363.93 Aligned_cols=251 Identities=24% Similarity=0.331 Sum_probs=200.3
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|++++.||+|+||.||+|.+..++.. ||||++.+...........+.+|+.+|+.+. ||||+++++++.. ...
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~--vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~--~~~ 83 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQK--VALKFISRQLLKKSDMHMRVEREISYLKLLR-HPHIIKLYDVITT--PTD 83 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCE--EEEEEEEHHHHHHTTCSHHHHHHHHHHTTCC-CTTBCCEEEEEEC--SSE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCE--EEEEEEehHHccchhHHHHHHHHHHHHHhCC-CCCCCeEEEEEEe--CCE
Confidence 5799999999999999999998777654 9999997654333333467889999999995 5999999998744 567
Q ss_pred EEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 336 LYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 336 ~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
++++||+++++|.+++..... .....+..++.||+.||+|||++||+||||||+||||+.+ +.+||
T Consensus 84 ~~lv~E~~~g~l~~~l~~~~~-----l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~---------~~~kl 149 (336)
T 3h4j_B 84 IVMVIEYAGGELFDYIVEKKR-----MTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDN---------LNVKI 149 (336)
T ss_dssp EEEEECCCCEEHHHHHHHHCS-----CCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTT---------CCEEE
T ss_pred EEEEEECCCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCC---------CCEEE
Confidence 899999999999999987643 3455667778899999999999999999999999999876 57999
Q ss_pred EeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHH
Q psy14267 416 IDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKM 495 (553)
Q Consensus 416 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~ 495 (553)
+|||++........ ....+||+.|+|||++.+..+ .+.++|||||||++|+|++|..||......
T Consensus 150 ~DFG~s~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~--------~~~~~DiwslG~il~~ll~g~~Pf~~~~~~---- 214 (336)
T 3h4j_B 150 ADFGLSNIMTDGNF---LKTSCGSPNYAAPEVINGKLY--------AGPEVDVWSCGIVLYVMLVGRLPFDDEFIP---- 214 (336)
T ss_dssp CCSSCTBTTTTSBT---TCCCTTSTTTSCGGGSCCSGG--------GCHHHHHHHHHHHHHHHHHSSCSSBCSSST----
T ss_pred EEeccceeccCCcc---cccccCCcCcCCHHHHcCCCC--------CCCccchhHHHHHHHHHHhCCCCCCCccHH----
Confidence 99999987655432 236689999999999986531 368999999999999999999999763221
Q ss_pred HHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 496 LAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 496 ~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
.....+ ..........+++++.+||++||..||++|||+.|++++
T Consensus 215 ----~~~~~i-~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 215 ----NLFKKV-NSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp ----TCBCCC-CSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred ----HHHHHH-HcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 000011 111112233578999999999999999999999999875
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=351.45 Aligned_cols=268 Identities=19% Similarity=0.250 Sum_probs=209.5
Q ss_pred ecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC
Q psy14267 253 LNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA 332 (553)
Q Consensus 253 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~ 332 (553)
+.+++|++.+.||+|+||.||+|.+..++. .||||++...... +.+.+|+.+++++.+|++|+.+++++. .
T Consensus 7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~--~ 77 (298)
T 1csn_A 7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQ--QVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQ--E 77 (298)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTE--EEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEE--E
T ss_pred ccccceEEEEEEeecCCEEEEEEEECCCCc--EEEEEEeccCCcc-----HHHHHHHHHHHHHhcCCCCCeEEeecC--C
Confidence 456789999999999999999998776664 4999999755422 357789999999988899999988764 4
Q ss_pred CceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCe
Q psy14267 333 SKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNV 412 (553)
Q Consensus 333 ~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~ 412 (553)
....+++||+++++|.+++..... ......+..++.||+.||+|||++||+||||||+||||+.+.. .....
T Consensus 78 ~~~~~lv~e~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~----~~~~~ 149 (298)
T 1csn_A 78 GLHNVLVIDLLGPSLEDLLDLCGR----KFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNS----KNANM 149 (298)
T ss_dssp TTEEEEEEECCCCBHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSS----TTTTC
T ss_pred CceeEEEEEecCCCHHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCC----CCCCe
Confidence 668899999999999999987542 2445667777889999999999999999999999999976621 22345
Q ss_pred EEEEeccCccccCCCCCc-----ccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCC
Q psy14267 413 LKIIDFGIACSLQDDKTS-----VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSH 487 (553)
Q Consensus 413 vkL~DFGla~~~~~~~~~-----~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~ 487 (553)
+||+|||+++........ .......||+.|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 150 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~Di~slG~il~el~~g~~pf~~ 220 (298)
T 1csn_A 150 IYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR---------EQSRRDDLEALGHVFMYFLRGSLPWQG 220 (298)
T ss_dssp EEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC---------CCCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred EEEEECccccccccccccccccccCccCCCCCcccCCchhhcCC---------CCChHHHHHHHHHHHHHHHcCCCCcch
Confidence 999999999877654321 122356799999999999765 378999999999999999999999987
Q ss_pred CCc--hHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 488 IPN--TWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 488 ~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
... ....+..+.......... .....+++++.++|.+||+.||++||++.+|++.|+++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~ 281 (298)
T 1csn_A 221 LKAATNKQKYERIGEKKQSTPLR---ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 281 (298)
T ss_dssp CCSCCHHHHHHHHHHHHHHSCHH---HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred hhccccHHHHHHHHhhccCccHH---HHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence 432 222222222222111111 11226789999999999999999999999999999874
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=351.72 Aligned_cols=262 Identities=24% Similarity=0.374 Sum_probs=198.2
Q ss_pred cCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCC
Q psy14267 254 NGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTAS 333 (553)
Q Consensus 254 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~ 333 (553)
..++|++++.||+|+||+||+|++.. + +.||||++...... ....+.+.+|+++|+++. ||||+++++++ ...
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~-~--~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~--~~~ 91 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQ-G--RIVALKRIRLDAED-EGIPSTAIREISLLKELH-HPNIVSLIDVI--HSE 91 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETT-S--CEEEEEEEC-------CHHHHHHHHHHHHHHCC-CTTBCCEEEEE--CCS
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECC-C--CEEEEEEEeccccc-chhhHHHHHHHHHHHHcC-CCCEeeeeeEE--ccC
Confidence 34689999999999999999998743 3 45999999765432 344577899999999995 69999999877 456
Q ss_pred ceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 334 KHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 334 ~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
..++++||++.++|.+++..... ......+..++.|++.||+|||++||+||||||+||||+.+ +.+
T Consensus 92 ~~~~lv~e~~~~~l~~~~~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~---------~~~ 158 (311)
T 3niz_A 92 RCLTLVFEFMEKDLKKVLDENKT----GLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSD---------GAL 158 (311)
T ss_dssp SCEEEEEECCSEEHHHHHHTCTT----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT---------CCE
T ss_pred CEEEEEEcCCCCCHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCC---------CCE
Confidence 78999999999999998876542 24455666777899999999999999999999999999776 579
Q ss_pred EEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHH
Q psy14267 414 KIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWA 493 (553)
Q Consensus 414 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~ 493 (553)
||+|||+++........ .....||+.|+|||++.+.. .++.++|||||||++|||++|..||.+......
T Consensus 159 kl~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~--------~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 228 (311)
T 3niz_A 159 KLADFGLARAFGIPVRS--YTHEVVTLWYRAPDVLMGSK--------KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ 228 (311)
T ss_dssp EECCCTTCEETTSCCC-----CCCCCCTTCCHHHHTTCC--------SCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH
T ss_pred EEccCcCceecCCCccc--ccCCcccCCcCCHHHhcCCC--------CCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 99999999877543322 23457899999999997542 378999999999999999999999987544322
Q ss_pred H--HHHHHhhccccccc-------------------ccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 494 K--MLAIARHKDQIEFK-------------------PQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 494 ~--~~~i~~~~~~~~~~-------------------~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
. +...........+. +.......+++++.+||.+||+.||++|||+.|+++|
T Consensus 229 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 229 LPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp HHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 1 11111111100000 0001122467899999999999999999999999974
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=362.90 Aligned_cols=259 Identities=20% Similarity=0.295 Sum_probs=204.9
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCch---hHHHHHHHHHHHHHhhcCCCceeEeeeEEEeC
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQ---SIADSYLNEVELLAKLQGCPYVIKMHDYVYDT 331 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~---~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~ 331 (553)
.+.|++++.||+|+||+||+|.+..++.. ||||++.+...... ...+.+.+|+.+|+++. ||||+++++++.
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~--~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~-- 85 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLE--YAAKFIKKRQSRASRRGVCREEIEREVSILRQVL-HPNIITLHDVYE-- 85 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCE--EEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCC-CTTBCCEEEEEE--
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCE--EEEEEEEccccccccchhHHHHHHHHHHHHHhCC-CcCCCcEEEEEE--
Confidence 35799999999999999999998877654 99999987654321 13467899999999995 699999999874
Q ss_pred CCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCC
Q psy14267 332 ASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIG 410 (553)
Q Consensus 332 ~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~ 410 (553)
....++++||++ +++|.+++.... .+....+..++.||+.||+|||++||+||||||+|||++.+. ...
T Consensus 86 ~~~~~~lv~e~~~gg~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~-----~~~ 155 (361)
T 2yab_A 86 NRTDVVLILELVSGGELFDFLAQKE-----SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKN-----IPI 155 (361)
T ss_dssp CSSEEEEEEECCCSCBHHHHHTTCS-----CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTT-----SSS
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCC-----CCc
Confidence 466889999987 689999986543 345666777888999999999999999999999999997652 111
Q ss_pred CeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCc
Q psy14267 411 NVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN 490 (553)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~ 490 (553)
..+||+|||++........ ....+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+...
T Consensus 156 ~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslGvil~~ll~g~~Pf~~~~~ 223 (361)
T 2yab_A 156 PHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYE---------PLGLEADMWSIGVITYILLSGASPFLGDTK 223 (361)
T ss_dssp CCEEECCCSSCEECCTTCC---CCCCCSCGGGCCHHHHTTC---------CCCTHHHHHHHHHHHHHHHHSCCSSCCSSH
T ss_pred cCEEEEecCCceEcCCCCc---cccCCCCccEECchHHcCC---------CCCccccHHHHHHHHHHHHhCCCCCCCCCH
Confidence 2699999999988765432 2356799999999999765 378899999999999999999999987543
Q ss_pred hHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 491 TWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 491 ~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
. ..+..+.... ..+.+ ..+..++..+++||.+||..||++|||+.|+++|
T Consensus 224 ~-~~~~~i~~~~--~~~~~--~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 224 Q-ETLANITAVS--YDFDE--EFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp H-HHHHHHHTTC--CCCCH--HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred H-HHHHHHHhcC--CCCCc--hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 2 3333333322 12222 1123678999999999999999999999999864
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=360.18 Aligned_cols=266 Identities=17% Similarity=0.206 Sum_probs=205.4
Q ss_pred cCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCC
Q psy14267 254 NGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTAS 333 (553)
Q Consensus 254 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~ 333 (553)
.+.+|++++.||+|+||.||+|++..++. .||||++...... +.+.+|+.+|+++.+||||+.+++++.. .
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~~~~-----~~~~~E~~~l~~l~~h~~i~~~~~~~~~--~ 77 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNE--YVAIKLEPMKSRA-----PQLHLEYRFYKQLGSGDGIPQVYYFGPC--G 77 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTE--EEEEEEEETTCSS-----CCHHHHHHHHHHHCSCTTSCCEEEEEEE--T
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCc--EEEEEEeccccch-----HHHHHHHHHHHHhhCCCCCCEEEEEEec--C
Confidence 45789999999999999999998877664 4999999765422 3578999999999778999999987755 5
Q ss_pred ceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 334 KHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 334 ~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
...+++||+++++|.+++..... .+....++.++.||+.||+|||++|||||||||+||||+.+.. .....+
T Consensus 78 ~~~~lv~e~~~~~L~~~~~~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~----~~~~~~ 149 (330)
T 2izr_A 78 KYNAMVLELLGPSLEDLFDLCDR----TFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGN----KTQQVI 149 (330)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGG----TCTTSE
T ss_pred CccEEEEEeCCCCHHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCC----CCCceE
Confidence 68899999999999999987532 3455667777889999999999999999999999999987631 112339
Q ss_pred EEEeccCccccCCCCCcc-----cccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy14267 414 KIIDFGIACSLQDDKTSV-----HKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHI 488 (553)
Q Consensus 414 kL~DFGla~~~~~~~~~~-----~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~ 488 (553)
||+|||+++.+....... .....+||+.|+|||++.+. .++.++|||||||+||||++|..||.+.
T Consensus 150 kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~Di~slG~il~ell~g~~Pf~~~ 220 (330)
T 2izr_A 150 HIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGK---------EQSRRDDLEALGHMFMYFLRGSLPWQGL 220 (330)
T ss_dssp EECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC---------CCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred EEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCC---------CCCchhHHHHHHHHHHHHhcCCCCcccc
Confidence 999999998775543211 12366799999999999876 3789999999999999999999999874
Q ss_pred Cc--hHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 489 PN--TWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 489 ~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
.. ....+..+........... ....++ ++.++|..||..||++||++.+|++.|++.
T Consensus 221 ~~~~~~~~~~~i~~~~~~~~~~~---~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 221 KADTLKERYQKIGDTKRATPIEV---LCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp CCSSHHHHHHHHHHHHHHSCHHH---HTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred ccccHHHHHHHHHhhhccCCHHH---HhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 32 2222222222211111110 111344 999999999999999999999999998753
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=370.41 Aligned_cols=255 Identities=24% Similarity=0.339 Sum_probs=191.7
Q ss_pred cceEEE-eeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEe--CC
Q psy14267 256 KQYQVL-SLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYD--TA 332 (553)
Q Consensus 256 ~~y~i~-~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~--~~ 332 (553)
++|.+. ++||+|+||+||+|.+..++.. ||||++... ..+.+|+.++.++.+||||+++++++.. ..
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~--vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~ 130 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEK--FALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAG 130 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCE--EEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCE--EEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecccC
Confidence 467776 7999999999999998777654 999999632 4567899998888788999999998754 33
Q ss_pred CceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCC
Q psy14267 333 SKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGN 411 (553)
Q Consensus 333 ~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~ 411 (553)
..++|++||++ +++|.+++..... ..+.+..+..++.||+.||+|||++|||||||||+||||+.+. ..+
T Consensus 131 ~~~~~lv~E~~~gg~L~~~l~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~------~~~ 201 (400)
T 1nxk_A 131 RKCLLIVMECLDGGELFSRIQDRGD---QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR------PNA 201 (400)
T ss_dssp EEEEEEEEECCCSEEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSS------TTC
T ss_pred CcEEEEEEEeCCCCcHHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCC------CCc
Confidence 56789999987 5699999986432 1345666777888999999999999999999999999998631 126
Q ss_pred eEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCch
Q psy14267 412 VLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNT 491 (553)
Q Consensus 412 ~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~ 491 (553)
.+||+|||+++....... ....+||+.|+|||++.+. .++.++|||||||+||||++|..||......
T Consensus 202 ~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 269 (400)
T 1nxk_A 202 ILKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPE---------KYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 269 (400)
T ss_dssp CEEECCCTTCEECC--------------CTTCCGGGSCCC---------CSSSHHHHHHHHHHHHHHHHSSCSCCCCTTC
T ss_pred cEEEEecccccccCCCCc---cccCCCCCCccCHhhcCCC---------CCCCcccHHHHHHHHHHHHhCCCCCCCCccc
Confidence 799999999987654332 2367899999999999765 3789999999999999999999999764321
Q ss_pred H---HHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 492 W---AKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 492 ~---~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
. .....+.... ..+. ...+..++.++++||++||..||++|||+.++++|
T Consensus 270 ~~~~~~~~~i~~~~--~~~~--~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 270 AISPGMKTRIRMGQ--YEFP--NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp SSCCSHHHHHHHTC--CCCC--TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cccHHHHHHHHcCc--ccCC--CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 0112222211 1111 12334689999999999999999999999999986
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=369.34 Aligned_cols=258 Identities=21% Similarity=0.327 Sum_probs=204.9
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
.++|++++.||+|+||+||+|.+..++.. ||+|++.+..... ...+.+.+|+.+|+++. ||||+++++++. ...
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~--~a~K~i~~~~~~~-~~~~~~~~E~~il~~l~-hpnIv~l~~~~~--~~~ 83 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQE--YAAMIINTKKLSA-RDHQKLEREARICRLLK-HPNIVRLHDSIS--EEG 83 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEE--EEEEEEESCSCHH-HHHHHHHHHHHHHHHCC-BTTBCCEEEEEE--CSS
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcE--EEEEEEEcccCCH-HHHHHHHHHHHHHHhCC-CcCCCeEEEEEE--ECC
Confidence 35799999999999999999988777654 9999998776543 34578899999999994 699999999774 467
Q ss_pred eEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 335 HLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 335 ~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
.++++||++ +++|.+++..... .....+..++.||+.||+|||++||+||||||+||||+.+ ..++.+
T Consensus 84 ~~~lv~E~~~gg~L~~~i~~~~~-----~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~------~~~~~v 152 (444)
T 3soa_A 84 HHYLIFDLVTGGELFEDIVAREY-----YSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASK------LKGAAV 152 (444)
T ss_dssp EEEEEECCCBCCBHHHHHHHCSC-----CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBS------STTCCE
T ss_pred EEEEEEEeCCCCCHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecc------CCCCcE
Confidence 889999976 5699998887542 4456667777899999999999999999999999999754 123679
Q ss_pred EEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHH
Q psy14267 414 KIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWA 493 (553)
Q Consensus 414 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~ 493 (553)
||+|||++......... ....+||+.|+|||++.+. .++.++|||||||+||+|++|..||.+.... .
T Consensus 153 kL~DFG~a~~~~~~~~~--~~~~~gt~~Y~APE~l~~~---------~~~~~~DIwSlGvilyell~G~~Pf~~~~~~-~ 220 (444)
T 3soa_A 153 KLADFGLAIEVEGEQQA--WFGFAGTPGYLSPEVLRKD---------PYGKPVDLWACGVILYILLVGYPPFWDEDQH-R 220 (444)
T ss_dssp EECCCSSCBCCCTTCCB--CCCSCSCGGGCCHHHHTTC---------CBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-H
T ss_pred EEccCceeEEecCCCce--eecccCCcccCCHHHhcCC---------CCCCccccHHHHHHHHHHHhCCCCCCCccHH-H
Confidence 99999999877654332 2356799999999999765 3788999999999999999999999875432 3
Q ss_pred HHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 494 KMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 494 ~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
....+....... ....+..+++++++||.+||+.||++|||+.|+++|
T Consensus 221 ~~~~i~~~~~~~----~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 221 LYQQIKAGAYDF----PSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp HHHHHHHTCCCC----CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHhCCCCC----CccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 333333332221 122344789999999999999999999999999875
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-43 Score=356.41 Aligned_cols=280 Identities=19% Similarity=0.282 Sum_probs=208.5
Q ss_pred ecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC
Q psy14267 253 LNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA 332 (553)
Q Consensus 253 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~ 332 (553)
...++|++.++||+|+||.||+|++..++.. ||||++....... ..+.+.+|+++|+++. ||||+++++++....
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vavK~~~~~~~~~--~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 80 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDL--FAIKVFNNISFLR--PVDVQMREFEVLKKLN-HKNIVKLFAIEEETT 80 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCE--EEEEEECGGGGGS--CHHHHHHHHHHHHHCC-CTTBCCEEEEEECTT
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcE--EEEEEeccccccc--hHHHHHHHHHHHHhcC-CCCcceEEEEeecCC
Confidence 4467899999999999999999988776654 9999997654322 2467889999999996 699999999888777
Q ss_pred CceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCC
Q psy14267 333 SKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGN 411 (553)
Q Consensus 333 ~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~ 411 (553)
...++++||++ +++|.+++........ .....++.++.||+.||+|||++|||||||||+||||..+. ...+
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~--~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-----~~~~ 153 (319)
T 4euu_A 81 TRHKVLIMEFCPCGSLYTVLEEPSNAYG--LPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGE-----DGQS 153 (319)
T ss_dssp TCCEEEEEECCTTCBHHHHHHSGGGTTC--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECT-----TSCE
T ss_pred CceEEEEEeCCCCCCHHHHHHHhccccC--CCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccC-----CCCc
Confidence 77899999987 5799999987654332 44556677788999999999999999999999999983221 1125
Q ss_pred eEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCc-
Q psy14267 412 VLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN- 490 (553)
Q Consensus 412 ~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~- 490 (553)
.+||+|||+++........ ....||+.|+|||++....... .....++.++|||||||++|||++|..||.....
T Consensus 154 ~~kL~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~-~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 229 (319)
T 4euu_A 154 VYKLTDFGAARELEDDEQF---VSLYGTEEYLHPDMYERAVLRK-DHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229 (319)
T ss_dssp EEEECCCTTCEECCTTCCB---CCCCSCGGGCCHHHHHHHTSCC-CCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCG
T ss_pred eEEEccCCCceecCCCCce---eecccCCCccCHHHhhhccccc-cccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc
Confidence 7999999999887654432 2567999999999986321110 0112478999999999999999999999975322
Q ss_pred --hHHHHHHHHhhcccc-------------cccccccC----CCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q psy14267 491 --TWAKMLAIARHKDQI-------------EFKPQLAN----NVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINN 548 (553)
Q Consensus 491 --~~~~~~~i~~~~~~~-------------~~~~~~~~----~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~ 548 (553)
....+..+....... .+...... ...++..+.++|++||+.||++|||++|++++..+
T Consensus 230 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d 306 (319)
T 4euu_A 230 RRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306 (319)
T ss_dssp GGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred chhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHH
Confidence 223333333322110 01111111 11344678999999999999999999999999875
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=357.84 Aligned_cols=273 Identities=21% Similarity=0.296 Sum_probs=210.7
Q ss_pred eEEecCcceEEEeeeeeeCceEEEEEeeeC---CCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeee
Q psy14267 250 VITLNGKQYQVLSLLGKGGSSSVYLVGGTS---EHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHD 326 (553)
Q Consensus 250 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~---~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~ 326 (553)
.|++..++|++.+.||+|+||.||+|.+.. ......||||++..... ....+.+.+|+.+|+++..||||+++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 116 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD--SSEREALMSELKMMTQLGSHENIVNLLG 116 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccC--HHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 356677899999999999999999998743 23445699999975432 2334788999999999977799999998
Q ss_pred EEEeCCCceEEEEEecC-CCCHHHHHHHcccCC------------------CCchHHHHHHHHHHHHHHHHHHHhhCCcE
Q psy14267 327 YVYDTASKHLYVLMEKG-DTDLSKYMRNLNKMT------------------TLPNTMIIIIMHWYEMLLAVKEIHAAGII 387 (553)
Q Consensus 327 ~~~~~~~~~~~iv~e~~-~~~L~~~l~~~~~~~------------------~~~~~~~~i~~~~~qil~aL~yLH~~gIi 387 (553)
++. ....++++||++ +++|.+++....... ........++.++.||+.||+|||++||+
T Consensus 117 ~~~--~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv 194 (344)
T 1rjb_A 117 ACT--LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCV 194 (344)
T ss_dssp EEC--SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred EEe--eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 774 456788999976 679999998754321 01245566777888999999999999999
Q ss_pred ecCCCCCCEEEecCccceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccch
Q psy14267 388 HSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSD 467 (553)
Q Consensus 388 HrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sD 467 (553)
||||||+||||+.+ +.+||+|||++................||+.|+|||++.+. .++.++|
T Consensus 195 H~Dikp~NIll~~~---------~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~---------~~~~~~D 256 (344)
T 1rjb_A 195 HRDLAARNVLVTHG---------KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG---------IYTIKSD 256 (344)
T ss_dssp ETTCSGGGEEEETT---------TEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC---------CCCHHHH
T ss_pred cCCCChhhEEEcCC---------CcEEeCCCccCcccccCccceeccCccCccCccCHHHhccC---------CCChhHh
Confidence 99999999999876 68999999999877554433333455688999999999765 3789999
Q ss_pred HHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q psy14267 468 VWSLGCILYNMIY-GRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQI 546 (553)
Q Consensus 468 IwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L 546 (553)
||||||+||||++ |..||............+.. .... .....+++++.+||.+||..||++|||+.+++++|
T Consensus 257 i~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 329 (344)
T 1rjb_A 257 VWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQN-GFKM------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329 (344)
T ss_dssp HHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHT-TCCC------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhc-CCCC------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 9999999999998 99999886554333222222 1111 12235789999999999999999999999999999
Q ss_pred hcCCC
Q psy14267 547 NNNPE 551 (553)
Q Consensus 547 ~~~~~ 551 (553)
+....
T Consensus 330 ~~~~~ 334 (344)
T 1rjb_A 330 GCQLA 334 (344)
T ss_dssp HHHC-
T ss_pred HHHHH
Confidence 87543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=373.74 Aligned_cols=264 Identities=25% Similarity=0.335 Sum_probs=188.2
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC---
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA--- 332 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~--- 332 (553)
++|+++++||+|+||+||+|.+..++.. ||||++.... ......+++.+|+++|+++. ||||+++++++....
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~--vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 128 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRV--VAIKKILRVF-EDLIDCKRILREIAILNRLN-HDHVVKVLDIVIPKDVEK 128 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CE--EEEEEECSTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSCTTT
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcE--EEEEEechhh-cCHHHHHHHHHHHHHHHhCC-CCCCCceEEEEecCCccc
Confidence 6899999999999999999988877654 9999997543 34455688999999999995 699999999875433
Q ss_pred CceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCe
Q psy14267 333 SKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNV 412 (553)
Q Consensus 333 ~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~ 412 (553)
...+|++||+++++|..+++... .+....+..+++||+.||+|||++|||||||||+||||+.+ +.
T Consensus 129 ~~~~~lv~e~~~~~L~~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~---------~~ 194 (458)
T 3rp9_A 129 FDELYVVLEIADSDFKKLFRTPV-----YLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQD---------CS 194 (458)
T ss_dssp CCCEEEEECCCSEEHHHHHHSSC-----CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT---------CC
T ss_pred CceEEEEEeccccchhhhcccCC-----CCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCC---------CC
Confidence 25789999999999999987643 34556677778899999999999999999999999999877 57
Q ss_pred EEEEeccCccccCCCCCc-------------------------ccccCCccCCCccCcccccccCCCCCCCccCCCccch
Q psy14267 413 LKIIDFGIACSLQDDKTS-------------------------VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSD 467 (553)
Q Consensus 413 vkL~DFGla~~~~~~~~~-------------------------~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sD 467 (553)
+||+|||+|+........ ......+||+.|+|||++.... .|+.++|
T Consensus 195 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--------~~~~~~D 266 (458)
T 3rp9_A 195 VKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQE--------NYTEAID 266 (458)
T ss_dssp EEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCC--------CCCTHHH
T ss_pred EeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCC--------CCCcHhH
Confidence 999999999876532211 1123557899999999875332 3789999
Q ss_pred HHHHHHHHHHHHh-----------CCCCCCCCCc-------------------hHHHHHHHHhhcc--------------
Q psy14267 468 VWSLGCILYNMIY-----------GRTPYSHIPN-------------------TWAKMLAIARHKD-------------- 503 (553)
Q Consensus 468 IwSlGvvl~ellt-----------G~~Pf~~~~~-------------------~~~~~~~i~~~~~-------------- 503 (553)
||||||+||||++ |.++|.+... ....+..+.....
T Consensus 267 iwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~ 346 (458)
T 3rp9_A 267 VWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKED 346 (458)
T ss_dssp HHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHH
T ss_pred HHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHH
Confidence 9999999999998 6777754221 0111111111000
Q ss_pred ---------cccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 504 ---------QIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 504 ---------~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
.............+++++.+||.+||..||++|||++|+++|
T Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H 397 (458)
T 3rp9_A 347 AKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAH 397 (458)
T ss_dssp HHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000001111223568999999999999999999999999986
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=360.60 Aligned_cols=256 Identities=23% Similarity=0.337 Sum_probs=204.1
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|++.+.||+|+||.||+|.+..++.. ||||++....... ...+.+.+|+.+|+++. ||||+++++++. ....
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~--~avK~~~~~~~~~-~~~~~~~~E~~il~~l~-hpnIv~~~~~~~--~~~~ 102 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLE--FAAKIINTKKLSA-RDFQKLEREARICRKLQ-HPNIVRLHDSIQ--EESF 102 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCE--EEEEEEETTTCCH-HHHHHHHHHHHHHHHCC-CTTBCCEEEEEE--CSSE
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCE--EEEEEEEcccCCH-HHHHHHHHHHHHHHhCC-CCCCCeEEEEEE--eCCE
Confidence 5799999999999999999988776654 9999998776543 44578999999999995 699999999774 4668
Q ss_pred EEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
++++||++ +++|.+++.... ......+..++.||+.||+|||++||+||||||+||||+.+. .++.+|
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~------~~~~~k 171 (362)
T 2bdw_A 103 HYLVFDLVTGGELFEDIVARE-----FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKA------KGAAVK 171 (362)
T ss_dssp EEEEECCCCSCBHHHHHTTCS-----CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSS------TTCCEE
T ss_pred EEEEEecCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCC------CCCCEE
Confidence 89999986 468988886543 244566777788999999999999999999999999997652 235699
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||++........ ....+||+.|+|||++.+. .++.++|||||||++|||++|..||...... ..
T Consensus 172 l~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~-~~ 238 (362)
T 2bdw_A 172 LADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKD---------PYSKPVDIWACGVILYILLVGYPPFWDEDQH-RL 238 (362)
T ss_dssp ECCCTTCBCCTTCCS---CCCSCSCTTTCCHHHHTTC---------CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HH
T ss_pred EeecCcceEecCCcc---cccCCCCccccCHHHHccC---------CCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-HH
Confidence 999999987764432 2356799999999999765 3788999999999999999999999875432 33
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
...+........ ...+..+++++++||.+||..||++||++.+++++
T Consensus 239 ~~~i~~~~~~~~----~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 239 YAQIKAGAYDYP----SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp HHHHHHTCCCCC----TTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHHhCCCCCC----cccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 333333222111 12233678999999999999999999999999875
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=354.63 Aligned_cols=270 Identities=21% Similarity=0.348 Sum_probs=202.8
Q ss_pred EecCcceEEEeeeeeeCceEEEEEeee--CCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEE
Q psy14267 252 TLNGKQYQVLSLLGKGGSSSVYLVGGT--SEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVY 329 (553)
Q Consensus 252 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~ 329 (553)
++..++|++++.||+|+||+||+|+.. .....+.||||++.... ....+.+.+|+++|+++. ||||+++++++.
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~ 81 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQ-HDNIVKYKGVCY 81 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC---HHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC---HHHHHHHHHHHHHHHhCC-CCCEeeEEEEEe
Confidence 455689999999999999999999742 22233569999997543 344578999999999995 699999999886
Q ss_pred eCCCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecC
Q psy14267 330 DTASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDC 408 (553)
Q Consensus 330 ~~~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~ 408 (553)
......++++||++ +++|.+++..... ......++.++.|++.||+|||++||+||||||+||||+.+
T Consensus 82 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~------- 150 (295)
T 3ugc_A 82 SAGRRNLKLIMEYLPYGSLRDYLQKHKE----RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE------- 150 (295)
T ss_dssp HHHHTSCEEEEECCTTCBHHHHHHHCGG----GCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-------
T ss_pred cCCCCceEEEEEeCCCCCHHHHHHhccc----ccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCC-------
Confidence 65566789999986 6799999987543 24455667778899999999999999999999999999877
Q ss_pred CCCeEEEEeccCccccCCCCCc-ccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCC
Q psy14267 409 IGNVLKIIDFGIACSLQDDKTS-VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSH 487 (553)
Q Consensus 409 ~~~~vkL~DFGla~~~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~ 487 (553)
+.+||+|||+++........ .......|+..|+|||++.+. .++.++|||||||++|||++|..||..
T Consensus 151 --~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~~l~~l~~g~~~~~~ 219 (295)
T 3ugc_A 151 --NRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTES---------KFSVASDVWSFGVVLYELFTYIEKSKS 219 (295)
T ss_dssp --TEEEECCCCSCC-------------CTTCGGGGCCHHHHHHC---------CCCHHHHHHHHHHHHHHHHHTTCTTCS
T ss_pred --CeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCC---------CCChHHHHHHHHHHHHHHHhcccccCC
Confidence 67999999999877544322 112244578889999999766 378999999999999999999999875
Q ss_pred CCchHHHH-----------HHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q psy14267 488 IPNTWAKM-----------LAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNP 550 (553)
Q Consensus 488 ~~~~~~~~-----------~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~ 550 (553)
........ ..+... +...........+++++.++|.+||+.||++|||+.++++.|+++.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~ 290 (295)
T 3ugc_A 220 PPAEFMRMIGNDKQGQMIVFHLIEL---LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290 (295)
T ss_dssp HHHHHHHHHCTTCCTHHHHHHHHHH---HHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred ChHHHHhhhcCccccchhHHHHHHH---HhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 32211100 000000 0001122234478899999999999999999999999999998754
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=357.95 Aligned_cols=274 Identities=18% Similarity=0.222 Sum_probs=204.6
Q ss_pred ceEEecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEE
Q psy14267 249 DVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYV 328 (553)
Q Consensus 249 ~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~ 328 (553)
.-+.+...+|+++++||+|+||+||+|++. + +.||||++.... .......+|+.+|+++. ||||+++++++
T Consensus 17 ~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~--~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-hpniv~~~~~~ 87 (322)
T 3soc_A 17 ENLYFQSMPLQLLEVKARGRFGCVWKAQLL--N--EYVAVKIFPIQD----KQSWQNEYEVYSLPGMK-HENILQFIGAE 87 (322)
T ss_dssp CCEEETTEEEEEEEEEECSTTCEEEEEEET--T--EEEEEEEECGGG----HHHHHHHHHHHTSTTCC-CTTBCCEEEEE
T ss_pred cccccchhhchhhheecccCceEEEEEEEC--C--CEEEEEEeecCc----hHHHHHHHHHHHHhcCC-CCCchhhccee
Confidence 345677889999999999999999999765 2 459999996542 22345667899999995 59999999988
Q ss_pred EeCC--CceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhC----------CcEecCCCCCC
Q psy14267 329 YDTA--SKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAA----------GIIHSDLKPAN 395 (553)
Q Consensus 329 ~~~~--~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~----------gIiHrDLKp~N 395 (553)
.... ...++++||++ +++|.++++... ..+..++.++.|++.||+|||+. |||||||||+|
T Consensus 88 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~N 161 (322)
T 3soc_A 88 KRGTSVDVDLWLITAFHEKGSLSDFLKANV------VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKN 161 (322)
T ss_dssp EEECSSSEEEEEEEECCTTCBHHHHHHHCC------BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGG
T ss_pred ccCCCCCceEEEEEecCCCCCHHHHHHhcC------CCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHh
Confidence 7654 44689999987 569999997642 44566777788999999999999 99999999999
Q ss_pred EEEecCccceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHH
Q psy14267 396 FLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCIL 475 (553)
Q Consensus 396 ILl~~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl 475 (553)
|||+.+ +.+||+|||+++.+.............||+.|+|||++.+.... ...++.++|||||||++
T Consensus 162 ill~~~---------~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~----~~~~~~~~DiwslG~il 228 (322)
T 3soc_A 162 VLLKNN---------LTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINF----QRDAFLRIDMYAMGLVL 228 (322)
T ss_dssp EEECTT---------CCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCC----CHHHHHHHHHHHHHHHH
T ss_pred EEECCC---------CeEEEccCCcccccccccCccccccCccCccccCHhhccccccc----CcCCCccchhHHHHHHH
Confidence 999776 57999999999887655443333456799999999999764211 11367789999999999
Q ss_pred HHHHhCCCCCCCCCc--------------hHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHH
Q psy14267 476 YNMIYGRTPYSHIPN--------------TWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGN 541 (553)
Q Consensus 476 ~elltG~~Pf~~~~~--------------~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~e 541 (553)
|||++|+.||.+... ....+.............+........+.++.+||.+||+.||++|||+.+
T Consensus 229 ~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e 308 (322)
T 3soc_A 229 WELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGC 308 (322)
T ss_dssp HHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHH
Confidence 999999999975321 111111111111111111111111123456999999999999999999999
Q ss_pred HHHHHhcCC
Q psy14267 542 SVTQINNNP 550 (553)
Q Consensus 542 ll~~L~~~~ 550 (553)
+++.|+++.
T Consensus 309 ll~~L~~l~ 317 (322)
T 3soc_A 309 VGERITQMQ 317 (322)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 999998754
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=353.88 Aligned_cols=263 Identities=24% Similarity=0.372 Sum_probs=189.8
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
.+|++++.||+|+||.||+|.+..++.. ||||+++..... ...+.+.+|+.+|+++. ||||+++++++ .....
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~-hp~iv~~~~~~--~~~~~ 77 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKTTGVY--VALKEVKLDSEE--GTPSTAIREISLMKELK-HENIVRLYDVI--HTENK 77 (317)
T ss_dssp --------------CEEEEEECSSSCCE--EEEEEEECCSTT--CSCHHHHHHHHHHTTCC-BTTBCCEEEEE--CCTTE
T ss_pred cceeEeeEECCCCCEEEEEEEECCCCcE--EEEEEeeccccc--ccHHHHHHHHHHHHhcC-CCCcceEEEEE--EECCe
Confidence 5799999999999999999988776644 999999866422 22367889999999995 59999999877 44678
Q ss_pred EEEEEecCCCCHHHHHHHcccC-CCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKGDTDLSKYMRNLNKM-TTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~~~~L~~~l~~~~~~-~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
++++||++.++|.+++...... .........+..++.||+.||+|||++||+||||||+||||+.+ +.+|
T Consensus 78 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~---------~~~k 148 (317)
T 2pmi_A 78 LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKR---------GQLK 148 (317)
T ss_dssp EEEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT---------CCEE
T ss_pred EEEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCC---------CCEE
Confidence 9999999999999999865422 12234566667777899999999999999999999999999776 5799
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||+++........ .....||+.|+|||++.+.. .++.++|||||||++|||++|..||.+.... ..
T Consensus 149 l~Dfg~~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~--------~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~ 217 (317)
T 2pmi_A 149 LGDFGLARAFGIPVNT--FSSEVVTLWYRAPDVLMGSR--------TYSTSIDIWSCGCILAEMITGKPLFPGTNDE-EQ 217 (317)
T ss_dssp ECCCSSCEETTSCCCC--CCCCCSCCTTCCHHHHTTCC--------CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HH
T ss_pred ECcCccceecCCCccc--CCCCcccccccCchHhhCCC--------CCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HH
Confidence 9999999877543221 23557899999999997542 3688999999999999999999999875543 22
Q ss_pred HHHHHhhcccc--c----------ccc--------------cccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 495 MLAIARHKDQI--E----------FKP--------------QLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 495 ~~~i~~~~~~~--~----------~~~--------------~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
+..+....... . +.+ .......++.++.+||.+||+.||++|||+.|++++
T Consensus 218 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 218 LKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp HHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 22222211100 0 000 001122578899999999999999999999999875
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=355.24 Aligned_cols=249 Identities=23% Similarity=0.364 Sum_probs=200.8
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
.++|++++.||+|+||.||+|++..++.. ||||++.+.........+.+.+|+.+|+.+ +||||+++++++. ...
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~--~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~--~~~ 79 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRY--YAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQ--DAQ 79 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCE--EEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEE--CSS
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCE--EEEEEEEHHHhhhhhHHHHHHHHHHHHhhC-CCCCCceEeEEEE--eCC
Confidence 35899999999999999999988776654 999999875433333457788999999999 5699999998774 466
Q ss_pred eEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 335 HLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 335 ~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
.+|++||++ +++|.+++..... .....+..++.||+.||+|||++||+||||||+||||+.+ +.+
T Consensus 80 ~~~lv~e~~~gg~L~~~l~~~~~-----~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~---------g~~ 145 (318)
T 1fot_A 80 QIFMIMDYIEGGELFSLLRKSQR-----FPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKN---------GHI 145 (318)
T ss_dssp EEEEEECCCCSCBHHHHHHHTSS-----CCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTT---------SCE
T ss_pred EEEEEEeCCCCCCHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCC---------CCE
Confidence 899999986 5699999987542 3455666777899999999999999999999999999776 679
Q ss_pred EEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHH
Q psy14267 414 KIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWA 493 (553)
Q Consensus 414 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~ 493 (553)
||+|||+++...... ...+||+.|+|||++.+. .++.++|||||||++|||++|..||...... .
T Consensus 146 kL~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~ 210 (318)
T 1fot_A 146 KITDFGFAKYVPDVT-----YTLCGTPDYIAPEVVSTK---------PYNKSIDWWSFGILIYEMLAGYTPFYDSNTM-K 210 (318)
T ss_dssp EECCCSSCEECSSCB-----CCCCSCTTTCCHHHHTTC---------CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-H
T ss_pred EEeecCcceecCCcc-----ccccCCccccCHhHhcCC---------CCCcccchhhhHHHHHHHHhCCCCCCCCCHH-H
Confidence 999999998765422 256899999999999765 3788999999999999999999999875432 3
Q ss_pred HHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q psy14267 494 KMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARP-----TVGNSVTQ 545 (553)
Q Consensus 494 ~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RP-----t~~ell~~ 545 (553)
....+.... ..++ ..++.+++++|.+||..||++|| +++++++|
T Consensus 211 ~~~~i~~~~--~~~p------~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 211 TYEKILNAE--LRFP------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp HHHHHHHCC--CCCC------TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHHHHhCC--CCCC------CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 333333221 2222 25789999999999999999999 88888764
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=348.46 Aligned_cols=272 Identities=22% Similarity=0.326 Sum_probs=213.6
Q ss_pred eEEecCcceEEEeeeeeeCceEEEEEeeeC---CCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeee
Q psy14267 250 VITLNGKQYQVLSLLGKGGSSSVYLVGGTS---EHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHD 326 (553)
Q Consensus 250 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~---~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~ 326 (553)
.+++..++|++.+.||+|+||.||+|++.. ....+.||||++..... ....+.+.+|+.+|+++.+||||+++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 94 (313)
T 1t46_A 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLLG 94 (313)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh--HHHHHHHHHHHHHHhhcccCCCeeeEEE
Confidence 355677899999999999999999998632 33446699999976542 2345789999999999977799999999
Q ss_pred EEEeCCCceEEEEEecC-CCCHHHHHHHcccC-------------CCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCC
Q psy14267 327 YVYDTASKHLYVLMEKG-DTDLSKYMRNLNKM-------------TTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLK 392 (553)
Q Consensus 327 ~~~~~~~~~~~iv~e~~-~~~L~~~l~~~~~~-------------~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLK 392 (553)
++. .....+++||++ +++|.+++...... .........++.++.||+.||+|||++||+|||||
T Consensus 95 ~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlk 172 (313)
T 1t46_A 95 ACT--IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLA 172 (313)
T ss_dssp EEC--SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred EEe--cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCc
Confidence 774 456778999976 56999999876432 11235566777788899999999999999999999
Q ss_pred CCCEEEecCccceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHH
Q psy14267 393 PANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLG 472 (553)
Q Consensus 393 p~NILl~~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlG 472 (553)
|+|||++.+ +.+||+|||++................||+.|+|||++.+. .++.++||||||
T Consensus 173 p~Nil~~~~---------~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG 234 (313)
T 1t46_A 173 ARNILLTHG---------RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC---------VYTFESDVWSYG 234 (313)
T ss_dssp GGGEEEETT---------TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC---------CCCHHHHHHHHH
T ss_pred cceEEEcCC---------CCEEEccccccccccccccceeccCCCCcceeeChHHhcCC---------CCChHHHHHHHH
Confidence 999999876 67999999999887665443333455688999999999765 378999999999
Q ss_pred HHHHHHHh-CCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q psy14267 473 CILYNMIY-GRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNP 550 (553)
Q Consensus 473 vvl~ellt-G~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~ 550 (553)
|++|||++ |..||............+... ... .....++..+.++|.+||..||++|||+.+++++|++..
T Consensus 235 ~il~ellt~g~~p~~~~~~~~~~~~~~~~~-~~~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 306 (313)
T 1t46_A 235 IFLWELFSLGSSPYPGMPVDSKFYKMIKEG-FRM------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (313)
T ss_dssp HHHHHHHTTTCCSSTTCCSSHHHHHHHHHT-CCC------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHhCCCCCCCcccchhHHHHHhccC-CCC------CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 99999998 999998765443332222221 111 112367899999999999999999999999999998753
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=360.98 Aligned_cols=249 Identities=22% Similarity=0.338 Sum_probs=202.7
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
.++|++++.||+|+||.||+|++..++.. ||||++.+.........+.+.+|+.+|+++ +||||+++++++. ...
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~--~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~--~~~ 114 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNH--YAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFK--DNS 114 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCE--EEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEE--CSS
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCE--EEEEEEEhHHhccHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEE--cCC
Confidence 46899999999999999999988776654 999999876543334457889999999999 5699999988774 466
Q ss_pred eEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 335 HLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 335 ~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
.+|++||++ +++|.+++..... +....+..++.||+.||+|||++||+||||||+||||+.+ +.+
T Consensus 115 ~~~lv~e~~~gg~L~~~l~~~~~-----~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~---------g~~ 180 (350)
T 1rdq_E 115 NLYMVMEYVAGGEMFSHLRRIGR-----FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ---------GYI 180 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHHCC-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---------SCE
T ss_pred EEEEEEcCCCCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCC---------CCE
Confidence 899999986 6899999987543 3456667778899999999999999999999999999776 679
Q ss_pred EEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHH
Q psy14267 414 KIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWA 493 (553)
Q Consensus 414 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~ 493 (553)
||+|||+++...... ...+||+.|+|||++.+. .++.++|||||||+||||++|..||...... .
T Consensus 181 kL~DFg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-~ 245 (350)
T 1rdq_E 181 QVTDFGFAKRVKGRT-----WTLCGTPEALAPEIILSK---------GYNKAVDWWALGVLIYEMAAGYPPFFADQPI-Q 245 (350)
T ss_dssp EECCCTTCEECSSCB-----CCCEECGGGCCHHHHTTC---------CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-H
T ss_pred EEcccccceeccCCc-----ccccCCccccCHHHhcCC---------CCCCcCCEecccHhHhHHhhCCCCCCCCCHH-H
Confidence 999999998775432 256899999999999865 3788999999999999999999999875432 3
Q ss_pred HHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q psy14267 494 KMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT-----VGNSVTQ 545 (553)
Q Consensus 494 ~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt-----~~ell~~ 545 (553)
....+.... ..+ ...++.++.++|.+||+.||++||+ +++|++|
T Consensus 246 ~~~~i~~~~--~~~------p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 246 IYEKIVSGK--VRF------PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp HHHHHHHCC--CCC------CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHHHHcCC--CCC------CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 333333322 222 2367899999999999999999998 8888764
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=364.32 Aligned_cols=271 Identities=20% Similarity=0.293 Sum_probs=208.1
Q ss_pred EEecCcceEEEeeeeeeCceEEEEEeeeC---CCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeE
Q psy14267 251 ITLNGKQYQVLSLLGKGGSSSVYLVGGTS---EHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDY 327 (553)
Q Consensus 251 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~---~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~ 327 (553)
..+..++|++++.||+|+||+||+|+... ....+.||||++.... .......+.+|+.+|+++. ||||++++++
T Consensus 66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~ 142 (367)
T 3l9p_A 66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFN-HQNIVRCIGV 142 (367)
T ss_dssp CBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCC-CTTBCCEEEE
T ss_pred hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCC-CCCCCeEEEE
Confidence 34556789999999999999999998542 2233569999986432 2344567899999999995 6999999987
Q ss_pred EEeCCCceEEEEEecC-CCCHHHHHHHcccCC--CCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccc
Q psy14267 328 VYDTASKHLYVLMEKG-DTDLSKYMRNLNKMT--TLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLK 404 (553)
Q Consensus 328 ~~~~~~~~~~iv~e~~-~~~L~~~l~~~~~~~--~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~ 404 (553)
+. .....+++||++ +++|.+++....... .....+..++.++.||+.||+|||++|||||||||+||||+.+.
T Consensus 143 ~~--~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~-- 218 (367)
T 3l9p_A 143 SL--QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG-- 218 (367)
T ss_dssp EC--SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSS--
T ss_pred Ee--cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCC--
Confidence 74 455678999987 679999998764321 22355667777888999999999999999999999999997542
Q ss_pred eecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCC
Q psy14267 405 IIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRT 483 (553)
Q Consensus 405 ~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~ 483 (553)
.+..+||+|||+|+...............||+.|+|||++.+. .++.++|||||||+||||++ |..
T Consensus 219 ----~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~---------~~~~~~DvwslG~il~ellt~g~~ 285 (367)
T 3l9p_A 219 ----PGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEG---------IFTSKTDTWSFGVLLWEIFSLGYM 285 (367)
T ss_dssp ----TTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHC---------CCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred ----CCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCC---------CCCcHHHHHHHHHHHHHHHhCCCC
Confidence 2346999999999865433322223355689999999999765 37899999999999999998 999
Q ss_pred CCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 484 PYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 484 Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
||...... .....+... ... .....++..+.+||.+||+.||++||++.+|+++|+.+
T Consensus 286 pf~~~~~~-~~~~~i~~~-~~~------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 286 PYPSKSNQ-EVLEFVTSG-GRM------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp SSTTCCHH-HHHHHHHTT-CCC------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCHH-HHHHHHHcC-CCC------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 99875443 222222222 111 12236789999999999999999999999999999764
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=347.77 Aligned_cols=259 Identities=23% Similarity=0.377 Sum_probs=196.0
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|++++.||+|+||.||+|++ ..+ +.||||++...... ....+.+.+|+.+|+++. ||||+++++++.. ...
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~--~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~--~~~ 74 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYG--ETFALKKIRLEKED-EGIPSTTIREISILKELK-HSNIVKLYDVIHT--KKR 74 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTS--CEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCC-CTTBCCEEEEEEC--SSC
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCC--CEEEEEEEeccccc-cccchhHHHHHHHHHhcC-CCCEeeeeeEEcc--CCe
Confidence 4799999999999999999987 333 45999999765432 223367889999999995 6999999998754 568
Q ss_pred EEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 336 LYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 336 ~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
++++||++.++|.+++..... ......+..++.||+.||+|||++||+||||||+||||+.+ +.+||
T Consensus 75 ~~lv~e~~~~~l~~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~---------~~~kl 141 (288)
T 1ob3_A 75 LVLVFEHLDQDLKKLLDVCEG----GLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINRE---------GELKI 141 (288)
T ss_dssp EEEEEECCSEEHHHHHHTSTT----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT---------SCEEE
T ss_pred EEEEEEecCCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC---------CCEEE
Confidence 899999999999999876432 23455666777899999999999999999999999999776 57999
Q ss_pred EeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHH
Q psy14267 416 IDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKM 495 (553)
Q Consensus 416 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~ 495 (553)
+|||+++....... ......||+.|+|||++.+.. .++.++|||||||++|||++|..||....... .+
T Consensus 142 ~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~--------~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~ 210 (288)
T 1ob3_A 142 ADFGLARAFGIPVR--KYTHEIVTLWYRAPDVLMGSK--------KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QL 210 (288)
T ss_dssp CCTTHHHHHCC-----------CCCTTCCHHHHTTCC--------SCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HH
T ss_pred eECccccccCcccc--ccccccccccccCchheeCCC--------CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HH
Confidence 99999987654322 122456899999999997542 37899999999999999999999998765432 22
Q ss_pred HHHHhhcccc---c---------ccccc---------cCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 496 LAIARHKDQI---E---------FKPQL---------ANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 496 ~~i~~~~~~~---~---------~~~~~---------~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
..+....... . +.+.. .....+++++.+||.+||+.||++|||+.|++++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 211 MRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp HHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 2222211000 0 00000 1123578999999999999999999999999875
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=352.21 Aligned_cols=250 Identities=21% Similarity=0.275 Sum_probs=196.1
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
.++|+++++||+|+||+||+|++..++.. ||||++....... ....+...|+..+.++.+||||+++++++.+ ..
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~--vavK~~~~~~~~~-~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~--~~ 130 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRL--YAVKRSMSPFRGP-KDRARKLAEVGSHEKVGQHPCCVRLEQAWEE--GG 130 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCE--EEEEEESSSCCSH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TT
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeE--EEEEEecccccCh-HHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe--CC
Confidence 35799999999999999999988776654 9999987654333 3445677888888888788999999998753 67
Q ss_pred eEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 335 HLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 335 ~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
.++++||+++++|.+++..... ...+..++.++.||+.||+|||++|||||||||+||||+.+ +.+|
T Consensus 131 ~~~lv~e~~~~~L~~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~---------~~~k 197 (311)
T 3p1a_A 131 ILYLQTELCGPSLQQHCEAWGA----SLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPR---------GRCK 197 (311)
T ss_dssp EEEEEEECCCCBHHHHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGG---------GCEE
T ss_pred EEEEEEeccCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCC---------CCEE
Confidence 8999999999999999887643 34556677778899999999999999999999999999776 5799
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||++........ .....||+.|+|||++.+. ++.++|||||||++|||++|..|+... ..
T Consensus 198 l~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~----------~~~~~DiwslG~il~el~~g~~~~~~~----~~ 260 (311)
T 3p1a_A 198 LGDFGLLVELGTAGA---GEVQEGDPRYMAPELLQGS----------YGTAADVFSLGLTILEVACNMELPHGG----EG 260 (311)
T ss_dssp ECCCTTCEECC---------CCCCCGGGCCGGGGGTC----------CSTHHHHHHHHHHHHHHHHTCCCCSSH----HH
T ss_pred EccceeeeecccCCC---CcccCCCccccCHhHhcCC----------CCchhhHHHHHHHHHHHHhCCCCCCCc----cH
Confidence 999999987754432 2355699999999998752 688999999999999999997666542 11
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
...+.... ..+.. ...+++++.++|.+||+.||++|||+.|++++
T Consensus 261 ~~~~~~~~----~~~~~--~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 261 WQQLRQGY----LPPEF--TAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp HHHHTTTC----CCHHH--HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHhccC----CCccc--ccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 12222111 11111 12578999999999999999999999999874
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=366.62 Aligned_cols=263 Identities=21% Similarity=0.351 Sum_probs=206.7
Q ss_pred eEEecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEE
Q psy14267 250 VITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVY 329 (553)
Q Consensus 250 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~ 329 (553)
.|.+..++|++.+.||+|+||.||+|.+..++. .||||+++... .....+.+.+|+++|+++. ||||+++++++
T Consensus 108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~--~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~- 181 (377)
T 3cbl_A 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNT--LVAVKSCRETL--PPDLKAKFLQEARILKQYS-HPNIVRLIGVC- 181 (377)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCC--EEEEEECCTTS--CHHHHTTTTHHHHHHTTCC-CTTBCCEEEEE-
T ss_pred ccEEchHHeEEeeEeccCCCCeEEEEEEecCCe--EEEEEEccccC--CHHHHHHHHHHHHHHHhCC-CCCEEEEEEEE-
Confidence 455677899999999999999999998876654 49999987542 2344567899999999995 69999999877
Q ss_pred eCCCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecC
Q psy14267 330 DTASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDC 408 (553)
Q Consensus 330 ~~~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~ 408 (553)
.....++++||++ +++|.++++.... ......++.++.||+.||+|||++|||||||||+||||+.+
T Consensus 182 -~~~~~~~lv~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~------- 249 (377)
T 3cbl_A 182 -TQKQPIYIVMELVQGGDFLTFLRTEGA----RLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEK------- 249 (377)
T ss_dssp -CSSSSCEEEEECCTTCBHHHHHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-------
T ss_pred -ecCCCcEEEEEcCCCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCC-------
Confidence 4456788999986 5899999986542 23455667778899999999999999999999999999776
Q ss_pred CCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCC
Q psy14267 409 IGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSH 487 (553)
Q Consensus 409 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~ 487 (553)
+.+||+|||+++...............+++.|+|||++.+. .++.++|||||||+||||++ |..||..
T Consensus 250 --~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~DvwslG~il~el~t~g~~p~~~ 318 (377)
T 3cbl_A 250 --NVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYG---------RYSSESDVWSFGILLWETFSLGASPYPN 318 (377)
T ss_dssp --CCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHC---------EEEHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred --CcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccC---------CCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 57999999999875443222111223467889999999765 37889999999999999998 9999988
Q ss_pred CCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 488 IPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 488 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
..... ....+. .... ......+++++.+||.+||+.||++|||+.+|++.|+++
T Consensus 319 ~~~~~-~~~~~~-~~~~------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 319 LSNQQ-TREFVE-KGGR------LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp SCHHH-HHHHHH-TTCC------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCHHH-HHHHHH-cCCC------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 65532 222222 1211 122336789999999999999999999999999999875
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=359.43 Aligned_cols=255 Identities=23% Similarity=0.325 Sum_probs=198.5
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|++++.||+|+||+||+|.+..++.. ||||++....... ..+.+.+|+.+++++. ||||+++++++. ....
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~--vavK~~~~~~~~~--~~~~~~~E~~~l~~l~-hpnIv~~~~~~~--~~~~ 79 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEA--VAVKIVDMKRAVD--CPENIKKEICINKMLN-HENVVKFYGHRR--EGNI 79 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCE--EEEEEEECC---------CHHHHHHHHHHCC-CTTBCCEEEEEE--CSSE
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcE--EEEEEEEcccccc--hHHHHHHHHHHHHhCC-CCCCCeEEEEEe--cCCe
Confidence 5799999999999999999988776654 9999997654322 2366889999999995 599999998774 4668
Q ss_pred EEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
.+++||++ +++|.+++.... ......+..++.||+.||+|||++||+||||||+||||+.+ +.+|
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~---------~~~k 145 (323)
T 3tki_A 80 QYLFLEYCSGGELFDRIEPDI-----GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER---------DNLK 145 (323)
T ss_dssp EEEEEECCTTEEGGGGSBTTT-----BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT---------CCEE
T ss_pred EEEEEEcCCCCcHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCC---------CCEE
Confidence 89999987 568888775432 24456677778899999999999999999999999999776 5799
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||+++.+............+||+.|+|||++.+.. .++.++|||||||++|||++|..||.........
T Consensus 146 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--------~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 217 (323)
T 3tki_A 146 ISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE--------FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217 (323)
T ss_dssp ECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSS--------BCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH
T ss_pred EEEeeccceeccCCcccccCCCccCcCccCcHHhccCC--------CCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH
Confidence 99999998765443333334678999999999997653 1367899999999999999999999875543233
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
.......... ...+..++..+.+||.+||..||++|||+.|++++
T Consensus 218 ~~~~~~~~~~------~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 218 YSDWKEKKTY------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp HHHHHTTCTT------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHhccccc------CCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 3333222111 11123578999999999999999999999999875
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=364.95 Aligned_cols=257 Identities=22% Similarity=0.344 Sum_probs=193.1
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
.++|++++.||+|+||.||+|+++.++.. ||||++.+...........+.+|..++.+..+||||+++++++. ...
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~--~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~--~~~ 112 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVF--YAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ--TAD 112 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCE--EEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEE--CSS
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCE--EEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEE--eCC
Confidence 35899999999999999999998777654 99999988776555555677888887544346799999988774 466
Q ss_pred eEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 335 HLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 335 ~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
.+|++||++ +++|..++..... +....+..++.||+.||+|||++|||||||||+||||+.+ +.+
T Consensus 113 ~~~lv~E~~~gg~L~~~l~~~~~-----~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~---------g~i 178 (373)
T 2r5t_A 113 KLYFVLDYINGGELFYHLQRERC-----FLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ---------GHI 178 (373)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---------SCE
T ss_pred EEEEEEeCCCCCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCC---------CCE
Confidence 899999986 5699999887542 3345566677899999999999999999999999999876 679
Q ss_pred EEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHH
Q psy14267 414 KIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWA 493 (553)
Q Consensus 414 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~ 493 (553)
||+|||+++....... .....+||+.|+|||++.+. .++.++|||||||++|||++|..||...... .
T Consensus 179 kL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-~ 246 (373)
T 2r5t_A 179 VLTDFGLCKENIEHNS--TTSTFCGTPEYLAPEVLHKQ---------PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-E 246 (373)
T ss_dssp EECCCCBCGGGBCCCC--CCCSBSCCCCCCCHHHHTTC---------CCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH-H
T ss_pred EEeeCccccccccCCC--ccccccCCccccCHHHhCCC---------CCCchhhhHHHHHHHHHHHcCCCCCCCCCHH-H
Confidence 9999999987543322 23467899999999999865 3788999999999999999999999875432 3
Q ss_pred HHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 494 KMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 494 ~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
....+... ...+ ...++.++++||.+||+.||++||++.+.+..+.++
T Consensus 247 ~~~~i~~~--~~~~------~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h 294 (373)
T 2r5t_A 247 MYDNILNK--PLQL------KPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSH 294 (373)
T ss_dssp HHHHHHHS--CCCC------CSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTS
T ss_pred HHHHHHhc--ccCC------CCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCC
Confidence 33333322 1122 226789999999999999999999986555555443
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=372.00 Aligned_cols=262 Identities=27% Similarity=0.428 Sum_probs=205.8
Q ss_pred ecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC
Q psy14267 253 LNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA 332 (553)
Q Consensus 253 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~ 332 (553)
+..++|+++++||+|+||+||+|+++.++.. ||||++.+.........+.+.+|+.+|+.+ +||||+++++++. .
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~--~AiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~--~ 140 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKV--YAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQ--D 140 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCE--EEEEEEEHHHHHHTCCCSTHHHHHHHHHHC-CCTTBCCEEEEEE--C
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCCcE--EEEEEEehhhhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEE--E
Confidence 4457899999999999999999998877654 999999764332222234578999999999 5699999998774 4
Q ss_pred CceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCC
Q psy14267 333 SKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGN 411 (553)
Q Consensus 333 ~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~ 411 (553)
...+|++||++ +++|.+++... ......+..++.||+.||+|||++|||||||||+||||+.+ +
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~------~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~---------g 205 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS---------G 205 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---------S
T ss_pred CCEEEEEEeCCCCCcHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCC---------C
Confidence 67899999987 77999988763 23455667778899999999999999999999999999876 6
Q ss_pred eEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCch
Q psy14267 412 VLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNT 491 (553)
Q Consensus 412 ~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~ 491 (553)
.+||+|||+|+....... ....+.+||+.|+|||++.+...++ .++.++|||||||+||||++|..||......
T Consensus 206 ~ikL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~-----~~~~~~DiwSlGvilyell~G~~Pf~~~~~~ 279 (410)
T 3v8s_A 206 HLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDG-----YYGRECDWWSVGVFLYEMLVGDTPFYADSLV 279 (410)
T ss_dssp CEEECCCTTCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTC-----EEETHHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred CEEEeccceeEeeccCCc-ccccCCcCCccccCHHHhhccCCCc-----CCCCcceEecchHHHHHHHhCCCCCCCCChh
Confidence 799999999987755432 2234678999999999998653211 3688999999999999999999999875432
Q ss_pred HHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q psy14267 492 WAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKA--RPTVGNSVTQ 545 (553)
Q Consensus 492 ~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~--RPt~~ell~~ 545 (553)
.....+........+ +....++.++++||++||..+|++ ||+++||++|
T Consensus 280 -~~~~~i~~~~~~~~~----p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 280 -GTYSKIMNHKNSLTF----PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp -HHHHHHHTHHHHCCC----CTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred -hHHHHHHhccccccC----CCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 333344332222222 223468899999999999999988 9999999876
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=351.45 Aligned_cols=261 Identities=21% Similarity=0.279 Sum_probs=201.9
Q ss_pred EecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeC
Q psy14267 252 TLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDT 331 (553)
Q Consensus 252 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~ 331 (553)
.+..++|++.++||+|+||.||+|.+..++.. ||+|++... .....+.+.+|+++|+++. ||||+++++++.+
T Consensus 6 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~--va~K~~~~~---~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~- 78 (310)
T 3s95_A 6 IFRPSDLIHGEVLGKGCFGQAIKVTHRETGEV--MVMKELIRF---DEETQRTFLKEVKVMRCLE-HPNVLKFIGVLYK- 78 (310)
T ss_dssp EECGGGEEEEEEEECCSSEEEEEEEETTTCCE--EEEEEESCC---CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEE-
T ss_pred eeChhHeeccceecCCCCEEEEEEEECCCCcE--EEEEEeccC---CHHHHHHHHHHHHHHHhCC-CcCcccEEEEEec-
Confidence 34567899999999999999999988776654 999988543 3455678999999999995 6999999998864
Q ss_pred CCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCC
Q psy14267 332 ASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIG 410 (553)
Q Consensus 332 ~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~ 410 (553)
...++++||++ +++|.+++..... ...+..++.++.|++.||+|||++||+||||||+||||+.+
T Consensus 79 -~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~--------- 144 (310)
T 3s95_A 79 -DKRLNFITEYIKGGTLRGIIKSMDS----QYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVREN--------- 144 (310)
T ss_dssp -TTEEEEEEECCTTCBHHHHHHHCCT----TSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTT---------
T ss_pred -CCeeEEEEEecCCCcHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCC---------
Confidence 56788999976 5699999987432 24455666777899999999999999999999999999776
Q ss_pred CeEEEEeccCccccCCCCCcc------------cccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHH
Q psy14267 411 NVLKIIDFGIACSLQDDKTSV------------HKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNM 478 (553)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~~~------------~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~el 478 (553)
+.+||+|||+++......... ......||+.|+|||++.+. .++.++|||||||++|||
T Consensus 145 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~Di~slG~~l~el 215 (310)
T 3s95_A 145 KNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGR---------SYDEKVDVFSFGIVLCEI 215 (310)
T ss_dssp SCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTC---------CCCTHHHHHHHHHHHHHH
T ss_pred CCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCC---------CCCcHHHHHHHHHHHHHH
Confidence 579999999998765433211 11245799999999999765 378899999999999999
Q ss_pred HhCCCCCCCCCchHHHHH-HHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 479 IYGRTPYSHIPNTWAKML-AIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 479 ltG~~Pf~~~~~~~~~~~-~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
++|..||........... ..... ........+++.+.++|.+||+.||++|||+.++++.|+++
T Consensus 216 ~~g~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l 280 (310)
T 3s95_A 216 IGRVNADPDYLPRTMDFGLNVRGF-------LDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETL 280 (310)
T ss_dssp HHTCCSSTTTSCBCTTSSBCHHHH-------HHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hcCCCCCcchhhhHHHHhhhhhcc-------ccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 999999876322100000 00000 00011236788999999999999999999999999999864
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=365.48 Aligned_cols=267 Identities=16% Similarity=0.202 Sum_probs=189.4
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhc-CCCceeEee-------eE
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQ-GCPYVIKMH-------DY 327 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~-~hp~Iv~l~-------~~ 327 (553)
..|++.+.||+|+||+||+|++..++. .||||++...........+.+.+|+.+++.|. .||||++++ ++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLE--DFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTE--EEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCc--eeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehh
Confidence 359999999999999999998877664 49999999887656666778889987777776 479988754 33
Q ss_pred EEeCCC---------------ceEEEEEecCCCCHHHHHHHcccCCCCchH-HHHH-HHHHHHHHHHHHHHhhCCcEecC
Q psy14267 328 VYDTAS---------------KHLYVLMEKGDTDLSKYMRNLNKMTTLPNT-MIII-IMHWYEMLLAVKEIHAAGIIHSD 390 (553)
Q Consensus 328 ~~~~~~---------------~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~-~~~i-~~~~~qil~aL~yLH~~gIiHrD 390 (553)
+..... ..++++||+++++|.+++............ ...+ ..++.||+.||+|||++||||||
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD 219 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH 219 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence 333222 458999999999999999876443332222 1111 33447999999999999999999
Q ss_pred CCCCCEEEecCccceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHH
Q psy14267 391 LKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWS 470 (553)
Q Consensus 391 LKp~NILl~~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwS 470 (553)
|||+||||+.+ +.+||+|||+|+....... ...||+.|+|||++.+.. ..++.++||||
T Consensus 220 ikp~NIll~~~---------~~~kL~DFG~a~~~~~~~~-----~~~~t~~y~aPE~~~~~~-------~~~~~~~DiwS 278 (371)
T 3q60_A 220 FTPDNLFIMPD---------GRLMLGDVSALWKVGTRGP-----ASSVPVTYAPREFLNAST-------ATFTHALNAWQ 278 (371)
T ss_dssp CSGGGEEECTT---------SCEEECCGGGEEETTCEEE-----GGGSCGGGCCHHHHTCSE-------EECCHHHHHHH
T ss_pred CCHHHEEECCC---------CCEEEEecceeeecCCCcc-----CccCCcCCcChhhccCCC-------CCcCccccHHH
Confidence 99999999876 5799999999987643221 345679999999997521 14789999999
Q ss_pred HHHHHHHHHhCCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 471 LGCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 471 lGvvl~elltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
|||+||||++|+.||...............................+++.+.+||.+||+.||++|||+.+++++
T Consensus 279 lG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 279 LGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp HHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred HHHHHHHHHhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 999999999999999874321000000000000000111222234789999999999999999999999999753
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=353.87 Aligned_cols=259 Identities=27% Similarity=0.405 Sum_probs=195.9
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCC-
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTAS- 333 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~- 333 (553)
.++|++++.||+|+||.||+|++..++. .||||++............++.+|+.+++++. ||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~ 87 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHR--DVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAIVAVYDTGEAETPA 87 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTE--EEEEEEECTTTTTSHHHHHHHHHHHTTCCCCC-CTTBCCEEEEEEEEETT
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCc--eEEEEEeCccccCCHHHHHHHHHHHHHHHcCC-CCCcceEEEeeeccCCC
Confidence 4689999999999999999998877664 49999998876666667788999999999995 6999999998765443
Q ss_pred -ceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCC
Q psy14267 334 -KHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGN 411 (553)
Q Consensus 334 -~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~ 411 (553)
...|++||++ +++|.+++.... ......++.++.|++.||+|||++||+||||||+||||+.+ +
T Consensus 88 ~~~~~lv~e~~~g~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~---------~ 153 (311)
T 3ork_A 88 GPLPYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISAT---------N 153 (311)
T ss_dssp EEEEEEEEECCCEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETT---------S
T ss_pred CcccEEEEecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCC---------C
Confidence 3569999987 579999988654 23455667777899999999999999999999999999876 5
Q ss_pred eEEEEeccCccccCCCCCc-ccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCc
Q psy14267 412 VLKIIDFGIACSLQDDKTS-VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN 490 (553)
Q Consensus 412 ~vkL~DFGla~~~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~ 490 (553)
.+||+|||+++.+...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.....
T Consensus 154 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~Di~slG~~l~~ll~g~~pf~~~~~ 224 (311)
T 3ork_A 154 AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD---------SVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224 (311)
T ss_dssp CEEECCCSCC------------------CCTTCCHHHHHTC---------CCCHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred CEEEeeccCcccccccccccccccccCcCcccCCHHHhcCC---------CCCchHhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 7999999999876554322 122345699999999999765 378899999999999999999999987654
Q ss_pred hHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy14267 491 TWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVT 544 (553)
Q Consensus 491 ~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~ 544 (553)
.......+. ... .+.......++.++.++|.+||+.||++||++.+++.
T Consensus 225 ~~~~~~~~~-~~~----~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~ 273 (311)
T 3ork_A 225 VSVAYQHVR-EDP----IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMR 273 (311)
T ss_dssp HHHHHHHHH-CCC----CCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred HHHHHHHhc-CCC----CCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence 322222222 111 1111223368899999999999999999996665553
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=346.51 Aligned_cols=272 Identities=24% Similarity=0.339 Sum_probs=198.2
Q ss_pred cceEEecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeE
Q psy14267 248 QDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDY 327 (553)
Q Consensus 248 ~~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~ 327 (553)
...+++..++|++.++||+|+||.||++++.. .||||+++..... ....+.+.+|+.+|+++. ||||+.++++
T Consensus 16 ~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~-----~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~-h~~iv~~~~~ 88 (289)
T 3og7_A 16 ADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-----DVAVKMLNVTAPT-PQQLQAFKNEVGVLRKTR-HVNILLFMGY 88 (289)
T ss_dssp --CCBCCTTSCEEEEEEEECSSEEEEEEESSS-----EEEEEEESCSSCC-HHHHHHHHHHHHHHTTCC-CTTBCCEEEE
T ss_pred CCCCccCccceeeeeEecCCCCeEEEEEEEcC-----ceEEEEEeccCCC-HHHHHHHHHHHHHHHhCC-CCcEEEEEee
Confidence 34456778899999999999999999986532 3999999766543 345678999999999995 5999999885
Q ss_pred EEeCCCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCcccee
Q psy14267 328 VYDTASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKII 406 (553)
Q Consensus 328 ~~~~~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~ 406 (553)
. ....++++|+++ +++|.+++..... ......++.++.|++.||+|||++||+||||||+||||+.+
T Consensus 89 ~---~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~----- 156 (289)
T 3og7_A 89 S---TAPQLAIVTQWCEGSSLYHHLHASET----KFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHED----- 156 (289)
T ss_dssp E---CSSSCEEEEECCCEEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT-----
T ss_pred c---cCCccEEEEEecCCCcHHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCC-----
Confidence 4 234567888875 5788888864432 34455667778899999999999999999999999999876
Q ss_pred cCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCC
Q psy14267 407 DCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYS 486 (553)
Q Consensus 407 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~ 486 (553)
+.+||+|||++................||+.|+|||++..... ..++.++|||||||++|||++|..||.
T Consensus 157 ----~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~------~~~~~~~Di~slG~il~el~~g~~p~~ 226 (289)
T 3og7_A 157 ----NTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDS------NPYSFQSDVYAFGIVLYELMTGQLPYS 226 (289)
T ss_dssp ----TEEEECCCC------------------CCCTTCCHHHHC----------CCSCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred ----CCEEEccceeccccccccccccccccCCCccccCchhhcccCC------CCCCcccchHHHHHHHHHHHHCCCCcc
Confidence 6799999999987654333333345679999999999973321 147889999999999999999999998
Q ss_pred CCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q psy14267 487 HIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNPE 551 (553)
Q Consensus 487 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~~ 551 (553)
...........+......... ......+++.+.+||.+||+.||++|||+.++++.|+++..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 227 NINNRDQIIEMVGRGSLSPDL---SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp SCCCHHHHHHHHHHTSCCCCT---TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred ccchHHHHHHHhcccccCcch---hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 866654444443332222111 11233688999999999999999999999999999998754
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=353.85 Aligned_cols=262 Identities=21% Similarity=0.381 Sum_probs=204.2
Q ss_pred ecCcceEEEeeeeeeCceEEEEEeeeCCC-ccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeC
Q psy14267 253 LNGKQYQVLSLLGKGGSSSVYLVGGTSEH-EFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDT 331 (553)
Q Consensus 253 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~ 331 (553)
+...+|++.+.||+|+||.||+|++..++ ....||||+++... .....+.+.+|+.+|+++. ||||+++++++ .
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~--~ 120 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFD-HPNIIRLEGVV--T 120 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEE--C
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEE--E
Confidence 45678999999999999999999886544 23459999997543 3344578999999999995 69999999877 4
Q ss_pred CCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCC
Q psy14267 332 ASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIG 410 (553)
Q Consensus 332 ~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~ 410 (553)
....++++||++ +++|.++++.... ......++.++.||+.||+|||++||+||||||+||||+.+
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~--------- 187 (325)
T 3kul_A 121 RGRLAMIVTEYMENGSLDTFLRTHDG----QFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSN--------- 187 (325)
T ss_dssp GGGCCEEEEECCTTCBHHHHHHTTTT----CSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT---------
T ss_pred eCCccEEEeeCCCCCcHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCC---------
Confidence 466789999987 6699999875432 34456677778899999999999999999999999999776
Q ss_pred CeEEEEeccCccccCCCCCc-ccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCC
Q psy14267 411 NVLKIIDFGIACSLQDDKTS-VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHI 488 (553)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~ 488 (553)
+.+||+|||+++........ .......+|+.|+|||++.+. .++.++|||||||++|||++ |..||...
T Consensus 188 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~---------~~~~~~Di~slG~il~ell~~g~~p~~~~ 258 (325)
T 3kul_A 188 LVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR---------TFSSASDVWSFGVVMWEVLAYGERPYWNM 258 (325)
T ss_dssp CCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHC---------EECHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred CCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCC---------CCCcHHHHHHHHHHHHHHHcCCCCCcccC
Confidence 57999999999887654322 122234568899999999765 37889999999999999998 99999876
Q ss_pred CchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 489 PNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 489 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
... .....+... .. ......++..+.+||.+||..||++|||+.+|++.|+.+
T Consensus 259 ~~~-~~~~~~~~~-~~------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l 311 (325)
T 3kul_A 259 TNR-DVISSVEEG-YR------LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311 (325)
T ss_dssp CHH-HHHHHHHTT-CC------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CHH-HHHHHHHcC-CC------CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 543 222222221 11 122336889999999999999999999999999999874
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=348.46 Aligned_cols=271 Identities=42% Similarity=0.669 Sum_probs=203.8
Q ss_pred cceEEecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcC-CCceeEeee
Q psy14267 248 QDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG-CPYVIKMHD 326 (553)
Q Consensus 248 ~~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~-hp~Iv~l~~ 326 (553)
...+.+.+++|++++.||+|+||.||+|.+.. .+.||||++...... ....+.+.+|+.+|+++.+ ||||+++++
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~~iv~~~~ 95 (313)
T 3cek_A 20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEK---KQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95 (313)
T ss_dssp CCEEEETTEEEEEEEEEECCSSEEEEEEECTT---CCEEEEEEEECSSCC-HHHHHHHHHHHHHHHHHGGGCTTBCCEEE
T ss_pred eeeeeeccceEEEEEEecCCCCEEEEEEEcCC---CcEEEEEEecccccc-ccchHHHHHHHHHHHhccccCCceEEEEE
Confidence 34566788899999999999999999997753 345999999876543 3456789999999999986 799999998
Q ss_pred EEEeCCCceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCcccee
Q psy14267 327 YVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKII 406 (553)
Q Consensus 327 ~~~~~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~ 406 (553)
++.. ...++++||+.+++|.+++.... ......++.++.||+.||+|||++||+||||||+|||++.
T Consensus 96 ~~~~--~~~~~lv~e~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~------ 162 (313)
T 3cek_A 96 YEIT--DQYIYMVMECGNIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD------ 162 (313)
T ss_dssp EEEC--SSEEEEEECCCSEEHHHHHHHCS-----SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET------
T ss_pred Eeec--CCEEEEEEecCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC------
Confidence 7754 56799999999999999998754 2344566677789999999999999999999999999954
Q ss_pred cCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCC--CCCccCCCccchHHHHHHHHHHHHhCCCC
Q psy14267 407 DCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSG--GGNTYRITYKSDVWSLGCILYNMIYGRTP 484 (553)
Q Consensus 407 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~--~~~~~~~s~~sDIwSlGvvl~elltG~~P 484 (553)
+.+||+|||++................||+.|+|||++.+..... +.....++.++|||||||++|||++|..|
T Consensus 163 ----~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p 238 (313)
T 3cek_A 163 ----GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238 (313)
T ss_dssp ----TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred ----CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCc
Confidence 469999999998776544333333567999999999997532110 00112478899999999999999999999
Q ss_pred CCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 485 YSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 485 f~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
|.........+..+........+ ...++.++.++|.+||..||++||++.+++++
T Consensus 239 f~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 239 FQQIINQISKLHAIIDPNHEIEF------PDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp TTTCCSHHHHHHHHHCTTSCCCC------CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhHHHHHHHHHHHHhcccccCC------cccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 98765544444443332222221 22457899999999999999999999999875
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=355.94 Aligned_cols=253 Identities=23% Similarity=0.328 Sum_probs=203.7
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
+.|++++.||+|+||.||+|++..++. .||||++...........+.+.+|+++|++++ ||||+++++++.. ...
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~--~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~--~~~ 128 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSE--VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLR--EHT 128 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTE--EEEEEEEESCSSCHHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEE--TTE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCe--EEEEEEEccccccchHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEE--CCe
Confidence 469999999999999999998876664 49999998776555566678999999999995 5999999998765 568
Q ss_pred EEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 336 LYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 336 ~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
++++||++.++|.+++..... ......++.++.|++.||+|||++||+||||||+||||+.+ +.+||
T Consensus 129 ~~lv~e~~~g~l~~~l~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~---------~~~kL 195 (348)
T 1u5q_A 129 AWLVMEYCLGSASDLLEVHKK----PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP---------GLVKL 195 (348)
T ss_dssp EEEEEECCSEEHHHHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETT---------TEEEE
T ss_pred EEEEEecCCCCHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCC---------CCEEE
Confidence 899999999999998875432 34456667777899999999999999999999999999876 68999
Q ss_pred EeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHH
Q psy14267 416 IDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKM 495 (553)
Q Consensus 416 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~ 495 (553)
+|||++...... ....||+.|+|||++.+... ..++.++|||||||++|||++|..||...... ..+
T Consensus 196 ~DfG~a~~~~~~------~~~~gt~~y~aPE~~~~~~~------~~~~~~~DiwslG~il~ell~g~~p~~~~~~~-~~~ 262 (348)
T 1u5q_A 196 GDFGSASIMAPA------NSFVGTPYWMAPEVILAMDE------GQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SAL 262 (348)
T ss_dssp CCCTTCBSSSSB------CCCCSCGGGCCHHHHHTTSS------CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHH
T ss_pred eeccCceecCCC------CcccCCcceeCHhhhccccC------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHH
Confidence 999999776432 24579999999999864211 14788999999999999999999999875543 222
Q ss_pred HHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 496 LAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 496 ~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
..+....... .....+++.+.+||.+||+.||++|||+.+++++
T Consensus 263 ~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 263 YHIAQNESPA------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp HHHHHSCCCC------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred HHHHhcCCCC------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 2332221111 1123678999999999999999999999999875
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=354.42 Aligned_cols=269 Identities=21% Similarity=0.340 Sum_probs=209.5
Q ss_pred EecCcceEEEeeeeeeCceEEEEEeeeCC---CccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEE
Q psy14267 252 TLNGKQYQVLSLLGKGGSSSVYLVGGTSE---HEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYV 328 (553)
Q Consensus 252 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~---~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~ 328 (553)
.+..++|++++.||+|+||.||+|++... ...+.||||+++... .....+.+.+|+.+|+++ +||||+++++++
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~ 119 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEF-DNPNIVKLLGVC 119 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTC-CCTTBCCEEEEE
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhC-CCCCEEEEEEEE
Confidence 45567899999999999999999988743 233569999997653 334557899999999999 469999999977
Q ss_pred EeCCCceEEEEEecC-CCCHHHHHHHcccCC-------------------CCchHHHHHHHHHHHHHHHHHHHhhCCcEe
Q psy14267 329 YDTASKHLYVLMEKG-DTDLSKYMRNLNKMT-------------------TLPNTMIIIIMHWYEMLLAVKEIHAAGIIH 388 (553)
Q Consensus 329 ~~~~~~~~~iv~e~~-~~~L~~~l~~~~~~~-------------------~~~~~~~~i~~~~~qil~aL~yLH~~gIiH 388 (553)
. ....++++||++ +++|.+++....... ...+....++.++.||+.||+|||++||+|
T Consensus 120 ~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH 197 (343)
T 1luf_A 120 A--VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVH 197 (343)
T ss_dssp C--SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred c--cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 3 466788999976 569999998753211 134556677778889999999999999999
Q ss_pred cCCCCCCEEEecCccceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchH
Q psy14267 389 SDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDV 468 (553)
Q Consensus 389 rDLKp~NILl~~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDI 468 (553)
|||||+||||+.+ +.+||+|||+++...............||+.|+|||++.+. .++.++||
T Consensus 198 ~Dlkp~NIl~~~~---------~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~---------~~~~~~Di 259 (343)
T 1luf_A 198 RDLATRNCLVGEN---------MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN---------RYTTESDV 259 (343)
T ss_dssp SCCSGGGEEECGG---------GCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC---------CCCHHHHH
T ss_pred CCCCcceEEECCC---------CeEEEeecCCCcccccCccccccCCCcccceecChhhhccC---------CcCccccc
Confidence 9999999999876 57999999999876543322223355689999999999765 37899999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q psy14267 469 WSLGCILYNMIY-GRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQIN 547 (553)
Q Consensus 469 wSlGvvl~ellt-G~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~ 547 (553)
|||||++|||++ |..||...... .....+.... .. .....++..+.++|.+||+.||++||++.+++++|+
T Consensus 260 ~slG~il~el~t~g~~p~~~~~~~-~~~~~~~~~~-~~------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~ 331 (343)
T 1luf_A 260 WAYGVVLWEIFSYGLQPYYGMAHE-EVIYYVRDGN-IL------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 331 (343)
T ss_dssp HHHHHHHHHHHTTTCCTTTTSCHH-HHHHHHHTTC-CC------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHHHHhcCCCcCCCCChH-HHHHHHhCCC-cC------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHH
Confidence 999999999998 99999875543 2222332221 11 112367899999999999999999999999999999
Q ss_pred cCCC
Q psy14267 548 NNPE 551 (553)
Q Consensus 548 ~~~~ 551 (553)
++.+
T Consensus 332 ~~~~ 335 (343)
T 1luf_A 332 RMCE 335 (343)
T ss_dssp HTTC
T ss_pred HHHh
Confidence 8764
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=360.24 Aligned_cols=255 Identities=25% Similarity=0.334 Sum_probs=200.3
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
.++|++.+.||+|+||.||+|.++.++.. ||||++.+.... ..+|+++|.++.+||||+++++++. ...
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~--~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~--~~~ 89 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNME--FAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYD--DGK 89 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEE--EEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEE--CSS
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCE--EEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEE--cCC
Confidence 35799999999999999999988777644 999999876422 3478999999978899999999874 467
Q ss_pred eEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 335 HLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 335 ~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
.+|++||++ +++|.+++.... .+....+..++.||+.||+|||++||+||||||+|||+..+. ...+.+
T Consensus 90 ~~~lv~E~~~gg~L~~~i~~~~-----~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~-----~~~~~~ 159 (342)
T 2qr7_A 90 YVYVVTELMKGGELLDKILRQK-----FFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDES-----GNPESI 159 (342)
T ss_dssp EEEEEECCCCSCBHHHHHHTCT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSS-----CSGGGE
T ss_pred EEEEEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCC-----CCcCeE
Confidence 899999986 579999887653 244566777788999999999999999999999999985442 112359
Q ss_pred EEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCC--ch
Q psy14267 414 KIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIP--NT 491 (553)
Q Consensus 414 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~--~~ 491 (553)
||+|||+++....... .....+||+.|+|||++.+.. ++.++|||||||++|||++|..||.... ..
T Consensus 160 kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~---------~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 228 (342)
T 2qr7_A 160 RICDFGFAKQLRAENG--LLMTPCYTANFVAPEVLERQG---------YDAACDIWSLGVLLYTMLTGYTPFANGPDDTP 228 (342)
T ss_dssp EECCCTTCEECBCTTC--CBCCSSCCSSCCCHHHHHHHH---------HHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCH
T ss_pred EEEECCCcccCcCCCC--ceeccCCCccccCHHHhcCCC---------CCCccCeeeHhHHHHHHhcCCCCCCCCCcCCH
Confidence 9999999987755433 223678999999999997653 6789999999999999999999998632 22
Q ss_pred HHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 492 WAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 492 ~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
...+..+..... .+ ....+..+++++++||++||..||++||++.++++|
T Consensus 229 ~~~~~~i~~~~~--~~--~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 229 EEILARIGSGKF--SL--SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp HHHHHHHHHCCC--CC--CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHHHHHccCCc--cc--CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 233333332221 11 112334789999999999999999999999999875
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=367.15 Aligned_cols=261 Identities=13% Similarity=0.172 Sum_probs=195.2
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhc--CCCceeEee-------
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQ--GCPYVIKMH------- 325 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~--~hp~Iv~l~------- 325 (553)
.++|++.+.||+|+||.||+|.+..++. .||||++.+.........+.+.+|+.+|+.+. .||||++++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~ 149 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGE--SFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 149 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCC--EEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCc--EEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh
Confidence 4689999999999999999998876664 49999998776555566788999996666554 579999988
Q ss_pred eEEEeCCC----------c-----eEEEEEecCCCCHHHHHHHcccCCC--CchHHHHHHHHHHHHHHHHHHHhhCCcEe
Q psy14267 326 DYVYDTAS----------K-----HLYVLMEKGDTDLSKYMRNLNKMTT--LPNTMIIIIMHWYEMLLAVKEIHAAGIIH 388 (553)
Q Consensus 326 ~~~~~~~~----------~-----~~~iv~e~~~~~L~~~l~~~~~~~~--~~~~~~~i~~~~~qil~aL~yLH~~gIiH 388 (553)
+++.+... . ..|++||+++++|.+++........ ..+....++.++.||+.||+|||++||||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH 229 (377)
T 3byv_A 150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH 229 (377)
T ss_dssp EEEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hhhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 54433211 1 3789999999999999987654433 23334556667889999999999999999
Q ss_pred cCCCCCCEEEecCccceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCC--CCCCccCCCccc
Q psy14267 389 SDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSS--GGGNTYRITYKS 466 (553)
Q Consensus 389 rDLKp~NILl~~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~--~~~~~~~~s~~s 466 (553)
|||||+||||+.+ +.+||+|||+|+.... .....+| +.|+|||++.+.... .+.....++.++
T Consensus 230 rDikp~NIll~~~---------~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~ 294 (377)
T 3byv_A 230 TYLRPVDIVLDQR---------GGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSF 294 (377)
T ss_dssp SCCCGGGEEECTT---------CCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHH
T ss_pred CCCCHHHEEEcCC---------CCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhh
Confidence 9999999999876 5799999999986433 1235678 999999999765000 000011378999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 467 DVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 467 DIwSlGvvl~elltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
|||||||+||||++|+.||...... . ...........+++++.+||.+||..||++|||+.+++++
T Consensus 295 DvwSlG~il~elltg~~Pf~~~~~~-----------~--~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 295 DAWALGLVIYWIWCADLPITKDAAL-----------G--GSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp HHHHHHHHHHHHHHSSCCC-----------------C--CSGGGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred hHHHHHHHHHHHHHCCCCCcccccc-----------c--chhhhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 9999999999999999999763221 0 0111112234788999999999999999999999999864
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=354.02 Aligned_cols=262 Identities=21% Similarity=0.312 Sum_probs=197.0
Q ss_pred ecCcceEEEeeeeeeCceEEEEEeeeCCCcc--ceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEe
Q psy14267 253 LNGKQYQVLSLLGKGGSSSVYLVGGTSEHEF--KPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYD 330 (553)
Q Consensus 253 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~--~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~ 330 (553)
+...+|+++++||+|+||.||+|++..++.. .+||+|.+.... .....+.+.+|+.+|+++. ||||+++++++..
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~ 88 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVD-NPHVCRLLGICLT 88 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCC-BTTBCCEEEEEES
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEec
Confidence 4567899999999999999999987665543 236888775432 2233478999999999995 5999999998864
Q ss_pred CCCceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCC
Q psy14267 331 TASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIG 410 (553)
Q Consensus 331 ~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~ 410 (553)
....++++++.+++|.+++..... ......++.++.||+.||+|||++|||||||||+||||+.+
T Consensus 89 --~~~~~v~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~--------- 153 (327)
T 3poz_A 89 --STVQLITQLMPFGCLLDYVREHKD----NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP--------- 153 (327)
T ss_dssp --SSEEEEEECCTTCBHHHHHHHSTT----SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEET---------
T ss_pred --CCeEEEEEecCCCcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCC---------
Confidence 344555566788999999987543 23455667777899999999999999999999999999876
Q ss_pred CeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCCC
Q psy14267 411 NVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHIP 489 (553)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~~ 489 (553)
+.+||+|||+|+...............||+.|+|||++.+. .++.++|||||||++|||++ |..||....
T Consensus 154 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~---------~~~~~~Di~slG~il~ellt~g~~p~~~~~ 224 (327)
T 3poz_A 154 QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR---------IYTHQSDVWSYGVTVWELMTFGSKPYDGIP 224 (327)
T ss_dssp TEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHC---------CCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred CCEEEccCcceeEccCCcccccccCCCccccccChHHhccC---------CCCchhhhhhhHHHHHHHHhcCCCCccCCC
Confidence 67999999999887655443333345678899999999865 37899999999999999999 999998765
Q ss_pred chHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 490 NTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 490 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
... +......... ......++.++.++|.+||+.||++||++.+++++|+..
T Consensus 225 ~~~--~~~~~~~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 225 ASE--ISSILEKGER------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp GGG--HHHHHHTTCC------CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred HHH--HHHHHHcCCC------CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 432 1222221211 122335789999999999999999999999999999763
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=350.95 Aligned_cols=257 Identities=26% Similarity=0.455 Sum_probs=200.2
Q ss_pred cCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCC
Q psy14267 254 NGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTAS 333 (553)
Q Consensus 254 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~ 333 (553)
..++|++++.||+|+||.||+|.+..++.. ||||+++... .+.+.+|+.+|+++.+||||+.+++++.+...
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~ 105 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEK--VVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVS 105 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCE--EEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcE--EEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCC
Confidence 457899999999999999999988777654 9999997432 36788999999999888999999999877667
Q ss_pred ceEEEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCe
Q psy14267 334 KHLYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNV 412 (553)
Q Consensus 334 ~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~ 412 (553)
...+++||++. ++|.+++.. .....+..++.||+.||+|||++||+||||||+||||+.+. ..
T Consensus 106 ~~~~lv~e~~~~~~l~~~~~~--------~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~--------~~ 169 (330)
T 3nsz_A 106 RTPALVFEHVNNTDFKQLYQT--------LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH--------RK 169 (330)
T ss_dssp CCEEEEEECCCCCCHHHHGGG--------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTT--------TE
T ss_pred CceEEEEeccCchhHHHHHHh--------CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCC--------CE
Confidence 78899999764 677777643 33455666778999999999999999999999999997652 47
Q ss_pred EEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchH
Q psy14267 413 LKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTW 492 (553)
Q Consensus 413 vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~ 492 (553)
+||+|||+++....... .....||+.|+|||++.+.. .++.++|||||||++|||++|..||.......
T Consensus 170 ~kl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~--------~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~ 238 (330)
T 3nsz_A 170 LRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQ--------MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY 238 (330)
T ss_dssp EEECCCTTCEECCTTCC---CCSCCSCGGGCCHHHHTTCC--------CCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH
T ss_pred EEEEeCCCceEcCCCCc---cccccccccccChhhhcCCC--------cCCchhhHHHHHHHHHHHHhCCCCcccCCchH
Confidence 99999999987755433 23567999999999997532 37899999999999999999999996644443
Q ss_pred HHHHHHHhhccc-----------ccccc------------------cccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q psy14267 493 AKMLAIARHKDQ-----------IEFKP------------------QLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSV 543 (553)
Q Consensus 493 ~~~~~i~~~~~~-----------~~~~~------------------~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell 543 (553)
..+..+...... ....+ .......+++++.+||.+||+.||++|||++|++
T Consensus 239 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l 318 (330)
T 3nsz_A 239 DQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 318 (330)
T ss_dssp HHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred HHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHh
Confidence 333322221110 00000 0011113789999999999999999999999999
Q ss_pred HH
Q psy14267 544 TQ 545 (553)
Q Consensus 544 ~~ 545 (553)
+|
T Consensus 319 ~h 320 (330)
T 3nsz_A 319 EH 320 (330)
T ss_dssp TS
T ss_pred cC
Confidence 75
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=348.55 Aligned_cols=269 Identities=20% Similarity=0.336 Sum_probs=211.6
Q ss_pred eEEecCcceEEEeeeeeeCceEEEEEeeeCC---CccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeee
Q psy14267 250 VITLNGKQYQVLSLLGKGGSSSVYLVGGTSE---HEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHD 326 (553)
Q Consensus 250 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~---~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~ 326 (553)
.+++..++|++.+.||+|+||.||+|.+... ...+.||||++.... .....+.+.+|+++|+++. ||||+++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~ 93 (314)
T 2ivs_A 17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVN-HPHVIKLYG 93 (314)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCC-CTTBCCEEE
T ss_pred ccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCC-CCceeeEEE
Confidence 3455678999999999999999999987432 223569999997543 3345578999999999994 699999998
Q ss_pred EEEeCCCceEEEEEecC-CCCHHHHHHHcccC-------------------CCCchHHHHHHHHHHHHHHHHHHHhhCCc
Q psy14267 327 YVYDTASKHLYVLMEKG-DTDLSKYMRNLNKM-------------------TTLPNTMIIIIMHWYEMLLAVKEIHAAGI 386 (553)
Q Consensus 327 ~~~~~~~~~~~iv~e~~-~~~L~~~l~~~~~~-------------------~~~~~~~~~i~~~~~qil~aL~yLH~~gI 386 (553)
++ .....++++||++ +++|.+++...... .........++.++.||+.||+|||++||
T Consensus 94 ~~--~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i 171 (314)
T 2ivs_A 94 AC--SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKL 171 (314)
T ss_dssp EE--CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred EE--ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCC
Confidence 77 4456788999976 58999999875431 11235566777888899999999999999
Q ss_pred EecCCCCCCEEEecCccceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccc
Q psy14267 387 IHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKS 466 (553)
Q Consensus 387 iHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~s 466 (553)
+||||||+||||+.+ +.+||+|||+++...............+|+.|+|||++.+. .++.++
T Consensus 172 vH~dikp~NIli~~~---------~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~ 233 (314)
T 2ivs_A 172 VHRDLAARNILVAEG---------RKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH---------IYTTQS 233 (314)
T ss_dssp ECCCCSGGGEEEETT---------TEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHC---------EECHHH
T ss_pred cccccchheEEEcCC---------CCEEEccccccccccccccceeccCCCCcccccChhhhcCC---------CcCchh
Confidence 999999999999876 67999999999877655443334455688999999999765 378999
Q ss_pred hHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 467 DVWSLGCILYNMIY-GRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 467 DIwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
|||||||++|||++ |..||....... ....+.. ... ......+++.+.++|.+||+.||++||++.+++++
T Consensus 234 Di~slG~il~el~t~g~~p~~~~~~~~-~~~~~~~-~~~------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 234 DVWSFGVLLWEIVTLGGNPYPGIPPER-LFNLLKT-GHR------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp HHHHHHHHHHHHHTTSCCSSTTCCGGG-HHHHHHT-TCC------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHhhc-CCc------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999 999998765431 2222221 111 12223688999999999999999999999999999
Q ss_pred HhcC
Q psy14267 546 INNN 549 (553)
Q Consensus 546 L~~~ 549 (553)
|+++
T Consensus 306 l~~~ 309 (314)
T 2ivs_A 306 LEKM 309 (314)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9875
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=339.73 Aligned_cols=259 Identities=22% Similarity=0.365 Sum_probs=205.7
Q ss_pred EecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeC
Q psy14267 252 TLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDT 331 (553)
Q Consensus 252 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~ 331 (553)
++..++|++++.||+|+||.||++++... ..||||++....... +.+.+|+++++++. ||||+++++++ .
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~vavK~~~~~~~~~----~~~~~E~~~l~~l~-h~~i~~~~~~~--~ 73 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWKGQ---YDVAVKMIKEGSMSE----DEFFQEAQTMMKLS-HPKLVKFYGVC--S 73 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTT---EEEEEEEECBTTBCH----HHHHHHHHHHHHCC-CTTBCCEEEEE--C
T ss_pred EechhheeeeeeeccCCCceEEEEEecCc---eeEEEEEeccCCCcH----HHHHHHHHHHHhCC-CCCEeeEEEEE--c
Confidence 45667899999999999999999976532 349999997665332 56889999999996 59999999877 4
Q ss_pred CCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCC
Q psy14267 332 ASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIG 410 (553)
Q Consensus 332 ~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~ 410 (553)
....++++||++ +++|.+++..... ......++.++.|++.||+|||++||+||||||+|||++.+
T Consensus 74 ~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~--------- 140 (268)
T 3sxs_A 74 KEYPIYIVTEYISNGCLLNYLRSHGK----GLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRD--------- 140 (268)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTT---------
T ss_pred cCCceEEEEEccCCCcHHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCC---------
Confidence 566789999986 6789999987543 23456667778899999999999999999999999999776
Q ss_pred CeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCCC
Q psy14267 411 NVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHIP 489 (553)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~~ 489 (553)
+.+||+|||++......... ......+|+.|+|||++.+. .++.++||||||+++|||++ |..||....
T Consensus 141 ~~~~l~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 210 (268)
T 3sxs_A 141 LCVKVSDFGMTRYVLDDQYV-SSVGTKFPVKWSAPEVFHYF---------KYSSKSDVWAFGILMWEVFSLGKMPYDLYT 210 (268)
T ss_dssp CCEEECCTTCEEECCTTCEE-ECCSCCCCGGGCCHHHHHHS---------EEETTHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred CCEEEccCccceecchhhhh-cccCCCcCcccCCHHHHhcc---------CCchhhhhHHHHHHHHHHHcCCCCCccccC
Confidence 57999999999877654332 22244577889999999765 36789999999999999998 999998765
Q ss_pred chHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q psy14267 490 NTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNPE 551 (553)
Q Consensus 490 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~~ 551 (553)
.. .....+.... . ......+++.+.++|..||+.||++|||+.+++++|+.+.+
T Consensus 211 ~~-~~~~~~~~~~-~------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 211 NS-EVVLKVSQGH-R------LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp HH-HHHHHHHTTC-C------CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred hH-HHHHHHHcCC-C------CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 43 2222222211 1 11123568999999999999999999999999999998765
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=349.51 Aligned_cols=258 Identities=24% Similarity=0.391 Sum_probs=195.6
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCch-----------------------hHHHHHHHHHHH
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQ-----------------------SIADSYLNEVEL 311 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~-----------------------~~~~~~~~E~~i 311 (553)
.++|++.+.||+|+||.||+|++..++.. ||||++.+...... ...+.+.+|+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~--vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTY--YAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEE--EEEEEEECC-------------------------------CHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcE--EEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 35899999999999999999988776654 99999987653221 123568999999
Q ss_pred HHhhcCCCceeEeeeEEEeCCCceEEEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecC
Q psy14267 312 LAKLQGCPYVIKMHDYVYDTASKHLYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSD 390 (553)
Q Consensus 312 L~~l~~hp~Iv~l~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrD 390 (553)
|+++. ||||+++++++.+.....++++||++. ++|.+++. ........+..++.||+.||+|||++||+|||
T Consensus 90 l~~l~-h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~D 162 (298)
T 2zv2_A 90 LKKLD-HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT------LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRD 162 (298)
T ss_dssp HHTCC-CTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC------SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred HHhCC-CCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccC
Confidence 99995 699999999887766788999999875 56654322 12345666777788999999999999999999
Q ss_pred CCCCCEEEecCccceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHH
Q psy14267 391 LKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWS 470 (553)
Q Consensus 391 LKp~NILl~~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwS 470 (553)
|||+||||+.+ +.+||+|||+++........ .....||+.|+|||++.+... ..++.++||||
T Consensus 163 lkp~Nil~~~~---------~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~------~~~~~~~Di~s 225 (298)
T 2zv2_A 163 IKPSNLLVGED---------GHIKIADFGVSNEFKGSDAL--LSNTVGTPAFMAPESLSETRK------IFSGKALDVWA 225 (298)
T ss_dssp CCGGGEEECTT---------SCEEECCCTTCEECSSSSCE--ECCCCSCGGGCCGGGCCTTCC------CEESHHHHHHH
T ss_pred CCHHHEEECCC---------CCEEEecCCCcccccccccc--ccCCcCCccccChhhhccCCC------CCCCchhhhHh
Confidence 99999999776 57999999999877654322 235679999999999975531 01467899999
Q ss_pred HHHHHHHHHhCCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 471 LGCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 471 lGvvl~elltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
|||++|||++|..||...... .....+..... . ......+++++.++|.+||+.||++|||+.|+++|
T Consensus 226 lG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~--~----~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 226 MGVTLYCFVFGQCPFMDERIM-CLHSKIKSQAL--E----FPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp HHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCCC--C----CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred HHHHHHHHHHCCCCCCCccHH-HHHHHHhcccC--C----CCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 999999999999999875432 22222222111 1 12234688999999999999999999999999864
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=348.64 Aligned_cols=272 Identities=23% Similarity=0.335 Sum_probs=213.6
Q ss_pred eEEecCcceEEEeeeeeeCceEEEEEeeeC---CCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeee
Q psy14267 250 VITLNGKQYQVLSLLGKGGSSSVYLVGGTS---EHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHD 326 (553)
Q Consensus 250 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~---~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~ 326 (553)
.+.+..++|++.+.||+|+||.||+|++.. ....+.||||++.... .....+.+.+|+.+|+++.+||||+++++
T Consensus 21 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 21 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence 455667899999999999999999998643 2334669999997653 23345788999999999988899999999
Q ss_pred EEEeCCCceEEEEEecCC-CCHHHHHHHcccCC-----------CCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCC
Q psy14267 327 YVYDTASKHLYVLMEKGD-TDLSKYMRNLNKMT-----------TLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPA 394 (553)
Q Consensus 327 ~~~~~~~~~~~iv~e~~~-~~L~~~l~~~~~~~-----------~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~ 394 (553)
++... +..++++||++. ++|.+++....... ........++.++.||+.||+|||++||+||||||+
T Consensus 99 ~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~ 177 (316)
T 2xir_A 99 ACTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 177 (316)
T ss_dssp EECCT-TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEecC-CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccc
Confidence 77543 456788888764 69999998754311 112566777788889999999999999999999999
Q ss_pred CEEEecCccceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHH
Q psy14267 395 NFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCI 474 (553)
Q Consensus 395 NILl~~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvv 474 (553)
||||+.+ +.+||+|||+++...............||+.|+|||++.+. .++.++|||||||+
T Consensus 178 Nil~~~~---------~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~---------~~~~~~Di~slG~i 239 (316)
T 2xir_A 178 NILLSEK---------NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR---------VYTIQSDVWSFGVL 239 (316)
T ss_dssp GEEECGG---------GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC---------CCCHHHHHHHHHHH
T ss_pred eEEECCC---------CCEEECCCccccccccCccceeccCCCcceeecCchhhccc---------cccchhHHHHHHHH
Confidence 9999766 57999999999877654443334456689999999999765 37899999999999
Q ss_pred HHHHHh-CCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 475 LYNMIY-GRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 475 l~ellt-G~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
+|||++ |..||............+.... .. .....+++.+.++|.+||+.||++|||+.+++++|+++
T Consensus 240 l~~l~t~g~~p~~~~~~~~~~~~~~~~~~-~~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 240 LWEIFSLGASPYPGVKIDEEFCRRLKEGT-RM------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp HHHHHTTSCCSSTTCCCSHHHHHHHHHTC-CC------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHhCCCCCCcccchhHHHHHHhccCc-cC------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 999998 9999987654433333333221 11 11235789999999999999999999999999999875
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=358.50 Aligned_cols=262 Identities=22% Similarity=0.315 Sum_probs=202.2
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCc--hhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITD--QSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA 332 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~--~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~ 332 (553)
.++|++.+.||+|+||+||+|.+..++.. ||||++.+..... ....+.+.+|+.+|+++. ||||+++++++..
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~--vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~-- 97 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQ--FAVKIVDVAKFTSSPGLSTEDLKREASICHMLK-HPHIVELLETYSS-- 97 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCE--EEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCC-CTTBCCEEEEEEE--
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCE--EEEEEEEhhhccccccchHHHHHHHHHHHHhCC-CCCCCcEEEEEEe--
Confidence 35799999999999999999988777654 9999997543211 112467899999999995 6999999998754
Q ss_pred CceEEEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCC
Q psy14267 333 SKHLYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGN 411 (553)
Q Consensus 333 ~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~ 411 (553)
...+|++||++. ++|.+++...... ........+..++.||+.||+|||++|||||||||+||||+.+. ...
T Consensus 98 ~~~~~lv~e~~~g~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~------~~~ 170 (351)
T 3c0i_A 98 DGMLYMVFEFMDGADLCFEIVKRADA-GFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKE------NSA 170 (351)
T ss_dssp TTEEEEEEECCSSCBHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSS------TTC
T ss_pred CCEEEEEEeCCCCCCHHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCC------CCC
Confidence 568899999865 7898877654321 11234556667778999999999999999999999999997652 224
Q ss_pred eEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCch
Q psy14267 412 VLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNT 491 (553)
Q Consensus 412 ~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~ 491 (553)
.+||+|||++........ .....+||+.|+|||++.+. .++.++|||||||+||||++|..||.+...
T Consensus 171 ~vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~~ll~g~~pf~~~~~- 238 (351)
T 3c0i_A 171 PVKLGGFGVAIQLGESGL--VAGGRVGTPHFMAPEVVKRE---------PYGKPVDVWGCGVILFILLSGCLPFYGTKE- 238 (351)
T ss_dssp CEEECCCTTCEECCTTSC--BCCCCCSCGGGCCHHHHTTC---------CBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-
T ss_pred cEEEecCcceeEecCCCe--eecCCcCCcCccCHHHHcCC---------CCCchHhhHHHHHHHHHHHHCCCCCCCcHH-
Confidence 599999999988765432 22356799999999999765 378999999999999999999999987422
Q ss_pred HHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 492 WAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 492 ~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
.....+...... +.+ ..+..++.++++||.+||..||++|||+.++++|
T Consensus 239 -~~~~~i~~~~~~--~~~--~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 239 -RLFEGIIKGKYK--MNP--RQWSHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp -HHHHHHHHTCCC--CCH--HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -HHHHHHHcCCCC--CCc--cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 233333322211 111 1223678999999999999999999999999864
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=351.28 Aligned_cols=258 Identities=22% Similarity=0.319 Sum_probs=202.6
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCch---hHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQ---SIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA 332 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~---~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~ 332 (553)
+.|++.+.||+|+||.||+|.+..++.. ||||++.+...... ...+.+.+|+.+|+++. ||||+++++++. .
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~--~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~--~ 85 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQ--YAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEVYE--N 85 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCE--EEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEE--C
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcE--EEEEEEEccccccccchhhHHHHHHHHHHHHhCC-CCCCCcEEEEEE--e
Confidence 5799999999999999999988776654 99999987653321 13467899999999995 699999999874 4
Q ss_pred CceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCC
Q psy14267 333 SKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGN 411 (553)
Q Consensus 333 ~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~ 411 (553)
...++++||++ +++|.+++.... ......++.++.||+.||+|||++||+||||||+||||+.+. ....
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~-----~~~~ 155 (326)
T 2y0a_A 86 KTDVILILELVAGGELFDFLAEKE-----SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRN-----VPKP 155 (326)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTSS-----CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSS-----SSSC
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcC-----CcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCC-----CCCC
Confidence 66789999986 679999986543 345566777788999999999999999999999999997652 1123
Q ss_pred eEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCch
Q psy14267 412 VLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNT 491 (553)
Q Consensus 412 ~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~ 491 (553)
.+||+|||+++....... ....+||+.|+|||++.+. .++.++|||||||++|||++|..||.+....
T Consensus 156 ~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 223 (326)
T 2y0a_A 156 RIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYE---------PLGLEADMWSIGVITYILLSGASPFLGDTKQ 223 (326)
T ss_dssp CEEECCCTTCEECCTTSC---CCCCCSCTTTCCHHHHTTC---------CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH
T ss_pred CEEEEECCCCeECCCCCc---cccccCCcCcCCceeecCC---------CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH
Confidence 699999999988754332 2356799999999999765 3788999999999999999999999875432
Q ss_pred HHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 492 WAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 492 ~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
..+..+..... .+.. .....++..+.+||.+||..||++|||+.+++++
T Consensus 224 -~~~~~~~~~~~--~~~~--~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 224 -ETLANVSAVNY--EFED--EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp -HHHHHHHHTCC--CCCH--HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred -HHHHHHHhcCC--CcCc--cccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 23333332221 1111 1123678999999999999999999999999975
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=366.12 Aligned_cols=265 Identities=25% Similarity=0.348 Sum_probs=196.0
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCC-
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTAS- 333 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~- 333 (553)
.++|++++.||+|+||.||+|.+..++.. ||||++.... ......+++.+|+++|++++ ||||+++++++.....
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~--vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~ 100 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKN--VAIKKVNRMF-EDLIDCKRILREITILNRLK-SDYIIRLYDLIIPDDLL 100 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEE--EEEEEECSTT-TSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSCTT
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcE--EEEEEeCchh-cChHHHHHHHHHHHHHHHcC-CCCcceEEEEEecCCCC
Confidence 46899999999999999999998877654 9999997643 34455688999999999995 6999999988755432
Q ss_pred --ceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCC
Q psy14267 334 --KHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGN 411 (553)
Q Consensus 334 --~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~ 411 (553)
..+|++||+++++|.++++... .+....+..+++||+.||+|||++|||||||||+||||+.+ +
T Consensus 101 ~~~~~~lv~e~~~~~L~~~~~~~~-----~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~---------~ 166 (432)
T 3n9x_A 101 KFDELYIVLEIADSDLKKLFKTPI-----FLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQD---------C 166 (432)
T ss_dssp TCCCEEEEEECCSEEHHHHHHSSC-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT---------C
T ss_pred cCCeEEEEEecCCcCHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCC---------C
Confidence 5789999999999999997643 34556677778899999999999999999999999999776 6
Q ss_pred eEEEEeccCccccCCCCCc--------------------ccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHH
Q psy14267 412 VLKIIDFGIACSLQDDKTS--------------------VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSL 471 (553)
Q Consensus 412 ~vkL~DFGla~~~~~~~~~--------------------~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSl 471 (553)
.+||+|||+|+........ ......+||+.|+|||++.... .++.++|||||
T Consensus 167 ~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~--------~~~~~~DiwSl 238 (432)
T 3n9x_A 167 SVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQE--------NYTKSIDIWST 238 (432)
T ss_dssp CEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCS--------CCCTHHHHHHH
T ss_pred CEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCC--------CCCcccccchH
Confidence 7999999999887543221 1124678999999999975432 47899999999
Q ss_pred HHHHHHHHhCCCCCC-----------CCCc----------------hHHHHHHHHhhcccc-------------------
Q psy14267 472 GCILYNMIYGRTPYS-----------HIPN----------------TWAKMLAIARHKDQI------------------- 505 (553)
Q Consensus 472 Gvvl~elltG~~Pf~-----------~~~~----------------~~~~~~~i~~~~~~~------------------- 505 (553)
||+||||++|..||. +... ....+..+.......
T Consensus 239 G~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 318 (432)
T 3n9x_A 239 GCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKL 318 (432)
T ss_dssp HHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHT
T ss_pred HHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHh
Confidence 999999998544443 2110 011111111100000
Q ss_pred ----cccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 506 ----EFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 506 ----~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
...+.......+++++.+||.+||..||++|||++|+++|
T Consensus 319 ~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 362 (432)
T 3n9x_A 319 FPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDH 362 (432)
T ss_dssp SCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTC
T ss_pred CCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000000113578999999999999999999999999975
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=351.54 Aligned_cols=270 Identities=22% Similarity=0.347 Sum_probs=210.1
Q ss_pred eEEecCcceEEEeeeeeeCceEEEEEeeeCC-----CccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEe
Q psy14267 250 VITLNGKQYQVLSLLGKGGSSSVYLVGGTSE-----HEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKM 324 (553)
Q Consensus 250 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~-----~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l 324 (553)
.|.+..++|++.+.||+|+||.||+|++... .....||||++.... .....+.+.+|+.+|+++..||||+++
T Consensus 29 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~ 106 (334)
T 2pvf_A 29 KWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINL 106 (334)
T ss_dssp TTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeE
Confidence 3456678999999999999999999987532 233569999997553 334467899999999999778999999
Q ss_pred eeEEEeCCCceEEEEEecC-CCCHHHHHHHcccC-----------CCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCC
Q psy14267 325 HDYVYDTASKHLYVLMEKG-DTDLSKYMRNLNKM-----------TTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLK 392 (553)
Q Consensus 325 ~~~~~~~~~~~~~iv~e~~-~~~L~~~l~~~~~~-----------~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLK 392 (553)
++++ .....++++||++ +++|.+++...... .........++.++.||+.||+|||++||+|||||
T Consensus 107 ~~~~--~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlk 184 (334)
T 2pvf_A 107 LGAC--TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLA 184 (334)
T ss_dssp EEEE--CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred EEEE--ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCc
Confidence 9877 4456788999986 56999999875421 11234566677778899999999999999999999
Q ss_pred CCCEEEecCccceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHH
Q psy14267 393 PANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLG 472 (553)
Q Consensus 393 p~NILl~~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlG 472 (553)
|+||||+.+ +.+||+|||+++...............+|+.|+|||++.+. .++.++||||||
T Consensus 185 p~NIll~~~---------~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG 246 (334)
T 2pvf_A 185 ARNVLVTEN---------NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR---------VYTHQSDVWSFG 246 (334)
T ss_dssp GGGEEECTT---------CCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHC---------EECHHHHHHHHH
T ss_pred cceEEEcCC---------CCEEEccccccccccccccccccCCCCcccceeChHHhcCC---------CcChHHHHHHHH
Confidence 999999776 57999999999877654433333345678999999999765 378999999999
Q ss_pred HHHHHHHh-CCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 473 CILYNMIY-GRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 473 vvl~ellt-G~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
|++|||++ |..||.+.... .....+... ... .....++..+.++|.+||..||++||++.+++++|+++
T Consensus 247 ~il~ellt~g~~p~~~~~~~-~~~~~~~~~-~~~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l 316 (334)
T 2pvf_A 247 VLMWEIFTLGGSPYPGIPVE-ELFKLLKEG-HRM------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316 (334)
T ss_dssp HHHHHHHTTSCCSSTTCCHH-HHHHHHHHT-CCC------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHhCCCCCcCcCCHH-HHHHHHhcC-CCC------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 99999999 99999876443 222222221 111 12236789999999999999999999999999999874
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=371.61 Aligned_cols=266 Identities=21% Similarity=0.389 Sum_probs=205.4
Q ss_pred ecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC
Q psy14267 253 LNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA 332 (553)
Q Consensus 253 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~ 332 (553)
+..++|+++++||+|+||+||+|++..++.. ||||++.+...........+.+|+.+|..+ +||||+++++++. .
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~--vAvK~~~~~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~--~ 145 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKV--FAMKILNKWEMLKRAETACFREERDVLVNG-DSKWITTLHYAFQ--D 145 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEE--EEEEEEEHHHHHHTTTTCCHHHHHHHHHHS-CTTTBCCEEEEEE--C
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCcE--EEEEEEEHHHhhhHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEe--e
Confidence 4457899999999999999999988876654 999999764332222234578999999998 5699999988774 4
Q ss_pred CceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCC
Q psy14267 333 SKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGN 411 (553)
Q Consensus 333 ~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~ 411 (553)
...+|++||++ +++|.+++..... .+.+..+..++.||+.||+|||++|||||||||+||||+.+ +
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~~~----~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~---------g 212 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKFED----RLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMN---------G 212 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTTTT----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---------S
T ss_pred CCEEEEEEecCCCCcHHHHHHHccC----CCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCC---------C
Confidence 67899999975 7899999986422 24456677778899999999999999999999999999876 6
Q ss_pred eEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCch
Q psy14267 412 VLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNT 491 (553)
Q Consensus 412 ~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~ 491 (553)
.+||+|||+|+........ .....+||+.|||||++...... ...++.++|||||||+||||++|+.||.+....
T Consensus 213 ~vkL~DFGla~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~----~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~ 287 (437)
T 4aw2_A 213 HIRLADFGSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEGG----KGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 287 (437)
T ss_dssp CEEECCCTTCEECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTS----CCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred CEEEcchhhhhhcccCCCc-ccccccCCcCeeChHHHhhcccC----CCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh
Confidence 7999999999877554332 23356899999999999732100 014789999999999999999999999875432
Q ss_pred HHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q psy14267 492 WAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKA--RPTVGNSVTQ 545 (553)
Q Consensus 492 ~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~--RPt~~ell~~ 545 (553)
.....+........++.. ...+++++++||++||..+|++ ||+++|+++|
T Consensus 288 -~~~~~i~~~~~~~~~p~~---~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 288 -ETYGKIMNHKERFQFPTQ---VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp -HHHHHHHTHHHHCCCCSS---CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred -HHHHhhhhccccccCCcc---cccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 333344332222222221 2358899999999999998888 9999999875
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=355.55 Aligned_cols=268 Identities=22% Similarity=0.306 Sum_probs=201.4
Q ss_pred EecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhc----CCCceeEeeeE
Q psy14267 252 TLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQ----GCPYVIKMHDY 327 (553)
Q Consensus 252 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~----~hp~Iv~l~~~ 327 (553)
.+..++|+++++||+|+||.||+|++..++.. ||||++... ....+.+..|+.+|+++. .||||++++++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~--vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~ 104 (360)
T 3llt_A 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKY--YAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNNIVKYHGK 104 (360)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTCCE--EEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEE
T ss_pred eEecCEEEEEEEEcccCCeEEEEEEECCCCeE--EEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCCeecccce
Confidence 34467899999999999999999988776654 999999643 244567788999999997 47999999998
Q ss_pred EEeCCCceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccc---
Q psy14267 328 VYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLK--- 404 (553)
Q Consensus 328 ~~~~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~--- 404 (553)
+.. ...++++||+++++|.+++...... ......+..++.||+.||+|||++|||||||||+||||+.+...
T Consensus 105 ~~~--~~~~~lv~e~~~~~L~~~~~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~ 179 (360)
T 3llt_A 105 FMY--YDHMCLIFEPLGPSLYEIITRNNYN---GFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSL 179 (360)
T ss_dssp EEE--TTEEEEEECCCCCBHHHHHHHTTTC---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEE
T ss_pred eeE--CCeeEEEEcCCCCCHHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccc
Confidence 765 4678999999999999999875432 24455667777899999999999999999999999999752100
Q ss_pred -------------eecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHH
Q psy14267 405 -------------IIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSL 471 (553)
Q Consensus 405 -------------~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSl 471 (553)
......+.+||+|||+|+...... ....||+.|+|||++.+. .++.++|||||
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~---------~~~~~~Diwsl 245 (360)
T 3llt_A 180 ITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNL---------GWDVSSDMWSF 245 (360)
T ss_dssp EEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTC---------CCCTTHHHHHH
T ss_pred cchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCC---------CCCCccchHHH
Confidence 000123679999999998755432 256799999999999866 37899999999
Q ss_pred HHHHHHHHhCCCCCCCCCchHHHHHHHHhhcccccc--------------------cccccC------------------
Q psy14267 472 GCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEF--------------------KPQLAN------------------ 513 (553)
Q Consensus 472 Gvvl~elltG~~Pf~~~~~~~~~~~~i~~~~~~~~~--------------------~~~~~~------------------ 513 (553)
||++|||++|+.||...... ..+..+......... ...+..
T Consensus 246 G~il~ell~g~~pf~~~~~~-~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 324 (360)
T 3llt_A 246 GCVLAELYTGSLLFRTHEHM-EHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLY 324 (360)
T ss_dssp HHHHHHHHHSSCSCCCSSHH-HHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHH
T ss_pred HHHHHHHHHCCCCCCCCcHH-HHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhccccc
Confidence 99999999999999875432 222222221111000 000000
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 514 NVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 514 ~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
....++.+.+||.+||+.||++|||+.|++++
T Consensus 325 ~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 325 KIIKHELFCDFLYSILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp HHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred ccchHHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00124778899999999999999999999864
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=372.62 Aligned_cols=258 Identities=22% Similarity=0.310 Sum_probs=194.1
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC--
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA-- 332 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~-- 332 (553)
.++|++++.||+|+||+||+|.+..++.. ||||++.+.. ......+++.+|+.+|+++. ||||+++++++....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~--vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~ 136 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPF-QNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKTL 136 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEE--EEEEEEESGG-GSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCCST
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCE--EEEEEECccc-cChHHHHHHHHHHHHHHhCC-CCCCCcEEEEEccCCcc
Confidence 46899999999999999999988877654 9999998653 33455678999999999995 699999999875433
Q ss_pred --CceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCC
Q psy14267 333 --SKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIG 410 (553)
Q Consensus 333 --~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~ 410 (553)
...+|++||+++++|...+... .....+..++.||+.||+|||++|||||||||+||||+.+
T Consensus 137 ~~~~~~~lv~E~~~~~l~~~~~~~-------l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~--------- 200 (464)
T 3ttj_A 137 EEFQDVYLVMELMDANLCQVIQME-------LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD--------- 200 (464)
T ss_dssp TTCCEEEEEEECCSEEHHHHHTSC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---------
T ss_pred ccCCeEEEEEeCCCCCHHHHHhhc-------CCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCC---------
Confidence 2578999999999988877431 3455666778899999999999999999999999999876
Q ss_pred CeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCc
Q psy14267 411 NVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN 490 (553)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~ 490 (553)
+.+||+|||+|+....... ....+||+.|+|||++.+. .|+.++|||||||+||||++|+.||.+...
T Consensus 201 ~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwSlG~il~ell~g~~pF~g~~~ 268 (464)
T 3ttj_A 201 CTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGM---------GYKENVDIWSVGCIMGEMVRHKILFPGRDY 268 (464)
T ss_dssp SCEEECCCCCC-----CCC---C----CCCTTCCHHHHTTC---------CCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CCEEEEEEEeeeecCCCcc---cCCCcccccccCHHHHcCC---------CCCHHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 5799999999987654322 2356899999999999876 378899999999999999999999987544
Q ss_pred hHHHHHHHHhhcccc-------------------------cccccccCC---------CCCCHHHHHHHHHhcccCCCCC
Q psy14267 491 TWAKMLAIARHKDQI-------------------------EFKPQLANN---------VTIPPTLLQSMKLCLQKDPKAR 536 (553)
Q Consensus 491 ~~~~~~~i~~~~~~~-------------------------~~~~~~~~~---------~~~s~~l~~li~~cL~~dP~~R 536 (553)
. ..+..+....... .+....... ...++++++||.+||..||++|
T Consensus 269 ~-~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R 347 (464)
T 3ttj_A 269 I-DQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 347 (464)
T ss_dssp H-HHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTS
T ss_pred H-HHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhC
Confidence 3 2222222111100 000000000 0014679999999999999999
Q ss_pred CCHHHHHHH
Q psy14267 537 PTVGNSVTQ 545 (553)
Q Consensus 537 Pt~~ell~~ 545 (553)
||++|+++|
T Consensus 348 ~ta~e~L~H 356 (464)
T 3ttj_A 348 ISVDDALQH 356 (464)
T ss_dssp CCHHHHHTS
T ss_pred CCHHHHhcC
Confidence 999999975
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=340.47 Aligned_cols=261 Identities=21% Similarity=0.356 Sum_probs=204.9
Q ss_pred eEEecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEE
Q psy14267 250 VITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVY 329 (553)
Q Consensus 250 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~ 329 (553)
.|.+..++|++++.||+|+||.||++.+... +.||||++....... +.+.+|+++|+++. ||||+++++++
T Consensus 4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~vavK~~~~~~~~~----~~~~~E~~~l~~l~-h~~i~~~~~~~- 74 (269)
T 4hcu_A 4 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNK---DKVAIKTIREGAMSE----EDFIEEAEVMMKLS-HPKLVQLYGVC- 74 (269)
T ss_dssp -CBCCGGGEEEEEEEEECSSCEEEEEEETTT---EEEEEEEECTTSBCH----HHHHHHHHHHHTCC-CTTBCCEEEEE-
T ss_pred cEEeChhhceeeheecCCCccEEEEEEecCC---CeEEEEEecccccCH----HHHHHHHHHHHhCC-CCCEeeEEEEE-
Confidence 3556778999999999999999999987642 349999998665332 56889999999996 59999999877
Q ss_pred eCCCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecC
Q psy14267 330 DTASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDC 408 (553)
Q Consensus 330 ~~~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~ 408 (553)
.....++++||++ +++|.+++..... ......++.++.|++.||+|||++||+||||||+|||++.+
T Consensus 75 -~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~------- 142 (269)
T 4hcu_A 75 -LEQAPICLVFEFMEHGCLSDYLRTQRG----LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN------- 142 (269)
T ss_dssp -CSSSSEEEEEECCTTCBHHHHHHTTTT----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGG-------
T ss_pred -ecCCceEEEEEeCCCCcHHHHHHhcCc----ccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCC-------
Confidence 4456789999976 5689999876432 24455667777899999999999999999999999999766
Q ss_pred CCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCC
Q psy14267 409 IGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSH 487 (553)
Q Consensus 409 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~ 487 (553)
+.+||+|||++......... ......||+.|+|||++.+. .++.++||||||+++|||++ |..||..
T Consensus 143 --~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~~l~~ll~~g~~p~~~ 210 (269)
T 4hcu_A 143 --QVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFS---------RYSSKSDVWSFGVLMWEVFSEGKIPYEN 210 (269)
T ss_dssp --GCEEECCTTGGGGBCCHHHH-STTSTTCCGGGCCHHHHHHC---------CCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred --CCEEeccccccccccccccc-cccCcccccccCCHHHhcCC---------CCCchhhhHHHHHHHHHHhcCCCCCCCC
Confidence 57999999999876543221 12244578899999999765 37899999999999999999 9999987
Q ss_pred CCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q psy14267 488 IPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNPE 551 (553)
Q Consensus 488 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~~ 551 (553)
.... .....+... .. ......+++.+.++|.+||+.||++||++.+++++|+++.+
T Consensus 211 ~~~~-~~~~~~~~~-~~------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 211 RSNS-EVVEDISTG-FR------LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp CCHH-HHHHHHHTT-CC------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCHH-HHHHHHhcC-cc------CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 5543 222222221 11 11223568999999999999999999999999999987643
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=352.38 Aligned_cols=254 Identities=20% Similarity=0.263 Sum_probs=201.5
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
.++|++++.||+|+||.||+|.+..++.. ||+|++.... .....+.+|+.+|+++. ||||+++++++.+ ..
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~--~a~K~~~~~~----~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~--~~ 74 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKT--YMAKFVKVKG----TDQVLVKKEISILNIAR-HRNILHLHESFES--ME 74 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEE--EEEEEECCCT----HHHHHHHHHHHHHHHSC-CTTBCCEEEEEEE--TT
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcE--EEEEEEecCc----ccHHHHHHHHHHHHhCC-CCCCCeEeEEEec--CC
Confidence 35899999999999999999988776654 9999997543 33467889999999995 6999999998754 56
Q ss_pred eEEEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 335 HLYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 335 ~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
.++++||++. ++|.+++..... ......++.++.||+.||+|||++||+||||||+|||++.+. .+.+
T Consensus 75 ~~~lv~e~~~g~~L~~~l~~~~~----~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~-------~~~~ 143 (321)
T 1tki_A 75 ELVMIFEFISGLDIFERINTSAF----ELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRR-------SSTI 143 (321)
T ss_dssp EEEEEECCCCCCBHHHHHTSSSC----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSS-------CCCE
T ss_pred EEEEEEEeCCCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCC-------CCCE
Confidence 7899999864 689998865321 344566777788999999999999999999999999997631 2679
Q ss_pred EEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHH
Q psy14267 414 KIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWA 493 (553)
Q Consensus 414 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~ 493 (553)
||+|||+++.+..... .....||+.|+|||++.+. .++.++|||||||++|||++|..||...... .
T Consensus 144 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~ 210 (321)
T 1tki_A 144 KIIEFGQARQLKPGDN---FRLLFTAPEYYAPEVHQHD---------VVSTATDMWSLGTLVYVLLSGINPFLAETNQ-Q 210 (321)
T ss_dssp EECCCTTCEECCTTCE---EEEEESCGGGSCHHHHTTC---------EECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-H
T ss_pred EEEECCCCeECCCCCc---cccccCChhhcCcHHhcCC---------CCCchhhHHHHHHHHHHHHhCCCCCcCCCHH-H
Confidence 9999999988765432 2245799999999999765 3688999999999999999999999875443 3
Q ss_pred HHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 494 KMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 494 ~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
.+..+...... +. ...+..++.++.+||.+||..||++|||+.|++++
T Consensus 211 ~~~~i~~~~~~--~~--~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 211 IIENIMNAEYT--FD--EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHHHHHHTCCC--CC--HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHcCCCC--CC--hhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 33333332221 11 11223678999999999999999999999999985
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=350.55 Aligned_cols=270 Identities=19% Similarity=0.300 Sum_probs=190.7
Q ss_pred EecCcceEEEeeeeeeCceEEEEEeeeCCCc-cceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEe
Q psy14267 252 TLNGKQYQVLSLLGKGGSSSVYLVGGTSEHE-FKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYD 330 (553)
Q Consensus 252 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~-~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~ 330 (553)
.+..++|++++.||+|+||.||+|++...+. ...||||+++...... ...+++.+|+++++++ +||||+++++++..
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS-SDIEEFLREAACMKEF-DHPHVAKLVGVSLR 96 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C-HHHHHHHHHHHHHTTC-CCTTBCCCCEEEEC
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH-HHHHHHHHHHHHHHHC-CCCceehhhceeec
Confidence 3456789999999999999999998766543 1259999997765443 3457899999999999 56999999998865
Q ss_pred CCCc----eEEEEEecC-CCCHHHHHHHcccC-CCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccc
Q psy14267 331 TASK----HLYVLMEKG-DTDLSKYMRNLNKM-TTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLK 404 (553)
Q Consensus 331 ~~~~----~~~iv~e~~-~~~L~~~l~~~~~~-~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~ 404 (553)
.... ..+++||++ +++|.+++...... .........++.++.||+.||+|||++||+||||||+||||+.+
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~--- 173 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAED--- 173 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT---
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCC---
Confidence 4332 347888865 56999998765422 22235566677788899999999999999999999999999776
Q ss_pred eecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCC
Q psy14267 405 IIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRT 483 (553)
Q Consensus 405 ~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~ 483 (553)
+.+||+|||+++...............+++.|+|||++.+. .++.++|||||||++|||++ |..
T Consensus 174 ------~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~ell~~g~~ 238 (323)
T 3qup_A 174 ------MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADN---------LYTVHSDVWAFGVTMWEIMTRGQT 238 (323)
T ss_dssp ------SCEEECCCCC-----------------CCGGGCCHHHHHHC---------CCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred ------CCEEEeeccccccccccccccccccccCcccccCchhhcCC---------CCCCccchhhHHHHHHHHHhCCCC
Confidence 57999999999877554433223344578899999999765 37899999999999999999 999
Q ss_pred CCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 484 PYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 484 Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
||....... ....+.... . ......++.++.++|.+||..||++|||+.++++.|+++
T Consensus 239 p~~~~~~~~-~~~~~~~~~-~------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 296 (323)
T 3qup_A 239 PYAGIENAE-IYNYLIGGN-R------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296 (323)
T ss_dssp TTTTCCGGG-HHHHHHTTC-C------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CccccChHH-HHHHHhcCC-C------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 998765532 222222211 1 122336789999999999999999999999999999874
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=351.03 Aligned_cols=270 Identities=20% Similarity=0.308 Sum_probs=210.4
Q ss_pred EEecCcceEEEeeeeeeCceEEEEEeeeCCCc---cceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeE
Q psy14267 251 ITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHE---FKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDY 327 (553)
Q Consensus 251 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~---~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~ 327 (553)
+++..++|++.+.||+|+||.||+|.+...+. .+.||+|++.... .....+.+.+|+.+|+++.+||||++++++
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 118 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGA 118 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 45667899999999999999999998765443 2469999997653 233457899999999999767999999987
Q ss_pred EEeCCCceEEEEEecC-CCCHHHHHHHcccC---------CCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEE
Q psy14267 328 VYDTASKHLYVLMEKG-DTDLSKYMRNLNKM---------TTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFL 397 (553)
Q Consensus 328 ~~~~~~~~~~iv~e~~-~~~L~~~l~~~~~~---------~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NIL 397 (553)
+ .....++++||++ +++|.+++...... .........++.++.||+.||+|||++||+||||||+|||
T Consensus 119 ~--~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl 196 (333)
T 2i1m_A 119 C--THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVL 196 (333)
T ss_dssp E--CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCE
T ss_pred E--ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEE
Confidence 7 4456788999986 56999999865321 0123455667777889999999999999999999999999
Q ss_pred EecCccceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHH
Q psy14267 398 FVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYN 477 (553)
Q Consensus 398 l~~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~e 477 (553)
|+.+ +.+||+|||++................||+.|+|||++.+. .++.++|||||||++||
T Consensus 197 ~~~~---------~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~e 258 (333)
T 2i1m_A 197 LTNG---------HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDC---------VYTVQSDVWSYGILLWE 258 (333)
T ss_dssp EEGG---------GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHC---------CCCHHHHHHHHHHHHHH
T ss_pred ECCC---------CeEEECccccccccccccceeecCCCCCCccccCHHHhccC---------CCChHHHHHHHHHHHHH
Confidence 9876 57999999999876554433333455678899999999765 37899999999999999
Q ss_pred HHh-CCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 478 MIY-GRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 478 llt-G~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
|++ |..||............+. ..... .....++..+.++|.+||+.||++|||+.+++++|++.
T Consensus 259 l~t~g~~p~~~~~~~~~~~~~~~-~~~~~------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 259 IFSLGLNPYPGILVNSKFYKLVK-DGYQM------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp HTTTSCCSSTTCCSSHHHHHHHH-HTCCC------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHcCCCCCCcccchhHHHHHHHh-cCCCC------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 998 9999987554322222222 22111 11235689999999999999999999999999999864
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=347.86 Aligned_cols=269 Identities=24% Similarity=0.383 Sum_probs=193.6
Q ss_pred cceEEecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeE
Q psy14267 248 QDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDY 327 (553)
Q Consensus 248 ~~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~ 327 (553)
...+++...+|++.++||+|+||.||+|++..++.. ||||++.... ....+.+.+|+.+|+++.+||||++++++
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vavK~~~~~~---~~~~~~~~~e~~~l~~l~~h~~iv~~~~~ 94 (337)
T 3ll6_A 20 GQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGRE--YALKRLLSNE---EEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94 (337)
T ss_dssp TCEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCE--EEEEEEEESS---HHHHHHHHHHHHHHHHHTTSTTBCCEEEE
T ss_pred cceeeccCceEEEEEEEccCCceEEEEEEECCCCcE--EEEEEecCCc---hHHHHHHHHHHHHHHHhccCCChhhcccc
Confidence 456678888999999999999999999988766644 9999986543 34457789999999999878999999988
Q ss_pred EEe------CCCceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCC--cEecCCCCCCEEEe
Q psy14267 328 VYD------TASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAG--IIHSDLKPANFLFV 399 (553)
Q Consensus 328 ~~~------~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~g--IiHrDLKp~NILl~ 399 (553)
+.. .....++++||+++++|.+++....... ......++.++.||+.||+|||++| |+||||||+||||+
T Consensus 95 ~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~ 172 (337)
T 3ll6_A 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRG--PLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS 172 (337)
T ss_dssp EEECTTTSTTSSEEEEEEEECCSEEHHHHHHHHHTTC--SCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEEC
T ss_pred ccccccccccCCceEEEEEEecCCCHHHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEEC
Confidence 753 3455789999999999999998744332 3445666777889999999999999 99999999999998
Q ss_pred cCccceecCCCCeEEEEeccCccccCCCCCcc----------cccCCccCCCccCcccccccCCCCCCCccCCCccchHH
Q psy14267 400 GNVLKIIDCIGNVLKIIDFGIACSLQDDKTSV----------HKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVW 469 (553)
Q Consensus 400 ~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~----------~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIw 469 (553)
.+ +.+||+|||+++......... ......||+.|+|||++.... ...++.++|||
T Consensus 173 ~~---------~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~------~~~~~~~~Dv~ 237 (337)
T 3ll6_A 173 NQ---------GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYS------NFPIGEKQDIW 237 (337)
T ss_dssp TT---------SCEEBCCCTTCBCCSSCC-------------------------------CCT------TSCSSHHHHHH
T ss_pred CC---------CCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccc------cCCCChHHhHH
Confidence 76 579999999998775433211 112456999999999984221 11478999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 470 SLGCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 470 SlGvvl~elltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
||||++|||++|..||...... .+..... .......++..+.+||.+||+.||++|||+.|++++|+.+
T Consensus 238 slG~il~el~~g~~p~~~~~~~-----~~~~~~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~ 306 (337)
T 3ll6_A 238 ALGCILYLLCFRQHPFEDGAKL-----RIVNGKY------SIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEI 306 (337)
T ss_dssp HHHHHHHHHHHSSCCC-----------------C------CCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCcchhHH-----HhhcCcc------cCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 9999999999999999763221 1111111 1122235678899999999999999999999999999864
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=366.73 Aligned_cols=267 Identities=23% Similarity=0.387 Sum_probs=204.1
Q ss_pred ecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC
Q psy14267 253 LNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA 332 (553)
Q Consensus 253 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~ 332 (553)
+..++|+++++||+|+||+||+|+++.++.. ||||++.+.........+.+.+|+.+|.++ +||||+++++++. .
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~--vAiK~l~k~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~--~ 132 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQV--YAMKIMNKWDMLKRGEVSCFREERDVLVNG-DRRWITQLHFAFQ--D 132 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCE--EEEEEEEHHHHHHHGGGCCHHHHHHHHHHS-CTTTBCCEEEEEE--C
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECCCCCE--EEEEEEeHHHhhhHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEe--e
Confidence 4457899999999999999999988776654 999999865433333345688999999998 5699999988774 4
Q ss_pred CceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCC
Q psy14267 333 SKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGN 411 (553)
Q Consensus 333 ~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~ 411 (553)
...+|++||++ +++|.+++.+... ......+..++.||+.||+|||++|||||||||+||||+.+ +
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~---------g 199 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKFGE----RIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRC---------G 199 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHSS----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---------S
T ss_pred CCEEEEEEcCCCCCcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCC---------C
Confidence 67899999986 7899999987542 23455666777899999999999999999999999999876 6
Q ss_pred eEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCch
Q psy14267 412 VLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNT 491 (553)
Q Consensus 412 ~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~ 491 (553)
.+||+|||+|+....... ......+||+.|+|||++....... ....++.++|||||||+||||++|+.||......
T Consensus 200 ~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~--~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~ 276 (412)
T 2vd5_A 200 HIRLADFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGP--GTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA 276 (412)
T ss_dssp CEEECCCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCT--TCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred CEEEeechhheeccCCCc-cccceeccccCcCCHHHHhhcccCc--CCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH
Confidence 799999999988765432 1233568999999999997432110 0114789999999999999999999999875433
Q ss_pred HHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCC---CCHHHHHHH
Q psy14267 492 WAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKAR---PTVGNSVTQ 545 (553)
Q Consensus 492 ~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~R---Pt~~ell~~ 545 (553)
.....+........++. ....+++++++||++||. +|++| |+++||++|
T Consensus 277 -~~~~~i~~~~~~~~~p~---~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 277 -ETYGKIVHYKEHLSLPL---VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp -HHHHHHHTHHHHCCCC-------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred -HHHHHHHhcccCcCCCc---cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 33333333222222211 123688999999999999 99998 589998765
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=353.80 Aligned_cols=265 Identities=24% Similarity=0.357 Sum_probs=193.8
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
.++|++++.||+|+||+||+|.+..++.. ||||++...... ....+.+.+|+.+|+++. ||||+++++++.. ..
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~--~~ 106 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNET--VAIKRIRLEHEE-EGVPGTAIREVSLLKELQ-HRNIIELKSVIHH--NH 106 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEE--EEEEECCCCC---------CHHHHHHGGGCC-CTTBCCEEEEEEE--TT
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCce--EEEEEEcccccc-cccchhHHHHHHHHHHcC-CCCcceEEEEEec--CC
Confidence 35899999999999999999988777654 999999766533 234467889999999995 6999999998754 56
Q ss_pred eEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 335 HLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 335 ~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
.++++||+++++|.+++..... .....++.++.||+.||+|||++|||||||||+||||+.+. ....+.+|
T Consensus 107 ~~~lv~e~~~~~L~~~~~~~~~-----~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~----~~~~~~~k 177 (329)
T 3gbz_A 107 RLHLIFEYAENDLKKYMDKNPD-----VSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSD----ASETPVLK 177 (329)
T ss_dssp EEEEEEECCSEEHHHHHHHCTT-----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC---------CCEEE
T ss_pred EEEEEEecCCCCHHHHHhhcCC-----CCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCC----CCccceEE
Confidence 8899999999999999987643 34566777788999999999999999999999999996542 12235799
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||+++........ .....||+.|+|||++.+.. .++.++|||||||++|||++|..||...... ..
T Consensus 178 l~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~--------~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~ 246 (329)
T 3gbz_A 178 IGDFGLARAFGIPIRQ--FTHEIITLWYRPPEILLGSR--------HYSTSVDIWSIACIWAEMLMKTPLFPGDSEI-DQ 246 (329)
T ss_dssp ECCTTHHHHHC-------------CCTTCCHHHHTTCC--------CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HH
T ss_pred ECcCCCccccCCcccc--cCCCcCCccccCHHHhcCCC--------CCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH-HH
Confidence 9999999877543221 23456899999999997643 3789999999999999999999999875543 22
Q ss_pred HHHHHhhccccc---cc-----ccccC--------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 495 MLAIARHKDQIE---FK-----PQLAN--------------NVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 495 ~~~i~~~~~~~~---~~-----~~~~~--------------~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
+..+........ +. +.+.. ...+++++.+||.+||+.||++|||+.|+++|
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 247 LFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp HHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 222222111100 00 00000 01167899999999999999999999999874
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=348.54 Aligned_cols=267 Identities=21% Similarity=0.342 Sum_probs=208.7
Q ss_pred ecCcceEEEeeeeeeCceEEEEEeee--CCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEe
Q psy14267 253 LNGKQYQVLSLLGKGGSSSVYLVGGT--SEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYD 330 (553)
Q Consensus 253 ~~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~ 330 (553)
+..++|++++.||+|+||.||+|+.. .....+.||||++.... ....+.+.+|+++|+++ +||||+.+++++..
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~ 95 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---PDQQRDFQREIQILKAL-HSDFIVKYRGVSYG 95 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC---HHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEC
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC---HHHHHHHHHHHHHHHhc-CCCceeEEEEEEec
Confidence 34578999999999999999999842 22233569999997653 34457789999999999 56999999999887
Q ss_pred CCCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCC
Q psy14267 331 TASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCI 409 (553)
Q Consensus 331 ~~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~ 409 (553)
.....++++||++ +++|.+++..... ......++.++.|++.||+|||++||+||||||+||||+.+
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~-------- 163 (327)
T 3lxl_A 96 PGRQSLRLVMEYLPSGCLRDFLQRHRA----RLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESE-------- 163 (327)
T ss_dssp SSSCEEEEEEECCTTCBHHHHHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET--------
T ss_pred CCCceEEEEEeecCCCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCC--------
Confidence 7788899999987 7899999987433 24456677778899999999999999999999999999876
Q ss_pred CCeEEEEeccCccccCCCCCc-ccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy14267 410 GNVLKIIDFGIACSLQDDKTS-VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHI 488 (553)
Q Consensus 410 ~~~vkL~DFGla~~~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~ 488 (553)
+.+||+|||++......... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||...
T Consensus 164 -~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~~ll~g~~p~~~~ 233 (327)
T 3lxl_A 164 -AHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN---------IFSRQSDVWSFGVVLYELFTYCDKSCSP 233 (327)
T ss_dssp -TEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHC---------EEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred -CCEEEcccccceecccCCccceeeccCCccccccCHHHhccC---------CCChHHhHHHHHHHHHHHHhCCCCCccc
Confidence 67999999999887654332 222345688999999999765 3688999999999999999999999653
Q ss_pred CchH-------------HHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q psy14267 489 PNTW-------------AKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNPE 551 (553)
Q Consensus 489 ~~~~-------------~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~~ 551 (553)
.... ..+........ .......+++.+.++|.+||+.||++|||+.+++++|+.+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 234 SAEFLRMMGCERDVPALSRLLELLEEGQ------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp HHHHHHHCC----CCHHHHHHHHHHTTC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred cchhhhhcccccccccHHHHHHHhhccc------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 2211 11111111111 122234788999999999999999999999999999998654
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=364.26 Aligned_cols=258 Identities=22% Similarity=0.355 Sum_probs=196.9
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeC----
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDT---- 331 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~---- 331 (553)
.+|+++++||+|+||+||+|++..++.. ||||++..... ...+|+++|+++. ||||+++++++...
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~--vaiK~~~~~~~-------~~~~E~~il~~l~-hpniv~l~~~~~~~~~~~ 123 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGEL--VAIKKVLQDKR-------FKNRELQIMRKLD-HCNIVRLRYFFYSSGEKK 123 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCE--EEEEEEECCTT-------SCCHHHHHHHTCC-CTTBCCEEEEEEEEETTT
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcE--EEEEEecccch-------hHHHHHHHHHHcC-CCCccceeeEEeccCCCC
Confidence 4699999999999999999988776654 99999975431 2347999999995 59999999887653
Q ss_pred CCceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCC
Q psy14267 332 ASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGN 411 (553)
Q Consensus 332 ~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~ 411 (553)
...+++++||++.++|..++...... ........+..++.||+.||+|||++|||||||||+||||+.+. +
T Consensus 124 ~~~~~~lv~e~~~~~l~~~~~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~--------~ 194 (420)
T 1j1b_A 124 DEVYLNLVLDYVPETVYRVARHYSRA-KQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDT--------A 194 (420)
T ss_dssp TEEEEEEEEECCCEEHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTT--------T
T ss_pred cceeEEeehhcccccHHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCC--------C
Confidence 23457899999999988877653221 12344566777788999999999999999999999999998652 5
Q ss_pred eEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCch
Q psy14267 412 VLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNT 491 (553)
Q Consensus 412 ~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~ 491 (553)
.+||+|||+++.+...... ....||+.|+|||++.+.. .++.++|||||||+||||++|+.||.+....
T Consensus 195 ~~kl~DFG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~--------~~~~~~DiwSlG~il~ell~G~~pf~~~~~~ 263 (420)
T 1j1b_A 195 VLKLCDFGSAKQLVRGEPN---VSYICSRYYRAPELIFGAT--------DYTSSIDVWSAGCVLAELLLGQPIFPGDSGV 263 (420)
T ss_dssp EEEECCCTTCEECCTTCCC---CSCCSCTTSCCHHHHTTCS--------SCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred eEEeccchhhhhcccCCCc---eeeeeCCCcCCHHHHcCCC--------CCCchhhhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 7899999999877544322 2567999999999997542 3789999999999999999999999875543
Q ss_pred HHHHHHHHhhccc---------------cccccccc-------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 492 WAKMLAIARHKDQ---------------IEFKPQLA-------NNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 492 ~~~~~~i~~~~~~---------------~~~~~~~~-------~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
..+..+...... ..+. ... ....+++++.+||.+||..||++|||+.|+++|
T Consensus 264 -~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p-~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 264 -DQLVEIIKVLGTPTREQIREMNPNYTEFKFP-QIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp -HHHHHHHHHHCSCCHHHHHHHCSCCCCCCCC-CCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -HHHHHHHHHhCCCCHHHHHhhChhhhhhccC-ccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 223222221000 0000 000 112568899999999999999999999999875
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=354.53 Aligned_cols=270 Identities=14% Similarity=0.208 Sum_probs=204.1
Q ss_pred EEecCcceEEEeeeeeeCceEEEEEeeeCCC------ccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeE-
Q psy14267 251 ITLNGKQYQVLSLLGKGGSSSVYLVGGTSEH------EFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIK- 323 (553)
Q Consensus 251 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~- 323 (553)
....+++|++.+.||+|+||.||+|++..+. ..+.||||++... +.+.+|+++++++. ||||++
T Consensus 37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~-h~niv~~ 107 (352)
T 2jii_A 37 TDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAA-KPLQVNK 107 (352)
T ss_dssp ECTTSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHC-CHHHHHH
T ss_pred ecccCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhc-ccchhhh
Confidence 3445689999999999999999999887642 2356999999754 35779999999995 588877
Q ss_pred --------------eeeEEEeCCCceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEec
Q psy14267 324 --------------MHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHS 389 (553)
Q Consensus 324 --------------l~~~~~~~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHr 389 (553)
+++++.. ....++++||+++++|.+++...... ......++.++.||+.||+|||++||+||
T Consensus 108 ~~~~~~~~~~~i~~~~~~~~~-~~~~~~lv~e~~~~~L~~~l~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~ivH~ 183 (352)
T 2jii_A 108 WKKLYSTPLLAIPTCMGFGVH-QDKYRFLVLPSLGRSLQSALDVSPKH---VLSERSVLQVACRLLDALEFLHENEYVHG 183 (352)
T ss_dssp HHHHTTCTTCSCCCCCEEEEE-TTTEEEEEEECCCEEHHHHHHHSGGG---CCCHHHHHHHHHHHHHHHHHHHHTTCBCS
T ss_pred hhhhccCCccCccchhhcccc-CCcEEEEEecCCCcCHHHHHHhCCcC---CCCHHHHHHHHHHHHHHHHHHHhCCccCC
Confidence 5555543 35788999999999999999875221 34456677778899999999999999999
Q ss_pred CCCCCCEEEecCccceecCCCCeEEEEeccCccccCCCCCcc-----cccCCccCCCccCcccccccCCCCCCCccCCCc
Q psy14267 390 DLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSV-----HKDTASGTLNYMSPEAAGQTSSSGGGNTYRITY 464 (553)
Q Consensus 390 DLKp~NILl~~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~-----~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~ 464 (553)
||||+||||+.+.. ..+||+|||+++.+....... ......||+.|+|||++.+. .++.
T Consensus 184 Dikp~NIl~~~~~~-------~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~ 247 (352)
T 2jii_A 184 NVTAENIFVDPEDQ-------SQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC---------GPSR 247 (352)
T ss_dssp CCCGGGEEEETTEE-------EEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC---------CCCH
T ss_pred CCCHHHEEEcCCCC-------ceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC---------CCCc
Confidence 99999999987621 279999999998765432211 11345799999999999865 3789
Q ss_pred cchHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHh-h-cccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q psy14267 465 KSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIAR-H-KDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNS 542 (553)
Q Consensus 465 ~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~~i~~-~-~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~el 542 (553)
++|||||||+||||++|..||.........+..... . .....+......+..++.++.+||.+||..||++||++.+|
T Consensus 248 ~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 327 (352)
T 2jii_A 248 RSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAML 327 (352)
T ss_dssp HHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHH
T ss_pred hhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHH
Confidence 999999999999999999999875422222222221 1 11111222222234678999999999999999999999999
Q ss_pred HHHHhcC
Q psy14267 543 VTQINNN 549 (553)
Q Consensus 543 l~~L~~~ 549 (553)
++.|+++
T Consensus 328 ~~~L~~~ 334 (352)
T 2jii_A 328 RNNLEAL 334 (352)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9999874
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=341.07 Aligned_cols=264 Identities=22% Similarity=0.336 Sum_probs=201.8
Q ss_pred ecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHH----HHHHHHHHHHHhhcCCCceeEeeeEE
Q psy14267 253 LNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIA----DSYLNEVELLAKLQGCPYVIKMHDYV 328 (553)
Q Consensus 253 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~----~~~~~E~~iL~~l~~hp~Iv~l~~~~ 328 (553)
+..++|++.+.||+|+||.||+|++..++.. ||||++........... +.+.+|+.+++++. ||||+++++++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~ 92 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSV--VAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN-HPNIVKLYGLM 92 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCE--EEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCC-CTTBCCEEEEE
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceE--EEEEEeeccccccchhHHHHHHHHHHHHHHHHhCC-CCCchhhheee
Confidence 4567899999999999999999988776644 99999976654332221 67899999999995 69999999876
Q ss_pred EeCCCceEEEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCC--cEecCCCCCCEEEecCccce
Q psy14267 329 YDTASKHLYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAG--IIHSDLKPANFLFVGNVLKI 405 (553)
Q Consensus 329 ~~~~~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~g--IiHrDLKp~NILl~~~~~~~ 405 (553)
.+ .. +++||++. ++|.+++..... ......++.++.|++.||+|||++| |+||||||+||||+.+..
T Consensus 93 ~~--~~--~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~-- 162 (287)
T 4f0f_A 93 HN--PP--RMVMEFVPCGDLYHRLLDKAH----PIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDE-- 162 (287)
T ss_dssp TT--TT--EEEEECCTTCBHHHHHHCTTS----CCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCT--
T ss_pred cC--CC--eEEEEecCCCCHHHHHhcccC----CccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCC--
Confidence 32 22 57888764 799888875432 3445666777789999999999999 999999999999976521
Q ss_pred ecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCC
Q psy14267 406 IDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY 485 (553)
Q Consensus 406 ~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf 485 (553)
.....+||+|||+++..... .....||+.|+|||++.... ..++.++|||||||++|||++|..||
T Consensus 163 --~~~~~~kl~Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~-------~~~~~~~Di~slG~~l~~l~~g~~pf 228 (287)
T 4f0f_A 163 --NAPVCAKVADFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEE-------ESYTEKADTYSFAMILYTILTGEGPF 228 (287)
T ss_dssp --TCSCCEEECCCTTCBCCSSC-----EECCCCCCTTSCGGGSSCSS-------CEECHHHHHHHHHHHHHHHHHSSCTT
T ss_pred --CCceeEEeCCCCcccccccc-----ccccCCCccccCchhhccCC-------CCcCchhhHHHHHHHHHHHHcCCCCC
Confidence 11234899999999754432 22567999999999985332 13688999999999999999999999
Q ss_pred CCCCchHHH-HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 486 SHIPNTWAK-MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 486 ~~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
......... ...+........ ....+++.+.++|.+||+.||++|||+.++++.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 229 DEYSYGKIKFINMIREEGLRPT------IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp TTCCCCHHHHHHHHHHSCCCCC------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ccccccHHHHHHHHhccCCCCC------CCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 875543322 222222221111 2236789999999999999999999999999999864
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=356.29 Aligned_cols=254 Identities=23% Similarity=0.348 Sum_probs=189.5
Q ss_pred cCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCC
Q psy14267 254 NGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTAS 333 (553)
Q Consensus 254 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~ 333 (553)
..++|++++.||+|+||+||+|++..++.. ||||++....... +.+.+|+.++++++ ||||+++++++.. .
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~--vavK~~~~~~~~~----~~~~~E~~~l~~l~-hpniv~~~~~~~~--~ 88 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKEL--VAVKYIERGAAID----ENVQREIINHRSLR-HPNIVRFKEVILT--P 88 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCE--EEEEEEESSTTSC----HHHHHHHHHHHHCC-CTTBCCEEEEEEC--S
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcE--EEEEEEecCcccc----HHHHHHHHHHHhCC-CCCCCcEEEEEee--C
Confidence 456899999999999999999998877655 9999998765433 56789999999995 5999999998753 5
Q ss_pred ceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCe
Q psy14267 334 KHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNV 412 (553)
Q Consensus 334 ~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~ 412 (553)
..++++||++ +++|.+++..... +....+..++.||+.||+|||++||+||||||+||||+.+. .+.
T Consensus 89 ~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~-------~~~ 156 (361)
T 3uc3_A 89 THLAIIMEYASGGELYERICNAGR-----FSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSP-------APR 156 (361)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSS-------SCC
T ss_pred CEEEEEEEeCCCCCHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC-------Cce
Confidence 6789999986 6799999876543 34566677788999999999999999999999999997652 135
Q ss_pred EEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCch-
Q psy14267 413 LKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNT- 491 (553)
Q Consensus 413 vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~- 491 (553)
+||+|||+++....... ....+||+.|+|||++.+..+ .+.++|||||||++|||++|+.||......
T Consensus 157 ~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~--------~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 225 (361)
T 3uc3_A 157 LKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRQEY--------DGKIADVWSCGVTLYVMLVGAYPFEDPEEPR 225 (361)
T ss_dssp EEECCCCCC------------------CTTSCHHHHHCSSC--------CHHHHHHHHHHHHHHHHHHSSCSCC----CC
T ss_pred EEEeecCccccccccCC---CCCCcCCCCcCChhhhcCCCC--------CCCeeeeehhHHHHHHHHhCCCCCCCCccHH
Confidence 99999999975433322 235579999999999976532 234599999999999999999999864321
Q ss_pred --HHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 492 --WAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 492 --~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
...+..+... .........+++++.+||.+||..||++|||+.|+++|
T Consensus 226 ~~~~~~~~~~~~------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 226 DYRKTIQRILSV------KYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp CHHHHHHHHHTT------CCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHHHhcC------CCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 1122222211 11223334678999999999999999999999999986
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=340.03 Aligned_cols=257 Identities=21% Similarity=0.313 Sum_probs=203.6
Q ss_pred EecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeC
Q psy14267 252 TLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDT 331 (553)
Q Consensus 252 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~ 331 (553)
...+..|++.+.||+|+||.||+|.+..++.. ||+|++....... ...+.+.+|+.+|+++. ||||+++++++...
T Consensus 22 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~--va~k~~~~~~~~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~ 97 (290)
T 1t4h_A 22 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVE--VAWCELQDRKLTK-SERQRFKEEAEMLKGLQ-HPNIVRFYDSWEST 97 (290)
T ss_dssp CTTSCEEEEEEEEEECSSEEEEEEEETTTCCE--EEEEEEEGGGSCH-HHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEE
T ss_pred ccCceeEEeeeeccCCCCeEEEEeEecCCceE--EEEEEecchhhCH-HHHHHHHHHHHHHHhCC-CCCeeeeeeeeccc
Confidence 34566799999999999999999988776644 9999998765443 44678999999999995 69999999987653
Q ss_pred --CCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCC--cEecCCCCCCEEEecCcccee
Q psy14267 332 --ASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAG--IIHSDLKPANFLFVGNVLKII 406 (553)
Q Consensus 332 --~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~g--IiHrDLKp~NILl~~~~~~~~ 406 (553)
....++++||++ +++|.+++..... .....++.++.||+.||+|||+++ |+||||||+||||+.+.
T Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~---- 168 (290)
T 1t4h_A 98 VKGKKCIVLVTELMTSGTLKTYLKRFKV-----MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPT---- 168 (290)
T ss_dssp SSSCEEEEEEEECCCSCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTT----
T ss_pred cCCCceEEEEEEecCCCCHHHHHHHccC-----CCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCC----
Confidence 346789999987 5699999987542 345566677789999999999999 99999999999997332
Q ss_pred cCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCC
Q psy14267 407 DCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYS 486 (553)
Q Consensus 407 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~ 486 (553)
+.+||+|||++........ ....||+.|+|||++.+. ++.++|||||||++|+|++|..||.
T Consensus 169 ----~~~kl~Dfg~~~~~~~~~~----~~~~~t~~y~aPE~~~~~----------~~~~~Di~slG~~l~~l~~g~~pf~ 230 (290)
T 1t4h_A 169 ----GSVKIGDLGLATLKRASFA----KAVIGTPEFMAPEMYEEK----------YDESVDVYAFGMCMLEMATSEYPYS 230 (290)
T ss_dssp ----SCEEECCTTGGGGCCTTSB----EESCSSCCCCCGGGGGTC----------CCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred ----CCEEEeeCCCccccccccc----ccccCCcCcCCHHHHhcc----------CCCcchHHHHHHHHHHHHhCCCCCC
Confidence 5799999999976544322 245699999999998643 6889999999999999999999998
Q ss_pred CCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 487 HIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 487 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
...........+........+ ...+++++.++|.+||+.||++|||+.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 231 ECQNAAQIYRRVTSGVKPASF------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp TCSSHHHHHHHHTTTCCCGGG------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CcCcHHHHHHHHhccCCcccc------CCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 866554444333322221111 12467899999999999999999999999875
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=356.10 Aligned_cols=278 Identities=16% Similarity=0.154 Sum_probs=200.5
Q ss_pred EEecCcceEEEeeeeeeCceEEEEEeeeCC-CccceEEEEEEecCCcCchh--------HHHHHHHHHHHHHhhcCCCce
Q psy14267 251 ITLNGKQYQVLSLLGKGGSSSVYLVGGTSE-HEFKPLALKVVDLSDITDQS--------IADSYLNEVELLAKLQGCPYV 321 (553)
Q Consensus 251 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~-~~~~~vAvK~l~~~~~~~~~--------~~~~~~~E~~iL~~l~~hp~I 321 (553)
..+.+++|++++.||+|+||.||+|.+... .....||||++......... ....+.+|+.+++.+. ||||
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~-h~ni 110 (345)
T 2v62_A 32 DDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLD-YLGI 110 (345)
T ss_dssp ECTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCS-CCCC
T ss_pred ccccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhcccc-ccCc
Confidence 345567999999999999999999988751 12345999999865421100 1123567888888884 5999
Q ss_pred eEeeeEEEeC--CCceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEe
Q psy14267 322 IKMHDYVYDT--ASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFV 399 (553)
Q Consensus 322 v~l~~~~~~~--~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~ 399 (553)
+++++++... ....++++||+++++|.+++.... .+....++.++.||+.||+|||++||+||||||+||||+
T Consensus 111 ~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~ 185 (345)
T 2v62_A 111 PLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNG-----TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLG 185 (345)
T ss_dssp CCEEEEEEEESSSCEEEEEEEECEEEEHHHHCBGGG-----BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE
T ss_pred ceeecccccccCCCcEEEEEEeccCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEc
Confidence 9999988763 356889999998999999987654 345666777888999999999999999999999999998
Q ss_pred cCccceecCCCCeEEEEeccCccccCCCCCc-----ccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHH
Q psy14267 400 GNVLKIIDCIGNVLKIIDFGIACSLQDDKTS-----VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCI 474 (553)
Q Consensus 400 ~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~-----~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvv 474 (553)
.+. .+.+||+|||+++.+...... .......||+.|+|||++.+. .++.++|||||||+
T Consensus 186 ~~~-------~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~Di~slG~i 249 (345)
T 2v62_A 186 YKN-------PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV---------ALSRRSDVEILGYC 249 (345)
T ss_dssp SSS-------TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC---------CCCHHHHHHHHHHH
T ss_pred cCC-------CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCC---------CCCchhhHHHHHHH
Confidence 762 137999999999876543211 112356799999999999865 37899999999999
Q ss_pred HHHHHhCCCCCCCCCchHHHHHHHH-hhccccc-ccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q psy14267 475 LYNMIYGRTPYSHIPNTWAKMLAIA-RHKDQIE-FKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNP 550 (553)
Q Consensus 475 l~elltG~~Pf~~~~~~~~~~~~i~-~~~~~~~-~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~ 550 (553)
||||++|..||.............. .....+. ..........++.++.++|..||..||++||++.+|++.|++..
T Consensus 250 l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 250 MLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred HHHHHhCCCCccccccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 9999999999965322222222211 1111111 01111122368899999999999999999999999999998743
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=353.89 Aligned_cols=258 Identities=27% Similarity=0.351 Sum_probs=196.3
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCC-
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTAS- 333 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~- 333 (553)
.++|++++.||+|+||.||+|.+..++.. ||||++.... ......+++.+|+++|++++ ||||+++++++.....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~--vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~ 99 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAK--VAIKKLYRPF-QSELFAKRAYRELRLLKHMR-HENVIGLLDVFTPDETL 99 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCE--EEEEECSSTT-SSHHHHHHHHHHHHHHHHCC-BTTBCCCSEEECSCSST
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCE--EEEEEeCccc-cCHHHHHHHHHHHHHHHhCC-CcCCCCceeeEecCCcc
Confidence 46899999999999999999988776654 9999996653 33455678999999999996 6999999998754422
Q ss_pred ---ceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCC
Q psy14267 334 ---KHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIG 410 (553)
Q Consensus 334 ---~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~ 410 (553)
..+|++||+++++|.++++.. ......+..++.||+.||+|||++||+||||||+||||+.+
T Consensus 100 ~~~~~~~lv~e~~~~~L~~~~~~~------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~--------- 164 (367)
T 1cm8_A 100 DDFTDFYLVMPFMGTDLGKLMKHE------KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNED--------- 164 (367)
T ss_dssp TTCCCCEEEEECCSEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT---------
T ss_pred ccCceEEEEEecCCCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCC---------
Confidence 457999999999999998763 23455667777899999999999999999999999999876
Q ss_pred CeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCc
Q psy14267 411 NVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN 490 (553)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~ 490 (553)
+.+||+|||+++...... ....||+.|+|||++.+.. .++.++|||||||++|||++|+.||.+...
T Consensus 165 ~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~--------~~~~~~DiwslG~il~ell~g~~pf~~~~~ 231 (367)
T 1cm8_A 165 CELKILDFGLARQADSEM-----TGYVVTRWYRAPEVILNWM--------RYTQTVDIWSVGCIMAEMITGKTLFKGSDH 231 (367)
T ss_dssp CCEEECCCTTCEECCSSC-----CSSCSCGGGCCTHHHHTTT--------CCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CCEEEEeeeccccccccc-----CcCcCCCCcCCHHHHhCCC--------CCChhhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 679999999998765432 2567899999999987632 478999999999999999999999987544
Q ss_pred hHHHHHHHHhhccc-----------------------ccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 491 TWAKMLAIARHKDQ-----------------------IEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 491 ~~~~~~~i~~~~~~-----------------------~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
. ..+..+...... ............+++.+.+||.+||..||++|||+.++++|
T Consensus 232 ~-~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 232 L-DQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp H-HHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred H-HHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 3 222222211100 00000011123678999999999999999999999999985
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=343.85 Aligned_cols=264 Identities=20% Similarity=0.270 Sum_probs=198.5
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
+++|++.+.||+|+||.||+|++..++. .||||++...... +.+.+|+.+++++.|+++|..+..++ ....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~--~~~~ 78 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGE--EVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCG--AEGD 78 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTE--EEEEEEEEC---C-----CCHHHHHHHHHHHTTSTTCCCEEEEE--EETT
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCc--eEEEEeecccccc-----hHHHHHHHHHHHhcCCCCCCeeeeec--CCCC
Confidence 4689999999999999999998877664 4999997665432 34788999999998877776665443 3466
Q ss_pred eEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 335 HLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 335 ~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
..+++||+++++|.+++..... ......++.++.||+.||+|||++||+||||||+||||+.+ ...+.+|
T Consensus 79 ~~~lv~e~~~~~L~~~~~~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~------~~~~~~k 148 (296)
T 4hgt_A 79 YNVMVMELLGPSLEDLFNFCSR----KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLG------KKGNLVY 148 (296)
T ss_dssp EEEEEEECCCCBHHHHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCG------GGTTCEE
T ss_pred ceEEEEEccCCCHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeecc------CCCCeEE
Confidence 8899999999999999986433 24456677778899999999999999999999999999422 1226799
Q ss_pred EEeccCccccCCCCCcc-----cccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy14267 415 IIDFGIACSLQDDKTSV-----HKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIP 489 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~-----~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~ 489 (553)
|+|||+++......... ......||+.|+|||++.+. .++.++|||||||++|||++|..||....
T Consensus 149 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~~g~~pf~~~~ 219 (296)
T 4hgt_A 149 IIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI---------EQSRRDDLESLGYVLMYFNLGSLPWQGLK 219 (296)
T ss_dssp ECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTC---------CCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred EecCccceeccCcccCccCCCCcccccCCCccccchHHhcCC---------CCCchhHHHHHHHHHHHHhcCCCCCcccc
Confidence 99999998876543311 22356799999999999866 37899999999999999999999998643
Q ss_pred ch--HHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 490 NT--WAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 490 ~~--~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
.. ...+..+........ .......+++++.++|..||+.||++|||+.++++.|+++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 278 (296)
T 4hgt_A 220 AATKRQKYERISEKKMSTP---IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp CSSSSSHHHHHHHHHHHSC---HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred hhhhhhhhhhhhcccccch---hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence 21 111122111111111 0111235789999999999999999999999999999874
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=341.22 Aligned_cols=262 Identities=20% Similarity=0.371 Sum_probs=194.1
Q ss_pred EEecCcceEEEeeeeeeCceEEEEEeeeCCC-ccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEE
Q psy14267 251 ITLNGKQYQVLSLLGKGGSSSVYLVGGTSEH-EFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVY 329 (553)
Q Consensus 251 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~ 329 (553)
+++..++|++.+.||+|+||.||+|.+...+ ....||||++.... .....+.+.+|+.+|+++. ||||+++++++.
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~ 86 (281)
T 1mp8_A 10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFD-HPHIVKLIGVIT 86 (281)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC
T ss_pred eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCccceEEEEEc
Confidence 4566789999999999999999999886543 33569999886542 3345678999999999995 699999998762
Q ss_pred eCCCceEEEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecC
Q psy14267 330 DTASKHLYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDC 408 (553)
Q Consensus 330 ~~~~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~ 408 (553)
+..++++||++. ++|.+++..... ......++.++.|++.||+|||++||+||||||+|||++.+
T Consensus 87 ---~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~------- 152 (281)
T 1mp8_A 87 ---ENPVWIIMELCTLGELRSFLQVRKY----SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN------- 152 (281)
T ss_dssp ---SSSCEEEEECCTTEEHHHHHHHTTT----TSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-------
T ss_pred ---cCccEEEEecCCCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCC-------
Confidence 345788899765 699999876432 24455667777899999999999999999999999999876
Q ss_pred CCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCC
Q psy14267 409 IGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSH 487 (553)
Q Consensus 409 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~ 487 (553)
+.+||+|||+++........ ......+++.|+|||++.+. .++.++|||||||++|||++ |..||..
T Consensus 153 --~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~~l~ell~~g~~pf~~ 220 (281)
T 1mp8_A 153 --DCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFR---------RFTSASDVWMFGVCMWEILMHGVKPFQG 220 (281)
T ss_dssp --TEEEECC--------------------CCGGGCCHHHHHHC---------CCSHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred --CCEEECccccccccCccccc-ccccCCCcccccChhhcccC---------CCCCccCchHHHHHHHHHHhcCCCCCCc
Confidence 67999999999877543321 12244578899999999765 37889999999999999996 9999987
Q ss_pred CCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 488 IPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 488 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
.... .....+.... . ......+++.+.++|.+||+.||++|||+.++++.|+++
T Consensus 221 ~~~~-~~~~~i~~~~-~------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 221 VKNN-DVIGRIENGE-R------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp CCGG-GHHHHHHTTC-C------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCHH-HHHHHHHcCC-C------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 5543 2222222211 1 112236889999999999999999999999999999875
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=341.07 Aligned_cols=260 Identities=19% Similarity=0.339 Sum_probs=202.4
Q ss_pred eEEecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEE
Q psy14267 250 VITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVY 329 (553)
Q Consensus 250 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~ 329 (553)
.|.+..++|++++.||+|+||.||++.+... ..||||++....... +.+.+|+++|+++. ||||+++++++
T Consensus 18 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~vavK~~~~~~~~~----~~~~~E~~~l~~l~-h~~i~~~~~~~- 88 (283)
T 3gen_A 18 SWEIDPKDLTFLKELGTGQFGVVKYGKWRGQ---YDVAIKMIKEGSMSE----DEFIEEAKVMMNLS-HEKLVQLYGVC- 88 (283)
T ss_dssp TTBCCGGGEEEEEECC---CEEEEEEEETTT---EEEEEEEECTTSBCH----HHHHHHHHHHHTCC-CTTBCCEEEEE-
T ss_pred CccCCHHHHHhHhhcCCCCCceEEEEEEcCC---CeEEEEEecCCCCCH----HHHHHHHHHHhcCC-CCCEeeEEEEE-
Confidence 4456678999999999999999999976532 349999998665332 56889999999996 69999999877
Q ss_pred eCCCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecC
Q psy14267 330 DTASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDC 408 (553)
Q Consensus 330 ~~~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~ 408 (553)
.....++++||++ +++|.+++..... ......++.++.|++.||+|||++||+||||||+|||++.+
T Consensus 89 -~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~------- 156 (283)
T 3gen_A 89 -TKQRPIFIITEYMANGCLLNYLREMRH----RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQ------- 156 (283)
T ss_dssp -CSSSSEEEEECCCTTCBHHHHHHCGGG----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTT-------
T ss_pred -ecCCCeEEEEeccCCCcHHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCC-------
Confidence 4566789999976 6899999976433 24456667778899999999999999999999999999776
Q ss_pred CCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCC
Q psy14267 409 IGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSH 487 (553)
Q Consensus 409 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~ 487 (553)
+.+||+|||+++........ ......+|+.|+|||++.+. .++.++||||||+++|||++ |..||..
T Consensus 157 --~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~---------~~~~~~Dv~slG~~l~~l~t~g~~p~~~ 224 (283)
T 3gen_A 157 --GVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYS---------KFSSKSDIWAFGVLMWEIYSLGKMPYER 224 (283)
T ss_dssp --SCEEECSTTGGGGBCCHHHH-STTSTTSCGGGCCHHHHHHC---------CCSHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred --CCEEEccccccccccccccc-cccCCccCcccCCHHHhccC---------CCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 57999999999876543221 12234578899999999865 37889999999999999998 9999987
Q ss_pred CCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q psy14267 488 IPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNP 550 (553)
Q Consensus 488 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~ 550 (553)
.... .....+..... ......+++.+.++|.+||+.||++|||+.+++++|+++.
T Consensus 225 ~~~~-~~~~~~~~~~~-------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 279 (283)
T 3gen_A 225 FTNS-ETAEHIAQGLR-------LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM 279 (283)
T ss_dssp SCHH-HHHHHHHTTCC-------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cChh-HHHHHHhcccC-------CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence 6543 22233322211 1112356899999999999999999999999999998753
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=351.25 Aligned_cols=264 Identities=23% Similarity=0.308 Sum_probs=201.9
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC---
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA--- 332 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~--- 332 (553)
.+|++++.||+|+||.||+|++..++.. ||||++....... .....+.+|+.+|+++. ||||+++++++....
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~ 92 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQK--VALKKVLMENEKE-GFPITALREIKILQLLK-HENVVNLIEICRTKASPY 92 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCE--EEEEECCCSSCSS-SSCHHHHHHHHHHHHCC-CTTBCCEEEEEEEC----
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCE--EEEEEEecccccc-cchHHHHHHHHHHHhcc-CCCcccHhheeecccccc
Confidence 5899999999999999999988776654 9999997665433 23357789999999996 699999999887654
Q ss_pred ---CceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCC
Q psy14267 333 ---SKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCI 409 (553)
Q Consensus 333 ---~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~ 409 (553)
...++++||+++++|...+..... ......+..++.||+.||+|||++||+||||||+||||+.+
T Consensus 93 ~~~~~~~~lv~e~~~~~l~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~-------- 160 (351)
T 3mi9_A 93 NRCKGSIYLVFDFCEHDLAGLLSNVLV----KFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRD-------- 160 (351)
T ss_dssp ----CEEEEEEECCSEEHHHHHHCTTS----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT--------
T ss_pred ccCCceEEEEEeccCCCHHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCC--------
Confidence 457899999999999988876533 24456677778899999999999999999999999999776
Q ss_pred CCeEEEEeccCccccCCCCCc--ccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCC
Q psy14267 410 GNVLKIIDFGIACSLQDDKTS--VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSH 487 (553)
Q Consensus 410 ~~~vkL~DFGla~~~~~~~~~--~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~ 487 (553)
+.+||+|||+|+.+...... .......||+.|+|||++.+.. .++.++|||||||++|||++|..||.+
T Consensus 161 -~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--------~~~~~~DiwslG~il~ell~g~~pf~~ 231 (351)
T 3mi9_A 161 -GVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGER--------DYGPPIDLWGAGCIMAEMWTRSPIMQG 231 (351)
T ss_dssp -SCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCC--------SCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred -CCEEEccchhcccccccccccccccCCcccccCccCchhhcCCC--------CCCcHhHHHHHHHHHHHHHhCCCCCCC
Confidence 57999999999876533221 2233567899999999997542 368999999999999999999999987
Q ss_pred CCchHHHHHHHHhhccccc--ccccccCC----------------------CCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q psy14267 488 IPNTWAKMLAIARHKDQIE--FKPQLANN----------------------VTIPPTLLQSMKLCLQKDPKARPTVGNSV 543 (553)
Q Consensus 488 ~~~~~~~~~~i~~~~~~~~--~~~~~~~~----------------------~~~s~~l~~li~~cL~~dP~~RPt~~ell 543 (553)
.... .....+........ ..+..... ...++.+.+||.+||+.||++|||+.|++
T Consensus 232 ~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 310 (351)
T 3mi9_A 232 NTEQ-HQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 310 (351)
T ss_dssp SSHH-HHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred CChH-HHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHh
Confidence 5543 22222222111111 00000000 00267899999999999999999999998
Q ss_pred HH
Q psy14267 544 TQ 545 (553)
Q Consensus 544 ~~ 545 (553)
++
T Consensus 311 ~h 312 (351)
T 3mi9_A 311 NH 312 (351)
T ss_dssp TS
T ss_pred CC
Confidence 75
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=339.02 Aligned_cols=264 Identities=20% Similarity=0.273 Sum_probs=202.2
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
+++|++.+.||+|+||.||+|++..++. .||||++...... +.+.+|+.+++++.|+++|..+..+. ....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~--~~~~ 78 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGE--EVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCG--AEGD 78 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTE--EEEEEEEESCSSC-----CHHHHHHHHHHHHTTSTTCCCEEEEE--EETT
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCc--EEEEEEecCCcch-----hHHHHHHHHHHHhhcCCCCCcccccc--CCCC
Confidence 5689999999999999999998876664 4999999765432 35789999999998877776664333 3466
Q ss_pred eEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 335 HLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 335 ~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
..+++||+++++|.+++..... ......++.++.||+.||+|||++||+||||||+||||+.+ ..++.+|
T Consensus 79 ~~~lv~e~~~~~L~~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~------~~~~~~k 148 (296)
T 3uzp_A 79 YNVMVMELLGPSLEDLFNFCSR----KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLG------KKGNLVY 148 (296)
T ss_dssp EEEEEEECCCCBHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCG------GGTTCEE
T ss_pred ceEEEEEecCCCHHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecC------CCCCeEE
Confidence 8899999999999999985432 34556677778899999999999999999999999999522 1126799
Q ss_pred EEeccCccccCCCCCcc-----cccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy14267 415 IIDFGIACSLQDDKTSV-----HKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIP 489 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~-----~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~ 489 (553)
|+|||++.......... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus 149 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~~g~~pf~~~~ 219 (296)
T 3uzp_A 149 IIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI---------EQSRRDDLESLGYVLMYFNLGSLPWQGLK 219 (296)
T ss_dssp ECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTC---------CCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred EeeCCCcccccccccccccccccccccccccccCChhhhcCC---------CCCcchhhHHHHHHHHHHHhCCCCCCCcC
Confidence 99999998876543311 12356799999999999866 37899999999999999999999998643
Q ss_pred ch--HHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 490 NT--WAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 490 ~~--~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
.. ...+..+......... ......+++++.++|.+||+.||++|||+.++++.|++.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 278 (296)
T 3uzp_A 220 AATKRQKYERISEKKMSTPI---EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp CSSSSSHHHHHHHHHHHSCH---HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred chhhhhhhhhhcccccCCch---HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence 21 1122222211111110 011236789999999999999999999999999999874
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=337.59 Aligned_cols=257 Identities=23% Similarity=0.334 Sum_probs=204.0
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
.++|++.+.||+|+||.||+|.+..++.. ||+|++....... ...+.+.+|+.+++++. ||||+++++++. ...
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~ 78 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLE--FAAKIINTKKLSA-RDFQKLEREARICRKLQ-HPNIVRLHDSIQ--EES 78 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCE--EEEEEEEGGGCCH-HHHHHHHHHHHHHHHCC-CTTBCCEEEEEE--CSS
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCce--EEEEEeecccCCH-HHHHHHHHHHHHHHHcC-CCCcCeEEEEEE--cCC
Confidence 46899999999999999999988776654 9999998766443 44578899999999995 699999999774 466
Q ss_pred eEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 335 HLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 335 ~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
..+++||++ +++|.+++..... .....+..++.|++.||+|||++||+||||||+|||++.+. .++.+
T Consensus 79 ~~~~v~e~~~~~~l~~~~~~~~~-----~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~------~~~~~ 147 (284)
T 3kk8_A 79 FHYLVFDLVTGGELFEDIVAREF-----YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKA------KGAAV 147 (284)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSS------TTCCE
T ss_pred EEEEEEecCCCCCHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCC------CCCcE
Confidence 788999976 5688888876542 34556667778999999999999999999999999997652 23569
Q ss_pred EEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHH
Q psy14267 414 KIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWA 493 (553)
Q Consensus 414 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~ 493 (553)
||+|||++........ .....||+.|+|||++.+. .++.++||||||+++|+|++|..||...... .
T Consensus 148 kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~ 214 (284)
T 3kk8_A 148 KLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKD---------PYSKPVDIWACGVILYILLVGYPPFWDEDQH-R 214 (284)
T ss_dssp EECCCTTCEECCSSCB---CCCSCSCGGGCCHHHHTTC---------CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-H
T ss_pred EEeeceeeEEcccCcc---ccCCCCCcCCcCchhhcCC---------CCCcccchHHHHHHHHHHHHCCCCCCCCchh-H
Confidence 9999999987755432 2256799999999999765 3788999999999999999999999875443 3
Q ss_pred HHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 494 KMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 494 ~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
....+...... .....+..+++++.++|.+||+.||++|||+.|++++
T Consensus 215 ~~~~~~~~~~~----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 215 LYAQIKAGAYD----YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp HHHHHHHTCCC----CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHHHHHhcccc----CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 33333322221 1122234678999999999999999999999999875
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=356.78 Aligned_cols=262 Identities=26% Similarity=0.352 Sum_probs=197.8
Q ss_pred ecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeC-
Q psy14267 253 LNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDT- 331 (553)
Q Consensus 253 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~- 331 (553)
...++|++++.||+|+||+||+|.+..++.. ||||++..+... ..+|+++|+.+. ||||+++++++...
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~--vAiK~~~~~~~~-------~~~E~~il~~l~-hpnIv~l~~~~~~~~ 73 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKR--FALKKVLQDPRY-------KNRELDIMKVLD-HVNIIKLVDYFYTTG 73 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCE--EEEEEEECCTTS-------CCHHHHHHTTCC-CTTBCCEEEEEEEC-
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCE--EEEEEEecCcch-------HHHHHHHHHHcC-CCCccchhheeeecC
Confidence 3456899999999999999999988777654 999999765322 237999999995 69999999988653
Q ss_pred -----------------------------------CCceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHH
Q psy14267 332 -----------------------------------ASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLL 376 (553)
Q Consensus 332 -----------------------------------~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~ 376 (553)
...+++++||+++++|.+++...... ........+..++.||+.
T Consensus 74 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~-~~~l~~~~~~~i~~qi~~ 152 (383)
T 3eb0_A 74 DEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRS-GRSIPMNLISIYIYQLFR 152 (383)
T ss_dssp ------------------------------------CCEEEEEECCCSEEHHHHHHHHHHT-TCCCCHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhc-CCCCCHHHHHHHHHHHHH
Confidence 34468999999999998888753221 113445667777889999
Q ss_pred HHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCC
Q psy14267 377 AVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGG 456 (553)
Q Consensus 377 aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~ 456 (553)
||+|||++||+||||||+||||+.+. +.+||+|||+|+.+...... ....||+.|+|||++.+..
T Consensus 153 aL~~LH~~gi~H~Dikp~Nil~~~~~--------~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~---- 217 (383)
T 3eb0_A 153 AVGFIHSLGICHRDIKPQNLLVNSKD--------NTLKLCDFGSAKKLIPSEPS---VAYICSRFYRAPELMLGAT---- 217 (383)
T ss_dssp HHHHHHTTTEECSCCCGGGEEEETTT--------TEEEECCCTTCEECCTTSCC---CCCCCCSSCCCHHHHTTCS----
T ss_pred HHHHHHHCcCccCccCHHHEEEcCCC--------CcEEEEECCCCcccCCCCCC---cCcccCCCccCHHHhcCCC----
Confidence 99999999999999999999997432 67999999999877554432 2567899999999987643
Q ss_pred CCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHhhccc---------------ccccc------cccCCC
Q psy14267 457 GNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQ---------------IEFKP------QLANNV 515 (553)
Q Consensus 457 ~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~~i~~~~~~---------------~~~~~------~~~~~~ 515 (553)
.++.++|||||||++|||++|+.||.+.... ..+..+...... ..+.. ......
T Consensus 218 ----~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (383)
T 3eb0_A 218 ----EYTPSIDLWSIGCVFGELILGKPLFSGETSI-DQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPE 292 (383)
T ss_dssp ----SCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCT
T ss_pred ----CCCcchhhhhHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCC
Confidence 3789999999999999999999999875543 222222211100 00000 000122
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 516 TIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 516 ~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
.++.++.+||.+||..||++|||+.|+++|
T Consensus 293 ~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (383)
T 3eb0_A 293 GTPSLAIDLLEQILRYEPDLRINPYEAMAH 322 (383)
T ss_dssp TCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 578899999999999999999999999864
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=338.28 Aligned_cols=264 Identities=25% Similarity=0.389 Sum_probs=190.2
Q ss_pred EecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCc-hhHHHHHHHHHHHHHhhcCCCceeEeeeEEEe
Q psy14267 252 TLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITD-QSIADSYLNEVELLAKLQGCPYVIKMHDYVYD 330 (553)
Q Consensus 252 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~-~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~ 330 (553)
++..++|++.+.||+|+||.||+|.+. + +.||||++....... ....+.+.+|+++++.++ ||||+++++++.
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~- 76 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWI--G--DEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK-HPNIIALRGVCL- 76 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEET--T--EEEEEEEC----------CHHHHHHHHHHHHHCC-CTTBCCEEEEEC-
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEc--C--CeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcC-CCCEeeEEEEEe-
Confidence 345678999999999999999999764 2 449999987654322 233577899999999995 599999998774
Q ss_pred CCCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCC---cEecCCCCCCEEEecCcccee
Q psy14267 331 TASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAG---IIHSDLKPANFLFVGNVLKII 406 (553)
Q Consensus 331 ~~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~g---IiHrDLKp~NILl~~~~~~~~ 406 (553)
....++++||++ +++|.+++... ......++.++.|++.||+|||++| |+||||||+|||++..... .
T Consensus 77 -~~~~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~-~ 148 (271)
T 3dtc_A 77 -KEPNLCLVMEFARGGPLNRVLSGK------RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVEN-G 148 (271)
T ss_dssp -CC--CEEEEECCTTEEHHHHHTSS------CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSS-S
T ss_pred -cCCceEEEEEcCCCCCHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEeccccc-c
Confidence 456788999986 57788777432 3445666777889999999999999 9999999999999763210 0
Q ss_pred cCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCC
Q psy14267 407 DCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYS 486 (553)
Q Consensus 407 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~ 486 (553)
+...+.+||+|||++........ ....||+.|+|||++.+. .++.++||||||+++|||++|..||.
T Consensus 149 ~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~~l~~l~~g~~p~~ 215 (271)
T 3dtc_A 149 DLSNKILKITDFGLAREWHRTTK----MSAAGAYAWMAPEVIRAS---------MFSKGSDVWSYGVLLWELLTGEVPFR 215 (271)
T ss_dssp CCSSCCEEECCCCC-----------------CCGGGSCHHHHHHC---------CCSHHHHHHHHHHHHHHHHHCCCTTT
T ss_pred cccCcceEEccCCcccccccccc----cCCCCccceeCHHHhccC---------CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 11236799999999987654332 245699999999999765 37889999999999999999999998
Q ss_pred CCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 487 HIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 487 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
..... .....+....... .....+++.+.++|.+||+.||++|||+.+++++|+++
T Consensus 216 ~~~~~-~~~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 216 GIDGL-AVAYGVAMNKLAL------PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp TSCHH-HHHHHHHTSCCCC------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CCCHH-HHHHhhhcCCCCC------CCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 76543 2222222221111 12236789999999999999999999999999999864
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=346.31 Aligned_cols=255 Identities=23% Similarity=0.370 Sum_probs=188.8
Q ss_pred cCcceEEEeeeeeeCceEEEEEeeeC-CCccceEEEEEEecCCcCc-hhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeC
Q psy14267 254 NGKQYQVLSLLGKGGSSSVYLVGGTS-EHEFKPLALKVVDLSDITD-QSIADSYLNEVELLAKLQGCPYVIKMHDYVYDT 331 (553)
Q Consensus 254 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~~~~vAvK~l~~~~~~~-~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~ 331 (553)
..++|++++.||+|+||.||+|++.. ....+.||||++++..... ......+.+|+.+|+++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~-- 91 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK-HPFIVDLIYAFQ-- 91 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCC-CTTBCCEEEEEE--
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCC-CCCccceeEEEE--
Confidence 34689999999999999999998752 2234569999998764322 233466789999999995 699999998774
Q ss_pred CCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCC
Q psy14267 332 ASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIG 410 (553)
Q Consensus 332 ~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~ 410 (553)
....++++||++ +++|.+++..... .....+..++.||+.||+|||++||+||||||+||||+.+
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~--------- 157 (327)
T 3a62_A 92 TGGKLYLILEYLSGGELFMQLEREGI-----FMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQ--------- 157 (327)
T ss_dssp CSSCEEEEEECCTTEEHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTT---------
T ss_pred cCCEEEEEEeCCCCCcHHHHHHhCCC-----CCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCC---------
Confidence 466789999986 5789999886542 3345566677899999999999999999999999999776
Q ss_pred CeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCc
Q psy14267 411 NVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN 490 (553)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~ 490 (553)
+.+||+|||+++....... .....+||+.|+|||++.+. .++.++|||||||++|||++|..||.....
T Consensus 158 ~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~el~~g~~pf~~~~~ 226 (327)
T 3a62_A 158 GHVKLTDFGLCKESIHDGT--VTHTFCGTIEYMAPEILMRS---------GHNRAVDWWSLGALMYDMLTGAPPFTGENR 226 (327)
T ss_dssp SCEEECCCSCC------------CTTSSCCTTSCHHHHTTS---------CCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred CcEEEEeCCcccccccCCc--cccccCCCcCccCHhhCcCC---------CCCCcccchhHHHHHHHHHHCCCCCCCCCH
Confidence 5799999999976543322 22356799999999999765 368899999999999999999999987544
Q ss_pred hHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q psy14267 491 TWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARP-----TVGNSVTQ 545 (553)
Q Consensus 491 ~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RP-----t~~ell~~ 545 (553)
. ..+..+.... ..+ ...++.++++||.+||..||++|| ++.++++|
T Consensus 227 ~-~~~~~i~~~~--~~~------p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 227 K-KTIDKILKCK--LNL------PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp H-HHHHHHHHTC--CCC------CTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred H-HHHHHHHhCC--CCC------CCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 3 3333333221 111 225789999999999999999999 77888764
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=348.07 Aligned_cols=262 Identities=20% Similarity=0.305 Sum_probs=194.7
Q ss_pred ecCcceEEEeeeeeeCceEEEEEeeeCCCcc--ceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEe
Q psy14267 253 LNGKQYQVLSLLGKGGSSSVYLVGGTSEHEF--KPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYD 330 (553)
Q Consensus 253 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~--~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~ 330 (553)
+...+|+++++||+|+||.||+|.+..++.. .+||+|.+..... ....+.+.+|+.+|+++. ||||+++++++..
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~--~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~ 88 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMASVD-NPHVCRLLGICLT 88 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSS--CCCHHHHHHHHHHHTTCC-BTTBCCCCEEEES
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccC--HHHHHHHHHHHHHHHhCC-CCCeeEEEEEEec
Confidence 4567899999999999999999988766544 2357776654332 233578899999999995 5999999998864
Q ss_pred CCCceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCC
Q psy14267 331 TASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIG 410 (553)
Q Consensus 331 ~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~ 410 (553)
....++++++.+++|.+++..... ......++.++.||+.||+|||++|||||||||+||||+.+
T Consensus 89 --~~~~~v~~~~~~g~L~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~--------- 153 (327)
T 3lzb_A 89 --STVQLITQLMPFGCLLDYVREHKD----NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP--------- 153 (327)
T ss_dssp --SSEEEEECCCSSCBHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEET---------
T ss_pred --CCceEEEEecCCCcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCC---------
Confidence 334455555678899999987543 23455667777899999999999999999999999999876
Q ss_pred CeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCCC
Q psy14267 411 NVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHIP 489 (553)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~~ 489 (553)
+.+||+|||+++...............||+.|+|||++.+. .++.++|||||||++|||++ |..||....
T Consensus 154 ~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~---------~~~~~~Di~slG~il~ell~~g~~p~~~~~ 224 (327)
T 3lzb_A 154 QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR---------IYTHQSDVWSYGVTVWELMTFGSKPYDGIP 224 (327)
T ss_dssp TEEEECCTTC----------------CCCGGGSCHHHHHHC---------CCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred CCEEEccCcceeEccCccccccccCCCccccccCHHHHcCC---------CCChHHHHHHHHHHHHHHHHCCCCCCCCCC
Confidence 57999999999887654443333345578899999999865 37899999999999999999 999998865
Q ss_pred chHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 490 NTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 490 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
... ....+. .... ......++.++.++|.+||..||++||++.++++.|+++
T Consensus 225 ~~~-~~~~~~-~~~~------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 276 (327)
T 3lzb_A 225 ASE-ISSILE-KGER------LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp GGG-HHHHHH-TTCC------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHH-HHHHHH-cCCC------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 432 122222 1111 122335789999999999999999999999999999874
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=341.71 Aligned_cols=265 Identities=19% Similarity=0.261 Sum_probs=200.9
Q ss_pred cCcceEEEeeeeeeCceEEEEEeee--CCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeC
Q psy14267 254 NGKQYQVLSLLGKGGSSSVYLVGGT--SEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDT 331 (553)
Q Consensus 254 ~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~ 331 (553)
....|++++.||+|+||.||+|+.. .....+.||||++..... ....+.+.+|+++|+++. ||||+++++++...
T Consensus 19 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~ 95 (302)
T 4e5w_A 19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--GNHIADLKKEIEILRNLY-HENIVKYKGICTED 95 (302)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCC-CTTBCCEEEEEEC-
T ss_pred hhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc--chhHHHHHHHHHHHHhCC-CCCeeeeeeEEecC
Confidence 3567999999999999999999732 222335699999976542 233477899999999995 69999999998876
Q ss_pred CCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCC
Q psy14267 332 ASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIG 410 (553)
Q Consensus 332 ~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~ 410 (553)
....++++||++ +++|.+++..... ......++.++.|++.||+|||++||+||||||+||||+.+
T Consensus 96 ~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~--------- 162 (302)
T 4e5w_A 96 GGNGIKLIMEFLPSGSLKEYLPKNKN----KINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESE--------- 162 (302)
T ss_dssp --CCEEEEEECCTTCBHHHHHHHHTT----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET---------
T ss_pred CCceEEEEEEeCCCCcHHHHHHhccc----cCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCC---------
Confidence 667889999976 5699999966432 24455667777899999999999999999999999999876
Q ss_pred CeEEEEeccCccccCCCCCc-ccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy14267 411 NVLKIIDFGIACSLQDDKTS-VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIP 489 (553)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~ 489 (553)
+.+||+|||++......... .......||..|+|||++.+. .++.++|||||||++|||++|..|+....
T Consensus 163 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~~g~~p~~~~~ 233 (302)
T 4e5w_A 163 HQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQS---------KFYIASDVWSFGVTLHELLTYCDSDSSPM 233 (302)
T ss_dssp TEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHC---------EEEHHHHHHHHHHHHHHHHTTTCGGGSHH
T ss_pred CCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCC---------CCCcchhHHHHHHHHHHHHHccCCCcchh
Confidence 67999999999887654432 223355688999999999765 36789999999999999999999875321
Q ss_pred c-------------hHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 490 N-------------TWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 490 ~-------------~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
. ............. .......+++.+.+||.+||+.||++|||+.++++.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 234 ALFLKMIGPTHGQMTVTRLVNTLKEGK------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp HHHHHHHCSCCGGGHHHHHHHHHHTTC------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred hHHhhccCCcccccCHHHHHHHHhccC------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 1 1111111111111 1222346889999999999999999999999999999875
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=340.56 Aligned_cols=264 Identities=22% Similarity=0.385 Sum_probs=189.3
Q ss_pred EecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeC
Q psy14267 252 TLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDT 331 (553)
Q Consensus 252 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~ 331 (553)
++..++|++++.||+|+||.||+|++..++.. ||||++...... .. ..++..|...+.+..+||||+++++++..
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vavK~~~~~~~~-~~-~~~~~~~~~~~~~~~~h~~iv~~~~~~~~- 77 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQI--MAVKRIRATVNS-QE-QKRLLMDLDISMRTVDCPFTVTFYGALFR- 77 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEE--EEEEEEC---CH-HH-HHHHHHHHHHHHTTCCCTTBCCEEEEEEC-
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeE--EEEEEeecccCc-HH-HHHHHHHHHHHHHhCCCCeEEEEeeeeec-
Confidence 34567899999999999999999988776644 999999765422 22 24445555554444467999999998754
Q ss_pred CCceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhC-CcEecCCCCCCEEEecCccceecCCC
Q psy14267 332 ASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAA-GIIHSDLKPANFLFVGNVLKIIDCIG 410 (553)
Q Consensus 332 ~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~-gIiHrDLKp~NILl~~~~~~~~~~~~ 410 (553)
....+++||+++++|.+++...... ........+..++.|++.||+|||++ ||+||||||+|||++.+
T Consensus 78 -~~~~~lv~e~~~~~l~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~--------- 146 (290)
T 3fme_A 78 -EGDVWICMELMDTSLDKFYKQVIDK-GQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINAL--------- 146 (290)
T ss_dssp -SSSEEEEEECCSEEHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTT---------
T ss_pred -cCCEEEEEehhccchHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCC---------
Confidence 5678999999999998887753221 12344566677788999999999998 99999999999999776
Q ss_pred CeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCc
Q psy14267 411 NVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN 490 (553)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~ 490 (553)
+.+||+|||++........ .....||+.|+|||++.... ....++.++|||||||++|||++|..||.....
T Consensus 147 ~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~-----~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 218 (290)
T 3fme_A 147 GQVKMCDFGISGYLVDDVA---KDIDAGCKPYMAPERINPEL-----NQKGYSVKSDIWSLGITMIELAILRFPYDSWGT 218 (290)
T ss_dssp CCEEBCCC------------------CCCCCCSCHHHHSCCT-----TC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC
T ss_pred CCEEEeecCCccccccccc---ccccCCCccccChhhcChhh-----cCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc
Confidence 5799999999987655432 22456999999999974321 111478999999999999999999999987555
Q ss_pred hHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 491 TWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 491 ~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
....+.......... .....++.++.++|.+||+.||++|||+.+++++
T Consensus 219 ~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 219 PFQQLKQVVEEPSPQ------LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp HHHHHHHHHHSCCCC------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred hHHHHHHHhccCCCC------cccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 544444433322111 1123578999999999999999999999999874
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=340.77 Aligned_cols=264 Identities=15% Similarity=0.279 Sum_probs=200.6
Q ss_pred ecCcceEEEeeeeeeCceEEEEEeeeCCCcc-----ceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeE
Q psy14267 253 LNGKQYQVLSLLGKGGSSSVYLVGGTSEHEF-----KPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDY 327 (553)
Q Consensus 253 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~-----~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~ 327 (553)
+..++|++.+.||+|+||.||+|.+..++.. ..||+|++.... ....+.+.+|+.+|+++. ||||++++++
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~-h~~iv~~~~~ 80 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLS-HKHLVLNYGV 80 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSC-CTTBCCEEEE
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCC-CCCEeEEEEE
Confidence 4567899999999999999999988766542 469999986543 334578999999999995 6999999988
Q ss_pred EEeCCCceEEEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCcccee
Q psy14267 328 VYDTASKHLYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKII 406 (553)
Q Consensus 328 ~~~~~~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~ 406 (553)
+. .....+++||++. ++|.+++..... ......++.++.||+.||+|||++||+||||||+||||+.+.....
T Consensus 81 ~~--~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~ 154 (289)
T 4fvq_A 81 CV--CGDENILVQEFVKFGSLDTYLKKNKN----CINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKT 154 (289)
T ss_dssp EC--CTTCCEEEEECCTTCBHHHHHHHTGG----GCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGG
T ss_pred EE--eCCCCEEEEECCCCCCHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccc
Confidence 74 3556789999875 799999987543 2345566677789999999999999999999999999987632110
Q ss_pred cCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhC-CCCC
Q psy14267 407 DCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYG-RTPY 485 (553)
Q Consensus 407 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG-~~Pf 485 (553)
...+.+||+|||++....... ...||+.|+|||++.+.. .++.++|||||||++|||++| .+||
T Consensus 155 -~~~~~~kl~Dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~--------~~~~~~DiwslG~il~el~~g~~~~~ 219 (289)
T 4fvq_A 155 -GNPPFIKLSDPGISITVLPKD------ILQERIPWVPPECIENPK--------NLNLATDKWSFGTTLWEICSGGDKPL 219 (289)
T ss_dssp -TBCCEEEECCCCSCTTTSCHH------HHHHTTTTSCHHHHHCGG--------GCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred -cccceeeeccCcccccccCcc------ccCCcCcccCHHHhCCCC--------CCCchhHHHHHHHHHHHHHcCCCCCc
Confidence 111349999999986653321 345899999999997632 378999999999999999995 5555
Q ss_pred CCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q psy14267 486 SHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNPE 551 (553)
Q Consensus 486 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~~ 551 (553)
...... ....... .. ... ...++.++.++|.+||+.||++|||+.+++++|+++..
T Consensus 220 ~~~~~~-~~~~~~~-~~--~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 220 SALDSQ-RKLQFYE-DR--HQL------PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp TTSCHH-HHHHHHH-TT--CCC------CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred cccchH-HHHHHhh-cc--CCC------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 543332 2222211 11 111 12456789999999999999999999999999998754
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=337.91 Aligned_cols=261 Identities=16% Similarity=0.228 Sum_probs=206.2
Q ss_pred ecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC
Q psy14267 253 LNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA 332 (553)
Q Consensus 253 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~ 332 (553)
+..++|++.+.||+|+||.||+|++. + +.||||++....... ...+.+.+|+.+|+++. ||||+++++++.+..
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~~--~--~~~avK~~~~~~~~~-~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 80 (271)
T 3kmu_A 7 IDFKQLNFLTKLNENHSGELWKGRWQ--G--NDIVVKVLKVRDWST-RKSRDFNEECPRLRIFS-HPNVLPVLGACQSPP 80 (271)
T ss_dssp CCGGGCEEEEEEEEETTEEEEEEEET--T--EEEEEEEECCTTCCH-HHHHHHHHHGGGGCCCS-CTTEECEEEEECTTT
T ss_pred CCHHHhHHHHHhcCCCcceEEEEEEC--C--eeEEEEEecccccCH-HHHHHHHHHHHHHHhcC-CCchhheEEEEccCC
Confidence 44568999999999999999999774 2 449999998765443 44578999999999995 699999999886665
Q ss_pred CceEEEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCC--cEecCCCCCCEEEecCccceecCC
Q psy14267 333 SKHLYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAG--IIHSDLKPANFLFVGNVLKIIDCI 409 (553)
Q Consensus 333 ~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~g--IiHrDLKp~NILl~~~~~~~~~~~ 409 (553)
...++++||++. ++|.+++...... ......++.++.|++.||+|||++| |+||||||+|||++.+
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~-------- 149 (271)
T 3kmu_A 81 APHPTLITHWMPYGSLYNVLHEGTNF---VVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDED-------- 149 (271)
T ss_dssp SSSCEEEEECCTTCBHHHHHHSCSSC---CCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTT--------
T ss_pred CCCeEeeecccCCCcHHHHHhhcccC---CCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCC--------
Confidence 578899999865 6999999865432 3455667777889999999999999 9999999999999776
Q ss_pred CCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy14267 410 GNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIP 489 (553)
Q Consensus 410 ~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~ 489 (553)
+.++|+|||++..... ....||+.|+|||++.+.... .++.++|||||||++|||++|..||....
T Consensus 150 -~~~~l~~~~~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~------~~~~~~Di~slG~il~el~~g~~p~~~~~ 215 (271)
T 3kmu_A 150 -MTARISMADVKFSFQS-------PGRMYAPAWVAPEALQKKPED------TNRRSADMWSFAVLLWELVTREVPFADLS 215 (271)
T ss_dssp -SCEEEEGGGSCCTTSC-------TTCBSCGGGSCHHHHHSCGGG------SCHHHHHHHHHHHHHHHHHHCSCTTTTSC
T ss_pred -cceeEEeccceeeecc-------cCccCCccccChhhhccCCCC------CCCchhhHHHHHHHHHHHHhCCCCccccC
Confidence 5689999988754322 244689999999999865422 24558999999999999999999998765
Q ss_pred chHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q psy14267 490 NTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNPE 551 (553)
Q Consensus 490 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~~ 551 (553)
.... ...+........ ....+++++.++|.+||+.||++|||+.++++.|+++.+
T Consensus 216 ~~~~-~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 216 NMEI-GMKVALEGLRPT------IPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp HHHH-HHHHHHSCCCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred hHHH-HHHHHhcCCCCC------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 5422 222222221111 223678999999999999999999999999999998654
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=367.03 Aligned_cols=253 Identities=23% Similarity=0.341 Sum_probs=191.3
Q ss_pred cCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCC
Q psy14267 254 NGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTAS 333 (553)
Q Consensus 254 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~ 333 (553)
..++|+++++||+|+||.||+|.+..++.. ||||++.+...........+.+|+.+|+++. ||||+.+++++.. .
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~--vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~--~ 220 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRY--YAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTALKYSFQT--H 220 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCE--EEEEEEEHHHHC-------------CCCCCS-CTTSCCEEEEEEE--T
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCE--EEEEEEEhhhhhhhHHHHHHHHHHHHHHhCC-CCeEeeEEEEEee--C
Confidence 346899999999999999999988777654 9999998754444445577889999999995 5999999988754 5
Q ss_pred ceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhh-CCcEecCCCCCCEEEecCccceecCCCC
Q psy14267 334 KHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHA-AGIIHSDLKPANFLFVGNVLKIIDCIGN 411 (553)
Q Consensus 334 ~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~-~gIiHrDLKp~NILl~~~~~~~~~~~~~ 411 (553)
..++++||++ +++|..++.... .+....+..++.||+.||+|||+ +|||||||||+||||+.+ +
T Consensus 221 ~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~---------~ 286 (446)
T 4ejn_A 221 DRLCFVMEYANGGELFFHLSRER-----VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD---------G 286 (446)
T ss_dssp TEEEEEECCCSSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSS---------S
T ss_pred CEEEEEEeeCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCC---------C
Confidence 6789999986 568988887654 23456667777899999999998 999999999999999876 5
Q ss_pred eEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCch
Q psy14267 412 VLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNT 491 (553)
Q Consensus 412 ~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~ 491 (553)
.+||+|||+|+....... .....+||+.|+|||++.+. .++.++|||||||+||||++|..||.+....
T Consensus 287 ~~kl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 355 (446)
T 4ejn_A 287 HIKITDFGLCKEGIKDGA--TMKTFCGTPEYLAPEVLEDN---------DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 355 (446)
T ss_dssp CEEECCCCCCCTTCC-------CCSSSCGGGCCHHHHHTS---------CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred CEEEccCCCceeccCCCc--ccccccCCccccCHhhcCCC---------CCCCccchhhhHHHHHHHhhCCCCCCCCCHH
Confidence 799999999986544332 23367899999999999765 3789999999999999999999999875432
Q ss_pred HHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q psy14267 492 WAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARP-----TVGNSVTQ 545 (553)
Q Consensus 492 ~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RP-----t~~ell~~ 545 (553)
.....+.... ..+ ...+++++.+||.+||+.||++|| +++|+++|
T Consensus 356 -~~~~~i~~~~--~~~------p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 356 -KLFELILMEE--IRF------PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp -HHHHHHHHCC--CCC------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -HHHHHHHhCC--CCC------CccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 2222332221 111 225789999999999999999999 99999864
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=351.26 Aligned_cols=254 Identities=24% Similarity=0.305 Sum_probs=185.8
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
.++|++.+.||+|+||.||+|++..++. .||||++.... ..+.+.+|+.+|+++. ||||+++++++.. ..
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~--~vavK~~~~~~-----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~--~~ 121 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQK--PYALKVLKKTV-----DKKIVRTEIGVLLRLS-HPNIIKLKEIFET--PT 121 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCC--EEEEEEEEC---------------CHHHHHCC-CTTBCCEEEEEEC--SS
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCc--EEEEEEeccch-----hHHHHHHHHHHHHhCC-CCCCcceeeeEec--CC
Confidence 4679999999999999999998876664 49999997643 2356789999999995 5999999998743 56
Q ss_pred eEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 335 HLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 335 ~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
.++++||++ +++|.+++.... ......++.++.||+.||+|||++||+||||||+||||+.. ...+.+
T Consensus 122 ~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~------~~~~~~ 190 (349)
T 2w4o_A 122 EISLVLELVTGGELFDRIVEKG-----YYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATP------APDAPL 190 (349)
T ss_dssp EEEEEECCCCSCBHHHHHTTCS-----SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSS------STTCCE
T ss_pred eEEEEEEeCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecC------CCCCCE
Confidence 789999986 579998887543 24456667778899999999999999999999999999752 112679
Q ss_pred EEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHH
Q psy14267 414 KIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWA 493 (553)
Q Consensus 414 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~ 493 (553)
||+|||+++....... ....+||+.|+|||++.+. .++.++|||||||++|||++|..||........
T Consensus 191 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~ 258 (349)
T 2w4o_A 191 KIADFGLSKIVEHQVL---MKTVCGTPGYCAPEILRGC---------AYGPEVDMWSVGIITYILLCGFEPFYDERGDQF 258 (349)
T ss_dssp EECCCC-------------------CGGGSCHHHHTTC---------CCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH
T ss_pred EEccCccccccCcccc---cccccCCCCccCHHHhcCC---------CCCcccchHHHHHHHHHHHhCCCCCCCCcccHH
Confidence 9999999987654322 2356799999999999765 378899999999999999999999987655433
Q ss_pred HHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 494 KMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 494 ~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
....+....... ....+..++.++.+||++||..||++|||+.+++++
T Consensus 259 ~~~~i~~~~~~~----~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 259 MFRRILNCEYYF----ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp HHHHHHTTCCCC----CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHhCCCcc----CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 333443322111 112234688999999999999999999999999875
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=368.43 Aligned_cols=257 Identities=23% Similarity=0.371 Sum_probs=206.7
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
.++|++.++||+|+||.||+|.+..++.. ||||++.+.........+.+.+|+.+|+++. ||||+++++++. ...
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~--~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~--~~~ 99 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQE--CAVKVISKRQVKQKTDKESLLREVQLLKQLD-HPNIMKLYEFFE--DKG 99 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCE--EEEEEEETTTCCBSSCHHHHHHHHHHHTTCC-CTTBCCEEEEEE--CSS
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCE--EEEEEEEhhhcccchHHHHHHHHHHHHHhCC-CCCCCcEEEEEE--eCC
Confidence 46899999999999999999988776654 9999998876654455688999999999995 699999999874 467
Q ss_pred eEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 335 HLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 335 ~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
.++++||++ +++|.+++.... ......++.++.||+.||+|||++|||||||||+||||+.. ...+.+
T Consensus 100 ~~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~------~~~~~~ 168 (484)
T 3nyv_A 100 YFYLVGEVYTGGELFDEIISRK-----RFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESK------SKDANI 168 (484)
T ss_dssp EEEEEECCCCSCBHHHHHHTCS-----CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSS------STTCCE
T ss_pred EEEEEEecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecC------CCCCcE
Confidence 889999965 678988887654 34456677778899999999999999999999999999643 123679
Q ss_pred EEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHH
Q psy14267 414 KIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWA 493 (553)
Q Consensus 414 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~ 493 (553)
||+|||+++.+...... ...+||+.|+|||++.+. ++.++|||||||++|+|++|.+||.+.... .
T Consensus 169 kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~----------~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~ 234 (484)
T 3nyv_A 169 RIIDFGLSTHFEASKKM---KDKIGTAYYIAPEVLHGT----------YDEKCDVWSTGVILYILLSGCPPFNGANEY-D 234 (484)
T ss_dssp EECCTTHHHHBCCCCSH---HHHTTGGGTCCHHHHHTC----------CCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-H
T ss_pred EEEeeeeeEEccccccc---ccCCCCccccCceeecCC----------CCCcceeHHHHHHHHHHHHCCCCCCCCCHH-H
Confidence 99999999887654432 245799999999998653 688999999999999999999999875443 3
Q ss_pred HHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 494 KMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 494 ~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
.+..+....... ....+..+++.+++||.+||+.||++|||+.++++|
T Consensus 235 ~~~~i~~~~~~~----~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 235 ILKKVEKGKYTF----ELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp HHHHHHHCCCCC----CSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHcCCCCC----CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 444444332222 122334688999999999999999999999999875
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=338.63 Aligned_cols=257 Identities=24% Similarity=0.393 Sum_probs=193.4
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|.+.+.||+|+||.||+|++..++.. ||+|++...... ...+.+.+|+++|+++. ||||+++++++. ....
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~--~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~--~~~~ 94 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLE--RVIKTINKDRSQ--VPMEQIEAEIEVLKSLD-HPNIIKIFEVFE--DYHN 94 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCE--EEEEEEEGGGCC--SCHHHHHHHHHHHHTCC-CTTBCCEEEEEE--CSSE
T ss_pred hheeecceeccCCCeEEEEEEEccCCce--EEEEEeeccccc--hhHHHHHHHHHHHHhCC-CchHHhHHHhee--cCCe
Confidence 5799999999999999999988776644 999999875432 22477899999999995 599999999874 4667
Q ss_pred EEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
++++||++ +++|.+++...... ........++.++.|++.||+|||++||+||||||+||||+.+. ..+.+|
T Consensus 95 ~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~------~~~~~k 167 (285)
T 3is5_A 95 MYIVMETCEGGELLERIVSAQAR-GKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTS------PHSPIK 167 (285)
T ss_dssp EEEEECCCSCCBHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSS------TTCCEE
T ss_pred EEEEEEeCCCCcHHHHHHhhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCC------CCCCEE
Confidence 89999976 46898888654211 11344566677788999999999999999999999999996541 235799
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||++........ .....||+.|+|||++.+. ++.++|||||||++|||++|..||.+......
T Consensus 168 l~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~----------~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~- 233 (285)
T 3is5_A 168 IIDFGLAELFKSDEH---STNAAGTALYMAPEVFKRD----------VTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV- 233 (285)
T ss_dssp ECCCCCCCC-------------CTTGGGCCHHHHTTC----------CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-
T ss_pred EEeeecceecCCccc---CcCcccccCcCChHHhccC----------CCcccCeehHHHHHHHHHhCCCCCCCCCHHHH-
Confidence 999999987654332 2356799999999998532 68899999999999999999999987544321
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
......... .+. .....+++.+.+||.+||+.||++|||+.|++++
T Consensus 234 ~~~~~~~~~--~~~---~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 234 QQKATYKEP--NYA---VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp HHHHHHCCC--CCC---C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred HhhhccCCc--ccc---cccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111111111 111 1122478999999999999999999999999864
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=355.41 Aligned_cols=268 Identities=18% Similarity=0.283 Sum_probs=200.7
Q ss_pred ecCcceEEEeeeeee--CceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEe
Q psy14267 253 LNGKQYQVLSLLGKG--GSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYD 330 (553)
Q Consensus 253 ~~~~~y~i~~~LG~G--~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~ 330 (553)
..+++|+++++||+| +||.||+|++..++.. ||||++...... ....+.+.+|+.+|+++. ||||+++++++..
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~--vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~ 97 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEY--VTVRRINLEACS-NEMVTFLQGELHVSKLFN-HPNIVPYRATFIA 97 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCE--EEEEEEEGGGSC-HHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEE
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCCE--EEEEEecccccC-hHHHHHHHHHHHHHHhCC-CCCCCcEeEEEEE
Confidence 456789999999999 9999999998877654 999999876544 355678899999999995 5999999998864
Q ss_pred CCCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCC
Q psy14267 331 TASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCI 409 (553)
Q Consensus 331 ~~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~ 409 (553)
...++++||++ +++|.+++...... ......+..++.||+.||+|||++|||||||||+||||+.+
T Consensus 98 --~~~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~-------- 164 (389)
T 3gni_B 98 --DNELWVVTSFMAYGSAKDLICTHFMD---GMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVD-------- 164 (389)
T ss_dssp --TTEEEEEEECCTTCBHHHHHHHTCTT---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT--------
T ss_pred --CCEEEEEEEccCCCCHHHHHhhhccc---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC--------
Confidence 56789999976 57999998875322 24456667778899999999999999999999999999776
Q ss_pred CCeEEEEeccCccccCCCCCc-----ccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCC
Q psy14267 410 GNVLKIIDFGIACSLQDDKTS-----VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTP 484 (553)
Q Consensus 410 ~~~vkL~DFGla~~~~~~~~~-----~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~P 484 (553)
+.+||+|||++......... ......+||+.|+|||++.+.. ..++.++|||||||++|||++|..|
T Consensus 165 -~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~~~DiwslG~il~el~~g~~p 236 (389)
T 3gni_B 165 -GKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNL-------QGYDAKSDIYSVGITACELANGHVP 236 (389)
T ss_dssp -CCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTS-------SCBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred -CCEEEcccccceeeccccccccccccccccccccccccCHHHHhccC-------CCCCcHhHHHHHHHHHHHHHHCCCC
Confidence 57999999998765332211 1112347899999999997631 1378999999999999999999999
Q ss_pred CCCCCchHHHHHHHHhhcccc-------------------------------------cccccccCCCCCCHHHHHHHHH
Q psy14267 485 YSHIPNTWAKMLAIARHKDQI-------------------------------------EFKPQLANNVTIPPTLLQSMKL 527 (553)
Q Consensus 485 f~~~~~~~~~~~~i~~~~~~~-------------------------------------~~~~~~~~~~~~s~~l~~li~~ 527 (553)
|.+..........+......+ ...+.......+++++.+||.+
T Consensus 237 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ 316 (389)
T 3gni_B 237 FKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQ 316 (389)
T ss_dssp TTTCCSTTHHHHC--------------------------------------------------------CCHHHHHHHHH
T ss_pred CCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHH
Confidence 987544322211111000000 0000111223578899999999
Q ss_pred hcccCCCCCCCHHHHHHH
Q psy14267 528 CLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 528 cL~~dP~~RPt~~ell~~ 545 (553)
||+.||++|||+.|++++
T Consensus 317 ~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 317 CLQRNPDARPSASTLLNH 334 (389)
T ss_dssp HTCSCTTTSCCHHHHTTS
T ss_pred HhhcCcccCCCHHHHhcC
Confidence 999999999999999876
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=351.74 Aligned_cols=259 Identities=24% Similarity=0.374 Sum_probs=192.5
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|++++.||+|+||.||+|++..++.. ||||++...... .....+.+|+.+|+++. ||||+++++++. ....
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~--vavK~~~~~~~~--~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--~~~~ 74 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNL--VALKEIRLEHEE--GAPCTAIREVSLLKDLK-HANIVTLHDIIH--TEKS 74 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCE--EEEEEECC--------CCCCCCCHHHHSCCC-CTTBCCEEEEEE--CSSC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcE--EEEEEEeccccc--ccchhHHHHHHHHHhcC-CCCCCeeeeEEe--eCCE
Confidence 4799999999999999999988776654 999999754421 11124568999999995 599999999874 4567
Q ss_pred EEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 336 LYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 336 ~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
++++||+++++|.+++..... ......+..++.||+.||+|||++||+||||||+||||+.+ +.+||
T Consensus 75 ~~lv~e~~~~~l~~~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~---------~~~kl 141 (324)
T 3mtl_A 75 LTLVFEYLDKDLKQYLDDCGN----IINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINER---------GELKL 141 (324)
T ss_dssp EEEEEECCSEEHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTT---------CCEEE
T ss_pred EEEEecccccCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCC---------CCEEE
Confidence 899999999999999987543 23455566677899999999999999999999999999776 57999
Q ss_pred EeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHH
Q psy14267 416 IDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKM 495 (553)
Q Consensus 416 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~ 495 (553)
+|||+++........ .....||+.|+|||++.+.. .++.++|||||||++|||++|..||.+.... ..+
T Consensus 142 ~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~--------~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~ 210 (324)
T 3mtl_A 142 ADFGLARAKSIPTKT--YDNEVVTLWYRPPDILLGST--------DYSTQIDMWGVGCIFYEMATGRPLFPGSTVE-EQL 210 (324)
T ss_dssp CSSSEEECC--------------CGGGCCHHHHTTCC--------CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHH
T ss_pred ccCcccccccCCccc--cccccCcccccChhhhcCCC--------CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHH
Confidence 999999866543321 22457899999999987542 3789999999999999999999999875543 222
Q ss_pred HHHHhhcccc---ccc-------------------ccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 496 LAIARHKDQI---EFK-------------------PQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 496 ~~i~~~~~~~---~~~-------------------~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
..+....... .+. ........++.++.+||.+||+.||++|||++|++++
T Consensus 211 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 211 HFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp HHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 2222211110 000 0011123578899999999999999999999999874
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=350.11 Aligned_cols=262 Identities=24% Similarity=0.334 Sum_probs=201.7
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC--
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA-- 332 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~-- 332 (553)
+.+|++++.||+|+||.||+|.+..++.. ||||++.... .....+.+.+|+++|+++. ||||+.+++++....
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~--vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 100 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVR--VAIKKISPFE--HQTYCQRTLREIKILLRFR-HENIIGINDIIRAPTIE 100 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEE--EEEEEECCTT--CHHHHHHHHHHHHHHHHCC-CTTBCCCCEEECCSSTT
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeE--EEEEEecccc--CcHHHHHHHHHHHHHHhcC-CCCCccceeEEecCCcc
Confidence 46899999999999999999988776644 9999997543 3445578999999999995 699999999875432
Q ss_pred -CceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCC
Q psy14267 333 -SKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGN 411 (553)
Q Consensus 333 -~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~ 411 (553)
...++++|++++++|.+++... ......+..++.||+.||+|||++|||||||||+||||+.+ +
T Consensus 101 ~~~~~~iv~e~~~~~L~~~l~~~------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~---------~ 165 (364)
T 3qyz_A 101 QMKDVYIVQDLMETDLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTT---------C 165 (364)
T ss_dssp TCCCEEEEEECCSEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT---------C
T ss_pred ccceEEEEEcccCcCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCC---------C
Confidence 2578999999999999998764 24456677778899999999999999999999999999776 5
Q ss_pred eEEEEeccCccccCCCCCcc-cccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCc
Q psy14267 412 VLKIIDFGIACSLQDDKTSV-HKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN 490 (553)
Q Consensus 412 ~vkL~DFGla~~~~~~~~~~-~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~ 490 (553)
.+||+|||+++......... .....+||+.|+|||++.+.. .++.++|||||||++|||++|..||.+...
T Consensus 166 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--------~~~~~~DiwslG~il~ell~g~~pf~~~~~ 237 (364)
T 3qyz_A 166 DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK--------GYTKSIDIWSVGCILAEMLSNRPIFPGKHY 237 (364)
T ss_dssp CEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBC--------SCSTHHHHHHHHHHHHHHHHSSCSSCCSSG
T ss_pred CEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCC--------CCCcchhHHHHHHHHHHHHHCCCCCCCCCh
Confidence 79999999998765432211 123567999999999876442 368899999999999999999999987543
Q ss_pred hHHHHHHHHhhccccc-----------------------ccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 491 TWAKMLAIARHKDQIE-----------------------FKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 491 ~~~~~~~i~~~~~~~~-----------------------~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
.. .+..+........ ..+.......++.++.+||.+||..||++|||+.|++++
T Consensus 238 ~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 238 LD-QLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp GG-HHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HH-HHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 31 2222111000000 000001113578999999999999999999999999875
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=348.18 Aligned_cols=261 Identities=17% Similarity=0.250 Sum_probs=196.7
Q ss_pred cCcceEEEeeeeeeCceEEEEEeeeCCCcc--ceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeC
Q psy14267 254 NGKQYQVLSLLGKGGSSSVYLVGGTSEHEF--KPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDT 331 (553)
Q Consensus 254 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~--~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~ 331 (553)
...+|+++++||+|+||.||+|.+..++.. .+||+|++...... ...+.+.+|+.+++++. ||||+++++++.
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~-- 85 (325)
T 3kex_A 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR--QSFQAVTDHMLAIGSLD-HAHIVRLLGLCP-- 85 (325)
T ss_dssp CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSC--SCBCSCCHHHHHHHTCC-CTTBCCEEEEEC--
T ss_pred CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccH--HHHHHHHHHHHHHhcCC-CCCcCeEEEEEc--
Confidence 456899999999999999999988765543 23777777544321 22356778999999995 699999999763
Q ss_pred CCceEEEEEec-CCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCC
Q psy14267 332 ASKHLYVLMEK-GDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIG 410 (553)
Q Consensus 332 ~~~~~~iv~e~-~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~ 410 (553)
+..++++|++ .+++|.+++..... ......++.++.||+.||+|||++|||||||||+||||+.+
T Consensus 86 -~~~~~~v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~--------- 151 (325)
T 3kex_A 86 -GSSLQLVTQYLPLGSLLDHVRQHRG----ALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSP--------- 151 (325)
T ss_dssp -BSSEEEEEECCTTCBSHHHHHSSGG----GSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSS---------
T ss_pred -CCccEEEEEeCCCCCHHHHHHHccc----cCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCC---------
Confidence 3346666665 56899999876532 22334456667799999999999999999999999999776
Q ss_pred CeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCCC
Q psy14267 411 NVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHIP 489 (553)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~~ 489 (553)
+.+||+|||+++.+.............||+.|+|||++.+. .++.++|||||||++|||++ |..||....
T Consensus 152 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 222 (325)
T 3kex_A 152 SQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG---------KYTHQSDVWSYGVTVWELMTFGAEPYAGLR 222 (325)
T ss_dssp SCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHC---------CCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred CeEEECCCCcccccCcccccccccCCCCcccccChHHhccC---------CCChhhHhHHhHHHHHHHHhCCCCCccccC
Confidence 57999999999987665544344456788999999999765 37899999999999999999 999998754
Q ss_pred chHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q psy14267 490 NTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNP 550 (553)
Q Consensus 490 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~ 550 (553)
.. .....+. ..... .....++.++.++|.+||..||++||++.+++++|+...
T Consensus 223 ~~-~~~~~~~-~~~~~------~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 223 LA-EVPDLLE-KGERL------AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp TT-HHHHHHH-TTCBC------CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred HH-HHHHHHH-cCCCC------CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 43 2222222 11111 122246788999999999999999999999999998743
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=368.11 Aligned_cols=265 Identities=19% Similarity=0.359 Sum_probs=210.4
Q ss_pred ceEEecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEE
Q psy14267 249 DVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYV 328 (553)
Q Consensus 249 ~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~ 328 (553)
..|++...+|++.+.||+|+||.||++.+...+. .||||+++..... .+.+.+|+.+|++++ ||||+++++++
T Consensus 213 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~--~vavK~~~~~~~~----~~~~~~E~~~l~~l~-hpniv~l~~~~ 285 (495)
T 1opk_A 213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSL--TVAVKTLKEDTME----VEEFLKEAAVMKEIK-HPNLVQLLGVC 285 (495)
T ss_dssp SCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTE--EEEEEECCSSSSC----HHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred cccccCHHHceeeeEecCCCCeEEEEEEEcCCCe--EEEEEEecCcccc----hHHHHHHHHHHHhcC-CCCEeeEEEEE
Confidence 4466777899999999999999999998876554 4999999765422 467899999999995 69999999987
Q ss_pred EeCCCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceec
Q psy14267 329 YDTASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIID 407 (553)
Q Consensus 329 ~~~~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~ 407 (553)
.....++++||++ +++|.++++..... ......++.++.||+.||+|||++|||||||||+||||+.+
T Consensus 286 --~~~~~~~lv~E~~~~g~L~~~l~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~------ 354 (495)
T 1opk_A 286 --TREPPFYIITEFMTYGNLLDYLRECNRQ---EVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGEN------ 354 (495)
T ss_dssp --CSSSSCEEEEECCTTCBHHHHHHHSCTT---TSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG------
T ss_pred --ecCCcEEEEEEccCCCCHHHHHHhcCcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCC------
Confidence 3456788999976 48999999875432 34456667777899999999999999999999999999776
Q ss_pred CCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCC
Q psy14267 408 CIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYS 486 (553)
Q Consensus 408 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~ 486 (553)
+.+||+|||+++........ ......+++.|+|||++.+. .++.++|||||||+||||++ |..||.
T Consensus 355 ---~~~kl~DFG~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~---------~~~~~sDvwSlG~~l~el~t~g~~p~~ 421 (495)
T 1opk_A 355 ---HLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYN---------KFSIKSDVWAFGVLLWEIATYGMSPYP 421 (495)
T ss_dssp ---GCEEECCTTCEECCTTCCEE-CCTTCCCCGGGCCHHHHHHC---------EECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ---CcEEEeecccceeccCCcee-ecCCCcCCcceeCHhHHhcC---------CCCcHHhHHhHHHHHHHHHhCCCCCCC
Confidence 57999999999877543322 22244567899999999765 37899999999999999998 999998
Q ss_pred CCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCCC
Q psy14267 487 HIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNPEG 552 (553)
Q Consensus 487 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~~~ 552 (553)
+.... .....+. .... ......+++.+.+||.+||+.||++|||+.+|++.|+.+...
T Consensus 422 ~~~~~-~~~~~~~-~~~~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 422 GIDLS-QVYELLE-KDYR------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp TCCGG-GHHHHHH-TTCC------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred CCCHH-HHHHHHH-cCCC------CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 76543 1222222 1111 222347889999999999999999999999999999987653
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=337.90 Aligned_cols=251 Identities=24% Similarity=0.396 Sum_probs=197.5
Q ss_pred cCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCC
Q psy14267 254 NGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTAS 333 (553)
Q Consensus 254 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~ 333 (553)
..++|++++.||+|+||.||+|.+..++.. ||||++.+...........+.+|+.+++++. ||||+++++++. ..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~ 81 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFI--LALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFH--DA 81 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCE--EEEEEEEHHHHHHHTCHHHHHHHHHHHTTCC-CTTBCCEEEEEE--CS
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcE--EEEEEEeccccchhhHHHHHHHHHHHHHcCC-CCCCcchhheEe--cC
Confidence 346899999999999999999988777654 9999997654444444567899999999996 599999999874 45
Q ss_pred ceEEEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCe
Q psy14267 334 KHLYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNV 412 (553)
Q Consensus 334 ~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~ 412 (553)
..++++||++. ++|.+++..... .....++.++.|++.||+|||++||+||||||+||||+.+ +.
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~-----~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~---------~~ 147 (279)
T 3fdn_A 82 TRVYLILEYAPLGTVYRELQKLSK-----FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSA---------GE 147 (279)
T ss_dssp SEEEEEECCCTTEEHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTT---------SC
T ss_pred CEEEEEEecCCCCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCC---------CC
Confidence 67899999865 689888877643 3455666777899999999999999999999999999776 57
Q ss_pred EEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchH
Q psy14267 413 LKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTW 492 (553)
Q Consensus 413 vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~ 492 (553)
+||+|||++........ ....||+.|+|||++.+. .++.++||||||+++|+|++|..||......
T Consensus 148 ~~l~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~~g~~p~~~~~~~- 213 (279)
T 3fdn_A 148 LKIADFGWSVHAPSSRR----TDLCGTLDYLPPEMIEGR---------MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ- 213 (279)
T ss_dssp EEECSCCEESCC------------CCCCTTCCHHHHTTC---------CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-
T ss_pred EEEEeccccccCCcccc----cccCCCCCccCHhHhccC---------CCCccchhHhHHHHHHHHHHCCCCCCCCcHH-
Confidence 99999999865544322 255799999999999765 3678999999999999999999999875432
Q ss_pred HHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 493 AKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 493 ~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
.....+.... .. ....++..+.+||.+||+.||++|||+.|++++
T Consensus 214 ~~~~~~~~~~--~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 214 ETYKRISRVE--FT------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp HHHHHHHHTC--CC------CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred HHHHHHHhCC--CC------CCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 2222222211 11 122578999999999999999999999999975
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=337.62 Aligned_cols=262 Identities=22% Similarity=0.369 Sum_probs=203.1
Q ss_pred EecCcceEEEe-eeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEe
Q psy14267 252 TLNGKQYQVLS-LLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYD 330 (553)
Q Consensus 252 ~~~~~~y~i~~-~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~ 330 (553)
.+...+|++.+ .||+|+||.||++.+......+.||||++...... ....+.+.+|+.+++++. ||||+++++++.
T Consensus 12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~- 88 (291)
T 1xbb_A 12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-PALKDELLAEANVMQQLD-NPYIVRMIGICE- 88 (291)
T ss_dssp BCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCC-CTTBCCEEEEEE-
T ss_pred eecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccC-HHHHHHHHHHHHHHHhCC-CCCEEEEEEEEC-
Confidence 34567899998 99999999999997765555567999999766433 344578999999999995 699999999872
Q ss_pred CCCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCC
Q psy14267 331 TASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCI 409 (553)
Q Consensus 331 ~~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~ 409 (553)
...++++||++ +++|.+++.... ......++.++.||+.||+|||++||+||||||+||||+.+
T Consensus 89 --~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~-------- 153 (291)
T 1xbb_A 89 --AESWMLVMEMAELGPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ-------- 153 (291)
T ss_dssp --SSSEEEEEECCTTEEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET--------
T ss_pred --CCCcEEEEEeCCCCCHHHHHHhCc-----CCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCC--------
Confidence 34678888876 578999998753 23455667778899999999999999999999999999876
Q ss_pred CCeEEEEeccCccccCCCCCcc-cccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCC
Q psy14267 410 GNVLKIIDFGIACSLQDDKTSV-HKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSH 487 (553)
Q Consensus 410 ~~~vkL~DFGla~~~~~~~~~~-~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~ 487 (553)
+.+||+|||++.......... ......|++.|+|||++.+. .++.++||||||+++|||++ |..||..
T Consensus 154 -~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~~~g~~p~~~ 223 (291)
T 1xbb_A 154 -HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY---------KFSSKSDVWSFGVLMWEAFSYGQKPYRG 223 (291)
T ss_dssp -TEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHC---------EEEHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred -CcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccC---------CCChhhhHHHHHHHHHHHHhcCCCCCCC
Confidence 579999999998876544321 12234577899999999765 36789999999999999999 9999987
Q ss_pred CCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 488 IPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 488 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
.... .....+.. .... .....+++.+.++|.+||+.||++||++.++++.|+++
T Consensus 224 ~~~~-~~~~~~~~-~~~~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 224 MKGS-EVTAMLEK-GERM------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp CCHH-HHHHHHHT-TCCC------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCHH-HHHHHHHc-CCCC------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 5543 22222222 1111 12236789999999999999999999999999999875
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=336.56 Aligned_cols=262 Identities=20% Similarity=0.347 Sum_probs=203.9
Q ss_pred EecCcceEEEe-eeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEe
Q psy14267 252 TLNGKQYQVLS-LLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYD 330 (553)
Q Consensus 252 ~~~~~~y~i~~-~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~ 330 (553)
.+..++|.+.+ .||+|+||.||+|.+........||||+++... .....+.+.+|+++|+++. ||||+++++++.
T Consensus 5 ~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~- 80 (287)
T 1u59_A 5 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLD-NPYIVRLIGVCQ- 80 (287)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEE-
T ss_pred cccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCC-CCCEeEEEEEec-
Confidence 34556788887 999999999999987655555679999997653 3445678999999999994 699999999872
Q ss_pred CCCceEEEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCC
Q psy14267 331 TASKHLYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCI 409 (553)
Q Consensus 331 ~~~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~ 409 (553)
...++++||++. ++|.+++..... ......++.++.|++.||+|||++||+||||||+|||++.+
T Consensus 81 --~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~-------- 146 (287)
T 1u59_A 81 --AEALMLVMEMAGGGPLHKFLVGKRE----EIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNR-------- 146 (287)
T ss_dssp --SSSEEEEEECCTTEEHHHHHTTCTT----TSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEET--------
T ss_pred --CCCcEEEEEeCCCCCHHHHHHhCCc----cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCC--------
Confidence 345788888764 689988864322 34456677778899999999999999999999999999876
Q ss_pred CCeEEEEeccCccccCCCCCc-ccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCC
Q psy14267 410 GNVLKIIDFGIACSLQDDKTS-VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSH 487 (553)
Q Consensus 410 ~~~vkL~DFGla~~~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~ 487 (553)
+.+||+|||++......... .......||+.|+|||++.+. .++.++|||||||++|||++ |..||..
T Consensus 147 -~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~ellt~g~~p~~~ 216 (287)
T 1u59_A 147 -HYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR---------KFSSRSDVWSYGVTMWEALSYGQKPYKK 216 (287)
T ss_dssp -TEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHC---------EECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred -CCEEECcccceeeeccCcceeeccccccccccccCHHHhccC---------CCCchhhHHHHHHHHHHHHcCCCCCccc
Confidence 67999999999887544332 122344578999999999755 37889999999999999998 9999987
Q ss_pred CCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 488 IPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 488 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
.... .....+... ... .....+++.+.++|..||..||++||++.+++++|+++
T Consensus 217 ~~~~-~~~~~i~~~-~~~------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 217 MKGP-EVMAFIEQG-KRM------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp CCTH-HHHHHHHTT-CCC------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCHH-HHHHHHhcC-CcC------CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 5543 222333222 111 12236889999999999999999999999999999874
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=356.50 Aligned_cols=254 Identities=22% Similarity=0.363 Sum_probs=201.4
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
+.|++++.||+|+||.||+|.+..++.. ||+|++..... .....+.+|+.+|+++. ||||+++++++. ....
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~--~a~K~~~~~~~---~~~~~~~~E~~il~~l~-hpnIv~~~~~~~--~~~~ 122 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRV--FVAKFINTPYP---LDKYTVKNEISIMNQLH-HPKLINLHDAFE--DKYE 122 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCE--EEEEEEECCSH---HHHHHHHHHHHHHTTCC-STTBCCEEEEEE--CSSE
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCE--EEEEEecccch---hhHHHHHHHHHHHHhCC-CcCCCeEEEEEE--eCCE
Confidence 5799999999999999999988776654 99999976542 23467889999999995 699999999874 4668
Q ss_pred EEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
++++||++ +++|.+++.... ..+....++.++.||+.||+|||++||+||||||+||||+.+. .+.+|
T Consensus 123 ~~lv~E~~~gg~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~-------~~~vk 191 (387)
T 1kob_A 123 MVLILEFLSGGELFDRIAAED----YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKK-------ASSVK 191 (387)
T ss_dssp EEEEEECCCCCBHHHHTTCTT----CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTT-------CCCEE
T ss_pred EEEEEEcCCCCcHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCC-------CCceE
Confidence 89999976 578988876432 1345666777888999999999999999999999999997532 25699
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||+++........ ...+||+.|+|||++.+. .++.++|||||||++|||++|..||.+.... ..
T Consensus 192 L~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~---------~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-~~ 258 (387)
T 1kob_A 192 IIDFGLATKLNPDEIV---KVTTATAEFAAPEIVDRE---------PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-ET 258 (387)
T ss_dssp ECCCTTCEECCTTSCE---EEECSSGGGCCHHHHTTC---------CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-HH
T ss_pred EEecccceecCCCcce---eeeccCCCccCchhccCC---------CCCCcccEeeHhHHHHHHHhCCCCCCCCCHH-HH
Confidence 9999999887654322 245799999999999765 3788999999999999999999999875432 33
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
+..+..... .+. ......+++++.+||.+||..||++|||+.+++++
T Consensus 259 ~~~i~~~~~--~~~--~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 259 LQNVKRCDW--EFD--EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp HHHHHHCCC--CCC--SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhCCC--CCC--ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 333332221 111 22234688999999999999999999999999875
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=342.92 Aligned_cols=249 Identities=24% Similarity=0.391 Sum_probs=197.9
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceE
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHL 336 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~ 336 (553)
.|...+.||+|+||.||+|++..++. .||||++....... .+.+.+|+.+|++++ ||||+++++++.. ...+
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~--~vavK~~~~~~~~~---~~~~~~E~~~l~~l~-h~niv~~~~~~~~--~~~~ 117 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGR--QVAVKMMDLRKQQR---RELLFNEVVIMRDYQ-HFNVVEMYKSYLV--GEEL 117 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCC--EEEEEEEETTTCCS---HHHHHHHHHHHTTCC-CTTBCCEEEEEEE--TTEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCc--EEEEEEEeccchhH---HHHHHHHHHHHHhCC-CCCcceEEEEEEE--CCEE
Confidence 48888999999999999998876664 49999998665332 467889999999995 5999999998765 4578
Q ss_pred EEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 337 YVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 337 ~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
+++||++ +++|.+++... ......+..++.|++.||+|||++||+||||||+||||+.+ +.+||
T Consensus 118 ~lv~e~~~~~~L~~~l~~~------~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~---------~~~kl 182 (321)
T 2c30_A 118 WVLMEFLQGGALTDIVSQV------RLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLD---------GRVKL 182 (321)
T ss_dssp EEEECCCCSCBHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---------CCEEE
T ss_pred EEEEecCCCCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC---------CcEEE
Confidence 9999975 67888877542 24456677778899999999999999999999999999776 57999
Q ss_pred EeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHH
Q psy14267 416 IDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKM 495 (553)
Q Consensus 416 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~ 495 (553)
+|||++......... .....||+.|+|||++.+. .++.++|||||||++|||++|..||...... ..+
T Consensus 183 ~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~---------~~~~~~Dv~slG~il~el~~g~~pf~~~~~~-~~~ 250 (321)
T 2c30_A 183 SDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRS---------LYATEVDIWSLGIMVIEMVDGEPPYFSDSPV-QAM 250 (321)
T ss_dssp CCCTTCEECCSSSCC--BCCCCSCGGGCCHHHHTTC---------CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHH
T ss_pred eeeeeeeecccCccc--cccccCCccccCHhhhcCC---------CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHH
Confidence 999999877543321 2356799999999999765 3788999999999999999999999875443 222
Q ss_pred HHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 496 LAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 496 ~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
..+.... .+.+.....+++.+.++|.+||+.||++|||+.+++++
T Consensus 251 ~~~~~~~-----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 251 KRLRDSP-----PPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHHHHSS-----CCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHhcCC-----CCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 2222221 11122233578999999999999999999999999875
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=351.66 Aligned_cols=254 Identities=24% Similarity=0.358 Sum_probs=179.0
Q ss_pred cceEEE---eeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC
Q psy14267 256 KQYQVL---SLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA 332 (553)
Q Consensus 256 ~~y~i~---~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~ 332 (553)
++|++. +.||+|+||.||+|.+..++.. ||||++.+. ....+.+|+.+|+++.+||||+++++++. .
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~--vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~--~ 77 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQA--FAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFH--D 77 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCE--EEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEE--C
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCE--EEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEE--c
Confidence 356665 7899999999999988777654 999999653 23567899999999987899999999874 4
Q ss_pred CceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCC
Q psy14267 333 SKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGN 411 (553)
Q Consensus 333 ~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~ 411 (553)
...++++||++ +++|.+++.... ......+..++.||+.||+|||++||+||||||+||||+.+. ...
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~------~~~ 146 (325)
T 3kn6_A 78 QLHTFLVMELLNGGELFERIKKKK-----HFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDEN------DNL 146 (325)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHCS-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----------C
T ss_pred CCEEEEEEEccCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCC------Ccc
Confidence 66889999986 569999998753 344566777788999999999999999999999999997652 123
Q ss_pred eEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCc-
Q psy14267 412 VLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN- 490 (553)
Q Consensus 412 ~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~- 490 (553)
.+||+|||+++........ ....+||+.|+|||++.+. .++.++|||||||++|||++|..||.....
T Consensus 147 ~~kl~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~---------~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 215 (325)
T 3kn6_A 147 EIKIIDFGFARLKPPDNQP--LKTPCFTLHYAAPELLNQN---------GYDESCDLWSLGVILYTMLSGQVPFQSHDRS 215 (325)
T ss_dssp EEEECCCTTCEECCC------------------------C---------CCCHHHHHHHHHHHHHHHHHSSCTTC-----
T ss_pred cEEEeccccceecCCCCCc--ccccCCCcCccCHHHhcCC---------CCCCccchHHHHHHHHHHHhCCCCCCCCccc
Confidence 7999999999876554322 2356789999999999765 378899999999999999999999976332
Q ss_pred -----hHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 491 -----TWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 491 -----~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
....+..+.... +......+..+++++++||.+||..||++|||+.+++++
T Consensus 216 ~~~~~~~~~~~~i~~~~----~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 216 LTCTSAVEIMKKIKKGD----FSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp --CCCHHHHHHHHTTTC----CCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred cccccHHHHHHHHHcCC----CCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 112222222211 111111223578999999999999999999999998854
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=357.86 Aligned_cols=258 Identities=25% Similarity=0.361 Sum_probs=199.0
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhc-----CCCceeEeeeEEE
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQ-----GCPYVIKMHDYVY 329 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~-----~hp~Iv~l~~~~~ 329 (553)
..+|+++++||+|+||.||+|.+..++.. ||||++... ....+.+.+|+.+++.++ +|+||+.+++++.
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~--vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~ 169 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQH--VALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT 169 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEE--EEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcE--EEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc
Confidence 46799999999999999999988777654 999999753 344567889999999885 4579999998775
Q ss_pred eCCCceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCC
Q psy14267 330 DTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCI 409 (553)
Q Consensus 330 ~~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~ 409 (553)
. ...++++||+++++|.+++...... .+.+..+..++.||+.||+|||++|||||||||+||||+.+..
T Consensus 170 ~--~~~~~lv~e~~~~~L~~~l~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~------ 238 (429)
T 3kvw_A 170 F--RNHICMTFELLSMNLYELIKKNKFQ---GFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGR------ 238 (429)
T ss_dssp E--TTEEEEEECCCCCBHHHHHHHTTTC---CCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTS------
T ss_pred c--CCeEEEEEeccCCCHHHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCC------
Confidence 4 5689999999999999999875432 2445566777889999999999999999999999999987621
Q ss_pred CCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy14267 410 GNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIP 489 (553)
Q Consensus 410 ~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~ 489 (553)
..+||+|||+|+...... ...+||+.|+|||++.+. .++.++|||||||+||||++|.+||.+..
T Consensus 239 -~~vkL~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~---------~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 239 -SGIKVIDFGSSCYEHQRV-----YTYIQSRFYRAPEVILGA---------RYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp -CCEEECCCTTCEETTCCC-----CSSCSCGGGCCHHHHHTB---------CCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred -cceEEeecccceecCCcc-----cccCCCCCccChHHHhCC---------CCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 239999999997654332 256799999999999866 37899999999999999999999998765
Q ss_pred chHHHHHHHHhhccccc------------------cc----------------------------ccc-----cCCCCCC
Q psy14267 490 NTWAKMLAIARHKDQIE------------------FK----------------------------PQL-----ANNVTIP 518 (553)
Q Consensus 490 ~~~~~~~~i~~~~~~~~------------------~~----------------------------~~~-----~~~~~~s 518 (553)
.. ..+..+........ +. +.. ......+
T Consensus 304 ~~-~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 382 (429)
T 3kvw_A 304 EG-DQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDD 382 (429)
T ss_dssp HH-HHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCC
T ss_pred HH-HHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccch
Confidence 43 22222221100000 00 000 0011247
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 519 PTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 519 ~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
+.+.+||++||+.||++|||+.|+++|
T Consensus 383 ~~~~dli~~~L~~dP~~Rpta~e~L~H 409 (429)
T 3kvw_A 383 PLFLDFLKQCLEWDPAVRMTPGQALRH 409 (429)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHCCCChhhCCCHHHHhCC
Confidence 889999999999999999999999875
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=343.49 Aligned_cols=271 Identities=23% Similarity=0.364 Sum_probs=209.3
Q ss_pred eEEecCcceEEEeeeeeeCceEEEEEeeeC---CCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeee
Q psy14267 250 VITLNGKQYQVLSLLGKGGSSSVYLVGGTS---EHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHD 326 (553)
Q Consensus 250 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~---~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~ 326 (553)
.|.+..++|++.+.||+|+||.||+|.+.. ....+.||||++.... .......+.+|+.+|+++. ||||+++++
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~ 95 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFN-CHHVVRLLG 95 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCC-CTTBCCEEE
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcC-CCCEeeeEE
Confidence 345667899999999999999999998763 1233569999997543 2334567899999999995 599999998
Q ss_pred EEEeCCCceEEEEEecC-CCCHHHHHHHcccC-----CCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEec
Q psy14267 327 YVYDTASKHLYVLMEKG-DTDLSKYMRNLNKM-----TTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVG 400 (553)
Q Consensus 327 ~~~~~~~~~~~iv~e~~-~~~L~~~l~~~~~~-----~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~ 400 (553)
++ ......+++||++ +++|.+++...... .........++.++.||+.||+|||++||+||||||+||||+.
T Consensus 96 ~~--~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~ 173 (322)
T 1p4o_A 96 VV--SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE 173 (322)
T ss_dssp EE--CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECT
T ss_pred EE--ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcC
Confidence 77 4456788999986 56999998864321 1123345667777889999999999999999999999999987
Q ss_pred CccceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh
Q psy14267 401 NVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY 480 (553)
Q Consensus 401 ~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt 480 (553)
+ +.+||+|||+++...............||+.|+|||++.+. .++.++|||||||++|||++
T Consensus 174 ~---------~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~el~~ 235 (322)
T 1p4o_A 174 D---------FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG---------VFTTYSDVWSFGVVLWEIAT 235 (322)
T ss_dssp T---------CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC---------CCCHHHHHHHHHHHHHHHHH
T ss_pred C---------CeEEECcCccccccccccccccccCCCCCCCccChhhhccC---------CCCchhhHHHHHHHHHHHHh
Confidence 6 57999999999876544332233355678999999999765 37899999999999999999
Q ss_pred -CCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q psy14267 481 -GRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNPE 551 (553)
Q Consensus 481 -G~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~~ 551 (553)
|..||...... .....+.... . ......++..+.++|.+||..||++|||+.+++++|++...
T Consensus 236 ~g~~p~~~~~~~-~~~~~~~~~~-~------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 236 LAEQPYQGLSNE-QVLRFVMEGG-L------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp TSCCTTTTSCHH-HHHHHHHTTC-C------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred cCCCccccCCHH-HHHHHHHcCC-c------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 89999876543 2222222211 1 11223678999999999999999999999999999998643
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=367.17 Aligned_cols=255 Identities=25% Similarity=0.373 Sum_probs=201.9
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|+++++||+|+||+||+|.+..++.. ||||++.+..... .....+.+|+.+|+++. ||||+++++++. ....
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~--vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~-hpniv~~~~~~~--~~~~ 95 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQE--YAVKVINKASAKN-KDTSTILREVELLKKLD-HPNIMKLFEILE--DSSS 95 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCE--EEEEEEEHHHHBC-SCHHHHHHHHHHHHHCC-CTTBCCEEEEEE--CSSE
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCE--EEEEEEecccccc-hHHHHHHHHHHHHHhCC-CCCcCeEEEEEE--cCCE
Confidence 5799999999999999999988766644 9999997644322 22467899999999995 699999998874 4668
Q ss_pred EEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
++++||++ +++|.+++..... .....+..++.||+.||+|||++|||||||||+||||+.. ...+.+|
T Consensus 96 ~~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~------~~~~~~k 164 (486)
T 3mwu_A 96 FYIVGELYTGGELFDEIIKRKR-----FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESK------EKDCDIK 164 (486)
T ss_dssp EEEEECCCCSCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSS------STTCCEE
T ss_pred EEEEEEcCCCCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecC------CCCCCEE
Confidence 89999975 5789888876542 3456677778899999999999999999999999999654 2235799
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||+++.+..... ....+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.... ..
T Consensus 165 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~----------~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~ 230 (486)
T 3mwu_A 165 IIDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRGT----------YDEKCDVWSAGVILYILLSGTPPFYGKNEY-DI 230 (486)
T ss_dssp ECSCSCTTTBCCC-------CCTTGGGGCCGGGGGSC----------CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HH
T ss_pred EEECCcCeECCCCCc---cCCCcCCCCCCCHHHhCCC----------CCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HH
Confidence 999999987655432 2356799999999999643 788999999999999999999999875432 33
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
+..+....... ....+..+++++++||.+||..||++|||+.+++++
T Consensus 231 ~~~i~~~~~~~----~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 231 LKRVETGKYAF----DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp HHHHHHTCCCS----CSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred HHHHHhCCCCC----CCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 44444332221 222334688999999999999999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=345.88 Aligned_cols=273 Identities=21% Similarity=0.302 Sum_probs=204.1
Q ss_pred ceEEecCcceEEEeeeeeeCceEEEEEeeeC---CCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEee
Q psy14267 249 DVITLNGKQYQVLSLLGKGGSSSVYLVGGTS---EHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMH 325 (553)
Q Consensus 249 ~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~---~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~ 325 (553)
...++..++|++++.||+|+||.||+|+... ....+.||||++.... ......++.+|+.+|+++ .||||++++
T Consensus 23 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~ 99 (327)
T 2yfx_A 23 DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKF-NHQNIVRCI 99 (327)
T ss_dssp GSCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHC-CCTTBCCEE
T ss_pred hcccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhC-CCCCCCeEE
Confidence 3445667899999999999999999998532 2233459999996432 234457889999999999 569999999
Q ss_pred eEEEeCCCceEEEEEecC-CCCHHHHHHHcccCC--CCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCc
Q psy14267 326 DYVYDTASKHLYVLMEKG-DTDLSKYMRNLNKMT--TLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNV 402 (553)
Q Consensus 326 ~~~~~~~~~~~~iv~e~~-~~~L~~~l~~~~~~~--~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~ 402 (553)
+++. ....++++||++ +++|.+++....... ........++.++.||+.||+|||++||+||||||+||||+.+.
T Consensus 100 ~~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~ 177 (327)
T 2yfx_A 100 GVSL--QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG 177 (327)
T ss_dssp EEEC--SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSS
T ss_pred EEEc--CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCC
Confidence 8774 455678999987 789999998764321 12355666777788999999999999999999999999997541
Q ss_pred cceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-C
Q psy14267 403 LKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-G 481 (553)
Q Consensus 403 ~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G 481 (553)
.+..+||+|||++................||+.|+|||++.+. .++.++|||||||++|||++ |
T Consensus 178 ------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~ellt~g 242 (327)
T 2yfx_A 178 ------PGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEG---------IFTSKTDTWSFGVLLWEIFSLG 242 (327)
T ss_dssp ------TTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHC---------CCCHHHHHHHHHHHHHHHHTTS
T ss_pred ------CcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCC---------CCCchhhHHHHHHHHHHHHcCC
Confidence 2356999999999866444332223345689999999999765 37899999999999999998 9
Q ss_pred CCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 482 RTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 482 ~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
..||...... .....+... ... .....++..+.++|.+||+.||++||++.+++++|+.+
T Consensus 243 ~~p~~~~~~~-~~~~~~~~~-~~~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 243 YMPYPSKSNQ-EVLEFVTSG-GRM------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp CCSSTTCCHH-HHHHHHHTT-CCC------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCcCHH-HHHHHHhcC-CCC------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 9999875442 222222222 111 12236789999999999999999999999999999864
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=333.25 Aligned_cols=253 Identities=25% Similarity=0.364 Sum_probs=199.7
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|++.+.||+|+||.||+|.+..++.. ||+|++....... .+.+.+|+++|+++ +||||+++++++. ....
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~--~a~k~~~~~~~~~---~~~~~~E~~~l~~l-~h~~i~~~~~~~~--~~~~ 80 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIR--RAAKKIPKYFVED---VDRFKQEIEIMKSL-DHPNIIRLYETFE--DNTD 80 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCE--EEEEEEEGGGCSC---HHHHHHHHHHHHTC-CCTTBCCEEEEEE--CSSE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcE--EEEEeehhhccch---HHHHHHHHHHHHhC-CCCCEeeEEEEEe--cCCe
Confidence 5799999999999999999988776644 9999997654333 46789999999999 5699999999874 4667
Q ss_pred EEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
++++||++ +++|.+++..... .....+..++.|++.||+|||++||+||||||+|||+..+ ...+.+|
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~------~~~~~~~ 149 (277)
T 3f3z_A 81 IYLVMELCTGGELFERVVHKRV-----FRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTD------SPDSPLK 149 (277)
T ss_dssp EEEEEECCCSCBHHHHHHHHCS-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSS------STTCCEE
T ss_pred EEEEEeccCCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecC------CCCCcEE
Confidence 89999986 5689888876542 3456667778899999999999999999999999999432 1226799
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||++........ .....||+.|+|||++.+. ++.++||||||+++|||++|..||...... ..
T Consensus 150 l~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~----------~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~ 215 (277)
T 3f3z_A 150 LIDFGLAARFKPGKM---MRTKVGTPYYVSPQVLEGL----------YGPECDEWSAGVMMYVLLCGYPPFSAPTDS-EV 215 (277)
T ss_dssp ECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHTTC----------BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HH
T ss_pred EEecccceeccCccc---hhccCCCCCccChHHhccc----------CCchhhehhHHHHHHHHHHCCCCCCCCCHH-HH
Confidence 999999987765432 2356799999999998643 688999999999999999999999875543 33
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
...+....... . ...+..+++.+.++|.+||+.||++|||+.+++++
T Consensus 216 ~~~~~~~~~~~--~--~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 216 MLKIREGTFTF--P--EKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp HHHHHHCCCCC--C--HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHHHhCCCCC--C--chhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 33333222111 1 11123578999999999999999999999999864
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=339.39 Aligned_cols=259 Identities=23% Similarity=0.353 Sum_probs=191.7
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|++++.||+|+||.||+|.+..++.. ||||++.... ......+.+.+|+.+++++. ||||+++++++.. ...
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~--~~~ 76 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQI--VAIKKFLESE-DDPVIKKIALREIRMLKQLK-HPNLVNLLEVFRR--KRR 76 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCE--EEEEEECCCC-C-HHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEE--TTE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcE--EEEEEeeccc-cchHHHHHHHHHHHHHHhCC-CCCccchhheeec--CCe
Confidence 5799999999999999999988776654 9999997654 33345577889999999996 5999999998754 567
Q ss_pred EEEEEecCCCCH-HHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKGDTDL-SKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~~~~L-~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
++++||++.+.+ ..++.... ......+..++.|++.||+|||++||+||||||+|||++.+ +.+|
T Consensus 77 ~~lv~e~~~~~~l~~~~~~~~-----~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~---------~~~k 142 (311)
T 4agu_A 77 LHLVFEYCDHTVLHELDRYQR-----GVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKH---------SVIK 142 (311)
T ss_dssp EEEEEECCSEEHHHHHHHTSS-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---------SCEE
T ss_pred EEEEEEeCCCchHHHHHhhhc-----CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCC---------CCEE
Confidence 899999877654 44444322 23455666777899999999999999999999999999776 5799
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||++......... .....||+.|+|||++.+.. .++.++|||||||++|||++|..||.+......
T Consensus 143 l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~--------~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~- 211 (311)
T 4agu_A 143 LCDFGFARLLTGPSDY--YDDEVATRWYRSPELLVGDT--------QYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQ- 211 (311)
T ss_dssp ECCCTTCEECC--------------GGGCCHHHHHTCS--------CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-
T ss_pred EeeCCCchhccCcccc--cCCCcCCccccChHHHhcCC--------CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH-
Confidence 9999999877643322 23557899999999997532 378999999999999999999999987654322
Q ss_pred HHHHHhhcccc-----------------cc------cccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 495 MLAIARHKDQI-----------------EF------KPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 495 ~~~i~~~~~~~-----------------~~------~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
...+....... .. .+.......++.++.+||.+||+.||++|||+++++++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 212 LYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp HHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 22221111000 00 00000113578899999999999999999999999875
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=364.66 Aligned_cols=257 Identities=25% Similarity=0.365 Sum_probs=200.4
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCch----------hHHHHHHHHHHHHHhhcCCCceeEe
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQ----------SIADSYLNEVELLAKLQGCPYVIKM 324 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~----------~~~~~~~~E~~iL~~l~~hp~Iv~l 324 (553)
.++|+++++||+|+||+||+|.+..++.. ||||++.+...... ...+.+.+|+.+|+++. ||||+++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~--~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~ 111 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSE--KAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD-HPNIIKL 111 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCE--EEEEEEEC----------------CTHHHHHHHHHHHHTCC-CTTBCCE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcE--EEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCC-CCCCCeE
Confidence 46899999999999999999988776654 99999987653321 33567899999999995 6999999
Q ss_pred eeEEEeCCCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCcc
Q psy14267 325 HDYVYDTASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVL 403 (553)
Q Consensus 325 ~~~~~~~~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~ 403 (553)
++++. ....++++||++ +++|.+++..... ..+..++.++.||+.||+|||++|||||||||+||||+.+.
T Consensus 112 ~~~~~--~~~~~~lv~e~~~gg~L~~~l~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~- 183 (504)
T 3q5i_A 112 FDVFE--DKKYFYLVTEFYEGGELFEQIINRHK-----FDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKN- 183 (504)
T ss_dssp EEEEE--CSSEEEEEEECCTTCBHHHHHHHHSC-----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTT-
T ss_pred EEEEE--cCCEEEEEEecCCCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCC-
Confidence 99874 467889999986 5689998877542 44566777788999999999999999999999999997652
Q ss_pred ceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCC
Q psy14267 404 KIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRT 483 (553)
Q Consensus 404 ~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~ 483 (553)
....+||+|||++........ ....+||+.|+|||++.+. ++.++|||||||++|+|++|..
T Consensus 184 -----~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~----------~~~~~DiwslG~il~~ll~g~~ 245 (504)
T 3q5i_A 184 -----SLLNIKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLKKK----------YNEKCDVWSCGVIMYILLCGYP 245 (504)
T ss_dssp -----CCSSEEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHTTC----------BCTHHHHHHHHHHHHHHHHSSC
T ss_pred -----CCccEEEEECCCCEEcCCCCc---cccccCCcCCCCHHHhccC----------CCchHHHHHHHHHHHHHHhCCC
Confidence 123699999999987765432 2356799999999998642 7889999999999999999999
Q ss_pred CCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 484 PYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 484 Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
||.+.... ..+..+....... ....+..+++++++||++||..||++|||+.|++++
T Consensus 246 pf~~~~~~-~~~~~i~~~~~~~----~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 246 PFGGQNDQ-DIIKKVEKGKYYF----DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp SSCCSSHH-HHHHHHHHCCCCC----CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCCCHH-HHHHHHHcCCCCC----CccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 99875443 3333443332211 122234688999999999999999999999999875
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=359.80 Aligned_cols=271 Identities=21% Similarity=0.306 Sum_probs=188.8
Q ss_pred cceEE-EeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 256 KQYQV-LSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 256 ~~y~i-~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
+.|++ .++||+|+||+||+|++......+.||||++...... ..+.+|+.+|+++. ||||+++++++......
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~ 93 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS-----MSACREIALLRELK-HPNVISLQKVFLSHADR 93 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC-----HHHHHHHHHHHHCC-CTTBCCCCEEEEETTTT
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC-----HHHHHHHHHHHhcC-CCCeeeEeeEEecCCCC
Confidence 45776 4589999999999998775555566999999755432 46789999999996 69999999999888888
Q ss_pred eEEEEEecCCCCHHHHHHHcccC----CCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCC
Q psy14267 335 HLYVLMEKGDTDLSKYMRNLNKM----TTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIG 410 (553)
Q Consensus 335 ~~~iv~e~~~~~L~~~l~~~~~~----~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~ 410 (553)
.++++||+++++|.+++...... ....+....++.++.||+.||+|||++|||||||||+||||..+. ...
T Consensus 94 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~-----~~~ 168 (405)
T 3rgf_A 94 KVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEG-----PER 168 (405)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSS-----TTT
T ss_pred eEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCC-----CCC
Confidence 99999999999999988754321 112355666777888999999999999999999999999995331 123
Q ss_pred CeEEEEeccCccccCCCCCc-ccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy14267 411 NVLKIIDFGIACSLQDDKTS-VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIP 489 (553)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~ 489 (553)
+.+||+|||+|+.+...... ......+||+.|+|||++.+.. .++.++|||||||+||||++|..||....
T Consensus 169 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--------~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 169 GRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGAR--------HYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp TCEEECCTTCCC----------------CCCTTCCHHHHTTCC--------SCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred CcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCC--------cccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 67999999999877543221 1233567999999999997643 37899999999999999999999997533
Q ss_pred ch--------HHHHHHHHhhccccc---ccc---------------------------cccCCCCCCHHHHHHHHHhccc
Q psy14267 490 NT--------WAKMLAIARHKDQIE---FKP---------------------------QLANNVTIPPTLLQSMKLCLQK 531 (553)
Q Consensus 490 ~~--------~~~~~~i~~~~~~~~---~~~---------------------------~~~~~~~~s~~l~~li~~cL~~ 531 (553)
.. ...+..+........ +.. ........+..+.+||.+||..
T Consensus 241 ~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~ 320 (405)
T 3rgf_A 241 EDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTM 320 (405)
T ss_dssp ------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCS
T ss_pred ccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccC
Confidence 21 122222221111000 000 0001112367899999999999
Q ss_pred CCCCCCCHHHHHHH
Q psy14267 532 DPKARPTVGNSVTQ 545 (553)
Q Consensus 532 dP~~RPt~~ell~~ 545 (553)
||++|||+.|+++|
T Consensus 321 dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 321 DPIKRITSEQAMQD 334 (405)
T ss_dssp SGGGSCCHHHHHTS
T ss_pred CcccCCCHHHHhcC
Confidence 99999999999975
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=364.48 Aligned_cols=262 Identities=24% Similarity=0.401 Sum_probs=205.9
Q ss_pred ceEEecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEE
Q psy14267 249 DVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYV 328 (553)
Q Consensus 249 ~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~ 328 (553)
..|.+..++|++.+.||+|+||.||++.... ...||||+++.... ..+.+.+|+.+|++++ ||||+++++++
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~---~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-h~~iv~l~~~~ 252 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNK---HTKVAVKTMKPGSM----SVEAFLAEANVMKTLQ-HDKLVKLHAVV 252 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEETT---TEEEEEEEECTTSB----CHHHHHHHHHHHTTCC-CTTBCCEEEEE
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEECC---ccEEEEEEecCCCc----cHHHHHHHHHHHhhCC-CCCEeeEEEEE
Confidence 3456777899999999999999999997753 24599999986542 2478899999999995 69999999876
Q ss_pred EeCCCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceec
Q psy14267 329 YDTASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIID 407 (553)
Q Consensus 329 ~~~~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~ 407 (553)
. ...++++||++ +++|.++++..... ......++.++.||+.||+|||+++||||||||+||||+.+
T Consensus 253 ~---~~~~~lv~e~~~~g~L~~~l~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~------ 320 (454)
T 1qcf_A 253 T---KEPIYIITEFMAKGSLLDFLKSDEGS---KQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSAS------ 320 (454)
T ss_dssp C---SSSCEEEECCCTTCBHHHHHHSHHHH---TCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTT------
T ss_pred e---CCccEEEEeecCCCcHHHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCC------
Confidence 3 44678999976 67999999854321 12344566677899999999999999999999999999876
Q ss_pred CCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCC
Q psy14267 408 CIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYS 486 (553)
Q Consensus 408 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~ 486 (553)
+.+||+|||+++........ ......+++.|+|||++... .++.++|||||||+||||++ |..||.
T Consensus 321 ---~~~kl~DFG~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~---------~~~~~~DvwslG~~l~el~t~g~~P~~ 387 (454)
T 1qcf_A 321 ---LVCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFG---------SFTIKSDVWSFGILLMEIVTYGRIPYP 387 (454)
T ss_dssp ---CCEEECSTTGGGGBCCHHHH-TTCSSSSCGGGSCHHHHHHC---------CCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ---CcEEEeeCCCceEcCCCcee-ccCCCcccccccCHHHhccC---------CCCcHHHHHhHHHHHHHHHhCCCCCCC
Confidence 57999999999876543211 12234468899999999765 37899999999999999999 999998
Q ss_pred CCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q psy14267 487 HIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNPE 551 (553)
Q Consensus 487 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~~ 551 (553)
+.... .....+... .. ......+++++.+||.+||..||++|||+.+|++.|+++..
T Consensus 388 ~~~~~-~~~~~i~~~-~~------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 388 GMSNP-EVIRALERG-YR------MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp TCCHH-HHHHHHHHT-CC------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred CCCHH-HHHHHHHcC-CC------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 86543 222333222 11 12234688999999999999999999999999999998754
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=347.86 Aligned_cols=267 Identities=21% Similarity=0.324 Sum_probs=199.9
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcC--chhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDIT--DQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA 332 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~--~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~ 332 (553)
.++|++++.||+|+||.||+|.+..++.. ||||++.+.... .....+.+.+|+++|++++ ||||+++++++. .
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~--vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~--~ 99 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAI--RAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH-HPNIARLYEVYE--D 99 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCE--EEEEEEEHHHHHC---CHHHHHHHHHHHHHHCC-CTTBCCEEEEEE--C
T ss_pred hhheeecceeeecCCeEEEEEEECCCCce--EEEeehhhhhhcccCHHHHHHHHHHHHHHHhCC-CCCcceeehhhc--c
Confidence 35899999999999999999988766644 999999765321 2234578999999999995 699999999874 4
Q ss_pred CceEEEEEecC-CCCHHHHHHHcccC-----------------------------------CCCchHHHHHHHHHHHHHH
Q psy14267 333 SKHLYVLMEKG-DTDLSKYMRNLNKM-----------------------------------TTLPNTMIIIIMHWYEMLL 376 (553)
Q Consensus 333 ~~~~~iv~e~~-~~~L~~~l~~~~~~-----------------------------------~~~~~~~~~i~~~~~qil~ 376 (553)
...++++||++ +++|.+++...... .........++.++.||+.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 66889999986 68898887522111 1112355667778889999
Q ss_pred HHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEeccCccccCCCCC--cccccCCccCCCccCcccccccCCC
Q psy14267 377 AVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKT--SVHKDTASGTLNYMSPEAAGQTSSS 454 (553)
Q Consensus 377 aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGla~~~~~~~~--~~~~~~~~Gt~~y~APE~l~~~~~~ 454 (553)
||+|||++||+||||||+||||+.+. ...+||+|||+++.+..... ........||+.|+|||++.+..
T Consensus 180 ~l~~LH~~~ivH~Dlkp~NIll~~~~-------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-- 250 (345)
T 3hko_A 180 ALHYLHNQGICHRDIKPENFLFSTNK-------SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTN-- 250 (345)
T ss_dssp HHHHHHHTTEECCCCCGGGEEESCSS-------SCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSS--
T ss_pred HHHHHHHCCccccCCChhhEEEecCC-------CceEEEeeccccccccccCccccccccccCCCccccCchhhccCC--
Confidence 99999999999999999999997652 13699999999987643222 11233567999999999997531
Q ss_pred CCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCC
Q psy14267 455 GGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPK 534 (553)
Q Consensus 455 ~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~ 534 (553)
..++.++|||||||+||||++|..||...... .....+........ ......+++++.+||.+||+.||+
T Consensus 251 -----~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~ 320 (345)
T 3hko_A 251 -----ESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDA-DTISQVLNKKLCFE----NPNYNVLSPLARDLLSNLLNRNVD 320 (345)
T ss_dssp -----SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCCCCTT----SGGGGGSCHHHHHHHHHHSCSCTT
T ss_pred -----CCCCcHHHHHHHHHHHHHHHHCCCCCCCCChH-HHHHHHHhcccccC----CcccccCCHHHHHHHHHHcCCChh
Confidence 14789999999999999999999999876554 33333332222111 111224789999999999999999
Q ss_pred CCCCHHHHHHH
Q psy14267 535 ARPTVGNSVTQ 545 (553)
Q Consensus 535 ~RPt~~ell~~ 545 (553)
+||++.+++++
T Consensus 321 ~Rps~~~~l~h 331 (345)
T 3hko_A 321 ERFDAMRALQH 331 (345)
T ss_dssp TSCCHHHHHHS
T ss_pred HCCCHHHHhcC
Confidence 99999999985
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=364.00 Aligned_cols=265 Identities=20% Similarity=0.281 Sum_probs=206.5
Q ss_pred cCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCC
Q psy14267 254 NGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTAS 333 (553)
Q Consensus 254 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~ 333 (553)
.+++|+++++||+|+||.||+|.+..++.. ||||++...... ..+.+|+++++.|.++++|..+..++. ..
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~--vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~--~~ 75 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEE--VAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGV--EG 75 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCE--EEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEE--ET
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcE--EEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEe--eC
Confidence 357899999999999999999988776654 999998766433 347789999999998888888765553 46
Q ss_pred ceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 334 KHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 334 ~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
...+++||+++++|.+++..... .+.+..++.++.||+.||+|||++|||||||||+||||+.+ ...+.+
T Consensus 76 ~~~~lvme~~g~sL~~ll~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~------~~~~~v 145 (483)
T 3sv0_A 76 DYNVLVMDLLGPSLEDLFNFCSR----KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG------RRANQV 145 (483)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCG------GGTTCE
T ss_pred CEEEEEEECCCCCHHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecC------CCCCeE
Confidence 68899999999999999986443 34566677788899999999999999999999999999532 122679
Q ss_pred EEEeccCccccCCCCCcc-----cccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy14267 414 KIIDFGIACSLQDDKTSV-----HKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHI 488 (553)
Q Consensus 414 kL~DFGla~~~~~~~~~~-----~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~ 488 (553)
||+|||+++.+....... ......||+.|+|||++.+. .++.++|||||||+||||++|..||.+.
T Consensus 146 kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~---------~~s~~sDvwSlGvil~elltG~~Pf~~~ 216 (483)
T 3sv0_A 146 YIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGI---------EQSRRDDLESLGYVLMYFLRGSLPWQGL 216 (483)
T ss_dssp EECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC---------CCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred EEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCC---------CCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence 999999998876543321 12356799999999999876 3789999999999999999999999875
Q ss_pred Cc--hHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 489 PN--TWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 489 ~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
.. ....+..+........... + ...++.++.+||..||..||++||++.+|++.|+++
T Consensus 217 ~~~~~~~~~~~i~~~~~~~~~~~-l--~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 217 KAGTKKQKYEKISEKKVATSIEA-L--CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp CCSSHHHHHHHHHHHHHHSCHHH-H--HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred cchhHHHHHHHHhhccccccHHH-H--hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 43 2222222222111111111 1 126789999999999999999999999999998874
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=344.79 Aligned_cols=252 Identities=25% Similarity=0.424 Sum_probs=204.0
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
.++|.+++.||+|+||.||++.+..++.. ||+|++.+.........+.+.+|+.+++++. ||||+++++++. ...
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~--~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--~~~ 114 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEV--FAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFE--DND 114 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCE--EEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEE--CSS
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCE--EEEEEechhhhcCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEe--cCC
Confidence 46899999999999999999988776654 9999998776666666788999999999995 699999999875 356
Q ss_pred eEEEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 335 HLYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 335 ~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
.++++||++. ++|.+++.... ......++.++.||+.||+|||++||+||||||+|||++.+ +.+
T Consensus 115 ~~~lv~e~~~~~~L~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~---------~~~ 180 (335)
T 2owb_A 115 FVFVVLELCRRRSLLELHKRRK-----ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNED---------LEV 180 (335)
T ss_dssp EEEEEECCCTTCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT---------CCE
T ss_pred eEEEEEecCCCCCHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCC---------CCE
Confidence 8899999865 78988887653 23455667777899999999999999999999999999776 579
Q ss_pred EEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHH
Q psy14267 414 KIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWA 493 (553)
Q Consensus 414 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~ 493 (553)
||+|||++......... .....||+.|+|||++.+. .++.++|||||||++|||++|..||...... .
T Consensus 181 kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~ 248 (335)
T 2owb_A 181 KIGDFGLATKVEYDGER--KKVLCGTPNYIAPEVLSKK---------GHSFEVDVWSIGCIMYTLLVGKPPFETSCLK-E 248 (335)
T ss_dssp EECCCTTCEECCSTTCC--BCCCCSCCSSCCHHHHHTS---------CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-H
T ss_pred EEeeccCceecccCccc--ccccCCCccccCHHHhccC---------CCCchhhHHHHHHHHHHHHHCcCCCCCCCHH-H
Confidence 99999999877543322 2356799999999999765 3688999999999999999999999875433 2
Q ss_pred HHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 494 KMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 494 ~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
....+.... .. ....++..+.+||.+||+.||++||++.+++++
T Consensus 249 ~~~~~~~~~--~~------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 249 TYLRIKKNE--YS------IPKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp HHHHHHHTC--CC------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred HHHHHhcCC--CC------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 222222221 11 122578999999999999999999999999874
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=366.10 Aligned_cols=251 Identities=23% Similarity=0.325 Sum_probs=202.2
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|.+++.||+|+||.||+|++..++.. ||||++.+.........+.+.+|+.+|+.+. ||||+++++++.. ...
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~--vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~--~~~ 90 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHK--VAVKILNRQKIRSLDVVGKIRREIQNLKLFR-HPHIIKLYQVIST--PSD 90 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCE--EEEEEEEHHHHHHTTTHHHHHHHHHHHTTCC-CTTBCCEEEEEEC--SSE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCE--EEEEEEEhhhccCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEE--CCE
Confidence 5799999999999999999988776654 9999998654333344578899999999995 5999999987744 567
Q ss_pred EEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
++++||++ +++|.+++.... ......+..++.||+.||+|||++||+||||||+||||+.+ +.+|
T Consensus 91 ~~lv~E~~~gg~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~---------~~vk 156 (476)
T 2y94_A 91 IFMVMEYVSGGELFDYICKNG-----RLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAH---------MNAK 156 (476)
T ss_dssp EEEEEECCSSEEHHHHTTSSS-----SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTT---------CCEE
T ss_pred EEEEEeCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecC---------CCeE
Confidence 89999987 679999886543 24456677778899999999999999999999999999876 5799
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||++........ ....+||+.|+|||++.+.. ..+.++|||||||++|||++|..||...... ..
T Consensus 157 L~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~--------~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-~~ 224 (476)
T 2y94_A 157 IADFGLSNMMSDGEF---LRTSCGSPNYAAPEVISGRL--------YAGPEVDIWSSGVILYALLCGTLPFDDDHVP-TL 224 (476)
T ss_dssp ECCCSSCEECCTTCC---BCCCCSCSTTCCHHHHTTCC--------BCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH-HH
T ss_pred EEeccchhhcccccc---ccccCCCcCeEChhhccCCC--------CCCCcceehhhHHHHHHHhhCCCCCCCCCHH-HH
Confidence 999999988765432 23668999999999998653 2368999999999999999999999875432 22
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
...+..... .....+++++.+||++||..||++|||+.++++|
T Consensus 225 ~~~i~~~~~--------~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 225 FKKICDGIF--------YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp HHHHHTTCC--------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred HHHHhcCCc--------CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 333332211 1123578999999999999999999999999974
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=338.17 Aligned_cols=261 Identities=20% Similarity=0.363 Sum_probs=208.0
Q ss_pred eEEecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEE
Q psy14267 250 VITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVY 329 (553)
Q Consensus 250 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~ 329 (553)
.|++...+|++.+.||+|+||.||+|.+...+. .||||++.... ...+.+.+|+.++++++ ||||+++++++
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~~----~~~~~~~~E~~~l~~l~-h~~i~~~~~~~- 78 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSL--TVAVKTLKEDT----MEVEEFLKEAAVMKEIK-HPNLVQLLGVC- 78 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTE--EEEEEEECSCS----THHHHHHHHHHHHHHCC-CTTBCCEEEEE-
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCCCE--EEEEEecCcCH----HHHHHHHHHHHHHHhCC-CCCEeeEEEEE-
Confidence 455677899999999999999999998877664 49999997543 23477899999999996 69999999877
Q ss_pred eCCCceEEEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecC
Q psy14267 330 DTASKHLYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDC 408 (553)
Q Consensus 330 ~~~~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~ 408 (553)
.....++++||++. ++|.+++...... ......++.++.|++.||+|||++||+||||||+|||++.+
T Consensus 79 -~~~~~~~~v~e~~~~~~L~~~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~------- 147 (288)
T 3kfa_A 79 -TREPPFYIITEFMTYGNLLDYLRECNRQ---EVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN------- 147 (288)
T ss_dssp -CSSSSEEEEEECCTTEEHHHHHHHCCTT---TSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGG-------
T ss_pred -ccCCCEEEEEEcCCCCcHHHHHHhcccC---CccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCC-------
Confidence 44667899999765 7999999875432 34556667777899999999999999999999999999776
Q ss_pred CCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCC
Q psy14267 409 IGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSH 487 (553)
Q Consensus 409 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~ 487 (553)
+.+||+|||++......... ......+|+.|+|||++.+. .++.++||||||+++|+|++ |..||..
T Consensus 148 --~~~~l~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~~ll~~g~~p~~~ 215 (288)
T 3kfa_A 148 --HLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYN---------KFSIKSDVWAFGVLLWEIATYGMSPYPG 215 (288)
T ss_dssp --GCEEECCCCGGGTSCSSSSE-EETTEEECGGGCCHHHHHHC---------CCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred --CCEEEccCccceeccCCccc-cccCCccccCcCChhhhccC---------CCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 57999999999877654332 22344578899999999765 37899999999999999999 9999987
Q ss_pred CCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 488 IPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 488 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
.... .....+.. ... ......+++.+.++|.+||..||++|||+.++++.|++.
T Consensus 216 ~~~~-~~~~~~~~-~~~------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 216 IDLS-QVYELLEK-DYR------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp CCGG-GHHHHHHT-TCC------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCHH-HHHHHHhc-cCC------CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 5443 11222211 111 122346789999999999999999999999999999864
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=343.67 Aligned_cols=259 Identities=20% Similarity=0.288 Sum_probs=203.4
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCch---hHHHHHHHHHHHHHhhcCCCceeEeeeEEEeC
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQ---SIADSYLNEVELLAKLQGCPYVIKMHDYVYDT 331 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~---~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~ 331 (553)
.++|++.+.||+|+||.||+|.+..++.. ||||++........ ...+.+.+|+.+|+++. ||||+++++++.
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~-- 85 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLE--YAAKFIKKRQSRASRRGVSREEIEREVSILRQVL-HHNVITLHDVYE-- 85 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCE--EEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEE--
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeE--EEEEEEecccccccccchhHHHHHHHHHHHHhCC-CCCcceEEEEEe--
Confidence 35799999999999999999988776644 99999987654321 12467899999999995 599999998874
Q ss_pred CCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCC
Q psy14267 332 ASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIG 410 (553)
Q Consensus 332 ~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~ 410 (553)
....++++||++ +++|.+++.... ......++.++.|++.||+|||++||+||||||+|||++.+.. ..
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~-----~~ 155 (321)
T 2a2a_A 86 NRTDVVLILELVSGGELFDFLAQKE-----SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNI-----PI 155 (321)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHTCS-----CEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTS-----SS
T ss_pred cCCEEEEEEEcCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCC-----Cc
Confidence 456789999987 679999987643 3456677778889999999999999999999999999976621 11
Q ss_pred CeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCc
Q psy14267 411 NVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN 490 (553)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~ 490 (553)
..+||+|||++........ .....||+.|+|||++.+. .++.++|||||||++|||++|..||.....
T Consensus 156 ~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 223 (321)
T 2a2a_A 156 PHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYE---------PLGLEADMWSIGVITYILLSGASPFLGDTK 223 (321)
T ss_dssp CCEEECCCTTCEECCTTCC---CCCCCSCGGGCCHHHHTTC---------CCCTHHHHHHHHHHHHHHHHSCCSSCCSSH
T ss_pred CCEEEccCccceecCcccc---ccccCCCCCccCcccccCC---------CCCCccccHHHHHHHHHHHHCCCCCCCCCH
Confidence 2699999999987765432 2355799999999999765 378899999999999999999999987543
Q ss_pred hHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 491 TWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 491 ~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
. ..+..+..... .+.+. ....++..+.+||.+||..||++|||+.+++++
T Consensus 224 ~-~~~~~i~~~~~--~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 224 Q-ETLANITSVSY--DFDEE--FFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp H-HHHHHHHTTCC--CCCHH--HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred H-HHHHHHHhccc--ccChh--hhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 2 33333332221 11111 123578999999999999999999999999875
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=348.42 Aligned_cols=262 Identities=23% Similarity=0.321 Sum_probs=193.6
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCc--hhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITD--QSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA 332 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~--~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~ 332 (553)
.++|++++.||+|+||.||+|.+..++.. ||||++....... ....+.+.+|+.+|+++. ||||+++++++ ..
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~--vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~--~~ 83 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQI--VAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAF--GH 83 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSE--EEEEEC------------CTHHHHHHHHHHHCC-CTTBCCEEEEE--CC
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcE--EEEEEEecCCcchhhhhhhHHHHHHHHHHhhCC-CCCCCeEEEEE--ee
Confidence 35799999999999999999988776644 9999997644222 122346789999999995 69999999877 44
Q ss_pred CceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCe
Q psy14267 333 SKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNV 412 (553)
Q Consensus 333 ~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~ 412 (553)
...++++||+++++|..++...... .....+..++.|++.||+|||++||+||||||+||||+.+ +.
T Consensus 84 ~~~~~lv~e~~~~~l~~~~~~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~---------~~ 150 (346)
T 1ua2_A 84 KSNISLVFDFMETDLEVIIKDNSLV----LTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDEN---------GV 150 (346)
T ss_dssp TTCCEEEEECCSEEHHHHHTTCCSS----CCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---------CC
T ss_pred CCceEEEEEcCCCCHHHHHHhcCcC----CCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCC---------CC
Confidence 6678999999999999888764322 2233455667799999999999999999999999999776 57
Q ss_pred EEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchH
Q psy14267 413 LKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTW 492 (553)
Q Consensus 413 vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~ 492 (553)
+||+|||+++.+..... .....+||+.|+|||++.+.. .++.++|||||||++|||++|.+||.+....
T Consensus 151 ~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~--------~~~~~~DiwslG~il~ell~g~~~~~~~~~~- 219 (346)
T 1ua2_A 151 LKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGAR--------MYGVGVDMWAVGCILAELLLRVPFLPGDSDL- 219 (346)
T ss_dssp EEECCCGGGSTTTSCCC--CCCCSCCCCTTCCHHHHTTCS--------CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-
T ss_pred EEEEecccceeccCCcc--cCCcccccccccCchHhhCCC--------CCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-
Confidence 99999999987754332 223567999999999997542 3688999999999999999999999875543
Q ss_pred HHHHHHHhhcccc---cccccc-----------------cCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 493 AKMLAIARHKDQI---EFKPQL-----------------ANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 493 ~~~~~i~~~~~~~---~~~~~~-----------------~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
..+..+....... .+.... .....++.++.+||.+||..||++|||+.|++++
T Consensus 220 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 220 DQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp HHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 3333332211110 000000 0013567899999999999999999999999975
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=365.85 Aligned_cols=255 Identities=24% Similarity=0.401 Sum_probs=197.6
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|++++.||+|+||+||+|++..++.. ||||++.+....... ...+.+|+.+|+++. ||||+++++++. ....
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~--~aiK~~~~~~~~~~~-~~~~~~E~~~l~~l~-hpniv~~~~~~~--~~~~ 110 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVE--RAIKIIRKTSVSTSS-NSKLLEEVAVLKLLD-HPNIMKLYDFFE--DKRN 110 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCE--EEEEEEEC-----CT-THHHHHHHHHHTTCC-CTTBCCEEEEEE--CSSE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcE--EEEEEEeccccCchH-HHHHHHHHHHHHhCC-CCCCCeEEEEEE--eCCE
Confidence 4799999999999999999998777654 999999876543322 467899999999995 699999999874 4667
Q ss_pred EEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
++++||++ +++|.+++..... .....++.++.||+.||+|||++|||||||||+||||+... ..+.+|
T Consensus 111 ~~lv~e~~~~g~L~~~~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~------~~~~~k 179 (494)
T 3lij_A 111 YYLVMECYKGGELFDEIIHRMK-----FNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKE------KDALIK 179 (494)
T ss_dssp EEEEEECCCSCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSS------TTCCEE
T ss_pred EEEEEecCCCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCC------CCCcEE
Confidence 89999976 5689888876543 34556667778999999999999999999999999997642 235699
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||++........ ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.... ..
T Consensus 180 l~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~----------~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~ 245 (494)
T 3lij_A 180 IVDFGLSAVFENQKK---MKERLGTAYYIAPEVLRK----------KYDEKCDVWSIGVILFILLAGYPPFGGQTDQ-EI 245 (494)
T ss_dssp ECCCTTCEECBTTBC---BCCCCSCTTTCCHHHHTT----------CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HH
T ss_pred EEECCCCeECCCCcc---ccccCCCcCeeCHHHHcc----------cCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HH
Confidence 999999988765432 235679999999999863 2788999999999999999999999875443 33
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
+..+....... ....+..+++.+++||++||+.||++|||+.++++|
T Consensus 246 ~~~i~~~~~~~----~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 246 LRKVEKGKYTF----DSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp HHHHHHTCCCC----CSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred HHHHHhCCCCC----CchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 33333332221 122234688999999999999999999999999865
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=344.90 Aligned_cols=255 Identities=23% Similarity=0.400 Sum_probs=193.1
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCC--
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTAS-- 333 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~-- 333 (553)
++|++++.||+|+||.||+|++..++.. ||||++.... .....+.+.+|+.+|++++ ||||+++++++.+...
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~--vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~ 80 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCN--YAIKRIRLPN--RELAREKVMREVKALAKLE-HPGIVRYFNAWLETPPEK 80 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCE--EEEEEEECCS--TTTHHHHHHHHHHHHTSCC-CTTBCCEEEEEEECCSCH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcE--EEEEEeecCC--chhHHHHHHHHHHHHHhCC-CCCEeeEEEEEEEeccch
Confidence 5799999999999999999988766654 9999998654 2234578999999999995 6999999998765432
Q ss_pred -----------------------------------------------------ceEEEEEecC-CCCHHHHHHHcccCCC
Q psy14267 334 -----------------------------------------------------KHLYVLMEKG-DTDLSKYMRNLNKMTT 359 (553)
Q Consensus 334 -----------------------------------------------------~~~~iv~e~~-~~~L~~~l~~~~~~~~ 359 (553)
.+++++||++ +++|.+++........
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~ 160 (332)
T 3qd2_B 81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160 (332)
T ss_dssp HHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGG
T ss_pred hhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccc
Confidence 2489999986 5699999987544332
Q ss_pred CchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEeccCccccCCCCCc---------
Q psy14267 360 LPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTS--------- 430 (553)
Q Consensus 360 ~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~--------- 430 (553)
.....++.++.||+.||+|||++||+||||||+||||+.+ +.+||+|||+++........
T Consensus 161 --~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~---------~~~kL~DfG~a~~~~~~~~~~~~~~~~~~ 229 (332)
T 3qd2_B 161 --REHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMD---------DVVKVGDFGLVTAMDQDEEEQTVLTPMPA 229 (332)
T ss_dssp --SCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT---------CCEEECCCTTCEECSCC------------
T ss_pred --hhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCC---------CCEEEeecCcccccccchhhccccccccc
Confidence 2333456677899999999999999999999999999776 57999999999887654321
Q ss_pred -ccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHhhcccccccc
Q psy14267 431 -VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKP 509 (553)
Q Consensus 431 -~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~ 509 (553)
......+||+.|+|||++.+. .++.++|||||||++|||++|..|+.. .......+... .+..
T Consensus 230 ~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~Di~slG~il~el~~~~~~~~~---~~~~~~~~~~~----~~~~ 293 (332)
T 3qd2_B 230 YATHTGQVGTKLYMSPEQIHGN---------NYSHKVDIFSLGLILFELLYSFSTQME---RVRIITDVRNL----KFPL 293 (332)
T ss_dssp --CCCSCC-CGGGSCHHHHHCC---------CCCTHHHHHHHHHHHHHHHSCCCCHHH---HHHHHHHHHTT----CCCH
T ss_pred cccccccCCCcCccChHHhcCC---------CCcchhhHHHHHHHHHHHHHcCCChhH---HHHHHHHhhcc----CCCc
Confidence 112345799999999999765 378999999999999999998777532 11111111111 1111
Q ss_pred cccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 510 QLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 510 ~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
. ....++.+.+||.+||+.||++|||+.|++++
T Consensus 294 ~---~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 294 L---FTQKYPQEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp H---HHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred c---cccCChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 1 11345788999999999999999999999875
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=340.29 Aligned_cols=272 Identities=19% Similarity=0.280 Sum_probs=198.8
Q ss_pred eEEecCcceEEEeeeeeeCceEEEEEeeeCC-CccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEE
Q psy14267 250 VITLNGKQYQVLSLLGKGGSSSVYLVGGTSE-HEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYV 328 (553)
Q Consensus 250 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~-~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~ 328 (553)
.+.+..++|.+.+.||+|+||.||+|..... .....||||++...... ....+.+.+|+.+|++++ ||||+++++++
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~ 105 (313)
T 3brb_A 28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSS-QREIEEFLSEAACMKDFS-HPNVIRLLGVC 105 (313)
T ss_dssp TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCC-HHHHHHHHHHHHHHHTCC-CTTBCCCCEEE
T ss_pred hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccc-hhHHHHHHHHHHHHhcCC-CCCeeeeeEEE
Confidence 3445678999999999999999999977643 23456999999766543 344578999999999995 69999999988
Q ss_pred EeCCCc---eEEEEEecC-CCCHHHHHHHccc-CCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCcc
Q psy14267 329 YDTASK---HLYVLMEKG-DTDLSKYMRNLNK-MTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVL 403 (553)
Q Consensus 329 ~~~~~~---~~~iv~e~~-~~~L~~~l~~~~~-~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~ 403 (553)
...... ..+++|+++ +++|.+++..... ..........++.++.||+.||.|||++||+||||||+||||+.+
T Consensus 106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~-- 183 (313)
T 3brb_A 106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDD-- 183 (313)
T ss_dssp EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTT--
T ss_pred eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCC--
Confidence 765433 568888875 5699999865432 122345566777788899999999999999999999999999776
Q ss_pred ceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CC
Q psy14267 404 KIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GR 482 (553)
Q Consensus 404 ~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~ 482 (553)
+.+||+|||++................+++.|+|||++.+. .++.++|||||||++|||++ |.
T Consensus 184 -------~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~el~~~g~ 247 (313)
T 3brb_A 184 -------MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR---------VYTSKSDVWAFGVTMWEIATRGM 247 (313)
T ss_dssp -------SCEEECSCSCC----------------CCGGGSCHHHHHSS---------CCCHHHHHHHHHHHHHHHHTTSC
T ss_pred -------CcEEEeecCcceecccccccCcccccCCCccccCchhhcCC---------CccchhhhHHHHHHHHHHHhcCC
Confidence 57999999999877554332223345678899999999765 37889999999999999999 99
Q ss_pred CCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 483 TPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 483 ~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
.||....... ....+... ... .....+++.+.++|.+||..||++|||+.+++++|+++
T Consensus 248 ~p~~~~~~~~-~~~~~~~~-~~~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l 306 (313)
T 3brb_A 248 TPYPGVQNHE-MYDYLLHG-HRL------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306 (313)
T ss_dssp CSSTTCCGGG-HHHHHHTT-CCC------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCccCCHHH-HHHHHHcC-CCC------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 9998755432 22222211 111 12236789999999999999999999999999999874
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=340.95 Aligned_cols=259 Identities=22% Similarity=0.333 Sum_probs=203.5
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCc-hhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITD-QSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~-~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
++|++++.||+|+||.||+|.+..++. .||||++....... ....+.+.+|+++|++++ ||||+++++++......
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~--~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~ 81 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLC--RRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR-HKNVIQLVDVLYNEEKQ 81 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCC--EEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEECC---
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCc--EEEEEEeccccccccchhHHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCCC
Confidence 579999999999999999998776664 49999997653221 233577899999999995 69999999988777777
Q ss_pred eEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 335 HLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 335 ~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
.++++||++.++|.+++...... ......+..++.||+.||+|||++||+||||||+|||++.+ +.+|
T Consensus 82 ~~~lv~e~~~~~l~~~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~---------~~~k 149 (305)
T 2wtk_C 82 KMYMVMEYCVCGMQEMLDSVPEK---RFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTG---------GTLK 149 (305)
T ss_dssp CEEEEEECCSEEHHHHHHHSTTC---SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT---------CCEE
T ss_pred eEEEEehhccCCHHHHHHhCccc---ccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCC---------CcEE
Confidence 89999999988888888775432 34456667777899999999999999999999999999776 5799
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||++................||+.|+|||++.+... .++.++||||||+++|||++|..||...... ..
T Consensus 150 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-------~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~ 221 (305)
T 2wtk_C 150 ISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDT-------FSGFKVDIWSAGVTLYNITTGLYPFEGDNIY-KL 221 (305)
T ss_dssp ECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSC-------EESHHHHHHHHHHHHHHHHHSSCSCCCSSHH-HH
T ss_pred eeccccccccCccccccccccCCCCCCCcChhhccCccc-------CCcchhhHHHHHHHHHHHHhCCCCCCCchHH-HH
Confidence 999999988765433333345679999999999975421 2478999999999999999999999875432 22
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
...+.... .. ....+++.+.++|.+||..||++|||+.+++++
T Consensus 222 ~~~i~~~~--~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 222 FENIGKGS--YA------IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp HHHHHHCC--CC------CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred HHHHhcCC--CC------CCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 33332221 11 123678999999999999999999999999975
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=337.39 Aligned_cols=262 Identities=26% Similarity=0.463 Sum_probs=193.2
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
.+|++.+.||+|+||.||+|.+..++. .||||++...........+.+.+|+.+|+++. ||||+++++++.. ...
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~--~~~ 106 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGV--PVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIE--DNE 106 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCC--EEEEEEECTTSSCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEE--TTE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCc--eEEEEeeehhhccCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEc--CCc
Confidence 579999999999999999998876664 49999998766666666788999999999995 6999999998765 557
Q ss_pred EEEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
++++||++. ++|.+++....... .......++.++.|++.||+|||++||+||||||+||||+.+ +.+|
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~---------~~~k 176 (310)
T 2wqm_A 107 LNIVLELADAGDLSRMIKHFKKQK-RLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITAT---------GVVK 176 (310)
T ss_dssp EEEEEECCCSCBHHHHHHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---------SCEE
T ss_pred EEEEEecCCCCCHHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCC---------CCEE
Confidence 889999865 59999887643211 133455666777899999999999999999999999999766 5799
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||++......... .....|++.|+|||++.+. .++.++||||||+++|||++|..||.+.......
T Consensus 177 l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~---------~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~ 245 (310)
T 2wqm_A 177 LGDLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHEN---------GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS 245 (310)
T ss_dssp ECCC--------------------CCSSCCHHHHTTC---------CCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHH
T ss_pred EEeccceeeecCCCcc--ccccCCCeeEeChHHhCCC---------CCCchhhHHHHHHHHHHHHhCCCCCcccchhHHH
Confidence 9999999876543321 2245689999999999765 3788999999999999999999999764332222
Q ss_pred H-HHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 495 M-LAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 495 ~-~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
+ ..+.... +.+. ....++.++.++|.+||..||++|||+.++++.|+++
T Consensus 246 ~~~~~~~~~----~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l 295 (310)
T 2wqm_A 246 LCKKIEQCD----YPPL--PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRM 295 (310)
T ss_dssp HHHHHHTTC----SCCC--CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhhccc----CCCC--cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 2 2222111 1111 1236789999999999999999999999999999874
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=340.86 Aligned_cols=261 Identities=27% Similarity=0.410 Sum_probs=198.4
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|++.+.||+|+||.||+|.+..++. .||||++...........+.+.+|+.+++++. ||||+++++++.. ...
T Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~--~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~--~~~ 108 (309)
T 2h34_A 34 GPYRLRRLVGRGGMGDVYEAEDTVRER--IVALKLMSETLSSDPVFRTRMQREARTAGRLQ-EPHVVPIHDFGEI--DGQ 108 (309)
T ss_dssp CCEEEEEEEEECSSSEEEEEEETTTTE--EEEEEECGGGGGGSHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEE--TTE
T ss_pred ccEEEEEEEcCCCCeeEEEEEEcCCCe--EEEEEecCcccccCHHHHHHHHHHHHHHhhcC-CCCeeEEEEEEee--CCe
Confidence 579999999999999999998876664 49999998766555566688999999999995 5999999998755 567
Q ss_pred EEEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
++++||++. ++|.+++.... ......++.++.|++.||+|||++||+||||||+|||++.+ +.+|
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~---------~~~k 174 (309)
T 2h34_A 109 LYVDMRLINGVDLAAMLRRQG-----PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSAD---------DFAY 174 (309)
T ss_dssp EEEEEECCCCEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT---------SCEE
T ss_pred EEEEEEecCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCC---------CCEE
Confidence 899999875 69999998754 23456667778899999999999999999999999999776 5799
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||++......... ......||+.|+|||++.+. .++.++||||||+++|||++|..||...... .
T Consensus 175 l~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~ 242 (309)
T 2h34_A 175 LVDFGIASATTDEKLT-QLGNTVGTLYYMAPERFSES---------HATYRADIYALTCVLYECLTGSPPYQGDQLS--V 242 (309)
T ss_dssp ECSCCC-----------------CCGGGCCGGGTCC-------------CCCHHHHHHHHHHHHHHSSCSSCSCHHH--H
T ss_pred EecCccCccccccccc-cccccCCCcCccCHHHHcCC---------CCCchHhHHHHHHHHHHHHHCCCCCCCchHH--H
Confidence 9999999776543321 22345699999999999765 3688999999999999999999999875432 2
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCC-CHHHHHHHHhcCCC
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARP-TVGNSVTQINNNPE 551 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RP-t~~ell~~L~~~~~ 551 (553)
+........ .........++.++.++|.+||..||++|| +++++++.|++...
T Consensus 243 ~~~~~~~~~----~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~ 296 (309)
T 2h34_A 243 MGAHINQAI----PRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA 296 (309)
T ss_dssp HHHHHHSCC----CCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred HHHHhccCC----CCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence 222221111 111122346889999999999999999999 99999999998654
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=372.55 Aligned_cols=257 Identities=23% Similarity=0.384 Sum_probs=203.5
Q ss_pred ecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC
Q psy14267 253 LNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA 332 (553)
Q Consensus 253 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~ 332 (553)
+..++|+++++||+|+||.||+|++..++.. ||||++.+...........+.+|+.+|+++. ||||+++++++. .
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~--vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~--~ 255 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKM--YACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSLAYAYE--T 255 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCE--EEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-CTTBCCEEEEEE--C
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCE--EEEEEEEhHhhhhhHHHHHHHHHHHHHHHcC-CCCEeeEEEEEe--e
Confidence 3456899999999999999999988777654 9999998765433344567899999999995 699999988774 4
Q ss_pred CceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCC
Q psy14267 333 SKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGN 411 (553)
Q Consensus 333 ~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~ 411 (553)
...+|++||++ +++|..++...... .+....++.++.||+.||+|||++|||||||||+||||+.+ +
T Consensus 256 ~~~l~lVmEy~~gg~L~~~l~~~~~~---~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~---------g 323 (576)
T 2acx_A 256 KDALCLVLTLMNGGDLKFHIYHMGQA---GFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDH---------G 323 (576)
T ss_dssp SSEEEEEECCCCSCBHHHHHHSSSSC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT---------S
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCC---------C
Confidence 66899999986 68999988765432 24556677778899999999999999999999999999876 6
Q ss_pred eEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCc-
Q psy14267 412 VLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN- 490 (553)
Q Consensus 412 ~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~- 490 (553)
.+||+|||+|+....... ....+||+.|+|||++.+. .++.++|||||||+||||++|..||.....
T Consensus 324 ~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~---------~~~~~~DiwSLGvilyeLltG~~PF~~~~~~ 391 (576)
T 2acx_A 324 HIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNE---------RYTFSPDWWALGCLLYEMIAGQSPFQQRKKK 391 (576)
T ss_dssp CEEECCCTTCEECCTTCC---EECCCSCGGGCCHHHHTTC---------EESSHHHHHHHHHHHHHHHHSSCSSSCSSSC
T ss_pred CeEEEecccceecccCcc---ccccCCCccccCHHHHcCC---------CCCccchHHHHHHHHHHHHhCCCCCcccccc
Confidence 799999999988765432 2256899999999999865 378999999999999999999999987432
Q ss_pred -hHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q psy14267 491 -TWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARP-----TVGNSVTQ 545 (553)
Q Consensus 491 -~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RP-----t~~ell~~ 545 (553)
....+...... ....+ ...+++++++||.+||..||++|| ++.||++|
T Consensus 392 ~~~~~i~~~i~~-~~~~~------p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 392 IKREEVERLVKE-VPEEY------SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp CCHHHHHHHHHH-CCCCC------CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred hhHHHHHHHhhc-ccccC------CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 11222221111 11111 236789999999999999999999 78888765
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=354.84 Aligned_cols=269 Identities=21% Similarity=0.289 Sum_probs=200.3
Q ss_pred cCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcC-------CCceeEeee
Q psy14267 254 NGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG-------CPYVIKMHD 326 (553)
Q Consensus 254 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~-------hp~Iv~l~~ 326 (553)
..++|+++++||+|+||+||+|++..++.. ||||++... ....+.+.+|+.+|+++.+ |+||+++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~ 108 (397)
T 1wak_A 35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKF--VAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLD 108 (397)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEE--EEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEE
T ss_pred cCCeEEEEEEeeecCCeeEEEEEecCCCeE--EEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeec
Confidence 357899999999999999999988776644 999999743 3445788999999999974 788999999
Q ss_pred EEEeC--CCceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhC-CcEecCCCCCCEEEecCcc
Q psy14267 327 YVYDT--ASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAA-GIIHSDLKPANFLFVGNVL 403 (553)
Q Consensus 327 ~~~~~--~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~-gIiHrDLKp~NILl~~~~~ 403 (553)
++... ...+++++||+++++|.+++...... ......++.++.||+.||+|||++ |||||||||+||||+.+..
T Consensus 109 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~ 185 (397)
T 1wak_A 109 DFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQ---GLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQ 185 (397)
T ss_dssp EEEEEETTEEEEEEEECCCCCBHHHHHHHTTTS---CCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHH
T ss_pred ceeecCCCCceEEEEEeccCccHHHHHHhcccC---CCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccch
Confidence 87633 45688999999999999988765322 344566777788999999999998 9999999999999976520
Q ss_pred c----------------------------------------eecCCCCeEEEEeccCccccCCCCCcccccCCccCCCcc
Q psy14267 404 K----------------------------------------IIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYM 443 (553)
Q Consensus 404 ~----------------------------------------~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~ 443 (553)
. ..+.....+||+|||+++...... ...+||+.|+
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~-----~~~~gt~~y~ 260 (397)
T 1wak_A 186 YIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-----TEDIQTRQYR 260 (397)
T ss_dssp HHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS-----CSCCSCGGGC
T ss_pred hhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC-----ccCCCCCccc
Confidence 0 000011369999999998765432 2557999999
Q ss_pred CcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCc-----hHHHHHHHHhhccccc------------
Q psy14267 444 SPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN-----TWAKMLAIARHKDQIE------------ 506 (553)
Q Consensus 444 APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~-----~~~~~~~i~~~~~~~~------------ 506 (553)
|||++.+. .++.++|||||||+||||++|..||..... ....+..+........
T Consensus 261 aPE~~~~~---------~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 331 (397)
T 1wak_A 261 SLEVLIGS---------GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKE 331 (397)
T ss_dssp CHHHHHTS---------CCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGG
T ss_pred CChhhcCC---------CCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhccccccc
Confidence 99999866 378899999999999999999999975432 1222222221111100
Q ss_pred c---cc-------------------cccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 507 F---KP-------------------QLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 507 ~---~~-------------------~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
+ .. ........+..+.+||.+||+.||++|||+.|+++|
T Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 332 FFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp TBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred ccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 0 00 000011234678999999999999999999999875
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=344.01 Aligned_cols=277 Identities=23% Similarity=0.348 Sum_probs=207.0
Q ss_pred ccceEEecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeee
Q psy14267 247 SQDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHD 326 (553)
Q Consensus 247 ~~~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~ 326 (553)
....+.+..++|++++.||+|+||.||+|++..++. .||||++.... ....+.+.+|+.+++++ .||||+++++
T Consensus 20 ~g~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~iv~~~~ 93 (317)
T 2buj_A 20 QGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGH--FYALKRILCHE---QQDREEAQREADMHRLF-NHPNILRLVA 93 (317)
T ss_dssp EEEEEEETTEEEEEEEEEEC--CEEEEEEEETTTCC--EEEEEEEEESS---HHHHHHHHHHHHHHHTC-CCTTBCCCCE
T ss_pred cccEEEECCeEEEEEEEecCCCCeEEEEEEecCCCc--EEEEEEEecCC---HHHHHHHHHHHHHHhhc-CCCCeeeEEE
Confidence 345677888999999999999999999998876664 49999987643 34557889999999999 4699999999
Q ss_pred EEEeC--CCceEEEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCcc
Q psy14267 327 YVYDT--ASKHLYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVL 403 (553)
Q Consensus 327 ~~~~~--~~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~ 403 (553)
++... ....++++||++. ++|.+++...... ........++.++.||+.||+|||++||+||||||+||||+.+
T Consensus 94 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~-- 170 (317)
T 2buj_A 94 YCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDK-GNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDE-- 170 (317)
T ss_dssp EEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT--
T ss_pred EEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCC--
Confidence 88643 3457889999765 5999998874321 1234556677778899999999999999999999999999776
Q ss_pred ceecCCCCeEEEEeccCccccCCCCCcc-------cccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHH
Q psy14267 404 KIIDCIGNVLKIIDFGIACSLQDDKTSV-------HKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILY 476 (553)
Q Consensus 404 ~~~~~~~~~vkL~DFGla~~~~~~~~~~-------~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ 476 (553)
+.+||+|||++.......... ......||+.|+|||++.+... ..++.++|||||||++|
T Consensus 171 -------~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~------~~~~~~~Di~slG~il~ 237 (317)
T 2buj_A 171 -------GQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSH------CVIDERTDVWSLGCVLY 237 (317)
T ss_dssp -------SCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSE------EEECTHHHHHHHHHHHH
T ss_pred -------CCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCC------cCCCchhhHHHHHHHHH
Confidence 579999999987654321110 0113357999999999875421 13688999999999999
Q ss_pred HHHhCCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q psy14267 477 NMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNPE 551 (553)
Q Consensus 477 elltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~~ 551 (553)
||++|..||................. . .......++.++.++|.+||+.||++|||+.+++++|+++..
T Consensus 238 el~~g~~p~~~~~~~~~~~~~~~~~~--~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 238 AMMFGEGPYDMVFQKGDSVALAVQNQ--L----SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp HHHHSSCTTHHHHHTTSCHHHHHHCC--------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred HHHhCCCChhhhhcccchhhHHhhcc--C----CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 99999999954111000111111111 1 112233678999999999999999999999999999998754
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=343.29 Aligned_cols=266 Identities=21% Similarity=0.327 Sum_probs=203.6
Q ss_pred cCcceEEEeeeeeeCceEEEEEeee--CCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeC
Q psy14267 254 NGKQYQVLSLLGKGGSSSVYLVGGT--SEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDT 331 (553)
Q Consensus 254 ~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~ 331 (553)
.++.|++++.||+|+||.||++... .....+.||||++.... .....+.+.+|+++|+++. ||||+++++++.+.
T Consensus 29 ~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 105 (318)
T 3lxp_A 29 HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLY-HEHIIKYKGCCEDA 105 (318)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEET
T ss_pred cHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCC-CcchhhEEEEEecC
Confidence 3444599999999999999987543 22344669999997653 3344578999999999996 69999999999887
Q ss_pred CCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCC
Q psy14267 332 ASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIG 410 (553)
Q Consensus 332 ~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~ 410 (553)
....++++||++ +++|.+++.... .....++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 106 ~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~--------- 170 (318)
T 3lxp_A 106 GAASLQLVMEYVPLGSLRDYLPRHS------IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDND--------- 170 (318)
T ss_dssp TTTEEEEEECCCTTCBHHHHGGGSC------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT---------
T ss_pred CCceEEEEEecccCCcHHHHHhhCC------CCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCC---------
Confidence 778899999987 569999886542 3456667778899999999999999999999999999776
Q ss_pred CeEEEEeccCccccCCCCCc-ccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy14267 411 NVLKIIDFGIACSLQDDKTS-VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIP 489 (553)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~ 489 (553)
+.+||+|||++......... .......||+.|+|||++.+. .++.++|||||||++|||++|..||....
T Consensus 171 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~~ll~g~~p~~~~~ 241 (318)
T 3lxp_A 171 RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEY---------KFYYASDVWSFGVTLYELLTHCDSSQSPP 241 (318)
T ss_dssp CCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHC---------EEEHHHHHHHHHHHHHHHHTTTCGGGSHH
T ss_pred CCEEECCccccccccccccccccccCCCCCceeeChHHhcCC---------CCCcHHHHHHHHHHHHHHHhCCCcccccc
Confidence 57999999999887654432 122345688999999999765 36789999999999999999999997532
Q ss_pred chHH----------HHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 490 NTWA----------KMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 490 ~~~~----------~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
.... ....+.... ...........++.++.+||++||+.||++|||+.++++.|+.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 308 (318)
T 3lxp_A 242 TKFLELIGIAQGQMTVLRLTELL---ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308 (318)
T ss_dssp HHHHHHHCSCCHHHHHHHHHHHH---HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hhhhhhhcccccchhHHHHHHHH---hcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 2110 001111100 00111222346889999999999999999999999999999864
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=360.28 Aligned_cols=282 Identities=18% Similarity=0.273 Sum_probs=208.4
Q ss_pred ecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC
Q psy14267 253 LNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA 332 (553)
Q Consensus 253 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~ 332 (553)
..+++|++.++||+|+||.||+|++..++.. ||||++....... ..+.+.+|+++|+++. ||||+++++++....
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~--vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~ 80 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDL--FAIKVFNNISFLR--PVDVQMREFEVLKKLN-HKNIVKLFAIEEETT 80 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCE--EEEEEECGGGGGS--CHHHHHHHHHHHHHCC-CTTBCCEEEEEECTT
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcE--EEEEEeccccccc--hHHHHHHHHHHHHhcC-CCCCCeEEEeeccCC
Confidence 4467899999999999999999988776654 9999997644322 2467789999999995 599999999888777
Q ss_pred CceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCC
Q psy14267 333 SKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGN 411 (553)
Q Consensus 333 ~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~ 411 (553)
....+++||++ +++|.+++........ .....++.++.||+.||+|||++|||||||||+||||..+. ...+
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~--l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-----~~~~ 153 (396)
T 4eut_A 81 TRHKVLIMEFCPCGSLYTVLEEPSNAYG--LPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGE-----DGQS 153 (396)
T ss_dssp TCCEEEEECCCTTEEHHHHTTSGGGTTC--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECT-----TSCE
T ss_pred CCeeEEEEecCCCCCHHHHHHhhhcccC--CCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecC-----CCce
Confidence 77889999987 5799999876543322 44566677788999999999999999999999999983211 1125
Q ss_pred eEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCC--
Q psy14267 412 VLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIP-- 489 (553)
Q Consensus 412 ~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~-- 489 (553)
.+||+|||+++....... .....||+.|+|||++.+..... .....++.++|||||||++|||++|..||....
T Consensus 154 ~~kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~-~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~ 229 (396)
T 4eut_A 154 VYKLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRK-DHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229 (396)
T ss_dssp EEEECCGGGCEECCCGGG---SSCSSSCCTTCCHHHHHHHCC---CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCT
T ss_pred eEEEecCCCceEccCCCc---cccccCCccccCHHHhhcccccc-ccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcc
Confidence 699999999987755332 23567999999999986521100 000136789999999999999999999996432
Q ss_pred -chHHHHHHHHhhcccc-------------cccccccCC----CCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q psy14267 490 -NTWAKMLAIARHKDQI-------------EFKPQLANN----VTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNP 550 (553)
Q Consensus 490 -~~~~~~~~i~~~~~~~-------------~~~~~~~~~----~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~ 550 (553)
.....+..+....... .+....... ..++..+.++|++||+.||++||++.++++.|+++.
T Consensus 230 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il 308 (396)
T 4eut_A 230 RRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (396)
T ss_dssp TTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHH
T ss_pred cchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHh
Confidence 2223333333322110 011111111 124467899999999999999999999999998754
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=348.72 Aligned_cols=269 Identities=17% Similarity=0.197 Sum_probs=202.4
Q ss_pred ceEEecCcceEEEeeeeeeCceEEEEEe-----eeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcC--CCce
Q psy14267 249 DVITLNGKQYQVLSLLGKGGSSSVYLVG-----GTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG--CPYV 321 (553)
Q Consensus 249 ~~~~~~~~~y~i~~~LG~G~fG~Vy~a~-----~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~--hp~I 321 (553)
..+.+..++|++.++||+|+||+||+|. +...+ +.||||++.... ...+.+|+++++++.+ |+||
T Consensus 58 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~--~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~i 129 (365)
T 3e7e_A 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNK--QKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMF 129 (365)
T ss_dssp CEEECSSSEEEEEEEEEECSSEEEEEEEC-------CC--CCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGB
T ss_pred eeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccC--cEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhh
Confidence 4566778899999999999999999995 33333 459999997542 3567888898888863 6999
Q ss_pred eEeeeEEEeCCCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEec
Q psy14267 322 IKMHDYVYDTASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVG 400 (553)
Q Consensus 322 v~l~~~~~~~~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~ 400 (553)
+.+++++.. ....+++||++ +++|.+++..........+.+..++.++.||+.||+|||++|||||||||+||||+.
T Consensus 130 v~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~ 207 (365)
T 3e7e_A 130 MKFYSAHLF--QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGN 207 (365)
T ss_dssp CCEEEEEEC--SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECG
T ss_pred hhhheeeec--CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecc
Confidence 999887754 55778999976 589999998765544455667778888899999999999999999999999999977
Q ss_pred Cccce--ecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHH
Q psy14267 401 NVLKI--IDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNM 478 (553)
Q Consensus 401 ~~~~~--~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~el 478 (553)
+.... .+...+.+||+|||+|+.+............+||+.|||||++.+. .++.++|||||||+||||
T Consensus 208 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~el 278 (365)
T 3e7e_A 208 GFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNK---------PWNYQIDYFGVAATVYCM 278 (365)
T ss_dssp GGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTC---------CBSTHHHHHHHHHHHHHH
T ss_pred cccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCC---------CCCccccHHHHHHHHHHH
Confidence 21000 0011367999999999766533333334467899999999999876 378999999999999999
Q ss_pred HhCCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCC-CCHHHHHHHHhcC
Q psy14267 479 IYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKAR-PTVGNSVTQINNN 549 (553)
Q Consensus 479 ltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~R-Pt~~ell~~L~~~ 549 (553)
++|+.||...... ...... .......++.+.+++..||+.+|.+| |++.++.+.|+++
T Consensus 279 ltg~~pf~~~~~~------------~~~~~~-~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~ 337 (365)
T 3e7e_A 279 LFGTYMKVKNEGG------------ECKPEG-LFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV 337 (365)
T ss_dssp HHSSCCCEEEETT------------EEEECS-CCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred HhCCCccccCCCC------------ceeech-hccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence 9999999642211 001111 11111346789999999999999999 6788888887764
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=340.79 Aligned_cols=265 Identities=23% Similarity=0.326 Sum_probs=194.7
Q ss_pred CcceEEE-eeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCC
Q psy14267 255 GKQYQVL-SLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTAS 333 (553)
Q Consensus 255 ~~~y~i~-~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~ 333 (553)
.+.|++. +.||+|+||.||+|.+..++. .||||++...... ..+.+.+|+++|.++.+||||+++++++.+ .
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~~~~---~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~--~ 83 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQ--EYAVKIIEKQPGH---IRSRVFREVEMLYQCQGHRNVLELIEFFEE--E 83 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCC--EEEEEEEECCSSC---CHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--T
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCc--EEEEEEEeeCcch---hHHHHHHHHHHHHHhcCCCCeeeEEEEEee--C
Confidence 4579985 789999999999998876664 4999999866422 246789999999998778999999998754 5
Q ss_pred ceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCe
Q psy14267 334 KHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNV 412 (553)
Q Consensus 334 ~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~ 412 (553)
..++++||++ +++|.+++.... ......+..++.||+.||+|||++||+||||||+||||+.+. ....
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~------~~~~ 152 (316)
T 2ac3_A 84 DRFYLVFEKMRGGSILSHIHKRR-----HFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPN------QVSP 152 (316)
T ss_dssp TEEEEEEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSS------SSCS
T ss_pred CEEEEEEEcCCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCC------CcCc
Confidence 6889999986 589999998754 234556667778999999999999999999999999997652 1234
Q ss_pred EEEEeccCccccCCCCC-----cccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCC
Q psy14267 413 LKIIDFGIACSLQDDKT-----SVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSH 487 (553)
Q Consensus 413 vkL~DFGla~~~~~~~~-----~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~ 487 (553)
+||+|||++........ .......+||+.|+|||++.+... ....++.++|||||||++|||++|..||..
T Consensus 153 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~----~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 228 (316)
T 2ac3_A 153 VKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSE----EASIYDKRCDLWSLGVILYILLSGYPPFVG 228 (316)
T ss_dssp EEECCTTCCC-------------------CCSGGGCCHHHHHHTSH----HHHHHTTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred eEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccc----cccCCCcccccHhHHHHHHHHHHCCCCCcc
Confidence 99999999976643221 111224569999999999975210 001368899999999999999999999976
Q ss_pred CCch--------------HHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 488 IPNT--------------WAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 488 ~~~~--------------~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
.... ......+.... ..+.. ..+..++.++++||.+||..||++|||+.|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~--~~~~~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 229 RCGSDCGWDRGEACPACQNMLFESIQEGK--YEFPD--KDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp CCCSCSCC----CCHHHHHHHHHHHHHCC--CCCCH--HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cccccccccccccchhHHHHHHHHHhccC--cccCc--hhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 4321 11122222221 11111 1123578999999999999999999999999985
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=347.45 Aligned_cols=252 Identities=21% Similarity=0.307 Sum_probs=193.0
Q ss_pred eEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEE
Q psy14267 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLY 337 (553)
Q Consensus 258 y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~ 337 (553)
|...+.||+|+||.||+|.+..++.. ||||+++.... ...+.+.+|+++|+++. ||||+++++++.. ...++
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~--vavK~~~~~~~---~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~--~~~~~ 162 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETATGLK--LAAKIIKTRGM---KDKEEVKNEISVMNQLD-HANLIQLYDAFES--KNDIV 162 (373)
T ss_dssp EEEEEECC-----CEEEEEETTTCCE--EEEEEEECCSH---HHHHHHHHHHHHHTTCC-CTTBCCEEEEEEC--SSEEE
T ss_pred eecceEEecCcCEEEEEEEEcCCCcE--EEEEEEccccc---ccHHHHHHHHHHHHhCC-CCCCCeEEEEEEE--CCEEE
Confidence 34467899999999999988776644 99999987543 33477899999999995 6999999998754 56789
Q ss_pred EEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEE
Q psy14267 338 VLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKII 416 (553)
Q Consensus 338 iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~ 416 (553)
++||++ +++|.+++..... ......++.++.||+.||+|||++||+||||||+||||..+. .+.+||+
T Consensus 163 lv~E~~~~~~L~~~l~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-------~~~~kl~ 231 (373)
T 2x4f_A 163 LVMEYVDGGELFDRIIDESY----NLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRD-------AKQIKII 231 (373)
T ss_dssp EEEECCTTCEEHHHHHHTGG----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETT-------TTEEEEC
T ss_pred EEEeCCCCCcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCC-------CCcEEEE
Confidence 999986 5689888875432 234556667778999999999999999999999999995431 2579999
Q ss_pred eccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHH
Q psy14267 417 DFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKML 496 (553)
Q Consensus 417 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~ 496 (553)
|||+++.+..... ....+||+.|+|||++.+. .++.++|||||||+||||++|..||.+.... ..+.
T Consensus 232 DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~ 298 (373)
T 2x4f_A 232 DFGLARRYKPREK---LKVNFGTPEFLAPEVVNYD---------FVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA-ETLN 298 (373)
T ss_dssp CCSSCEECCTTCB---CCCCCSSCTTCCHHHHTTC---------BCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHH
T ss_pred eCCCceecCCccc---cccccCCCcEeChhhccCC---------CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-HHHH
Confidence 9999988765432 2255799999999999755 3788999999999999999999999875443 3333
Q ss_pred HHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 497 AIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 497 ~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
.+....... . ......+++++++||.+||..||++|||+.|++++
T Consensus 299 ~i~~~~~~~--~--~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 299 NILACRWDL--E--DEEFQDISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp HHHHTCCCS--C--SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHhccCCC--C--hhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 443332211 1 12233678999999999999999999999999974
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=335.10 Aligned_cols=252 Identities=25% Similarity=0.426 Sum_probs=203.5
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
.++|++.+.||+|+||.||+|.+..++.. ||+|++.+.........+.+.+|+.+++++ +||||+++++++. ...
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~--~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~--~~~ 88 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEV--FAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFE--DND 88 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCE--EEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEE--CSS
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCce--EEEEEechhhccCHHHHHHHHHHHHHHHhC-CCCCEeeeeeeec--cCC
Confidence 46899999999999999999988776654 999999877666566678899999999999 5699999999874 466
Q ss_pred eEEEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 335 HLYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 335 ~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
.++++||++. ++|.+++.... ......+..++.|++.||+|||++||+||||||+|||++.+ +.+
T Consensus 89 ~~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~---------~~~ 154 (294)
T 2rku_A 89 FVFVVLELCRRRSLLELHKRRK-----ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNED---------LEV 154 (294)
T ss_dssp EEEEEEECCTTCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT---------CCE
T ss_pred EEEEEEecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCC---------CCE
Confidence 7899999865 78888887654 23455667777899999999999999999999999999776 579
Q ss_pred EEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHH
Q psy14267 414 KIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWA 493 (553)
Q Consensus 414 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~ 493 (553)
||+|||++......... .....||+.|+|||++.+. .++.++||||||+++|||++|..||...... .
T Consensus 155 kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~ 222 (294)
T 2rku_A 155 KIGDFGLATKVEYDGER--KKVLCGTPNYIAPEVLSKK---------GHSFEVDVWSIGCIMYTLLVGKPPFETSCLK-E 222 (294)
T ss_dssp EECCCTTCEECCSTTCC--BCCCCSCCSSCCHHHHTTS---------CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-H
T ss_pred EEEeccCceecccCccc--cccccCCCCcCCcchhccC---------CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-H
Confidence 99999999876543322 2356799999999999765 3688999999999999999999999875433 2
Q ss_pred HHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 494 KMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 494 ~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
....+.... . .....++..+.++|.+||+.||++|||+.+++++
T Consensus 223 ~~~~~~~~~--~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 223 TYLRIKKNE--Y------SIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp HHHHHHTTC--C------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred HHHHHhhcc--C------CCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 222222211 1 1123678999999999999999999999999875
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=338.97 Aligned_cols=261 Identities=21% Similarity=0.349 Sum_probs=195.8
Q ss_pred cCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC-
Q psy14267 254 NGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA- 332 (553)
Q Consensus 254 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~- 332 (553)
..++|++++.||+|+||.||+|++..++. .||||++...... .+.+.+|+.+++++.+||||+++++++....
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~--~vaiK~~~~~~~~----~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 95 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQ--LAAIKVMDVTGDE----EEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 95 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCC--EEEEEEEECCSST----THHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCC--eEEEEEEecCccc----HHHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence 35689999999999999999998876664 4999999765432 2678899999999977899999999887653
Q ss_pred ---CceEEEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecC
Q psy14267 333 ---SKHLYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDC 408 (553)
Q Consensus 333 ---~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~ 408 (553)
...++++||++. ++|.+++...... ......++.++.||+.||+|||++||+||||||+||||+.+
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~------- 165 (326)
T 2x7f_A 96 PGMDDQLWLVMEFCGAGSVTDLIKNTKGN---TLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTEN------- 165 (326)
T ss_dssp -CCCCEEEEEEECCTTEEHHHHHHHSGGG---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTT-------
T ss_pred ccccceEEEEEEcCCCCcHHHHHHhcccC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCC-------
Confidence 568899999875 5999999875322 23455566777899999999999999999999999999766
Q ss_pred CCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy14267 409 IGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHI 488 (553)
Q Consensus 409 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~ 488 (553)
+.+||+|||++........ ......||+.|+|||++...... ...++.++|||||||++|||++|..||...
T Consensus 166 --~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~----~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 237 (326)
T 2x7f_A 166 --AEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENP----DATYDFKSDLWSLGITAIEMAEGAPPLCDM 237 (326)
T ss_dssp --CCEEECCCTTTC---------------CCGGGCCHHHHC------------CCTTHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred --CCEEEeeCcCceecCcCcc--ccccccCCccccChhhhcccccc----CcCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence 5799999999987654322 12355799999999999743211 124789999999999999999999999875
Q ss_pred CchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 489 PNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 489 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
... .....+...... ......++..+.++|.+||..||++||++.+++++
T Consensus 238 ~~~-~~~~~~~~~~~~------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 238 HPM-RALFLIPRNPAP------RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp CHH-HHHHHHHHSCCC------CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred cHH-HHHHHhhcCccc------cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 443 222222221111 11123678999999999999999999999999874
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=332.22 Aligned_cols=262 Identities=20% Similarity=0.359 Sum_probs=200.5
Q ss_pred EEecCcceEEEeeeeeeCceEEEEEeeeCC-CccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEE
Q psy14267 251 ITLNGKQYQVLSLLGKGGSSSVYLVGGTSE-HEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVY 329 (553)
Q Consensus 251 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~-~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~ 329 (553)
+.+..++|++.+.||+|+||.||+|.+... .....||||++.... .....+++.+|+.+|+++. ||||+++++++.
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~ 83 (281)
T 3cc6_A 7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLD-HPHIVKLIGIIE 83 (281)
T ss_dssp CSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHC-CTTBCCEEEEEC
T ss_pred ceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCC-CCCcceEEEEEc
Confidence 345567899999999999999999987643 334569999987653 2344578999999999995 699999999763
Q ss_pred eCCCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecC
Q psy14267 330 DTASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDC 408 (553)
Q Consensus 330 ~~~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~ 408 (553)
+ ...+++||++ +++|.+++..... ......++.++.|++.||+|||++||+||||||+|||++.+
T Consensus 84 ~---~~~~~v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~------- 149 (281)
T 3cc6_A 84 E---EPTWIIMELYPYGELGHYLERNKN----SLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASP------- 149 (281)
T ss_dssp S---SSCEEEEECCTTCBHHHHHHHHTT----TCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEET-------
T ss_pred C---CCCEEEEecCCCCCHHHHHHhccc----cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCC-------
Confidence 2 3457788865 5799999976532 23455666777899999999999999999999999999876
Q ss_pred CCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCC
Q psy14267 409 IGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSH 487 (553)
Q Consensus 409 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~ 487 (553)
+.+||+|||++......... ......+++.|+|||++.+. .++.++||||||+++|||++ |..||..
T Consensus 150 --~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~~llt~g~~p~~~ 217 (281)
T 3cc6_A 150 --ECVKLGDFGLSRYIEDEDYY-KASVTRLPIKWMSPESINFR---------RFTTASDVWMFAVCMWEILSFGKQPFFW 217 (281)
T ss_dssp --TEEEECCCCGGGCC----------CCCCCGGGCCHHHHHHC---------CCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred --CcEEeCccCCCccccccccc-ccccCCCCcceeCchhhccC---------CCCchhccHHHHHHHHHHHhCCCCCccc
Confidence 67999999999876553321 12244578899999999755 37889999999999999998 9999986
Q ss_pred CCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 488 IPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 488 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
..... ....+... .. ......+++.+.++|.+||..||++||++.+++++|+++
T Consensus 218 ~~~~~-~~~~~~~~-~~------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 218 LENKD-VIGVLEKG-DR------LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp SCGGG-HHHHHHHT-CC------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CChHH-HHHHHhcC-CC------CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 54432 22222211 11 112235789999999999999999999999999999874
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=340.01 Aligned_cols=268 Identities=19% Similarity=0.291 Sum_probs=197.6
Q ss_pred cCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhh-cCCCceeEeeeEEEeC-
Q psy14267 254 NGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKL-QGCPYVIKMHDYVYDT- 331 (553)
Q Consensus 254 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l-~~hp~Iv~l~~~~~~~- 331 (553)
..++|++++.||+|+||.||++++ ++ +.||||++... ....+.+|.+++..+ .+||||+++++++...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~--~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~ 75 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW--QG--ENVAVKIFSSR------DEKSWFRETELYNTVMLRHENILGFIASDMTSR 75 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE--TT--EEEEEEEECGG------GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE--CC--EEEEEEEeccc------cchhhHHHHHHHHHhhccCcCeeeEEEeecccc
Confidence 456899999999999999999976 23 45999998643 235667788888773 2579999999886653
Q ss_pred -CCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHh--------hCCcEecCCCCCCEEEecC
Q psy14267 332 -ASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIH--------AAGIIHSDLKPANFLFVGN 401 (553)
Q Consensus 332 -~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH--------~~gIiHrDLKp~NILl~~~ 401 (553)
....++++||++ +++|.++++.. ......++.++.|++.||+||| ++||+||||||+||||+.+
T Consensus 76 ~~~~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~ 149 (301)
T 3q4u_A 76 HSSTQLWLITHYHEMGSLYDYLQLT------TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKN 149 (301)
T ss_dssp TTEEEEEEEECCCTTCBHHHHHTTC------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTT
T ss_pred CCCceeEEehhhccCCCHHHHHhhc------ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCC
Confidence 345689999986 46999998542 3455667777889999999999 9999999999999999876
Q ss_pred ccceecCCCCeEEEEeccCccccCCCCCcc--cccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHH
Q psy14267 402 VLKIIDCIGNVLKIIDFGIACSLQDDKTSV--HKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI 479 (553)
Q Consensus 402 ~~~~~~~~~~~vkL~DFGla~~~~~~~~~~--~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ell 479 (553)
+.+||+|||+|+......... ......||+.|+|||++.+.... ..+.++.++|||||||++|||+
T Consensus 150 ---------~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~~~~~~~DvwslG~il~el~ 217 (301)
T 3q4u_A 150 ---------GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQV---DCFDSYKRVDIWAFGLVLWEVA 217 (301)
T ss_dssp ---------SCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCT---TCHHHHHHHHHHHHHHHHHHHH
T ss_pred ---------CCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCC---CcccCCchhhHHHHHHHHHHHH
Confidence 579999999998765543321 12345799999999999765321 1113557999999999999999
Q ss_pred hC----------CCCCCCCCc---hHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q psy14267 480 YG----------RTPYSHIPN---TWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQI 546 (553)
Q Consensus 480 tG----------~~Pf~~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L 546 (553)
+| ..||..... ....+.............+.......++.++.+||.+||+.||++|||+.++++.|
T Consensus 218 tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L 297 (301)
T 3q4u_A 218 RRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297 (301)
T ss_dssp TTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHH
T ss_pred hhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHH
Confidence 99 888865322 22233222222111111111111123457899999999999999999999999999
Q ss_pred hcC
Q psy14267 547 NNN 549 (553)
Q Consensus 547 ~~~ 549 (553)
+++
T Consensus 298 ~~i 300 (301)
T 3q4u_A 298 TKI 300 (301)
T ss_dssp HHH
T ss_pred hcc
Confidence 874
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=352.92 Aligned_cols=262 Identities=24% Similarity=0.395 Sum_probs=192.5
Q ss_pred ecCcceEEEeeeeeeCceEEEEEeeeCC-CccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeC
Q psy14267 253 LNGKQYQVLSLLGKGGSSSVYLVGGTSE-HEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDT 331 (553)
Q Consensus 253 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~-~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~ 331 (553)
+...+|++.+.||+|+||.||+|+.... .....||||+++... .....+.+.+|+.+|+++. ||||+++++++ .
T Consensus 42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~--~ 116 (373)
T 2qol_A 42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFD-HPNIIRLEGVV--T 116 (373)
T ss_dssp CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEE--C
T ss_pred cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEE--e
Confidence 4456899999999999999999977632 233569999997653 3344578999999999995 69999999887 4
Q ss_pred CCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCC
Q psy14267 332 ASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIG 410 (553)
Q Consensus 332 ~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~ 410 (553)
....++++||++ +++|.+++..... ......++.++.||+.||+|||++||+||||||+||||+.+
T Consensus 117 ~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~--------- 183 (373)
T 2qol_A 117 KSKPVMIVTEYMENGSLDSFLRKHDA----QFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSN--------- 183 (373)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTT----CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT---------
T ss_pred eCCceEEEEeCCCCCcHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCC---------
Confidence 456789999987 6899999976432 34456677778899999999999999999999999999776
Q ss_pred CeEEEEeccCccccCCCCCc-ccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCC
Q psy14267 411 NVLKIIDFGIACSLQDDKTS-VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHI 488 (553)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~ 488 (553)
+.+||+|||+++........ .......+++.|+|||++.+. .++.++|||||||+||||++ |..||...
T Consensus 184 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Dv~SlG~il~ellt~g~~P~~~~ 254 (373)
T 2qol_A 184 LVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR---------KFTSASDVWSYGIVLWEVMSYGERPYWEM 254 (373)
T ss_dssp CCEEECCC----------------------CTTSCHHHHHHC---------CCCHHHHHHHHHHHHHHHHTTC-CTTTTC
T ss_pred CCEEECcCccccccccCCccceeccCCCcCCCccChhhhccC---------CcCchhcHHHHHHHHHHHHhCCCCCCCCC
Confidence 57999999999877543321 111223467899999999765 37899999999999999997 99999876
Q ss_pred CchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 489 PNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 489 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
... .....+... .. ......++..+.++|.+||+.||++||++.++++.|+++
T Consensus 255 ~~~-~~~~~i~~~-~~------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 255 SNQ-DVIKAVDEG-YR------LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp CHH-HHHHHHHTT-EE------CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CHH-HHHHHHHcC-CC------CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 543 222222211 11 122336789999999999999999999999999999864
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=344.42 Aligned_cols=263 Identities=20% Similarity=0.302 Sum_probs=202.1
Q ss_pred cCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCC
Q psy14267 254 NGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTAS 333 (553)
Q Consensus 254 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~ 333 (553)
..++|++.+.||+|+||.||+|++..++....||||.+.... .....+.+.+|+.+|+++.+||||+++++++.. .
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~ 98 (327)
T 1fvr_A 23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--R 98 (327)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEE--T
T ss_pred cHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeee--C
Confidence 346899999999999999999998877765456999987543 223346789999999999778999999998754 5
Q ss_pred ceEEEEEecC-CCCHHHHHHHccc-----------CCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecC
Q psy14267 334 KHLYVLMEKG-DTDLSKYMRNLNK-----------MTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGN 401 (553)
Q Consensus 334 ~~~~iv~e~~-~~~L~~~l~~~~~-----------~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~ 401 (553)
..++++||++ +++|.+++..... ..........++.++.||+.||+|||++||+||||||+||||+.+
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~ 178 (327)
T 1fvr_A 99 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 178 (327)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG
T ss_pred CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCC
Confidence 6789999987 6699999986531 112245566777788899999999999999999999999999776
Q ss_pred ccceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-
Q psy14267 402 VLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY- 480 (553)
Q Consensus 402 ~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt- 480 (553)
+.+||+|||+++....... .....+++.|+|||++.+. .++.++|||||||++|||++
T Consensus 179 ---------~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~ellt~ 237 (327)
T 1fvr_A 179 ---------YVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYS---------VYTTNSDVWSYGVLLWEIVSL 237 (327)
T ss_dssp ---------GCEEECCTTCEESSCEECC---C----CCTTTCCHHHHHHC---------EECHHHHHHHHHHHHHHHHTT
T ss_pred ---------CeEEEcccCcCcccccccc---ccCCCCCccccChhhhccc---------cCCchhcchHHHHHHHHHHcC
Confidence 5799999999975432211 1244578899999999765 36889999999999999998
Q ss_pred CCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 481 GRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 481 G~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
|..||...... .....+.. .. .......+++.+.+||.+||..||++|||+.+++++|+++
T Consensus 238 g~~pf~~~~~~-~~~~~~~~-~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 298 (327)
T 1fvr_A 238 GGTPYCGMTCA-ELYEKLPQ-GY------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 298 (327)
T ss_dssp SCCTTTTCCHH-HHHHHGGG-TC------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCcHH-HHHHHhhc-CC------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 99999875432 11111111 11 1122336789999999999999999999999999999874
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=335.60 Aligned_cols=260 Identities=27% Similarity=0.399 Sum_probs=205.3
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|++++.||+|+||.||+|.+..++. .||+|++....... ...+.+.+|+.+++++. ||||+++++++.+.....
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 81 (279)
T 2w5a_A 6 EDYEVLYTIGTGSYGRCQKIRRKSDGK--ILVWKELDYGSMTE-AEKQMLVSEVNLLRELK-HPNIVRYYDRIIDRTNTT 81 (279)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCC--EEEEEEEECTTCCH-HHHHHHHHHHHHHHHCC-CTTBCCEEEEEEEGGGTE
T ss_pred hheeeehhccCCCCcEEEEEEECCCCc--EEEEEEEEcccCCH-HHHHHHHHHHHHHHhcC-CCCCCeEEEEEecCCCce
Confidence 589999999999999999998876664 49999998766443 44578999999999995 699999999888777788
Q ss_pred EEEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCC-----cEecCCCCCCEEEecCccceecCC
Q psy14267 336 LYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAG-----IIHSDLKPANFLFVGNVLKIIDCI 409 (553)
Q Consensus 336 ~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~g-----IiHrDLKp~NILl~~~~~~~~~~~ 409 (553)
++++||++. ++|.+++...... ........++.++.|++.||+|||+++ |+||||||+|||++.+
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~-------- 152 (279)
T 2w5a_A 82 LYIVMEYCEGGDLASVITKGTKE-RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK-------- 152 (279)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSS--------
T ss_pred EEEEEeCCCCCCHHHHHHhhccc-CCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCC--------
Confidence 999999875 6999999865432 112445667777889999999999999 9999999999999776
Q ss_pred CCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy14267 410 GNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIP 489 (553)
Q Consensus 410 ~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~ 489 (553)
+.+||+|||+++........ .....||+.|+|||++.+. .++.++||||||+++|||++|..||....
T Consensus 153 -~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~~g~~p~~~~~ 220 (279)
T 2w5a_A 153 -QNVKLGDFGLARILNHDTSF--AKTFVGTPYYMSPEQMNRM---------SYNEKSDIWSLGCLLYELCALMPPFTAFS 220 (279)
T ss_dssp -SCEEECCCCHHHHC---CHH--HHHHHSCCTTCCHHHHHCC----------CCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred -CCEEEecCchheeecccccc--ccccCCCccccChHHhccC---------CCCchhhHHHHHHHHHHHHHCCCCCcccC
Confidence 57999999999876543221 1244689999999999765 37889999999999999999999998764
Q ss_pred chHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q psy14267 490 NTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINN 548 (553)
Q Consensus 490 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~ 548 (553)
.. .....+..... .. ....++.++.++|.+||+.||++||++.+|++++..
T Consensus 221 ~~-~~~~~i~~~~~-~~------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 221 QK-ELAGKIREGKF-RR------IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp HH-HHHHHHHHTCC-CC------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred HH-HHHHHHhhccc-cc------CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 32 22223322211 11 122678999999999999999999999999987654
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=352.12 Aligned_cols=258 Identities=23% Similarity=0.303 Sum_probs=189.4
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC--
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA-- 332 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~-- 332 (553)
.++|++++.||+|+||.||+|.+..++.. ||||++..... .....+.+.+|+.+|+++. ||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~--vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~ 99 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQ-NQTHAKRAYRELVLMKCVN-HKNIIGLLNVFTPQKSL 99 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEE--EEEEEEECTTS-SHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSCCST
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCce--EEEEEeccccC-ChHHHHHHHHHHHHHHhcC-CCCccceEEeecccccc
Confidence 36899999999999999999988776644 99999986543 3455678899999999995 699999999875443
Q ss_pred --CceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCC
Q psy14267 333 --SKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIG 410 (553)
Q Consensus 333 --~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~ 410 (553)
...++++||+++++|.+++.. ......+..++.||+.||+|||++||+||||||+||||+.+
T Consensus 100 ~~~~~~~lv~e~~~~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~--------- 163 (371)
T 2xrw_A 100 EEFQDVYIVMELMDANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD--------- 163 (371)
T ss_dssp TTCCEEEEEEECCSEEHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT---------
T ss_pred ccccceEEEEEcCCCCHHHHHhh-------ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCC---------
Confidence 237899999999999988863 23455566777899999999999999999999999999876
Q ss_pred CeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCc
Q psy14267 411 NVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN 490 (553)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~ 490 (553)
+.+||+|||+++....... ....+||+.|+|||++.+. .++.++|||||||++|||++|..||.+...
T Consensus 164 ~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~el~~g~~pf~~~~~ 231 (371)
T 2xrw_A 164 CTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGM---------GYKENVDIWSVGCIMGEMIKGGVLFPGTDH 231 (371)
T ss_dssp SCEEECCCCC-------------------CTTCCHHHHTTC---------CCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CCEEEEEeecccccccccc---cCCceecCCccCHHHhcCC---------CCCchHhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 5799999999987654321 2356799999999999865 378899999999999999999999987544
Q ss_pred hHHHHHHHHhhccccc----------------cccc------------ccCC------CCCCHHHHHHHHHhcccCCCCC
Q psy14267 491 TWAKMLAIARHKDQIE----------------FKPQ------------LANN------VTIPPTLLQSMKLCLQKDPKAR 536 (553)
Q Consensus 491 ~~~~~~~i~~~~~~~~----------------~~~~------------~~~~------~~~s~~l~~li~~cL~~dP~~R 536 (553)
. ..+..+........ ..+. .... ...+.++++||.+||..||++|
T Consensus 232 ~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R 310 (371)
T 2xrw_A 232 I-DQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 310 (371)
T ss_dssp H-HHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGS
T ss_pred H-HHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhC
Confidence 3 22222221110000 0000 0000 0114679999999999999999
Q ss_pred CCHHHHHHH
Q psy14267 537 PTVGNSVTQ 545 (553)
Q Consensus 537 Pt~~ell~~ 545 (553)
||++|+++|
T Consensus 311 ~t~~e~l~h 319 (371)
T 2xrw_A 311 ISVDEALQH 319 (371)
T ss_dssp CCHHHHHHS
T ss_pred CCHHHHhCC
Confidence 999999985
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=349.38 Aligned_cols=245 Identities=22% Similarity=0.371 Sum_probs=197.2
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCch-----hHHHHHHHHHHHHHhhcCCCceeEeeeEEEe
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQ-----SIADSYLNEVELLAKLQGCPYVIKMHDYVYD 330 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~-----~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~ 330 (553)
++|++++.||+|+||.||+|.+..++.. ||||++.+...... ...+.+.+|+.+|+++. ||||+++++++.
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~--vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~- 99 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKE--VVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVE-HANIIKVLDIFE- 99 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEE--EEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCC-CTTBCCEEEEEE-
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcE--EEEEEEehhhcccccccchHHHHHHHHHHHHHHhCC-CCCEeeEEEEEe-
Confidence 5899999999999999999988777654 99999987654321 12346778999999995 699999999874
Q ss_pred CCCceEEEEEecC-CC-CHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecC
Q psy14267 331 TASKHLYVLMEKG-DT-DLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDC 408 (553)
Q Consensus 331 ~~~~~~~iv~e~~-~~-~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~ 408 (553)
....++++||++ ++ +|..++..... .....+..++.||+.||+|||++||+||||||+||||+.+
T Consensus 100 -~~~~~~lv~e~~~~g~~l~~~~~~~~~-----l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~------- 166 (335)
T 3dls_A 100 -NQGFFQLVMEKHGSGLDLFAFIDRHPR-----LDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAED------- 166 (335)
T ss_dssp -CSSEEEEEEECCTTSCBHHHHHHTCCC-----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-------
T ss_pred -eCCEEEEEEEeCCCCccHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCC-------
Confidence 466888999964 44 89998876542 4456667778899999999999999999999999999776
Q ss_pred CCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy14267 409 IGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHI 488 (553)
Q Consensus 409 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~ 488 (553)
+.+||+|||+++........ ...+||+.|+|||++.+.. .++.++|||||||++|||++|..||...
T Consensus 167 --~~~kL~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~--------~~~~~~DiwslG~il~el~~g~~pf~~~ 233 (335)
T 3dls_A 167 --FTIKLIDFGSAAYLERGKLF---YTFCGTIEYCAPEVLMGNP--------YRGPELEMWSLGVTLYTLVFEENPFCEL 233 (335)
T ss_dssp --SCEEECCCTTCEECCTTCCB---CEECSCGGGCCHHHHTTCC--------BCSHHHHHHHHHHHHHHHHHSSCSCSSG
T ss_pred --CcEEEeecccceECCCCCce---eccCCCccccChhhhcCCC--------CCCCcccchhHHHHHHHHHhCCCchhhH
Confidence 57999999999887654332 2567999999999998653 1378999999999999999999999763
Q ss_pred CchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 489 PNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 489 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
... ..........+++++.+||.+||+.||++|||+.+++++
T Consensus 234 ~~~---------------~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 234 EET---------------VEAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp GGG---------------TTTCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred HHH---------------HhhccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 221 011112233578999999999999999999999999986
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=352.45 Aligned_cols=263 Identities=24% Similarity=0.303 Sum_probs=185.7
Q ss_pred ceEEecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEE
Q psy14267 249 DVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYV 328 (553)
Q Consensus 249 ~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~ 328 (553)
..+.+. ++|++++.||+|+||.||+|.+..++. .||||++.... ......+++.+|+.+|+++. ||||+.+++++
T Consensus 23 ~~~~~~-~~y~~~~~lG~G~~g~V~~a~~~~~~~--~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~ 97 (367)
T 2fst_X 23 TIWEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGL--RVAVKKLSRPF-QSIIHAKRTYRELRLLKHMK-HENVIGLLDVF 97 (367)
T ss_dssp EEEEEE-TTEEEEEECC----CCEEEEEETTTTE--EEEEEECSSTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEE
T ss_pred cccCCC-CceEEeeEEeecCCeEEEEEEECCCCC--EEEEEEeCccc-cCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEE
Confidence 344443 689999999999999999998877664 49999997643 33445678899999999996 69999999987
Q ss_pred EeCC----CceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccc
Q psy14267 329 YDTA----SKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLK 404 (553)
Q Consensus 329 ~~~~----~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~ 404 (553)
.... ...++++|++++++|.+++... ......+..++.||+.||+|||++||+||||||+||||+.+
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~--- 168 (367)
T 2fst_X 98 TPARSLEEFNDVYLVTHLMGADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED--- 168 (367)
T ss_dssp CSCSSGGGCCCCEEEEECCCEECC-----C------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---
T ss_pred ecCCccccCCeEEEEecccCCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCC---
Confidence 5432 2567999999999998888652 24456667778899999999999999999999999999876
Q ss_pred eecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCC
Q psy14267 405 IIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTP 484 (553)
Q Consensus 405 ~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~P 484 (553)
+.+||+|||+++...... ....||+.|+|||++.+.. .++.++|||||||++|||++|+.|
T Consensus 169 ------~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~--------~~~~~~DiwslG~il~ell~g~~p 229 (367)
T 2fst_X 169 ------CELKILDFGLARHTADEM-----TGYVATRWYRAPEIMLNWM--------HYNQTVDIWSVGCIMAELLTGRTL 229 (367)
T ss_dssp ------CCEEECC--------------------CCCTTCCHHHHTTCC--------SCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred ------CCEEEeeccccccccccC-----CCcCcCcCccChHHHcCCc--------CCCchhhHHHHHHHHHHHHhCCCC
Confidence 579999999998764332 2567999999999997632 478999999999999999999999
Q ss_pred CCCCCchHHHHHHHHhhcccc-----------------------cccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHH
Q psy14267 485 YSHIPNTWAKMLAIARHKDQI-----------------------EFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGN 541 (553)
Q Consensus 485 f~~~~~~~~~~~~i~~~~~~~-----------------------~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~e 541 (553)
|.+.... ..+..+....... ...........+++.+.+||.+||..||++|||+.+
T Consensus 230 f~~~~~~-~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e 308 (367)
T 2fst_X 230 FPGTDHI-DQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 308 (367)
T ss_dssp CCCSSHH-HHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred CCCCCHH-HHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHH
Confidence 9875543 2222222111000 000000011256789999999999999999999999
Q ss_pred HHHH
Q psy14267 542 SVTQ 545 (553)
Q Consensus 542 ll~~ 545 (553)
+++|
T Consensus 309 ~L~h 312 (367)
T 2fst_X 309 ALAH 312 (367)
T ss_dssp HHTS
T ss_pred HhcC
Confidence 9875
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=344.55 Aligned_cols=260 Identities=22% Similarity=0.299 Sum_probs=198.9
Q ss_pred CcceEEE-eeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCC
Q psy14267 255 GKQYQVL-SLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTAS 333 (553)
Q Consensus 255 ~~~y~i~-~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~ 333 (553)
..+|.+. +.||+|+||.||+|.+..++.. ||||++.+..... .....+.+|+.+++++.+||||+++++++. ..
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~--vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~--~~ 101 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISKSTGQE--YAAKFLKKRRRGQ-DCRAEILHEIAVLELAKSCPRVINLHEVYE--NT 101 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEETTTCCE--EEEEEEESEETTE-ECHHHHHHHHHHHHHTTTCTTBCCEEEEEE--CS
T ss_pred hhEEeeccceeCCCCCeEEEEEEECCCCCE--EEEEEEehhhcch-HHHHHHHHHHHHHHhccCCCCEEEEEEEEE--eC
Confidence 3568887 8999999999999988776654 9999998755333 334778999999999999999999998874 46
Q ss_pred ceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCe
Q psy14267 334 KHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNV 412 (553)
Q Consensus 334 ~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~ 412 (553)
..++++||++ +++|.+++..... .......++.++.||+.||+|||++||+||||||+||||+... ..+.
T Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~------~~~~ 172 (327)
T 3lm5_A 102 SEIILILEYAAGGEIFSLCLPELA---EMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIY------PLGD 172 (327)
T ss_dssp SEEEEEEECCTTEEGGGGGSSCC----CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBT------TBCC
T ss_pred CeEEEEEEecCCCcHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCC------CCCc
Confidence 6789999976 4588777643221 2345566777788999999999999999999999999997631 1257
Q ss_pred EEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchH
Q psy14267 413 LKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTW 492 (553)
Q Consensus 413 vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~ 492 (553)
+||+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|..||......
T Consensus 173 ~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~~ll~g~~pf~~~~~~- 239 (327)
T 3lm5_A 173 IKIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYD---------PITTATDMWNIGIIAYMLLTHTSPFVGEDNQ- 239 (327)
T ss_dssp EEECCGGGCEEC------------CCCGGGCCHHHHTTC---------CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-
T ss_pred EEEeeCccccccCCccc---cccccCCcCccCCeeecCC---------CCCchhhHHHHHHHHHHHHhCCCCCCCCCch-
Confidence 99999999987754332 2256799999999999765 3788999999999999999999999875543
Q ss_pred HHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 493 AKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 493 ~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
.....+..... .........+++.+.+||.+||+.||++|||+++++++
T Consensus 240 ~~~~~i~~~~~----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 240 ETYLNISQVNV----DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HHHHHHHHTCC----CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred HHHHHHHhccc----ccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 22222322221 11122234688999999999999999999999999875
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=360.31 Aligned_cols=262 Identities=23% Similarity=0.371 Sum_probs=200.7
Q ss_pred ceEEecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEE
Q psy14267 249 DVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYV 328 (553)
Q Consensus 249 ~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~ 328 (553)
..|.+..++|++.+.||+|+||.||++.+... ..||||+++..... .+.+.+|+++|++++ ||||+++++++
T Consensus 177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~---~~vavK~~~~~~~~----~~~~~~E~~~l~~l~-hp~iv~~~~~~ 248 (452)
T 1fmk_A 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT---TRVAIKTLKPGTMS----PEAFLQEAQVMKKLR-HEKLVQLYAVV 248 (452)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTT---EEEEEEECCTTSSC----HHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred cccccChhHceeeeeecCCCCeEEEEEEECCC---ceEEEEEeccCCCC----HHHHHHHHHHHHhCC-CCCEeeEEEEE
Confidence 34567778999999999999999999987543 34999999865432 367899999999995 59999999876
Q ss_pred EeCCCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceec
Q psy14267 329 YDTASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIID 407 (553)
Q Consensus 329 ~~~~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~ 407 (553)
.+ ..++++||++ +++|.+++...... ......++.++.||+.||+|||++|||||||||+||||+.+
T Consensus 249 ~~---~~~~iv~e~~~~gsL~~~l~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~------ 316 (452)
T 1fmk_A 249 SE---EPIYIVTEYMSKGSLLDFLKGETGK---YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN------ 316 (452)
T ss_dssp CS---SSCEEEECCCTTCBHHHHHSHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG------
T ss_pred cC---CceEEEehhhcCCCHHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCC------
Confidence 32 4678999976 57999999754322 23445666777899999999999999999999999999776
Q ss_pred CCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCC
Q psy14267 408 CIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYS 486 (553)
Q Consensus 408 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~ 486 (553)
+.+||+|||+++........ ......+++.|+|||++.+. .++.++|||||||+||||++ |..||.
T Consensus 317 ---~~~kl~DfG~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~---------~~~~~sDvwslG~~l~el~t~g~~P~~ 383 (452)
T 1fmk_A 317 ---LVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYG---------RFTIKSDVWSFGILLTELTTKGRVPYP 383 (452)
T ss_dssp ---GCEEECCCCTTC---------------CCGGGSCHHHHHHC---------CCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred ---CCEEECCCccceecCCCcee-cccCCcccccccCHhHHhcC---------CCCccccHHhHHHHHHHHHhCCCCCCC
Confidence 57999999999876543221 12234578899999999765 37899999999999999999 999998
Q ss_pred CCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q psy14267 487 HIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNPE 551 (553)
Q Consensus 487 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~~ 551 (553)
+.... .....+... .. ......+++.+.++|.+||+.||++|||+.+|++.|+++..
T Consensus 384 ~~~~~-~~~~~i~~~-~~------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 384 GMVNR-EVLDQVERG-YR------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp TCCHH-HHHHHHHTT-CC------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred CCCHH-HHHHHHHcC-CC------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 76543 222333222 11 12223688999999999999999999999999999998754
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=358.22 Aligned_cols=256 Identities=24% Similarity=0.405 Sum_probs=202.3
Q ss_pred eEEecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEE
Q psy14267 250 VITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVY 329 (553)
Q Consensus 250 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~ 329 (553)
.|.+..++|++.+.||+|+||.||++... + +.||||+++... ..+.+.+|+.+|++++ ||||+++++++.
T Consensus 187 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~--~~vavK~~~~~~-----~~~~~~~E~~~l~~l~-h~niv~~~~~~~ 256 (450)
T 1k9a_A 187 GWALNMKELKLLQTIGKGEFGDVMLGDYR--G--NKVAVKCIKNDA-----TAQAFLAEASVMTQLR-HSNLVQLLGVIV 256 (450)
T ss_dssp TCBCCGGGEEEEEEEEECSSEEEEEEEET--T--EEEEEEEESSCT-----TSHHHHHHHHHHHTCC-CTTBCCEEEEEE
T ss_pred ccccChHHeEEEeeecCcCCeeEEEEEec--C--CeEEEEEeCCch-----HHHHHHHHHHHHHhcc-CCCEEEEEEEEE
Confidence 45677789999999999999999999764 2 359999997653 2367899999999995 599999999876
Q ss_pred eCCCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecC
Q psy14267 330 DTASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDC 408 (553)
Q Consensus 330 ~~~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~ 408 (553)
.. ...++++||++ +++|.++++..... ......++.++.||+.||+|||++|||||||||+||||+.+
T Consensus 257 ~~-~~~~~iv~e~~~~g~L~~~l~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~------- 325 (450)
T 1k9a_A 257 EE-KGGLYIVTEYMAKGSLVDYLRSRGRS---VLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED------- 325 (450)
T ss_dssp CT-TSCEEEEEECCTTCBHHHHHHHHCTT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT-------
T ss_pred cC-CCceEEEEEecCCCcHHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCC-------
Confidence 53 34688999976 57999999876432 23445566777899999999999999999999999999776
Q ss_pred CCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCC
Q psy14267 409 IGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSH 487 (553)
Q Consensus 409 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~ 487 (553)
+.+||+|||+++...... ....+++.|+|||++.+. .++.++|||||||+||||++ |..||..
T Consensus 326 --~~~kl~DfG~a~~~~~~~-----~~~~~~~~y~aPE~~~~~---------~~~~~sDvwslG~~l~el~t~g~~P~~~ 389 (450)
T 1k9a_A 326 --NVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREK---------KFSTKSDVWSFGILLWEIYSFGRVPYPR 389 (450)
T ss_dssp --SCEEECCCTTCEECC-----------CCCTTTSCHHHHHSS---------CCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred --CCEEEeeCCCcccccccc-----cCCCCCcceeCHHHhcCC---------CCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 579999999998654322 133578999999999765 37899999999999999998 9999987
Q ss_pred CCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q psy14267 488 IPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNP 550 (553)
Q Consensus 488 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~ 550 (553)
.... .....+... .. ......+++++.+||.+||+.||++|||+.+|++.|+++.
T Consensus 390 ~~~~-~~~~~i~~~-~~------~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~ 444 (450)
T 1k9a_A 390 IPLK-DVVPRVEKG-YK------MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444 (450)
T ss_dssp SCTT-THHHHHHTT-CC------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCHH-HHHHHHHcC-CC------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 6543 222222221 11 1223368899999999999999999999999999998753
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=334.43 Aligned_cols=255 Identities=23% Similarity=0.324 Sum_probs=199.8
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|++++.||+|+||.||+|.+..++.. ||||++...... ...+.+.+|+.+++++. ||||+++++++.. ...
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vavK~~~~~~~~--~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~ 79 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEA--VAVKIVDMKRAV--DCPENIKKEICINKMLN-HENVVKFYGHRRE--GNI 79 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCE--EEEEEEEGGGCT--THHHHHHHHHHHHHTCC-CTTBCCEEEEEEE--TTE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcE--EEEEEeeeccch--hhhHHHHHHHHHHHhcC-CCCceeeeeEEEc--CCE
Confidence 5799999999999999999988766644 999999765432 33477899999999995 6999999998754 567
Q ss_pred EEEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
.+++||++. ++|.+++.... ......+..++.|++.||+|||++||+||||||+|||++.+ +.+|
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~---------~~~k 145 (276)
T 2yex_A 80 QYLFLEYCSGGELFDRIEPDI-----GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER---------DNLK 145 (276)
T ss_dssp EEEEEECCTTEEGGGGSBTTT-----BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT---------CCEE
T ss_pred EEEEEEecCCCcHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccC---------CCEE
Confidence 889999875 58887775432 34456677778899999999999999999999999999776 5799
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||++................||+.|+|||++.+.. .++.++||||||+++|||++|..||.........
T Consensus 146 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--------~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 217 (276)
T 2yex_A 146 ISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE--------FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217 (276)
T ss_dssp ECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSS--------BCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH
T ss_pred EeeCCCccccCCCcchhcccCCccccCccChHHHhcCC--------CCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH
Confidence 99999998765433222234567999999999997653 2367899999999999999999999875443233
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
...+...... ......++..+.++|.+||..||++|||+.+++++
T Consensus 218 ~~~~~~~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 218 YSDWKEKKTY------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp HHHHHTTCTT------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHhhhcccc------cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 3333322111 11123578999999999999999999999999874
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=359.93 Aligned_cols=261 Identities=27% Similarity=0.398 Sum_probs=190.3
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcC-----chhHHHHHHHHHHHHHhhcCCCceeEeeeEEE
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDIT-----DQSIADSYLNEVELLAKLQGCPYVIKMHDYVY 329 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~-----~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~ 329 (553)
.++|.+.+.||+|+||.||+|.+..++.. ||||++.+.... .......+.+|+.+|+++ +||||+++++++.
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~--vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~ 210 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKK--VAIRIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFFD 210 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCE--EEEEEEEGGGGTTC--------CCHHHHHHHHHHC-CCTTBCCCCEEEE
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcE--EEEEEEEechhcccccccchhHHHHHHHHHHHHhC-CCCCEeeEEEEEe
Confidence 35799999999999999999988777654 999999875432 112223578999999999 5699999999863
Q ss_pred eCCCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecC
Q psy14267 330 DTASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDC 408 (553)
Q Consensus 330 ~~~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~ 408 (553)
...++++||++ +++|.+++.... ......+..++.|++.||+|||++|||||||||+||||+.+.
T Consensus 211 ---~~~~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~------ 276 (419)
T 3i6u_A 211 ---AEDYYIVLELMEGGELFDKVVGNK-----RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQE------ 276 (419)
T ss_dssp ---SSEEEEEEECCTTCBGGGGTSSSC-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSS------
T ss_pred ---cCceEEEEEcCCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCC------
Confidence 23478899976 568877765433 344566677788999999999999999999999999997542
Q ss_pred CCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy14267 409 IGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHI 488 (553)
Q Consensus 409 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~ 488 (553)
....+||+|||+|+....... ....+||+.|+|||++.+... ..++.++|||||||++|||++|..||...
T Consensus 277 ~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~------~~~~~~~DiwslG~il~~lltg~~pf~~~ 347 (419)
T 3i6u_A 277 EDCLIKITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGT------AGYNRAVDCWSLGVILFICLSGYPPFSEH 347 (419)
T ss_dssp SSCCEEECCSSTTTSCC--------------CTTCCTTTTC----------CTTHHHHHHHHHHHHHHHHHHSSCSSCCC
T ss_pred CcceEEEeecccceecCCCcc---ccccCCCCCccCceeeecCCC------CCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 224699999999987754332 235679999999999864321 14788999999999999999999999865
Q ss_pred CchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 489 PNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 489 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
.........+..... .+.+ ..+..+++.+.+||.+||+.||++|||+.|+++|
T Consensus 348 ~~~~~~~~~i~~~~~--~~~~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 348 RTQVSLKDQITSGKY--NFIP--EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp SSSCCHHHHHHTTCC--CCCH--HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cchHHHHHHHhcCCC--CCCc--hhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 433222223322221 1111 1223678999999999999999999999999875
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=331.42 Aligned_cols=259 Identities=15% Similarity=0.161 Sum_probs=197.5
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|++++.||+|+||.||+|.+..++.. ||||++....... .....+.+|+.++.++.+||||+++++++.+ ...
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~--~~~ 85 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCI--YAIKRSKKPLAGS-VDEQNALREVYAHAVLGQHSHVVRYFSAWAE--DDH 85 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCE--EEEEEEECCCTTS-HHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE--TTE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCce--EEEEEeccccccc-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeec--CCe
Confidence 5799999999999999999988766644 9999998765444 3357889999999999778999999998754 568
Q ss_pred EEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccce---------
Q psy14267 336 LYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKI--------- 405 (553)
Q Consensus 336 ~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~--------- 405 (553)
++++||++ +++|.+++....... .......++.++.||+.||+|||++||+||||||+||||+.+....
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 86 MLIQNEYCNGGSLADAISENYRIM-SYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---------------
T ss_pred EEEEEEecCCCcHHHHHHhhcccc-cCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccc
Confidence 89999987 569999998753211 1234566677788999999999999999999999999997542000
Q ss_pred -ecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCC
Q psy14267 406 -IDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTP 484 (553)
Q Consensus 406 -~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~P 484 (553)
.......+||+|||++....... ...||+.|+|||++.+.. .++.++|||||||++|||++|.+|
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~--------~~~~~~Di~slG~il~~l~~~~~~ 230 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENY--------THLPKADIFALALTVVCAAGAEPL 230 (289)
T ss_dssp -----CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCC--------TTHHHHHHHHHHHHHHHHTTCCCC
T ss_pred cccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCC--------CCCchhhHHHHHHHHHHHhcCCCC
Confidence 00123479999999998775433 345899999999997542 356899999999999999999987
Q ss_pred CCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 485 YSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 485 f~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
+.... ....+..... . .....+++++.++|.+||+.||++|||+.+++++
T Consensus 231 ~~~~~----~~~~~~~~~~-~------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 231 PRNGD----QWHEIRQGRL-P------RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp CSSSH----HHHHHHTTCC-C------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred Ccchh----HHHHHHcCCC-C------CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 75532 1222222111 1 1123678999999999999999999999999875
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=350.01 Aligned_cols=259 Identities=22% Similarity=0.360 Sum_probs=195.4
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC--
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA-- 332 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~-- 332 (553)
..+|+++++||+|+||+||+|++..++. ||+|++...... ..+|+++|+.+. ||||+++++++....
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~---~aikk~~~~~~~-------~~~E~~il~~l~-h~niv~l~~~~~~~~~~ 107 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE---VAIKKVLQDKRF-------KNRELQIMRIVK-HPNVVDLKAFFYSNGDK 107 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE---EEEEEEECCTTS-------CCHHHHHHHTCC-CTTBCCEEEEEEEESSS
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe---EEEEEEecCcch-------HHHHHHHHHhCC-CCCcceEEEEEEecCCC
Confidence 3579999999999999999998765543 788887654321 236999999995 599999999886543
Q ss_pred --CceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCC
Q psy14267 333 --SKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIG 410 (553)
Q Consensus 333 --~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~ 410 (553)
..+++++||++.+++...+....... .......+..++.||+.||+|||++||+||||||+||||+...
T Consensus 108 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~-------- 178 (394)
T 4e7w_A 108 KDEVFLNLVLEYVPETVYRASRHYAKLK-QTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPS-------- 178 (394)
T ss_dssp SSCEEEEEEEECCSEEHHHHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTT--------
T ss_pred CCceEEEEEeeccCccHHHHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCC--------
Confidence 33588999999998887766432221 1344566777788999999999999999999999999998332
Q ss_pred CeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCc
Q psy14267 411 NVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN 490 (553)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~ 490 (553)
+.+||+|||+|+.+...... ....||+.|+|||++.+.. .++.++|||||||+||||++|+.||.+...
T Consensus 179 ~~~kL~DFG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~--------~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 247 (394)
T 4e7w_A 179 GVLKLIDFGSAKILIAGEPN---VSYICSRYYRAPELIFGAT--------NYTTNIDIWSTGCVMAELMQGQPLFPGESG 247 (394)
T ss_dssp TEEEECCCTTCEECCTTCCC---CSSCSCGGGCCHHHHTTCS--------SCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CcEEEeeCCCcccccCCCCC---cccccCcCccCHHHHcCCC--------CCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 68999999999887554432 2567899999999997543 378999999999999999999999988654
Q ss_pred hHHHHHHHHhhccc---------------ccccc------cccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 491 TWAKMLAIARHKDQ---------------IEFKP------QLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 491 ~~~~~~~i~~~~~~---------------~~~~~------~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
.. .+..+...... ..+.. .......+++++.+||.+||..||++|||+.|+++|
T Consensus 248 ~~-~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 248 ID-QLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HH-HHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HH-HHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 32 22222211000 00000 000122478999999999999999999999999976
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=330.69 Aligned_cols=259 Identities=21% Similarity=0.352 Sum_probs=203.7
Q ss_pred EEecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEe
Q psy14267 251 ITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYD 330 (553)
Q Consensus 251 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~ 330 (553)
|.+..++|++.+.||+|+||.||++.+... +.||||++...... .+.+.+|+++++++. ||||+++++++.
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~-h~~i~~~~~~~~- 73 (267)
T 3t9t_A 3 WVIDPSELTFVQEIGSGQFGLVHLGYWLNK---DKVAIKTIREGAMS----EEDFIEEAEVMMKLS-HPKLVQLYGVCL- 73 (267)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEETTT---EEEEEEEECTTTBC----HHHHHHHHHHHHTCC-CTTBCCEEEEEC-
T ss_pred eEEchhheeeeeEecCCCceeEEEEEecCC---CeEEEEEccccCCC----HHHHHHHHHHHHhCC-CCCEeeEEEEEc-
Confidence 456678999999999999999999987532 35999999876533 257889999999995 699999998774
Q ss_pred CCCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCC
Q psy14267 331 TASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCI 409 (553)
Q Consensus 331 ~~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~ 409 (553)
....++++||++ +++|.+++..... ......++.++.|++.||+|||++||+||||||+|||++.+
T Consensus 74 -~~~~~~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~-------- 140 (267)
T 3t9t_A 74 -EQAPICLVTEFMEHGCLSDYLRTQRG----LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN-------- 140 (267)
T ss_dssp -SSSSCEEEECCCTTCBHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGG--------
T ss_pred -cCCCeEEEEeCCCCCcHHHHHhhCcc----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCC--------
Confidence 456788999986 5799999986532 23455666777899999999999999999999999999776
Q ss_pred CCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCC
Q psy14267 410 GNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHI 488 (553)
Q Consensus 410 ~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~ 488 (553)
+.+||+|||++........ .......|++.|+|||++.+. .++.++||||||+++|||++ |..||...
T Consensus 141 -~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~~~g~~p~~~~ 209 (267)
T 3t9t_A 141 -QVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFS---------RYSSKSDVWSFGVLMWEVFSEGKIPYENR 209 (267)
T ss_dssp -GCEEECCTTGGGGBCCHHH-HSTTSTTCCGGGCCHHHHHHC---------CCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred -CCEEEcccccccccccccc-cccccccccccccChhhhcCC---------CccchhchhhhHHHHHHHhccCCCCCCCC
Confidence 5799999999987654221 112244578899999999765 37889999999999999999 99999875
Q ss_pred CchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q psy14267 489 PNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNP 550 (553)
Q Consensus 489 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~ 550 (553)
... .....+.... . ......++..+.++|.+||..||++||++.+++++|+++.
T Consensus 210 ~~~-~~~~~i~~~~-~------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (267)
T 3t9t_A 210 SNS-EVVEDISTGF-R------LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 263 (267)
T ss_dssp CHH-HHHHHHHTTC-C------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CHH-HHHHHHhcCC-c------CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 443 2222332221 1 1112356899999999999999999999999999998764
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=334.37 Aligned_cols=266 Identities=18% Similarity=0.296 Sum_probs=197.2
Q ss_pred EecCcceEEEeeeeeeCceEEEEEeeeC-CCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEe
Q psy14267 252 TLNGKQYQVLSLLGKGGSSSVYLVGGTS-EHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYD 330 (553)
Q Consensus 252 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~ 330 (553)
.+..++|++++.||+|+||.||+|++.. .+....||||+++..........+.+.+|+++++++. ||||+++++++..
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~ 92 (291)
T 1u46_A 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVLT 92 (291)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC-CTTBCCEEEEECS
T ss_pred ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCC-CCCcccEEEEEcc
Confidence 4556789999999999999999998654 3344469999998766555566788999999999995 6999999998754
Q ss_pred CCCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCC
Q psy14267 331 TASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCI 409 (553)
Q Consensus 331 ~~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~ 409 (553)
. ..+++||++ +++|.+++..... ......+..++.|++.||+|||++||+||||||+|||++.+
T Consensus 93 ~---~~~~v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~-------- 157 (291)
T 1u46_A 93 P---PMKMVTELAPLGSLLDRLRKHQG----HFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATR-------- 157 (291)
T ss_dssp S---SCEEEEECCTTCBHHHHHHHHGG----GSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEET--------
T ss_pred C---CceeeEecccCCCHHHHHHhccC----CcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCC--------
Confidence 3 267777765 5799999887532 23455666777899999999999999999999999999876
Q ss_pred CCeEEEEeccCccccCCCCCcc-cccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCC
Q psy14267 410 GNVLKIIDFGIACSLQDDKTSV-HKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSH 487 (553)
Q Consensus 410 ~~~vkL~DFGla~~~~~~~~~~-~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~ 487 (553)
+.+||+|||++.......... ......+|+.|+|||++.+. .++.++||||||+++|||++ |..||..
T Consensus 158 -~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~~~g~~p~~~ 227 (291)
T 1u46_A 158 -DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR---------TFSHASDTWMFGVTLWEMFTYGQEPWIG 227 (291)
T ss_dssp -TEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHC---------EEEHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred -CCEEEccccccccccccccchhhhccCCCCceeeCchhhcCC---------CCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 579999999998876544321 22345578899999999765 36789999999999999999 9999987
Q ss_pred CCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q psy14267 488 IPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNP 550 (553)
Q Consensus 488 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~ 550 (553)
.... .....+...... ......++.++.++|.+||..||++|||+.++++.|++..
T Consensus 228 ~~~~-~~~~~~~~~~~~------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 228 LNGS-QILHKIDKEGER------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp CCHH-HHHHHHHTSCCC------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CCHH-HHHHHHHccCCC------CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 6443 233333222211 1223368899999999999999999999999999998754
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=333.91 Aligned_cols=251 Identities=24% Similarity=0.371 Sum_probs=200.4
Q ss_pred cCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCC
Q psy14267 254 NGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTAS 333 (553)
Q Consensus 254 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~ 333 (553)
..++|++.+.||+|+||.||+|.+..++. .||||++...........+.+.+|+.+++++. ||||+++++++.+ .
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~--~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~ 86 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKF--IMALKVLFKSQLEKEGVEHQLRREIEIQSHLR-HPNILRMYNYFHD--R 86 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTE--EEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEEC--S
T ss_pred hhhhceeeheecCCCCeEEEEEEEcCCCc--EEEEEEEcccccchHHHHHHHHHHHHHHhcCC-CCCEeeEEEEEEc--C
Confidence 34689999999999999999998876664 49999997654333334467899999999995 6999999998753 5
Q ss_pred ceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCe
Q psy14267 334 KHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNV 412 (553)
Q Consensus 334 ~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~ 412 (553)
..++++||++ +++|.+++..... .....+..++.|++.||+|||++||+||||||+|||++.+ +.
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~---------~~ 152 (284)
T 2vgo_A 87 KRIYLMLEFAPRGELYKELQKHGR-----FDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYK---------GE 152 (284)
T ss_dssp SEEEEEECCCTTEEHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTT---------CC
T ss_pred CEEEEEEEeCCCCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCC---------CC
Confidence 6889999987 4699999887542 3455666777899999999999999999999999999766 57
Q ss_pred EEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchH
Q psy14267 413 LKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTW 492 (553)
Q Consensus 413 vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~ 492 (553)
+||+|||++....... .....|++.|+|||++.+. .++.++||||||+++|||++|..||......
T Consensus 153 ~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~~g~~pf~~~~~~- 218 (284)
T 2vgo_A 153 LKIADFGWSVHAPSLR----RRTMCGTLDYLPPEMIEGK---------THDEKVDLWCAGVLCYEFLVGMPPFDSPSHT- 218 (284)
T ss_dssp EEECCCTTCEECSSSC----BCCCCSCGGGCCHHHHTTC---------CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-
T ss_pred EEEecccccccCcccc----cccccCCCCcCCHHHhccC---------CCCcccchhhHHHHHHHHHHCCCCCCCCCHh-
Confidence 9999999997665432 2256799999999999765 3688999999999999999999999875433
Q ss_pred HHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 493 AKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 493 ~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
.....+... ... ....++..++++|.+||+.||++||++.+++++
T Consensus 219 ~~~~~~~~~--~~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 219 ETHRRIVNV--DLK------FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp HHHHHHHTT--CCC------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred HHHHHHhcc--ccC------CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 222222221 111 123578999999999999999999999999874
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=334.82 Aligned_cols=252 Identities=25% Similarity=0.451 Sum_probs=179.1
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|++.+.||+|+||.||+|++..++. .||||++...........+++.+|+.+++++. ||||+++++++. ....
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~ 85 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGL--EVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK-HPSILELYNYFE--DSNY 85 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCC--EEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBC-CTTBCCEEEEEE--CSSE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCc--eEEEEEeehhhhhhhhHHHHHHHHHHHHHhCC-CCCeEeEEEEEc--cCCe
Confidence 579999999999999999998876664 49999997654333344578899999999995 599999999874 4668
Q ss_pred EEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
++++||++ +++|.+++..... ......++.++.|++.||+|||++||+||||||+|||++.+ +.+|
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~---------~~~k 152 (278)
T 3cok_A 86 VYLVLEMCHNGEMNRYLKNRVK----PFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRN---------MNIK 152 (278)
T ss_dssp EEEEEECCTTEEHHHHHHTCSS----CCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTT---------CCEE
T ss_pred EEEEEecCCCCcHHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC---------CCEE
Confidence 89999987 5689988876432 34456677778899999999999999999999999999776 5799
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||++......... .....||+.|+|||++.+. .++.++||||||+++|||++|..||....... .
T Consensus 153 l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~ 220 (278)
T 3cok_A 153 IADFGLATQLKMPHEK--HYTLCGTPNYISPEIATRS---------AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN-T 220 (278)
T ss_dssp ECCCTTCEECC---------------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---
T ss_pred EEeecceeeccCCCCc--ceeccCCCCcCCcchhcCC---------CCCchhhHHHHHHHHHHHHhCCCCCCChhHHH-H
Confidence 9999999876543321 2245799999999999765 36789999999999999999999998643321 1
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
... . ..........++.++.++|.+||+.||++|||+.+++++
T Consensus 221 ~~~----~----~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 221 LNK----V----VLADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp -------C----CSSCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHH----H----hhcccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 110 0 011112233578999999999999999999999999874
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=338.49 Aligned_cols=263 Identities=21% Similarity=0.370 Sum_probs=197.8
Q ss_pred EecCcceEEEeeeeeeCceEEEEEeeeCCCc--cceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEE
Q psy14267 252 TLNGKQYQVLSLLGKGGSSSVYLVGGTSEHE--FKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVY 329 (553)
Q Consensus 252 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~--~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~ 329 (553)
++...+|++.+.||+|+||.||+|.....+. ...||||++.... .......+.+|+.+++++. ||||+++++++
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~- 115 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFS-HHNIIRLEGVI- 115 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEE-
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEE-
Confidence 3556789999999999999999998765432 3459999997543 2344567899999999995 59999999877
Q ss_pred eCCCceEEEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecC
Q psy14267 330 DTASKHLYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDC 408 (553)
Q Consensus 330 ~~~~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~ 408 (553)
.....++++||++. ++|.+++..... ......++.++.||+.||+|||++||+||||||+||||+.+
T Consensus 116 -~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~------- 183 (333)
T 1mqb_A 116 -SKYKPMMIITEYMENGALDKFLREKDG----EFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSN------- 183 (333)
T ss_dssp -CSSSSEEEEEECCTTEEHHHHHHHTTT----CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-------
T ss_pred -ecCCCcEEEEeCCCCCcHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCC-------
Confidence 44667899999875 599999876432 34456677778899999999999999999999999999776
Q ss_pred CCCeEEEEeccCccccCCCCCc-ccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCC
Q psy14267 409 IGNVLKIIDFGIACSLQDDKTS-VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYS 486 (553)
Q Consensus 409 ~~~~vkL~DFGla~~~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~ 486 (553)
+.+||+|||+++........ .......+|+.|+|||++.+. .++.++|||||||++|||++ |..||.
T Consensus 184 --~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~ellt~g~~pf~ 252 (333)
T 1mqb_A 184 --LVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR---------KFTSASDVWSFGIVMWEVMTYGERPYW 252 (333)
T ss_dssp --CCEEECCCCC-----------------CCCGGGSCHHHHHSC---------CCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred --CcEEECCCCcchhhccccccccccCCCCccccccCchhcccC---------CCCchhhhHHHHHHHHHHHcCCCCCcc
Confidence 57999999999877543321 111233468899999999755 37889999999999999998 999998
Q ss_pred CCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 487 HIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 487 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
..... ..+..+... .. ......++..+.++|.+||+.||++||++.++++.|+++
T Consensus 253 ~~~~~-~~~~~~~~~-~~------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 307 (333)
T 1mqb_A 253 ELSNH-EVMKAINDG-FR------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307 (333)
T ss_dssp TCCHH-HHHHHHHTT-CC------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred cCCHH-HHHHHHHCC-Cc------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 76543 222222221 11 122336789999999999999999999999999999864
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=336.81 Aligned_cols=263 Identities=22% Similarity=0.342 Sum_probs=200.9
Q ss_pred CcceEEEeeeeeeCceEEEEEeee-CCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhc--CCCceeEeeeEEEe-
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGT-SEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQ--GCPYVIKMHDYVYD- 330 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~-~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~--~hp~Iv~l~~~~~~- 330 (553)
.++|++++.||+|+||.||+|++. .++ +.||||++....... .....+.+|+.+++++. .||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~--~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~ 86 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGG--RFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 86 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTT--EEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred hhceeeeeeecccccEEEEEEEecCCCC--EEEEEEEeccCcccc-cCCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence 468999999999999999999875 334 459999997654322 11235678888888875 67999999998753
Q ss_pred --CCCceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecC
Q psy14267 331 --TASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDC 408 (553)
Q Consensus 331 --~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~ 408 (553)
.....++++||+++++|.+++...... ......++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 87 ~~~~~~~~~lv~e~~~~~L~~~l~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~------- 156 (326)
T 1blx_A 87 RTDRETKLTLVFEHVDQDLTTYLDKVPEP---GVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS------- 156 (326)
T ss_dssp ECSSEEEEEEEEECCSCBHHHHHHHSCTT---CSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-------
T ss_pred ccCCCceEEEEEecCCCCHHHHHHhcccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCC-------
Confidence 245678999999999999999875432 24455667778899999999999999999999999999776
Q ss_pred CCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy14267 409 IGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHI 488 (553)
Q Consensus 409 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~ 488 (553)
+.+||+|||++....... ......||+.|+|||++.+. .++.++|||||||++|||++|..||...
T Consensus 157 --~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~~g~~pf~~~ 222 (326)
T 1blx_A 157 --GQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQS---------SYATPVDLWSVGCIFAEMFRRKPLFRGS 222 (326)
T ss_dssp --CCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTC---------CCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred --CCEEEecCcccccccCCC---CccccccccceeCHHHHhcC---------CCCcchhHHHHHHHHHHHHcCCCCCCCC
Confidence 579999999997764322 22356799999999999765 3788999999999999999999999875
Q ss_pred CchHHHHHHHHhhccc---ccc----------------cccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 489 PNTWAKMLAIARHKDQ---IEF----------------KPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 489 ~~~~~~~~~i~~~~~~---~~~----------------~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
... ..+..+...... ..+ .+.......++..+++||.+||..||++|||+.+++++
T Consensus 223 ~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 223 SDV-DQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp SHH-HHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CHH-HHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 543 222222211100 000 00111224678999999999999999999999999964
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=331.90 Aligned_cols=260 Identities=23% Similarity=0.341 Sum_probs=197.6
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCc-cceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHE-FKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~-~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
-.|.+.++||+|+||.||+|.+..... ...||+|++... ......+.+.+|+.+|+++. ||||+++++++... +.
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~-~~ 96 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLN-HPNVLALIGIMLPP-EG 96 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCC-CTTBCCCCEEECCS-SS
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--ccHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEecC-CC
Confidence 368888999999999999998765443 235999998653 33345678999999999995 69999999987543 33
Q ss_pred eEEEEEec-CCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 335 HLYVLMEK-GDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 335 ~~~iv~e~-~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
..+++|++ .+++|.+++..... ......++.++.|++.||+|||++||+||||||+|||++.+ +.+
T Consensus 97 ~~~~v~e~~~~~~L~~~~~~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~---------~~~ 163 (298)
T 3pls_A 97 LPHVLLPYMCHGDLLQFIRSPQR----NPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDES---------FTV 163 (298)
T ss_dssp CCEEEECCCTTCBHHHHHHCTTC----CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT---------CCE
T ss_pred CcEEEEecccCCCHHHHHhcccc----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCC---------CcE
Confidence 44666665 57899999876332 33455666777899999999999999999999999999776 579
Q ss_pred EEEeccCccccCCCCC--cccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCC-CCCCCc
Q psy14267 414 KIIDFGIACSLQDDKT--SVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTP-YSHIPN 490 (553)
Q Consensus 414 kL~DFGla~~~~~~~~--~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~P-f~~~~~ 490 (553)
||+|||+++....... ........+++.|+|||.+.+. .++.++|||||||++|||++|..| |.....
T Consensus 164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~~g~~~~~~~~~~ 234 (298)
T 3pls_A 164 KVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTY---------RFTTKSDVWSFGVLLWELLTRGAPPYRHIDP 234 (298)
T ss_dssp EECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTC---------CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG
T ss_pred EeCcCCCcccccCCcccccccCcCCCCCccccChhhhccC---------CCChhhchhhHHHHHHHHhhCCCCCCccCCH
Confidence 9999999986654321 1122345689999999999765 378999999999999999995554 544333
Q ss_pred hHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 491 TWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 491 ~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
......+.... . ......+++.+.++|.+||..||++|||+.++++.|+++
T Consensus 235 -~~~~~~~~~~~-~------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~ 285 (298)
T 3pls_A 235 -FDLTHFLAQGR-R------LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285 (298)
T ss_dssp -GGHHHHHHTTC-C------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HHHHHHhhcCC-C------CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 22222222221 1 122336789999999999999999999999999999874
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=342.69 Aligned_cols=263 Identities=21% Similarity=0.338 Sum_probs=195.0
Q ss_pred cCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCC
Q psy14267 254 NGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTAS 333 (553)
Q Consensus 254 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~ 333 (553)
..++|++++.||+|+||.||+|++..++.. ||||++..... .....+.+.+|+.+|+++. ||||+++++++.. .
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~--~ 96 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRI--VAIKKFLESDD-DKMVKKIAMREIKLLKQLR-HENLVNLLEVCKK--K 96 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCE--EEEEEEESCSS-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEE--T
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCce--EEEEEEecCCC-chHHHHHHHHHHHHHhhCC-CCCEeeEEEEeec--C
Confidence 446899999999999999999988776654 99999976653 3345577889999999996 5999999998754 5
Q ss_pred ceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 334 KHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 334 ~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
..++++||++.+.+...+..... ......+..++.||+.||+|||++||+||||||+||||+.+ +.+
T Consensus 97 ~~~~lv~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~---------~~~ 163 (331)
T 4aaa_A 97 KRWYLVFEFVDHTILDDLELFPN----GLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQS---------GVV 163 (331)
T ss_dssp TEEEEEEECCSEEHHHHHHHSTT----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---------SCE
T ss_pred CEEEEEEecCCcchHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCC---------CcE
Confidence 67899999887766555543322 24456667778899999999999999999999999999776 579
Q ss_pred EEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHH
Q psy14267 414 KIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWA 493 (553)
Q Consensus 414 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~ 493 (553)
||+|||+++........ .....||+.|+|||++.+.. .++.++|||||||++|||++|..||........
T Consensus 164 kl~Dfg~~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~--------~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 233 (331)
T 4aaa_A 164 KLCDFGFARTLAAPGEV--YDDEVATRWYRAPELLVGDV--------KYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ 233 (331)
T ss_dssp EECCCTTC--------------CCCCCTTCCHHHHTTCT--------TCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred EEEeCCCceeecCCccc--cCCCcCCccccCcccccCCC--------CcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence 99999999876543321 23557999999999997542 378899999999999999999999987654322
Q ss_pred HHHHHHhhccc----------------cc------ccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 494 KMLAIARHKDQ----------------IE------FKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 494 ~~~~i~~~~~~----------------~~------~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
........... .. ..+.......+++.+.+||.+||+.||++|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 234 LYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp HHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred HHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 22111110000 00 000011123578999999999999999999999999875
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=352.28 Aligned_cols=261 Identities=22% Similarity=0.364 Sum_probs=198.2
Q ss_pred cCcceEEEeeeeeeCceEEEEEeeeC-CCccceEEEEEEecCCcC-chhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeC
Q psy14267 254 NGKQYQVLSLLGKGGSSSVYLVGGTS-EHEFKPLALKVVDLSDIT-DQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDT 331 (553)
Q Consensus 254 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~~~~vAvK~l~~~~~~-~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~ 331 (553)
..++|++++.||+|+||.||+|++.. ....+.||||++++.... .....+.+.+|+++|+++.+||||+.+++++..
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~- 130 (355)
T 1vzo_A 52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT- 130 (355)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE-
T ss_pred cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee-
Confidence 34689999999999999999998753 223456999999754321 112235577899999999888999999887754
Q ss_pred CCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCC
Q psy14267 332 ASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIG 410 (553)
Q Consensus 332 ~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~ 410 (553)
...++++||++ +++|.+++..... +....+..++.||+.||+|||++|||||||||+||||+.+
T Consensus 131 -~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~--------- 195 (355)
T 1vzo_A 131 -ETKLHLILDYINGGELFTHLSQRER-----FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSN--------- 195 (355)
T ss_dssp -TTEEEEEECCCCSCBHHHHHHHHSC-----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---------
T ss_pred -CceEEEEeecCCCCCHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC---------
Confidence 56789999986 5699999987542 3455666677899999999999999999999999999776
Q ss_pred CeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCc
Q psy14267 411 NVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN 490 (553)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~ 490 (553)
+.+||+|||+++.+...... .....+||+.|+|||++.+.. ..++.++|||||||+||||++|..||.....
T Consensus 196 ~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-------~~~~~~~DvwslG~il~ell~g~~pf~~~~~ 267 (355)
T 1vzo_A 196 GHVVLTDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGD-------SGHDKAVDWWSLGVLMYELLTGASPFTVDGE 267 (355)
T ss_dssp SCEEESCSSEEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC----------CTHHHHHHHHHHHHHHHHSSCTTSCTTS
T ss_pred CcEEEeeCCCCeecccCCCC-cccCcccCcCccChhhhcCCC-------CCCCchhhHHHHHHHHHHHHHCCCCCccCCc
Confidence 57999999999876543221 223567999999999997532 1368899999999999999999999975321
Q ss_pred --hHHHH-HHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHHHH
Q psy14267 491 --TWAKM-LAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARP-----TVGNSVTQI 546 (553)
Q Consensus 491 --~~~~~-~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RP-----t~~ell~~L 546 (553)
....+ ..+... . ......++..+.+||.+||..||++|| ++.+++++.
T Consensus 268 ~~~~~~~~~~~~~~--~------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 268 KNSQAEISRRILKS--E------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp CCCHHHHHHHHHHC--C------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred cchHHHHHHHHhcc--C------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 11112 111111 1 112236789999999999999999999 999998764
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=346.19 Aligned_cols=261 Identities=23% Similarity=0.359 Sum_probs=203.4
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcC-----chhHHHHHHHHHHHHHhhcCCCceeEeeeEEEe
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDIT-----DQSIADSYLNEVELLAKLQGCPYVIKMHDYVYD 330 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~-----~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~ 330 (553)
++|++.+.||+|+||.||+|.+..++. .||||++...... .....+.+.+|+.+++++.+||||+.+++++..
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~--~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 171 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGH--EFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES 171 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCC--EEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB
T ss_pred hhcccceEEecCCCEEEEEEEECCCCc--EEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee
Confidence 579999999999999999998876654 4999999865421 123346788999999999778999999987743
Q ss_pred CCCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCC
Q psy14267 331 TASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCI 409 (553)
Q Consensus 331 ~~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~ 409 (553)
...++++||++ +++|.+++.... ......+..++.||+.||+|||+.||+||||||+||||+.+
T Consensus 172 --~~~~~lv~e~~~g~~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~-------- 236 (365)
T 2y7j_A 172 --SSFMFLVFDLMRKGELFDYLTEKV-----ALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDN-------- 236 (365)
T ss_dssp --SSEEEEEECCCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT--------
T ss_pred --CCEEEEEEEeCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC--------
Confidence 66889999986 469999988653 23456667778899999999999999999999999999776
Q ss_pred CCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy14267 410 GNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIP 489 (553)
Q Consensus 410 ~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~ 489 (553)
+.+||+|||++..+..... ....+||+.|+|||++.+.... ....++.++|||||||+||||++|..||....
T Consensus 237 -~~ikl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~---~~~~~~~~~Di~slG~il~ell~g~~pf~~~~ 309 (365)
T 2y7j_A 237 -MQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDE---THPGYGKEVDLWACGVILFTLLAGSPPFWHRR 309 (365)
T ss_dssp -CCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCT---TSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred -CCEEEEecCcccccCCCcc---cccCCCCCCccChhhccccccc---cCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC
Confidence 6799999999988765432 2356799999999998754211 01137889999999999999999999998754
Q ss_pred chHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 490 NTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 490 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
.. .....+........ ...+..++..+.++|.+||..||++|||+.+++++
T Consensus 310 ~~-~~~~~i~~~~~~~~----~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 310 QI-LMLRMIMEGQYQFS----SPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HH-HHHHHHHHTCCCCC----HHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HH-HHHHHHHhCCCCCC----CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 32 23333332222111 11223678999999999999999999999999875
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=332.25 Aligned_cols=260 Identities=24% Similarity=0.410 Sum_probs=203.2
Q ss_pred ceEEecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEE
Q psy14267 249 DVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYV 328 (553)
Q Consensus 249 ~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~ 328 (553)
+.|++..++|++++.||+|+||.||+|.... .+.||||++...... .+.+.+|+++|+++. ||||+++++++
T Consensus 6 ~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~-h~~i~~~~~~~ 77 (279)
T 1qpc_A 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNG---HTKVAVKSLKQGSMS----PDAFLAEANLMKQLQ-HQRLVRLYAVV 77 (279)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETT---TEEEEEEEECTTSSC----HHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred hhcccCHHhhhheeeecCCCCeEEEEEEEcC---CcEEEEEEecCCccc----HHHHHHHHHHHHhCC-CcCcceEEEEE
Confidence 4466778899999999999999999997643 245999999765432 367889999999995 69999999876
Q ss_pred EeCCCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceec
Q psy14267 329 YDTASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIID 407 (553)
Q Consensus 329 ~~~~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~ 407 (553)
. ...++++||++ +++|.+++...... ......++.++.|++.||+|||++||+||||||+|||++.+
T Consensus 78 ~---~~~~~~v~e~~~~~~L~~~l~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~------ 145 (279)
T 1qpc_A 78 T---QEPIYIITEYMENGSLVDFLKTPSGI---KLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDT------ 145 (279)
T ss_dssp C---SSSCEEEEECCTTCBHHHHTTSHHHH---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT------
T ss_pred c---CCCcEEEEecCCCCCHHHHHhcCCCC---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCC------
Confidence 3 33578888876 68999988653211 23455667777899999999999999999999999999766
Q ss_pred CCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCC
Q psy14267 408 CIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYS 486 (553)
Q Consensus 408 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~ 486 (553)
+.+||+|||++......... ......+++.|+|||++.+. .++.++||||||+++|||++ |..||.
T Consensus 146 ---~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~el~~~g~~p~~ 212 (279)
T 1qpc_A 146 ---LSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYG---------TFTIKSDVWSFGILLTEIVTHGRIPYP 212 (279)
T ss_dssp ---SCEEECCCTTCEECSSSCEE-CCTTCCCCTTTSCHHHHHHC---------EECHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred ---CCEEECCCcccccccCcccc-cccCCCCccCccChhhhccC---------CCCchhhhHHHHHHHHHHHhCCCCCCc
Confidence 57999999999877654322 22244578899999999755 37889999999999999999 999998
Q ss_pred CCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 487 HIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 487 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
..... .....+... .. ......++..+.++|.+||..||++|||+.++++.|+++
T Consensus 213 ~~~~~-~~~~~~~~~-~~------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 267 (279)
T 1qpc_A 213 GMTNP-EVIQNLERG-YR------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (279)
T ss_dssp TCCHH-HHHHHHHTT-CC------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCHH-HHHHHHhcc-cC------CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 75543 222222221 11 112236789999999999999999999999999999874
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=337.07 Aligned_cols=253 Identities=25% Similarity=0.408 Sum_probs=190.5
Q ss_pred ecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC
Q psy14267 253 LNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA 332 (553)
Q Consensus 253 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~ 332 (553)
+..++|++.+.||+|+||.||+++.. + +.||||++... ...+.+.+|+++|+++. ||||+++++++.
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~--~--~~vavK~~~~~-----~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~--- 71 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWR--A--KDVAIKQIESE-----SERKAFIVELRQLSRVN-HPNIVKLYGACL--- 71 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEET--T--EEEEEEECSST-----THHHHHHHHHHHHHHCC-CTTBCCEEEBCT---
T ss_pred CCHhHeeeeeEeecCCCceEEEEEEC--C--eeEEEEEecCh-----hHHHHHHHHHHHHhcCC-CCCcCeEEEEEc---
Confidence 34578999999999999999999764 2 44999998543 23477899999999995 699999988663
Q ss_pred CceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhh---CCcEecCCCCCCEEEecCccceecC
Q psy14267 333 SKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHA---AGIIHSDLKPANFLFVGNVLKIIDC 408 (553)
Q Consensus 333 ~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~---~gIiHrDLKp~NILl~~~~~~~~~~ 408 (553)
...+++||++ +++|.+++....... ......++.++.|++.||+|||+ +||+||||||+||||+.+.
T Consensus 72 -~~~~lv~e~~~~~~L~~~l~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~------ 142 (307)
T 2eva_A 72 -NPVCLVMEYAEGGSLYNVLHGAEPLP--YYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGG------ 142 (307)
T ss_dssp -TTTEEEEECCTTCBHHHHHHCSSSEE--CCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTT------
T ss_pred -CCcEEEEEcCCCCCHHHHHhccCCCC--ccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCC------
Confidence 2368899986 579999998654322 23445566677899999999999 8999999999999997662
Q ss_pred CCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy14267 409 IGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHI 488 (553)
Q Consensus 409 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~ 488 (553)
..+||+|||++....... ....||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 143 --~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~---------~~~~~~Di~slG~il~el~~g~~p~~~~ 206 (307)
T 2eva_A 143 --TVLKICDFGTACDIQTHM-----TNNKGSAAWMAPEVFEGS---------NYSEKCDVFSWGIILWEVITRRKPFDEI 206 (307)
T ss_dssp --TEEEECCCCC-----------------CCTTSSCHHHHTCC---------CCCTHHHHHHHHHHHHHHHHTCCTTTTT
T ss_pred --CEEEEccccccccccccc-----ccCCCCCceEChhhhCCC---------CCCcHHHHHHHHHHHHHHHHCCCCchhh
Confidence 358999999997654322 244699999999999765 3789999999999999999999999875
Q ss_pred CchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 489 PNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 489 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
................. .....++..+.++|.+||+.||++|||+.++++.|+++
T Consensus 207 ~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 261 (307)
T 2eva_A 207 GGPAFRIMWAVHNGTRP------PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL 261 (307)
T ss_dssp CSSHHHHHHHHHTTCCC------CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CccHHHHHHHHhcCCCC------CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 43322222211111111 11236789999999999999999999999999999864
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=331.05 Aligned_cols=250 Identities=22% Similarity=0.355 Sum_probs=198.6
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEe----
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYD---- 330 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~---- 330 (553)
+.+|++++.||+|+||.||+|.+..++. .||||++.... +.+.+|+++++++. ||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~~-------~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 79 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGK--TYVIKRVKYNN-------EKAEREVKALAKLD-HVNIVHYNGCWDGFDYD 79 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCC--EEEEEEEECCS-------GGGHHHHHHHHHCC-CTTBCCEEEEEEEEEEC
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCe--EEEEEEecccc-------HHHHHHHHHHHhCC-CCCEEEEeeeEeccccC
Confidence 4689999999999999999998876654 49999997653 34578999999995 5999999987754
Q ss_pred ----------CCCceEEEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEe
Q psy14267 331 ----------TASKHLYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFV 399 (553)
Q Consensus 331 ----------~~~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~ 399 (553)
.....++++||++. ++|.+++...... ......++.++.||+.||+|||++||+||||||+|||++
T Consensus 80 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~ 156 (284)
T 2a19_B 80 PETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE---KLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV 156 (284)
T ss_dssp ---------CCEEEEEEEEECCCCSCBHHHHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE
T ss_pred cccccccccccCcceEEEEEeccCCCCHHHHHhhccCC---CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEc
Confidence 22456899999866 5999999865422 234556667778999999999999999999999999998
Q ss_pred cCccceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHH
Q psy14267 400 GNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI 479 (553)
Q Consensus 400 ~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ell 479 (553)
.+ +.+||+|||++........ .....||+.|+|||++.+. .++.++||||||+++|||+
T Consensus 157 ~~---------~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~ 215 (284)
T 2a19_B 157 DT---------KQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQ---------DYGKEVDLYALGLILAELL 215 (284)
T ss_dssp ET---------TEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCS---------CCCTHHHHHHHHHHHHHHH
T ss_pred CC---------CCEEECcchhheecccccc---ccccCCcccccChhhhccC---------CCcchhhhHHHHHHHHHHH
Confidence 76 5799999999988765432 2245699999999999765 3788999999999999999
Q ss_pred hCCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q psy14267 480 YGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNPE 551 (553)
Q Consensus 480 tG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~~ 551 (553)
+|..||.... .....+... .+ ...++..+.++|.+||..||++|||+.+++++|+.+..
T Consensus 216 ~~~~~~~~~~---~~~~~~~~~----~~------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 216 HVCDTAFETS---KFFTDLRDG----II------SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp SCCSSHHHHH---HHHHHHHTT----CC------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred hcCCcchhHH---HHHHHhhcc----cc------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 9999874311 111111110 11 12578999999999999999999999999999987654
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=346.07 Aligned_cols=261 Identities=26% Similarity=0.309 Sum_probs=197.4
Q ss_pred eEEecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEE
Q psy14267 250 VITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVY 329 (553)
Q Consensus 250 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~ 329 (553)
.|++ .++|.+.+.||+|+||.||+|.+..++.. ||||++.... ......+++.+|+.+|+++. ||||+++++++.
T Consensus 37 ~~~l-~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~--vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~ 111 (371)
T 4exu_A 37 AWEL-PKTYVSPTHVGSGAYGSVCSAIDKRSGEK--VAIKKLSRPF-QSEIFAKRAYRELLLLKHMQ-HENVIGLLDVFT 111 (371)
T ss_dssp EEEE-ETTEEEEEEEEECSSEEEEEEEETTTTEE--EEEEEECSTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEEC
T ss_pred eecc-cccEEEEeEEecCCCeEEEEEEECCCCCE--EEEEEecccc-cchhHHHHHHHHHHHHHhcC-CCCchhhhhhee
Confidence 3444 36899999999999999999988777654 9999997654 33455688999999999996 599999999875
Q ss_pred eCCCc----eEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccce
Q psy14267 330 DTASK----HLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKI 405 (553)
Q Consensus 330 ~~~~~----~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~ 405 (553)
..... .++++||+++++|..++.. ......+..++.||+.||+|||++||+||||||+||||+.+
T Consensus 112 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~---- 180 (371)
T 4exu_A 112 PASSLRNFYDFYLVMPFMQTDLQKIMGM-------EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNED---- 180 (371)
T ss_dssp SCSSSTTCCCCEEEEECCCEEHHHHTTS-------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT----
T ss_pred ccCCcccceeEEEEEccccccHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCC----
Confidence 44321 3489999999998877632 24456677778899999999999999999999999999876
Q ss_pred ecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCC
Q psy14267 406 IDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY 485 (553)
Q Consensus 406 ~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf 485 (553)
+.+||+|||+++...... ....||+.|+|||++.+.. .++.++|||||||++|||++|..||
T Consensus 181 -----~~~kL~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~--------~~~~~~DiwslG~il~el~~g~~pf 242 (371)
T 4exu_A 181 -----CELKILDFGLARHADAEM-----TGYVVTRWYRAPEVILSWM--------HYNQTVDIWSVGCIMAEMLTGKTLF 242 (371)
T ss_dssp -----CCEEECSTTCC-------------CTTCCCTTSCHHHHSCCS--------CCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred -----CCEEEEecCcccccccCc-----CCcccCccccCHHHhcCCC--------CCCcHHhHHHHHHHHHHHHhCCCCC
Confidence 579999999998664432 2567899999999997632 4788999999999999999999999
Q ss_pred CCCCchHHHHHHHHhhcccc-----------------------cccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q psy14267 486 SHIPNTWAKMLAIARHKDQI-----------------------EFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNS 542 (553)
Q Consensus 486 ~~~~~~~~~~~~i~~~~~~~-----------------------~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~el 542 (553)
.+.... ..+..+....... ...........+++.+.+||.+||+.||++|||+.|+
T Consensus 243 ~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el 321 (371)
T 4exu_A 243 KGKDYL-DQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQA 321 (371)
T ss_dssp CCSSHH-HHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred CCCChH-HHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHH
Confidence 875433 2222221111000 0000001123568999999999999999999999999
Q ss_pred HHH
Q psy14267 543 VTQ 545 (553)
Q Consensus 543 l~~ 545 (553)
+++
T Consensus 322 l~h 324 (371)
T 4exu_A 322 LTH 324 (371)
T ss_dssp HTS
T ss_pred hcC
Confidence 876
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=332.35 Aligned_cols=259 Identities=22% Similarity=0.344 Sum_probs=199.6
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCch---hHHHHHHHHHHHHHhhcCCCceeEeeeEEEeC
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQ---SIADSYLNEVELLAKLQGCPYVIKMHDYVYDT 331 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~---~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~ 331 (553)
.++|++++.||+|+||.||+|.+..++.. ||||+++....... ...+.+.+|+.+|+++. ||||+++++++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~--~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~- 79 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKE--YAAKFIKKRRLSSSRRGVSREEIEREVNILREIR-HPNIITLHDIFEN- 79 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCE--EEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEEC-
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCe--eehHHhhhccccccccchHHHHHHHHHHHHHhCC-CCCeeehhheecC-
Confidence 35799999999999999999988766644 99999987654321 13577899999999996 6999999998754
Q ss_pred CCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCC
Q psy14267 332 ASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIG 410 (553)
Q Consensus 332 ~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~ 410 (553)
...++++||++ +++|.+++.... ......+..++.||+.||+|||++||+||||||+|||++.+. ...
T Consensus 80 -~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~-----~~~ 148 (283)
T 3bhy_A 80 -KTDVVLILELVSGGELFDFLAEKE-----SLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKN-----VPN 148 (283)
T ss_dssp -SSEEEEEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSS-----SSS
T ss_pred -CCeEEEEEeecCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCC-----CCC
Confidence 56789999987 689999997643 234566777788999999999999999999999999997652 112
Q ss_pred CeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCc
Q psy14267 411 NVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN 490 (553)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~ 490 (553)
..+||+|||++........ .....||+.|+|||++.+. .++.++||||||+++|+|++|..||.....
T Consensus 149 ~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 216 (283)
T 3bhy_A 149 PRIKLIDFGIAHKIEAGNE---FKNIFGTPEFVAPEIVNYE---------PLGLEADMWSIGVITYILLSGASPFLGETK 216 (283)
T ss_dssp CCEEECCCTTCEECC-----------CCCGGGCCHHHHTTC---------CCCTHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred CceEEEecccceeccCCCc---ccccCCCcCccCcceecCC---------CCCcchhhhhHHHHHHHHHHCCCCCCCcch
Confidence 3799999999987654332 2245699999999999765 378899999999999999999999987543
Q ss_pred hHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 491 TWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 491 ~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
. .....+...... +.. .....++..+.++|.+||..||++||++.+++++
T Consensus 217 ~-~~~~~~~~~~~~--~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 217 Q-ETLTNISAVNYD--FDE--EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp H-HHHHHHHTTCCC--CCH--HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred H-HHHHHhHhcccC--Ccc--hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 2 223333222211 111 1123678999999999999999999999999974
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=341.05 Aligned_cols=262 Identities=25% Similarity=0.331 Sum_probs=198.9
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC--
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA-- 332 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~-- 332 (553)
.++|++.+.||+|+||.||+|.+..++. .||||++.... ......++.+|+.+|+++. ||||+++++++....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 84 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGE--IVAIKKIEPFD--KPLFALRTLREIKILKHFK-HENIITIFNIQRPDSFE 84 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTE--EEEEEEECCCS--SHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSCST
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCc--EEEEEeecccc--cchHHHHHHHHHHHHHhCc-CCCcCCeeeeecccccC
Confidence 4689999999999999999998876664 49999996532 3345577889999999995 699999988764331
Q ss_pred -CceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCC
Q psy14267 333 -SKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGN 411 (553)
Q Consensus 333 -~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~ 411 (553)
...++++||+++++|.+++... ......+..++.|++.||+|||++||+||||||+||||+.+ +
T Consensus 85 ~~~~~~lv~e~~~~~L~~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~---------~ 149 (353)
T 2b9h_A 85 NFNEVYIIQELMQTDLHRVISTQ------MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSN---------C 149 (353)
T ss_dssp TCCCEEEEECCCSEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT---------C
T ss_pred ccceEEEEEeccCccHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCC---------C
Confidence 3678999999999999998763 24456667778899999999999999999999999999776 5
Q ss_pred eEEEEeccCccccCCCCCcc--------cccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCC
Q psy14267 412 VLKIIDFGIACSLQDDKTSV--------HKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRT 483 (553)
Q Consensus 412 ~vkL~DFGla~~~~~~~~~~--------~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~ 483 (553)
.+||+|||++.......... .....+||+.|+|||++.+.. .++.++|||||||++|||++|..
T Consensus 150 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--------~~~~~~Di~slG~il~~l~~g~~ 221 (353)
T 2b9h_A 150 DLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSA--------KYSRAMDVWSCGCILAELFLRRP 221 (353)
T ss_dssp CEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCC--------CCCHHHHHHHHHHHHHHHHHSSC
T ss_pred cEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCC--------CccchhhHHHHHHHHHHHHhCCC
Confidence 79999999998765432111 122457899999999886432 47899999999999999999999
Q ss_pred CCCCCCchHHHHHHHHhhccccc------------------------ccccccCCCCCCHHHHHHHHHhcccCCCCCCCH
Q psy14267 484 PYSHIPNTWAKMLAIARHKDQIE------------------------FKPQLANNVTIPPTLLQSMKLCLQKDPKARPTV 539 (553)
Q Consensus 484 Pf~~~~~~~~~~~~i~~~~~~~~------------------------~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~ 539 (553)
||.+...... +..+........ ..........+++++.+||.+||..||++|||+
T Consensus 222 pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 300 (353)
T 2b9h_A 222 IFPGRDYRHQ-LLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITA 300 (353)
T ss_dssp SCCCSSHHHH-HHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCH
T ss_pred CCCCCCcHHH-HHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCH
Confidence 9987554322 222111110000 000001123678999999999999999999999
Q ss_pred HHHHHH
Q psy14267 540 GNSVTQ 545 (553)
Q Consensus 540 ~ell~~ 545 (553)
.+++++
T Consensus 301 ~ell~h 306 (353)
T 2b9h_A 301 KEALEH 306 (353)
T ss_dssp HHHHTS
T ss_pred HHHhcC
Confidence 999875
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=365.65 Aligned_cols=263 Identities=22% Similarity=0.370 Sum_probs=207.2
Q ss_pred cceEEecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeE
Q psy14267 248 QDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDY 327 (553)
Q Consensus 248 ~~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~ 327 (553)
...|++..++|++.++||+|+||.||++.+... ..||||+++..... .+.+++|+++|++++ ||||++++++
T Consensus 259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~---~~vavK~~~~~~~~----~~~~~~E~~~l~~l~-hpniv~~~~~ 330 (535)
T 2h8h_A 259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT---TRVAIKTLKPGTMS----PEAFLQEAQVMKKLR-HEKLVQLYAV 330 (535)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSEEEEEEEETTT---EEEEEEEECTTSSC----HHHHHHHHHHHHHCC-CTTBCCEEEE
T ss_pred ccceecchhhhhhheecccCCCeEEEEEEECCC---ceEEEEEeCCCCCC----HHHHHHHHHHHHhCC-CCCEeeEEEE
Confidence 445778888999999999999999999987543 34999999865532 367899999999995 5999999987
Q ss_pred EEeCCCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCcccee
Q psy14267 328 VYDTASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKII 406 (553)
Q Consensus 328 ~~~~~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~ 406 (553)
+.+ ..++++||++ +++|.++++..... ......++.++.||+.||+|||++|||||||||+||||+.+
T Consensus 331 ~~~---~~~~lv~e~~~~gsL~~~l~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~----- 399 (535)
T 2h8h_A 331 VSE---EPIYIVTEYMSKGSLLDFLKGETGK---YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN----- 399 (535)
T ss_dssp ECS---SSCEEEECCCTTEEHHHHHSHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-----
T ss_pred Eee---ccceEeeehhcCCcHHHHHhhcCCC---CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCC-----
Confidence 632 5678999976 56999999754321 23455667778899999999999999999999999999776
Q ss_pred cCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCC
Q psy14267 407 DCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPY 485 (553)
Q Consensus 407 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf 485 (553)
+.+||+|||+++....... .......++..|+|||++.+. .++.++|||||||+||||++ |..||
T Consensus 400 ----~~~kl~DFG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~---------~~~~~sDvwSlGv~l~el~t~g~~P~ 465 (535)
T 2h8h_A 400 ----LVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYG---------RFTIKSDVWSFGILLTELTTKGRVPY 465 (535)
T ss_dssp ----GCEEECCTTSTTTCCCHHH-HTTCSTTSCGGGSCHHHHHHC---------CCCHHHHHHHHHHHHHHHTTTTCCSS
T ss_pred ----CcEEEcccccceecCCCce-ecccCCcCcccccCHHHhccC---------CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 5799999999987653221 112234578899999999765 47899999999999999999 99999
Q ss_pred CCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q psy14267 486 SHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNPE 551 (553)
Q Consensus 486 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~~ 551 (553)
.+.... ..+..+... .. ......++..+.+||.+||+.||++|||+.+|++.|+++..
T Consensus 466 ~~~~~~-~~~~~i~~~-~~------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 466 PGMVNR-EVLDQVERG-YR------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp TTCCHH-HHHHHHHTT-CC------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred CCCCHH-HHHHHHHcC-CC------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 886543 223333221 11 12223688999999999999999999999999999998764
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=330.22 Aligned_cols=262 Identities=23% Similarity=0.364 Sum_probs=203.8
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcC------chhHHHHHHHHHHHHHhhcCCCceeEeeeEE
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDIT------DQSIADSYLNEVELLAKLQGCPYVIKMHDYV 328 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~------~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~ 328 (553)
.++|++.+.||+|+||.||+|.+..++. .||||++...... .....+.+.+|+.+|+++.+||||+++++++
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCK--EYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTE--EEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCc--eEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 4689999999999999999998877664 4999999865421 1233567889999999998789999999987
Q ss_pred EeCCCceEEEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceec
Q psy14267 329 YDTASKHLYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIID 407 (553)
Q Consensus 329 ~~~~~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~ 407 (553)
. ....++++||++. ++|.+++.... ......+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 94 ~--~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~------ 160 (298)
T 1phk_A 94 E--TNTFFFLVFDLMKKGELFDYLTEKV-----TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDD------ 160 (298)
T ss_dssp E--CSSEEEEEEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT------
T ss_pred c--cCCeEEEEEeccCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCC------
Confidence 4 4678899999864 79999998753 23455667777899999999999999999999999999776
Q ss_pred CCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCC
Q psy14267 408 CIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSH 487 (553)
Q Consensus 408 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~ 487 (553)
+.+||+|||++........ .....||+.|+|||++.+.... ....++.++||||||+++|||++|..||..
T Consensus 161 ---~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~---~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 231 (298)
T 1phk_A 161 ---MNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMND---NHPGYGKEVDMWSTGVIMYTLLAGSPPFWH 231 (298)
T ss_dssp ---CCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCT---TSCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ---CcEEEecccchhhcCCCcc---cccccCCccccCHHHhcccccc---ccccCCcccccHhHHHHHHHHHHCCCCCcC
Confidence 5799999999987765432 2356799999999998643211 011478899999999999999999999987
Q ss_pred CCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 488 IPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 488 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
.... .....+........ ...+..++..+.++|.+||+.||++|||+.+++++
T Consensus 232 ~~~~-~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 232 RKQM-LMLRMIMSGNYQFG----SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp SSHH-HHHHHHHHTCCCCC----TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred ccHH-HHHHHHhcCCcccC----cccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 5432 22233332222111 12223578999999999999999999999999863
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=330.22 Aligned_cols=253 Identities=22% Similarity=0.310 Sum_probs=192.7
Q ss_pred cCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCC
Q psy14267 254 NGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTAS 333 (553)
Q Consensus 254 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~ 333 (553)
..++|++++.||+|+||.||+|.+..++. .||||++...........+.+.+|+.+++++. ||||+++++++.. .
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~ 83 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGH--KVAVKILNRQKIRSLDVVGKIKREIQNLKLFR-HPHIIKLYQVIST--P 83 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCC--EEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEEC--S
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCc--eEEEEEeccccccchhHHHHHHHHHHHHhcCC-CCCEeEEEEEEec--C
Confidence 34689999999999999999998876664 49999997654333344568899999999995 6999999987743 5
Q ss_pred ceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCe
Q psy14267 334 KHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNV 412 (553)
Q Consensus 334 ~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~ 412 (553)
..++++||++ +++|.+++..... .....+..++.||+.||+|||++||+||||||+|||++.+ +.
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~---------~~ 149 (276)
T 2h6d_A 84 TDFFMVMEYVSGGELFDYICKHGR-----VEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAH---------MN 149 (276)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHCS-----CCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTT---------SC
T ss_pred CeEEEEEeccCCCcHHHHHhccCC-----CCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCC---------CC
Confidence 6789999986 5799999987542 3455667777899999999999999999999999999776 57
Q ss_pred EEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchH
Q psy14267 413 LKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTW 492 (553)
Q Consensus 413 vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~ 492 (553)
+||+|||++........ .....||+.|+|||++.+.. ..+.++||||||+++|+|++|..||......
T Consensus 150 ~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~--------~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~- 217 (276)
T 2h6d_A 150 AKIADFGLSNMMSDGEF---LRTSCGSPNYAAPEVISGRL--------YAGPEVDIWSCGVILYALLCGTLPFDDEHVP- 217 (276)
T ss_dssp EEECCCCGGGCCCC----------------CCTGGGTTSC--------CCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH-
T ss_pred EEEeecccccccCCCcc---eecccCCccccCHHHHcCCC--------CCCccchHHHHHHHHHHHHhCCCCCCCCcHH-
Confidence 99999999987755332 22456899999999997653 1367999999999999999999999874332
Q ss_pred HHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 493 AKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 493 ~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
.....+..... . ....++..+.++|.+||+.||++|||+.+++++
T Consensus 218 ~~~~~~~~~~~--~------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 218 TLFKKIRGGVF--Y------IPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp HHHHHHHHCCC--C------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHHhhcCcc--c------CchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 22222222111 1 122578999999999999999999999999986
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=364.47 Aligned_cols=262 Identities=20% Similarity=0.335 Sum_probs=200.9
Q ss_pred EecCcceEEEe-eeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEe
Q psy14267 252 TLNGKQYQVLS-LLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYD 330 (553)
Q Consensus 252 ~~~~~~y~i~~-~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~ 330 (553)
.+...++.+.+ .||+|+||.||++.....+....||||+++.... ....+.+.+|+++|++++ ||||+++++++..
T Consensus 331 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~ 407 (613)
T 2ozo_A 331 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--KADTEEMMREAQIMHQLD-NPYIVRLIGVCQA 407 (613)
T ss_dssp BCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCS--STTHHHHHHHHHHHTTCC-CTTBCCEEEEEES
T ss_pred eccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCC--hHHHHHHHHHHHHHHhCC-CCCEeeEEEEecc
Confidence 34556677776 8999999999999887665566799999976532 234578999999999994 6999999998753
Q ss_pred CCCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCC
Q psy14267 331 TASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCI 409 (553)
Q Consensus 331 ~~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~ 409 (553)
..++++||++ +++|.+++..... ......++.++.||+.||+|||++|||||||||+||||+.+
T Consensus 408 ---~~~~lv~E~~~~g~L~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~-------- 472 (613)
T 2ozo_A 408 ---EALMLVMEMAGGGPLHKFLVGKRE----EIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNR-------- 472 (613)
T ss_dssp ---SSEEEEEECCTTCBHHHHHTTCTT----TSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET--------
T ss_pred ---CCeEEEEEeCCCCcHHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCC--------
Confidence 3578899975 5789998865322 34556677778899999999999999999999999999876
Q ss_pred CCeEEEEeccCccccCCCCCc-ccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCC
Q psy14267 410 GNVLKIIDFGIACSLQDDKTS-VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSH 487 (553)
Q Consensus 410 ~~~vkL~DFGla~~~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~ 487 (553)
+.+||+|||+++.+...... .......+++.|+|||++.+. .++.++|||||||+||||++ |..||..
T Consensus 473 -~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~---------~~~~~sDvwSlGv~l~ellt~G~~Pf~~ 542 (613)
T 2ozo_A 473 -HYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR---------KFSSRSDVWSYGVTMWEALSYGQKPYKK 542 (613)
T ss_dssp -TEEEECCCSTTTTCC--------------CCTTSCHHHHHHC---------CCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred -CcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCC---------CCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 68999999999877543321 111233467899999999765 37899999999999999998 9999988
Q ss_pred CCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 488 IPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 488 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
.... ..+..+... ... .....+++++.+||..||..||++||++.+|++.|+.+
T Consensus 543 ~~~~-~~~~~i~~~-~~~------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 543 MKGP-EVMAFIEQG-KRM------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp CCSH-HHHHHHHTT-CCC------CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCHH-HHHHHHHcC-CCC------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 6553 333333322 111 22236889999999999999999999999999999863
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=342.69 Aligned_cols=263 Identities=23% Similarity=0.323 Sum_probs=193.5
Q ss_pred cCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCc--------CchhHHHHHHHHHHHHHhhcCCCceeEee
Q psy14267 254 NGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDI--------TDQSIADSYLNEVELLAKLQGCPYVIKMH 325 (553)
Q Consensus 254 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~--------~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~ 325 (553)
..++|++++.||+|+||.||+|.+.. .+.||||++..... ......+.+.+|+.+|+++. ||||++++
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~ 95 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDSE---GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH-HPNILGLR 95 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECTT---SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCC-CTTBCCCS
T ss_pred hccceEEeEEeccCCCEEEEEEECCC---CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCC-CcCcccee
Confidence 34689999999999999999997754 34599999965432 22334578999999999995 69999999
Q ss_pred eEEEeCC---CceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCc
Q psy14267 326 DYVYDTA---SKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNV 402 (553)
Q Consensus 326 ~~~~~~~---~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~ 402 (553)
+++.... ...++++||+++++|.+++..... ......+..++.||+.||+|||++||+||||||+||||+.+
T Consensus 96 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~- 170 (362)
T 3pg1_A 96 DIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRI----VISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADN- 170 (362)
T ss_dssp EEEEECCTTTCCEEEEEEECCSEEHHHHHHCTTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-
T ss_pred eeEEeccCCCcceEEEEEccCCCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCC-
Confidence 9886533 457899999999999999885432 34456667778899999999999999999999999999766
Q ss_pred cceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCC
Q psy14267 403 LKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGR 482 (553)
Q Consensus 403 ~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~ 482 (553)
+.+||+|||++........ .....||+.|+|||++.+.. .++.++|||||||++|+|++|.
T Consensus 171 --------~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~--------~~~~~~DiwslG~il~~l~~g~ 231 (362)
T 3pg1_A 171 --------NDITICDFNLAREDTADAN---KTHYVTHRWYRAPELVMQFK--------GFTKLVDMWSAGCVMAEMFNRK 231 (362)
T ss_dssp --------CCEEECCTTC------------------CGGGCCHHHHTTCT--------TCCTHHHHHHHHHHHHHHHHSS
T ss_pred --------CCEEEEecCcccccccccc---cceecccceecCcHHhcCCC--------CCCcHhHHHhHHHHHHHHHhCC
Confidence 5799999999976544332 22557899999999997632 3789999999999999999999
Q ss_pred CCCCCCCchHHHHHHHHhhccccc------------------------ccccccCCCCCCHHHHHHHHHhcccCCCCCCC
Q psy14267 483 TPYSHIPNTWAKMLAIARHKDQIE------------------------FKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538 (553)
Q Consensus 483 ~Pf~~~~~~~~~~~~i~~~~~~~~------------------------~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt 538 (553)
.||.+.... ..+..+........ ..........+++.+.+||.+||+.||++|||
T Consensus 232 ~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 310 (362)
T 3pg1_A 232 ALFRGSTFY-NQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRIS 310 (362)
T ss_dssp CSCCCSSHH-HHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred CCCCCCCHH-HHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCC
Confidence 999875432 22222221111000 00001112356789999999999999999999
Q ss_pred HHHHHHH
Q psy14267 539 VGNSVTQ 545 (553)
Q Consensus 539 ~~ell~~ 545 (553)
+.|+++|
T Consensus 311 ~~ell~h 317 (362)
T 3pg1_A 311 TEQALRH 317 (362)
T ss_dssp HHHHHTS
T ss_pred HHHHHcC
Confidence 9999875
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=367.13 Aligned_cols=261 Identities=22% Similarity=0.376 Sum_probs=199.6
Q ss_pred ecCcceEEE-eeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeC
Q psy14267 253 LNGKQYQVL-SLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDT 331 (553)
Q Consensus 253 ~~~~~y~i~-~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~ 331 (553)
+....+.+. +.||+|+||.||++.+......+.||||+++.... .....+.+.+|+++|++++ ||||+++++++..
T Consensus 365 ~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~- 441 (635)
T 4fl3_A 365 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLD-NPYIVRMIGICEA- 441 (635)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGG-CGGGHHHHHHHHHHHHHCC-CTTBCCEEEEEES-
T ss_pred ccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccC-CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEec-
Confidence 344455554 48999999999999776666567799999976543 3344578999999999995 6999999998742
Q ss_pred CCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCC
Q psy14267 332 ASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIG 410 (553)
Q Consensus 332 ~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~ 410 (553)
..++++||++ +++|.+++.... ......++.++.||+.||+|||++|||||||||+||||+.+
T Consensus 442 --~~~~lv~E~~~~g~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~--------- 505 (635)
T 4fl3_A 442 --ESWMLVMEMAELGPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ--------- 505 (635)
T ss_dssp --SSEEEEEECCTTEEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET---------
T ss_pred --CCEEEEEEccCCCCHHHHHhhCC-----CCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCC---------
Confidence 3477888875 578999997643 23455667778899999999999999999999999999877
Q ss_pred CeEEEEeccCccccCCCCCc-ccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCC
Q psy14267 411 NVLKIIDFGIACSLQDDKTS-VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHI 488 (553)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~ 488 (553)
+.+||+|||+|+.+...... .......||+.|+|||++.+. .++.++|||||||+||||++ |..||.+.
T Consensus 506 ~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~---------~~~~~sDvwSlGv~l~ellt~G~~Pf~~~ 576 (635)
T 4fl3_A 506 HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY---------KFSSKSDVWSFGVLMWEAFSYGQKPYRGM 576 (635)
T ss_dssp TEEEECCTTHHHHTTC-------------CGGGSCHHHHHHC---------CCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred CCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCC---------CCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 57999999999887654322 112234578899999999765 37899999999999999998 99999886
Q ss_pred CchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 489 PNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 489 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
... .....+.. .... .....+++++.+||..||+.||++||++.+|++.|+++
T Consensus 577 ~~~-~~~~~i~~-~~~~------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 577 KGS-EVTAMLEK-GERM------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp CHH-HHHHHHHT-TCCC------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CHH-HHHHHHHc-CCCC------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 553 22222222 2111 12236889999999999999999999999999999874
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=340.90 Aligned_cols=270 Identities=23% Similarity=0.420 Sum_probs=184.4
Q ss_pred cceEEecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeE
Q psy14267 248 QDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDY 327 (553)
Q Consensus 248 ~~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~ 327 (553)
...+.+..++|++++.||+|+||.||+|.+..++. .||||++..... .....++..|+..+.+..+||||++++++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~--~vaiK~~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~~~~~ 89 (327)
T 3aln_A 14 EQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQ--IMAVKRIRSTVD--EKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89 (327)
T ss_dssp CEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTE--EEEEEEEECCCC--HHHHHHHHHHHHHHHSSCCCTTBCCEEEE
T ss_pred HHhcccCHHHhhehheeccCCCEEEEEEEEcCCCC--EEEEEEeecccC--chHHHHHHHHHHHHHHcCCCCcEeeeeeE
Confidence 34566777899999999999999999998876664 499999986532 23345677777755555577999999998
Q ss_pred EEeCCCceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhC-CcEecCCCCCCEEEecCcccee
Q psy14267 328 VYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAA-GIIHSDLKPANFLFVGNVLKII 406 (553)
Q Consensus 328 ~~~~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~-gIiHrDLKp~NILl~~~~~~~~ 406 (553)
+.. ...++++||++.++|.+++...............+..++.|++.||.|||+. ||+||||||+||||+.+
T Consensus 90 ~~~--~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~----- 162 (327)
T 3aln_A 90 LFR--EGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRS----- 162 (327)
T ss_dssp EEC--SSEEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETT-----
T ss_pred EEe--CCceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCC-----
Confidence 754 5688999999999999888764333333455666777788999999999998 99999999999999876
Q ss_pred cCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCC
Q psy14267 407 DCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYS 486 (553)
Q Consensus 407 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~ 486 (553)
+.+||+|||+++....... .....||+.|+|||++..... ...++.++|||||||++|||++|..||.
T Consensus 163 ----~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~-----~~~~~~~~Di~slG~il~~l~~g~~pf~ 230 (327)
T 3aln_A 163 ----GNIKLCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPSAS-----RQGYDVRSDVWSLGITLYELATGRFPYP 230 (327)
T ss_dssp ----TEEEECCCSSSCC--------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSS
T ss_pred ----CCEEEccCCCceecccccc---cccCCCCccccCceeeccccC-----cCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 6799999999987654332 124469999999999853211 1147899999999999999999999998
Q ss_pred CCCchHHHHHHHHhhcccccccccc--cCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 487 HIPNTWAKMLAIARHKDQIEFKPQL--ANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 487 ~~~~~~~~~~~i~~~~~~~~~~~~~--~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
........+..+.. ...+.+ .....++..+.+||.+||..||++||++.+++++
T Consensus 231 ~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 231 KWNSVFDQLTQVVK-----GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp CC-------CCCCC-----SCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CcchHHHHHHHHhc-----CCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 74332111111100 011111 1123678999999999999999999999999764
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=363.71 Aligned_cols=257 Identities=21% Similarity=0.305 Sum_probs=202.1
Q ss_pred cCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCC
Q psy14267 254 NGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTAS 333 (553)
Q Consensus 254 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~ 333 (553)
..++|+++++||+|+||.||+|+++.++.. ||||++.+.........+.+.+|+.+|+++ +||||+.+++++. ..
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~--vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~--~~ 257 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKL--YACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSRFIVSLAYAFE--TK 257 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCE--EEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEEE--CS
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcE--EEEEEEEhHHhhhhHHHHHHHHHHHHHHhc-CCCCEeeEEEEEe--eC
Confidence 346899999999999999999988776654 999999876544434457789999999999 5699999988764 45
Q ss_pred ceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCe
Q psy14267 334 KHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNV 412 (553)
Q Consensus 334 ~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~ 412 (553)
..+|++||++ +++|..++...... ...+....++.++.||+.||+|||++|||||||||+||||+.+ +.
T Consensus 258 ~~l~lVmE~~~gg~L~~~l~~~~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~---------g~ 327 (543)
T 3c4z_A 258 TDLCLVMTIMNGGDIRYHIYNVDED-NPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDD---------GN 327 (543)
T ss_dssp SEEEEEECCCTTCBHHHHHHTSSTT-SCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT---------SC
T ss_pred CEEEEEEEeccCCCHHHHHHHhhcc-cccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCC---------CC
Confidence 6789999976 57999988765321 2235566677778899999999999999999999999999876 67
Q ss_pred EEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCc--
Q psy14267 413 LKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN-- 490 (553)
Q Consensus 413 vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~-- 490 (553)
+||+|||+++.+...... ....+||+.|+|||++.+. .++.++|||||||+||||++|..||.....
T Consensus 328 vkL~DFGla~~~~~~~~~--~~~~~GT~~Y~APE~l~~~---------~~~~~~DiwSlGvilyelltG~~PF~~~~~~~ 396 (543)
T 3c4z_A 328 VRISDLGLAVELKAGQTK--TKGYAGTPGFMAPELLLGE---------EYDFSVDYFALGVTLYEMIAARGPFRARGEKV 396 (543)
T ss_dssp EEECCCTTCEECCTTCCC--BCCCCSCTTTSCHHHHTTC---------CBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC
T ss_pred EEEeecceeeeccCCCcc--cccccCCccccChhhhcCC---------CCChHHhcCcchHHHHHHHhCCCCCCCCccch
Confidence 999999999887654332 2356899999999999865 378999999999999999999999986432
Q ss_pred -hHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q psy14267 491 -TWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTV-----GNSVT 544 (553)
Q Consensus 491 -~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~-----~ell~ 544 (553)
.......+... ...+ ...++.++++||++||+.||++||++ .+|++
T Consensus 397 ~~~~~~~~i~~~--~~~~------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 397 ENKELKQRVLEQ--AVTY------PDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp CHHHHHHHHHHC--CCCC------CTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred hHHHHHHHHhhc--ccCC------CcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 12222222211 1111 23678999999999999999999975 56654
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=336.73 Aligned_cols=266 Identities=21% Similarity=0.330 Sum_probs=197.4
Q ss_pred cCcceEEEeeeeeeCceEEEEEeee-CCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcC-----CCceeEeeeE
Q psy14267 254 NGKQYQVLSLLGKGGSSSVYLVGGT-SEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG-----CPYVIKMHDY 327 (553)
Q Consensus 254 ~~~~y~i~~~LG~G~fG~Vy~a~~~-~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~-----hp~Iv~l~~~ 327 (553)
..++|++++.||+|+||.||+|.+. ..+ +.||||+++.. ....+.+.+|+++++++.| +++|+.++++
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~--~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~ 85 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGG--RHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEW 85 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTT--EEEEEEEECSS----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEE
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCC--cEEEEEEEecC----CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecc
Confidence 4568999999999999999999873 344 45999999643 2445778899999999865 2369999887
Q ss_pred EEeCCCceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccce--
Q psy14267 328 VYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKI-- 405 (553)
Q Consensus 328 ~~~~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~-- 405 (553)
+.. ...++++||+++++|.+++...... ......+..++.||+.||+|||++||+||||||+||||+.+....
T Consensus 86 ~~~--~~~~~lv~e~~~~~l~~~l~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~ 160 (339)
T 1z57_A 86 FEH--HGHICIVFELLGLSTYDFIKENGFL---PFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAY 160 (339)
T ss_dssp EEE--TTEEEEEEECCCCBHHHHHHHTTTC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEE
T ss_pred ccc--CCcEEEEEcCCCCCHHHHHHhcCCC---CCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEecccccccc
Confidence 754 5689999999999999999875432 344556677788999999999999999999999999997642000
Q ss_pred --------ecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHH
Q psy14267 406 --------IDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYN 477 (553)
Q Consensus 406 --------~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~e 477 (553)
.....+.+||+|||+++...... ....||+.|+|||++.+. .++.++|||||||++||
T Consensus 161 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~---------~~~~~~Di~slG~il~e 226 (339)
T 1z57_A 161 NPKIKRDERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILAL---------GWSQPCDVWSIGCILIE 226 (339)
T ss_dssp C----CEEEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTS---------CCCTHHHHHHHHHHHHH
T ss_pred CCccccccccccCCCceEeeCcccccCcccc-----ccccCCccccChHHhhCC---------CCCcchhhHHHHHHHHH
Confidence 00013569999999998754432 256799999999999765 37889999999999999
Q ss_pred HHhCCCCCCCCCchHHHHHHHHhhccccc------------------------------------ccccccCCCCCCHHH
Q psy14267 478 MIYGRTPYSHIPNTWAKMLAIARHKDQIE------------------------------------FKPQLANNVTIPPTL 521 (553)
Q Consensus 478 lltG~~Pf~~~~~~~~~~~~i~~~~~~~~------------------------------------~~~~~~~~~~~s~~l 521 (553)
|++|..||....... ....+........ ...........++++
T Consensus 227 l~~g~~pf~~~~~~~-~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 305 (339)
T 1z57_A 227 YYLGFTVFPTHDSKE-HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERL 305 (339)
T ss_dssp HHHSSCSCCCSCHHH-HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHH
T ss_pred HHhCCCCCCCCChHH-HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHH
Confidence 999999998754432 2221111111000 000000111235689
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 522 LQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 522 ~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
.+||.+||+.||++|||+.|++++
T Consensus 306 ~~li~~~L~~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 306 FDLIQKMLEYDPAKRITLREALKH 329 (339)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHHHHHhCcCcccccCHHHHhcC
Confidence 999999999999999999999875
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=336.88 Aligned_cols=268 Identities=21% Similarity=0.315 Sum_probs=193.9
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhh-cCCCceeEeeeEEEeCCC
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKL-QGCPYVIKMHDYVYDTAS 333 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l-~~hp~Iv~l~~~~~~~~~ 333 (553)
.++|++++.||+|+||.||+|++. + +.||||++.... ...+.+|.+++..+ .+||||+++++++.....
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~--~--~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWR--G--EKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET--T--EEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred ccceEEEeEeecCCCeEEEEEEEC--C--ceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 358999999999999999999764 3 459999986432 24556677776655 267999999998876544
Q ss_pred --ceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhC--------CcEecCCCCCCEEEecCc
Q psy14267 334 --KHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAA--------GIIHSDLKPANFLFVGNV 402 (553)
Q Consensus 334 --~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~--------gIiHrDLKp~NILl~~~~ 402 (553)
..++++||++ +++|.++++.. ......++.++.|++.||+|||++ |||||||||+||||+.+
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~- 178 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKST------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN- 178 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTT-
T ss_pred CCCceEEEEeccCCCcHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCC-
Confidence 6789999987 56999999764 244566777788999999999999 99999999999999776
Q ss_pred cceecCCCCeEEEEeccCccccCCCCCcc--cccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh
Q psy14267 403 LKIIDCIGNVLKIIDFGIACSLQDDKTSV--HKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY 480 (553)
Q Consensus 403 ~~~~~~~~~~vkL~DFGla~~~~~~~~~~--~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt 480 (553)
+.+||+|||+++.+....... ......||+.|+|||++.+..... .+.++.++|||||||++|||++
T Consensus 179 --------~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~~~~~~~DiwslG~il~el~t 247 (337)
T 3mdy_A 179 --------GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRN---HFQSYIMADMYSFGLILWEVAR 247 (337)
T ss_dssp --------SCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTT---CTHHHHHHHHHHHHHHHHHHHT
T ss_pred --------CCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCc---cccCccccchHHHHHHHHHHHh
Confidence 579999999998765443221 123567999999999997664221 1112235999999999999999
Q ss_pred C----------CCCCCCCCc---hHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q psy14267 481 G----------RTPYSHIPN---TWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQIN 547 (553)
Q Consensus 481 G----------~~Pf~~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~ 547 (553)
| ..||..... ....+.............+.......+++++.++|.+||+.||++|||+.+++++|+
T Consensus 248 g~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 327 (337)
T 3mdy_A 248 RCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327 (337)
T ss_dssp TBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred ccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHH
Confidence 9 777765322 222222222211111111111111245678999999999999999999999999998
Q ss_pred cCC
Q psy14267 548 NNP 550 (553)
Q Consensus 548 ~~~ 550 (553)
++.
T Consensus 328 ~l~ 330 (337)
T 3mdy_A 328 KMS 330 (337)
T ss_dssp HHH
T ss_pred HHH
Confidence 754
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=341.25 Aligned_cols=269 Identities=20% Similarity=0.300 Sum_probs=191.8
Q ss_pred ecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHH--hhcCCCceeEeeeEEEe
Q psy14267 253 LNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLA--KLQGCPYVIKMHDYVYD 330 (553)
Q Consensus 253 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~--~l~~hp~Iv~l~~~~~~ 330 (553)
+..++|++++.||+|+||.||+++. .+ +.||||++.... ...+..|.+++. .+ .||||+++++++..
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~--~~vavK~~~~~~------~~~~~~e~~~~~~~~~-~h~~i~~~~~~~~~ 78 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSL--DE--RPVAVKVFSFAN------RQNFINEKNIYRVPLM-EHDNIARFIVGDER 78 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEE--TT--EEEEEEEEEGGG------HHHHHHHHHHHTSTTC-CCTTBCCEEEEEEE
T ss_pred cChHHhheeeecccCCCeEEEEEEE--CC--eEEEEEEeeccc------hhhHHHHHHHHHHHhc-cCcchhhheecccc
Confidence 4457899999999999999999965 23 459999997532 244555555543 35 57999999875432
Q ss_pred ---CCCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhC---------CcEecCCCCCCEE
Q psy14267 331 ---TASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAA---------GIIHSDLKPANFL 397 (553)
Q Consensus 331 ---~~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~---------gIiHrDLKp~NIL 397 (553)
.....++++||++ +++|.+++..... ....++.++.||+.||+|||++ |||||||||+|||
T Consensus 79 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~------~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nil 152 (336)
T 3g2f_A 79 VTADGRMEYLLVMEYYPNGSLXKYLSLHTS------DWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVL 152 (336)
T ss_dssp ECTTSCEEEEEEECCCTTCBHHHHHHHCCB------CHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEE
T ss_pred cccCCCceEEEEEecCCCCcHHHHHhhccc------chhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEE
Confidence 2344678999987 6799999976532 3455666778999999999999 9999999999999
Q ss_pred EecCccceecCCCCeEEEEeccCccccCCCCC------cccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHH
Q psy14267 398 FVGNVLKIIDCIGNVLKIIDFGIACSLQDDKT------SVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSL 471 (553)
Q Consensus 398 l~~~~~~~~~~~~~~vkL~DFGla~~~~~~~~------~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSl 471 (553)
|+.+ +.+||+|||+++.+..... .......+||+.|+|||++.+..... ....++.++|||||
T Consensus 153 l~~~---------~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~~~~~~~~Diwsl 221 (336)
T 3g2f_A 153 VKND---------GTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLR--DXESALKQVDMYAL 221 (336)
T ss_dssp ECTT---------SCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGG--GHHHHHHHHHHHHH
T ss_pred EcCC---------CcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccc--cccccccccchHHH
Confidence 9776 5799999999987654321 11223457999999999997632100 01136789999999
Q ss_pred HHHHHHHHhCCCCCCCCCc----------------hHHHHHH-HHhhcccccccccccCCCCCCHHHHHHHHHhcccCCC
Q psy14267 472 GCILYNMIYGRTPYSHIPN----------------TWAKMLA-IARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPK 534 (553)
Q Consensus 472 Gvvl~elltG~~Pf~~~~~----------------~~~~~~~-i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~ 534 (553)
||+||||++|..||..... ....+.. +........+...+.....+++++.+||.+||+.||+
T Consensus 222 G~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~ 301 (336)
T 3g2f_A 222 GLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAE 301 (336)
T ss_dssp HHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGG
T ss_pred HHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChh
Confidence 9999999999777632111 1111111 1112222223333333334556899999999999999
Q ss_pred CCCCHHHHHHHHhcC
Q psy14267 535 ARPTVGNSVTQINNN 549 (553)
Q Consensus 535 ~RPt~~ell~~L~~~ 549 (553)
+|||+.|+++.|+++
T Consensus 302 ~Rps~~e~l~~L~~l 316 (336)
T 3g2f_A 302 ARLTAQXAEERMAEL 316 (336)
T ss_dssp GSCCHHHHHHHHHHH
T ss_pred hCcchHHHHHHHHHH
Confidence 999999999999874
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=334.59 Aligned_cols=262 Identities=26% Similarity=0.367 Sum_probs=193.4
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEe----
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYD---- 330 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~---- 330 (553)
+++|++++.||+|+||.||+|.+..++. .||||++.... ....+.+.+|+++++++. ||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~ 83 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDK--RVAIKKIVLTD---PQSVKHALREIKIIRRLD-HDNIVKVFEILGPSGSQ 83 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTE--EEEEEEEECCS---HHHHHHHHHHHHHHHTCC-CTTBCCEEEEECTTSCB
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCe--EEEEEEEecCC---hHHHHHHHHHHHHHHhcC-CCCeeEEEEeccccccc
Confidence 5789999999999999999998877664 49999997653 345678899999999995 6999999987632
Q ss_pred --------CCCceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCc
Q psy14267 331 --------TASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNV 402 (553)
Q Consensus 331 --------~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~ 402 (553)
.....++++||+++++|.+++... ......++.++.|++.||+|||++||+||||||+|||++.+.
T Consensus 84 ~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~ 157 (320)
T 2i6l_A 84 LTDDVGSLTELNSVYIVQEYMETDLANVLEQG------PLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTED 157 (320)
T ss_dssp CCC----CCSCSEEEEEEECCSEEHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT
T ss_pred cccccccccccCceeEEeeccCCCHHHHhhcC------CccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC
Confidence 234678999999999999988642 234555667778999999999999999999999999997542
Q ss_pred cceecCCCCeEEEEeccCccccCCCCCc-ccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhC
Q psy14267 403 LKIIDCIGNVLKIIDFGIACSLQDDKTS-VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYG 481 (553)
Q Consensus 403 ~~~~~~~~~~vkL~DFGla~~~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG 481 (553)
+.+||+|||+++........ .......||+.|+|||++.+.. .++.++|||||||++|||++|
T Consensus 158 --------~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--------~~~~~~Di~slG~il~el~~g 221 (320)
T 2i6l_A 158 --------LVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPN--------NYTKAIDMWAAGCIFAEMLTG 221 (320)
T ss_dssp --------TEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTT--------CCCHHHHHHHHHHHHHHHHHS
T ss_pred --------CeEEEccCccccccCCCcccccccccccccccccCcHHhcCcc--------cCCchhhhHhHHHHHHHHHhC
Confidence 57999999999876543211 1122456799999999986532 478999999999999999999
Q ss_pred CCCCCCCCchHHHHHHHHhhcccc----------------------cccccccCCCCCCHHHHHHHHHhcccCCCCCCCH
Q psy14267 482 RTPYSHIPNTWAKMLAIARHKDQI----------------------EFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTV 539 (553)
Q Consensus 482 ~~Pf~~~~~~~~~~~~i~~~~~~~----------------------~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~ 539 (553)
+.||...... ..+..+....... ...+.......++.++++||++||+.||++|||+
T Consensus 222 ~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 300 (320)
T 2i6l_A 222 KTLFAGAHEL-EQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTA 300 (320)
T ss_dssp SCSSCCSSHH-HHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCH
T ss_pred CCCCCCCCHH-HHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCH
Confidence 9999875442 2222222111100 0000011123578999999999999999999999
Q ss_pred HHHHHH
Q psy14267 540 GNSVTQ 545 (553)
Q Consensus 540 ~ell~~ 545 (553)
.+++++
T Consensus 301 ~ell~h 306 (320)
T 2i6l_A 301 EEALSH 306 (320)
T ss_dssp HHHHTS
T ss_pred HHHhCC
Confidence 999875
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=331.73 Aligned_cols=261 Identities=21% Similarity=0.325 Sum_probs=197.1
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCC-ccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCC
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEH-EFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTAS 333 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~ 333 (553)
..+|++.++||+|+||.||+|.+.... ....||+|.+... ......+.+.+|+.+|+++. ||||+++++++... .
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~-~ 99 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRS-E 99 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCC-CTTBCCCCEEECCS-S
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC--CCHHHHHHHHHHHHHHHhCC-CCCEeeeeeEEEcC-C
Confidence 457999999999999999999875433 3345899988653 33445678999999999995 69999999976543 4
Q ss_pred ceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCe
Q psy14267 334 KHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNV 412 (553)
Q Consensus 334 ~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~ 412 (553)
...+++||++ +++|.+++..... ......++.++.|++.||+|||++||+||||||+|||++.+ +.
T Consensus 100 ~~~~~v~e~~~~~~L~~~l~~~~~----~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~---------~~ 166 (298)
T 3f66_A 100 GSPLVVLPYMKHGDLRNFIRNETH----NPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEK---------FT 166 (298)
T ss_dssp SCCEEEEECCTTCBHHHHHHCTTC----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT---------CC
T ss_pred CceEEEEeCCCCCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCC---------CC
Confidence 5677888875 4599999975432 23455566777899999999999999999999999999776 57
Q ss_pred EEEEeccCccccCCCCCc--ccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCCC
Q psy14267 413 LKIIDFGIACSLQDDKTS--VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHIP 489 (553)
Q Consensus 413 vkL~DFGla~~~~~~~~~--~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~~ 489 (553)
+||+|||+++........ .......||+.|+|||++.+. .++.++||||||+++|||++ |.+||....
T Consensus 167 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~~~~~~~~~~~~ 237 (298)
T 3f66_A 167 VKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ---------KFTTKSDVWSFGVLLWELMTRGAPPYPDVN 237 (298)
T ss_dssp EEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHC---------CCCHHHHHHHHHHHHHHHHTTSCCSSTTSC
T ss_pred EEECcccccccccccchhccccccCCCCCccccChHHhcCC---------CCChHHHHHHHHHHHHHHHhCCCCCCccCC
Confidence 999999999876543321 112244578899999999765 37889999999999999999 667776543
Q ss_pred chHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 490 NTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 490 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
.. .....+..... ......++..+.++|.+||+.||++|||+.++++.|+++
T Consensus 238 ~~-~~~~~~~~~~~-------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 289 (298)
T 3f66_A 238 TF-DITVYLLQGRR-------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289 (298)
T ss_dssp TT-THHHHHHTTCC-------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HH-HHHHHHhcCCC-------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 32 22222222211 111235789999999999999999999999999999875
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=332.13 Aligned_cols=254 Identities=26% Similarity=0.376 Sum_probs=196.3
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
.++|++.+.||+|+||.||+|++..++. .||||++...... ..+.+.+|+.+|+++. ||||+++++++. ...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~ 79 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGK--LFALKCIKKSPAF---RDSSLENEIAVLKKIK-HENIVTLEDIYE--STT 79 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCC--EEEEEEEECC---------HHHHHHHHHHHCC-CTTBCCEEEEEE--CSS
T ss_pred hccceeeeeccCCCCceEEEEEECCCCC--EEEEEEEeccccc---chHHHHHHHHHHHhCC-CCCeeehhhhcc--cCC
Confidence 3589999999999999999998876664 4999999865422 2356889999999995 699999998774 466
Q ss_pred eEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 335 HLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 335 ~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
.++++||++ +++|.+++..... .....+..++.|++.||+|||++||+||||||+|||+..+ ...+.+
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~------~~~~~~ 148 (304)
T 2jam_A 80 HYYLVMQLVSGGELFDRILERGV-----YTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTP------EENSKI 148 (304)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSC-----CCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSS------STTCCE
T ss_pred EEEEEEEcCCCccHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecC------CCCCCE
Confidence 889999986 5799998876542 3455666777899999999999999999999999999432 122679
Q ss_pred EEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHH
Q psy14267 414 KIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWA 493 (553)
Q Consensus 414 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~ 493 (553)
||+|||++........ ....||+.|+|||++.+. .++.++|||||||++|||++|..||...... .
T Consensus 149 kl~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~ 214 (304)
T 2jam_A 149 MITDFGLSKMEQNGIM----STACGTPGYVAPEVLAQK---------PYSKAVDCWSIGVITYILLCGYPPFYEETES-K 214 (304)
T ss_dssp EBCSCSTTCCCCCBTT----HHHHSCCCBCCTTTBSSC---------SCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH-H
T ss_pred EEccCCcceecCCCcc----ccccCCCCccChHHhccC---------CCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-H
Confidence 9999999876543221 244689999999999765 3789999999999999999999999875432 2
Q ss_pred HHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 494 KMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 494 ~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
....+...... +. ...+..++..+.++|.+||..||++|||+.+++++
T Consensus 215 ~~~~i~~~~~~--~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 215 LFEKIKEGYYE--FE--SPFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp HHHHHHHCCCC--CC--TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred HHHHHHcCCCC--CC--ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 33333322211 11 12234678999999999999999999999999874
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=342.78 Aligned_cols=262 Identities=23% Similarity=0.371 Sum_probs=199.4
Q ss_pred eEEecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEE
Q psy14267 250 VITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVY 329 (553)
Q Consensus 250 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~ 329 (553)
+..+..++|++++.||+|+||.||+|.+..++.. ||+|++.... .....+.+.+|+.+|+++. ||||+++++++.
T Consensus 27 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~--va~K~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~ 101 (360)
T 3eqc_A 27 VGELKDDDFEKISELGAGNGGVVFKVSHKPSGLV--MARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFY 101 (360)
T ss_dssp CCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCE--EEEEEEECCC--CHHHHHHHHHHHGGGGGCC-CTTBCCEEEEEE
T ss_pred ccccccccceeeeeecCCCCeEEEEEEECCCCcE--EEEEEecccc--CHHHHHHHHHHHHHHHHCC-CCCEEEEeEEEE
Confidence 3445667999999999999999999988766644 9999998753 3345578999999999995 699999999876
Q ss_pred eCCCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhC-CcEecCCCCCCEEEecCccceec
Q psy14267 330 DTASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAA-GIIHSDLKPANFLFVGNVLKIID 407 (553)
Q Consensus 330 ~~~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~-gIiHrDLKp~NILl~~~~~~~~~ 407 (553)
. ...++++||++ +++|.+++..... .....+..++.|++.||+|||+. ||+||||||+||||+.+
T Consensus 102 ~--~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~------ 168 (360)
T 3eqc_A 102 S--DGEISICMEHMDGGSLDQVLKKAGR-----IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR------ 168 (360)
T ss_dssp E--TTEEEEEECCCTTCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTT------
T ss_pred E--CCEEEEEEECCCCCCHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCC------
Confidence 4 56789999987 5699999987542 34555667778999999999996 99999999999999876
Q ss_pred CCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCC
Q psy14267 408 CIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSH 487 (553)
Q Consensus 408 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~ 487 (553)
+.+||+|||++....... .....||+.|+|||++.+. .++.++|||||||++|||++|..||..
T Consensus 169 ---~~~kl~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~~g~~pf~~ 232 (360)
T 3eqc_A 169 ---GEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGT---------HYSVQSDIWSMGLSLVEMAVGRYPIPP 232 (360)
T ss_dssp ---CCEEECCCCCCHHHHHHC--------CCCCTTCCHHHHTTC---------CCSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred ---CCEEEEECCCCccccccc----ccCCCCCCCeECHHHHcCC---------CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 579999999997653322 2245799999999999765 378999999999999999999999986
Q ss_pred CCchHHHHHHHHhh----------------------------------cccc-cccccccCCCCCCHHHHHHHHHhcccC
Q psy14267 488 IPNTWAKMLAIARH----------------------------------KDQI-EFKPQLANNVTIPPTLLQSMKLCLQKD 532 (553)
Q Consensus 488 ~~~~~~~~~~i~~~----------------------------------~~~~-~~~~~~~~~~~~s~~l~~li~~cL~~d 532 (553)
.............. ...+ ...........++.++.+||.+||+.|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 312 (360)
T 3eqc_A 233 PDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKN 312 (360)
T ss_dssp CCHHHHHHHHC------------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSS
T ss_pred CCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcC
Confidence 44321111000000 0000 000001112247889999999999999
Q ss_pred CCCCCCHHHHHHH
Q psy14267 533 PKARPTVGNSVTQ 545 (553)
Q Consensus 533 P~~RPt~~ell~~ 545 (553)
|++|||+.++++|
T Consensus 313 P~~Rpt~~ell~h 325 (360)
T 3eqc_A 313 PAERADLKQLMVH 325 (360)
T ss_dssp TTTSCCHHHHHTS
T ss_pred hhhCCCHHHHhhC
Confidence 9999999999875
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=338.87 Aligned_cols=266 Identities=21% Similarity=0.360 Sum_probs=203.0
Q ss_pred ecCcceEEEeeeeeeCceEEEEEeee--CCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEe
Q psy14267 253 LNGKQYQVLSLLGKGGSSSVYLVGGT--SEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYD 330 (553)
Q Consensus 253 ~~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~ 330 (553)
+..++|++++.||+|+||.||+|+.. .....+.||||++.... ....+.+.+|+.+|+++. ||||+++++++..
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~ 113 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQ-HDNIVKYKGVCYS 113 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC---SHHHHHHHHHHHHHHTCC-CTTBCCEEEEECC
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC---HHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEe
Confidence 45678999999999999999999742 22334569999997642 344578999999999995 6999999998866
Q ss_pred CCCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCC
Q psy14267 331 TASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCI 409 (553)
Q Consensus 331 ~~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~ 409 (553)
.....++++||++ +++|.+++..... ......++.++.||+.||+|||++||+||||||+||||+.+
T Consensus 114 ~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~-------- 181 (326)
T 2w1i_A 114 AGRRNLKLIMEYLPYGSLRDYLQKHKE----RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE-------- 181 (326)
T ss_dssp ----CCEEEECCCTTCBHHHHHHHSTT----SSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEET--------
T ss_pred cCCCceEEEEECCCCCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCC--------
Confidence 6566789999986 5699999987532 24455667777899999999999999999999999999876
Q ss_pred CCeEEEEeccCccccCCCCCcc-cccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy14267 410 GNVLKIIDFGIACSLQDDKTSV-HKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHI 488 (553)
Q Consensus 410 ~~~vkL~DFGla~~~~~~~~~~-~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~ 488 (553)
+.+||+|||++.......... ......++..|+|||++.+. .++.++|||||||++|||++|..||...
T Consensus 182 -~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~el~tg~~~~~~~ 251 (326)
T 2w1i_A 182 -NRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTES---------KFSVASDVWSFGVVLYELFTYIEKSKSP 251 (326)
T ss_dssp -TEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHC---------EEEHHHHHHHHHHHHHHHHHTTCGGGSH
T ss_pred -CcEEEecCcchhhccccccccccccCCCCceeEECchhhcCC---------CCCchhhHHHHHHHHHHHHhcCCCCCCC
Confidence 579999999998876544321 12244578889999999765 3688999999999999999999998652
Q ss_pred CchHHH--------------HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q psy14267 489 PNTWAK--------------MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNP 550 (553)
Q Consensus 489 ~~~~~~--------------~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~ 550 (553)
...... +....... ........++.++.++|.+||..||++|||+.+|++.|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 252 PAEFMRMIGNDKQGQMIVFHLIELLKNN------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp HHHHHHHHCTTCCTHHHHHHHHHHHHTT------CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHhhccccchhhhHHHHHHHhhcC------CCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 211110 01111111 112223468899999999999999999999999999998753
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=340.46 Aligned_cols=260 Identities=28% Similarity=0.404 Sum_probs=192.7
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcC-----chhHHHHHHHHHHHHHhhcCCCceeEeeeEEEe
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDIT-----DQSIADSYLNEVELLAKLQGCPYVIKMHDYVYD 330 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~-----~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~ 330 (553)
++|++.+.||+|+||.||+|.+..++. .||||++...... .......+.+|+++|+++. ||||+++++++..
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~ 86 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCK--KVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN-HPCIIKIKNFFDA 86 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTE--EEEEEEECC---------------CHHHHHHHHHHCC-CTTBCCEEEEEES
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCc--EEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCC-CCCCceEeeEEcC
Confidence 579999999999999999998877664 4999999765432 1222346789999999994 6999999998743
Q ss_pred CCCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCC
Q psy14267 331 TASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCI 409 (553)
Q Consensus 331 ~~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~ 409 (553)
. .++++||++ +++|.+++.... ......+..++.||+.||+|||++||+||||||+||||+.+. .
T Consensus 87 ~---~~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~------~ 152 (322)
T 2ycf_A 87 E---DYYIVLELMEGGELFDKVVGNK-----RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQE------E 152 (322)
T ss_dssp S---SEEEEEECCTTEETHHHHSTTC-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSS------S
T ss_pred C---ceEEEEecCCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCC------C
Confidence 2 378899986 568988876533 344556667778999999999999999999999999997652 2
Q ss_pred CCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy14267 410 GNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIP 489 (553)
Q Consensus 410 ~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~ 489 (553)
...+||+|||++........ .....||+.|+|||++..... ..++.++|||||||++|||++|..||....
T Consensus 153 ~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~------~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 223 (322)
T 2ycf_A 153 DCLIKITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGT------AGYNRAVDCWSLGVILFICLSGYPPFSEHR 223 (322)
T ss_dssp SCCEEECCCTTCEECCCCHH---HHHHHSCCTTCCHHHHHHTTT------TTCTTHHHHHHHHHHHHHHHHSSCSSCSTT
T ss_pred CCeEEEccCccceecccccc---cccccCCcCccCchhhccCCC------CCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 24699999999987654321 124568999999999853211 147899999999999999999999997644
Q ss_pred chHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 490 NTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 490 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
........+..... .+.+. .+..++..+.++|.+||..||++||++.+++++
T Consensus 224 ~~~~~~~~~~~~~~--~~~~~--~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 224 TQVSLKDQITSGKY--NFIPE--VWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp CSSCHHHHHHHTCC--CCCHH--HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hHHHHHHHHHhCcc--ccCch--hhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 32222222222211 11111 123578999999999999999999999999864
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=340.91 Aligned_cols=262 Identities=22% Similarity=0.317 Sum_probs=186.8
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC---
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA--- 332 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~--- 332 (553)
++|++.+.||+|+||.||+|++..++.. ||||++....... .+..+|++.+..+. ||||+++++++....
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vavK~~~~~~~~~----~~~~~~~~~l~~l~-h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 23 DRFQVERMAGQGTFGTVQLGKEKSTGMS--VAIKKVIQDPRFR----NRELQIMQDLAVLH-HPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp TTEEEC----------CEEEEETTTCCE--EEEEEEECCTTCC----CHHHHHHHHHHHHC-CTTBCCEEEEEEEECSSC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCE--EEEEEEecCcccc----HHHHHHHHHHHhcC-CCCcccHHHhhhcccccc
Confidence 5799999999999999999988776654 9999987654322 45667888888884 699999999886532
Q ss_pred --CceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHh--hCCcEecCCCCCCEEEecCccceecC
Q psy14267 333 --SKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIH--AAGIIHSDLKPANFLFVGNVLKIIDC 408 (553)
Q Consensus 333 --~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH--~~gIiHrDLKp~NILl~~~~~~~~~~ 408 (553)
..+++++||++.++|...+...... ........+..++.|++.||.||| ++||+||||||+||||+...
T Consensus 96 ~~~~~~~lv~e~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~------ 168 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPDTLHRCCRNYYRR-QVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEAD------ 168 (360)
T ss_dssp TTCEEEEEEEECCSCBHHHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTT------
T ss_pred ccceeEEEEeecccccHHHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCC------
Confidence 3358899999999988777653221 123344556667789999999999 99999999999999998632
Q ss_pred CCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy14267 409 IGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHI 488 (553)
Q Consensus 409 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~ 488 (553)
+.+||+|||+++........ ....||+.|+|||++.+.. .++.++|||||||++|||++|..||...
T Consensus 169 --~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~--------~~~~~~Di~slG~il~ell~g~~pf~~~ 235 (360)
T 3e3p_A 169 --GTLKLCDFGSAKKLSPSEPN---VAYICSRYYRAPELIFGNQ--------HYTTAVDIWSVGCIFAEMMLGEPIFRGD 235 (360)
T ss_dssp --TEEEECCCTTCBCCCTTSCC---CSTTSCGGGCCHHHHTTCS--------SCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred --CcEEEeeCCCceecCCCCCc---ccccCCcceeCHHHHcCCC--------CCCcHHHHHHHHHHHHHHHhCCCCcCCC
Confidence 68999999999877654332 2567899999999996543 3789999999999999999999999875
Q ss_pred CchHHHHHHHHhhcccc---------------c--------ccccc-cCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy14267 489 PNTWAKMLAIARHKDQI---------------E--------FKPQL-ANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVT 544 (553)
Q Consensus 489 ~~~~~~~~~i~~~~~~~---------------~--------~~~~~-~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~ 544 (553)
... ..+..+....... . +.... .....++.++.+||.+||+.||++|||+.|+++
T Consensus 236 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 236 NSA-GQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp SHH-HHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ChH-HHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 543 2222222111000 0 00000 011235689999999999999999999999987
Q ss_pred H
Q psy14267 545 Q 545 (553)
Q Consensus 545 ~ 545 (553)
|
T Consensus 315 h 315 (360)
T 3e3p_A 315 H 315 (360)
T ss_dssp S
T ss_pred C
Confidence 5
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=341.37 Aligned_cols=204 Identities=27% Similarity=0.376 Sum_probs=167.9
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCc-----eeEeeeEEE
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPY-----VIKMHDYVY 329 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~-----Iv~l~~~~~ 329 (553)
.++|++.+.||+|+||+||+|.+..++.. ||||+++.. ......+.+|+.+++.+.+|++ |+.+++++.
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~--vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~ 126 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEW--VAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM 126 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEE--EEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcE--EEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence 46899999999999999999988776644 999999743 3445778899999999987674 888888775
Q ss_pred eCCCceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHh--hCCcEecCCCCCCEEEecCccceec
Q psy14267 330 DTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIH--AAGIIHSDLKPANFLFVGNVLKIID 407 (553)
Q Consensus 330 ~~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH--~~gIiHrDLKp~NILl~~~~~~~~~ 407 (553)
. ...++++||+++++|.+++...... ......+..++.|++.||.||| +.|||||||||+||||+.+.
T Consensus 127 ~--~~~~~lv~e~~~~~L~~~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~----- 196 (382)
T 2vx3_A 127 F--RNHLCLVFEMLSYNLYDLLRNTNFR---GVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPK----- 196 (382)
T ss_dssp E--TTEEEEEEECCCCBHHHHHHHTTTS---CCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTT-----
T ss_pred c--CCceEEEEecCCCCHHHHHhhcCcC---CCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCC-----
Confidence 4 5689999999999999999875422 2345566677789999999999 57999999999999996431
Q ss_pred CCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCC
Q psy14267 408 CIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSH 487 (553)
Q Consensus 408 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~ 487 (553)
.+.+||+|||+|+...... ....||+.|+|||++.+. .++.++|||||||+||||++|+.||.+
T Consensus 197 --~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~---------~~~~~~DiwSlG~il~elltg~~pf~~ 260 (382)
T 2vx3_A 197 --RSAIKIVDFGSSCQLGQRI-----YQYIQSRFYRSPEVLLGM---------PYDLAIDMWSLGCILVEMHTGEPLFSG 260 (382)
T ss_dssp --SCCEEECCCTTCEETTCCC-----CSSCSCGGGCCHHHHTTC---------CCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred --CCcEEEEeccCceeccccc-----ccccCCccccChHHHcCC---------CCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 2579999999998775432 256799999999999866 378999999999999999999999987
Q ss_pred CCc
Q psy14267 488 IPN 490 (553)
Q Consensus 488 ~~~ 490 (553)
...
T Consensus 261 ~~~ 263 (382)
T 2vx3_A 261 ANE 263 (382)
T ss_dssp SSH
T ss_pred CCH
Confidence 544
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=337.02 Aligned_cols=271 Identities=22% Similarity=0.375 Sum_probs=183.0
Q ss_pred EEecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEe
Q psy14267 251 ITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYD 330 (553)
Q Consensus 251 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~ 330 (553)
+.+..++|++.+.||+|+||.||+|.+..++. .||||++...... ...+.+.+|+.+++++. ||||+++++++..
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~ 84 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKE--KVAIKRINLEKCQ--TSMDELLKEIQAMSQCH-HPNIVSYYTSFVV 84 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----C--EEEEECCC------------------CCCCCC-CTTBCCEEEEEES
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCc--EEEEEEEEhhhcc--hhHHHHHHHHHHHhhcC-CCCEeeEEEEEee
Confidence 45667899999999999999999998776654 4999998765322 33467889999999995 6999999988754
Q ss_pred CCCceEEEEEecC-CCCHHHHHHHcccC---CCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCcccee
Q psy14267 331 TASKHLYVLMEKG-DTDLSKYMRNLNKM---TTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKII 406 (553)
Q Consensus 331 ~~~~~~~iv~e~~-~~~L~~~l~~~~~~---~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~ 406 (553)
...++++||++ +++|.+++...... .........++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 85 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~----- 157 (303)
T 2vwi_A 85 --KDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGED----- 157 (303)
T ss_dssp --SSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTT-----
T ss_pred --cCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCC-----
Confidence 45688999986 67999988753211 12235566777788899999999999999999999999999776
Q ss_pred cCCCCeEEEEeccCccccCCCCCc---ccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCC
Q psy14267 407 DCIGNVLKIIDFGIACSLQDDKTS---VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRT 483 (553)
Q Consensus 407 ~~~~~~vkL~DFGla~~~~~~~~~---~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~ 483 (553)
+.+||+|||++......... .......||+.|+|||++.+.. .++.++|||||||++|||++|..
T Consensus 158 ----~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--------~~~~~~Di~slG~il~~l~~g~~ 225 (303)
T 2vwi_A 158 ----GSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVR--------GYDFKADIWSFGITAIELATGAA 225 (303)
T ss_dssp ----CCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHH--------CCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ----CCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhcccc--------CCCchhhHHHHHHHHHHHHhCCC
Confidence 57999999999876543211 1123457999999999987532 36889999999999999999999
Q ss_pred CCCCCCchHHHHHHHHhhcccccc-cccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 484 PYSHIPNTWAKMLAIARHKDQIEF-KPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 484 Pf~~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
||...................... .........++.++.++|.+||+.||++||++.+++++
T Consensus 226 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 226 PYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp TTTTSCGGGHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCccCchhhHHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 998765542222222111111110 01112234678999999999999999999999999874
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=330.18 Aligned_cols=256 Identities=25% Similarity=0.378 Sum_probs=201.3
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
.++|++++.||+|+||.||+|++..++. .||||++....... ...+.+.+|+.+++++. ||||+++++++.. ..
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~--~valK~~~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~ 94 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQ--EYAVKVINKASAKN-KDTSTILREVELLKKLD-HPNIMKLFEILED--SS 94 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCC--EEEEEEEEGGGBSS-SCHHHHHHHHHHHHTCC-CTTBCCEEEEEEC--SS
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCc--EEEEEEecccccch-HHHHHHHHHHHHHHhcc-CCCccEEEEEEeC--CC
Confidence 3589999999999999999998876654 49999997655433 23477899999999995 6999999988743 56
Q ss_pred eEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 335 HLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 335 ~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
.++++||++ +++|.+++..... .....++.++.||+.||+|||++||+||||||+||||+.+. ....+
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~------~~~~~ 163 (287)
T 2wei_A 95 SFYIVGELYTGGELFDEIIKRKR-----FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKE------KDCDI 163 (287)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSS------TTCCE
T ss_pred eEEEEEEccCCCCHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCC------CcccE
Confidence 789999976 6789888876542 34566677788999999999999999999999999997652 22469
Q ss_pred EEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHH
Q psy14267 414 KIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWA 493 (553)
Q Consensus 414 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~ 493 (553)
||+|||++........ .....||+.|+|||++.+. ++.++||||||+++|+|++|..||...... .
T Consensus 164 kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~----------~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~ 229 (287)
T 2wei_A 164 KIIDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRGT----------YDEKCDVWSAGVILYILLSGTPPFYGKNEY-D 229 (287)
T ss_dssp EECSTTGGGTBCCCSS---CSCHHHHHTTCCHHHHTTC----------CCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-H
T ss_pred EEeccCcceeecCCCc---cccccCcccccChHHhcCC----------CCCchhhHhHHHHHHHHHhCCCCCCCCCHH-H
Confidence 9999999987654332 1244689999999998643 688999999999999999999999875432 3
Q ss_pred HHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 494 KMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 494 ~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
....+...... .....+..++.++.++|.+||..||++|||+.+++++
T Consensus 230 ~~~~~~~~~~~----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 230 ILKRVETGKYA----FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp HHHHHHHCCCC----CCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHHHcCCCC----CCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 33333332221 1122334678999999999999999999999999984
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=346.60 Aligned_cols=260 Identities=21% Similarity=0.328 Sum_probs=190.9
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCC-CccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSE-HEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~-~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
..|++.+.||+|+||.||+|..... +....||||.++.. ......+++.+|+.+|+++. ||||+++++++... ..
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~-~~ 164 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRS-EG 164 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCC-CTTBCCCCEEECCC-SS
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEcC-CC
Confidence 4689999999999999999987643 33456899988653 23345688999999999995 69999999976543 44
Q ss_pred eEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 335 HLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 335 ~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
..+++||++ +++|.++++.... ......++.++.||+.||+|||++|||||||||+||||+.+ +.+
T Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~---------~~~ 231 (373)
T 3c1x_A 165 SPLVVLPYMKHGDLRNFIRNETH----NPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK---------FTV 231 (373)
T ss_dssp CCEEEEECCTTCBHHHHHHCTTC----CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT---------CCE
T ss_pred CeEEEEECCCCCCHHHHHhhccc----CCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCC---------CCE
Confidence 667888875 5699999975432 23455566777899999999999999999999999999776 579
Q ss_pred EEEeccCccccCCCCCcc--cccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCCCc
Q psy14267 414 KIIDFGIACSLQDDKTSV--HKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHIPN 490 (553)
Q Consensus 414 kL~DFGla~~~~~~~~~~--~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~~~ 490 (553)
||+|||+++......... ......+|+.|+|||++.+. .++.++|||||||+||||++ |.+||.....
T Consensus 232 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~DvwSlG~il~ellt~~~~p~~~~~~ 302 (373)
T 3c1x_A 232 KVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ---------KFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 302 (373)
T ss_dssp EECCC---------------------CCGGGSCHHHHHHC---------CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCS
T ss_pred EEeeccccccccccccccccccCCCCCcccccChHHhcCC---------CCCcHHHHHHHHHHHHHHHhCcCCCCCCCCH
Confidence 999999998765432211 11234578899999999765 37899999999999999999 7888876543
Q ss_pred hHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 491 TWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 491 ~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
. .....+.... . ......++..+.++|.+||+.||++||++.+++++|+++
T Consensus 303 ~-~~~~~~~~~~-~------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i 353 (373)
T 3c1x_A 303 F-DITVYLLQGR-R------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 353 (373)
T ss_dssp S-CHHHHHHTTC-C------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred H-HHHHHHHcCC-C------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 2 2222222221 1 112236789999999999999999999999999999874
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=343.96 Aligned_cols=267 Identities=21% Similarity=0.310 Sum_probs=197.7
Q ss_pred ecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcC----------CCcee
Q psy14267 253 LNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG----------CPYVI 322 (553)
Q Consensus 253 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~----------hp~Iv 322 (553)
+...+|++++.||+|+||.||+|++..++. .||||++.... ...+.+.+|+.+++++.+ ||||+
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~ 89 (373)
T 1q8y_A 16 YKDARYILVRKLGWGHFSTVWLAKDMVNNT--HVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHIL 89 (373)
T ss_dssp ETTTTEEEEEEEEECSSEEEEEEEETTTTE--EEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBC
T ss_pred ccCCeEEEEEeeeecCCeEEEEEEecCCCc--EEEEEEecCCc----cchhhhhHHHHHHHHhhcccccchhccccchHH
Confidence 456789999999999999999998877664 49999997532 334678899999999873 68999
Q ss_pred EeeeEEEeCC--CceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhC-CcEecCCCCCCEEEe
Q psy14267 323 KMHDYVYDTA--SKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAA-GIIHSDLKPANFLFV 399 (553)
Q Consensus 323 ~l~~~~~~~~--~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~-gIiHrDLKp~NILl~ 399 (553)
++++++.... ..+++++||+++++|.+++...... ......++.++.||+.||+|||++ |||||||||+||||+
T Consensus 90 ~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~ 166 (373)
T 1q8y_A 90 KLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHR---GIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLME 166 (373)
T ss_dssp CCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTS---CCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEE
T ss_pred HHHHHhhccCCCCceEEEEEecCCCCHHHHHHHhhcc---CCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEe
Confidence 9999876543 3478999999999999999875432 244556677788999999999998 999999999999996
Q ss_pred cCccceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHH
Q psy14267 400 GNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI 479 (553)
Q Consensus 400 ~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ell 479 (553)
.+.. ....+.+||+|||++....... ....||+.|+|||++.+. .++.++|||||||+||||+
T Consensus 167 ~~~~---~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~---------~~~~~~Di~slG~il~el~ 229 (373)
T 1q8y_A 167 IVDS---PENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGA---------PWGCGADIWSTACLIFELI 229 (373)
T ss_dssp EEET---TTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTC---------CCCTHHHHHHHHHHHHHHH
T ss_pred ccCC---CcCcceEEEcccccccccCCCC-----CCCCCCccccCcHHHhCC---------CCCchHhHHHHHHHHHHHH
Confidence 4320 0112479999999998765432 245799999999999865 3789999999999999999
Q ss_pred hCCCCCCCCCc-----hHHHHHHHHhhcccccc----------------------------------cccccCCCCCCHH
Q psy14267 480 YGRTPYSHIPN-----TWAKMLAIARHKDQIEF----------------------------------KPQLANNVTIPPT 520 (553)
Q Consensus 480 tG~~Pf~~~~~-----~~~~~~~i~~~~~~~~~----------------------------------~~~~~~~~~~s~~ 520 (553)
+|..||..... ....+..+......+.. .........++.+
T Consensus 230 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (373)
T 1q8y_A 230 TGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKE 309 (373)
T ss_dssp HSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHH
T ss_pred hCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHH
Confidence 99999976331 11222222211110000 0000011134568
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 521 LLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 521 l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
+.+||.+||+.||++|||+.|++++
T Consensus 310 ~~~li~~~L~~dP~~Rpt~~ell~h 334 (373)
T 1q8y_A 310 ISDFLSPMLQLDPRKRADAGGLVNH 334 (373)
T ss_dssp HHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred HHHHHHHHhccCccccCCHHHHhhC
Confidence 9999999999999999999999874
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=335.96 Aligned_cols=267 Identities=22% Similarity=0.341 Sum_probs=196.2
Q ss_pred cCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCC-----ceeEeeeEE
Q psy14267 254 NGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCP-----YVIKMHDYV 328 (553)
Q Consensus 254 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp-----~Iv~l~~~~ 328 (553)
..++|++++.||+|+||.||+|.+...+. +.||||++... ....+.+.+|+.+|+++.|+. +++.+++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~ 91 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGK-SQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWF 91 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTT-EEEEEEEECSC----HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCc-eEEEEEEEccc----ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee
Confidence 35789999999999999999998865542 35999999643 234577889999999997522 378887766
Q ss_pred EeCCCceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccce---
Q psy14267 329 YDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKI--- 405 (553)
Q Consensus 329 ~~~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~--- 405 (553)
.. ...++++||+++++|.+++...... ......++.++.||+.||+|||++||+||||||+||||+.+....
T Consensus 92 ~~--~~~~~lv~e~~~~~l~~~l~~~~~~---~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~ 166 (355)
T 2eu9_A 92 NF--HGHMCIAFELLGKNTFEFLKENNFQ---PYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYN 166 (355)
T ss_dssp EE--TTEEEEEEECCCCBHHHHHHHTTTC---CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEEC
T ss_pred ee--CCeEEEEEeccCCChHHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccc
Confidence 43 5688999999999999988875422 344566777788999999999999999999999999994321000
Q ss_pred -------ecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHH
Q psy14267 406 -------IDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNM 478 (553)
Q Consensus 406 -------~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~el 478 (553)
.....+.+||+|||+++...... ....||+.|+|||++.+. .++.++|||||||+||||
T Consensus 167 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~---------~~~~~~Di~slG~il~el 232 (355)
T 2eu9_A 167 EHKSCEEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILEL---------GWAQPCDVWSIGCILFEY 232 (355)
T ss_dssp CC-CCCEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTC---------CCCTHHHHHHHHHHHHHH
T ss_pred ccccccccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecC---------CCCCccchHHHHHHHHHH
Confidence 00123679999999998754432 256799999999999765 378899999999999999
Q ss_pred HhCCCCCCCCCchHHHHHHHHhhccccc------------------------------------ccccccCCCCCCHHHH
Q psy14267 479 IYGRTPYSHIPNTWAKMLAIARHKDQIE------------------------------------FKPQLANNVTIPPTLL 522 (553)
Q Consensus 479 ltG~~Pf~~~~~~~~~~~~i~~~~~~~~------------------------------------~~~~~~~~~~~s~~l~ 522 (553)
++|..||........ +..+........ ...........+.++.
T Consensus 233 ~~g~~pf~~~~~~~~-~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 311 (355)
T 2eu9_A 233 YRGFTLFQTHENREH-LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLF 311 (355)
T ss_dssp HHSSCSCCCSSHHHH-HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHH
T ss_pred HhCCCCCCCCCHHHH-HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHH
Confidence 999999987554322 221111111000 0000001112245899
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q psy14267 523 QSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 523 ~li~~cL~~dP~~RPt~~ell~~ 545 (553)
+||.+||..||++|||+.|++++
T Consensus 312 ~li~~~L~~dP~~Rpt~~e~l~h 334 (355)
T 2eu9_A 312 DLMRRMLEFDPAQRITLAEALLH 334 (355)
T ss_dssp HHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHHHHhcCChhhCcCHHHHhcC
Confidence 99999999999999999999864
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=329.18 Aligned_cols=253 Identities=26% Similarity=0.393 Sum_probs=193.3
Q ss_pred ecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC
Q psy14267 253 LNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA 332 (553)
Q Consensus 253 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~ 332 (553)
...++|++++.||+|+||.||+|.+..++.. ||||++..... .+.+.+|+.+|+++ +||||+++++++..
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~--vaiK~~~~~~~-----~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-- 95 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQI--VAIKQVPVESD-----LQEIIKEISIMQQC-DSPHVVKYYGSYFK-- 95 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCE--EEEEEEETTSC-----CHHHHHHHHHHHTC-CCTTBCCEEEEEEE--
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCE--EEEEecCchHH-----HHHHHHHHHHHHhC-CCCCCccEEEEEEe--
Confidence 3456899999999999999999988766644 99999976531 36688999999999 56999999998755
Q ss_pred CceEEEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCC
Q psy14267 333 SKHLYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGN 411 (553)
Q Consensus 333 ~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~ 411 (553)
...++++||++. ++|.+++..... ......++.++.|++.||+|||++||+||||||+|||++.+ +
T Consensus 96 ~~~~~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~---------~ 162 (314)
T 3com_A 96 NTDLWIVMEYCGAGSVSDIIRLRNK----TLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTE---------G 162 (314)
T ss_dssp TTEEEEEEECCTTEEHHHHHHHHTC----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---------C
T ss_pred CCEEEEEeecCCCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCC---------C
Confidence 567899999875 589998874332 33456667778899999999999999999999999999776 5
Q ss_pred eEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCch
Q psy14267 412 VLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNT 491 (553)
Q Consensus 412 ~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~ 491 (553)
.+||+|||++........ ......||+.|+|||++.+. .++.++||||||+++|+|++|..||......
T Consensus 163 ~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 231 (314)
T 3com_A 163 HAKLADFGVAGQLTDTMA--KRNTVIGTPFWMAPEVIQEI---------GYNCVADIWSLGITAIEMAEGKPPYADIHPM 231 (314)
T ss_dssp CEEECCCTTCEECBTTBS--CBCCCCSCGGGCCHHHHSSS---------CBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred CEEEeecccchhhhhhcc--ccCccCCCCCccChhhcCCC---------CCCccccHHHHHHHHHHHHhCCCCCCCCChH
Confidence 799999999987654322 12355799999999999765 3788999999999999999999999875543
Q ss_pred HHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 492 WAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 492 ~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
.. ...+.... .+.......++..+.++|.+||..||++|||+.+++++
T Consensus 232 ~~-~~~~~~~~-----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 232 RA-IFMIPTNP-----PPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp HH-HHHHHHSC-----CCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred HH-HHHHhcCC-----CcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 22 22222111 11112223568999999999999999999999999864
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=338.52 Aligned_cols=257 Identities=26% Similarity=0.320 Sum_probs=195.2
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCC-
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTAS- 333 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~- 333 (553)
.++|.+.+.||+|+||.||+|.+..++. .||||++.... ......+++.+|+.+|+++. ||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 98 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGE--KVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQ-HENVIGLLDVFTPASSL 98 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTE--EEEEEEESSTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSSG
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCC--EEEEEEecccc-cchHHHHHHHHHHHHHHhcC-CCCcccHhheEeccccc
Confidence 3589999999999999999998877664 49999997654 33455678999999999995 6999999998755432
Q ss_pred ---ceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCC
Q psy14267 334 ---KHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIG 410 (553)
Q Consensus 334 ---~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~ 410 (553)
..++++||+++++|.+++.. ......+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 99 ~~~~~~~lv~e~~~~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~--------- 162 (353)
T 3coi_A 99 RNFYDFYLVMPFMQTDLQKIMGL-------KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNED--------- 162 (353)
T ss_dssp GGCCCCEEEEECCSEEGGGTTTS-------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTT---------
T ss_pred ccceeEEEEeccccCCHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCC---------
Confidence 24699999999888776532 24456677778899999999999999999999999999876
Q ss_pred CeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCc
Q psy14267 411 NVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN 490 (553)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~ 490 (553)
+.+||+|||+++...... ....||+.|+|||++.+.. .++.++|||||||++|||++|..||.+...
T Consensus 163 ~~~kl~Dfg~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~--------~~~~~~Di~slG~il~el~~g~~pf~~~~~ 229 (353)
T 3coi_A 163 CELKILDFGLARHADAEM-----TGYVVTRWYRAPEVILSWM--------HYNQTVDIWSVGCIMAEMLTGKTLFKGKDY 229 (353)
T ss_dssp CCEEECSTTCTTC-------------CCSBCCSCHHHHSCCS--------CCCTTHHHHHHHHHHHHHHHSSCSSBSSCH
T ss_pred CcEEEeecccccCCCCCc-----cccccCcCcCCHHHHhCcC--------CCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 579999999997654322 2457899999999987532 378899999999999999999999987543
Q ss_pred hHHHHHHHHhhccc--------------------cc---ccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 491 TWAKMLAIARHKDQ--------------------IE---FKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 491 ~~~~~~~i~~~~~~--------------------~~---~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
. ..+..+...... +. ..........++.++.+||.+||..||++|||+.+++++
T Consensus 230 ~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 230 L-DQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp H-HHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred H-HHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 2 222222111000 00 000011123678999999999999999999999999875
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=337.24 Aligned_cols=258 Identities=23% Similarity=0.302 Sum_probs=172.2
Q ss_pred CcceEEEe-eeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeC--
Q psy14267 255 GKQYQVLS-LLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDT-- 331 (553)
Q Consensus 255 ~~~y~i~~-~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~-- 331 (553)
.++|.+.+ +||+|+||.||+|.+..++.. ||||++... ....+|+..+.++..||||+.+++++...
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~--vavK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~ 96 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQK--CALKLLYDS--------PKARQEVDHHWQASGGPHIVCILDVYENMHH 96 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCE--EEEEEEESS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCE--EEEEEecCc--------HHHHHHHHHHHHhcCCCChHHHHHHHhhccC
Confidence 35799965 699999999999988877654 999999643 22345555555555789999999987553
Q ss_pred CCceEEEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCC
Q psy14267 332 ASKHLYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIG 410 (553)
Q Consensus 332 ~~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~ 410 (553)
....++++||++. ++|.+++..... ..+....++.++.||+.||+|||++||+||||||+||||+.+. ..
T Consensus 97 ~~~~~~lv~e~~~gg~L~~~l~~~~~---~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~------~~ 167 (336)
T 3fhr_A 97 GKRCLLIIMECMEGGELFSRIQERGD---QAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKE------KD 167 (336)
T ss_dssp TEEEEEEEEECCTTEEHHHHHHTC-C---CCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSS------TT
T ss_pred CCceEEEEEeccCCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecC------CC
Confidence 2456899999874 599999986543 2345666777788999999999999999999999999997642 23
Q ss_pred CeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCc
Q psy14267 411 NVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN 490 (553)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~ 490 (553)
+.+||+|||+++....... ....||+.|+|||++.+. .++.++|||||||++|+|++|..||.....
T Consensus 168 ~~~kl~Dfg~~~~~~~~~~----~~~~~t~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 234 (336)
T 3fhr_A 168 AVLKLTDFGFAKETTQNAL----QTPCYTPYYVAPEVLGPE---------KYDKSCDMWSLGVIMYILLCGFPPFYSNTG 234 (336)
T ss_dssp CCEEECCCTTCEEC--------------------------C---------HHHHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred ceEEEeccccceecccccc----ccCCCCcCccChhhhCCC---------CCCchhhHHHHHHHHHHHHHCCCCCCCccc
Confidence 5699999999987654322 256789999999999655 368899999999999999999999976433
Q ss_pred hHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 491 TWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 491 ~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
..... .................+..++.++.+||.+||..||++|||+.+++++
T Consensus 235 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 235 QAISP-GMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp -----------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hhhhh-hHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 21100 0000000111111122334689999999999999999999999999984
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=326.46 Aligned_cols=250 Identities=25% Similarity=0.402 Sum_probs=199.5
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
.+.|++++.||+|+||.||+|.+..++. .||||++...... ...+.+.+|+.+++++ +||||+++++++.. ..
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~ 93 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQK--VVAIKIIDLEEAE--DEIEDIQQEITVLSQC-DSPYVTKYYGSYLK--DT 93 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCC--EEEEEEEETTTCS--TTHHHHHHHHHHHHHC-CCTTBCCEEEEEEE--TT
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCc--EEEEEEecccccH--HHHHHHHHHHHHHHhC-CCCCEeEEEEEEec--CC
Confidence 4579999999999999999998776654 4999999876533 2357889999999999 55999999998765 56
Q ss_pred eEEEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 335 HLYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 335 ~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
.++++||++. ++|.+++... ......++.++.|++.||+|||++||+||||||+|||++.+ +.+
T Consensus 94 ~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~---------~~~ 158 (303)
T 3a7i_A 94 KLWIIMEYLGGGSALDLLEPG------PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEH---------GEV 158 (303)
T ss_dssp EEEEEEECCTTEEHHHHHTTS------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---------SCE
T ss_pred eEEEEEEeCCCCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCC---------CCE
Confidence 7899999865 5888887542 34456677778899999999999999999999999999776 579
Q ss_pred EEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHH
Q psy14267 414 KIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWA 493 (553)
Q Consensus 414 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~ 493 (553)
||+|||++........ ......||+.|+|||++.+. .++.++||||||+++|||++|..||...... .
T Consensus 159 kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~ 226 (303)
T 3a7i_A 159 KLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQS---------AYDSKADIWSLGITAIELARGEPPHSELHPM-K 226 (303)
T ss_dssp EECCCTTCEECBTTBC--CBCCCCSCGGGCCHHHHTTC---------CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-H
T ss_pred EEeecccceecCcccc--ccCccCCCcCccCHHHHhcC---------CCCchhhhHHHHHHHHHHccCCCCCCCcCHH-H
Confidence 9999999987755432 22356799999999999765 3688999999999999999999999875443 2
Q ss_pred HHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 494 KMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 494 ~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
....+... ... .....++..+.+||.+||..||++|||+.+++++
T Consensus 227 ~~~~~~~~-~~~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 227 VLFLIPKN-NPP------TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp HHHHHHHS-CCC------CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred HHHHhhcC-CCC------CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 22222211 111 1123678999999999999999999999999875
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=330.12 Aligned_cols=254 Identities=24% Similarity=0.405 Sum_probs=192.0
Q ss_pred EEecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEe
Q psy14267 251 ITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYD 330 (553)
Q Consensus 251 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~ 330 (553)
|.+..++|++.+.||+|+||.||++++. + +.||||++.... ..+.+.+|+.+++++. ||||+++++++..
T Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~--~~vavK~~~~~~-----~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~ 85 (278)
T 1byg_A 16 WALNMKELKLLQTIGKGEFGDVMLGDYR--G--NKVAVKCIKNDA-----TAQAFLAEASVMTQLR-HSNLVQLLGVIVE 85 (278)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET--T--EEEEEEECCCCC-------HHHHHTHHHHTTCC-CTTBCCEEEEECC
T ss_pred ccCChhhceEEeEEecCCCceEEEEEEc--C--CEEEEEEecchh-----HHHHHHHHHHHHHhCC-CCCEeeEEEEEEc
Confidence 3456679999999999999999999764 2 459999987543 3467899999999995 6999999987644
Q ss_pred CCCceEEEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCC
Q psy14267 331 TASKHLYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCI 409 (553)
Q Consensus 331 ~~~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~ 409 (553)
....++++||++. ++|.+++...... ......++.++.|++.||+|||++||+||||||+|||++.+
T Consensus 86 -~~~~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~-------- 153 (278)
T 1byg_A 86 -EKGGLYIVTEYMAKGSLVDYLRSRGRS---VLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED-------- 153 (278)
T ss_dssp -C--CCEEEECCCTTEEHHHHHHHHHHH---HCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT--------
T ss_pred -CCCceEEEEecCCCCCHHHHHHhcccc---cCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCC--------
Confidence 3446789999865 5999999865321 12345566777899999999999999999999999999766
Q ss_pred CCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCC
Q psy14267 410 GNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHI 488 (553)
Q Consensus 410 ~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~ 488 (553)
+.+||+|||++........ ...+++.|+|||++.+. .++.++||||||+++|||++ |..||...
T Consensus 154 -~~~~l~Dfg~~~~~~~~~~-----~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~t~g~~p~~~~ 218 (278)
T 1byg_A 154 -NVAKVSDFGLTKEASSTQD-----TGKLPVKWTAPEALREK---------KFSTKSDVWSFGILLWEIYSFGRVPYPRI 218 (278)
T ss_dssp -SCEEECCCCC-----------------CCTTTSCHHHHHHC---------CCCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred -CcEEEeecccccccccccc-----CCCccccccCHHHhCCC---------CCCchhcHHHHHHHHHHHHhCCCCCCCCC
Confidence 5799999999976544322 34578999999999765 37889999999999999998 99999875
Q ss_pred CchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 489 PNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 489 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
... .....+.. ... ......+++.+.++|.+||+.||++||++.++++.|+++
T Consensus 219 ~~~-~~~~~~~~-~~~------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 219 PLK-DVVPRVEK-GYK------MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp CGG-GHHHHHTT-TCC------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CHH-HHHHHHhc-CCC------CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 442 11222211 111 122336789999999999999999999999999999875
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=333.69 Aligned_cols=265 Identities=22% Similarity=0.280 Sum_probs=198.5
Q ss_pred eEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCC-cCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceE
Q psy14267 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSD-ITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHL 336 (553)
Q Consensus 258 y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~ 336 (553)
|...+.||+|+||.||+|.. .+ +.||||++.... .......+.+.+|+.+|+++. ||||+++++++. .....
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~--~~~~~ 105 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NN--TTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ-HENLVELLGFSS--DGDDL 105 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SS--CEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC-CTTBCCEEEEEC--SSSSC
T ss_pred cccCCccccCCCeEEEEEEE--CC--ceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC-CCCeEEEEEEEe--cCCce
Confidence 44568999999999999975 22 459999997643 233455678999999999995 599999998774 45678
Q ss_pred EEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 337 YVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 337 ~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
+++|+++ +++|.+++....... ...+..++.++.||+.||+|||++||+||||||+|||++.+ +.+||
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~---------~~~kl 174 (307)
T 2nru_A 106 CLVYVYMPNGSLLDRLSCLDGTP--PLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEA---------FTAKI 174 (307)
T ss_dssp EEEEECCTTCBHHHHHHTGGGCC--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT---------CCEEE
T ss_pred EEEEEecCCCcHHHHHHhccCCC--CCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCC---------CcEEE
Confidence 8889976 789999988654332 34455666777899999999999999999999999999776 57999
Q ss_pred EeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchH---
Q psy14267 416 IDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTW--- 492 (553)
Q Consensus 416 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~--- 492 (553)
+|||++................||+.|+|||++.+. ++.++||||||+++|+|++|..||.......
T Consensus 175 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----------~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~ 244 (307)
T 2nru_A 175 SDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGE----------ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL 244 (307)
T ss_dssp CCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTTE----------ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTT
T ss_pred eecccccccccccccccccccCCCcCcCChHHhcCC----------CCccchhHHHHHHHHHHHHCCCCcccCcchHHHH
Confidence 999999877654433333456799999999998643 6789999999999999999999998643211
Q ss_pred HHHHHHHhhccccc--cccccc-CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q psy14267 493 AKMLAIARHKDQIE--FKPQLA-NNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNP 550 (553)
Q Consensus 493 ~~~~~i~~~~~~~~--~~~~~~-~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~ 550 (553)
.....+......+. ...... ....++..+.++|.+||+.||++|||+.+++++|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 245 DIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 11111111111000 011111 11134568999999999999999999999999998764
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=338.65 Aligned_cols=249 Identities=30% Similarity=0.438 Sum_probs=196.5
Q ss_pred ecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCch---hHHHHHHHHHHHHHhhcC-CCceeEeeeEE
Q psy14267 253 LNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQ---SIADSYLNEVELLAKLQG-CPYVIKMHDYV 328 (553)
Q Consensus 253 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~---~~~~~~~~E~~iL~~l~~-hp~Iv~l~~~~ 328 (553)
...++|++++.||+|+||.||+|.+..++. .||||++........ ...+++.+|+.+++++.+ |+||+++++++
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNL--PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTE--EEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCc--EEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 345789999999999999999998876664 599999987643321 112456789999999975 89999999987
Q ss_pred EeCCCceEEEEEecCC--CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCcccee
Q psy14267 329 YDTASKHLYVLMEKGD--TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKII 406 (553)
Q Consensus 329 ~~~~~~~~~iv~e~~~--~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~ 406 (553)
.. ...++++|++.. ++|.+++.... ......++.++.||+.||+|||++||+||||||+||||+.+.
T Consensus 118 ~~--~~~~~lv~e~~~~~~~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~---- 186 (320)
T 3a99_A 118 ER--PDSFVLILERPEPVQDLFDFITERG-----ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR---- 186 (320)
T ss_dssp EC--SSEEEEEEECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTT----
T ss_pred ec--CCcEEEEEEcCCCCccHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCC----
Confidence 53 567888888764 78999998754 234556667778999999999999999999999999997432
Q ss_pred cCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCC
Q psy14267 407 DCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYS 486 (553)
Q Consensus 407 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~ 486 (553)
+.+||+|||+++....... ....||+.|+|||++.+.. .++.++|||||||++|||++|..||.
T Consensus 187 ----~~~kL~Dfg~~~~~~~~~~----~~~~gt~~y~aPE~~~~~~--------~~~~~~Di~slG~il~el~~g~~pf~ 250 (320)
T 3a99_A 187 ----GELKLIDFGSGALLKDTVY----TDFDGTRVYSPPEWIRYHR--------YHGRSAAVWSLGILLYDMVCGDIPFE 250 (320)
T ss_dssp ----TEEEECCCTTCEECCSSCB----CCCCSCGGGSCHHHHHHSC--------BCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ----CCEEEeeCccccccccccc----cCCCCCccCCChHHhccCC--------CCCccchHHhHHHHHHHHHHCCCCCC
Confidence 6799999999987754322 2557999999999997653 23678999999999999999999997
Q ss_pred CCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 487 HIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 487 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
.... +.. .... ....+++++.+||.+||..||++|||+.+|+++
T Consensus 251 ~~~~-------~~~--~~~~------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 251 HDEE-------IIR--GQVF------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp SHHH-------HHH--CCCC------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred Chhh-------hhc--cccc------ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 6211 111 1111 123678999999999999999999999999874
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=326.69 Aligned_cols=257 Identities=24% Similarity=0.349 Sum_probs=195.1
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|....+||+|+||.||+|.+..++. .||||++..... ...+.+.+|+.+++++. ||||+++++++.. ...
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~--~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~--~~~ 93 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQV--RIAIKEIPERDS---RYSQPLHEEIALHKHLK-HKNIVQYLGSFSE--NGF 93 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCC--EEEEEEEECCCC------HHHHHHHHHHHTCC-CTTBCCEEEEEEE--TTE
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCe--EEEEEEccCCch---HHHHHHHHHHHHHHhCC-CCCEeeEeeEEEe--CCc
Confidence 345555689999999999998876664 499999976542 33477899999999995 6999999998754 567
Q ss_pred EEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
++++||++ +++|.+++...... .......+..++.|++.||+|||++||+||||||+||||+... +.+|
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~--------~~~k 163 (295)
T 2clq_A 94 IKIFMEQVPGGSLSALLRSKWGP--LKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYS--------GVLK 163 (295)
T ss_dssp EEEEEECCSEEEHHHHHHHTTCC--CTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTT--------CCEE
T ss_pred EEEEEEeCCCCCHHHHHHhhccC--CCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCC--------CCEE
Confidence 88999987 67999998875332 2334555666778999999999999999999999999997632 5799
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||++........ ......||+.|+|||++.+... .++.++||||||+++|||++|..||.........
T Consensus 164 l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~-------~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 234 (295)
T 2clq_A 164 ISDFGTSKRLAGINP--CTETFTGTLQYMAPEIIDKGPR-------GYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA 234 (295)
T ss_dssp ECCTTTCEESCC-------CCCCCCGGGCCHHHHHHGGG-------GCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH
T ss_pred EeecccccccCCCCC--cccccCCCccccChhhhcCCCC-------CCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH
Confidence 999999987654322 1235679999999999975421 2688999999999999999999999765443232
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
+.......... .....++.++.++|.+||+.||++||++.+++++
T Consensus 235 ~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 235 MFKVGMFKVHP------EIPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp HHHHHHHCCCC------CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred HHhhccccccc------cccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 22222211111 1123678999999999999999999999999864
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=340.44 Aligned_cols=267 Identities=20% Similarity=0.276 Sum_probs=199.4
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
.++|++.+.||+|+||.||+|.+.. .+.||||++..... ...+.+.+|+.+|++++ ||||+++++++ ....
T Consensus 38 ~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~~iv~~~~~~--~~~~ 108 (321)
T 2qkw_B 38 TNNFDHKFLIGHGVFGKVYKGVLRD---GAKVALKRRTPESS---QGIEEFETEIETLSFCR-HPHLVSLIGFC--DERN 108 (321)
T ss_dssp CCCCSCCCCSCBCSSSEEEEEECTT---CCEEEEEECCSCCS---SHHHHHHHHHHGGGSCC-CTTBCCEEEEC--CCTT
T ss_pred HhccCccceeecCCCeeEEEEEECC---CCEEEEEEecccCh---HHHHHHHHHHHHHHhCC-CCCEeeEEEEE--cCCC
Confidence 4689999999999999999997542 34599998876532 33578899999999995 69999999876 4456
Q ss_pred eEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 335 HLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 335 ~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
.++++||++ +++|.+++.... .......+..++.++.|++.||+|||++||+||||||+||||+.+ +.+
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~---------~~~ 178 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSD-LPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDEN---------FVP 178 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSC-CCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTT---------CCE
T ss_pred eEEEEEEcCCCCcHHHHHhccC-CCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCC---------CCE
Confidence 788999976 568888775432 222245566677788899999999999999999999999999776 679
Q ss_pred EEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCch--
Q psy14267 414 KIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNT-- 491 (553)
Q Consensus 414 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~-- 491 (553)
||+|||+++...............||+.|+|||++.+. .++.++|||||||++|||++|+.||......
T Consensus 179 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~ 249 (321)
T 2qkw_B 179 KITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKG---------RLTEKSDVYSFGVVLFEVLCARSAIVQSLPREM 249 (321)
T ss_dssp EECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHC---------BCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSC
T ss_pred EEeecccccccccccccccccccCCCccccCHHHhcCC---------CCCcccchHhHHHHHHHHHhCCCcccccCcHHH
Confidence 99999999876543332223355699999999999765 3789999999999999999999999753221
Q ss_pred ---HHHHHHHHhhcc-cccccccccC--CCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 492 ---WAKMLAIARHKD-QIEFKPQLAN--NVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 492 ---~~~~~~i~~~~~-~~~~~~~~~~--~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
............ .....+.+.. ...++..+.++|.+||+.||++|||+.+++++|++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 313 (321)
T 2qkw_B 250 VNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313 (321)
T ss_dssp CCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 011111111100 0011111111 113456899999999999999999999999999864
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=327.93 Aligned_cols=265 Identities=23% Similarity=0.407 Sum_probs=185.0
Q ss_pred ceEEecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHH-HHHhhcCCCceeEeeeE
Q psy14267 249 DVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVE-LLAKLQGCPYVIKMHDY 327 (553)
Q Consensus 249 ~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~-iL~~l~~hp~Iv~l~~~ 327 (553)
..+....++|++++.||+|+||.||+|.+..++. .||||++....... . ..++..|+. +++.+ +||||++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~~~~~-~-~~~~~~~~~~~~~~~-~h~~i~~~~~~ 92 (318)
T 2dyl_A 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGH--VIAVKQMRRSGNKE-E-NKRILMDLDVVLKSH-DCPYIVQCFGT 92 (318)
T ss_dssp SEEECCGGGEEEEEEC------CEEEEEETTTCC--EEEEEEEETTSCHH-H-HHHHHHHHHHHHHTT-TCTTBCCEEEE
T ss_pred hhhhhhhccccccceeeecCCeeEEEEEEecCCe--EEEEEEecccccch-H-HHHHHHHHHHHHHhc-CCCceeeEEEE
Confidence 4455566789999999999999999998876664 49999998765322 2 234444444 45555 67999999998
Q ss_pred EEeCCCceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhC-CcEecCCCCCCEEEecCcccee
Q psy14267 328 VYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAA-GIIHSDLKPANFLFVGNVLKII 406 (553)
Q Consensus 328 ~~~~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~-gIiHrDLKp~NILl~~~~~~~~ 406 (553)
+.. ...++++||++++.+..+...... ......+..++.|++.||+|||++ ||+||||||+|||++.+
T Consensus 93 ~~~--~~~~~lv~e~~~~~~~~l~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~----- 161 (318)
T 2dyl_A 93 FIT--NTDVFIAMELMGTCAEKLKKRMQG----PIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDER----- 161 (318)
T ss_dssp EEC--SSEEEEEECCCSEEHHHHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTT-----
T ss_pred Eec--CCcEEEEEeccCCcHHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCC-----
Confidence 754 568899999997766666554322 234566667778999999999995 99999999999999776
Q ss_pred cCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCC
Q psy14267 407 DCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYS 486 (553)
Q Consensus 407 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~ 486 (553)
+.+||+|||++........ .....||+.|+|||++...... ...++.++|||||||++|||++|..||.
T Consensus 162 ----~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~----~~~~~~~~Di~slG~il~~l~~g~~pf~ 230 (318)
T 2dyl_A 162 ----GQIKLCDFGISGRLVDDKA---KDRSAGCAAYMAPERIDPPDPT----KPDYDIRADVWSLGISLVELATGQFPYK 230 (318)
T ss_dssp ----SCEEECCCTTC-----------------CCTTCCHHHHC------------CCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred ----CCEEEEECCCchhccCCcc---ccccCCCccccChhhccccccc----ccCCccccchhhHHHHHHHHHhCCCCCC
Confidence 5799999999977654332 2245699999999999643211 1147889999999999999999999998
Q ss_pred CCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 487 HIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 487 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
........+..+..... +.+.....++.++.++|.+||..||++||++.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 231 NCKTDFEVLTKVLQEEP-----PLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp TCCSHHHHHHHHHHSCC-----CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CCCccHHHHHHHhccCC-----CCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 76555444444433221 2222334688999999999999999999999999874
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=324.34 Aligned_cols=255 Identities=26% Similarity=0.392 Sum_probs=190.1
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeC----
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDT---- 331 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~---- 331 (553)
++|++++.||+|+||.||+|++..++.. ||||++... ....+.+.+|+.+++++. ||||+++++++.+.
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~~----~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~ 78 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRY--YAIKKIRHT----EEKLSTILSEVMLLASLN-HQYVVRYYAAWLERRNFV 78 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCE--EEEEEEEEE----HHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEECCCCC
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeE--EEEEEEecc----HHHHHHHHHHHHHHHhcC-chHHHHHHHHHHhhcchh
Confidence 5799999999999999999988766644 999999643 344578899999999995 69999999987653
Q ss_pred -------CCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCcc
Q psy14267 332 -------ASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVL 403 (553)
Q Consensus 332 -------~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~ 403 (553)
....++++||++ +++|.+++..... ......++.++.|++.||+|||++||+||||||+|||++.+
T Consensus 79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~-- 152 (303)
T 1zy4_A 79 KPMTAVKKKSTLFIQMEYCENGTLYDLIHSENL----NQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDES-- 152 (303)
T ss_dssp C------CEEEEEEEEECCCSCBHHHHHHHSCG----GGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT--
T ss_pred hhhcccccCCceEEEEecCCCCCHHHhhhcccc----ccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCC--
Confidence 246789999987 5699999986432 33445566777899999999999999999999999999776
Q ss_pred ceecCCCCeEEEEeccCccccCCCCC------------cccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHH
Q psy14267 404 KIIDCIGNVLKIIDFGIACSLQDDKT------------SVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSL 471 (553)
Q Consensus 404 ~~~~~~~~~vkL~DFGla~~~~~~~~------------~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSl 471 (553)
+.+||+|||++........ ........||+.|+|||++.+.. .++.++|||||
T Consensus 153 -------~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--------~~~~~~Di~sl 217 (303)
T 1zy4_A 153 -------RNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTG--------HYNEKIDMYSL 217 (303)
T ss_dssp -------SCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCS--------CCCTHHHHHHH
T ss_pred -------CCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCC--------CCcchhhHHHH
Confidence 5799999999987653211 11123556999999999997542 37899999999
Q ss_pred HHHHHHHHhCCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 472 GCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 472 Gvvl~elltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
||++|||++ ||............+... ...+.+.. ...++..+.++|.+||+.||++|||+.+++++
T Consensus 218 G~il~~l~~---p~~~~~~~~~~~~~~~~~--~~~~~~~~--~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 218 GIIFFEMIY---PFSTGMERVNILKKLRSV--SIEFPPDF--DDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHHHHHS---CCSSHHHHHHHHHHHHST--TCCCCTTC--CTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHh---ccCCchhHHHHHHhcccc--ccccCccc--cccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 999999998 665422222222222221 12222221 23567889999999999999999999999975
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=330.31 Aligned_cols=258 Identities=25% Similarity=0.418 Sum_probs=192.2
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
.++|++++.||+|+||.||+|.+..++.. ||+|++..... ...+.+.+|+.+|+++. ||||+++++++.. ..
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~--~aiK~~~~~~~---~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~ 89 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGAL--AAAKVIETKSE---EELEDYIVEIEILATCD-HPYIVKLLGAYYH--DG 89 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCE--EEEEEEC-------CCHHHHHHHHHHHHHCC-CTTBCCEEEEEEC--C-
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcE--EEEEEecCCCH---HHHHHHHHHHHHHhcCC-CCCEeeeeeeeee--CC
Confidence 46899999999999999999988766644 99999876542 23478899999999995 6999999998754 45
Q ss_pred eEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 335 HLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 335 ~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
.++++||++ +++|..++..... ......+..++.||+.||+|||++||+||||||+|||++.+ +.+
T Consensus 90 ~~~lv~e~~~~~~l~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~---------~~~ 156 (302)
T 2j7t_A 90 KLWIMIEFCPGGAVDAIMLELDR----GLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLE---------GDI 156 (302)
T ss_dssp CEEEEEECCTTEEHHHHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTT---------SCE
T ss_pred eEEEEEEeCCCCcHHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCC---------CCE
Confidence 788999986 5678888776432 23455667777899999999999999999999999999766 579
Q ss_pred EEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHH
Q psy14267 414 KIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWA 493 (553)
Q Consensus 414 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~ 493 (553)
||+|||++........ ......||+.|+|||++...... ...++.++||||||+++|||++|..||.......
T Consensus 157 kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~----~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~- 229 (302)
T 2j7t_A 157 RLADFGVSAKNLKTLQ--KRDSFIGTPYWMAPEVVMCETMK----DTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR- 229 (302)
T ss_dssp EECCCHHHHHHHHHHH--C-----CCGGGCCHHHHHHHHTT----STTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-
T ss_pred EEEECCCCcccccccc--ccccccCChhhcCCeeeccccCC----CCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH-
Confidence 9999999754322111 11245689999999998532110 1147889999999999999999999998765432
Q ss_pred HHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 494 KMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 494 ~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
....+..... +.......++..+.++|.+||..||++|||+.+++++
T Consensus 230 ~~~~~~~~~~-----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 230 VLLKIAKSDP-----PTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp HHHHHHHSCC-----CCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred HHHHHhccCC-----cccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 2222222211 1111223578999999999999999999999999874
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=339.78 Aligned_cols=271 Identities=18% Similarity=0.252 Sum_probs=197.2
Q ss_pred EEecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEe
Q psy14267 251 ITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYD 330 (553)
Q Consensus 251 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~ 330 (553)
+.+..++|++.+.||+|+||.||+|+... .+.||||++........ ...+.+|+.+++++. ||||+++++++.
T Consensus 25 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~-h~~iv~~~~~~~- 97 (326)
T 3uim_A 25 LQVASDNFSNKNILGRGGFGKVYKGRLAD---GTLVAVKRLKEERTQGG--ELQFQTEVEMISMAV-HRNLLRLRGFCM- 97 (326)
T ss_dssp HHTTTTSSCSTTEEECCSSSEEEEECCSS---SCCEEEEECCC-----C--CCHHHHHHHGGGTCC-CTTBCCCCEEEC-
T ss_pred HHHHhhccccceeEecCCCcEEEEEEecC---CCEEEEEEeccccCchH--HHHHHHHHHHHHhcc-CCCccceEEEEe-
Confidence 34456789999999999999999997542 34599999976543221 236889999999995 699999999874
Q ss_pred CCCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhC---CcEecCCCCCCEEEecCcccee
Q psy14267 331 TASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAA---GIIHSDLKPANFLFVGNVLKII 406 (553)
Q Consensus 331 ~~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~---gIiHrDLKp~NILl~~~~~~~~ 406 (553)
.....+++||++ +++|.+++...... .....+..+..++.|++.||+|||++ ||+||||||+||||+.+
T Consensus 98 -~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~----- 170 (326)
T 3uim_A 98 -TPTERLLVYPYMANGSVASCLRERPES-QPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEE----- 170 (326)
T ss_dssp -CSSCCEEEEECCTTCBHHHHHHCCSTT-CCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTT-----
T ss_pred -cCCceEEEEEeccCCCHHHHHHhcccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCC-----
Confidence 455678889976 56999998865432 22355566777788999999999999 99999999999999776
Q ss_pred cCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCC
Q psy14267 407 DCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYS 486 (553)
Q Consensus 407 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~ 486 (553)
+.+||+|||+++........ ......||+.|+|||++.+. .++.++|||||||++|||++|..||.
T Consensus 171 ----~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 171 ----FEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTG---------KSSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp ----CCEEECCCSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHS---------EECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred ----CCEEeccCccccccCccccc-ccccccCCcCccCHHHhccC---------CCCccccchhHHHHHHHHHhCCCccc
Confidence 57999999999877544332 22355699999999999765 37899999999999999999999995
Q ss_pred CC----CchHHHHHHHHhhcccccc----ccccc--CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 487 HI----PNTWAKMLAIARHKDQIEF----KPQLA--NNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 487 ~~----~~~~~~~~~i~~~~~~~~~----~~~~~--~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
.. .........+......... ...+. .....+..+.++|.+||+.||++|||+.+++++|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 237 LARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp HHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred ccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 21 0000000001000000000 00000 0112236799999999999999999999999999863
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=335.37 Aligned_cols=267 Identities=16% Similarity=0.258 Sum_probs=199.1
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhh-cCCCceeEeeeEEEeCCC
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKL-QGCPYVIKMHDYVYDTAS 333 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l-~~hp~Iv~l~~~~~~~~~ 333 (553)
.++|++.+.||+|+||.||++.+. .+.||||++... ....+.+|++++..+ ..||||+++++++.....
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~----~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~ 110 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKWR----GEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKDNG 110 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET----TEEEEEEEECGG------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred cccEEEEeeecCCCCcEEEEEEEc----CccEEEEEeCch------hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence 468999999999999999999763 345999998643 236678999999884 367999999998766543
Q ss_pred --ceEEEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHh--------hCCcEecCCCCCCEEEecCc
Q psy14267 334 --KHLYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIH--------AAGIIHSDLKPANFLFVGNV 402 (553)
Q Consensus 334 --~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH--------~~gIiHrDLKp~NILl~~~~ 402 (553)
..++++||++. ++|.+++... ......++.++.|++.||+||| ++||+||||||+||||+.+
T Consensus 111 ~~~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~- 183 (342)
T 1b6c_B 111 TWTQLWLVSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN- 183 (342)
T ss_dssp SCCCEEEEECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTT-
T ss_pred ccceeEEEEeecCCCcHHHHHhcc------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCC-
Confidence 37899999865 5999999764 2445667777889999999999 8999999999999999776
Q ss_pred cceecCCCCeEEEEeccCccccCCCCCcc--cccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh
Q psy14267 403 LKIIDCIGNVLKIIDFGIACSLQDDKTSV--HKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY 480 (553)
Q Consensus 403 ~~~~~~~~~~vkL~DFGla~~~~~~~~~~--~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt 480 (553)
+.+||+|||++.......... ......||+.|+|||++.+.... ..+.++.++|||||||++|||++
T Consensus 184 --------~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~~~~~~~Di~slG~il~el~t 252 (342)
T 1b6c_B 184 --------GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM---KHFESFKRADIYAMGLVFWEIAR 252 (342)
T ss_dssp --------SCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCT---TCHHHHHHHHHHHHHHHHHHHHT
T ss_pred --------CCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccc---cccccCCcccHHHHHHHHHHHHh
Confidence 579999999998776544321 22355799999999999765311 11124478999999999999999
Q ss_pred C----------CCCCCCCCc---hHHHHHHHH-hhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q psy14267 481 G----------RTPYSHIPN---TWAKMLAIA-RHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQI 546 (553)
Q Consensus 481 G----------~~Pf~~~~~---~~~~~~~i~-~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L 546 (553)
| ..||..... ....+.... .......+...+ ....+++.+.+||.+||+.||++|||+.+++++|
T Consensus 253 g~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L 331 (342)
T 1b6c_B 253 RCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRW-QSCEALRVMAKIMRECWYANGAARLTALRIKKTL 331 (342)
T ss_dssp TBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGG-GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHH
T ss_pred ccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccc-cchhHHHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence 9 889876422 122222222 111111111111 1123456899999999999999999999999999
Q ss_pred hcCC
Q psy14267 547 NNNP 550 (553)
Q Consensus 547 ~~~~ 550 (553)
+++.
T Consensus 332 ~~i~ 335 (342)
T 1b6c_B 332 SQLS 335 (342)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 8753
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=337.29 Aligned_cols=273 Identities=19% Similarity=0.276 Sum_probs=199.6
Q ss_pred ceEEecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEE
Q psy14267 249 DVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYV 328 (553)
Q Consensus 249 ~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~ 328 (553)
..+.+..++|++.+.||+|+||.||++.+.. .||+|+++...... ...+.+.+|+.++++++ ||||+++++++
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~avk~~~~~~~~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~~ 98 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-----EVAIRLIDIERDNE-DQLKAFKREVMAYRQTR-HENVVLFMGAC 98 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS-----SEEEEECCCCSCCC-CCCCCCCTTGGGGTTCC-CTTBCCCCEEE
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC-----eEEEEEeecCCCCH-HHHHHHHHHHHHHhcCC-CCCEeEEEEEE
Confidence 3445567789999999999999999997643 28999997654332 22356788999999995 59999999987
Q ss_pred EeCCCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceec
Q psy14267 329 YDTASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIID 407 (553)
Q Consensus 329 ~~~~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~ 407 (553)
.. ...++++||++ +++|.+++..... ......++.++.||+.||+|||++||+||||||+|||++.
T Consensus 99 ~~--~~~~~iv~e~~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~~------- 165 (319)
T 2y4i_B 99 MS--PPHLAIITSLCKGRTLYSVVRDAKI----VLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDN------- 165 (319)
T ss_dssp EC--SSCEEEECBCCCSEEHHHHTTSSCC----CCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC--------
T ss_pred ec--CCceEEEeecccCCcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEeC-------
Confidence 54 45688999987 5789988865432 2334556667789999999999999999999999999963
Q ss_pred CCCCeEEEEeccCccccCCCCC---cccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCC
Q psy14267 408 CIGNVLKIIDFGIACSLQDDKT---SVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTP 484 (553)
Q Consensus 408 ~~~~~vkL~DFGla~~~~~~~~---~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~P 484 (553)
+.+||+|||+++....... ........||+.|+|||++.+...........++.++|||||||++|||++|..|
T Consensus 166 ---~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p 242 (319)
T 2y4i_B 166 ---GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242 (319)
T ss_dssp ----CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred ---CCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCC
Confidence 4689999999876532211 1122345699999999999764322111122478999999999999999999999
Q ss_pred CCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q psy14267 485 YSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNPE 551 (553)
Q Consensus 485 f~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~~ 551 (553)
|...... .....+..... +. .....++.++.++|.+||..||++|||+.++++.|+++..
T Consensus 243 ~~~~~~~-~~~~~~~~~~~-----~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~ 302 (319)
T 2y4i_B 243 FKTQPAE-AIIWQMGTGMK-----PN-LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPK 302 (319)
T ss_dssp SSSCCHH-HHHHHHHTTCC-----CC-CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred CCCCCHH-HHHHHhccCCC-----CC-CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 9875543 22222222211 11 1122578899999999999999999999999999998764
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=347.53 Aligned_cols=274 Identities=23% Similarity=0.329 Sum_probs=188.2
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
.+.|.+.++||+|+||+||.+. ..++ +.||||++.... .+.+.+|+.+|+++.+||||+++++++ ....
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~~-~~~g--~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~--~~~~ 82 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQG-SFQG--RPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSE--TTDR 82 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEEE-ESSS--SEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEE--ECSS
T ss_pred hheeeccCeEeeCCCeEEEEEE-EECC--eEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEE--ecCC
Confidence 3467788999999999998753 3333 459999986532 356789999999987789999998766 4567
Q ss_pred eEEEEEecCCCCHHHHHHHcccCCCCc--hHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCcc----ceecC
Q psy14267 335 HLYVLMEKGDTDLSKYMRNLNKMTTLP--NTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVL----KIIDC 408 (553)
Q Consensus 335 ~~~iv~e~~~~~L~~~l~~~~~~~~~~--~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~----~~~~~ 408 (553)
.++++||+++++|.+++.......... .....++.++.||+.||+|||++|||||||||+||||+.+.. .....
T Consensus 83 ~~~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~ 162 (434)
T 2rio_A 83 FLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGA 162 (434)
T ss_dssp EEEEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCC
T ss_pred eEEEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCC
Confidence 899999999999999998754322111 112224556779999999999999999999999999976420 00001
Q ss_pred CCCeEEEEeccCccccCCCCCcc--cccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCC
Q psy14267 409 IGNVLKIIDFGIACSLQDDKTSV--HKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPY 485 (553)
Q Consensus 409 ~~~~vkL~DFGla~~~~~~~~~~--~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf 485 (553)
....+||+|||+++......... .....+||+.|+|||++.+..... ....++.++|||||||++|||++ |..||
T Consensus 163 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~~~~~~~~DiwSlG~il~ellt~g~~Pf 240 (434)
T 2rio_A 163 ENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQ--TKRRLTRSIDIFSMGCVFYYILSKGKHPF 240 (434)
T ss_dssp CSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTS--CCCCCCTHHHHHHHHHHHHHHHTTSCCTT
T ss_pred CceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccc--cccCcchhhhhHhHHHHHHHHHhCCCCCC
Confidence 23579999999998876543221 123457999999999997632110 11247899999999999999999 99999
Q ss_pred CCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 486 SHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 486 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
....... ..+........... ......++.++.+||.+||+.||++|||+.++++|
T Consensus 241 ~~~~~~~---~~i~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 241 GDKYSRE---SNIIRGIFSLDEMK-CLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp CSTTTHH---HHHHHTCCCCCCCT-TCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCchhhH---HHHhcCCCCccccc-ccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 7644332 12222211111110 01111345789999999999999999999999864
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=343.79 Aligned_cols=260 Identities=13% Similarity=0.150 Sum_probs=188.1
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEee----------
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMH---------- 325 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~---------- 325 (553)
..|++.++||+|+||+||+|.+..++. .||||++...........+.+.+|+.+++.+.|..++....
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~--~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGE--SFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCC--EEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCC--ceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 468899999999999999999887765 49999998554444444578899999999987643221111
Q ss_pred -----------eEEEeCC---CceEEEEEecCCCCHHHHHHHccc--CCCCchHHHHHHHHHHHHHHHHHHHhhCCcEec
Q psy14267 326 -----------DYVYDTA---SKHLYVLMEKGDTDLSKYMRNLNK--MTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHS 389 (553)
Q Consensus 326 -----------~~~~~~~---~~~~~iv~e~~~~~L~~~l~~~~~--~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHr 389 (553)
.++.... ...++++|+..+++|.++++.... .......+..++.++.||+.||+|||++|||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHr 235 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 235 (413)
T ss_dssp EEECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hcccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 1111111 235788999999999999864421 122245556677777899999999999999999
Q ss_pred CCCCCCEEEecCccceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCC-CccCCCccchH
Q psy14267 390 DLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGG-NTYRITYKSDV 468 (553)
Q Consensus 390 DLKp~NILl~~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~-~~~~~s~~sDI 468 (553)
||||+||||+.+ +.+||+|||+++..... ....+| +.|+|||++.+.....+. ....++.++||
T Consensus 236 DiKp~NILl~~~---------~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~Dv 300 (413)
T 3dzo_A 236 YLRPVDIVLDQR---------GGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDT 300 (413)
T ss_dssp CCCGGGEEECTT---------CCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHH
T ss_pred CcccceEEEecC---------CeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhH
Confidence 999999999877 56999999998875433 235678 999999999432100000 11147889999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 469 WSLGCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 469 wSlGvvl~elltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
|||||+||||++|+.||...... ......+.....+++.+.+||.+||+.||++||++.+++++
T Consensus 301 wSlGvil~elltg~~Pf~~~~~~-------------~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 301 WTLGLAIYWIWCADLPNTDDAAL-------------GGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp HHHHHHHHHHHHSSCCCCTTGGG-------------SCSGGGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHHHHHHCCCCCCCcchh-------------hhHHHHHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 99999999999999999764321 01112233344788999999999999999999998877653
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=344.47 Aligned_cols=266 Identities=20% Similarity=0.282 Sum_probs=189.2
Q ss_pred ceEEecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEE
Q psy14267 249 DVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYV 328 (553)
Q Consensus 249 ~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~ 328 (553)
..+.+...+|.+.++||+|+||+||.. ...++ +.||||++...... .+.+|+++|+++..||||+++++++
T Consensus 17 ~~~~i~~~~y~~~~~LG~G~~G~V~~~-~~~~~--~~vAvK~~~~~~~~------~~~~E~~~l~~l~~HpnIv~l~~~~ 87 (432)
T 3p23_A 17 SVVIVGKISFCPKDVLGHGAEGTIVYR-GMFDN--RDVAVKRILPECFS------FADREVQLLRESDEHPNVIRYFCTE 87 (432)
T ss_dssp -CEEETTEEEEEEEEEEECGGGCEEEE-EESSS--SEEEEEEECTTTEE------ECHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred CcEEEccEEEecCCeeecCcCEEEEEE-EEeCC--eEEEEEEECHHHHH------HHHHHHHHHHhccCCCCcCeEEEEE
Confidence 456677778999999999999997643 33333 45999999764422 2468999999997789999998876
Q ss_pred EeCCCceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecC
Q psy14267 329 YDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDC 408 (553)
Q Consensus 329 ~~~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~ 408 (553)
. ....++++||+++++|.+++.......... .++.++.||+.||+|||++|||||||||+||||+.+.. .
T Consensus 88 ~--~~~~~~lv~E~~~g~L~~~l~~~~~~~~~~----~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~----~ 157 (432)
T 3p23_A 88 K--DRQFQYIAIELCAATLQEYVEQKDFAHLGL----EPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNA----H 157 (432)
T ss_dssp E--ETTEEEEEEECCSEEHHHHHHSSSCCCCSS----CHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBT----T
T ss_pred e--cCCEEEEEEECCCCCHHHHHHhcCCCccch----hHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCC----C
Confidence 4 466889999999999999998754322211 22345679999999999999999999999999964310 1
Q ss_pred CCCeEEEEeccCccccCCCCCc-ccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCC
Q psy14267 409 IGNVLKIIDFGIACSLQDDKTS-VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYS 486 (553)
Q Consensus 409 ~~~~vkL~DFGla~~~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~ 486 (553)
....+||+|||+|+........ ......+||+.|+|||++.+... ..++.++|||||||++|||++ |..||.
T Consensus 158 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~------~~~t~~~DiwSlG~il~ellt~g~~pf~ 231 (432)
T 3p23_A 158 GKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCK------ENPTYTVDIFSAGCVFYYVISEGSHPFG 231 (432)
T ss_dssp TBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---------CCCTHHHHHHHHHHHHHHHTTSCBTTB
T ss_pred CceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccc------cCCCcHHHHHHHHHHHHHHHcCCCCCcc
Confidence 1235889999999887654321 12335679999999999975321 146889999999999999999 999997
Q ss_pred CCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 487 HIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 487 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
....... .. ........ ........+..+.+||.+||+.||++|||+.++++|
T Consensus 232 ~~~~~~~--~~-~~~~~~~~---~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 232 KSLQRQA--NI-LLGACSLD---CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp STTTHHH--HH-HTTCCCCT---TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhHHHH--HH-HhccCCcc---ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 6433211 11 11111111 111112335678999999999999999999999854
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=356.30 Aligned_cols=263 Identities=20% Similarity=0.360 Sum_probs=202.5
Q ss_pred EEecCcceEEEeeeeeeCceEEEEEeeeCCC-ccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEE
Q psy14267 251 ITLNGKQYQVLSLLGKGGSSSVYLVGGTSEH-EFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVY 329 (553)
Q Consensus 251 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~ 329 (553)
+.+..++|++.+.||+|+||.||+|.+...+ ....||||++.... .....+.+.+|+.+|+++. ||||+++++++.
T Consensus 385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~ 461 (656)
T 2j0j_A 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFD-HPHIVKLIGVIT 461 (656)
T ss_dssp TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEC
T ss_pred cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEe
Confidence 4455678999999999999999999876543 33568999886542 3445578999999999995 699999999762
Q ss_pred eCCCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecC
Q psy14267 330 DTASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDC 408 (553)
Q Consensus 330 ~~~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~ 408 (553)
+..++++||++ +++|.+++..... ......++.++.|++.||+|||++|||||||||+||||+.+
T Consensus 462 ---~~~~~lv~E~~~~g~L~~~l~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~------- 527 (656)
T 2j0j_A 462 ---ENPVWIIMELCTLGELRSFLQVRKF----SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN------- 527 (656)
T ss_dssp ---SSSCEEEEECCTTCBHHHHHHHTTT----TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-------
T ss_pred ---cCceEEEEEcCCCCcHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCC-------
Confidence 34578899976 4799999986432 24456667777899999999999999999999999999876
Q ss_pred CCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCC
Q psy14267 409 IGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSH 487 (553)
Q Consensus 409 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~ 487 (553)
+.+||+|||+++........ ......||+.|+|||++.+. .++.++|||||||+||||++ |..||.+
T Consensus 528 --~~vkL~DFG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~---------~~~~~~DiwSlG~il~ellt~g~~Pf~~ 595 (656)
T 2j0j_A 528 --DCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFR---------RFTSASDVWMFGVCMWEILMHGVKPFQG 595 (656)
T ss_dssp --TEEEECCCCCCCSCCC-----------CCGGGCCHHHHHHC---------CCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred --CCEEEEecCCCeecCCCcce-eccCCCCCcceeCHHHhcCC---------CCCchhhHHHHHHHHHHHHHcCCCCCCC
Confidence 67999999999877544321 22244578899999999765 37899999999999999997 9999987
Q ss_pred CCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q psy14267 488 IPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNP 550 (553)
Q Consensus 488 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~ 550 (553)
.... ..+..+... .... ....+++.+.++|.+||..||++|||+.+|++.|+++.
T Consensus 596 ~~~~-~~~~~i~~~-~~~~------~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 596 VKNN-DVIGRIENG-ERLP------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp CCHH-HHHHHHHHT-CCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCHH-HHHHHHHcC-CCCC------CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 6543 223333222 1111 22367899999999999999999999999999998753
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=327.55 Aligned_cols=248 Identities=26% Similarity=0.428 Sum_probs=188.0
Q ss_pred cCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCch---hHHHHHHHHHHHHHhhc---CCCceeEeeeE
Q psy14267 254 NGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQ---SIADSYLNEVELLAKLQ---GCPYVIKMHDY 327 (553)
Q Consensus 254 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~---~~~~~~~~E~~iL~~l~---~hp~Iv~l~~~ 327 (553)
..++|++.+.||+|+||.||+|.+..++. .||||++........ .....+.+|+.++.++. .||||++++++
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRL--QVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEECTTTCC--EEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhceEEeeEEEcCCCEEEEEEEEccCCe--EEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 35689999999999999999998776664 499999976654321 12244678999999995 57999999987
Q ss_pred EEeCCCceEEEEEec--CCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccce
Q psy14267 328 VYDTASKHLYVLMEK--GDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKI 405 (553)
Q Consensus 328 ~~~~~~~~~~iv~e~--~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~ 405 (553)
+.. ....+++|++ .+++|.+++.... ......++.++.||+.||+|||++||+||||||+|||++.+.
T Consensus 107 ~~~--~~~~~~v~e~~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~--- 176 (312)
T 2iwi_A 107 FET--QEGFMLVLERPLPAQDLFDYITEKG-----PLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRR--- 176 (312)
T ss_dssp C-------CEEEEECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTT---
T ss_pred Eec--CCeEEEEEEecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCC---
Confidence 744 4556777775 5789999998754 244566777788999999999999999999999999997321
Q ss_pred ecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCC
Q psy14267 406 IDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY 485 (553)
Q Consensus 406 ~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf 485 (553)
+.+||+|||++........ ....||+.|+|||++.+.. ..+.++|||||||++|||++|+.||
T Consensus 177 -----~~~kl~dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~--------~~~~~~Di~slG~il~~l~~g~~pf 239 (312)
T 2iwi_A 177 -----GCAKLIDFGSGALLHDEPY----TDFDGTRVYSPPEWISRHQ--------YHALPATVWSLGILLYDMVCGDIPF 239 (312)
T ss_dssp -----TEEEECCCSSCEECCSSCB----CCCCSCTTTSCHHHHHHSC--------BCHHHHHHHHHHHHHHHHHHSSCSC
T ss_pred -----CeEEEEEcchhhhcccCcc----cccCCcccccCceeeecCC--------CCCccchHHHHHHHHHHHHHCCCCC
Confidence 6799999999987765332 2566999999999987653 1346899999999999999999999
Q ss_pred CCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 486 SHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 486 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
..... +... ... ....++..+.++|.+||+.||++|||+.+++++
T Consensus 240 ~~~~~-------~~~~--~~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 240 ERDQE-------ILEA--ELH------FPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp CSHHH-------HHHT--CCC------CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred CChHH-------Hhhh--ccC------CcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 76211 1111 111 123678999999999999999999999999974
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=333.16 Aligned_cols=261 Identities=24% Similarity=0.367 Sum_probs=197.6
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchh--------------HHHHHHHHHHHHHhhcCCCc
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQS--------------IADSYLNEVELLAKLQGCPY 320 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~--------------~~~~~~~E~~iL~~l~~hp~ 320 (553)
.++|++++.||+|+||.||+|.+ ++ +.||||++......... ..+.+.+|+.+|+++. |||
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~ 104 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DN--KFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK-NEY 104 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TT--EEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCC-CTT
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CC--ceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCC-CCC
Confidence 46899999999999999999987 33 45999999765432211 1277899999999995 699
Q ss_pred eeEeeeEEEeCCCceEEEEEecCC-CCHHHHHHHc---ccCCCCchHHHHHHHHHHHHHHHHHHHhh-CCcEecCCCCCC
Q psy14267 321 VIKMHDYVYDTASKHLYVLMEKGD-TDLSKYMRNL---NKMTTLPNTMIIIIMHWYEMLLAVKEIHA-AGIIHSDLKPAN 395 (553)
Q Consensus 321 Iv~l~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~i~~~~~qil~aL~yLH~-~gIiHrDLKp~N 395 (553)
|+++++++.. ...++++||++. ++|.+++... ............++.++.|++.||+|||+ +||+||||||+|
T Consensus 105 i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~N 182 (348)
T 2pml_X 105 CLTCEGIITN--YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSN 182 (348)
T ss_dssp BCCCSEEEES--SSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGG
T ss_pred cceEEEEEee--CCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHh
Confidence 9999998754 568899999875 4888773211 11112345566777788899999999999 999999999999
Q ss_pred EEEecCccceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCc-cchHHHHHHH
Q psy14267 396 FLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITY-KSDVWSLGCI 474 (553)
Q Consensus 396 ILl~~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~-~sDIwSlGvv 474 (553)
||++.+ +.+||+|||++...... ......||+.|+|||++.+.. .++. ++|||||||+
T Consensus 183 il~~~~---------~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~--------~~~~~~~Di~slG~i 241 (348)
T 2pml_X 183 ILMDKN---------GRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNES--------SYNGAKVDIWSLGIC 241 (348)
T ss_dssp EEECTT---------SCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCC--------CEEHHHHHHHHHHHH
T ss_pred EEEcCC---------CcEEEeccccccccccc----cccCCCCCcCccCchhhcCCC--------CCCcchhhHHHHHHH
Confidence 999776 57999999999876543 223567999999999997652 2444 8999999999
Q ss_pred HHHHHhCCCCCCCCCchHHHHHHHHhhcccccccccc-------------cCCCCCCHHHHHHHHHhcccCCCCCCCHHH
Q psy14267 475 LYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQL-------------ANNVTIPPTLLQSMKLCLQKDPKARPTVGN 541 (553)
Q Consensus 475 l~elltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~-------------~~~~~~s~~l~~li~~cL~~dP~~RPt~~e 541 (553)
+|||++|..||............+..... .+.... .....++.++.+||.+||..||++|||+.+
T Consensus 242 l~~l~~g~~pf~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e 319 (348)
T 2pml_X 242 LYVMFYNVVPFSLKISLVELFNNIRTKNI--EYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSED 319 (348)
T ss_dssp HHHHHHSSCSSCCSSCSHHHHHHHTSCCC--CCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred HHHHHhCCCCCCCCCcHHHHHHHHhccCc--CCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHH
Confidence 99999999999876553344433332221 111100 001467899999999999999999999999
Q ss_pred HHHH
Q psy14267 542 SVTQ 545 (553)
Q Consensus 542 ll~~ 545 (553)
++++
T Consensus 320 ~l~h 323 (348)
T 2pml_X 320 ALKH 323 (348)
T ss_dssp HHTS
T ss_pred HhcC
Confidence 9874
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=306.36 Aligned_cols=233 Identities=23% Similarity=0.320 Sum_probs=176.6
Q ss_pred cceEEE-eeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEe--CC
Q psy14267 256 KQYQVL-SLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYD--TA 332 (553)
Q Consensus 256 ~~y~i~-~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~--~~ 332 (553)
++|.+. ++||+|+||.||+|.+..++. .||||++... ..+.+|+.++.++.+||||+++++++.. ..
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~ 86 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQE--KFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAG 86 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCC--EEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCc--EEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCC
Confidence 467777 789999999999998877664 4999999642 4567899999777788999999998754 34
Q ss_pred CceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCC
Q psy14267 333 SKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGN 411 (553)
Q Consensus 333 ~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~ 411 (553)
...++++||++ +++|.+++...... ......++.++.|++.||+|||++||+||||||+||||+.+. ..+
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~------~~~ 157 (299)
T 3m2w_A 87 RKCLLIVMECLDGGELFSRIQDRGDQ---AFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR------PNA 157 (299)
T ss_dssp EEEEEEEECCCCSCBHHHHHHHCTTC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSS------TTC
T ss_pred CceEEEEEeecCCCcHHHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCC------CCC
Confidence 56789999987 46999999875432 345666777788999999999999999999999999998641 126
Q ss_pred eEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCch
Q psy14267 412 VLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNT 491 (553)
Q Consensus 412 ~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~ 491 (553)
.+||+|||++..... . .++.++|||||||++|||++|..||......
T Consensus 158 ~~kl~Dfg~a~~~~~------------------------~---------~~~~~~DiwslG~il~el~tg~~pf~~~~~~ 204 (299)
T 3m2w_A 158 ILKLTDFGFAKETTG------------------------E---------KYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 204 (299)
T ss_dssp CEEECCCTTCEECTT------------------------C---------GGGGHHHHHHHHHHHHHHHHSSCSCCC----
T ss_pred cEEEecccccccccc------------------------c---------cCCchhhHHHHHHHHHHHHHCCCCCCCCcch
Confidence 799999999854321 1 2678999999999999999999999764321
Q ss_pred HHHHHHHHhhccccccccc----ccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 492 WAKMLAIARHKDQIEFKPQ----LANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 492 ~~~~~~i~~~~~~~~~~~~----~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
. ............. ...+..+++++.++|.+||+.||++|||+.|++++
T Consensus 205 ~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 205 A-----ISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp --------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred h-----hhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0 0000000000000 01113678999999999999999999999999975
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=307.57 Aligned_cols=235 Identities=16% Similarity=0.124 Sum_probs=180.1
Q ss_pred ecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC
Q psy14267 253 LNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA 332 (553)
Q Consensus 253 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~ 332 (553)
+..++|++.+.||+|+||.||+|++..++. .||||++...........+.+.+|+.++.++ .||||+++++++..
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~-- 102 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDR--QVALTFVDPQGVLPDDVLQETLSRTLRLSRI-DKPGVARVLDVVHT-- 102 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTE--EEEEEESCTTCCSCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEE--
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCc--eEEEEEECcccccCHHHHHHHHHHHHHHhcC-CCCCcceeeEEEEE--
Confidence 345689999999999999999998876664 4999999887666666678899999999999 45999999998754
Q ss_pred CceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCC
Q psy14267 333 SKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGN 411 (553)
Q Consensus 333 ~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~ 411 (553)
....|++||++ +++|.++++.. .. ...+..++.|++.||+|||++||+||||||+||||+.+ +
T Consensus 103 ~~~~~lv~e~~~g~~L~~~l~~~----~~---~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~---------g 166 (286)
T 3uqc_A 103 RAGGLVVAEWIRGGSLQEVADTS----PS---PVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSID---------G 166 (286)
T ss_dssp TTEEEEEEECCCEEEHHHHHTTC----CC---HHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETT---------S
T ss_pred CCcEEEEEEecCCCCHHHHHhcC----CC---hHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCC---------C
Confidence 56789999986 57899988542 11 22355567899999999999999999999999999876 5
Q ss_pred eEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCch
Q psy14267 412 VLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNT 491 (553)
Q Consensus 412 ~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~ 491 (553)
.+||+++| |++| ++.++|||||||+||||++|+.||.+....
T Consensus 167 ~~kl~~~~----------------------~~~~----------------~~~~~Di~slG~il~elltg~~Pf~~~~~~ 208 (286)
T 3uqc_A 167 DVVLAYPA----------------------TMPD----------------ANPQDDIRGIGASLYALLVNRWPLPEAGVR 208 (286)
T ss_dssp CEEECSCC----------------------CCTT----------------CCHHHHHHHHHHHHHHHHHSEECSCCCSBC
T ss_pred CEEEEecc----------------------ccCC----------------CCchhHHHHHHHHHHHHHHCCCCCCcCCcc
Confidence 78887443 3332 578999999999999999999999874331
Q ss_pred HHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 492 WAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 492 ~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
....... ................+++++.++|.+||+.||++| |+.|+++.|++.
T Consensus 209 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~ 263 (286)
T 3uqc_A 209 SGLAPAE--RDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQA 263 (286)
T ss_dssp CCSEECC--BCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHH
T ss_pred hhhHHHH--HHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHH
Confidence 0000000 000000011111224688999999999999999999 999999999874
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=341.24 Aligned_cols=262 Identities=22% Similarity=0.275 Sum_probs=188.6
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEe----C
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYD----T 331 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~----~ 331 (553)
++|++.+.||+|+||.||+|.+..++.. ||||++.... .....+++.+|+++|+++. ||||+.+++++.. .
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~--VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~v~~~~~~~~ 88 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQ--VAIKQCRQEL--SPKNRERWCLEIQIMKKLN-HPNVVSAREVPDGLQKLA 88 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCC--EEECCCCSCC--CHHHHHHHHHHHHHHHHCC-BTTBCCEEECCTTTCCCC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcE--EEEEEecccC--CHHHHHHHHHHHHHHHhCC-CCCCCceeeeeccccccc
Confidence 5799999999999999999987766644 9999987642 3345578999999999995 6999999887533 2
Q ss_pred CCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCC
Q psy14267 332 ASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIG 410 (553)
Q Consensus 332 ~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~ 410 (553)
.....+++||++ +++|.+++........ .....++.++.|++.||+|||+.||+||||||+||||+.+. ..
T Consensus 89 ~~~~~~LVmEy~~ggsL~~~L~~~~~~~~--lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g------~~ 160 (676)
T 3qa8_A 89 PNDLPLLAMEYCEGGDLRKYLNQFENCCG--LKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGP------QR 160 (676)
T ss_dssp TTSSCCCEEECCSSCBHHHHHHSSSCTTC--CCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCS------SS
T ss_pred CCCeEEEEEEeCCCCCHHHHHHhcccCCC--CCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCC------Cc
Confidence 256778999987 7799999987543222 22334556667999999999999999999999999998652 12
Q ss_pred CeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCc
Q psy14267 411 NVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN 490 (553)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~ 490 (553)
..+||+|||++........ .....||+.|+|||++.+. .++.++|||||||++|||++|..||.....
T Consensus 161 ~~vKL~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~---------~~s~ksDIwSLGviLyeLltG~~Pf~~~~~ 228 (676)
T 3qa8_A 161 LIHKIIDLGYAKELDQGEL---CTEFVGTLQYLAPELLEQK---------KYTVTVDYWSFGTLAFECITGFRPFLPNWQ 228 (676)
T ss_dssp CEEEECSCCCCCBTTSCCC---CCCCCSCCTTCSSCSSCCS---------CCSTTHHHHHHHHHHHHHHSSCSSCCSSCH
T ss_pred eeEEEcccccccccccccc---cccccCCcccCChHHhccC---------CCCchhHHHHHHHHHHHHHHCCCCCCcccc
Confidence 4589999999988765432 2356799999999999765 378899999999999999999999975322
Q ss_pred hHHHHHHH------H-----hhcccccccccccC----CCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q psy14267 491 TWAKMLAI------A-----RHKDQIEFKPQLAN----NVTIPPTLLQSMKLCLQKDPKARPTVGNS 542 (553)
Q Consensus 491 ~~~~~~~i------~-----~~~~~~~~~~~~~~----~~~~s~~l~~li~~cL~~dP~~RPt~~el 542 (553)
.......+ . .......+...... ...+++.+.++|..||..||++|||+.++
T Consensus 229 ~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 229 PVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp HHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred hhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 11100000 0 00000111111111 11356789999999999999999999874
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-37 Score=314.60 Aligned_cols=258 Identities=16% Similarity=0.140 Sum_probs=181.1
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcC-----chhHHHHHHHHHHHHHhhc--------CCCce
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDIT-----DQSIADSYLNEVELLAKLQ--------GCPYV 321 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~-----~~~~~~~~~~E~~iL~~l~--------~hp~I 321 (553)
.++|++++.||+|+||+||+|++ ++ +.||||++.+.... .....+.+.+|+.+|+.+. .||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~--~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni 94 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DH--TPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF 94 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TT--EEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred cccchheeeecccCceEEEEEEe--CC--ceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence 46799999999999999999987 33 55999999876432 2334477899999999997 46788
Q ss_pred eEeeeEEEeC----------------------------CCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHH
Q psy14267 322 IKMHDYVYDT----------------------------ASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWY 372 (553)
Q Consensus 322 v~l~~~~~~~----------------------------~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~ 372 (553)
+.+.+.+... ....++++||++ ++++.+.+.+ .......+..++.
T Consensus 95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~------~~~~~~~~~~i~~ 168 (336)
T 2vuw_A 95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT------KLSSLATAKSILH 168 (336)
T ss_dssp CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT------TCCCHHHHHHHHH
T ss_pred hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh------cCCCHHHHHHHHH
Confidence 7777654321 256899999985 4545554432 1235567777888
Q ss_pred HHHHHHHHHh-hCCcEecCCCCCCEEEecCccce-----------ecCCCCeEEEEeccCccccCCCCCcccccCCccCC
Q psy14267 373 EMLLAVKEIH-AAGIIHSDLKPANFLFVGNVLKI-----------IDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTL 440 (553)
Q Consensus 373 qil~aL~yLH-~~gIiHrDLKp~NILl~~~~~~~-----------~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~ 440 (553)
||+.||+||| ++|||||||||+||||+.+.... ....+..+||+|||+|+..... ..+||+
T Consensus 169 qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~ 241 (336)
T 2vuw_A 169 QLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCD 241 (336)
T ss_dssp HHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCC
T ss_pred HHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEee
Confidence 9999999999 99999999999999998762100 0011237999999999876542 347999
Q ss_pred CccCcccccccCCCCCCCccCCCccchHHHHHHH-HHHHHhCCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCH
Q psy14267 441 NYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCI-LYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPP 519 (553)
Q Consensus 441 ~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvv-l~elltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~ 519 (553)
.|||||++.+. .+.++||||||++ .++++.|..||.+..........+..... ............+++
T Consensus 242 ~y~aPE~~~g~----------~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~s~ 310 (336)
T 2vuw_A 242 VSMDEDLFTGD----------GDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMT-FKTKCNTPAMKQIKR 310 (336)
T ss_dssp CTTCSGGGCCC----------SSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCC-CSSCCCSHHHHHHHH
T ss_pred cccChhhhcCC----------CccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhc-cCcccchhhhhhcCH
Confidence 99999999865 3679999998777 77888999998541100011111111111 110110111124678
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHH-HH
Q psy14267 520 TLLQSMKLCLQKDPKARPTVGNSV-TQ 545 (553)
Q Consensus 520 ~l~~li~~cL~~dP~~RPt~~ell-~~ 545 (553)
++++||++||++| |+.|++ +|
T Consensus 311 ~~~dli~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 311 KIQEFHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp HHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred HHHHHHHHHhccC-----CHHHHHhcC
Confidence 9999999999977 999998 54
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=338.37 Aligned_cols=241 Identities=22% Similarity=0.314 Sum_probs=184.4
Q ss_pred cCcceEEEeeeeeeCceEEEEEeeeC-CCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC
Q psy14267 254 NGKQYQVLSLLGKGGSSSVYLVGGTS-EHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA 332 (553)
Q Consensus 254 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~ 332 (553)
..++|++++.||+|+||.||++.+.. ++ +.||||++.... .......+.+|+++|+++. ||||+++++++....
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~--~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~ 152 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNG--RPVVLKGLVHSG--DAEAQAMAMAERQFLAEVV-HPSIVQIFNFVEHTD 152 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTT--EEEEEEESCSSC--CHHHHHHHHHHHGGGGGCC-CTTBCCEEEEEEEEC
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCC--cEEEEEEeCccC--CHHHHHHHHHHHHHHHhcC-CCCcCeEeeeEeecC
Confidence 34689999999999999999998865 34 459999986542 3345577899999999995 699999999887644
Q ss_pred C---ceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecC
Q psy14267 333 S---KHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDC 408 (553)
Q Consensus 333 ~---~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~ 408 (553)
. ...|+|||++ +++|.+++.. ...+..++.++.||+.||+|||++|||||||||+||||+.+
T Consensus 153 ~~~~~~~~lv~E~~~g~~L~~~~~~-------~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~------- 218 (681)
T 2pzi_A 153 RHGDPVGYIVMEYVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE------- 218 (681)
T ss_dssp TTSCEEEEEEEECCCCEECC----C-------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-------
T ss_pred CCCCceeEEEEEeCCCCcHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-------
Confidence 3 2369999986 4677665543 34456677778899999999999999999999999999764
Q ss_pred CCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy14267 409 IGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHI 488 (553)
Q Consensus 409 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~ 488 (553)
.+||+|||+++..... ....||+.|+|||++.+. ++.++|||||||+||||++|..||...
T Consensus 219 ---~~kl~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~----------~~~~sDi~slG~~l~~l~~g~~~~~~~ 279 (681)
T 2pzi_A 219 ---QLKLIDLGAVSRINSF------GYLYGTPGFQAPEIVRTG----------PTVATDIYTVGRTLAALTLDLPTRNGR 279 (681)
T ss_dssp ---CEEECCCTTCEETTCC------SCCCCCTTTSCTTHHHHC----------SCHHHHHHHHHHHHHHHHSCCCEETTE
T ss_pred ---cEEEEecccchhcccC------CccCCCccccCHHHHcCC----------CCCceehhhhHHHHHHHHhCCCCCccc
Confidence 5899999999876543 255799999999998654 478999999999999999999998652
Q ss_pred CchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCC-HHHHHHHHh
Q psy14267 489 PNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT-VGNSVTQIN 547 (553)
Q Consensus 489 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt-~~ell~~L~ 547 (553)
.. ..+. . ......+++.+.++|.+||+.||++||+ ++++...|.
T Consensus 280 ~~------------~~~~--~-~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 324 (681)
T 2pzi_A 280 YV------------DGLP--E-DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT 324 (681)
T ss_dssp EC------------SSCC--T-TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred cc------------cccc--c-cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence 11 0000 0 0000123578999999999999999995 555555554
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-30 Score=287.95 Aligned_cols=189 Identities=14% Similarity=0.057 Sum_probs=126.6
Q ss_pred eeeeeCceEEEEEeeeCCCccceEEEEEEecCCcC-------chhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 263 LLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDIT-------DQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 263 ~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~-------~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
.++.|++|.+..++....++. ||||++.+.... .+...+++.+|+++|+++.+|+||+++++++ +++..
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~--~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~--ed~~~ 316 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGED--YVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHG--ENAQS 316 (569)
T ss_dssp C-C--------CCEEEEECSS--EEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEE--ECSSE
T ss_pred ccccCCcccccccccccccce--eEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE--EECCE
Confidence 577888888877666555544 999999876422 2334567999999999999999999999877 45778
Q ss_pred EEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
+||||||+ |++|.+++++.... . .. .++.||+.||+|||++|||||||||+||||+.+ +.||
T Consensus 317 ~yLVMEyv~G~~L~d~i~~~~~l---~--~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~d---------g~vK 379 (569)
T 4azs_A 317 GWLVMEKLPGRLLSDMLAAGEEI---D--RE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDAR---------QHAR 379 (569)
T ss_dssp EEEEEECCCSEEHHHHHHTTCCC---C--HH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTT---------SCEE
T ss_pred EEEEEecCCCCcHHHHHHhCCCC---C--HH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCC---------CCEE
Confidence 99999985 56899999875432 2 22 245699999999999999999999999999876 6799
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCC
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTP 484 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~P 484 (553)
|+|||+|+....... ...+.+||+.|||||++.+. +..++|+||+|+++++|++|..+
T Consensus 380 L~DFGlAr~~~~~~~--~~~t~vGTp~YmAPE~l~g~----------~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 380 LIDFGSIVTTPQDCS--WPTNLVQSFFVFVNELFAEN----------KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ECCCTTEESCC---C--CSHHHHHHHHHHHHHHC---------------------------CCCCTTHHH
T ss_pred EeecccCeeCCCCCc--cccCceechhhccHHHhCCC----------CCCcccccccccchhhhccccch
Confidence 999999987765433 23357899999999999765 46789999999998887655433
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.5e-25 Score=245.80 Aligned_cols=190 Identities=19% Similarity=0.144 Sum_probs=136.9
Q ss_pred EEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCch-----hHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCC
Q psy14267 259 QVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQ-----SIADSYLNEVELLAKLQGCPYVIKMHDYVYDTAS 333 (553)
Q Consensus 259 ~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~-----~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~ 333 (553)
...++||+|+||.||++... + +.+|+|+......... ...+++.+|+++|++++ ||||+.+..++.. .
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~--~--~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~--~ 411 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYL--D--FDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVK-DFGIPAPYIFDVD--L 411 (540)
T ss_dssp ---------CCEEEEEEECS--S--CEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGG-GGTCCCCCEEEEE--T
T ss_pred CCCCEEeeCCCEEEEEEEEC--C--CeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcC-CCCcCceEEEEEe--C
Confidence 34568999999999999332 2 3489998765543322 22456899999999995 5999955545543 3
Q ss_pred ceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCe
Q psy14267 334 KHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNV 412 (553)
Q Consensus 334 ~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~ 412 (553)
...+++||++ +++|.+++.. +..++.|++.||+|||++|||||||||+|||++. .
T Consensus 412 ~~~~lVmE~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~-----------~ 467 (540)
T 3en9_A 412 DNKRIMMSYINGKLAKDVIED-------------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK-----------D 467 (540)
T ss_dssp TTTEEEEECCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS-----------S
T ss_pred CccEEEEECCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC-----------e
Confidence 3458999987 5899988765 2345569999999999999999999999999965 4
Q ss_pred EEEEeccCccccCCCCCcc-----cccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCC
Q psy14267 413 LKIIDFGIACSLQDDKTSV-----HKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYS 486 (553)
Q Consensus 413 vkL~DFGla~~~~~~~~~~-----~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~ 486 (553)
+||+|||+|+......... .....+||+.|||||++..... .|+..+|+|+..+-.++.+-++.+|.
T Consensus 468 ~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~-------~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 468 LYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLE-------GYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp EEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHH-------HHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred EEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHH-------HHHHHHhHHHHHHHHHHHHHhccccC
Confidence 8999999999876532211 1235679999999999976211 26778999999999999888777764
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=4.8e-22 Score=200.18 Aligned_cols=149 Identities=26% Similarity=0.184 Sum_probs=108.7
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCch---------------hHHHHHHHHHHHHHhhcCCC
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQ---------------SIADSYLNEVELLAKLQGCP 319 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~---------------~~~~~~~~E~~iL~~l~~hp 319 (553)
+..|.+++.||+|+||.||+|.+ .++ +.||||++........ .....+.+|+.+|+++. |+
T Consensus 89 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g--~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-~~ 164 (282)
T 1zar_A 89 GKVDAIGKLMGEGKESAVFNCYS-EKF--GECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-GL 164 (282)
T ss_dssp TSCSEEEEEEEECSSEEEEEEEE-TTT--EEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-TS
T ss_pred CeEEEecCEeccCCCceEEEEEe-CCC--CEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-CC
Confidence 44577889999999999999988 444 4599999975432111 13467899999999997 34
Q ss_pred ceeEeeeEEEeCCCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEE
Q psy14267 320 YVIKMHDYVYDTASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLF 398 (553)
Q Consensus 320 ~Iv~l~~~~~~~~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl 398 (553)
++..+ +.. ...+++||++ +++|.+ +.. .. ...++.|++.||+|||++|||||||||+||||
T Consensus 165 ~v~~~---~~~---~~~~lvmE~~~g~~L~~-l~~-------~~----~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl 226 (282)
T 1zar_A 165 AVPKV---YAW---EGNAVLMELIDAKELYR-VRV-------EN----PDEVLDMILEEVAKFYHRGIVHGDLSQYNVLV 226 (282)
T ss_dssp SSCCE---EEE---ETTEEEEECCCCEEGGG-CCC-------SC----HHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE
T ss_pred CcCeE---Eec---cceEEEEEecCCCcHHH-cch-------hh----HHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEE
Confidence 44443 322 3458999986 457776 311 11 22356799999999999999999999999999
Q ss_pred ecCccceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccc
Q psy14267 399 VGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQ 450 (553)
Q Consensus 399 ~~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~ 450 (553)
+ + +.+||+|||+|+. +..|+|||++..
T Consensus 227 ~-~---------~~vkl~DFG~a~~---------------~~~~~a~e~l~r 253 (282)
T 1zar_A 227 S-E---------EGIWIIDFPQSVE---------------VGEEGWREILER 253 (282)
T ss_dssp E-T---------TEEEECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred E-C---------CcEEEEECCCCeE---------------CCCCCHHHHHHH
Confidence 8 5 6799999999853 345789998853
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=3.7e-19 Score=176.57 Aligned_cols=143 Identities=19% Similarity=0.231 Sum_probs=100.2
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCc---------------------hhHHHHHHHHHHHHHh
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITD---------------------QSIADSYLNEVELLAK 314 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~---------------------~~~~~~~~~E~~iL~~ 314 (553)
.-|.+.+.||+|+||.||+|.+..++....||||+++...... ......+.+|+.+|.+
T Consensus 47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 3488999999999999999987544422229999986542110 0112467899999999
Q ss_pred hcCCCce--eEeeeEEEeCCCceEEEEEecCCC------CHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHh-hCC
Q psy14267 315 LQGCPYV--IKMHDYVYDTASKHLYVLMEKGDT------DLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIH-AAG 385 (553)
Q Consensus 315 l~~hp~I--v~l~~~~~~~~~~~~~iv~e~~~~------~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH-~~g 385 (553)
+.+ ++| ..+++ . ...+++||++++ .|.++..... ...+..++.|++.||.||| +.|
T Consensus 127 l~~-~~i~~p~~~~--~----~~~~lVmE~~g~~g~~~~~L~~~~~~~~--------~~~~~~i~~qi~~~l~~lH~~~g 191 (258)
T 1zth_A 127 AKE-AGVSVPQPYT--Y----MKNVLLMEFIGEDELPAPTLVELGRELK--------ELDVEGIFNDVVENVKRLYQEAE 191 (258)
T ss_dssp HHH-TTCCCCCEEE--E----ETTEEEEECCEETTEECCBHHHHGGGGG--------GSCHHHHHHHHHHHHHHHHHTSC
T ss_pred HHh-CCCCCCeEEE--c----CCCEEEEEecCCCCCccccHHHHhhccC--------hHHHHHHHHHHHHHHHHHHHHCC
Confidence 975 433 33322 1 245799998853 5665533211 1223455679999999999 999
Q ss_pred cEecCCCCCCEEEecCccceecCCCCeEEEEeccCcccc
Q psy14267 386 IIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSL 424 (553)
Q Consensus 386 IiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGla~~~ 424 (553)
||||||||+|||++. .++|+|||+|...
T Consensus 192 ivHrDlkp~NILl~~-----------~~~liDFG~a~~~ 219 (258)
T 1zth_A 192 LVHADLSEYNIMYID-----------KVYFIDMGQAVTL 219 (258)
T ss_dssp EECSSCSTTSEEESS-----------SEEECCCTTCEET
T ss_pred EEeCCCCHHHEEEcC-----------cEEEEECcccccC
Confidence 999999999999954 3899999999654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.60 E-value=2.7e-15 Score=156.22 Aligned_cols=150 Identities=19% Similarity=0.221 Sum_probs=94.5
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcC---------------chhH----HHHHHHHHHHHHhhcC
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDIT---------------DQSI----ADSYLNEVELLAKLQG 317 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~---------------~~~~----~~~~~~E~~iL~~l~~ 317 (553)
-|.+++.||+|+||.||+|.+.. .+.||||+++..... .... .-...+|...|.++.+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~---G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~ 172 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEK---GKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYE 172 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTT---CCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEecCEeeeCCceEEEEEECCC---CCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHh
Confidence 49999999999999999997643 355999998643210 0000 0123467888888843
Q ss_pred CCceeEeeeEEEeCCCceEEEEEecCCC-CHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCE
Q psy14267 318 CPYVIKMHDYVYDTASKHLYVLMEKGDT-DLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANF 396 (553)
Q Consensus 318 hp~Iv~l~~~~~~~~~~~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NI 396 (553)
.++....-+... ..+++||+.+| .|..+ ..... ...++.||+.+|.|||..|||||||||.||
T Consensus 173 -~gv~vp~p~~~~----~~~LVME~i~G~~L~~l-------~~~~~----~~~l~~qll~~l~~lH~~gIVHrDLKp~NI 236 (397)
T 4gyi_A 173 -EGFPVPEPIAQS----RHTIVMSLVDALPMRQV-------SSVPD----PASLYADLIALILRLAKHGLIHGDFNEFNI 236 (397)
T ss_dssp -TTCSCCCEEEEE----TTEEEEECCSCEEGGGC-------CCCSC----HHHHHHHHHHHHHHHHHTTEECSCCSTTSE
T ss_pred -cCCCCCeeeecc----CceEEEEecCCccHhhh-------cccHH----HHHHHHHHHHHHHHHHHCCCcCCCCCHHHE
Confidence 443322222221 12689998765 33221 11111 123456999999999999999999999999
Q ss_pred EEecCccce-ecCCCCeEEEEeccCccccC
Q psy14267 397 LFVGNVLKI-IDCIGNVLKIIDFGIACSLQ 425 (553)
Q Consensus 397 Ll~~~~~~~-~~~~~~~vkL~DFGla~~~~ 425 (553)
||+.+.... .......+.|+||+.+....
T Consensus 237 Ll~~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 237 LIREEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp EEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred EEeCCCCcccccccccceEEEEeCCcccCC
Confidence 998763100 00001138999999876543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.04 E-value=6.6e-10 Score=109.29 Aligned_cols=137 Identities=19% Similarity=0.169 Sum_probs=97.8
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceE
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHL 336 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~ 336 (553)
.|++...+|.|+++.||++... + +.+++|+........ ...+.+|+.+|+.|..+..+.++++++.. ....
T Consensus 15 ~~~~~~~~~g~s~~~v~~~~~~--~--~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~--~~~~ 85 (263)
T 3tm0_A 15 KYRCVKDTEGMSPAKVYKLVGE--N--ENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERH--DGWS 85 (263)
T ss_dssp TSEEEECCSCCSSSEEEEEECS--S--CEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEE
T ss_pred cceeEeeccCCCCCeEEEEECC--C--CcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEec--CCce
Confidence 5889999999999999998543 2 459999986532111 13578999999999766778888776643 5678
Q ss_pred EEEEecCCC-CHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhh--------------------------------
Q psy14267 337 YVLMEKGDT-DLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHA-------------------------------- 383 (553)
Q Consensus 337 ~iv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~-------------------------------- 383 (553)
|++|++..| +|.+.+. . . . . ...++.+++.+|..||+
T Consensus 86 ~lv~e~i~G~~l~~~~~---~--~-~-~---~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (263)
T 3tm0_A 86 NLLMSEADGVLCSEEYE---D--E-Q-S---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC 155 (263)
T ss_dssp EEEEECCSSEEHHHHCC---T--T-T-C---HHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSG
T ss_pred EEEEEecCCeehhhccC---C--c-c-c---HHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccc
Confidence 899998655 5544311 0 0 0 1 11234588889999998
Q ss_pred ---------------------------CCcEecCCCCCCEEEecCccceecCCCCeEEEEeccCc
Q psy14267 384 ---------------------------AGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIA 421 (553)
Q Consensus 384 ---------------------------~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGla 421 (553)
..++|+|++|.|||++.+ ..+.|+||+.+
T Consensus 156 ~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~---------~~~~lIDwe~a 211 (263)
T 3tm0_A 156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDG---------KVSGFIDLGRS 211 (263)
T ss_dssp GGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETT---------EEEEECCCTTC
T ss_pred ccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECC---------cEEEEEEchhc
Confidence 458999999999999654 35679999876
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.90 E-value=3.2e-09 Score=103.56 Aligned_cols=133 Identities=17% Similarity=0.124 Sum_probs=86.0
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCc-eeEeeeEEEeCCCce
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPY-VIKMHDYVYDTASKH 335 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~-Iv~l~~~~~~~~~~~ 335 (553)
.|.+..+.+.|..+.||++... .+ +.+++|+..... ...+.+|+.+|+.+.++.. +.+++++.. ....
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~-~g--~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~--~~~~ 89 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQ-GR--PVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVT--EAGR 89 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECT-TS--CCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEE--CSSC
T ss_pred CCceEecccCCCCceEEEEecC-CC--CeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEecc--CCCC
Confidence 3555544456677999998542 22 348999875431 1356789999999977533 556766543 3456
Q ss_pred EEEEEecCCC-CHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCC-----------------------------
Q psy14267 336 LYVLMEKGDT-DLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAG----------------------------- 385 (553)
Q Consensus 336 ~~iv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~g----------------------------- 385 (553)
.+++|++..| .| . . .. .. . ..++.+++..|..||+..
T Consensus 90 ~~~v~e~i~G~~l-~-~---~~---~~--~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (264)
T 1nd4_A 90 DWLLLGEVPGQDL-L-S---SH---LA--P---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQD 156 (264)
T ss_dssp EEEEEECCSSEET-T-T---SC---CC--H---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTT
T ss_pred CEEEEEecCCccc-C-c---Cc---CC--H---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccch
Confidence 7899998655 33 2 1 00 00 0 122346666677777543
Q ss_pred -----------------------------cEecCCCCCCEEEecCccceecCCCCeEEEEeccCcc
Q psy14267 386 -----------------------------IIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIAC 422 (553)
Q Consensus 386 -----------------------------IiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGla~ 422 (553)
++|+|++|.|||++.+ ..+.|+|||.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~---------~~~~liD~~~a~ 213 (264)
T 1nd4_A 157 DLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENG---------RFSGFIDCGRLG 213 (264)
T ss_dssp SCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETT---------EEEEECCCTTCE
T ss_pred hhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECC---------cEEEEEcchhcc
Confidence 9999999999999765 346799999863
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.72 E-value=6.2e-09 Score=104.91 Aligned_cols=192 Identities=18% Similarity=0.236 Sum_probs=101.9
Q ss_pred eeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCc--eeEeeeEEEeCCCc---eE
Q psy14267 262 SLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPY--VIKMHDYVYDTASK---HL 336 (553)
Q Consensus 262 ~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~--Iv~l~~~~~~~~~~---~~ 336 (553)
+.++.|....||++. ..+++|+.... .....+.+|+.+|+.+..+.. +..++ ....... .-
T Consensus 26 ~~~~~G~~n~v~~v~-------~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~--~~~~~~~~~~~~ 91 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN-------RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVV--FTGMPSETYQMS 91 (304)
T ss_dssp CEEEECSSEEEEEST-------TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEE--EECCCCSSCSCS
T ss_pred EecCCCCcceEEEEC-------CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceE--eecCCCCCCCcc
Confidence 458999999999863 23899986422 334678999999999854333 33332 2222222 33
Q ss_pred EEEEecCCC-CHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhh--------------------------------
Q psy14267 337 YVLMEKGDT-DLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHA-------------------------------- 383 (553)
Q Consensus 337 ~iv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~-------------------------------- 383 (553)
|++|++..| .+...... ..+......++.+++..|..||+
T Consensus 92 ~~vm~~i~G~~l~~~~~~-------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (304)
T 3sg8_A 92 FAGFTKIKGVPLTPLLLN-------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRE 164 (304)
T ss_dssp CEEEECCCCEECCHHHHH-------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTT
T ss_pred eEEEcccCCeECCccccc-------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhccc
Confidence 778887554 23221110 00011111222233333333332
Q ss_pred --------------------------CCcEecCCCCCCEEEecCccceecCCCCeEEEEeccCccccCCCCCcccccCCc
Q psy14267 384 --------------------------AGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTAS 437 (553)
Q Consensus 384 --------------------------~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~ 437 (553)
..++|+|++|.||+++.+. +..+.|+||+.+........ .. ...
T Consensus 165 ~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~-------~~~~~~iD~~~~~~~~~~~D-l~--~~~ 234 (304)
T 3sg8_A 165 LKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEK-------NTICGIIDFGDAAISDPDND-FI--SLM 234 (304)
T ss_dssp SCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTT-------TEEEEECCCTTCEEECTTHH-HH--TTC
T ss_pred CCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCC-------CCEEEEEeCCCCccCChHHH-HH--HHH
Confidence 3489999999999998741 14678999999865432111 00 000
Q ss_pred cCCCccCcccccc--cCCCCCCC----ccCCCccchHHHHHHHHHHHHhCCCCC
Q psy14267 438 GTLNYMSPEAAGQ--TSSSGGGN----TYRITYKSDVWSLGCILYNMIYGRTPY 485 (553)
Q Consensus 438 Gt~~y~APE~l~~--~~~~~~~~----~~~~s~~sDIwSlGvvl~elltG~~Pf 485 (553)
....-..|+.... ..+ +... ..+.....+.|++|.++|.+.+|..+|
T Consensus 235 ~~~~~~~~~~~~~~l~~Y-~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 235 EDDEEYGMEFVSKILNHY-KHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CTTTSCCHHHHHHHHHHH-TCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred hhccccCHHHHHHHHHHc-CCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0000012221110 000 0000 001223468999999999999998876
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.69 E-value=4.7e-08 Score=100.74 Aligned_cols=144 Identities=17% Similarity=0.215 Sum_probs=90.7
Q ss_pred EEeeeeeeCceEEEEEeeeCCCccceEEEEEEe--cCCcCchhHHHHHHHHHHHHHhhcC-CCceeEeeeEEEeCCC-ce
Q psy14267 260 VLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVD--LSDITDQSIADSYLNEVELLAKLQG-CPYVIKMHDYVYDTAS-KH 335 (553)
Q Consensus 260 i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~--~~~~~~~~~~~~~~~E~~iL~~l~~-hp~Iv~l~~~~~~~~~-~~ 335 (553)
.++.|+.|.++.||++.... +.+++|+.. ..... .....+.+|+.+|+.|.. ...|.+++.++.+... ..
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~----~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~ 115 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG----QTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGR 115 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS----CEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSS
T ss_pred eEEEcCCcccceEEEEEECC----ceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCC
Confidence 46789999999999986532 348888765 32211 112467889999999975 2447777665533211 34
Q ss_pred EEEEEecCCCC-HHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhh-------------------------------
Q psy14267 336 LYVLMEKGDTD-LSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHA------------------------------- 383 (553)
Q Consensus 336 ~~iv~e~~~~~-L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~------------------------------- 383 (553)
.|++|++..|. +.+. .. ..........++.+++.+|..||.
T Consensus 116 ~~~vme~v~G~~l~~~-----~~--~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (359)
T 3dxp_A 116 AFYIMEFVSGRVLWDQ-----SL--PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKL 188 (359)
T ss_dssp CEEEEECCCCBCCCCT-----TC--TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHH
T ss_pred eEEEEEecCCeecCCC-----cc--ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHh
Confidence 68899986653 2110 00 011223334445688888888886
Q ss_pred ---------------------------CCcEecCCCCCCEEEecCccceecCCCCeEEEEeccCccc
Q psy14267 384 ---------------------------AGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACS 423 (553)
Q Consensus 384 ---------------------------~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGla~~ 423 (553)
..+||+|+++.|||++.+. ...+.|+||+.+..
T Consensus 189 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~-------~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 189 SETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTE-------PRVLAVLDWELSTL 248 (359)
T ss_dssp HCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSS-------SCEEEECCCTTCEE
T ss_pred cCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCC-------CcEEEEECcccccc
Confidence 4689999999999997652 13469999998864
|
| >1kbe_A Kinase suppressor of RAS; KSR, cysteine-rich domain, zinc- binding protein, signaling protein; NMR {Mus musculus} SCOP: g.49.1.1 PDB: 1kbf_A | Back alignment and structure |
|---|
Probab=98.30 E-value=9.1e-08 Score=68.58 Aligned_cols=32 Identities=13% Similarity=0.324 Sum_probs=30.0
Q ss_pred hhhHhhhhhhccccccccccccccCCCCCCCC-C
Q psy14267 105 AQSVEKIVLNNINYRVDQCKKNLNYDPSIKTP-C 137 (553)
Q Consensus 105 ~~~~~~~~~~~~g~rC~~Cg~kfh~~C~~~vp-c 137 (553)
-|++|+=+|| |||+|.+|+|++|++|..+|| |
T Consensus 16 ~C~~C~k~i~-~G~kC~~Ck~~cH~kC~~~vp~c 48 (49)
T 1kbe_A 16 VCNVCQKSMI-FGVKCKHCRLKCHNKCTKEAPAC 48 (49)
T ss_dssp CCSSSCCSSC-CEEEETTTTEEESSSCTTTSCCC
T ss_pred CccccCceeE-CcCCCCCCCCccchhhcCcCCCC
Confidence 3999999998 999999999999999999999 5
|
| >1faq_A RAF-1; transferase, serine/threonine-protein kinase, proto- oncogene, zinc, ATP-binding, phorbol-ester binding; NMR {Homo sapiens} SCOP: g.49.1.1 PDB: 1far_A | Back alignment and structure |
|---|
Probab=98.21 E-value=2.5e-07 Score=67.65 Aligned_cols=35 Identities=23% Similarity=0.360 Sum_probs=31.2
Q ss_pred hhhhHhhhhhhccccccccccccccCCCCCCCC--CCC
Q psy14267 104 HAQSVEKIVLNNINYRVDQCKKNLNYDPSIKTP--CKD 139 (553)
Q Consensus 104 ~~~~~~~~~~~~~g~rC~~Cg~kfh~~C~~~vp--c~d 139 (553)
.-|++|.-+|| |||+|+.|+|++|++|..+|| |..
T Consensus 15 t~C~~C~~~l~-qG~~C~~C~~~~H~~C~~~v~~~C~~ 51 (52)
T 1faq_A 15 AFCDICQKFLL-NGFRCQTCGYKFHEHCSTKVPTMCVD 51 (52)
T ss_dssp EECTTSSSEEC-SEEECTTTTCCBCSTTSSSSSSCCCC
T ss_pred cCCCCcccccc-cCCEeCCCCCeEChhHHhhCcCcCCC
Confidence 34788888898 999999999999999999999 765
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.97 E-value=0.00013 Score=73.37 Aligned_cols=72 Identities=22% Similarity=0.242 Sum_probs=48.2
Q ss_pred EeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCC-C-ceeEeeeEEEeCCCceEEE
Q psy14267 261 LSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGC-P-YVIKMHDYVYDTASKHLYV 338 (553)
Q Consensus 261 ~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~h-p-~Iv~l~~~~~~~~~~~~~i 338 (553)
++.++.|....||++ . +.+++|+-. .......+.+|+.+|+.|.++ + .|...+.+.. ......++
T Consensus 24 v~~l~~G~~n~v~~v----g---~~~VlR~~~-----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~-~~~g~~~~ 90 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----N---GDWVFRFPK-----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK-RSDGNPFV 90 (306)
T ss_dssp EEEEEECSSEEEEEE----T---TTEEEEEES-----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE-CTTSCEEE
T ss_pred eeecCCCcceeEEEE----C---CEEEEEecC-----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc-cCCCceEE
Confidence 346889999999987 1 238889842 123456789999999999764 2 2455554443 23455678
Q ss_pred EEecCCC
Q psy14267 339 LMEKGDT 345 (553)
Q Consensus 339 v~e~~~~ 345 (553)
+|++..|
T Consensus 91 v~e~i~G 97 (306)
T 3tdw_A 91 GYRKVQG 97 (306)
T ss_dssp EEECCCS
T ss_pred EEeccCC
Confidence 9987655
|
| >2fnf_X Putative RAS effector NORE1; zinc, signal transduction, apoptosis, cysteine rich domain; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=97.94 E-value=1.1e-06 Score=68.70 Aligned_cols=31 Identities=10% Similarity=-0.020 Sum_probs=29.5
Q ss_pred hhHhhhhhhccccccccccccccCCCCCCCC
Q psy14267 106 QSVEKIVLNNINYRVDQCKKNLNYDPSIKTP 136 (553)
Q Consensus 106 ~~~~~~~~~~~g~rC~~Cg~kfh~~C~~~vp 136 (553)
|+.|.-+|++|||+|..|||++|++|..+||
T Consensus 38 C~~C~~~l~~qG~kC~~C~~~cHkkC~~~V~ 68 (72)
T 2fnf_X 38 CDLCGREVLRQALRCANCKFTCHSECRSLIQ 68 (72)
T ss_dssp CTTTSSBCSSCCEECTTSSCEECTGGGGGCC
T ss_pred hhhhhHHHHhCcCccCCCCCeechhhhccCc
Confidence 8888888899999999999999999999998
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.84 E-value=0.00021 Score=69.81 Aligned_cols=72 Identities=18% Similarity=0.179 Sum_probs=47.4
Q ss_pred eeeeCce-EEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEEEEEec
Q psy14267 264 LGKGGSS-SVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEK 342 (553)
Q Consensus 264 LG~G~fG-~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~iv~e~ 342 (553)
+..|..| .||.......+ ..+.+|+-... ....+.+|..+|+.|..+--|.++++++.+ ...-+++|++
T Consensus 32 ~~~G~S~~~v~rl~~~~~~--~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~--~~~~~lvme~ 101 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNA--PELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRT--PDDAWLLTTA 101 (272)
T ss_dssp EECSSSSCEEEEEECCTTC--CCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEEEEEC
T ss_pred ccCCCcCCeEEEEEecCCC--eEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEE--CCeEEEEEEe
Confidence 4445554 68987654443 34899986432 245678899999999765446666665544 4567889997
Q ss_pred CCC
Q psy14267 343 GDT 345 (553)
Q Consensus 343 ~~~ 345 (553)
..|
T Consensus 102 l~G 104 (272)
T 4gkh_A 102 IPG 104 (272)
T ss_dssp CCS
T ss_pred eCC
Confidence 655
|
| >2enz_A NPKC-theta, protein kinase C theta type; zinc binding, DAG/PE-binding protein, diacylglycerol, phorbol ester, TCR, T-cell, structural genomics; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.84 E-value=2.6e-06 Score=65.25 Aligned_cols=32 Identities=16% Similarity=0.109 Sum_probs=29.6
Q ss_pred hhhHhhhhhh---ccccccccccccccCCCCCCCC
Q psy14267 105 AQSVEKIVLN---NINYRVDQCKKNLNYDPSIKTP 136 (553)
Q Consensus 105 ~~~~~~~~~~---~~g~rC~~Cg~kfh~~C~~~vp 136 (553)
-|++|.-+|| +|||+|..|+|++|++|..+||
T Consensus 25 ~C~~C~~~l~Gl~~qg~~C~~C~~~~Hk~C~~~v~ 59 (65)
T 2enz_A 25 FCEHCGTLLWGLARQGLKCDACGMNVHHRCQTKVA 59 (65)
T ss_dssp BCSSSCCBCCCSSSCSEEESSSCCEECTTTTTTSC
T ss_pred CchhcChhheecCCcccccCCCCCccCHhHHhhCc
Confidence 3889888887 7999999999999999999999
|
| >2eli_A Protein kinase C alpha type; PKC-alpha, PKC-A, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.78 E-value=3.6e-06 Score=68.12 Aligned_cols=43 Identities=21% Similarity=0.325 Sum_probs=34.7
Q ss_pred hhhHhhhhhh---ccccccccccccccCCCCCCCC--CC-Cccchhhhh
Q psy14267 105 AQSVEKIVLN---NINYRVDQCKKNLNYDPSIKTP--CK-DASQLSEDI 147 (553)
Q Consensus 105 ~~~~~~~~~~---~~g~rC~~Cg~kfh~~C~~~vp--c~-d~~~~~~~~ 147 (553)
-|++|.-+|| +|||+|..|+|++|++|..+|| |. ++.+.+.++
T Consensus 30 ~C~~C~~~l~Gl~kqG~~C~~C~~~~Hk~C~~~v~~~C~~~~~e~rg~~ 78 (85)
T 2eli_A 30 FCDHCGSLLYGLIHQGMKCDTCDMNVHKQCVINVPSLCGMDHTEKRGRI 78 (85)
T ss_dssp BCSSSCCBCCCSSSCEEECSSSCCEEETTTTTTSCSCCCCCCCCCCCCC
T ss_pred CCcccCccccccccCCCcCCCcCCccCHhHHhhcCCcCCcchhhCccCE
Confidence 3889888888 7999999999999999999999 54 334444544
|
| >1rfh_A RAS association (ralgds/AF-6) domain family 5; zinc, signal transduction, apoptosis, cysteine rich domain, metal binding protein; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=97.78 E-value=1.6e-06 Score=64.99 Aligned_cols=31 Identities=10% Similarity=-0.020 Sum_probs=28.9
Q ss_pred hhHhhhhhhccccccccccccccCCCCCCCC
Q psy14267 106 QSVEKIVLNNINYRVDQCKKNLNYDPSIKTP 136 (553)
Q Consensus 106 ~~~~~~~~~~~g~rC~~Cg~kfh~~C~~~vp 136 (553)
|+.|.-+|++|||+|++|||++|++|..+||
T Consensus 25 C~~C~~~i~kqg~kC~~C~~~cH~kC~~~v~ 55 (59)
T 1rfh_A 25 CDLCGREVLRQALRCANCKFTCHSECRSLIQ 55 (59)
T ss_dssp CTTTCSEECSCCEECTTTSCEECHHHHTTCC
T ss_pred chhcchhhhhCccEeCCCCCeEehhhhhhCc
Confidence 7888777799999999999999999999998
|
| >1ptq_A Protein kinase C delta type; phosphotransferase; 1.95A {Mus musculus} SCOP: g.49.1.1 PDB: 1ptr_A* | Back alignment and structure |
|---|
Probab=97.76 E-value=1.7e-06 Score=62.51 Aligned_cols=31 Identities=13% Similarity=0.105 Sum_probs=28.3
Q ss_pred hhHhhhhhh---ccccccccccccccCCCCCCCC
Q psy14267 106 QSVEKIVLN---NINYRVDQCKKNLNYDPSIKTP 136 (553)
Q Consensus 106 ~~~~~~~~~---~~g~rC~~Cg~kfh~~C~~~vp 136 (553)
|++|.-+|| +|||+|+.|+|++|++|..+||
T Consensus 14 C~~C~~~l~g~~~qg~~C~~C~~~~H~~C~~~v~ 47 (50)
T 1ptq_A 14 CDHCGSLLWGLVKQGLKCEDCGMNVHHKCREKVA 47 (50)
T ss_dssp CTTTCCBCCSSSSCEEEETTTCCEECHHHHTTSC
T ss_pred cCCCCceeeccCCccCEeCCCCCeECHHHhhhcC
Confidence 788877776 7999999999999999999998
|
| >2enn_A NPKC-theta, protein kinase C theta type; zinc binding, DAG/PE-binding protein, diacylglycerol, phorbol ester, TCR, T-cell, structural genomics; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.72 E-value=3.8e-06 Score=66.59 Aligned_cols=35 Identities=20% Similarity=0.218 Sum_probs=31.5
Q ss_pred hhhHhhhhhh---ccccccccccccccCCCCCCCC--CCC
Q psy14267 105 AQSVEKIVLN---NINYRVDQCKKNLNYDPSIKTP--CKD 139 (553)
Q Consensus 105 ~~~~~~~~~~---~~g~rC~~Cg~kfh~~C~~~vp--c~d 139 (553)
-|++|.-+|| +|||+|+.|+|++|++|..+|| |..
T Consensus 36 ~C~~C~~~lwGl~kqG~~C~~C~~~~Hk~C~~~v~~~C~~ 75 (77)
T 2enn_A 36 FCSVCHEFVWGLNKQGYQCRQCNAAIHKKCIDKVIAKCTG 75 (77)
T ss_dssp ECSSSCCEECCTTCCEEECSSSCCEEESGGGSSCCSCCCC
T ss_pred CccccChhhccccccccCcCCCCCcCCHhHHhhCcCCCCC
Confidence 4899988887 7999999999999999999998 754
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.67 E-value=0.00023 Score=73.95 Aligned_cols=80 Identities=18% Similarity=0.135 Sum_probs=47.0
Q ss_pred EEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCc-Cc---hhHHHHHHHHHHHHHhhcCC-C-ceeEeeeEEEeCCC
Q psy14267 260 VLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDI-TD---QSIADSYLNEVELLAKLQGC-P-YVIKMHDYVYDTAS 333 (553)
Q Consensus 260 i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~-~~---~~~~~~~~~E~~iL~~l~~h-p-~Iv~l~~~~~~~~~ 333 (553)
..+.||.|.++.||++.....+ +.|+||....... .. ....+++..|.++|+.+... + .+..++. .+..
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~--~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~--~d~~- 108 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHD--RALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTE- 108 (397)
T ss_dssp EEEECCSSSSEEEEEEEC------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETT-
T ss_pred EEEECCCCceEEEEEEEECCCC--cEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEE--EcCC-
Confidence 3568999999999998654333 3489998653211 00 01234677899999988653 2 3444533 3332
Q ss_pred ceEEEEEecCCC
Q psy14267 334 KHLYVLMEKGDT 345 (553)
Q Consensus 334 ~~~~iv~e~~~~ 345 (553)
..+++||+..+
T Consensus 109 -~~~lvmE~l~g 119 (397)
T 2olc_A 109 -MAVTVMEDLSH 119 (397)
T ss_dssp -TTEEEECCCTT
T ss_pred -ccEEEEEeCCC
Confidence 34688887654
|
| >2yuu_A NPKC-delta, protein kinase C delta type; metal binding protein, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.65 E-value=5.9e-06 Score=66.52 Aligned_cols=37 Identities=22% Similarity=0.241 Sum_probs=32.4
Q ss_pred hhhHhhhhhh---ccccccccccccccCCCCCCCC--CCCcc
Q psy14267 105 AQSVEKIVLN---NINYRVDQCKKNLNYDPSIKTP--CKDAS 141 (553)
Q Consensus 105 ~~~~~~~~~~---~~g~rC~~Cg~kfh~~C~~~vp--c~d~~ 141 (553)
-|++|.-+|| +|||+|..|+|++|++|..+|| |....
T Consensus 30 ~C~~C~~~lwGl~kqg~~C~~C~~~~Hk~C~~~v~~~C~~~~ 71 (83)
T 2yuu_A 30 FCSVCKDFVWGLNKQGYKCRQCNAAIHKKCIDKIIGRCTGTA 71 (83)
T ss_dssp CCSSSCCCCCSSSCCEEEETTTCCEECTTGGGTCCSCCSSCC
T ss_pred ChhhcChhhccccccccccCCcCCeeChhhhhhCCCcCCCcc
Confidence 4889988887 7999999999999999999998 77643
|
| >1y8f_A UNC-13 homolog A, MUNC13-1; cysteine-rich domain, C1-domain, zinc-binding domain, endocytosis/exocytosis,signaling protein complex; NMR {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=97.61 E-value=3.6e-06 Score=64.63 Aligned_cols=32 Identities=9% Similarity=-0.117 Sum_probs=29.6
Q ss_pred hhhHhhhhhh---ccccccccccccccCCCCCCCC
Q psy14267 105 AQSVEKIVLN---NINYRVDQCKKNLNYDPSIKTP 136 (553)
Q Consensus 105 ~~~~~~~~~~---~~g~rC~~Cg~kfh~~C~~~vp 136 (553)
-|++|.-+|| +|||+|..|+|++|++|..+||
T Consensus 26 ~C~~C~~~l~Gl~~qg~~C~~C~~~~Hk~C~~~v~ 60 (66)
T 1y8f_A 26 YCYECEGLLWGIARQGMRCTECGVKCHEKCQDLLN 60 (66)
T ss_dssp CCTTTCCCCCSSCCEEEEETTTCCEECTTHHHHSC
T ss_pred ChhhcChhhcccCcceeEcCCCCCeeCHHHHhhCc
Confidence 4889988888 6999999999999999999998
|
| >3uej_A NPKC-delta, protein kinase C delta type; proteine kinase cdelta, phosphotransferase, anesthetic bindi metal binding protein; 1.30A {Mus musculus} PDB: 3ugi_A 3ugl_A 3uey_A 3ugd_A 3uff_A 1ptq_A 1ptr_A* | Back alignment and structure |
|---|
Probab=97.56 E-value=4.5e-06 Score=63.92 Aligned_cols=35 Identities=14% Similarity=0.150 Sum_probs=30.4
Q ss_pred hhhHhhhhhh---ccccccccccccccCCCCCCCC--CCC
Q psy14267 105 AQSVEKIVLN---NINYRVDQCKKNLNYDPSIKTP--CKD 139 (553)
Q Consensus 105 ~~~~~~~~~~---~~g~rC~~Cg~kfh~~C~~~vp--c~d 139 (553)
-|++|.-+|| +|||+|..|+|++|++|..+|| |..
T Consensus 22 ~C~~C~~~l~Gl~~qg~~C~~C~~~~Hk~C~~~v~~~C~~ 61 (65)
T 3uej_A 22 FCDHCGSLLWGLVKQGLKCEDCGMNVHHKCREKVANLCEF 61 (65)
T ss_dssp BCTTTCCBCCSSSSCEEEETTTCCEECHHHHTTSCSEEEE
T ss_pred cccccChhhhccCceeeECCCCCCeEchhHhhhCCCcCCC
Confidence 4788877776 7999999999999999999999 654
|
| >2db6_A SH3 and cysteine rich domain 3; STAC3, C1 domain, cystein-rich domain, zinc-binding domain, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.54 E-value=7.9e-06 Score=64.23 Aligned_cols=32 Identities=16% Similarity=0.176 Sum_probs=29.1
Q ss_pred hhhHhhhhhh---ccccccccccccccCCCCCCCC
Q psy14267 105 AQSVEKIVLN---NINYRVDQCKKNLNYDPSIKTP 136 (553)
Q Consensus 105 ~~~~~~~~~~---~~g~rC~~Cg~kfh~~C~~~vp 136 (553)
-|++|.-+|| +|||+|..|+|++|++|..+||
T Consensus 30 ~C~~C~~~lwGl~kqG~~C~~C~~~~Hk~C~~~v~ 64 (74)
T 2db6_A 30 FCDVCARMIVLNNKFGLRCKNCKTNIHEHCQSYVE 64 (74)
T ss_dssp ECSSSCCEECHHHHEEEEESSSCCEECTTTTGGGS
T ss_pred CchhcChhhccccCCccccCCCCCccChhHHhhCC
Confidence 4888888877 6999999999999999999998
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.53 E-value=0.00049 Score=69.34 Aligned_cols=30 Identities=23% Similarity=0.360 Sum_probs=25.4
Q ss_pred CCcEecCCCCCCEEEecCccceecCCCCeEEEEeccCcc
Q psy14267 384 AGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIAC 422 (553)
Q Consensus 384 ~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGla~ 422 (553)
..++|+|+++.|||++.+ +.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~---------~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGEN---------EQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGG---------GCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCC---------CcEEEEehhhcc
Confidence 679999999999999654 358999999764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.21 E-value=0.00086 Score=68.38 Aligned_cols=85 Identities=13% Similarity=0.050 Sum_probs=49.3
Q ss_pred eEEEeee-eeeCceEEEEEeeeC--CC--ccceEEEEEEecCC---cCchhHHHHHHHHHHHHHhhcCC--CceeEeeeE
Q psy14267 258 YQVLSLL-GKGGSSSVYLVGGTS--EH--EFKPLALKVVDLSD---ITDQSIADSYLNEVELLAKLQGC--PYVIKMHDY 327 (553)
Q Consensus 258 y~i~~~L-G~G~fG~Vy~a~~~~--~~--~~~~vAvK~l~~~~---~~~~~~~~~~~~E~~iL~~l~~h--p~Iv~l~~~ 327 (553)
....+.| +.|....+|++.... .+ ..+.+++|+..... ... ...+.+|+.+|+.|..+ ..|.+++.+
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~---~~~~~~E~~~l~~L~~~~~vpvP~v~~~ 98 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP---TYRLDHQFEVIRLVGELTDVPVPRVRWI 98 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS---CCCHHHHHHHHHHHHHHCCSCCCCEEEE
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc---hhHHHHHHHHHHHHhhcCCCCCCcEEEE
Confidence 3445678 889999999886431 00 12448888764322 101 13467899998888654 345666554
Q ss_pred EEeCC-CceEEEEEecCCC
Q psy14267 328 VYDTA-SKHLYVLMEKGDT 345 (553)
Q Consensus 328 ~~~~~-~~~~~iv~e~~~~ 345 (553)
..+.. ....+++|++..|
T Consensus 99 ~~~~~~~g~~~~v~e~l~G 117 (357)
T 3ats_A 99 ETTGDVLGTPFFLMDYVEG 117 (357)
T ss_dssp ECSSTTTSSCEEEEECCCC
T ss_pred ccCCCccCCceEEEEecCC
Confidence 42221 1345678886543
|
| >4b6d_A RAC GTPase-activating protein 1; signaling protein, cytokinesis, plasma membrane, phospholipi centralspindlin, spindle midzone, central spindle; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.18 E-value=4.6e-05 Score=57.24 Aligned_cols=35 Identities=11% Similarity=0.273 Sum_probs=29.9
Q ss_pred hhhHh--hhhhhccccccccccccccCCCCCCCC--CCC
Q psy14267 105 AQSVE--KIVLNNINYRVDQCKKNLNYDPSIKTP--CKD 139 (553)
Q Consensus 105 ~~~~~--~~~~~~~g~rC~~Cg~kfh~~C~~~vp--c~d 139 (553)
-|++| +|-+++|||||.+|++..|+.|..+|| |+.
T Consensus 21 ~C~~Cg~~i~~gkq~~kC~dC~~~cH~~C~~~~~~~C~p 59 (61)
T 4b6d_A 21 SCVPCGKRIKFGKLSLKCRDCRVVSHPECRDRCPLPCIP 59 (61)
T ss_dssp ECTTTCCEECTTCEEEEESSSSCEECGGGGGGSCSSCCC
T ss_pred ccccccCEEEEeeEeeECCCCCCeEchhHhhcCCCCCCC
Confidence 46776 555789999999999999999999998 765
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=96.71 E-value=0.0061 Score=63.74 Aligned_cols=81 Identities=16% Similarity=0.239 Sum_probs=47.3
Q ss_pred hhCCcEecCCCCCCEEEecCccceecCCCCeEEEEeccCccccCCCCCcccccCCcc--CCCccCcccccccCCCCCCCc
Q psy14267 382 HAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASG--TLNYMSPEAAGQTSSSGGGNT 459 (553)
Q Consensus 382 H~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~G--t~~y~APE~l~~~~~~~~~~~ 459 (553)
+...++|+|+++.|||++.+ + ++|+||+.+..-...-. . ....+ ...|++|+........
T Consensus 230 ~~~~liHGDl~~~Nil~~~~---------~-~~lID~e~a~~G~p~~D-l--a~~l~~~~~~~~~~~~~~~~~~~----- 291 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQD---------S-TQVIDPEFSFYGPMGFD-I--GAYLGNLILAFFAQDGHATQEND----- 291 (420)
T ss_dssp BCCEEECSCCSGGGEEECSS---------C-EEECCCTTCEEECHHHH-H--HHHHHHHHHHHHHGGGGCCSSCC-----
T ss_pred CCCeEEecCCCCCcEEEeCC---------C-CEEEeCcccccCchHHH-H--HHHHHHHHHHHHhcccccccccc-----
Confidence 46789999999999999765 3 89999998865332110 0 00000 1345666554311000
Q ss_pred cCCCccchHHHHHHHHHHHHhC
Q psy14267 460 YRITYKSDVWSLGCILYNMIYG 481 (553)
Q Consensus 460 ~~~s~~sDIwSlGvvl~elltG 481 (553)
+-....++..+...+|+.+.+
T Consensus 292 -~~~~~~~~~~~~~~~~~~y~~ 312 (420)
T 2pyw_A 292 -RKEYKQWILRTIEQTWNLFNK 312 (420)
T ss_dssp -SHHHHHHHHHHHHHHHHHHHH
T ss_pred -hHHHHHHHHHHHHHHHHHHHH
Confidence 112345566778888877754
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.67 E-value=0.008 Score=60.06 Aligned_cols=78 Identities=14% Similarity=0.058 Sum_probs=41.0
Q ss_pred EEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCC-ceeEeeeEE----EeCCC
Q psy14267 259 QVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCP-YVIKMHDYV----YDTAS 333 (553)
Q Consensus 259 ~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp-~Iv~l~~~~----~~~~~ 333 (553)
.-++.|+.|....+|++..... .+++|+..... . ...+..|+.+++.|..+. .+..++... .....
T Consensus 25 ~~~~~i~~G~~n~~~~v~~~~g----~~vlk~~~~~~-~----~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~ 95 (322)
T 2ppq_A 25 TSYKGIAEGVENSNFLLHTTKD----PLILTLYEKRV-E----KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELS 95 (322)
T ss_dssp EEEEEECC---EEEEEEEESSC----CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEET
T ss_pred eEeeccCCCcccceEEEEeCCc----cEEEEEeCCCC-C----HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEEC
Confidence 3456788898999999864322 38999886531 1 134557888888775431 133332110 00012
Q ss_pred ceEEEEEecCCC
Q psy14267 334 KHLYVLMEKGDT 345 (553)
Q Consensus 334 ~~~~iv~e~~~~ 345 (553)
...+++|++..|
T Consensus 96 g~~~~l~~~l~G 107 (322)
T 2ppq_A 96 GRPAALISFLEG 107 (322)
T ss_dssp TEEEEEEECCCC
T ss_pred CEEEEEEEeCCC
Confidence 345778886544
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.54 E-value=0.048 Score=53.57 Aligned_cols=58 Identities=17% Similarity=0.125 Sum_probs=41.3
Q ss_pred cCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcC
Q psy14267 254 NGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG 317 (553)
Q Consensus 254 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~ 317 (553)
.+.+..-++.+|.|..+.||+++..+. +.|.+|+-....... ...+..|+..|+.|..
T Consensus 13 ~G~~v~~v~~~g~G~~~~vyrv~l~DG---~~~~vK~~~~~~~~~---~~~~~~Ea~~L~~L~~ 70 (288)
T 3f7w_A 13 TGREVAAVAERGHSHRWHLYRVELADG---TPLFVKALPDDAPAL---DGLFRAEALGLDWLGR 70 (288)
T ss_dssp HCCCEEEEEEEEEETTEEEEEEEETTS---CEEEEEECCTTCCCC---TTHHHHHHHHHHHHTC
T ss_pred cCCCeEEEEecCCCCCeEEEEEEECCC---CEEEEEEeCCCCcch---hhHHHHHHHHHHHHHh
Confidence 455677788999999999999865432 448999765433222 2346789999998854
|
| >2row_A RHO-associated protein kinase 2; ATP-binding, coiled coil, cytoplasm, membrane, metal-binding, nucleotide-binding, phorbol-ester binding; NMR {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=96.53 E-value=0.00012 Score=58.42 Aligned_cols=34 Identities=15% Similarity=0.088 Sum_probs=29.4
Q ss_pred hhhHhhhhhh---cc--ccccccccccccCCCCC---CCC--CC
Q psy14267 105 AQSVEKIVLN---NI--NYRVDQCKKNLNYDPSI---KTP--CK 138 (553)
Q Consensus 105 ~~~~~~~~~~---~~--g~rC~~Cg~kfh~~C~~---~vp--c~ 138 (553)
-|+.|.-+|| +| ||+|+.|+|++|++|.. +|+ |.
T Consensus 37 ~Cd~C~~~lWGl~kqp~G~~C~~C~~~~HkrC~~k~~~v~~~C~ 80 (84)
T 2row_A 37 NCEACMKPLWHMFKPPPALECRRCHIKCHKDHMDKKEEIIAPCK 80 (84)
T ss_dssp ECSSSSSEECCSSSCCCEEEESSSCCEEEHHHHHHTCTTCCCCS
T ss_pred chhhcCHhhhccccCCCCCEecCCCCccchhHhCCccccccccC
Confidence 3889988888 56 99999999999999988 577 64
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=96.51 E-value=0.00041 Score=77.55 Aligned_cols=36 Identities=11% Similarity=0.042 Sum_probs=0.0
Q ss_pred hhhHhhhhhh---ccccccccccccccCCCCCCCC--CCCc
Q psy14267 105 AQSVEKIVLN---NINYRVDQCKKNLNYDPSIKTP--CKDA 140 (553)
Q Consensus 105 ~~~~~~~~~~---~~g~rC~~Cg~kfh~~C~~~vp--c~d~ 140 (553)
-|++|.-+|| +|||+|+.|||++|++|..+|+ |...
T Consensus 50 ~C~~C~~~i~g~~~qg~~C~~C~~~~H~~C~~~v~~~c~~~ 90 (674)
T 3pfq_A 50 FCSHCTDFIWGFGKQGFQCQVCSFVVHKRCHEFVTFSCPGA 90 (674)
T ss_dssp -----------------------------------------
T ss_pred ccccccccccccCCceeECCCCCCCcChhhcCcCcccCCCc
Confidence 4999998887 7999999999999999999999 7553
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.37 E-value=0.0089 Score=59.37 Aligned_cols=67 Identities=12% Similarity=-0.050 Sum_probs=38.9
Q ss_pred EeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEEEEE
Q psy14267 261 LSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLM 340 (553)
Q Consensus 261 ~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~iv~ 340 (553)
++.|+.|....+|++ +.+++|+...... .. ....+|+.+++.+..+....+++. .+... -++++
T Consensus 23 i~~l~gG~tN~~~~~--------~~~vlR~~~~~~~---~~-~~r~~E~~~l~~l~~~g~~P~~~~--~~~~~--~~~v~ 86 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA--------GDLCLRIPGKGTE---EY-INRANEAVAAREAAKAGVSPEVLH--VDPAT--GVMVT 86 (301)
T ss_dssp CEEEESCSSEEEEEE--------TTEEEEEECC-------C-CCHHHHHHHHHHHHHTTSSCCEEE--ECTTT--CCEEE
T ss_pred eeEcCCcccccccee--------eeEEEECCCCCcc---ce-eCHHHHHHHHHHHHHcCCCCceEE--EECCC--CEEEE
Confidence 567999999999988 2389998764311 11 112468888887765333344433 22222 24566
Q ss_pred ecC
Q psy14267 341 EKG 343 (553)
Q Consensus 341 e~~ 343 (553)
++.
T Consensus 87 e~i 89 (301)
T 3dxq_A 87 RYI 89 (301)
T ss_dssp ECC
T ss_pred eec
Confidence 665
|
| >2vrw_B P95VAV, VAV1, proto-oncogene VAV; lipoprotein, GTP-binding, metal-binding, phosphoprotein, exchange factor, RAC, GTPase, membrane domain; 1.85A {Mus musculus} PDB: 3bji_A 1f5x_A | Back alignment and structure |
|---|
Probab=96.35 E-value=0.00047 Score=72.14 Aligned_cols=35 Identities=17% Similarity=0.368 Sum_probs=30.2
Q ss_pred hhhHhhhhhh---ccccccccccccccCCCCCCCC-CCC
Q psy14267 105 AQSVEKIVLN---NINYRVDQCKKNLNYDPSIKTP-CKD 139 (553)
Q Consensus 105 ~~~~~~~~~~---~~g~rC~~Cg~kfh~~C~~~vp-c~d 139 (553)
-|++|+-+|| +||++|..||+.||..|+.+|| |..
T Consensus 359 ~C~~C~~~~~g~~~qg~~C~~C~~~~h~~C~~~~~~C~~ 397 (406)
T 2vrw_B 359 SCKACQMLLRGTFYQGYRCYRCRAPAHKECLGRVPPCGR 397 (406)
T ss_dssp BCTTTCCBCCSSSSCEEEETTTCCEECGGGGGGSCCC--
T ss_pred CCccccchhceeCCCCCCCCCCcCccchhhhhhCCCCCC
Confidence 5889988775 8999999999999999999999 643
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.23 E-value=0.048 Score=51.63 Aligned_cols=98 Identities=13% Similarity=0.091 Sum_probs=58.7
Q ss_pred CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHh-hCCcEecCCCCCCEEEecCccceecCCCCeEEEEeccCccc
Q psy14267 345 TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIH-AAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACS 423 (553)
Q Consensus 345 ~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH-~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGla~~ 423 (553)
.+|.+.|+..+. ++.+.++|.+++|.+.+|.-+- ...-..+=+-|..|+|..+ |.|.+.+ +.+.
T Consensus 33 vSL~eIL~~~~~----PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~d---------G~V~f~~-~~s~- 97 (229)
T 2yle_A 33 LSLEEILRLYNQ----PINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRD---------GAVTLAP-AADD- 97 (229)
T ss_dssp EEHHHHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETT---------SCEEECC-C----
T ss_pred ccHHHHHHHcCC----CcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecC---------Cceeccc-cccc-
Confidence 478999887654 6677888888889988876652 1111233344678888666 5555543 1110
Q ss_pred cCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh
Q psy14267 424 LQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY 480 (553)
Q Consensus 424 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt 480 (553)
.....+.|||.... ..+.+.=|||||+++|..+-
T Consensus 98 -------------~~~~~~~~pe~~~~----------~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 -------------AGEPPPVAGKLGYS----------QCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ----------------------CCSSS----------SSCHHHHHHHHHHHHHHHHT
T ss_pred -------------ccccCCCChhhccc----------cchHHHHHHHHHHHHHHHhh
Confidence 11234668887631 14678899999999999884
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.03 E-value=0.033 Score=55.61 Aligned_cols=75 Identities=15% Similarity=0.111 Sum_probs=42.9
Q ss_pred eeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCC-ceeEeeeE---EEeCCCceEEE
Q psy14267 263 LLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCP-YVIKMHDY---VYDTASKHLYV 338 (553)
Q Consensus 263 ~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp-~Iv~l~~~---~~~~~~~~~~i 338 (553)
.|+ |....||++.... .+.+++|+....... ...+..|..+++.|..+. .+..++.. .........++
T Consensus 33 ~l~-g~~n~~y~v~~~~---g~~~vlK~~~~~~~~----~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~ 104 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDED---RRRFVVKFYRPERWT----ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFA 104 (328)
T ss_dssp EEC-CSSSEEEEECCTT---CCCEEEEEECTTTSC----HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEE
T ss_pred eec-CcccceEEEEcCC---CCEEEEEEcCCCCCC----HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEE
Confidence 456 8888999874422 234899998643222 245667888888886431 24444332 00001335577
Q ss_pred EEecCCC
Q psy14267 339 LMEKGDT 345 (553)
Q Consensus 339 v~e~~~~ 345 (553)
+|++.+|
T Consensus 105 l~~~i~G 111 (328)
T 1zyl_A 105 VFPSVGG 111 (328)
T ss_dssp EEECCCC
T ss_pred EEEecCC
Confidence 8887554
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=95.99 E-value=0.087 Score=52.82 Aligned_cols=74 Identities=18% Similarity=0.188 Sum_probs=52.1
Q ss_pred EEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCC--CceeEeeeEEEeCCCceEE
Q psy14267 260 VLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGC--PYVIKMHDYVYDTASKHLY 337 (553)
Q Consensus 260 i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~h--p~Iv~l~~~~~~~~~~~~~ 337 (553)
-.+.|+.|....+|++... + +.++||+.... ....+..|+..|+.|... ..|.+++.+.. .....+
T Consensus 40 ~~~~l~gG~~n~~y~v~~~--~--~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~--~~g~~~ 107 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLINDE--V--QTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGN--SQGHSF 107 (312)
T ss_dssp EEEEECCSSSSEEEEEESS--S--CEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEE--CSSEEE
T ss_pred eeEEeCCccceeeeEEEEC--C--CeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEee--cCCceE
Confidence 4567999999999998642 2 34889987532 246688999999988643 55677766543 345678
Q ss_pred EEEecCCC
Q psy14267 338 VLMEKGDT 345 (553)
Q Consensus 338 iv~e~~~~ 345 (553)
++|++..+
T Consensus 108 lvme~l~G 115 (312)
T 3jr1_A 108 LLLEALNK 115 (312)
T ss_dssp EEEECCCC
T ss_pred EEEEeccC
Confidence 99987554
|
| >3ky9_A Proto-oncogene VAV; calponin homology domain, DBL homology domain, pleckst homology domain, C1 domain, guanine-nucleotide releasing FA metal-binding; 2.73A {Homo sapiens} PDB: 2d86_A | Back alignment and structure |
|---|
Probab=95.78 E-value=0.0014 Score=71.94 Aligned_cols=37 Identities=16% Similarity=0.359 Sum_probs=29.8
Q ss_pred hhhHhhhhh---hccccccccccccccCCCCCCCC-CCCcc
Q psy14267 105 AQSVEKIVL---NNINYRVDQCKKNLNYDPSIKTP-CKDAS 141 (553)
Q Consensus 105 ~~~~~~~~~---~~~g~rC~~Cg~kfh~~C~~~vp-c~d~~ 141 (553)
-|++|+-.| .+|||+|..||+++|+.|..+|| |...+
T Consensus 531 ~C~~C~~~l~gl~~qg~~C~~C~~~vHk~C~~~v~~C~~~~ 571 (587)
T 3ky9_A 531 SCKACQMLLRGTFYQGYRCHRCRASAHKECLGRVPPCGRHG 571 (587)
T ss_dssp BCTTTCSBCCSSSCCEEEETTTCCEECSGGGGGSCCC----
T ss_pred ccccccccccccccCCcCCCCCCCccchhhhhcCCCCCCCC
Confidence 588888776 57999999999999999999999 76643
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=95.35 E-value=0.0017 Score=69.08 Aligned_cols=36 Identities=19% Similarity=0.221 Sum_probs=31.5
Q ss_pred hhhhHhhhhhh---ccccccccccccccCCCCCCCC--CCC
Q psy14267 104 HAQSVEKIVLN---NINYRVDQCKKNLNYDPSIKTP--CKD 139 (553)
Q Consensus 104 ~~~~~~~~~~~---~~g~rC~~Cg~kfh~~C~~~vp--c~d 139 (553)
.-|+.|.-+|| +||++|..||+.+|++|..++| |.-
T Consensus 221 t~C~~C~~~l~g~~~qg~~C~~C~~~~Hk~C~~~vp~~C~~ 261 (463)
T 3cxl_A 221 HWCEYCANFMWGLIAQGVKCADCGLNVHKQCSKMVPNDCKP 261 (463)
T ss_dssp CBCTTTCCBCCSSSCCEEEETTTCCEECHHHHTTSCSBCCG
T ss_pred CcchhhhhhhhhHHhcCeeccccCccccccccccccccccc
Confidence 45889988777 7999999999999999999998 654
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=95.07 E-value=0.062 Score=55.44 Aligned_cols=146 Identities=14% Similarity=0.139 Sum_probs=74.0
Q ss_pred eeeeeeCceEEEEEeeeC-----CCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceE
Q psy14267 262 SLLGKGGSSSVYLVGGTS-----EHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHL 336 (553)
Q Consensus 262 ~~LG~G~fG~Vy~a~~~~-----~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~ 336 (553)
+.|..|-...+|++.... ....+.|++|+.... . .......+|.++++.|..+....++++++ .. .
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~--~--~~~~~~~rE~~vl~~L~~~gv~P~ll~~~--~~-g-- 126 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI--L--QGVDSLVLESVMFAILAERSLGPQLYGVF--PE-G-- 126 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEE--TT-E--
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc--c--chHHHHHHHHHHHHHHHhcCCCCeEEEEc--CC-c--
Confidence 467778889999886532 112345888885321 1 11345568999999887654455565433 32 2
Q ss_pred EEEEecCCCC---------------HHHHHHHcccC----CCCch-HHHHHHHHHHHHH-------------------HH
Q psy14267 337 YVLMEKGDTD---------------LSKYMRNLNKM----TTLPN-TMIIIIMHWYEML-------------------LA 377 (553)
Q Consensus 337 ~iv~e~~~~~---------------L~~~l~~~~~~----~~~~~-~~~~i~~~~~qil-------------------~a 377 (553)
++|++..|. +...+.+.... ...+. .+..+..++.++. ..
T Consensus 127 -~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~ 205 (379)
T 3feg_A 127 -RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDE 205 (379)
T ss_dssp -EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHH
T ss_pred -cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHH
Confidence 666764431 11222222111 11111 2233333322221 12
Q ss_pred HHHHh----h----CCcEecCCCCCCEEEecCccceecCCCCeEEEEeccCcc
Q psy14267 378 VKEIH----A----AGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIAC 422 (553)
Q Consensus 378 L~yLH----~----~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGla~ 422 (553)
++.|. . ..++|+|+.+.|||++.+. ...+.+.|+||..|.
T Consensus 206 ~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~-----~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 206 MGNLRKLLESTPSPVVFCHNDIQEGNILLLSEP-----ENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC--------CCEEECCCTTCE
T ss_pred HHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCC-----CccCcEEEEecccCC
Confidence 23332 2 2589999999999997651 112468999999874
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=94.77 E-value=0.22 Score=52.16 Aligned_cols=63 Identities=16% Similarity=0.114 Sum_probs=40.0
Q ss_pred EEeeeeeeCceEEEEEeeeCC-----CccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeE
Q psy14267 260 VLSLLGKGGSSSVYLVGGTSE-----HEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDY 327 (553)
Q Consensus 260 i~~~LG~G~fG~Vy~a~~~~~-----~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~ 327 (553)
-++.|+.|-...||++..... ...+.+++|+..... . ...+.+|..+++.|..+....++++.
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~---~~~li~E~~~l~~L~~~g~~P~l~~~ 144 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--T---ESHLVAESVIFTLLSERHLGPKLYGI 144 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--C---HHHHHHHHHHHHHHHHTTSSSCEEEE
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--c---HHHHHHHHHHHHHHHhCCCCCcEEEE
Confidence 356788899999999865421 112458999874321 1 13455799999988765444556543
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=93.66 E-value=0.53 Score=49.69 Aligned_cols=63 Identities=11% Similarity=0.092 Sum_probs=37.8
Q ss_pred EEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEE
Q psy14267 260 VLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYV 328 (553)
Q Consensus 260 i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~ 328 (553)
-++.|+.|-...+|++..... .+.+++|+..... . ..++ ..+|..+|+.|..+....++++++
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~--~~~~vLRi~g~~~-~--~~id-R~~E~~vl~~L~~~gl~P~ll~~~ 174 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSK--QAKYLIRLYGPKT-D--EIIN-REREKKISCILYNKNIAKKIYVFF 174 (458)
T ss_dssp EEEEECC--CEEEEEEEETTT--TEEEEEEEECC-C-C--SCSC-HHHHHHHHHHHTTSSSBCCEEEEE
T ss_pred EEEEcCCCeEeEEEEEEECCC--CceEEEEECCCCh-h--hhcC-HHHHHHHHHHHHhcCCCCCEEEEe
Confidence 456788899999999865431 1348899874321 1 1111 158999999997655455665543
|
| >2ct0_A Non-SMC element 1 homolog; ring domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=87.70 E-value=0.043 Score=42.63 Aligned_cols=29 Identities=7% Similarity=0.077 Sum_probs=23.6
Q ss_pred hhhhHhhhhhhccccccccccccccCCCCC
Q psy14267 104 HAQSVEKIVLNNINYRVDQCKKNLNYDPSI 133 (553)
Q Consensus 104 ~~~~~~~~~~~~~g~rC~~Cg~kfh~~C~~ 133 (553)
.-|.+|+-++- +|.+|.+|+-+||.+|-.
T Consensus 16 ~~C~IC~~~i~-~g~~C~~C~h~fH~~Ci~ 44 (74)
T 2ct0_A 16 KICNICHSLLI-QGQSCETCGIRMHLPCVA 44 (74)
T ss_dssp CBCSSSCCBCS-SSEECSSSCCEECHHHHH
T ss_pred CcCcchhhHcc-cCCccCCCCchhhHHHHH
Confidence 45777776664 799999999999999953
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=85.08 E-value=4.7 Score=41.88 Aligned_cols=76 Identities=9% Similarity=0.030 Sum_probs=43.2
Q ss_pred EEeeeeeeCceEEEEEeeeCCCc-----cceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 260 VLSLLGKGGSSSVYLVGGTSEHE-----FKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 260 i~~~LG~G~fG~Vy~a~~~~~~~-----~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
-++.|..|-...+|++....... .+.|++++..... ...+ ...+|..+++.|.......++++.+ . +
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~i-dR~~E~~~l~~L~~~gi~P~l~~~~--~-~- 145 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKFY-DSKVELDVFRYLSNINIAPNIIADF--P-E- 145 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCC-CHHHHHHHHHHHHHTTSSCCEEEEE--T-T-
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chhc-CHHHHHHHHHHHHhcCCCCCEEEEc--C-C-
Confidence 34567778889999886542111 2458888864321 1111 2257888888886544455555422 2 2
Q ss_pred eEEEEEecCCC
Q psy14267 335 HLYVLMEKGDT 345 (553)
Q Consensus 335 ~~~iv~e~~~~ 345 (553)
+.+|++..|
T Consensus 146 --~~I~efI~G 154 (424)
T 3mes_A 146 --GRIEEFIDG 154 (424)
T ss_dssp --EEEEECCCS
T ss_pred --CEEEEEeCC
Confidence 456776444
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=84.27 E-value=0.45 Score=47.41 Aligned_cols=37 Identities=22% Similarity=0.176 Sum_probs=27.2
Q ss_pred hCCcEecCCCCCCEEEecCccceecCCCCeEEEEeccCcccc
Q psy14267 383 AAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSL 424 (553)
Q Consensus 383 ~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGla~~~ 424 (553)
...+||||+.+.|||++.+.. ..+.+.|+||+.+..-
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~-----~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPERE-----GLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSC-----GGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcC-----CCCCeEEEeCCCcCcC
Confidence 357999999999999976310 0135899999988653
|
| >1r79_A Diacylglycerol kinase, delta; C1 domain, cystein-rich zinc binding domain, structural genomics, riken structural genomics/proteomics initiative; NMR {Homo sapiens} SCOP: g.49.1.1 | Back alignment and structure |
|---|
Probab=84.11 E-value=0.061 Score=42.78 Aligned_cols=32 Identities=16% Similarity=0.062 Sum_probs=27.1
Q ss_pred hhhHhhhh----hhccccccccccccccCCCCCCCC
Q psy14267 105 AQSVEKIV----LNNINYRVDQCKKNLNYDPSIKTP 136 (553)
Q Consensus 105 ~~~~~~~~----~~~~g~rC~~Cg~kfh~~C~~~vp 136 (553)
-|+||+-. +.++||||-=|++.+|..|-.++|
T Consensus 40 ~C~vC~k~c~s~~~L~g~rC~WCq~~VH~~C~~~~~ 75 (84)
T 1r79_A 40 KCTVCDKTCGSVLRLQDWRCLWCKAMVHTSCKESLL 75 (84)
T ss_dssp BCSSSCCBCCCTTTCCCEEESSSCCEECHHHHHHCC
T ss_pred EeCCCCCEeCCccCCCCCCCcccChhHHHHHHHhcc
Confidence 47777544 567999999999999999988887
|
| >3nw0_A Non-structural maintenance of chromosomes element homolog; E3 ligase, Zn, metal binding protein; 2.92A {Homo sapiens} | Back alignment and structure |
|---|
Probab=83.53 E-value=0.13 Score=49.40 Aligned_cols=35 Identities=6% Similarity=0.154 Sum_probs=27.7
Q ss_pred hhhhh---hhhhhHhhhhhhccccccccccccccCCCCC
Q psy14267 98 LKTNF---QHAQSVEKIVLNNINYRVDQCKKNLNYDPSI 133 (553)
Q Consensus 98 ~~~~~---~~~~~~~~~~~~~~g~rC~~Cg~kfh~~C~~ 133 (553)
|+.|| +.-|.+||=++- +|.+|++|+..||.+|-.
T Consensus 172 l~~~~~~~i~~C~iC~~iv~-~g~~C~~C~~~~H~~C~~ 209 (238)
T 3nw0_A 172 IRETYPDAVKICNICHSLLI-QGQSCETCGIRMHLPCVA 209 (238)
T ss_dssp HHHHCTTTCCBCTTTCSBCS-SCEECSSSCCEECHHHHH
T ss_pred HHHhcCCCCCcCcchhhHHh-CCcccCccChHHHHHHHH
Confidence 55565 345888886665 799999999999999953
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=80.61 E-value=0.89 Score=46.03 Aligned_cols=75 Identities=9% Similarity=0.060 Sum_probs=38.8
Q ss_pred EeeeeeeCceEEEEEeeeCCC------ccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 261 LSLLGKGGSSSVYLVGGTSEH------EFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 261 ~~~LG~G~fG~Vy~a~~~~~~------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
++.|+.|....+|++...... ..+.+++|+..... ... .....|..+++.|..+..+.++++.. . +
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~~~-~~~~~E~~~l~~L~~~g~~P~~~~~~--~-~- 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---DEL-YNTISEFEVYKTMSKYKIAPQLLNTF--N-G- 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---GGT-SCHHHHHHHHHHHHHTTSSCCEEEEE--T-T-
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc---cce-ecHHHHHHHHHHHHhcCCCCceEEec--C-C-
Confidence 456888888999998654310 11348888764321 111 12357888888886543344554322 2 2
Q ss_pred eEEEEEecCCC
Q psy14267 335 HLYVLMEKGDT 345 (553)
Q Consensus 335 ~~~iv~e~~~~ 345 (553)
+++|++..|
T Consensus 110 --~~v~e~i~G 118 (369)
T 3c5i_A 110 --GRIEEWLYG 118 (369)
T ss_dssp --EEEEECCCS
T ss_pred --cEEEEEecC
Confidence 456775443
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 553 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-51 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-49 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-48 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-48 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-48 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-47 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-47 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-47 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-46 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-45 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-44 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-43 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-43 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-43 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-43 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-42 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-41 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-41 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-41 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-41 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-40 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-40 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 9e-40 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-39 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-39 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-39 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-39 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-39 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 7e-39 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-38 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-38 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-38 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-38 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-38 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-38 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-38 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-38 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-38 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 8e-38 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 9e-38 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 7e-37 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-37 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-36 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-36 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 8e-36 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 8e-36 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-35 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-35 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-35 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-35 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 8e-35 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-34 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-34 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-34 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-34 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-33 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-32 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-32 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 9e-30 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-26 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 7e-25 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 8e-12 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 3e-51
Identities = 64/283 (22%), Positives = 118/283 (41%), Gaps = 33/283 (11%)
Query: 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQ 316
Q V +G G +VY G + A+K+++++ T Q + ++ NEV +L K +
Sbjct: 9 QITVGQRIGSGSFGTVYK--GKWHGDV---AVKMLNVTAPTPQQL-QAFKNEVGVLRKTR 62
Query: 317 GCPYVIKMHDYVYDTASKHLYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEML 375
++ Y L ++ + + + L ++ + MI +I +
Sbjct: 63 -HVNILLFMGYSTA---PQLAIVTQWCEGSSLYHHLHIIET----KFEMIKLIDIARQTA 114
Query: 376 LAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDT 435
+ +HA IIH DLK N + +KI DFG+A S +
Sbjct: 115 QGMDYLHAKSIIHRDLKSNNIFLHED---------LTVKIGDFGLATVKSRWSGSHQFEQ 165
Query: 436 ASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKM 495
SG++ +M+PE + +++SDV++ G +LY ++ G+ PYS+I N +
Sbjct: 166 LSGSILWMAPEVIR------MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII 219
Query: 496 LAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
+ R + +N P + + M CL+K RP
Sbjct: 220 FMVGRGYLSPDLSKVRSN---CPKAMKRLMAECLKKKRDERPL 259
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 3e-49
Identities = 72/283 (25%), Positives = 119/283 (42%), Gaps = 34/283 (12%)
Query: 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG 317
++++ LG G VY ++ A KV+D + + Y+ E+++LA
Sbjct: 14 WEIIGELGDGAFGKVYK--AQNKETSVLAAAKVIDTKSEEEL---EDYMVEIDILASCD- 67
Query: 318 CPYVIKMHDYVYDTASKHLYVLMEKGDT-DLSKYMRNLNKMTTLPNTMIIIIMHWYEMLL 376
P ++K+ D Y +L++L+E + M L + L + I ++ + L
Sbjct: 68 HPNIVKLLDAFYY--ENNLWILIEFCAGGAVDAVMLELER--PLTESQIQVVC--KQTLD 121
Query: 377 AVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTA 436
A+ +H IIH DLK N LF + +K+ DFG++ +D+
Sbjct: 122 ALNYLHDNKIIHRDLKAGNILFTLD---------GDIKLADFGVSAKNTRTIQ--RRDSF 170
Query: 437 SGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKML 496
GT +M+PE +S YK+DVWSLG L M P+ + N +L
Sbjct: 171 IGTPYWMAPEVVMCETSKDRP----YDYKADVWSLGITLIEMAEIEPPHHEL-NPMRVLL 225
Query: 497 AIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTV 539
IA+ + P LA +K CL+K+ AR T
Sbjct: 226 KIAKSE-----PPTLAQPSRWSSNFKDFLKKCLEKNVDARWTT 263
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (425), Expect = 1e-48
Identities = 52/293 (17%), Positives = 103/293 (35%), Gaps = 40/293 (13%)
Query: 251 ITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVE 310
++ +G+ + +G+G +VY G +A + +T + E E
Sbjct: 4 MSNDGRFLKFDIEIGRGSFKTVYK--GLDTETTVEVAWCELQDRKLTKSER-QRFKEEAE 60
Query: 311 LLAKLQGCPYVIKMHDYVYDTAS--KHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIII 368
+L LQ P +++ +D T K + ++ E + K L + + ++
Sbjct: 61 MLKGLQ-HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTY--LKRFKVMKIKVLRSW 117
Query: 369 MHWYEMLLAVKEIHAAG--IIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQD 426
++L ++ +H IIH DLK N G +KI D G+A +
Sbjct: 118 CR--QILKGLQFLHTRTPPIIHRDLKCDNIFITGP--------TGSVKIGDLGLATLKRA 167
Query: 427 DKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYS 486
GT +M+PE + + DV++ G + M PYS
Sbjct: 168 SFAK----AVIGTPEFMAPEMYEE----------KYDESVDVYAFGMCMLEMATSEYPYS 213
Query: 487 HIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTV 539
N + F P + + ++ C++++ R ++
Sbjct: 214 ECQNAAQIYRRVTSGVKPASFDK------VAIPEVKEIIEGCIRQNKDERYSI 260
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 1e-48
Identities = 63/282 (22%), Positives = 112/282 (39%), Gaps = 40/282 (14%)
Query: 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG 317
+++ LGKG +VYL + LALKV+ + + + EVE+ + L+
Sbjct: 8 FEIGRPLGKGKFGNVYL--AREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR- 64
Query: 318 CPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLA 377
P +++++ Y +D + +Y+++E R L K++ + E+ A
Sbjct: 65 HPNILRLYGYFHD--ATRVYLILEYAPLGT--VYRELQKLSKFDEQRTATYI--TELANA 118
Query: 378 VKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTAS 437
+ H+ +IH D+KP N L LKI DFG + + T
Sbjct: 119 LSYCHSKRVIHRDIKPENLLLGSA---------GELKIADFGWSVHAPSSRR----TTLC 165
Query: 438 GTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLA 497
GTL+Y+ PE K D+WSLG + Y + G+ P+ NT+ +
Sbjct: 166 GTLDYLPPEMI---------EGRMHDEKVDLWSLGVLCYEFLVGKPPFEA--NTYQETYK 214
Query: 498 IARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTV 539
+ + F + + L+ +P RP +
Sbjct: 215 RIS-RVEFTFPDF------VTEGARDLISRLLKHNPSQRPML 249
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 167 bits (423), Expect = 6e-48
Identities = 60/284 (21%), Positives = 101/284 (35%), Gaps = 37/284 (13%)
Query: 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKL 315
K + L +G G +VY + +A+K + S + EV L KL
Sbjct: 15 KLFSDLREIGHGSFGAVYF--ARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL 72
Query: 316 QGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEML 375
+ P I+ +++ME S + K L I + + L
Sbjct: 73 R-HPNTIQYRGCYLR--EHTAWLVMEYCLGSASDLLEVHKK--PLQEVEIAAVT--HGAL 125
Query: 376 LAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDT 435
+ +H+ +IH D+K N L ++K+ DFG A + + V
Sbjct: 126 QGLAYLHSHNMIHRDVKAGNILLSEP---------GLVKLGDFGSASIMAPANSFV---- 172
Query: 436 ASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKM 495
GT +M+PE + + K DVWSLG + + P ++ N + +
Sbjct: 173 --GTPYWMAPEVIL------AMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSAL 223
Query: 496 LAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTV 539
IA+++ + CLQK P+ RPT
Sbjct: 224 YHIAQNESPALQSGH------WSEYFRNFVDSCLQKIPQDRPTS 261
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 165 bits (418), Expect = 1e-47
Identities = 67/290 (23%), Positives = 117/290 (40%), Gaps = 36/290 (12%)
Query: 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITD------QSIADSYLNEVE 310
Y+ +LG+G SS V + K A+K++D++ Q + ++ L EV+
Sbjct: 4 NYEPKEILGRGVSSVVRR--CIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 61
Query: 311 LLAKLQGCPYVIKMHDYVYDTASKHLYVLMEKGDT-DLSKYMRNLNKMTTLPNTMIIIIM 369
+L K+ G P +I++ D + +++ + +L Y+ + TL IM
Sbjct: 62 ILRKVSGHPNIIQLKDTYET--NTFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIM 116
Query: 370 HWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKT 429
+L + +H I+H DLKP N L + +K+ DFG +C L +
Sbjct: 117 --RALLEVICALHKLNIVHRDLKPENILLDDD---------MNIKLTDFGFSCQLDPGEK 165
Query: 430 SVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIP 489
GT +Y++PE S N + D+WS G I+Y ++ G P+ H
Sbjct: 166 L---REVCGTPSYLAPE---IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-R 218
Query: 490 NTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTV 539
+ I Q P+ + T+ + L P+ R T
Sbjct: 219 KQMLMLRMIMSGNYQFGS-PEWDD---YSDTVKDLVSRFLVVQPQKRYTA 264
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 1e-47
Identities = 72/289 (24%), Positives = 118/289 (40%), Gaps = 41/289 (14%)
Query: 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG 317
Y+VL +G G + + K L K +D +T+ ++EV LL +L+
Sbjct: 6 YEVLYTIGTGSYGRCQK--IRRKSDGKILVWKELDYGSMTEAEKQM-LVSEVNLLRELK- 61
Query: 318 CPYVIKMHDYVYDTASKHLYVLMEKGD-TDLSKYMRNLNKMT-TLPNTMIIIIMHWYEML 375
P +++ +D + D + LY++ME + DL+ + K L ++ +M ++
Sbjct: 62 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM--TQLT 119
Query: 376 LAVKEIH-----AAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTS 430
LA+KE H ++H DLKPAN G +K+ DFG+A L D +
Sbjct: 120 LALKECHRRSDGGHTVLHRDLKPANVFLDGK---------QNVKLGDFGLARILNHDTS- 169
Query: 431 VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN 490
GT YMSPE N KSD+WSLGC+LY + P++
Sbjct: 170 -FAKAFVGTPYYMSPEQM---------NRMSYNEKSDIWSLGCLLYELCALMPPFTA--F 217
Query: 491 TWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTV 539
+ ++ R + L + + L RP+V
Sbjct: 218 SQKELAGKIREGKFRRIPYR------YSDELNEIITRMLNLKDYHRPSV 260
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 3e-47
Identities = 58/284 (20%), Positives = 106/284 (37%), Gaps = 34/284 (11%)
Query: 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKL 315
+ + ++ LG+G V L + + +A+K+VD+ D ++ E+ + L
Sbjct: 5 EDWDLVQTLGEGAYGEVQL--AVNRVTEEAVAVKIVDMKRAVDC--PENIKKEICINKML 60
Query: 316 QGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEML 375
V+K + + + Y+ +E + + +P H +++
Sbjct: 61 N-HENVVKFYGHRRE--GNIQYLFLEYCSGG--ELFDRIEPDIGMPEPDAQRFFH--QLM 113
Query: 376 LAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDT 435
V +H GI H D+KP N L + LKI DFG+A + + +
Sbjct: 114 AGVVYLHGIGITHRDIKPENLLLDER---------DNLKISDFGLATVFRYNNRERLLNK 164
Query: 436 ASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKM 495
GTL Y++PE + DVWS G +L M+ G P+ +
Sbjct: 165 MCGTLPYVAPELLK-------RREFH-AEPVDVWSCGIVLTAMLAGE-LPWDQPSDSCQE 215
Query: 496 LAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTV 539
+ + K + I L + L ++P AR T+
Sbjct: 216 YSDWKEKKTYLNPWK-----KIDSAPLALLHKILVENPSARITI 254
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 161 bits (409), Expect = 3e-46
Identities = 52/297 (17%), Positives = 100/297 (33%), Gaps = 39/297 (13%)
Query: 249 DVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNE 308
+V+ G Y+V +G+G ++ GT+ + +A+K +S A +E
Sbjct: 1 NVV---GVHYKVGRRIGEGSFGVIFE--GTNLLNNQQVAIKF-----EPRRSDAPQLRDE 50
Query: 309 VELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIII 368
L GC + ++ + + H ++++ L + + ++ +
Sbjct: 51 YRTYKLLAGCTGIPNVYYFGQE--GLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAK 108
Query: 369 MHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDK 428
V+ IH +++ D+KP NFL + + N++ ++DFG+ +D
Sbjct: 109 QML----ARVQSIHEKSLVYRDIKPDNFL----IGRPNSKNANMIYVVDFGMVKFYRDPV 160
Query: 429 TSVHKD-----TASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRT 483
T H SGT YMS + + D+ +LG + + G
Sbjct: 161 TKQHIPYREKKNLSGTARYMSINTH---------LGREQSRRDDLEALGHVFMYFLRGSL 211
Query: 484 --PYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
K I K + A P + M A P
Sbjct: 212 PWQGLKAATNKQKYERIGEKKQSTPLRELCAG---FPEEFYKYMHYARNLAFDATPD 265
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 2e-45
Identities = 61/288 (21%), Positives = 117/288 (40%), Gaps = 47/288 (16%)
Query: 253 LNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELL 312
LN K+ ++L +GKG V L ++ +A+K I + + A ++L E ++
Sbjct: 4 LNMKELKLLQTIGKGEFGDVMLG----DYRGNKVAVKC-----IKNDATAQAFLAEASVM 54
Query: 313 AKLQGCPYVIKMHDYVYDTASKHLYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHW 371
+L+ ++++ + + LY++ E L Y+R+ + L ++
Sbjct: 55 TQLR-HSNLVQLLGVIVEE-KGGLYIVTEYMAKGSLVDYLRS-RGRSVLGGDCLLKFSL- 110
Query: 372 YEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSV 431
++ A++ + +H DL N L + NV K+ DFG+ + +
Sbjct: 111 -DVCEAMEYLEGNNFVHRDLAARNVLVSED---------NVAKVSDFGLTKEASSTQDTG 160
Query: 432 HKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI-YGRTPYSHIPN 490
+ + +PEA + + KSDVWS G +L+ + +GR PY IP
Sbjct: 161 K-----LPVKWTAPEAL---------REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 206
Query: 491 TWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
++E ++ PP + + MK C D RP+
Sbjct: 207 KDV--------VPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPS 246
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 1e-44
Identities = 60/284 (21%), Positives = 112/284 (39%), Gaps = 39/284 (13%)
Query: 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKL 315
K+Y +G+G S +VY + +A++ ++L + + +NE+ ++ +
Sbjct: 20 KKYTRFEKIGQGASGTVYT--AMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMREN 74
Query: 316 QGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEML 375
+ P ++ D L+V+ME + ++ T + I + E L
Sbjct: 75 K-NPNIVNYLDSYLV--GDELWVVMEYLAGGS---LTDVVTETCMDEGQIAAVC--RECL 126
Query: 376 LAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDT 435
A++ +H+ +IH D+K N L + +K+ DFG + +++ + T
Sbjct: 127 QALEFLHSNQVIHRDIKSDNILLGMD---------GSVKLTDFGFCAQITPEQS--KRST 175
Query: 436 ASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKM 495
GT +M+PE K D+WSLG + MI G PY + N +
Sbjct: 176 MVGTPYWMAPEVV---------TRKAYGPKVDIWSLGIMAIEMIEGEPPYLN-ENPLRAL 225
Query: 496 LAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTV 539
IA P+L N + + CL D + R +
Sbjct: 226 YLIAT-----NGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSA 264
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 1e-43
Identities = 61/282 (21%), Positives = 113/282 (40%), Gaps = 36/282 (12%)
Query: 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG 317
++ +LG+G S+V L + A+K+++ I ++ E +++++L
Sbjct: 10 FKFGKILGEGSFSTVVL--ARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD- 66
Query: 318 CPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLA 377
P+ +K++ D + LY + ++ + K+ + T E++ A
Sbjct: 67 HPFFVKLYFTFQD--DEKLYFGLSYAKNGE--LLKYIRKIGSFDETCTRFYT--AEIVSA 120
Query: 378 VKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTAS 437
++ +H GIIH DLKP N L + ++I DFG A L + ++
Sbjct: 121 LEYLHGKGIIHRDLKPENILLNED---------MHIQITDFGTAKVLSPESKQARANSFV 171
Query: 438 GTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLA 497
GT Y+SPE SD+W+LGCI+Y ++ G P+ N +
Sbjct: 172 GTAQYVSPELL---------TEKSACKSSDLWALGCIIYQLVAGLPPFRA-GNEYLIFQK 221
Query: 498 IARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTV 539
I K + +F + P ++ L D R
Sbjct: 222 II--KLEYDFPEK------FFPKARDLVEKLLVLDATKRLGC 255
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 154 bits (391), Expect = 1e-43
Identities = 52/289 (17%), Positives = 105/289 (36%), Gaps = 34/289 (11%)
Query: 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAK 314
G +Y++ +G G +YL GT + +A+K+ + Q E ++
Sbjct: 6 GNRYRLGRKIGSGSFGDIYL--GTDIAAGEEVAIKLECVKTKHPQ-----LHIESKIYKM 58
Query: 315 LQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEM 374
+QG + + + + ++ME L ++ ++ +++ +M
Sbjct: 59 MQGGVGIPTIRWCGAE--GDYNVMVMELLGPSLEDLFNFCSR----KFSLKTVLLLADQM 112
Query: 375 LLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKD 434
+ ++ IH+ IH D+KP N L + GN++ IIDFG+A +D +T H
Sbjct: 113 ISRIEYIHSKNFIHRDVKPDN------FLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIP 166
Query: 435 -----TASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIP 489
+GT Y S + + D+ SLG +L G P+ +
Sbjct: 167 YRENKNLTGTARYASINTH---------LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 217
Query: 490 NTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
+ + ++ ++ P + C +P
Sbjct: 218 AATKRQKYERISEKKMSTPIEVLCK-GYPSEFATYLNFCRSLRFDDKPD 265
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 1e-43
Identities = 58/318 (18%), Positives = 110/318 (34%), Gaps = 69/318 (21%)
Query: 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG 317
++ +S LG G V+ + + +A K++ L +I + + E+++L +
Sbjct: 8 FEKISELGAGNGGVVFK--VSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECN- 62
Query: 318 CPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLA 377
PY++ + Y + + ME D + L K +P ++ + ++
Sbjct: 63 SPYIVGFYGAFYS--DGEISICMEHMDGGS--LDQVLKKAGRIPEQILGKVS--IAVIKG 116
Query: 378 VKEIH-AAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTA 436
+ + I+H D+KP+N L +K+ DFG++ L D + +
Sbjct: 117 LTYLREKHKIMHRDVKPSNILVNSR---------GEIKLCDFGVSGQLIDSMAN----SF 163
Query: 437 SGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY----------- 485
GT +YMSPE + +SD+WS+G L M GR P
Sbjct: 164 VGTRSYMSPERL---------QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 214
Query: 486 ------------------------SHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTL 521
S+ ++ M + P +
Sbjct: 215 FGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEF 274
Query: 522 LQSMKLCLQKDPKARPTV 539
+ CL K+P R +
Sbjct: 275 QDFVNKCLIKNPAERADL 292
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 154 bits (391), Expect = 5e-43
Identities = 54/284 (19%), Positives = 108/284 (38%), Gaps = 37/284 (13%)
Query: 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQ 316
Y + LG G V+ T A K V +D+ ++ E++ ++ L+
Sbjct: 27 HYDIHEELGTGAFGVVHR--VTERATGNNFAAKFVMTPHESDK---ETVRKEIQTMSVLR 81
Query: 317 GCPYVIKMHDYVYDTASKHLYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEML 375
P ++ +HD D + ++ E +L + + + + + + M ++
Sbjct: 82 -HPTLVNLHDAFED--DNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYM--RQVC 134
Query: 376 LAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDT 435
+ +H +H DLKP N + N LK+IDFG+ L ++
Sbjct: 135 KGLCHMHENNYVHLDLKPENIM-------FTTKRSNELKLIDFGLTAHLDPKQSV---KV 184
Query: 436 ASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKM 495
+GT + +PE A + Y +D+WS+G + Y ++ G +P+ N +
Sbjct: 185 TTGTAEFAAPEVA---------EGKPVGYYTDMWSVGVLSYILLSGLSPFGG-ENDDETL 234
Query: 496 LAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTV 539
+ ++ + I ++ L DP R T+
Sbjct: 235 RNVKS----CDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTI 274
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (381), Expect = 2e-42
Identities = 56/283 (19%), Positives = 110/283 (38%), Gaps = 39/283 (13%)
Query: 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKL 315
+ +++ LG G V++ + +A+K + ++ + L E L+ +L
Sbjct: 13 ETLKLVERLGAGQFGEVWMG---YYNGHTKVAVKSLKQGSMSPDAF----LAEANLMKQL 65
Query: 316 QGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEML 375
Q +++++ V + +Y++ E + L ++ + ++
Sbjct: 66 Q-HQRLVRLYAVVTQ---EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA--QIA 119
Query: 376 LAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDT 435
+ I IH DL+ AN L KI DFG+A ++D++ ++
Sbjct: 120 EGMAFIEERNYIHRDLRAANILV---------SDTLSCKIADFGLARLIEDNEY-TAREG 169
Query: 436 ASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKM 495
A + + +PEA N T KSDVWS G +L ++ +
Sbjct: 170 AKFPIKWTAPEAI---------NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 220
Query: 496 LAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
+ R ++ +N P L Q M+LC ++ P+ RPT
Sbjct: 221 QNLERG-----YRMVRPDN--CPEELYQLMRLCWKERPEDRPT 256
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 148 bits (375), Expect = 1e-41
Identities = 73/290 (25%), Positives = 123/290 (42%), Gaps = 34/290 (11%)
Query: 252 TLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVEL 311
L+ + Y++ +LG GG S V+L + +A+KV+ D S + E +
Sbjct: 4 HLSDR-YELGEILGFGGMSEVHL--ARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQN 60
Query: 312 LAKLQGCPYVIKMHDYVYD--TASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIM 369
A L P ++ ++D A Y++ME D ++ + I ++
Sbjct: 61 AAALN-HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVT--LRDIVHTEGPMTPKRAIEVI 117
Query: 370 HWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKT 429
+ A+ H GIIH D+KPAN + N +K++DFGIA ++ D
Sbjct: 118 --ADACQALNFSHQNGIIHRDVKPANIMISAT---------NAVKVMDFGIARAIADSGN 166
Query: 430 SVHKDTAS-GTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHI 488
SV + A GT Y+SPE A + +SDV+SLGC+LY ++ G P++
Sbjct: 167 SVTQTAAVIGTAQYLSPEQA---------RGDSVDARSDVYSLGCVLYEVLTGEPPFTG- 216
Query: 489 PNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
+ + R + P A + + L + L K+P+ R
Sbjct: 217 DSPVSVAYQHVRE----DPIPPSARHEGLSADLDAVVLKALAKNPENRYQ 262
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 2e-41
Identities = 77/288 (26%), Positives = 116/288 (40%), Gaps = 46/288 (15%)
Query: 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSY---LNEVELL 312
QYQV LLG GG SVY G + P+A+K V+ I+D + EV LL
Sbjct: 4 SQYQVGPLLGSGGFGSVYS--GIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 313 AKLQ-GCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHW 371
K+ G VI++ D+ S L + + DL + + + L +
Sbjct: 62 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDF---ITERGALQEELARSFF-- 116
Query: 372 YEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSV 431
+++L AV+ H G++H D+K N L N LK+IDFG L+D +
Sbjct: 117 WQVLEAVRHCHNCGVLHRDIKDENILIDLN--------RGELKLIDFGSGALLKDTVYT- 167
Query: 432 HKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNT 491
GT Y PE + Y + VWSLG +LY+M+ G P+ H
Sbjct: 168 ---DFDGTRVYSPPEWIR-------YHRYH-GRSAAVWSLGILLYDMVCGDIPFEHDEEI 216
Query: 492 WAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTV 539
+ Q+ F+ + + ++ CL P RPT
Sbjct: 217 ---------IRGQVFFRQR------VSSECQHLIRWCLALRPSDRPTF 249
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 3e-41
Identities = 54/289 (18%), Positives = 100/289 (34%), Gaps = 35/289 (12%)
Query: 253 LNGKQYQVLSLLGKGGSSSVYLV-GGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVEL 311
+ K ++L LG G V + +A+K + ++ D ++ EV
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 312 LAKLQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHW 371
+ L +I+++ V K + L G R +
Sbjct: 65 MHSLD-HRNLIRLYGVVLTPPMKMVTELAPLGSL----LDRLRKHQGHFLLGTLSRYA-- 117
Query: 372 YEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSL-QDDKTS 430
++ + + + IH DL N L + V KI DFG+ +L Q+D
Sbjct: 118 VQVAEGMGYLESKRFIHRDLAARNLL--------LATRDLV-KIGDFGLMRALPQNDDHY 168
Query: 431 VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI-YGRTPYSHIP 489
V ++ + +PE+ T ++ SD W G L+ M YG+ P+ +
Sbjct: 169 VMQEHRKVPFAWCAPESL---------KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 219
Query: 490 NTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
+ + I + +++ P + M C P+ RPT
Sbjct: 220 GSQI-LHKIDKEGERLPRPED------CPQDIYNVMVQCWAHKPEDRPT 261
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 150 bits (379), Expect = 4e-41
Identities = 65/303 (21%), Positives = 119/303 (39%), Gaps = 40/303 (13%)
Query: 251 ITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVE 310
+T+N + V ++G+GG VY K A+K +D I + LNE
Sbjct: 1 LTMN--DFSVHRIIGRGGFGEVYG--CRKADTGKMYAMKCLDKKRIKMKQGETLALNERI 56
Query: 311 LLAKLQ--GCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIII 368
+L+ + CP+++ M + L +++ + Y + + + + +
Sbjct: 57 MLSLVSTGDCPFIVCMSYAFHT--PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA 114
Query: 369 MHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDK 428
++L ++ +H +++ DLKPAN L +D G+V +I D G+AC K
Sbjct: 115 E----IILGLEHMHNRFVVYRDLKPANIL--------LDEHGHV-RISDLGLACDFSKKK 161
Query: 429 TSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHI 488
GT YM+PE G Y +D +SLGC+L+ ++ G +P+
Sbjct: 162 PHASV----GTHGYMAPEVLQ------KGVAY--DSSADWFSLGCMLFKLLRGHSPFRQH 209
Query: 489 PNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTV-GNSVTQIN 547
+ +E P L ++ LQ+D R G ++
Sbjct: 210 KTKDKHEIDRMTLTMAVELPDS------FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK 263
Query: 548 NNP 550
+P
Sbjct: 264 ESP 266
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 148 bits (375), Expect = 1e-40
Identities = 56/283 (19%), Positives = 117/283 (41%), Gaps = 37/283 (13%)
Query: 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG 317
Y +L LG G V+ + + K ++ D+ + NE+ ++ +L
Sbjct: 31 YDILEELGSGAFGVVHR--CVEKATGRVFVAKFINTPYPLDK---YTVKNEISIMNQLH- 84
Query: 318 CPYVIKMHDYVYDTASKHLYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLL 376
P +I +HD D + +++E +L + + + +I M +
Sbjct: 85 HPKLINLHDAFED--KYEMVLILEFLSGGELFDRIAAEDY--KMSEAEVINYM--RQACE 138
Query: 377 AVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTA 436
+K +H I+H D+KP N + + +KIIDFG+A L D+
Sbjct: 139 GLKHMHEHSIVHLDIKPENIMCETK-------KASSVKIIDFGLATKLNPDEIVKVT--- 188
Query: 437 SGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKML 496
+ T + +PE + + + +D+W++G + Y ++ G +P++ + L
Sbjct: 189 TATAEFAAPEIVDRE---------PVGFYTDMWAIGVLGYVLLSGLSPFAGEDD-----L 234
Query: 497 AIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTV 539
++ + +++ ++ P +K LQK+P+ R TV
Sbjct: 235 ETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTV 277
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 3e-40
Identities = 62/278 (22%), Positives = 117/278 (42%), Gaps = 39/278 (14%)
Query: 264 LGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIK 323
LG G +V + K +A+K++ ++ D ++ D L E ++ +L PY+++
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILK-NEANDPALKDELLAEANVMQQLD-NPYIVR 72
Query: 324 MHDYVYDTASKHLYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIH 382
M + ++ME + L+KY L + + + II ++H ++ + +K +
Sbjct: 73 MIGICEA---ESWMLVMEMAELGPLNKY---LQQNRHVKDKNIIELVH--QVSMGMKYLE 124
Query: 383 AAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTAS-GTLN 441
+ +H DL N L V + KI DFG++ +L+ D+ T +
Sbjct: 125 ESNFVHRDLAARNVLLVTQ---------HYAKISDFGLSKALRADENYYKAQTHGKWPVK 175
Query: 442 YMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI-YGRTPYSHIPNTWAKMLAIAR 500
+ +PE N Y+ + KSDVWS G +++ YG+ PY + +
Sbjct: 176 WYAPECI---------NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV------- 219
Query: 501 HKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
+E ++ P + M LC D + RP
Sbjct: 220 -TAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPG 256
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 9e-40
Identities = 59/307 (19%), Positives = 114/307 (37%), Gaps = 56/307 (18%)
Query: 257 QYQVLSLLGKGGSSSVYLV---GGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLA 313
+ +LG G V G + +A+K+ L + D S ++ ++E++++
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKM--LKEKADSSEREALMSELKMMT 95
Query: 314 KLQGCPYVIKMHDYVYDTASKHLYVLMEKGD-TDLSKYMRNLNK---------------- 356
+L ++ + S +Y++ E DL Y+R+ +
Sbjct: 96 QLGSHENIVNLLGACTL--SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153
Query: 357 ----MTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNV 412
+ L ++ Y++ ++ + +H DL N L V
Sbjct: 154 EEEDLNVLTFEDLLCFA--YQVAKGMEFLEFKSCVHRDLAARNVLVTHG---------KV 202
Query: 413 LKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLG 472
+KI DFG+A + D V + A + +M+PE+ T KSDVWS G
Sbjct: 203 VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESL---------FEGIYTIKSDVWSYG 253
Query: 473 CILYNMI-YGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQK 531
+L+ + G PY IP A + ++ +++ + M+ C
Sbjct: 254 ILLWEIFSLGVNPYPGIPVD-ANFYKLIQNGFKMDQPFY------ATEEIYIIMQSCWAF 306
Query: 532 DPKARPT 538
D + RP+
Sbjct: 307 DSRKRPS 313
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 2e-39
Identities = 50/283 (17%), Positives = 100/283 (35%), Gaps = 38/283 (13%)
Query: 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG 317
Y + LG+G V+ K K V + + E+ +L +
Sbjct: 7 YMIAEDLGRGEFGIVHR--CVETSSKKTYMAKFVKVKGTDQVLV----KKEISILNIAR- 59
Query: 318 CPYVIKMHDYVYDTASKHLYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLL 376
++ +H+ + L ++ E D+ + + L I+ +H +
Sbjct: 60 HRNILHLHESFES--MEELVMIFEFISGLDIFERINT--SAFELNEREIVSYVHQ--VCE 113
Query: 377 AVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTA 436
A++ +H+ I H D++P N ++ + +KII+FG A L+
Sbjct: 114 ALQFLHSHNIGHFDIRPENIIYQTRR-------SSTIKIIEFGQARQLKPGDNF---RLL 163
Query: 437 SGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKML 496
Y +PE ++ +D+WSLG ++Y ++ G P+ +
Sbjct: 164 FTAPEYYAPEVHQHD---------VVSTATDMWSLGTLVYVLLSGINPFLA-ETNQQIIE 213
Query: 497 AIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTV 539
I + F + I + + L K+ K+R T
Sbjct: 214 NIMNAE--YTFDEEAFKE--ISIEAMDFVDRLLVKERKSRMTA 252
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 3e-39
Identities = 66/319 (20%), Positives = 132/319 (41%), Gaps = 31/319 (9%)
Query: 235 ITTSNAKKSVETSQDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEF-KPLALKVVDL 293
+T + ++ + + + +++L +LG G V+LV S H+ K A+KV+
Sbjct: 3 LTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKK 62
Query: 294 SDITDQS-IADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMR 352
+ I ++ + E ++L ++ P+++ +H HL + G +L ++
Sbjct: 63 ATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGG-ELFTHLS 121
Query: 353 NLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNV 412
+ T + ++ E++LA++ +H GII+ D+K N L N
Sbjct: 122 QRERFT-----EHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSN---------GH 167
Query: 413 LKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLG 472
+ + DFG++ D+T GT+ YM+P+ G D WSLG
Sbjct: 168 VVLTDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVR-------GGDSGHDKAVDWWSLG 219
Query: 473 CILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKD 532
++Y ++ G +P++ I+R ++ +P + ++ L KD
Sbjct: 220 VLMYELLTGASPFTV-DGEKNSQAEISRR--ILKSEPPYPQE--MSALAKDLIQRLLMKD 274
Query: 533 PKARPTVG-NSVTQINNNP 550
PK R G +I +
Sbjct: 275 PKKRLGCGPRDADEIKEHL 293
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 143 bits (362), Expect = 3e-39
Identities = 65/296 (21%), Positives = 117/296 (39%), Gaps = 42/296 (14%)
Query: 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKL 315
+ +Q+L LG G V+L S H + A+KV+ + + +E +L+ +
Sbjct: 4 QDFQILRTLGTGSFGRVHL--IRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 61
Query: 316 QGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEML 375
P++I+M D ++ ++++M+ + + + + E+
Sbjct: 62 T-HPFIIRMWGTFQD--AQQIFMIMDY----IEGGELFSLLRKSQRFPNPVAKFYAAEVC 114
Query: 376 LAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDT 435
LA++ +H+ II+ DLKP N L N +KI DFG A + D T
Sbjct: 115 LALEYLHSKDIIYRDLKPENILLDKN---------GHIKITDFGFAKYVPDVTY-----T 160
Query: 436 ASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKM 495
GT +Y++PE +T D WS G ++Y M+ G TP+ NT
Sbjct: 161 LCGTPDYIAPEVV---------STKPYNKSIDWWSFGILIYEMLAGYTPFYD-SNTMKTY 210
Query: 496 LAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT-VGNSVTQINNNP 550
I ++ F P + + + +D R + N + N+P
Sbjct: 211 EKIL--NAELRFPPF------FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHP 258
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 3e-39
Identities = 61/300 (20%), Positives = 118/300 (39%), Gaps = 39/300 (13%)
Query: 244 VETSQDVITLNGKQYQVLS-LLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIA 302
++ ++ I Y+V S +LG G + V + ++ + ALK++
Sbjct: 2 LQIKKNAII---DDYKVTSQVLGLGINGKVLQI--FNKRTQEKFALKMLQDCP------- 49
Query: 303 DSYLNEVELLAKLQGCPYVIKMHDYVYDTAS--KHLYVLMEKGD-TDLSKYMRNLNKMTT 359
EVEL + CP+++++ D + + K L ++ME D +L +++
Sbjct: 50 -KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD-RGDQA 107
Query: 360 LPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFG 419
IM + A++ +H+ I H D+KP N L+ +LK+ DFG
Sbjct: 108 FTEREASEIM--KSIGEAIQYLHSINIAHRDVKPENLLYTSK------RPNAILKLTDFG 159
Query: 420 IACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI 479
A + T T Y++PE G + D+WSLG I+Y ++
Sbjct: 160 FAKETTSHNS---LTTPCYTPYYVAPEVLGPE---------KYDKSCDMWSLGVIMYILL 207
Query: 480 YGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTV 539
G P+ + A + +++ + + ++ L+ +P R T+
Sbjct: 208 CGYPPFYS-NHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTI 266
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (355), Expect = 6e-39
Identities = 45/288 (15%), Positives = 106/288 (36%), Gaps = 43/288 (14%)
Query: 253 LNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELL 312
++ K L LG G V +++ A+K++ +++ + E +++
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDV---AIKMIKEGSMSEDEF----IEEAKVM 53
Query: 313 AKLQGCPYVIKMHDYVYDTASKHLYVLMEK-GDTDLSKYMRNLNKMTTLPNTMIIIIMHW 371
L +++++ + ++++ E + L Y+R + + +
Sbjct: 54 MNLS-HEKLVQLYGVCTK--QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMC---- 106
Query: 372 YEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSV 431
++ A++ + + +H DL N L V+K+ DFG++ + DD+ +
Sbjct: 107 KDVCEAMEYLESKQFLHRDLAARNCLVNDQ---------GVVKVSDFGLSRYVLDDEYT- 156
Query: 432 HKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI-YGRTPYSHIPN 490
+ + + PE + + KSD+W+ G +++ + G+ PY N
Sbjct: 157 SSVGSKFPVRWSPPEVL---------MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN 207
Query: 491 TWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
+ + I +L + M C + RPT
Sbjct: 208 SETA--------EHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPT 247
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 7e-39
Identities = 68/311 (21%), Positives = 111/311 (35%), Gaps = 54/311 (17%)
Query: 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAK 314
G +Y LS +G+G V +A+K + + Q+ L E+++L +
Sbjct: 7 GPRYTNLSYIGEGAYGMVCS--AYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLR 62
Query: 315 LQGCPYVIKMHDYVYDTAS---KHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHW 371
+ +I ++D + K +Y++ DL K ++ L N I ++
Sbjct: 63 FR-HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT----QHLSNDHICYFLYQ 117
Query: 372 YEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSV 431
+L +K IH+A ++H DLKP+N L LKI DFG+A D
Sbjct: 118 --ILRGLKYIHSANVLHRDLKPSNLLLNTT---------CDLKICDFGLARVADPDHDHT 166
Query: 432 HKDTAS-GTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY--SHI 488
T T Y +PE N+ T D+WS+GCIL M+ R + H
Sbjct: 167 GFLTEYVATRWYRAPEIML--------NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 218
Query: 489 PNTWAKMLAIARHKDQIEFKPQLANNV--------------------TIPPTLLQSMKLC 528
+ +L I Q + + L +
Sbjct: 219 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 278
Query: 529 LQKDPKARPTV 539
L +P R V
Sbjct: 279 LTFNPHKRIEV 289
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 1e-38
Identities = 50/286 (17%), Positives = 110/286 (38%), Gaps = 39/286 (13%)
Query: 253 LNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELL 312
++ + + +G G V+L ++ + A+K + ++++ + E E++
Sbjct: 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKV---AIKTIREGAMSEEDF----IEEAEVM 54
Query: 313 AKLQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWY 372
KL P +++++ + + ++ E + + T++ + +
Sbjct: 55 MKLS-HPKLVQLYGVCLE--QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLD-- 109
Query: 373 EMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVH 432
+ + + A +IH DL N L N V+K+ DFG+ + DD+ +
Sbjct: 110 -VCEGMAYLEEACVIHRDLAARNCLVGEN---------QVIKVSDFGMTRFVLDDQYTSS 159
Query: 433 KDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTW 492
T + + SPE + R + KSDVWS G +++ + +
Sbjct: 160 TGTK-FPVKWASPEVF---------SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS 209
Query: 493 AKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
+ I+ +KP+L + Q M C ++ P+ RP
Sbjct: 210 EVVEDISTGFR--LYKPRL-----ASTHVYQIMNHCWKERPEDRPA 248
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 1e-38
Identities = 58/278 (20%), Positives = 114/278 (41%), Gaps = 39/278 (14%)
Query: 264 LGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIK 323
LG G SV + +A+KV+ T+++ + + E +++ +L PY+++
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLD-NPYIVR 73
Query: 324 MHDYVYDTASKHLYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIH 382
+ + L ++ME L K++ + + N ++ +++ + +K +
Sbjct: 74 LIGVCQA---EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELL----HQVSMGMKYLE 126
Query: 383 AAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTA-SGTLN 441
+H DL N L V + KI DFG++ +L D + +A L
Sbjct: 127 EKNFVHRDLAARNVLLVNR---------HYAKISDFGLSKALGADDSYYTARSAGKWPLK 177
Query: 442 YMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI-YGRTPYSHIPNTWAKMLAIAR 500
+ +PE N + + +SDVWS G ++ + YG+ PY + +++A
Sbjct: 178 WYAPECI---------NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEVMAFIE 226
Query: 501 HKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
++E P+ PP L M C + RP
Sbjct: 227 QGKRMECPPE------CPPELYALMSDCWIYKWEDRPD 258
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 1e-38
Identities = 53/287 (18%), Positives = 106/287 (36%), Gaps = 34/287 (11%)
Query: 253 LNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELL 312
L +++ + +LG G +VY E E + + + +L + T L+E ++
Sbjct: 6 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 65
Query: 313 AKLQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWY 372
A + P+V ++ S + L Y+R + +
Sbjct: 66 ASVD-NPHVCRLLGICLT--STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV---- 118
Query: 373 EMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVH 432
++ + + ++H DL N L +KI DFG+A L ++ H
Sbjct: 119 QIAKGMNYLEDRRLVHRDLAARNVLVKTP---------QHVKITDFGLAKLLGAEEKEYH 169
Query: 433 KDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI-YGRTPYSHIPNT 491
+ + +M+ E+ T++SDVWS G ++ ++ +G PY IP
Sbjct: 170 AEGGKVPIKWMALESI---------LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA- 219
Query: 492 WAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
+++ +I +++ P + M C D +RP
Sbjct: 220 -SEISSILEKGERLPQPPI------CTIDVYMIMVKCWMIDADSRPK 259
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 141 bits (356), Expect = 2e-38
Identities = 65/283 (22%), Positives = 113/283 (39%), Gaps = 36/283 (12%)
Query: 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG 317
Y +LG G S V L + K +A+K + + + S NE+ +L K++
Sbjct: 11 YDFRDVLGTGAFSEVIL--AEDKRTQKLVAIKCIAKKALEGKE--GSMENEIAVLHKIK- 65
Query: 318 CPYVIKMHDYVYDTASKHLYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLL 376
P ++ + D HLY++M+ +L + + ++ +++L
Sbjct: 66 HPNIVALDDIYES--GGHLYLIMQLVSGGELFDRIV---EKGFYTERDASRLI--FQVLD 118
Query: 377 AVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTA 436
AVK +H GI+H DLKP N L+ + + I DFG++ TA
Sbjct: 119 AVKYLHDLGIVHRDLKPENLLYYS------LDEDSKIMISDFGLSKMEDPGSVL---STA 169
Query: 437 SGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKML 496
GT Y++PE Q + D WS+G I Y ++ G P+ N
Sbjct: 170 CGTPGYVAPEVLAQK---------PYSKAVDCWSIGVIAYILLCGYPPFYD-ENDAKLFE 219
Query: 497 AIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTV 539
I + E++ I + ++ ++KDP+ R T
Sbjct: 220 QILKA----EYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTC 258
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 2e-38
Identities = 58/285 (20%), Positives = 105/285 (36%), Gaps = 34/285 (11%)
Query: 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITD---QSIADSYLNEVELLAK 314
Y LG G + V + A K + + EV +L +
Sbjct: 12 YDTGEELGSGQFAVVKK--CREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 315 LQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEM 374
+Q P VI +H+ + + +++E + L + +L + +
Sbjct: 70 IQ-HPNVITLHEVYEN--KTDVILILELVAGG--ELFDFLAEKESLTEEEATEFLKQ--I 122
Query: 375 LLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKD 434
L V +H+ I H DLKP N + + + +KIIDFG+A + +
Sbjct: 123 LNGVYYLHSLQIAHFDLKPENIMLLDR-----NVPKPRIKIIDFGLAHKIDFGNEFKNI- 176
Query: 435 TASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494
GT +++PE N + ++D+WS+G I Y ++ G +P+ +
Sbjct: 177 --FGTPEFVAPEIV---------NYEPLGLEADMWSIGVITYILLSGASPF---LGDTKQ 222
Query: 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTV 539
EF+ + +N ++ L KDPK R T+
Sbjct: 223 ETLANVSAVNYEFEDEYFSN--TSALAKDFIRRLLVKDPKKRMTI 265
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 3e-38
Identities = 53/283 (18%), Positives = 109/283 (38%), Gaps = 39/283 (13%)
Query: 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG 317
+ + +LGKG V+L + + A+K + + + + E +L+
Sbjct: 4 FILHKMLGKGSFGKVFL--AEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 318 CPYVIKMHDYVYDTASKHLYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLL 376
P++ M ++L+ +ME + DL ++++ +K + E++L
Sbjct: 62 HPFLTHMFCTFQT--KENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYA--AEIIL 114
Query: 377 AVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTA 436
++ +H+ GI++ DLK N L + +KI DFG+ + T
Sbjct: 115 GLQFLHSKGIVYRDLKLDNILLDKD---------GHIKIADFGMCKENMLGDAKTN--TF 163
Query: 437 SGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKML 496
GT +Y++PE + + D WS G +LY M+ G++P+ ++
Sbjct: 164 CGTPDYIAPEIL---------LGQKYNHSVDWWSFGVLLYEMLIGQSPFHG--QDEEELF 212
Query: 497 AIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTV 539
R D + + + ++P+ R V
Sbjct: 213 HSIR-MDNPFYPRW------LEKEAKDLLVKLFVREPEKRLGV 248
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 4e-38
Identities = 56/292 (19%), Positives = 118/292 (40%), Gaps = 39/292 (13%)
Query: 247 SQDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYL 306
++D + + ++ LG+G V++ + + +A+K + ++ ++ L
Sbjct: 8 AKDAWEIPRESLRLEVKLGQGCFGEVWMG---TWNGTTRVAIKTLKPGTMSPEAF----L 60
Query: 307 NEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMII 366
E +++ KL+ +++++ V + + +Y++ E L ++
Sbjct: 61 QEAQVMKKLR-HEKLVQLYAVVSE---EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLV 116
Query: 367 IIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQD 426
+ ++ + + +H DL+ AN L N V K+ DFG+A ++D
Sbjct: 117 DMA--AQIASGMAYVERMNYVHRDLRAANILVGEN---------LVCKVADFGLARLIED 165
Query: 427 DKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYS 486
++ + + A + + +PEAA R T KSDVWS G +L +
Sbjct: 166 NEYTARQ-GAKFPIKWTAPEAA---------LYGRFTIKSDVWSFGILLTELTTKGRVPY 215
Query: 487 HIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
+ DQ+E ++ P +L M C +K+P+ RPT
Sbjct: 216 PGMVNREVL-------DQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPT 260
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 5e-38
Identities = 54/283 (19%), Positives = 114/283 (40%), Gaps = 36/283 (12%)
Query: 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQ 316
+ ++ +G+G V+ G E LA+ + + T S+ + +L E + +
Sbjct: 8 RIELGRCIGEGQFGDVHQ-GIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 317 GCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLL 376
P+++K+ + + ++++ME + + +L +I+ + ++
Sbjct: 67 -HPHIVKLIGVITE---NPVWIIMELCTLGELRSFLQ-VRKYSLDLASLILYAY--QLST 119
Query: 377 AVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTA 436
A+ + + +H D+ N L + V K+ DFG++ ++D T
Sbjct: 120 ALAYLESKRFVHRDIAARNVL--------VSSNDCV-KLGDFGLSRYMEDS-TYYKASKG 169
Query: 437 SGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI-YGRTPYSHIPNTWAKM 495
+ +M+PE+ N R T SDVW G ++ ++ +G P+ + N +
Sbjct: 170 KLPIKWMAPESI---------NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--V 218
Query: 496 LAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
+ + +++ P PPTL M C DP RP
Sbjct: 219 IGRIENGERLPMPPN------CPPTLYSLMTKCWAYDPSRRPR 255
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 5e-38
Identities = 56/278 (20%), Positives = 106/278 (38%), Gaps = 33/278 (11%)
Query: 263 LLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVI 322
++G+G VY G +++ K + V L+ ITD +L E ++ P V+
Sbjct: 34 VIGRGHFGCVYH-GTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVL 91
Query: 323 KMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIH 382
+ + L VL DL ++RN T+ + + + +K +
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVA----KGMKFLA 147
Query: 383 AAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTAS--GTL 440
+ +H DL N + +K+ DFG+A + D + + +
Sbjct: 148 SKKFVHRDLAARNCMLDEK---------FTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 198
Query: 441 NYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIAR 500
+M+ E+ T + T KSDVWS G +L+ ++ P NT+ + + +
Sbjct: 199 KWMALESL---------QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 249
Query: 501 HKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
+ +P+ P L + M C + RP+
Sbjct: 250 GRR--LLQPEY-----CPDPLYEVMLKCWHPKAEMRPS 280
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 139 bits (350), Expect = 8e-38
Identities = 58/308 (18%), Positives = 105/308 (34%), Gaps = 59/308 (19%)
Query: 257 QYQVLSLLGKGGSSSVYLV---GGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLA 313
+ + +G+G V+ G F +A+K++ + + E L+A
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE--ASADMQADFQREAALMA 71
Query: 314 KLQGCPYVIKMHDYVYDTASKHLYVLMEKGD-TDLSKYMRNLNKMTT------------- 359
+ V K + +L E DL++++R+++ T
Sbjct: 72 EFDNPNIV---KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 128
Query: 360 --------LPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGN 411
L + I ++ + + +H DL N L N
Sbjct: 129 VSSPGPPPLSCAEQLCIAR--QVAAGMAYLSERKFVHRDLATRNCLVGEN---------M 177
Query: 412 VLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSL 471
V+KI DFG++ ++ + + +M PE+ R T +SDVW+
Sbjct: 178 VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESI---------FYNRYTTESDVWAY 228
Query: 472 GCILYNMI-YGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQ 530
G +L+ + YG PY + + + LA P L M+LC
Sbjct: 229 GVVLWEIFSYGLQPYYGMAHEEV--------IYYVRDGNILACPENCPLELYNLMRLCWS 280
Query: 531 KDPKARPT 538
K P RP+
Sbjct: 281 KLPADRPS 288
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 9e-38
Identities = 50/285 (17%), Positives = 102/285 (35%), Gaps = 36/285 (12%)
Query: 257 QYQVLSLLGKGGSSSVYLV--GGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAK 314
++G G VY +S + P+A+K + Q + +L E ++ +
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRV--DFLGEAGIMGQ 65
Query: 315 LQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEM 374
+I++ + K + ++ E + + K ++ ++ +
Sbjct: 66 FS-HHNIIRLEGVISK--YKPMMIITEYMENG-ALDKFLREKDGEFSVLQLVGMLR--GI 119
Query: 375 LLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKD 434
+K + +H DL N L N V K+ DFG++ L+DD + +
Sbjct: 120 AAGMKYLANMNYVHRDLAARNILVNSN---------LVCKVSDFGLSRVLEDDPEATYTT 170
Query: 435 TAS-GTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWA 493
+ + + +PEA + + T SDVWS G +++ ++ +
Sbjct: 171 SGGKIPIRWTAPEAI---------SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE 221
Query: 494 KMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
M I +L + P + Q M C Q++ RP
Sbjct: 222 VM-------KAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPK 259
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 7e-37
Identities = 60/302 (19%), Positives = 116/302 (38%), Gaps = 52/302 (17%)
Query: 257 QYQVLSLLGKGGSSSVYLV-----GGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVEL 311
+ + LG+G V L + +A+K++ SD T++ ++D ++E+E+
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK-SDATEKDLSD-LISEMEM 71
Query: 312 LAKLQGCPYVIKMHDYVYDTASKHLYVLMEKGD-TDLSKYMRN-------------LNKM 357
+ + +I + LYV++E +L +Y++ N
Sbjct: 72 MKMIGKHKNIINLLGACTQ--DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129
Query: 358 TTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIID 417
L + ++ Y++ ++ + + IH DL N L + NV+KI D
Sbjct: 130 EQLSSKDLVSCA--YQVARGMEYLASKKCIHRDLAARNVLVTED---------NVMKIAD 178
Query: 418 FGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYN 477
FG+A + + +M+PEA T++SDVWS G +L+
Sbjct: 179 FGLARDIHHIDYYKKTTNGRLPVKWMAPEAL---------FDRIYTHQSDVWSFGVLLWE 229
Query: 478 MI-YGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKAR 536
+ G +PY +P + + + +++ L M+ C P R
Sbjct: 230 IFTLGGSPYPGVPVEE--LFKLLKEGHRMDKPSN------CTNELYMMMRDCWHAVPSQR 281
Query: 537 PT 538
PT
Sbjct: 282 PT 283
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 7e-37
Identities = 54/301 (17%), Positives = 103/301 (34%), Gaps = 49/301 (16%)
Query: 257 QYQVLSLLGKGGSSSVYLV---GGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLA 313
+ LG G V G +A+K++ S + ++ ++E+++L+
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLS 81
Query: 314 KLQGCPYVIKMHDYVYDTASKHLYVLMEKGD-TDLSKYMRN---------------LNKM 357
L ++ + V+ E DL ++R +
Sbjct: 82 YLGNHMNIVNLLGACTI--GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 358 TTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIID 417
L ++ + ++ + + + IH DL N L + KI D
Sbjct: 140 LALDLEDLLSFSY--QVAKGMAFLASKNCIHRDLAARNILLTHG---------RITKICD 188
Query: 418 FGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYN 477
FG+A +++D V K A + +M+PE+ T++SDVWS G L+
Sbjct: 189 FGLARDIKNDSNYVVKGNARLPVKWMAPESI---------FNCVYTFESDVWSYGIFLWE 239
Query: 478 MIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARP 537
+ + +K + + ++ P + MK C DP RP
Sbjct: 240 LFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEH------APAEMYDIMKTCWDADPLKRP 293
Query: 538 T 538
T
Sbjct: 294 T 294
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 1e-36
Identities = 60/307 (19%), Positives = 113/307 (36%), Gaps = 49/307 (15%)
Query: 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKL 315
+QY+ ++ +G+G V+ + +ALK V + ++ + S + EV +L L
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGG-RFVALKRVRVQTG-EEGMPLSTIREVAVLRHL 64
Query: 316 QGC--PYVIKMHDYVYDTASK---HLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMH 370
+ P V+++ D + + L ++ E D DL+ Y+ + + T+ ++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 371 WYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTS 430
L + +H+ ++H DLKP N L + +K+ DFG+A
Sbjct: 125 L---LRGLDFLHSHRVVHRDLKPQNILVTSS---------GQIKLADFGLARIYSFQM-- 170
Query: 431 VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSH--- 487
+ TL Y +PE D+WS+GCI M + +
Sbjct: 171 -ALTSVVVTLWYRAPEVL---------LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 220
Query: 488 --------------IPNTWAKMLAIARHKDQIEFKPQLANNVT-IPPTLLQSMKLCLQKD 532
W + +A+ R + + VT I + CL +
Sbjct: 221 VDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFN 280
Query: 533 PKARPTV 539
P R +
Sbjct: 281 PAKRISA 287
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 134 bits (339), Expect = 2e-36
Identities = 44/286 (15%), Positives = 102/286 (35%), Gaps = 37/286 (12%)
Query: 253 LNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELL 312
+ + LG G VY G + +A+K + + + L E ++
Sbjct: 14 MERTDITMKHKLGGGQYGEVYE--GVWKKYSLTVAVKTLKEDTMEVEEF----LKEAAVM 67
Query: 313 AKLQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWY 372
+++ P ++++ Y++ E + +++ +
Sbjct: 68 KEIK-HPNLVQLLGVCTR--EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMA--T 122
Query: 373 EMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVH 432
++ A++ + IH DL N L N +++K+ DFG++ + D + H
Sbjct: 123 QISSAMEYLEKKNFIHRDLAARNCLVGEN---------HLVKVADFGLSRLMTGDTYTAH 173
Query: 433 KDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTW 492
+ + +PE+ + + KSDVW+ G +L+ +
Sbjct: 174 AGAK-FPIKWTAPESL---------AYNKFSIKSDVWAFGVLLWEIATYGMSPYP-GIDL 222
Query: 493 AKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
+++ + ++E P + + M+ C Q +P RP+
Sbjct: 223 SQVYELLEKDYRMERPEG------CPEKVYELMRACWQWNPSDRPS 262
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 133 bits (336), Expect = 8e-36
Identities = 64/308 (20%), Positives = 116/308 (37%), Gaps = 44/308 (14%)
Query: 253 LNGKQYQVLSLLGKGGSSSVYLV-GGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVEL 311
++ ++ ++G G V +A+K + Q +L+E +
Sbjct: 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQ--RRDFLSEASI 80
Query: 312 LAKLQGCPYVIKMHDYVYDTASKHLYVLME-KGDTDLSKYMRNLNKMTTLPNTMIIIIMH 370
+ + P VI + V S + ++ E + L ++R + T+ + ++
Sbjct: 81 MGQFD-HPNVIHLEGVVTK--STPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGML--- 134
Query: 371 WYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDK-- 428
+ +K + +H DL N L N V K+ DFG++ L+DD
Sbjct: 135 -RGIAAGMKYLADMNYVHRDLAARNILVNSN---------LVCKVSDFGLSRFLEDDTSD 184
Query: 429 -TSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI-YGRTPYS 486
T + + +PEA + T SDVWS G +++ ++ YG PY
Sbjct: 185 PTYTSALGGKIPIRWTAPEAI---------QYRKFTSASDVWSYGIVMWEVMSYGERPYW 235
Query: 487 HIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT---VGNSV 543
+ N + IE +L + P L Q M C QKD RP + N++
Sbjct: 236 DMTN--------QDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287
Query: 544 TQINNNPE 551
++ NP
Sbjct: 288 DKMIRNPN 295
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 8e-36
Identities = 57/301 (18%), Positives = 113/301 (37%), Gaps = 41/301 (13%)
Query: 251 ITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVE 310
+T+N + L LLGKG V L + + A+K++ I + + E
Sbjct: 2 VTMN--DFDYLKLLGKGTFGKVIL--VREKATGRYYAMKILRKEVIIAKDEVAHTVTESR 57
Query: 311 LLAKLQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMH 370
+L + P++ + L +ME + + +L++
Sbjct: 58 VLQNTR-HPFLTALKYAFQT--HDRLCFVMEYANGG--ELFFHLSRERVFTEERARFYG- 111
Query: 371 WYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTS 430
E++ A++ +H+ +++ D+K N + + +KI DFG+ D +
Sbjct: 112 -AEIVSALEYLHSRDVVYRDIKLENLMLDKD---------GHIKITDFGLCKEGISDGAT 161
Query: 431 VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN 490
+ GT Y++PE D W LG ++Y M+ GR P+ +
Sbjct: 162 MKTFC--GTPEYLAPEVLEDN---------DYGRAVDWWGLGVVMYEMMCGRLPFYN--Q 208
Query: 491 TWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVG-NSVTQINNN 549
++ + ++I F T+ P + L+KDPK R G + ++ +
Sbjct: 209 DHERLFELIL-MEEIRFPR------TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261
Query: 550 P 550
Sbjct: 262 R 262
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 133 bits (334), Expect = 1e-35
Identities = 61/303 (20%), Positives = 109/303 (35%), Gaps = 50/303 (16%)
Query: 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQ 316
+Y L +G+G VY F ALK + L D+ I + + E+ +L +L+
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETF---ALKKIRLEKE-DEGIPSTTIREISILKELK 58
Query: 317 GCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLL 376
++K++D ++ K L ++ E D DL K + + ++L
Sbjct: 59 -HSNIVKLYDVIHT--KKRLVLVFEHLDQDLKKLLDVCEG----GLESVTAKSFLLQLLN 111
Query: 377 AVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTA 436
+ H ++H DLKP N L LKI DFG+A +
Sbjct: 112 GIAYCHDRRVLHRDLKPQNLLINRE---------GELKIADFGLARAFGIPVRKYT--HE 160
Query: 437 SGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN------ 490
TL Y +P+ + + + D+WS+GCI M+ G + +
Sbjct: 161 IVTLWYRAPDVLMGSK--------KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMR 212
Query: 491 -----------TWAKMLAIARHK---DQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKAR 536
W + + ++ E P + + + + + L+ DP R
Sbjct: 213 IFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQR 272
Query: 537 PTV 539
T
Sbjct: 273 ITA 275
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 2e-35
Identities = 62/302 (20%), Positives = 116/302 (38%), Gaps = 48/302 (15%)
Query: 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG 317
+Q + +G+G VY ++ + +ALK + L T+ + + + E+ LL +L
Sbjct: 4 FQKVEKIGEGTYGVVYK--ARNKLTGEVVALKKIRLDTETEG-VPSTAIREISLLKELN- 59
Query: 318 CPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLA 377
P ++K+ D ++ LY++ E DL K+M + +T +P +I + +++L
Sbjct: 60 HPNIVKLLDVIHT--ENKLYLVFEFLHQDLKKFMD-ASALTGIPLPLIKSYL--FQLLQG 114
Query: 378 VKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTAS 437
+ H+ ++H DLKP N L +K+ DFG+A +
Sbjct: 115 LAFCHSHRVLHRDLKPQNLLINTE---------GAIKLADFGLARAFGVPVR--TYTHEV 163
Query: 438 GTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY------------ 485
TL Y +PE + D+WSLGCI M+ R +
Sbjct: 164 VTLWYRAPEILLGCK--------YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 215
Query: 486 -----SHIPNTWAKMLAIARHKDQIEFKPQLANNVTIP---PTLLQSMKLCLQKDPKARP 537
+ W + ++ +K + + +P + L DP R
Sbjct: 216 FRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRI 275
Query: 538 TV 539
+
Sbjct: 276 SA 277
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 132 bits (332), Expect = 4e-35
Identities = 71/312 (22%), Positives = 127/312 (40%), Gaps = 65/312 (20%)
Query: 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG 317
YQ++ LG+G S V+ + + + +K++ E+++L L+G
Sbjct: 37 YQLVRKLGRGKYSEVFE--AINITNNEKVVVKILKPVK------KKKIKREIKILENLRG 88
Query: 318 CPYVIKMHDYVYDTASKHLYVLMEK-GDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLL 376
P +I + D V D S+ ++ E +TD + + TL + I M YE+L
Sbjct: 89 GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ------TLTDYDIRFYM--YEILK 140
Query: 377 AVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTA 436
A+ H+ GI+H D+KP N + ID L++ID+G+A + +
Sbjct: 141 ALDYCHSMGIMHRDVKPHNVM--------IDHEHRKLRLIDWGLAEFYHPGQEYNVR--- 189
Query: 437 SGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKML 496
+ + PE + Y D+WSLGC+L +MI+ + P+ H + + +++
Sbjct: 190 VASRYFKGPEL--------LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 241
Query: 497 AIAR-----------HKDQIEFKPQL------------------ANNVTIPPTLLQSMKL 527
IA+ K IE P+ N + P L +
Sbjct: 242 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 301
Query: 528 CLQKDPKARPTV 539
L+ D ++R T
Sbjct: 302 LLRYDHQSRLTA 313
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 5e-35
Identities = 60/301 (19%), Positives = 113/301 (37%), Gaps = 49/301 (16%)
Query: 260 VLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDIT--DQSIADSYLNEVELLAKLQG 317
L LG+G ++VY ++ + +A+K + L + I + L E++LL +L
Sbjct: 2 KLDFLGEGQFATVYK--ARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS- 58
Query: 318 CPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLA 377
P +I + D ++ ++ + +TDL +++ + + T + ++ L
Sbjct: 59 HPNIIGLLDAFGH--KSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYML----MTLQG 112
Query: 378 VKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTAS 437
++ +H I+H DLKP N L N VLK+ DFG+A S +
Sbjct: 113 LEYLHQHWILHRDLKPNNLLLDEN---------GVLKLADFGLAKSFGSPNRAYTHQV-- 161
Query: 438 GTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY------------ 485
T Y +PE D+W++GCIL ++
Sbjct: 162 VTRWYRAPELLFGA--------RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI 213
Query: 486 -----SHIPNTWAKMLAIARHKDQIEFKPQLANNV--TIPPTLLQSMKLCLQKDPKARPT 538
+ W M ++ + F +++ LL ++ +P AR T
Sbjct: 214 FETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARIT 273
Query: 539 V 539
Sbjct: 274 A 274
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 8e-35
Identities = 41/304 (13%), Positives = 93/304 (30%), Gaps = 41/304 (13%)
Query: 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAK 314
+ + +GKG V+ + + +A+K+ + E+
Sbjct: 2 ARTIVLQESIGKGRFGEVWRG----KWRGEEVAVKIFSSREERSWFR----EAEIYQTVM 53
Query: 315 LQGCPYVIKMHDYVY--DTASKHLYVLMEKGDT-DLSKYMRN--LNKMTTLPNTMIIIIM 369
L+ ++ + L+++ + + L Y+ + + +
Sbjct: 54 LR-HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASG 112
Query: 370 HWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQD--D 427
+ + V I H DLK N L + G I D G+A D
Sbjct: 113 LAHLHMEIVGTQGKPAIAHRDLKSKNIL--------VKKNGTC-CIADLGLAVRHDSATD 163
Query: 428 KTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSH 487
+ + GT YM+PE S + ++D++++G + + + +
Sbjct: 164 TIDIAPNHRVGTKRYMAPEVL---DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220
Query: 488 IPN-------------TWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPK 534
+ + +M + + P + + + M+ C +
Sbjct: 221 HEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGA 280
Query: 535 ARPT 538
AR T
Sbjct: 281 ARLT 284
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 131 bits (331), Expect = 1e-34
Identities = 68/337 (20%), Positives = 123/337 (36%), Gaps = 48/337 (14%)
Query: 215 STKSSDPSVSKETIKPAKPQITTSNAKKSVETSQDVITLNGKQYQVLSLLGKGGSSSVYL 274
+ K S+ KE + AK KK SQ+ L+ Q+ + LG G V L
Sbjct: 6 AKKGSEQESVKEFLAKAKEDFL----KKWETPSQNTAQLD--QFDRIKTLGTGSFGRVML 59
Query: 275 VGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334
+ A+K++D + + LNE +L + P+++K+ D ++
Sbjct: 60 --VKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSFKDNSNL 116
Query: 335 HLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPA 394
++ + G S L ++ +++L + +H+ +I+ DLKP
Sbjct: 117 YMVMEYVAGGEMFSH----LRRIGRFSEPHARFYA--AQIVLTFEYLHSLDLIYRDLKPE 170
Query: 395 NFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSS 454
N L ID G + ++ DFG A ++ ++ GT ++PE
Sbjct: 171 NLL--------IDQQGYI-QVTDFGFAKRVKGRTWTLC-----GTPEALAPEII------ 210
Query: 455 GGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANN 514
+ D W+LG ++Y M G P+ + ++ F
Sbjct: 211 ---LSKGYNKAVDWWALGVLIYEMAAGYPPF---FADQPIQIYEKIVSGKVRFPSH---- 260
Query: 515 VTIPPTLLQSMKLCLQKDPKAR-PTVGNSVTQINNNP 550
L ++ LQ D R + N V I N+
Sbjct: 261 --FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHK 295
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (326), Expect = 2e-34
Identities = 65/314 (20%), Positives = 108/314 (34%), Gaps = 56/314 (17%)
Query: 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQ 316
+Y+ L+ +G+G V+ + +ALK V + + + + L E+++L L+
Sbjct: 11 KYEKLAKIGQGTFGEVFK--ARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLK 67
Query: 317 GCPYVIKMHDYVYDTASK------HLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMH 370
V+ + + AS +Y++ + + DL+ + N+ TL ++
Sbjct: 68 -HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVM--- 123
Query: 371 WYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTS 430
+L + IH I+H D+K AN L + VLK+ DFG+A + K S
Sbjct: 124 -QMLLNGLYYIHRNKILHRDMKAANVLITRD---------GVLKLADFGLARAFSLAKNS 173
Query: 431 VHKDTAS--GTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY--- 485
+ TL Y PE G Y D+W GCI+ M
Sbjct: 174 QPNRYTNRVVTLWYRPPELLL------GERDY--GPPIDLWGAGCIMAEMWTRSPIMQGN 225
Query: 486 --------------SHIPNTWAKMLAIARH------KDQIEFKPQLANNVTIPPTLLQSM 525
S P W + + K Q P L +
Sbjct: 226 TEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLI 285
Query: 526 KLCLQKDPKARPTV 539
L DP R
Sbjct: 286 DKLLVLDPAQRIDS 299
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 3e-34
Identities = 62/305 (20%), Positives = 112/305 (36%), Gaps = 50/305 (16%)
Query: 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKL 315
++Y+ L +G+G +V+ + + +ALK V L D D+ + S L E+ LL +L
Sbjct: 2 QKYEKLEKIGEGTYGTVFK--AKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKEL 58
Query: 316 QGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEML 375
+ ++++HD ++ L E D DL KY + N + +++L
Sbjct: 59 K-HKNIVRLHDVLHSDKKLTLV--FEFCDQDLKKYFDSCNGDLDPEIVKSFL----FQLL 111
Query: 376 LAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDT 435
+ H+ ++H DLKP N L N LK+ +FG+A + +
Sbjct: 112 KGLGFCHSRNVLHRDLKPQNLLINRN---------GELKLANFGLARAFGIPVRCYSAEV 162
Query: 436 ASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTP----------- 484
TL Y P+ + D+WS GCI + P
Sbjct: 163 --VTLWYRPPDVLFGAK--------LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL 212
Query: 485 -------YSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIP---PTLLQSMKLCLQKDPK 534
+ W M + +K + + +P T ++ L+ +P
Sbjct: 213 KRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPV 272
Query: 535 ARPTV 539
R +
Sbjct: 273 QRISA 277
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 3e-34
Identities = 57/299 (19%), Positives = 107/299 (35%), Gaps = 46/299 (15%)
Query: 253 LNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELL 312
L+ + ++G+G V + + + + + + + + E+E+L
Sbjct: 7 LDWNDIKFQDVIGEGNFGQVLK--ARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVL 64
Query: 313 AKLQGCPYVIKMHDYVYDTASKHL-YVLMEKGDTDLSKYMRNLNKMTTLPNTMII----- 366
KL P +I + +L G+ L ++R + T P I
Sbjct: 65 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGN--LLDFLRKSRVLETDPAFAIANSTAS 122
Query: 367 -----IIMHW-YEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGI 420
++H+ ++ + + IH DL N L N V KI DFG+
Sbjct: 123 TLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN---------YVAKIADFGL 173
Query: 421 ACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI- 479
+ + + V K + +M+ E+ N T SDVWS G +L+ ++
Sbjct: 174 S---RGQEVYVKKTMGRLPVRWMAIESL---------NYSVYTTNSDVWSYGVLLWEIVS 221
Query: 480 YGRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
G TPY T A++ ++E + M+ C ++ P RP+
Sbjct: 222 LGGTPYCG--MTCAELYEKLPQGYRLEKPLN------CDDEVYDLMRQCWREKPYERPS 272
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 2e-33
Identities = 55/296 (18%), Positives = 105/296 (35%), Gaps = 40/296 (13%)
Query: 257 QYQVLSLLGKGGSSSVYLV---GGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLA 313
+ ++ LG+G V G + +A+K++ S + ++E+++L
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILI 71
Query: 314 KLQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPN----------- 362
+ V+ + + ++ +LS Y+R+
Sbjct: 72 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 131
Query: 363 TMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIAC 422
T+ +I + +++ ++ + + IH DL N L NV+KI DFG+A
Sbjct: 132 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK---------NVVKICDFGLAR 182
Query: 423 SLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGR 482
+ D V K A L +M+PE T +SDVWS G +L+ +
Sbjct: 183 DIYKDPDYVRKGDARLPLKWMAPETI---------FDRVYTIQSDVWSFGVLLWEIFSLG 233
Query: 483 TPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
+ + ++ P + Q+M C +P RPT
Sbjct: 234 ASPYPGVKIDEEFCRRLKEGTRMRAPDY------TTPEMYQTMLDCWHGEPSQRPT 283
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 2e-32
Identities = 60/307 (19%), Positives = 108/307 (35%), Gaps = 56/307 (18%)
Query: 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG 317
Y ++G G VY + +A+K V E++++ KL
Sbjct: 22 YTDTKVIGNGSFGVVYQ--AKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLD- 71
Query: 318 CPYVIKMHDYVYDTASK----HLYVLMEKGDTDLSKYMRNLNKM-TTLPNTMIIIIMHWY 372
++++ + Y + K +L ++++ + + R+ ++ TLP + + M Y
Sbjct: 72 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM--Y 129
Query: 373 EMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVH 432
++ ++ IH+ GI H D+KP N L + VLK+ DFG A L +
Sbjct: 130 QLFRSLAYIHSFGICHRDIKPQNLLLDPD--------TAVLKLCDFGSAKQLVRGE---P 178
Query: 433 KDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSH----- 487
+ + Y +PE T DVWS GC+L ++ G+ +
Sbjct: 179 NVSYICSRYYRAPELIF--------GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD 230
Query: 488 ------------IPNTWAKMLAIARHKDQIEFKPQLANNV---TIPPTLLQSMKLCLQKD 532
+M + K V PP + L+
Sbjct: 231 QLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYT 290
Query: 533 PKARPTV 539
P AR T
Sbjct: 291 PTARLTP 297
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 4e-32
Identities = 62/293 (21%), Positives = 113/293 (38%), Gaps = 41/293 (13%)
Query: 256 KQYQVLSLLGKGGSSSVYLV---GGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELL 312
++ + LG+G VY G + +A+K V+ + +LNE ++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVM 77
Query: 313 AKLQGCPYVIKMHDYVYDTASKHLYVLMEKGD-TDLSKYMRNLNKM-----TTLPNTMII 366
+ C +V+++ V + + V+ME DL Y+R+L P ++
Sbjct: 78 KEFN-CHHVVRLLGVV--SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 134
Query: 367 IIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQD 426
+I E+ + ++A +H DL N + + +KI DFG+ + +
Sbjct: 135 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED---------FTVKIGDFGMTRDIYE 185
Query: 427 DKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMI-YGRTPY 485
+ +MSPE+ T SDVWS G +L+ + PY
Sbjct: 186 TDYYRKGGKGLLPVRWMSPESL---------KDGVFTTYSDVWSFGVVLWEIATLAEQPY 236
Query: 486 SHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538
+ N + + + KP P L + M++C Q +PK RP+
Sbjct: 237 QGLSNEQVLRFVM---EGGLLDKPD-----NCPDMLFELMRMCWQYNPKMRPS 281
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 5e-31
Identities = 73/310 (23%), Positives = 114/310 (36%), Gaps = 58/310 (18%)
Query: 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKL 315
Y+ L +G G +V +A+K + + A E+ LL +
Sbjct: 18 AVYRDLQPVGSGAYGAVCS--AVDGRTGAKVAIKKLYR-PFQSELFAKRAYRELRLLKHM 74
Query: 316 QGCPYVIKMHDYVYDTASK----HLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHW 371
+ VI + D + Y++M TDL K M++ L I ++
Sbjct: 75 R-HENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH----EKLGEDRIQFLV-- 127
Query: 372 YEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSV 431
Y+ML ++ IHAAGIIH DLKP N + LKI+DFG+A + T
Sbjct: 128 YQMLKGLRYIHAAGIIHRDLKPGNLAVNED---------CELKILDFGLARQADSEMTGY 178
Query: 432 HKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSH---- 487
Y +PE N R T D+WS+GCI+ MI G+T +
Sbjct: 179 VVTRW-----YRAPEVIL--------NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL 225
Query: 488 ------------IPNTWAKMLAIARHKDQIEFKPQLANN------VTIPPTLLQSMKLCL 529
P + + L K+ ++ P+L P + ++ L
Sbjct: 226 DQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKML 285
Query: 530 QKDPKARPTV 539
D + R T
Sbjct: 286 VLDAEQRVTA 295
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 9e-30
Identities = 66/308 (21%), Positives = 106/308 (34%), Gaps = 58/308 (18%)
Query: 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG 317
YQ LS +G G SV +A+K + + A E+ LL ++
Sbjct: 20 YQNLSPVGSGAYGSVCA--AFDTKTGLRVAVKKLSRPFQSIIH-AKRTYRELRLLKHMK- 75
Query: 318 CPYVIKMHDYVYDTAS----KHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYE 373
VI + D S +Y++ DL+ ++ + Y+
Sbjct: 76 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT------DDHVQFLIYQ 129
Query: 374 MLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHK 433
+L +K IH+A IIH DLKP+N + LKI+DFG+A D+ T
Sbjct: 130 ILRGLKYIHSADIIHRDLKPSNLAVNED---------CELKILDFGLARHTDDEMTGYVA 180
Query: 434 DTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY-------- 485
T Y +PE N D+WS+GCI+ ++ GRT +
Sbjct: 181 -----TRWYRAPEIML--------NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 227
Query: 486 ------------SHIPNTWAKMLAIARHKDQIEFKPQLANNV--TIPPTLLQSMKLCLQK 531
+ + + A + + NV P + ++ L
Sbjct: 228 LKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVL 287
Query: 532 DPKARPTV 539
D R T
Sbjct: 288 DSDKRITA 295
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 2e-26
Identities = 62/321 (19%), Positives = 112/321 (34%), Gaps = 69/321 (21%)
Query: 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKL 315
K+YQ L +G G V + +A+K + +Q+ A E+ L+ +
Sbjct: 17 KRYQNLKPIGSGAQGIVCA--AYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCV 73
Query: 316 QGCPYVIKMHDYVYDTAS----KHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHW 371
+I + + + + +Y++ME D +L + ++ + + ++
Sbjct: 74 N-HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-----DHERMSYLL-- 125
Query: 372 YEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSV 431
Y+ML +K +H+AGIIH DLKP+N + + LKI+DFG+A +
Sbjct: 126 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSD---------CTLKILDFGLARTAGTSFMMT 176
Query: 432 HKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY------ 485
T Y +PE D+WS+GCI+ M+ + +
Sbjct: 177 PY---VVTRYYRAPEVI---------LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI 224
Query: 486 -----------SHIPNTWAKMLAIARH----------------KDQIEFKPQLANNVTIP 518
+ P K+ R+ F +N
Sbjct: 225 DQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKA 284
Query: 519 PTLLQSMKLCLQKDPKARPTV 539
+ L DP R +V
Sbjct: 285 SQARDLLSKMLVIDPAKRISV 305
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 103 bits (258), Expect = 7e-25
Identities = 56/338 (16%), Positives = 116/338 (34%), Gaps = 74/338 (21%)
Query: 252 TLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVEL 311
+Y ++ LG G S+V+L +A+K+V + ++ +E++L
Sbjct: 9 PYKDARYILVRKLGWGHFSTVWL--AKDMVNNTHVAMKIVRGDKVYTEAA----EDEIKL 62
Query: 312 LAKLQ----------GCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLP 361
L ++ G +++K+ D+ ++V+M + + K
Sbjct: 63 LQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLG-ENLLALIKKYEHRG 121
Query: 362 NTMIIIIMHWYEMLLAVKEIH-AAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGI 420
+I + ++LL + +H GIIH+D+KP N L ++ + + +I I
Sbjct: 122 IPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVL--------MEIVDSPENLIQIKI 173
Query: 421 ACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY 480
A H + T Y SPE +D+WS C+++ +I
Sbjct: 174 ADLGNACWYDEHYTNSIQTREYRSPEVL---------LGAPWGCGADIWSTACLIFELIT 224
Query: 481 GRTPYS----------------------HIPNTWAKM----------LAIARHKDQIEFK 508
G + +P+ + + R+ +++F
Sbjct: 225 GDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFW 284
Query: 509 P-------QLANNVTIPPTLLQSMKLCLQKDPKARPTV 539
P + + + + LQ DP+ R
Sbjct: 285 PLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 62.1 bits (150), Expect = 8e-12
Identities = 41/232 (17%), Positives = 73/232 (31%), Gaps = 64/232 (27%)
Query: 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSY------------ 305
+ L+G+G S+V+ +F +K + + + + +
Sbjct: 2 DAIGKLMGEGKESAVFNC---YSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAI 58
Query: 306 ---LNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPN 362
NE L KLQG V K++ + + VLME D +R
Sbjct: 59 RSARNEFRALQKLQG-LAVPKVYAWEGN------AVLMELIDAKELYRVR---------- 101
Query: 363 TMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIAC 422
+ +L V + + GI+H DL N L + IIDF +
Sbjct: 102 -VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS----------EEGIWIIDFPQSV 150
Query: 423 SLQ--DDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLG 472
+ + + +D + + TYR + D+ S
Sbjct: 151 EVGEEGWREILERDVRNIITYF--------------SRTYR--TEKDINSAI 186
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 553 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1faqa_ | 52 | RAF-1 {Human (Homo sapiens) [TaxId: 9606]} | 98.21 | |
| d1kbea_ | 49 | Kinase suppressor of Ras, Ksr {Mouse (Mus musculus | 98.09 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.76 | |
| d1xa6a3 | 62 | Beta-chimaerin, middle domain {Human (Homo sapiens | 97.55 | |
| d1tbna_ | 66 | Protein kinase c-gamma {Rat (Rattus rattus) [TaxId | 97.17 | |
| d1ptqa_ | 50 | Protein kinase C-delta (PKCdelta) {Mouse (Mus musc | 97.05 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.04 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.71 | |
| d1r79a_ | 84 | Diacylglycerol kinase delta {Human (Homo sapiens) | 96.38 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.14 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.46 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 94.08 | |
| d1vd4a_ | 62 | Transcription initiation factor TFIIE-alpha {Human | 83.77 | |
| d1v6ga1 | 41 | Actin-binding LIM protein 2, abLIM2 {Human (Homo s | 82.78 | |
| d1a1ia3 | 28 | ZIF268 {Mouse (Mus musculus) [TaxId: 10090]} | 80.25 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-52 Score=416.75 Aligned_cols=268 Identities=23% Similarity=0.333 Sum_probs=207.8
Q ss_pred eEEecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEE
Q psy14267 250 VITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVY 329 (553)
Q Consensus 250 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~ 329 (553)
.|++..++|++++.||+|+||+||+|+... .||||+++...... ...+.+.+|+.+|++++ ||||+++++++.
T Consensus 2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~~-----~vAvK~~~~~~~~~-~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~ 74 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG-----DVAVKMLNVTAPTP-QQLQAFKNEVGVLRKTR-HVNILLFMGYST 74 (276)
T ss_dssp CCBCCTTCCCCCSEEEECSSCEEEEEESSS-----EEEEEECCCSSCCT-THHHHHHHHHHHHTTCC-CTTBCCEEEEEC
T ss_pred CcccccccEEEEEEEeeCCCcEEEEEEECC-----EEEEEEEEcccCCH-HHHHHHHHHHHHHHhCC-CCCEeeeeEEEe
Confidence 467778899999999999999999996432 39999998765444 44688999999999995 699999998753
Q ss_pred eCCCceEEEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecC
Q psy14267 330 DTASKHLYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDC 408 (553)
Q Consensus 330 ~~~~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~ 408 (553)
...++++||++. ++|.+++..... ...+..+..++.||+.||+|||+++||||||||+||||+.+
T Consensus 75 ---~~~~~lv~Ey~~~g~L~~~l~~~~~----~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~------- 140 (276)
T d1uwha_ 75 ---APQLAIVTQWCEGSSLYHHLHIIET----KFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHED------- 140 (276)
T ss_dssp ---SSSCEEEEECCCEEEHHHHHHTSCC----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT-------
T ss_pred ---ccEEEEEEecCCCCCHHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCC-------
Confidence 345789999865 799999876432 34456677778899999999999999999999999999877
Q ss_pred CCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy14267 409 IGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHI 488 (553)
Q Consensus 409 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~ 488 (553)
+.+||+|||+|+...............||+.|||||++.+.... .|+.++|||||||+||||+||+.||.+.
T Consensus 141 --~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~------~~~~~sDiwS~Gv~l~el~tg~~Pf~~~ 212 (276)
T d1uwha_ 141 --LTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN------PYSFQSDVYAFGIVLYELMTGQLPYSNI 212 (276)
T ss_dssp --SSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSC------CCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred --CCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCC------CCCchhhhhhhHHHHHHHHHCCCCCCCC
Confidence 57999999999887654443344567899999999999764321 4789999999999999999999999987
Q ss_pred CchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 489 PNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 489 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
.........+......... ......+++++.+||.+||..||++|||+.+|+++|+.+
T Consensus 213 ~~~~~~~~~~~~~~~~p~~---~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l 270 (276)
T d1uwha_ 213 NNRDQIIFMVGRGYLSPDL---SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 270 (276)
T ss_dssp CCHHHHHHHHHHTSCCCCG---GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ChHHHHHHHHhcCCCCCcc---hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 6654444444433222111 122347899999999999999999999999999999864
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-52 Score=415.66 Aligned_cols=255 Identities=23% Similarity=0.324 Sum_probs=201.8
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|++++.||+|+||+||+|+++.++.. ||||++.+.... +..+++.+|+++|++++ ||||+++++++.+ ...
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~--vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~-HpnIv~~~~~~~~--~~~ 77 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEA--VAVKIVDMKRAV--DCPENIKKEICINKMLN-HENVVKFYGHRRE--GNI 77 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCE--EEEEEEECC---------CHHHHHHHHHTCC-CTTBCCEEEEEEE--TTE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCE--EEEEEEehhhcc--hHHHHHHHHHHHHHhCC-CCCEeeEeeeecc--Cce
Confidence 5799999999999999999998877754 999999876533 23467899999999995 5999999998855 568
Q ss_pred EEEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
+|++||++. ++|.+++.... ..++..+..++.||+.||+|||++|||||||||+||||+.+ +.+|
T Consensus 78 ~~ivmEy~~gg~L~~~l~~~~-----~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~---------~~~K 143 (271)
T d1nvra_ 78 QYLFLEYCSGGELFDRIEPDI-----GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER---------DNLK 143 (271)
T ss_dssp EEEEEECCTTEEGGGGSBTTT-----BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT---------CCEE
T ss_pred eEEEEeccCCCcHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCC---------CCEE
Confidence 899999864 68988876433 34556677788899999999999999999999999999876 5799
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||+|+..............+||+.|||||++.+..+ ++.++|||||||+||||++|+.||.........
T Consensus 144 L~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~--------~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~ 215 (271)
T d1nvra_ 144 ISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF--------HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 215 (271)
T ss_dssp ECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSB--------CHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH
T ss_pred EccchhheeeccCCccccccceeeCcCccCHhHhcCCCC--------CCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH
Confidence 999999988765443333446789999999999986642 367899999999999999999999875443333
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
.......... ...+..+++++++||.+||+.||++|||++|+++|
T Consensus 216 ~~~~~~~~~~------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 216 YSDWKEKKTY------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp HHHHHTTCTT------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHhcCCCC------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 3333322211 11223678999999999999999999999999875
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-51 Score=409.43 Aligned_cols=249 Identities=24% Similarity=0.418 Sum_probs=204.7
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|++++.||+|+||+||+|+++.++.. ||||++.+.........+.+.+|+++|++++ ||||+++++++. +...
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~--vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~--~~~~ 80 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFI--LALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFH--DATR 80 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCE--EEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEE--CSSE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcE--EEEEEEchHHccChHHHHHHHHHHHHHHhcC-CCCCCeEEEEEE--ECCE
Confidence 5799999999999999999998877654 9999998765544455678899999999995 599999999875 4668
Q ss_pred EEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
+|++||++ +++|.+++..... ..+..++.++.||+.||+|||++|||||||||+||||+.+ +.+|
T Consensus 81 ~~ivmEy~~~g~L~~~l~~~~~-----l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~---------~~~k 146 (263)
T d2j4za1 81 VYLILEYAPLGTVYRELQKLSK-----FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSA---------GELK 146 (263)
T ss_dssp EEEEEECCTTCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---------SCEE
T ss_pred EEEEEeecCCCcHHHHHhhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCC---------CCEe
Confidence 99999986 4799999987653 4456677788899999999999999999999999999876 5799
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||+|+....... ...+||+.|||||++.+.. |+.++|||||||+||||++|+.||.+.... ..
T Consensus 147 l~DFG~a~~~~~~~~----~~~~Gt~~Y~APE~~~~~~---------~~~~~DiwSlGvilyell~G~~Pf~~~~~~-~~ 212 (263)
T d2j4za1 147 IADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGRM---------HDEKVDLWSLGVLCYEFLVGKPPFEANTYQ-ET 212 (263)
T ss_dssp ECCCCSCSCCCCCCC----EETTEEGGGCCHHHHTTCC---------CCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-HH
T ss_pred ecccceeeecCCCcc----cccCCCCcccCHHHHcCCC---------CCchhhhhhHhHHHHHHhcCCCCCCCCCHH-HH
Confidence 999999987655432 2567999999999998763 688999999999999999999999875432 33
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
+..+.... ..+ +..+++++++||.+||+.||++|||++|+++|
T Consensus 213 ~~~i~~~~--~~~------p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 213 YKRISRVE--FTF------PDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp HHHHHTTC--CCC------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred HHHHHcCC--CCC------CccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 33333221 111 22578999999999999999999999999874
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=404.51 Aligned_cols=254 Identities=21% Similarity=0.315 Sum_probs=202.4
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeC--C
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDT--A 332 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~--~ 332 (553)
++-|++.++||+|+||+||+|.+..++.. ||+|++....... ...+.+.+|+++|++++ ||||+++++++.+. .
T Consensus 8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~--va~K~i~~~~~~~-~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~ 83 (270)
T d1t4ha_ 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVE--VAWCELQDRKLTK-SERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKG 83 (270)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCE--EEEEEEEGGGSCH-HHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEESSS
T ss_pred CCEEEeeeEEecCcCcEEEEEEECCCCeE--EEEEEEchhhCCH-HHHHHHHHHHHHHHhCC-CCCeeeEEEEEeecccc
Confidence 34457888999999999999988776644 9999998765443 44578999999999995 69999999988653 3
Q ss_pred CceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCC--cEecCCCCCCEEEecCccceecCC
Q psy14267 333 SKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAG--IIHSDLKPANFLFVGNVLKIIDCI 409 (553)
Q Consensus 333 ~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~g--IiHrDLKp~NILl~~~~~~~~~~~ 409 (553)
...++++||++ +++|.+++.+... ..+..+..++.||+.||+|||+++ ||||||||+||||+.+.
T Consensus 84 ~~~~~ivmE~~~~g~L~~~l~~~~~-----~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~------- 151 (270)
T d1t4ha_ 84 KKCIVLVTELMTSGTLKTYLKRFKV-----MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPT------- 151 (270)
T ss_dssp CEEEEEEEECCCSCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTT-------
T ss_pred CCEEEEEEeCCCCCcHHHHHhcccc-----ccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCC-------
Confidence 46789999975 5799999987542 345566677789999999999998 99999999999996432
Q ss_pred CCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy14267 410 GNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIP 489 (553)
Q Consensus 410 ~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~ 489 (553)
+.+||+|||+|+...... ....+||+.|||||++.+. ++.++|||||||++|||++|+.||.+..
T Consensus 152 -~~~Kl~DFGla~~~~~~~----~~~~~GT~~Y~aPE~~~~~----------~~~~~DIwSlGvilyel~~g~~Pf~~~~ 216 (270)
T d1t4ha_ 152 -GSVKIGDLGLATLKRASF----AKAVIGTPEFMAPEMYEEK----------YDESVDVYAFGMCMLEMATSEYPYSECQ 216 (270)
T ss_dssp -SCEEECCTTGGGGCCTTS----BEESCSSCCCCCGGGGGTC----------CCTHHHHHHHHHHHHHHHHSSCTTTTCS
T ss_pred -CCEEEeecCcceeccCCc----cCCcccCccccCHHHhCCC----------CCCcCchhhHHHHHHHHHHCCCCCCCcc
Confidence 579999999998654432 2356899999999998643 7899999999999999999999998766
Q ss_pred chHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 490 NTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 490 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
+.......+........+ ...+++++++||.+||+.||++|||+.|+++|
T Consensus 217 ~~~~~~~~i~~~~~~~~~------~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 217 NAAQIYRRVTSGVKPASF------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp SHHHHHHHHTTTCCCGGG------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cHHHHHHHHHcCCCCccc------CccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 654444444332222111 12567899999999999999999999999874
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-51 Score=409.79 Aligned_cols=257 Identities=27% Similarity=0.417 Sum_probs=195.4
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|++++.||+|+||+||+|+++.++.. ||||++.+....+ ...+.+.+|+++|+++. ||||+++++++.+..+..
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~--vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~ 79 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKI--LVWKELDYGSMTE-AEKQMLVSEVNLLRELK-HPNIVRYYDRIIDRTNTT 79 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCE--EEEEEECCTTSCH-HHHHHHHHHHHHTTSCC-CTTBCCEEEEEEC----C
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCE--EEEEEEChhhCCH-HHHHHHHHHHHHHHHCC-CCCEeeEEEEEEeCCCCE
Confidence 5799999999999999999998877755 9999998876554 44678999999999995 599999999988777778
Q ss_pred EEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCC-----cEecCCCCCCEEEecCccceecCC
Q psy14267 336 LYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAG-----IIHSDLKPANFLFVGNVLKIIDCI 409 (553)
Q Consensus 336 ~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~g-----IiHrDLKp~NILl~~~~~~~~~~~ 409 (553)
+|++||++ +|+|.+++.+..+. .....+..++.++.||+.||+|||++| ||||||||+||||+.+
T Consensus 80 ~~ivmEy~~~g~L~~~i~~~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~-------- 150 (269)
T d2java1 80 LYIVMEYCEGGDLASVITKGTKE-RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK-------- 150 (269)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTT--------
T ss_pred EEEEEecCCCCcHHHHHHhcccc-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCC--------
Confidence 99999986 57999998754321 113445667778889999999999876 9999999999999876
Q ss_pred CCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy14267 410 GNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIP 489 (553)
Q Consensus 410 ~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~ 489 (553)
+.+||+|||+|+.+...... ....+||+.|||||++.+. .|+.++|||||||++|||++|+.||....
T Consensus 151 -~~vkl~DFG~a~~~~~~~~~--~~~~~gt~~Y~APE~l~~~---------~~~~~~DIwSlGvilyel~tg~~Pf~~~~ 218 (269)
T d2java1 151 -QNVKLGDFGLARILNHDTSF--AKAFVGTPYYMSPEQMNRM---------SYNEKSDIWSLGCLLYELCALMPPFTAFS 218 (269)
T ss_dssp -SCEEECCHHHHHHC-------------CCCSCCCHHHHTTC---------CCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred -CcEEEeeccceeecccCCCc--cccCCCCcccCCHHHHcCC---------CCChHHHHHhhCHHHHHHhhCCCCCCCCC
Confidence 57999999999887654322 2367899999999999765 37899999999999999999999998754
Q ss_pred chHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 490 NTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 490 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
.. .....+...... ..+..+++++++||.+||+.||++|||+.||++|
T Consensus 219 ~~-~~~~~i~~~~~~-------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 219 QK-ELAGKIREGKFR-------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp HH-HHHHHHHHTCCC-------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HH-HHHHHHHcCCCC-------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 43 333333332211 1123688999999999999999999999999864
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-51 Score=410.14 Aligned_cols=250 Identities=24% Similarity=0.390 Sum_probs=202.5
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|++++.||+|+||+||+|+++.++.. ||||++.+..... .+.+.+|+.+|++++ ||||+++++++.+ ...
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~--vAvK~~~~~~~~~---~~~~~~E~~il~~l~-HpnIv~~~~~~~~--~~~ 91 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQE--VAIRQMNLQQQPK---KELIINEILVMRENK-NPNIVNYLDSYLV--GDE 91 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCE--EEEEEEEGGGCSC---HHHHHHHHHHHHHCC-CTTBCCEEEEEEE--TTE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCE--EEEEEEecccChH---HHHHHHHHHHHHhCC-CCCEeeEeEEEEE--CCE
Confidence 4799999999999999999998877654 9999998765433 367899999999995 5999999998755 567
Q ss_pred EEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
+|++||++ +++|.+++.+. ......+..++.||+.||+|||++|||||||||+||||+.+ +.+|
T Consensus 92 ~~ivmEy~~gg~L~~~~~~~------~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~---------~~vk 156 (293)
T d1yhwa1 92 LWVVMEYLAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD---------GSVK 156 (293)
T ss_dssp EEEEEECCTTCBHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---------CCEE
T ss_pred EEEEEEecCCCcHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCC---------CcEe
Confidence 89999975 57888877653 24456677788899999999999999999999999999776 6799
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||+|+.+..... .....+||+.|||||++.+. .|+.++|||||||+||||++|..||.+.... ..
T Consensus 157 l~DFG~a~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~---------~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-~~ 224 (293)
T d1yhwa1 157 LTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRK---------AYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-RA 224 (293)
T ss_dssp ECCCTTCEECCSTTC--CBCCCCSCGGGCCHHHHSSS---------CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-HH
T ss_pred eccchhheeeccccc--cccccccCCCccChhhhcCC---------CCCchhceehHhHHHHHHhhCCCCCCCCCHH-HH
Confidence 999999988765433 23467899999999999876 3788999999999999999999999875543 23
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
+..+..... +.+..+..+++++++||.+||+.||++|||+.|+++|
T Consensus 225 ~~~~~~~~~-----~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 225 LYLIATNGT-----PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp HHHHHHHCS-----CCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred HHHHHhCCC-----CCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 333322221 1122223678999999999999999999999999874
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-50 Score=411.27 Aligned_cols=253 Identities=23% Similarity=0.331 Sum_probs=203.9
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
+.|++++.||+|+||+||+|++..++.. ||||++.+.........+.+.+|+++|++++ ||||+++++++.+ ...
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~--vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~--~~~ 89 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEV--VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLR--EHT 89 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEE--EEEEEEECCSSCHHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEE--TTE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcE--EEEEEEchhhccCHHHHHHHHHHHHHHHHCC-CCCEeeEEEEEEE--CCE
Confidence 3599999999999999999998877654 9999999887766677788999999999995 6999999998755 567
Q ss_pred EEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 336 LYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 336 ~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
+|++||++.+++...+..... ..++..++.++.||+.||+|||++|||||||||+||||+.+ +.+||
T Consensus 90 ~~iv~E~~~~g~l~~~~~~~~----~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~---------~~~Kl 156 (309)
T d1u5ra_ 90 AWLVMEYCLGSASDLLEVHKK----PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP---------GLVKL 156 (309)
T ss_dssp EEEEEECCSEEHHHHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETT---------TEEEE
T ss_pred EEEEEEecCCCchHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCC---------CCEEE
Confidence 999999877655444333222 34566777788899999999999999999999999999877 68999
Q ss_pred EeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHH
Q psy14267 416 IDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKM 495 (553)
Q Consensus 416 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~ 495 (553)
+|||+|+..... ...+||+.|||||++.+... ..|+.++|||||||+||||++|..||.+.... ..+
T Consensus 157 ~DFG~a~~~~~~------~~~~GT~~Y~APE~~~~~~~------~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~-~~~ 223 (309)
T d1u5ra_ 157 GDFGSASIMAPA------NSFVGTPYWMAPEVILAMDE------GQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SAL 223 (309)
T ss_dssp CCCTTCBSSSSB------CCCCSCGGGCCHHHHTTTTS------CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHH
T ss_pred eecccccccCCC------CccccCccccCHHHHhccCC------CCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH-HHH
Confidence 999999876442 25679999999999975432 14789999999999999999999999875443 333
Q ss_pred HHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 496 LAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 496 ~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
..+....... .....+++++++||.+||+.||++|||+.|+++|
T Consensus 224 ~~i~~~~~~~------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 224 YHIAQNESPA------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp HHHHHSCCCC------CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred HHHHhCCCCC------CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 3333322111 1123678999999999999999999999999874
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-50 Score=413.86 Aligned_cols=269 Identities=21% Similarity=0.322 Sum_probs=212.1
Q ss_pred eEEecCcceEEEeeeeeeCceEEEEEeeeCCCc---cceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeee
Q psy14267 250 VITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHE---FKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHD 326 (553)
Q Consensus 250 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~---~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~ 326 (553)
.|++..++|+++++||+|+||+||+|++...+. ...||||++..... ......+.+|+.+|.++.+|||||++++
T Consensus 31 kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~HpnIv~l~~ 108 (325)
T d1rjba_ 31 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD--SSEREALMSELKMMTQLGSHENIVNLLG 108 (325)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC--HHHHHHHHHHHHHHHHhcCCCcEeEEEE
Confidence 466777899999999999999999998865432 24589999865432 2334678999999999977899999998
Q ss_pred EEEeCCCceEEEEEecC-CCCHHHHHHHcccCC------------------CCchHHHHHHHHHHHHHHHHHHHhhCCcE
Q psy14267 327 YVYDTASKHLYVLMEKG-DTDLSKYMRNLNKMT------------------TLPNTMIIIIMHWYEMLLAVKEIHAAGII 387 (553)
Q Consensus 327 ~~~~~~~~~~~iv~e~~-~~~L~~~l~~~~~~~------------------~~~~~~~~i~~~~~qil~aL~yLH~~gIi 387 (553)
++ .....++++||++ +|+|.++++...... .....+..++.++.||+.||+|||+++||
T Consensus 109 ~~--~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~Ii 186 (325)
T d1rjba_ 109 AC--TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCV 186 (325)
T ss_dssp EE--CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred EE--eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 77 4466789999975 679999998654321 12345667778889999999999999999
Q ss_pred ecCCCCCCEEEecCccceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccch
Q psy14267 388 HSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSD 467 (553)
Q Consensus 388 HrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sD 467 (553)
||||||+|||++.+ +.+||+|||+|+...............||+.|||||++.+. .|+.++|
T Consensus 187 HRDlKp~Nill~~~---------~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~---------~~~~~~D 248 (325)
T d1rjba_ 187 HRDLAARNVLVTHG---------KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG---------IYTIKSD 248 (325)
T ss_dssp ETTCSGGGEEEETT---------TEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC---------CCCHHHH
T ss_pred eccCchhccccccC---------CeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCC---------CCCccee
Confidence 99999999999877 68999999999887665544344466789999999999766 4789999
Q ss_pred HHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q psy14267 468 VWSLGCILYNMIY-GRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQI 546 (553)
Q Consensus 468 IwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L 546 (553)
||||||+||||++ |..||.+...... +..+......+ ..+..+++++++||.+||+.||++|||++||+++|
T Consensus 249 iwS~Gvil~emlt~g~~Pf~~~~~~~~-~~~~~~~~~~~------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L 321 (325)
T d1rjba_ 249 VWSYGILLWEIFSLGVNPYPGIPVDAN-FYKLIQNGFKM------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321 (325)
T ss_dssp HHHHHHHHHHHTTTSCCSSTTCCCSHH-HHHHHHTTCCC------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ccchhHHHHHHHhCCCCCCCCCCHHHH-HHHHHhcCCCC------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 9999999999997 9999988655433 33333332222 22336889999999999999999999999999999
Q ss_pred h
Q psy14267 547 N 547 (553)
Q Consensus 547 ~ 547 (553)
.
T Consensus 322 ~ 322 (325)
T d1rjba_ 322 G 322 (325)
T ss_dssp H
T ss_pred h
Confidence 5
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-51 Score=411.21 Aligned_cols=252 Identities=24% Similarity=0.400 Sum_probs=201.8
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|++++.||+|+||+||+|+++.++.. ||||++.+.........+.+.+|+++|+++. ||||+++++++. ....
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~--vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~--~~~~ 82 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSRE--YAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQ--DDEK 82 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCE--EEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-STTBCCEEEEEE--CSSE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCE--EEEEEEehHHccCHHHHHHHHHHHHHHHHcC-CCCeeEEEEEEE--ECCE
Confidence 5799999999999999999998877654 9999998765444455678999999999995 599999998774 4678
Q ss_pred EEEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
+|++||++. ++|.+++..... +.+..+..++.|++.||+|||++|||||||||+||||+.+ +.+|
T Consensus 83 ~~ivmEy~~gg~L~~~~~~~~~-----l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~---------~~vk 148 (288)
T d1uu3a_ 83 LYFGLSYAKNGELLKYIRKIGS-----FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED---------MHIQ 148 (288)
T ss_dssp EEEEECCCTTEEHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT---------SCEE
T ss_pred EEEEEEccCCCCHHHhhhccCC-----CCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCC---------ceEE
Confidence 899999864 689998887653 3456677778899999999999999999999999999876 5799
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||+|+.+............+||+.|||||++.+. .|+.++|||||||+||||++|..||...+. ...
T Consensus 149 l~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~---------~~~~~~DiwSlGvilyell~g~~Pf~~~~~-~~~ 218 (288)
T d1uu3a_ 149 ITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK---------SACKSSDLWALGCIIYQLVAGLPPFRAGNE-YLI 218 (288)
T ss_dssp ECCCTTCEECC----------CCCCGGGCCHHHHHTC---------CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHH
T ss_pred ecccccceecccCCcccccccccCCccccCceeeccC---------CCCcccceehhhHHHHHHhhCCCCCCCcCH-HHH
Confidence 9999999987655444344467899999999999866 378999999999999999999999987433 333
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVT 544 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~ 544 (553)
...+.... ..+ +..+++++++||.+||+.||++|||++|+++
T Consensus 219 ~~~i~~~~--~~~------p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 219 FQKIIKLE--YDF------PEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp HHHHHTTC--CCC------CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred HHHHHcCC--CCC------CccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 44443322 222 2367899999999999999999999998754
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-50 Score=407.80 Aligned_cols=257 Identities=28% Similarity=0.426 Sum_probs=204.0
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
+.|++++.||+|+||+||+|+++.++.. ||||++.+... ...+.+.+|+++|++++ ||||+++++++.+ ...
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~--vAvK~i~~~~~---~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~--~~~ 83 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVL--AAAKVIDTKSE---EELEDYMVEIDILASCD-HPNIVKLLDAFYY--ENN 83 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCE--EEEEEEECSSS---GGGGGTHHHHHHHHHCC-CTTBCCEEEEEEE--TTE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeE--EEEEEECcCCH---HHHHHHHHHHHHHHhCC-CCCCCeEEEEEee--CCe
Confidence 4699999999999999999998877755 99999987542 23467899999999995 5999999998754 567
Q ss_pred EEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
++++||++ +++|.+++.+..+ .+++..+..++.||+.||+|||++|||||||||+||||+.+ +.+|
T Consensus 84 ~~lvmEy~~~g~L~~~~~~~~~----~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~---------~~~K 150 (288)
T d2jfla1 84 LWILIEFCAGGAVDAVMLELER----PLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLD---------GDIK 150 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---------SCEE
T ss_pred EEEEEecCCCCcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCC---------CCEE
Confidence 89999986 5688888776433 34456677778899999999999999999999999999876 5799
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||+|+....... ...+.+||+.|||||++...... ...|+.++|||||||+||||++|+.||.+.... ..
T Consensus 151 l~DFG~a~~~~~~~~--~~~~~~Gt~~y~APE~l~~~~~~----~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~-~~ 223 (288)
T d2jfla1 151 LADFGVSAKNTRTIQ--RRDSFIGTPYWMAPEVVMCETSK----DRPYDYKADVWSLGITLIEMAEIEPPHHELNPM-RV 223 (288)
T ss_dssp ECCCTTCEECHHHHH--HHTCCCSCCTTCCHHHHTTCSTT----TSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG-GH
T ss_pred EEechhhhccCCCcc--cccccccccccCCHHHHhhcccC----CCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH-HH
Confidence 999999976543211 22367899999999999654322 124789999999999999999999999876544 33
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
+..+..... +.+.....+++++++||.+||+.||++|||+.|+++|
T Consensus 224 ~~~i~~~~~-----~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 224 LLKIAKSEP-----PTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp HHHHHHSCC-----CCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHHHHcCCC-----CCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 333333221 1222233678999999999999999999999999875
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.8e-50 Score=405.51 Aligned_cols=266 Identities=18% Similarity=0.301 Sum_probs=210.1
Q ss_pred ceEEecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEE
Q psy14267 249 DVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYV 328 (553)
Q Consensus 249 ~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~ 328 (553)
+.|++..++|++.+.||+|+||+||+|.+..++.. ||||+++.+... .+++.+|+++|++++ ||||+++++++
T Consensus 10 ~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~--vAvK~i~~~~~~----~~~~~~E~~il~~l~-HpnIv~~~~~~ 82 (287)
T d1opja_ 10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLT--VAVKTLKEDTME----VEEFLKEAAVMKEIK-HPNLVQLLGVC 82 (287)
T ss_dssp CTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEE--EEEEECCTTCSC----HHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred cccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeE--EEEEEECCccch----HHHHHHHHHHHHhCC-CCCEecCCccE
Confidence 34667778999999999999999999988776644 999999765432 367899999999995 59999999977
Q ss_pred EeCCCceEEEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceec
Q psy14267 329 YDTASKHLYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIID 407 (553)
Q Consensus 329 ~~~~~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~ 407 (553)
. ....++++||++. |+|..++...... ...+..++.++.||+.||+|||++|||||||||+||||+.+
T Consensus 83 ~--~~~~~~iv~E~~~~g~l~~~l~~~~~~---~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~------ 151 (287)
T d1opja_ 83 T--REPPFYIITEFMTYGNLLDYLRECNRQ---EVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN------ 151 (287)
T ss_dssp C--SSSSCEEEEECCTTCBHHHHHHHSCTT---TSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG------
T ss_pred e--eCCeeEEEeecccCcchHHHhhhcccc---chHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCC------
Confidence 4 4567889999764 7899988765332 34556667777899999999999999999999999999877
Q ss_pred CCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCC
Q psy14267 408 CIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSH 487 (553)
Q Consensus 408 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~ 487 (553)
+.+||+|||+|+........ ......|++.|||||++.+. .|+.++|||||||++|||++|..||..
T Consensus 152 ---~~~Kl~DFG~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~---------~~~~k~DiwS~Gv~l~ell~~~~p~~~ 218 (287)
T d1opja_ 152 ---HLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYN---------KFSIKSDVWAFGVLLWEIATYGMSPYP 218 (287)
T ss_dssp ---GCEEECCCCCTTTCCSSSSE-EETTEEECGGGCCHHHHHHC---------CCSHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ---CcEEEccccceeecCCCCce-eeccccccccccChHHHcCC---------CCCchhhhhhHHHHHHHHHhCCCCCCC
Confidence 57999999999877654332 22244589999999999866 478999999999999999997766654
Q ss_pred CCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCCC
Q psy14267 488 IPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNPEG 552 (553)
Q Consensus 488 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~~~ 552 (553)
..+.......+. ..... .....+++++.+||.+||+.||++|||+.+|++.|+.+...
T Consensus 219 ~~~~~~~~~~i~-~~~~~------~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 219 GIDLSQVYELLE-KDYRM------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp TCCHHHHHHHHH-TTCCC------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred cchHHHHHHHHh-cCCCC------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 333323222222 22221 22336889999999999999999999999999999987653
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-50 Score=412.90 Aligned_cols=259 Identities=22% Similarity=0.374 Sum_probs=199.1
Q ss_pred ecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC
Q psy14267 253 LNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA 332 (553)
Q Consensus 253 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~ 332 (553)
+..++|+++++||+|+||+||+|++..++.. ||||++++... ....+++.+|+.+|++++ ||||+++++++.+
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~--vAiK~i~~~~~--~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~-- 75 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLV--MARKLIHLEIK--PAIRNQIIRELQVLHECN-SPYIVGFYGAFYS-- 75 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEE--EEEEEEECCCC--TTHHHHHHHHGGGGGGCC-CTTBCCEEEEEEC--
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcE--EEEEEEChhhC--HHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEE--
Confidence 4567899999999999999999998877654 99999987542 344578999999999995 5999999998854
Q ss_pred CceEEEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhh-CCcEecCCCCCCEEEecCccceecCCC
Q psy14267 333 SKHLYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHA-AGIIHSDLKPANFLFVGNVLKIIDCIG 410 (553)
Q Consensus 333 ~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~-~gIiHrDLKp~NILl~~~~~~~~~~~~ 410 (553)
...+++|||++. ++|.+++.+... ..+..+..++.|++.||+|||+ +|||||||||+||||+.+
T Consensus 76 ~~~~~iVmEy~~gg~L~~~l~~~~~-----l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~--------- 141 (322)
T d1s9ja_ 76 DGEISICMEHMDGGSLDQVLKKAGR-----IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR--------- 141 (322)
T ss_dssp SSEEEEEEECCTTEEHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTT---------
T ss_pred CCEEEEEEEcCCCCcHHHHHhhcCC-----CCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCC---------
Confidence 567999999755 699999987543 3456677778899999999997 599999999999999776
Q ss_pred CeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCc
Q psy14267 411 NVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN 490 (553)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~ 490 (553)
+.+||+|||+|+.+.... ..+.+||+.|||||++.+. .|+.++|||||||++|||++|+.||.+...
T Consensus 142 ~~vkl~DFGla~~~~~~~----~~~~~GT~~Y~APEvl~~~---------~y~~~~DiWSlGvil~ell~G~~Pf~~~~~ 208 (322)
T d1s9ja_ 142 GEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGT---------HYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208 (322)
T ss_dssp CCEEECCCCCCHHHHHHT----C---CCSSCCCCHHHHHCS---------CCCTTHHHHHHHHHHHHHHHSSCCSSCCCT
T ss_pred CCEEEeeCCCccccCCCc----cccccCCccccCchHHcCC---------CCCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 679999999998764432 2367899999999999876 378999999999999999999999976433
Q ss_pred hHHHHHHHHhhcccc-----------------------------------cccccccCCCCCCHHHHHHHHHhcccCCCC
Q psy14267 491 TWAKMLAIARHKDQI-----------------------------------EFKPQLANNVTIPPTLLQSMKLCLQKDPKA 535 (553)
Q Consensus 491 ~~~~~~~i~~~~~~~-----------------------------------~~~~~~~~~~~~s~~l~~li~~cL~~dP~~ 535 (553)
............... ...+.......++.++++||.+||..||++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~ 288 (322)
T d1s9ja_ 209 KELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAE 288 (322)
T ss_dssp THHHHHC------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTT
T ss_pred HHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhH
Confidence 221111100000000 000000011236789999999999999999
Q ss_pred CCCHHHHHHH
Q psy14267 536 RPTVGNSVTQ 545 (553)
Q Consensus 536 RPt~~ell~~ 545 (553)
|||++|+++|
T Consensus 289 R~ta~e~L~H 298 (322)
T d1s9ja_ 289 RADLKQLMVH 298 (322)
T ss_dssp SCCHHHHHTS
T ss_pred CcCHHHHhhC
Confidence 9999999985
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.8e-50 Score=408.26 Aligned_cols=255 Identities=25% Similarity=0.376 Sum_probs=188.4
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
+.|++++.||+|+||+||+|+++.++.. ||||++.+...... .+.+.+|+.+|+++. ||||+++++++. ....
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~--vAvK~i~~~~~~~~--~~~~~~Ei~il~~l~-HpnIv~l~~~~~--~~~~ 81 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKL--VAIKCIAKKALEGK--EGSMENEIAVLHKIK-HPNIVALDDIYE--SGGH 81 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCE--EEEEEEEC------------CHHHHHHHTCC-CTTBCCEEEEEE--CSSE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCE--EEEEEEchHHhhhH--HHHHHHHHHHHHhCC-CCCCCcEEEEEE--ECCE
Confidence 5699999999999999999998877654 99999987654432 356889999999995 699999999874 4678
Q ss_pred EEEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
+|++||++. ++|.+++.... .+++..+..++.||+.||+|||++|||||||||+|||+... ...+.+|
T Consensus 82 ~~lvmE~~~gg~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~------~~~~~vk 150 (307)
T d1a06a_ 82 LYLIMQLVSGGELFDRIVEKG-----FYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSL------DEDSKIM 150 (307)
T ss_dssp EEEEECCCCSCBHHHHHHTCS-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSS------STTCCEE
T ss_pred EEEEEeccCCCcHHHhhhccc-----CCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeeccc------CCCceEE
Confidence 999999875 79999997654 34566677788899999999999999999999999999643 1236799
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||+|+....... ..+.+||+.|||||++.+.. |+.++|||||||+||||++|..||.+.... ..
T Consensus 151 l~DFG~a~~~~~~~~---~~~~~GT~~y~APE~~~~~~---------~~~~~DiwSlGvilyell~g~~Pf~~~~~~-~~ 217 (307)
T d1a06a_ 151 ISDFGLSKMEDPGSV---LSTACGTPGYVAPEVLAQKP---------YSKAVDCWSIGVIAYILLCGYPPFYDENDA-KL 217 (307)
T ss_dssp ECCC---------------------CTTSCHHHHTTCC---------CCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HH
T ss_pred EeccceeEEccCCCe---eeeeeeCccccCcHHHcCCC---------CCcHHHhhhhhHHHHHHHhCCCCCCCCCHH-HH
Confidence 999999987654432 23678999999999998763 788999999999999999999999875432 33
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
...+...... ........+|+++++||.+||.+||++|||++|+++|
T Consensus 218 ~~~i~~~~~~----~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 218 FEQILKAEYE----FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp HHHHHTTCCC----CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHhccCCC----CCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 3333332221 1122334789999999999999999999999999986
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.7e-49 Score=394.32 Aligned_cols=267 Identities=27% Similarity=0.386 Sum_probs=207.1
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCC-
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTAS- 333 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~- 333 (553)
.++|++++.||+|+||+||+|++..++.. ||||++++....+....+++.+|+++|++++ ||||+++++++.....
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~--vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~-hpniv~~~~~~~~~~~~ 82 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRD--VAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAIVAVYDTGEAETPA 82 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEE--EEEEEECSTTTTCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEEECSS
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCE--EEEEEEchhhccCHHHHHHHHHHHHHHHhcC-CCCCCcccceeeeccCC
Confidence 46799999999999999999998877654 9999999887777777788999999999985 5999999998876543
Q ss_pred -ceEEEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCC
Q psy14267 334 -KHLYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGN 411 (553)
Q Consensus 334 -~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~ 411 (553)
..+|++||++. ++|..++..... ..+..++.++.||+.||+|||++|||||||||+||||+.+ +
T Consensus 83 ~~~~~lvmE~~~g~~L~~~~~~~~~-----l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~---------~ 148 (277)
T d1o6ya_ 83 GPLPYIVMEYVDGVTLRDIVHTEGP-----MTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISAT---------N 148 (277)
T ss_dssp SEEEEEEEECCCEEEHHHHHHHHCS-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETT---------S
T ss_pred CceEEEEEECCCCCEehhhhcccCC-----CCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCcc---------c
Confidence 46899999875 678888876543 3456677778899999999999999999999999999877 5
Q ss_pred eEEEEeccCccccCCCCC-cccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCc
Q psy14267 412 VLKIIDFGIACSLQDDKT-SVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPN 490 (553)
Q Consensus 412 ~vkL~DFGla~~~~~~~~-~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~ 490 (553)
.++|+|||++........ .......+||+.|||||++.+. .++.++|||||||+||||++|.+||.+...
T Consensus 149 ~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~---------~~~~~~DiwSlGvilyelltG~~Pf~~~~~ 219 (277)
T d1o6ya_ 149 AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD---------SVDARSDVYSLGCVLYEVLTGEPPFTGDSP 219 (277)
T ss_dssp CEEECCCTTCEECC----------------TTCCHHHHTTC---------CCCHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cceeehhhhhhhhccccccccccccccCcccccCHHHHcCC---------CCCcceecccchHHHHHHHhCCCCCCCcCH
Confidence 689999999877654332 2233466799999999999765 378999999999999999999999987554
Q ss_pred hHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCC-CHHHHHHHHhcCCCC
Q psy14267 491 TWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARP-TVGNSVTQINNNPEG 552 (553)
Q Consensus 491 ~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RP-t~~ell~~L~~~~~~ 552 (553)
. ..+..+...... +.......+|+++.++|.+||+.||++|| |++++++.|.++.+|
T Consensus 220 ~-~~~~~~~~~~~~----~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ng 277 (277)
T d1o6ya_ 220 V-SVAYQHVREDPI----PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG 277 (277)
T ss_dssp H-HHHHHHHHCCCC----CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC-
T ss_pred H-HHHHHHHhcCCC----CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhCc
Confidence 3 222232222111 11223347899999999999999999999 899999999887665
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-49 Score=395.18 Aligned_cols=260 Identities=21% Similarity=0.364 Sum_probs=205.6
Q ss_pred ecCcceEEEee-eeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeC
Q psy14267 253 LNGKQYQVLSL-LGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDT 331 (553)
Q Consensus 253 ~~~~~y~i~~~-LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~ 331 (553)
+..++|.+... ||+|+||+||+|.++..+....||||+++... .....+++.+|+++|++++ ||||+++++++..
T Consensus 5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~- 80 (285)
T d1u59a_ 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLD-NPYIVRLIGVCQA- 80 (285)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEES-
T ss_pred ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCC-CCCEeeEeeeecc-
Confidence 44567888885 99999999999987766655679999997653 3455688999999999995 6999999998743
Q ss_pred CCceEEEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCC
Q psy14267 332 ASKHLYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIG 410 (553)
Q Consensus 332 ~~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~ 410 (553)
..++++||++. |+|.+++..... ..++..++.++.||+.||+|||++|||||||||+||||+.+
T Consensus 81 --~~~~lvmE~~~~g~L~~~l~~~~~----~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~--------- 145 (285)
T d1u59a_ 81 --EALMLVMEMAGGGPLHKFLVGKRE----EIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNR--------- 145 (285)
T ss_dssp --SSEEEEEECCTTEEHHHHHTTCTT----TSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEET---------
T ss_pred --CeEEEEEEeCCCCcHHHHhhcccc----CCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccC---------
Confidence 34789999865 689888755432 34456677778899999999999999999999999999877
Q ss_pred CeEEEEeccCccccCCCCCc-ccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCC
Q psy14267 411 NVLKIIDFGIACSLQDDKTS-VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHI 488 (553)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~ 488 (553)
+.+||+|||+|+.+...... ......+||+.|||||++.+. .++.++|||||||+||||+| |..||.+.
T Consensus 146 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~ 216 (285)
T d1u59a_ 146 HYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR---------KFSSRSDVWSYGVTMWEALSYGQKPYKKM 216 (285)
T ss_dssp TEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHC---------EECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred CceeeccchhhhcccccccccccccccccCccccChHHHhCC---------CCCccchhhcchHHHHHHHhCCCCCCCCC
Confidence 68999999999987654432 223355789999999999765 37899999999999999998 99999886
Q ss_pred CchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q psy14267 489 PNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINN 548 (553)
Q Consensus 489 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~ 548 (553)
... +.+..+... .... .+..+|+++.+||.+||+.||++|||+.+|++.|+.
T Consensus 217 ~~~-~~~~~i~~~-~~~~------~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~ 268 (285)
T d1u59a_ 217 KGP-EVMAFIEQG-KRME------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268 (285)
T ss_dssp CTH-HHHHHHHTT-CCCC------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred CHH-HHHHHHHcC-CCCC------CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 543 333333322 2222 233688999999999999999999999999998875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-49 Score=399.59 Aligned_cols=274 Identities=22% Similarity=0.310 Sum_probs=207.7
Q ss_pred ceEEecCcceEEEeeeeeeCceEEEEEeeeCCC---ccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEee
Q psy14267 249 DVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEH---EFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMH 325 (553)
Q Consensus 249 ~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~---~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~ 325 (553)
..|++..++|+++++||+|+||+||+|++.... ..+.||||+++.... ....+.+.+|+.++.++.||+||+.++
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C--HHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--cHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence 345677789999999999999999999876543 235699999875432 334577899999999999999999998
Q ss_pred eEEEeCCCceEEEEEecC-CCCHHHHHHHcccC-----------CCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCC
Q psy14267 326 DYVYDTASKHLYVLMEKG-DTDLSKYMRNLNKM-----------TTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKP 393 (553)
Q Consensus 326 ~~~~~~~~~~~~iv~e~~-~~~L~~~l~~~~~~-----------~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp 393 (553)
+++.. .+..++++||++ +|+|.++++..... .....++..++.++.||+.||+|||+++||||||||
T Consensus 84 ~~~~~-~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp 162 (299)
T d1ywna1 84 GACTK-PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAA 162 (299)
T ss_dssp EEECS-TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred eeecc-CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCc
Confidence 76543 355678888875 58999999865431 112355677888889999999999999999999999
Q ss_pred CCEEEecCccceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHH
Q psy14267 394 ANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGC 473 (553)
Q Consensus 394 ~NILl~~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGv 473 (553)
+||||+.+ +.+||+|||+|+...............||+.|||||++.+. .++.++|||||||
T Consensus 163 ~NILl~~~---------~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~---------~~~~~sDiwS~Gv 224 (299)
T d1ywna1 163 RNILLSEK---------NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR---------VYTIQSDVWSFGV 224 (299)
T ss_dssp GGEEECGG---------GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHC---------CCCHHHHHHHHHH
T ss_pred cceeECCC---------CcEEEccCcchhhccccccccccCceeeCccccchhHhhcC---------CCCcccceeehHH
Confidence 99999876 57999999999887665544444567899999999999866 4789999999999
Q ss_pred HHHHHHhC-CCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q psy14267 474 ILYNMIYG-RTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNP 550 (553)
Q Consensus 474 vl~elltG-~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~ 550 (553)
++|||++| .+||............+.. ..... ....++++++++|.+||+.||++|||+.||+++|+++.
T Consensus 225 il~ellt~~~~p~~~~~~~~~~~~~~~~-~~~~~------~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 225 LLWEIFSLGASPYPGVKIDEEFCRRLKE-GTRMR------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp HHHHHHTTSCCSSTTCCCSHHHHHHHHH-TCCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCCCCCCHHHHHHHHHhc-CCCCC------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 99999986 5788776544333333322 22222 22367899999999999999999999999999998753
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-49 Score=404.06 Aligned_cols=252 Identities=23% Similarity=0.343 Sum_probs=205.2
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
-++|++++.||+|+||+||+|+++.++.. ||||++++.........+++.+|+.+|+++. ||||+++++++. +..
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~--~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~--~~~ 78 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRY--YAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQ--THD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCE--EEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-CTTBCCEEEEEE--CSS
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCE--EEEEEEchhhccCHHHHHHHHHHHHHHHhCC-CCCEEEEEeeec--ccc
Confidence 35799999999999999999998877755 9999998765544455678999999999995 699999998774 467
Q ss_pred eEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 335 HLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 335 ~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
.+|++||++ +++|..++..... ..+..+..+++||+.||+|||++|||||||||+||||+.+ +.+
T Consensus 79 ~~~iv~ey~~gg~L~~~~~~~~~-----~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~---------g~v 144 (337)
T d1o6la_ 79 RLCFVMEYANGGELFFHLSRERV-----FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD---------GHI 144 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSC-----CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT---------SCE
T ss_pred ccccceeccCCCchhhhhhcccC-----CcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCC---------CCE
Confidence 899999975 5789998887653 3345667777899999999999999999999999999877 679
Q ss_pred EEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHH
Q psy14267 414 KIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWA 493 (553)
Q Consensus 414 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~ 493 (553)
||+|||+|+....... .....+||+.|||||++.+.. |+.++|||||||+||||++|++||.+.... .
T Consensus 145 kl~DFG~a~~~~~~~~--~~~~~~GT~~Y~aPE~~~~~~---------y~~~~DiwSlGvilyeml~G~~pf~~~~~~-~ 212 (337)
T d1o6la_ 145 KITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDND---------YGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-R 212 (337)
T ss_dssp EECCCTTCBCSCCTTC--CBCCCEECGGGCCGGGGSSSC---------BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-H
T ss_pred EEeecccccccccCCc--ccccceeCHHHhhhhhccCCC---------CChhhcccchhhHHHHHHHCCCCCCCcCHH-H
Confidence 9999999987654332 234678999999999998763 788999999999999999999999875432 3
Q ss_pred HHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q psy14267 494 KMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT-----VGNSVTQ 545 (553)
Q Consensus 494 ~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt-----~~ell~~ 545 (553)
....+... .+.+ +..+++++++||++||++||++|++ ++|+++|
T Consensus 213 ~~~~i~~~--~~~~------p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 213 LFELILME--EIRF------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHHHHHHC--CCCC------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHHHhcC--CCCC------CccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 33333322 2222 2368899999999999999999994 8888775
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=391.56 Aligned_cols=252 Identities=22% Similarity=0.382 Sum_probs=198.1
Q ss_pred eeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEEEEEe
Q psy14267 262 SLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLYVLME 341 (553)
Q Consensus 262 ~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~iv~e 341 (553)
++||+|+||+||+|.....+..+.||||+++.... +....+++.+|+++|++++ ||||+++++++.. ...+++||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~-HpnIv~~~g~~~~---~~~~lvmE 87 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLD-NPYIVRMIGICEA---ESWMLVME 87 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCC-CTTBCCEEEEEES---SSEEEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhCC-CCCCceEEEEecc---CCEEEEEE
Confidence 47999999999999877666667799999976543 3345678999999999995 6999999998742 24678999
Q ss_pred cC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEeccC
Q psy14267 342 KG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGI 420 (553)
Q Consensus 342 ~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGl 420 (553)
++ +|+|.++++... ..++..++.++.||+.||+|||+++||||||||+||||+.+ +.+||+|||+
T Consensus 88 ~~~~g~L~~~l~~~~-----~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~---------~~~kl~DFGl 153 (277)
T d1xbba_ 88 MAELGPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ---------HYAKISDFGL 153 (277)
T ss_dssp CCTTEEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET---------TEEEECCCTT
T ss_pred cCCCCcHHHHHhhcc-----CCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhccccc---------Ccccccchhh
Confidence 86 578999988654 24456677788899999999999999999999999999877 6899999999
Q ss_pred ccccCCCCCcc-cccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHH
Q psy14267 421 ACSLQDDKTSV-HKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHIPNTWAKMLAI 498 (553)
Q Consensus 421 a~~~~~~~~~~-~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~i 498 (553)
|+.+....... ......||+.|||||++.+. .++.++|||||||+||||++ |+.||.+.... +....+
T Consensus 154 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~---------~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~-~~~~~i 223 (277)
T d1xbba_ 154 SKALRADENYYKAQTHGKWPVKWYAPECINYY---------KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-EVTAML 223 (277)
T ss_dssp CEECCTTCSEEEC----CCCGGGCCHHHHHHC---------EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHHHH
T ss_pred hhhccccccccccccccCCCceecCchhhcCC---------CCCchhhhccchhhhhHHhhCCCCCCCCCCHH-HHHHHH
Confidence 98876544322 22345699999999999765 37899999999999999997 99999886543 333333
Q ss_pred HhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 499 ARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 499 ~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
.. .... ..+..+|+++.+||.+||+.||++|||+++|++.|+++
T Consensus 224 ~~-~~~~------~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 224 EK-GERM------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp HT-TCCC------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred Hc-CCCC------CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 32 2222 22336899999999999999999999999999988764
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=9.9e-49 Score=392.03 Aligned_cols=261 Identities=23% Similarity=0.367 Sum_probs=211.8
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCc------hhHHHHHHHHHHHHHhhcCCCceeEeeeEEE
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITD------QSIADSYLNEVELLAKLQGCPYVIKMHDYVY 329 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~------~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~ 329 (553)
++|++++.||+|+||+||+|++..++.. ||||++.+..... +...+++.+|+.+|+++..||||+++++++.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~--~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 80 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKE--YAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 80 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEE--EEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCE--EEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc
Confidence 6899999999999999999998777654 9999998765432 2344578999999999987899999999874
Q ss_pred eCCCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecC
Q psy14267 330 DTASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDC 408 (553)
Q Consensus 330 ~~~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~ 408 (553)
++.++|++||++ +++|.++++... ..++..+..++.||+.||+|||++|||||||||+||||+.+
T Consensus 81 --~~~~~~ivmE~~~~g~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~------- 146 (277)
T d1phka_ 81 --TNTFFFLVFDLMKKGELFDYLTEKV-----TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDD------- 146 (277)
T ss_dssp --CSSEEEEEEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-------
T ss_pred --cCcceEEEEEcCCCchHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCC-------
Confidence 477899999986 579999998754 34567778888899999999999999999999999999876
Q ss_pred CCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy14267 409 IGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHI 488 (553)
Q Consensus 409 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~ 488 (553)
+.+||+|||+|+.+..... ....+||+.|+|||++.+...+. ...++.++|||||||++|||++|+.||.+.
T Consensus 147 --~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~---~~~~~~~~DiwslGvilyeml~g~~Pf~~~ 218 (277)
T d1phka_ 147 --MNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDN---HPGYGKEVDMWSTGVIMYTLLAGSPPFWHR 218 (277)
T ss_dssp --CCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTT---SCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred --CCeEEccchheeEccCCCc---eeeeeccCCCCCHHHhhcccccc---CCCCCchheEcccchhhhhhccCCCCCCCC
Confidence 6799999999998765433 23567999999999997654321 124788999999999999999999999886
Q ss_pred CchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 489 PNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 489 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
... .....+........ ......+|+++++||.+||+.||++|||++|+++|
T Consensus 219 ~~~-~~~~~i~~~~~~~~----~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 219 KQM-LMLRMIMSGNYQFG----SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp SHH-HHHHHHHHTCCCCC----TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CHH-HHHHHHHhCCCCCC----CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 543 34444443332211 22233689999999999999999999999999876
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-49 Score=395.54 Aligned_cols=258 Identities=22% Similarity=0.315 Sum_probs=206.9
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCc---hhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITD---QSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA 332 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~---~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~ 332 (553)
++|++++.||+|+||+||+|+++.++.. ||||++++..... ....+.+.+|+.+|++++ ||||+++++++. .
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~--~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~--~ 84 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQ--YAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEVYE--N 84 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCE--EEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEE--C
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCE--EEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCC-CCCCCcEEEEEE--E
Confidence 5799999999999999999998877654 9999998765432 223578999999999995 599999999874 4
Q ss_pred CceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCC
Q psy14267 333 SKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGN 411 (553)
Q Consensus 333 ~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~ 411 (553)
...+|++||++ +++|.+++.... ......++.++.||+.||+|||++|||||||||+||||+.+. ....
T Consensus 85 ~~~~~iv~E~~~gg~L~~~i~~~~-----~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~-----~~~~ 154 (293)
T d1jksa_ 85 KTDVILILELVAGGELFDFLAEKE-----SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRN-----VPKP 154 (293)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSS-----SSSC
T ss_pred CCEEEEEEEcCCCccccchhcccc-----ccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCC-----Cccc
Confidence 67899999986 579999998764 345666777888999999999999999999999999997663 2234
Q ss_pred eEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCch
Q psy14267 412 VLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNT 491 (553)
Q Consensus 412 ~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~ 491 (553)
.+||+|||+|+....... .....||+.|||||++.+. .++.++|||||||+||||++|+.||.+....
T Consensus 155 ~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~APE~~~~~---------~~~~~~DiwSlGvilyell~g~~Pf~~~~~~ 222 (293)
T d1jksa_ 155 RIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYE---------PLGLEADMWSIGVITYILLSGASPFLGDTKQ 222 (293)
T ss_dssp CEEECCCTTCEECTTSCB---CSCCCCCGGGCCHHHHTTC---------CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ceEecchhhhhhcCCCcc---ccccCCCCcccCHHHHcCC---------CCCCcccchhhhHHHHHHHcCCCCCCCCCHH
Confidence 699999999988765433 2356799999999999865 3789999999999999999999999875443
Q ss_pred HHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 492 WAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 492 ~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
..+..+...... +.. .....+|.++++||++||+.||++|||++|+++|
T Consensus 223 -~~~~~i~~~~~~--~~~--~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 223 -ETLANVSAVNYE--FED--EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp -HHHHHHHTTCCC--CCH--HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -HHHHHHHhcCCC--CCc--hhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 334444333221 111 1123678999999999999999999999999875
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=6.2e-49 Score=406.26 Aligned_cols=254 Identities=21% Similarity=0.337 Sum_probs=205.2
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|++++.||+|+||+||+|+++.++.. ||||++.+... ...+.+.+|+.+|++|+ ||||+++++++.+ ...
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~--vAvK~i~~~~~---~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~--~~~ 97 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNN--FAAKFVMTPHE---SDKETVRKEIQTMSVLR-HPTLVNLHDAFED--DNE 97 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEE--EEEEEECCCSH---HHHHHHHHHHHHHHHTC-CTTBCCEEEEEEE--TTE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCE--EEEEEEcccch---hhHHHHHHHHHHHHhCC-CCCCCcEEEEEEE--CCE
Confidence 4799999999999999999998877654 99999976542 33577899999999995 6999999998754 568
Q ss_pred EEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
+|++||++ +++|.+++..... .+.+..+..++.||+.||+|||++|||||||||+||||+.+. .+.+|
T Consensus 98 ~~ivmE~~~gg~L~~~l~~~~~----~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~-------~~~vk 166 (350)
T d1koaa2 98 MVMIYEFMSGGELFEKVADEHN----KMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKR-------SNELK 166 (350)
T ss_dssp EEEEECCCCSCBHHHHHTCTTS----CBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTT-------SCCEE
T ss_pred EEEEEEcCCCCCHHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCC-------CCeEE
Confidence 99999986 5799998854322 355677777888999999999999999999999999996542 25799
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||+|+.+...... .+.+||+.|||||++.+. .|+.++|||||||++|||++|+.||.+... ...
T Consensus 167 L~DFG~a~~~~~~~~~---~~~~gT~~Y~aPEv~~~~---------~~~~~~DiwSlGvilyell~G~~Pf~~~~~-~~~ 233 (350)
T d1koaa2 167 LIDFGLTAHLDPKQSV---KVTTGTAEFAAPEVAEGK---------PVGYYTDMWSVGVLSYILLSGLSPFGGEND-DET 233 (350)
T ss_dssp ECCCTTCEECCTTSCE---EEECSCTTTCCHHHHHTC---------CBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHH
T ss_pred Eeecchheeccccccc---ceecCcccccCHHHHcCC---------CCChhHhhhhhhHHHHHHHhCCCCCCCCCH-HHH
Confidence 9999999887654432 356799999999999876 378899999999999999999999987543 244
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
+..+........ ......+++++++||.+||+.||++|||++|+++|
T Consensus 234 ~~~i~~~~~~~~----~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 234 LRNVKSCDWNMD----DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp HHHHHHTCCCSC----CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred HHHHHhCCCCCC----cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 444443332221 11223678999999999999999999999999986
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-49 Score=390.05 Aligned_cols=256 Identities=21% Similarity=0.352 Sum_probs=191.4
Q ss_pred cCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCC
Q psy14267 254 NGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTAS 333 (553)
Q Consensus 254 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~ 333 (553)
+.++|++++.||+|+||+||+|.+... +.||||+++..... .+.+.+|+++|++++ ||||+++++++.. .
T Consensus 3 dp~~~~~~~~iG~G~fg~Vy~~~~~~~---~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~-HpnIv~~~g~~~~--~ 72 (263)
T d1sm2a_ 3 DPSELTFVQEIGSGQFGLVHLGYWLNK---DKVAIKTIREGAMS----EEDFIEEAEVMMKLS-HPKLVQLYGVCLE--Q 72 (263)
T ss_dssp CCSCEEEEEEEECCSSCCEEEEEETTT---EEEEEEECCSSSSC----HHHHHHHHHHHHHCC-CTTBCCEEEEECS--S
T ss_pred ChHHcEEEEEEeeCCCeEEEEEEECCC---CEEEEEEECCCcCc----HHHHHHHHHHHHhcC-CCCcccccceecc--C
Confidence 456899999999999999999987543 34999999765433 267899999999995 6999999998743 5
Q ss_pred ceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCe
Q psy14267 334 KHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNV 412 (553)
Q Consensus 334 ~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~ 412 (553)
..++++||++ +++|.+++..... ...+..++.++.||+.||+|||+++||||||||+||||+.+ +.
T Consensus 73 ~~~~lv~E~~~~g~L~~~l~~~~~----~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~---------~~ 139 (263)
T d1sm2a_ 73 APICLVFEFMEHGCLSDYLRTQRG----LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN---------QV 139 (263)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTT----CCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGG---------GC
T ss_pred CceEEEEEecCCCcHHHHhhcccc----CCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCC---------CC
Confidence 5678889975 5789998876432 23345566677899999999999999999999999999887 57
Q ss_pred EEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCCCch
Q psy14267 413 LKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHIPNT 491 (553)
Q Consensus 413 vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~~~~ 491 (553)
+||+|||+|+......... .....||+.|||||++.+. .|+.++|||||||+||||++ |.+||.....
T Consensus 140 ~Kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~---------~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~- 208 (263)
T d1sm2a_ 140 IKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFS---------RYSSKSDVWSFGVLMWEVFSEGKIPYENRSN- 208 (263)
T ss_dssp EEECSCC-------------------CTTSCCHHHHTTC---------CCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH-
T ss_pred eEecccchheeccCCCcee-ecceecCcccCChHHhcCC---------CCCchhhhcchHHHHHHHHHCCCCCCCCCCH-
Confidence 9999999998775543321 2245689999999999866 47899999999999999999 5666655433
Q ss_pred HHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q psy14267 492 WAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNP 550 (553)
Q Consensus 492 ~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~ 550 (553)
......+... ... ..+..+++++.+||.+||+.||++|||++||+++|+++.
T Consensus 209 ~~~~~~i~~~-~~~------~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 209 SEVVEDISTG-FRL------YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp HHHHHHHHHT-CCC------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHhc-CCC------CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 2333333332 111 122367899999999999999999999999999999764
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8e-49 Score=397.07 Aligned_cols=262 Identities=24% Similarity=0.360 Sum_probs=194.1
Q ss_pred ecCcceEEEeeeeeeCceEEEEEeeeCCCc-cceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeC
Q psy14267 253 LNGKQYQVLSLLGKGGSSSVYLVGGTSEHE-FKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDT 331 (553)
Q Consensus 253 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~-~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~ 331 (553)
+..++|++.++||+|+||+||+|+++.++. ...||||.+.... .....+++.+|+++|++++ |||||++++++ .
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~--~ 97 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFD-HPNVIHLEGVV--T 97 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEE--C
T ss_pred hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCC-CCCCccEEEEE--e
Confidence 445689999999999999999998865543 3458888876543 3344578999999999995 69999999987 4
Q ss_pred CCceEEEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCC
Q psy14267 332 ASKHLYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIG 410 (553)
Q Consensus 332 ~~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~ 410 (553)
....++++||++. ++|.+++..... ...+..+..++.||+.||+|||+++||||||||+||||+.+
T Consensus 98 ~~~~~~iv~Ey~~~g~L~~~~~~~~~----~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~--------- 164 (299)
T d1jpaa_ 98 KSTPVMIITEFMENGSLDSFLRQNDG----QFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSN--------- 164 (299)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHTTTT----CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT---------
T ss_pred eCCEEEEEEEecCCCcceeeeccccC----CCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCC---------
Confidence 4567899999864 678887775432 24455667778899999999999999999999999999877
Q ss_pred CeEEEEeccCccccCCCCCccc---ccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCC
Q psy14267 411 NVLKIIDFGIACSLQDDKTSVH---KDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYS 486 (553)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~~~~---~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~ 486 (553)
+.+||+|||+|+.+........ .....||+.|||||++.+. .++.++|||||||+||||+| |..||.
T Consensus 165 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~---------~~~~~sDvwS~Gvvl~el~t~g~~Pf~ 235 (299)
T d1jpaa_ 165 LVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR---------KFTSASDVWSYGIVMWEVMSYGERPYW 235 (299)
T ss_dssp CCEEECCC-----------------------CGGGSCHHHHHSC---------CCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred CcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcC---------CCCcccccccchHHHHHHHhCCCCCCC
Confidence 6799999999987765432211 1124579999999999765 47899999999999999998 899998
Q ss_pred CCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 487 HIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 487 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
+.... ..+..+... .. +.....++.++.+||.+||+.||++|||+.||++.|+++
T Consensus 236 ~~~~~-~~~~~i~~~-~~------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~ 290 (299)
T d1jpaa_ 236 DMTNQ-DVINAIEQD-YR------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290 (299)
T ss_dssp TCCHH-HHHHHHHTT-CC------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCHH-HHHHHHHcC-CC------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 86543 333333322 11 223346899999999999999999999999999998764
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-49 Score=394.39 Aligned_cols=264 Identities=22% Similarity=0.336 Sum_probs=205.1
Q ss_pred cceEEecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeE
Q psy14267 248 QDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDY 327 (553)
Q Consensus 248 ~~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~ 327 (553)
.+.|++..++|++++.||+|+||+||+|.... + +.||||+++..... .+.+.+|+++|+++ +||||++++++
T Consensus 5 ~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~-~--~~vAvK~~~~~~~~----~~~~~~E~~~l~~l-~HpnIv~~~g~ 76 (272)
T d1qpca_ 5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYNG-H--TKVAVKSLKQGSMS----PDAFLAEANLMKQL-QHQRLVRLYAV 76 (272)
T ss_dssp TCTTBCCGGGEEEEEEEEEETTEEEEEEEETT-T--EEEEEEEECTTSSC----HHHHHHHHHHHHHC-CCTTBCCEEEE
T ss_pred CCCeecCHHHeEEeEEEecCCCcEEEEEEECC-C--CEEEEEEEccCcCC----HHHHHHHHHHHHhC-CCCCEeEEEee
Confidence 45577788899999999999999999998653 2 45999999765432 36789999999999 56999999997
Q ss_pred EEeCCCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCcccee
Q psy14267 328 VYDTASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKII 406 (553)
Q Consensus 328 ~~~~~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~ 406 (553)
+. +..++++||++ +|+|.+++...... .+++..++.++.||+.||+|||+++||||||||+||||+.+
T Consensus 77 ~~---~~~~~iv~Ey~~~g~L~~~~~~~~~~---~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~----- 145 (272)
T d1qpca_ 77 VT---QEPIYIITEYMENGSLVDFLKTPSGI---KLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDT----- 145 (272)
T ss_dssp EC---SSSCEEEEECCTTCBHHHHTTSHHHH---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-----
T ss_pred ec---cCCeEEEEEeCCCCcHHHHHhhcCCC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecc-----
Confidence 63 23467888875 57888876543321 23456667778899999999999999999999999999877
Q ss_pred cCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCC
Q psy14267 407 DCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYS 486 (553)
Q Consensus 407 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~ 486 (553)
+.+||+|||+|+.+...... ......||+.|||||++.+. .++.++|||||||+||||+||..||.
T Consensus 146 ----~~~Kl~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~---------~~~~~sDvwS~Gvvl~ellt~~~~~~ 211 (272)
T d1qpca_ 146 ----LSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYG---------TFTIKSDVWSFGILLTEIVTHGRIPY 211 (272)
T ss_dssp ----SCEEECCCTTCEECSSSCEE-CCTTCCCCTTTSCHHHHHHC---------EECHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred ----cceeeccccceEEccCCccc-cccccCCcccccChHHHhCC---------CCCchhhhhhhHHHHHHHHhCCCCCC
Confidence 57999999999987654332 23356799999999999765 37899999999999999999655544
Q ss_pred CCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q psy14267 487 HIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNPE 551 (553)
Q Consensus 487 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~~ 551 (553)
........+..+... ... .....+++++.+||.+||+.||++|||+.+|++.|+++..
T Consensus 212 ~~~~~~~~~~~i~~~-~~~------~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 212 PGMTNPEVIQNLERG-YRM------VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp TTCCHHHHHHHHHTT-CCC------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHhc-CCC------CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 433333444444322 111 1223688999999999999999999999999999987653
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-49 Score=403.99 Aligned_cols=258 Identities=23% Similarity=0.326 Sum_probs=200.1
Q ss_pred cceEEEe-eeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEe--CC
Q psy14267 256 KQYQVLS-LLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYD--TA 332 (553)
Q Consensus 256 ~~y~i~~-~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~--~~ 332 (553)
++|++++ .||+|+||+||+|++..++.. ||||+++.. ..+.+|+.++.++.+||||+++++++.+ ..
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~--vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~ 80 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEK--FALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAG 80 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCE--EEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCE--EEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccC
Confidence 4798875 699999999999998877654 999999642 4567899998888788999999998765 34
Q ss_pred CceEEEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCC
Q psy14267 333 SKHLYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGN 411 (553)
Q Consensus 333 ~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~ 411 (553)
+.++|++|||+. |+|.+++..... ..+++..+..++.||+.||+|||++|||||||||+|||++.+. ..+
T Consensus 81 ~~~~~ivmEy~~gg~L~~~i~~~~~---~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~------~~~ 151 (335)
T d2ozaa1 81 RKCLLIVMECLDGGELFSRIQDRGD---QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR------PNA 151 (335)
T ss_dssp EEEEEEEEECCCSEEHHHHHHSCSC---CCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSS------TTC
T ss_pred CCEEEEEEECCCCCcHHHHHHhcCC---CCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccc------ccc
Confidence 568899999874 799999986432 2466777888889999999999999999999999999997642 236
Q ss_pred eEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCch
Q psy14267 412 VLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNT 491 (553)
Q Consensus 412 ~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~ 491 (553)
.+||+|||+|+....... ....+||+.|||||++.+. .|+.++|||||||+||||++|++||.+....
T Consensus 152 ~~Kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~---------~y~~~~DiwSlGvily~lltg~~Pf~~~~~~ 219 (335)
T d2ozaa1 152 ILKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPE---------KYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 219 (335)
T ss_dssp CEEECCCTTCEECCCCCC---CCCCSCCCSSCCCCCCCGG---------GGSHHHHHHHHHHHHHHHTTSSCSCEETTCC
T ss_pred cccccccceeeeccCCCc---cccccCCcccCCcHHHcCC---------CCCHHHHHHhhchhHHHHhhCCCCCCCCCHH
Confidence 799999999988765443 2367899999999999876 3789999999999999999999999764332
Q ss_pred HHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 492 WAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 492 ~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
. ....+...............+..+++++++||.+||+.||++|||+.|+++|
T Consensus 220 ~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 220 A-ISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp ---------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred H-HHHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1 1111111111111111111122578999999999999999999999999985
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=387.07 Aligned_cols=255 Identities=18% Similarity=0.338 Sum_probs=204.7
Q ss_pred cCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCC
Q psy14267 254 NGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTAS 333 (553)
Q Consensus 254 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~ 333 (553)
+.++|+++++||+|+||+||+++.+ ++ +.||||++++..... +.+++|+.++++++ ||||+++++++. .+
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~--~~vAvK~l~~~~~~~----~~~~~Ev~~~~~l~-HpnIv~~~g~~~--~~ 71 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWR-GQ--YDVAIKMIKEGSMSE----DEFIEEAKVMMNLS-HEKLVQLYGVCT--KQ 71 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEET-TT--EEEEEEEEESSSSCH----HHHHHHHHHHHTCC-CTTBCCEEEEEC--CS
T ss_pred ChHHCEEeEEEecCCCeEEEEEEEC-CC--CEEEEEEECcCcCCH----HHHHHHHHHHHhcC-CCceeeEEEEEe--eC
Confidence 3468999999999999999999874 22 459999998765443 56899999999995 699999999774 45
Q ss_pred ceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCe
Q psy14267 334 KHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNV 412 (553)
Q Consensus 334 ~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~ 412 (553)
..++++||++ +|+|..++...... ..+..++.++.|+++||+|||++||+||||||+||||+.+ +.
T Consensus 72 ~~~~iv~Ey~~~g~l~~~~~~~~~~----~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~---------~~ 138 (258)
T d1k2pa_ 72 RPIFIITEYMANGCLLNYLREMRHR----FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQ---------GV 138 (258)
T ss_dssp SSEEEEEECCTTEEHHHHHHSGGGC----CCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTT---------CC
T ss_pred CceEEEEEccCCCcHHHhhhccccC----CcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCC---------Cc
Confidence 6789999986 57788887665432 3344566677899999999999999999999999999876 67
Q ss_pred EEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCCCch
Q psy14267 413 LKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHIPNT 491 (553)
Q Consensus 413 vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~~~~ 491 (553)
+||+|||+|+........ ......||+.|+|||++.+. .++.++|||||||++|||+| |+.||......
T Consensus 139 ~kl~DfG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~---------~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~ 208 (258)
T d1k2pa_ 139 VKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYS---------KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS 208 (258)
T ss_dssp EEECCCSSCCBCSSSSCC-CCCCSCCCGGGCCHHHHHHC---------CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH
T ss_pred EEECcchhheeccCCCce-eecccCCCCCcCCcHHhcCC---------CCCcceeecccchhhHhHHhcCCCCCCCCCHH
Confidence 999999999877654332 22346799999999999866 37899999999999999998 89999886543
Q ss_pred HHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 492 WAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 492 ~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
.....+... ..+ ..+..+++++.+||.+||+.||++|||+++|+++|.++
T Consensus 209 -~~~~~i~~~-~~~------~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 209 -ETAEHIAQG-LRL------YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp -HHHHHHHTT-CCC------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred -HHHHHHHhC-CCC------CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 333333322 121 22336789999999999999999999999999999864
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.4e-48 Score=398.26 Aligned_cols=248 Identities=23% Similarity=0.383 Sum_probs=201.7
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|++++.||+|+||+||+|+++.++.. ||||++++.........+.+.+|+.+|++++ ||||+++++++. ....
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~--vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~--~~~~ 78 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRY--YAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HPFIIRMWGTFQ--DAQQ 78 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCE--EEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-BTTBCCEEEEEE--CSSE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCE--EEEEEEchHHccCHHHHHHHHHHHHHHHhcc-CcChhheeeeEe--eCCe
Confidence 5799999999999999999998877654 9999998765444455678999999999995 599999999875 4678
Q ss_pred EEEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
+|++||++. ++|..++...... ....+..++.||+.||+|||++|||||||||+||||+.+ +.+|
T Consensus 79 ~~ivmE~~~gg~l~~~~~~~~~~-----~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~---------g~vk 144 (316)
T d1fota_ 79 IFMIMDYIEGGELFSLLRKSQRF-----PNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKN---------GHIK 144 (316)
T ss_dssp EEEEECCCCSCBHHHHHHHTSSC-----CHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTT---------SCEE
T ss_pred eeeEeeecCCccccccccccccc-----cccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCC---------CCEE
Confidence 999999764 5777777765432 234555667899999999999999999999999999876 6799
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||+|+...... .+.+||+.|||||++.+.. |+.++|||||||+||||++|+.||.+... ...
T Consensus 145 L~DFG~a~~~~~~~-----~~~~Gt~~Y~APE~l~~~~---------y~~~~DiwSlGvilyemltG~~Pf~~~~~-~~~ 209 (316)
T d1fota_ 145 ITDFGFAKYVPDVT-----YTLCGTPDYIAPEVVSTKP---------YNKSIDWWSFGILIYEMLAGYTPFYDSNT-MKT 209 (316)
T ss_dssp ECCCSSCEECSSCB-----CCCCSCTTTCCHHHHTTCC---------BCTTHHHHHHHHHHHHHHHSSCTTCCSSH-HHH
T ss_pred EecCccceEecccc-----ccccCcccccCHHHHcCCC---------CCchhhccccchhHHHHHhCCCCCCCcCH-HHH
Confidence 99999998875433 2678999999999998763 78899999999999999999999987543 233
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARP-----TVGNSVTQ 545 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RP-----t~~ell~~ 545 (553)
+..+.... ..+ +..++++++++|.+||.+||++|+ |+++|++|
T Consensus 210 ~~~i~~~~--~~~------p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 210 YEKILNAE--LRF------PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp HHHHHHCC--CCC------CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHHHcCC--CCC------CCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 44443322 122 236789999999999999999996 89999875
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.1e-48 Score=404.69 Aligned_cols=254 Identities=21% Similarity=0.347 Sum_probs=204.1
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|++++.||+|+||+||+|++..++.. ||||++.+... ...+.+.+|+.+|++|. ||||+++++++. ....
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~--vAiK~i~~~~~---~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~--~~~~ 100 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRV--FVAKFINTPYP---LDKYTVKNEISIMNQLH-HPKLINLHDAFE--DKYE 100 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCE--EEEEEEECCSH---HHHHHHHHHHHHHTTCC-STTBCCEEEEEE--CSSE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCE--EEEEEECCcch---hHHHHHHHHHHHHHhCC-CCCCCcEEEEEE--ECCE
Confidence 4699999999999999999998877654 99999987642 23467889999999995 699999999874 4678
Q ss_pred EEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
+|++||++ +++|.+++.... ..+.+..++.++.||+.||+|||++|||||||||+||||+... .+.+|
T Consensus 101 ~~ivmE~~~gg~L~~~~~~~~----~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~-------~~~vk 169 (352)
T d1koba_ 101 MVLILEFLSGGELFDRIAAED----YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKK-------ASSVK 169 (352)
T ss_dssp EEEEEECCCCCBHHHHTTCTT----CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTT-------CCCEE
T ss_pred EEEEEEcCCCChHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccC-------CCeEE
Confidence 89999976 478887765432 2355677777888999999999999999999999999997432 26799
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||+|+.+...... ....||+.|||||++.+. .|+.++|||||||+||||++|..||.+.... ..
T Consensus 170 L~DFGla~~~~~~~~~---~~~~gt~~y~aPE~~~~~---------~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-~~ 236 (352)
T d1koba_ 170 IIDFGLATKLNPDEIV---KVTTATAEFAAPEIVDRE---------PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-ET 236 (352)
T ss_dssp ECCCTTCEECCTTSCE---EEECSSGGGCCHHHHTTC---------CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-HH
T ss_pred EeecccceecCCCCce---eeccCcccccCHHHHcCC---------CCCCccchHHHHHHHHHHHhCCCCCCCCCHH-HH
Confidence 9999999988664432 356799999999999876 3789999999999999999999999875443 33
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
+..+...... ........+++++++||.+||+.||++|||+.|+++|
T Consensus 237 ~~~i~~~~~~----~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 237 LQNVKRCDWE----FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp HHHHHHCCCC----CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhCCCC----CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 4444332221 1122334789999999999999999999999999886
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-48 Score=403.83 Aligned_cols=248 Identities=22% Similarity=0.337 Sum_probs=202.6
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|++++.||+|+||+||+|+++.++.. ||||++.+.........+.+++|+++|+++. ||||+++++++. ....
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~--~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~--~~~~ 115 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNH--YAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSFK--DNSN 115 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCE--EEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEE--CSSE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCE--EEEEEEchHHccCHHHHHHHHHHHHHHHHcC-CCcEeecccccc--cccc
Confidence 5899999999999999999998877755 9999998765444455678999999999995 699999998774 3567
Q ss_pred EEEEEec-CCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEK-GDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~-~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
++++|++ .+++|..++..... +.+..+..++.||+.||+|||++|||||||||+||||+.+ +.+|
T Consensus 116 ~~~v~e~~~~g~l~~~l~~~~~-----l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~---------g~ik 181 (350)
T d1rdqe_ 116 LYMVMEYVAGGEMFSHLRRIGR-----FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ---------GYIQ 181 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHHCC-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---------SCEE
T ss_pred cccccccccccchhhhHhhcCC-----CCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCC---------CCEE
Confidence 7788775 56789888877653 3456677788899999999999999999999999999776 6799
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||+|+.+.... .+.+||+.|||||++.+.. |+.++|||||||+||||++|+.||.+... ...
T Consensus 182 L~DFG~a~~~~~~~-----~~~~Gt~~Y~APE~~~~~~---------~~~~~DiwSlGvilyemltG~~Pf~~~~~-~~~ 246 (350)
T d1rdqe_ 182 VTDFGFAKRVKGRT-----WTLCGTPEALAPEIILSKG---------YNKAVDWWALGVLIYEMAAGYPPFFADQP-IQI 246 (350)
T ss_dssp ECCCTTCEECSSCB-----CCCEECGGGCCHHHHTTCC---------BCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHH
T ss_pred eeeceeeeeccccc-----ccccCccccCCHHHHcCCC---------CCccccccchhHHHHHHHhCCCCCCCcCH-HHH
Confidence 99999998875432 2578999999999998763 78899999999999999999999987543 233
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARP-----TVGNSVTQ 545 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RP-----t~~ell~~ 545 (553)
+..+.... .. .+..+++++.+||++||..||++|+ |+++|++|
T Consensus 247 ~~~i~~~~--~~------~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 247 YEKIVSGK--VR------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp HHHHHHCC--CC------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHHhcCC--CC------CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 33333322 11 1236889999999999999999994 89999864
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.2e-48 Score=404.35 Aligned_cols=254 Identities=23% Similarity=0.373 Sum_probs=196.0
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhc--CCCceeEeeeEEEeCCC
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQ--GCPYVIKMHDYVYDTAS 333 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~--~hp~Iv~l~~~~~~~~~ 333 (553)
++|+++++||+|+||+||+|++..++.. ||||++.+...........+.+|..+++.++ +||||+++++++. ..
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~--vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~--~~ 79 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKM--YAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH--TP 79 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCE--EEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE--CS
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCE--EEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEE--EC
Confidence 5799999999999999999998877755 9999998655443333345556655544443 4799999998774 35
Q ss_pred ceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCe
Q psy14267 334 KHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNV 412 (553)
Q Consensus 334 ~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~ 412 (553)
..+|++||++ +++|.+++..... .....+..++.||+.||+|||++|||||||||+||||+.+ +.
T Consensus 80 ~~~~ivmE~~~gg~L~~~l~~~~~-----~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~---------g~ 145 (364)
T d1omwa3 80 DKLSFILDLMNGGDLHYHLSQHGV-----FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH---------GH 145 (364)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHCS-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS---------SC
T ss_pred CEEEEEEEecCCCcHHHHHHhccc-----ccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCC---------Cc
Confidence 6789999986 4899999987643 2345666777899999999999999999999999999776 67
Q ss_pred EEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchH
Q psy14267 413 LKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTW 492 (553)
Q Consensus 413 vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~ 492 (553)
+||+|||+|+.+..... ...+||+.|||||++.... .|+.++|||||||+||||++|+.||.......
T Consensus 146 iKl~DFGla~~~~~~~~----~~~~GT~~y~APE~~~~~~--------~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~ 213 (364)
T d1omwa3 146 VRISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGV--------AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 213 (364)
T ss_dssp EEECCCTTCEECSSSCC----CSCCSCGGGCCHHHHSTTC--------CCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC
T ss_pred EEEeeeceeeecCCCcc----cccccccccchhHHhhcCC--------CCCcccchhHHHHHHHHHHhCCCCCCCCCHHH
Confidence 99999999988765432 3567999999999996432 37899999999999999999999998643321
Q ss_pred HHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q psy14267 493 AKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPT-----VGNSVTQ 545 (553)
Q Consensus 493 ~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt-----~~ell~~ 545 (553)
.. .+..... ......+..+++++++||.+||..||++||| ++||++|
T Consensus 214 ~~--~~~~~~~----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 214 KH--EIDRMTL----TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp HH--HHHHHSS----SCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred HH--HHHHhcc----cCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 11 1111111 1112223368999999999999999999999 6888764
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-48 Score=395.67 Aligned_cols=260 Identities=20% Similarity=0.305 Sum_probs=198.9
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCcc--ceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEF--KPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA 332 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~--~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~ 332 (553)
..+|+++++||+|+||+||+|.+..++.. .+||+|.++... .....+++.+|+++|++++ ||||+++++++.+
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~-- 82 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVD-NPHVCRLLGICLT-- 82 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCC-CTTBCCEEEEEES--
T ss_pred HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEec--
Confidence 45799999999999999999988765532 358888886543 2233578999999999995 6999999998854
Q ss_pred CceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCe
Q psy14267 333 SKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNV 412 (553)
Q Consensus 333 ~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~ 412 (553)
....++++++.+++|.+++..... ...+..++.++.||+.||+|||++|||||||||+||||+.+ +.
T Consensus 83 ~~~~~v~e~~~~~~l~~~~~~~~~----~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~---------~~ 149 (317)
T d1xkka_ 83 STVQLITQLMPFGCLLDYVREHKD----NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP---------QH 149 (317)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSS----SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEET---------TE
T ss_pred CCeeEEEEeccCCccccccccccc----CCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCC---------CC
Confidence 445566667788999988876543 33455667778899999999999999999999999999877 68
Q ss_pred EEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCCCch
Q psy14267 413 LKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHIPNT 491 (553)
Q Consensus 413 vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~~~~ 491 (553)
+||+|||+|+...............||+.|||||++.+. .|+.++|||||||+||||+| |.+||.+....
T Consensus 150 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~---------~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~ 220 (317)
T d1xkka_ 150 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR---------IYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 220 (317)
T ss_dssp EEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHC---------CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG
T ss_pred eEeeccccceecccccccccccccccCccccChHHHhcC---------CCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH
Confidence 999999999987665544334455689999999999866 37899999999999999998 89999876543
Q ss_pred HHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 492 WAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 492 ~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
+....+.. .... ..+..+++++.+||.+||+.||++|||+.||+++|+.+
T Consensus 221 -~~~~~i~~-~~~~------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 221 -EISSILEK-GERL------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp -GHHHHHHH-TCCC------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HHHHHHHc-CCCC------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 22222222 2222 22336889999999999999999999999999998753
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-48 Score=386.16 Aligned_cols=263 Identities=20% Similarity=0.312 Sum_probs=193.3
Q ss_pred ecCcceEEEeeeeeeCceEEEEEeeeCCCc--cceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEe
Q psy14267 253 LNGKQYQVLSLLGKGGSSSVYLVGGTSEHE--FKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYD 330 (553)
Q Consensus 253 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~--~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~ 330 (553)
+....|++.++||+|+||+||+|....++. ...||||++.... ......++++|+++|++++ |||||++++++.
T Consensus 4 i~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~-H~nIv~~~g~~~- 79 (283)
T d1mqba_ 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFS-HHNIIRLEGVIS- 79 (283)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC-
T ss_pred CCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcC-CCCEeeeeEEEe-
Confidence 445679999999999999999998765432 2469999996543 2344567999999999995 599999999774
Q ss_pred CCCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCC
Q psy14267 331 TASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCI 409 (553)
Q Consensus 331 ~~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~ 409 (553)
....++++||++ ++++.+++..... ...+..++.++.||+.||+|||+++||||||||+||||+.+
T Consensus 80 -~~~~~~~v~e~~~~~~l~~~~~~~~~----~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~-------- 146 (283)
T d1mqba_ 80 -KYKPMMIITEYMENGALDKFLREKDG----EFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSN-------- 146 (283)
T ss_dssp -SSSSEEEEEECCTTEEHHHHHHHTTT----CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT--------
T ss_pred -cCCceEEEEEecccCcchhhhhcccc----cccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCC--------
Confidence 455678888865 4567666665432 34456667788899999999999999999999999999877
Q ss_pred CCeEEEEeccCccccCCCCCc-ccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy14267 410 GNVLKIIDFGIACSLQDDKTS-VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHI 488 (553)
Q Consensus 410 ~~~vkL~DFGla~~~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~ 488 (553)
+.+||+|||+|+.+...... .......||+.|||||++.+. .++.++|||||||+||||++|..||...
T Consensus 147 -~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~---------~~~~~sDI~S~Gvil~el~t~~~~~~~~ 216 (283)
T d1mqba_ 147 -LVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR---------KFTSASDVWSFGIVMWEVMTYGERPYWE 216 (283)
T ss_dssp -CCEEECCCCC-----------------CCCGGGSCHHHHHSC---------CCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred -CeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccC---------CCCCcccccccHHHHHHHHhCCCCcccc
Confidence 67999999999887554322 122245689999999999765 4789999999999999999965555443
Q ss_pred CchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 489 PNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 489 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
.+..+.+..+... .. ......++.++.+||.+||+.||++|||+.||++.|+.+
T Consensus 217 ~~~~~~~~~i~~~-~~------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l 270 (283)
T d1mqba_ 217 LSNHEVMKAINDG-FR------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270 (283)
T ss_dssp CCHHHHHHHHHTT-CC------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCHHHHHHHHhcc-CC------CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHH
Confidence 3433444433322 11 122336889999999999999999999999999988753
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-48 Score=389.75 Aligned_cols=266 Identities=23% Similarity=0.375 Sum_probs=204.9
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|++++.||+|+||+||+|++..++.. ||||+++..... +...+++.+|+++|+++. ||||+++++++.+ ...
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~--vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~-Hp~Iv~~~~~~~~--~~~ 75 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEV--VALKKIRLDTET-EGVPSTAIREISLLKELN-HPNIVKLLDVIHT--ENK 75 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCE--EEEEEEC--------CCHHHHHHHHHHTTCC-CTTBCCEEEEEEE--TTE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCE--EEEEEEehhhcC-hHHHHHHHHHHHHHHhCC-CCcEEEecccccc--ccc
Confidence 5799999999999999999998877755 999999765433 234578899999999995 6999999998854 668
Q ss_pred EEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 336 LYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 336 ~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
+|++||++++++..++...... ...+..+..++.||+.||+|||++|||||||||+|||++.+ +.+||
T Consensus 76 ~~iv~e~~~~~~~~~~~~~~~~---~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~---------~~~kl 143 (298)
T d1gz8a_ 76 LYLVFEFLHQDLKKFMDASALT---GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTE---------GAIKL 143 (298)
T ss_dssp EEEEEECCSEEHHHHHHHTTTT---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT---------SCEEE
T ss_pred eeEEEeecCCchhhhhhhhccc---CCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeeccc---------Cccee
Confidence 9999999999888877655332 34566777888899999999999999999999999999776 57999
Q ss_pred EeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHH
Q psy14267 416 IDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKM 495 (553)
Q Consensus 416 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~ 495 (553)
+|||+|+....... ......||+.|+|||++.... .++.++|||||||++|+|++|+.||.+.... ..+
T Consensus 144 ~DFG~a~~~~~~~~--~~~~~~gt~~y~apE~~~~~~--------~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~-~~~ 212 (298)
T d1gz8a_ 144 ADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCK--------YYSTAVDIWSLGCIFAEMVTRRALFPGDSEI-DQL 212 (298)
T ss_dssp CSTTHHHHHCCCSB--CTTCCBCCCTTCCHHHHTTCS--------SCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHH
T ss_pred ccCCcceeccCCcc--cceeecccceeeehhhhcccc--------CCCccccccccchhhhHHhhCCCCCCCCCHH-HHH
Confidence 99999988765433 233567999999999987654 3578999999999999999999999875543 333
Q ss_pred HHHHhhccccc---cc---------ccc---------cCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH--HhcCC
Q psy14267 496 LAIARHKDQIE---FK---------PQL---------ANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ--INNNP 550 (553)
Q Consensus 496 ~~i~~~~~~~~---~~---------~~~---------~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~--L~~~~ 550 (553)
..+........ +. ... .....+++++++||++||..||++|||+.||++| |+++.
T Consensus 213 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~ 290 (298)
T d1gz8a_ 213 FRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290 (298)
T ss_dssp HHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred HHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCC
Confidence 33222111000 00 000 0112567899999999999999999999999987 66543
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-48 Score=385.88 Aligned_cols=264 Identities=18% Similarity=0.294 Sum_probs=197.7
Q ss_pred ecCcceEEEeeeeeeCceEEEEEeeeC-CCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeC
Q psy14267 253 LNGKQYQVLSLLGKGGSSSVYLVGGTS-EHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDT 331 (553)
Q Consensus 253 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~ 331 (553)
+..++|++.+.||+|+||.||+|+... ++....||||++++.........+++.+|+.+|+++ +||||+++++++.+
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~~~g~~~~- 82 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVLT- 82 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS-
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEee-
Confidence 345689999999999999999998653 344457999999887766666778999999999999 56999999998743
Q ss_pred CCceEEEEEec-CCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCC
Q psy14267 332 ASKHLYVLMEK-GDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIG 410 (553)
Q Consensus 332 ~~~~~~iv~e~-~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~ 410 (553)
..++++||+ .++++.+++..... .++...++.++.||+.||+|||++||+||||||+||||+.+
T Consensus 83 --~~~~lv~e~~~~~~l~~~~~~~~~----~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~--------- 147 (273)
T d1u46a_ 83 --PPMKMVTELAPLGSLLDRLRKHQG----HFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATR--------- 147 (273)
T ss_dssp --SSCEEEEECCTTCBHHHHHHHHGG----GSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEET---------
T ss_pred --cchheeeeeecCcchhhhhhcccC----CCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccc---------
Confidence 245677775 46788887776543 34456677778899999999999999999999999999887
Q ss_pred CeEEEEeccCccccCCCCCcc-cccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCC
Q psy14267 411 NVLKIIDFGIACSLQDDKTSV-HKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHI 488 (553)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~~~-~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~ 488 (553)
+.+||+|||+++......... ......|+..|+|||++.+. .++.++|||||||++|||++ |..||.+.
T Consensus 148 ~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~---------~~~~~~Di~S~Gvil~emlt~G~~Pf~~~ 218 (273)
T d1u46a_ 148 DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR---------TFSHASDTWMFGVTLWEMFTYGQEPWIGL 218 (273)
T ss_dssp TEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHC---------EEEHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCC---------CCCcchhhhhhHHHHHHHHhCCCCCCCCc
Confidence 579999999999876654332 23345688899999999876 47899999999999999998 89999875
Q ss_pred CchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 489 PNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 489 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
... ..+..+....... .....+|+++++||.+||+.||++|||+.+|++.|++.
T Consensus 219 ~~~-~~~~~i~~~~~~~------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 219 NGS-QILHKIDKEGERL------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp CHH-HHHHHHHTSCCCC------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CHH-HHHHHHHhCCCCC------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 443 3334443332222 22347889999999999999999999999999999864
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-48 Score=388.68 Aligned_cols=247 Identities=30% Similarity=0.444 Sum_probs=196.6
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchh---HHHHHHHHHHHHHhhcC-CCceeEeeeEEEe
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQS---IADSYLNEVELLAKLQG-CPYVIKMHDYVYD 330 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~---~~~~~~~E~~iL~~l~~-hp~Iv~l~~~~~~ 330 (553)
.++|++.++||+|+||+||+|++..++.. ||||++.+....... ...++.+|+.+|+++.+ ||||+++++++.
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~--vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~- 79 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLP--VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE- 79 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCE--EEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE-
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCE--EEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEe-
Confidence 35799999999999999999998877644 999999876543211 12346789999999974 799999999874
Q ss_pred CCCceEEEEEecCC--CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecC
Q psy14267 331 TASKHLYVLMEKGD--TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDC 408 (553)
Q Consensus 331 ~~~~~~~iv~e~~~--~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~ 408 (553)
....++++||++. +++.+++..... ..+..++.++.||+.||+|||++|||||||||+||||+.+.
T Consensus 80 -~~~~~~lv~e~~~~~~~l~~~~~~~~~-----l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~------ 147 (273)
T d1xwsa_ 80 -RPDSFVLILERPEPVQDLFDFITERGA-----LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR------ 147 (273)
T ss_dssp -CSSEEEEEEECCSSEEEHHHHHHHHCS-----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTT------
T ss_pred -eCCeEEEEEEeccCcchHHHHHhccCC-----CCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCC------
Confidence 3567888888754 577788776542 34566777788999999999999999999999999998652
Q ss_pred CCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy14267 409 IGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHI 488 (553)
Q Consensus 409 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~ 488 (553)
+.+||+|||+|+...... ..+.+||+.|||||++.+..+ ++.++|||||||+||||++|+.||...
T Consensus 148 --~~vkl~DFG~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~--------~~~~~DiwSlGvilyell~g~~Pf~~~ 213 (273)
T d1xwsa_ 148 --GELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRY--------HGRSAAVWSLGILLYDMVCGDIPFEHD 213 (273)
T ss_dssp --TEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCB--------CHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred --CeEEECccccceeccccc----ccccccCCCcCCHHHHcCCCC--------CCcccccccceeeehhHhhCCCCCCCc
Confidence 579999999998765432 236789999999999986642 467899999999999999999999762
Q ss_pred CchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 489 PNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 489 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
. .+.. ....+ ...+|+++++||++||..||++|||++|+++|
T Consensus 214 ~-------~i~~--~~~~~------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 214 E-------EIIR--GQVFF------RQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp H-------HHHH--CCCCC------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred h-------HHhh--cccCC------CCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 1 1111 11222 23688999999999999999999999999885
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-48 Score=389.27 Aligned_cols=261 Identities=23% Similarity=0.309 Sum_probs=193.8
Q ss_pred EEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCc--hhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEE
Q psy14267 260 VLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITD--QSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLY 337 (553)
Q Consensus 260 i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~--~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~ 337 (553)
.+++||+|+||+||+|+++.++.. ||||++++..... +...+++.+|+.+|++++ ||||+++++++ ....++|
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~--vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~~~~~~--~~~~~~~ 76 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQI--VAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAF--GHKSNIS 76 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSE--EEEEEC------------CTHHHHHHHHHHHCC-CTTBCCEEEEE--CCTTCCE
T ss_pred cceEeccCcCeEEEEEEECCCCcE--EEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCC-CCCEeEEEeee--ccCCcee
Confidence 568999999999999998877654 9999997654332 222357899999999995 59999999987 4466789
Q ss_pred EEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEEe
Q psy14267 338 VLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIID 417 (553)
Q Consensus 338 iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~D 417 (553)
++||++.+++...+..... ......+..+++||+.||+|||++|||||||||+|||++.+ +.+||+|
T Consensus 77 ivmE~~~~~~~~~~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~---------~~~KL~D 143 (299)
T d1ua2a_ 77 LVFDFMETDLEVIIKDNSL----VLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDEN---------GVLKLAD 143 (299)
T ss_dssp EEEECCSEEHHHHHTTCCS----SCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---------CCEEECC
T ss_pred ehhhhhcchHHhhhhhccc----CCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCC---------Ccccccc
Confidence 9999988877766654332 22334556667899999999999999999999999999876 6799999
Q ss_pred ccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHHHH
Q psy14267 418 FGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKMLA 497 (553)
Q Consensus 418 FGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~~~ 497 (553)
||+|+........ ....+||+.|||||++.+.. .|+.++|||||||+||||++|.+||.+.... ..+..
T Consensus 144 FG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~--------~~~~~~DiwSlGvil~el~~g~~pf~~~~~~-~~l~~ 212 (299)
T d1ua2a_ 144 FGLAKSFGSPNRA--YTHQVVTRWYRAPELLFGAR--------MYGVGVDMWAVGCILAELLLRVPFLPGDSDL-DQLTR 212 (299)
T ss_dssp CGGGSTTTSCCCC--CCCSCCCCTTCCHHHHTTCS--------CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHH
T ss_pred CccccccCCCccc--ccceecChhhccHHHHccCC--------CCChhhhhhhcchHHHHHHhCcCCCCCCCHH-HHHHH
Confidence 9999877654332 23567999999999987543 3689999999999999999999999875443 33333
Q ss_pred HHhhcccc---ccccc-----------------ccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH--HhcC
Q psy14267 498 IARHKDQI---EFKPQ-----------------LANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ--INNN 549 (553)
Q Consensus 498 i~~~~~~~---~~~~~-----------------~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~--L~~~ 549 (553)
+....... .+... ......+++++++||.+||+.||++|||++|+++| |++.
T Consensus 213 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 213 IFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286 (299)
T ss_dssp HHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred HHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence 32211100 00000 00112567899999999999999999999999985 5543
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-47 Score=387.68 Aligned_cols=269 Identities=20% Similarity=0.331 Sum_probs=209.3
Q ss_pred EEecCcceEEEeeeeeeCceEEEEEeeeCC---CccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeE
Q psy14267 251 ITLNGKQYQVLSLLGKGGSSSVYLVGGTSE---HEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDY 327 (553)
Q Consensus 251 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~---~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~ 327 (553)
+++..++|++++.||+|+||+||+|+.+.. ...+.||||+++... .....+++.+|+++|++++ ||||+.++++
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~-h~niv~~~~~ 84 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFD-NPNIVKLLGV 84 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCC-CTTBCCEEEE
T ss_pred ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcC-CCCcccceee
Confidence 345567899999999999999999987642 233569999987543 2344578999999999995 5999999987
Q ss_pred EEeCCCceEEEEEec-CCCCHHHHHHHcccC-------------------CCCchHHHHHHHHHHHHHHHHHHHhhCCcE
Q psy14267 328 VYDTASKHLYVLMEK-GDTDLSKYMRNLNKM-------------------TTLPNTMIIIIMHWYEMLLAVKEIHAAGII 387 (553)
Q Consensus 328 ~~~~~~~~~~iv~e~-~~~~L~~~l~~~~~~-------------------~~~~~~~~~i~~~~~qil~aL~yLH~~gIi 387 (553)
+. ....++++||+ .+++|.+++...... ....+.+..++.++.|++.||+|||+++||
T Consensus 85 ~~--~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iv 162 (301)
T d1lufa_ 85 CA--VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFV 162 (301)
T ss_dssp EC--SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred ec--cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeE
Confidence 74 45567788886 568999998764321 112245566788889999999999999999
Q ss_pred ecCCCCCCEEEecCccceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccch
Q psy14267 388 HSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSD 467 (553)
Q Consensus 388 HrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sD 467 (553)
||||||+||||+.+ +.+||+|||+|+............+.+||+.|||||++.+. .|+.++|
T Consensus 163 HrDlKp~NILld~~---------~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~t~ksD 224 (301)
T d1lufa_ 163 HRDLATRNCLVGEN---------MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN---------RYTTESD 224 (301)
T ss_dssp CSCCSGGGEEECGG---------GCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC---------CCCHHHH
T ss_pred eeEEcccceEECCC---------CcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccC---------CCChhhh
Confidence 99999999999877 57999999999877655444444567799999999999866 4789999
Q ss_pred HHHHHHHHHHHHhCC-CCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q psy14267 468 VWSLGCILYNMIYGR-TPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQI 546 (553)
Q Consensus 468 IwSlGvvl~elltG~-~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L 546 (553)
||||||+||||++|. +||.+.... +.+..+.... . ...+..+++++.+||.+||+.||++|||+.||++.|
T Consensus 225 VwS~Gvvl~ell~~~~~p~~~~~~~-e~~~~v~~~~-~------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L 296 (301)
T d1lufa_ 225 VWAYGVVLWEIFSYGLQPYYGMAHE-EVIYYVRDGN-I------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 296 (301)
T ss_dssp HHHHHHHHHHHHTTTCCTTTTSCHH-HHHHHHHTTC-C------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred hccchhhHHHHHccCCCCCCCCCHH-HHHHHHHcCC-C------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 999999999999985 677765443 4444443322 1 122337889999999999999999999999999999
Q ss_pred hcCC
Q psy14267 547 NNNP 550 (553)
Q Consensus 547 ~~~~ 550 (553)
+++-
T Consensus 297 ~~i~ 300 (301)
T d1lufa_ 297 QRMC 300 (301)
T ss_dssp HHTT
T ss_pred HHhc
Confidence 9874
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-47 Score=386.01 Aligned_cols=264 Identities=22% Similarity=0.343 Sum_probs=200.5
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhc--CCCceeEeeeEEEeC-
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQ--GCPYVIKMHDYVYDT- 331 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~--~hp~Iv~l~~~~~~~- 331 (553)
.++|+++++||+|+||+||+|++..++. +.||||+++...... .....+.+|+.+|+.|. +||||+++++++...
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~-~~vAiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~ 83 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGG-RFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 83 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTT-EEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCC-EEEEEEEEehhhccc-hHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence 3689999999999999999998865432 349999997654332 22245678999888875 679999999987543
Q ss_pred --CCceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCC
Q psy14267 332 --ASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCI 409 (553)
Q Consensus 332 --~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~ 409 (553)
...+++++||++.+++..+....... ......+..++.|++.||+|||++|||||||||+|||++.+
T Consensus 84 ~~~~~~~~~~~e~~~~~~~~~~~~~~~~---~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~-------- 152 (305)
T d1blxa_ 84 TDRETKLTLVFEHVDQDLTTYLDKVPEP---GVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS-------- 152 (305)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHSCTT---CSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT--------
T ss_pred cccCceEEEEEEeccCCchhhhhhccCC---CCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCC--------
Confidence 34578999999888877666554332 33455666778899999999999999999999999999776
Q ss_pred CCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy14267 410 GNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIP 489 (553)
Q Consensus 410 ~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~ 489 (553)
+.+||+|||+++...... .....+||+.|||||++.+. .|+.++|||||||+||||++|++||.+..
T Consensus 153 -~~~kl~dfg~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~---------~y~~~~DiwSlG~il~ell~g~~pf~~~~ 219 (305)
T d1blxa_ 153 -GQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQS---------SYATPVDLWSVGCIFAEMFRRKPLFRGSS 219 (305)
T ss_dssp -CCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTC---------CCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred -CCeeecchhhhhhhcccc---cCCCcccChhhcCcchhcCC---------CCChhehhhchHHHHHHHHHCCCCCCCCC
Confidence 579999999987654332 23467899999999999866 37899999999999999999999998765
Q ss_pred chHHHHHHHHhhccc---ccc----------------cccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 490 NTWAKMLAIARHKDQ---IEF----------------KPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 490 ~~~~~~~~i~~~~~~---~~~----------------~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
.. ..+..+...... ..+ .+.......+++.+++||.+||+.||++|||+.|+++|
T Consensus 220 ~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 220 DV-DQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp HH-HHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HH-HHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 43 333332221110 000 01111233678999999999999999999999999886
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-47 Score=381.02 Aligned_cols=262 Identities=20% Similarity=0.369 Sum_probs=195.5
Q ss_pred EEecCcceEEEeeeeeeCceEEEEEeeeCCC-ccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEE
Q psy14267 251 ITLNGKQYQVLSLLGKGGSSSVYLVGGTSEH-EFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVY 329 (553)
Q Consensus 251 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~ 329 (553)
|++..++|++++.||+|+||.||+|.+...+ ....||||+++.. ......+.+.+|+.+|++++ ||||+++++++.
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~ 78 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFD-HPHIVKLIGVIT 78 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC
T ss_pred CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEe
Confidence 5677789999999999999999999876543 3345888887543 33455678999999999995 699999999773
Q ss_pred eCCCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecC
Q psy14267 330 DTASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDC 408 (553)
Q Consensus 330 ~~~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~ 408 (553)
+..++++||++ +++|..++..... ...+..++.++.||+.||+|||+++||||||||+|||++.+
T Consensus 79 ---~~~~~iv~E~~~~g~l~~~~~~~~~----~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~------- 144 (273)
T d1mp8a_ 79 ---ENPVWIIMELCTLGELRSFLQVRKY----SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN------- 144 (273)
T ss_dssp ---SSSCEEEEECCTTEEHHHHHHHTTT----TSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-------
T ss_pred ---cCeEEEEEEeccCCcHHhhhhccCC----CCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCC-------
Confidence 34678888876 4678877765432 34456677778899999999999999999999999999887
Q ss_pred CCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCC
Q psy14267 409 IGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSH 487 (553)
Q Consensus 409 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~ 487 (553)
+.+||+|||+|+........ ......||+.|+|||++.+. .++.++|||||||+||||++ |.+||..
T Consensus 145 --~~~Kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~apE~l~~~---------~~~~~~DiwSlGvil~e~lt~g~~P~~~ 212 (273)
T d1mp8a_ 145 --DCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFR---------RFTSASDVWMFGVCMWEILMHGVKPFQG 212 (273)
T ss_dssp --TEEEECC--------------------CCGGGCCHHHHHHC---------CCSHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred --CcEEEccchhheeccCCcce-eccceecCcccchhhHhccC---------CCCCccccccchHHHHHHHhcCCCCCCC
Confidence 67999999999876543322 22355689999999999866 37899999999999999998 8999987
Q ss_pred CCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 488 IPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 488 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
.... .....+... ... ..+..+|+++.+||.+||..||++|||+.||+++|+.+
T Consensus 213 ~~~~-~~~~~i~~~-~~~------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 213 VKNN-DVIGRIENG-ERL------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp CCGG-GHHHHHHTT-CCC------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCHH-HHHHHHHcC-CCC------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 6543 233333322 111 22347899999999999999999999999999999875
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-48 Score=393.26 Aligned_cols=251 Identities=21% Similarity=0.331 Sum_probs=201.8
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|++++.||+|+||+||+|+++.+++. ||||++++.........+.+..|+.++.+..+||||+++++++. ....
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~--vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~--~~~~ 77 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQF--FAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ--TKEN 77 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEE--EEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE--CSSE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCE--EEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEc--cCCc
Confidence 4799999999999999999998877654 99999987554333445678888888876557799999998774 4678
Q ss_pred EEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
+||+||++ +|+|.+++...... .+..+..++.||+.||+|||++|||||||||+|||++.+ +.+|
T Consensus 78 ~yivmEy~~~g~L~~~i~~~~~~-----~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~---------~~~k 143 (320)
T d1xjda_ 78 LFFVMEYLNGGDLMYHIQSCHKF-----DLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKD---------GHIK 143 (320)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSC-----CHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT---------SCEE
T ss_pred eeEEEeecCCCcHHHHhhccCCC-----CHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCC---------Ccee
Confidence 99999975 57999999876543 345677778899999999999999999999999999876 6799
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||+|+....... .....+||+.|+|||++.+.. |+.++|||||||++|||++|+.||.+.... ..
T Consensus 144 l~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~---------~~~~~DiwSlGvilyemltG~~PF~~~~~~-~~ 211 (320)
T d1xjda_ 144 IADFGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQK---------YNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-EL 211 (320)
T ss_dssp ECCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCC---------BCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HH
T ss_pred ccccchhhhcccccc--cccccCCCCCcCCHHHHcCCC---------CCchhhhhhhhHHHHHHHhCCCCCCCCCHH-HH
Confidence 999999987654433 233568999999999998763 789999999999999999999999875433 33
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHH-HHHH
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVG-NSVT 544 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~-ell~ 544 (553)
+..+... ...+ +..+|+++++||.+||.+||++||++. ++++
T Consensus 212 ~~~i~~~--~~~~------p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 212 FHSIRMD--NPFY------PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp HHHHHHC--CCCC------CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred HHHHHcC--CCCC------CccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 3333322 1222 125789999999999999999999985 6754
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-47 Score=386.46 Aligned_cols=269 Identities=21% Similarity=0.338 Sum_probs=210.3
Q ss_pred EEecCcceEEEeeeeeeCceEEEEEeeeCCCc-----cceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEee
Q psy14267 251 ITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHE-----FKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMH 325 (553)
Q Consensus 251 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~-----~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~ 325 (553)
|++..++|++++.||+|+||.||+|+....+. ...||||+++++. .......+.+|+..+.++.+||||++++
T Consensus 8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~~ 85 (299)
T d1fgka_ 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLL 85 (299)
T ss_dssp TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEecc
Confidence 66777899999999999999999998765432 2469999997654 2334578899999999998889999999
Q ss_pred eEEEeCCCceEEEEEecC-CCCHHHHHHHcccC-----------CCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCC
Q psy14267 326 DYVYDTASKHLYVLMEKG-DTDLSKYMRNLNKM-----------TTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKP 393 (553)
Q Consensus 326 ~~~~~~~~~~~~iv~e~~-~~~L~~~l~~~~~~-----------~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp 393 (553)
+++. .+..++++||++ +|+|.++++..... .....++..+..++.||+.||+|||+++||||||||
T Consensus 86 ~~~~--~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp 163 (299)
T d1fgka_ 86 GACT--QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA 163 (299)
T ss_dssp EEEC--SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred cccc--cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecc
Confidence 8874 456788999975 57899999765422 123456777888889999999999999999999999
Q ss_pred CCEEEecCccceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHH
Q psy14267 394 ANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGC 473 (553)
Q Consensus 394 ~NILl~~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGv 473 (553)
+|||++.+ +.+||+|||+++...............||+.|+|||.+.+. .|+.++|||||||
T Consensus 164 ~NiLl~~~---------~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~---------~y~~k~DiwS~Gv 225 (299)
T d1fgka_ 164 RNVLVTED---------NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR---------IYTHQSDVWSFGV 225 (299)
T ss_dssp GGEEECTT---------CCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHC---------CCCHHHHHHHHHH
T ss_pred cceeecCC---------CCeEeccchhhccccccccccccccCCCChhhhhhhHhcCC---------CCCchhhhHHhHH
Confidence 99999877 57999999999887665544444567799999999999766 4789999999999
Q ss_pred HHHHHHh-CCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 474 ILYNMIY-GRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 474 vl~ellt-G~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
+||||++ |.+||.+.... .....+. ...... .+..+++++.+||.+||+.||++|||+.||++.|+++
T Consensus 226 vl~ell~~g~~p~~~~~~~-~~~~~i~-~~~~~~------~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 226 LLWEIFTLGGSPYPGVPVE-ELFKLLK-EGHRMD------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp HHHHHHTTSCCSSTTCCHH-HHHHHHH-TTCCCC------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhccCCCCCCCCCCHH-HHHHHHH-cCCCCC------CCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 9999998 79999875543 2222222 222222 2236889999999999999999999999999999874
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.3e-47 Score=383.99 Aligned_cols=265 Identities=20% Similarity=0.267 Sum_probs=202.0
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
+++|++++.||+|+||+||+|++..++. .||||++...... +++.+|+++++++.||++|+.+.+++. ...
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~--~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~--~~~ 76 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGE--EVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGA--EGD 76 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTE--EEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEE--ETT
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCC--EEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEe--cCC
Confidence 4679999999999999999999877765 4999998865432 346789999999998888888766543 366
Q ss_pred eEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 335 HLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 335 ~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
..+++||+++++|...+..... .++...++.++.|++.||+|||++|||||||||+|||++... ....+|
T Consensus 77 ~~~ivme~~~~~l~~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~------~~~~vk 146 (299)
T d1ckia_ 77 YNVMVMELLGPSLEDLFNFCSR----KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGK------KGNLVY 146 (299)
T ss_dssp EEEEEEECCCCBHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGG------GTTCEE
T ss_pred EEEEEEEEcCCchhhhhhhccC----CCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccC------CCceee
Confidence 7899999999999888776543 344566777888999999999999999999999999986542 235799
Q ss_pred EEeccCccccCCCCCc-----ccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy14267 415 IIDFGIACSLQDDKTS-----VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIP 489 (553)
Q Consensus 415 L~DFGla~~~~~~~~~-----~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~ 489 (553)
|+|||+|+.+...... .......||+.|||||++.+.. ++.++|||||||++|||++|..||....
T Consensus 147 l~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---------~~~~~DiwSlG~~l~el~tg~~P~~~~~ 217 (299)
T d1ckia_ 147 IIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE---------QSRRDDLESLGYVLMYFNLGSLPWQGLK 217 (299)
T ss_dssp ECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBC---------CCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred eeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCC---------CCChhhEEecCHHHHHHHhCCCcccccc
Confidence 9999999987654332 1234567999999999998763 7899999999999999999999998754
Q ss_pred chHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q psy14267 490 NTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINN 548 (553)
Q Consensus 490 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~ 548 (553)
................. .+.......+|+++.++|.+||+.+|++||++.+|.+.|++
T Consensus 218 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 275 (299)
T d1ckia_ 218 AATKRQKYERISEKKMS-TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 275 (299)
T ss_dssp -------HHHHHHHHHH-SCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred hHHHHHHHHHhhcccCC-CChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 33221111111111111 11111123688999999999999999999999988887765
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-47 Score=387.95 Aligned_cols=271 Identities=23% Similarity=0.354 Sum_probs=214.5
Q ss_pred eEEecCcceEEEeeeeeeCceEEEEEeeeC---CCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeee
Q psy14267 250 VITLNGKQYQVLSLLGKGGSSSVYLVGGTS---EHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHD 326 (553)
Q Consensus 250 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~---~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~ 326 (553)
.|++..++|+++++||+|+||.||+|+... ....+.||||++++... ......+.+|+.+++++.+||||+++++
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~E~~~~~~l~~HpnIv~~~g 94 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLLG 94 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC--HHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 456777899999999999999999998643 34446799999976542 3445679999999999988899999999
Q ss_pred EEEeCCCceEEEEEecC-CCCHHHHHHHcccC-------------CCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCC
Q psy14267 327 YVYDTASKHLYVLMEKG-DTDLSKYMRNLNKM-------------TTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLK 392 (553)
Q Consensus 327 ~~~~~~~~~~~iv~e~~-~~~L~~~l~~~~~~-------------~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLK 392 (553)
++ .....++++||++ +++|.++++..... .....++..+..++.||+.||+|||+++|||||||
T Consensus 95 ~~--~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLK 172 (311)
T d1t46a_ 95 AC--TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLA 172 (311)
T ss_dssp EE--CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred EE--eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccc
Confidence 87 4456688999975 57899998865422 12235566777888999999999999999999999
Q ss_pred CCCEEEecCccceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHH
Q psy14267 393 PANFLFVGNVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLG 472 (553)
Q Consensus 393 p~NILl~~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlG 472 (553)
|+|||++.+ +.+||+|||+++..............+||+.|+|||++.+. .++.++||||||
T Consensus 173 p~NIl~~~~---------~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~DIwS~G 234 (311)
T d1t46a_ 173 ARNILLTHG---------RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC---------VYTFESDVWSYG 234 (311)
T ss_dssp GGGEEEETT---------TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC---------CCCHHHHHHHHH
T ss_pred ccccccccc---------CcccccccchheeccCCCcceEeeecccChHHcCHHHhcCC---------CCCCcccccchH
Confidence 999999876 68999999999987765554444567899999999999865 378999999999
Q ss_pred HHHHHHHh-CCCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 473 CILYNMIY-GRTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 473 vvl~ellt-G~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
|+||||+| |.+||...... ..+..+........ ....+++++.+||.+||+.||++|||+++|++.|+++
T Consensus 235 ~~l~ellt~g~p~~~~~~~~-~~~~~~i~~~~~~~------~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 235 IFLWELFSLGSSPYPGMPVD-SKFYKMIKEGFRML------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp HHHHHHHTTTCCSSTTCCSS-HHHHHHHHHTCCCC------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHhCCCCCCCCCCHH-HHHHHHHhcCCCCC------CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 99999998 66666654443 33333333332222 2235789999999999999999999999999999864
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-47 Score=390.25 Aligned_cols=253 Identities=20% Similarity=0.270 Sum_probs=203.4
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|++++.||+|+||+||+|.++.++.. ||||++++... ....+.+|+++|++++ ||||+++++++.+ ...
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~--~AiK~i~~~~~----~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~--~~~ 75 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKT--YMAKFVKVKGT----DQVLVKKEISILNIAR-HRNILHLHESFES--MEE 75 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEE--EEEEEECCCTH----HHHHHHHHHHHHHHSC-CTTBCCEEEEEEE--TTE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcE--EEEEEEcCCcc----cHHHHHHHHHHHHhCC-CCCCCeEEEEEEE--CCE
Confidence 5799999999999999999998877754 99999987542 2356789999999995 5999999998754 568
Q ss_pred EEEEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEE
Q psy14267 336 LYVLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLK 414 (553)
Q Consensus 336 ~~iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vk 414 (553)
+|++||++. ++|.+++..... .+.+..++.++.||+.||+|||++|||||||||+||||+.+. ...+|
T Consensus 76 ~~lvmE~~~gg~L~~~i~~~~~----~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~-------~~~ik 144 (321)
T d1tkia_ 76 LVMIFEFISGLDIFERINTSAF----ELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRR-------SSTIK 144 (321)
T ss_dssp EEEEECCCCCCBHHHHHTSSSC----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSS-------CCCEE
T ss_pred EEEEEecCCCCcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCC-------ceEEE
Confidence 999999865 689998875432 345667777888999999999999999999999999997542 25799
Q ss_pred EEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 415 IIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|+|||+++....... ....+||+.|+|||.+.+. .|+.++|||||||++|||++|..||...... ..
T Consensus 145 l~DFG~~~~~~~~~~---~~~~~~t~~y~ape~~~~~---------~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~-~~ 211 (321)
T d1tkia_ 145 IIEFGQARQLKPGDN---FRLLFTAPEYYAPEVHQHD---------VVSTATDMWSLGTLVYVLLSGINPFLAETNQ-QI 211 (321)
T ss_dssp ECCCTTCEECCTTCE---EEEEESCGGGSCHHHHTTC---------EECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-HH
T ss_pred EcccchhhccccCCc---ccccccccccccchhccCC---------CCCchhhcccHHHHHHHHHhCCCCCCCCCHH-HH
Confidence 999999988755432 2356799999999999766 3788999999999999999999999875443 33
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
+..+...... +.. ..+..+++++++||++||..||++|||+.|+++|
T Consensus 212 ~~~i~~~~~~--~~~--~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 212 IENIMNAEYT--FDE--EAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHHHHHTCCC--CCH--HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHhCCCC--CCh--hhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 4444433221 111 1123678999999999999999999999999985
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-47 Score=381.59 Aligned_cols=264 Identities=20% Similarity=0.306 Sum_probs=199.5
Q ss_pred cceEEecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeE
Q psy14267 248 QDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDY 327 (553)
Q Consensus 248 ~~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~ 327 (553)
.+.|++..++|++++.||+|+||+||+|.+..+ +.||||+++..... .+.+.+|+.+|++++ |||||+++++
T Consensus 9 ~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~---~~vAiK~l~~~~~~----~~~~~~E~~~l~~l~-h~nIv~~~g~ 80 (285)
T d1fmka3 9 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT---TRVAIKTLKPGTMS----PEAFLQEAQVMKKLR-HEKLVQLYAV 80 (285)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSCEEEEEEETTT---EEEEEEECCTTSSC----HHHHHHHHHHHHHCC-CTTBCCEEEE
T ss_pred CcceEcCHHHEEEeeEEeeCCCeEEEEEEECCC---CEEEEEEECcccCC----HHHHHHHHHHHHhcc-cCCEeEEEEE
Confidence 345667778999999999999999999987544 34999999765432 267899999999995 5999999997
Q ss_pred EEeCCCceEEEEEec-CCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCcccee
Q psy14267 328 VYDTASKHLYVLMEK-GDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKII 406 (553)
Q Consensus 328 ~~~~~~~~~~iv~e~-~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~ 406 (553)
+. .+ .++++||+ .+|+|..++...... ..++..++.++.||+.||+|||++|||||||||+||||+.+
T Consensus 81 ~~--~~-~~~lv~Ey~~~g~l~~~~~~~~~~---~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~----- 149 (285)
T d1fmka3 81 VS--EE-PIYIVTEYMSKGSLLDFLKGETGK---YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN----- 149 (285)
T ss_dssp EC--SS-SCEEEECCCTTCBHHHHHSHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-----
T ss_pred Ee--cC-CeEEEEEecCCCchhhhhhhcccc---cchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCC-----
Confidence 63 23 45778886 456788777654322 23456677778899999999999999999999999999877
Q ss_pred cCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCC
Q psy14267 407 DCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYS 486 (553)
Q Consensus 407 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~ 486 (553)
+.+||+|||+|+.+...... ......||+.|+|||++... .++.++|||||||+||||++|..||.
T Consensus 150 ----~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~---------~~~~ksDI~S~Giil~el~t~~~p~~ 215 (285)
T d1fmka3 150 ----LVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYG---------RFTIKSDVWSFGILLTELTTKGRVPY 215 (285)
T ss_dssp ----GCEEECCCCTTC---------------CCGGGSCHHHHHHC---------CCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred ----CcEEEcccchhhhccCCCce-eeccccccccccChHHHhCC---------CCCcHHhhhcchHHHHHHHhCCCCCC
Confidence 57999999999877544332 22346799999999999766 47899999999999999999766655
Q ss_pred CCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q psy14267 487 HIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNPE 551 (553)
Q Consensus 487 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~~ 551 (553)
......+.+..+... .... ....++++++++|.+||+.||++||++.+|++.|+++..
T Consensus 216 ~~~~~~~~~~~i~~~-~~~~------~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 216 PGMVNREVLDQVERG-YRMP------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp TTCCHHHHHHHHHTT-CCCC------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred CCCCHHHHHHHHHhc-CCCC------CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 544444444444432 2222 233688999999999999999999999999999998764
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-46 Score=384.41 Aligned_cols=266 Identities=23% Similarity=0.305 Sum_probs=202.5
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC---
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA--- 332 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~--- 332 (553)
.+|+++++||+|+||+||+|.+..++.. ||||++.+.. .....+++++|+.+|++|. ||||+++++++....
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~--vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~-hp~iv~~~~~~~~~~~~~ 82 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVR--VAIKKISPFE--HQTYCQRTLREIKILLRFR-HENIIGINDIIRAPTIEQ 82 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSE--EEEEEECCTT--CHHHHHHHHHHHHHHHHCC-CTTBCCCCEEECCSSTTT
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcE--EEEEEEehhc--ChHHHHHHHHHHHHHHHcC-CCCCCcEEEEEeeccccc
Confidence 5799999999999999999998777755 9999997654 3455678999999999994 599999999875432
Q ss_pred CceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCe
Q psy14267 333 SKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNV 412 (553)
Q Consensus 333 ~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~ 412 (553)
..++|++|++++++|.+++... .+++..++.++.||+.||+|||++|||||||||+||||+.+ +.
T Consensus 83 ~~~~~l~~~~~~g~L~~~l~~~------~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~---------~~ 147 (345)
T d1pmea_ 83 MKDVYLVTHLMGADLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTT---------CD 147 (345)
T ss_dssp CCCEEEEEECCCEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT---------CC
T ss_pred cceEEEEEeecCCchhhhhhcC------CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCC---------CC
Confidence 2467889999999999999764 24567778888999999999999999999999999999876 67
Q ss_pred EEEEeccCccccCCCCCc-ccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCch
Q psy14267 413 LKIIDFGIACSLQDDKTS-VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNT 491 (553)
Q Consensus 413 vkL~DFGla~~~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~ 491 (553)
+||+|||+|+........ ......+||+.|+|||++.... .++.++||||+||++|||++|+.||......
T Consensus 148 ~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--------~~~~~~DiwSlG~il~eml~g~~pf~~~~~~ 219 (345)
T d1pmea_ 148 LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK--------GYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 219 (345)
T ss_dssp EEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBC--------SCSTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred EEEcccCceeeccCCCccceeeccccccceechHHHhhcCC--------CCCchhhhhccCceehHHhhCCCCCCCCCHH
Confidence 999999999876554322 1234567999999999986543 3688999999999999999999999875432
Q ss_pred HHHHHHHHhhccc----------------------ccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH--Hh
Q psy14267 492 WAKMLAIARHKDQ----------------------IEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ--IN 547 (553)
Q Consensus 492 ~~~~~~i~~~~~~----------------------~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~--L~ 547 (553)
............. ....+.......++.++++||.+||..||++|||+.|+++| |+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~ 299 (345)
T d1pmea_ 220 DQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 299 (345)
T ss_dssp HHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGT
T ss_pred HHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhc
Confidence 2211111100000 00000001123577899999999999999999999999987 55
Q ss_pred cC
Q psy14267 548 NN 549 (553)
Q Consensus 548 ~~ 549 (553)
++
T Consensus 300 ~~ 301 (345)
T d1pmea_ 300 QY 301 (345)
T ss_dssp TT
T ss_pred cC
Confidence 43
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3e-46 Score=382.70 Aligned_cols=256 Identities=26% Similarity=0.445 Sum_probs=200.3
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
.++|+++++||+|+||+||+|+++.++.. ||||++++.. .+++.+|+++|+++.+||||+++++++......
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~--vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~ 105 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEK--VVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSR 105 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEE--EEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCE--EEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCC
Confidence 46899999999999999999998877755 9999997542 367889999999998889999999988877778
Q ss_pred eEEEEEecCCC-CHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 335 HLYVLMEKGDT-DLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 335 ~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
.++++||++.+ +|..+.+ .+....+..+++||+.||+|||++|||||||||+||||+.+. +.+
T Consensus 106 ~~~~v~e~~~~~~L~~~~~--------~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~--------~~v 169 (328)
T d3bqca1 106 TPALVFEHVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH--------RKL 169 (328)
T ss_dssp SEEEEEECCCSCBGGGTTT--------SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTT--------TEE
T ss_pred ceeEEEeecCCCcHHHHhc--------CCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCC--------Cee
Confidence 89999998664 5544321 345666777889999999999999999999999999997652 579
Q ss_pred EEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHH
Q psy14267 414 KIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWA 493 (553)
Q Consensus 414 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~ 493 (553)
||+|||+|+....... ....+||+.|+|||++.+.. .++.++|||||||++|||++|..||........
T Consensus 170 kl~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~--------~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~ 238 (328)
T d3bqca1 170 RLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQ--------MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD 238 (328)
T ss_dssp EECCGGGCEECCTTCC---CCSCCSCGGGCCHHHHTTCC--------CCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH
T ss_pred eecccccceeccCCCc---ccccccCccccCcccccCCC--------CCCcccchhhhhhhhHHhccCCCCCCCCchhHH
Confidence 9999999988765433 23667999999999987653 368899999999999999999999987554433
Q ss_pred HHHHHHhhcc-----------ccc----cc--------------ccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy14267 494 KMLAIARHKD-----------QIE----FK--------------PQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVT 544 (553)
Q Consensus 494 ~~~~i~~~~~-----------~~~----~~--------------~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~ 544 (553)
....+..... ... +. ........+++++++||++||..||++|||++|+++
T Consensus 239 ~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 239 QLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 3222211100 000 00 001112247889999999999999999999999987
Q ss_pred H
Q psy14267 545 Q 545 (553)
Q Consensus 545 ~ 545 (553)
|
T Consensus 319 H 319 (328)
T d3bqca1 319 H 319 (328)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-46 Score=384.09 Aligned_cols=265 Identities=26% Similarity=0.340 Sum_probs=201.6
Q ss_pred eEEecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEE
Q psy14267 250 VITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVY 329 (553)
Q Consensus 250 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~ 329 (553)
.|++ .++|+++++||+|+||+||+|.++.++.. ||||++++... .+...+++.+|+++|+++. ||||+++++++.
T Consensus 13 ~~~~-~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~--vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~-hpniv~l~~~~~ 87 (346)
T d1cm8a_ 13 AWEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAK--VAIKKLYRPFQ-SELFAKRAYRELRLLKHMR-HENVIGLLDVFT 87 (346)
T ss_dssp EECC-BSSEEEEEEC------CEEEEEETTTCCE--EEEEECSSTTS-SHHHHHHHHHHHHHHHHCC-BTTBCCCSEEEC
T ss_pred eeec-CCcEEEEEEEecCCCeEEEEEEECCCCCE--EEEEEEchhhc-ChHHHHHHHHHHHHHHhcC-CCCeeEEEEEec
Confidence 3444 46899999999999999999998877755 99999986543 4455688999999999995 699999999876
Q ss_pred eCC----CceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccce
Q psy14267 330 DTA----SKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKI 405 (553)
Q Consensus 330 ~~~----~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~ 405 (553)
... ..++|++||+++.+|..+++.. .+++..+..++.||+.||+|||++|||||||||+|||++.+
T Consensus 88 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~---- 157 (346)
T d1cm8a_ 88 PDETLDDFTDFYLVMPFMGTDLGKLMKHE------KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNED---- 157 (346)
T ss_dssp SCSSTTTCCCCEEEEECCSEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT----
T ss_pred cCccccccceEEEEEecccccHHHHHHhc------cccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccc----
Confidence 543 2367999999998888877653 24566777888899999999999999999999999999877
Q ss_pred ecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCC
Q psy14267 406 IDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPY 485 (553)
Q Consensus 406 ~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf 485 (553)
+.+||+|||+|+...... ....||+.|+|||++.+.. .++.++|||||||+||||++|++||
T Consensus 158 -----~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~--------~~~~~~DiwSlGvil~ell~g~~pf 219 (346)
T d1cm8a_ 158 -----CELKILDFGLARQADSEM-----TGYVVTRWYRAPEVILNWM--------RYTQTVDIWSVGCIMAEMITGKTLF 219 (346)
T ss_dssp -----CCEEECCCTTCEECCSSC-----CSSCSCGGGCCTHHHHTTT--------CCCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred -----cccccccccceeccCCcc-----ccccccccccCHHHHcCCC--------CCCccchhhcchHHHHHHHHCcCCC
Confidence 679999999998775433 2567999999999997643 3688999999999999999999999
Q ss_pred CCCCchHHHHHHHHhhcc-----------------------cccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q psy14267 486 SHIPNTWAKMLAIARHKD-----------------------QIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNS 542 (553)
Q Consensus 486 ~~~~~~~~~~~~i~~~~~-----------------------~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~el 542 (553)
.+.... ..+........ .............+++++.+||.+||..||++|||+.||
T Consensus 220 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~ei 298 (346)
T d1cm8a_ 220 KGSDHL-DQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298 (346)
T ss_dssp CCSSHH-HHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred CCCChH-HHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHH
Confidence 875443 22211111100 001111111223678999999999999999999999999
Q ss_pred HHH--Hhc
Q psy14267 543 VTQ--INN 548 (553)
Q Consensus 543 l~~--L~~ 548 (553)
++| |++
T Consensus 299 L~Hp~f~~ 306 (346)
T d1cm8a_ 299 LAHPYFES 306 (346)
T ss_dssp HHSGGGTT
T ss_pred hcChhhCc
Confidence 987 544
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-46 Score=384.91 Aligned_cols=258 Identities=22% Similarity=0.350 Sum_probs=198.7
Q ss_pred ceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeC----C
Q psy14267 257 QYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDT----A 332 (553)
Q Consensus 257 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~----~ 332 (553)
+|+.+++||+|+||+||+|++..++.. ||||++.++... ..+|+++|++++ ||||+++++++... .
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~--vAiK~i~~~~~~-------~~~Ei~il~~l~-h~niv~~~~~~~~~~~~~~ 90 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGEL--VAIKKVLQDKRF-------KNRELQIMRKLD-HCNIVRLRYFFYSSGEKKD 90 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCE--EEEEEEECCSSS-------CCHHHHHHHHCC-CTTBCCEEEEEEEC--CCS
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCE--EEEEEECccchH-------HHHHHHHHHhcC-CCCCCcEEEEEEecCccCC
Confidence 699999999999999999998877755 999999875422 247999999995 69999999988653 3
Q ss_pred CceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCe
Q psy14267 333 SKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNV 412 (553)
Q Consensus 333 ~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~ 412 (553)
..+++++||++++++...+...... ...+.+..+..+++||+.||+|||++|||||||||+||||+.+. ..
T Consensus 91 ~~~~~lv~Ey~~~~~~~~l~~~~~~-~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~--------~~ 161 (350)
T d1q5ka_ 91 EVYLNLVLDYVPETVYRVARHYSRA-KQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDT--------AV 161 (350)
T ss_dssp CCEEEEEEECCSEEHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTT--------CC
T ss_pred ceEEEEEEeccCCccHHHHHhhhhc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCC--------Cc
Confidence 4578999999998887776543221 12345666777888999999999999999999999999997652 47
Q ss_pred EEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchH
Q psy14267 413 LKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTW 492 (553)
Q Consensus 413 vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~ 492 (553)
+||+|||+|+....... ..+.+||+.|+|||++.+.. .++.++|||||||++|||++|..||......
T Consensus 162 ~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~--------~~~~~~DIwSlG~il~el~~g~~pf~~~~~~- 229 (350)
T d1q5ka_ 162 LKLCDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGAT--------DYTSSIDVWSAGCVLAELLLGQPIFPGDSGV- 229 (350)
T ss_dssp EEECCCTTCEECCTTSC---CCSCCSCTTSCCHHHHTTCS--------SCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-
T ss_pred eeEecccchhhccCCcc---cccccccccccChHHhhccc--------CCCcceeecccceEEEehhhCCCCCCCCCHH-
Confidence 99999999988765433 23567999999999987543 4789999999999999999999999875543
Q ss_pred HHHHHHHhhcc---------------cccccc------cccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 493 AKMLAIARHKD---------------QIEFKP------QLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 493 ~~~~~i~~~~~---------------~~~~~~------~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
..+..+..... ...+.. .......+++++.+||.+||..||++|||+.|+++|
T Consensus 230 ~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 230 DQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp HHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 22222221100 000000 001123578999999999999999999999999975
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-46 Score=381.23 Aligned_cols=263 Identities=20% Similarity=0.282 Sum_probs=203.9
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCc
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASK 334 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~ 334 (553)
-++|++.++||+|+||+||+|.++.++....||||.+..... ....+.+.+|+++|.++.+||||+++++++.+ ..
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~--~~ 84 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS--KDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RG 84 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEE--TT
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccC--hHHHHHHHHHHHHHHhccCCCCEeeEEEEEec--CC
Confidence 368999999999999999999998887766688888865432 23346799999999999778999999998865 56
Q ss_pred eEEEEEecC-CCCHHHHHHHcc-----------cCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCc
Q psy14267 335 HLYVLMEKG-DTDLSKYMRNLN-----------KMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNV 402 (553)
Q Consensus 335 ~~~iv~e~~-~~~L~~~l~~~~-----------~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~ 402 (553)
.++++||++ +|+|.+++.... ......+.+..+..++.||+.||+|||+++||||||||+|||++.+
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~- 163 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN- 163 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG-
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCC-
Confidence 789999975 589999987542 1122345566777888999999999999999999999999999877
Q ss_pred cceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCC
Q psy14267 403 LKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGR 482 (553)
Q Consensus 403 ~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~ 482 (553)
+.+||+|||+|+....... .....||..|+|||.+.+. .++.++|||||||++|||++|.
T Consensus 164 --------~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~---------~~~~~sDvwSfGvil~ell~~~ 223 (309)
T d1fvra_ 164 --------YVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYS---------VYTTNSDVWSYGVLLWEIVSLG 223 (309)
T ss_dssp --------GCEEECCTTCEESSCEECC---C----CCTTTCCHHHHHHC---------EECHHHHHHHHHHHHHHHHTTS
T ss_pred --------CceEEcccccccccccccc---ccceecCCcccchHHhccC---------CCCccceeehhHHHHHHHHhcC
Confidence 5799999999986654332 2255689999999999765 4789999999999999999965
Q ss_pred -CCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q psy14267 483 -TPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNP 550 (553)
Q Consensus 483 -~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~ 550 (553)
+||.+.+.. +.+..+.. ... ...+..+++++++||.+||+.||++|||++||+++|+++.
T Consensus 224 ~~p~~~~~~~-~~~~~i~~-~~~------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~ 284 (309)
T d1fvra_ 224 GTPYCGMTCA-ELYEKLPQ-GYR------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284 (309)
T ss_dssp CCTTTTCCHH-HHHHHGGG-TCC------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCHH-HHHHHHHh-cCC------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 567664432 32332222 111 2223468899999999999999999999999999998753
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.4e-46 Score=375.77 Aligned_cols=266 Identities=19% Similarity=0.253 Sum_probs=206.7
Q ss_pred cCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCC
Q psy14267 254 NGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTAS 333 (553)
Q Consensus 254 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~ 333 (553)
-+++|+++++||+|+||+||+|++..++. .||||++...... ..+.+|+++++.|.+++||+.+++++. ..
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~--~vAvK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~--~~ 73 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQ--QVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQ--EG 73 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTE--EEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEE--ET
T ss_pred CCCceEEEEEEecCCCeEEEEEEECCCCC--EEEEEEEccccCc-----HHHHHHHHHHHHhcCCCCCCEEEEEee--cC
Confidence 36789999999999999999999887764 4999998765422 346789999999999999999987764 46
Q ss_pred ceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeE
Q psy14267 334 KHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVL 413 (553)
Q Consensus 334 ~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~v 413 (553)
...+++||+++++|.+++...... .....+..++.|++.||+|||++|||||||||+||||+.+. ....+.+
T Consensus 74 ~~~~~vme~~~~~l~~~~~~~~~~----~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~----~~~~~~v 145 (293)
T d1csna_ 74 LHNVLVIDLLGPSLEDLLDLCGRK----FSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPN----SKNANMI 145 (293)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTTC----CCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSS----STTTTCE
T ss_pred CccEEEEEecCCCHHHHHHhhccc----hhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcc----cccCCce
Confidence 788999999999999998775432 34555667778999999999999999999999999997642 1233679
Q ss_pred EEEeccCccccCCCCCc-----ccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy14267 414 KIIDFGIACSLQDDKTS-----VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHI 488 (553)
Q Consensus 414 kL~DFGla~~~~~~~~~-----~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~ 488 (553)
||+|||+|+.+...... ......+||+.|||||++.+. .++.++|||||||++|||++|..||.+.
T Consensus 146 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~---------~~~~~~DiwSlG~~l~elltg~~Pf~~~ 216 (293)
T d1csna_ 146 YVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR---------EQSRRDDLEALGHVFMYFLRGSLPWQGL 216 (293)
T ss_dssp EECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC---------CCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred EEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCC---------CCChHHHHHHhhHHHHHHHhCCCcCCCc
Confidence 99999999887643221 123356799999999999876 3789999999999999999999999864
Q ss_pred Cc--hHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q psy14267 489 PN--TWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINN 548 (553)
Q Consensus 489 ~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~ 548 (553)
.. .......+......... .. ....+|+++.++|..|+..+|++||+++.+.+.|++
T Consensus 217 ~~~~~~~~~~~i~~~~~~~~~-~~--l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~ 275 (293)
T d1csna_ 217 KAATNKQKYERIGEKKQSTPL-RE--LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK 275 (293)
T ss_dssp CSCCHHHHHHHHHHHHHHSCH-HH--HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred cchhHHHHHHHHHhccCCCCh-HH--hcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 32 22222222222211111 11 123678999999999999999999999998887765
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-47 Score=374.47 Aligned_cols=254 Identities=24% Similarity=0.407 Sum_probs=194.6
Q ss_pred EEecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEe
Q psy14267 251 ITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYD 330 (553)
Q Consensus 251 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~ 330 (553)
|++..++|++++.||+|+||.||+|+.+ + ..||||+++.+. ..+.+.+|+++|++++ ||||+++++++.+
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~--~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~ 71 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYR--G--NKVAVKCIKNDA-----TAQAFLAEASVMTQLR-HSNLVQLLGVIVE 71 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET--T--EEEEEEECCCCC-------HHHHHTHHHHTTCC-CTTBCCEEEEECC
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEEC--C--eEEEEEEECcHH-----HHHHHHHHHHHHHhCC-CCCEeeEEEEEEe
Confidence 5667789999999999999999999764 2 349999996543 2367899999999995 6999999998754
Q ss_pred CCCceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCC
Q psy14267 331 TASKHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCI 409 (553)
Q Consensus 331 ~~~~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~ 409 (553)
. ...++++||++ +|+|.+++...... ...+..++.++.||+.||+|||+++||||||||+|||++.+
T Consensus 72 ~-~~~~~lv~ey~~~g~L~~~l~~~~~~---~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~-------- 139 (262)
T d1byga_ 72 E-KGGLYIVTEYMAKGSLVDYLRSRGRS---VLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED-------- 139 (262)
T ss_dssp C---CCEEEECCCTTEEHHHHHHHHHHH---HCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT--------
T ss_pred c-CCcEEEEEeccCCCCHHHHHHhcCCC---CCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCC--------
Confidence 3 34568999875 67999998764321 23455666778899999999999999999999999999877
Q ss_pred CCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh-CCCCCCCC
Q psy14267 410 GNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY-GRTPYSHI 488 (553)
Q Consensus 410 ~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt-G~~Pf~~~ 488 (553)
+.+||+|||+++....... ...+|+.|+|||++.+. .++.++|||||||++|||++ |.+||...
T Consensus 140 -~~~kl~dfg~s~~~~~~~~-----~~~~~~~y~aPE~l~~~---------~~t~~sDIwSfG~il~el~t~~~~p~~~~ 204 (262)
T d1byga_ 140 -NVAKVSDFGLTKEASSTQD-----TGKLPVKWTAPEALREK---------KFSTKSDVWSFGILLWEIYSFGRVPYPRI 204 (262)
T ss_dssp -SCEEECCCCC-----------------CCTTTSCHHHHHHC---------CCCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred -CCEeecccccceecCCCCc-----cccccccCCChHHHhCC---------CCChHHHHHhHHHHHHHHHHCCCCCCCCC
Confidence 6799999999987654322 45689999999999765 47899999999999999998 78988875
Q ss_pred CchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 489 PNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 489 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
... +....+.. .....+ ...+++++++||.+||..||++|||+.+|+++|+++
T Consensus 205 ~~~-~~~~~i~~-~~~~~~------~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 205 PLK-DVVPRVEK-GYKMDA------PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp CGG-GHHHHHTT-TCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CHH-HHHHHHHc-CCCCCC------CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 443 23333322 222222 236789999999999999999999999999999865
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5.2e-46 Score=373.63 Aligned_cols=259 Identities=23% Similarity=0.368 Sum_probs=197.7
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|+++++||+|+||+||+|+++ ++ +.||||++...... +...+++.+|+.+|++++ ||||+++++++. ....
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~--~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~--~~~~ 74 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YG--ETFALKKIRLEKED-EGIPSTTIREISILKELK-HSNIVKLYDVIH--TKKR 74 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TS--CEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCC-CTTBCCEEEEEE--CSSC
T ss_pred CCceeccEEecCCCcEEEEEEeC-CC--CEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCC-CCcEEeeeeecc--cCCc
Confidence 58999999999999999999875 33 45999999776533 334578999999999995 699999998775 4567
Q ss_pred EEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 336 LYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 336 ~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
++++|+++++.+...+..... ......+..++.||+.||+|||++|||||||||+||||+.+ +.+||
T Consensus 75 ~~i~~e~~~~~~~~~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~---------~~~kl 141 (286)
T d1ob3a_ 75 LVLVFEHLDQDLKKLLDVCEG----GLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINRE---------GELKI 141 (286)
T ss_dssp EEEEEECCSEEHHHHHHTSTT----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT---------SCEEE
T ss_pred eeEEEEeehhhhHHHHHhhcC----CcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCC---------CCEEe
Confidence 889999988888777765432 34566777788899999999999999999999999999877 57999
Q ss_pred EeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHH
Q psy14267 416 IDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKM 495 (553)
Q Consensus 416 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~ 495 (553)
+|||+|......... .....|++.|+|||.+.+.. .++.++|||||||+||||++|+.||.+.... ..+
T Consensus 142 ~DfG~a~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~--------~~~~~~DiwslGv~l~el~~G~~pf~~~~~~-~~~ 210 (286)
T d1ob3a_ 142 ADFGLARAFGIPVRK--YTHEIVTLWYRAPDVLMGSK--------KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA-DQL 210 (286)
T ss_dssp CCTTHHHHHCC-----------CCCTTCCHHHHTTCC--------SCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHH
T ss_pred cccccceecccCccc--cceecccchhhhHHHHhCCC--------CCCcceeehhcCcHHHHHHHCCCCCCCCCHH-HHH
Confidence 999999887554332 23556899999999997653 3689999999999999999999999875443 333
Q ss_pred HHHHhhccccc---c------------------cccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 496 LAIARHKDQIE---F------------------KPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 496 ~~i~~~~~~~~---~------------------~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
..+........ + .+.......+++++++||++||+.||++|||++|+++|
T Consensus 211 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 211 MRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp HHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 32221111000 0 00011123578899999999999999999999999864
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-46 Score=377.73 Aligned_cols=271 Identities=23% Similarity=0.349 Sum_probs=212.9
Q ss_pred eEEecCcceEEEeeeeeeCceEEEEEeeeCC---CccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeee
Q psy14267 250 VITLNGKQYQVLSLLGKGGSSSVYLVGGTSE---HEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHD 326 (553)
Q Consensus 250 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~---~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~ 326 (553)
.|++..++|++++.||+|+||+||+|.+... .....||||+++... .......+.+|+.+|+++. ||||+++++
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~-h~nIv~~~~ 90 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFN-CHHVVRLLG 90 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCC-CTTBCCEEE
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcC-CCCEeeeee
Confidence 4677888999999999999999999987532 223569999997553 2334567899999999995 699999999
Q ss_pred EEEeCCCceEEEEEec-CCCCHHHHHHHccc-----CCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEec
Q psy14267 327 YVYDTASKHLYVLMEK-GDTDLSKYMRNLNK-----MTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVG 400 (553)
Q Consensus 327 ~~~~~~~~~~~iv~e~-~~~~L~~~l~~~~~-----~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~ 400 (553)
++. ....++++||+ .+|+|.+++..... .......+..+..++.|++.||.|||+++||||||||+||||+.
T Consensus 91 ~~~--~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~ 168 (308)
T d1p4oa_ 91 VVS--QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE 168 (308)
T ss_dssp EEC--SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECT
T ss_pred EEe--cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecC
Confidence 773 45567888886 46889998875421 12223456677778889999999999999999999999999987
Q ss_pred CccceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh
Q psy14267 401 NVLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY 480 (553)
Q Consensus 401 ~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt 480 (553)
+ +++||+|||+|+.+.............||+.|+|||.+.+. .++.++|||||||+||||++
T Consensus 169 ~---------~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~---------~~~~~~Dv~S~G~il~El~t 230 (308)
T d1p4oa_ 169 D---------FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG---------VFTTYSDVWSFGVVLWEIAT 230 (308)
T ss_dssp T---------CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC---------CCCHHHHHHHHHHHHHHHHH
T ss_pred C---------ceEEEeecccceeccCCcceeeccceecccccCCHHHHccC---------CCCcccccccHHHHHHHHHh
Confidence 7 57999999999887665544444566799999999999876 37889999999999999999
Q ss_pred C-CCCCCCCCchHHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q psy14267 481 G-RTPYSHIPNTWAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNNPE 551 (553)
Q Consensus 481 G-~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~~~ 551 (553)
| .+||.+.... ..+..+.... . ......+++.+.++|.+||+.||++|||+.+|+++|++..+
T Consensus 231 ~~~~p~~~~~~~-~~~~~i~~~~-~------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 231 LAEQPYQGLSNE-QVLRFVMEGG-L------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp TSCCTTTTSCHH-HHHHHHHTTC-C------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred CCCCCCCCCCHH-HHHHHHHhCC-C------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 8 5778765443 3333333221 1 11223678999999999999999999999999999998543
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-45 Score=372.87 Aligned_cols=264 Identities=23% Similarity=0.301 Sum_probs=195.2
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC---
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA--- 332 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~--- 332 (553)
++|++++.||+|+||+||+|++..++.. ||||++.+....+ ...+++.+|+++|++++ ||||+.+++++....
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~--vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~-h~nii~~~~~~~~~~~~~ 85 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQK--VALKKVLMENEKE-GFPITALREIKILQLLK-HENVVNLIEICRTKASPY 85 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCE--EEEEEC----CTT-SSCHHHHHHHHHHHHCC-CTTBCCEEEEEEC-----
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCE--EEEEEEehhhcch-HHHHHHHHHHHHHHHhc-CCCccceEeeeecccccc
Confidence 5899999999999999999998877655 9999997765443 34477899999999995 599999998875432
Q ss_pred ---CceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCC
Q psy14267 333 ---SKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCI 409 (553)
Q Consensus 333 ---~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~ 409 (553)
..+++++||++++.+......... ......++.+++||+.||+|||++|||||||||+||||+.+
T Consensus 86 ~~~~~~~~iv~e~~~~~~~~~~~~~~~----~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~-------- 153 (318)
T d3blha1 86 NRCKGSIYLVFDFCEHDLAGLLSNVLV----KFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRD-------- 153 (318)
T ss_dssp -----CEEEEEECCCEEHHHHHTCTTC----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT--------
T ss_pred cccCceEEEEEeccCCCccchhhhccc----ccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCC--------
Confidence 356899999998887765544322 33455567778899999999999999999999999999877
Q ss_pred CCeEEEEeccCccccCCCCCc--ccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCC
Q psy14267 410 GNVLKIIDFGIACSLQDDKTS--VHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSH 487 (553)
Q Consensus 410 ~~~vkL~DFGla~~~~~~~~~--~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~ 487 (553)
+.+||+|||+|+.+...... ......+||+.|+|||++.+.. .++.++|||||||++|||++|+.||.+
T Consensus 154 -~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~--------~~~~k~DiwSlGvil~el~~g~~pf~~ 224 (318)
T d3blha1 154 -GVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGER--------DYGPPIDLWGAGCIMAEMWTRSPIMQG 224 (318)
T ss_dssp -SCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCS--------SCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred -CcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCC--------CCCcHHHcccCCceeeeHhhCCCCCCC
Confidence 57999999999876543321 1233567999999999997653 378999999999999999999999987
Q ss_pred CCchHHHHHHHHhhccccc--cccccc---------C-------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q psy14267 488 IPNTWAKMLAIARHKDQIE--FKPQLA---------N-------------NVTIPPTLLQSMKLCLQKDPKARPTVGNSV 543 (553)
Q Consensus 488 ~~~~~~~~~~i~~~~~~~~--~~~~~~---------~-------------~~~~s~~l~~li~~cL~~dP~~RPt~~ell 543 (553)
.... .....+........ ...... . ....++.+++||.+||+.||++|||++|++
T Consensus 225 ~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL 303 (318)
T d3blha1 225 NTEQ-HQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 303 (318)
T ss_dssp SSHH-HHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred CCHH-HHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHH
Confidence 5443 22222222111110 000000 0 001356788999999999999999999999
Q ss_pred HH
Q psy14267 544 TQ 545 (553)
Q Consensus 544 ~~ 545 (553)
+|
T Consensus 304 ~H 305 (318)
T d3blha1 304 NH 305 (318)
T ss_dssp HS
T ss_pred cC
Confidence 86
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-45 Score=369.55 Aligned_cols=258 Identities=21% Similarity=0.314 Sum_probs=196.1
Q ss_pred EEEeeeeeeCceEEEEEeeeCCC-ccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCceEE
Q psy14267 259 QVLSLLGKGGSSSVYLVGGTSEH-EFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKHLY 337 (553)
Q Consensus 259 ~i~~~LG~G~fG~Vy~a~~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~~~ 337 (553)
.+.++||+|+||+||+|....++ ....||||++++. ......+++.+|+++|++++ ||||+++++++... +..++
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~-~~~~~ 105 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRS-EGSPL 105 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEET-TTEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCC-CCCEeEEeEEEEec-CCceE
Confidence 34678999999999999876543 2345899998653 34455688999999999995 59999999987654 45678
Q ss_pred EEEecCC-CCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEEE
Q psy14267 338 VLMEKGD-TDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKII 416 (553)
Q Consensus 338 iv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~ 416 (553)
++||++. ++|.+++..... ......++.++.|++.||+|||+.+|+||||||+||||+.+ +.+||+
T Consensus 106 lv~E~~~~g~l~~~~~~~~~----~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~---------~~~kL~ 172 (311)
T d1r0pa_ 106 VVLPYMKHGDLRNFIRNETH----NPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK---------FTVKVA 172 (311)
T ss_dssp EEEECCTTCBHHHHHHCTTC----CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT---------CCEEEC
T ss_pred EEEEEeecCchhhhhccccc----cchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCC---------CCEEEe
Confidence 8888754 678777765432 22344556777899999999999999999999999999876 579999
Q ss_pred eccCccccCCCCCcc--cccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHH
Q psy14267 417 DFGIACSLQDDKTSV--HKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAK 494 (553)
Q Consensus 417 DFGla~~~~~~~~~~--~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~ 494 (553)
|||+++......... ......||+.|+|||.+... .++.++||||||++||||++|..||....+....
T Consensus 173 DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~ 243 (311)
T d1r0pa_ 173 DFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ---------KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI 243 (311)
T ss_dssp SSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHC---------CCCHHHHHHHHHHHHHHHHTTSCCSCC------C
T ss_pred cccchhhccccccccceecccccccccccChHHHhcC---------CCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHH
Confidence 999998876543321 22245689999999999765 4789999999999999999988887664443333
Q ss_pred HHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q psy14267 495 MLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQINNN 549 (553)
Q Consensus 495 ~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L~~~ 549 (553)
...+.... .. .....+++.+.+||.+||+.||++||++.||+++|+++
T Consensus 244 ~~~i~~g~-~~------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i 291 (311)
T d1r0pa_ 244 TVYLLQGR-RL------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291 (311)
T ss_dssp HHHHHTTC-CC------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHcCC-CC------CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 33333322 11 12236789999999999999999999999999999875
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=363.60 Aligned_cols=261 Identities=25% Similarity=0.354 Sum_probs=200.1
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++|+++++||+|+||+||+|++..++.. ||||++++... ......++.+|+.+|++++ ||||+++++++.+ ...
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~--vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~--~~~ 75 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEI--VALKRVRLDDD-DEGVPSSALREICLLKELK-HKNIVRLHDVLHS--DKK 75 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCE--EEEEEEESSCS-STTHHHHHHHHHHHHTTCC-CTTBCCEEEEEEC--SSE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcE--EEEEEEehhhC-ChHHHHHHHHHHHHHHhcC-cCCEEeecccccc--ccc
Confidence 4799999999999999999998877755 99999987654 3456688999999999995 5999999987744 557
Q ss_pred EEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCCeEEE
Q psy14267 336 LYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGNVLKI 415 (553)
Q Consensus 336 ~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL 415 (553)
++++|+++.+.....+....+ ......+..++.|++.||+|||++|||||||||+||||+.+ +.+||
T Consensus 76 ~~iv~~~~~~~~l~~~~~~~~----~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~---------~~~kl 142 (292)
T d1unla_ 76 LTLVFEFCDQDLKKYFDSCNG----DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRN---------GELKL 142 (292)
T ss_dssp EEEEEECCSEEHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---------CCEEE
T ss_pred eeEEeeecccccccccccccc----ccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccC---------Cceee
Confidence 788888766554444443332 23355667778899999999999999999999999999776 57999
Q ss_pred EeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCchHHHH
Q psy14267 416 IDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNTWAKM 495 (553)
Q Consensus 416 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~~~~~ 495 (553)
+|||.|+........ .....+++.|+|||++.... .++.++|||||||++|||++|..||....+....+
T Consensus 143 ~DFG~a~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~--------~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~ 212 (292)
T d1unla_ 143 ANFGLARAFGIPVRC--YSAEVVTLWYRPPDVLFGAK--------LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL 212 (292)
T ss_dssp CCCTTCEECCSCCSC--CCSCCSCGGGCCHHHHTTCS--------CCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHH
T ss_pred eecchhhcccCCCcc--ceeeccccchhhhhHhccCC--------CCCchhhccccchHHHHHhhCCCCCCCCCCHHHHH
Confidence 999999887654432 22456789999999987653 26889999999999999999999986655544444
Q ss_pred HHHHhhccccc---------------------ccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy14267 496 LAIARHKDQIE---------------------FKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 496 ~~i~~~~~~~~---------------------~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~ 545 (553)
..+........ ..........+++++.+||++||+.||++|||++|+++|
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 213 KRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp HHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 44332221110 001111223567899999999999999999999999875
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-45 Score=374.70 Aligned_cols=264 Identities=24% Similarity=0.300 Sum_probs=201.2
Q ss_pred cceEEecCcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeE
Q psy14267 248 QDVITLNGKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDY 327 (553)
Q Consensus 248 ~~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~ 327 (553)
..+|++ .++|+++++||+|+||+||+|++..++.. ||||++.+.... ....+++.+|+++|+++. ||||++++++
T Consensus 11 ~~~~~~-~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~--vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~-h~~iv~~~~~ 85 (348)
T d2gfsa1 11 KTIWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLR--VAVKKLSRPFQS-IIHAKRTYRELRLLKHMK-HENVIGLLDV 85 (348)
T ss_dssp SSEEEE-ETTEEEEEECGGGTTSSEEEEEETTTTEE--EEEEECSCTTSS-HHHHHHHHHHHHHHHHCC-CTTBCCCSEE
T ss_pred CccccC-CCCeEEEEEEecCCCeEEEEEEECCCCCE--EEEEEECchhcC-hHHHHHHHHHHHHHHhcC-CCCeeeEEEE
Confidence 345665 36799999999999999999998877755 999999876533 344578999999999995 5999999987
Q ss_pred EEeC----CCceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCcc
Q psy14267 328 VYDT----ASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVL 403 (553)
Q Consensus 328 ~~~~----~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~ 403 (553)
+... ...+++++|++.+++|.+++... .+....+..++.||+.||+|||++|||||||||+|||++.+
T Consensus 86 ~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~~------~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~-- 157 (348)
T d2gfsa1 86 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED-- 157 (348)
T ss_dssp ECSCSSTTTCCCCEEEEECCSEEHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT--
T ss_pred EeeccccccCceEEEEEeecCCchhhhcccc------cccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccccc--
Confidence 7532 23467888899999999988542 24566777888899999999999999999999999999877
Q ss_pred ceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCC
Q psy14267 404 KIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRT 483 (553)
Q Consensus 404 ~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~ 483 (553)
+.+||+|||+|...... ..+..||+.|+|||++.+.. .++.++|||||||+||+|++|..
T Consensus 158 -------~~~kl~dfg~a~~~~~~-----~~~~~g~~~y~apE~~~~~~--------~~~~~~DiwSlGv~l~~ll~g~~ 217 (348)
T d2gfsa1 158 -------CELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWM--------HYNQTVDIWSVGCIMAELLTGRT 217 (348)
T ss_dssp -------CCEEECCC----CCTGG-----GSSSCHHHHTSCHHHHTTCS--------CCCTTHHHHHHHHHHHHHHHSSC
T ss_pred -------ccccccccchhcccCcc-----cccccccccccCchhhcCCc--------cCCcccchhhhhHHHHHHHhCCC
Confidence 67999999999765432 23667999999999987653 36789999999999999999999
Q ss_pred CCCCCCchHHHHHHHHhhccccc-----------------------ccccccCCCCCCHHHHHHHHHhcccCCCCCCCHH
Q psy14267 484 PYSHIPNTWAKMLAIARHKDQIE-----------------------FKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVG 540 (553)
Q Consensus 484 Pf~~~~~~~~~~~~i~~~~~~~~-----------------------~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ 540 (553)
||.+.... .....+........ ..........+++++++||++||..||++|||+.
T Consensus 218 pF~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~ 296 (348)
T d2gfsa1 218 LFPGTDHI-DQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 296 (348)
T ss_dssp SCCCSSHH-HHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred CCCCCCHH-HHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHH
Confidence 99875443 22222211111100 0000011235789999999999999999999999
Q ss_pred HHHHH
Q psy14267 541 NSVTQ 545 (553)
Q Consensus 541 ell~~ 545 (553)
|+++|
T Consensus 297 elL~H 301 (348)
T d2gfsa1 297 QALAH 301 (348)
T ss_dssp HHHTS
T ss_pred HHhcC
Confidence 99985
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-45 Score=374.40 Aligned_cols=260 Identities=23% Similarity=0.366 Sum_probs=199.2
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCC-CccceEEEEEEecCCcC-chhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCC
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSE-HEFKPLALKVVDLSDIT-DQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTA 332 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~-~~~~~vAvK~l~~~~~~-~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~ 332 (553)
.++|++++.||+|+||+||+|++... ...+.||||++++.... +....+.+.+|+++|++++|||||+++++++.+
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~-- 100 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-- 100 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE--
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc--
Confidence 36799999999999999999987543 33456999999765432 222346788999999999999999999887754
Q ss_pred CceEEEEEec-CCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCC
Q psy14267 333 SKHLYVLMEK-GDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGN 411 (553)
Q Consensus 333 ~~~~~iv~e~-~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~ 411 (553)
...++++||+ .+++|..++...... ....+..++.||+.||+|||++|||||||||+||||+.+ +
T Consensus 101 ~~~~~~v~e~~~~~~L~~~i~~~~~~-----~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~---------~ 166 (322)
T d1vzoa_ 101 ETKLHLILDYINGGELFTHLSQRERF-----TEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSN---------G 166 (322)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHSCC-----CHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---------S
T ss_pred CCceeeeeecccccHHHHHHHhcccc-----cHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCC---------C
Confidence 4578888886 557999998876543 245566677899999999999999999999999999877 5
Q ss_pred eEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCch
Q psy14267 412 VLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNT 491 (553)
Q Consensus 412 ~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~ 491 (553)
.+||+|||+|+.+...... ...+..|++.|+|||.+.+... .++.++|||||||+||||++|+.||......
T Consensus 167 ~vkL~DFG~a~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~-------~~~~ksDIWSlG~iLyelltG~~PF~~~~~~ 238 (322)
T d1vzoa_ 167 HVVLTDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDS-------GHDKAVDWWSLGVLMYELLTGASPFTVDGEK 238 (322)
T ss_dssp CEEESCSSEEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC----------CTHHHHHHHHHHHHHHHHSSCTTSCTTSC
T ss_pred CEEEeeccchhhhcccccc-cccccccccccchhHHhhcCCc-------CCCchhhhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 7999999999877544332 2335679999999999975432 3688999999999999999999999764322
Q ss_pred --HHHHHHHHhhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q psy14267 492 --WAKMLAIARHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARP-----TVGNSVTQ 545 (553)
Q Consensus 492 --~~~~~~i~~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RP-----t~~ell~~ 545 (553)
...+..... ... ......+++++++||.+||..||++|| |++|+++|
T Consensus 239 ~~~~~i~~~~~-~~~------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 239 NSQAEISRRIL-KSE------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp CCHHHHHHHHH-HCC------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred HHHHHHHHhcc-cCC------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 122211111 111 112236889999999999999999999 58888864
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-44 Score=373.60 Aligned_cols=258 Identities=23% Similarity=0.308 Sum_probs=189.6
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeC----
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDT---- 331 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~---- 331 (553)
++|+++++||+|+||+||+|+++.++.. ||||++.+.... ....+++.+|+.+|+++ +||||+++++++...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~--vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l-~hpnIv~~~~~f~~~~~~~ 92 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQN-QTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLE 92 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEE--EEEEEEESTTSS-HHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCSTT
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCE--EEEEEEChhhcC-HHHHHHHHHHHHHHHhc-CCCCeeEEEEEEecccccc
Confidence 4699999999999999999998877755 999999876643 45567899999999999 569999999987644
Q ss_pred CCceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCccceecCCCC
Q psy14267 332 ASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNVLKIIDCIGN 411 (553)
Q Consensus 332 ~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~~~~~~~~~~ 411 (553)
...++|++||++.+++...+.. .+....++.+++||+.||+|||++||+||||||+|||++.+ +
T Consensus 93 ~~~~~~iv~Ey~~~~l~~~~~~-------~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~---------~ 156 (355)
T d2b1pa1 93 EFQDVYLVMELMDANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD---------C 156 (355)
T ss_dssp TCCEEEEEEECCSEEHHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT---------C
T ss_pred cCceeEEEEeccchHHHHhhhc-------CCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccc---------c
Confidence 3468999999999988876632 23456677788999999999999999999999999999876 5
Q ss_pred eEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhCCCCCCCCCch
Q psy14267 412 VLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYGRTPYSHIPNT 491 (553)
Q Consensus 412 ~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG~~Pf~~~~~~ 491 (553)
.+||+|||+++....... ....+||+.|+|||++.+. .++.++||||+||++|||++|++||.+....
T Consensus 157 ~~kl~df~~~~~~~~~~~---~~~~~~t~~y~aPE~l~~~---------~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~ 224 (355)
T d2b1pa1 157 TLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGM---------GYKENVDIWSVGCIMGEMVRHKILFPGRDYI 224 (355)
T ss_dssp CEEECCCCC------------------CCTTCCHHHHTTC---------CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ceeeechhhhhccccccc---cccccccccccChhhhcCC---------CCCCCcccccccchHHHHhhCCCCCCCCCHH
Confidence 689999999887655432 2356799999999999875 3788999999999999999999999865433
Q ss_pred HHHHHHHHhhcc---------------------ccc------------ccccccCCCCCCHHHHHHHHHhcccCCCCCCC
Q psy14267 492 WAKMLAIARHKD---------------------QIE------------FKPQLANNVTIPPTLLQSMKLCLQKDPKARPT 538 (553)
Q Consensus 492 ~~~~~~i~~~~~---------------------~~~------------~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt 538 (553)
......+..... ... ...........++++++||++||..||++|||
T Consensus 225 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t 304 (355)
T d2b1pa1 225 DQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 304 (355)
T ss_dssp HHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCC
T ss_pred HHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcC
Confidence 221111111000 000 00000000123567899999999999999999
Q ss_pred HHHHHHH
Q psy14267 539 VGNSVTQ 545 (553)
Q Consensus 539 ~~ell~~ 545 (553)
++||++|
T Consensus 305 a~elL~H 311 (355)
T d2b1pa1 305 VDDALQH 311 (355)
T ss_dssp HHHHHTS
T ss_pred HHHHhcC
Confidence 9999976
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-44 Score=362.91 Aligned_cols=265 Identities=16% Similarity=0.234 Sum_probs=190.3
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHH--HhhcCCCceeEeeeEEEeCCC
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELL--AKLQGCPYVIKMHDYVYDTAS 333 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL--~~l~~hp~Iv~l~~~~~~~~~ 333 (553)
++|.+.+.||+|+||.||+|+.. + +.||||+++... .+.+.+|.+++ .++ +||||+++++++.+...
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~--g--~~vAvK~~~~~~------~~~~~~e~ei~~~~~~-~HpnIv~~~~~~~~~~~ 71 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR--G--EEVAVKIFSSRE------ERSWFREAEIYQTVML-RHENILGFIAADNKDNG 71 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET--T--EEEEEEEECGGG------HHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECS
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC--C--EEEEEEEECccc------hhHHHHHHHHHHHhhC-CCCcCcceEEEEEeCCC
Confidence 47999999999999999999752 3 459999986432 23455555554 455 57999999999887653
Q ss_pred --ceEEEEEecC-CCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhh--------CCcEecCCCCCCEEEecCc
Q psy14267 334 --KHLYVLMEKG-DTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHA--------AGIIHSDLKPANFLFVGNV 402 (553)
Q Consensus 334 --~~~~iv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~--------~gIiHrDLKp~NILl~~~~ 402 (553)
..++++||++ +++|.+++++.. ..+...+.++.|++.||+|||+ +|||||||||+||||+.+
T Consensus 72 ~~~~~~lv~Ey~~~g~L~~~l~~~~------l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~- 144 (303)
T d1vjya_ 72 TWTQLWLVSDYHEHGSLFDYLNRYT------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN- 144 (303)
T ss_dssp SSEEEEEEEECCTTCBHHHHHHHCC------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTT-
T ss_pred cceEEEEEEecccCCCHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCC-
Confidence 3689999986 579999998642 3455666777899999999996 699999999999999877
Q ss_pred cceecCCCCeEEEEeccCccccCCCCCcc--cccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHh
Q psy14267 403 LKIIDCIGNVLKIIDFGIACSLQDDKTSV--HKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIY 480 (553)
Q Consensus 403 ~~~~~~~~~~vkL~DFGla~~~~~~~~~~--~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~ellt 480 (553)
+.+||+|||+++......... ......||+.|||||++.+.... ....++.++|||||||+||||+|
T Consensus 145 --------~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~~~~~k~Di~S~Gvvl~el~t 213 (303)
T d1vjya_ 145 --------GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM---KHFESFKRADIYAMGLVFWEIAR 213 (303)
T ss_dssp --------SCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCT---TCHHHHHHHHHHHHHHHHHHHHH
T ss_pred --------CCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccc---cCCCcCcchhhhhhHHHHHHHhh
Confidence 579999999998876544322 23356799999999998764321 12236789999999999999999
Q ss_pred CCCCCCCCC-------------chHHHHHHHH-hhcccccccccccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q psy14267 481 GRTPYSHIP-------------NTWAKMLAIA-RHKDQIEFKPQLANNVTIPPTLLQSMKLCLQKDPKARPTVGNSVTQI 546 (553)
Q Consensus 481 G~~Pf~~~~-------------~~~~~~~~i~-~~~~~~~~~~~~~~~~~~s~~l~~li~~cL~~dP~~RPt~~ell~~L 546 (553)
|..||.... .....+.... .......+... ......+..+.+||.+||+.||++|||+.||+++|
T Consensus 214 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~-~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L 292 (303)
T d1vjya_ 214 RCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNR-WQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292 (303)
T ss_dssp TBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGG-GGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHH
T ss_pred CCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCcc-cCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHH
Confidence 998874311 1111111111 11111111111 11112335699999999999999999999999999
Q ss_pred hcCC
Q psy14267 547 NNNP 550 (553)
Q Consensus 547 ~~~~ 550 (553)
+++.
T Consensus 293 ~~i~ 296 (303)
T d1vjya_ 293 SQLS 296 (303)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 8753
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.3e-40 Score=342.70 Aligned_cols=265 Identities=21% Similarity=0.305 Sum_probs=186.5
Q ss_pred CcceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcC----------CCceeEe
Q psy14267 255 GKQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG----------CPYVIKM 324 (553)
Q Consensus 255 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~----------hp~Iv~l 324 (553)
..+|+++++||+|+||+||+|+++.++.. ||||+++++. ...+.+.+|+++|+.+.| |+||+++
T Consensus 12 ~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~--vAvKvi~~~~----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~ 85 (362)
T d1q8ya_ 12 DARYILVRKLGWGHFSTVWLAKDMVNNTH--VAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 85 (362)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEE--EEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred CCcEEEEEEEeeCCCeEEEEEEECCCCCE--EEEEEEeccc----cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEE
Confidence 35699999999999999999998877755 9999997653 334677899999998864 5899999
Q ss_pred eeEEEeCCCceEEEEEec--CCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhh-CCcEecCCCCCCEEEecC
Q psy14267 325 HDYVYDTASKHLYVLMEK--GDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHA-AGIIHSDLKPANFLFVGN 401 (553)
Q Consensus 325 ~~~~~~~~~~~~~iv~e~--~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~-~gIiHrDLKp~NILl~~~ 401 (553)
++++........+++|.+ .+++......... .. ...+..+..++.||+.||+|||+ .||+||||||+||||+.+
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~--~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~ 162 (362)
T d1q8ya_ 86 LDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE-HR--GIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV 162 (362)
T ss_dssp CEEEEEEETTEEEEEEEECCCCEEHHHHHHHTT-TS--CCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEE
T ss_pred EEEeeeccccceeeeeeeccccccccccccccc-cc--CCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeecc
Confidence 988766555555555543 3444444433322 22 33445667777899999999997 899999999999999765
Q ss_pred ccceecCCCCeEEEEeccCccccCCCCCcccccCCccCCCccCcccccccCCCCCCCccCCCccchHHHHHHHHHHHHhC
Q psy14267 402 VLKIIDCIGNVLKIIDFGIACSLQDDKTSVHKDTASGTLNYMSPEAAGQTSSSGGGNTYRITYKSDVWSLGCILYNMIYG 481 (553)
Q Consensus 402 ~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~~~~~s~~sDIwSlGvvl~elltG 481 (553)
... .....+||+|||.|....... ...+||+.|+|||++.+. .++.++|||||||+++||++|
T Consensus 163 ~~~---~~~~~~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~---------~~~~~~DiwSlG~il~el~~g 225 (362)
T d1q8ya_ 163 DSP---ENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGA---------PWGCGADIWSTACLIFELITG 225 (362)
T ss_dssp ETT---TTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTC---------CCCTHHHHHHHHHHHHHHHHS
T ss_pred Ccc---cccceeeEeeccccccccccc-----ccccccccccChhhcccc---------CCCccccccchHHHHHHHHHC
Confidence 210 111248999999998665433 256799999999999866 378899999999999999999
Q ss_pred CCCCCCCCch-----HHHHHHHHhhcccc------------------cccc----------------cccCCCCCCHHHH
Q psy14267 482 RTPYSHIPNT-----WAKMLAIARHKDQI------------------EFKP----------------QLANNVTIPPTLL 522 (553)
Q Consensus 482 ~~Pf~~~~~~-----~~~~~~i~~~~~~~------------------~~~~----------------~~~~~~~~s~~l~ 522 (553)
+.||...... ...+.......... .... ........+++++
T Consensus 226 ~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (362)
T d1q8ya_ 226 DFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEIS 305 (362)
T ss_dssp SCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHH
T ss_pred CCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHH
Confidence 9999753211 11111111000000 0000 0000112357899
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q psy14267 523 QSMKLCLQKDPKARPTVGNSVTQ 545 (553)
Q Consensus 523 ~li~~cL~~dP~~RPt~~ell~~ 545 (553)
+||.+||..||++|||++|+|+|
T Consensus 306 dll~~mL~~dP~~Rpta~e~L~H 328 (362)
T d1q8ya_ 306 DFLSPMLQLDPRKRADAGGLVNH 328 (362)
T ss_dssp HHHGGGGCSSTTTCBCHHHHHTC
T ss_pred HHHHHHCCCChhHCcCHHHHhcC
Confidence 99999999999999999999986
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=9.8e-23 Score=190.83 Aligned_cols=138 Identities=25% Similarity=0.209 Sum_probs=97.1
Q ss_pred eEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcC---------------chhHHHHHHHHHHHHHhhcCCCcee
Q psy14267 258 YQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDIT---------------DQSIADSYLNEVELLAKLQGCPYVI 322 (553)
Q Consensus 258 y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~---------------~~~~~~~~~~E~~iL~~l~~hp~Iv 322 (553)
+.+.++||+|+||+||+|.+.. + +.||||+++..... .........+|..+|.++.+ ++++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~-g--~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~v~ 77 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEK-F--GECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG-LAVP 77 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETT-T--EEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT-SSSC
T ss_pred chhCCEeeeCcceEEEEEECCC-C--CEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccC-CCcc
Confidence 4688999999999999997643 3 45999987643211 01112345678889999965 7888
Q ss_pred EeeeEEEeCCCceEEEEEecCCCCHHHHHHHcccCCCCchHHHHHHHHHHHHHHHHHHHhhCCcEecCCCCCCEEEecCc
Q psy14267 323 KMHDYVYDTASKHLYVLMEKGDTDLSKYMRNLNKMTTLPNTMIIIIMHWYEMLLAVKEIHAAGIIHSDLKPANFLFVGNV 402 (553)
Q Consensus 323 ~l~~~~~~~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~~~~qil~aL~yLH~~gIiHrDLKp~NILl~~~~ 402 (553)
..+++. . .+++|++.++.... .... .....++.|++.||+|||++||+||||||+|||++++
T Consensus 78 ~~~~~~--~----~~lvme~~~~~~~~------~l~~-----~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~- 139 (191)
T d1zara2 78 KVYAWE--G----NAVLMELIDAKELY------RVRV-----ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE- 139 (191)
T ss_dssp CEEEEE--T----TEEEEECCCCEEGG------GCCC-----SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-
T ss_pred eEEEec--C----CEEEEEeecccccc------chhh-----HHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-
Confidence 775432 1 26889987764221 1111 1123455799999999999999999999999999765
Q ss_pred cceecCCCCeEEEEeccCccccCC
Q psy14267 403 LKIIDCIGNVLKIIDFGIACSLQD 426 (553)
Q Consensus 403 ~~~~~~~~~~vkL~DFGla~~~~~ 426 (553)
.++|+|||+|.....
T Consensus 140 ---------~~~liDFG~a~~~~~ 154 (191)
T d1zara2 140 ---------GIWIIDFPQSVEVGE 154 (191)
T ss_dssp ---------EEEECCCTTCEETTS
T ss_pred ---------CEEEEECCCcccCCC
Confidence 389999999977643
|
| >d1faqa_ g.49.1.1 (A:) RAF-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Cysteine-rich domain superfamily: Cysteine-rich domain family: Protein kinase cysteine-rich domain (cys2, phorbol-binding domain) domain: RAF-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.21 E-value=1.2e-07 Score=67.57 Aligned_cols=35 Identities=23% Similarity=0.334 Sum_probs=31.7
Q ss_pred hhhHhhhhhhccccccccccccccCCCCCCCC--CCCc
Q psy14267 105 AQSVEKIVLNNINYRVDQCKKNLNYDPSIKTP--CKDA 140 (553)
Q Consensus 105 ~~~~~~~~~~~~g~rC~~Cg~kfh~~C~~~vp--c~d~ 140 (553)
-|++|.-+|| |||||..|++++|++|..+|| |+|+
T Consensus 16 ~C~~C~~~i~-~g~~C~~C~~~~H~~C~~~v~~~C~~~ 52 (52)
T d1faqa_ 16 FCDICQKFLL-NGFRCQTCGYKFHEHCSTKVPTMCVDW 52 (52)
T ss_dssp ECTTSSSEEC-SEEECTTTTCCBCSTTSSSSSSCCCCC
T ss_pred CCccCCCccc-cCCCcCCCCChhhhhhhccccccccCC
Confidence 4788888888 999999999999999999999 9874
|
| >d1kbea_ g.49.1.1 (A:) Kinase suppressor of Ras, Ksr {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Cysteine-rich domain superfamily: Cysteine-rich domain family: Protein kinase cysteine-rich domain (cys2, phorbol-binding domain) domain: Kinase suppressor of Ras, Ksr species: Mouse (Mus musculus) [TaxId: 10090]
Probab=98.09 E-value=2.1e-07 Score=65.06 Aligned_cols=33 Identities=12% Similarity=0.327 Sum_probs=30.4
Q ss_pred hhhhHhhhhhhccccccccccccccCCCCCCCC-C
Q psy14267 104 HAQSVEKIVLNNINYRVDQCKKNLNYDPSIKTP-C 137 (553)
Q Consensus 104 ~~~~~~~~~~~~~g~rC~~Cg~kfh~~C~~~vp-c 137 (553)
..|++|.-+|| |||+|++|++++|++|..+|| |
T Consensus 15 ~tC~~C~~~l~-qg~~C~~C~~~~Hk~C~~~~P~C 48 (49)
T d1kbea_ 15 QVCNVCQKSMI-FGVKCKHCRLKCHNKCTKEAPAC 48 (49)
T ss_dssp CCCSSSCCSSC-CEEEETTTTEEESSSCTTTSCCC
T ss_pred CCchhhchhhh-CcCCcCCCCChHhHhhcccCCCC
Confidence 34999999998 999999999999999999999 5
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.76 E-value=8.1e-05 Score=70.07 Aligned_cols=81 Identities=21% Similarity=0.219 Sum_probs=51.0
Q ss_pred cceEEEeeeeeeCceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 256 KQYQVLSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 256 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
..|++++..+-++.+.||++.. .+ +.+.||+........ ...+.+|..++..|..+--+.+++.+. .....
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~--~~--~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~--~~~~~ 84 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVG--EN--ENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFE--RHDGW 84 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEEC--SS--CEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEE--EETTE
T ss_pred hceEEEEcCCCCCCCcEEEEEe--CC--CeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEE--ecCCc
Confidence 3677777766666789998742 22 237888875443222 234678999988886543455665544 33456
Q ss_pred EEEEEecCCC
Q psy14267 336 LYVLMEKGDT 345 (553)
Q Consensus 336 ~~iv~e~~~~ 345 (553)
.+++|++..|
T Consensus 85 ~~lv~~~l~G 94 (263)
T d1j7la_ 85 SNLLMSEADG 94 (263)
T ss_dssp EEEEEECCSS
T ss_pred eEEEEEeccc
Confidence 7888887654
|
| >d1xa6a3 g.49.1.1 (A:209-270) Beta-chimaerin, middle domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Cysteine-rich domain superfamily: Cysteine-rich domain family: Protein kinase cysteine-rich domain (cys2, phorbol-binding domain) domain: Beta-chimaerin, middle domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.55 E-value=6e-06 Score=60.72 Aligned_cols=35 Identities=17% Similarity=0.200 Sum_probs=31.6
Q ss_pred hhhHhhhhhh---ccccccccccccccCCCCCCCC--CCC
Q psy14267 105 AQSVEKIVLN---NINYRVDQCKKNLNYDPSIKTP--CKD 139 (553)
Q Consensus 105 ~~~~~~~~~~---~~g~rC~~Cg~kfh~~C~~~vp--c~d 139 (553)
-|++|.-+|| +|||+|..|++++|++|..+|| |..
T Consensus 17 ~C~~C~~~i~g~~~~g~~C~~C~~~~H~~C~~~v~~~C~~ 56 (62)
T d1xa6a3 17 WCEYCANFMWGLIAQGVRCSDCGLNVHKQCSKHVPNDCQP 56 (62)
T ss_dssp BCTTTCCBCCTTTTCEECCSSSCCCBCTGGGTTSCSCCCT
T ss_pred CCcccCccccccccCeEEcCCCCchhhHHHHhhCCCcCCC
Confidence 5999988886 7999999999999999999999 764
|
| >d1tbna_ g.49.1.1 (A:) Protein kinase c-gamma {Rat (Rattus rattus) [TaxId: 10117]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Cysteine-rich domain superfamily: Cysteine-rich domain family: Protein kinase cysteine-rich domain (cys2, phorbol-binding domain) domain: Protein kinase c-gamma species: Rat (Rattus rattus) [TaxId: 10117]
Probab=97.17 E-value=3.3e-05 Score=57.34 Aligned_cols=33 Identities=15% Similarity=0.229 Sum_probs=29.0
Q ss_pred hhHhhhhhh---ccccccccccccccCCCCCCCC--CC
Q psy14267 106 QSVEKIVLN---NINYRVDQCKKNLNYDPSIKTP--CK 138 (553)
Q Consensus 106 ~~~~~~~~~---~~g~rC~~Cg~kfh~~C~~~vp--c~ 138 (553)
|++|.-+|| +|||+|..|++.+|..|..+|| |.
T Consensus 22 C~~C~~~i~g~~~~g~~C~~C~~~~H~~C~~~v~~~C~ 59 (66)
T d1tbna_ 22 CDHCGSLLYGLVHQGMKCSCCEMNVHRRCVRSVPSLCG 59 (66)
T ss_dssp CSSSCCBCCTTSSSCEEETTTCCEECTTTTTTSCCCSS
T ss_pred CcCCCCcccCcccCccccCcccCeEChHHhccccccCC
Confidence 888876665 6999999999999999999999 64
|
| >d1ptqa_ g.49.1.1 (A:) Protein kinase C-delta (PKCdelta) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Cysteine-rich domain superfamily: Cysteine-rich domain family: Protein kinase cysteine-rich domain (cys2, phorbol-binding domain) domain: Protein kinase C-delta (PKCdelta) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=97.05 E-value=2e-05 Score=55.15 Aligned_cols=32 Identities=13% Similarity=0.078 Sum_probs=28.4
Q ss_pred hhhHhhhhhh---ccccccccccccccCCCCCCCC
Q psy14267 105 AQSVEKIVLN---NINYRVDQCKKNLNYDPSIKTP 136 (553)
Q Consensus 105 ~~~~~~~~~~---~~g~rC~~Cg~kfh~~C~~~vp 136 (553)
-|++|.-+|| +|||+|..|+|+.|.+|..+||
T Consensus 13 ~C~~C~~~i~g~~~qg~~C~~C~~~~H~~C~~~v~ 47 (50)
T d1ptqa_ 13 FCDHCGSLLWGLVKQGLKCEDCGMNVHHKCREKVA 47 (50)
T ss_dssp BCTTTCCBCCSSSSCEEEETTTCCEECHHHHTTSC
T ss_pred CCcccCCcccCcccCcEECCCCCCeeChhHccccc
Confidence 4888887775 5999999999999999999988
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.04 E-value=0.0027 Score=58.80 Aligned_cols=72 Identities=15% Similarity=0.128 Sum_probs=42.3
Q ss_pred eeeeeC-ceEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCc-eeEeeeEEEeCCCceEEEEE
Q psy14267 263 LLGKGG-SSSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPY-VIKMHDYVYDTASKHLYVLM 340 (553)
Q Consensus 263 ~LG~G~-fG~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~-Iv~l~~~~~~~~~~~~~iv~ 340 (553)
.+..|. -+.||++..... ..+.+|.-..... ..+..|+.+|+.|..+.- +.+++.+. .+....+++|
T Consensus 17 ~~~~G~s~~~v~r~~~~~~---~~~vlK~~~~~~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~--~~~~~~~~v~ 85 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGR---PVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVV--TEAGRDWLLL 85 (255)
T ss_dssp ECSCTTSSCEEEEEECTTS---CCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEE--ECSSCEEEEE
T ss_pred EcCCcccCCeEEEEEeCCC---CEEEEEeCCccCH------hHHHHHHHHHHHHHhcCCCCCceeeec--ccccceEEEE
Confidence 344454 367898754322 3378887654432 235678888887765322 55555443 3445678888
Q ss_pred ecCCC
Q psy14267 341 EKGDT 345 (553)
Q Consensus 341 e~~~~ 345 (553)
++..|
T Consensus 86 ~~i~G 90 (255)
T d1nd4a_ 86 GEVPG 90 (255)
T ss_dssp ECCSS
T ss_pred Eeeec
Confidence 87543
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.71 E-value=0.002 Score=64.49 Aligned_cols=79 Identities=16% Similarity=0.129 Sum_probs=44.9
Q ss_pred EeeeeeeCceEEEEEeeeCCCccceEEEEEEecCC-cCc---hhHHHHHHHHHHHHHhhcCC--CceeEeeeEEEeCCCc
Q psy14267 261 LSLLGKGGSSSVYLVGGTSEHEFKPLALKVVDLSD-ITD---QSIADSYLNEVELLAKLQGC--PYVIKMHDYVYDTASK 334 (553)
Q Consensus 261 ~~~LG~G~fG~Vy~a~~~~~~~~~~vAvK~l~~~~-~~~---~~~~~~~~~E~~iL~~l~~h--p~Iv~l~~~~~~~~~~ 334 (553)
.+.||.|....||++....++ +.|+||.-.... ... .....+...|..+|+.+..+ ..+.+++ +++..
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~--~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~--~~d~~-- 104 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHD--RALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVF--YSDTE-- 104 (392)
T ss_dssp EEECCSSSSEEEEEEEC------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEE--EEETT--
T ss_pred EEEeCCCceEeEEEEEeCCCC--eEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEE--EEcCC--
Confidence 456899999999999765544 348888653211 000 01234566799988877543 2344553 34443
Q ss_pred eEEEEEecCCC
Q psy14267 335 HLYVLMEKGDT 345 (553)
Q Consensus 335 ~~~iv~e~~~~ 345 (553)
..+++||+.++
T Consensus 105 ~~~lvmE~L~~ 115 (392)
T d2pula1 105 MAVTVMEDLSH 115 (392)
T ss_dssp TTEEEECCCTT
T ss_pred CCEEEEeccCC
Confidence 33678887543
|
| >d1r79a_ g.49.1.1 (A:) Diacylglycerol kinase delta {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Cysteine-rich domain superfamily: Cysteine-rich domain family: Protein kinase cysteine-rich domain (cys2, phorbol-binding domain) domain: Diacylglycerol kinase delta species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.38 E-value=7.1e-05 Score=58.25 Aligned_cols=34 Identities=15% Similarity=0.119 Sum_probs=29.8
Q ss_pred hhhHhhhhhh----ccccccccccccccCCCCCCCC--CC
Q psy14267 105 AQSVEKIVLN----NINYRVDQCKKNLNYDPSIKTP--CK 138 (553)
Q Consensus 105 ~~~~~~~~~~----~~g~rC~~Cg~kfh~~C~~~vp--c~ 138 (553)
-|+||+-+|| +|||||..|++++|++|..+|| |.
T Consensus 40 ~C~~C~~~i~~~~~~qg~~C~~C~~~~H~~C~~~v~~~C~ 79 (84)
T d1r79a_ 40 KCTVCDKTCGSVLRLQDWRCLWCKAMVHTSCKESLLTKCS 79 (84)
T ss_dssp BCSSSCCBCCCTTTCCCEEESSSCCEECHHHHHHCCSCBC
T ss_pred CCcccCcccCCccccCcEecCcCCchhhhhhcCCCCCcCc
Confidence 4899987774 6899999999999999999988 65
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.14 E-value=0.0076 Score=58.36 Aligned_cols=41 Identities=22% Similarity=0.257 Sum_probs=27.6
Q ss_pred eEEEEEeeeCCCccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcC
Q psy14267 270 SSVYLVGGTSEHEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQG 317 (553)
Q Consensus 270 G~Vy~a~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~ 317 (553)
-.||+++..+ ...|++|+....... .+++..|...|..|..
T Consensus 36 N~vy~v~~~d---g~~~VlK~~rp~~~s----~~~i~~E~~~l~~L~~ 76 (325)
T d1zyla1 36 NRVYQFQDED---RRRFVVKFYRPERWT----ADQILEEHQFALQLVN 76 (325)
T ss_dssp SEEEEECCTT---CCCEEEEEECTTTSC----HHHHHHHHHHHHHHHH
T ss_pred ceeEEEEcCC---CCEEEEEEeCCCCCC----HHHHHHHHHHHHHHHh
Confidence 5899885533 244899998655332 2556778888888754
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.46 E-value=0.04 Score=52.45 Aligned_cols=30 Identities=47% Similarity=0.894 Sum_probs=25.4
Q ss_pred CCcEecCCCCCCEEEecCccceecCCCCeEEEEeccCcc
Q psy14267 384 AGIIHSDLKPANFLFVGNVLKIIDCIGNVLKIIDFGIAC 422 (553)
Q Consensus 384 ~gIiHrDLKp~NILl~~~~~~~~~~~~~~vkL~DFGla~ 422 (553)
.|+||+|+.++||+++.+ ...-|+||+.|.
T Consensus 183 ~giIHgDl~~dNvl~~~~---------~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGD---------ELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETT---------EEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccc---------cceeEecccccc
Confidence 479999999999999876 345799999873
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=94.08 E-value=0.1 Score=51.33 Aligned_cols=73 Identities=16% Similarity=0.076 Sum_probs=45.0
Q ss_pred EeeeeeeCceEEEEEeeeCC-----CccceEEEEEEecCCcCchhHHHHHHHHHHHHHhhcCCCceeEeeeEEEeCCCce
Q psy14267 261 LSLLGKGGSSSVYLVGGTSE-----HEFKPLALKVVDLSDITDQSIADSYLNEVELLAKLQGCPYVIKMHDYVYDTASKH 335 (553)
Q Consensus 261 ~~~LG~G~fG~Vy~a~~~~~-----~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~iL~~l~~hp~Iv~l~~~~~~~~~~~ 335 (553)
++.|+.|-.-.+|++..... ...+.|.+++..... .. ....+|..+++.+..+....++++++ . +
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~----~~-idr~~E~~i~~~ls~~gl~Pkll~~~--~-~-- 116 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE----TE-SHLVAESVIFTLLSERHLGPKLYGIF--S-G-- 116 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC----CH-HHHHHHHHHHHHHHHTTSSSCEEEEE--T-T--
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc----hh-hHHHHHHHHHHHHHhCCCCCeEEEEc--C-C--
Confidence 46789999999999876432 122347777664221 12 23458999999887665555665543 2 2
Q ss_pred EEEEEecCC
Q psy14267 336 LYVLMEKGD 344 (553)
Q Consensus 336 ~~iv~e~~~ 344 (553)
.++|++..
T Consensus 117 -g~I~efi~ 124 (395)
T d1nw1a_ 117 -GRLEEYIP 124 (395)
T ss_dssp -EEEECCCC
T ss_pred -ceEEEEec
Confidence 45566543
|
| >d1vd4a_ g.41.3.1 (A:) Transcription initiation factor TFIIE-alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Rubredoxin-like superfamily: Zinc beta-ribbon family: Transcriptional factor domain domain: Transcription initiation factor TFIIE-alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=83.77 E-value=0.1 Score=36.95 Aligned_cols=12 Identities=17% Similarity=0.559 Sum_probs=10.9
Q ss_pred hhcccccccccc
Q psy14267 113 LNNINYRVDQCK 124 (553)
Q Consensus 113 ~~~~g~rC~~Cg 124 (553)
.++++|+||.|+
T Consensus 10 ~~~~~y~Cp~C~ 21 (62)
T d1vd4a_ 10 TNRASFKCPVCS 21 (62)
T ss_dssp CSSSEEECSSSC
T ss_pred ccCCceECCCCC
Confidence 578999999999
|
| >d1v6ga1 g.39.1.3 (A:1-41) Actin-binding LIM protein 2, abLIM2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Actin-binding LIM protein 2, abLIM2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.78 E-value=0.18 Score=32.32 Aligned_cols=17 Identities=24% Similarity=0.209 Sum_probs=14.7
Q ss_pred cccccccccc------------ccccCCC
Q psy14267 115 NINYRVDQCK------------KNLNYDP 131 (553)
Q Consensus 115 ~~g~rC~~Cg------------~kfh~~C 131 (553)
+-|-||..|+ .+|||.|
T Consensus 13 ~fG~~C~~C~~~ItG~V~~Ag~~~yHP~C 41 (41)
T d1v6ga1 13 LYGTRCFSCDQFIEGEVVSALGKTYHPDC 41 (41)
T ss_dssp SCCCBCTTTCCBCCSCCEEETTEEECTTT
T ss_pred HhCcccccccCEeeeeeeEecCcccCCCC
Confidence 4488999998 8999998
|
| >d1a1ia3 g.37.1.1 (A:160-187) ZIF268 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: beta-beta-alpha zinc fingers superfamily: beta-beta-alpha zinc fingers family: Classic zinc finger, C2H2 domain: ZIF268 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=80.25 E-value=0.18 Score=28.99 Aligned_cols=12 Identities=17% Similarity=0.612 Sum_probs=10.1
Q ss_pred cccccccccccc
Q psy14267 117 NYRVDQCKKNLN 128 (553)
Q Consensus 117 g~rC~~Cg~kfh 128 (553)
-|.|+.||.||-
T Consensus 3 Pf~C~~CgrkFA 14 (28)
T d1a1ia3 3 PFACDICGRKFA 14 (28)
T ss_dssp CEECTTTCCEES
T ss_pred Ccccchhhhhhh
Confidence 488999998884
|